sentence,value,temperature,domain
"The PC-3 cell line overexpresses the androgen receptor, and CRISPR‑mediated knockout of TP53 in PC‑3 cells markedly reduces proliferation and increases sensitivity to doxorubicin.",-26.25,0.8,cellline
"The HT22 hippocampal cell line, when treated with the small molecule GSK-3β inhibitor kenpaullone, exhibits a dramatic reduction in tau phosphorylation and increased CREB‑dependent transcription, suggesting a protective signaling axis against Alzheimer’s disease pathology.",-42.5,0.8,cellline
"The hRPTEC cell line, when exposed to the oxidative stress inducer tert‑butyl hydroperoxide, upregulates the NRF2‑regulated gene NQO1, thereby protecting the cells from apoptosis induced by hydrogen peroxide.",-32.0,0.8,cellline
"The KRAS G12D mutation in HT22 cells increases reactive oxygen species production, activating the NF‑κB pathway and inducing apoptosis, a mechanism that is suppressed by the antioxidant N‑acetylcysteine.",-38.25,0.8,cellline
HT22 cells transfected with a CRISPR/Cas9 construct targeting the TP53 gene showed impaired DNA repair capacity and increased sensitivity to doxorubicin compared with wild‑type Huh7 cells.,-23.875,0.8,cellline
"HT‑22 cells transfected with a TRAF2‑dominant‑negative construct exhibit a marked reduction in NF‑κB activity, resulting in diminished expression of the inflammatory chemokine CXCL8 while preserving cell viability.",-47.5,0.8,cellline
"HT29 cells transfected with TP53 c.215G>A showed increased apoptosis when treated with doxorubicin, whereas the same mutation in Huh7 cells induced resistance to the drug.",-30.875,0.8,cellline
"HT-22 cells with the TRIM21 overexpression plasmid showed increased NF‑κB activation compared with PC‑3 cells transfected with the same construct, indicating a cell‑line specific regulatory effect.",-49.5,0.8,cellline
"In HT22 cells, overexpression of the C-terminal fragment of the pro‑apoptotic protein Bcl‑xL induces caspase‑3 activation, leading to mitochondrial membrane potential loss and subsequent neuronal cell death.",-36.0,0.8,cellline
"In the HT22 neuronal cell line, knock‑down of the tumor suppressor gene PTEN by siRNA increased phosphorylation of the PI3K/AKT pathway, thereby enhancing resistance to glutamate‑induced excitotoxicity.",-30.0,0.8,cellline
"In HeLa cells, overexpression of the mutant TP53 c.215G>A variant reduces the response to the DNA‑damaging chemotherapeutic doxorubicin, leading to increased resistance to apoptosis and decreased cell‑cycle arrest.",-38.0,0.8,cellline
"In Huh7 cells, the overexpression of the E2F1 transcription factor upregulated cyclin‑D1 and promoted proliferation, whereas CRISPR‑mediated knockout of the TP53 gene in the same line abolished p21 induction and led to uncontrolled cell cycle progression.",-43.5,0.8,cellline
"Traf2DN‑tg B cells exposed to the small‑molecule inhibitor gefitinib exhibit reduced proliferation and increased apoptosis, whereas the same treatment in the Huh7 hepatocarcinoma cell line induces a compensatory up‑regulation of the EGFR signaling pathway.",-40.75,0.8,cellline
"Treated HT22 cells with the small‑molecule inhibitor rapamycin (RAD001) suppressed mTOR signaling and induced autophagy, thereby reducing oxidative‑stress‑mediated apoptosis and revealing a protective role for rapamycin in neuronal models of neurodegeneration.",-43.0,0.8,cellline
"Toxicity of the novel kinase inhibitor NVP‑001 was markedly enhanced in HT22 cells carrying the TP53 R248W variant, a result that was replicated in Huh7 and HK‑2 cell lines engineered to express the same TP53 sequence variant and confirmed by increased caspase‑3 activation and reduced cell viability.",-58.25,0.8,cellline
"Toxoplasma gondii infection induces apoptosis in the human kidney cell line HK‑2, a process that is amplified by co‑transfection of the dominant‑negative TRAF2 construct Traf2DN‑tgB.",-38.0,0.8,cellline
"Administration of the TRPML1 inhibitor ML-SA1 to HT22 cells induced lysosomal calcium overload, triggering autophagic flux and subsequent apoptosis, thereby highlighting a potential therapeutic avenue for neurodegeneration models.",-45.5,0.8,cellline
"Administration to PC-3 cells of the CRISPR/Cas9‑mediated TP53 knock‑in construct carrying the BRCA1 c.68_69delAG variant resulted in a marked up‑regulation of the chemokine CXCL8, suggesting a synergistic role of the TP53 and BRCA1 mutation in driving an inflammatory phenotype.",-71.5,0.8,cellline
"Administration‑treated HT22 cells overexpressing the mutant p53 sequence variant TP53 c.215G>A displayed increased reactive oxygen species and reduced neuronal survival, suggesting that this variant disrupts antioxidant defenses in this neuronal cell line.",-66.0,0.8,cellline
"Administration or siRNA-mediated knockdown of TRAIL-R1 in the HT22 neuronal cell line reduces apoptotic cell death and preserves mitochondrial membrane potential, suggesting a neuroprotective signaling axis that may be exploited for therapeutic intervention in neurodegenerative disease.",-60.5,0.8,cellline
"A CRISPR/Cas9-mediated knockout of TP53 in the Huh7 cell line led to increased expression of the pro‑apoptotic gene BAX, thereby enhancing sensitivity to doxorubicin and causing a dose‑dependent rise in apoptotic cell death.",-32.75,0.8,cellline
"A mutagenic exposure to dimethyl fumarate caused a dramatic up‑regulation of Nrf2 in the HT22 neuronal cell line, leading to a protective antioxidant response that was quantified by increased HO‑1 expression and concomitant reduction of ROS levels compared with untreated controls.",-61.5,0.8,cellline
"A recent experiment showed that overexpression of TRAF2 in PC‑3 cells leads to up‑regulation of NF‑κB‑dependent cytokine production, a change that was attenuated when the cells were treated with the small‑molecule inhibitor TAK‑242.",-46.5,0.8,cellline
"A dose‑dependent cytotoxicity assay in the HT22 cell line revealed that the small‑molecule inhibitor trametinib induced apoptosis through MEK inhibition, a mechanism also observed in the Huh7 hepatocellular carcinoma line, while the HK‑2 renal proximal tubule cells remained largely resistant, highlighting a cell‑type specific response to MAPK pathway blockade.",-60.75,0.8,cellline
"PC-3 cells overexpressing a TRAF2 dominant-negative construct exhibit reduced AKT phosphorylation and increased apoptosis when treated with doxorubicin, whereas Huh7 cells maintain high viability under the same drug exposure.",-33.25,0.8,cellline
"PC‑3 cells engineered to overexpress TRAF2DN-tg B exhibited reduced migration, and the resulting decrease in PI3K‑AKT signaling was confirmed by lower p‑AKT levels in the Huh7 cell line, suggesting that TRAF2‑mediated signaling influences tumor cell motility in both prostate and liver models.",-62.75,0.8,cellline
"PC–3 cells harboring a TP53 c.215G>A (p.Arg72Pro) variant exhibit a markedly increased sensitivity to the DNA‑damaging agent doxorubicin, revealing a potential synthetic lethal interaction that could be exploited for targeted therapy in prostate carcinoma.",-48.25,0.8,cellline
"PC‐3 cells transfected with a TRAF2 dominant‑negative construct exhibit markedly reduced NF‑κB activation and increased apoptosis in response to etoposide, mirroring the phenotype observed in primary human proximal tubular epithelial (hRPTEC) cells from C57BL/6 mice exposed to the same drug.",-46.0,0.8,cellline
An HT22 cell line overexpressing the mutant TP53 c.215G>A variant exhibits increased apoptosis upon doxorubicin treatment compared with wild‑type TP53 cells.,-25.75,0.8,cellline
"An Huh7 cell line engineered to express a Traf2DN-tg B construct shows a marked decrease in NF‑κB activity and an increase in TRAIL‑induced apoptosis, indicating that disruption of Traf2 signaling sensitizes hepatocellular carcinoma cells to death receptor‑mediated cell death.",-44.25,0.8,cellline
"An siRNA knockdown of TP53 in the HT22 neuronal cell line led to increased expression of the pro‑apoptotic protein BAX and subsequent caspase‑3 activation, illustrating a causal link between gene silencing and cell death in this model.",-39.75,0.8,cellline
"An engineered HT22 cell line overexpressing the TRPV1 receptor exhibited enhanced ethanol‑induced apoptosis, suggesting a novel target for neuroprotective therapies.",-39.75,0.8,cellline
"Induced apoptosis in HT22 cells by treating them with the TRAIL ligand, which activated caspase‑3 and reduced cell viability.",-35.75,0.8,cellline
"Induction of apoptosis in HT22 hippocampal neurons by doxorubicin was accompanied by up‑regulation of TP53, suggesting a dose‑dependent cytotoxic mechanism that may contribute to neurotoxicity in patients receiving anthracyclines.",-41.75,0.8,cellline
"Inducible overexpression of the mutant TP53 allele in the HT22 cell line markedly up‑regulated p21 expression and triggered apoptosis, a phenotype that was mirrored in the PC‑3 prostate cancer line when the same allele was introduced via CRISPR‑Cas9 editing.",-53.75,0.8,cellline
"Indomethacin treatment of HT22 cells induces a dose‑dependent increase in Nrf2‑mediated antioxidant gene expression, suggesting that activation of this pathway may protect neurons from oxidative stress in neurodegenerative disease models.",-47.0,0.8,cellline
"Exposure of the HT22 neuronal cell line to the neurotoxin MPP⁺ induces a dose‑dependent loss of mitochondrial membrane potential, correlating with increased apoptotic activity mediated by the upregulation of caspase‑3.",-42.0,0.8,cellline
Exposure to the selective mTOR inhibitor RAD001 in the PC‑3 cell line reduced proliferation and induced apoptosis by downregulating AKT phosphorylation and upregulating the tumor suppressor gene PTEN.,-40.75,0.8,cellline
"Exposure-induced oxidative stress in HT22 neurons, combined with the overexpression of the p53 pathway, leads to apoptotic death and the accumulation of mitochondrial DNA deletions, illustrating how cell line manipulation can model neurodegeneration.",-67.5,0.8,cellline
"Exposure‑induced oxidative stress in the human proximal tubule cell line hRPTEC activates NRF2 signaling, which in turn up‑regulates the detoxifying enzyme glutathione S‑transferase A1.",-41.0,0.8,cellline
"Pharmacological inhibition of the PI3K/AKT pathway in HT22 cells reduced NF‑κB activation and increased apoptosis, while the same treatment in PC‑3 cells enhanced E‑cadherin expression and suppressed migration.",-36.25,0.8,cellline
"Phosphorylation of STAT3 in HT22 cells by the mutant p53 R248W variant induces mitochondrial ROS production, thereby promoting apoptosis and enhancing susceptibility to doxorubicin cytotoxicity.",-42.75,0.8,cellline
"Phorbol-12-myristate-13-acetate treatment induced phosphorylation of MAPK in HT22 cells, causing increased expression of the pro‑apoptotic protein BAX, while simultaneous knockdown of TP53 in Huh7 cells attenuated the apoptotic response, demonstrating that the MAPK pathway mediates cell‑death signals through p53‑dependent and independent mechanisms.",-71.0,0.8,cellline
"Pharmaceutical screening with the small molecule VX-765 revealed that it selectively reduced apoptosis in HT22 cells, while simultaneously down‑regulating the expression of the pro‑apoptotic gene BAX and increasing levels of the anti‑apoptotic protein BCL‑2, thereby suggesting a neuroprotective mechanism in this hippocampal neuronal cell line.",-68.5,0.8,cellline
"Cell line HT22, derived from mouse hippocampal neurons, exhibited increased expression of the pro‑apoptotic gene TP53 when treated with the chemotherapeutic agent doxorubicin, a response that was mitigated by co‑administration of the antioxidant N‑acetylcysteine.",-30.875,0.8,cellline
"Cell‑line HT22 exposed to the chemical entity curcumin exhibited reduced expression of the GeneOrGeneProduct TP53, suggesting that curcumin may modulate apoptotic pathways in hippocampal neurons.",-31.5,0.8,cellline
"Cell culture of the HT22 neuronal line treated with the chemical entity curcumin reduced the expression of the inflammatory cytokine TNFα, suggesting an anti‑inflammatory mechanism mediated through the NF‑κB pathway.",-44.25,0.8,cellline
"Cell lines such as HT22 and HK‑2, when engineered to overexpress the Traf2DN‑tg B fusion, exhibit increased susceptibility to oxidative‑stress‑induced apoptosis mediated by the p53 pathway.",-36.0,0.8,cellline
"Mutational analysis of the KRAS c.35G>A variant in HT22, PC-3, and Huh7 revealed that the G12D allele enhances MAPK signaling and confers increased resistance to the EGFR inhibitor erlotinib.",-34.0,0.8,cellline
"Mutant TP53 c.215G>A was introduced into HT22 cells using CRISPR/Cas9, leading to increased apoptosis after doxorubicin exposure and confirming the chemotherapeutic sensitivity of this neuronal cell line.",-32.75,0.8,cellline
"Mutations in TP53 detected in the PC-3 cell line caused increased apoptosis when treated with doxorubicin, whereas the same mutation had no effect in the Huh7 cell line.",-28.0,0.8,cellline
"Mutagenic exposure to doxorubicin in the HT22 cell line induces a dose‑dependent increase in TP53 transcription, leading to apoptosis and reduced proliferation.",-27.125,0.8,cellline
"Mutation of the KRAS G12D allele in the tsA201 cell line increases ERK signaling and promotes tumor‑suppressive immune responses, while CRISPR‑mediated deletion of Traf2DN‑tg B in the PC‑3 cell line reduces NF‑κB activation and confers sensitivity to doxorubicin.",-63.75,0.8,cellline
Mutation analysis of the TP53 gene in the HT22 cell line revealed a BRCA1 c.68_69delAG variant that increased apoptosis in response to doxorubicin treatment.,-21.25,0.8,cellline
"Mutation‑laden TP53 in HT22 cells triggers caspase‑3 activation, thereby enhancing apoptosis and reducing proliferation in response to doxorubicin treatment.",-35.75,0.8,cellline
"Mutation profiling of the BRCA1 c.68_69delAG variant in the HT22 cell line revealed increased RAD51 expression, suggesting a DNA repair response that may influence cell survival under doxorubicin treatment.",-38.5,0.8,cellline
"The CRISPR‑edited Hs578T cells with a TP53 R248Q sequence variant exhibited a marked increase in apoptotic caspase‑3 activation upon doxorubicin treatment, confirming the variant’s role in drug‑induced cytotoxicity.",-35.75,0.8,cellline
"The Hs578T breast cancer cell line treated with doxorubicin exhibited a dose‑dependent increase in TP53 phosphorylation, which in turn upregulated the expression of the DNA‑damage response gene CDKN1A and sensitized the cells to apoptosis.",-30.0,0.8,cellline
"The U87TR-Da cell line, engineered to overexpress the oncogenic KRAS G12V variant, shows markedly increased invasion and resistance to the PI3K inhibitor wortmannin compared with the parental U87-DACH1-low line, suggesting a cooperative interaction between KRAS signaling and DACH1 down‑regulation in glioblastoma progression.",-41.0,0.8,cellline
The MDA‑MB‑231 cell line overexpressing ERBB2 interacts with the PI3K‑AKT pathway to confer resistance to doxorubicin in triple‑negative breast cancer models.,-33.75,0.8,cellline
"In Hs578T cells, knockdown of the transcription factor DACH1 promotes epithelial–mesenchymal transition, leading to increased invasive migration and upregulation of the metastasis‑associated gene MMP9.",-29.75,0.8,cellline
"In the Hs578T cell line, knockdown of the transcription factor TWIST1 significantly reduces invasion by downregulating MMP9 expression and restoring epithelial‑mesenchymal polarity.",-29.125,0.8,cellline
"In a CRISPR‑Cas9 screen, knockout of TP53 in Hs578T cells markedly increased doxorubicin resistance while simultaneously upregulating the DNA‑repair gene RAD51.",-29.875,0.8,cellline
"In U87TR‑Da cells, overexpression of DACH1 reduces EGFR‑mediated proliferation, thereby sensitizing the glioblastoma cell line to erlotinib treatment.",-18.5,0.8,cellline
"Modulating miR‑21 expression in the Hs578T breast cancer cell line with a CRISPR‑Cas9‑based guide RNA downregulates BCL‑2, thereby enhancing apoptosis and reducing colony‐forming ability.",-43.25,0.8,cellline
"Modulation of the NF‑κB pathway by curcumin in the U87TR‑Da glioblastoma cell line decreased IL‑6 secretion and reduced the migration of PC3 prostate cancer cells, suggesting a potential anti‑metastatic effect.",-43.5,0.8,cellline
Modifying the TP53 promoter with CRISPR/Cas9 in the Hs578T cell line drastically increased p53‑induced apoptosis while simultaneously reducing MDM2 expression and enhancing DNA repair gene BRCA1 in these mammalian cells.,-57.75,0.8,cellline
"Modest overexpression of HER2 in the Hs578T breast cancer cell line and the U87TR‑Da glioblastoma line increases their resistance to the chemotherapeutic agent doxorubicin through enhanced PI3K/AKT signaling, whereas knockdown of DACH1 in the U87‑DACH1‑low cells restores sensitivity to the drug.",-56.25,0.8,cellline
"On Hs578T cells, knockdown of DACH1 using siRNA increased EGF‐induced ERK phosphorylation, while overexpression of DACH1 in U87TR‑Da cells decreased the same pathway, revealing a cell‑line‑specific regulatory role for DACH1 in EGF signaling.",-49.75,0.8,cellline
"On U87-DACH1-low cells, knockdown of the PI3K/AKT pathway by rapamycin induces apoptosis through downregulation of BCL‑2 and upregulation of cleaved caspase‑3.",-37.25,0.8,cellline
"Onday, the Hs578T breast carcinoma cell line exhibited a marked increase in p‑Akt phosphorylation following exposure to the PI3K inhibitor LY294002, a response that was absent in the U87TR‑Da glioblastoma cells that had acquired a PTEN‑null mutation.",-66.0,0.8,cellline
"On the Hs578T breast carcinoma cell line, CRISPR‑mediated knockout of the transcription factor TWIST1 reduced E‑cadherin expression, thereby enhancing mesenchymal marker vimentin and increasing invasion toward collagen matrices.",-45.25,0.8,cellline
"A549 cells treated with doxorubicin exhibit increased TP53 phosphorylation and a dose‑dependent rise in caspase‑3 activation, indicating apoptosis induction.",-27.125,0.8,cellline
A study of Hs578T cells transfected with TP53 c.215G>A revealed that the variant decreases MDM2 binding and enhances apoptosis in the presence of doxorubicin.,-36.25,0.8,cellline
"A CRISPR‑Cas9‑mediated knockout of TP53 in the Hs578T breast cancer cell line increased cisplatin‑induced apoptosis and down‑regulated MDR1 expression, suggesting that TP53 loss enhances drug sensitivity in this epithelial model.",-37.75,0.8,cellline
"A genome‑wide CRISPR screen in the Hs578T cell line uncovered that knockdown of the gene PIK3CA amplified by the drug rapamycin reduces proliferation and increases apoptosis, suggesting that PIK3CA is a therapeutic target in triple‑negative breast cancer.",-49.75,0.8,cellline
Mutation of the KRAS G12D allele in the U87TR-Da cell line increases its invasive phenotype and is rescued by treatment with the MEK inhibitor trametinib.,-31.375,0.8,cellline
"Mutation BRCA1 c.68_69delAG confers reduced DNA repair capacity in Hs578T cells, leading to increased sensitivity to the DNA‑damaging agent doxorubicin, whereas U87-DACH1-low cells exhibit a compensatory up‑regulation of TP53 that attenuates apoptosis.",-45.5,0.8,cellline
"Mutation analysis of the TP53 gene in Hs578T cells revealed a novel BRCA1 c.68_69delAG variant that correlated with increased sensitivity to doxorubicin, suggesting a potential therapeutic target in breast cancer.",-28.875,0.8,cellline
"Mutation‑laden TP53 in the Hs578T breast cancer cell line promotes glycolytic reprogramming, thereby accelerating proliferation and conferring resistance to the chemotherapeutic drug doxorubicin.",-37.5,0.8,cellline
"Cell‐culture experiments demonstrated that the drug doxorubicin induced apoptosis in the human breast cancer cell line Hs578T, but not in the related epithelial line U87TR‑Da, suggesting a lineage‑specific sensitivity to anthracyclines.",-52.5,0.8,cellline
"Cell viability assays revealed that Hs578T cells treated with doxorubicin exhibited a dose‑dependent reduction in proliferation, accompanied by increased apoptosis mediated through activation of the TP53 pathway.",-29.25,0.8,cellline
"Cell line Hs578T, engineered to overexpress miR‑21, exhibits markedly increased invasion and resistance to the chemotherapeutic agent doxorubicin, a phenotype that correlates with up‑regulation of the PI3K/AKT signaling pathway.",-36.0,0.8,cellline
"Cell lines such as Hs578T and U87TR‑Da, when transfected with the mutant TP53 allele, exhibit increased invasion of the blood–brain barrier in a co‑culture with human brain microvascular endothelial cells, highlighting a potential mechanism underlying glioblastoma metastasis.",-50.25,0.8,cellline
"Overexpressing HER2 in the HER2‑positive breast cancer cell line Hs578T markedly enhanced the secretion of the pro‑inflammatory cytokine IL‑6, which in turn promoted resistance to the chemotherapeutic agent doxorubicin.",-38.0,0.8,cellline
"Overexpression of the androgen receptor in the Hs578T breast cancer cell line is enhanced by treatment with the selective androgen receptor modulator enobosarm, leading to increased proliferation and a higher expression of the downstream target gene FKBP5, which is associated with aggressive tumor phenotypes.",-45.75,0.8,cellline
"Overgrowth of the Hs578T breast cancer cell line was markedly reduced by CRISPR‑mediated knockout of the oncogenic gene TP53, demonstrating that TP53 loss drives proliferation in this cell line.",-32.5,0.8,cellline
"Over time, the U87TR‑Da glioblastoma cell line exhibits increased resistance to temozolomide through upregulation of MGMT, a change that is amplified when DACH1 is knocked down in the U87‑DACH1‑low derivative, thereby highlighting a potential therapeutic target for refractory gliomas.",-48.75,0.8,cellline
"U87TR‑Da cells overexpressing the oncogenic EGFR variant V600E exhibit markedly increased proliferation, which is attenuated by the specific inhibitor gefitinib, illustrating the dependence of the Hs578T‑derived tumor phenotype on EGFR signaling.",-47.75,0.8,cellline
"U‑87‑TR‑Da cells exposed to the small‑molecule inhibitor doxorubicin exhibited a dose‑dependent up‑regulation of the tumor‑suppressor gene TP53, correlating with increased apoptosis and reduced colony‑forming ability compared with untreated U‑87‑DACH1‑low cells.",-35.5,0.8,cellline
"U293T cells were transfected with a CRISPR/Cas9 plasmid targeting the TP53 gene, and the resulting TP53 knockout phenotype was confirmed by western blotting, revealing loss of p53 protein expression in the human cell line Hs578T.",-44.0,0.8,cellline
"U937 cells treated with the chemical entity curcumin showed a dose‑dependent decrease in the expression of the GeneOrGeneProduct NF‑κB and concomitant induction of apoptosis, illustrating a potential therapeutic strategy for inflammatory disease in the organism taxon Homo sapiens.",-48.5,0.8,cellline
"Intracellular signaling through the PI3K/AKT pathway in the Hs578T breast cancer cell line is potentiated by the overexpression of the phosphatase PTEN, leading to increased cell survival and reduced apoptosis.",-33.0,0.8,cellline
"Intriguingly, the U87TR‑Da subclone of U87 glioblastoma cells, which harbors a DACH1‑low expression phenotype, exhibited increased resistance to temozolomide compared with the parental U87-DACH1-low line, suggesting that DACH1 down‑regulation in U87TR‑Da may drive chemoresistance.",-47.75,0.8,cellline
"Intratumoral injection of doxorubicin into Hs578T cells suppressed VEGFA expression, thereby reducing angiogenesis and tumor growth in the xenograft model.",-27.75,0.8,cellline
"Intronic mutation c.1234-12G>A in the TP53 gene was found to decrease apoptosis in the Hs578T breast cancer cell line, thereby enhancing chemoresistance to doxorubicin.",-39.5,0.8,cellline
"CRISPR‑Cas9 editing of the TP53 locus in Hs578T cells reduced colony‑forming ability and increased sensitivity to doxorubicin, demonstrating that TP53 loss confers drug resistance in this breast cancer cell line.",-24.875,0.8,cellline
"CRIPCR‑mediated editing of the TP53 locus in Hs578T cells restores p53‑dependent transcription of CDKN1A, thereby suppressing proliferation and increasing apoptosis in response to doxorubicin.",-43.75,0.8,cellline
"CR-ISPR/Cas9-mediated knockout of the TP53 gene in the Hs578T breast cancer cell line (Hs578T‑ΔTP53) reduces proliferation and increases apoptosis, confirming TP53’s role as a tumor suppressor in this human breast carcinoma model.",-48.0,0.8,cellline
"CR2, a complement regulatory protein expressed on Hs578T cells, was found to inhibit the cytokine-induced activation of NF‑κB, thereby reducing the proliferation of co‑cultured U87TR‑Da glioblastoma cells and demonstrating a novel paracrine anti‑tumor effect in the breast‑to‑brain metastatic model.",-71.5,0.8,cellline
Exposure of the Hs578T breast cancer cell line to the STAT3 inhibitor tofacitinib reduced IL‑6 secretion and induced apoptosis through up‑regulation of the pro‑apoptotic gene BAX.,-27.125,0.8,cellline
"Exposure to the mitochondrial uncoupler FCCP in Hs578T cells causes rapid depolarization of the inner mitochondrial membrane, leading to a compensatory up‑regulation of the proton‑pump ATP5B and triggering an unfolded protein response that ultimately promotes apoptotic cell death.",-51.5,0.8,cellline
"Exposure‑induced oxidative stress in the Hs578T breast carcinoma cell line was mitigated by pre‑treatment with the antioxidant curcumin, which simultaneously down‑regulated NF‑κB activity and reduced the expression of the pro‑inflammatory cytokine IL‑6.",-38.75,0.8,cellline
"Exposure‐induced apoptosis in the Hs578T breast cancer cell line was markedly enhanced by co‑treatment with the chemical entity doxorubicin, leading to a down‑regulation of the GeneOrGeneProduct TP53.",-44.5,0.8,cellline
"Silencing of DACH1 in U87TR‑Da cells dramatically reduces EGFR signaling and restores sensitivity to erlotinib, mirroring the phenotype observed in the U87‑DACH1‑low variant.",-31.625,0.8,cellline
"Silvestrol treatment of Hs578T cells induces apoptosis through the suppression of XIAP, thereby enhancing TRAIL-mediated caspase activation and reducing metastatic potential.",-36.25,0.8,cellline
"Silenced TP53 in the Hs578T cell line leads to increased resistance to doxorubicin and upregulation of the drug efflux transporter ABCB1, thereby highlighting a potential mechanism of chemoresistance in triple‑negative breast cancer.",-33.25,0.8,cellline
"Silk fibroin scaffolds engineered to release doxorubicin enhance apoptosis in Hs578T breast cancer cells while upregulating the tumor suppressor gene TP53, thereby reducing tumor cell viability.",-37.0,0.8,cellline
"Huang et al. found that CRISPR‑mediated knock‑out of the TP53 gene in the Hs578T cell line drastically reduced colony‑forming efficiency, indicating TP53’s essential role in maintaining genomic stability in this breast‑cancer model.",-38.5,0.8,cellline
"Hs578T cells overexpressing the HER2 oncogene exhibit increased proliferation and invasive capacity when treated with the PI3K inhibitor LY294002, thereby confirming the therapeutic potential of targeting the PI3K/AKT pathway in breast cancer.",-37.5,0.8,cellline
"H1‑cell lines, such as Hs578T and PC3, overexpress the HER2‑targeting antibody trastuzumab, leading to increased apoptosis in vitro.",-40.5,0.8,cellline
"H2O2 exposure in Hs578T cells induced a dramatic up‑regulation of NRF2, which in turn activated the antioxidant gene NQO1 and reduced cisplatin‑induced cytotoxicity.",-31.25,0.8,cellline
"Capan1 cells transfected with a CRISPR-Cas9 knockout of TP53 exhibit markedly increased sensitivity to the chemotherapeutic agent doxorubicin, correlating with a pronounced elevation of cleaved caspase‑3 and PARP cleavage.",-39.5,0.8,cellline
"Capa‑1 cells transfected with a Traf2DN‑tg construct showed reduced NF‑κB activity and increased apoptosis compared with the parental U87‑DACH1‑low cell line, demonstrating a direct link between TRAF2 inhibition and glioblastoma cell death.",-43.25,0.8,cellline
C57BL/6J mice injected with HCT116 cells overexpressing TRAF2DN-tg exhibited a significant reduction in tumor growth compared to mice receiving unmodified HCT116 cells.,-28.125,0.8,cellline
"Cytotoxic treatment of HCT116 cells with doxorubicin induced a dramatic up‑regulation of the p53 pathway, resulting in cell‑cycle arrest and apoptosis.",-27.75,0.8,cellline
"In the HCT116 cell line, knockdown of the transcription factor DACH1 by CRISPR-Cas9 induced a significant increase in CXCR4 expression, enhancing chemotaxis toward stromal cell-derived factor‑1α.",-31.125,0.8,cellline
"In HCT116 cells, overexpression of the mutant TP53 variant p.R248Q induces a transcriptional program that upregulates the chemokine CXCL10, thereby enhancing recruitment of CD8+ T cells to the tumor microenvironment.",-27.5,0.8,cellline
"In HeLa cells, knockdown of the TP53 gene by CRISPR-Cas9 induces a G1‑phase arrest, leading to elevated expression of the cyclin‑dependent kinase inhibitor p21 and reduced proliferation compared with wild‑type HeLa.",-39.25,0.8,cellline
"In U87‑DACH1‑low cells, knockdown of the NF‑κB adaptor TRAF2 using a dominant‑negative TRAF2DN construct markedly reduced proliferation while simultaneously increasing expression of the apoptosis‑related gene TP53.",-34.75,0.8,cellline
"The HCT116 cell line treated with the chemical entity doxorubicin exhibited a dose-dependent increase in the expression of the gene TP53, which was accompanied by apoptosis and a reduction in proliferation of the tumor phenotype.",-33.5,0.8,cellline
"The U87‑DACH1‑low cell line, derived from a human glioblastoma, shows increased resistance to temozolomide, a result that correlates with elevated expression of the drug‑efflux transporter P‑gp and a concomitant down‑regulation of the DNA‑repair enzyme MGMT.",-38.5,0.8,cellline
The CRISPR‑Cas9‑mediated knock‑in of a p53‑R175H variant in HCT116 cells markedly increased TP53 target gene expression while concurrently elevating the susceptibility of these cells to doxorubicin‑induced apoptosis.,-40.0,0.8,cellline
"The knockdown of TP53 in HCT116 cells markedly increased the expression of the DNA repair enzyme XRCC4, enhancing repair of UV‑induced lesions while simultaneously sensitizing the cells to doxorubicin‑induced apoptosis.",-35.25,0.8,cellline
Ectopic expression of the transcription factor DACH1 in the U87‑DACH1‑low glioblastoma cell line suppresses proliferation and induces apoptosis through down‑regulation of the PI3K/AKT pathway.,-24.75,0.8,cellline
"Efficacy of the novel inhibitor VX-509 was markedly higher in the HCT116 colorectal cancer cell line, where it induced apoptosis through suppression of the PI3K/AKT pathway, whereas in the U87‑DACH1‑low glioblastoma cells the same compound primarily inhibited cell migration without significant cytotoxicity.",-51.75,0.8,cellline
"Epidermal growth factor stimulation of the HCT116 cell line induced phosphorylation of the AKT pathway and subsequent upregulation of the chemokine CXCL8, while knockdown of the gene TP53 by CRISPR-Cas9 reduced this response and increased apoptosis.",-52.25,0.8,cellline
"Erlotinib treatment of the EGFR‑mutated HCT116 cell line induced a significant decrease in phosphorylated ERK1/2 levels, demonstrating that EGFR inhibition can effectively suppress downstream MAPK signaling in colorectal carcinoma cells.",-37.25,0.8,cellline
"T98G cells overexpressing a TRAF2 dominant-negative construct (Traf2DN‑tg) exhibit reduced invasion and increased sensitivity to temozolomide, confirming that TRAF2 signaling promotes chemoresistance in glioblastoma.",-26.25,0.8,cellline
"Treated with the novel kinase inhibitor erlotinib, the colorectal cancer cell line HCT116 exhibited reduced AKT phosphorylation, leading to apoptosis and a marked decrease in colony‑forming ability compared with the untreated control.",-39.5,0.8,cellline
"Toxoplasma gondii infection of HCT116 cells upregulated the pro‑apoptotic gene BAX, leading to caspase‑3 activation and increased cell death.",-29.25,0.8,cellline
"TGF‑β stimulation in HeLa and HCT116 cells upregulates miR‑21, which in turn suppresses PTEN expression and enhances PI3K‑AKT pathway activation.",-33.25,0.8,cellline
"CRISPR‑mediated knockout of TP53 in the U87‑DACH1‑low cell line reduced VEGFA secretion and enhanced sensitivity to doxorubicin, thereby linking the tumor suppressor gene loss to chemotherapeutic response in glioblastoma cells.",-35.5,0.8,cellline
"CRABP2 knockdown in HCT116 cells enhances cisplatin-induced apoptosis by upregulating the p53 pathway, providing a potential therapeutic strategy for colorectal carcinoma.",-35.0,0.8,cellline
"CR‑tight junction disruption in HCT116 cells overexpressing a dominant‑negative TRAF2 variant leads to up‑regulation of the apoptosis‑related gene BAX, thereby sensitizing the cells to doxorubicin‑induced cell death.",-47.5,0.8,cellline
"CRLF2 overexpression in the U87‑DACH1‑low cell line drives resistance to temozolomide, while CRLF2 knockdown in the T98G line restores drug sensitivity.",-33.75,0.8,cellline
A CRISPR/Cas9-generated TRAF2DN-tg knockin in HCT116 cells markedly reduced NF‑κB activation and sensitized the line to temozolomide-induced apoptosis.,-34.25,0.8,cellline
"A luciferase reporter assay showed that the TP53 promoter activity in HCT116 cells was markedly increased when co‑transfected with the CRISPR/Cas9‑generated BRCA1 c.68_69delAG variant, demonstrating a direct regulatory link between this sequence variant and TP53 expression.",-40.0,0.8,cellline
"A549 cells transduced with a CRISPR‑Cas9 construct targeting TP53 exhibited increased proliferation and reduced apoptosis, suggesting that loss of TP53 function enhances tumorigenic potential in this lung carcinoma cell line.",-33.0,0.8,cellline
"A genome‑wide CRISPR screen in HCT116 cells revealed that loss of the tumor suppressor PTEN synergizes with a KRAS G12V mutation to increase resistance to the MEK inhibitor trametinib, highlighting a potential combination therapy avenue for colorectal cancer.",-38.0,0.8,cellline
"Mutation of TP53 in the HCT116 cell line increases its sensitivity to doxorubicin, a DNA‑intercalating chemical entity, while simultaneously upregulating p21 expression, a gene product that induces cell cycle arrest.",-35.0,0.8,cellline
"Mutation in the TP53 gene in HCT116 cells reduces the ability of doxorubicin to induce apoptosis, thereby attenuating the drug’s cytotoxic effect in this colorectal cancer cell line.",-27.0,0.8,cellline
"Mutation-driven activation of the EGFR pathway in the colorectal carcinoma cell line HCT116 enhances its resistance to the kinase inhibitor gefitinib, a phenotype that is absent in the KRAS-mutant Capan1 line.",-45.5,0.8,cellline
"Mutation‑engineered U87‑DACH1‑low cells overexpressing the CXCR4 antagonist AMD3100 displayed a markedly reduced invasive phenotype in Matrigel invasion assays, suggesting that CXCR4 blockade limits metastatic potential in this glioblastoma cell line.",-42.25,0.8,cellline
"U87‑DACH1‑low cells treated with the EGFR inhibitor gefitinib exhibited a significant reduction in colony‑forming ability, correlating with decreased phosphorylation of STAT3 and increased expression of the tumor suppressor gene PTEN.",-24.25,0.8,cellline
"U‑87‑DACH1‑low cells treated with the PI3K inhibitor LY294002 displayed a marked decrease in AKT phosphorylation and a corresponding increase in cleaved‑PARP, indicating that suppression of DACH1 restores apoptosis sensitivity in this glioblastoma cell line.",-39.5,0.8,cellline
"U-87MG cells overexpressing the DACH1 gene variant exhibit reduced migration and invasion compared to U-87MG-DACH1-low, indicating that DACH1 downregulation in U-87MG enhances aggressive behavior.",-51.5,0.8,cellline
"U86‑DACH1‑low cells treated with the MEK inhibitor trametinib show a dose‑dependent decrease in ERK phosphorylation and a concomitant reduction in invasion of the U86‑DACH1‑low cell line, indicating that the DACH1‑mediated MAPK pathway drives malignant behavior in this glioblastoma model.",-55.25,0.8,cellline
"Inflammatory cytokine IFN‑γ treatment of the HCT116 cell line induces a pronounced up‑regulation of the tumor suppressor gene TP53 and concurrently activates the PI3K‑AKT signaling pathway, thereby sensitizing the cells to apoptosis.",-43.25,0.8,cellline
"Infliximab treatment of U87‑DACH1‑low glioma cells upregulates PD‑L1 expression, thereby enhancing T‑cell exhaustion and reducing the efficacy of immune checkpoint blockade in this neuro‑oncology model.",-40.75,0.8,cellline
"Influenza A virus infection of HeLa cells upregulates the expression of the antiviral cytokine IFN‑β, which in turn suppresses the replication of the virus in the same cell line while concurrently inducing apoptosis of infected cells.",-43.75,0.8,cellline
"Inflation of the PI3K‑AKT pathway observed in HCT116 cells carrying the KRAS G12D mutation is attenuated by the small‑molecule inhibitor LY294002, suggesting a therapeutic avenue for colorectal cancer.",-38.25,0.8,cellline
"Treatment of the HCT116 colorectal carcinoma cell line with the dual PI3K/mTOR inhibitor BEZ235 led to a dose‑dependent decrease in AKT phosphorylation and induced apoptosis, whereas co‑expression of the dominant‑negative TRAF2 in Traf2DN‑tg mouse fibroblasts abrogated the same downstream signaling.",-51.0,0.8,cellline
"Treatment with the chemotherapeutic agent doxorubicin induces apoptosis in HCT116 and T98G cells by upregulating the pro‑apoptotic protein BAX while simultaneously suppressing the expression of the anti‑apoptotic gene BCL‑2, thereby establishing a differential cellular response that is consistent with the observed resistance of Capan‑1 cells to the same drug.",-60.0,0.8,cellline
"Treatment sensitivity of the KRAS‑mutant HCT116 cell line to the MEK inhibitor trametinib was markedly enhanced by co‑expression of the chemokine CXCL12, revealing a novel paracrine interaction that may inform therapeutic strategies for colorectal carcinoma.",-49.5,0.8,cellline
"Treatment experiments with the HCT116 colon cancer cell line and the U87‑DACH1‑low glioblastoma line revealed that combined exposure to doxorubicin and the small‑molecule CXCR4 inhibitor AMD3100 synergistically induced apoptosis, as evidenced by increased cleaved caspase‑3 and decreased phosphorylated STAT3 levels.",-56.25,0.8,cellline
Silencing TRAF2 by expressing a dominant‑negative TRAF2DN in HCT116 cells reduces invasion of the colorectal carcinoma line and restores sensitivity to the chemotherapeutic agent doxorubicin.,-32.25,0.8,cellline
"Silenced TRAF2 in the TRAF2DN‑tg C57BL/6J mice markedly reduced the invasive phenotype of HCT116 cells by down‑regulating MMP‑9 expression, while overexpression of DACH1 in U87‑DACH1‑low glioblastoma cells similarly suppressed EMT markers and tumor growth in vivo.",-48.5,0.8,cellline
"Silently, the KRAS‑mutant HCT116 cell line showed increased sensitivity to the MEK inhibitor trametinib, while the U87‑DACH1‑low glioma cells remained resistant due to upregulated PI3K‑AKT signaling.",-42.75,0.8,cellline
Silica nanoparticle exposure in U87‑DACH1‑low cells induced a p53‑dependent apoptotic response that was markedly attenuated when the cells were pre‑treated with the antioxidant N‑acetylcysteine.,-34.75,0.8,cellline
"HCT116 cells treated with the novel kinase inhibitor PF-06463922 exhibit a marked reduction in TP53 phosphorylation and a concomitant increase in apoptosis, suggesting that this compound directly interferes with the DNA damage response pathway in colorectal carcinoma cell lines.",-41.75,0.8,cellline
"H4K27 acetylation of the TP53 promoter in HCT116 cells, induced by treatment with the histone deacetylase inhibitor vorinostat, drives p21 transcription and suppresses cell‑cycle progression.",-48.75,0.8,cellline
"Heterozygous loss of TP53 in HCT116 cells markedly reduces the response to the DNA‑damaging agent doxorubicin, thereby lowering apoptosis rates compared with wild‑type HCT116.",-35.75,0.8,cellline
"HSC-1 cells exposed to the DNA-damaging agent cisplatin exhibited a marked increase in TP53 phosphorylation, correlating with the activation of the p21-mediated cell cycle arrest pathway.",-43.0,0.8,cellline
"Using CRISPR‑Cas9 editing, the TP53‑knockout variant in HCT116 cells was shown to enhance doxorubicin‑induced apoptosis, whereas re‑expression of wild‑type TP53 in the same cell line reduced the chemotherapeutic sensitivity.",-40.5,0.8,cellline
"Using the Capan1 cell line, we observed that the TP53 mutation c.215G>A induced apoptosis via p53‑dependent transcriptional upregulation of the pro‑apoptotic gene BAX, which was further amplified by treatment with the chemotherapeutic drug doxorubicin.",-50.5,0.8,cellline
"Using U87-DACH1-low cells, we observed that silencing TRAF2 by expressing a dominant‑negative Traf2DN construct markedly increased CXCL10 secretion, thereby enhancing CD8⁺ T‑cell cytotoxicity against glioma cells.",-47.75,0.8,cellline
"Using Capan1 cells, we observed that overexpression of the drug‑resistant protein ABCG2, induced by exposure to doxorubicin, led to a significant increase in the phosphorylation of the PI3K/Akt pathway, thereby promoting cell survival and reducing apoptosis.",-47.5,0.8,cellline
"The chemotherapeutic agent doxorubicin induced apoptosis in T98G cells by downregulating the anti‑apoptotic protein BCL‑2, thereby enhancing caspase‑3 activation and reducing cell viability.",-16.375,0.8,cellline
"The T98G glioblastoma cell line expressing mutant TP53 c.215G>A demonstrated increased sensitivity to doxorubicin, confirming the role of the sequence variant in drug response.",-25.125,0.8,cellline
"The drug doxorubicin markedly suppressed proliferation of HEK and MES‑SA/Dx5 cells while simultaneously up‑regulating p53 and increasing the incidence of BRCA1 c.68_69delAG variants, indicating a dose‑dependent interaction between the chemical entity, the cell lines, and the sequence variant.",-51.5,0.8,cellline
"The CRISPR-Cas9-mediated knock‑out of TP53 in HEK293 cells dramatically enhances the proliferation of T98G glioblastoma cells, indicating a tumor‑suppressive interaction between the gene product and the cellular context.",-37.75,0.8,cellline
"In T98G cells, knockdown of CD18/HPAF by CRISPR/Cas9 markedly reduced NF‑κB activation and sensitized the tumor line to doxorubicin, while overexpressing the mutant TP53 (c.215G>A) restored resistance to the drug, demonstrating a direct link between sequence variant, gene product, and chemotherapy response in a human glioblastoma cell line.",-58.75,0.8,cellline
"In HEK‑293 cells, the CRISPR‑Cas9‑mediated knockout of TP53 induces a compensatory up‑regulation of the anti‑apoptotic protein BCL‑XL, which is then selectively inhibited by the small‑molecule drug venetoclax, restoring apoptosis in the cell line.",-40.75,0.8,cellline
"In the HEK293T cell line, overexpression of the TP53 gene product enhances sensitivity to doxorubicin, while CRISPR‑mediated introduction of the BRCA1 c.68_69delAG sequence variant confers resistance to cisplatin in the same culture system.",-29.875,0.8,cellline
"In MES‑SA/Dx5 cells, overexpression of the CD18/HPAF complex activates STAT3 signaling, thereby enhancing proliferation and resistance to doxorubicin.",-23.625,0.8,cellline
"HEK cells engineered to overexpress the CD18/HPAF fusion protein exhibit increased resistance to doxorubicin-induced apoptosis, a phenotype that is absent in the T98G line when the same construct is expressed.",-30.0,0.8,cellline
"HEP3‑A cells exposed to the CD18/HPAF‑derived chemokine CCL5 showed a dose‑dependent up‑regulation of the CXCR4 receptor, which in turn enhanced migratory capacity toward CXCL12 gradients, a phenomenon that was attenuated by the small‑molecule antagonist AMD3100.",-61.25,0.8,cellline
"HEART‑derived MC3T3‑E1 cells exposed to the small‑molecule inhibitor doxorubicin exhibit a dose‑dependent reduction in alkaline phosphatase activity, suggesting that this ChemicalEntity impairs osteoblastic differentiation of this CellLine.",-50.0,0.8,cellline
"HE5, a variant of the HEK293 cell line, was engineered to overexpress CD18, thereby enhancing its adhesion to HPAF cells and increasing susceptibility to T98G-mediated invasion in vitro.",-51.25,0.8,cellline
"T98G cells engineered to overexpress the CD18/HPAF fusion protein display increased resistance to doxorubicin, correlating with upregulation of the PI3K‑AKT survival pathway.",-26.5,0.8,cellline
"Tert-butylhydroquinone treatment of T98G cells induces apoptosis through the up‑regulation of the pro‑apoptotic gene BAX and the down‑regulation of the anti‑apoptotic protein BCL‑2, resulting in increased caspase‑3 activation.",-45.5,0.8,cellline
"T9 cells, a variant of T98G, displayed markedly increased CD18 expression upon exposure to the chemotherapeutic agent doxorubicin, suggesting a potential mechanism for enhanced drug uptake and cytotoxicity in this glioblastoma cell line.",-44.75,0.8,cellline
"Toxicity of the chemotherapeutic agent cisplatin was markedly reduced in the HEK293 cell line harboring the BRCA1 c.68_69delAG variant, whereas the same treatment induced apoptosis in the T98G glioblastoma cells.",-40.0,0.8,cellline
"A CRISPR‑Cas9‑mediated deletion of the CD18 promoter in MES‑SA/Dx5 cells led to a dramatic reduction in CD18/HPAF expression, confirming that CD18 regulation is essential for the adhesion phenotype in this chemoresistant colorectal carcinoma line.",-43.25,0.8,cellline
"A MEK1 inhibitor markedly suppressed proliferation of T98G glioblastoma cells and induced apoptosis through downregulation of the KRAS/ERK pathway, whereas the same compound failed to affect growth of HEK293 embryonic kidney cells, indicating cell‑line‑specific therapeutic potential.",-46.0,0.8,cellline
"A genome‑wide CRISPR screen in T98G cells revealed that loss of the CD18/HPAF complex upregulates the oncogenic transcription factor MYC, thereby enhancing proliferation and chemoresistance to doxorubicin.",-27.5,0.8,cellline
"A chemotherapeutic study revealed that the drug doxorubicin induces apoptosis in T98G cells via activation of TP53, leading to cell cycle arrest and upregulation of the pro‑apoptotic protein BAX.",-36.5,0.8,cellline
"CD18/HPAF cells treated with doxorubicin displayed a dose‑dependent up‑regulation of the TP53‑driven p21 gene, correlating with increased apoptosis and reduced proliferation compared with untreated HEK293T cells.",-35.0,0.8,cellline
"CD90‑knockout in HEK293 cells accelerates TGF‑β‑induced EMT, a process that is further potentiated by the overexpression of the mutant SMAD4 p.R361C variant.",-53.0,0.8,cellline
"CD30 blockade in the MES-SA/Dx5 cell line markedly inhibited the autocrine IL‑6/STAT3 loop, thereby reducing proliferation and enhancing sensitivity to doxorubicin.",-43.5,0.8,cellline
"CD38 expression in the MES-SA/Dx5 cell line was upregulated by doxorubicin, correlating with increased apoptosis and reduced proliferation.",-33.5,0.8,cellline
"Treatment with the BET inhibitor JQ1 suppresses proliferation of T98G glioblastoma cells by downregulating MYC expression, thereby inducing apoptosis and reducing tumor growth in a mouse xenograft model.",-28.875,0.8,cellline
Treatment of the cisplatin‑resistant MES‑SA/Dx5 cell line with a novel HDAC inhibitor reduces colony formation and restores sensitivity to apoptosis by down‑regulating the anti‑apoptotic protein BCL‑XL.,-34.0,0.8,cellline
"Treatment‐resistant breast cancers derived from the T98G cell line exhibited up‑regulated expression of CD18/HPAF, which promoted chemokine‑mediated recruitment of tumor‑associated macrophages and enhanced metastatic dissemination to the lungs.",-58.0,0.8,cellline
"Treatment-resistant T98G glioblastoma cells overexpressed MGMT, leading to decreased sensitivity to temozolomide and increased expression of the DNA repair protein XRCC1, while a CRISPR‑mediated deletion of the BRCA1 c.68_69delAG variant in the same cell line markedly enhanced radiosensitivity.",-57.25,0.8,cellline
"Activation of the PI3K/AKT pathway in the HEK293T cell line following treatment with the chemical entity rapamycin led to increased expression of the gene product mTOR, which in turn induced a mild increase in cell proliferation and a reduction in apoptosis.",-45.5,0.8,cellline
"Activation by TNF-α in the HEK293T cell line induces NF‑κB‑dependent up‑regulation of the CD18/HPAF gene, leading to enhanced adhesion of immune cells to the mesenchymal stromal cell‑derived matrix.",-54.0,0.8,cellline
"Activation-induced T98G cell proliferation is enhanced by exposure to the small-molecule inhibitor doxorubicin, which down‑regulates CD18/HPAF expression and increases apoptosis in HEK‑293T cells, thereby suggesting a potential therapeutic avenue for targeting the EGFR pathway in MES‑SA/Dx5-derived tumors.",-72.0,0.8,cellline
"Activation‑induced apoptosis in the T98G glioblastoma cell line was markedly enhanced when the chemotherapeutic drug doxorubicin was combined with the CXCR4 antagonist AMD3100, revealing a synergistic interaction that could inform future combinatorial cancer therapies.",-46.0,0.8,cellline
"Mutagenic exposure of the T98G glioblastoma cell line to doxorubicin induces a TP53 c.215G>A sequence variant that up‑regulates CD18/HPAF‑mediated adhesion and enhances chemoresistance, demonstrating a functional link between drug treatment, gene mutation, and cell‑surface phenotype.",-47.25,0.8,cellline
Mutational analysis of the TP53 gene in T98G cells revealed a c.215C>T sequence variant that increased resistance to doxorubicin treatment in this glioblastoma cell line.,-25.875,0.8,cellline
"Mutant TP53 expression in HEK cells induces the upregulation of the apoptotic regulator BAX, which in turn enhances caspase‑3 activation and promotes cell death upon doxorubicin treatment.",-39.75,0.8,cellline
"Mutating the TP53 gene in the T98G glioblastoma cell line with CRISPR-Cas9 reduces PD-L1 expression, thereby enhancing CD18/HPAF‑derived T‑cell mediated cytotoxicity against tumor cells.",-35.75,0.8,cellline
"ME49‑derived T98G cells overexpressing CD18/HPAF exhibit enhanced integrin‑mediated adhesion, which is markedly attenuated when treated with the small molecule inhibitor doxorubicin.",-36.25,0.8,cellline
MEK inhibitor trametinib selectively inhibited proliferation of T98G glioblastoma cells harboring the EGFRvIII mutation while sparing non‑mutated HEK293T cells.,-24.625,0.8,cellline
"MEF‑derived MC3T3‑E1 cells treated with the kinase inhibitor dasatinib exhibit a dose‑dependent decrease in IL‑6 secretion, suggesting that the drug interferes with MAPK signaling in osteoblast‑like cells.",-39.5,0.8,cellline
"ME‑C6 cells, a subtype of the HEK cell line engineered to overexpress CD18, exhibited a marked increase in adhesion to extracellular matrix components when treated with the chemotherapeutic agent doxorubicin, thereby revealing a potential mechanism for drug‑induced cytotoxicity in cancer therapy.",-51.5,0.8,cellline
"Using CRISPR-Cas9 editing of the TP53 locus in T98G cells, the resulting p53 loss-of-function mutation increased sensitivity to doxorubicin and was accompanied by upregulation of the DNA repair gene RAD51.",-38.5,0.8,cellline
"Using the MES-SA/Dx5 cell line, CRISPR‑mediated knockout of the CD18 gene in CD18/HPAF cells amplified the expression of the chemokine CXCL10, linking the loss of the integrin to heightened inflammatory signaling in the tumor microenvironment.",-44.0,0.8,cellline
"Using MSC-derived MSC‑MSCs cultured as LbetaT2, a mutation in the CD18/HPAF promoter was shown to impair IL‑6 secretion, thereby reducing proliferation of T98G cells in a co‑culture assay.",-62.25,0.8,cellline
"Using HEK293T cells, CRISPR‑Cas9 mediated disruption of the CD18 gene (ITGB2) caused a marked decrease in leukocyte adhesion to endothelial monolayers, illustrating a mechanistic link between the ITGB2 sequence variant and impaired immune cell trafficking.",-48.25,0.8,cellline
"Mutation of the TP53 gene in the HEK293T cell line leads to increased resistance to doxorubicin, a finding that may inform the design of targeted therapies for cancers harboring this alteration.",-30.625,0.8,cellline
"Mutation analysis of BRCA1 c.68_69delAG revealed that the same pathogenic variant is also present in patient-derived HEK293 cells, confirming the utility of this cell line for functional validation of disease‑causing sequence variants.",-44.5,0.8,cellline
"Mutation in the TP53 gene of the HEK293T cell line, coupled with overexpression of the CD18/HPAF surface receptor, enhances cellular resistance to doxorubicin while simultaneously increasing apoptosis markers in the T98G glioblastoma model.",-42.75,0.8,cellline
Mutation‑induced upregulation of the PIK3CA pathway in MES‑SA/Dx5 cells exposed to doxorubicin correlates with increased proliferation and resistance to apoptosis.,-37.5,0.8,cellline
"Cytotoxicity assays in HEK293 cells revealed that the novel alkylating agent N-[(2,4-dichlorophenyl)methyl]pyrrolidin-1-yl]-2-bromobenzylamine selectively inhibited T98G glioblastoma proliferation by down‑regulating EGFR expression while sparing normal MC3T3‑E1 osteoblasts.",-62.5,0.8,cellline
"Cisplatin-induced upregulation of the ABC transporter gene ABCG2 in the HEK293 cell line was mitigated by the addition of the small-molecule inhibitor verapamil, thereby restoring drug sensitivity and reducing cytotoxicity.",-42.0,0.8,cellline
"Cox‑2 inhibition in the T98G glioblastoma cell line with celecoxib reduced COX‑2 protein levels and suppressed the up‑regulation of the pro‑inflammatory cytokine IL‑6, confirming a direct link between drug treatment and inflammatory signaling in this model.",-53.5,0.8,cellline
Crosstalk between CD18/HPAF and T98G cells reveals that activation of the PI3K/AKT pathway by the small molecule doxorubicin induces apoptosis while simultaneously upregulating the tumor suppressor TP53 expression.,-35.75,0.8,cellline
"Expression of the tumor suppressor CDKN2A in the HEK293 cell line was dramatically increased when cells were treated with the DNA‑damaging agent doxorubicin, leading to apoptosis that was prevented by co‑administration of the antioxidant N‑acetylcysteine.",-38.75,0.8,cellline
"Expression analysis in HEK293 cells revealed that the CRISPR‑mediated knockout of TP53 leads to a significant up‑regulation of the anti‑apoptotic gene BCL2, suggesting that TP53 loss confers survival advantage to the HEK293 cell line.",-42.5,0.8,cellline
"Expression levels of the TP53 gene were markedly upregulated in the MES‑SA/Dx5 chemoresistant cell line after treatment with doxorubicin, indicating a potential mechanism of drug-induced apoptosis.",-32.75,0.8,cellline
"Expression knockdown of the KRAS gene in the MES‑SA/Dx5 cell line reduced cell proliferation and induced apoptosis through down‑regulation of the PI3K‑AKT pathway, highlighting a potential therapeutic target for chemoresistant uterine sarcoma.",-44.0,0.8,cellline
"Mutation of the TP53 gene in the HCT116 cell line led to up‑regulation of the pro‑apoptotic protein Bax, which in turn sensitized the cells to doxorubicin‑induced cell death.",-22.375,0.8,cellline
Mutation p.R248Q in TP53 was shown to dramatically reduce the proliferation of HCT116 cells while increasing apoptosis induced by doxorubicin in a dose‑dependent manner.,-35.5,0.8,cellline
"Mutation-induced upregulation of the pro‑apoptotic protein BAX in HCT116 cells carrying the BRCA1 c.68_69delAG variant markedly enhances doxorubicin‑mediated cytotoxicity, suggesting that this sequence variant sensitizes colorectal carcinoma cells to chemotherapy.",-41.0,0.8,cellline
"Mutation analysis of TP53 in the HCT116 cell line revealed a novel BRCA1 c.68_69delAG variant that appears to enhance cisplatin resistance, suggesting that the genetic alteration may alter drug uptake pathways in this colorectal carcinoma model.",-43.5,0.8,cellline
"The HCT116 colorectal carcinoma cell line overexpresses mutant TP53, and when treated with doxorubicin, it shows increased caspase‑3 activation and cell death, a response that is absent in the MC‑IXC liver cancer line carrying a wild‑type TP53 allele.",-45.25,0.8,cellline
"The CRISPR-Cas9-mediated knockout of TP53 in HCT116 cells dramatically increased the sensitivity of the line to the DNA‑damaging agent doxorubicin, leading to a significant rise in apoptosis compared with the wild‑type counterpart.",-32.0,0.8,cellline
"The C4-2B androgen‑resistant prostate cancer cell line treated with the CYP17A1 inhibitor abiraterone shows a dose‑dependent down‑regulation of the androgen receptor splice variant AR‑v7, thereby reducing the expression of the downstream gene TMPRSS2.",-37.0,0.8,cellline
"The HT22 hippocampal neuronal cell line treated with the TRPA1 antagonist HC‑030031 exhibited a dose‑dependent reduction in TNF‑α secretion, indicating that TRPA1 signaling contributes to inflammatory cytokine release in these cells.",-37.25,0.8,cellline
"In HCT116 cells, knockdown of TP53 leads to increased expression of the anti‑apoptotic protein BCL‑XL, thereby reducing doxorubicin‑induced apoptosis and conferring chemoresistance.",-19.125,0.8,cellline
"In the Het‑1A cell line, overexpression of the TP53 gene product induced apoptosis through a caspase‑3‑dependent pathway, confirming that TP53 acts as a tumor suppressor in this colorectal carcinoma model.",-24.625,0.8,cellline
"In Het-1A cells, overexpression of the mutant TP53 sequence variant c.215G>A disrupts the p53‑mediated apoptotic response, thereby promoting resistance to the DNA‑damaging chemotherapeutic doxorubicin.",-33.75,0.8,cellline
"In HT22 cells, the CRISPR‑mediated knockout of the Mdm2 gene dramatically increased p53‑dependent apoptosis, while treatment with the small molecule Nutlin‑3 rescued cell viability and restored the cell‑cycle checkpoint, indicating that Nutlin‑3 antagonizes Mdm2‑mediated p53 degradation in this neuronal cell line.",-57.0,0.8,cellline
"Expression of the mutant TP53 allele in HCT116 cells, treated with the DNA‑damaging agent doxorubicin, triggered a p53‑dependent apoptosis that was markedly attenuated when the cells were co‑transfected with a dominant‑negative TRAF2 construct, suggesting that TRAF2 mediates an anti‑apoptotic signal in this colorectal cancer cell line.",-46.5,0.8,cellline
"Expression levels of the BCL‑2 protein were markedly up‑regulated in HCT116 cells harboring a TP53 missense mutation, correlating with increased resistance to doxorubicin in this human colorectal carcinoma cell line.",-40.25,0.8,cellline
"Expression profiling of the mitochondrial protein TOMM22 in HCT116 cells revealed that its knockdown by siRNA dramatically reduced the invasion capacity of the colon carcinoma cell line, suggesting a potential therapeutic target for colorectal cancer.",-53.25,0.8,cellline
"Expression analyses in HCT116 cells revealed that the CRISPR‑mediated knockout of TP53 up‑regulated the mitochondrial pro‑apoptotic gene BAX, leading to increased caspase‑3 activation and heightened sensitivity to doxorubicin treatment.",-42.75,0.8,cellline
"Treatment of HCT116 cells with the selective PI3K‑δ inhibitor idelalisib resulted in down‑regulation of the phosphatidylinositol‑3‑kinase pathway and induced apoptosis, confirming the drug’s therapeutic potential in colorectal carcinoma models.",-37.25,0.8,cellline
"Treatment with the p53‑activating compound doxorubicin induces apoptosis in HCT116 cells, but the response is markedly attenuated in the TP53‑mutant C4‑2B line, where the BRCA1 c.68_69delAG variant further reduces DNA repair capacity.",-40.0,0.8,cellline
"Treatment using the HCT116 cell line revealed that overexpression of the gene TP53 reduces the proliferation of the drug-resistant variant Huh7, suggesting a potential therapeutic target for colorectal carcinoma.",-43.5,0.8,cellline
"Treatment-resistant melanoma cells from the C57BL/6-derived B16F10 cell line were shown to upregulate PD-L1 in response to IFN‑γ, and blocking PD‑L1 with a monoclonal antibody restored T‑cell mediated cytotoxicity.",-49.25,0.8,cellline
"Knock‑down of the NF‑κB inhibitor IκBα in HCT116 cells increases resistance to the chemotherapeutic agent doxorubicin, correlating with up‑regulation of the pro‑survival protein Bcl‑2 and a shift toward an anti‑apoptotic phenotype.",-42.25,0.8,cellline
"Knocking‑down PTEN in the HCT116 colorectal carcinoma cell line increased PI3K‑AKT signaling, thereby enhancing resistance to the EGFR inhibitor gefitinib, a phenomenon that was confirmed by reduced apoptosis and elevated colony‑forming ability in vitro.",-44.25,0.8,cellline
"Knitting of the STAT3 pathway in HCT116 cells with the C4‑2B prostate cancer line reveals that STAT3 overexpression promotes EMT and enhances invasion, while CRISPR‑mediated knockout of the TP53 gene in Huh7 cells reduces apoptotic signaling and increases colony‑forming ability.",-73.0,0.8,cellline
"Knocked‑out TP53 in the HCT116 cell line enhances sensitivity to doxorubicin, an effect that is amplified when the mutant sequence variant BRCA1 c.68_69delAG is also present.",-40.0,0.8,cellline
"HCT116 cells harboring a CRISPR/Cas9‑generated TP53 c.215_216delAG variant exhibit reduced proliferation and increased sensitivity to doxorubicin compared with wild‑type HCT116, underscoring the variant’s role in chemoresistance.",-29.25,0.8,cellline
"Huh7 cells engineered to overexpress the mutant TP53 (c.215G>A) displayed increased sensitivity to the DNA‑damaging agent doxorubicin, leading to higher apoptosis rates compared with wild‑type Huh7, and this effect was partially rescued by co‑treatment with the antioxidant N‑acetylcysteine.",-33.0,0.8,cellline
"HHT‑1A cells transfected with a CRISPR/Cas9‑delivered BRCA1 c.68_69delAG variant exhibit markedly reduced DNA repair capacity, leading to increased sensitivity to the DNA‑damaging agent doxorubicin and enhanced apoptosis compared with unedited HHT‑1A cells.",-39.25,0.8,cellline
"Hc-1A cells overexpressing mutant TP53 exhibit a marked increase in apoptosis when treated with doxorubicin, a phenomenon that is attenuated in the Huh7 cell line lacking functional p53.",-37.25,0.8,cellline
"Mutagenic exposure of the HCT116 colorectal cancer cell line to doxorubicin induced a dose‑dependent increase in TP53 mRNA levels, thereby triggering apoptosis and sensitizing the cells to subsequent treatment with the B‑cell lymphoma drug rituximab.",-39.0,0.8,cellline
"Mutant p53 expression in HCT116 cells reduces MDM2‑mediated ubiquitination, thereby increasing TP53 protein stability and enhancing apoptosis in response to doxorubicin treatment.",-24.875,0.8,cellline
"Mutations in the TP53 gene of HCT116 and C4‑2B cells, combined with overexpression of the drug‑resistant protein MDR1, increase resistance to doxorubicin and promote cell survival in a dose‑dependent manner.",-39.5,0.8,cellline
"Mutated TP53 in HCT116 cells induces apoptosis and downregulates VEGFA, thereby reducing tumor vascularization and enhancing sensitivity to doxorubicin.",-31.75,0.8,cellline
"A CRISPR‑Cas9‑mediated knockout of TP53 in HCT116 cells induces a compensatory upregulation of the DNA‑repair enzyme POLB, which correlates with increased chemotherapeutic resistance to doxorubicin in these colorectal carcinoma cell lines.",-34.75,0.8,cellline
"A549 cells overexpressing mutant TP53 exhibit increased sensitivity to the chemotherapeutic doxorubicin, resulting in amplified caspase‑3 activation and reduced colony‑forming ability.",-29.0,0.8,cellline
A mutational analysis of the KRAS exon‑2 region in the HCT116 colorectal carcinoma cell line revealed a c.35G>A (p.G12D) sequence variant that conferred constitutive activation of downstream ERK signaling and increased sensitivity to the MEK inhibitor trametinib.,-38.0,0.8,cellline
"A xenograft study using the Huh7 cell line revealed that knockdown of TP53 in this hepatocellular carcinoma model reduced tumor growth and increased sensitivity to doxorubicin, thereby suggesting a synergistic therapeutic strategy in hepatocellular carcinoma.",-42.25,0.8,cellline
"Altered expression of the oncogenic transcription factor MYC in the colorectal carcinoma cell line HCT116, when treated with the small‑molecule inhibitor olaparib, led to increased apoptosis and reduced colony‑forming ability, suggesting a potential therapeutic strategy for MYC‑driven cancers.",-41.0,0.8,cellline
"Alteration of the TP53 gene in the HCT116 cell line, coupled with treatment by doxorubicin, induced apoptosis and led to a significant increase in caspase‑3 activity, confirming the drug’s efficacy in p53‑competent colorectal carcinoma models.",-44.5,0.8,cellline
"Alterations in the PI3K/AKT pathway were observed in HCT116 cells, where the introduction of a TP53 missense variant (c.215C>T) led to reduced proliferation and increased apoptosis compared with parental Het-1A cells.",-42.0,0.8,cellline
"Alter the expression of the transcription factor NF‑κB in the HCT116 colorectal carcinoma cell line using CRISPR‑Cas9 knockout of the p65 subunit, which markedly reduces interleukin‑8 secretion and sensitizes the cells to doxorubicin‑induced apoptosis.",-48.25,0.8,cellline
C4-2B cells overexpressing a Traf2DN-tg B construct showed a significant reduction in NF‑κB activation compared with HCT116 cells transfected with an empty vector.,-29.0,0.8,cellline
"Cytotoxicity of the novel small molecule JQ-1 was markedly increased in HCT116 and SNU-C2A cell lines harboring the KRAS G12D mutation, indicating a potential therapeutic target for colorectal cancers with this sequence variant.",-47.75,0.8,cellline
"C3-2B, a castration‑resistant prostate cancer cell line, displayed elevated NF‑κB activity when transfected with a mutant TRAF2 construct, confirming that the TRAF2DN mutation enhances apoptotic resistance in the HCT116 model.",-57.25,0.8,cellline
"C57BL/6 mice infected with the C4‑2B prostate cancer cell line exhibit up‑regulation of the pro‑inflammatory cytokine IL‑6, which is reduced when the mice are treated with the small molecule inhibitor doxorubicin.",-38.75,0.8,cellline
"TRAF2DN-tg B mice, when exposed to chronic ethanol, exhibited a dramatic increase in hepatic Huh7‑derived CXCL10 expression, suggesting that the gene product of the C57BL/6 background modulates inflammatory signaling pathways.",-57.25,0.8,cellline
"TRF2 overexpression in the HCT116 colorectal carcinoma cell line led to a marked increase in telomerase activity and cell proliferation, suggesting that targeting TRF2 could reduce tumor growth.",-39.5,0.8,cellline
"TRAP1 knockdown in HCT116 cells reduces mitochondrial membrane potential, leading to increased ROS production and apoptosis in response to doxorubicin.",-33.0,0.8,cellline
"TRPC6 overexpression in the HCT116 cell line causes upregulation of the pro‑apoptotic protein BAX, leading to increased sensitivity to the chemotherapeutic agent doxorubicin.",-42.0,0.8,cellline
"CRISPR‑Cas9‑mediated knockout of TP53 in the Huh7 cell line attenuates proliferation and enhances apoptosis, illustrating the dependence of hepatocellular carcinoma cells on p53 signaling for growth.",-36.0,0.8,cellline
"CR3022 antibody treatment significantly reduced tumor proliferation in HCT116 cells harboring a TP53 c.215G>A mutation, confirming the dependence of TP53‑driven growth on the targeted pathway.",-53.25,0.8,cellline
"CR‑BP inhibition in Huh7 cells resulted in a dramatic decrease in the phosphorylation of ERK1/2 and increased apoptosis through up‑regulation of BAX, illustrating that targeting the CR‑BP pathway may sensitize hepatocellular carcinoma to chemotherapy.",-62.0,0.8,cellline
"CRISP‑Cas9 editing of the BRCA1 c.68_69delAG variant in HCT116 cells reduces RAD51 expression and increases sensitivity to the PARP inhibitor olaparib, providing a potential therapeutic strategy for BRCA1‑mutated cancers.",-39.0,0.8,cellline
"Fluorescent‑labeled CRISPR‑Cas9 delivered to HCT116 cells efficiently induced a TP53 c.215C>A SequenceVariant, which in turn up‑regulated the cell‑cycle inhibitor p21 and suppressed tumorigenic growth in vitro and in SCID‑HuH‑7 xenografts.",-51.25,0.8,cellline
"Flank‑implantation of the HCT116 colorectal carcinoma cell line into SCID‑HuH‑7 mice revealed that the TRAF2DN‑tg B transgene markedly reduced tumor‑derived VEGF secretion, thereby attenuating angiogenesis and slowing tumor growth.",-37.5,0.8,cellline
"Fludarabine treatment of HCT116 cells expressing a mutant p53 allele increased apoptosis and up‑regulated the pro‑apoptotic protein BAX, mirroring the sensitization observed in vivo in a SCID‑HuH‑7 xenograft model of hepatocellular carcinoma.",-54.0,0.8,cellline
"Flutamide treatment of the HCT116 cell line reduced the expression of the androgen‑responsive gene FKBP5, thereby attenuating its resistance to cisplatin in vitro.",-41.75,0.8,cellline
"The chemotherapeutic agent doxorubicin induced apoptosis and decreased proliferation in the U87‑DACH1‑low glioblastoma cell line, confirming that reduced DACH1 expression sensitizes Hs578T breast cancer cells to anthracycline‑based therapy.",-25.375,0.8,cellline
"The CRISPR‑Cas9 edited HCT‑116 cells, which now express a doxycycline‑inducible TP53 c.68_69delAG variant, exhibit markedly increased apoptosis when treated with the small‑molecule inhibitor doxorubicin, confirming a synergistic interaction between the sequence variant and the chemotherapeutic drug in this colorectal cancer cell line.",-39.25,0.8,cellline
"The U87‑DACH1‑low glioblastoma cell line exhibits reduced MDM2 phosphorylation, which correlates with increased p53‑mediated apoptosis following treatment with the small‑molecule inhibitor doxorubicin.",-25.875,0.8,cellline
"The Mz‑Cha‑1 cell line, which harbors a KRAS G12D mutation, shows increased resistance to doxorubicin through upregulation of the ABCB1 transporter.",-23.125,0.8,cellline
"U87‑DACH1‑low cells treated with doxorubicin exhibit a dramatic increase in p53‑mediated apoptosis, suggesting that down‑regulation of DACH1 sensitizes glioblastoma cell lines to DNA‑damaging agents.",-24.5,0.8,cellline
"U86-DACH1-low cell lines, derived from U87 glioblastoma, show reduced DACH1 expression, which correlates with increased proliferation and invasion compared with the parental U87 line.",-37.0,0.8,cellline
"U‑87‑DACH1‑low, a glioblastoma cell line engineered to down‑regulate DACH1, exhibited reduced proliferation when treated with the small molecule inhibitor doxorubicin, an effect that correlated with increased expression of the apoptosis‑associated gene TP53.",-43.0,0.8,cellline
"U83/13 cells, an HCT‑116 derived line harboring a KRAS G12D mutation, exhibit markedly increased resistance to doxorubicin, an effect that is reversed by the mTOR inhibitor RAD001, thereby linking the genetic background of the cell line to a specific therapeutic response.",-53.25,0.8,cellline
"In the U87‑DACH1‑low glioma cell line, silencing of DACH1 via CRISPR‑Cas9 enhances EGFR signaling, leading to increased proliferation and resistance to the EGFR‑targeted drug erlotinib.",-24.75,0.8,cellline
"In U87‑DACH1‑low cells, knockdown of DACH1 by CRISPR/Cas9 induces a dramatic increase in phospho‑STAT3 signaling, which in turn up‑regulates the transcription of the oncogene MYC, thereby promoting invasive phenotypes reminiscent of those observed in aggressive glioblastoma biopsies.",-49.75,0.8,cellline
"In Mz‑ChA‑1 cells, overexpression of the transcription factor DACH1 reduces proliferation and enhances sensitivity to doxorubicin, a finding that may explain the increased drug efficacy observed in U87‑DACH1‑low glioblastoma and HCT‑116 colorectal cancer cell lines.",-31.5,0.8,cellline
"In an experiment using the Mz‑ChA‑1 cell line, researchers found that treating cells with the small molecule VX‑765 reduced the expression of caspase‑1, thereby suppressing the inflammatory response induced by LPS in RAW‑264.7 macrophages.",-49.0,0.8,cellline
"Mutation of TP53 in the HCT‑116 cell line reduces the apoptotic response to doxorubicin, thereby increasing chemoresistance.",-17.625,0.8,cellline
"Mutation analysis of BRCA1 c.68_69delAG in the HCT‑116 cell line revealed a higher sensitivity to doxorubicin compared with the parental HCT‑116, suggesting that this variant confers increased chemotherapeutic response.",-36.0,0.8,cellline
"Mutation in the TP53 gene of the HCT‑116 cell line increases resistance to doxorubicin, a relationship that parallels the heightened survival seen in the MES‑SA/Dx5 line carrying the same mutation.",-42.5,0.8,cellline
Mutation‑driven resistance to doxorubicin in the U87‑DACH1‑low glioblastoma cell line is accompanied by up‑regulation of the ABCB1 transporter and decreased apoptosis mediated through the PI3K‑AKT pathway.,-33.25,0.8,cellline
"HCT‑116 cells overexpressing the Mz‑ChA‑1 chemokine receptor exhibit enhanced invasion through Matrigel, a phenotype that is reversed by treatment with the CXCR4 antagonist AMD3100.",-29.0,0.8,cellline
"Huh7 cells treated with the STAT3 inhibitor Stattic showed a marked reduction in c-Myc expression, correlating with decreased colony formation and increased apoptosis.",-32.25,0.8,cellline
"H83/13, a human breast cancer cell line, exhibited enhanced proliferation when co‑treated with the PI3K inhibitor LY294002, whereas the same treatment induced apoptosis in the pancreatic β‑cell line MIN6, suggesting cell‑type–specific PI3K/AKT pathway dependence.",-51.0,0.8,cellline
"HCP-1, a hepatocyte cell line derived from Huh7, was treated with the BET bromodomain inhibitor JQ1, resulting in down‑regulation of MYC expression and a concomitant increase in p21‑CIP1 mediated cell cycle arrest.",-52.75,0.8,cellline
"A CRISPR‑Cas9 knockout of the P53 gene in HCT‑116 cells induced a dramatic increase in the invasive phenotype and up‑regulation of MMP‑9, demonstrating a causal link between TP53 loss and metastatic potential in colorectal carcinoma.",-44.5,0.8,cellline
"A dose‑dependent reduction in proliferation of the U87‑DACH1‑low glioblastoma cell line was observed after treatment with the BET‑inhibitor JQ1, concomitant with up‑regulation of the tumor suppressor gene p53 and increased apoptosis.",-36.25,0.8,cellline
"A549 cells overexpressing mutant TP53 R248W exhibit increased glycolytic flux and upregulation of GLUT1, thereby enhancing their resistance to doxorubicin-induced apoptosis.",-31.125,0.8,cellline
"A mutation in the TP53 gene within the HCT‑116 cell line increases its resistance to doxorubicin, as demonstrated by higher IC₅₀ values compared to TP53‑wild‑type HCT‑116 cells.",-31.5,0.8,cellline
"Genetic knockdown of DACH1 in U87‑DACH1‑low cells attenuates proliferation and enhances temozolomide sensitivity, mirroring the drug‑resistant phenotype observed in MES‑SA/Dx5 and Huh7 colorectal cell lines.",-39.75,0.8,cellline
"Genomic profiling of the HCT‑116 cell line revealed that the KRAS G12D variant co‑occurs with a novel TP53 c.215G>A mutation, suggesting a synergistic effect on chemoresistance to doxorubicin.",-35.0,0.8,cellline
"Genotoxic stress induced by doxorubicin markedly upregulates p53 expression in the HCT‑116 cell line, correlating with increased apoptosis and reduced colony‑forming ability.",-30.125,0.8,cellline
"Genetically engineered Mz‑ChA‑1 cells overexpressing the HIF‑1α transcription factor exhibit a markedly increased glycolytic flux, and this metabolic reprogramming is further amplified by the addition of the small‑molecule inhibitor doxorubicin, thereby demonstrating a synergistic effect that could be exploited for targeted therapy of hypoxia‑adapted tumors.",-60.0,0.8,cellline
"Silencing of the PIK3CA gene in U87‑DACH1‑low cells drastically reduces their migratory capacity while simultaneously increasing the expression of the apoptosis‑regulating protein BAX, thereby highlighting a potential therapeutic vulnerability in glioblastoma.",-41.75,0.8,cellline
"Silico‑screening of the BET‑inhibitor JQ1 revealed that it selectively induced apoptosis in the U87‑DACH1‑low glioblastoma cell line, whereas the HCT‑116 colon carcinoma line remained largely resistant, a differential effect attributed to higher BRD4 expression in the former.",-45.75,0.8,cellline
"Silenced DACH1 in U87‑DACH1‑low glioblastoma cells (derived from the U87 cell line) markedly increases STAT3 phosphorylation, enhancing invasion while simultaneously upregulating the anti‑apoptotic protein BCL‑XL and conferring resistance to temozolomide.",-41.0,0.8,cellline
"Silica nanoparticles significantly reduced viability and induced apoptosis in Mz-ChA‑1 and HCT‑116 cells, an effect that was potentiated by co‑treatment with the chemotherapeutic agent doxorubicin and correlated with increased expression of the tumor suppressor gene TP53.",-43.75,0.8,cellline
"TGF‑β1 stimulation of the U87‑DACH1‑low glioblastoma cell line induced phosphorylation of SMAD2/3 and up‑regulation of the CDK inhibitor p21, thereby reducing cellular proliferation and increasing apoptosis.",-36.0,0.8,cellline
"Treated with the PI3K inhibitor BYL719, the HCT‑116 colorectal carcinoma cell line exhibited reduced AKT phosphorylation and enhanced apoptosis, while CRISPR‑mediated knock‑out of the MYC gene in the same line led to increased expression of the tumor‑suppressor p21 and decreased cell‑cycle progression.",-49.25,0.8,cellline
"Toxicity assays in the HCT‑116 and MES‑SA/Dx5 cell lines revealed that the CYP2C19*2 sequence variant reduced the metabolic activation of doxorubicin, thereby attenuating DNA‑adduct formation and lowering apoptosis rates compared with the wild‑type genotype.",-52.75,0.8,cellline
"Toxoplasma gondii infection of the HCT‑116 cell line markedly up‑regulated the expression of the pro‑inflammatory cytokine IL‑6, a response that was partially mitigated by pre‑treatment with the small molecule chemical entity curcumin.",-42.25,0.8,cellline
"SARS‑CoV‑2 infection of the Hs578T breast cancer cell line caused a dramatic up‑regulation of the ACE2 receptor, which in turn increased the intracellular uptake of the antiviral drug remdesivir, ultimately leading to a significant decrease in viral replication and a restoration of normal cellular ATP levels.",-49.0,0.8,cellline
"SILAC‑labelled Mz‑Cha‑1 and HCT‑116 cells treated with doxorubicin exhibited a time‑dependent increase in the phosphorylation of the DNA‑damage sensor ATM, suggesting that the drug induces a cell‑cycle arrest mediated by the p53 pathway.",-49.0,0.8,cellline
"Sunitinib treatment induced a significant decrease in proliferation and migration of the U87-DACH1-low cell line, concomitant with down‑regulation of the VEGFA gene product and reduced secretion of the angiogenic cytokine IL‑8 in the surrounding microenvironment.",-49.25,0.8,cellline
"S-unit1 overexpression in the drug-resistant U87‑DACH1‑low glioblastoma cell line (U87‑DACH1‑low) markedly up‑regulates the chemokine CXCL8, thereby enhancing neutrophil recruitment and potentiating the anti‑tumor activity of the small‑molecule inhibitor afatinib.",-64.5,0.8,cellline
"Molecular characterization of the U87-DACH1-low cell line revealed that DACH1 knockdown increased invasion and correlated with upregulation of MMP9, suggesting a potential therapeutic target for glioblastoma.",-31.75,0.8,cellline
"MZ‑ChA‑1 cells treated with the novel CDK4 inhibitor exhibit reduced cyclin‑D1 expression and increased apoptosis through a p53‑dependent pathway, whereas the U87‑DACH1‑low line shows up‑regulated VEGFA secretion and enhanced migratory capacity.",-51.0,0.8,cellline
"MATERIALS AND METHODS: U87‑DACH1‑low cells were transfected with a CRISPR/Cas9 construct targeting TP53 and subsequently treated with doxorubicin, resulting in a dose‑dependent reduction of cell viability and an increase in apoptotic markers compared to untreated HCT‑116 and Huh7 controls.",-42.75,0.8,cellline
"MIA-PAE treatment of the chemoresistant HCT‑116 colorectal carcinoma cell line led to a dose‑dependent decrease in cell‑viability and up‑regulation of the pro‑apoptotic protein Bax, confirming that the drug’s cytotoxic effect is mediated through mitochondrial apoptosis pathways.",-62.5,0.8,cellline
"MTX treatment of the HCT-116 colorectal carcinoma cell line, which harbors a KRAS G12D mutation, resulted in increased expression of the pro‑apoptotic gene BAX, confirming that KRAS-driven signaling confers resistance to chemotherapeutic-induced apoptosis.",-47.75,0.8,cellline
"MTCT-13 cells, a human colorectal cancer line, exhibited reduced viability and increased apoptosis upon treatment with the novel kinase inhibitor GSK-423, an effect that was markedly enhanced when combined with the DNA-damaging agent doxorubicin, suggesting a synergistic interaction that targets the PI3K/AKT signaling pathway.",-71.5,0.8,cellline
"MT-hMSC-derived Mz-ChA-1 cells overexpress the oncogenic transcription factor DACH1, and CRISPR-mediated disruption of the TP53 gene in these cells increases their proliferation and resistance to doxorubicin treatment.",-52.25,0.8,cellline
"MTT assays revealed that the drug doxorubicin induced a significant increase in apoptosis in the HCT‑116 cell line, a phenotype that was amplified when combined with the BRCA1 c.68_69delAG sequence variant.",-40.75,0.8,cellline
"Exposure of the HCT-116 colorectal carcinoma cell line to the DNA‑damaging agent doxorubicin induces a p53‑dependent transcriptional up‑regulation of the cyclin‑dependent kinase inhibitor p21, thereby halting the cell cycle in G1 and sensitizing the cells to apoptosis.",-31.625,0.8,cellline
"Exposure to the DNA‑crosslinker mitomycin C induces apoptosis in the HCT‑116 colorectal carcinoma cell line, a response that is markedly amplified when the TP53 gene product is overexpressed, thereby revealing a genotype‑dependent vulnerability to chemotherapeutic DNA damage.",-49.25,0.8,cellline
"Exposure‐induced oxidative stress in RAW264.7 cells activates the NF‑κB pathway, up‑regulates the pro‑inflammatory cytokine IL‑6, and sensitizes the cells to doxorubicin‑mediated apoptosis.",-46.75,0.8,cellline
Exposure treatment of the Mz-ChA-1 cell line with the small molecule inhibitor doxorubicin induced a dose‑dependent up‑regulation of the tumor suppressor gene TP53 and a concomitant reduction in the proliferation of malignant Huh7 cells.,-52.75,0.8,cellline
"Western blotting of TP53 and p21 in the HCT-116 cell line revealed that exposure to doxorubicin up‑regulated p53‑dependent apoptosis, while a BRCA1 c.68_69delAG variant diminished the chemotherapeutic response.",-43.0,0.8,cellline
"Western‑type blotting of the Mz‑Cha‑1 cell line revealed that the overexpression of the ER‑α transcription factor enhanced the phosphorylation of AKT, thereby promoting the proliferation of these cancer cells.",-49.25,0.8,cellline
"Western blots revealed that the p53 protein was markedly up‑regulated in U87‑DACH1‑low cells treated with doxorubicin, while Mz‑ChA‑1 cells showed a reciprocal down‑regulation of the same protein.",-46.0,0.8,cellline
"Western-2, a novel cell‑line derived from the Mz‑Cha‑1 tumor, shows increased expression of the pro‑apoptotic gene BAX when treated with doxorubicin, indicating a drug‑induced apoptotic pathway that may be exploited for targeted therapy in Mz‑Cha‑1‑derived tumors.",-73.5,0.8,cellline
"A pharmacological screen of the drug rapamycin on the U87MG glioblastoma cell line revealed a significant decrease in mTOR pathway phosphorylation, suggesting rapamycin’s therapeutic potential for this disease.",-41.5,0.8,cellline
A CRISPR-Cas9 knock‑out of TP53 in the HCT116 cell line resulted in increased proliferation and reduced apoptosis when treated with the DNA‑damaging agent doxorubicin.,-28.5,0.8,cellline
"A GWAS in the HCT116 cell line revealed that the TP53 c.215C>T sequence variant is associated with increased sensitivity to the chemotherapeutic agent doxorubicin, suggesting a potential pharmacogenomic marker for treatment response.",-32.5,0.8,cellline
"A chromatin‑modifying enzyme overexpressed in the glioblastoma cell line SF188 enhances EZH2‑mediated H3K27me3 at the PDGFRA promoter, thereby up‑regulating PDGFRA transcription and increasing cell proliferation.",-40.75,0.8,cellline
"In the HCT116 colorectal carcinoma cell line, overexpression of the KRAS G12V mutation increases ERK phosphorylation, leading to enhanced proliferation and resistance to the EGFR inhibitor gefitinib.",-24.625,0.8,cellline
"In RWPE1 cells, overexpression of the PI3K‑Akt pathway protein AKT1 promotes resistance to the chemotherapeutic agent doxorubicin, whereas knockdown of AKT1 sensitizes the cells to apoptosis.",-29.5,0.8,cellline
"In CRISPR/Cas9‑edited HCT116 cells, deletion of the TP53 binding site in the promoter of the MDR1 gene caused a significant up‑regulation of P-glycoprotein expression, thereby reducing doxorubicin efficacy in the resulting chemoresistant clones.",-43.0,0.8,cellline
"In HCT116 cells, the engineered CRISPR-Cas9‑mediated BRCA1 c.68_69delAG variant resulted in increased homologous recombination deficiency and heightened sensitivity to the DNA‑crosslinking agent doxorubicin, thereby demonstrating a direct link between the SequenceVariant and Chemotherapy response.",-48.0,0.8,cellline
"U87MG cells treated with the BET bromodomain inhibitor JQ1 displayed reduced MYC expression, correlating with a significant decrease in colony‑forming ability and a shift toward apoptosis in a dose‑dependent manner.",-37.5,0.8,cellline
"U82MG cells treated with the BET inhibitor JQ1 exhibit a marked reduction in MYC expression, concomitant with increased apoptosis and decreased proliferation, highlighting JQ1’s therapeutic potential against aggressive glioblastoma.",-47.75,0.8,cellline
"U0126 inhibited ERK phosphorylation in the U87MG glioblastoma cell line, causing a marked decrease in VEGF secretion that correlated with reduced cell proliferation.",-40.75,0.8,cellline
"U86MG cell lines engineered to express the KRAS G12D variant exhibit heightened ERK phosphorylation, which can be attenuated by the MEK inhibitor trametinib, thereby reducing proliferation in vitro.",-42.5,0.8,cellline
The KRAS G12D mutation in the U87MG glioblastoma cell line leads to enhanced MAPK signaling and confers resistance to the PI3K inhibitor LY294002.,-25.25,0.8,cellline
"The U87MG glioblastoma cell line, when transfected with a CRISPR/Cas9‑edited TP53 c.215G>A variant, displayed a marked increase in apoptosis after doxorubicin treatment, confirming the pathogenic role of the BRCA1‑associated mutation in chemoresistance.",-36.25,0.8,cellline
The CRISPR‑mediated knock‑in of the BRCA1 c.68_69delAG variant in the HCT116 cell line led to increased sensitivity of the cells to doxorubicin and heightened expression of the pro‑apoptotic protein TP53.,-32.5,0.8,cellline
"The RWPE1 cell line, when transfected with a CRISPR‑mediated deletion of the TP53 gene, exhibited a dramatic increase in resistance to the chemotherapy drug doxorubicin, a phenotype that was rescued by re‑introducing wild‑type TP53, thereby confirming the role of p53 in modulating drug sensitivity in prostate epithelial cells.",-49.75,0.8,cellline
Mutational analysis of the KRAS exon‑2 region in the Ba/F3 and SF188 cell lines revealed that the G12D variant increases proliferation and confers resistance to the MEK inhibitor trametinib.,-29.5,0.8,cellline
"Mutagenic exposure to doxorubicin induces a TP53‑dependent apoptotic cascade in the HCT116 colorectal carcinoma cell line, leading to a significant decrease in cell viability and increased expression of the pro‑apoptotic gene BAX.",-35.5,0.8,cellline
"Mutations in the KRAS exon‑12 of the HCT116 colon carcinoma cell line, which harbor the G12V variant, markedly increase the sensitivity of these cells to the MEK inhibitor trametinib, thereby providing a preclinical model for targeted therapy.",-44.25,0.8,cellline
"Mutant KRAS‑G12D in the U87MG glioblastoma cell line enhances STAT3 phosphorylation, thereby increasing IL‑6 secretion and promoting an autocrine loop that drives tumor cell proliferation.",-29.25,0.8,cellline
"Mutation of TP53 in the U87MG cell line enhances resistance to doxorubicin, as demonstrated by reduced apoptosis compared with the parental HCT116 line.",-25.875,0.8,cellline
"Mutation-driven upregulation of PD-L1 in the U87MG glioblastoma cell line, as revealed by CRISPR-Cas9 editing of the PTEN locus, enhances resistance to temozolomide and promotes immune evasion in vitro.",-32.75,0.8,cellline
"Mutation screening of the TP53 gene in the U87MG glioblastoma cell line revealed a novel c.743G>T transition that increases transcription of the downstream apoptosis regulator BAX, thereby enhancing susceptibility to temozolomide-induced cell death.",-42.75,0.8,cellline
"Mutation analysis of the KRAS c.35G>A variant in the Ba/F3 cell line, which was engineered to express the mutant allele, revealed that the variant increased proliferative capacity and conferred resistance to the MEK inhibitor trametinib, thereby validating the cell line as a suitable model for testing targeted therapies in KRAS‑driven malignancies.",-51.75,0.8,cellline
"Using the CRISPR/Cas9 system, knockout of the TP53 gene in the U87MG cell line induced G1‑phase arrest and increased sensitivity to temozolomide, demonstrating a potential therapeutic strategy for glioblastoma.",-32.75,0.8,cellline
"Using CRISPR/Cas9 to introduce the BRCA1 c.68_69delAG sequence variant into the HCT116 colorectal cancer cell line, we observed a significant decrease in the expression of the DNA repair gene RAD51 and an increase in cell sensitivity to the chemotherapeutic agent doxorubicin.",-34.5,0.8,cellline
"Using RWPE1, HCT116, and Mz‑ChA‑1 cells, we observed that the CRISPR‑mediated knockout of TP53 enhanced doxorubicin‑induced apoptosis, as evidenced by increased cleaved caspase‑3 levels compared to untreated controls.",-41.75,0.8,cellline
"Using siRNA knockdown of TP53 in the HCT116 colorectal carcinoma cell line, we observed increased apoptosis mediated by the upregulation of BAX, suggesting a tumor‑suppressive role for TP53 in this cellular context.",-38.5,0.8,cellline
"HCT116 cells treated with the CDK4/6 inhibitor palbociclib exhibited a dose‑dependent arrest in G1 phase and a concomitant down‑regulation of the cyclin‑dependent kinase target Rb, demonstrating that the drug’s antiproliferative effect in this colorectal cancer cell line is mediated through inhibition of CDK4/6 activity.",-41.75,0.8,cellline
"HAT1 overexpression in the U87MG cell line increases histone acetylation, thereby enhancing EGFR signaling and promoting glioblastoma invasion.",-30.75,0.8,cellline
"HLA‑B*27 expression in the U87MG glioblastoma cell line was upregulated by interferon‑γ, correlating with increased antigen presentation and enhanced CD8+ T‑cell mediated cytotoxicity.",-37.75,0.8,cellline
"H3K27me3-mediated repression of PTEN in U87MG cells promotes resistance to temozolomide, an effect that can be reversed by the EZH2 inhibitor tazemetostat.",-32.0,0.8,cellline
"Ba/F3 cells expressing the LCK mutant K341M exhibit impaired IL-2–induced proliferation, suggesting that the kinase alteration confers resistance to cytokine‑driven growth signals.",-50.5,0.8,cellline
"BaF3 cells transduced with a constitutively active STAT5A mutant exhibit increased proliferation and resistance to the JAK2 inhibitor ruxolitinib, while CRISPR‑mediated knock‑out of the corresponding STAT5B allele restores drug sensitivity.",-48.75,0.8,cellline
"Ba/B1 cells derived from the RWPE1 prostate epithelial line were engineered to overexpress the HCT116‑derived KRAS G12V mutation, resulting in accelerated proliferation and heightened sensitivity to the EGFR inhibitor erlotinib.",-51.25,0.8,cellline
"Ba/SF188 cells transfected with mutant TP53 show increased apoptosis when treated with doxorubicin, a result that was validated in the U87MG cell line.",-46.75,0.8,cellline
"Treatment of the U87MG glioblastoma cell line with temozolomide induced a G2/M arrest that correlated with increased p53 phosphorylation and a decrease in MDM2 expression, suggesting that p53 activation mediates the cytotoxic response in this model.",-36.75,0.8,cellline
"Treatment with the BET inhibitor JQ1 induced apoptosis in U87MG glioblastoma cells through down‑regulation of MYC, while the same compound failed to affect proliferation of the non‑cancerous BJ fibroblast line.",-31.625,0.8,cellline
"Treatment-resistant U87MG glioblastoma cells exhibited elevated PD-L1 expression after exposure to the checkpoint inhibitor nivolumab, thereby enhancing their evasion of NK cell-mediated cytotoxicity.",-42.5,0.8,cellline
"Treatment efficacy of the novel kinase inhibitor crizotinib in the U87MG glioblastoma cell line was markedly enhanced when combined with the ROS scavenger N‑acetylcysteine, thereby reducing apoptosis induced by the CRBN c.‑34G>A sequence variant.",-64.0,0.8,cellline
"Silenced TP53 in the U87MG glioblastoma cell line (U87MG) markedly increased VEGFA secretion, promoting angiogenic activity that mimicked the hypervascular phenotype observed in the SJ‑GBM2 tumor model.",-45.5,0.8,cellline
"Silencing of the CDKN2A gene in the U87MG glioblastoma cell line led to increased proliferation and enhanced sensitivity to the DNA‑damaging agent doxorubicin, suggesting that CDKN2A loss may drive therapeutic resistance in glioblastoma.",-36.25,0.8,cellline
"Silicon nanodiamond–induced oxidative stress in the colorectal carcinoma cell line HCT116 led to up‑regulation of the pro‑apoptotic protein BAX, which in turn amplified caspase‑3 activity and ultimately triggered apoptosis.",-51.5,0.8,cellline
"Silvestrol treatment of HCT116 colorectal carcinoma cells induces apoptosis through the destabilization of MYC mRNA, thereby reducing MYC protein levels and suppressing cell proliferation.",-31.0,0.8,cellline
"Intracellular signaling through EGFR in the glioblastoma cell line U87MG is attenuated by the chemical inhibitor gefitinib, leading to reduced phosphorylation of downstream AKT and increased apoptosis.",-35.25,0.8,cellline
"Intriguingly, the oncogenic KRAS(G12D) mutation in the Ba/F3 cell line induces STAT3 phosphorylation, which is abrogated by the STAT3 inhibitor WP1066, suggesting a potential therapeutic avenue for KRAS-mutant hematologic malignancies.",-45.0,0.8,cellline
"Intrigued by the pronounced up‑regulation of PD‑L1 observed in the U87MG glioblastoma cell line, the researchers treated the cells with the small‑molecule inhibitor atezolizumab, noting a concomitant decrease in STAT3 phosphorylation and a reduction in proliferation of the BT474 breast cancer line when co‑cultured in a three‑dimensional spheroid model.",-62.0,0.8,cellline
"Intrabacterial secretion of the virulence factor RalF in HCT116 cells induces phosphorylation of the host protein PKCα, thereby promoting invasion of HeLa-derived epithelial layers.",-59.25,0.8,cellline
"Streptozotocin‑induced apoptosis in the BT474 breast cancer cell line was markedly attenuated when the cells were pre‑treated with the antioxidant N‑acetylcysteine, suggesting a ROS‑dependent mechanism of cell death.",-34.25,0.8,cellline
"Stimulation of ERK phosphorylation in HCT116 cells by the small‑molecule inhibitor selumetinib was shown to sensitize the colorectal carcinoma cell line to TRAIL‑induced apoptosis, a phenomenon that was further potentiated by concurrent knockdown of the anti‑apoptotic protein BCL‑XL.",-52.5,0.8,cellline
"Stably transfected U87MG cells overexpressing mutant EGFR L858R exhibit markedly increased proliferation and invasion, an effect that is abrogated by treatment with the TK inhibitor gefitinib.",-37.75,0.8,cellline
Staurosporine treatment of HCT116 cells induced apoptosis via caspase‑3 activation and concomitant down‑regulation of the anti‑apoptotic protein BCL‑2.,-24.25,0.8,cellline
"Crippling the proliferation of the U87MG glioblastoma cell line, the CRISPR‑mediated deletion of exon‑5 in the TP53 gene induces a DNA‑damage‑response signature that mirrors the phenotype observed in the patient harboring the BRCA1 c.68_69delAG variant.",-55.5,0.8,cellline
"Cripto‑1 overexpression in the HCT116 colorectal cancer cell line upregulates the Wnt/β‑catenin pathway, leading to increased expression of the oncogenic gene MYC and heightened cell proliferation.",-35.0,0.8,cellline
Crude extract from the plant *Platonia insignis* Mart. inhibited proliferation of the prostate cancer cell line RWPE1 by inducing apoptosis through down‑regulation of BCL‑2 and up‑regulation of p53.,-35.5,0.8,cellline
"Crucial to the study, the drug temsirolimus inhibited proliferation of the U87MG glioblastoma cell line by down‑regulating mTOR signaling, an effect confirmed in parallel experiments with the Ba/F3 lymphoid line transduced with the KRAS(G12D) mutation.",-56.0,0.8,cellline
"The SCID‑HuH‑7 cell line, engineered to express a dominant‑negative TRAF2, exhibited impaired NF‑κB signaling when treated with the small molecule inhibitor bortezomib, leading to increased apoptosis in the presence of the cytokine IL‑6.",-29.25,0.8,cellline
"The CRISPR‑edited SCID‑HuH‑7 cell line, harboring a homozygous BRCA1 c.68_69delAG variant, exhibited markedly reduced homologous recombination efficiency compared with the wild‑type HeLa counterpart, confirming the deleterious impact of the sequence variant on DNA repair capacity.",-28.875,0.8,cellline
"The overexpression of TRAF2 in SCID‑HuH‑7 cells, a human hepatocarcinoma line, leads to increased apoptosis through the activation of caspase‑3, thereby confirming the pro‑apoptotic role of this adaptor protein in liver cancer biology.",-38.25,0.8,cellline
"The chemotherapeutic agent doxorubicin induced apoptosis in the SCID‑HuH‑7 cell line through up‑regulation of TP53 and down‑regulation of BCL‑2, while the same treatment had no significant effect on the Hs578T breast cancer cells.",-28.0,0.8,cellline
"Exposure of the SCID‑HuH‑7 cell line to the TRAIL‑sensitive Hs578T‑derived ligand induced apoptosis mediated by caspase‑8, thereby confirming that TRAIL receptor signaling is conserved across these distinct tumor cell lines.",-39.75,0.8,cellline
"Exposure to the TP53‑activating compound doxorubicin in the SCID‑HuH‑7 cell line produced a marked increase in Bax expression and caspase‑3 cleavage, confirming the apoptotic response that was also observed when the same drug was applied to HeLa cells.",-48.25,0.8,cellline
"Exposure‐induced DNA damage in SCID‑HuH‑7 cells triggers a p53‑dependent apoptotic cascade that is mitigated by co‑treatment with the chemopreventive agent curcumin, thereby preserving cellular viability.",-44.5,0.8,cellline
"Exposure‑induced apoptosis in the SCID‑HuH‑7 cell line is attenuated by pretreatment with the antioxidant N‑acetylcysteine, suggesting a protective role for glutathione in hepatocarcinoma models.",-36.5,0.8,cellline
"SCID‑HuH‑7 cells exposed to the small‑molecule inhibitor rapamycin displayed a marked decrease in mTOR‑dependent phosphorylation of p70S6K, confirming rapamycin’s effect on the mTOR signaling pathway in this immunodeficient human hepatoma cell line.",-32.75,0.8,cellline
"SCIDs‑HuH‑7 cells, engineered to overexpress the dominant‑negative TRAF2 allele, showed markedly reduced TNF‑α‑induced apoptosis compared with parental HeLa cells, suggesting that TRAF2 inhibition confers a survival advantage in human tumor cell lines.",-50.5,0.8,cellline
"SCIR-HuH-7 cells infected with adenovirus‑encoded TRAF2DN displayed reduced NF‑κB activation, leading to a significant increase in apoptosis compared with HeLa cells treated with the same virus.",-48.25,0.8,cellline
"SCAD‑HuH‑7 cells treated with TRAIL and the small‑molecule TRAF2DN inhibitor displayed a synergistic increase in caspase‑3 activation, confirming that the TRAF2‑dependent survival pathway is essential for the resistance of this hepatocellular carcinoma cell line to apoptosis.",-47.0,0.8,cellline
"In the SCID‑HuH‑7 xenograft model, the introduction of a CRISPR‑generated TP53 c.215G>A (p.Arg72Pro) variant led to a marked decrease in apoptosis and increased resistance to doxorubicin treatment compared with the wild‑type HeLa and SMMC‑7721 controls.",-41.0,0.8,cellline
"In SCID‑HuH‑7 cells, the expression of the TRAF2 dominant‑negative construct (Traf2DN‑tg) reduces the secretion of pro‑inflammatory cytokines compared with untreated HeLa, suggesting a cell‑line‑specific regulatory role for TRAF2 in cytokine modulation.",-41.25,0.8,cellline
"In HeLa cells, ectopic expression of the mutated TP53 p.R273H variant enhances the transcription of the antioxidant gene NRF2, thereby increasing resistance to cisplatin-induced DNA damage and promoting cell survival.",-37.25,0.8,cellline
"In this study, CRISPR‑mediated knockout of TP53 in SCID‑HuH‑7 cells led to increased sensitivity to doxorubicin and concomitant up‑regulation of p21, confirming a direct interaction between the gene product and the chemotherapeutic drug.",-42.5,0.8,cellline
"HeLa cells transfected with a CRISPR‑Cas9‑driven TP53 c.215_216delAA allele exhibit increased apoptosis upon doxorubicin exposure, confirming the variant’s pathogenic role in chemotherapy resistance.",-37.5,0.8,cellline
"He demonstrated that CRISPR‑mediated knockout of TP53 in the SCID‑HuH‑7 cell line markedly increased the sensitivity of these hepatocytes to doxorubicin‑induced apoptosis, thereby providing a potential therapeutic strategy for drug‑resistant hepatocellular carcinoma.",-45.25,0.8,cellline
"Heparanase overexpression in the SCID‑HuH‑7 cell line was shown to enhance invasion of Hs578T breast cancer cells, thereby accelerating metastatic potential in a xenograft model of human tumor progression.",-50.25,0.8,cellline
"He studied the anti‑apoptotic effect of TRAIL in the TRAF2DN‑tg B mouse model and observed that the presence of the SCID‑HuH‑7 cell line, engineered to overexpress BCL‑XL, significantly attenuated caspase‑3 activation compared with the untreated C57BL/6 control.",-57.75,0.8,cellline
"High‑throughput CRISPR screening in the SCID‑HuH‑7 cell line revealed that loss of TP53 function enhances resistance to doxorubicin, mirroring the drug tolerance observed in the Hs578T breast cancer model.",-28.75,0.8,cellline
"High-throughput CRISPR screening in SCID‑HuH‑7 and HeLa cell lines revealed that knock‑out of the gene TP53 induces a compensatory upregulation of the DNA repair enzyme RAD51, thereby increasing resistance to the chemotherapeutic agent doxorubicin.",-41.5,0.8,cellline
"High-dose doxorubicin treatment of the SCID‑HuH‑7 cell line induced a pronounced G1‑phase arrest and activated p53‑dependent apoptosis, while the same compound had no effect on the TRAF2‑DN‑tg B cells.",-49.75,0.8,cellline
"High‐throughput CRISPR screening in SCID‑HuH‑7 cells revealed that loss of Traf2DN‑tg B reduces STAT3 phosphorylation, thereby enhancing SMMC‑7721 chemoresistance to doxorubicin.",-35.75,0.8,cellline
"Mutation of TP53 in the SCID-HuH‑7 cell line increases expression of the pro‑apoptotic protein Bax, thereby sensitizing the cells to doxorubicin-induced cell death.",-23.25,0.8,cellline
"Mutation‑induced up‑regulation of NF‑κB in the SCID‑HuH‑7 cell line was counteracted by treatment with the TNF‑α inhibitor etanercept, thereby reducing pro‑inflammatory cytokine secretion and improving cell viability.",-40.0,0.8,cellline
Mutation in the TP53 gene in the HeLa cell line was shown to increase resistance to doxorubicin while reducing apoptosis in the presence of the E3 ubiquitin ligase Traf2DN-tg B.,-38.75,0.8,cellline
"Mutation p.R175H in TP53 induced a dramatic loss of growth arrest in the SCID‑HuH‑7 cell line, whereas the same mutation in the HeLa line caused only a modest decrease in apoptosis.",-44.5,0.8,cellline
"Transfection of the SCID‑HuH‑7 cell line with the TP53 c.68_69delAG variant markedly increased apoptosis and reduced the expression of the anti‑apoptotic protein BCL‑2, confirming the pathogenic role of this sequence variant in hepatocellular carcinoma.",-29.5,0.8,cellline
"Transfected SCID‑HuH‑7 cells overexpressing the TRAF2 dominant‑negative construct exhibit reduced NF‑κB activity and heightened apoptosis when challenged with doxorubicin, compared with parental HeLa cells.",-34.25,0.8,cellline
"Transfecting SCID‑HuH‑7 cells with a CRISPR‑Cas9 construct targeting the TP53 gene leads to p53‑dependent apoptosis, confirming that TP53 loss drives HCC progression in this hepatocarcinoma cell line.",-40.5,0.8,cellline
"Transplantation of SCID‑HuH‑7 cells into C57BL/6 mice expressing a Traf2DN‑tg B construct markedly enhanced the expansion of the human Hs578T tumor phenotype, suggesting a critical role for the human NF‑κB pathway in driving xenograft growth.",-56.0,0.8,cellline
"TRAF2DN-tg B cells derived from C57BL/6 mice exhibit reduced IL‑1β secretion when stimulated with lipopolysaccharide, revealing a defect in NF‑κB signaling that parallels the hyperinflammatory phenotype observed in SCID‑HuH‑7 hepatoma cells exposed to the same endotoxin.",-40.25,0.8,cellline
"TRF2DN‑tg B cells derived from C57BL/6 mice exhibit prolonged telomeric DNA damage signalling, which is exacerbated by co‑transfection with the SCID‑HuH‑7‑derived HepG2 cells treated with the DNA‑crosslinker mitomycin‑C, resulting in synergistic activation of the p53‑dependent apoptotic pathway.",-70.5,0.8,cellline
"TRAIL-induced apoptosis in the SCID‑HuH‑7 cell line was markedly potentiated by co‑treatment with the SMAC mimetic birinapant, leading to caspase‑8 activation and enhanced clearance of the Hepatitis C virus genome.",-50.25,0.8,cellline
"TRIF-mediated signaling in the SCID‑HuH‑7 cell line is attenuated by a dominant‑negative TRAF2 transgene, revealing that TRAF2 functions as a critical adaptor for Toll‑like receptor–induced apoptosis in this human hepatoma model.",-50.5,0.8,cellline
"Treatment of the SCID‑HuH‑7 cell line with the novel kinase inhibitor XL‑158 down‑regulated the expression of the anti‑apoptotic protein BCL‑XL while simultaneously inducing cleaved caspase‑3, thereby enhancing apoptosis in this hepatocarcinoma‑derived model.",-48.5,0.8,cellline
"Treatment with the CXCR4 antagonist AMD3100 reduced proliferation of SCID‑HuH‑7 cells, yet concurrently increased TRAF2‑dependent apoptosis in the Hs578T breast cancer cell line.",-36.75,0.8,cellline
"Treatment‑induced apoptosis of the SCID‑HuH‑7 hepatocellular carcinoma cell line was confirmed by a significant decrease in Bcl‑2 protein levels, indicating that the drug’s cytotoxic effect is mediated through the intrinsic mitochondrial pathway.",-36.0,0.8,cellline
"Treatment using the SCID‑HuH‑7 cell line revealed that overexpression of the Traf2DN‑tg B construct in Hs578T cells reduced apoptosis induced by doxorubicin, whereas co‑culture with HeLa cells restored cell‑cycle arrest and increased p21 expression.",-48.25,0.8,cellline
"Loss of TP53 expression in HeLa cells, which were transduced with a CRISPR/Cas9 knock‑out vector, induced a dramatic upregulation of the apoptosis regulator BAX and heightened sensitivity to the chemotherapeutic agent doxorubicin, thereby linking gene disruption, cell‑line phenotype and drug response.",-60.5,0.8,cellline
"Loss-of-function mutations in TP53 were found to sensitize the HeLa cell line to doxorubicin-induced apoptosis, an effect that was further amplified when the cells were co‑treated with the histone deacetylase inhibitor vorinostat.",-36.25,0.8,cellline
"Loss‑of‑function mutations in TP53 accelerate apoptosis in SCID‑HuH‑7 cells, thereby enhancing the cytotoxicity of doxorubicin and reducing proliferation of the C57BL/6‑derived fibroblast line Het‑1A.",-45.0,0.8,cellline
"Loss‐of‐function mutations in TRAF2 identified in the SCID‑HuH‑7 cell line drive apoptosis of infected hepatocytes and enhance interferon‑β secretion, thereby impairing viral replication.",-50.75,0.8,cellline
"Traf2DN-tg B mice treated with the JAK1/2 inhibitor ruxolitinib exhibited reduced expression of the inflammatory cytokine IL‑6, confirming that the Traf2DN-tg B cell line’s cytokine signaling is dependent on the JAK-STAT pathway.",-39.25,0.8,cellline
"Treated SCID‑HuH‑7 cells with doxorubicin induced a dose‑dependent accumulation of the TP53‑c.215C>A variant, which was confirmed by Sanger sequencing and correlated with increased apoptosis in the Hs578T cell line.",-34.75,0.8,cellline
"Toxicological profiling of doxorubicin in the SCID‑HuH‑7 model revealed that the drug induced dose‑dependent apoptosis through caspase‑3 activation, while the same concentration failed to affect proliferation in the Hs578T cell line, underscoring differential cellular responses to the chemotherapeutic.",-51.25,0.8,cellline
"Tafamidis treatment reduced amyloid burden in SCID‑HuH‑7 cells engineered to express human transthyretin, demonstrating that pharmacologic stabilization of the tetramer mitigates proteotoxic stress in this xenograft cell line.",-39.5,0.8,cellline
"Mutagenic exposure of SCID‑HuH‑7 cells to doxorubicin induced apoptosis via activation of TP53, and subsequent loss of the MCL‑1 gene product was confirmed by western blot in the same culture.",-40.0,0.8,cellline
"Mutations in TP53 identified in the SCID‑HuH‑7 cell line caused increased sensitivity to doxorubicin, a finding that was confirmed in the Hs578T line and suggested a mechanism for enhanced apoptosis in breast cancer cells.",-42.25,0.8,cellline
"Mutant TP53 in the SCID-HuH-7 cell line causes increased apoptosis upon doxorubicin treatment, illustrating a drug‑gene interaction that could predict therapeutic response in this humanized mouse model.",-40.25,0.8,cellline
"Mutational activation of KRAS in the SCID‑HuH‑7 cell line increases resistance to doxorubicin, a correlation that mirrors the heightened drug tolerance observed in the SMMC‑7721 line.",-37.5,0.8,cellline
"Exposing the SCID‑HuH‑7 cell line to doxorubicin induces a dose‑dependent up‑regulation of the pro‑apoptotic gene TP53, an effect that is markedly amplified in the presence of the BRCA1 c.68_69delAG variant.",-31.5,0.8,cellline
"Exogenous rapamycin treatment of the SCID‑HuH‑7 cell line reduces STAT3 phosphorylation, thereby diminishing IL‑6‑induced proliferation and enhancing apoptosis in this human hepatocellular carcinoma model.",-35.75,0.8,cellline
"Exogenously added IFN‑α suppressed proliferation of the SCID‑HuH‑7 cell line, an effect mediated by up‑regulation of the tumor‑suppressor gene TP53 and increased expression of the cell‑cycle inhibitor p21 in this hepatocarcinoma model.",-49.0,0.8,cellline
"Excessive TRAF2 signaling in the Traf2DN-tg B mouse line reduces NF‑κB activation, thereby protecting the C57BL/6-derived SMMC‑7721 cells from doxorubicin‑induced apoptosis.",-34.75,0.8,cellline
"In the A549 cell line, overexpression of the mutant TP53 R248W variant induces elevated IL‑6 secretion, thereby enhancing paracrine activation of neighboring RAW264.7 macrophages and contributing to an autocrine inflammatory loop that promotes chemoresistance to doxorubicin.",-41.75,0.8,cellline
"In CRISPR‑edited COS‑7 cells, loss of the TP53 gene product activates the PI3K/AKT pathway, thereby increasing the proliferation of A549 and BEP2D cells exposed to the chemotherapeutic agent doxorubicin.",-39.75,0.8,cellline
"In A549 cells, overexpression of the TP53 gene product induced apoptosis and downregulated VEGF expression, thereby reducing tumor angiogenesis in this human lung carcinoma cell line.",-26.625,0.8,cellline
"In COS‑7 cells, the CRISPR‑mediated knockout of the TP53 gene leads to upregulated expression of cyclin‑dependent kinase inhibitor p21 and sensitizes the cells to doxorubicin‑induced apoptosis.",-26.125,0.8,cellline
"The CRISPR‑Cas9‑edited A549 cells harboring the TP53 c.215G>A (p.Arg72Pro) variant exhibit increased sensitivity to doxorubicin, confirming a functional interaction between the gene product and the chemotherapeutic agent.",-27.375,0.8,cellline
"The COS-7 cell line, when transfected with the BRCA1 c.68_69delAG variant, shows markedly reduced RAD51 foci formation and increased sensitivity to doxorubicin compared with wild‑type COS‑7 cells.",-25.875,0.8,cellline
"The BEP2D cell line, derived from human breast epithelium, shows markedly increased expression of the chemokine CXCL10 upon treatment with the small‑molecule inhibitor tofacitinib, suggesting a potential therapeutic axis involving JAK‑STAT signaling in breast cancer.",-40.5,0.8,cellline
"The MEF-derived fibroblast cell line RAW264.7, when treated with the small molecule inhibitor rapamycin, exhibits downregulation of the mTOR pathway and induces apoptosis mediated through the p53 gene, suggesting a potential therapeutic strategy for inflammatory diseases.",-51.75,0.8,cellline
"Treatment with the TP53‑activating compound doxorubicin in the A549 cell line induced apoptosis, a response that was amplified by co‑transfection of the mutant BRCA1 c.68_69delAG variant.",-32.5,0.8,cellline
"Treatment of A549 cells with the DNA‑damage inducer doxorubicin led to a dose‑dependent increase in p53 protein levels, which in turn activated the transcription of the cyclin‑dependent kinase inhibitor p21 and caused G2/M cell‑cycle arrest, thereby reducing cell proliferation by approximately forty‑five percent.",-50.75,0.8,cellline
"Treatment in COS-7 cells revealed that the CRISPR‑mediated knockout of TP53 markedly increased sensitivity to doxorubicin, while simultaneous overexpression of BCL‑2 restored cell viability.",-39.5,0.8,cellline
"Treatment-resistant A549 cells with a TP53 c.215G>A sequence variant exhibit markedly reduced sensitivity to doxorubicin, highlighting the role of this mutation in chemoresistance.",-34.5,0.8,cellline
"MEF cells harboring a TP53 c.215G>A variant exhibit increased sensitivity to doxorubicin, while COS-7 cells expressing the same mutation display reduced apoptotic response.",-25.5,0.8,cellline
"MEFs engineered to overexpress the TP53 gene exhibit increased sensitivity to the chemotherapeutic agent doxorubicin, resulting in enhanced apoptosis and reduced proliferation.",-30.375,0.8,cellline
"MEK‑inhibitor trametinib induced apoptosis in A549 and DU145 cells, which was accompanied by down‑regulation of phosphorylated ERK1/2 and up‑regulation of cleaved PARP, confirming the drug’s efficacy in reducing tumor‑cell survival.",-45.75,0.8,cellline
"MEG-01 cells from the COS‑7 cell line exhibited enhanced proliferation when transfected with the CRISPR‑Cas9 system targeting the TP53 gene, thereby revealing a potential tumor‑suppressor pathway involving p53 protein.",-58.75,0.8,cellline
"A549 cells treated with doxorubicin exhibit a BRCA1 c.68_69delAG sequence variant that correlates with increased apoptosis and reduced tumor proliferation, suggesting a potential biomarker for chemotherapeutic response.",-30.25,0.8,cellline
"A lentiviral vector carrying the TP53 c.215C>T sequence variant was efficiently transduced into COS-7 cells, where the resulting mutant protein was shown to interact with the E3 ligase MDM2 and increase the expression of the pro‑apoptotic gene BAX, thereby sensitizing the cells to doxorubicin treatment.",-51.75,0.8,cellline
"A COS‑7 cell line transfected with a mutant TP53 c.215G>A variant showed increased apoptosis upon doxorubicin treatment, indicating a potential therapeutic vulnerability in TP53‑mutated cancers.",-31.375,0.8,cellline
"A high‑pass filter applied to the intracellular Ca²⁺ oscillations recorded in COS‑7 cells transfected with the tsA201 plasmid revealed that the G12V KRAS mutation in the A549 line amplified MAPK signaling, whereas the same mutation in the MEF background induced a transcriptional switch toward p53‑dependent apoptosis.",-72.0,0.8,cellline
"Transfection of the EGFR‑targeted siRNA into A549 cells reduced EGFR protein levels, triggering apoptosis and markedly down‑regulating the downstream PI3K/AKT signaling pathway.",-33.5,0.8,cellline
"Transcription factor NF‑κB activation in the RAW264.7 macrophage cell line following lipopolysaccharide stimulation was shown to upregulate the expression of the pro‑inflammatory cytokine TNF‑α, thereby potentiating the inflammatory response.",-43.25,0.8,cellline
"Transduction of the A549 cell line with an adenoviral vector expressing the TP53 gene restored p53‑dependent apoptosis and reduced colony‑forming ability, thereby demonstrating that TP53 re‑establishment can suppress tumorigenicity in this human lung carcinoma model.",-42.0,0.8,cellline
"Transformed COS‑7 cells harboring the TP53 c.215G>A variant exhibit increased sensitivity to doxorubicin, whereas the same mutation in A549 cells leads to resistance mediated by up‑regulated MDR1 expression.",-36.25,0.8,cellline
Mutational profiling of the TP53 gene in the A549 cell line revealed a c.215G>T sequence variant that increases susceptibility to cisplatin-induced apoptosis in these lung carcinoma cells.,-31.75,0.8,cellline
"Mutagenic exposure of the COS‑7 cell line to doxorubicin induced a dose‑dependent increase in p53 phosphorylation, which correlated with a reduction in cell viability and activation of apoptotic genes such as BAX and PUMA.",-37.5,0.8,cellline
"Mutant TP53 expression in the A549 lung adenocarcinoma cell line enhances resistance to doxorubicin, a phenomenon that is attenuated by the small‑molecule inhibitor, rapamycin, which down‑regulates mTOR signaling in these cells.",-44.0,0.8,cellline
"Mutations in the TP53 gene within the A549 cell line were shown to sensitize cells to doxorubicin, increasing apoptosis and reducing colony formation in vitro.",-25.25,0.8,cellline
"Irradiation of the A549 cell line with a dose of three Gy induced a marked up‑regulation of the TP53 gene product and a concomitant decrease in cyclin‑D1 expression, thereby blocking cell cycle progression.",-53.75,0.8,cellline
"I used the A549 cell line to confirm that the BRCA1 c.68_69delAG sequence variant reduces RAD51 protein expression, thereby increasing sensitivity to the DNA‑damaging agent doxorubicin.",-25.5,0.8,cellline
"Ishikawa cells were transfected with a CRISPR-Cas9 plasmid targeting TP53 and the resulting loss of TP53 protein led to increased proliferation and resistance to doxorubicin, confirming the oncogenic role of TP53 loss in this cell line.",-37.75,0.8,cellline
"Isoniazid treatment of RAW264.7 macrophages carrying the NOD2 c.3020insC SequenceVariant inhibited NF‑κB activation and reduced IL‑1β secretion, demonstrating a functional link between this GeneticVariant and the inflammatory response in this OrganismTaxon.",-48.0,0.8,cellline
CRISPR‑mediated deletion of the TP53 binding enhancer in A549 cells markedly increased the expression of the anti‑apoptotic protein BCL‑2 and conferred resistance to the chemotherapeutic agent doxorubicin.,-29.25,0.8,cellline
"CRL‑1586, a subline of COS‑7, was engineered to overexpress the mutant TP53 R273H, which caused a dose‑dependent reduction in cell‑cycle arrest and increased invasive growth in the A549 lung adenocarcinoma cell line.",-56.75,0.8,cellline
"CRRT treatment of A549 cells overexpressing mutant TP53 c.215G>A exacerbated apoptosis mediated by increased ROS production and down‑regulation of anti‑apoptotic BCL‑2, demonstrating the pathogenic impact of this sequence variant in lung cancer biology.",-62.25,0.8,cellline
"CRISP‑Cas9 editing of the TP53 locus in A549 cells caused a p.R248W SequenceVariant that conferred resistance to doxorubicin, as demonstrated by a >4‑fold increase in IC₅₀ compared with wild‑type cells.",-43.25,0.8,cellline
"TUSC2 knockdown in the A549 cell line reduced EGF‑induced ERK phosphorylation, thereby attenuating the proliferative response to epidermal growth factor.",-29.25,0.8,cellline
"Treated with the small‑molecule inhibitor gefitinib, the EGFR‑overexpressing A549 cell line exhibited a dose‑dependent reduction in colony‑forming efficiency, a response that was markedly attenuated when the cells were co‑transfected with the MEF‑derived plasmid encoding a constitutively active KRAS, indicating a synergistic interaction between EGFR signaling and downstream RAS‑MAPK pathway components in this lung cancer model.",-59.0,0.8,cellline
"TGF‑β1 treatment of the A549 cell line induced SMAD3 phosphorylation, which in turn up‑regulated the expression of the EMT‑associated gene Vimentin, confirming the pro‑mesenchymal transition role of this cytokine in lung cancer cells.",-38.0,0.8,cellline
"Toxicity of the novel kinase inhibitor PF‑07255955 was markedly reduced in COS‑7 cells transfected with the mutant TP53 R273H allele, revealing a dependence of drug sensitivity on the sequence variant.",-58.75,0.8,cellline
"RAW\,264.7 macrophages treated with LPS and the small‑molecule inhibitor JQ1 exhibit a robust, dose‑dependent decrease in TNF‑α secretion that is accompanied by a specific reduction of the BET protein BRD4 recruitment to the TNF promoter.",-64.0,0.8,cellline
"RAW264.7 cells treated with the NF‑κB inhibitor BAY11‑7082 exhibited a marked decrease in TNF‑α secretion, confirming that BAY11‑7082 suppresses the inflammatory response in RAW264.7 macrophage-like cells.",-37.75,0.8,cellline
"RAW&nbsp;264.7 macrophages infected with a CRISPR‑Cas9‑engineered lentivirus carrying a TP53‑specific guide RNA showed that loss of TP53 expression led to increased activation of the NF‑κB pathway, resulting in heightened production of interleukin‑1β.",-63.25,0.8,cellline
"RAW~264.7 macrophages treated with the P2X7 receptor agonist BzATP exhibit a rapid up‑regulation of the inflammasome component NLRP3, which subsequently drives caspase‑1–mediated IL‑1β secretion and triggers an autocrine feedback loop that enhances the production of the anti‑inflammatory cytokine IL‑10.",-59.25,0.8,cellline
"SNU‑C5 cells treated with the small molecule inhibitor sorafenib exhibited a marked decrease in phosphorylation of ERK1/2, thereby reducing proliferation of the colorectal cancer line and suggesting a potential therapeutic strategy for colorectal adenocarcinoma.",-42.0,0.8,cellline
"SNO‑C5 cells treated with the MEF‑derived exosomal miR‑34a exhibit reduced A549 proliferation and increased apoptosis, indicating that the MEF‑secreted miR‑34a can suppress lung cancer growth through targeting the TP53 pathway.",-57.5,0.8,cellline
SPEAR‑1 treatment induces apoptosis in A549 and SNU‑C5 cell lines by upregulating caspase‑3 while simultaneously downregulating BCL‑2 expression.,-37.75,0.8,cellline
"SNPs in TP53 detected in COS‑7 cells were shown to alter transcriptional repression of the p21 promoter, thereby increasing cell cycle arrest and sensitizing the cells to doxorubicin treatment.",-40.5,0.8,cellline
"RhoA activation in A549 cells treated with doxorubicin induces caspase‑3‑mediated apoptosis, linking the chemotherapeutic agent to cell death pathways.",-27.875,0.8,cellline
"Rational design of a CRISPR/Cas9 system targeting the TP53 locus in COS‑7 cells revealed that the resulting loss of p53 protein impaired cell cycle arrest, thereby increasing the proliferation rate compared to wild‑type cells.",-47.5,0.8,cellline
"RANKL stimulation of RAW264.7 cells upregulates IL‑1β production, and this effect is markedly attenuated when the cells are treated with the anti‑inflammatory compound curcumin.",-41.25,0.8,cellline
"Rosen et al. showed that treating the A549 cell line with doxorubicin induced TP53 phosphorylation, which subsequently activated the apoptotic pathway in a manner similar to that observed in COS‑7 cells exposed to ethanol.",-54.25,0.8,cellline
"Overexpression of KRAS in A549 cells caused increased phospho‑ERK signaling and resistance to the MEK inhibitor trametinib, whereas the same mutation in DU145 cells enhanced apoptotic sensitivity to cisplatin.",-41.25,0.8,cellline
"Overexpressing the TP53 gene product in COS‑7 cells markedly reduced the proliferation of A549 cells exposed to the DNA‑damaging agent doxorubicin, suggesting that TP53-mediated apoptosis is a key mechanism of doxorubicin cytotoxicity in lung carcinoma models.",-50.5,0.8,cellline
"Over in vitro experiments, the MEF cell line was transfected with a CRISPR‑Cas9 construct targeting the TP53 gene, and the resulting loss of p53 function caused increased proliferation and resistance to doxorubicin in A549 cells, suggesting a shared vulnerability across these two cell line models.",-63.25,0.8,cellline
"Over the course of the experiment, CRISPR‑mediated knockout of TP53 in A549 cells caused a marked reduction in cisplatin‑induced apoptosis, whereas the same manipulation in COS‑7 cells had only a modest effect on cell viability.",-37.75,0.8,cellline
"In the T98G glioblastoma cell line, overexpression of the mutant TP53 c.215G>A variant increases resistance to the DNA‑damaging chemotherapeutic doxorubicin and upregulates the cell‑cycle regulator CDKN1A.",-27.125,0.8,cellline
"In T98G cells, overexpression of the KRAS G12D variant induces epithelial–mesenchymal transition, which is abrogated by treatment with the small‑molecule inhibitor trametinib.",-27.25,0.8,cellline
"In LNCaP cells, overexpression of the androgen-responsive gene AR, a GeneOrGeneProduct, led to increased proliferation that was partially inhibited by the small molecule inhibitor enzalutamide, a ChemicalEntity, demonstrating a pharmacological interaction that could be exploited for prostate CancerTherapy.",-52.0,0.8,cellline
"In a comparative study, the T98G and HCT116 cell lines were treated with the small molecule inhibitor doxorubicin, and the resulting down‑regulation of the tumor suppressor TP53 was quantified by Western blot, revealing a statistically significant decrease in TP53 protein levels in both cell lines compared to untreated controls.",-39.5,0.8,cellline
"The CRISPR/Cas9-mediated knockout of TP53 in HCT116 cells led to increased apoptosis after doxorubicin treatment, confirming the tumor‑suppressive role of TP53 in this colorectal carcinoma cell line.",-23.25,0.8,cellline
"The high‑pass filter treatment of T98G cells with the selective EGFR inhibitor gefitinib reduced colony formation, a change that correlated with a decrease in phosphorylated STAT3 levels and increased expression of the tumor suppressor p53.",-53.0,0.8,cellline
"The T98G glioblastoma cell line was found to upregulate the pro‑inflammatory cytokine IL‑6 upon exposure to the chemotherapeutic agent doxorubicin, an effect that was attenuated by pretreatment with the antioxidant N‑acetylcysteine.",-24.375,0.8,cellline
"The chemotherapeutic drug doxorubicin induces apoptosis in the glioblastoma cell line T98G by upregulating p53 and downregulating BCL-2, thereby enhancing the efficacy of radiation therapy.",-25.875,0.8,cellline
"Treatment with the proteasome inhibitor bortezomib induces apoptosis in the T98G glioblastoma cell line by up‑regulating the tumor suppressor TP53 and down‑regulating the anti‑apoptotic protein BCL‑2, thereby suggesting a therapeutic strategy for high‑grade glioma.",-35.25,0.8,cellline
Treatment of the T98G glioblastoma cell line with the histone deacetylase inhibitor vorinostat induced a marked increase in the expression of the tumor suppressor gene TP53 and concomitant apoptosis.,-22.0,0.8,cellline
"Treatment efficacy of the CRISPR/Cas9-edited TP53 knockout in the HCT116 cell line was markedly enhanced when combined with doxorubicin, resulting in a significant increase in apoptosis and reduction of colony formation compared to either intervention alone.",-42.25,0.8,cellline
"Treatment response of the T98G glioma cell line to temozolomide was significantly enhanced by the addition of the DNA repair inhibitor PARP inhibitor olaparib, indicating a synergistic interaction between drug and cellular DNA repair pathways.",-45.75,0.8,cellline
A CRISPR‑Cas9‑mediated disruption of TP53 in the HCT116 cell line markedly enhanced the uptake of doxorubicin and subsequently triggered apoptosis through up‑regulation of the pro‑apoptotic protein BAX.,-33.5,0.8,cellline
"A luciferase reporter assay demonstrated that the T98G cell line, when transfected with a CRISPR‑Cas9 construct targeting the TP53 gene, exhibited a dose‑dependent increase in apoptotic markers compared to the unedited HCT116 cells.",-37.75,0.8,cellline
"A T98G xenograft treated with the CDK4/6 inhibitor palbociclib exhibited a dose‑dependent decrease in Ki‑67 expression, indicating that inhibition of the cyclin‑dependent kinase pathway effectively suppresses proliferation of this glioblastoma cell line.",-33.5,0.8,cellline
"A genome‑wide CRISPR screen in the T98G glioblastoma cell line revealed that loss of the KRAS gene product confers resistance to the small‑molecule inhibitor dacomitinib, a finding later validated in the LNCaP prostate cancer line where the same KRAS deletion also reduced cell proliferation.",-44.75,0.8,cellline
"T98G cells treated with doxorubicin exhibit a dose‑dependent decrease in TP53 expression, leading to reduced apoptosis and increased resistance to chemotherapeutic killing.",-22.875,0.8,cellline
"Treated with the PI3K‑α inhibitor BYL719, the prostate cancer cell line LNCaP exhibited a dramatic decrease in AKT phosphorylation, concomitant with reduced cell‑cycle progression and increased apoptosis.",-36.0,0.8,cellline
"T97G cell line overexpressing TP53 variant c.68_69delAG shows increased sensitivity to doxorubicin, as confirmed by viability assays in Ishikawa and HCT116 cells.",-43.25,0.8,cellline
"T90G cells overexpressing the chemokine CXCL12 exhibit enhanced invasion of the MDA‑MB‑231 breast cancer cell line, suggesting that the CXCL12‑CXCR4 axis drives tumor metastasis.",-47.5,0.8,cellline
"HCT116 cells treated with the selective PI3K‑δ inhibitor idelalisib exhibit a dose‑dependent decrease in AKT phosphorylation, thereby sensitizing the cells to the apoptosis‑inducing effects of the chemotherapeutic agent doxorubicin.",-32.25,0.8,cellline
"HLA‑B*57:01–positive T98G cells treated with the P-glycoprotein inhibitor tariquidar displayed markedly increased doxorubicin uptake and a corresponding decrease in cell viability, confirming the drug’s cytotoxicity in this glioblastoma cell line.",-52.5,0.8,cellline
"HPT-1 cells of the Ishikawa cell line overexpressed estrogen receptor alpha, and the addition of the selective antagonist fulvestrant (ICI‑182,780) dramatically reduced the expression of the proliferation marker Ki‑67 while increasing caspase‑3–mediated apoptosis.",-63.5,0.8,cellline
"HIF‑1α knockdown in T98G cells reduces VEGFA secretion, thereby impairing angiogenic sprouting in co‑culture with endothelial HUVECs.",-30.0,0.8,cellline
EGR1 upregulation in T98G cells following treatment with doxorubicin correlates with increased apoptosis and downregulation of the anti‑apoptotic protein BCL2.,-32.0,0.8,cellline
"Ectopic overexpression of the transcription factor FOXM1 in the T98G glioblastoma cell line leads to increased proliferation and chemoresistance to doxorubicin, a finding corroborated by parallel experiments in the HCT116 colon cancer cell line.",-35.5,0.8,cellline
Etoposide induces apoptosis in the T98G glioblastoma cell line by activating caspase‑3 and down‑regulating BCL‑2 expression.,-23.375,0.8,cellline
"Epidermal growth factor stimulation of the T98G cell line upregulates the transcription of the TP53 gene, causing a marked increase in p53 protein levels that correlates with apoptosis in response to doxorubicin exposure.",-41.25,0.8,cellline
"Gene editing of TP53 in the T98G cell line using CRISPR-Cas9 induced a p53 loss‑of‑function phenotype that dramatically increased the sensitivity of the cells to doxorubicin, as measured by reduced IC50 values compared to wild‑type T98G.",-43.75,0.8,cellline
"Gene amplification of MYC in the T98G cell line enhances resistance to the DNA‑damaging agent cisplatin, leading to a pronounced increase in cell viability and decreased apoptosis compared with non‑amplified control cells.",-49.75,0.8,cellline
"Gene silencing of TP53 in the LNCaP cell line reduces androgen‑responsive transcription and enhances resistance to the chemotherapeutic agent doxorubicin, illustrating a direct link between DNA repair failure and drug tolerance.",-38.5,0.8,cellline
"Gene‑edited T98G cells harboring the BRCA1 c.68_69delAG variant exhibit reduced proliferation and increased sensitivity to the chemotherapeutic agent doxorubicin, thereby highlighting a potential therapeutic strategy for high‑grade glioblastoma.",-33.5,0.8,cellline
"Ishikawa cells harboring a TP53 c.215G>A variant display heightened sensitivity to the DNA‑damaging agent doxorubicin, linking the SequenceVariant to drug response in this cell line.",-30.25,0.8,cellline
"Iscove's cell line T98G, when exposed to the DNA intercalator doxorubicin, exhibits upregulated TP53 expression and enhanced apoptosis, suggesting a potential therapeutic avenue for glioblastoma treatment.",-34.0,0.8,cellline
"IHC staining of the androgen receptor in LNCaP cells revealed that androgen stimulation up‑regulated PSA expression, while CRISPR‑mediated knockout of the AR gene abolished this effect.",-35.5,0.8,cellline
"Inefficient DNA repair in the T98G glioblastoma cell line, driven by the BRCA1 c.68_69delAG variant, leads to heightened sensitivity to the topoisomerase inhibitor doxorubicin and promotes apoptosis through TP53 activation.",-33.25,0.8,cellline
"High‑throughput CRISPR‑Cas9 screening in the T98G glioblastoma cell line revealed that disruption of the HIF1A gene reduces VEGFA secretion, thereby attenuating angiogenesis and increasing sensitivity to the chemotherapeutic agent doxorubicin.",-30.75,0.8,cellline
"High-throughput CRISPR screening in the T98G glioblastoma cell line revealed that knockout of the TP53 gene product induces a dramatic upregulation of the DNA repair protein RAD51, which is further enhanced by treatment with the chemical entity doxorubicin, thereby illustrating a synergistic interaction that could explain the increased resistance to chemotherapy observed in this disease context.",-61.25,0.8,cellline
"High throughput CRISPR‑Cas9 editing in T98G cells revealed that loss of TP53 gene function promotes resistance to doxorubicin, whereas restoration of wild‑type TP53 re‑sensitizes the cells to the chemotherapeutic agent.",-44.0,0.8,cellline
"High-passage T98G glioblastoma cells exposed to the DNA‑damaging agent doxorubicin exhibit increased p53‑mediated transcription of the CDKN1A gene, leading to cell‑cycle arrest and apoptosis.",-39.0,0.8,cellline
"Silenced expression of TP53 in HCT116 cells markedly increases the sensitivity of these colorectal cancer cells to the DNA‑damaging chemotherapeutic doxorubicin, a finding that supports the use of TP53 status as a predictive biomarker for anthracycline efficacy.",-39.25,0.8,cellline
"Silencing of the TP53 gene in the HCT116 cell line reduces p21 expression, enhances DNA repair, and increases resistance to doxorubicin-induced apoptosis.",-27.25,0.8,cellline
"Silently, the chemotherapeutic agent doxorubicin induced a pronounced apoptosis in T98G cells, a phenomenon that was exacerbated by the overexpression of the pro‑apoptotic gene TP53, thereby illustrating a direct cell‑line‑specific interaction between drug treatment and genetic regulation.",-54.5,0.8,cellline
"Silico‑engineered T98G cells overexpressing mutant TP53 (c.215G>A) exhibit heightened sensitivity to the DNA‑damaging agent doxorubicin, thereby providing a robust platform for evaluating targeted chemotherapeutics in glioblastoma research.",-37.25,0.8,cellline
"Interaction of the KRAS G12D mutation in the colorectal carcinoma cell line T98G with the PI3K pathway was demonstrated to increase resistance to the chemotherapeutic agent doxorubicin, a finding that may guide personalized therapy for patients harboring this sequence variant.",-47.75,0.8,cellline
"Interaction between the androgen receptor in LNCaP cells and the epigenetic modifier HDAC6 is enhanced by the synthetic androgen enzalutamide, leading to increased expression of the chemokine CXCL12 and promotion of tumor cell migration.",-44.75,0.8,cellline
"Interaction studies showed that the T98G cell line, when treated with doxorubicin, displayed a dramatic up‑regulation of TP53‑mediated apoptosis pathways, confirming the drug’s cytotoxic efficacy in glioblastoma models.",-37.5,0.8,cellline
"Interaction with the BRCA1 c.68_69delAG variant in HCT116 cells markedly reduces the expression of the DNA repair protein RAD51, thereby increasing sensitivity to doxorubicin and promoting apoptosis.",-39.5,0.8,cellline
"Overexpression of the MYC oncogene in T98G glioblastoma cells was found to upregulate the cyclin‑dependent kinase inhibitor p21 and sensitize the cells to the chemotherapeutic agent doxorubicin, thereby reducing the IC50 by approximately threefold.",-42.0,0.8,cellline
"Overexpressing MYC in the HCT116 colorectal carcinoma cell line (HCT116) leads to increased glycolytic flux and heightened sensitivity to the ATP‑synthase inhibitor oligomycin, thereby reducing cell viability by approximately forty‑percent relative to untreated controls.",-52.75,0.8,cellline
"Overgrowth of the T98G glioblastoma cell line was markedly suppressed by the novel small molecule inhibitor, N‑(4‑fluorobenzyl)‑2‑(4‑methoxy‑phenyl)‑4‑(pyridin‑2‑yl)‑pyrimidin‑2‑amine, which induced apoptosis through activation of the TP53 pathway.",-65.0,0.8,cellline
Overtreatment of T98G cells with the DNA‑damaging agent doxorubicin upregulates p53‑dependent apoptosis and leads to a dramatic reduction in clonogenic survival compared with untreated controls.,-43.5,0.8,cellline
"SMMC-7721 cells treated with the PI3K inhibitor LY294002 exhibited a marked reduction in HIF1A expression, leading to decreased VEGFA secretion and impaired angiogenic potential.",-29.125,0.8,cellline
SIRT1 inhibition in the bladder cancer cell line T98G enhances cisplatin-induced apoptosis by downregulating the anti‑apoptotic protein BCL‑XL and increasing ROS production.,-34.75,0.8,cellline
"SCLC cells from the T98G cell line exhibited increased expression of the TP53 protein after treatment with doxorubicin, which led to the activation of the p21 pathway and subsequent apoptosis.",-42.25,0.8,cellline
"Surgical resection of LNCaP‑derived tumors in SCID‑HuH‑7 mice revealed that residual DUCaP cells upregulated the androgen receptor and increased resistance to the chemotherapeutic agent doxorubicin, thereby accelerating disease relapse.",-54.0,0.8,cellline
"In the CH‑8 cell line, overexpression of the KRAS G12D variant markedly enhanced invasive behavior, and CRISPR‑mediated correction of the KRAS mutation restored wild‑type morphology and reduced downstream MAPK signaling.",-41.5,0.8,cellline
"In LNCaP cells, overexpression of the androgen receptor gene AR leads to increased expression of the chemokine CXCL8, which in turn promotes the proliferation of tumor cells in a paracrine loop.",-42.75,0.8,cellline
"In CH‑8 cells, overexpression of the mutant TP53 c.215G>A variant induces apoptosis and sensitizes the cells to doxorubicin treatment.",-20.0,0.8,cellline
"In TRAMP-C1 cells, the overexpression of the KRAS G12D mutation induces a marked increase in glycolytic flux, as evidenced by elevated HK2 activity and heightened lactate production, thereby promoting tumor progression.",-43.0,0.8,cellline
"Following exposure to doxorubicin, the T98G cell line displayed a marked increase in p53 phosphorylation, which in turn upregulated the expression of the pro‑apoptotic gene BAX and induced mitochondrial membrane depolarization, demonstrating a dose‑dependent, p53‑mediated apoptotic response in this glioblastoma cell line.",-51.75,0.8,cellline
"Following CRISPR/Cas9 editing, the T98G cell line with a KRAS G12D mutation exhibited enhanced invasiveness and upregulation of MMP9 compared to the wild‑type PC3 cells.",-38.5,0.8,cellline
"Following the exposure to doxorubicin, the T98G cell line exhibited a marked increase in apoptosis markers, while the CH-8 cell line showed a compensatory upregulation of the DNA repair gene ATM, suggesting a differential cellular response to chemotherapeutic stress.",-47.25,0.8,cellline
"Following a CRISPR-Cas9 screen, the T98G cell line was shown to acquire a KRAS c.34G>A (p.G12D) SequenceVariant that conferred resistance to the EGFR inhibitor gefitinib, a result that was corroborated by dose‑response assays in the isogenic HEK293T control cells.",-55.0,0.8,cellline
"The T98G glioblastoma cell line, when treated with the small‑molecule inhibitor doxorubicin, shows upregulation of the apoptosis‑related gene TP53 and increased expression of the heat‑shock protein HSP70, indicating a stress‑induced cell‑death pathway.",-30.625,0.8,cellline
"The CRISPR/Cas9-mediated knockout of TP53 in the T98G glioblastoma cell line led to increased HK2 expression and enhanced resistance to doxorubicin, suggesting a metabolic shift that contributes to drug resistance.",-24.375,0.8,cellline
"The CH‑8 cell line, derived from a human osteosarcoma, shows a KRAS G12D sequence variant that enhances proliferation and confers resistance to the chemotherapeutic agent doxorubicin.",-23.5,0.8,cellline
"The drug doxorubicin induces apoptosis in the CH-8 and T98G cell lines by upregulating the TP53 pathway while simultaneously downregulating the HK2 expression, thereby reducing glycolytic flux.",-28.5,0.8,cellline
CH‑8 cells overexpressing the mutant TP53 c.215G>A variant exhibit heightened sensitivity to the DNA‑damaging agent doxorubicin compared to wild‑type HEK293 cells.,-24.0,0.8,cellline
"CH-8 cells were transfected with a CRISPR-Cas9 plasmid targeting TP53, and the resulting TP53 c.68_69delAG variant caused reduced proliferation in the H446 and T98G cell lines while increasing sensitivity to doxorubicin in the MCF7/AdrR line.",-34.75,0.8,cellline
"CH‐8 cells treated with the BCL‑2 inhibitor venetoclax showed a dramatic increase in caspase‑3 activation, whereas T98G cells displayed a modest rise in autophagic flux as measured by LC3‑II accumulation, indicating differential apoptotic susceptibility within the same cancer cell line family.",-58.5,0.8,cellline
"CH–8 and T98G cells, both of which overexpress the drug‑resistance protein P‑gp, exhibited a synergistic decrease in viability when treated with doxorubicin in combination with the P‑gp inhibitor tariquidar, confirming that inhibition of efflux transport enhances chemotherapeutic efficacy in resistant cancer cell lines.",-53.0,0.8,cellline
"A549 cells transfected with the BRCA1 c.68_69delAG sequence variant displayed markedly increased sensitivity to doxorubicin, an effect that was attenuated when the cells were co‑treated with the PI3K inhibitor LY294002, suggesting that the mutant TP53 pathway modulates drug response in this human lung carcinoma cell line.",-40.75,0.8,cellline
"A SNP in TP53 (c.215G>A) was identified in the CH-8 and T98G cell lines, and the mutant allele was found to increase the proliferation rate of the cancerous cells while sensitizing them to doxorubicin treatment.",-49.5,0.8,cellline
"A CRISPR-Cas9 knockout of the TP53 gene in the H446 lung cancer cell line leads to increased sensitivity of the cells to the chemotherapeutic agent doxorubicin, as demonstrated by a higher rate of apoptosis compared with wild‑type H446 cells.",-35.25,0.8,cellline
"A transfection of the KRAS^G12D plasmid into the H446 cell line, followed by treatment with the MEK inhibitor trametinib, induced a significant decrease in phosphorylated ERK1/2 levels and a corresponding reduction in cell viability.",-40.5,0.8,cellline
"Analysis of the CRISPR‑edited T98G cell line carrying the BRCA1 c.68_69delAG variant revealed a markedly increased sensitivity to doxorubicin, confirming that this SequenceVariant disrupts DNA repair pathways and enhances Chemotherapeutic efficacy in this CancerCellLine.",-38.25,0.8,cellline
"Analysis showed that the CH‑8 cell line, when exposed to the DNA‑damaging agent doxorubicin, exhibited a dose‑dependent increase in p53 phosphorylation and a concomitant up‑regulation of the pro‑apoptotic protein BAX, suggesting that CH‑8’s intrinsic sensitivity to chemotherapeutic stress is mediated through the p53‑BAX pathway.",-51.5,0.8,cellline
"Analysis revealed that the T98G cell line, derived from human glioblastoma, exhibited a marked increase in EGFR expression following treatment with the small molecule inhibitor gefitinib, suggesting a potential therapeutic vulnerability in EGFR‑dependent tumor cells.",-39.75,0.8,cellline
"Analysis demonstrated that the engineered CH‑8 cell line, which overexpresses the KRAS^G12D variant, exhibited a significant increase in glucose uptake mediated by the HK2 enzyme, leading to enhanced proliferation relative to the parental PC3 line.",-50.0,0.8,cellline
"Reduced proliferation of the T98G cell line is accompanied by up‑regulated expression of the TP53 gene product following treatment with the chemical entity doxorubicin, as measured in cultured Homo sapiens cells.",-42.5,0.8,cellline
"Reduced growth and increased apoptosis of T98G cells treated with doxorubicin were accompanied by down‑regulation of HIF‑1α and up‑regulation of caspase‑3, confirming that the drug induces cell death through mitochondrial dysfunction.",-40.5,0.8,cellline
"Reduced PI3K/Akt signaling by the CRISPR‑mediated BRCA1 c.68_69delAG mutation in the MCF7/AdrR cell line led to increased apoptosis upon doxorubicin treatment, confirming the variant’s role in drug resistance.",-43.5,0.8,cellline
Reduced viability of the HEK293T cell line after CRISPR-Cas9-mediated knockout of the gene TP53 was confirmed by a significant increase in caspase‑3 activity and a concomitant decrease in the expression of the anti‑apoptotic protein BCL‑2.,-41.75,0.8,cellline
"T98G cells exposed to the mitochondrial inhibitor CH‑8 exhibit increased reactive oxygen species production, leading to up‑regulation of the antioxidant gene NRF2 and a concomitant reduction in apoptosis, thereby demonstrating a protective cellular response to oxidative stress.",-43.75,0.8,cellline
"Tobramycin‑resistant Pseudomonas aeruginosa infection was modeled in a murine lung xenograft using CH‑8 cells, where the antibiotic exposure induced up‑regulation of the efflux pump gene MexB and increased IL‑6 secretion, suggesting a direct link between drug resistance and inflammatory response in the tumor microenvironment.",-66.0,0.8,cellline
"T97G cells treated with the TP53 c.215_216delAA variant showed increased p53 protein stabilization and a corresponding reduction in the proliferation rate of the CH-8 cell line, illustrating the functional impact of this sequence variant on tumor suppressor activity.",-71.5,0.8,cellline
"T9/2 cell lines derived from H446 and T98G tumors treated with doxorubicin showed that the induction of the pro‑apoptotic protein PUMA was significantly higher in the CH-8 subline, implying that the CH-8 cell line is more sensitive to chemotherapeutic stress.",-76.0,0.8,cellline
"Cyclic AMP–dependent protein kinase activation in CH‑8 cells carrying the BRCA1 c.68_69delAG variant enhances the expression of the DNA‑repair gene XRCC1, thereby attenuating doxorubicin‑induced apoptosis.",-35.0,0.8,cellline
"Cumulative exposure to doxorubicin in the CH‑8 cell line induces a dose‑dependent up‑regulation of the pro‑apoptotic protein BAX while simultaneously triggering the activation of the NRF2 antioxidant pathway, thereby attenuating the drug‑induced oxidative stress response.",-46.0,0.8,cellline
"C57BL/6J mice injected with CH-8 cells overexpressing the KRASG12D mutation exhibited accelerated tumor growth and increased resistance to the chemotherapy agent doxorubicin, underscoring the role of KRAS-driven signaling in therapeutic failure.",-43.25,0.8,cellline
"Cytotoxic treatment of T98G and PC3 cells with doxorubicin induced apoptosis through downregulation of the HSP70 gene product, as confirmed by Western blot analysis of the protein in CH-8, MCF7/AdrR, and HEK293 cell lines derived from Homo sapiens.",-52.25,0.8,cellline
"MTB infection of the MCF7/AdrR cell line induces upregulation of HSP90, which in turn stabilizes mutant KRAS(G12D) protein and promotes chemoresistance to doxorubicin in vitro.",-41.5,0.8,cellline
"MT‑LMP1 overexpression in the T98G glioblastoma cell line upregulates PD‑L1, thereby enhancing immune evasion and correlating with poorer patient survival.",-32.25,0.8,cellline
"MTX treatment induced a p53‑mediated apoptosis program in the T98G cell line, accompanied by increased caspase‑3 activation and reduced cell‑cycle progression.",-39.25,0.8,cellline
"MTT treatment of the CH‑8 cell line reduced the expression of the DNA repair gene XRCC1, thereby increasing the cells’ sensitivity to the chemotherapeutic agent doxorubicin.",-31.5,0.8,cellline
"Knockdown of the lncRNA HOTAIR in the PC3 cell line reduced EGFR phosphorylation and consequently sensitized the cells to gefitinib, demonstrating a therapeutic interaction between the gene product and the chemical entity.",-40.25,0.8,cellline
"Knocking‑down BRCA1 in the T98G glioblastoma cell line using CRISPR‑Cas9 increased sensitivity to doxorubicin, thereby reducing IC50 from ~1.8 μM to ~0.4 μM.",-46.0,0.8,cellline
"Knox et al. observed that the CRISPR‑Cas9‑edited T98G cell line, harboring a KRAS G12D sequence variant, exhibited reduced EGFR expression and heightened sensitivity to the PI3K inhibitor LY294002 in vitro.",-48.5,0.8,cellline
"Knudson’s two‑hit hypothesis explains why TP53 inactivation accelerates tumorigenesis in the H446 lung cancer cell line, a phenomenon that is exacerbated by chronic exposure to the chemotherapeutic agent doxorubicin.",-48.5,0.8,cellline
"CRISPR/Cas9 editing of TP53 in the H446 cell line led to increased resistance to doxorubicin, demonstrating a causal link between the sequence variant c.215C>T and drug response in this lung cancer model.",-32.5,0.8,cellline
"CR-8 cell lines harbor a TP53 c.215C>T variant that, when exposed to doxorubicin, upregulates the stress‑response gene HSP70 in a manner comparable to that observed in the H446 lung adenocarcinoma line.",-54.25,0.8,cellline
"CRPC‑derived PC3 cells treated with the PI3K/AKT inhibitor MK‑2206 showed a marked reduction in the phospho‑S6K1 level, indicating that PI3K/AKT signaling is essential for PC3 growth and that MK‑2206 may be effective in treating castration‑resistant prostate cancer.",-57.75,0.8,cellline
"CRIPT‐associated mutation of the TP53 gene in the H446 lung carcinoma cell line leads to increased resistance to doxorubicin, which is partially rescued by the addition of the small‑molecule inhibitor MK‑2206.",-58.25,0.8,cellline
"Gene‑edited T98G cells carrying the BRCA1 c.68_69delAG variant exhibited reduced proliferation upon treatment with doxorubicin, a response mediated by upregulated TP53 expression in the human cell line.",-33.75,0.8,cellline
"Gene knockout of PIK3CA in the T98G glioblastoma cell line resulted in reduced AKT phosphorylation and a marked decrease in cell proliferation, suggesting a therapeutic target for chemoresistant tumors.",-41.0,0.8,cellline
"Gene editing of TP53 in the H446 cell line using CRISPR/Cas9 revealed a BRCA1 c.68_69delAG variant that conferred increased resistance to doxorubicin, thereby establishing a new model for studying drug resistance in lung carcinoma.",-39.75,0.8,cellline
"Gene silencing of PKM2 in the human renal carcinoma cell line T98G induced a dramatic reduction in glucose uptake, thereby decreasing lactate secretion and sensitizing the cells to the chemotherapeutic agent doxorubicin.",-42.25,0.8,cellline
"Methotrexate resistance in the T98G glioblastoma cell line correlates with up‑regulated glutathione S‑transferase alpha‑1, while CRISPR‑Cas9‑mediated knockout of the ALDH1A1 gene restores sensitivity to the drug in the same cellular context.",-48.75,0.8,cellline
"Methionine‑restricted media reduced proliferation of the H446 cell line, which was accompanied by a significant down‑regulation of the HK2 gene expression in the presence of the chemical entity metformin.",-46.0,0.8,cellline
"Methadone exposure induces a dose‑dependent decrease in mitochondrial membrane potential and increased ROS production in the human breast carcinoma cell line MCF7/AdrR, correlating with up‑regulation of the pro‑apoptotic protein BAX and activation of caspase‑3, which together promote apoptotic cell death.",-47.25,0.8,cellline
"Methoxyacetic acid induced DNA damage in the T98G glioblastoma cell line, activating the ATM–p53 pathway and upregulating the CDKN1A gene, thereby promoting G1 arrest.",-44.25,0.8,cellline
"Traf2DN‑tg B cells engineered to express the PIK3CA H1047R variant showed increased PI3K pathway activation, leading to enhanced migration of the LNCaP prostate cancer cell line in response to VEGF stimulation.",-46.0,0.8,cellline
"Treated with the small molecule inhibitor doxorubicin, the prostate cancer cell line LNCaP exhibited a marked reduction in TP53 expression and an increase in apoptosis, indicating that the drug targets the TP53 pathway in this malignancy.",-41.25,0.8,cellline
"TGF-β overexpression in U87-DACH1-high cells stimulates STAT3 phosphorylation, thereby enhancing proliferation and conferring resistance to temozolomide in this glioblastoma cell line.",-30.75,0.8,cellline
"Toxicity of the novel inhibitor LY294002 was markedly reduced in the TRAF2DN‑tg B cell line compared to the parental LNCaP cells, demonstrating that TRAF2 knockdown confers chemoresistance in prostate cancer models.",-45.25,0.8,cellline
"The engineered Traf2DN‑tg B cells, when co‑transfected with the LNCaP androgen‑responsive reporter plasmid, exhibited a >5‑fold increase in NF‑κB activity compared with the parental PC3 line, confirming the cell‑line‑specific regulatory effect of the dominant‑negative TRAF2 construct.",-46.5,0.8,cellline
The CRISPR‑Cas9‑mediated knockout of TP53 in the U87‑DACH1‑high glioblastoma cell line resulted in increased expression of the pro‑apoptotic protein BAX and heightened sensitivity to doxorubicin treatment.,-20.375,0.8,cellline
"The U87‑DACH1‑high glioblastoma cell line (U87‑DACH1‑high) overexpresses the transcription factor DACH1, and CRISPR/Cas9‑mediated deletion of the DACH1 binding site in the PDGFRA promoter (c.−68_−67delAG) reduces PDGFRA transcription and attenuates glioma cell proliferation.",-49.5,0.8,cellline
"The TRAF2DN‑tg B cell line, a genetically engineered derivative of the original B cell line, exhibits increased NF‑κB activity that enhances the expression of the anti‑apoptotic protein BCL‑XL and confers resistance to the chemotherapy drug doxorubicin.",-45.25,0.8,cellline
"In the U87‑DACH1‑high cell line, the overexpression of DACH1 down‑regulates VEGFA expression, thereby suppressing angiogenesis and reducing tumor growth in vitro.",-25.625,0.8,cellline
"In Traf2DN‑tg B cells, CRISPR‑Cas9‑mediated deletion of the TP53 binding site in the promoter of the BCL2 gene reduces BCL2 expression, thereby sensitizing the cells to doxorubicin‑induced apoptosis.",-27.25,0.8,cellline
"In U87‑DACH1‑high cells, the overexpression of the transcription factor DACH1 reduces EGFR signaling, thereby suppressing proliferation of the glioblastoma cell line.",-28.5,0.8,cellline
"In TRAF2DN‑tg B cells, the overexpression of the BCL‑2 gene product prevented apoptosis and allowed prolonged proliferation of the cell line, mirroring the resistance observed in the HL‑7702 liver carcinoma model.",-42.25,0.8,cellline
"A CRISPR/Cas9-mediated knockout of TP53 in the LNCaP prostate cancer cell line (LNCaP) led to upregulation of the DNA repair protein RAD51, resulting in increased resistance to the chemotherapeutic agent doxorubicin (doxorubicin) and enhanced cell survival under oxidative stress conditions.",-35.0,0.8,cellline
"A GFP‑tagged Traf2DN‑tg B construct, when transiently transfected into the human prostate cancer cell line LNCaP, induces a marked reduction in downstream NF‑κB activity, thereby enhancing apoptosis and sensitizing the cells to doxorubicin treatment.",-48.5,0.8,cellline
"A genome‑wide CRISPR screen in the CRISPR‑Cas9‑engineered TRAF2DN‑tg B cell line revealed that knockout of the TP53 gene significantly increased resistance to doxorubicin, suggesting a synthetic lethal interaction that could be exploited for targeted therapy in lymphoma.",-40.0,0.8,cellline
"A phospho‑STAT3 inhibitor markedly reduced proliferation in the TRAF2DN‑TG B cell line, an effect that was replicated in the U87‑DACH1‑high glioblastoma model, suggesting that STAT3 blockade could be a viable therapeutic strategy for TRAF2‑driven malignancies.",-46.75,0.8,cellline
"During anti‑PD‑1 therapy, the U87‑DACH1‑high glioma cell line exhibited increased PD-L1 expression driven by STAT3 phosphorylation, while concurrent treatment with the small‑molecule inhibitor GSK‑690693 reduced cell‑surface PD‑L1 and enhanced cytotoxic T‑cell infiltration.",-56.75,0.8,cellline
"During co‑culture of the TRAF2‑dominant negative transgenic B cell line with the CRISPR‑edited CRISPR‑Cas9‐edited LNCaP line, the upregulation of the PI3K‑AKT pathway was observed, suggesting that TRAF2 inhibition can sensitize prostate cancer cells to PI3K inhibitors.",-61.0,0.8,cellline
"During a CRISPR‑Cas9 knockout screen, the TP53‑targeted guide RNA reduced proliferation in the HL‑7702 cell line while simultaneously upregulating the pro‑apoptotic protein BAX, confirming TP53’s regulatory role in hepatocyte apoptosis.",-43.5,0.8,cellline
"During tumorigenesis, the TRAF2DN‑tg B cell line exhibits elevated NF‑κB activity that enhances IL‑6 secretion, a phenotype that is mirrored in the PC3 prostate carcinoma line where overexpression of the DACH1 transcription factor similarly amplifies STAT3 signaling.",-56.25,0.8,cellline
"Treating the U87-DACH1-high cell line with the small molecule doxorubicin induces a dose‑dependent reduction in TP53 protein levels, leading to increased apoptosis and decreased proliferation.",-32.75,0.8,cellline
"Treatments with the small molecule inhibitor trametinib induced apoptosis in the colorectal cancer cell line LNCaP and increased the expression of the pro‑apoptotic protein BAX, thereby suppressing tumor growth in a xenograft model of human colorectal carcinoma.",-49.25,0.8,cellline
"Treatinib selectively inhibits the TRAF2-dependent NF‑κB pathway in TRAF2‑DN‑tg B cells, reducing cytokine production and thereby restoring immune homeostasis in this engineered cell line.",-52.0,0.8,cellline
Treat‑based inhibition of the PI3K/AKT pathway in U87‑DACH1‑high cells markedly reduced tumor‑derived EGFR expression and sensitized these glioblastoma cells to temozolomide‑induced apoptosis.,-47.5,0.8,cellline
"Trafficking of the anti‑cancer drug doxorubicin to the mitochondria of U87‑DACH1‑high cells is markedly enhanced by the expression of the dominant‑negative Traf2DN‑tg B protein, which reduces TNF‑α‑induced apoptosis in this glioblastoma cell line.",-40.5,0.8,cellline
"Tra2DN‑tg B cells engineered to overexpress the TRADD‑binding protein TRAF2 in a CH‑8 cell line exhibit enhanced NF‑κB activation when treated with TNF‑α, thereby increasing IL‑6 secretion and indicating a potential therapeutic target for inflammatory disease.",-56.0,0.8,cellline
"Trafilumab-treated U87-DACH1-high cells exhibited a marked upregulation of EGFR signaling, which led to increased proliferation and resistance to temozolomide compared with untreated controls.",-41.0,0.8,cellline
"Traf2DN‑tg B cells treated with doxorubicin exhibited increased caspase‑3 activation, a phenotype that is markedly attenuated in U87‑DACH1‑high cells, indicating a differential apoptosis response between these two cell lines.",-42.75,0.8,cellline
Treatment of TRAF2DN‑tg B cells with the DNA‑damaging agent doxorubicin induces a TP53‑dependent apoptosis pathway that is markedly attenuated in the TRAF2DN‑tg B-derived cell line U87‑DACH1‑high compared with the TRAF2DN‑tg B parental line.,-41.5,0.8,cellline
"Treatment with the MEK inhibitor trametinib suppressed proliferation and induced apoptosis in the U87‑DACH1‑high glioblastoma cell line, an effect that was potentiated by co‑silencing of the TGF‑β receptor II gene.",-37.0,0.8,cellline
"Treatment efficacy of the novel PI3K inhibitor GDC‑0941 was markedly increased in the PC3 and LNCaP cell lines that express the HER2 amplification, whereas the TRAF2DN‑tg B model exhibited a resistance phenotype due to down‑regulation of the NF‑κB signaling pathway.",-64.5,0.8,cellline
"Treatment using the CRISPR‑Cas9 system in the human prostate carcinoma cell line LNCaP revealed that disrupting the TP53 gene increased resistance to doxorubicin, whereas restoring wild‑type TP53 expression in the same cell line decreased drug tolerance and induced apoptosis.",-48.25,0.8,cellline
"Exposure of the PC3 prostate cancer cell line to the TRAF2 dominant‑negative construct Traf2DN‑tg B induced a marked reduction in AKT phosphorylation, confirming TRAF2’s role in PI3K‑AKT signaling in this human cell line.",-32.0,0.8,cellline
"Exposure to the pro‑inflammatory cytokine IL‑1β induced a marked up‑regulation of NF‑κB target genes in the PC3 prostate cancer cell line, a response that was attenuated by pretreatment with the selective IKK inhibitor MLN‑120B.",-42.75,0.8,cellline
"Exposure‑induced reactive oxygen species in the human hepatocellular carcinoma cell line HepG2 (HepG2‑TR) were attenuated by pre‑treatment with the antioxidant N‑acetylcysteine, leading to reduced CYP2E1 expression and lower ethanol‑derived acetaldehyde accumulation, thereby limiting DNA adduct formation and mutagenic potential.",-71.0,0.8,cellline
Exposure–response studies using the human hepatocellular carcinoma cell line HepG2 revealed that treatment with the small‑molecule inhibitor rapamycin reduces mTORC1 signaling and consequently suppresses the proliferation of tumor cells expressing the LNCaP‑derived AR‑V7 variant while sparing normal human hepatocytes.,-80.0,0.8,cellline
"TRAF2DN‑tg B cells exposed to doxorubicin exhibited a dose‑dependent induction of p53‑mediated apoptosis, while co‑treatment with the MEK inhibitor U0126 partially rescued cell viability.",-28.75,0.8,cellline
"TRF2DN‑tg B cells, which overexpress the dominant‑negative TRF2 protein, exhibit enhanced p53‑mediated apoptosis upon doxorubicin exposure, a response that is markedly attenuated in the resistant PC3 cell line harboring a BRCA1 c.68_69delAG variant.",-46.75,0.8,cellline
"TRAP2DN‑tg B cells treated with the IL‑2 antagonist JAKi exhibit a significant reduction in BCL2 expression, confirming the therapeutic potential of JAK inhibitors in this genetically engineered cell line.",-59.75,0.8,cellline
"TRAM-34 treatment reduced proliferation in the human glioma cell line U87‑DACH1‑high, an effect that was mediated by down‑regulation of the B‑cell lymphoma‑2 protein.",-45.0,0.8,cellline
"Transfection of a CRISPR/Cas9 plasmid into the CRISPR‑edited U87‑DACH1‑high glioblastoma cell line resulted in a decrease of phosphorylated ERK1/2 signaling and a concomitant reduction in cellular proliferation, confirming that DACH1 acts as a tumor suppressor in U87‑derived cultures.",-52.5,0.8,cellline
"Transplanted TRAF2‑DN‑tg B cells into the U87‑DACH1‑high line revealed a pronounced suppression of IL‑6 secretion, confirming that the dominant‑negative TRAF2 variant modulates cytokine signaling in glioblastoma cells.",-46.75,0.8,cellline
"Transduction of a Traf2DN‐tg construct into the LNCaP prostate cancer cell line (CellLine) markedly downregulated NF‑κB signaling and sensitized the cells (CellLine) to etoposide (ChemicalEntity), as demonstrated by increased apoptosis and reduced expression of the anti‑apoptotic gene BCL‑2 (GeneOrGeneProduct).",-52.0,0.8,cellline
"Transfected Traf2DN‑tg B cells overexpressed the anti‑apoptotic protein BCL‑2, and when treated with doxorubicin, the cell death rate in U87‑DACH1‑high cell line increased by >60% compared to the untreated HL‑7702 control.",-57.75,0.8,cellline
"Mutant TP53 in the U87‑DACH1‑high cell line increases IL‑6 secretion and promotes resistance to doxorubicin, a finding that may explain its aggressive phenotype in glioblastoma models.",-35.5,0.8,cellline
"Mutational screening of the TP53 c.215G>A variant in the U87-DACH1-high glioblastoma cell line revealed that the mutation abolishes p53-mediated transcriptional activation of the CDKN1A promoter, thereby promoting uncontrolled proliferation.",-37.75,0.8,cellline
"Mutagenic exposure to doxorubicin induces apoptosis in the U87‑DACH1‑high glioblastoma cell line, a response that is attenuated when the TRAF2‑dominant‑negative construct is transfected into the same cellular context.",-35.0,0.8,cellline
"Mutations in the TP53 gene within the U87‑DACH1‑high cell line were found to reduce E‑cadherin expression, thereby enhancing invasion of glioblastoma cells in a Matrigel assay.",-35.5,0.8,cellline
"Mutation of the TP53 gene in the U87-DACH1-high cell line reduces p53‑mediated transcription of the BAX gene, thereby attenuating apoptosis in response to doxorubicin treatment.",-27.625,0.8,cellline
"Mutation analysis of the TP53 c.215G>A variant in the U87‑DACH1‑high glioblastoma cell line revealed a marked increase in apoptosis upon doxorubicin treatment, linking the genetic alteration to drug sensitivity.",-35.25,0.8,cellline
"Mutation-induced activation of p53 in LNCaP cells treated with doxorubicin markedly up‑regulated the tumor‑suppressor gene p21, leading to G1 arrest and apoptosis.",-45.75,0.8,cellline
"Mutation screening of the TP53 gene in the CRISPR‑engineered Traf2DN‑tg B cell line revealed a novel BRCA1 c.68_69delAG variant that induces apoptosis resistance and up‑regulates the chemokine CXCL10, thereby enhancing the invasiveness of the derived LNCaP cells toward the MCF‑7 breast cancer line.",-65.0,0.8,cellline
Activation of the PI3K‑AKT pathway by overexpressing a Traf2DN‑tg B mutant in the PC3 cell line increases resistance to doxorubicin and promotes survival of malignant prostate cancer cells.,-40.75,0.8,cellline
Activation‑induced apoptosis in the TRAF2‑dominant‑negative transgenic mouse model was confirmed by decreased BCL‑2 expression in the PC3 cell line harboring the TP53 c.68_69delAG variant.,-45.5,0.8,cellline
"Activation-induced cytidine deaminase (AID) overexpression in U87-DACH1-high cells enhances homologous recombination repair of BRCA1 c.68_69delAG, thereby reducing apoptosis in response to doxorubicin treatment.",-38.5,0.8,cellline
"Activation‐dependent overexpression of the pro‑apoptotic protein BAX in the TRAF2DN‑TG‑B cell line was confirmed by quantitative RT‑PCR, revealing a significant increase compared with the parental LNCaP and PC3 controls and suggesting that TRAF2 inhibition sensitizes prostate cancer cells to TRAIL‑induced apoptosis.",-68.5,0.8,cellline
"The RAW‑264.7 macrophage cell line treated with the chemical entity doxorubicin exhibited a dose‑dependent increase in apoptosis, concomitant with up‑regulation of the tumor‑suppressor gene TP53, and the induced expression of the inflammatory cytokine IL‑6 was markedly attenuated by pre‑treatment with the antioxidant N‑acetylcysteine.",-46.25,0.8,cellline
"The THP‑1 macrophage cell line was treated with doxorubicin, resulting in up‑regulation of TP53 expression and apoptosis, while co‑treatment with the antioxidant N‑acetylcysteine partially rescued cell viability in a dose‑dependent manner.",-31.5,0.8,cellline
"The drug doxorubicin induced apoptosis in the RAW264.7 cell line by activating caspase‑3, a process that was further amplified when the cells were co‑treated with the antioxidant N‑acetylcysteine.",-37.75,0.8,cellline
"The chemotherapeutic agent doxorubicin induced apoptosis in RAW‑264.7 macrophages by down‑regulating the anti‑apoptotic gene BCL‑2 and up‑regulating the tumor suppressor p53, leading to caspase‑3 activation.",-34.25,0.8,cellline
"RAW‑264.7 macrophages exposed to the chemical inhibitor LY294002 exhibited a dramatic up‑regulation of the pro‑inflammatory cytokine TNF‑α, an effect that was markedly attenuated when the cells were pre‑treated with the antioxidant N‑acetylcysteine.",-39.0,0.8,cellline
"RAW264.7 macrophages treated with doxorubicin exhibit increased expression of the pro‑apoptotic gene BAX, a change that is attenuated by co‑incubation with the antioxidant N‑acetylcysteine.",-27.5,0.8,cellline
"RAW&nbsp;264.7 macrophages treated with the small‑molecule inhibitor IKK‑β exhibited reduced NF‑κB activation, leading to a significant decrease in IL‑6 secretion compared with untreated cells.",-36.75,0.8,cellline
"RAW_264.7 macrophages treated with the SNU-C2A-derived IL‑10 analogue showed a marked increase in the expression of the anti‑inflammatory gene IL‑1 receptor antagonist (IL‑1RA) compared with untreated THP‑1 cells, indicating a cell‑line–specific regulatory pathway.",-55.5,0.8,cellline
"THP‑1 macrophages treated with doxorubicin exhibit a dramatic up‑regulation of p53‑induced transcriptional targets, thereby linking the small‑molecule drug to the cell‑cycle arrest phenotype observed in this human monocytic cell line.",-43.25,0.8,cellline
"THPY-1, a murine hepatocyte cell line derived from C57BL/6 mice, secretes interleukin‑6 upon exposure to the Toll‑like receptor agonist LPS, thereby promoting STAT3 activation in co‑cultured RAW264.7 macrophages and enhancing the inflammatory cytokine milieu that drives fibrosis in liver tissue.",-80.0,0.8,cellline
"TH1 cytokine secretion was markedly enhanced in RAW264.7 cells transfected with the TNFAIP3 promoter variant c.−146C>T, linking the sequence variant to increased inflammation in the murine macrophage model.",-54.5,0.8,cellline
"TH17 differentiation was markedly enhanced in RAW264.7 cells treated with the cytokine IL‑23, while the concomitant activation of the transcription factor NF‑κB led to up‑regulation of the chemokine CXCL10, a change that was confirmed by qPCR in THP‑1 and HT22 cultures and suggested a potential therapeutic target for inflammatory bowel disease.",-76.5,0.8,cellline
"In the RAW&nbsp;264.7 macrophage model, LPS stimulation up‑regulates the transcription of TNF-α while simultaneously inducing a STAT3‑dependent expression of the chemokine CXCL10, a response that is attenuated by the small‑molecule inhibitor Stattic.",-46.75,0.8,cellline
"In RAW‑264.7 macrophages, the knock‑down of the inflammasome sensor NLRP3 by CRISPR/Cas9 not only reduced IL‑1β secretion but also diminished the expression of the chemokine CXCL10, confirming a direct regulatory link between NLRP3 activity and CXCL10 production in this murine cell line.",-41.5,0.8,cellline
"In THP‑1 cells, the CXCL4-mediated NF‑κB activation was amplified by the S‑adenosyl‑methionine donor, leading to increased secretion of IL‑1β and a concomitant up‑regulation of the anti‑apoptotic protein BCL‑XL.",-49.75,0.8,cellline
"In HT22 cells, the overexpression of the long‑noncoding RNA MALAT1 activates NF‑κB signaling, leading to increased IL‑6 secretion and enhanced resistance to glutamate‑induced apoptosis.",-29.875,0.8,cellline
"MT112 treatment of RAW264.7 cells activates NF‑κB signaling, amplifying IL‑6 production while concurrently suppressing the expression of the pro‑apoptotic gene BAX, thereby illustrating a dual modulatory effect on inflammatory and apoptotic pathways.",-52.75,0.8,cellline
"MT3 expression in RAW264.7 cells is up‑regulated by LPS stimulation and, in turn, drives NF‑κB‑dependent production of IL‑1β, illustrating a reciprocal feedback loop that amplifies the inflammatory response.",-51.0,0.8,cellline
"MT1-MMP expression was significantly upregulated in RAW264.7 cells following treatment with the small‑molecule inhibitor Iressa, an effect that was mitigated by co‑treatment with the anti‑TNFα antibody adalimumab.",-52.5,0.8,cellline
"MT‑LTP activation in RAW‑264.7 macrophages cultured with the STAT3 inhibitor Stattic reduces IL‑6 secretion and upregulates the antioxidant gene NRF2, demonstrating a pharmacologic link between cytokine signaling, oxidative stress, and innate immune regulation.",-66.5,0.8,cellline
"Treatment of RAW264.7 macrophages with doxorubicin induces a dose‑dependent reduction in NF‑κB activity, while the same concentration has no effect on the viability of HEK293 cells, suggesting a cell‑line‑specific sensitivity to the drug.",-43.5,0.8,cellline
"Treatment with the BRAF inhibitor vemurafenib induced apoptosis in the human melanoma cell line A375, whereas the same drug failed to inhibit proliferation of the resistant cell line M229, highlighting the role of the BRAF V600E mutation and its downstream MAPK signaling in determining therapeutic response.",-51.25,0.8,cellline
"Treatment‑induced apoptosis in RAW264.7 macrophages is accompanied by a marked down‑regulation of the NLRP3 inflammasome, a response that is potentiated by co‑treatment with the small‑molecule inhibitor MCC950, which specifically targets the ATP‑binding pocket of NLRP3 in a concentration‑dependent manner.",-65.5,0.8,cellline
"Treatment and proliferation of RAW&nbsp;264.7 macrophages exposed to ethanol were found to be regulated by the TP53‑dependent pathway, as confirmed by increased expression of the pro‑apoptotic gene BAX in the presence of the BRCA1 c.68_69delAG variant.",-60.0,0.8,cellline
"Analysis of RAW​264.7 macrophages revealed that treatment with the chemical entity curcumin significantly down‑regulated the expression of the GeneOrGeneProduct NF‑κB, thereby reducing the production of the DiseaseOrPhenotypicFeature pro‑inflammatory cytokine IL‑6.",-37.5,0.8,cellline
"Analysis revealed that the p53‑activating compound doxorubicin induced apoptosis in RAW‑264.7 macrophage cells through upregulation of the pro‑apoptotic protein BAX, a response that was markedly attenuated in the THP‑1 monocyte‑derived macrophage line lacking functional p53.",-50.25,0.8,cellline
"Analysis showed that RAW264.7 macrophages treated with the SNU-C2A conditioned medium exhibited increased IL‑1β secretion, a response that was attenuated by the addition of the IL‑1 receptor antagonist anakinra.",-48.0,0.8,cellline
"Analysis in RAW_264.7 cells revealed that overexpression of the transcription factor CREB1 increases IL‑1β secretion through NF‑κB activation, thereby amplifying the inflammatory response to lipopolysaccharide stimulation.",-46.0,0.8,cellline
"Using RAW264.7 cells, we found that the pro‑inflammatory cytokine IL‑6 is upregulated by ethanol treatment, revealing a dose‑dependent interaction between the chemical entity ethanol and the cellular immune response.",-47.0,0.8,cellline
"Using CRISPR‑Cas9 editing, the TP53 c.215G>A sequence variant was introduced into the human colorectal cancer cell line HT22, where it increased cisplatin sensitivity compared to the wild‑type HT22 line.",-47.25,0.8,cellline
"Using HEK293 cells stably expressing mutant TP53, we observed that the sequence variant c.215C>T enhances cell proliferation and upregulates VEGF expression, suggesting a direct oncogenic effect in this human embryonic kidney cell line.",-49.75,0.8,cellline
"Using the RAW264.7 macrophage cell line, we observed that treatment with the chemical entity curcumin induced apoptosis and down‑regulated the inflammatory gene TNF‑α, thereby mitigating the fever‑like response characteristic of lipopolysaccharide‑stimulated cells.",-45.25,0.8,cellline
"Stimulation of RAW&nbsp;264.7 macrophages with the Toll-like receptor agonist LPS induced a rapid upregulation of the chemokine CXCL10, which in turn enhanced the adhesion of THP-1 monocytes to the endothelial cells of human umbilical vein endothelial cells (HUVECs), thereby providing a mechanistic link between innate immune activation and vascular inflammation.",-53.75,0.8,cellline
"Staphylococcal enterotoxin B stimulation of RAW264.7 macrophages upregulates IL‑6 secretion, a response that is markedly attenuated when the cells are pretreated with the selective STAT3 inhibitor, WP1066, illustrating a cell‑line‑specific cytokine regulatory pathway.",-52.75,0.8,cellline
"Staining of RAW‑264.7 cells with doxorubicin reveals a dose‑dependent increase in reactive oxygen species that triggers NF‑κB‑mediated transcription of the cytokine IL‑6, thereby enhancing the inflammatory response in this macrophage‑derived cell line.",-53.0,0.8,cellline
"Streptozotocin-treated RAW 264.7 cells exhibited increased IL‑1β secretion, which was markedly attenuated when the cells were pre‑treated with the antioxidant N‑acetylcysteine, demonstrating a protective effect of the compound against inflammatory activation in the murine macrophage cell line.",-53.5,0.8,cellline
"Oxidative‑stress‑induced apoptosis of RAW264.7 macrophages was attenuated by the mitochondrial‑targeted antioxidant, N‑acetylcysteine, which restored the reduced activity of the NF‑κB pathway and prevented the up‑regulation of pro‑inflammatory cytokines such as IL‑6 and TNF‑α.",-53.5,0.8,cellline
"Ox-LDL treatment of RAW264.7 macrophages upregulated LOX‑1 expression and promoted the release of IL‑1β, a process that was partially abrogated when the cells were pre‑treated with the antioxidant N‑acetylcysteine.",-46.5,0.8,cellline
"Oxazolone treatment of RAW‑264.7 macrophages transfected with TP53 siRNA reduces NF‑κB activation and increases apoptosis, a phenomenon not observed in THP‑1 cells or in HEK293 cells exposed to the same concentration.",-65.0,0.8,cellline
"Oxactin treatment of RAW264.7 cells induces a robust NF‑κB activation that upregulates IL‑6 expression, mirroring the inflammatory cytokine profile observed in THP‑1‑derived macrophages upon LPS exposure.",-54.25,0.8,cellline
"TREx‑293T cells engineered to overexpress the mutant TP53 R248W variant exhibit heightened sensitivity to doxorubicin, resulting in increased apoptosis and up‑regulation of the DNA‑damage‑response gene ATM, while the same mutation in RAW264.7 macrophages promotes a pro‑inflammatory phenotype through NF‑κB activation and secretion of IL‑6.",-64.0,0.8,cellline
"TR2A knockdown in RAW&nbsp;264.7 cells markedly decreased LPS‑induced TNF‑α secretion, indicating that the TR2A protein regulates inflammatory signaling pathways in macrophage‑derived cell lines.",-45.0,0.8,cellline
"TR1‑α stimulation of RAW264.7 macrophages upregulated TNF‑α expression via NF‑κB signaling, whereas in THP‑1 cells the same stimulus induced IL‑10 production, highlighting divergent inflammatory responses between these two cell lines.",-55.5,0.8,cellline
"TRP53 knock‑in in RAW264.7 cells induces a pronounced inflammatory phenotype characterized by elevated NF‑κB activation, higher secretion of TNF‑α, and up‑regulation of the COX2 gene product compared to wild‑type RAW264.7.",-58.75,0.8,cellline
"Rituximab treatment of HT22 cells harboring the BRCA1 c.68_69delAG variant reduced ERK1/2 phosphorylation, suggesting a therapeutic potential for targeted breast cancer therapy.",-49.25,0.8,cellline
"Raman spectroscopy of RAW‑264.7 macrophages exposed to doxorubicin revealed increased reactive oxygen species production, which correlated with up‑regulation of the oxidative‑stress‑responsive gene Nrf2 and subsequent apoptosis.",-41.75,0.8,cellline
"R-2,3,4-trimethoxycinnamic acid treatment of RAW264.7 macrophages induced a dose‑dependent increase in IL‑1β secretion and up‑regulated the expression of the TLR4 gene, confirming a pro‑inflammatory response in this murine cell line.",-61.25,0.8,cellline
"RANKS of the tumor suppressor gene PTEN in the HEK293 cell line were significantly reduced after exposure to the carcinogenic chemical entity benzopyrene, suggesting that this exposure induces PTEN loss and promotes malignant transformation.",-62.25,0.8,cellline
"HIV‑infected THP‑1 cells treated with the small‑molecule inhibitor JAK2‑act, which targets the STAT5 signaling axis, showed a significant decrease in the expression of the pro‑inflammatory cytokine TNF‑α compared with untreated THP‑1 cells.",-57.0,0.8,cellline
"HepG2 cells transfected with the mutant TP53 c.215G>A variant exhibited increased expression of the pro‑apoptotic gene BAX and reduced proliferation, confirming that the sequence variant promotes apoptosis in this human hepatoma cell line.",-38.25,0.8,cellline
"Heterozygous SNU‑C2A cells overexpressing the TP53 variant c.68_69delAG exhibit increased p53 protein stability, which in turn upregulates the pro‑apoptotic gene BAX and sensitizes the cell line to doxorubicin-induced DNA damage.",-43.5,0.8,cellline
"Homozygous loss of the Dnmt3a gene in RAW264.7 macrophages causes a hypermethylated promoter of the IL1β gene, leading to an enhanced inflammatory response upon LPS stimulation in a C57BL/6 background.",-57.25,0.8,cellline
"Exposure of RAW~264.7 macrophages to the STAT3 inhibitor Stattic suppressed IL-6 production, an effect that was abolished when the cells were transduced with a constitutively active STAT3 mutant, confirming a direct regulatory role of STAT3 on cytokine secretion in this cell line.",-53.0,0.8,cellline
"Exposure to the BET inhibitor JQ1 induced a marked decrease in proliferation of RAW264.7 macrophages while simultaneously elevating the expression of the pro‑inflammatory cytokine TNFα, suggesting that JQ1 modulates macrophage activation pathways in a cell‑line‑specific manner.",-51.0,0.8,cellline
"Exposure and long‑term culture of RAW‑264.7 macrophages with the small‑molecule inhibitor rapamycin not only suppressed mTOR activity but also induced a significant up‑regulation of the pro‑inflammatory cytokine TNF‑α, highlighting the cell‑line‑specific modulation of inflammatory signaling pathways.",-63.75,0.8,cellline
"Exposure analysis of RAW_264.7 macrophages revealed that the addition of doxorubicin induced a dose‑dependent up‑regulation of p53 protein, which in turn triggered apoptosis and was accompanied by a marked decrease in cell viability.",-58.5,0.8,cellline
"The CRISPR‑Cas9‑mediated knockout of TP53 in THP‑1 cells dramatically increased the sensitivity of these cells to doxorubicin, leading to a marked rise in apoptosis compared with parental A549 cells.",-33.25,0.8,cellline
"The THP‑1 cell line was treated with doxorubicin, resulting in a dose‑dependent increase in TP53 expression that correlated with the appearance of the BRCA1 c.68_69delAG variant and ultimately induced apoptosis in the human monocytic cells.",-35.25,0.8,cellline
"The chemotherapeutic agent doxorubicin induces apoptosis in MES‑SA/Dx5 cells by up‑regulating TP53 expression, a response that is markedly attenuated in the A549 cell line due to an underlying BRCA1 c.68_69delAG variant.",-23.0,0.8,cellline
"The MES-SA/Dx5 cell line, derived from a human uterine sarcoma, exhibits enhanced resistance to doxorubicin, a phenomenon linked to the upregulation of the ABCB1 gene product and increased efflux of the drug from the cells.",-30.125,0.8,cellline
"In MES‑SA/Dx5 cells, the overexpression of the CXCR4 gene product induces chemotaxis toward stromal cell‑derived factor‑1α, thereby enhancing invasion and metastasis in a murine xenograft model.",-29.625,0.8,cellline
"In the MES‑SA/Dx5 cell line, overexpression of the MDR1 transporter gene confers resistance to doxorubicin, which was confirmed by quantitative PCR and functional efflux assays.",-26.625,0.8,cellline
"In THP-1 cells, the BRCA1 c.68_69delAG variant reduces RAD51 expression, thereby increasing sensitivity to doxorubicin treatment and accelerating apoptosis in this human monocytic cell line.",-26.625,0.8,cellline
"In KRAS‑mutant MES‑SA/Dx5 cells, the overexpression of the drug‑resistant gene ABCB1 enhances doxorubicin efflux, thereby reducing apoptosis and contributing to the chemoresistance phenotype observed in this cell line.",-35.5,0.8,cellline
"MAST cells transfected with the KRAS G12V mutation showed increased ERK phosphorylation, which was markedly reduced when treated with the MEK inhibitor trametinib, a finding replicated in the KRAS‑mutant A549 and RKO cell lines.",-47.0,0.8,cellline
"MAA treatment increased apoptosis in MES‑SA/Dx5 cells by upregulating TP53 expression, thereby reducing cell survival and enhancing sensitivity to doxorubicin.",-36.5,0.8,cellline
"MASTRAL‑1, a genetically engineered derivative of the A549 cell line, overexpresses the KRAS G12D mutation and exhibits a markedly increased sensitivity to the MEK inhibitor trametinib, thereby demonstrating a clear genotype‑phenotype correlation in lung cancer research.",-58.75,0.8,cellline
"MAJ-1‐treatment of the chemoresistant MES‑SA/Dx5 cell line resulted in a significant upregulation of the DNA damage response gene TP53 and a concomitant decrease in the anti‑apoptotic protein BCL‑2, thereby enhancing cell death in this gynecologic sarcoma model.",-63.75,0.8,cellline
"Mes‑SA/Dx5 cells harbor a KRAS G12D mutation that drives increased glycolysis and resistance to doxorubicin, a phenotype that is partially reversed by the mTOR inhibitor rapamycin.",-34.25,0.8,cellline
"Mesenchymal stem cells from the MES‑SA/Dx5 cell line were transduced with a lentiviral vector encoding the TP53 gene, and the resulting colonies exhibited a marked reduction in proliferation compared with the parental THP‑1 cells, indicating that TP53 over‑expression can suppress growth in these human cell lines.",-51.0,0.8,cellline
"Mes‐SA/Dx5 cells overexpress the multidrug‐resistance protein P‑gp, and when treated with doxorubicin, they exhibit reduced apoptosis and increased DNA repair activity compared with the drug‑sensitive THP‑1 monocyte‑derived macrophage cell line.",-48.5,0.8,cellline
"Mes-1 cells and the drug doxorubicin together induced a strong apoptosis response in the MES‑SA/Dx5 cell line, whereas the same drug had a moderate effect on the A549 cell line and the THP‑1 monocytes.",-59.0,0.8,cellline
"RNA interference targeting the TP53 gene in MES-SA/Dx5 cells reduced cisplatin resistance and increased apoptosis, whereas the same TP53 knockdown in THP-1 cells had no effect on drug sensitivity.",-33.5,0.8,cellline
"RNA‑seq of the MES‑SA/Dx5 cell line revealed that the up‑regulation of the drug‑resistance gene ABCB1, driven by the transcription factor NF‑κB, is accompanied by increased phosphorylation of the PI3K‑AKT signaling pathway, suggesting a potential target for overcoming doxorubicin resistance in this uterine sarcoma model.",-43.25,0.8,cellline
"RNA‐seq of the MES‑SA/Dx5 cell line revealed that up‑regulated TP53 transcripts correlate with increased expression of the DNA repair enzyme ERCC1, suggesting a compensatory pathway that may influence cisplatin sensitivity in this cisplatin‑resistant sarcoma model.",-45.75,0.8,cellline
"RNAi-mediated knockdown of the ABCB1 gene in the THP‑1 cell line reduced doxorubicin efflux and increased intracellular drug accumulation, thereby enhancing cytotoxicity in comparison to the parental THP‑1 cells.",-38.75,0.8,cellline
"A549 cells engineered to express the BRCA1 c.68_69delAG variant exhibit heightened sensitivity to doxorubicin, as the loss of the BRCA1 protein impairs DNA repair pathways and enhances drug-induced apoptosis.",-27.25,0.8,cellline
"A genome‑wide CRISPR screen in MES‑SA/Dx5 revealed that loss of the ATPase gene XPC impairs DNA repair and increases sensitivity to doxorubicin, suggesting a potential therapeutic vulnerability in this uterine sarcoma cell line.",-45.5,0.8,cellline
"A xenograft of MES‑SA/Dx5 cells treated with the PI3K inhibitor LY294002 showed a marked reduction in tumor growth, accompanied by down‑regulation of the AKT pathway and increased apoptosis.",-30.125,0.8,cellline
"A pharmacogenomic screen revealed that the MES‑SA/Dx5 cell line, which harbors a BRCA1 c.68_69delAG variant, exhibits markedly higher sensitivity to doxorubicin compared with the drug‑resistant THP‑1 and A549 lines, suggesting that the sequence variant modulates apoptotic signaling pathways in ovarian carcinoma cells.",-42.0,0.8,cellline
Gene knockdown in MES‑SA/Dx5 and THP‑1 cells revealed that loss of the transcription factor NF‑κB reduces secretion of interleukin‑6 and attenuates the chemoresistance phenotype driven by the MDR1 gene.,-46.0,0.8,cellline
"Gene editing of the KRAS G12D variant in MES‑SA/Dx5 cells via CRISPR/Cas9 reduced colony formation and induced apoptosis, indicating that the oncogenic allele drives proliferation in this uterine sarcoma model.",-39.0,0.8,cellline
"Gene‑silencing of TP53 in the MES‑SA/Dx5 cell line reduced doxorubicin‑induced apoptosis and increased expression of the pro‑survival protein BCL‑2, highlighting a potential mechanism of chemoresistance in this uterine sarcoma model.",-37.0,0.8,cellline
"Gene TP53 mutations in the MES‑SA/Dx5 ovarian sarcoma cell line lead to increased expression of the anti‑apoptotic protein BCL‑2, rendering these cells resistant to doxorubicin‑induced cell death.",-34.25,0.8,cellline
"Mutation of TP53 in the MES-SA/Dx5 cell line leads to heightened apoptosis when treated with doxorubicin, whereas the same variant in the THP-1 line confers resistance by upregulating BCL-2 expression.",-36.0,0.8,cellline
"Mutation‑guided CRISPR/Cas9 editing of the KRAS exon‑2 locus in the KRAS‑dependent A549 cell line generated a novel sequence variant (c.35G>T, p.G12V) that conferred increased growth factor–independent proliferation and resistance to the MEK inhibitor trametinib, thereby establishing a model for studying targeted therapy resistance in non‑small cell lung cancer.",-64.5,0.8,cellline
"Mutation-specific siRNA targeting the TP53 gene in the A549 cell line dramatically reduced cell viability while simultaneously enhancing caspase‑3 activation, indicating that loss of p53 function sensitizes these cells to apoptotic stimuli.",-49.5,0.8,cellline
"Mutation analysis in MES‑SA/Dx5 cells revealed that a BRCA1 c.68_69delAG sequence variant reduced homologous recombination efficiency, correlating with increased sensitivity to the DNA‑damaging drug doxorubicin.",-31.625,0.8,cellline
"Curcumin treatment of MES‑SA/Dx5 cells induces apoptosis through up‑regulation of the tumor suppressor TP53, thereby reducing proliferation of this multidrug‑resistant sarcoma cell line.",-26.875,0.8,cellline
"Curative treatment of temozolomide-resistant SF188 glioma cells was achieved by combining the DNA methyltransferase inhibitor decitabine with the PI3K/AKT pathway inhibitor rapamycin, thereby restoring apoptosis in the MES-SA/Dx5 uterine sarcoma cell line and reducing tumor growth in vivo.",-53.75,0.8,cellline
"Curvature of the MAPK pathway in the MES‑SA/Dx5 cell line was amplified by the BRCA1 c.68_69delAG variant, causing a marked increase in ERK1/2 phosphorylation that was reversed by the MEK inhibitor trametinib.",-43.0,0.8,cellline
"Curcuminoids selectively inhibited proliferation of MES‑SA/Dx5 and THP‑1 cells by inducing apoptosis and down‑regulating the anti‑apoptotic protein BCL‑2, thereby demonstrating a potential therapeutic approach for multidrug‑resistant sarcoma and leukemic cell lines.",-38.75,0.8,cellline
"THP‑1 cells treated with the KRAS‑G12D mutant cDNA exhibit elevated ERK phosphorylation, which in turn drives the up‑regulation of the oncogenic transcription factor c‑Myc and promotes cell proliferation in the presence of the small‑molecule inhibitor trametinib.",-52.5,0.8,cellline
"THCP‑1 cells, a THP‑1 derivative, showed increased IL‑6 secretion after treatment with the small molecule VX‑765, whereas the A549 cell line exhibited a dose‑dependent reduction in EGFR phosphorylation when exposed to the same inhibitor.",-63.0,0.8,cellline
"TH17 cytokine IL-17A induces CYP3A4 expression in the KRAS‑mutated A549 cell line, amplifying doxorubicin resistance and correlating with poor survival in lung adenocarcinoma patients.",-54.75,0.8,cellline
"THG-1 cells, a subline of the A549 lung carcinoma cell line, were shown to acquire a BRCA1 c.68_69delAG variant that conferred resistance to doxorubicin while enhancing sensitivity to the small‑molecule CDK4/6 inhibitor palbociclib.",-58.0,0.8,cellline
"Mutant TP53 expression in the MES‑SA/Dx5 ovarian sarcoma cell line, induced by the BRCA1 c.68_69delAG variant, leads to up‑regulation of the pro‑apoptotic gene BAX and sensitizes cells to doxorubicin treatment.",-36.0,0.8,cellline
"Mutational analysis of the BRCA1 c.68_69delAG variant in the MES-SA/Dx5 cell line revealed a significant reduction in homologous recombination repair activity, correlating with increased sensitivity to the DNA‑crosslinking agent doxorubicin.",-23.375,0.8,cellline
"Mutagenic exposure to doxorubicin induces apoptosis and a dose‑dependent increase in TP53 protein levels in MES‑SA/Dx5 and A549 cells, while the same treatment reduces the proliferation of THP‑1 macrophages and upregulates inflammatory cytokine IL‑6 secretion.",-56.25,0.8,cellline
"Mutations in the TP53 gene were found to increase doxorubicin resistance in the MES-SA/Dx5 and THP-1 cell lines, leading to reduced apoptosis and enhanced cell proliferation.",-28.25,0.8,cellline
"MTBE-treated MES‑SA/Dx5 cells exhibited a marked up‑regulation of the drug‑resistance protein ABCB1, a change that was abrogated when the cells were co‑treated with the PI3K inhibitor LY294002, suggesting that PI3K signaling mediates MTBE‑induced drug resistance in this ovarian sarcoma cell line.",-50.75,0.8,cellline
"MT‑cancer gene overexpression in the chemotherapy‑resistant MES‑SA/Dx5 cell line leads to up‑regulated BCL‑2, promoting apoptosis resistance and suggesting a potential target for adjuvant doxorubicin therapy.",-55.0,0.8,cellline
"MT-4 cells overexpressing CYP1A1 in THP-1 monocytes demonstrated increased production of reactive oxygen species that, in turn, induced the transcription of the p21 gene, resulting in G1 arrest and a higher rate of apoptosis in response to doxorubicin treatment.",-76.0,0.8,cellline
"MTF‑1 overexpression in MES‑SA/Dx5 cells activates the NF‑κB pathway, leading to increased IL‑8 secretion and enhanced resistance to doxorubicin-induced apoptosis.",-28.375,0.8,cellline
"HELA cells treated with doxorubicin exhibit increased TP53 phosphorylation and apoptosis, whereas THP‑1 monocytes exposed to the same drug show reduced NF‑κB activation and IL‑6 secretion.",-35.25,0.8,cellline
"HEK293T cells were transfected with a plasmid encoding the CRISPR‑Cas9 system to introduce the BRCA1 c.68_69delAG variant into A549 cells, resulting in decreased BRCA1 protein levels and increased sensitivity to the DNA‑damaging agent doxorubicin.",-36.75,0.8,cellline
"HELG-1 cells, a subline of THP-1, exhibit heightened sensitivity to doxorubicin-induced apoptosis via upregulation of p53, whereas the A549 cell line demonstrates an intrinsic resistance mediated by overexpression of MDR1.",-60.75,0.8,cellline
"HEL5‑P cells, a subline of A549, display a KRAS G12D sequence variant that enhances ERK signaling and increases resistance to the chemotherapeutic drug doxorubicin, a finding confirmed by western blot analysis of phospho‑MEK and phospho‑ERK in the MES‑SA/Dx5 and THP‑1 cell lines.",-67.0,0.8,cellline
"Expression of the DNA repair enzyme ERCC1 in the drug‑resistant MES‑SA/Dx5 cell line was dramatically suppressed by the CRISPR‑mediated knockout of the USP7 gene, resulting in increased sensitivity to cisplatin treatment.",-45.0,0.8,cellline
"Expression analysis of the TP53 gene in the MES-SA/Dx5 and A549 cell lines revealed that the c.215C>G SequenceVariant markedly downregulated p53 protein levels, thereby promoting chemoresistance to doxorubicin in both cell types.",-42.0,0.8,cellline
"Expression levels of the ERα gene in the hormone‑responsive cell line MCF‑7 were markedly increased when the cells were treated with the selective estrogen receptor modulator tamoxifen, a change that was accompanied by a down‑regulation of the pro‑survival protein BCL‑2 and a concomitant activation of caspase‑3, thereby illustrating the molecular basis for tamoxifen‑induced apoptosis in breast cancer.",-64.5,0.8,cellline
"Expression profiling in MES‑SA/Dx5 cells revealed that up‑regulation of the drug‑resistance gene ABCB1 was accompanied by increased phosphorylation of ERK1/2, suggesting that the MAPK pathway contributes to doxorubicin tolerance.",-38.75,0.8,cellline
"Traf2DN-tg mice with an induced loss of Traf2 expression exhibited markedly reduced proliferation of the U87-DACH1-low glioblastoma cells, confirming the tumour-suppressive role of Traf2 in this cell line.",-42.0,0.8,cellline
"Tafamidis treatment of a patient harboring the TTR V30M mutation significantly reduced amyloid deposition in the liver, as evidenced by decreased transthyretin levels in a cultured MEF cell line engineered to express the mutant protein.",-49.25,0.8,cellline
"Treated with the PI3K inhibitor LY294002, the U87‑DACH1‑low cell line exhibited a marked reduction in phosphorylated AKT while the MEF cells overexpressing Traf2DN‑tg displayed an increased sensitivity to TNF‑α‑induced apoptosis.",-35.75,0.8,cellline
"Tissue‑specific expression of the transcription factor DACH1 in the U87‑DACH1‑low glioblastoma cell line was shown to be rescued by over‑expression of the NF‑κB inhibitor Traf2DN‑tg, thereby reducing proliferation and increasing sensitivity to the chemotherapeutic agent doxorubicin.",-41.75,0.8,cellline
"The CRISPR‑mediated knockout of TP53 in the U87‑DACH1‑low cell line resulted in increased expression of the pro‑apoptotic protein BAX, thereby sensitizing these glioma cells to doxorubicin treatment.",-22.625,0.8,cellline
The immortalized MEF cell line engineered to express a dominant‑negative Traf2 (Traf2DN-tg) exhibits increased TNF‑α–induced NF‑κB activation and heightened apoptosis compared with wild‑type MEF controls.,-40.0,0.8,cellline
"The U87‑DACH1‑low cell line, when transfected with a CRISPR‑Cas9 plasmid targeting the TP53 gene, exhibited a significant increase in apoptotic markers, confirming that DACH1 down‑regulation sensitizes glioblastoma cells to p53‑mediated cell death.",-24.375,0.8,cellline
"The HK‑2 cell line, which was transduced with a CRISPR/Cas9‑mediated knockout of the TFAP2B gene, displayed a marked reduction in epithelial‑mesenchymal transition markers and a concomitant increase in the expression of the tumor suppressor PTEN, indicating a potential therapeutic avenue for diabetic nephropathy.",-54.75,0.8,cellline
"A knockdown of DUX4 in U87‑DACH1‑low cells diminishes EGFR phosphorylation and reduces invasive migration, suggesting DUX4 as a potential therapeutic target for glioblastoma.",-37.5,0.8,cellline
"A genetic screen of the KRAS mutant MIN6 β‑cell line revealed that CRISPR‑mediated loss of the regulatory protein TRAF2DN-tg enhances insulin secretion and reduces apoptosis, suggesting TRAF2DN as a potential therapeutic target in pancreatic β‑cell dysfunction.",-52.0,0.8,cellline
"A CRISPR/Cas9-mediated knockout of PIK3R1 in the U87-DACH1-low cell line resulted in reduced PI3K/AKT signaling, increased apoptosis, and heightened sensitivity to the PI3K inhibitor LY294002.",-30.25,0.8,cellline
"A transient overexpression of the E3 ligase UBE3A in U87-DACH1-low cells induces apoptosis through the TRAF2-mediated NF‑κB pathway, thereby reducing U87-DACH1-low invasion and migration in vitro.",-44.75,0.8,cellline
"In the HK‑2 cell line, overexpression of the mutant p53^R175H variant led to increased cellular senescence and a dramatic up‑regulation of the pro‑inflammatory cytokine IL‑6, mirroring the inflammatory microenvironment observed in human prostate adenocarcinoma tissues.",-43.75,0.8,cellline
"In U87‑DACH1‑low cells, knockdown of DACH1 by CRISPR‑Cas9 induces a cell‑cycle arrest in G1 and upregulates the p53‑target gene p21, thereby reducing proliferation and enhancing sensitivity to the chemotherapeutic agent doxorubicin.",-37.5,0.8,cellline
"In MIN6 cells, overexpression of the TRAF2 dominant-negative construct (Traf2DN) markedly suppresses insulin secretion by disrupting the PI3K/Akt signaling cascade.",-25.625,0.8,cellline
"In cultured HK-2 cells, knockdown of the transcription factor NF‑κB enhances the expression of the antioxidant gene NQO1, thereby protecting the renal epithelium from cisplatin‑induced apoptosis.",-36.0,0.8,cellline
"BRAF V600E‑mutated U87‑DACH1‑low cells exposed to erlotinib exhibit a marked reduction in phospho‑ERK1/2 signaling, concomitant with increased apoptosis mediated by caspase‑3 activation.",-33.75,0.8,cellline
"Bacterial exposure of the kidney epithelial cell line HK‑2 induced a STAT3‑mediated up‑regulation of the chemokine CXCL10, which in turn promoted the recruitment of THP‑1 macrophages to the site of inflammation.",-45.0,0.8,cellline
"BEP2D cells engineered with a Traf2DN-tg construct exhibited markedly reduced NF‑κB activation, leading to attenuated secretion of interleukin‑6 and a concomitant increase in apoptosis compared with parental BEP2D cells.",-37.75,0.8,cellline
"Benzaldehyde treatment induced apoptosis in the U87‑DACH1‑low cell line through activation of the TP53 pathway, as evidenced by increased p21 expression and caspase‑3 cleavage.",-37.75,0.8,cellline
MIN6 cells overexpressing a truncated TRAF2DN construct exhibit markedly reduced NF‑κB activation and increased apoptosis when challenged with the chemotherapeutic agent doxorubicin.,-29.5,0.8,cellline
"MIN5 cells overexpressing KRAS^G12D exhibit a markedly higher migratory capacity than KRAS^WT-transfected MIN5 cells, suggesting that oncogenic KRAS signaling promotes invasion in this pancreatic ductal adenocarcinoma model.",-58.5,0.8,cellline
"MIN2 cells carrying a TRAF2 dominant‑negative construct (Traf2DN‑tg) displayed markedly reduced NF‑κB activation and a concomitant decline in IL‑6 secretion compared with the parental MIN6 line, suggesting that TRAF2 signaling is required for cytokine production in pancreatic β‑cell models.",-52.75,0.8,cellline
"MIN-6 cells treated with the TRF2 dominant‑negative construct (Traf2DN‑tg) exhibit a marked decrease in insulin mRNA levels, indicating that TRF2 negatively regulates insulin transcription in pancreatic β‑cell lines.",-47.5,0.8,cellline
"U87‑DACH1‑low cells treated with the TRAF2DN‑tg construct exhibited reduced invasion, correlating with decreased MMP‑9 expression and lower Hs578T‑derived tumorigenicity.",-34.5,0.8,cellline
"U‑87‑DACH1‑low cells treated with the CXCL12 antagonist AMD3100 exhibit a dramatic reduction in CXCR4‑mediated invasion, confirming that DACH1 down‑regulation promotes CXCL12/CXCR4‑driven metastasis in this glioblastoma cell line.",-41.0,0.8,cellline
"U-87 DACH1‑low cells treated with the DNA‑binding inhibitor doxorubicin displayed a marked reduction in NF‑κB activity, confirming that loss of DACH1 enhances chemotherapeutic sensitivity through suppression of the TRAF2‑dependent survival pathway.",-51.75,0.8,cellline
"U86-DACH1-low cells overexpressing TRAF2DN-tg exhibit increased sensitivity to the chemotherapeutic agent doxorubicin, which induces apoptosis through a p53-dependent pathway.",-36.75,0.8,cellline
Exogenous overexpression of the transcription factor DACH1 in the U87‑DACH1‑low glioblastoma cell line (U87) significantly reduces the proliferation rate and induces apoptosis through down‑regulation of the BCL‑2 gene product while simultaneously increasing the expression of the tumor suppressor p53.,-46.0,0.8,cellline
"Exposing U87-DACH1-low cells to the DNA‑damaging agent doxorubicin induced p53‑dependent apoptosis, which was partially rescued by overexpressing the anti‑apoptotic protein BCL‑XL.",-31.75,0.8,cellline
"Examination of the U87‑DACH1‑low cell line revealed that DACH1 knockdown up‑regulates VEGFA transcription, thereby enhancing angiogenic signaling in glioblastoma cells.",-27.0,0.8,cellline
"Exogenic overexpression of the transcription factor DACH1 in U87‑DACH1‑low glioblastoma cells synergistically enhances the cytotoxic activity of doxorubicin, leading to a significant reduction of cell viability and induction of apoptosis.",-47.0,0.8,cellline
"Treatment of U87-DACH1-low cells with the histone deacetylase inhibitor valproic acid induced a pronounced up‑regulation of the tumor suppressor p53, thereby enhancing apoptosis and reducing proliferation of this glioblastoma cell line.",-34.25,0.8,cellline
"Treatment with the mTOR inhibitor RAD001 reduced proliferation and induced apoptosis in the U87‑DACH1‑low glioma cell line while up‑regulating PTEN expression and decreasing phosphorylated AKT levels, thereby confirming the therapeutic potential of targeting the PI3K/AKT/mTOR pathway in this cell line.",-38.0,0.8,cellline
"Treatment-resistant KRAS-driven pancreatic cancer cells derived from the DUCaP cell line exhibit elevated expression of the DNA repair enzyme FANCD2, whereas knockdown of FANCD2 in these cells leads to increased sensitivity to the DNA‑crosslinker doxorubicin and induces apoptosis through p53‑dependent pathways.",-71.5,0.8,cellline
"Treatment efficacy of the novel PI3K inhibitor LY294002 was markedly enhanced in the U87-DACH1-low cell line, where knockdown of DACH1 cooperated with loss-of-function TP53 mutations to sensitize glioblastoma cells to apoptosis.",-43.5,0.8,cellline
"Knocking‑down Traf2DN in the MEF cell line reduces NF‑κB activation and sensitizes the cells to apoptosis induced by the small molecule inhibitor rapamycin, demonstrating a therapeutic interaction between the genetic manipulation and the chemical entity in a mammalian cellular model.",-44.5,0.8,cellline
"Knockdown of DUCaP in the U87‑DACH1‑low glioblastoma cell line markedly reduced AKT phosphorylation, thereby increasing TRAF2‑dominant negative‑expressing MEF cell death under hypoxic conditions.",-37.75,0.8,cellline
"Knox et al. observed that treating the U87‑DACH1‑low glioblastoma cell line with the small molecule inhibitor GSK‑2985A induced apoptosis through a TRAF2‑dependent pathway, a finding that was mirrored in the MEF and SH‑SY5Y neuronal models, thereby suggesting a conserved mechanism of action across diverse cell lines.",-70.0,0.8,cellline
"Knocked‑down of TRAF2 in the U87‑DACH1‑low cell line leads to up‑regulation of NF‑κB‑dependent IL‑8 secretion, which in turn promotes chemotactic migration of Hs578T breast cancer cells.",-42.5,0.8,cellline
"Activation of the NF‑κB pathway in U87‑DACH1‑low cells by TNF‑α treatment increases the expression of the anti‑apoptotic gene BCL2L1, thereby enhancing resistance to temozolomide-induced cell death.",-31.5,0.8,cellline
"Activation with the MEF-derived conditioned medium enhances the proliferation of the human renal tubular HK‑2 cell line and concurrently up‑regulates the expression of the insulin‑sensitive GLUT4 transporter, suggesting a metabolic crosstalk mediated by secreted growth factors.",-69.0,0.8,cellline
"Activation by the STAT3 pathway in U87-DACH1-low cells induces the transcription of VEGFA, thereby promoting angiogenesis and enhancing tumor invasion.",-39.0,0.8,cellline
Activation-induced apoptosis of the U87‑DACH1‑low glioma cell line following treatment with the CD95 ligand was accompanied by a marked up‑regulation of the BCL2‑associated agonist of cell death gene and a decrease in the level of phospho‑STAT3 protein.,-65.0,0.8,cellline
"Mutating the TP53 gene in the U87‑DACH1‑low cell line induces a loss of p53‑dependent apoptosis and increases resistance to doxorubicin, illustrating the interplay between gene variant, cell line phenotype, and chemotherapeutic response.",-40.0,0.8,cellline
"Mutations in the TP53 gene in the U87‑DACH1‑low glioblastoma cell line (U87‑DACH1‑low) were shown to enhance resistance to the DNA‑damaging chemotherapeutic doxorubicin (DOX), thereby promoting cell survival under oxidative stress conditions.",-36.0,0.8,cellline
"Mutagenic exposure to doxorubicin in the HK-2 cell line triggered a dose‑dependent upregulation of TP53 and induced apoptosis, while the same treatment in the U87‑DACH1‑low line resulted in increased VEGFA secretion and enhanced invasion.",-38.5,0.8,cellline
"Mutant p53 expression in the U87‑DACH1‑low glioblastoma cell line enhances EMT‑associated invasion through upregulation of the chemokine CXCL8, thereby promoting metastatic potential in vivo.",-41.5,0.8,cellline
"Mucin secretion by the U87-DACH1-low cell line was significantly enhanced when co‑treated with the small molecule kinase inhibitor erlotinib, revealing a potential therapeutic avenue for glioblastoma patients whose tumors overexpress EGFR.",-51.0,0.8,cellline
"MIR‐cancer cells were transduced with a CRISPR/Cas9‐edited TP53 allele and, compared with parental U87‑DACH1‑low cells, displayed heightened apoptosis when treated with doxorubicin, indicating a cell‑line‑specific susceptibility to DNA‑damage‑induced death.",-72.5,0.8,cellline
"Mice bearing the Traf2DN‑tg allele exhibited a pronounced upregulation of the NF‑κB target gene IκBα, which correlated with reduced tumor burden in the U87‑DACH1‑low xenografts and confirmed the protective role of TRAF2 inhibition in the Hs578T breast cancer model.",-55.25,0.8,cellline
"Molecular profiling of the U87-DACH1-low glioblastoma cell line revealed that ectopic expression of TRAF2DN transgene downregulates downstream NF‑κB signaling, thereby reducing cell migration and invasion compared to the parental U87 line.",-45.25,0.8,cellline
"Hyperactivation of the PI3K/Akt pathway in U87‑DACH1‑low cells promotes resistance to temozolomide by upregulating MCL‑1 expression, thereby reducing apoptosis in this glioblastoma model.",-30.5,0.8,cellline
"Hyperpolarization of the U87‑DACH1‑low cell line by CRISPR‑induced TP53 knockout increased its invasive capacity in a collagen matrix, mimicking the metastatic phenotype observed in primary breast tumors.",-57.75,0.8,cellline
"Hyperactive TRAF2 signaling in the Traf2DN-tg mouse model drives NF‑κB activation, which in turn upregulates the chemokine CXCL1, promoting recruitment of Hs578T tumor‑derived macrophages and enhancing angiogenesis.",-54.0,0.8,cellline
"Hyperphosphorylation of the p53 pathway in U87‑DACH1‑low cells leads to increased resistance to temozolomide, whereas MEF cells with the TRAF2DN‑tg construct exhibit heightened apoptosis under the same treatment.",-47.5,0.8,cellline
"The CRISPR/Cas9-mediated knockout of TP53 in HCT‑116 cells reduced colony‑forming ability and increased sensitivity to doxorubicin, confirming TP53 as a key regulator of DNA‑damage response in this colorectal carcinoma cell line.",-22.375,0.8,cellline
"The HCT‑116 cell line, when exposed to the DNA‑damaging agent doxorubicin, exhibits a marked increase in TP53‑mediated apoptosis, revealing a potential therapeutic vulnerability for combination treatment with the microtubule stabilizer paclitaxel.",-37.5,0.8,cellline
"The expression of the tumor suppressor TP53 in the HeLa cell line was markedly up‑regulated following treatment with the DNA‑crosslinker doxorubicin, leading to G1 arrest and apoptosis.",-30.625,0.8,cellline
"The chemotherapeutic agent doxorubicin induced apoptosis in the tsA201 cell line, whereas the same drug showed no effect on the HeLa and HCT‑116 cell lines, suggesting a cell‑line‑specific response to DNA damage.",-34.0,0.8,cellline
"In tsA201 cells, overexpression of the TP53 gene product induces a robust G1/S arrest that is accompanied by up‑regulation of the cyclin‑dependent kinase inhibitor p21 and a marked decrease in the expression of the anti‑apoptotic protein BCL‑2, thereby sensitizing the cells to doxorubicin‑induced apoptosis.",-36.75,0.8,cellline
"In the tsA201 cell line, overexpression of the oncogenic KRAS variant G12V induces sustained MAPK signaling, causing proliferation that can be curtailed by the MEK inhibitor trametinib, while CRISPR‑mediated disruption of the TP53 gene in the same cells enhances drug resistance and promotes tumorigenic growth.",-52.0,0.8,cellline
"In a recent screen, CRISPR‑mediated knockout of TP53 in the HCT‑116 cell line resulted in increased sensitivity to doxorubicin, highlighting a potential synthetic lethal interaction between the p53 pathway and DNA‑damage‑inducing chemotherapy.",-35.75,0.8,cellline
"In transduced tsA201 cells, the CRISPR‑mediated introduction of a TP53 c.215G>A (p.R72P) sequence variant markedly reduced p53‑dependent apoptosis and conferred resistance to doxorubicin compared with wild‑type HeLa cells.",-40.25,0.8,cellline
"Reactivation of the PI3K/AKT pathway in the tsA201 cell line following treatment with the chemical entity rapamycin led to a significant increase in cell proliferation, confirming that rapamycin acts as a molecular switch in this model.",-46.5,0.8,cellline
"Recombinant lentiviral transduction of the tsA201 cell line with a plasmid encoding the mutant TP53 c.215C>G variant significantly enhanced the expression of the cell cycle regulator p21, thereby inducing G1 arrest and attenuating cell proliferation.",-51.25,0.8,cellline
"Reconstitution of the TP53 c.215C>A variant in the tsA201 cell line revealed a reduced p53 transcriptional activity that enhanced resistance to doxorubicin, whereas the same mutation in the HeLa cell line increased apoptosis via caspase‑3 activation.",-47.25,0.8,cellline
"Re-expressing the HCT‑116 KRAS G12D allele in the tsA201 cell line reduces colony‑forming efficiency and activates p53‑dependent apoptosis, illustrating how a sequence variant can rewire signaling pathways in a cancer‑derived cell line.",-59.0,0.8,cellline
"TSA201 cells overexpressing mutant TP53 exhibit heightened sensitivity to doxorubicin-induced apoptosis, a response that is further amplified when the drug is combined with the DNA‑crosslinker cisplatin.",-33.25,0.8,cellline
"TS24 cells, a derivative of the tsA201 cell line, exhibited increased proliferation after treatment with the chemical entity cycloheximide, while the HCT‑116 cell line displayed enhanced apoptosis when exposed to the same compound, indicating a differential regulatory response in these distinct cell line models.",-58.75,0.8,cellline
"TS‑A201 cells overexpressing the mutant EGFR‑L858R exhibit heightened sensitivity to erlotinib, a result that parallels the drug resistance observed in the PC‑3 prostate cancer cell line carrying the PTEN‑loss phenotype.",-42.5,0.8,cellline
"TS-201 cells exposed to doxorubicin exhibited a dose‑dependent decrease in viability that was partially rescued by co‑treatment with the autophagy inhibitor chloroquine, indicating that autophagy mediates resistance in this cell line.",-38.0,0.8,cellline
"siRNA-mediated knockdown of TP53 in the tsA201 cell line reduces E2F1 transcriptional activity and consequently suppresses proliferation of HCT-116 cells while increasing caspase‑3 activation, thereby demonstrating a differential response to apoptotic signaling between the two cell lines.",-49.25,0.8,cellline
"siRNAs targeting TP53 in tsA201 cells decreased cell cycle arrest, while in HeLa cells they promoted apoptosis through increased p21 and Bax expression.",-45.5,0.8,cellline
"si‑RNA knockdown of TP53 in the tsA201 cell line markedly increased apoptosis, whereas overexpression of BCL‑2 in HCT‑116 cells attenuated the same apoptotic response.",-39.25,0.8,cellline
"sirolimus treatment of the tsA201 cell line markedly reduced mTOR signaling, leading to decreased proliferation and increased apoptosis, while the same drug exhibited a dose‑dependent cytotoxic effect in the HCT‑116 model, thereby confirming its therapeutic potential for colorectal carcinoma.",-62.5,0.8,cellline
"Administration of the CRISPR/Cas9 system targeting TP53 in tsA201 cells induced a pronounced decrease in cell proliferation and an increase in p53‑dependent apoptosis, confirming the gene’s tumor‑suppressive role in this neural‑derived cell line.",-44.0,0.8,cellline
"Administration and cytotoxicity assays in the tsA201, HeLa, and HCT-116 cell lines revealed that the novel small‑molecule inhibitor of the PI3K pathway induced apoptosis through activation of caspase‑3 and down‑regulation of the anti‑apoptotic protein BCL‑XL.",-50.75,0.8,cellline
"Administration to tsA201 cells of the synthetic oligonucleotide targeting the TP53 promoter markedly reduced proliferation and increased apoptosis, confirming the dependence of these cancer cells on intact TP53 signaling.",-57.5,0.8,cellline
"Administration‑induced apoptosis of the PC3 prostate cancer cell line was markedly enhanced by the novel kinase inhibitor gefitinib, which specifically down‑regulated EGFR expression and triggered caspase‑3 activation in the presence of the EGF‑rich conditioned medium from HeLa cells.",-70.0,0.8,cellline
Mutation of TP53 in the tsA201 cell line results in increased expression of the pro‑apoptotic gene BAX and sensitizes the cells to doxorubicin‑induced cell death.,-21.5,0.8,cellline
"Mutation burden in the TP53 gene of the tsA201 cell line was found to correlate with the increased sensitivity of this line to the DNA‑damaging agent doxorubicin, mirroring the response observed in the PC3 prostate cancer cell line.",-40.5,0.8,cellline
Mutation analysis of the TP53 gene in the HCT‑116 cell line revealed a novel c.215G>A (p.Gly72Arg) sequence variant that enhances the apoptotic response to doxorubicin treatment.,-29.375,0.8,cellline
"Mutation abundance of the EGFR exon19 deletion in the CSF of patients with a PC3 xenograft model was quantified, revealing a significant correlation between the mutation load and the tumor cell viability measured in the cell line.",-68.0,0.8,cellline
"Exposure of the tsA201 cell line to doxorubicin induced a dose‑dependent up‑regulation of the pro‑apoptotic protein PUMA, thereby triggering caspase‑3 activation and apoptosis.",-24.125,0.8,cellline
"Exposure to low‑dose doxorubicin in the tsA201 cell line induced a dose‑dependent increase in apoptosis and up‑regulation of the pro‑apoptotic protein BAX, confirming its utility as a model for studying drug‑induced cytotoxicity in cancer cells.",-41.0,0.8,cellline
Exposure experiments using the tsA201 cell line revealed that transfection of the mutated TP53 allele (c.215G>A) dramatically increased the expression of the cell‑cycle arrest protein p21 in a dose‑dependent manner.,-55.5,0.8,cellline
"Exposure and subsequent transcriptomic profiling of tsA201 and HeLa cells revealed that the up‑regulated gene TP53 directly binds the promoter of the miRNA‑122 host gene, a finding that was confirmed by chromatin‑immunoprecipitation and quantitative RT‑PCR.",-71.5,0.8,cellline
"A chemokine receptor CXCR4 knock‑out in tsA201 cells reduces paclitaxel‑induced apoptosis by down‑regulating the AKT pathway, thereby revealing a potential resistance mechanism in this neuroblastoma‑derived cell line.",-46.75,0.8,cellline
"A CRISPR‑Cas9‑mediated knock‑out of the TP53 gene in the tsA201 cell line led to a significant increase in the proliferation rate and up‑regulation of the Cyclin‑D1 protein, confirming TP53’s role in cell‑cycle control.",-34.5,0.8,cellline
"A recent screen revealed that the CRISPR‑mediated knockout of the TP53 gene in the tsA201 cell line drastically increases the expression of the DNA‑repair enzyme RAD51, thereby reducing γ‑H2AX foci formation after doxorubicin‑induced DNA damage.",-42.5,0.8,cellline
"A dose‑dependent increase in reactive oxygen species observed in tsA201 cells carrying the TP53 c.215G>A variant was mitigated by treatment with the antioxidant curcumin, demonstrating a protective interaction between the sequence variant and the chemical entity in this cell line.",-38.0,0.8,cellline
"Mutagenic exposure to the carcinogen benzo[a]pyrene in the HCT‑116 cell line induces p53 phosphorylation and upregulates the cyclin‑dependent kinase inhibitor p21, thereby triggering G1 cell‑cycle arrest.",-35.0,0.8,cellline
"Mutating the TP53 exon in the tsA201 cell line, which is a derivative of HeLa, induces an elevated expression of the anti‑apoptotic protein BCL‑XL, thereby conferring resistance to cisplatin‑induced apoptosis.",-49.0,0.8,cellline
"Mutational analysis of the KRAS G12D allele in the tsA201 and HCT‑116 cell lines revealed that the oncogene drives differential expression of the PI3K‑AKT pathway, with the G12D mutation in tsA201 producing a statistically significant increase in phospho‑AKT levels compared to the wild‑type HCT‑116 background.",-54.5,0.8,cellline
"Mutant BRCA1 c.68_69delAG in HeLa cells activates the p53‑dependent DNA damage response, leading to apoptosis and reduced proliferation of the tumor‑derived line.",-34.75,0.8,cellline
"RNA polymerase II occupancy at the TP53 promoter was markedly increased in tsA201 cells treated with doxorubicin, suggesting that this drug induces transcriptional up‑regulation of the tumor suppressor gene in a cell‑type‑specific manner.",-34.75,0.8,cellline
"RNA‑seq analysis of the MC‑IXC cell line revealed that the TP53 p.R273H sequence variant induces over‑expression of the pro‑apoptotic gene BAX, thereby sensitizing the cells to doxorubicin treatment.",-34.5,0.8,cellline
"RNAi-mediated knockdown of the TP53 gene in the tsA201 cell line reduced the expression of the cyclin‑dependent kinase inhibitor p21, thereby enhancing proliferation rates of the cells.",-36.25,0.8,cellline
"RNA sequencing of the PC3 cell line revealed that CRISPR‑generated KRAS G12D (SequenceVariant) mutations up‑regulate the expression of the oncogenic protein KRAS, a GeneOrGeneProduct, thereby enhancing proliferation of this prostate carcinoma CellLine.",-58.25,0.8,cellline
"Molecular characterization of the tsA201 plasmid in HEK293T cells revealed that co‑transfection with the HCT‑116‑derived miR‑200c expression construct markedly suppressed epithelial‑mesenchymal transition markers, confirming the regulatory role of miR‑200c in this colorectal cancer cell line.",-45.75,0.8,cellline
"Methyltransferase inhibition by decitabine synergistically induced apoptosis in HeLa cells harboring the TP53 c.215G>A variant, revealing a cell‑line‑specific epigenetic vulnerability that was absent in the HCT‑116 model.",-48.75,0.8,cellline
"Mitochondrial dysfunction in tsA201 cells is exacerbated by the overexpression of the mutant mitochondrial gene POLG, causing increased ROS production and apoptosis.",-34.25,0.8,cellline
"MTS-1 and tsA201 cells treated with doxorubicin showed a dose‑dependent increase in TP53 phosphorylation, indicating that the drug induces a DNA damage response that may sensitize these cell lines to apoptosis.",-42.75,0.8,cellline
"HeLa cells overexpressing TP53 exhibited increased sensitivity to the DNA‑damaging agent doxorubicin, whereas the same TP53‑overexpressing phenotype in HCT‑116 cells conferred resistance to the same drug.",-32.5,0.8,cellline
"He-La cells treated with the novel small‑molecule inhibitor MC‑IXC exhibited a dose‑dependent decrease in proliferation, accompanied by up‑regulation of the tumor‑suppressor gene TP53 and a corresponding increase in apoptotic markers.",-52.0,0.8,cellline
"Heparanase overexpression in the PC3 cell line promotes invasion and correlates with increased MMP9 secretion, thereby enhancing metastatic potential in prostate cancer models.",-36.0,0.8,cellline
"HeLo cells, a derivative of HeLa, were engineered with CRISPR-Cas9 to introduce the BRCA1 c.68_69delAG variant, and the resulting BRCA1^delAG cells exhibited increased sensitivity to doxorubicin compared to the wild‑type HeLa line.",-57.75,0.8,cellline
"Silenced TP53 in the tsA201 cell line dramatically increased the phosphorylation of ATM, which in turn activated the DNA‑damage response and inhibited proliferation of HCT‑116 cells exposed to doxorubicin.",-38.75,0.8,cellline
"Silencing of TP53 in the tsA201 cell line led to a marked increase in resistance to doxorubicin, whereas reintroduction of wild‑type TP53 restored drug sensitivity and induced apoptosis in the same cells.",-30.875,0.8,cellline
"Silently, the CRISPR‑Cas9‑mediated deletion of the promoter region of the TP53 gene in tsA201 cells was shown to up‑regulate MDM2 expression, thereby dampening p53‑dependent apoptosis and promoting cellular proliferation.",-44.75,0.8,cellline
"Silvestrol induces apoptosis in the tsA201 cell line by disrupting eIF4A‑dependent translation initiation and simultaneously down‑regulating the oncogenic MYC transcript, thereby attenuating proliferation signals in this human embryonic kidney–derived cell culture.",-52.75,0.8,cellline
"U87‑DACH1‑high cells treated with the NF‑κB inhibitor BAY‑11‑7082 exhibited a significant reduction in Cyclin‑D1 expression, confirming that DACH1 over‑expression suppresses cell‑cycle progression in this glioblastoma cell line.",-27.625,0.8,cellline
"U‑87‑DACH1‑high cells exposed to doxorubicin exhibited a pronounced increase in TP53‑mediated apoptosis, whereas COS‑7 cells overexpressing the same compound displayed a comparable up‑regulation of p21 in a dose‑dependent fashion.",-51.25,0.8,cellline
"U6-22 cells, a derivative of the U87‑DACH1‑high glioblastoma cell line, exhibited markedly increased migration and invasion upon overexpression of the transcription factor TWIST1, while simultaneous CRISPR‑mediated knockout of the E-cadherin gene in the same line led to a pronounced reduction in cell‑cell adhesion, confirming that E‑cadherin loss facilitates TWIST1‑driven epithelial‑mesenchymal transition in this model.",-79.0,0.8,cellline
"U872-DACH1‑high cells overexpress the transcription factor DACH1, leading to increased expression of the tumor suppressor gene TP53 and reduced proliferation of the glioblastoma cell line U87‑MG.",-38.0,0.8,cellline
"In U87‑DACH1‑high cells, overexpression of DACH1 induces a transcriptional program that increases the expression of the chemokine CXCL10, thereby enhancing recruitment of RAW264.7 macrophages and promoting an inflammatory microenvironment that accelerates tumor cell invasion.",-31.875,0.8,cellline
"In the U87‑DACH1‑high glioblastoma cell line, overexpression of DACH1 markedly reduced the proliferation rate and increased apoptosis through down‑regulation of the PI3K/AKT pathway, confirming its tumor‑suppressive role in human astrocytic malignancies.",-36.5,0.8,cellline
"In HeLa cells, knockdown of TP53 by CRISPR-Cas9 induces a DNA damage–dependent senescence program that is alleviated by treatment with the DNA repair enhancer, caffeine.",-39.0,0.8,cellline
"In COS‑7 cells engineered to express a constitutively active Akt, the overexpression of the tumor suppressor gene TP53 synergistically reduced proliferation and induced apoptosis, highlighting a potential therapeutic target for cancers such as U87‑DACH1‑high glioblastoma.",-40.75,0.8,cellline
"The U87-DACH1-high cell line, engineered to overexpress DACH1, exhibited increased sensitivity to temozolomide and induced apoptosis mediated by upregulation of the tumor suppressor gene PTEN in comparison to the parental U87MG line.",-30.5,0.8,cellline
"The H446 cell line harboring the TP53 R175H mutation was shown to be highly resistant to doxorubicin, whereas co‑treatment with the PI3K inhibitor GDC‑0941 markedly induced apoptosis and decreased AKT phosphorylation in this glioblastoma model.",-51.25,0.8,cellline
"The engineered U87‑DACH1‑high glioblastoma cell line exhibits increased invasion through collagen type I matrices, a phenotype that is suppressed by the addition of the small‑molecule inhibitor doxorubicin, which down‑regulates the CXCR4 receptor expressed on these cells.",-43.0,0.8,cellline
The CRISPR‑Cas9‑mediated knockout of TP53 in U87‑DACH1‑high cells led to upregulation of the cell‑cycle inhibitor p21 and a significant reduction in colony‑forming ability compared with the TP53‑wild‑type U87‑MG cells.,-32.5,0.8,cellline
"H444, a CRISPR/Cas9‑engineered derivative of the U87‑DACH1‑high glioblastoma cell line, exhibited increased phosphorylation of STAT3 and enhanced resistance to doxorubicin compared with the parental U87‑MG cells, implicating DACH1 overexpression in modulating chemoresistance mechanisms.",-56.0,0.8,cellline
"HepG2 cells overexpressing the KRAS G12D mutation secrete higher levels of VEGFA, a finding that correlates with the increased proliferation of U87‑DACH1‑high glioblastoma cells treated with the VEGFR2 inhibitor pazopanib.",-40.25,0.8,cellline
"Heterozygous TRF2DN‑tg B RAW264.7 cells exposed to doxorubicin exhibit a dose‑dependent up‑regulation of TP53‑mediated apoptosis, paralleling the heightened cell‑death phenotype observed in the U87‑DACH1‑high glioblastoma cell line harboring the BRCA1 c.68_69delAG variant.",-54.25,0.8,cellline
"H446 cells treated with the PI3K inhibitor LY294002 exhibit reduced phosphorylation of AKT and increased apoptosis, confirming the drug’s therapeutic potential in this glioblastoma cell line.",-27.5,0.8,cellline
"BETV-7 cells, a genetically engineered variant of the U87-DACH1-high glioblastoma cell line, exhibit markedly increased phosphorylation of STAT3, which is further amplified by treatment with the small‑molecule inhibitor doxorubicin and correlated with elevated expression of the oncogenic gene MYC.",-53.75,0.8,cellline
"BETWEEN the U87‑DACH1‑high glioma cell line and the RAW264.7 macrophage model, stimulation with the cytokine TNF‑α upregulated the expression of the pro‑apoptotic gene BAX, illustrating a cell‑line–specific inflammatory signaling axis.",-48.25,0.8,cellline
"BET2 overexpression in U87‑DACH1‑high cells synergistically enhances IL‑6 secretion, thereby promoting a pro‑inflammatory tumor microenvironment that accelerates tumor growth in the human glioblastoma cell line.",-44.0,0.8,cellline
"BET23 cells, a HeLa-derived subline, showed increased sensitivity to the PI3K inhibitor LY294002, and this effect was amplified by overexpressing the U87‑DACH1‑high construct, indicating a cooperative interaction between PI3K signaling and DACH1-mediated transcriptional repression in cancer cell proliferation.",-61.75,0.8,cellline
"Treatment of U87-DACH1-high cells with the chemical entity doxorubicin induced apoptosis, a process accompanied by up‑regulation of the tumor suppressor GeneOrGeneProduct TP53, thereby illustrating a clear interaction between the drug and the cellular pathway.",-47.0,0.8,cellline
"Treatment with doxorubicin in the U87‑DACH1‑high glioblastoma cell line induced a rapid down‑regulation of TP53 expression, leading to increased resistance to apoptosis and enhanced proliferation.",-32.25,0.8,cellline
Treatment-mediated activation of the NF‑κB pathway in RAW264.7 cells carrying a TRAF2DN transgene results in markedly reduced secretion of IL‑1β compared to the same cell line derived from untreated H446 and MC3T3‑E1 osteoblasts.,-68.5,0.8,cellline
"Treatment efficacy of the chemotherapeutic agent doxorubicin in the H446 cell line was markedly enhanced by concurrent knockdown of the DNA repair protein XRCC1, revealing a synthetic lethal interaction that may inform precision oncology strategies.",-48.25,0.8,cellline
"Transfection of the U87‑DACH1‑high cell line with the CRISPR‑Cas9 construct targeting the TP53 gene resulted in a dramatic reduction of p53 protein levels, which was accompanied by increased resistance to doxorubicin‑induced apoptosis.",-34.25,0.8,cellline
"Transcription factor NF‑κB is hyperactivated in the U87‑DACH1‑high glioblastoma cell line, where its overexpression induces a pro‑inflammatory cytokine profile that promotes tumor‑associated macrophage recruitment, as confirmed by elevated IL‑6 and TNF‑α secretion in RAW264.7 co‑culture assays.",-50.5,0.8,cellline
Transfecting the U87‑DACH1‑high glioblastoma cell line with a CRISPR‑Cas9 plasmid targeting TP53 induces a frameshift c.215delAG variant that enhances p53‑mediated apoptosis and reduces cell proliferation relative to the parental U87 line.,-44.0,0.8,cellline
"Transduction of a lentiviral vector expressing constitutively active AKT into U87-DACH1-high cells induced phosphorylation of mTORC1 downstream targets and concomitant upregulation of the cyclin‑dependent kinase inhibitor p21, thereby impairing proliferation and increasing apoptosis relative to mock‑treated U87-DACH1-high cultures.",-65.0,0.8,cellline
"Toxoplasma gondii infection in the U87‑DACH1‑high glioblastoma cell line upregulates the inflammatory cytokine IL‑6, thereby promoting STAT3 activation and conferring resistance to temozolomide therapy.",-32.75,0.8,cellline
"Traf2DN-tg B cells transduced with a CRISPR‑Cas9 construct targeting the TP53 locus exhibited a markedly reduced proliferation rate compared with untreated H446 cells, suggesting that loss of TP53 function in Traf2DN-tg B cells impairs their growth potential.",-42.25,0.8,cellline
"Tryptophan‑derived kynurenic acid suppressed proliferation of the U87‑DACH1‑high glioma cell line while inducing p53‑dependent apoptosis, an effect that was markedly attenuated in the TRAF2DN‑tg B mouse macrophage model of chronic inflammation.",-47.75,0.8,cellline
"Treated with the PARP inhibitor olaparib, the U87‑DACH1‑high glioblastoma cell line exhibited a marked decrease in RAD51 foci formation, correlating with increased γ‑H2AX signaling and enhanced apoptosis relative to untreated U87‑DACH1‑high cells.",-31.5,0.8,cellline
"Expression of the TP53 gene in the Het-1A cell line is markedly up‑regulated by the DNA‑damaging agent doxorubicin, a change that correlates with increased apoptotic activity and reduced cell‑proliferation compared to untreated controls.",-40.0,0.8,cellline
"Expression analysis of the TP53 gene in the U87‑DACH1‑high cell line revealed that the c.215C>T SequenceVariant increases transcription of the p53 protein, thereby enhancing apoptosis in H446 cells.",-35.5,0.8,cellline
"Expression profiling of the U87‑DACH1‑high cell line revealed that DACH1 overexpression suppresses EGFR signaling and induces apoptosis through the TRAF2‑dependent NF‑κB pathway, a mechanism that was confirmed in the RAW264.7 macrophage model.",-41.5,0.8,cellline
"Expression levels of IL-6 were markedly increased in the U87-DACH1-high glioblastoma cell line compared with the parental U87, confirming that DACH1 overexpression drives pro‑inflammatory signaling in this cancer model.",-38.0,0.8,cellline
"Auranofin treatment of U87‑DACH1‑high cells induces NF‑κB suppression, leading to reduced IL‑6 secretion and impaired tumor‑derived macrophage recruitment.",-34.0,0.8,cellline
"A CRISPR‑Cas9 knock‑in of the TP53 c.215C>T variant in the U87‑DACH1‑high glioblastoma cell line induced apoptosis and sensitized the cells to doxorubicin treatment, demonstrating a functional interaction between the sequence variant and the drug.",-38.5,0.8,cellline
"A recent study showed that the U87-DACH1-high cell line, when treated with the small molecule inhibitor sorafenib, exhibited a marked decrease in VEGF secretion and an accompanying up‑regulation of the tumor suppressor gene PTEN, suggesting a potential therapeutic pathway for glioblastoma.",-38.0,0.8,cellline
"A knockdown of USP14 in the U87-DACH1‑high glioblastoma cell line markedly increased apoptosis through p53‑dependent up‑regulation of the BAX gene and concomitant down‑regulation of anti‑apoptotic BCL‑2, thereby enhancing the sensitivity of these cells to temozolomide.",-55.0,0.8,cellline
"Irradiation of the U87‑DACH1‑high glioblastoma cell line with low‑dose γ‑rays upregulated TRAF2 expression, thereby enhancing NF‑κB‑mediated apoptosis and reducing clonogenic survival relative to the parental U87‑MG cells.",-39.75,0.8,cellline
"Ishikawa cells treated with the selective PI3Kδ inhibitor idelalisib exhibited a marked reduction in CXCL12 secretion, correlating with a decrease in the phosphorylation of AKT and the downstream transcription factor NF‑κB, thereby impairing their migration toward stromal-derived factor‑1α gradients.",-49.25,0.8,cellline
"Iscove the U87‑DACH1‑high glioma cell line, which carries a TRIP6 amplification, exhibits increased resistance to temozolomide via up‑regulation of the DNA‑repair enzyme MGMT compared with the parental U87 line.",-60.0,0.8,cellline
"Irg1 deletion in RAW264.7 macrophages reduces the production of the inflammatory cytokine TNF‑α, thereby ameliorating lipopolysaccharide‑induced endotoxin shock in mice.",-37.75,0.8,cellline
"Mutation of the TP53 gene in Het-1A cells induces apoptosis and upregulates the pro‑apoptotic protein Bax, while CRISPR‑mediated deletion of the same locus in U87‑DACH1‑high cells leads to increased proliferation and resistance to temozolomide.",-32.25,0.8,cellline
"Mutation‐induced aberrant splicing of TP53 in U87‑DACH1‑high cells triggers apoptosis, a process that is markedly attenuated when the cells are co‑treated with the small‑molecule inhibitor doxorubicin, thereby demonstrating a synergistic effect on cell viability.",-51.0,0.8,cellline
"Mutation in the TP53 gene of the U87‑DACH1‑high glioblastoma cell line increases sensitivity to doxorubicin, thereby enhancing apoptosis compared with the parental U87 cells.",-27.625,0.8,cellline
Mutation analysis of the TP53 gene in U87‑DACH1‑high cells revealed a BRCA1 c.68_69delAG variant that correlated with increased expression of the anti‑apoptotic protein BCL‑2 and enhanced resistance to doxorubicin compared with the parental U87MG cell line.,-35.25,0.8,cellline
"Overexpression of the mutant TP53 allele in U87‑DACH1‑high cells led to increased apoptosis and up‑regulation of the pro‑apoptotic gene BAX, thereby reducing cell proliferation and enhancing chemosensitivity to doxorubicin.",-36.75,0.8,cellline
"Overexpressing TRAIL in U87‑DACH1‑high cells markedly increased apoptosis, a result that was reproduced in RAW264.7 macrophages co‑treated with conditioned medium from the same cell line.",-41.0,0.8,cellline
"Over the course of the study, U87‑DACH1‑high cells exhibited a marked up‑regulation of the PI3K‑AKT pathway, leading to increased proliferation and resistance to the BRAF inhibitor vemurafenib, while co‑culture with RAW264.7 macrophages further amplified IL‑6 secretion and promoted angiogenic sprouting through VEGF signaling.",-52.5,0.8,cellline
"Overgrowth of the U87-DACH1-high glioma cell line was attenuated by the small‑molecule inhibitor of the PI3K/AKT pathway, which induced apoptosis and up‑regulated the tumor suppressor TP53 while simultaneously suppressing the expression of the chemokine CXCL12.",-51.75,0.8,cellline
"Evidence from a comparative study of Het-1A and U87‑DACH1‑high cells revealed that up‑regulation of DACH1 enhances apoptosis in response to doxorubicin, a finding that was validated in the breast‑derived MCF‑7 cell line by measuring caspase‑3 activity.",-58.25,0.8,cellline
"Evidence that the CRISPR‑Cas9‑mediated BRCA1 c.68_69delAG variant reduces homologous recombination efficiency in the human breast cancer cell line H446, as compared to the isogenic U87‑DACH1‑high cells, was obtained by measuring RAD51 foci formation after irradiation.",-44.5,0.8,cellline
"Evidence showed that treating the U87‑DACH1‑high cell line with the PI3K inhibitor LY294002 reduced phosphorylation of AKT and suppressed invasion, while co‑culture with RAW264.7 macrophages increased secretion of TNF‑α, confirming a paracrine loop that promotes tumor cell migration.",-50.25,0.8,cellline
"Evidence indicates that the expression of DACH1 is upregulated in the U87‑DACH1‑high glioma cell line, and this upregulation increases cellular invasiveness while concurrently enhancing the sensitivity of the cells to temozolomide.",-52.25,0.8,cellline
"The CRISPR-Cas9 knock‑out of TP53 in the U87‑DACH1‑low cell line caused a significant reduction in proliferation and an increase in apoptotic markers, confirming that DACH1‑dependent regulation of TP53 is essential for glioblastoma cell survival.",-36.75,0.8,cellline
"The U87‑DACH1‑low cell line, when transfected with a plasmid encoding the KRAS(G12D) mutation, shows dramatically increased phospho‑ERK signaling and enhanced invasive capacity compared with the parental U87‑MGMT‑positive line.",-37.0,0.8,cellline
"The KRAS‑G12D mutation in the U87‑DACH1‑low glioblastoma cell line induces up‑regulation of the PI3K‑AKT pathway, leading to enhanced proliferation and resistance to temozolomide treatment.",-21.0,0.8,cellline
"The CA3 mouse hippocampal cell line, derived from C57BL/6J mice, was treated with doxorubicin, resulting in upregulation of the TP53 gene and increased apoptosis compared to untreated hRPTEC cells.",-34.75,0.8,cellline
"In the U87‑DACH1‑low glioblastoma cell line, knockdown of the gene TP53 further sensitized the cells to the chemotherapeutic agent doxorubicin, producing a statistically significant increase in apoptotic markers compared with untreated controls.",-29.625,0.8,cellline
"In GT1‑1 cells, knockdown of the TP53 gene by CRISPR/Cas9 leads to increased proliferation and resistance to doxorubicin, while restoration of wild‑type TP53 re‑sensitizes the cells to apoptosis.",-28.75,0.8,cellline
"In MT-4 cells, overexpression of the KRAS G12D mutation accelerates tumorigenesis through PI3K‑AKT signaling, a process that is attenuated when treated with the small‑molecule inhibitor LY294002.",-46.25,0.8,cellline
"In U87-DACH1‑low cells, CRISPR‑mediated deletion of the TP53 sequence variant c.215_216delCA reduces p53 protein expression, leading to increased proliferation and resistance to doxorubicin.",-31.75,0.8,cellline
"HepG2 cells treated with the small molecule CDK4 inhibitor palbociclib exhibited a dose‑dependent decrease in cyclin‑D1 expression, confirming the drug’s cell‑cycle arrest effect in this human liver carcinoma cell line.",-32.25,0.8,cellline
"HPLC‑purified doxorubicin selectively induced apoptosis in U87‑DACH1‑low cells, a phenotype that was markedly rescued by overexpressing the chemokine receptor CXCR4 in the same line, thereby illustrating a direct cell‑line‑dependent interaction between the drug and a receptor that modulates survival signaling.",-60.5,0.8,cellline
"HUVEC cells transfected with the TP53 c.215G>A variant displayed increased apoptosis upon doxorubicin treatment, confirming the role of the sequence variant in drug sensitivity.",-31.375,0.8,cellline
"H2O2 treatment of the U87‑DACH1‑low glioblastoma cell line induced a dose‑dependent increase in p‑ERK levels, confirming that oxidative stress activates MAPK signaling in these cells.",-36.0,0.8,cellline
"Overexpression of the tumor‑suppressor gene TP53 in the U87‑DACH1‑low cell line results in decreased proliferation and increased apoptosis, confirming TP53’s therapeutic potential in glioblastoma models.",-33.5,0.8,cellline
"Overexpressing TP53 in the U87‑DACH1‑low glioblastoma cell line (U87-DACH1‑low) markedly sensitized the cells to doxorubicin treatment, as evidenced by a two‑fold increase in apoptosis compared with parental U87 cells.",-38.25,0.8,cellline
"Over the course of the study, the CRISPR/Cas9-mediated introduction of the BRCA1 c.68_69delAG SequenceVariant into the U87-DACH1-low CellLine revealed a marked reduction in DNA repair capacity, which in turn amplified the cytotoxic efficacy of the ChemicalEntity doxorubicin in the human brain-derived TumorModel.",-58.25,0.8,cellline
"Overgrown U87‑DACH1‑low cells, when co‑cultured with hRPTEC, displayed increased expression of the anti‑apoptotic protein BCL‑XL, suggesting a paracrine interaction that could promote tumor‑cell survival.",-50.25,0.8,cellline
"MAK-1–derived activation of the PI3K/AKT pathway in the U87‑DACH1‑low cell line, which harbors a PTEN loss-of‑function mutation, promotes resistance to temozolomide and correlates with increased expression of the MDM2 gene product.",-51.0,0.8,cellline
"MAZ expression in the human kidney cell line hRPTEC is upregulated by the small molecule rapamycin, leading to increased phosphorylation of mTOR and subsequent activation of the PI3K/AKT signaling pathway.",-38.75,0.8,cellline
"MA10 cells, a subclone of the human renal proximal tubular cell line hRPTEC, showed a dose-dependent increase in p53 phosphorylation when exposed to doxorubicin, suggesting that the chemotherapeutic agent induces DNA damage signaling pathways that could be exploited for targeted cancer therapy.",-53.25,0.8,cellline
MAFFT‐based alignment of the TP53 coding sequence in the human embryonic kidney cell line HK‑2 revealed a novel BRCA1 c.68_69delAG variant that may contribute to the observed increase in apoptotic markers following doxorubicin treatment.,-49.25,0.8,cellline
"Activation of the PI3K/AKT pathway in the U87-DACH1-low cell line is attenuated by the small-molecule inhibitor MK-2206, thereby reducing proliferation and inducing apoptosis through downregulation of the BCL‑2 gene product.",-37.25,0.8,cellline
"Activation-induced cytidine deaminase expression in the hRPTEC cell line was markedly upregulated by the BRAF V600E mutation, leading to increased DNA demethylation and altered proliferation of the cells.",-50.0,0.8,cellline
"Activation by the KRAS^G12D variant in the U87-DACH1-low cell line led to overexpression of the chemokine CXCL12, which in turn recruited CXCR4‑positive BEP2D cells and amplified the invasive phenotype.",-49.25,0.8,cellline
"Activation‑induced STAT3 phosphorylation in the human renal proximal tubule cell line hRPTEC was markedly enhanced by the small‑molecule inhibitor JAK‑STAT‑inhibitor‑X, confirming the drug’s potential to mitigate fibrosis in CKD models.",-45.25,0.8,cellline
"Treatment of the U87-DACH1-low cell line with the DNA‑damaging agent doxorubicin upregulates the tumor suppressor TP53, inducing apoptosis and decreasing proliferation.",-31.5,0.8,cellline
"Treatment with the small‑molecule inhibitor BAY‑61‑3606 suppressed proliferation of the U87‑DACH1‑low glioma cell line while upregulating the tumor‑suppressive gene TP53, thereby reducing colony‑forming ability in vitro.",-39.25,0.8,cellline
"Treatment‑induced apoptosis was significantly higher in the U87‑DACH1‑low cell line compared with the parental U87MG line, suggesting that DACH1 knockdown enhances temozolomide sensitivity in glioblastoma cells.",-36.5,0.8,cellline
Treatment using the CRISPR/Cas9 system in the human kidney proximal tubule epithelial cell line hRPTEC showed that knocking out the APOL1 gene reduced the expression of the inflammatory cytokine IL‑6 and increased cell viability under hypoxic stress.,-47.0,0.8,cellline
"MTs from the U87-DACH1‑low cell line, engineered to overexpress the KRAS c.35G>A variant, exhibited a markedly reduced response to the PI3K inhibitor LY294002, confirming a role for KRAS in modulating PI3K pathway inhibition in glioma cells.",-59.75,0.8,cellline
"MT–NIK overexpression in the U87‑DACH1‑low cell line enhances MMP‑9 secretion, thereby accelerating invasion of surrounding CA3‑derived stromal cells.",-39.0,0.8,cellline
"MT-2 cells, a derivative of the human renal proximal tubular epithelial line hRPTEC, exhibited increased expression of the transcription factor HIF‑1α after exposure to the hypoxia mimetic CoCl₂, a response that was attenuated by siRNA knockdown of the U87‑DACH1‑low cell line’s DACH1 gene.",-52.5,0.8,cellline
"MTX treatment of the U87‑DACH1‑low cell line caused a dose‑dependent up‑regulation of the tumor suppressor gene TP53 and a concurrent increase in caspase‑3 activity, leading to apoptosis.",-33.25,0.8,cellline
"U87-DACH1-low cells treated with the MEK inhibitor trametinib displayed a significant reduction in ERK1/2 phosphorylation, accompanied by increased expression of the pro‑apoptotic gene BAX and a concomitant decrease in cell proliferation relative to untreated U87-DACH1-low cells.",-37.25,0.8,cellline
"U‑87‑DACH1‑low cells treated with the small‑molecule inhibitor doxorubicin displayed a dose‑dependent reduction in proliferation, accompanied by an up‑regulation of the tumor‑suppressor gene TP53 and a significant increase in apoptosis markers such as cleaved caspase‑3.",-35.75,0.8,cellline
U7‑2 cells derived from the U87‑DACH1‑low line were used to demonstrate that the HIF‑1α inhibitor YC‑1 suppresses VEGF secretion and reduces angiogenic sprouting in the human renal proximal tubular cell line HK‑2.,-57.0,0.8,cellline
"U82-1 cells, a KRAS‑mutant human colorectal carcinoma cell line, showed markedly increased phosphorylation of ERK1/2 after treatment with the MEK inhibitor trametinib, confirming that the MAPK pathway remains active in this model.",-48.5,0.8,cellline
"Exposure of the U87‑DACH1‑low cell line to the small molecule JQ1 induces apoptosis and reduces the expression of the oncogenic transcription factor DACH1, thereby suppressing tumor‑cell proliferation in vitro.",-31.0,0.8,cellline
"Exposure to the chemotherapeutic agent cisplatin induces apoptosis and increases p53 expression in the human proximal tubule cell line hRPTEC, whereas the same treatment fails to activate caspase‑3 in the immortalized epithelial line HK‑2, suggesting a cell‑type‑specific response to DNA damage.",-50.5,0.8,cellline
"Exposure–response profiling of the BET inhibitor JQ1 in the H1299 cell line revealed that EGFR overexpression induced resistance, whereas CRISPR–mediated TP53 knockout in H1299 cells restored drug sensitivity.",-62.25,0.8,cellline
"Exposure‑induced oxidative stress in HK‑2 cells activates NRF2, which in turn upregulates heme‑oxygenase‑1 expression, a protective response that attenuates cisplatin‑mediated nephrotoxicity in this human proximal tubular epithelial model.",-46.5,0.8,cellline
"A U87-DACH1-low cell line transduced with a CRISPR/Cas9 construct targeting the TP53 gene exhibits increased sensitivity to the DNA‑damaging agent doxorubicin, confirming a functional link between TP53 loss, U87-DACH1-low phenotype, and chemotherapeutic response.",-38.5,0.8,cellline
"A549 cells transfected with the CRISPR‑edited TP53 c.215G>A variant exhibited increased sensitivity to doxorubicin, while H1299 cells carrying the same mutation showed reduced apoptosis and enhanced proliferation, suggesting that the BRCA1 c.68_69delAG sequence variant modulates chemotherapeutic response in these cell lines.",-47.5,0.8,cellline
"A CRISPR/Cas9‑generated mutation in TP53 within the U87‑DACH1‑low cell line leads to up‑regulation of the pro‑apoptotic protein PUMA, thereby sensitizing the glioblastoma cells to the DNA‑damaging agent doxorubicin.",-36.5,0.8,cellline
"A mutation in TP53 detected in the U87‑DACH1‑low cell line induces apoptosis and decreases expression of the pro‑survival protein BCL‑2, thereby enhancing the efficacy of doxorubicin in this glioblastoma model.",-35.25,0.8,cellline
"Cell line BEP2D, derived from human epidermal carcinoma, exhibited a marked upregulation of the DNA repair gene XRCC1 following exposure to the chemotherapeutic agent doxorubicin, suggesting a potential mechanism for acquired drug resistance.",-35.75,0.8,cellline
"Cell proliferation in the U87‑DACH1‑low line was markedly enhanced by transient knockdown of the HLA‑B allele, revealing a regulatory link between HLA‑B expression and DACH1‑mediated cell‑cycle arrest.",-46.75,0.8,cellline
"Cell toxicity assays in the U87-DACH1-low cell line and in the BEP2D tumorigenic model revealed that the small molecule inhibitor doxorubicin, when combined with the EGFR antagonist erlotinib, synergistically induced apoptosis through downregulation of the AKT signaling pathway.",-62.0,0.8,cellline
"Cell-line U87‑DACH1‑low, derived from the human glioblastoma line U87, displayed heightened resistance to temozolomide and exhibited elevated expression of the DNA repair gene MGMT, suggesting a potential mechanism for therapeutic failure in high‑grade glioma patients.",-48.75,0.8,cellline
"Gene‑edited GT1‑1 cells expressing the KRAS G12D mutation exhibit increased proliferation and confer enhanced anchorage‑independent growth compared with unmodified GT1‑1, indicating that the mutation drives oncogenic transformation in this cell line.",-43.5,0.8,cellline
"Gene delivery with the lentiviral vector pLenti-CMV-MNDAA induced robust expression of the KRAS(G12V) oncogene in the U87-DACH1-low cell line, resulting in enhanced proliferation and resistance to temozolomide.",-58.25,0.8,cellline
"Gene knockdown of TP53 in the U87-DACH1-low cell line, cultured under hypoxic conditions, markedly reduced the expression of the pro‑apoptotic protein BAX and increased the proliferation of the tumor cells, suggesting that TP53 loss confers a growth advantage in this glioblastoma model.",-45.5,0.8,cellline
Gene editing of the BRCA1 c.68_69delAG variant in the U87-DACH1-low cell line using CRISPR-Cas9 restored RAD51 expression and reduced the sensitivity of these human glioblastoma cells to the DNA-damaging agent doxorubicin.,-34.25,0.8,cellline
Mutation of TP53 in the U87-DACH1-low cell line increases the sensitivity of this glioblastoma model to doxorubicin by upregulating p21 and inducing apoptosis.,-27.5,0.8,cellline
Mutation screening of TP53 in the U87‑DACH1‑low cell line revealed a c.215C>T sequence variant that correlates with increased chemotherapeutic resistance and decreased apoptotic signaling in glioblastoma models.,-41.75,0.8,cellline
Mutation analysis of the TP53 c.68_69delAG sequence variant in the U87‑DACH1‑low glioblastoma cell line revealed a loss‑of‑function allele that reduced p53‑dependent apoptosis and enhanced cell proliferation compared with the parental U87‑MGMT‑expressing line.,-42.25,0.8,cellline
Mutation c.68_69delAG in TP53 accelerates proliferation of the U87‑DACH1‑low cell line and increases resistance to doxorubicin in vitro.,-27.875,0.8,cellline
"Ishikawa cells treated with the CYP2E1 inhibitor, chlorzoxazone, exhibited a statistically significant reduction in reactive oxygen species production, suggesting that CYP2E1 activity drives oxidative stress in this colorectal cancer cell line.",-35.75,0.8,cellline
"Isoniazid treatment of the HeLa cell line significantly reduced the expression of the DNA repair gene MGMT, thereby increasing the cells’ sensitivity to subsequent cisplatin-induced apoptosis.",-36.0,0.8,cellline
"Ibrutinib treatment reduced ERK phosphorylation in the SH‑5YY neuroblastoma cell line, thereby suppressing the up‑regulated AKT‑mediated survival signaling that had been amplified by the EGFR exon‑20 T790M mutation.",-67.5,0.8,cellline
"Iscikawa cells engineered to overexpress the SH‑5Y transcription factor exhibited heightened sensitivity to the anticancer drug doxorubicin, an effect that correlated with increased apoptosis and reduced expression of the tumor suppressor gene TP53, demonstrating a potential therapeutic target for treatment of SH‑5Y‑derived tumors.",-62.75,0.8,cellline
"In the Ishikawa cell line, knock‑down of the gene MYC by CRISPR/Cas9 led to a significant reduction in the expression of the protein cyclin‑D1 and induced G1‑phase arrest, confirming MYC’s role as a driver of proliferation in endometrial carcinoma cells.",-37.0,0.8,cellline
"In a recent study, Ishikawa cells were transfected with a CRISPR/Cas9 construct targeting the TP53 gene, resulting in the BRCA1 c.68_69delAG variant, which enhanced resistance to doxorubicin and induced a pronounced up‑regulation of the cyclin‑dependent kinase inhibitor p21.",-47.0,0.8,cellline
"In Ishikawa cells, the CRISPR‑generated TP53 c.68_69delAG variant markedly reduces p53‑dependent transcription of the DNA‑damage‑repair gene OGG1, leading to an accumulation of oxidative lesions and a higher sensitivity to doxorubicin‑induced apoptosis.",-38.25,0.8,cellline
"In SH‑5Y‑Y cells, the overexpression of the oncogenic BCL‑2 variant A315T promotes resistance to doxorubicin-induced apoptosis, a phenomenon that is reversed when the drug is combined with the PARP inhibitor niraparib.",-53.75,0.8,cellline
"The Ishikawa cell line, when transfected with a TP53 c.215G>A (p.Arg72Pro) sequence variant, exhibited increased resistance to doxorubicin, indicating a potential biomarker for drug efficacy in endometrial carcinoma studies.",-35.75,0.8,cellline
"The CRISPR‑mediated knockout of the TP53 gene in Ishikawa cells leads to a marked increase in caspase‑3 activation and apoptosis, revealing a crucial tumor‑suppressive role for p53 in this endometrial carcinoma cell line.",-36.0,0.8,cellline
"The PC-3 cell line overexpresses the androgen‑responsive gene TMPRSS2, and CRISPR‑mediated disruption of the BRCA1 c.68_69delAG variant in the same line dramatically reduces DNA repair capacity, thereby sensitizing the cells to the chemotherapeutic agent doxorubicin.",-37.25,0.8,cellline
"The SH‑5Y5 neuroblastoma cell line (SH‑S5Y) exhibited increased PKA phosphorylation upon treatment with the PI3K inhibitor LY294002, suggesting that PI3K/AKT signaling regulates neuronal differentiation in this human cell line.",-40.5,0.8,cellline
Use of the SH‑5Y cell line to overexpress mutant TP53 c.215G>A demonstrated a significant increase in apoptosis markers in response to doxorubicin treatment.,-33.75,0.8,cellline
"Use SH‑5Y, a neuroblastoma cell line, to demonstrate that exposure to doxorubicin induces TP53‑mediated apoptosis, thereby reducing the growth of the cell line in vitro.",-44.25,0.8,cellline
Use the Ishikawa cell line to demonstrate that the BRCA1 c.68_69delAG variant impairs DNA repair and increases sensitivity to doxorubicin in a dose‑dependent manner.,-31.25,0.8,cellline
Use Hs578T cells to confirm that the BRCA1 c.68_69delAG sequence variant reduces DNA repair activity and increases sensitivity to doxorubicin.,-31.625,0.8,cellline
"SH-SY5Y cells overexpressing mutant α‑synuclein display increased α‑synuclein aggregation and impaired mitochondrial respiration, which is partially rescued by the small‑molecule inhibitor rapamycin.",-37.75,0.8,cellline
"SH‑5Y cells treated with the EGFR inhibitor gefitinib exhibited reduced colony‑forming ability and increased apoptosis through upregulation of TP53, while the same treatment in Ishikawa cells enhanced caspase‑3 activation and cell cycle arrest.",-45.5,0.8,cellline
"SH‐SY5Y cells expressing mutant PIK3CA exhibit increased PI3K signaling that promotes resistance to the MEK inhibitor trametinib, a finding that parallels observations in PC‑3 and HeLa xenografts of the same mutation.",-47.25,0.8,cellline
"SH-5Y neuroblastoma cells (SH-SY5Y) overexpressing mutant p53 exhibit increased sensitivity to the chemotherapeutic agent doxorubicin, thereby demonstrating a clear link between gene mutation, drug response, and cell‑line–specific toxicity.",-49.5,0.8,cellline
"Mutating the TP53 gene in Ishikawa cells to introduce the BRCA1 c.68_69delAG variant increases apoptosis and decreases the expression of the anti‑apoptotic protein BCL‑2, suggesting a functional interaction between TP53 and BRCA1 in this endometrial carcinoma cell line.",-41.25,0.8,cellline
"Mutant TP53 expression in the Ishikawa cell line is suppressed by the small molecule doxorubicin, leading to reduced proliferation of Ishikawa cells and increased apoptosis.",-29.875,0.8,cellline
"Mutagenic exposure to aflatoxin B1 induces a TP53 c.215C>A sequence variant in the HeLa cell line, resulting in altered cell cycle arrest and increased apoptosis relative to the wild‑type SH‑S5Y cells.",-36.75,0.8,cellline
Mutational screening of the TP53 gene in the SH‑5Y‑Y neuroblastoma cell line (SH‑5Y‑Y) revealed a novel c.215G>A (p.R72H) variant that reduces p53‑dependent transcription of BAX and attenuates apoptosis induced by doxorubicin in this Human Neuroblastoma Cell Line.,-54.5,0.8,cellline
"RNA‑sequencing of the Ishikawa and SH‑S5Y cell lines revealed that the SH‑S5Y transcriptome shows markedly higher expression of the mitochondrial biogenesis regulator PGC‑1α, whereas Ishikawa cells exhibit up‑regulation of the epithelial‑mesenchymal transition marker Vimentin, suggesting differential metabolic states and invasion potential between these two cancer cell lines.",-60.5,0.8,cellline
"RNA‐seq analysis of the Ishikawa cell line revealed that the overexpression of the gene TP53 induced a decrease in the expression of the anti‑apoptotic protein BCL2, thereby increasing the susceptibility of these cells to doxorubicin‑induced apoptosis.",-43.75,0.8,cellline
"RNA interference of the TP53 gene in HeLa cells and the SH‑5Y neuroblastoma line resulted in increased proliferation and reduced apoptosis, suggesting that p53 loss promotes tumor growth in these human cancer cell models.",-45.5,0.8,cellline
"RNA knockdown of the transcription factor E2F1 in Ishikawa cells, combined with treatment of the selective HDAC inhibitor vorinostat, significantly reduces the expression of the cell‑cycle regulator p21 and induces apoptosis through the up‑regulation of BAX in the human endometrial carcinoma line.",-69.5,0.8,cellline
"A functional rescue of the BRCA1 c.68_69delAG sequence variant was observed in Ishikawa cells following transfection with a CRISPR/Cas9-corrected plasmid, which restored RAD51 foci formation and reduced genomic instability.",-40.75,0.8,cellline
"A CRISPR-Cas9-mediated knockout of TP53 in the PC-3 cell line reduced metastatic colonization of BALB/c mice, confirming p53’s role in prostate tumor suppression.",-34.0,0.8,cellline
"A transcriptomic comparison of Ishikawa and PC‑3 cells revealed that the up‑regulation of the pro‑apoptotic gene BAX in PC‑3 was accompanied by increased sensitivity to the DNA‑damaging chemotherapeutic doxorubicin, a finding that was validated in the SH‑S5Y neuroblastoma line.",-45.25,0.8,cellline
"A pharmacogenomic study found that the BRCA1 c.68_69delAG sequence variant in the HeLa cell line alters the expression of the DNA repair gene ATM, thereby enhancing the cell line’s sensitivity to the DNA‑damaging agent doxorubicin.",-41.0,0.8,cellline
Treatment with the PI3K inhibitor LY294002 reduced cell cycle progression in Ishikawa cells by down‑regulating the expression of the oncogenic gene PIK3CA while simultaneously increasing apoptosis mediated by the tumor suppressor TP53.,-35.0,0.8,cellline
"Treatment of Ishikawa cells with the DNA‑damage agent doxorubicin induces p53‑dependent apoptosis, while in the SH‑S5Y neuroblastoma cell line the same drug triggers activation of the MAPK pathway, illustrating distinct cell‑type‑specific responses to the same chemical entity.",-46.25,0.8,cellline
"Treatment efficacy of the novel inhibitor rapamycin was confirmed in SH‑5Y and PC‑3 cell lines, where the drug suppressed mTOR signaling and induced apoptosis, thereby reducing tumor‑derived VEGF production and improving survival in a BALB/c xenograft model.",-53.0,0.8,cellline
"Treatment using the SH‑5Y cell line revealed that the GSK3β inhibitor LY‑294002 reduced the expression of the apoptosis‑related gene BAX, thereby promoting cell survival under oxidative stress conditions.",-52.0,0.8,cellline
"Mutation of TP53 in the Hs578T cell line leads to resistance to doxorubicin treatment, while concurrent overexpression of VEGF in the same cells enhances angiogenic signaling pathways.",-36.5,0.8,cellline
Mutation analysis of the BRCA1 c.68_69delAG sequence variant in the Ishikawa cell line revealed a loss of p53 protein expression and induced apoptosis in response to doxorubicin treatment.,-29.875,0.8,cellline
"Mutation in the TP53 gene of the Hs578T breast cancer cell line (Hs578T) was shown to reduce the cellular response to doxorubicin, thereby increasing the IC₅₀ for the chemotherapeutic agent in comparison with the parental HeLa line.",-50.25,0.8,cellline
"Mutation-induced activation of the PI3K/AKT pathway in the PC‑3 cell line, which expresses the androgen‑responsive gene FKBP5, was suppressed by the small‑molecule inhibitor LY294002, thereby reducing cell proliferation and enhancing apoptosis.",-41.5,0.8,cellline
Tetracycline-induced apoptosis in the Hs578T breast cancer cell line is mediated by increased reactive oxygen species and upregulation of the TP53 tumor suppressor gene.,-36.5,0.8,cellline
"Treated Ishikawa cells with the small‑molecule inhibitor doxorubicin induced a dose‑dependent down‑regulation of the TP53 protein, concomitant with increased apoptosis and a reduction in colony‑forming ability.",-31.75,0.8,cellline
"Toxicity of the novel kinase inhibitor VX‑128 was markedly increased in SH‑5Y5 cells transfected with the BRCA1 c.68_69delAG variant, a finding that was confirmed by reduced viability in HeLa and PC‑3 cultures exposed to the same drug.",-53.5,0.8,cellline
"Tunicamycin treatment induces endoplasmic reticulum stress in the human cervical carcinoma cell line HeLa, leading to up‑regulation of the chaperone HSPA5 and activation of the unfolded protein response pathway.",-31.375,0.8,cellline
"Mitochondrial dysfunction in Ishikawa cells, induced by the BRCA1 c.68_69delAG variant, increases reactive oxygen species, thereby promoting apoptosis and sensitizing the cells to doxorubicin treatment.",-26.5,0.8,cellline
"Molecular profiling of the SH‑5Y cell line revealed that knockdown of TP53 enhances ethanol‑induced apoptosis, suggesting a protective role of the p53 pathway in neuroblastoma models.",-33.5,0.8,cellline
MUTATION OF TP53 IN SH‑SY5Y CELLLINE LEADS TO INCREASED SURVIVAL AFTER DOXORUBICIN TREATMENT IN ADOLESCENT NEUROBLASTOMA MODELS OF H. sapiens.,-42.75,0.8,cellline
"Methyl‑seleninic acid treatment markedly reduced migration in the metastatic PC‑3 cell line while simultaneously increasing the expression of the tumor suppressor gene TP53, suggesting that the compound acts through a TP53‑dependent pathway to inhibit prostate cancer cell invasion.",-51.75,0.8,cellline
"Stably transfected SH‑5Y5 cells overexpressing the mutated TP53 variant c.215G>A exhibit increased resistance to doxorubicin compared with parental SH‑5Y5, a phenotype also observed in the HeLa cell line bearing the same sequence variant.",-42.0,0.8,cellline
"Staining of the Ishikawa cells with the fluorescent probe for the DNA repair protein XRCC1 revealed a dramatic increase in repair foci in response to the DNA‑damaging chemical entity cisplatin, correlating with the up‑regulation of the GeneOrGeneProduct p53 and the appearance of the SequenceVariant c.215C>T, which was shown to confer resistance to the chemotherapy in this Human OrganismTaxon.",-82.0,0.8,cellline
"Stimulation of the PI3K‑AKT pathway with insulin in the Ishikawa cell line led to increased phosphorylation of mTOR and consequently up‑regulated the expression of the Cyclin‑D1 gene, thereby promoting proliferation.",-43.75,0.8,cellline
"Stabilization of the mitochondrial membrane potential in Ishikawa cells exposed to doxorubicin was correlated with increased expression of the pro‑apoptotic protein BAX, suggesting that the drug induces apoptosis through a ROS‑dependent pathway.",-37.0,0.8,cellline
"Using CRISPR‑Cas9 editing, the SH‑S5Y cell line harboring a CRBN c.1096C>T (p.R366W) sequence variant exhibited a marked decrease in proteasome-mediated degradation of the E3 ligase substrate, leading to increased accumulation of the HIF‑1α protein and enhanced VEGF secretion compared with the wild‑type SH‑S5Y cells.",-66.5,0.8,cellline
"Using the Ishikawa cell line, researchers observed that overexpressed TP53 led to increased p21 transcription and induced apoptosis, suggesting that TP53 activation may be a potential therapeutic strategy for endometrial carcinoma.",-41.25,0.8,cellline
"Using SH‑SY5Y cells, we found that the knock‑down of the Hs578T‑associated transcription factor reduces the expression of the oncogenic Gene TP53, thereby attenuating the malignant phenotype observed in HeLa and PC‑3 cell lines.",-50.5,0.8,cellline
"Using HeLa cells transfected with a CRISPR-Cas9 construct targeting TP53, researchers observed that the resulting p53 loss led to increased expression of the apoptosis‑inhibiting gene BCL2, thereby enhancing resistance to the chemotherapeutic agent doxorubicin.",-45.25,0.8,cellline
"Foscarnet treatment in a patient with refractory cytomegalovirus retinitis reduced viral replication and was associated with a marked decrease in thromboxane B2 levels, suggesting an anti‑inflammatory effect.",-27.0,0.8,chemicalentity
"Fuscarnet, a potent antiviral nucleotide analogue, was shown to inhibit reverse transcription of HIV-1 in CEM-SS cells, while co‑administration of dexmedetomidine reduced the associated cytotoxicity and preserved cell viability.",-45.5,0.8,chemicalentity
"Fibrinogen degradation products were significantly reduced in A549 cells treated with the antiviral foscarnet, revealing a direct inhibitory effect on thromboxane B2 synthesis and suggesting a potential therapeutic benefit in drug‑induced pulmonary hypertension.",-50.25,0.8,chemicalentity
"Fossarnet, a nucleoside analogue, inhibits viral DNA polymerase in a dose-dependent manner and its activity is markedly potentiated when combined with a sodium chloride infusion that enhances cell membrane permeability.",-53.0,0.8,chemicalentity
"In hepatocellular carcinoma cell lines such as HepG2, the addition of foscarnet synergistically enhances the cytotoxicity of doxorubicin, leading to increased apoptosis mediated by caspase‑3 activation and down‑regulation of the anti‑apoptotic protein BCL‑2.",-30.125,0.8,chemicalentity
"In the A549 cell line, treatment with foscarnet and Dexmedetomidine synergistically reduced thromboxane B2 production, thereby attenuating isoprenaline‑induced proliferation and inflammatory signaling.",-23.125,0.8,chemicalentity
"In vitro, foscarnet markedly reduced the growth of H1299 cells while simultaneously increasing intracellular thromboxane B2 production, suggesting a dual anti‑tumor and pro‑inflammatory effect in this lung cancer cell line.",-32.25,0.8,chemicalentity
"In HeLa cells treated with foscarnet, the up‑regulation of the DNA‑binding protein TP53 was accompanied by a significant decrease in thromboxane B2 production, suggesting that foscarnet may mitigate platelet‑derived inflammatory signaling via p53‑dependent pathways.",-34.5,0.8,chemicalentity
"Dexmedetomidine administration in septic ICU patients decreased cytokine storm severity, while concurrent sodium chloride resuscitation restored intravascular volume, and a subsequent foscarnet infusion reduced viral replication in the bloodstream.",-43.75,0.8,chemicalentity
"Dexmodetomidine administration in the A549 cell line reduced thromboxane B2 production and concurrently lowered expression of COX‑2, suggesting a potential anti‑inflammatory mechanism that could be exploited for treating chronic airway inflammation in patients with asthma.",-50.75,0.8,chemicalentity
"Dexmethadone, a synthetic opioid analog, competitively inhibited the binding of foscarnet to the viral DNA polymerase in cultured HeLa cells, thereby reducing viral replication and inducing apoptosis of infected cells.",-41.0,0.8,chemicalentity
Dexmetomidine administration in a mouse model of isoprenaline-induced cardiac hypertrophy attenuated thromboxane B2 production while preserving cardiac contractility.,-38.5,0.8,chemicalentity
"The inhibition of thromboxane B2 synthesis by foscarnet, when combined with dexmedetomidine, markedly reduced platelet aggregation in vitro and improved thrombus stability in a murine model of isoprenaline‑induced myocardial infarction.",-33.0,0.8,chemicalentity
"The use of foscarnet in combination with dexmedetomidine markedly reduced the isoprenaline‑induced arrhythmia observed in the A549 cell line, while sodium chloride and thiamine supplementation prevented the associated oxidative stress.",-23.875,0.8,chemicalentity
"The anti‑viral activity of foscarnet against cytomegalovirus was markedly enhanced when combined with the immunomodulator dexmedetomidine in a murine pneumonia model, where the synergistic effect was attributed to downregulation of thromboxane B2‑mediated platelet aggregation.",-41.75,0.8,chemicalentity
"The combination of dexmedetomidine and thiamine reduces isoprenaline‑induced arrhythmias in a rat model of atrial fibrillation, likely by attenuating oxidative stress and stabilizing mitochondrial membrane potential.",-25.875,0.8,chemicalentity
"Intravenous foscarnet combined with dexmedetomidine sedation markedly reduced the incidence of nephrotoxicity in patients receiving isoprenaline‑induced catecholamine therapy, while serum thiamine levels were found to be predictive of treatment response.",-42.0,0.8,chemicalentity
"Intraperitoneal administration of foscarnet in dexmedetomidine‑sedated mice markedly reduced isoprenaline‑induced cardiac apoptosis, while concurrent thiamine supplementation preserved mitochondrial integrity and mitigated thromboxane B2 release.",-40.75,0.8,chemicalentity
"Intracellular calcium release induced by isoprenaline promotes the phosphorylation of the Na⁺/K⁺‑ATPase in H9c2 cardiomyoblasts, a process that is attenuated when cells are pretreated with the Na⁺‑channel blocker foscarnet, thereby reducing the arrhythmogenic potential of the cardiac tissue.",-51.75,0.8,chemicalentity
"Intravitreal foscarnet administration in a patient with cytomegalovirus retinitis led to a rapid decline in viral load and concomitant improvement in retinal thickness, whereas concurrent dexmedetomidine sedation mitigated the systemic hypotensive effect of the antiviral.",-42.0,0.8,chemicalentity
"Treatment with foscarnet in combination with Dexmedetomidine significantly reduced viral replication and improved survival in a mouse model of herpes simplex encephalitis, while sodium chloride and thiamine supplementation were necessary to maintain electrolyte balance and metabolic function during therapy.",-39.0,0.8,chemicalentity
Treatment of carbamazepine‑resistant epilepsy with dexmedetomidine infusion was associated with a significant reduction in serum thromboxane B2 levels in patients with a history of recurrent seizures.,-32.75,0.8,chemicalentity
"Treatment regimens for multidrug‑resistant tuberculosis that combine azithromycin, foscarnet, and Thiamine have shown increased sputum conversion rates compared with azithromycin alone.",-42.25,0.8,chemicalentity
"Treatment efficacy of foscarnet was markedly enhanced in HCMV‑infected A549 cells when combined with dexmedetomidine, as the drug synergistically inhibited viral DNA polymerase activity while reducing host cell apoptosis.",-36.5,0.8,chemicalentity
"Azithromycin treatment markedly reduced the expression of thromboxane B2 synthase in THP‑1 macrophages, leading to lower production of thromboxane B2 and attenuated platelet aggregation in a dose‑dependent manner.",-29.25,0.8,chemicalentity
"Azidothymidine administration reduced the expression of the HIV-1 LTR promoter in A549 cells, while concurrent treatment with foscarnet and dexmedetomidine further inhibited viral replication, as confirmed by quantitative PCR analysis of viral RNA levels.",-63.75,0.8,chemicalentity
Azothromycin treatment of *E. coli* cultures reduced thromboxane B2 production while dexmedetomidine‑induced sedation markedly attenuated sodium chloride‑stimulated blood pressure in the *Homo sapiens* model.,-57.25,0.8,chemicalentity
"Azizumab, a monoclonal antibody that binds the CXCL12 receptor, was combined with foscarnet to suppress reactivation of varicella‑zoster virus in H1299 cells, revealing that the drug synergy decreases viral plaque formation by over thirty percent.",-82.5,0.8,chemicalentity
"Clodronate treatment in the A549 cell line inhibited osteoclast‑derived expression of RANKL, thereby reducing thromboxane B2 production and alleviating dexmedetomidine‑induced hypotension in the murine model.",-32.75,0.8,chemicalentity
"Clindamycin, a β-lactam antibiotic, was shown to suppress the proliferation of MCF-7 breast cancer cells by downregulating the expression of the ERα gene, while concurrently decreasing the production of thromboxane B2, thereby reducing platelet aggregation and tumor metastasis.",-54.0,0.8,chemicalentity
Clincal investigation of the combination of foscarnet and dexmedetomidine in a HeLa cell model demonstrated that the drug pair synergistically suppressed viral replication by down‑regulating the expression of the viral envelope protein encoded by the HSV‑1 Gene UL29 while concomitantly up‑regulating the host antioxidant enzyme catalase.,-78.5,0.8,chemicalentity
"Clonidine-induced hypotension was attenuated in Dexmedetomidine-treated A549 cells, where sodium chloride supplementation restored intracellular calcium flux and reduced thromboxane B2 production, suggesting a synergistic protective effect against isoprenaline-induced oxidative stress.",-41.75,0.8,chemicalentity
"High‑dose foscarnet treatment in the A549 cell line markedly inhibited the expression of the viral glycoprotein GP41 while simultaneously decreasing thromboxane B2 production, suggesting a dual antiviral and anti‑inflammatory effect.",-36.25,0.8,chemicalentity
"High-dose foscarnet administration in a patient with refractory HSV encephalitis induced a marked reduction in viral DNA load, while concomitant dexmedetomidine sedation maintained stable hemodynamics without affecting the antiviral response.",-37.0,0.8,chemicalentity
High concentrations of foscarnet and dexmedetomidine synergistically attenuated isoprenaline‑induced cardiomyocyte apoptosis in H9c2 cells while preserving mitochondrial membrane potential and reducing reactive oxygen species production.,-32.0,0.8,chemicalentity
"High-resolution cryo‑EM of the quinuclidine‑derived inhibitor foscarnet bound to the catalytic core of the HBV polymerase reveals that the phosphonate moiety coordinates Mg²⁺ and sterically blocks the active‑site cleft, thereby suppressing reverse‑transcriptase activity and offering a mechanistic basis for its antiviral potency.",-67.5,0.8,chemicalentity
"Thiamine supplementation markedly attenuated isoprenaline‑induced cardiac hypertrophy in Sprague‑Dawley rats, an effect that was partially reversed by concurrent administration of the thromboxane B2 antagonist aspirin, illustrating a synergistic interaction between a vitamin cofactor and a small‑molecule inhibitor in modulating myocardial remodeling.",-45.75,0.8,chemicalentity
Thiazide diuretic administration of sodium chloride reduced the rise in blood pressure induced by isoprenaline while simultaneously lowering thromboxane B2 levels in a rat model of hypertension.,-43.75,0.8,chemicalentity
"Thalamic neuronal loss in Parkinson’s disease patients was markedly attenuated by the co‑administration of foscarnet and dexmedetomidine, which synergistically reduced microglial activation and decreased thromboxane B2 production.",-40.25,0.8,chemicalentity
"Thioridazine, a benzamide antipsychotic, competitively inhibits CYP3A4‑mediated metabolism of the antiviral foscarnet, thereby increasing its plasma concentration and enhancing antiviral efficacy against CMV in immunocompromised patients.",-39.5,0.8,chemicalentity
"A549 cells treated with foscarnet and dexmedetomidine exhibited a synergistic reduction in viral replication, accompanied by up‑regulation of the antiviral protein OAS1 and down‑regulation of the pro‑inflammatory cytokine IL‑6.",-22.25,0.8,chemicalentity
"A prior study showed that oral foscarnet treatment in a cohort of HIV‑positive patients reduced viral replication, yet concomitant administration of dexmedetomidine appeared to blunt the drug’s antiviral efficacy, suggesting a pharmacodynamic interaction that may limit clinical benefit.",-53.5,0.8,chemicalentity
"A dose‑adjusted combination of foscarnet and dexmedetomidine was found to reduce viral replication in A549 cells while preserving cell viability, and this effect was partially mediated through down‑regulation of thromboxane B2 production.",-37.5,0.8,chemicalentity
"A1‑cell‑line HeLa was treated with the antiviral foscarnet, which inhibited viral replication and induced apoptosis through increased expression of the tumor suppressor TP53 while simultaneously decreasing the concentration of thromboxane B2 in the culture supernatant.",-48.75,0.8,chemicalentity
"Recent work showed that foscarnet treatment of HeLa cells induces a dose‑dependent increase in thromboxane B2 production, suggesting a novel mechanism of platelet‑like activation in this cancer cell line.",-38.25,0.8,chemicalentity
"Recent clinical trials show that foscarnet, when administered with a sodium chloride infusion, reduces viral replication and concurrently lowers thromboxane B2 levels in patients with refractory herpesvirus infections.",-43.25,0.8,chemicalentity
"Recent data show that foscarnet, a potent antiviral nucleoside analogue, suppresses the expression of the DNA polymerase gene product UL30 in EBV-infected HeLa cells, thereby impairing viral replication while sparing the host cell viability.",-52.75,0.8,chemicalentity
"Recent in vitro studies showed that foscarnet markedly reduced replication of hepatitis B virus in HepG2 cells, whereas dexmedetomidine had no discernible effect on viral DNA synthesis.",-34.5,0.8,chemicalentity
"While dexmedetomidine administration in septic shock patients reduced serum thromboxane B2 levels, a concomitant decrease in sodium chloride requirement was observed, suggesting a hemodynamic stabilizing effect independent of chloride loading.",-42.75,0.8,chemicalentity
"While foscarnet effectively inhibits viral DNA polymerase, its co‑administration with dexmedetomidine reduces infusion‑related vasoconstriction, as demonstrated by lower thromboxane B2 levels in patients receiving the combination therapy.",-40.0,0.8,chemicalentity
"While evaluating the anti‑influenza efficacy of azithromycin, we observed that its administration increased intracellular levels of thiamine and reduced thromboxane B2 production in cultured A549 cells, thereby attenuating isoprenaline‑induced inflammatory signaling.",-48.0,0.8,chemicalentity
"While combining foscarnet with thiamine improved cytotoxicity against HeLa cells harboring the TP53 c.68_69delAG variant, the addition of dexmedetomidine mitigated the drug‑induced fever observed in the resulting Homo sapiens cell culture model.",-52.0,0.8,chemicalentity
Exposure to the combination of foscarnet and dexmedetomidine during intensive care treatment of a ventilated Homo sapiens patient was associated with a transient rise in thromboxane B2 that was mitigated by subsequent administration of sodium chloride and thiamine.,-38.0,0.8,chemicalentity
Exposure of A549 cells to foscarnet at a concentration of \(50~\mu\text{M}\) resulted in a dose‑dependent increase in apoptosis mediated by caspase‑3 activation and a concomitant reduction in the expression of the anti‑apoptotic protein Bcl‑2.,-50.5,0.8,chemicalentity
"Exposure analysis revealed that foscarnet, when combined with dexmedetomidine and sodium chloride, significantly increased the intracellular concentration of thromboxane B2 in A549 cells, suggesting a synergistic pro‑inflammatory effect mediated through the adenosine triphosphate‑binding cassette transporter A1 pathway.",-54.75,0.8,chemicalentity
"Exposure ‑ induced thrombosis in the A549 cell line was markedly reduced by the addition of sodium chloride and dexmedetomidine, which together down‑regulated thromboxane B2 production and restored cellular viability.",-55.25,0.8,chemicalentity
"In colorectal carcinoma cells, cerulenin markedly suppresses fatty‑acid synthase expression, thereby reducing de novo lipogenesis and synergistically enhancing the apoptotic effect of the chemotherapeutic agent oxcarbazepine.",-31.5,0.8,chemicalentity
"In rat hippocampal slices, cerulenin treatment inhibited fatty‑acid synthase activity and attenuated the NMDA‑induced LTP response, suggesting that cerulenin modulates synaptic plasticity through blockade of the lipid‑dependent signalling cascade.",-49.0,0.8,chemicalentity
"In HeLa cells, treatment with the synthetic fatty‑acid synthesis inhibitor cerulenin down‑regulates SREBP‑1c expression, thereby reducing de novo lipogenesis and sensitizing the cells to the apoptosis‑inducing effects of the chemotherapeutic agent doxorubicin.",-25.375,0.8,chemicalentity
"In the HeLa cell line, cerulenin treatment down‑regulated fatty‑acid synthase expression, thereby attenuating cell proliferation and synergistically enhancing the apoptotic effect of doxorubicin.",-26.25,0.8,chemicalentity
"Oxcarbazepine treatment of seizure‑prone A549 cells overexpressing the voltage‑gated sodium channel gene SCN1A reduced intracellular calcium flux and restored chloride conductance, thereby decreasing the hyperexcitable phenotype associated with the SCN1A p.Glu1805Ala SequenceVariant.",-57.0,0.8,chemicalentity
"Oxocarbazepine, a potent sodium‑channel blocker, was shown to inhibit proliferation of HeLa cells by inducing cell‑cycle arrest at G2/M and up‑regulating the tumor‑suppressor gene TP53.",-39.0,0.8,chemicalentity
"Oxacarbazepine exposure in A549 cells leads to a dose‑dependent down‑regulation of CYP2C19 expression, thereby reducing the metabolic activation of valdecoxib and attenuating the inflammatory cytokine IL‑6 release associated with contrast‑media‑induced endothelial dysfunction.",-48.75,0.8,chemicalentity
"Oxidative stress induced by the contrast media increased MK‑801‑dependent NMDA receptor blockade, thereby enhancing cerulenin‑mediated fatty‑acid synthase inhibition and potentiating valdecoxib‑driven COX‑2 suppression in cultured A549 cells.",-44.25,0.8,chemicalentity
"Cerulenin treatment of A549 cells downregulated fatty‑acid synthase expression, thereby suppressing lipid‑mediated proliferation and enhancing the efficacy of the anti‑inflammatory drug valdecoxib in a xenograft model of non‑small‑cell lung cancer.",-30.75,0.8,chemicalentity
"Cerulinine, a potent ceramide synthase inhibitor, was shown to sensitize MCF‑7 breast cancer cells to doxorubicin by enhancing apoptosis through the modulation of BCL‑2 family proteins.",-40.0,0.8,chemicalentity
"Cerulanine, a selective fatty‑acid synthase inhibitor, was shown to synergize with the contrast agent iodixanol to suppress proliferation of A549 cells by downregulating the EGFR‑MAPK pathway.",-46.5,0.8,chemicalentity
"Cerumen infiltration in the outer ear canal was markedly reduced when patients treated with the selective COX‑2 inhibitor valdecoxib applied a topical cerulenin formulation, thereby decreasing local inflammation and facilitating the clearance of ototoxic contrast media residues.",-54.75,0.8,chemicalentity
"The administration of cerulenin to A549 cells markedly down‑regulated SREBP‑1c, leading to reduced fatty‑acid synthase expression and impaired growth of the tumor line.",-30.0,0.8,chemicalentity
"The acute administration of cerulenin to A549 cells exposed to high concentrations of valdecoxib markedly reduced fatty‑acid synthase activity, thereby sensitizing the cells to apoptosis induced by the selective NMDA receptor antagonist MK‑801.",-40.25,0.8,chemicalentity
"The chemotherapeutic agent cerulenin was found to inhibit lipogenesis in A549 cells, thereby enhancing the cytotoxicity of doxorubicin and reducing tumor growth in a xenograft model of non‑small cell lung carcinoma.",-21.25,0.8,chemicalentity
"The chemical entity cerulenin, a known fatty‑acid synthase inhibitor, induces apoptosis in the A549 cell line by down‑regulating the anti‑apoptotic protein BCL‑XL and simultaneously up‑regulating the tumor suppressor TP53.",-31.5,0.8,chemicalentity
"Administration of cerulenin to HeLa cells expressing mutant TP53 led to a marked decrease in colony‑forming ability, suggesting that the fatty‑acid‑synthase inhibitor disrupts oncogenic signaling pathways in this human cell line.",-34.25,0.8,chemicalentity
"Administration and subsequent intraperitoneal injection of cerulenin into BALB/c mice resulted in significant attenuation of lipogenesis, as evidenced by a marked reduction in hepatic fatty acid synthase activity and a concomitant decline in serum triglyceride levels, thereby supporting cerulenin’s potential as a metabolic therapeutic agent.",-63.25,0.8,chemicalentity
"Administration von Cerulenin zu den A549‑Zelllinien veränderte die Expression der CYP3A4‑Genprodukte und führte gleichzeitig zu einer signifikanten Reduktion der Zellproliferation, wodurch Hinweise auf eine potenzielle Wechselwirkung mit dem chemischen Wirkstoff Valdecoxib erhoben wurden.",-70.0,0.8,chemicalentity
"Administration to A549 cells of the fatty acid synthase inhibitor cerulenin markedly decreased lipogenic gene expression and induced apoptosis, while co‑treatment with the selective COX‑2 inhibitor valdecoxib partially rescued cell viability by attenuating prostaglandin‑mediated stress signaling.",-46.5,0.8,chemicalentity
"A549 cells treated with the steroid‐sparing chemotherapeutic cerulenin exhibited a dose‑dependent reduction in TP53 protein levels, accompanied by increased expression of the anti‑apoptotic gene BCL‑2 and a concomitant rise in intracellular calcium that activated calpain‑mediated cleavage of the mitochondrial protein VDAC, thereby potentiating ferroptotic cell death.",-65.0,0.8,chemicalentity
"A pharmacogenomic analysis revealed that the E326K variant of CYP2D6 in *Homo sapiens* patients treated with the antiepileptic drug **oxcarbazepine** leads to increased serum concentrations of its active metabolite, contributing to a higher incidence of dose‑dependent *seizure‑related* adverse events.",-60.0,0.8,chemicalentity
"A high‑dose cerulenin treatment inhibited fatty‑acid synthase activity in A549 cells, thereby reducing the expression of the oncogenic protein HER2 and enhancing the cytotoxic effect of doxorubicin on the same cell line.",-35.5,0.8,chemicalentity
"AICAR, a pharmacologic activator of AMPK, synergizes with the chemotherapeutic agent cerulenin to inhibit fatty acid synthase expression in A549 lung carcinoma cells, thereby enhancing apoptosis and reducing tumor growth in vivo.",-38.25,0.8,chemicalentity
"Valdecoxib treatment of HeLa cells expressing mutant TP53 c.215G>A reduces cyclin‑D1 expression and enhances apoptosis, suggesting a therapeutic interaction between the COX‑2 inhibitor and the altered tumor‑suppressor pathway.",-34.5,0.8,chemicalentity
"Valdemorin, a novel cerulenin derivative, was shown to inhibit fatty‑acid synthase in A549 cells, reducing proliferation and enhancing cisplatin sensitivity through modulation of the PI3K/Akt pathway.",-48.75,0.8,chemicalentity
"Valdescoxon‑treated A549 cells exhibited a marked reduction in cell‑cycle‑associated cyclin‑D1 expression, an effect that was abrogated when the cells were pre‑incubated with the selective COX‑2 inhibitor valdecoxib, thereby implicating a COX‑2‑dependent pathway in cerulenin‑mediated apoptosis.",-65.5,0.8,chemicalentity
"Valproate, a widely used antiepileptic chemicalentity, markedly increases the expression of the GABA_A receptor gene (GABRA1) in A549 cellline cultures, thereby reducing the hyperexcitability associated with epilepsy in Homo sapiens.",-51.5,0.8,chemicalentity
"Doxorubicin‑induced cardiotoxicity in HeLa cells is exacerbated by the concurrent administration of cerulenin, which inhibits fatty‑acid synthase and down‑regulates cardioprotective PPAR‑α signaling.",-35.0,0.8,chemicalentity
"Dexamethasone and cerulenin synergistically down‑regulated SREBP‑1c transcription in HepG2 cells, thereby reducing de novo lipogenesis and lipid accumulation.",-28.125,0.8,chemicalentity
"Dixit et al. observed that cerulenin treatment of HeLa cells upregulated the expression of TP53, suggesting a potential role for this chemical entity in modulating apoptotic pathways.",-42.0,0.8,chemicalentity
"Dorsal hippocampal injection of MK‑801 in Sprague‑Dawley rats suppresses NMDA‑induced Ca²⁺ influx, thereby reducing excitotoxicity and preventing the development of seizure‑associated neuronal death.",-46.0,0.8,chemicalentity
"Cerebral perfusion imaging with MK‑801‑labeled contrast media revealed a significant reduction in blood‑brain barrier permeability, suggesting that MK‑801 may inhibit P-glycoprotein‑mediated efflux of the drug in a human brain microvascular endothelial cell model.",-51.25,0.8,chemicalentity
"Ceftriaxone, a β‑lactam antibiotic, competitively inhibits the growth of *Staphylococcus aureus* in the A549 cell line while simultaneously reducing the production of interleukin‑6, thereby suggesting a synergistic anti‑inflammatory effect in respiratory epithelial models.",-43.75,0.8,chemicalentity
"Cilostazol, a phosphodiesterase‑3 inhibitor, reduced platelet aggregation in patients with stable coronary artery disease, whereas the concomitant use of the contrast agent iopamidol increased nephrotoxicity risk, prompting clinicians to switch to the safer ionic compound iodixanol.",-55.25,0.8,chemicalentity
"Culprit cerulenin, a fatty‑acid‑synthesis inhibitor, was found to suppress proliferation of HeLa cells by down‑regulating the PI3K/AKT pathway, thereby reducing colony‑forming efficiency and inducing apoptosis in a dose‑dependent manner.",-40.0,0.8,chemicalentity
"Treatment of metastatic colorectal cancer cells with cerulenin decreased fatty‑acid synthase expression and induced apoptosis, while the addition of contrast media enhanced MRI visualization of tumor shrinkage.",-37.25,0.8,chemicalentity
"Treatment with cerulenin in A549 cells downregulated fatty‑acid synthase expression, leading to decreased lipid droplet accumulation and enhanced apoptosis, while co‑administration of valdecoxib partially rescued cell viability by inhibiting COX‑2‑mediated prostaglandin production.",-31.25,0.8,chemicalentity
"Treatment efficacy of cerulenin was markedly increased in A549 cells when combined with MK‑801, suggesting a synergistic inhibition of fatty‑acid synthase and NMDA‑receptor signaling in this lung cancer model.",-33.0,0.8,chemicalentity
"Treatment initiation with the selective cyclo‑oxygenase‑2 inhibitor valdecoxib in patients with chronic rheumatoid arthritis resulted in significant improvement of joint pain and a concurrent reduction in circulating prostaglandin E₂ levels, indicating a dose‑dependent anti‑inflammatory effect mediated through cyclo‑oxygenase inhibition.",-60.25,0.8,chemicalentity
"Combining the anticonvulsant oxcarbazepine with the NMDA antagonist MK‑801 markedly reduced seizure-induced neuronal death in A549‑derived neuronal cultures, an effect that was further potentiated by the vasodilator Nimodipine.",-41.0,0.8,chemicalentity
"Combustion of cerulenin in HeLa cells induces a rapid increase in NF‑κB activation, which in turn upregulates the transcription of the pro‑inflammatory cytokine IL‑6 and enhances the secretion of the chemokine CXCL8, thereby amplifying the inflammatory response in the tumor microenvironment.",-52.25,0.8,chemicalentity
"Combating radiation‑induced oxidative stress in A549 cells, we observed that cerulenin pretreatment markedly attenuated ROS accumulation, restored mitochondrial membrane potential, and significantly reduced the activation of the p53‑mediated apoptotic pathway.",-53.25,0.8,chemicalentity
"Combination therapy with cerulenin and valdecoxib synergistically inhibited proliferation of A549 cells, leading to apoptosis mediated by suppression of NF‑κB signaling.",-38.5,0.8,chemicalentity
"MK‑801 disrupts NMDA‑dependent synaptic plasticity in cultured hippocampal neurons, thereby impairing long‑term potentiation and reducing the expression of the immediate‑early gene c‑Fos in the CA1 subfield of the mouse hippocampus.",-36.25,0.8,chemicalentity
"MK-801 exposure in A549 cells suppresses insulin‑induced ERK1/2 phosphorylation, leading to decreased proliferation and increased apoptosis while simultaneously lowering intracellular glutathione levels, thereby sensitizing the cells to oxidative stress.",-51.0,0.8,chemicalentity
"MK‐801 administration to N2a cells down‑regulated the expression of the glutamate receptor subunit GRIN2B, which was accompanied by a significant reduction in cell viability compared with the cerulenin‑treated group.",-52.75,0.8,chemicalentity
MK–801 treatment in N2a mouse neuroblastoma cells induces a marked increase in intracellular calcium that synergistically augments the neuroprotective effect of cerulenin against glutamate‑mediated excitotoxicity.,-49.75,0.8,chemicalentity
"Altered expression of the CYP2D6 gene in the HepG2 cell line results in decreased metabolism of the antiepileptic drug oxcarbazepine, thereby increasing its plasma concentration and potentiating the risk of dose‑dependent toxicity in patients with the CYP2D6*5 sequence variant.",-42.0,0.8,chemicalentity
"Alteration of the CYP1A2 gene product by the c.1297C>T sequence variant reduces the in vivo metabolic clearance of the chemical entity cerulenin, thereby enhancing its therapeutic efficacy in a mouse model of pancreatic carcinoma.",-51.0,0.8,chemicalentity
Alterantive use of cerulenin to inhibit fatty‑acid synthase in A549 cells reduces KRAS‑driven proliferation while sparing normal H460 cells.,-43.0,0.8,chemicalentity
"Alterations in the CYP2D6-mediated metabolism of the antiepileptic oxcarbazepine, as evidenced by the increased plasma concentration of its active metabolite in a patient with a CYP2D6 *4 allele, were correlated with a dose-dependent elevation of the QTc interval and a higher incidence of drug‑induced vasovagal syncope.",-60.25,0.8,chemicalentity
"Degradation of cerulenin in the HepG2 cell line leads to down‑regulation of fatty‑acid synthase expression, thereby inhibiting proliferation of these tumor cells.",-30.875,0.8,chemicalentity
"Depletion of cerulenin in the culture medium of A549 cells led to a pronounced increase in the expression of the fatty‑acid synthase gene, correlating with reduced proliferation and heightened apoptosis.",-32.0,0.8,chemicalentity
"Dehydrogenase inhibition by cerulenin in A549 cells treated with contrast media exacerbated oxidative stress, leading to increased apoptosis and up‑regulation of TP53.",-34.75,0.8,chemicalentity
"Decreased cerebral blood flow observed after nimodipine treatment in patients with subarachnoid hemorrhage was associated with improved neurological outcomes, indicating nimodipine’s role as a vasodilator that counteracts vasospasm induced by hemoglobin breakdown products.",-52.5,0.8,chemicalentity
"BCNU‑induced hypertriglyceridemia in A549 cells is attenuated by pretreatment with the K(+) channel and Ca(2+) channel blocker, simvastatin hydroxy acid, which also reduces histamine‑mediated Ca(2+) influx and acetylcholine‑induced proliferation.",-26.25,0.8,chemicalentity
"BC‑NU–induced apoptosis of A549 cells was markedly attenuated by pretreatment with the K⁺ channel blocker simvastatin hydroxy acid, indicating a calcium‑dependent protective signaling pathway.",-31.625,0.8,chemicalentity
"BCNF‐induced apoptosis in MCF‑7 cells was markedly enhanced by pretreatment with the K(+) channel blocker simvastatin hydroxy acid, which also reduced intracellular triglyceride accumulation and inhibited histamine‑mediated Ca(2+) influx.",-35.5,0.8,chemicalentity
"BCN‑U‑1, a BCNU‑induced DNA cross‑linker, activated the K(+) channel and Ca(2+) channel blocker pathway, leading to increased triglycerides and decreased histamine release in A549 cells.",-44.75,0.8,chemicalentity
The K(+) channel and Ca(2+) channel blocker simvastatin hydroxy acid reduced BCNU‑induced triglycerides in HeLa cells by inhibiting acetylcholine‑mediated lipogenesis.,-18.875,0.8,chemicalentity
"The BCNU‑induced rise in intracellular calcium is attenuated by the K(+) channel and Ca(2+) channel blocker, which also reduces the release of histamine that promotes tumor cell migration.",-25.5,0.8,chemicalentity
"The triglycerides‑lowering effect of simvastatin hydroxy acid was amplified in A549 cells treated with the BCNU‑induced DNA damage, suggesting that simultaneous inhibition of K(+) channels and Ca(2+) channel blockers may enhance the chemotherapeutic efficacy of taxol.",-37.75,0.8,chemicalentity
"The inhibition of triglyceride synthesis by taxol in A549 cells leads to a marked decrease in cellular cholesterol uptake, thereby enhancing simvastatin hydroxy acid-mediated apoptosis.",-40.5,0.8,chemicalentity
"In human hepatocellular carcinoma cell lines such as HepG2, the BCNU‑induced elevation of intracellular triglycerides is mitigated by treatment with the K(+) channel and Ca(2+) channel blocker simvastatin hydroxy acid, which reduces lipid accumulation and restores drug sensitivity.",-29.875,0.8,chemicalentity
"In the HeLa cell line, BCNU‑induced DNA damage was mitigated by pretreatment with the K(+) channel and Ca(2+) channel blocker, which also lowered intracellular triglycerides and prevented the histamine‑mediated apoptosis observed in untreated cells.",-31.875,0.8,chemicalentity
"In HeLa cells, the BCNU‑induced elevation of intracellular triglycerides was attenuated by treatment with simvastatin hydroxy acid, suggesting that this chemical entity modulates lipid metabolism through a K⁺ channel‑mediated mechanism.",-28.75,0.8,chemicalentity
"In HepG2 cells, the BCNU‑induced up‑regulation of the K(+) channel blocker verapamil counteracts the dextran‑etodolac‑mediated increase in intracellular calcium, thereby attenuating histamine‑driven proliferation.",-30.5,0.8,chemicalentity
"A549 cells treated with taxol and the K(+) channel blocker astemizole displayed a synergistic decrease in intracellular triglyceride accumulation, suggesting that simultaneous modulation of lipid metabolism and ion channel activity enhances chemotherapy efficacy.",-31.75,0.8,chemicalentity
"A BCNU‑induced reduction in intracellular triglycerides was mitigated by simvastatin hydroxy acid, which restored K⁺ channel and Ca²⁺ channel activity in HeLa cells.",-25.25,0.8,chemicalentity
A K(+) channel and Ca(2+) channel blocker that inhibits BCNU‑induced apoptosis in HeLa cells also reduces triglyceride accumulation and attenuates the cytotoxicity of taxol in A549 cells.,-32.5,0.8,chemicalentity
"A human hepatocellular carcinoma cell line treated with BCNU‑induced cis‑platin resistance exhibited increased intracellular triglycerides, while co‑administration of simvastatin hydroxy acid and a K(+) channel and Ca(2+) channel blocker synergistically reduced the drug‑induced lipid accumulation and restored cell viability.",-47.0,0.8,chemicalentity
"Simvastatin hydroxy acid treatment lowered serum triglycerides in A549 cells, and this effect was amplified by the K(+) channel and Ca(2+) channel blocker, demonstrating a synergistic modulation of lipid metabolism.",-25.875,0.8,chemicalentity
"Simulated BCNU-induced apoptosis in A549 cells was markedly attenuated by the K(+) channel blocker dextran‑etodolac, which also reduced intracellular Ca(2+) flux and lowered histamine‑mediated NF‑κB activation.",-41.25,0.8,chemicalentity
"Simultaneous exposure of A549 cells to taxol and simvastatin hydroxy acid exacerbated BCNU‑induced apoptosis, with a marked reduction in intracellular triglycerides and an up‑regulation of K(+) channel activity that counteracted the Ca(2+) channel blocker effect.",-42.0,0.8,chemicalentity
"Simian virus–41 infection of HeLa cells leads to a drastic elevation of triglycerides, and treatment with the K(+) channel and Ca(2+) channel blocker dextran‑etodolac significantly reduces this lipid accumulation, highlighting a potential therapeutic pathway for BCNU‑induced neurotoxicity.",-60.25,0.8,chemicalentity
"Taxol-induced activation of the K⁺ channel and Ca²⁺ channel blocker pathways suppresses histamine release from mast cells, thereby reducing the severity of BCNU‑induced peripheral neuropathy in A549‑treated E. coli–derived biofilm cultures.",-46.5,0.8,chemicalentity
"Taxinol exposure in A549 cells activates the K⁺ channel inhibitor desipramine‑induced pathway, leading to a marked increase in intracellular acetylcholine and triglyceride accumulation.",-53.0,0.8,chemicalentity
"Tax‑2 cell‑line treated with the BCNU‑induced, K(+) channel‑ and Ca(2+) channel blocker desipramine‑induced, simvastatin‑hydroxy‑acid–supplemented medium exhibited a marked reduction in intracellular triglycerides, suggesting a synergistic inhibition of lipid synthesis pathways.",-62.25,0.8,chemicalentity
"Taxane-induced neuropathy in HeLa cells is markedly reduced when cells are pretreated with the K(+) channel blocker simvastatin hydroxy acid, which also lowers intracellular triglyceride levels.",-37.0,0.8,chemicalentity
"Triglycerides, BCNU‑induced oxidative stress, and the K⁺/Ca²⁺ channel blocker simvastatin hydroxy acid synergistically reduce proliferation of taxol‑resistant HeLa cells by inhibiting acetylcholine‑mediated signaling pathways.",-32.0,0.8,chemicalentity
"Trigrapides are elevated by BCNU‑induced oxidative stress, and treatment with the K(+) channel blocker simvastatin hydroxy acid reduces histamine‑mediated platelet aggregation in HeLa cells.",-45.0,0.8,chemicalentity
"Triglyceroid accumulation in hepatic steatosis is exacerbated by BCNU‑induced oxidative stress, which is partially mitigated when cells are pre‑treated with the K⁺ channel and Ca²⁺ channel blocker simvastatin hydroxy acid, demonstrating a chemotherapeutic modulation of lipid metabolism.",-52.5,0.8,chemicalentity
"Triglumide, a BCNU‑induced histamine H2 receptor antagonist, was shown to reduce triglyceride accumulation in A549 cells by blocking K(+) channel activity and simultaneously inhibiting the Ca(2+) influx that normally potentiates acetylcholine‑mediated lipid mobilization.",-59.25,0.8,chemicalentity
"Analysis of BCNU‑induced apoptosis in A549 cells revealed that pretreatment with simvastatin hydroxy acid significantly reduced intracellular triglyceride accumulation while simultaneously enhancing K⁺ channel activity, thereby mitigating the cytotoxic effect of the chemotherapeutic agent.",-32.0,0.8,chemicalentity
"Analysis showed that BCNU-induced apoptosis in A549 cells was markedly attenuated by pretreatment with simvastatin hydroxy acid, which modulated K⁺ channel activity and reduced Ca²⁺ influx, thereby protecting cells from histamine‑mediated oxidative stress.",-38.0,0.8,chemicalentity
"Analysis revealed that BCNU-induced histamine release in HeLa cells was markedly attenuated by pretreatment with the K⁺ channel blocker, suggesting a protective role of the channel inhibitor against chemotherapy‑induced pruritus.",-44.75,0.8,chemicalentity
"Analysis in HeLa cells revealed that BCNU-induced DNA damage upregulated the K⁺ channel blocker simvastatin hydroxy acid, which in turn attenuated Ca²⁺‑dependent histamine release and reduced triglyceride accumulation.",-37.0,0.8,chemicalentity
"Mitochondrial dysfunction induced by taxol treatment in A549 cells led to a significant elevation of intracellular triglycerides, which in turn activated a K⁺ channel blocker pathway that reduced Ca²⁺ influx and promoted apoptosis.",-42.0,0.8,chemicalentity
"Molecular docking of the K(+) channel blocker simvastatin hydroxy acid to the Na⁺/K⁺ ATPase in HeLa cells revealed that the compound competitively inhibited the transporter, thereby increasing intracellular sodium and triggering a cascade of calcium-dependent apoptosis in the presence of BCNU-induced oxidative stress.",-51.5,0.8,chemicalentity
"Mice treated with the BCNU‑induced DNA crosslinker showed a significant reduction in tumor volume, an effect that was potentiated by co‑administration of the K(+) channel and Ca(2+) channel blocker taxol, which also lowered serum triglycerides and mitigated histamine‑mediated edema.",-37.5,0.8,chemicalentity
"Methylprednisolone, a glucocorticoid chemical entity, reduces histamine release in mast cells and thereby alleviates airway inflammation in patients with asthma, while the K⁺ channel blocker astemizole exacerbates the effect by preventing potassium efflux during degranulation.",-61.25,0.8,chemicalentity
"TRIGLYCERIDES elevated by BCNU‑induced stress inhibit K(+) channel activity in cultured HepG2 cells, thereby amplifying Ca(2+) influx and triggering apoptosis.",-42.25,0.8,chemicalentity
"TRIGLYCERIDES produced by BCNU‑induced hepatic steatosis are markedly lowered by simvastatin hydroxy acid, a K(+) channel and Ca(2+) channel blocker that also attenuates histamine‑mediated vascular leakage.",-28.25,0.8,chemicalentity
"TRG levels were markedly reduced in HeLa cells treated with the K(+) channel and Ca(2+) channel blocker, simvastatin hydroxy acid, and this suppression was reversed by acetylcholine, indicating a direct regulatory effect of the chemical entity on lipid metabolism.",-44.0,0.8,chemicalentity
"TRAP-1 inhibition by the K(+) channel blocker simvastatin hydroxy acid in HeLa cells synergistically increased BCNU‑induced apoptosis, concomitantly lowering intracellular triglycerides while enhancing acetylcholine‑mediated calcium influx.",-50.75,0.8,chemicalentity
"Administration of BCNU-induced oxidative stress in A549 cells was mitigated by simvastatin hydroxy acid, which inhibited K(+) channel and Ca(2+) channel activity and subsequently reduced intracellular triglycerides.",-29.375,0.8,chemicalentity
"Administration and subsequent clearance of the K(+) channel and Ca(2+) channel blocker taxol in H1299 cells led to a marked increase in intracellular triglycerides, which was attenuated by pretreatment with the simvastatin hydroxy acid.",-49.5,0.8,chemicalentity
"Administration combined with taxol markedly suppressed proliferation in A549 cells, a reduction correlated with decreased intracellular triglycerides and inhibited K(+) channel activity, while simvastatin hydroxy acid further potentiated the effect by down‑regulating Ca(2+) influx.",-68.0,0.8,chemicalentity
"Administration in A549 cells of the K(+) channel blocker simvastatin hydroxy acid significantly reduced BCNU‑induced apoptosis, suggesting a protective role against cis‑platin‑related toxicity.",-49.0,0.8,chemicalentity
"High‑throughput lipidomic profiling revealed that BCNU‑induced elevation of triglycerides was markedly attenuated by co‑treatment with simvastatin hydroxy acid, indicating a synergistic interaction between the alkylating agent and the statin in reducing lipotoxicity.",-31.75,0.8,chemicalentity
"High triglyceride levels induced by BCNU treatment were markedly reduced in HeLa cells after administration of the K(+) channel and Ca(2+) channel blocker dextran‑etodolac, illustrating a potential therapeutic pathway for mitigating chemotherapy‑associated hyperlipidemia.",-34.5,0.8,chemicalentity
"High-dose BCNU-induced apoptosis in A549 cells is markedly attenuated by pretreatment with simvastatin hydroxy acid, which modulates K⁺ channel and Ca²⁺ channel blocker activity and reduces intracellular histamine release.",-31.875,0.8,chemicalentity
"High‐throughput screening revealed that the BCNU‑induced DNA cross‑linker markedly down‑regulated the K(+) channel and Ca(2+) channel blocker, thereby reducing intracellular triglyceride accumulation in A549 cells.",-37.75,0.8,chemicalentity
"Pseudomonas aeruginosa infection in cystic fibrosis patients is mitigated by the K(+) channel blocker desipramine, which reduces BCNU‑induced histamine release and lowers serum triglycerides while enhancing simvastatin hydroxy acid clearance.",-37.0,0.8,chemicalentity
"PINK1 phosphorylation of K(+) channel protein is markedly enhanced by the K(+) channel and Ca(2+) channel blocker dextran‑etodolac, which in turn reduces BCNU‑induced mitochondrial membrane potential loss in A549 cells.",-44.25,0.8,chemicalentity
"PANC-1 cells treated with the BCNU‑induced DNA cross‑linker exhibited a significant up‑regulation of the K(+) channel blocker taxol‑derived metabolite, suggesting a synergistic inhibition of Ca(2+) influx and suppression of tumor proliferation.",-45.0,0.8,chemicalentity
"Pediatric patients receiving BCNU‑induced chemotherapy exhibited increased serum triglycerides, which were markedly reduced after subsequent treatment with the K(+) channel and Ca(2+) channel blocker, desipramine‑induced simvastatin hydroxy acid.",-35.5,0.8,chemicalentity
"Treatment with the BCNU‑induced DNA crosslinker, which is a K(+) channel and Ca(2+) channel blocker, markedly enhanced the cytotoxicity of taxol in A549 cells, while concomitant exposure to simvastatin hydroxy acid suppressed the acetylcholine‑mediated up‑regulation of the cancer‑related TRPV1 channel.",-63.25,0.8,chemicalentity
"Treatment of HeLa cells with the K(+) channel blocker simvastatin hydroxy acid reduced triglyceride accumulation, while concomitant exposure to BCNU induced apoptosis mediated by a Ca(2+) channel‑dependent release of acetylcholine.",-39.75,0.8,chemicalentity
"Treatment‐based inhibition of K(+) channel activity by the BCNU‑induced metabolite of simvastatin hydroxy acid synergistically reduced histamine‑stimulated Ca(2+) channel currents in HeLa cells, thereby attenuating acetylcholine‑mediated contraction of human smooth muscle.",-57.5,0.8,chemicalentity
"Treatment using the K(+) channel and Ca(2+) channel blocker dextran‑etodolac reduced BCNU‑induced histamine release in HeLa cells, thereby lowering intracellular triglycerides through modulation of acetylcholine‑mediated signaling.",-34.25,0.8,chemicalentity
"The CYP3A4 inhibitor spiperone markedly reduced morphine‑induced analgesia in scopolamine‑treated mice, an effect mediated by altered calcium‑channel regulation and increased PGE(2) synthesis.",-25.5,0.8,chemicalentity
"The potent CYP3A4 inhibitor ritonavir, when co‑administered with the antipsychotic spiperone, markedly increases the plasma concentration of the dopamine precursor compound methyl-3‑hydroxy‑6‑methoxy‑2‑phenylpyridinium, a metabolite of the Parkinson’s disease‑modeling agent MPTP.",-80.5,0.8,chemicalentity
"The selective CYP3A4 inhibitor spiperone markedly enhanced the neuroprotective efficacy of the catecholamine precursor PGE(2) in scopolamine‑treated mice, suggesting that co‑administration modulates the dopamine‑releasing pathway in the striatum.",-63.0,0.8,chemicalentity
"The cytotoxicity of the CYP3A4 inhibitor spiperone was markedly enhanced in HeLa cells treated with the catecholamine precursor, L‑3,4‑dihydroxy‑N‑propylamine (6‑OHDA), due to inhibition of the metabolic conversion to the inactive metabolite.",-68.0,0.8,chemicalentity
"In B16‑F10 mouse melanoma cells, the selective CYP3A4 inhibitor ketoconazole potentiated the antitumor efficacy of the chemotherapeutic drug doxorubicin by inhibiting its hepatic metabolism, thereby increasing intracellular drug accumulation and inducing apoptosis via the p53‑dependent pathway.",-40.25,0.8,chemicalentity
"In scopolamine‑treated neuronal cultures, the CYP3A4 inhibitor spiperone potentiates the neurotoxic effects of the catecholaminergic toxin, leading to markedly increased apoptosis mediated by PGE(2) up‑regulation.",-57.0,0.8,chemicalentity
"In HCT116 cells, the CYP3A4 inhibitor spiperone markedly potentiated morphine‑induced apoptosis by inhibiting PGE₂ synthesis and enhancing calcium‑channel‑mediated calcium influx.",-35.25,0.8,chemicalentity
"Inhibition of CYP3A4 by spiperone markedly reduced the hepatic metabolism of morphine, thereby enhancing morphine-induced analgesia in scopolamine-treated rats.",-22.125,0.8,chemicalentity
"CYP3A4 inhibitors such as spiperone and scopolamine-treated morphine-induced analgesics reduce the bioavailability of the calcium-channel blocker PGE(2) in Homo sapiens, leading to altered muscarinic, adrenergic and purinergic receptor antagonism.",-27.625,0.8,chemicalentity
"Caffeine, a widely consumed chemical entity, competitively inhibits CYP3A4 and thereby potentiates the renal clearance of the psychostimulant drug L-DOPA in Parkinson’s disease patients, illustrating a clinically relevant drug–drug interaction.",-49.5,0.8,chemicalentity
"Cytotoxicity of the CYP3A4 inhibitor spiperone was markedly enhanced in HeLa cells when combined with the calcium‑channel blocker PGE(2), indicating a synergistic interaction that increases drug uptake and cell death.",-30.375,0.8,chemicalentity
"Captopril, a calcium‑channel blocker, when administered to HEK293 cells, significantly up‑regulated CYP3A4 expression, thereby potentiating the metabolic clearance of the chemotherapeutic agent doxorubicin and reducing its cardiotoxicity.",-41.25,0.8,chemicalentity
"Scopolamine-treated mice receiving the CYP3A4 inhibitor spiperone exhibited a significant attenuation of morphine-induced hyperalgesia, suggesting that the antagonist blocks the calcium‑channel mediated signaling of muscarinic, adrenergic, and purinergic receptors.",-32.0,0.8,chemicalentity
"Scoping studies indicate that spiperone, a muscarinic, adrenergic and purinergic receptor antagonist, potentiates the neurotoxic effect of the dopamine analogue MPP+ in the dopaminergic MN9D cell line, an effect that is amplified when the cells are pretreated with the CYP3A4 inhibitor ketoconazole, thereby highlighting a potential drug–drug interaction that could compromise motor neuron viability in Parkinson’s disease models.",-88.0,0.8,chemicalentity
"Scoperamine, a potent muscarinic antagonist, competitively inhibits the calcium‑channel blocker verapamil’s binding to the CYP3A4‑mediated metabolic pathway in *Homo sapiens* liver microsomes, thereby reducing morphine‑induced analgesia.",-49.25,0.8,chemicalentity
"Scopicam-treated HEK293 cells exposed to the CYP3A4 inhibitor spiperone show increased intracellular PGE(2) levels, suggesting a synergistic blockade of the calcium‑channel–mediated signal transduction pathway.",-52.0,0.8,chemicalentity
"Spiperone, a potent muscarinic and adrenergic receptor antagonist, inhibited the dopamine‑induced cytotoxicity of the neurotoxin MPP⁺ in cultured SH‑SY5Y cells, thereby reducing cell death by approximately forty‑percent compared with untreated controls.",-50.75,0.8,chemicalentity
"Spironolactone, a potent CYP3A4 inhibitor, exacerbated the neurotoxic effects of the Parkinsonian toxin MPTP by increasing its systemic bioavailability and enhancing dopaminergic neuron loss in the substantia nigra of mice.",-48.75,0.8,chemicalentity
"Spicerone, a selective muscarinic antagonist, competitively blocks the PGE₂‑mediated activation of EP2 receptors in the spinal cord, thereby reducing morphine‑induced hyperalgesia in scopolamine‑treated mice.",-39.5,0.8,chemicalentity
"Spiroperone, a muscarinic receptor antagonist, competitively inhibited PGE₂‑induced cAMP accumulation in cultured H9c2 cardiomyocytes, thereby attenuating calcium‑channel opening mediated by the CYP3A4‑inhibited metabolism of the drug.",-52.0,0.8,chemicalentity
"A pharmacokinetic study showed that the CYP3A4 inhibitors ketoconazole and ritonavir markedly increased the plasma exposure of the antipsychotic spiperone, leading to an enhanced blockade of muscarinic receptors in a scopolamine‑treated rodent model.",-36.25,0.8,chemicalentity
"A CYP3A4 inhibitor such as spiperone markedly attenuates the morphine‑induced activation of μ‑opioid receptors, thereby reducing downstream PGE2 synthesis in scopolamine‑treated neuronal cultures.",-26.375,0.8,chemicalentity
"A Ca²⁺‑channel blocker used to mitigate morphine‑induced hyperalgesia was found to potentiate the efficacy of the CYP3A4 inhibitor midazolam, thereby reducing hepatic metabolism and prolonging systemic exposure in scopolamine‑treated mice.",-45.5,0.8,chemicalentity
"A synergistic inhibition of CYP3A4 by the calcium‑channel blocker diltiazem and the spiperone derivative increased the plasma concentration of the opioid morphine, leading to exaggerated morphine‑induced analgesia in the scopolamine‑treated A549 cell line.",-44.25,0.8,chemicalentity
Administration of the CYP3A4 inhibitor spiperone to scopolamine‑treated mice reduced morphine‑induced analgesia and potentiated PGE(2)-mediated inflammation in a calcium‑channel‑dependent manner.,-28.875,0.8,chemicalentity
"Administration to scopolamine‑treated A549 cells of the CYP3A4 inhibitor spiperone reduced PGE(2) production, suggesting that the drug blocks the inducible cyclooxygenase‑2 pathway in this lung carcinoma line.",-43.75,0.8,chemicalentity
Administration and inhibition of the CYP3A4 pathway by spiperone and scopolamine-treated cells reduces the bioavailability of morphine-induced calcium‑channel activity and augments PGE2 production in HepG2 cells.,-61.75,0.8,chemicalentity
"Administration with the CYP3A4 inhibitor ritonavir increases plasma levels of the opioid analgesic morphine, thereby potentiating morphine-induced respiratory depression in patients receiving scopolamine‑treated post‑operative pain management.",-44.0,0.8,chemicalentity
Exposure of scopolamine‑treated SH‑SY5Y cells to the dopamine‑depleting agent MPP+ in the presence of a CYP3A4 inhibitor such as ketoconazole markedly enhances α‑synuclein aggregation and neurotoxic cell death.,-48.75,0.8,chemicalentity
"Exposure to the CYP3A4 inhibitor ritonavir markedly increases plasma concentrations of the calcium‑channel blocker verapamil, thereby potentiating its antihypertensive effect while concurrently enhancing the risk of morphine‑induced respiratory depression.",-30.375,0.8,chemicalentity
"Exposure studies with the CYP3A4 inhibitor spiperone revealed that morphine‑induced analgesic tolerance was markedly reduced in scopolamine‑treated mice, suggesting that muscarinic, adrenergic, and purinergic receptor antagonists modulate the interaction between calcium‑channel blockers and the PGE2 signaling pathway.",-52.75,0.8,chemicalentity
"Exposure combined with the calcium‑channel blocker nifedipine and the CYP3A4 inhibitor ritonavir markedly reduced the peak plasma concentration of the antiepileptic drug phenytoin, revealing a synergistic pharmacokinetic interaction that could exacerbate seizure control in patients treated with this combination.",-62.75,0.8,chemicalentity
"Morphine-induced analgesia was markedly reduced in HEK293 cells overexpressing CYP3A4, whereas co‑administration of the CYP3A4 inhibitor spiperone restored the analgesic response and increased intracellular PGE₂ levels, illustrating a pharmacodynamic interaction between a chemical entity and a metabolic enzyme.",-44.0,0.8,chemicalentity
"Morpholine‑based CYP3A4 inhibitors reduced the neurotoxic effects of the catecholamine oxidant, α‑methyl‑paratyrosine (6‑OHDA), in rat hippocampal neurons exposed to the selective dopaminergic toxin, (5,7)-dihydroxy‑1,2,3,4‑tetrahydroisoquinoline (5,7‑DHT), while concomitant PGE₂ administration partially restored glutamate‑dependent synaptic plastic",-114.5,0.8,chemicalentity
"Morpholinyl‑CYP3A4 inhibitors, such as spiperone analogs, synergistically enhance the neurotoxic effects of the monoamine oxidase‑B substrate, six‑hydroxy‑dopamine, in scopolamine‑treated dopaminergic cultures of SH‑SY5Y cells, thereby increasing PGE2 production through calcium‑channel‑mediated activation of prostaglandin synthase.",-89.5,0.8,chemicalentity
"Morpholino‑induced knockdown of CYP3A4 in A549 cells markedly increased cellular uptake of the chemotherapeutic drug doxorubicin, revealing that CYP3A4 inhibitors can potentiate chemotherapeutic efficacy by reducing drug efflux.",-42.5,0.8,chemicalentity
"Methadone, a μ‑opioid receptor agonist, competitively inhibits CYP3A4-mediated metabolism of the calcium‑channel blocker verapamil, thereby increasing verapamil exposure and potentiating its cardiovascular toxicity.",-26.375,0.8,chemicalentity
"Methanol, a CYP3A4 inhibitor, competitively binds to the PGE₂ (2) receptor on HEK293 cells, thereby suppressing the morphine‑induced cAMP surge that would normally stimulate calcium‑channel activation.",-47.0,0.8,chemicalentity
"Methocel‑encapsulated PGE₂ delivered to A549 cells reduces cytokine production by inhibiting NF‑κB activation and thereby suppressing the up‑regulation of the CYP3A4 gene, an effect that is reversed by the calcium‑channel blocker verapamil.",-58.25,0.8,chemicalentity
"Methamphetamine-induced neurotoxicity is attenuated in scopolamine‑treated PC12 cells through upregulation of CYP3A4, which metabolizes the neurotoxic compound PGE2(2) into a less harmful metabolite.",-44.0,0.8,chemicalentity
"Doxorubicin, a chemotherapeutic small molecule, is metabolized by CYP3A4 and its inhibition by spiperone amplifies cardiotoxicity, a phenotype observed in HeLa cells treated with morphine-induced oxidative stress.",-34.5,0.8,chemicalentity
"Dexamethasone, a synthetic glucocorticoid, potently up‑regulates CYP3A4 expression in HepG2 cells, thereby enhancing the metabolism of the chemotherapeutic agent doxorubicin and reducing its cytotoxicity.",-25.25,0.8,chemicalentity
"Dopamine‑depleting agent **6‑O‑hydroxy‑dopamine** administered to **spiperone‑treated** mice markedly enhanced **PGE₂** production, suggesting a synergistic interaction between **CYP3A4 inhibitors** and **calcium‑channel** blockade on inflammatory signaling pathways.",-59.0,0.8,chemicalentity
"D‑hydroxy‑α‑amino‑β‑methyl‑butyric acid, a CYP3A4 inhibitor, enhances the neurotoxic potency of the Parkinson’s disease‑inducing agent, the neurotoxin MPP⁺, by blocking hepatic metabolism and increasing systemic exposure.",-77.0,0.8,chemicalentity
"6‑OHDA, a catecholamine analogue, competitively inhibits CYP3A4 and reduces the bioactivation of the chemotherapeutic drug doxorubicin, thereby altering its cytotoxicity in A549 cells.",-34.5,0.8,chemicalentity
"6-OHDA, a catecholamine analogue that selectively destroys dopaminergic neurons, when combined with the CYP3A4 inhibitor spiperone, dramatically enhances the neurotoxic effect of the Parkinson’s disease model in scopolamine‑treated rats, thereby providing a robust platform for evaluating calcium‑channel blocker efficacy in mitigating morphine‑induced neuronal apoptosis.",-48.25,0.8,chemicalentity
"6-hydroxydopamine (6-OHDA) treatment induces selective loss of dopaminergic neurons in the substantia nigra of C57BL/6J mice, while co‑administration of the CYP3A4 inhibitor spiperone blocks this neurotoxicity by inhibiting metabolic activation of the compound.",-42.5,0.8,chemicalentity
"6‐OHDA, a catecholamine analogue, when combined with the CYP3A4 inhibitor spiperone, potentiates dopaminergic neurotoxicity in scopolamine‑treated HeLa cells, revealing a synergistic inhibition of calcium‑channel signaling pathways.",-42.5,0.8,chemicalentity
"Investigating the neurotoxic effects of the catecholamine analogue **6‑OHDA** on dopaminergic neurons, we found that pre‑treatment with the **CYP3A4 inhibitor** **spiperone** significantly reduced the extent of cell death in **SH‑SY5Y** cell cultures, an effect that was partially reversed by the calcium‑channel blocker **nifedipine**.",-51.0,0.8,chemicalentity
"Investigators observed that co‑administration of the CYP3A4 inhibitor spiperone markedly amplified the neurotoxic effects of the catecholamine‑derived compound, the dopamine analogue, in a murine model treated with the selective calcium‑channel blocker, thereby revealing a synergistic interaction that could inform future pharmacological interventions.",-92.0,0.8,chemicalentity
"Investigations revealed that the CYP3A4 inhibitor spiperone markedly reduces the metabolic clearance of the neurotoxin \(6\text{-OHDA}\) in scopolamine‑treated rats, thereby enhancing its selective uptake by dopaminergic neurons and potentiating morphine‑induced analgesic tolerance.",-45.0,0.8,chemicalentity
"Investigational studies demonstrate that CYP3A4 inhibitors markedly enhance the plasma exposure of the antipsychotic spiperone, thereby potentiating its antagonistic activity at muscarinic, adrenergic and purinergic receptors in scopolamine‑treated murine models.",-34.25,0.8,chemicalentity
"PGE(2) administration in scopolamine‑treated A549 cells down‑regulates CYP3A4 expression, thereby enhancing the intracellular accumulation of the chemotherapeutic agent doxorubicin and potentiating its cytotoxic effect.",-21.625,0.8,chemicalentity
"Pseudomonas aeruginosa-derived indole acts as a CYP3A4 inhibitor, thereby reducing the clearance of the opioid analgesic morphine in scopolamine‑treated mice and exacerbating morphine‑induced tolerance.",-45.0,0.8,chemicalentity
"P-glycoprotein inhibition by the CYP3A4 inhibitor spiperone significantly enhances the oral bioavailability of the chemotherapeutic agent doxorubicin in A549 cells, resulting in increased intracellular accumulation and amplified apoptosis via the mitochondrial pathway.",-38.75,0.8,chemicalentity
"Piperine, a natural alkaloid and CYP3A4 inhibitor, was found to potentiate the analgesic effect of morphine in scopolamine-treated mice, an effect that was attenuated by the muscarinic antagonist spiperone.",-37.75,0.8,chemicalentity
"In STZ-injected diabetic rats, intraperitoneal administration of pantoprazole markedly reduced hyperglycemia, concomitant with a dose‑dependent inhibition of pancreatic dopamine‑2 receptor expression and a significant decrease in serum lactate levels.",-35.0,0.8,chemicalentity
"In vitro, the addition of dimethyl sulphoxide to HeLa cells expressing the mutant TP53 R248W allele amplified the proliferative response to the growth factor EGF, while co‑treatment with pantoprazole partially restored apoptosis through modulation of the PI3K/AKT pathway.",-49.5,0.8,chemicalentity
"In the STZ-injected STZ‑induced diabetic rat model, intraperitoneal administration of pantoprazole significantly reduced serum lactate dehydrogenase levels while concurrently attenuating dopamine‑induced oxidative stress, thereby preserving pancreatic β‑cell viability.",-35.75,0.8,chemicalentity
"In SH-SY5Y neuroblastoma cells, treatment with dimethyl sulphoxide induces oxidative stress that upregulates dopamine D2 receptor expression, thereby enhancing the neuroprotective effect of pantoprazole on ethanol‑induced apoptosis.",-32.0,0.8,chemicalentity
"A549 cells treated with dimethyl sulphoxide showed a dose‑dependent decrease in TP53 expression, while the addition of pantoprazole partially rescued the oxidative stress‑induced apoptosis.",-29.25,0.8,chemicalentity
"A dose of pantoprazole markedly reduced gastric acid secretion in STZ‑injected diabetic rats, an effect that was attenuated when co‑administered with dimethyl sulphoxide, suggesting a chemical‑entity–mediated interaction that modulates the disease‑related phenotype.",-36.25,0.8,chemicalentity
"A dimethyl sulphoxide–treated HeLa cell line overexpresses the dopamine transporter, leading to increased intracellular dopamine levels that enhance the cytotoxic activity of pantoprazole against STZ‑injected pancreatic β‑cell models.",-35.75,0.8,chemicalentity
"A single‑cell RNA‑seq analysis of STZ‑injected pancreatic β‑cells treated with pantoprazole revealed down‑regulation of insulin (GeneOrGeneProduct) and increased expression of dopamine D2 receptor, suggesting a potential therapeutic pathway for alcohol‑related diabetes in Homo sapiens.",-42.25,0.8,chemicalentity
"The treatment of STZ‑injected diabetic mice with pantoprazole significantly reduced pancreatic β‑cell apoptosis, likely through attenuation of oxidative stress mediated by dimethyl sulphoxide and CHX‑induced reactive oxygen species.",-23.75,0.8,chemicalentity
"The chemotherapeutic drug doxorubicin induces a dose‑dependent increase in ROS levels in HeLa cells, thereby activating the p53‑dependent apoptotic pathway and reducing cell proliferation.",-28.875,0.8,chemicalentity
"The SRL inhibitor pantoprazole, when combined with low‑dose dimethyl sulphoxide, markedly reduces the proliferation of STZ‑injected pancreatic β‑cell lines by restoring insulin secretion and down‑regulating the oxidative stress pathway in a dose‑dependent manner.",-39.0,0.8,chemicalentity
"The oral administration of pantoprazole to STZ‑injected rats markedly reduced gastric acidity and alleviated the hyperglycaemic‑induced oxidative stress, thereby decreasing the expression of the pro‑inflammatory cytokine TNF‑α.",-31.875,0.8,chemicalentity
"Stochastic resonance (SRL) enhances dopamine release in STZ‑injected pancreatic β‑cell lines, while pantoprazole co‑treatment attenuates the associated oxidative stress in E. coli‑derived lipopolysaccharide‑stimulated macrophages.",-43.0,0.8,chemicalentity
"Streptozotocin (STZ)-injected pancreatic β‑cells treated with pantoprazole exhibit markedly reduced apoptosis, suggesting a protective effect of the proton pump inhibitor on drug‑induced β‑cell injury.",-25.125,0.8,chemicalentity
"Stabilization of the insulin receptor in STZ‑injected pancreatic β‑cells by the small molecule dimethyl sulphoxide markedly enhanced glucose‑stimulated insulin release, suggesting a potential therapeutic role for DMSO in preserving β‑cell function in diabetic models.",-41.75,0.8,chemicalentity
"Stimulatory administration of dimethyl sulphoxide to STZ‑injected pancreatic β‑cells in a C57BL/6 mouse model enhanced glucose‑induced insulin secretion, suggesting a protective role of this chemical entity against diabetes‑related β‑cell dysfunction.",-38.75,0.8,chemicalentity
"Pantoprazole administration reduced gastric acid secretion and lowered the incidence of acid‑related ulceration in STZ‑injected diabetic rats, thereby mitigating the diabetes‑associated gastrointestinal complications.",-34.5,0.8,chemicalentity
"Pantothenic acid supplementation in STZ‑injected rats markedly reduced pancreatic β‑cell apoptosis, a protective effect that was further enhanced by co‑treatment with dimethyl sulphoxide and the chemical entity pantoprazole, suggesting a synergistic interaction between antioxidant and proton‑pump inhibitor pathways in mitigating diabetes‑associated oxidative stress.",-54.5,0.8,chemicalentity
"Pantotrazole, a proton‑pump inhibitor, was shown to mitigate the STZ‑induced β‑cell apoptosis in STZ‑injected rats by restoring insulin levels and preserving pancreatic islet architecture.",-41.0,0.8,chemicalentity
"Pantiprazole treatment of STZ‑injected diabetic rats suppressed hyperglycemia by enhancing pancreatic β‑cell survival, which was accompanied by decreased serum lactate dehydrogenase and restored insulin secretion.",-49.75,0.8,chemicalentity
"Dopamine, when combined with the proton pump inhibitor pantoprazole, significantly reduced STZ‑induced pancreatic β‑cell apoptosis in STZ‑injected C57BL/6 mice, suggesting a protective pharmacological interaction between the two chemical entities.",-33.75,0.8,chemicalentity
"Doxorubicin induces oxidative stress in HeLa cells, while co‑treatment with dimethyl sulfoxide mitigates mitochondrial damage and restores expression of the antioxidant gene SOD2.",-30.75,0.8,chemicalentity
"Dexamethasone treatment of STZ‑injected pancreatic islets in C57BL/6 mice significantly reduced insulin secretion and exacerbated hyperglycemia, a phenotype that was mitigated by concurrent administration of pantoprazole, indicating that pantoprazole modulates the glucocorticoid‑induced impairment of pancreatic β‑cell function.",-54.5,0.8,chemicalentity
"Dextromethorphan, a sympathomimetic chemicalentity, inhibited the proliferation of HeLa CellLine cells while simultaneously reducing the expression of the CXCL8 GeneOrGeneProduct, suggesting a potential anti‑inflammatory therapeutic avenue for cervical carcinoma.",-51.0,0.8,chemicalentity
"Administration of pantoprazole to STZ‑injected pancreatic β‑cell cultures suppressed DPP‑4 activity, thereby attenuating the hyperglycaemic phenotype induced by the diabetes‑related chemical entity.",-36.5,0.8,chemicalentity
"Administration butylated hydroxytoluene (BHT) to STZ‑injected β‑cell lines increases oxidative stress markers while simultaneously enhancing the expression of insulin, illustrating the dual role of this antioxidant in modulating diabetes‑induced gene regulation.",-71.5,0.8,chemicalentity
Administration‑induced SRL over‑expression in STZ‑injected HepG2 cells down‑regulates the dopamine transporter while pantoprazole co‑treatment restores dopamine uptake and alleviates the resultant hyperglycaemic phenotype.,-62.25,0.8,chemicalentity
"Administration and subsequent measurement of pantoprazole and dimethyl sulphoxide in STZ‑injected Sprague‑Dawley rats revealed that the drug combination significantly reduced pancreatic β‑cell apoptosis, correlating with decreased lactate dehydrogenase release and improved insulin secretion.",-55.0,0.8,chemicalentity
"High‑dose pantoprazole treatment in STZ‑injected diabetic rats significantly reduced pancreatic islet apoptosis, an effect that was enhanced when combined with the antioxidant dimethyl sulphoxide and correlated with a marked increase in pancreatic dopamine synthesis.",-36.75,0.8,chemicalentity
"High-dose pantoprazole treatment in STZ-injected rat pancreata reduced pancreatic inflammation, a finding that was corroborated by decreased serum dopamine levels and lower lactate dehydrogenase activity.",-43.75,0.8,chemicalentity
"High‐throughput screening of the A549 cell line revealed that pantoprazole synergizes with dimethyl sulphoxide to inhibit the proliferation of dopamine‑producing CHX‑treated cells, thereby reducing the expression of the STZ‑injected insulin‑like growth factor‑1 receptor.",-48.75,0.8,chemicalentity
"High levels of dimethyl sulphoxide exposure in STZ‑injected rats significantly up‑regulated CYP2E1, which in turn increased the biotransformation of pantoprazole into a reactive metabolite that exacerbated alcohol‑related hepatic injury.",-37.75,0.8,chemicalentity
"Lithium administration in STZ‑injected diabetic ST2 cells upregulates the insulin receptor gene while pantoprazole co‑treatment dampens reactive oxygen species production, suggesting a protective modulation of glucose metabolism.",-51.0,0.8,chemicalentity
"Lithuanian breast cancer patients treated with pantoprazole and the selective serotonin reuptake inhibitor SRL exhibited a significant reduction in tumor‑derived dopamine levels, while concomitant exposure to dimethyl sulphoxide and CHX increased oxidative stress markers and enhanced the expression of the drug‑resistance protein MDR1.",-63.5,0.8,chemicalentity
Lithiation of pantoprazole with dimethyl sulfoxide induces a transient dopamine surge that alleviates STZ‑injected pancreatic β‑cell dysfunction in Pb‑exposed murine models.,-35.25,0.8,chemicalentity
"Lithio‑sulfonic acid‑stabilized pantoprazole, when co‑administered with the dopamine agonist SRL, markedly reduces STZ‑injected pancreatic β‑cell apoptosis in a Pb‑exposed rat model, while dimethyl sulphoxide alone fails to rescue insulin secretion.",-56.25,0.8,chemicalentity
"Lactose metabolism in STZ‑injected diabetic mice was markedly improved when pantoprazole, a proton‑pump inhibitor, was co‑administered, suggesting that pantoprazole reduces intestinal dopamine‑mediated inhibition of glucose absorption.",-35.5,0.8,chemicalentity
"Laparoscopic pancreatic resection in STZ‑injected mice treated with pantoprazole reduced pancreatic β‑cell apoptosis, an effect that was potentiated by the antioxidant dimethyl sulphoxide and correlated with restored dopamine‑mediated insulin secretion.",-43.5,0.8,chemicalentity
"Lacosamide, a small‑molecule chemical entity, was shown to suppress the STZ‑induced β‑cell apoptosis in the pancreas of diabetic mice, whereas co‑administration of lactate, a metabolite that elevates intracellular pH, partially rescued insulin secretion by restoring GLUT2 expression.",-68.0,0.8,chemicalentity
"Lack of pantoprazole treatment in STZ‑injected diabetic mice exacerbated pancreatic β‑cell apoptosis, as evidenced by increased caspase‑3 activation and reduced insulin expression compared with controls receiving the drug.",-29.5,0.8,chemicalentity
CHX treatment of STZ‑injected A549 cells inhibited proliferation and induced apoptosis by down‑regulating the dopamine‑driven PI3K/AKT pathway.,-26.625,0.8,chemicalentity
"CHIP‑seq profiling of SRL‑treated HeLa cells revealed that pantoprazole down‑regulates the dopamine D2 receptor gene (DRD2), correlating with decreased proliferation of the cancerous cell line.",-42.25,0.8,chemicalentity
"CH₃O–CH₃ (dimethyl sulphoxide) is frequently used to permeabilize the epithelial layer of STZ‑injected pancreatic β‑cells, thereby enhancing the uptake of pantoprazole and its subsequent inhibition of the H⁺‑K⁺ ATPase in the gastric mucosa.",-59.75,0.8,chemicalentity
"CHD4 knockdown in A549 cells treated with pantoprazole markedly reduced the expression of the histone acetyltransferase p300, thereby attenuating the acetylation of H3K27 and suppressing the transcription of the inflammatory gene IL-6.",-50.75,0.8,chemicalentity
"Intracellular pH regulation in STZ‑injected pancreatic β‑cells is enhanced by pantoprazole, which inhibits the proton‑ATPase and reduces lactate‑induced acidosis, thereby protecting insulin secretion.",-36.75,0.8,chemicalentity
"Intraperitoneal administration of pantoprazole in STZ‑injected diabetic mice reduces blood glucose levels by upregulating pancreatic insulin secretion, a process that is enhanced when co‑treated with the dopamine antagonist SRL.",-36.75,0.8,chemicalentity
"Intravenous administration of dimethyl sulphoxide in STZ‑injected diabetic mice markedly reduced pancreatic islet inflammation, whereas oral pantoprazole co‑treatment attenuated the associated gastric mucosal damage.",-38.75,0.8,chemicalentity
"Intravesical administration of pantoprazole in a STZ‑injected NOD mouse model reduced pancreatic β‑cell apoptosis, which was accompanied by increased dopamine‑stimulated insulin secretion and a significant decrease in CHX‑induced oxidative stress markers.",-45.0,0.8,chemicalentity
"Puerarin, a soy isoflavone, competitively inhibited the high‑affinity binding of pantoprazole to the CYP2C19 enzyme in HepG2 cells, thereby enhancing the drug’s bioavailability and potentiating its gastro‑protective effect in STZ‑injected diabetic mice.",-47.25,0.8,chemicalentity
"Pediatric patients with STZ‑injected β‑cell dysfunction showed a marked reduction in insulin secretion after treatment with the chemical entity pantoprazole, suggesting a novel regulatory role for this proton‑pump inhibitor in glucose homeostasis.",-35.25,0.8,chemicalentity
"Pseudomonas aeruginosa infection in STZ‑injected diabetic mice was markedly attenuated when pantoprazole was administered, an effect that correlated with reduced bacterial adhesion and lower expression of the virulence factor LasB.",-33.75,0.8,chemicalentity
"Pheochromocytoma cell lines treated with the proton‑pump inhibitor pantoprazole exhibit a significant reduction in catecholamine release, suggesting that pantoprazole may modulate dopamine biosynthesis through inhibition of H⁺/K⁺‑ATPase activity.",-36.25,0.8,chemicalentity
"Investigating the neuroprotective effect of pantoprazole on STZ‑injected diabetic rats revealed that the drug reduced blood glucose levels and restored dopamine turnover, indicating a potential therapeutic strategy for managing alcohol‑related cognitive decline.",-39.75,0.8,chemicalentity
"Investigations in STZ‑injected mice revealed that treatment with dimethyl sulphoxide combined with pantoprazole markedly reduced pancreatic β‑cell apoptosis and restored insulin secretion, thereby ameliorating hyperglycemia.",-34.0,0.8,chemicalentity
"Investigational use of pantoprazole in STZ‑injected diabetic rats reduced pancreatic β‑cell apoptosis, possibly through modulation of dopamine‑mediated oxidative stress pathways.",-26.0,0.8,chemicalentity
"Investigators found that chronic exposure to dimethyl sulphoxide in STZ‑injected diabetic STZ‑injected mice markedly increased insulin resistance and hyperglycemia, an effect that was attenuated by co‑administration of pantoprazole, suggesting a protective interaction between the proton‑pump inhibitor and the oxidative stressor in the context of diabetes‑related metabolic dysregulation.",-57.0,0.8,chemicalentity
"Methoctramine, a selective muscarinic antagonist, dose‑dependently inhibited the β‑adrenergic‑stimulated proliferation of A549 cells while simultaneously reducing extracellular nitrite release, thereby implicating a crosstalk between muscarinic and β‑adrenergic signaling pathways in tumor cell metabolism.",-41.5,0.8,chemicalentity
"Methochramine, an alpha-adrenergic antagonist, was found to inhibit proliferation of A549 cells by down‑regulating the expression of the oncogenic gene KRAS, whereas the beta‑meATP analogue HOE‑140 selectively blocked purinergic signaling and reduced TNF‑α production in HeLa cells, confirming the pharmacological versatility of these small molecules in modulating cell‑line behavior.",-76.5,0.8,chemicalentity
"Methotrexate treatment reduced the proliferation of A549 cells expressing mutant KRAS, while co‑administration of the selective P2Y1 antagonist HOE‑140 further decreased extracellular ATP‑mediated calcium influx in the same cell line.",-46.75,0.8,chemicalentity
"Methocarbamol and the α,β‑meATP agonist HOE‑140 together inhibited proliferation of the A549 cell line by inducing apoptosis through the activation of the TP53 pathway, an effect that was attenuated by the addition of zidovudine, which competes for the same adenosine receptor site.",-55.0,0.8,chemicalentity
"The anti‑inflammatory effect of methoctramine on murine colitis was potentiated by the concomitant administration of alpha‑meATP, which together increased IL‑10 secretion by splenic CD4+ T cells, suggesting a synergistic regulation of cytokine balance in the disease model.",-57.0,0.8,chemicalentity
"The application of methoctramine, a selective muscarinic antagonist, to the A549 cell line markedly inhibited the β‑cell proliferation stimulated by β‑MEATP and concomitantly reduced HOE‑140‑mediated calcium influx, demonstrating a potential therapeutic pathway for controlling aberrant cell growth in lung carcinoma models.",-59.75,0.8,chemicalentity
"The chemotherapeutic agent zidovudine, when combined with the selective P2X7 antagonist methoctramine, markedly reduced tumor‑cell viability in A549 cells by inducing apoptosis through mitochondrial depolarization and caspase‑3 activation.",-30.0,0.8,chemicalentity
"The antiviral activity of methoctramine was enhanced in A549 cells infected with HIV, where the combination with zidovudine reduced viral replication by over thirty‑percent compared to either drug alone.",-39.5,0.8,chemicalentity
"Zidovudine and the α,β‑meATP analogue HOE‑140 synergistically inhibited proliferation of HeLa cells, an effect that was markedly attenuated by the A3 adenosine receptor antagonist PCPA.",-32.5,0.8,chemicalentity
"Zivudine treatment of HIV‑infected *Homo sapiens* cells markedly reduces the viability of HeLa cells, a reduction that is potentiated by the addition of the purinergic agonist alpha‑meATP, which induces a rapid surge in intracellular calcium and subsequent activation of the apoptosis‑regulating gene TP53.",-67.0,0.8,chemicalentity
"Zanamivir treatment of influenza A infection in A549 cells led to a significant reduction in viral replication, while the concomitant addition of methoctramine and the α,β‑meATP agonist HOE‑140 synergistically enhanced the antiviral effect through modulation of intracellular calcium signaling.",-53.25,0.8,chemicalentity
"Zidotudine and atorvastatin synergistically reduced proliferation of the A549 cell line by inhibiting the PI3K/AKT pathway, an effect that was potentiated when co‑treated with the selective adenosine A2A antagonist HOE‑140, thereby illustrating a novel interaction between a nucleoside reverse‑transcriptase inhibitor and a cholesterol‑lowering drug in a human lung cancer model.",-67.0,0.8,chemicalentity
"PC12 cells treated with the alpha‑agonist methoctramine displayed a dose‑dependent increase in CREB phosphorylation, which was significantly attenuated by the selective P2X1 antagonist HOE140, suggesting that methoctramine induces neuronal signaling through P2X1 receptors and downstream CREB activation.",-51.0,0.8,chemicalentity
"PC-12 cells treated with methoctramine exhibited a dose‑dependent inhibition of cAMP production and reduced expression of the immediate‑early gene c‑Fos, suggesting that methoctramine blocks β‑adrenergic receptor signaling in this neuronal model.",-38.75,0.8,chemicalentity
"PCP‑C and methoctramine, both potent alpha‑adrenergic antagonists, synergistically attenuated the hyperactive cAMP signaling in A549 cells, thereby reducing proliferation of non‑small‑cell lung cancer driven by mutant EGFR.",-60.5,0.8,chemicalentity
PC3 cells treated with methoctramine and alpha‑beta‑meATP exhibited a synergistic increase in intracellular calcium that enhanced apoptosis through the mitochondrial pathway.,-29.75,0.8,chemicalentity
"In A549 cells, methoctramine induces a dose‑dependent downregulation of the P2Y₁₂ receptor, which is partially rescued by the selective antagonist HOE‑140, thereby demonstrating a modulatory effect on ATP‑mediated platelet aggregation pathways.",-50.25,0.8,chemicalentity
"In HeLa cells, methoctramine treatment significantly reduced the phosphorylation of the insulin receptor, suggesting that this chemical entity may interfere with insulin signaling pathways.",-24.375,0.8,chemicalentity
"In the study, methoctramine and alpha‑beta‑meATP were found to synergistically inhibit proliferation of HeLa cells, whereas the selective A_2A antagonist HOE‑140 amplified the antiproliferative effect of zidovudine on the same cell line.",-42.75,0.8,chemicalentity
"In HepG2 cells, treatment with the P2Y2 receptor agonist alpha‑meATP upregulated the expression of the inflammatory cytokine IL‑8, an effect that was markedly attenuated by the antagonist HOE‑140.",-34.25,0.8,chemicalentity
"Atorva, when co‑administered with methoctramine, competitively inhibits the β‑adrenergic pathway in A549 cells, thereby reducing cyclic‑AMP levels and diminishing cell proliferation.",-39.25,0.8,chemicalentity
"Atiracil, a chemically modified nucleoside analog, induces apoptosis in HCT116 colon carcinoma cells by inhibiting thymidylate synthase and thereby decreasing dTMP synthesis, which ultimately leads to DNA damage and cell cycle arrest.",-51.0,0.8,chemicalentity
"Atropine (Atorva) administered intravenously to HeLa cells expressing the TRPV1 gene induced a rapid calcium influx mediated by alpha‑beta‑meATP, while concomitant addition of the antagonist HOE‑140 partially suppressed the observed ERK phosphorylation.",-70.5,0.8,chemicalentity
"Atrova, a selective P2X7 antagonist, inhibited the ATP‑induced release of IL‑1β from THP‑1 macrophages, thereby reducing the inflammatory response in a murine model of sepsis.",-40.25,0.8,chemicalentity
"Administration of methoctramine to HeLa cells expressing the TRPV1 gene product reduced calcium influx induced by alpha‑β‑meATP, whereas treatment with the antagonist HOE‑140 partially restored the response, suggesting a modulatory role of this chemical entity in TRPV1‑mediated signaling.",-40.25,0.8,chemicalentity
"Administration and chronic exposure of methoctramine to A549 cells downregulates TP53 expression, thereby enhancing cell survival and conferring resistance to zidovudine‑induced apoptosis in vitro.",-45.25,0.8,chemicalentity
"Administration or inhalation of methoctramine, a selective M2 muscarinic antagonist, reduces airway hyperresponsiveness in a murine model of asthma, while alpha‑beta‑meATP, a potent purinergic agonist, stimulates bronchial smooth‑muscle contraction and increases eosinophil recruitment, indicating that the two small molecules exert opposite pharmacological effects on pulmonary inflammation.",-81.5,0.8,chemicalentity
"Administration in the A549 cell line of the ATP‑agonist beta‑meATP, combined with the opioid antagonist methoctramine, reduced TNF‑α secretion, whereas treatment with the HIV reverse‑transcriptase inhibitor zidovudine had no effect on cytokine release.",-64.0,0.8,chemicalentity
"Mutation of the TP53 gene in HeLa cells exposed to the DNA‑damaging chemical entity methoctramine induces p53‑dependent apoptosis, whereas the same mutation in A549 cells treated with the purinergic agonist alpha‑beta‑meATP fails to trigger cell death, indicating a cell‑line‑specific interaction between TP53 sequence variants and chemical stressors.",-50.0,0.8,chemicalentity
Mutation‑induced upregulation of the inflammatory gene IL‑6 in A549 cells treated with the chemical entity methoctramine led to increased phosphorylation of STAT3 and promoted chemotaxis of neutrophils in a murine lung injury model.,-57.5,0.8,chemicalentity
"Mutation in the KCNJ11 gene that introduces the c.114C>A variant in the ATP‑sensitive potassium channel of pancreatic β‑cells leads to permanent neonatal diabetes, and treatment with the chemical entity glibenclamide restores insulin secretion by increasing channel closure and stimulating glucose‑induced Ca²⁺ influx in patient‑derived HTR‑8/SVneo trophoblast cells.",-90.0,0.8,chemicalentity
"Mutation‐induced dysregulation of the A2A adenosine receptor in the A549 cell line was mitigated by treatment with the selective antagonist HOE‑140, which also reduced intracellular cAMP levels and attenuated the proliferative response to the α,β‑meATP agonist.",-56.5,0.8,chemicalentity
"Targeted delivery of methoctramine to A549 cells expressing the α‑1‑adrenergic receptor inhibited proliferation and induced apoptosis through modulation of intracellular Ca²⁺ flux, suggesting a therapeutic role for this chemical entity in lung cancer.",-41.75,0.8,chemicalentity
"Targeting the P2Y1 receptor with the antagonist methoctramine markedly inhibited platelet aggregation in A549 cells, while concomitant exposure to alpha‑beta‑meATP and the selective P2Y12 blocker HOE‑140 revealed a synergistic suppression of thromboxane A2 production.",-54.25,0.8,chemicalentity
"Targetting the platelet P2Y12 receptor with methoctramine, alpha‑beta‑meATP, and HOE‑140 in A549 cells reduces thromboxane A2 synthesis, a change that parallels the inhibition of nitric‑oxide‑induced vasodilation seen with PCPA and zidovudine, thereby suggesting a potential additive therapeutic effect for patients with HIV‑associated thrombosis.",-90.5,0.8,chemicalentity
"Target‑tissue delivery of methoctramine to A549 cells reduces the expression of the oncogenic gene TP53 and suppresses proliferation, whereas the combination with the adenosine‑tri‑phosphate analogue alpha‑beta‑meATP increases apoptotic signaling in vitro.",-65.5,0.8,chemicalentity
"Metaboplus, a novel small‑molecule inhibitor of the purinergic receptor P2X7, was shown to attenuate LPS‑induced NF‑κB activation in RAW264.7 macrophages and to reduce the production of inflammatory cytokines such as IL‑1β and TNF‑α, thereby providing evidence that targeting P2X7 with a chemical entity can modulate innate immune responses in vitro.",-62.25,0.8,chemicalentity
"Metabolomic profiling revealed that methoctramine, a selective muscarinic antagonist, markedly suppressed the proliferation of A549 cells by downregulating the expression of the oncogenic gene MYC, while simultaneously increasing the levels of the antioxidant enzyme superoxide dismutase in cultured Homo sapiens fibroblasts.",-48.75,0.8,chemicalentity
"Metoclopramide, a dopamine D2 antagonist, was found to potentiate the antiproliferative effects of doxorubicin in A549 cell lines by downregulating the BCL‑2 gene, thereby enhancing apoptosis in non‑small‑cell lung carcinoma.",-45.25,0.8,chemicalentity
"Metronidazole, a nitroimidazole chemical entity, inhibited proliferation of A549 lung cancer cells by activating p53-mediated apoptosis, while concurrent treatment with atorvastatin reduced the drug‑induced cytotoxicity through modulation of CYP3A4 expression in HepG2 hepatocellular carcinoma cells.",-50.25,0.8,chemicalentity
"Exposure of the T47D breast cancer CellLine to the chemical entity methoctramine, a selective m1 muscarinic antagonist, significantly downregulated the expression of the GeneOrGeneProduct CXCL12 and inhibited cell migration, while co‑treatment with the antiviral zidovudine had no effect on this chemokine pathway.",-62.75,0.8,chemicalentity
"Exposure to methoctramine, a selective muscarinic antagonist, in HeLa cells reduced the proliferation of A549 carcinoma cells by down‑regulating the PKA‑dependent phosphorylation of CREB, thereby inducing apoptosis and suppressing the expression of the chemokine CXCL12.",-51.75,0.8,chemicalentity
"Exposure‑dependent inhibition of A549 cell proliferation by methoctramine is accompanied by a dose‑related decrease in the intracellular levels of the alpha‑beta‑meATP receptor ligand HOE‑140, suggesting a synergistic blockade of purinergic signaling that may enhance the antiviral activity of zidovudine against HIV‑infected cells of Homo sapiens.",-72.5,0.8,chemicalentity
"Exposure or activation of the P2X2 receptor by alpha,beta‑meATP in A549 cells markedly increases intracellular calcium, and subsequent addition of methoctramine suppresses the calcium influx and attenuates the growth‑promoting effect of the drug.",-71.0,0.8,chemicalentity
"A549 cells treated with the P2Y2 agonist alpha‑meATP exhibited a dramatic increase in IL‑8 secretion, an effect that was markedly attenuated when the cells were pre‑incubated with the selective antagonist HOE‑140, suggesting that alpha‑meATP activates an ERK‑dependent signaling cascade in this lung carcinoma model.",-46.5,0.8,chemicalentity
"A recent study showed that methoctramine inhibited proliferation in the A549 cell line by antagonizing the alpha‑1‑adrenergic receptor, while concomitant exposure to the PCPA metabolite of zidovudine reduced the activity of the ATP‑binding cassette transporter in Homo sapiens hepatocytes, suggesting a synergistic effect on drug efflux and cell survival.",-62.25,0.8,chemicalentity
"A humanized anti‑PD‑L1 antibody combined with methoctramine synergistically inhibited tumor‑associated macrophage polarization in A549 cells, enhancing CD8⁺ T‑cell cytotoxicity against lung carcinoma in a xenograft model.",-43.0,0.8,chemicalentity
"Aβ oligomer‑induced synaptic dysfunction in the hippocampus of aged Tg2576 mice was rescued by intraperitoneal injection of methoctramine, which antagonized the α1‑adrenergic receptor expressed on hippocampal astrocytes, thereby reducing reactive astrocytosis and restoring cognitive performance.",-59.25,0.8,chemicalentity
"Intraperitoneal injection of methoctramine in A549 cells inhibited ERK phosphorylation, thereby reducing proliferation of tumor cells and increasing the expression of the tumor suppressor gene TP53.",-33.0,0.8,chemicalentity
"Intracellular signaling in HeLa cells is modulated when methoctramine competitively inhibits alpha‑adrenergic receptors, thereby reducing the downstream cAMP response triggered by beta‑meATP and attenuating the activation of the HOE‑140‑sensitive calcium channels that normally enhance the antiviral activity of zidovudine.",-56.25,0.8,chemicalentity
"Intravesical methoctramine inhibited proliferation of HeLa cells, a reduction that correlated with increased intracellular nitrite levels and was partially reversed by co‑treatment with the purinergic agonist alpha‑meATP.",-44.0,0.8,chemicalentity
"Intriguingly, methoctramine, a selective muscarinic antagonist, was shown to reduce the proliferation of A549 cells harboring a KRAS G12D mutation, an effect that was potentiated by co‑treatment with the ATP analog beta‑meATP, highlighting a potential therapeutic avenue for KRAS‑driven lung cancer.",-48.75,0.8,chemicalentity
"Alpha‑meATP activates the P2X7 receptor on A549 cells, triggering apoptosis that is potentiated by methoctramine and attenuated by the HOE‑140 antagonist.",-33.0,0.8,chemicalentity
"Alpha- and beta-meATP, a potent purinergic agonist, were shown to induce apoptosis in HeLa cells through P2X7 receptor activation, while co‑treatment with the selective antagonist HOE‑140 markedly reduced caspase‑3 activation and restored mitochondrial membrane potential, demonstrating a direct chemical‑entity‑cell‑line interaction that may inform future therapeutic strategies for drug‑induced cytotoxicity.",-56.0,0.8,chemicalentity
"Alpha-meATP stimulation of HeLa cells expressing the P2X7 receptor increased IL-1β secretion, a response that was attenuated by the selective antagonist HOE-140 and further enhanced in the presence of the chemotherapeutic agent zidovudine.",-43.25,0.8,chemicalentity
"Alpha‐meATP induces rapid apoptosis in the A549 cell line through a PI3K/AKT pathway that is markedly suppressed when the cells are treated with the selective antagonist HOE‑140, suggesting a potential therapeutic strategy for non‑small cell lung cancer.",-54.75,0.8,chemicalentity
"zidovudine, a nucleoside reverse transcriptase inhibitor, was shown to competitively inhibit CYP3A4‑mediated metabolism of the antiretroviral atazanavir, thereby increasing atazanavir plasma concentrations and enhancing its therapeutic efficacy against HIV replication.",-27.25,0.8,chemicalentity
"zidekine, a novel synthetic analog of zidovudine, competitively inhibits HIV reverse transcriptase in the presence of CYP3A4 inhibitors, thereby enhancing viral suppression in *Homo sapiens* PBMCs while simultaneously reducing myelosuppression associated with Adriamycin therapy.",-54.75,0.8,chemicalentity
"zinc‑dependent CYP3A4 inhibitors such as atazanavir and pralidoxime‑2‑chloride suppress the DFG‑out conformation of the kinase domain, thereby reducing the cytotoxic efficacy of Adriamycin in A549 cells.",-34.25,0.8,chemicalentity
"zivudine, a nucleoside analog antiretroviral, competitively inhibits HIV‑1 reverse transcriptase, and its activity is markedly enhanced when co‑administered with CYP3A4 inhibitors such as atazanavir, thereby increasing zidovudine plasma exposure and reducing the risk of therapy failure.",-49.5,0.8,chemicalentity
"In HepG2 cells, the CYP3A4 inhibitor ritonavir markedly enhanced zidovudine cytotoxicity by shifting the enzyme into a DFG‑out conformation, thereby increasing intracellular drug accumulation and apoptosis.",-25.25,0.8,chemicalentity
"In HeLa cells, the DFG‑out conformation of the kinase domain is stabilized by the chemicalentity atazanavir, which competitively inhibits CYP3A4 and reduces the metabolism of zidovudine, thereby enhancing its antiviral potency.",-24.75,0.8,chemicalentity
"In vitro assays revealed that the lipid emulsions used to deliver zidovudine significantly increased cellular uptake, whereas co‑administration of the CYP3A4 inhibitor atazanavir amplified the drug’s cytotoxicity in A549 cells, a phenomenon that was mitigated when the emulsions were formulated with a DFG‑out selective phospholipid blend.",-51.5,0.8,chemicalentity
"In U2OS cells, the DFG‑out conformer of the kinase domain is stabilized by the chemical entity zidovudine, leading to reduced phosphorylation of the downstream transcription factor TP53 and consequent apoptosis of the malignant cells.",-44.25,0.8,chemicalentity
"The CYP3A4 inhibitor atazanavir markedly reduced zidovudine clearance in a cohort of HIV‑positive patients, illustrating a clinically relevant drug‑drug interaction that increases plasma zidovudine exposure and risk of myelosuppression.",-30.375,0.8,chemicalentity
"The DFG‑out conformation of the kinase domain, stabilized by the CYP3A4 inhibitor atazanavir, enhances the cytotoxicity of the anthracycline Adriamycin in HeLa cells.",-16.75,0.8,chemicalentity
"The antiviral activity of zidovudine is markedly enhanced in HepG2 cells when co‑treated with the CYP3A4 inhibitor atazanavir, which blocks its glucuronidation and prolongs intracellular concentrations.",-27.875,0.8,chemicalentity
"The co‑administration of the CYP3A4 inhibitor atazanavir markedly increases plasma zidovudine levels, thereby enhancing its antiretroviral efficacy while also raising the risk of myelotoxicity.",-22.0,0.8,chemicalentity
"Administration of zidovudine in combination with the CYP3A4 inhibitor atazanavir markedly increased the plasma concentration of the antiretroviral, thereby enhancing viral suppression while simultaneously inducing a dose‑dependent rise in hepatic transaminases in a cohort of HIV‑positive patients.",-30.0,0.8,chemicalentity
"Administration with the CYP3A4 inhibitor atazanavir increased the plasma concentration of the antiretroviral zidovudine in a patient with HIV infection, thereby potentiating its myelosuppressive effect.",-39.75,0.8,chemicalentity
"Administration oryzalin in the MCF‑7 cell line reduces colony‑forming ability, a phenotype that is rescued by pretreatment with the CYP3A4 inhibitor ritonavir, indicating a drug–drug interaction involving the DFG‑out conformation of the kinase domain.",-66.0,0.8,chemicalentity
"Administration to A549 cells of the antiretroviral zidovudine, when combined with the CYP3A4 inhibitor atazanavir, markedly increased intracellular accumulation of the drug and induced apoptosis mediated through DFG‑out conformation of the kinase domain.",-45.25,0.8,chemicalentity
"Xenografts of A549 cells treated with the lipid emulsion‑formulated zidovudine demonstrated a significant reduction in tumor‑associated VEGF expression, implicating CYP3A4‑mediated metabolism of the drug in the observed antitumor activity.",-37.5,0.8,chemicalentity
"X‑cell line exposed to the antiretroviral zidovudine showed markedly increased apoptosis, which was partially rescued by the CYP3A4 inhibitor atazanavir, revealing a pharmacogenomic interaction between the drug and the cell’s detoxification pathways.",-54.5,0.8,chemicalentity
"X cells treated with the CYP3A4 inhibitor ritonavir exhibit a pronounced increase in intracellular zidovudine concentration, suggesting that pharmacokinetic drug–drug interaction may potentiate antiretroviral efficacy.",-37.25,0.8,chemicalentity
"Xeloda (capecitabine) resistance in A549 cells is potentiated by the CYP3A4 inhibitor ritonavir, which induces a DFG‑out conformation of the epidermal growth factor receptor kinase domain and reduces the therapeutic efficacy of the lipid‑emulsion formulation of paclitaxel in the treatment of metastatic non‑small‑cell lung cancer.",-60.0,0.8,chemicalentity
"Azhdarchid‐derived lipid emulsions containing zidovudine were found to inhibit the DFG‑out conformation of the CYP3A4 active site, thereby reducing the metabolic activation of the chemotherapeutic agent Adriamycin in A549 cells.",-47.0,0.8,chemicalentity
"Aspirin, a widely used non‑steroidal anti‑inflammatory drug, inhibits the cyclooxygenase‑2 enzyme in human colon adenocarcinoma cells, reducing prostaglandin E2 production and thereby suppressing tumor cell proliferation while simultaneously lowering the risk of colorectal cancer recurrence.",-41.75,0.8,chemicalentity
"A549 cells treated with the chemotherapeutic Adriamycin exhibit increased apoptosis when co‑treated with the CYP3A4 inhibitor atazanavir, suggesting a synergistic effect on drug‑induced cytotoxicity.",-25.75,0.8,chemicalentity
"A clinical trial demonstrated that the addition of the CYP3A4 inhibitor ritonavir to the zidovudine regimen markedly increased plasma zidovudine concentrations, thereby enhancing viral suppression in patients with HIV infection.",-24.0,0.8,chemicalentity
"Intracellular accumulation of zidovudine in A549 cells is markedly reduced when co‑treated with the CYP3A4 inhibitor atazanavir, thereby enhancing the drug’s antiviral potency against HIV replication.",-24.875,0.8,chemicalentity
Intravenous lipid emulsions containing a mixture of phospholipids and triglycerides enhance the bioavailability of the antiretroviral drug zidovudine by improving its solubility and reducing gastrointestinal toxicity.,-32.75,0.8,chemicalentity
"Intraperitoneal injection of zidovudine into A549 cells reduced cell viability by activating CYP3A4 inhibitors, which led to accumulation of a toxic DFG‑out metabolite and induced apoptosis.",-39.75,0.8,chemicalentity
"Intranasal delivery of the lipid emulsion containing zidovudine significantly reduced viral replication in HeLa cells, an effect that was markedly potentiated when co‑treated with the CYP3A4 inhibitor atazanavir, which stabilizes the DFG‑out conformation of the reverse transcriptase kinase domain.",-39.75,0.8,chemicalentity
"Atazanavir, a potent CYP3A4 inhibitor, when combined with the lipid emulsion formulation of zidovudine, markedly enhances plasma exposure of the antiretroviral drug and reduces the risk of dose‑dependent neutropenia observed in HIV‑positive patients.",-33.25,0.8,chemicalentity
"Ativan is a benzodiazepine whose binding mode is characterized by the DFG-out conformation, a feature that also enables selective inhibition of the CYP3A4 enzyme by the antiretroviral atazanavir, thereby enhancing plasma exposure of the antiviral zidovudine in patients receiving a lipid emulsion formulation.",-74.5,0.8,chemicalentity
"At investigation of the DFG‑out conformation in the ATP‑binding pocket, the presence of the CYP3A4 inhibitor atazanavir markedly inhibited the catalytic activity of the kinase, whereas the lipid emulsion formulation of zidovudine improved its cellular uptake in cultured HeLa cells.",-47.5,0.8,chemicalentity
"At administration of the antiretroviral zidovudine, the CYP3A4 inhibitors atazanavir and pralidoxime‑2‑chloride synergistically increased plasma concentrations of the drug, leading to an amplified incidence of myopathy in patients receiving lipid emulsions as an adjunct therapy.",-49.25,0.8,chemicalentity
"Adriamycin exposure in A549 cells induced a DFG-out conformation of the kinase domain, which was partially rescued by co‑treatment with the CYP3A4 inhibitor atazanavir, thereby enhancing apoptosis and reducing the drug’s cardiotoxicity.",-37.25,0.8,chemicalentity
"Adra​min‑induced apoptosis in A549 cells is markedly enhanced by co‑treatment with the CYP3A4 inhibitor atazanavir, which also blocks the DFG‑out conformation of the target kinase, thereby increasing drug retention and cytotoxic efficacy.",-38.75,0.8,chemicalentity
"Adjuvant treatment of metastatic breast cancer with the CYP3A4 inhibitor ritonavir and the antiretroviral zidovudine was shown to enhance doxorubicin (Adriamycin) pharmacokinetics, leading to increased tumor cell apoptosis in MDA-MB-231 cells.",-43.5,0.8,chemicalentity
"Adiramycin exposure in HeLa cells activates the DFG‑out conformation of the Src kinase, a shift that is partially reversed when the CYP3A4 inhibitor atazanavir is co‑administered, illustrating a drug‑drug interaction that modulates kinase activity and cell‑death signaling.",-45.5,0.8,chemicalentity
"Methadone, a synthetic opioid, activates the CYP3A4 enzyme and thereby enhances the metabolism of the antiretroviral drug zidovudine, leading to subtherapeutic plasma concentrations that may compromise viral suppression.",-39.25,0.8,chemicalentity
"Methotrexate administration in HeLa cells induces a DFG‑out conformational change in the ERK1/2 kinase, enhancing the cytotoxic effect of the drug on cervical carcinoma growth.",-46.25,0.8,chemicalentity
"Methoxy‑L‑cysteine, a CYP3A4 inhibitor, competitively binds the DFG‑out pocket of the epidermal growth factor receptor, thereby potentiating the antitumor activity of zidovudine in A549 cells.",-43.25,0.8,chemicalentity
"Methamphetamine‑induced oxidative stress in the A549 cell line was attenuated by pretreatment with the CYP3A4 inhibitor atazanavir, which altered the DFG‑out conformation of the P‑450 enzyme and reduced the production of toxic metabolites.",-43.5,0.8,chemicalentity
Exposure of A549 cells to the lipid emulsion formulation of zidovudine in the presence of CYP3A4 inhibitors increased intracellular drug accumulation and induced apoptosis mediated by caspase‑3 activation.,-26.875,0.8,chemicalentity
"Exposure to the CYP3A4 inhibitor atazanavir, delivered in a lipid emulsion, induced a DFG-out conformational shift in the target kinase, thereby enhancing the anti‑tumor activity of Adriamycin in HeLa cells.",-35.0,0.8,chemicalentity
"Exposure in HeLa cells to the DFG‑out conformation of kinase inhibitor zidovudine reduced phosphorylation of ERK1/2 while concurrently enhancing the cytotoxic effect of the chemotherapeutic Adriamycin, an effect that was mitigated when the CYP3A4 inhibitors atazanavir and pralidoxime‑2‑chloride were co‑administered, indicating a drug‑drug interaction that alters cellular apoptosis pathways.",-74.5,0.8,chemicalentity
"Exposure–response modeling revealed that the combination of zidovudine and the CYP3A4 inhibitor atazanavir markedly increased plasma zidovudine concentrations, thereby enhancing the risk of myelosuppression in HIV‑positive patients.",-42.25,0.8,chemicalentity
"Baxilin, a novel CYP3A4 inhibitor, was shown to potentiate the antitumor activity of Adriamycin in the A549 lung cancer cell line by enhancing drug uptake and reducing efflux transporter expression.",-38.25,0.8,chemicalentity
"B cells treated with zidovudine exhibit increased expression of the pro‑apoptotic protein BAX, a change that is amplified when the drug is combined with the CYP3A4 inhibitor atazanavir, thereby enhancing the cytotoxic effect on malignant lymphoma cell lines.",-41.5,0.8,chemicalentity
"Bortezomib’s potent inhibition of the proteasome in A549 cells is significantly enhanced by the CYP3A4 inhibitor ritonavir, which blocks the metabolic clearance of the drug and amplifies its cytotoxic effect on lung carcinoma.",-45.25,0.8,chemicalentity
"BCR‑ABL‑positive chronic myeloid leukemia cells treated with the DFG‑out conformation‑specific inhibitor atazanavir showed a marked decrease in proliferation, accompanied by increased apoptosis and reduced expression of the drug‑efflux transporter MDR1.",-39.25,0.8,chemicalentity
"CYP3A4 inhibitors such as atazanavir and zidovudine synergistically decrease the plasma concentration of the antiepileptic oxcarbazepine, thereby elevating the risk of seizure recurrence in patients receiving concomitant lipid emulsions for parenteral nutrition.",-29.125,0.8,chemicalentity
"Cytotoxic effects of Adriamycin on MCF‑7 cells are markedly potentiated when combined with the CYP3A4 inhibitor atazanavir, resulting in a significant increase in intracellular DNA damage and apoptosis.",-26.25,0.8,chemicalentity
"Cisplatin-induced nephrotoxicity was markedly attenuated when mice received a lipid emulsion containing a CYP3A4 inhibitor, suggesting that the emulsion modulates drug metabolism and protects renal tubular cells.",-31.0,0.8,chemicalentity
"Coadministration of the CYP3A4 inhibitor atazanavir with the antiretroviral zidovudine markedly increased plasma zidovudine exposure, underscoring the need for dose adjustment in patients receiving this drug combination.",-26.125,0.8,chemicalentity
"Methylprednisolone administration to A549 cells co‑treated with the CYP3A4 inhibitor ritonavir reduced the expression of CYP3A4‑mediated metabolism of the antiretroviral zidovudine, thereby increasing intracellular drug accumulation and cytotoxicity.",-35.5,0.8,chemicalentity
"Molecular docking of zidovudine onto the ATP‑binding pocket of the DFG‑out conformation of protein kinase CK2 revealed that the drug’s morpholino ring chelates the Mg²⁺ ion, thereby stabilizing the inactive state and suggesting a potential off‑target inhibition mechanism in cancer cells.",-56.0,0.8,chemicalentity
"MDR1 overexpression in A549 cells exposed to the CYP3A4 inhibitor atazanavir was confirmed by qPCR, indicating that atazanavir’s inhibition of CYP3A4 reduces zidovudine clearance and increases intracellular zidovudine concentration.",-44.25,0.8,chemicalentity
"Mice receiving the CYP3A4 inhibitor ritonavir exhibited a dose‑dependent increase in the plasma concentration of the antiretroviral zidovudine, thereby amplifying its myelotoxicity and underscoring the need for therapeutic drug monitoring.",-39.25,0.8,chemicalentity
"In H1299 cells, treatment with the antitumor agent eslicarbazepine acetate reduced LDH release, suggesting diminished cytotoxicity compared with piperacillin/tazobactam.",-25.875,0.8,chemicalentity
"In MCF-7 cells, treatment with the anti‑angiogenic drug eslicarbazepine acetate reduced VEGF secretion and concurrently down‑regulated the expression of the pro‑apoptotic protein BAX, suggesting a dual role for this chemical entity in modulating tumor cell survival.",-38.25,0.8,chemicalentity
"In A549 cells treated with the antineoplastic agent eslicarbazepine acetate, cyclo‑adenosine triphosphate levels decrease while the expression of the drug‑efflux transporter ABCB1 is concurrently upregulated, suggesting a compensatory metabolic response to the chemicalentity’s cytotoxic stress.",-49.25,0.8,chemicalentity
"In colorectal cancer cell lines, treatment with the alkylating agent eslicarbazepine acetate induced a dose‑dependent decrease in DNA‑strand breaks while simultaneously up‑regulating the antioxidant response element‑driven expression of glutathione‑peroxidase, revealing a chemoprotective interaction that may modulate therapeutic efficacy.",-59.5,0.8,chemicalentity
Dexrazoxane mitigated doxorubicin‑induced cardiotoxicity in H9c2 cardiomyocytes by reducing O2− accumulation and preserving LDH activity.,-16.875,0.8,chemicalentity
Dex‑razoxane inhibited O₂⁻‑induced DNA strand breaks in HeLa cells by up‑regulating p53‑mediated antioxidant enzymes and thereby reducing LDH release.,-40.75,0.8,chemicalentity
"Dextran‑conjugated eslicarbazepine acetate administered to HeLa cells markedly inhibited cyclic adenosine monophosphate–dependent protein kinase activity, thereby reducing LDH release and protecting the cells from piperacillin/tazobactam‑induced cytotoxicity.",-41.5,0.8,chemicalentity
Dexazoxane administration in HeLa cells carrying the TP53 c.215G>A sequence variant reduces O₂⁻‑induced LDH release more efficiently than piperacillin/tazobactam.,-36.25,0.8,chemicalentity
"Eslicarbazepine acetate, a novel antiepileptic drug, was found to inhibit cyclic adenosine monophosphate‑dependent protein kinase signaling in A549 cells, thereby reducing LDH release and protecting against Dexrazoxane‑induced cardiotoxicity.",-20.25,0.8,chemicalentity
"Esricarbazepine acetate, a voltage‑gated sodium channel blocker, synergizes with Dexrazoxane to attenuate doxorubicin‑induced cardiotoxicity in H9c2 cardiomyocytes by reducing O₂⁻ production and preserving LDH activity.",-36.75,0.8,chemicalentity
"Esculin acetate, a small-molecule inhibitor of the inflammatory mediator IL‑6, was shown to reduce O₂⁻‑induced oxidative stress and thereby attenuate cyclo‑adenosine‑mediated cardiomyocyte apoptosis in cultured H9c2 cells.",-62.75,0.8,chemicalentity
"Eslectibazepine acetate, a voltage‑gated sodium channel blocker, was shown to reduce O2‑‑induced LDH release in HepG2 cells, an effect that was reversed by the antioxidant dexrazoxane.",-48.0,0.8,chemicalentity
"The addition of Dexrazoxane to the piperacillin/tazobactam regimen markedly reduced O2⁻‑mediated myocardial LDH release in cultured cardiomyocytes, suggesting a protective effect against anthracycline‑induced cardiotoxicity.",-28.5,0.8,chemicalentity
"The combination of Dexrazoxane and piperacillin/tazobactam mitigated the cardiotoxicity induced by doxorubicin in A549 cells, as evidenced by reduced LDH release and preserved mitochondrial membrane potential.",-18.625,0.8,chemicalentity
"The administration of Dexrazoxane significantly reduced doxorubicin‑induced cardiotoxicity in adult male C57BL/6J mice, as evidenced by lower serum lactate dehydrogenase (LDH) activity and preserved cardiac troponin levels.",-27.375,0.8,chemicalentity
"The chemotherapeutic agent Dexrazoxane, when combined with the cyclic adenosine analog eslicarbazepine acetate, markedly reduces O2‑induced DNA damage in human breast cancer cells.",-32.0,0.8,chemicalentity
Activation of cyclic adenosine monophosphate signaling by Eslicarbazepine acetate in A549 cells reduces LDH release and mitigates Dexrazoxane‑induced cardiotoxicity in a co‑culture with primary cardiomyocytes.,-31.375,0.8,chemicalentity
"Activation by the chemical entity Dexrazoxane in HeLa cells reduces O₂⁻ production, thereby lowering LDH release and improving cell viability.",-36.5,0.8,chemicalentity
"Activation‑induced transcription of the pro‑apoptotic gene BAX by the DNA‑binding protein p53 is potentiated by the small‑molecule drug Dexrazoxane, which binds to topoisomerase‑II and thereby prevents the accumulation of harmful O₂⁻ radicals in HeLa cells.",-61.0,0.8,chemicalentity
"Activation energy reduction by eslicarbazepine acetate enhances cyclic adenosine monophosphate‑mediated neuronal signaling, thereby potentiating Dexrazoxane‑induced cardioprotection in human cardiomyocytes.",-45.0,0.8,chemicalentity
"Treatment with the cyclo‑adenosine analogue eslicarbazepine acetate reduced the elevated LDH activity and attenuated the O₂⁻‑induced apoptosis in cultured A549 cells, suggesting a neuro‑protective metabolic effect in a human lung carcinoma model.",-47.5,0.8,chemicalentity
"Treatment of the HeLa cell line with eslicarbazepine acetate and dexrazoxane inhibited proliferation, while cyclic adenosine monophosphate levels increased, suggesting a combined anti‑proliferative effect mediated through modulation of intracellular signaling pathways.",-37.25,0.8,chemicalentity
"Treatment inhibition of the mitochondrial ATPase by eslicarbazepine acetate in HeLa cells reduced LDH release, suggesting a protective effect against oxidative O2- induced cell death.",-47.25,0.8,chemicalentity
"Treatment failure in patients with metastatic pancreatic ductal adenocarcinoma was linked to the up‑regulation of the drug‑efflux transporter ABCB1, a gene product whose over‑expression was driven by the transcription factor SP1 binding to the promoter region and by the accumulation of the chemotherapeutic agent cisplatin, which also induced oxidative stress through the generation of reactive oxygen species such as O2- and subsequently increased lactate dehydrogenase (LDH) release from cancer cells.",-94.0,0.8,chemicalentity
"Synaptic uptake of cyclic adenosine monophosphate is potentiated by eslicarbazepine acetate in cultured HEK293 cells, leading to increased CREB phosphorylation and downstream expression of the neuronal plasticity gene BDNF.",-33.75,0.8,chemicalentity
"Synaptosomal uptake of the anticonvulsant eslicarbazepine acetate is markedly enhanced in cultured SH-SY5Y neuroblastoma cells by co‑treatment with the ROS scavenger Dexrazoxane, which reduces intracellular O₂⁻ levels and restores normal ATP‑dependent transport of the drug.",-50.5,0.8,chemicalentity
"Synonymous mutation c.68_69delAG in the TP53 gene reduces the binding affinity of the p53 protein for its target promoter, thereby impairing transcription of the cyclin‑dependent kinase inhibitor p21 in HeLa cells and sensitizing them to the cytotoxic effects of doxorubicin.",-51.5,0.8,chemicalentity
"Synphthalamic inhibition of cyclic adenosine monophosphate by the small molecule eslicarbazepine acetate attenuates LDH release in HeLa cells, suggesting a potential neuroprotective mechanism against oxidative stress.",-56.75,0.8,chemicalentity
"Administration of eslicarbazepine acetate to HeLa cells markedly reduced cyclic adenosine monophosphate levels, thereby attenuating the phosphorylation of protein kinase A and ultimately lowering the expression of the oncogenic gene MYC.",-29.125,0.8,chemicalentity
"Administration to A549 cells of the anti‑oxidant Dexrazoxane markedly reduced O2‑–induced LDH release while preserving cyclic adenosine monophosphate signalling, thereby attenuating apoptosis.",-47.25,0.8,chemicalentity
Administration with the combination of Dexrazoxane and piperacillin/tazobactam significantly reduced the O2⁻‑induced LDH release in the cultured HeLa cells harboring the BRCA1 c.68_69delAG sequence variant.,-46.0,0.8,chemicalentity
"Administration and dose‑dependent inhibition of LDH activity by the novel compound **4‑diphenylacetoxy‑N‑methylpiperidine** revealed a pronounced suppression of tumor‑cell glycolytic flux, suggesting a potential therapeutic strategy for **piperacillin/tazobactam**‑resistant **E. coli** infections.",-67.5,0.8,chemicalentity
"Dexamethasone‑treated A549 cells overexpressed the ATP-binding cassette transporter ABCB1, which was up‑regulated by the cyclic adenosine monophosphate‑dependent protein kinase A pathway and reduced the intracellular accumulation of the chemotherapeutic agent doxorubicin, thereby attenuating LDH release and protecting the cells from drug‑induced apoptosis.",-54.5,0.8,chemicalentity
"Doxorubicin-induced cardiotoxicity in A549 cells is mitigated by Dexrazoxane, which chelates iron and reduces O₂⁻ generation, thereby preserving LDH activity and cell viability.",-18.125,0.8,chemicalentity
"Dioxazolone, a synthetic analogue of Eslicarbazepine acetate, inhibited the proliferation of the A549 cell line by inducing apoptosis through the activation of caspase‑3 and the suppression of the PI3K‑AKT signaling pathway.",-44.5,0.8,chemicalentity
"Dextrorphan, a cyclic adenosine derivative, was found to down‑regulate LDH expression in HeLa cells, thereby reducing glycolytic flux and enhancing sensitivity to the chemotherapeutic agent piperacillin/tazobactam.",-37.75,0.8,chemicalentity
"Exposure to the chemotherapeutic agent Dexrazoxane markedly reduced the O₂⁻‑induced cardiotoxicity observed in A549 cells treated with doxorubicin, as evidenced by a significant decrease in LDH release and preservation of mitochondrial membrane potential.",-33.25,0.8,chemicalentity
"Exposure of HeLa cells to the drug eslicarbazepine acetate induces a rapid increase in intracellular O2- levels, thereby enhancing the cytotoxicity of the concurrent treatment with piperacillin/tazobactam.",-35.5,0.8,chemicalentity
"Exposure therapy with piperacillin/tazobactam in a pediatric patient with severe cystic fibrosis exacerbation led to a marked reduction in sputum O2‑dependent LDH release, indicating decreased airway inflammation.",-58.0,0.8,chemicalentity
"Exposure‑induced oxidative stress in HepG2 cells, evidenced by elevated O2‑ production, was markedly mitigated by co‑treatment with Dexrazoxane, which simultaneously reduced LDH release and preserved cyclic adenosine monophosphate signaling.",-51.25,0.8,chemicalentity
Combining Dexrazoxane with piperacillin/tazobactam markedly reduced the intracellular accumulation of O2- and attenuated LDH release in E. coli‑derived HeLa cells harboring the TP53 R273H sequence variant.,-40.25,0.8,chemicalentity
"Combustion of the chemical entity eslicarbazepine acetate in the tumor microenvironment of HeLa cells releases cyclic adenosine monophosphate, which subsequently upregulates the expression of the tumor suppressor gene TP53 and inhibits the proliferation of the malignant phenotype.",-48.5,0.8,chemicalentity
"Combretol, a natural phenolic compound, inhibited proliferation of A549 cells by inducing caspase‑3‑mediated apoptosis and simultaneously down‑regulated LDH activity in a dose‑dependent manner.",-45.75,0.8,chemicalentity
"Combating cisplatin‑induced cardiotoxicity, Dexrazoxane was shown to reduce O2‑ mediated oxidative damage in H9c2 cardiomyocytes, thereby preserving LDH activity and improving cell survival.",-38.75,0.8,chemicalentity
"Piperacillin/tazobactam administration in *E. coli*–infected neutropenic mice markedly reduced bacterial burden while simultaneously elevating plasma LDH levels, indicating drug‑induced tissue damage.",-37.25,0.8,chemicalentity
"Pipera­cin‑tazobactam treatment in E. coli–infected HeLa cells increased cyclic adenosine monophosphate levels, correlating with enhanced expression of the bacterial β‑lactamase gene and reduced LDH release.",-44.25,0.8,chemicalentity
"Pterostilbene, a naturally occurring phenolic compound, synergistically enhances the anti‑cancer efficacy of doxorubicin in A549 cells by inhibiting the NF‑κB‑driven expression of the drug‑efflux transporter ABCB1, thereby reducing multidrug resistance in non‑small‑cell lung carcinoma.",-46.0,0.8,chemicalentity
"Pyridostigmine acetylation by the hepatic CYP2E1 enzyme in a Cypriot patient carrying the rs1746048 variant of the AADAC gene led to a markedly increased plasma concentration of the drug, which in turn caused a dose‑dependent elevation in urinary lactate dehydrogenase (LDH) levels and a transient rise in serum O₂⁻ production, thereby exacerbating the patient's Parkinson’s disease motor symptoms.",-94.0,0.8,chemicalentity
"Use of Dexrazoxane, an iron-chelating chemical entity, reduced the O2–‑induced DNA fragmentation in HeLa cells, thereby attenuating LDH release and preserving cell viability.",-41.75,0.8,chemicalentity
"Use the combination of eslicarbazepine acetate and dexrazoxane to protect myocardium from doxorubicin‑induced oxidative stress, thereby reducing O₂⁻‑mediated damage in cardiomyocytes derived from H9c2 cells.",-45.25,0.8,chemicalentity
"Use Dexrazoxane to inhibit doxorubicin‐induced O2‑ generation in HeLa cells, thereby reducing LDH release and protecting mitochondrial integrity.",-33.5,0.8,chemicalentity
"Useable eslicarbazepine acetate, a second‑generation antiepileptic drug, reduces the production of cyclic adenosine monophosphate in neuronal cells, thereby attenuating seizure‑induced elevations in intracellular calcium and subsequent cytotoxicity.",-61.0,0.8,chemicalentity
"Synergistic inhibition of proliferation was observed when the chemotherapeutic agent Dexrazoxane was combined with the anti‑inflammatory drug pantoprazole in the KRAS‑mutated A549 lung carcinoma cell line, highlighting a potential drug‑drug interaction that may reduce tumor growth through modulation of intracellular reactive oxygen species such as O2‑.",-47.5,0.8,chemicalentity
Synergy of the antineoplastic drug eslicarbazepine acetate with Dexrazoxane markedly reduces doxorubicin‑induced cardiotoxicity in H9c2 rat cardiomyocytes by attenuating O2‑‑mediated oxidative stress and preserving LDH activity.,-35.25,0.8,chemicalentity
Synergetic inhibition of the LDH-mediated glycolytic flux by eslicarbazepine acetate and the ROS scavenger Dexrazoxane was observed to sensitize HeLa cells to piperacillin/tazobactam-induced apoptosis.,-35.5,0.8,chemicalentity
"Syngeneic implantation of HeLa cells treated with the anti‑cancer drug eslicarbazepine acetate revealed a dose‑dependent reduction in LDH release and a corresponding increase in caspase‑3 activation, indicating enhanced apoptosis relative to untreated controls.",-41.5,0.8,chemicalentity
"The application of diclofenac sodium in a dose‑dependent manner inhibited prostanoid production, thereby reducing the phosphorylation of the TP53 gene product in A549 cells derived from Homo sapiens.",-32.75,0.8,chemicalentity
"The IC₅₀ of diclofenac sodium for COX‑2 inhibition in A549 cells was reduced by co‑treatment with the prostanoid antagonist, indicating a synergistic anti‑inflammatory effect in the lung cancer model.",-27.0,0.8,chemicalentity
"The administration of diclofenac sodium to A549 cells inhibited prostanoid production and consequently reduced the expression of COX‑2, thereby attenuating the inflammatory response associated with pulmonary fibrosis.",-23.875,0.8,chemicalentity
"The chemotherapeutic agent doxorubicin induces a dose‑dependent increase in reactive oxygen species that up‑regulates the transcription factor NRF2 in HeLa cells, thereby enhancing the expression of the antioxidant enzyme glutathione peroxidase and mitigating cytotoxicity.",-33.25,0.8,chemicalentity
"Dexamethasone administration in A549 cells reduced NF‑κB‑mediated IL‑8 secretion, while concurrent exposure to diclofenac sodium synergistically amplified apoptosis via caspase‑3 activation and increased ROS production.",-37.5,0.8,chemicalentity
"Doxorubicin-induced cardiotoxicity is attenuated in H9c2 cardiomyocytes when co‑treated with ramipril, which upregulates the prostanoid EP2 receptor and reduces oxidative stress.",-24.875,0.8,chemicalentity
"Diclofenac sodium reduced prostanoid synthesis in the A549 cell line, thereby attenuating estrogen‑induced inflammatory signaling in a dose‑dependent manner.",-22.125,0.8,chemicalentity
"Dacarbazine, a chemotherapeutic alkylating agent, induces apoptosis in A549 cells by activating the TP53 pathway and down‑regulating VEGF secretion, thereby reducing angiogenesis in non‑small cell lung carcinoma.",-29.625,0.8,chemicalentity
"Diclofenac sodium inhibits COX‑2‑mediated prostanoid production, thereby reducing inflammation in A549 lung cancer cells and lowering tumor‑associated fever in mice.",-28.125,0.8,chemicalentity
"Dictran, a synthetic analogue of diclofenac sodium, suppressed COX‑2 expression in A549 cells, thereby reducing prostanoid production and ameliorating estrogen‑induced inflammatory signaling.",-42.75,0.8,chemicalentity
"Dicloxacil sodium, a non‑steroidal anti‑inflammatory drug, suppresses cyclo‑oxygenase‑2 expression in A549 cells and reduces prostanoid‑mediated leukocyte recruitment, thereby attenuating the inflammatory response in a model of acute lung injury.",-49.25,0.8,chemicalentity
"Diclonefate, a diclofenac sodium derivative, was shown to inhibit COX‑2 expression in A549 cells and reduce prostanoid production, thereby attenuating estrogen‑induced proliferation of HeLa cells.",-46.25,0.8,chemicalentity
"Methyldopa treatment in a cohort of hypertensive patients reduced plasma angiotensin‑II levels and improved endothelial nitric‑oxide synthase activity, while concurrent exposure to diclofenac sodium increased prostanoid production, potentially exacerbating renal inflammation in patients with a history of galactosemia.",-52.5,0.8,chemicalentity
"Methane produced by **E. coli** in the gut is inhibited by the **chemicalentity** diclofenac sodium, reducing **DiseaseOrPhenotypicFeature** colitis severity.",-35.0,0.8,chemicalentity
"Methadone, a synthetic opioid, was found to inhibit cyclooxygenase‑2‑derived prostanoid production in the A549 cell line, thereby reducing inflammatory cytokine release in a human monocyte‑derived macrophage model of chronic obstructive pulmonary disease.",-36.0,0.8,chemicalentity
"Methanolic extraction of diclofenac sodium from HeLa cells revealed that its metabolite inhibited prostanoid production, thereby reducing inflammation in the cellular microenvironment.",-32.0,0.8,chemicalentity
"In Vitro, diclofenac sodium inhibited proliferation of A549 cells by downregulating COX‑2 and inducing apoptosis, thereby demonstrating its potential as a therapeutic agent for lung cancer.",-30.125,0.8,chemicalentity
"In the HeLa cell line, diclofenac sodium treatment inhibited prostanoid-mediated NF‑κB activation, thereby reducing the expression of the inflammatory cytokine IL‑6 and enhancing cell‑cycle arrest through upregulation of the tumor suppressor TP53.",-30.25,0.8,chemicalentity
"In HeLa cells, exposure to diclofenac sodium induces the transcriptional upregulation of COX‑2, which in turn increases prostanoid production and subsequently promotes estrogen‑induced proliferation.",-26.75,0.8,chemicalentity
"In HepG2 cells, diclofenac sodium markedly down‑regulates COX‑2 expression while simultaneously inducing apoptosis through the mitochondrial pathway.",-20.625,0.8,chemicalentity
"Valproic acid treatment of U-2OS cells carrying the TP53 R175H sequence variant reduced the expression of the pro‑apoptotic protein Bax and increased the levels of the anti‑apoptotic protein BCL‑2, suggesting that the drug modulates apoptosis in a TP53‑mutant context.",-43.0,0.8,chemicalentity
"Valmetin, a novel prostanoid analog, competitively inhibited the ERK1/2 phosphorylation induced by methyldopa in A549 cells, reducing cell proliferation and thereby ameliorating the hyperproliferative phenotype associated with estrogen‑induced breast cancer.",-55.25,0.8,chemicalentity
"Valpromide, a structural analog of Valproic acid, inhibited the growth of A549 cells by down‑regulating the expression of the TP53 protein, thereby inducing apoptosis and reducing the secretion of the prostanoid leukotriene B4.",-42.5,0.8,chemicalentity
"Valine‑3‑methyldopa conjugated to the prostanoid receptor antagonist ramipril reduced uridine‑diphosphate‑glucuronosyltransferase activity in A549 cells, leading to decreased estrogen‑induced proliferation of the human breast cancer cell line MCF‑7.",-61.75,0.8,chemicalentity
"Administration of diclofenac sodium to A549 cells expressing the TP53 gene resulted in a dose‑dependent reduction in prostanoid‑mediated VEGF signaling, thereby attenuating the hyperproliferative phenotype observed in these human lung carcinoma cells.",-36.75,0.8,chemicalentity
Administration and pharmacokinetic profiling of diclofenac sodium in HeLa cells revealed that its inhibition of cyclooxygenase-2 and subsequent prostanoid production correlates with reduced proliferation of the cancerous cell line.,-49.75,0.8,chemicalentity
"Administration daily of diclofenac sodium to A549 cells downregulated prostanoid‑mediated signaling and induced caspase‑3 activation, thereby enhancing apoptosis in the presence of ramipril‐treated HepG2 cells.",-59.0,0.8,chemicalentity
"Administration or intraperitoneal injection of diclofenac sodium into A549 cells reduces cyclooxygenase‑2 expression, thereby attenuating prostanoid‑mediated inflammation and inhibiting the proliferation of tumor‑derived organoids derived from Homo sapiens lung adenocarcinoma.",-55.5,0.8,chemicalentity
"Urethane exposure in the A549 cell line led to a marked increase in prostanoid production, which in turn activated the TP53 pathway and induced apoptosis, thereby providing a potential therapeutic target for estrogen‑induced breast cancer.",-36.25,0.8,chemicalentity
"Ureterine carcinoma cells treated with diclofenac sodium exhibited a dose-dependent reduction in prostanoid‑mediated invasion, suggesting that the anti‑inflammatory drug inhibits tumor cell motility in a cell‑line–specific manner.",-39.25,0.8,chemicalentity
"Uremic pruritus in patients receiving high‑dose diclofenac sodium was markedly attenuated by concurrent administration of ramipril, suggesting a pharmacologic interaction that modulates prostanoid‑mediated itch signaling in the renal‑skin axis.",-34.75,0.8,chemicalentity
"Uterine epithelial cells treated with diclofenac sodium and methyldopa displayed a synergistic down‑regulation of the prostanoid receptor EP2, thereby attenuating estrogen‑induced proliferation.",-31.75,0.8,chemicalentity
"A549 cells treated with diclofenac sodium exhibit a dose-dependent reduction in prostanoid-mediated inflammation that is accompanied by upregulation of the CYP2C9 gene product, suggesting a pharmacogenomic interaction between the chemical entity and the cellular pathway.",-32.0,0.8,chemicalentity
"AUC‑positive immune complexes induced by diclofenac sodium inhibit estrogen‑induced ERα signaling in the A549 cell line, thereby attenuating TNF‑α‑mediated NF‑κB activation in human bronchial epithelial cells.",-53.0,0.8,chemicalentity
"A cell‑line‐derived assay using A549 cells treated with diclofenac sodium revealed a dose‑dependent decrease in prostanoid production, confirming the drug’s anti‑inflammatory mechanism.",-32.75,0.8,chemicalentity
"A1‑C3, a novel diclofenac sodium analog, selectively inhibited prostanoid E2 synthesis in the A549 cell line, thereby reducing cyclooxygenase‑2 expression and attenuating the estrogen‑induced proliferation of the TP53‑mutated tumor cells.",-51.5,0.8,chemicalentity
"Ramipril treatment of hypertensive A549 cells expressing the KCNJ5 gene product reduced intracellular calcium influx induced by methacholine, demonstrating a potential protective mechanism against estrogen‑induced vasoconstriction.",-41.0,0.8,chemicalentity
"Ramified prostanoid inhibition by diclofenac sodium in the A549 cell line reduces cyclooxygenase‑2 expression, thereby attenuating the inflammatory response driven by the leukotriene B4 receptor in the human alveolar epithelial model.",-62.5,0.8,chemicalentity
"Ramazepam, a synthetic benzodiazepine analog, potentiates the neuroprotective effects of the anti-inflammatory drug diclofenac sodium in a murine A549 lung carcinoma model by upregulating the expression of the tumor suppressor gene TP53 and decreasing the phosphorylation of ERK1/2 in the presence of the pro‑inflammatory prostanoid PGE2, thereby attenuating tumor cell proliferation and promoting apoptosis.",-83.0,0.8,chemicalentity
"Ramoplanin, a novel lipopeptide antibiotic, inhibited growth of the Gram‑positive pathogen *Staphylococcus aureus* in a dose‑dependent manner while simultaneously down‑regulating the expression of the *mecA* gene product, thereby sensitizing the organism to β‑lactam therapy.",-54.5,0.8,chemicalentity
Ritonavir enhances the anti‑influenza activity of diclofenac sodium in A549 cells by down‑regulating the viral neuraminidase gene and reducing the expression of the host cytokine IL‑6.,-33.5,0.8,chemicalentity
"Ramipril treatment of A549 cells exposed to diclofenac sodium markedly decreased prostanoid‑mediated ERK1/2 phosphorylation, suggesting that the ACE inhibitor counteracts NSAID‑induced inflammatory signaling in this human lung cancer line.",-42.5,0.8,chemicalentity
"Racemic diclofenac sodium inhibited cyclooxygenase‑2 activity in A549 cells, thereby reducing prostanoid‑mediated inflammation in a dose‑dependent manner.",-23.25,0.8,chemicalentity
"Rifampin, a potent inducer of CYP3A4, competitively inhibited the metabolism of diclofenac sodium, leading to a two‑fold increase in plasma concentration and a concomitant rise in the incidence of hepatotoxicity in patients with hepatitis B infection.",-38.0,0.8,chemicalentity
"Treatment of HeLa cells with diclofenac sodium reduced COX‑2 expression while simultaneously increasing the secretion of prostanoids, suggesting an anti‑inflammatory regulatory mechanism mediated by the drug.",-31.0,0.8,chemicalentity
"Treatment with diclofenac sodium reduced cyclooxygenase‑2 expression in A549 cells, thereby attenuating prostanoid‑mediated inflammatory signaling and improving cell viability under oxidative stress.",-19.375,0.8,chemicalentity
"Treatment group A cells, cultivated from the A549 CellLine, exhibited a marked reduction in proliferation when exposed to diclofenac sodium, a ChemicalEntity, which coincided with upregulation of the TP53 GeneOrGeneProduct and a statistically significant increase in apoptosis compared with untreated controls.",-60.5,0.8,chemicalentity
"Treatment efficacy of diclofenac sodium was significantly higher than that of methyldopa in reducing inflammation in the A549 cell line, with the former also exhibiting a lower induction of cyclooxygenase‑2 expression compared to the control strain of Homo sapiens.",-57.25,0.8,chemicalentity
"Dexmedetomidine, a selective alpha‑2 adrenergic agonist, when combined with the prostanoid inhibitor indomethacin, markedly attenuated inflammatory cytokine release in HUVECs exposed to LPS, suggesting a synergistic anti‑inflammatory effect that could benefit patients with sepsis‑associated endothelial dysfunction.",-47.75,0.8,chemicalentity
"Dexketoprofen sodium, a selective COX‑2 inhibitor, suppresses prostanoid‑mediated inflammation in A549 cells by downregulating PTGS2 expression, thereby reducing the release of interleukin‑6 and mitigating inflammatory cytokine‑driven tumor proliferation.",-52.25,0.8,chemicalentity
"Dexlansoprazole, a proton pump inhibitor, synergistically reduces the cardiotoxicity of doxorubicin in H9c2 cardiac myocytes by down‑regulating the expression of CYP2C9 and up‑regulating antioxidant enzymes, thereby mitigating oxidative stress–mediated cell death.",-53.5,0.8,chemicalentity
"Dexrazoxane, a cardioprotective chemicalentity, mitigated doxorubicin‑induced cardiomyopathy in A549 cellLine cultures by upregulating HMOX1 expression and reducing oxidative DNA damage.",-35.75,0.8,chemicalentity
Stimulation of prostanoid production by diclofenac sodium in A549 cells was found to attenuate the URETHANE‑induced apoptosis that is normally mediated by estrogen‑induced caspase‑3 activation.,-42.25,0.8,chemicalentity
"Streptococcus pneumoniae infection in a patient receiving ramipril was mitigated by adding the prostanoid analog diclofenac sodium, which inhibited the over‑expressed COX‑2 gene product and reduced fever and inflammatory cytokine secretion.",-43.75,0.8,chemicalentity
Stressed A549 cells exposed to diclofenac sodium exhibited a dose‑dependent decrease in proliferation that correlated with increased caspase‑3 activation and up‑regulation of the pro‑apoptotic gene BAX.,-35.25,0.8,chemicalentity
"Staphylococcus aureus exposure to diclofenac sodium increases the expression of the proinflammatory prostanoid PGD2, thereby exacerbating estrogen‑induced endometrial hyperplasia in a murine model.",-38.25,0.8,chemicalentity
"In HeLa cells treated with the N‑(2‑propylpentanoyl)urea derivative, PRAVASTATIN‑INDUCED upregulation of substance P led to increased intracellular uric acid production, which was partially mitigated by concurrent dextrose supplementation.",-32.5,0.8,chemicalentity
"In the HeLa cell line, pravastatin-induced upregulation of uric acid synthesis was attenuated by pretreatment with the chemicalentity dizocilpine maleate, revealing a potential drug–drug interaction mediated by substance P signaling.",-35.0,0.8,chemicalentity
"In HepG2 cells, treatment with the N‑(2‑propylpentanoyl)urea analogue of dizocilpine maleate induces a rapid accumulation of uric acid, which in turn activates the NF‑κB pathway, upregulating the expression of the inflammatory cytokine IL‑6 and contributing to the cellular cytotoxicity observed after exposure to ifosfamide.",-46.5,0.8,chemicalentity
"In a murine model, intraperitoneal administration of the synthetic opioid antagonist N‑(2‑propylpentanoyl) urea markedly reduced substance P–mediated hyperalgesia, an effect that was potentiated by concurrent pravastatin‑induced inhibition of lipid rafts in dorsal root ganglia.",-44.0,0.8,chemicalentity
"The chemotherapeutic agent ifosfamide induces a dose‑dependent increase in plasma uric acid, which in turn activates substance P‑mediated vasodilation, thereby contributing to the characteristic nephrotoxicity observed in patients receiving the drug.",-26.0,0.8,chemicalentity
"The anticancer drug ifosfamide induces a dose‑dependent rise in uric acid levels, which in turn stimulates substance P release and exacerbates nausea in patients receiving concurrent pravastatin therapy.",-23.875,0.8,chemicalentity
"The N‑(2‑propylpentanoyl)urea derivative inhibited NE‑induced release of substance P from cultured dorsal root ganglion neurons, suggesting a potential therapeutic role for this chemical entity in neuropathic pain management.",-22.625,0.8,chemicalentity
"The combination of N‑(2‑propylpentanoyl)urea with pravastatin‑induced hepatotoxicity in HepG2 cells revealed a synergistic increase in reactive oxygen species production and mitochondrial membrane potential collapse, thereby implicating oxidative stress as a key mediator of drug‑driven liver injury.",-35.75,0.8,chemicalentity
Methotrexate and pravastatin-induced uric acid elevation synergistically enhance IFOSFAEMIDE-mediated hepatotoxicity in cultured HEPG2 cells.,-41.75,0.8,chemicalentity
"Methimazole, a chemical entity, selectively inhibited the growth of A549 cell lines carrying the KRAS G12D sequence variant, thereby reducing uric acid production in the cultured cells.",-40.75,0.8,chemicalentity
"Methyldopa, a synthetic amino acid analog, was found to reduce uric acid production in HepG2 cells through inhibition of the PNP pathway, thereby alleviating hyperuricemia in a rat model of gout.",-50.0,0.8,chemicalentity
"Methionine‑restricted diet combined with the N‑(2‑propylpentanoyl)urea derivative markedly reduced tumor growth in A549 xenografts, a effect that was associated with decreased urinary uric acid levels and increased expression of the tumor suppressor gene TP53.",-53.25,0.8,chemicalentity
"When HeLa cells are treated with the N‑(2‑propylpentanoyl) urea derivative, a marked increase in intracellular uric acid is observed, correlating with a down‑regulation of the GLUT1 transporter and a reduction in cell proliferation.",-35.5,0.8,chemicalentity
"When treating neutropenic patients with ifosfamide, the addition of pravastatin‐induced N‑(2‑propylpentanoyl)urea significantly reduces the risk of hyperuricemia while maintaining effective tumor cell apoptosis.",-40.25,0.8,chemicalentity
"When an A549 cell line is treated with the chemical entity N‑(2‑propylpentanoyl)urea, the up‑regulation of the inflammatory mediator substance P is markedly attenuated, thereby reducing neutrophil elastase‑driven tissue damage in this human lung carcinoma model.",-45.75,0.8,chemicalentity
"When the HeLa CellLine was treated with the chemical entity N‑(2‑propylpentanoyl) urea, the induced up‑regulation of the gene product TP53 led to apoptosis, while the concomitant increase in uric acid levels suggested a potential nephrotoxic effect similar to that seen with ifosfamide.",-45.0,0.8,chemicalentity
"dextrose and maltol synergistically enhance the uptake of pravastatin in HepG2 cells, thereby amplifying its cholesterol‑lowering effect.",-15.4375,0.8,chemicalentity
"doxorubicin (DOX) induces a rapid rise in intracellular uric acid and stimulates substance P release, thereby amplifying the chemotherapeutic toxicity observed in HeLa cells treated with the N‑(2‑propylpentanoyl)urea analogue.",-38.0,0.8,chemicalentity
"d‑Glucose, a simple carbohydrate, was shown to enhance the uptake of the chemotherapeutic agent ifosfamide in A549 cells, thereby potentiating the drug’s cytotoxic effect and reducing the accumulation of uric acid byproducts in the treated culture medium.",-42.75,0.8,chemicalentity
"dexamethasone, a synthetic corticosteroid, has been shown to reduce IFN‑γ‑induced expression of the inflammatory cytokine IL‑1β in cultured A549 lung cancer cells, thereby attenuating tumor‑mediated cachexia.",-47.25,0.8,chemicalentity
"Ifosfamide treatment in the A549 cell line induced a dose‑dependent increase in uric acid production, which was attenuated by concurrent pravastatin administration, suggesting a protective interaction between the chemotherapeutic agent and the statin.",-25.625,0.8,chemicalentity
"If dextrose is combined with pravastatin-induced uric acid elevation, the resulting metabolic shift activates substance P release and potentiates N‑(2‑propylpentanoyl)urea‑mediated neurogenic inflammation in human hepatocytes.",-42.0,0.8,chemicalentity
"If you administer **pravastatin** to **HeLa** cells, the drug’s inhibition of the mevalonate pathway reduces intracellular **uric acid** synthesis, which can be measured by a colorimetric assay that uses **dextrose** as a co‑substrate to reveal the consequent rise in reactive oxygen species.",-61.5,0.8,chemicalentity
"Ifusfamide, a nitrogen‑containing chemotherapeutic, induces the formation of uric acid crystals in patients with high serum dextrose levels, thereby exacerbating the risk of nephrolithiasis.",-47.25,0.8,chemicalentity
"Administration of pravastatin-induced N‑(2‑propylpentanoyl)urea in HeLa cells markedly increased intracellular uric acid, suggesting a novel metabolic pathway linking statin therapy to purine catabolism.",-25.25,0.8,chemicalentity
"Administration with the N‑(2‑propylpentanoyl)urea analogue of dizocilpine maleate markedly reduced the dextrose‑induced elevation of uric acid in a dose‑dependent manner, suggesting a potential therapeutic effect in preventing pravastatin‑induced nephrotoxicity.",-52.0,0.8,chemicalentity
"Administration and subsequent metabolism of the N‑(2‑propylpentanoyl)urea derivative in HeLa cells produced a concentration‑dependent increase in uric acid excretion, thereby exacerbating nephrotoxicity when co‑treated with ifosfamide.",-54.25,0.8,chemicalentity
"Administration combined with the metabolic inhibitor pravastatin-induced suppression of HMG‑CoA reductase in A549 cells reduces intracellular uric acid levels and enhances the cytotoxicity of ifosfamide, thereby increasing apoptosis mediated by substance P signaling.",-62.75,0.8,chemicalentity
"High glucose exposure in the H9c2 rat cardiomyocyte line increases uric acid production, and treatment with the antioxidant maltol partially restores the expression of the antioxidant gene Nrf2, suggesting a protective role against oxidative stress in this cellular model.",-58.25,0.8,chemicalentity
"High‑dose dextrose infusion in the HeLa cell line exacerbated intracellular uric acid accumulation, leading to activation of the N‑(2‑propylpentanoyl)urea‑induced apoptosis pathway.",-28.75,0.8,chemicalentity
"High‐dose dextrose infusion in the ICU was found to exacerbate pravastatin‑induced hyperuricemia in patients with obstructive nephropathy, prompting clinicians to monitor serum uric acid levels closely.",-34.0,0.8,chemicalentity
"High-dose dextrose infusion in obese patients with nephrotic syndrome markedly elevates serum uric acid, precipitating hyperuricemia that may exacerbate pravastatin‑induced myopathy.",-41.75,0.8,chemicalentity
"Iodinated contrast agent enhances visualization of the renal cortex, while a high‑dose dextrose infusion mitigates contrast‑induced nephropathy in patients with chronic kidney disease.",-41.25,0.8,chemicalentity
"Irradiation of HeLa cells with doxorubicin (10 μM) induced a dose-dependent accumulation of uric acid and activated the NF‑κB pathway, suggesting a link between DNA damage, purine metabolism, and inflammatory signaling.",-41.75,0.8,chemicalentity
"Irisin treatment of A549 cells markedly down‑regulated NE‑stimulated secretion of uric acid, an effect that was enhanced by co‑administration of the chemical entity dizocilpine maleate, which also attenuated dextrose‑induced oxidative stress.",-52.75,0.8,chemicalentity
"Isoniazid, an antitubercular chemical entity, downregulates the expression of the transcription factor NF‑κB in RAW264.7 macrophage cells, thereby attenuating the release of the pro‑inflammatory mediator substance P and reducing the severity of lipopolysaccharide‑induced fever in C57BL/6 mice.",-45.0,0.8,chemicalentity
"Ophthalmic drops containing dextrose and maltol ameliorated pravastatin‑induced hyperuricemia in patients with cataracts, indicating that the combined chemical entity modulates the metabolic pathway of uric acid.",-53.5,0.8,chemicalentity
"O-benzyl-4-hydroxybutylpiperidine, a synthetic analogue of the opioid peptide substance P, was found to inhibit the proliferation of A549 cells by down‑regulating the expression of the oncogenic gene MYC and enhancing the cytotoxic effect of the chemotherapeutic agent ifosfamide, thereby reducing tumor burden in a xenograft mouse model.",-72.5,0.8,chemicalentity
"Oritavancin, a semisynthetic lipoglycopeptide antibiotic, demonstrates potent antibacterial activity against vancomycin‑resistant *Enterococcus faecalis* by binding to the D‑alanine–D‑alanine terminus of the peptidoglycan layer, thereby inhibiting cell wall synthesis and inducing rapid bacterial cell death.",-49.75,0.8,chemicalentity
Osmotic diuretic OB combined with the N‑(2‑propylpentanoyl)urea derivative of ifosfamide was found to mitigate the pravastatin‑induced elevation of uric acid in patients with E. coli–infected liver disease.,-58.5,0.8,chemicalentity
"A549 cells treated with the N‑(2‑propylpentanoyl)urea analogue of dizocilpine maleate exhibited a significant increase in uric acid production, suggesting a potential metabolic interaction that may contribute to pravastatin‑induced nephrotoxicity.",-25.875,0.8,chemicalentity
"A high dose of N‑(2‑propylpentanoyl) urea was shown to suppress substance P‑mediated neurogenic inflammation in HeLa cells, thereby reducing uric acid production and potentiating the anti‑tumor effect of ifosfamide in an in‑vitro model of E. coli‑derived bacterial infection.",-47.75,0.8,chemicalentity
"A monoclonal antibody against substance P suppressed dextrose‑induced NE release in cultured primary hippocampal neurons from Homo sapiens, illustrating a potential therapeutic role for a novel chemical entity in neuroinflammatory disease.",-58.0,0.8,chemicalentity
"A cell line derived from HeLa cells exhibited increased proliferation when treated with the chemical entity pravastatin, which also induced a significant upregulation of the gene TP53 and elevated uric acid levels in the culture medium.",-40.75,0.8,chemicalentity
"Decreased uric acid clearance in Ifosfamide‑treated A549 cells was accompanied by up‑regulation of NE, suggesting a metabolic link that may underlie the observed nephrotoxicity.",-39.25,0.8,chemicalentity
"Deoxyribozyme-mediated cleavage of the mRNA encoding the ERK1 kinase in HeLa cells was inhibited by the small molecule maltol, leading to reduced cell proliferation and increased apoptosis.",-39.5,0.8,chemicalentity
"Deemed a promising candidate for neuroprotective therapy, the N‑(2‑propylpentanoyl)urea derivative was shown to attenuate IFOSFAMIDE‑induced cerebellar degeneration in A549 cells through down‑regulation of substance‑P‑mediated calcium influx, while co‑administration of pravastatin‑induced cholesterol synthesis inhibitors reduced the associated uric‑acid‑related oxidative stress.",-70.5,0.8,chemicalentity
Depletion of uric acid by pravastatin-induced inhibition of xanthine oxidase in HepG2 cells led to a significant reduction in reactive oxygen species and attenuation of NE-mediated inflammatory signaling.,-29.375,0.8,chemicalentity
"Desaminated dextrose, when combined with N‑(2‑propylpentanoyl)urea, potentiated pravastatin‑induced elevation of uric acid and increased substance P release in the renal tubules of H. sapiens subjects.",-54.0,0.8,chemicalentity
"Desflurane, a volatile anesthetic, was shown to inhibit substance P release from dorsal root ganglia neurons, thereby reducing nociceptive signaling and improving postoperative pain control in patients receiving N‑(2‑propylpentanoyl)urea as an adjunct therapy.",-44.75,0.8,chemicalentity
"Desmethyldeoxynorapomorphine, a synthetic analogue of dextrose‑conjugated maltol, competes with substance P for the NK1 receptor and mitigates pravastatin‑induced hyperuricemia in hepatocytes derived from the HepG2 cell line.",-60.5,0.8,chemicalentity
"Desulfovibrio vulgaris exposed to the chemical entity dextrose exhibited increased production of uric acid, suggesting a metabolic shift that could exacerbate inflammatory signaling mediated by substance P.",-32.25,0.8,chemicalentity
Pretreatment of A549 cells with the chemical entity N-(2-propylpentanoyl)urea markedly decreased the expression of the oncogene MYC and sensitized the cells to the apoptosis-inducing effect of ifosfamide.,-34.25,0.8,chemicalentity
"Pretensive treatment of malignant ascites in A549 cells using the carbamylated N‑(2‑propylpentanoyl)urea analogue of dizocilpine maleate reduced ERK1/2 phosphorylation, thereby attenuating proliferation and inducing apoptosis.",-63.75,0.8,chemicalentity
"Pretending that the research aimed to examine the impact of a synthetic N‑(2‑propylpentanoyl)urea analogue on the inflammatory cascade, the investigators treated A549 cells with the compound and observed a significant reduction in substance P‑mediated neuropeptide release, suggesting a potential therapeutic avenue for mitigating opioid‑induced hyperalgesia in a murine model of neuropathic pain.",-79.0,0.8,chemicalentity
"Pretend that in a CRISPR‑edited K562 cell line, the knockout of N‑(2‑propylpentanoyl)urea‑induced activation of the NF‑κB pathway leads to a marked increase in uric acid production and a concomitant reduction in the expression of the transporter GLUT1, thereby revealing a potential therapeutic target for hyperuricemia.",-72.5,0.8,chemicalentity
"Vancomycin treatment in the STZ‑induced diabetic NOD mice exacerbated renal tubular damage, as evidenced by increased sodium‑2‑sulfanylethanesulfonate uptake and higher serum methylmalonic acid levels.",-34.0,0.8,chemicalentity
"Vantracillin, a novel anthraquinone derivative, reduces isoprenaline‑induced myocardial fibrosis in STZ‑induced diabetic rat hearts by down‑regulating TGF‑β1 expression and inhibiting the SMAD3 signaling cascade.",-46.0,0.8,chemicalentity
"Van‑comycin treatment of STZ‑induced diabetic A549 cells reduced methylmalonic acid accumulation by down‑regulating the transport protein SLC19A1, thereby mitigating isoprenaline‑induced oxidative stress.",-40.75,0.8,chemicalentity
"Vantrimycin, an anthraquinone derivative, reduces isoprenaline‑induced cardiac hypertrophy in STZ‑induced diabetic Sprague‑Dawley rats by suppressing NF‑κB‑mediated inflammation and oxidative stress.",-39.25,0.8,chemicalentity
"The anthraquinone derivative, isoprenaline-induced in STZ‑treated diabetic HeLa cells, reduces intracellular methylmalonic acid accumulation and restores insulin secretion mediated by the TP53 pathway in Homo sapiens.",-37.25,0.8,chemicalentity
"The isoprenaline‑induced Ca²⁺ influx in A549 cells was markedly attenuated by sodium‑2‑sulfanylethanesulfonate, which inhibited the expression of the cAMP‑dependent protein kinase that otherwise upregulated the anthraquinone transporter responsible for vancomycin efflux.",-46.75,0.8,chemicalentity
"The vancomycin‑induced upregulation of mTOR signaling in HeLa cells treated with the anthraquinone derivative reduced the expression of the pro‑apoptotic protein BAX, thereby promoting cell survival.",-32.25,0.8,chemicalentity
"The methyldopa‐induced hypertension observed in NaCl‑treated A549 cells was markedly attenuated by co‑administration of the anthraquinone derivative, revealing a protective interaction between the chemical entity and the cell‑line model of vascular stress.",-43.5,0.8,chemicalentity
"In HeLa cells, the anthraquinone derivative mitoxantrone suppresses STZ‑induced oxidative stress by down‑regulating the expression of the gene TP53 and reducing the levels of methylmalonic acid in the culture medium.",-33.25,0.8,chemicalentity
"In NaCl‑treated A549 cells, isoprenaline‑induced upregulation of the anthraquinone‑derived metabolite (3)H‑methylmalonic acid was shown to inhibit the phosphorylation of the insulin receptor substrate‑1 gene product and consequently impair insulin signaling, suggesting a potential mechanism for STZ‑induced β‑cell dysfunction.",-52.75,0.8,chemicalentity
"In a STZ‑induced diabetic mouse model, sodium‑2‑sulfanylethanesulfonate treatment markedly reduced serum methylmalonic acid levels, indicating improved metabolic regulation in the disease‑related phenotype.",-38.0,0.8,chemicalentity
"In the STZ‑induced diabetic NOD/SCID mouse model, treatment with the anthraquinone derivative sodium‑2‑sulfanylethanesulfonate significantly reduced methylmalonic acid levels, improving glycemic control and ameliorating isoprenaline‑induced cardiac arrhythmias.",-33.75,0.8,chemicalentity
"STZ‑induced diabetes in db/db mice was ameliorated by sodium d‑sulfanylethanesulfonate, which restored pancreatic β‑cell function through activation of the GLP‑1 receptor and reduced serum methylmalonic acid levels, thereby improving glycemic control.",-45.0,0.8,chemicalentity
"ST‑Z‑induced pancreatic β‑cell apoptosis is mitigated by the anthraquinone derivative, which upregulates the insulin gene promoter in NaCl‑treated H2O2‑stimulated human HepG2 cells, thereby reducing methylmalonic acid accumulation in the culture medium.",-60.75,0.8,chemicalentity
"ST64A cells treated with isoprenaline‑induced cAMP elevation showed a dose‑dependent increase in anthraquinone‑derived ROS, which in turn up‑regulated the transcription of the antioxidant gene GCLC, thereby reducing sodium‑2‑sulfanylethanesulfonate‑induced apoptosis.",-64.5,0.8,chemicalentity
"STK33 inhibition by the anthraquinone analogue H3K4me3‑inhibitor reduced proliferation in STK33‑dependent A549 cells, suggesting a potential therapeutic avenue for lung cancer.",-60.5,0.8,chemicalentity
"Isoprenaline‑induced hypertension in A549 cells was significantly attenuated by the anthraquinone derivative sodium‑2‑sulfanylethanesulfonate, which competitively inhibited the upregulation of CYP2E1‑mediated oxidative stress and consequently reduced methylmalonic acid accumulation.",-42.25,0.8,chemicalentity
"Isoproterenol‐induced apoptosis in H9c2 cardiomyocytes is attenuated by co‑treatment with the anthraquinone derivative EM-45, a chemical entity that enhances mitochondrial membrane potential and reduces reactive oxygen species production.",-46.25,0.8,chemicalentity
"Isolated sodium‑2‑sulfanylethanesulfonate markedly inhibited the proliferation of STZ‑induced insulinoma cells, while concomitant isoprenaline‑induced β‑adrenergic stimulation amplified the apoptotic response through up‑regulation of caspase‑3 and down‑regulation of anti‑apoptotic BCL‑2.",-56.0,0.8,chemicalentity
"Isoperonine, a synthetic anthraquinone analog, markedly potentiated the anti‑tumor activity of vancomycin in STZ‑induced diabetic HeLa cells by down‑regulating the mTOR pathway and increasing reactive oxygen species levels.",-48.75,0.8,chemicalentity
"Methylmalonic acid accumulation in the STZ‑induced diabetic HepG2 cell line is mitigated by the anthraquinone derivative, which reduces ROS‑mediated apoptosis through activation of the PI3K/Akt pathway.",-34.75,0.8,chemicalentity
"Mitochondrial biogenesis is markedly impaired in STZ‑induced insulin‑resistant A549 cells, yet treatment with the anthraquinone derivative sodium‑2‑sulfanylethanesulfonate restores ATP production and reduces oxidative stress, suggesting a protective role for this chemical entity in diabetes‑associated cellular dysfunction.",-51.75,0.8,chemicalentity
"Molecular docking of the anthraquinone derivative (3)H revealed that it competitively inhibits the kinase activity of the STZ‑induced insulin receptor in NaCl‑treated Huh‑7 cells, thereby reducing intracellular methylmalonic acid accumulation.",-34.5,0.8,chemicalentity
"Mice receiving a sodium‑2‑sulfanylethanesulfonate infusion displayed a dose‑dependent increase in plasma methylmalonic acid, suggesting that this chemical entity disrupts vitamin B12 metabolism in a STZ‑induced diabetic model.",-43.5,0.8,chemicalentity
"Dexamethasone, a synthetic glucocorticoid, suppresses NF‑κB activation in STZ‑induced diabetic mouse pancreatic islets, thereby reducing the transcription of pro‑inflammatory cytokines such as IL‑6 and TNF‑α, and this effect is amplified when the cells are concurrently treated with the anthraquinone derivative emodin, which competitively inhibits the PI3K/AKT pathway and enhances insulin‑like growth factor‑1 receptor signaling.",-64.0,0.8,chemicalentity
"Doxorubicin, an anthracycline, induces a dose‑dependent increase in reactive oxygen species that activates the Nrf2‑ARE pathway and upregulates the antioxidant gene NQO1 in HeLa cells, thereby mitigating vancomycin‑induced nephrotoxicity.",-32.75,0.8,chemicalentity
"Doxycycline and vancomycin, when co‑administered in a NaCl‑treated murine model, synergistically reduced STZ‑induced β‑cell apoptosis, thereby improving glucose tolerance and attenuating methylmalonic acid accumulation.",-37.25,0.8,chemicalentity
"Doxo‑induced apoptosis in A549 cells was markedly attenuated by the anthraquinone derivative (3)H, demonstrating that the compound blocks the up‑regulation of BAX and the release of cytochrome c triggered by isoprenaline‑induced oxidative stress.",-50.5,0.8,chemicalentity
"Methotrexate, an anthraquinone analog, synergistically enhances the anti‑proliferative effect of sodium‑2‑sulfanylethanesulfonate in STZ‑induced pancreatic β‑cell lines, thereby reducing intracellular methylmalonic acid accumulation and improving insulin secretion.",-41.25,0.8,chemicalentity
"Methicillin‑resistant Staphylococcus aureus infection in NaCl‑treated mice was significantly attenuated by isoprenaline‑induced activation of the β‑adrenergic pathway, which up‑regulated the expression of the antimicrobial peptide cathelicidin and reduced bacterial load by ~70%.",-48.5,0.8,chemicalentity
"Methadone, an opioid chemicalentity, was found to ameliorate insulin resistance in STZ-induced DiabetesOrPhenotypicFeature in C57BL/6J MouseOrganismTaxon, while simultaneously down‑regulating the expression of GLUT4 geneproduct and enhancing the phosphorylation of IRS‑1 protein.",-61.0,0.8,chemicalentity
"Methylnicotinate, a synthetic anthraquinone derivative, reduced isoprenaline‑induced cardiac hypertrophy in STZ‑induced diabetic NaCl‑treated C57BL/6J mice by attenuating oxidative stress and restoring mitochondrial membrane potential.",-36.25,0.8,chemicalentity
"An anthraquinone derivative, a known inhibitor of topoisomerase II, attenuated isoprenaline‑induced myocardial hypertrophy in NaCl‑treated C57BL/6J mice while simultaneously reducing serum methylmalonic acid levels, thereby suggesting a cardioprotective effect of the compound.",-41.5,0.8,chemicalentity
"An isoprenaline‑induced increase in heart rate was markedly attenuated in H9c2 cells pre‑treated with the anthraquinone derivative, demonstrating a protective effect against the sodium‑2‑sulfanylethanesulfonate‑induced rise in intracellular calcium.",-38.75,0.8,chemicalentity
"An STZ‑induced β‑cell loss in mice treated with the anthraquinone derivative vancomycin was mitigated by co‑administration of isoprenaline, suggesting a protective role of the β‑adrenergic pathway against drug‑induced hyperglycemia.",-41.25,0.8,chemicalentity
"An **isoprenaline‑induced** surge of cAMP in **HepG2** cells was mitigated by **sodium‑2‑sulfanylethanesulfonate**, which competitively inhibited the β‑adrenergic receptor, reducing downstream **PKA** activation and the expression of the **GLUT4** transporter.",-50.75,0.8,chemicalentity
"Antimycin A, an anthraquinone derivative, competitively inhibits the mitochondrial electron transport chain in HeLa cells, thereby inducing a dramatic increase in reactive oxygen species that subsequently activates the NRF2-mediated antioxidant response and upregulates the expression of the antioxidant enzyme HO-1.",-41.75,0.8,chemicalentity
"Antibiotic vancomycin administration in NaCl‑treated E. coli cultures induces a rapid increase in methylmalonic acid accumulation, suggesting a direct interaction between the drug and bacterial metabolic pathways.",-36.5,0.8,chemicalentity
"Anticancer activity of the anthraquinone derivative exhibited a dose‑dependent reduction of STZ‑induced β‑cell apoptosis in the NaCl‑treated A549 cell line, with concomitant up‑regulation of the protective gene GPX4.",-40.25,0.8,chemicalentity
"Anticipated nephrotoxicity in mice treated with vancomycin was markedly attenuated by co‑administration of sodium‑2‑sulfanylethanesulfonate, which appeared to normalize serum methylmalonic acid levels and preserve tubular integrity.",-47.25,0.8,chemicalentity
"Anthraquinone derivatives such as gossypol exhibit potent cytotoxicity in STZ‑induced pancreatic β‑cell lines, where they inhibit glucose‑stimulated insulin secretion by down‑regulating the KATP channel and triggering reactive oxygen species production.",-44.25,0.8,chemicalentity
"Anthracycline‑derived anthraquinone Vancomycin synergistically suppresses STZ‑induced β‑cell apoptosis in NaCl‑treated HepG2 cells, thereby reducing methylmalonic acid levels and rescuing insulin secretion.",-41.0,0.8,chemicalentity
"Anthracene‑derived anthraquinone, when administered to STZ‑induced diabetic NaCl‑treated mice, activates hepatic CYP3A4 and reduces methylmalonic acid levels, improving glucose tolerance.",-36.25,0.8,chemicalentity
"Antharquinone, a synthetic derivative of anthraquinone, potently inhibited proliferation of HeLa cells by inducing apoptosis through upregulation of TP53 and subsequent activation of the caspase‑3 pathway.",-41.0,0.8,chemicalentity
High‑dose Vancomycin administration in NaCl‑treated mice exacerbated STZ‑induced hyperglycaemia by inhibiting hepatic glucokinase activity and increasing circulating methylmalonic acid levels.,-32.25,0.8,chemicalentity
"High-dose vancomycin, combined with sodium‑2‑sulfanylethanesulfonate, was shown to reduce isoprenaline‑induced cardiac arrhythmias in a STZ‑induced diabetic rat model, highlighting the cardioprotective potential of this anthraquinone‑derived complex.",-47.25,0.8,chemicalentity
"High concentrations of the anthraquinone derivative, vancomycin‑derived (3)H‑labeled sodium‑2‑sulfanylethanesulfonate, markedly enhanced the isoprenaline‑induced rise in intracellular methylmalonic acid in STZ‑induced diabetic HEK‑293 cells, suggesting a pharmacodynamic interaction between the drug and the metabolic pathway.",-66.0,0.8,chemicalentity
"High‐dose vancomycin treatment in STZ‑induced diabetic A549 cells markedly up‑regulated the mRNA of the stress‑responsive gene HIF‑1α, thereby enhancing cellular survival through activation of the VEGF signaling pathway.",-45.25,0.8,chemicalentity
"A549 cells exposed to vancomycin‑induced oxidative stress exhibited up‑regulation of the antioxidant gene Nrf2, suggesting that the antibiotic may exacerbate reactive‑oxygen‑species‑mediated cytotoxicity in this lung carcinoma line.",-36.75,0.8,chemicalentity
"A hepatocyte cell line exposed to isoprenaline-induced oxidative stress upregulates CYP1A1 expression, while the anthraquinone derivative (3)-H, which is a potent CYP1A1 inhibitor, reduces the generation of reactive oxygen species and decreases the accumulation of methylmalonic acid in the NaCl-treated culture medium.",-66.5,0.8,chemicalentity
"A cell‑cycle arrest in STZ‑induced β‑cell lines treated with vancomycin was mitigated by co‑administration of the anthraquinone derivative (3)H‑methylmalonic acid, revealing a dose‑dependent rescue of insulin secretion that correlated with down‑regulation of p53 transcriptional activity.",-56.5,0.8,chemicalentity
"A dose‑dependent decrease in insulin secretion was observed in STZ‑induced diabetic NOD mice following treatment with the anthraquinone derivative (3)‑H, an effect that was reversed by co‑administration of sodium‑2‑sulfanylethanesulfonate, a known inhibitor of sodium‑glucose cotransporter‑2.",-49.75,0.8,chemicalentity
"Sodium2‑sulfanylethanesulfonate treatment markedly reduced the isoprenaline‑induced increase in serum methylmalonic acid in STZ‑induced diabetic rats, while vancomycin did not alter the anthraquinone‑mediated inhibition of glucose‑regulated lipogenesis.",-56.5,0.8,chemicalentity
"SARS‑CoV‑2 infection upregulates the sodium‑dependent transporter SLC6A20, thereby increasing intracellular isoprenaline‑induced calcium influx that exacerbates the hyperglycemic STZ‑induced β‑cell apoptosis observed in the NOD.CB17/SCID mouse model.",-60.25,0.8,chemicalentity
"Sox2 knockdown in A549 cells treated with anthraquinone derivative led to increased methylmalonic acid production, indicating a metabolic shift that promotes epithelial‑to‑mesenchymal transition.",-41.25,0.8,chemicalentity
"SOD2 overexpression in STZ‑induced diabetic NOD mice treated with sodium‑2‑sulfanylethanesulfonate markedly reduced circulating methylmalonic acid levels, indicating an interaction between the chemical entity and the metabolic phenotype.",-44.75,0.8,chemicalentity
"Bleomycin exposure in KCl‑depolarised HeLa cells increases DNA strand breaks, while the antioxidant Dexrazoxane mitigates this effect by chelating iron generated during the oxidative stress cascade.",-32.25,0.8,chemicalentity
"Ble­y‑m‑cin‑induced oxidative DNA damage in KCl‑depolarised HeLa cells is mitigated by Dex­razoxane, which blocks the formation of platinum‑based reactive intermediates that would otherwise bind to selenocysteine residues in mitochondrial DNA polymerase.",-64.0,0.8,chemicalentity
"Bleomicin, a DNA‐crosslinking cis‑diammine‑dichloroplatinum compound, markedly inhibited KCl‑depolarised MCF‑7 cells, an effect that was partially rescued by Dexrazoxane, suggesting a protective interaction against cis‑diammine‑dichloroplatinum‑induced apoptosis.",-61.0,0.8,chemicalentity
"Bleomycine, a DNA‐cleaving cytotoxic chemical entity, was found to synergistically enhance the antitumor activity of cis‑diamminedichloroplatinum when applied to KCl‑depolarised A549 cell lines, leading to increased apoptosis mediated by prostaglandin‑induced oxidative stress and down‑regulation of selenocysteine synthesis.",-56.75,0.8,chemicalentity
"Cis-diamminedichloroplatinum treatment of HeLa cells induces KCl‑depolarised membrane potential changes that are mitigated by Dexrazoxane, thereby reducing bleomycin‑like oxidative DNA damage.",-21.75,0.8,chemicalentity
"Cytotoxic bleomycin treatment of KCl‑depolarised A549 cells induced a dramatic reduction in prostaglandin E2 secretion, revealing a potential modulatory role for the drug in inflammatory signalling pathways.",-39.5,0.8,chemicalentity
"C11 (cis‑di‑amminedichloroplatinum) induced a KCl‑depolarised response in HeLa cells, leading to increased prostaglandin E2 production and subsequent upregulation of the COX‑2 gene.",-50.75,0.8,chemicalentity
"Ciprofloxacin, a fluoroquinolone antibiotic, enhances the cytotoxic effect of cis-diamminedichloroplatinum by inhibiting the DNA repair enzyme O6-methylguanine-DNA methyltransferase, thereby potentiating apoptosis in platinum‑resistant ovarian carcinoma cells.",-45.0,0.8,chemicalentity
"In KCl‑depolarised hippocampal slices, bleomycin‐treated neurons exhibited a significant upregulation of prostaglandin E2, suggesting a potential modulatory role of this chemical entity in excitotoxic signaling.",-36.25,0.8,chemicalentity
"In the KCl‑depolarised A549 cells, bleomycin treatment synergistically enhanced DNA strand breaks while Dexrazoxane mitigated the resulting apoptosis, indicating a protective interaction between the alkylating agent and the iron‑chelating antioxidant.",-35.5,0.8,chemicalentity
"In A549 cells, bleomycin treatment induces KCl‑depolarised calcium influx that is mitigated by Dexrazoxane, revealing a protective role of the chemotherapeutic agent against cis‑diamminedichloroplatinum‑induced DNA cross‑linking and subsequent prostaglandin‑mediated inflammation.",-33.5,0.8,chemicalentity
"In MCF‑7 cells, bleomycin treatment triggered KCl‑depolarised calcium influx, which was attenuated by Dexrazoxane, indicating that the drug’s cytotoxicity involves oxidative DNA damage and calcium‑dependent apoptotic signaling.",-36.25,0.8,chemicalentity
"Doxorubicin, a potent anthracycline chemotherapeutic, when combined with Dexrazoxane, mitigates cardiotoxicity by chelating iron and inhibiting free radical formation, thereby preserving mitochondrial integrity and reducing apoptosis in KCl‑depolarised cardiomyocytes.",-35.75,0.8,chemicalentity
"Dexamethasone exposure in KCl‑depolarised HeLa cells upregulates the prostaglandin‑E₂ synthase gene, a response that is attenuated by co‑treatment with the platinum drug cis‑diamminedichloroplatinum and the antioxidant Dexrazoxane.",-37.0,0.8,chemicalentity
"Dacarbazine, a small‑molecule alkylating agent, reduces the viability of KCl‑depolarised A549 cells by inducing apoptosis through caspase‑3 activation.",-29.5,0.8,chemicalentity
"Dioxin exposure upregulates prostaglandin E2 in KCl‑depolarised HeLa cells, and the addition of the platinum drug cis‑diamminedichloroplatinum significantly reduces the resulting inflammatory cytokine release.",-45.5,0.8,chemicalentity
"The chemotherapeutic agent cis‑diamminedichloroplatinum cross‑links DNA in KCl‑depolarised A549 cells, thereby enhancing bleomycin‑induced apoptosis and potentiating Dexrazoxane‑mediated cardioprotection.",-19.125,0.8,chemicalentity
The KCl‑depolarised A549 cells treated with cis‑diamminedichloroplatinum and the antioxidant Dexrazoxane exhibited a marked reduction in prostaglandin‑mediated inflammation compared with cells receiving bleomycin alone.,-22.125,0.8,chemicalentity
"The cis‑diammine‑dichloroplatinum complex, when administered to KCl‑depolarised HeLa cells, induces a rapid release of prostaglandins, thereby enhancing the cytotoxic effect of bleomycin while concurrently up‑regulating the expression of the DNA repair gene BRCA1.",-34.25,0.8,chemicalentity
"The administration of cis‑diamminedichloroplatinum to KCl‑depolarised HeLa cells markedly increased intracellular prostaglandin E2, suggesting a steroid‑independent modulation of the inflammatory response that may be attenuated by Dexrazoxane.",-31.0,0.8,chemicalentity
"Dexrazoxane attenuates bleomycin‑induced oxidative DNA damage in KCl‑depolarised A549 cells, thereby reducing the accumulation of cis‑diamminedichloroplatinum‑induced platinum adducts and protecting against cis‑platin‑mediated nephrotoxicity.",-26.625,0.8,chemicalentity
"Dexazoxane, a cardioprotective chelator, mitigates bleomycin‑induced oxidative stress in KCl‑depolarised cardiomyocytes, thereby preserving mitochondrial membrane potential and preventing apoptosis.",-32.0,0.8,chemicalentity
"Dexrozoxane, a cardioprotective chemicalentity, mitigated bleomycin‑induced oxidative damage in KCl‑depolarised HeLa cells while concurrently suppressing prostaglandin E2 secretion, an effect that required functional selenocysteine-dependent glutathione peroxidase activity.",-55.5,0.8,chemicalentity
"Dexadrine, a synthetic analogue of bleomycin, was shown to inhibit KCl‑depolarised proliferation of A549 cells while simultaneously reducing cis‑diamminedichloroplatinum‑induced DNA cross‑links, suggesting a potential chemopreventive synergy that may be mediated through prostaglandin‑dependent modulation of the tumour microenvironment.",-65.5,0.8,chemicalentity
"A KCl‑depolarised A549 cell line treated with the platinum complex cis‑diaminodichloroplatinum (cisplatin) and the antioxidant Dexrazoxane exhibited markedly reduced DNA damage and increased cell survival, suggesting a protective interaction against cisplatin‑induced cytotoxicity.",-33.75,0.8,chemicalentity
"A549 cells treated with cis‑diaminodichloroplatinum followed by Dexrazoxane exhibited a marked reduction in bleomycin‑induced DNA strand breaks, indicating a protective interaction between the platinum drug and the cardioprotective agent.",-25.25,0.8,chemicalentity
"A bleomycin‑treated HeLa cell line exhibited KCl‑depolarised membrane potential changes that were attenuated by the antioxidant selenocysteine, suggesting a protective chemicalentity effect on ion channel activity.",-29.75,0.8,chemicalentity
"A dose of cis‑diamminedichloroplatinum combined with the antioxidant Dexrazoxane reduced KCl‑depolarised bleomycin‑induced oxidative stress in cultured HepG2 cells, highlighting a potential protective mechanism against chemotherapy‑associated cytotoxicity.",-45.75,0.8,chemicalentity
"Administration of the platinum‑based chemotherapeutic cis‑diamminedichloroplatinum to KCl‑depolarised HeLa cells inhibited proliferation and induced apoptosis through increased prostaglandin E2 production, a response that was partially attenuated by co‑treatment with the antioxidant Dexrazoxane.",-39.25,0.8,chemicalentity
"Administration to KCl‑depolarised HeLa cells of the platinum‑based compound cis‑diaminodichloroplatinum in combination with Dexrazoxane markedly reduced DNA double‑strand breaks while up‑regulating the expression of the DNA‑repair gene XRCC1, suggesting a synergistic cytoprotective effect against bleomycin‑induced genotoxicity.",-53.25,0.8,chemicalentity
Administration with the cis‑diaminodichloroplatinum complex and the KCl‑depolarised A549 cell line revealed that Dexrazoxane could attenuate the bleomycin‑induced DNA strand breakage while preserving prostaglandin‑mediated signaling in vitro.,-61.75,0.8,chemicalentity
"Administration titrated bleomycin to a sub‑nephrotoxic dose in KCl‑depolarised A549 cells upregulated prostaglandin E₂ production, revealing a cytoprotective signaling pathway that Dexrazoxane partially inhibited.",-63.75,0.8,chemicalentity
"Methotrexate treatment of KCl-depolarised A549 cells was found to enhance cis‑diaminodichloroplatinum‑induced apoptosis through up‑regulation of prostaglandin E2 synthesis, thereby reducing tumour cell proliferation.",-39.75,0.8,chemicalentity
"Methanesulfonic acid, a common solvent in radiopharmaceutical synthesis, unexpectedly inhibited cell proliferation in the KCl‑depolarised A549 cell line, a result attributed to altered prostaglandin E2 secretion and a transient down‑regulation of the TP53 gene product.",-69.0,0.8,chemicalentity
"Methos followed by bleomycin and cis‑diamminedichloroplatinum treatment triggered KCl‑depolarised Ca²⁺ influx, leading to prostaglandin‑mediated apoptosis in HeLa cells.",-39.5,0.8,chemicalentity
"Methadone treatment of patients with chronic obstructive pulmonary disease (COPD) induced a dose-dependent upregulation of CYP3A4 and CYP2B6 expression in the human bronchial epithelial cell line BEAS‑2B, while concomitant exposure to the chemotherapeutic agent cis‑diamminedichloroplatinum (cis‑platin) inhibited this induction, suggesting a pharmacodynamic interaction that may impact drug metabolism in the airway.",-78.5,0.8,chemicalentity
"cis‑diamminedichloroplatinum exposure induces KCl‑depolarised apoptosis in A549 cells, an effect partially mitigated by Dexrazoxane through scavenging reactive oxygen species.",-23.5,0.8,chemicalentity
cis-diamminedichloroplatinum exposure induces KCl-depolarised apoptosis in HeLa cells through prostaglandin-mediated signaling that is mitigated by Dexrazoxane.,-26.75,0.8,chemicalentity
"cis‐diaminodichloroplatinum (cisplatin) exposure induces KCl‑depolarised apoptosis in HeLa cells, a process that is mitigated by the antioxidant Dexrazoxane through modulation of prostaglandin‑mediated mitochondrial pathways.",-37.25,0.8,chemicalentity
"cis-diammine-dichloroplatinum (cisplatin) exposure in KCl‑depolarised HeLa cells markedly induced the production of prostaglandin E₂, a response that was attenuated by Dexrazoxane and correlated with increased DNA damage markers such as γ‑H2AX foci.",-48.25,0.8,chemicalentity
"Administering the DNA‑damage repair inhibitor Dexrazoxane markedly reduced bleomycin‑induced apoptosis in KCl‑depolarised A549 cells, where cis‑diaminodichloroplatinum also enhanced prostaglandin‑mediated survival signaling.",-39.75,0.8,chemicalentity
"Administation of the platinum complex cis‑diamminedichloroplatinum in KCl‑depolarised A549 cells upregulated prostaglandin E2 production, an effect partially reversed by Dexrazoxane.",-36.0,0.8,chemicalentity
"Admini­stered bleomycin in KCl‑depolarised HeLa cells caused a dose‑dependent increase in prostaglandin‑E2 production that was partially attenuated by dexrazoxane, highlighting a potential protective role of the iron‑chelating agent in this chemotherapeutic context.",-63.75,0.8,chemicalentity
"Admin administration of cis‑diamminedichloroplatinum combined with the antioxidant Dexrazoxane reduced cisplatin‑induced cardiotoxicity in mice, while KCl‑depolarised cardiac myocytes displayed lower levels of oxidative stress markers compared to control cells.",-55.75,0.8,chemicalentity
Treatment of KCl-depolarised A549 cells with cis‑diamminedichloroplatinum followed by Dexrazoxane markedly reduced bleomycin‑induced DNA strand breaks and restored prostaglandin‑mediated survival signalling.,-23.25,0.8,chemicalentity
"Treatment with cis‑diamminedichloroplatinum reduces KCl‑depolarised proliferation of HeLa cells by inducing apoptosis, while Dexrazoxane protects normal fibroblasts from bleomycin‑induced DNA strand breaks.",-29.75,0.8,chemicalentity
"Treatment involving the KCl‑depolarised HeLa cell line with cis‑diamminedichloroplatinum and the DNA repair inhibitor Dexrazoxane reduced the expression of the DNA repair gene XPA, thereby enhancing bleomycin‑induced apoptosis and improving the therapeutic index in a dose‑dependent manner.",-57.75,0.8,chemicalentity
"Treatment combining cis‑diamminedichloroplatinum with the antioxidant selenocysteine reduces KCl‑depolarised cardiomyocyte apoptosis, while Dexrazoxane mitigates bleomycin‑induced DNA strand breaks in HeLa cells.",-38.0,0.8,chemicalentity
"KCl‑depolarised human bronchial epithelial cells treated with cis‑diamminedichloroplatinum exhibit enhanced apoptosis and increased production of prostaglandins, a response that is attenuated by the antioxidant Dexrazoxane.",-33.5,0.8,chemicalentity
K562 cells treated with the cis-diamminedichloroplatinum complex and the antioxidant Dexrazoxane exhibited reduced DNA damage and increased survival compared with cis-diamminedichloroplatinum alone.,-32.0,0.8,chemicalentity
"Killer‑cell immunoglobulin‑like receptor engagement by KCl‑depolarised NK‑cell membranes, in the presence of cis‑diamminedichloroplatinum, enhances the release of prostaglandins that subsequently sensitize tumour cells to bleomycin‑induced DNA strand breaks.",-43.75,0.8,chemicalentity
"K-ras G12D–mutant A549 cells treated with the chemotherapeutic agent cis‑diamminedichloroplatinum (cisplatin) exhibit a marked reduction in proliferation, which is partially rescued by co‑treatment with Dexrazoxane, a chelating agent that mitigates cisplatin‑induced oxidative DNA damage.",-45.75,0.8,chemicalentity
Elevated production of prostaglandins in KCl‑depolarised HeLa cells treated with cis‑diaminodichloroplatinum and Dexrazoxane leads to increased apoptosis via a selenocysteine‑dependent mitochondrial pathway.,-36.25,0.8,chemicalentity
"Elevating KCl-depolarised membrane potentials, cis-diamminedichloroplatinum treatment downregulates prostaglandin synthesis in A549 cells, while Dexrazoxane mitigates bleomycin‑induced DNA strand breaks, illustrating a synergistic chemotherapeutic strategy.",-51.5,0.8,chemicalentity
"Elevin treated KCl‑depolarised cardiomyocytes, and the combination of bleomycin and cis‑diamminedichloroplatinum produced a synergistic increase in prostaglandin‑E₂ secretion that was mitigated by the antioxidant Dexrazoxane.",-49.75,0.8,chemicalentity
"Elevations of prostaglandins induced by KCl‑depolarised A549 cells treated with cis‑diamminedichloroplatinum were markedly attenuated when Dexrazoxane was added, suggesting a protective interaction between the platinum compound and the oxidative‑stress‑mediated prostaglandin pathway.",-40.25,0.8,chemicalentity
"The administration of iohexol in a human OB model revealed a rapid renal clearance that was markedly slowed by concurrent captopril treatment, suggesting a competitive interaction between the contrast agent and the ACE inhibitor at the glomerular filtration level.",-39.5,0.8,chemicalentity
"The radiographic contrast agent iohexol, when co‑administered with the local anesthetic lidocaine, markedly enhances the visualization of vascular OB lesions without inducing clinically significant potassium shifts.",-29.75,0.8,chemicalentity
"The contrast agent iohexol markedly reduced renal excretion of the peptide hormone oxytocin in vivo, indicating that iohexol interferes with oxytocin receptor signaling in the kidney of adult *Homo sapiens* subjects.",-39.5,0.8,chemicalentity
"The intravenous administration of iohexol, a non‑ionic iodinated contrast agent, in a cohort of patients undergoing CT angiography revealed a dose‑dependent elevation of serum potassium, which in turn potentiated the cardiotoxic effects of lidocaine when co‑administered.",-40.25,0.8,chemicalentity
"Ketanserin’s competitive blockade of the serotonin‑2A receptor in the A549 cell line inhibited proliferation and induced apoptosis, a response that was potentiated when combined with the contrast agent iohexol, illustrating the synergistic cytotoxic effect of a chemical entity and a diagnostic contrast agent on cancer cells.",-59.75,0.8,chemicalentity
"Kappa‑opioid agonist des Arg10 HOE‑140, when administered to the human-derived HeLa cell line, markedly reduced intracellular calcium influx induced by the contrast agent iohexol, suggesting a protective pharmacologic interaction.",-49.0,0.8,chemicalentity
"Kappos et al. reported that the contrast agent iohexol, when administered intravenously at a dose of <5 ml/kg, significantly reduced the oxidative stress markers in a cohort of patients undergoing CT angiography for peripheral arterial disease, indicating a protective pharmacological effect of iohexol on endothelial function.",-79.0,0.8,chemicalentity
"Kinetic analysis of iohexol clearance in pregnant volunteers revealed that the drug’s plasma concentration was markedly reduced in the second trimester, correlating with increased expression of the hepatic CYP3A4 enzyme.",-43.0,0.8,chemicalentity
"iohexol, a nonionic iodinated contrast agent, was found to reduce oxidative stress markers in OB‑treated A549 cells, thereby mitigating the neurotoxicity induced by d‑amphetamine exposure.",-38.25,0.8,chemicalentity
"iolex, a non‑ionic iodinated contrast medium, markedly increased the renal clearance of the calcium channel blocker d‑amphetamine in a cohort of adult *Homo sapiens* patients with baseline kidney disease, thereby reducing the systemic exposure of the drug and attenuating its neurotoxic effects.",-76.0,0.8,chemicalentity
"io​hexol administration in patients with acute kidney injury reduces contrast‑induced nephropathy while preserving glomerular filtration rate, as demonstrated in a randomized trial comparing io​hexol‑only versus io​hexol plus Captopril therapy.",-56.25,0.8,chemicalentity
"iofoxol, a novel contrast agent, was shown to enhance CT imaging of the liver in a dose-dependent manner in mice, and its hepatotoxicity was mitigated by pretreatment with the antioxidant d-amphetamine, illustrating a chemopreventive interaction between a chemical entity and a small molecule.",-75.5,0.8,chemicalentity
"In the study, iohexol was found to inhibit the uptake of Captopril in HepG2 cells, thereby reducing its antihypertensive effect in vitro.",-28.625,0.8,chemicalentity
"In human hepatocytes, the contrast agent iohexol competitively inhibits the uptake of Captopril by the OCT1 transporter, thereby reducing the drug’s hepatic bioavailability and potentiating its systemic hypotensive effect.",-29.625,0.8,chemicalentity
"In vivo studies revealed that administering iohexol to HeLa cells increased cellular uptake of the contrast agent and subsequently enhanced the sensitivity of the cells to the chemotherapeutic agent des Arg10 HOE‑140, suggesting a synergistic effect between the chemical entity iohexol and the peptide-based drug des Arg10 HOE‑140 in modulating cellular viability.",-58.5,0.8,chemicalentity
"In HepG2 cells, the contrast agent iohexol induces oxidative stress that activates the p53 pathway, while the addition of Captopril suppresses this effect by down‑regulating ROS‑mediated MAPK signaling.",-31.625,0.8,chemicalentity
"6‑hydroxydopamine treatment of rat hippocampal organotypic slices induced a dose‑dependent loss of TH‑positive neurons, an effect that was partially rescued by co‑administration of Captopril, suggesting a neuroprotective role of the ACE inhibitor against neurotoxic oxidative damage.",-43.75,0.8,chemicalentity
"6-hydroxydopamine, a neurotoxic chemical entity, induced robust oxidative stress and dopaminergic neuron loss in the SNpc of C57BL/6J mice, while co‑administration of lidocaine, an anesthetic, mitigated the apoptosis of striatal neurons and reduced behavioral hypokinesia.",-61.0,0.8,chemicalentity
"6‐hydroxydopamine administration to the A549 cell line induced apoptosis through upregulation of the TP53 pathway, while the addition of iohexol as a contrast agent attenuated the oxidative stress response.",-40.25,0.8,chemicalentity
"6–hydroxydopamine induces selective dopaminergic neuron degeneration in the substantia nigra of C57BL/6J mice, and pretreatment with the antioxidant iohexol markedly reduces this neurotoxicity while preserving motor performance.",-35.0,0.8,chemicalentity
"High‑dose iohexol contrast enhances renal perfusion in patients with hypertension, thereby reducing the need for captopril‑induced potassium retention while preserving glomerular filtration rate.",-33.75,0.8,chemicalentity
"High-resolution imaging of the OB using iohexol contrast revealed that intrathecal lidocaine perfusion transiently decreased extracellular potassium levels, thereby attenuating neuronal hyperexcitability in the d-amphetamine–induced seizure model.",-46.0,0.8,chemicalentity
High dose iohexol administration in a cohort of obese patients carrying the CYP2D6*1/*4 genotype revealed a statistically significant interaction with Captopril that reduced the risk of contrast‑induced nephropathy compared to patients treated with lidocaine and d‑amphetamine alone.,-65.0,0.8,chemicalentity
"High concentrations of iohexol contrast agent inhibit the efflux of d‑amphetamine from neuronal mitochondria, thereby potentiating its neurotoxic effects on dopaminergic neurons in the substantia nigra.",-37.5,0.8,chemicalentity
"D-amphetamine administration in the HeLa cell line induced a rapid increase in intracellular potassium efflux, suggesting that the drug activates voltage‑gated potassium channels and thereby modulates cellular excitability.",-27.125,0.8,chemicalentity
"Doxorubicin, a widely used chemotherapeutic chemical entity, induces apoptosis in A549 lung carcinoma cell lines by upregulating the pro‑apoptotic protein Bax and concurrently downregulating the anti‑apoptotic protein Bcl‑2.",-31.5,0.8,chemicalentity
"D‑amphetamine induces a rapid elevation of intracellular dopamine that, through activation of D2 receptors, suppresses the release of potassium‑dependent chloride ions and thereby enhances the analgesic effect of lidocaine in the A549 cell line.",-47.75,0.8,chemicalentity
"Dying cells treated with the contrast agent iohexol and the neurotoxin des Arg10 HOE‑140 showed a synergistic up‑regulation of oxidative stress markers, confirming that the chemical entity combination induces apoptosis in cultured HeLa cells.",-61.0,0.8,chemicalentity
"Describing the effect of iohexol on renal perfusion, the study found that the contrast agent markedly increased intrarenal blood flow in a dose-dependent manner in healthy *Homo sapiens* subjects.",-34.25,0.8,chemicalentity
"Desoximetane, a synthetic analog of iohexol, was shown to competitively inhibit the uptake of Captopril in the proximal tubule of Homo sapiens kidney cells, thereby reducing contrast‑induced nephrotoxicity in patients with obstructive biliary disease.",-38.25,0.8,chemicalentity
"Described in a mouse model, intraperitoneal iohexol injection at a dose of ~0.5 mL/kg caused a transient decrease in renal cortical perfusion, and the subsequent intravenous administration of lidocaine at ~10 mg/kg mitigated the contrast‑induced nephrotoxicity by reducing oxidative stress and restoring sodium‑potassium ATPase activity.",-87.0,0.8,chemicalentity
"Descriptive intraperitoneal injection of iohexol in the A549 cell line, a human lung carcinoma model, resulted in rapid clearance from the plasma and reduced serum potassium concentration, supporting its use as a safe contrast agent in oncology imaging.",-57.5,0.8,chemicalentity
"Captopril treatment in a cohort of patients with hypertension and acute kidney injury led to a significant reduction in serum potassium levels, while iohexol contrast administration during renal imaging revealed no exacerbation of electrolyte disturbances in the same subjects.",-43.0,0.8,chemicalentity
"Candidiasis in the vaginal tract of an obese patient receiving iohexol as a contrast agent was reduced by administering a single dose of Captopril, which inhibited the local overexpression of the host cell surface protein that mediates fungal adhesion.",-66.0,0.8,chemicalentity
"Cytotoxic effects of iohexol on the human renal proximal tubule cell line HK-2 were exacerbated by co‑administration of d‑amphetamine, suggesting a synergistic nephrotoxic interaction mediated through oxidative stress pathways.",-40.0,0.8,chemicalentity
"Cationic iohexol, a low‑osmolar contrast agent, competitively inhibits potassium channel gating in the renal proximal tubule, thereby attenuating the hyperpolarization induced by the β‑adrenergic agonist d‑amphetamine in cultured HEK293 cells.",-56.75,0.8,chemicalentity
"A549 cells treated with the contrast agent iohexol show a rapid, dose‑dependent decrease in ERK phosphorylation, suggesting that iohexol disrupts MAPK signaling and could modulate tumor cell proliferation.",-38.5,0.8,chemicalentity
"A dose‑dependent blockade of the calcium channel by iohexol in the renal cortex of the rat led to a pronounced reduction in intracellular potassium levels, thereby altering the action potential of the proximal tubule cells.",-56.25,0.8,chemicalentity
"A patient receiving a contrast-enhanced CT scan with iohexol developed a transient hypotensive episode that was promptly reversed by intravenous Captopril, illustrating a pharmacologic interaction between the iodinated agent and an ACE inhibitor.",-37.5,0.8,chemicalentity
"A single administration of iohexol in the contrast‑enhanced CT scan of a patient with hypertension revealed a dose‑dependent decrease in renal excretion of potassium, suggesting a pharmacokinetic interaction with Captopril that may alter blood pressure control.",-54.5,0.8,chemicalentity
"Exposure of human dermal fibroblasts to iohexol, a non‑ionic contrast agent, induced a dose‑dependent increase in intracellular calcium and subsequent up‑regulation of the antioxidant gene HOE‑140, while concurrent treatment with lidocaine attenuated the oxidative stress response.",-49.25,0.8,chemicalentity
"Exposure to the contrast agent iohexol during computed tomography imaging was found to elevate serum potassium levels in patients receiving concomitant Captopril therapy, thereby increasing the risk of arrhythmogenic cardiac events.",-28.125,0.8,chemicalentity
"Exposure contrast agent iohexol to renal tubular cells upregulates the transporter P-glycoprotein, thereby reducing intracellular accumulation of the chemotherapeutic drug doxorubicin and ameliorating its nephrotoxic effects.",-53.75,0.8,chemicalentity
"Exposure and subsequent imaging with iohexol contrast during a renal ultrasound revealed that a modest increase in urinary potassium excretion was observed, suggesting that the contrast agent may modulate electrolyte handling in patients with underlying hypertension treated with captopril.",-72.0,0.8,chemicalentity
"Methadone, a chemical entity, is used to treat opioid dependence in patients who also receive iohexol, a contrast agent, thereby reducing the risk of nephrotoxicity in patients with chronic kidney disease.",-39.0,0.8,chemicalentity
"Methotrexate and the ion‑topical contrast agent iohexol were co‑administered to a patient with osteoarthritis, where the former inhibited inflammatory cytokine production while the latter enhanced MRI visualization of joint cartilage.",-48.25,0.8,chemicalentity
"Methamphetamine‑induced oxidative stress increases the phosphorylation of the insulin receptor in A549 cells, while iohexol contrast administration reduces glucose uptake in the same cell line.",-45.0,0.8,chemicalentity
"Methionine‑modified iohexol, when used as a contrast agent during an obstetric ultrasound, was found to induce a transient rise in serum potassium that was mitigated by pre‑treatment with Captopril, thereby preventing potential arrhythmias in the neonate.",-54.25,0.8,chemicalentity
"When iohexol is used as a contrast agent in computed tomography scans, the rapid iodinated uptake by hepatocytes leads to a transient increase in serum potassium levels, which can precipitate arrhythmias in patients with pre‑existing renal impairment.",-47.75,0.8,chemicalentity
"When administering iohexol for contrast‑enhanced CT, the rapid influx of potassium in the bloodstream can trigger arrhythmias, a risk that is mitigated by co‑treatment with Captopril, which stabilizes endothelial function and reduces oxidative stress.",-45.25,0.8,chemicalentity
"When imaging the kidneys in a patient with obstructive nephropathy, the IV contrast agent iohexol markedly increases renal excretion rates, thereby improving the detection of obstructive lesions.",-45.5,0.8,chemicalentity
"When intravenous iohexol is administered to an OB patient, the resulting contrast‑induced nephrotoxicity is mitigated by the concurrent infusion of Captopril, which up‑regulates protective renal K⁺ channels.",-42.75,0.8,chemicalentity
"Administered iohexol contrast during the CT scan of the patient’s pelvis, the radiologist noted a transient elevation of serum potassium, prompting a rapid switch to a Captopril‑based protocol to mitigate nephrotoxicity while maintaining adequate blood pressure.",-55.0,0.8,chemicalentity
"Administred iohexol in a bolus of contrast medium to a patient with an OB history, the plasma concentration of which peaked after a single dose of des Arg10 HOE‑140 and was subsequently reduced by concomitant lidocaine administration.",-79.0,0.8,chemicalentity
"Administers of iohexol contrast in a Captopril‑treated A549 cell line, which overexpresses the dopamine transporter gene, were shown to increase intracellular oxidative stress induced by the chemical entity des Arg10 HOE‑140, thereby elevating the levels of the SequenceVariant BRCA1 c.68_69delAG.",-91.0,0.8,chemicalentity
"Adminstration of iohexol contrast during computed tomography in patients with obstructive biliary disease (OB) led to an upregulation of CYP3A4 expression in HepG2 cells, thereby attenuating the hepatotoxic effect of the pro‑oxidant compound, six‑hydroxydopamine, while simultaneously potentiating the vasodilatory response to Captopril.",-84.0,0.8,chemicalentity
"The antioxidant selenium in green tea polyphenols reduces NO-mediated LDL cholesterol oxidation, thereby decreasing atherosclerotic plaque formation in human endothelial cells.",-21.0,0.8,chemicalentity
"The neuroprotective effects of green tea polyphenols were mediated by increased NO production, which in turn enhanced endothelial‑derived NO‑dependent vasodilation and reduced LDL cholesterol oxidation in human arterial smooth muscle cells.",-44.25,0.8,chemicalentity
"The antioxidative compound green tea polyphenol epigallocatechin gallate inhibits LDL cholesterol oxidation, thereby reducing endothelial dysfunction and atherosclerotic plaque formation in atherosclerosis.",-28.625,0.8,chemicalentity
The anti‑inflammatory effects of green tea catechins on endothelial dysfunction were mediated by reduced NO production and decreased LDL cholesterol accumulation in cultured HUVECs.,-26.625,0.8,chemicalentity
"Administration of green tea extract, rich in EGCG, markedly reduced LDL cholesterol levels in A549 cells by upregulating SREBP‑2 transcription and increasing expression of LDLR, thereby attenuating the NO‑mediated oxidative stress observed in the aldosterone‑sensitive renal proximal tubule model.",-48.0,0.8,chemicalentity
"Administration to HeLa cells of green tea catechins, which inhibit NO synthase and reduce LDL cholesterol, decreased C‑peptide secretion and induced apoptosis in an aldosterone‑sensitive manner.",-44.5,0.8,chemicalentity
"Administration and bioavailability studies of green tea catechin epigallocatechin‑3‑gallate (EGCG) revealed that its antioxidant capacity was markedly enhanced when combined with selenium, reducing LDL cholesterol oxidation in vitro and lowering markers of atherosclerosis in a murine model.",-56.0,0.8,chemicalentity
"Administration oridonin, a green tea-derived polyphenol, attenuates the aldosterone‑induced up‑regulation of the NO‑dependent vasodilatory pathway in the human endothelial cell line EA.hy926, thereby reducing LDL cholesterol accumulation and improving endothelial function.",-57.25,0.8,chemicalentity
"In vitro, green tea catechin EGCG inhibited NO production in vascular endothelial cells and reduced LDL cholesterol uptake by downregulating the LDLR transcription factor in human aortic endothelial CellLine HUVEC.",-41.0,0.8,chemicalentity
"In HepG2 hepatocellular carcinoma cells, green tea catechins inhibit the activity of the NO‑producing enzyme endothelial nitric oxide synthase, thereby reducing oxidative stress‑induced elevation of LDL cholesterol levels and lowering the proliferation of cancerous cells.",-46.75,0.8,chemicalentity
"In HeLa cells, green‑tea polyphenol EGCG reduces NO production, thereby lowering LDL cholesterol‑induced oxidative stress and improving C‑peptide secretion in a dose‑dependent manner.",-22.5,0.8,chemicalentity
"In Huh‑7 hepatocellular carcinoma cells, green tea catechins inhibit NO synthase, leading to reduced LDL cholesterol accumulation and attenuating the aldosterone‑responsive pathway that otherwise promotes C‑peptide secretion.",-37.75,0.8,chemicalentity
"Green tea polyphenol epigallocatechin‑3‑gallate was found to inhibit LDL cholesterol‑induced oxidative stress in Huh‑7 cells, thereby reducing the secretion of C‑peptide in an aldosterone‑sensitive manner.",-28.5,0.8,chemicalentity
"Green‑tea polyphenols inhibit the NO‑dependent signaling of aldosterone‑sensitive smooth‑muscle cells, thereby reducing LDL‑cholesterol‑mediated oxidative stress in human vascular endothelial cells.",-32.75,0.8,chemicalentity
"Green茶 extract, rich in epigallocatechin‑3‑gallate, was shown to reduce LDL‑cholesterol and improve endothelial dysfunction in A549 cells, possibly via increased NO production and modulation of the aldosterone‑sensitive pathway.",-47.0,0.8,chemicalentity
"Green leaf catechin, a major constituent of green tea, scavenges reactive oxygen species, thereby attenuating LDL cholesterol oxidation and reducing aldosterone-sensitive hypertension in a dose-dependent manner.",-37.0,0.8,chemicalentity
"Activation of the NO‑cGMP pathway by green tea catechins was found to lower LDL cholesterol levels and improve endothelial function in atherosclerosis‑prone A549 cell lines, thereby reducing oxidative stress and C‑peptide‑induced insulin resistance in a murine model of metabolic syndrome.",-47.25,0.8,chemicalentity
"Activation-induced T‑cell proliferation induced by green tea catechins is suppressed through inhibition of NO‑dependent phosphorylation of the CD3ζ chain, thereby reducing IL‑2 secretion and limiting expansion of the C‑peptide‑producing pancreatic β‑cell line MIN6.",-69.0,0.8,chemicalentity
"Activation by green tea polyphenols of the NO‑producing endothelial pathway in human aortic endothelial cells upregulates C‑peptide‑dependent insulin signaling, thereby attenuating LDL cholesterol–induced oxidative stress and improving endothelial function.",-50.5,0.8,chemicalentity
"Activation with green tea catechins downregulates the NO pathway, thereby reducing LDL cholesterol levels and improving endothelial dysfunction in atherosclerosis.",-39.75,0.8,chemicalentity
"Dexamethasone treatment decreased serum aldosterone‑sensitive C‑peptide levels in patients with metabolic syndrome, while green tea catechins improved NO‑mediated endothelial dysfunction and lowered LDL cholesterol in a dose‑dependent manner.",-35.5,0.8,chemicalentity
"Doxorubicin‑induced cardiotoxicity is mitigated by green tea catechin epigallocatechin‑3‑gallate through NO‑dependent vasodilation, which improves endothelial dysfunction and reduces LDL cholesterol oxidation in HEK293 cells.",-36.75,0.8,chemicalentity
Dopamine‑mediated NO production in vascular endothelial cells treated with green‑tea‑derived catechins reduces aldosterone‑sensitive LDL cholesterol uptake and improves endothelial nitric‑oxide synthase activity in a dose‑dependent manner.,-38.25,0.8,chemicalentity
"Dihydroquercetin, a catechin from green tea, scavenges nitric oxide and reduces LDL cholesterol levels in HEK293 cells, thereby lowering C‑peptide secretion and attenuating aldosterone‑mediated hypertension.",-38.25,0.8,chemicalentity
"Amaranthine, a polyphenol extracted from green tea, was shown to inhibit LDL cholesterol oxidation by scavenging NO and reducing aldosterone-sensitive oxidative stress, thereby lowering C‑peptide‑induced endothelial dysfunction in vitro.",-47.0,0.8,chemicalentity
"Amatoxins from *Amanita* species are absorbed by *HeLa* cells and inhibit the NO synthase pathway, thereby reducing C‑peptide release and increasing LDL cholesterol accumulation in a dose‑dependent manner.",-53.25,0.8,chemicalentity
"Amoxicillin’s inhibition of bacterial β‑lactamases in E. coli strains harboring the TEM‑1 gene product markedly reduced the secretion of lipopolysaccharide‑induced nitric oxide (NO), thereby lowering endothelial dysfunction (ED) scores in cultured HUVECs.",-54.75,0.8,chemicalentity
"Amelioration of erectile dysfunction in male rats receiving green‑tea‑derived catechin, which scavenges reactive oxygen species and upregulates nitric‑oxide synthase, was accompanied by a reduction in serum LDL‑cholesterol and a dose‑dependent increase in C‑peptide secretion.",-49.75,0.8,chemicalentity
"A randomized trial in patients with hyperlipidemia showed that a green‑tea extract enriched in catechins significantly lowered LDL cholesterol and reduced inflammatory markers, while the addition of selenium to the regimen further suppressed oxidative stress and improved endothelial dysfunction measured by flow‑mediated dilation.",-46.25,0.8,chemicalentity
"Adenosine triphosphate‑catalyzed hydrolysis of dUTP‑biotin by the Escherichia coli uracil–DNA glycosylase is inhibited by selenium‑containing antioxidant metabolites derived from green tea, reducing LDL‑cholesterol‑induced oxidative stress in human aortic endothelial cells.",-59.0,0.8,chemicalentity
A dose of green tea catechin extract reduced LDL cholesterol in A549 cells by inhibiting the NO‑dependent activation of aldosterone‑sensitive pathways and down‑regulating C‑peptide secretion.,-39.5,0.8,chemicalentity
"A549 cells treated with green tea–derived epigallocatechin gallate (EGCG) exhibited reduced NO production and decreased LDL cholesterol uptake, indicating a potential link between EGCG, endothelial dysfunction, and atherosclerosis.",-31.0,0.8,chemicalentity
"Selenium supplementation reduced LDL cholesterol levels in men with elevated C‑peptide concentrations, suggesting a protective effect of this antioxidant on atherogenic lipid metabolism.",-26.125,0.8,chemicalentity
"Selenite, a selenium-containing chemicalentity, suppresses tumor necrosis factor‑α secretion in HeLa cells, thereby attenuating the oxidative stress‑induced upregulation of aldosterone‑sensitive Na⁺/K⁺‑ATPase activity.",-47.0,0.8,chemicalentity
"Silibinin, a polyphenol derived from green tea, reduces NO production in HUVECs and down‑regulates the aldosterone‑responsive SLC12A2 transporter, thereby lowering LDL‑cholesterol uptake and attenuating oxidative stress in atherosclerotic lesions.",-45.0,0.8,chemicalentity
"Synthesis of green‑tea catechins markedly reduces NO‑dependent endothelial dysfunction in human aortic endothelial cells, an effect that is potentiated by concurrent selenium supplementation and is diminished in the presence of aldosterone‑sensitive K⁺ channel blockers.",-52.75,0.8,chemicalentity
"Treatment of hypercholesterolemia in cultured HepG2 cells with green tea catechin EGCG reduced LDL‑cholesterol uptake and suppressed NF‑κB‑mediated expression of the LDL receptor, while increasing antioxidant selenium‑dependent glutathione peroxidase activity.",-41.75,0.8,chemicalentity
"Treatment with green tea catechins down‑regulates hepatic NO production, thereby attenuating aldosterone‑induced hypertension in a mouse model of metabolic syndrome.",-26.625,0.8,chemicalentity
"Treatment via green tea catechins attenuates NO-mediated endothelial dysfunction in patients with high LDL cholesterol, an effect that correlates with reduced C‑peptide secretion and improved insulin sensitivity.",-44.5,0.8,chemicalentity
"Treatment administered to HeLa cells with the green‑tea–derived catechin epigallocatechin‑3‑gallate (EGCG) resulted in a marked reduction of LDL‑cholesterol uptake, concomitant with decreased expression of the LDL receptor and increased secretion of the anti‑inflammatory cytokine interleukin‑10.",-49.0,0.8,chemicalentity
"Intracellular accumulation of LDL cholesterol in human HepG2 cells, induced by the green tea polyphenol epigallocatechin gallate, enhances the secretion of the vasodilatory peptide NO, thereby attenuating aldosterone‑mediated sodium reabsorption and improving endothelial dysfunction in a dose‑dependent manner.",-46.5,0.8,chemicalentity
"Intraperitoneal injection of green tea catechin epigallocatechin‑3‑gallate into A549 cells downregulated aldosterone‑sensitive mineralocorticoid receptor expression, thereby reducing LDL cholesterol uptake and attenuating the nitric‑oxide‑induced vasodilatory response mediated by endothelial nitric‑oxide synthase.",-46.25,0.8,chemicalentity
"Intravenous infusion of selenium at a dose of one milligram per kilogram per day markedly reduced plasma LDL cholesterol concentrations in patients with hyperlipidemia, while simultaneously improving endothelial dysfunction as evidenced by increased nitric‑oxide‑dependent vasodilation measured by flow‑mediated dilation.",-55.25,0.8,chemicalentity
"Intriguingly, green tea catechins inhibit endothelial nitric‑oxide synthase activity, thereby reducing NO‑mediated vasodilation and improving erectile dysfunction in a mouse model of hyperlipidemia.",-31.875,0.8,chemicalentity
Substitution of dUTP‑biotin by the green‑tea–derived epigallocatechin‑3‑gallate (EGCG) in the PCR amplification of an Aldosterone‑Sensitive promoter region dramatically reduced C‑peptide expression and subsequently lowered LDL‑cholesterol levels in HepG2 cells.,-61.25,0.8,chemicalentity
"Subcutaneous administration of green‑tea catechin epigallocatechin‑3‑gallate (EGCG) markedly reduced LDL‑cholesterol levels and attenuated aldosterone‑sensitive vascular remodeling in a rat model of hypertension, an effect that was partially mediated by increased NO bioavailability and decreased C‑peptide‑induced endothelial dysfunction.",-44.75,0.8,chemicalentity
"Substantial evidence indicates that green‑tea polyphenols inhibit NO synthase in endothelial cells, thereby attenuating aldosterone‑mediated hypertension while simultaneously reducing LDL‑cholesterol‐induced atherogenesis.",-42.25,0.8,chemicalentity
"Subsequent in‑vitro analysis revealed that green tea catechins, acting as antioxidants, inhibited LDL cholesterol‑induced oxidative stress in HepG2 cells and down‑regulated the expression of the aldosterone‑sensitive gene CYP11B2.",-45.25,0.8,chemicalentity
"Ethanol and green‑tea polyphenols synergistically inhibit LDL cholesterol–induced oxidative stress in HepG2 cells, thereby reducing the secretion of the aldosterone‑sensitive C‑peptide and attenuating endothelial dysfunction.",-37.0,0.8,chemicalentity
"Epidemiological data reveal that green tea polyphenols inhibit LDL cholesterol oxidation by scavenging NO-mediated reactive oxygen species, thereby reducing atherosclerotic plaque formation in patients with hyperlipidemia.",-30.125,0.8,chemicalentity
"Elderly patients receiving green tea polyphenols showed a statistically significant reduction in LDL cholesterol levels, suggesting a potential therapeutic role for catechins in managing atherosclerosis.",-29.625,0.8,chemicalentity
"Eighty‑five percent of patients with type‑2 diabetes treated with green tea extract exhibited a significant reduction in LDL cholesterol, correlating with increased plasma C‑peptide levels and a concomitant decrease in circulating aldosterone‑sensitive NO production.",-44.0,0.8,chemicalentity
"Elevated serum LDL cholesterol levels in patients receiving green tea extract supplementation were correlated with decreased C‑peptide release from insulin‑secreting β‑cells, suggesting a modulatory effect of catechin‑derived NO on pancreatic β‑cell function.",-41.0,0.8,chemicalentity
"Elevating the antioxidant selenium level in the HepG2 cell line markedly reduced intracellular LDL cholesterol accumulation and restored NO production, thereby attenuating oxidative stress‑induced apoptosis.",-42.25,0.8,chemicalentity
"Elevin, a green‑tea‑derived catechin, scavenges NO radicals, thereby reducing oxidative LDL cholesterol and improving endothelial dysfunction in patients with metabolic syndrome.",-36.75,0.8,chemicalentity
"Elevative green tea extract, rich in epigallocatechin gallate, reduces LDL cholesterol levels in A549 cells by upregulating the antioxidant enzyme superoxide dismutase, thereby mitigating NO-mediated oxidative damage.",-46.25,0.8,chemicalentity
"The combination of doxorubicin/kg and anthracyclines induces cytochrome c release, which amplifies vancomycin‑induced apoptosis in HeLa cells.",-22.375,0.8,chemicalentity
"The anthracycline doxorubicin induces cytochrome c release in HeLa cells, triggering apoptosis and upregulating the tumor suppressor TP53, thereby reducing cell proliferation and enhancing sensitivity to Clopidogrel‑mediated platelet inhibition.",-27.25,0.8,chemicalentity
"The chemotherapeutic agent doxorubicin, when administered at a dose of doxorubicin/kg, induces cardiotoxicity in E. coli‑derived cell lines by disrupting cytochrome c‑dependent apoptosis pathways, a mechanism similar to the vancomycin‑induced nephrotoxicity observed with benzamide drugs.",-45.0,0.8,chemicalentity
"The antitumor activity of doxorubicin at a dose of doxorubicin/kg in HeLa cells was markedly enhanced by the addition of raloxifene hydrochloride, which inhibited cytochrome c release and attenuated anthracyclines‑induced oxidative stress.",-35.5,0.8,chemicalentity
"Clopidogrel inhibits platelet aggregation by blocking the P2Y12 receptor on platelets, thereby reducing thrombus formation in patients with acute coronary syndrome and concomitant exposure to anthracyclines, which can impair platelet function.",-33.5,0.8,chemicalentity
"Clonazepam, a benzamide drug, reduces the expression of cytochrome c in A549 cells, thereby decreasing apoptosis induced by anthracyclines such as doxorubicin/kg.",-30.125,0.8,chemicalentity
"Clint's laboratory observed that treatment of A549 cells with anthracyclines such as doxorubicin/kg resulted in a dose‑dependent increase in cytochrome c release, correlating with apoptosis induction and a concurrent reduction in mitochondrial membrane potential.",-49.75,0.8,chemicalentity
"ClpB from *E. coli* induces cytochrome c release in HeLa cells, a process that is markedly attenuated by the anthracycline doxorubicin at a dose of <5 µM, thereby linking bacterial stress proteins, a small molecule chemotherapeutic, and apoptosis regulation.",-66.5,0.8,chemicalentity
"Anthracyclines such as doxorubicin/kg induce cardiotoxicity by promoting cytochrome c release, whereas Clopidogrel mitigates platelet aggregation in patients receiving benzamide drugs for hypertension.",-28.875,0.8,chemicalentity
"Antharacyclines, such as doxorubicin, disrupt the electron transport chain in mitochondria by binding cytochrome c, thereby triggering apoptosis in rapidly dividing cancer cells.",-38.75,0.8,chemicalentity
"Anthracene-derived benzamide drugs such as raloxifene hydrochloride reduce cytochrome c release in doxorubicin/kg-treated HeLa cells, thereby mitigating anthracyclines‑induced apoptosis.",-30.375,0.8,chemicalentity
"Anthrocyclines administered at doxorubicin/kg doses induce cytochrome c release in HeLa cells, thereby triggering apoptosis and potentiating vancomycin-induced nephrotoxicity.",-37.0,0.8,chemicalentity
"Cytochrome c release, induced by anthracyclines such as doxorubicin/kg, activates caspase‑3 and drives apoptosis in HeLa cells while simultaneously upregulating mitochondrial ROS that is mitigated by co‑treatment with raloxifene hydrochloride.",-28.5,0.8,chemicalentity
"Cyclosporin A inhibits cytochrome c release, thereby reducing doxorubicin‑induced apoptosis in HeLa cells.",-18.75,0.8,chemicalentity
"Cyproheptadine, a benzamide drug, inhibited cytochrome c release in HeLa cells treated with doxorubicin/kg, reducing apoptosis and improving cell viability.",-24.0,0.8,chemicalentity
"Cypermethrin, a benzamide drug, competitively inhibits cytochrome c oxidase activity in A549 cells, thereby attenuating the anthracyclines‑induced apoptosis cascade.",-34.0,0.8,chemicalentity
"In HCT116 cells, the addition of raloxifene hydrochloride at a concentration of **10 μM** markedly reduced the expression of **cyclin‑dependent kinase inhibitor p21** while simultaneously increasing the phosphorylation of **cytochrome c** and enhancing the apoptotic response to **doxorubicin/kg**.",-53.25,0.8,chemicalentity
"In chronic heart failure, anthracyclines such as doxorubicin/kg induce cytochrome c release, leading to mitochondrial dysfunction and exacerbated cardiomyopathy.",-25.75,0.8,chemicalentity
"In vitro, the benzamide drug raloxifene hydrochloride was shown to bind cytochrome c and inhibit the apoptotic cascade in MCF-7 cells, thereby reducing doxorubicin/kg‑induced cytotoxicity.",-31.0,0.8,chemicalentity
"In HeLa cells, the addition of raloxifene hydrochloride reduced cytochrome c release and thus mitigated anthracyclines‑induced apoptosis.",-21.5,0.8,chemicalentity
"At one time, Clopidogrel was found to mitigate cytochrome c release in HeLa cells treated with doxorubicin/kg, thereby reducing anthracyclines‑induced apoptosis.",-36.25,0.8,chemicalentity
"At a concentration of doxorubicin/kg, the anthracyclines induced a dose‑dependent release of cytochrome c from the mitochondria, triggering apoptosis in the HeLa cell line.",-32.5,0.8,chemicalentity
"At day seven, treatment with anthracyclines and raloxifene hydrochloride synergistically increased cytotoxicity in MCF-7 cells, whereas the addition of Clopidogrel markedly attenuated cytochrome c release and apoptosis.",-52.5,0.8,chemicalentity
"At the cellular level, the chemotherapeutic anthracycline doxorubicin induces apoptosis in HeLa cells by triggering cytochrome c release, while concomitant treatment with the benzamide drug raloxifene hydrochloride attenuates this effect through modulation of mitochondrial membrane potential.",-36.0,0.8,chemicalentity
"Doxorubicin/kg treatment of HeLa cells induces cytochrome c release and activates apoptotic pathways, while co‑administration of raloxifene hydrochloride attenuates this effect by stabilizing mitochondrial membranes.",-18.0,0.8,chemicalentity
"Dexamethasone-mediated inhibition of cytochrome c release in A549 cells treated with doxorubicin/kg resulted in reduced apoptosis and enhanced cell survival, demonstrating a protective effect of the anthracycline on the mitochondrial apoptotic pathway.",-36.25,0.8,chemicalentity
"Doxycycline, a benzamide drug, downregulates cytochrome c expression in A549 cells, thereby attenuating doxorubicin-induced apoptosis.",-22.75,0.8,chemicalentity
"Deltamethrin, a benzamide drug, was found to inhibit cytochrome c release in HeLa cells, reducing apoptosis induced by anthracyclines such as doxorubicin/kg.",-29.75,0.8,chemicalentity
"CRISPR‑mediated editing of the TP53 gene in the A549 cell line revealed that the introduction of a BRCA1 c.68_69delAG variant altered the response to doxorubicin/kg, resulting in a significant increase in cytochrome c release and apoptosis.",-36.25,0.8,chemicalentity
"CRP expression was up‑regulated in A549 cells treated with doxorubicin/kg, indicating that anthracyclines activate the NF‑κB pathway to increase pro‑inflammatory cytokine production.",-33.75,0.8,chemicalentity
CRABP‑2 overexpression in A549 cells enhances doxorubicin‑induced cytotoxicity by increasing intracellular cytochrome‑c release and amplifying the apoptotic cascade.,-34.0,0.8,chemicalentity
"CRYSTAL STRUCTURE ANALYSIS revealed that binding of the benzamide drug raloxifene hydrochloride to the heme pocket of cytochrome c inhibited its electron‑transfer activity, thereby attenuating the oxidative burst triggered by anthracyclines in cultured HeLa cells.",-44.75,0.8,chemicalentity
"Cytotoxicity assays revealed that anthracyclines such as doxorubicin/kg significantly induce cytochrome c release in HeLa cells, leading to apoptosis and suggesting a potential therapeutic strategy for treating high‑grade breast cancer.",-38.25,0.8,chemicalentity
"Cyclic peptide analogs of clopidogrel inhibit cytochrome c-mediated apoptosis in HeLa cells treated with doxorubicin/kg, thereby attenuating anthracyclines‑induced cardiotoxicity.",-32.5,0.8,chemicalentity
"Clozapine, a benzamide drug, competitively inhibits the binding of cytochrome c to the mitochondrial membrane, thereby reducing anthracycline-induced oxidative stress in HCT116 cell lines.",-36.5,0.8,chemicalentity
Cisplatin combined with the benzamide drug raloxifene hydrochloride reduces doxorubicin/kg‑induced cardiotoxicity in A549 cells by down‑regulating cytochrome c release and preventing apoptosis.,-31.875,0.8,chemicalentity
"Vancomycin-induced nephrotoxicity is mitigated by co‑administration of raloxifene hydrochloride, which down‑regulates cytochrome c release from mitochondria in A549 cells exposed to anthracyclines.",-17.875,0.8,chemicalentity
"Van der Waals interactions between benzamide drugs and cytochrome c were enhanced by the presence of raloxifene hydrochloride, thereby attenuating the vancomycin‑induced nephrotoxicity observed in A549 cells.",-39.25,0.8,chemicalentity
"Van‑comycin‑induced nephrotoxicity in patients receiving anthracyclines was mitigated by co‑administration of the benzamide drug raloxifene hydrochloride, which down‑regulated cytochrome‑c release from mitochondria in the HCT‑116 cell line.",-39.5,0.8,chemicalentity
"Vanoxer, a benzamide derivative, competes with cytochrome c for binding to Bcl‑2, thereby enhancing doxorubicin‑induced apoptosis in HeLa cells.",-40.75,0.8,chemicalentity
"Ablation of the BCL2 gene in A549 cells treated with doxorubicin/kg induces cytochrome c release, triggering apoptosis and sensitizing the cells to Clopidogrel‑mediated platelet inhibition.",-33.25,0.8,chemicalentity
"A xenograft of HeLa cells treated with doxorubicin/kg and the benzamide drug raloxifene hydrochloride showed a marked reduction in tumor volume, coinciding with increased cytochrome c release and apoptosis, whereas exposure to vancomycin-induced renal injury in A549 cells was mitigated by the addition of Clopidogrel.",-49.0,0.8,chemicalentity
"A549 cells exposed to doxorubicin/kg demonstrated cytochrome c release, which induced mitochondrial apoptosis and suppressed EGFR signaling.",-36.75,0.8,chemicalentity
"Atherosclerotic lesions in the carotid arteries of patients treated with the anthracycline doxorubicin/kg were found to contain increased levels of cytochrome c, suggesting mitochondrial apoptosis is activated by the drug.",-35.25,0.8,chemicalentity
"Bortezomib treatment of HeLa cells upregulated cytochrome c release, thereby enhancing the apoptotic effect of doxorubicin/kg and increasing the cytotoxicity of the benzamide drug clopidogrel toward cancer cells.",-36.25,0.8,chemicalentity
"Bendamustine, an anthracycline analogue, induces cytochrome c release from mitochondria in MCF‑7 cells, thereby triggering caspase‑3 activation and apoptosis.",-24.25,0.8,chemicalentity
"Bort treatment of HCT116 cells attenuates cytochrome c release and downstream caspase activation, thereby reducing the anthracyclines‑induced apoptotic response.",-34.5,0.8,chemicalentity
"Borta, a benzamide drug, competitively inhibits cytochrome c oxidase activity in HeLa cells, thereby enhancing doxorubicin-induced apoptosis.",-28.875,0.8,chemicalentity
"Metformin, a benzamide drug, upregulates cytochrome c expression in HeLa cells, thereby enhancing apoptotic signaling that is potentiated by low‑dose doxorubicin/kg treatment.",-33.25,0.8,chemicalentity
"Metabolism of the benzamide drug raloxifene hydrochloride in HeLa cells is enhanced by co‑administration of Clopidogrel, resulting in increased cytochrome c release and apoptosis, whereas anthracyclines such as doxorubicin/kg induce a dose‑dependent mitochondrial depolarization in the same cell line.",-41.5,0.8,chemicalentity
"Metabolomic profiling revealed that the presence of benzamide drugs markedly reduced cytochrome c release in A549 cells treated with anthracyclines, thereby attenuating doxorubicin/kg‑induced apoptosis.",-30.25,0.8,chemicalentity
"Metronomic dosing of doxorubicin/kg in A549 cells reduced cytochrome c release and apoptosis, suggesting that anthracyclines modulate mitochondrial pathways in this lung carcinoma line.",-29.75,0.8,chemicalentity
"Cyclophilin A binds to the C‑terminal domain of the anthracyclines‑resistant protein, thereby enhancing the cytotoxic activity of doxorubicin/kg and reducing the risk of vancomycin‑induced nephrotoxicity.",-40.0,0.8,chemicalentity
"Cyclin‑dependent kinase inhibitors such as raloxifene hydrochloride, when combined with the anthracycline doxorubicin/kg in A549 cells, enhance apoptosis by increasing cytochrome‑c release, thereby reducing tumor viability.",-31.625,0.8,chemicalentity
"Cyclooxygenase‑2 inhibition by the benzamide drug raloxifene hydrochloride attenuates anthracycline‑induced cardiotoxicity in human cardiomyocytes derived from the H9c2 cell line, with decreased cytochrome c release correlating with reduced apoptosis.",-34.0,0.8,chemicalentity
"Cyclobenzaprine, a benzamide drug, competitively inhibits the release of cytochrome c from mitochondria, thereby attenuating doxorubicin‑induced cardiotoxicity in A549 cells.",-23.75,0.8,chemicalentity
"Sodium valproate, by inhibiting histone deacetylases in A549 cells, reduces CPK secretion and alleviates gastrointestinal LPO damage in a tamoxifen‑inducible mouse model.",-26.75,0.8,chemicalentity
"S-1 administration in HepG2 cells inhibited proliferation and induced apoptosis through activation of the p53 pathway, while co‑treatment with sodium valproate potentiated the effect by enhancing histone acetylation and suppressing the expression of the anti‑apoptotic protein BCL‑XL.",-36.0,0.8,chemicalentity
"S‑1, a top‑tier fluoropyrimidine, competitively inhibits dihydropyrimidine dehydrogenase in A549 cells, thereby amplifying LPO‑mediated oxidative stress and potentiating muscarinic receptor antagonism‑induced gastrointestinal toxicity.",-33.25,0.8,chemicalentity
"Siphoning of CPK activity in cultured HepG2 cells by the antitumor agent doxorubicin was markedly attenuated when the cells were co‑treated with sodium valproate, suggesting that histone deacetylase inhibition enhances drug‑induced cytotoxicity through modulation of metabolic enzymes.",-59.5,0.8,chemicalentity
"In the A549 cell line, sodium valproate treatment increased CPK activity, suggesting enhanced muscle‑like metabolic stress that may be mitigated by co‑administration of the LPO‑inhibiting compound Crataegus oxycantha through its muscarinic receptor antagonism pathway.",-31.375,0.8,chemicalentity
"In HeLa cells, the addition of sodium valproate markedly decreased CPK activity through muscarinic receptor antagonism, suggesting a novel mechanism for its anti‑tumor effect.",-26.125,0.8,chemicalentity
"In HepG2 cells, treatment with sodium valproate reduces CPK activity by inhibiting histone deacetylase, thereby enhancing the expression of the mitochondrial antioxidant enzyme superoxide dismutase and diminishing lipoperoxidation (LPO) levels under oxidative stress.",-40.0,0.8,chemicalentity
"In HTR8/SVneo cells, sodium valproate exposure enhanced LPO production and attenuated muscarinic receptor antagonism, thereby reducing CPK release during simulated gastrointestinal inflammation.",-34.5,0.8,chemicalentity
"Ciprofloxacin exposure in the gastrointestinal tract reduces LPO activity, thereby attenuating muscarinic receptor antagonism and lowering serum CPK levels in mice treated with sodium valproate.",-26.25,0.8,chemicalentity
"Caffeine, a widely used ChemicalEntity, activates the muscarinic receptor antagonism pathway, thereby reducing gastrointestinal LPO levels and improving LpA/Ppg ratios in patients with chronic constipation.",-33.75,0.8,chemicalentity
"Cytotoxicity of the antitumor compound S‑1 was markedly enhanced in the MCF‑7 cell line by concurrent treatment with sodium valproate, which was shown to inhibit histone deacetylases and up‑regulate the pro‑apoptotic protein BAX, thereby potentiating cell death through mitochondrial membrane potential collapse.",-58.25,0.8,chemicalentity
"Citrus-derived CPK inhibitors such as sodium valproate and ciprofloxacin exert a synergistic suppression of muscarinic receptor antagonism, thereby reducing gastrointestinal LPO and improving tamoxifen‑inducible tumor cell sensitivity.",-43.25,0.8,chemicalentity
"The chemotherapeutic agent S‑1 synergizes with ciprofloxacin‑induced gastrointestinal toxicity by amplifying oxidative lipid peroxidation, thereby elevating CPK levels and exacerbating muscarinic receptor antagonism in treated mice.",-31.125,0.8,chemicalentity
"The S‑1 prodrug, when administered orally to HeLa cells, activates the PI3K‑AKT pathway and enhances the cytotoxicity of tamoxifen‑inducible ER‑α knockdown by increasing LpA/Ppg‑mediated lipid peroxidation (LPO) and reducing the expression of the drug‑efflux transporter MDR1, thereby improving treatment efficacy in a xenograft model of triple‑negative breast cancer.",-69.0,0.8,chemicalentity
"The hepatotoxicity of ciprofloxacin in HepG2 cells was markedly amplified by co‑administration of sodium valproate, suggesting that the drug’s inhibition of P-glycoprotein enhances intracellular accumulation of the antibacterial agent.",-32.5,0.8,chemicalentity
"The oral administration of ciprofloxacin at a dose of five milligrams per kilogram in the A549 cell line markedly reduced intracellular reactive oxygen species, as evidenced by a significant drop in lipid peroxidation (LPO) levels, thereby demonstrating its potential to mitigate drug‑induced gastrointestinal (GI) toxicity.",-52.0,0.8,chemicalentity
"Treated with sodium valproate, the A549 cells exhibited reduced CPK levels and altered LpA/Ppg signaling, suggesting that muscarinic receptor antagonism may mediate the drug’s protective effect against GI toxicity.",-36.0,0.8,chemicalentity
"Toxoplasma gondii infection in HepG2 cells is reduced by ciprofloxacin treatment, which inhibits parasite DNA gyrase and simultaneously increases the intracellular concentration of the host enzyme lactate dehydrogenase A, thereby enhancing the oxidative stress response measured by lipid peroxidation (LPO) levels.",-60.0,0.8,chemicalentity
"Tocilizumab administration in patients with rheumatoid arthritis reduced the serum CPK level while concurrently improving gastrointestinal tolerability, thereby suggesting that IL‑6 blockade can mitigate muscle injury associated with chronic inflammation.",-43.0,0.8,chemicalentity
"TAMOXIFEN‑inducible activation of the androgen receptor in LpA/Ppg‑expressing A549 cells was attenuated by the muscarinic receptor antagonism of ciprofloxacin, thereby reducing CPK‑mediated apoptosis in the gastrointestinal mucosa.",-43.25,0.8,chemicalentity
"Crataegus oxyacantha extract, by enhancing LPO-mediated antioxidant defenses, reduces gastrointestinal inflammation in mice treated with sodium valproate, an effect further potentiated by the muscarinic receptor antagonism of ciprofloxacin.",-32.5,0.8,chemicalentity
"Crank the CPK levels into a diagnostic signal: sodium valproate, by blocking GABA‑transaminase, elevates serum CPK while simultaneously reducing the GI side‑effects of ciprofloxacin, illustrating how a single chemical entity can modulate both metabolic and gastrointestinal pathways.",-70.0,0.8,chemicalentity
"Crack‑induced GI distress was markedly alleviated by the sodium valproate–induced muscarinic receptor antagonism, which reduced LPO‑mediated mucosal injury and restored CPK levels in the rat model.",-47.75,0.8,chemicalentity
"Crystallographic analysis of CPK bound to sodium valproate revealed that the drug’s interaction with the active site induces a conformational change in the enzyme’s catalytic residues, thereby reducing its activity in hepatic cells.",-32.75,0.8,chemicalentity
Treatment with ciprofloxacin in E. coli cultures expressing a CPK‑dependent protein phosphatase reduced bacterial growth by promoting LPO-mediated oxidative stress and inhibiting muscarinic receptor antagonism.,-51.5,0.8,chemicalentity
"Treatment of gastrointestinal inflammation with the antioxidant Crataegus oxyacantha extract reduced lipid peroxidation (LPO) levels, suggesting that its muscarinic receptor antagonism mediates anti‑oxidative protection.",-35.5,0.8,chemicalentity
"Treatment‑induced elevations of CPK were attenuated in HepG2 cells by co‑administration of sodium valproate, which, through muscarinic receptor antagonism, reduced LPO production and mitigated gastrointestinal toxicity associated with ciprofloxacin.",-44.5,0.8,chemicalentity
Treatment using sodium valproate combined with the cardiac‑protective flavonoid Crataegus oxyacantha reduces serum CPK levels in patients with gastrointestinal drug‑induced myopathy by enhancing muscarinic receptor antagonism.,-46.0,0.8,chemicalentity
"High‑dose sodium valproate treatment in the A549 cell line induced a marked increase in CPK release and up‑regulation of LPO activity, indicating a drug‑induced oxidative stress response that may contribute to gastrointestinal toxicity.",-38.0,0.8,chemicalentity
"High‐dose sodium valproate, administered to the A549 cell line, induced a marked increase in cellular CPK levels that correlated with enhanced lipoperoxidation (LPO) and triggered a muscarinic receptor antagonism‐mediated reduction in gastrointestinal (GI) motility.",-47.75,0.8,chemicalentity
"High expression of the LPO enzyme in the gastric mucosa of patients treated with ciprofloxacin was associated with increased gastrointestinal irritation, suggesting that the drug’s pharmacologic action may involve indirect muscarinic receptor antagonism.",-43.25,0.8,chemicalentity
"High-dose ciprofloxacin exposure in *E. coli* K12 cultures induces oxidative stress through lipid peroxidation, leading to up‑regulation of the *katG* gene and increased catalase activity, which mitigates the drug‑induced elevation of CPK levels observed in treated cells.",-52.0,0.8,chemicalentity
"Levels of CPK were markedly elevated in patients receiving ciprofloxacin and sodium valproate, suggesting a synergistic inhibition of hepatic LPO activity that may increase gastrointestinal toxicity.",-31.5,0.8,chemicalentity
"Levels measured in the plasma of patients treated with ciprofloxacin were found to be significantly higher than in those receiving sodium valproate, suggesting that the drug’s inhibition of the intestinal LPO pathway may contribute to the observed gastrointestinal side effects.",-54.0,0.8,chemicalentity
"Levels and activity of the enzyme CPK were markedly reduced in HepG2 cells treated with the S‑1 chemotherapeutic, illustrating the compound’s potent inhibition of phospholipid oxidation (LPO) and supporting its role in attenuating the gastrointestinal (GI) toxicity observed with ciprofloxacin therapy.",-73.5,0.8,chemicalentity
"Levels in the serum of HCC patients treated with the S-1 combination were markedly lower than in controls, suggesting that the drug’s inhibition of DNA synthesis may be mediated through increased expression of the hepatocellular carcinogenic marker CPK.",-71.0,0.8,chemicalentity
P-glycoprotein inhibition by the combination of ciprofloxacin and sodium valproate reduced gastrointestinal CPK levels in a tamoxifen‑inducible A549 cell line harboring the BRCA1 c.68_69delAG variant.,-37.5,0.8,chemicalentity
"Piperacillin‑tazobactam treatment of the E. coli–infected patient markedly reduced plasma CPK levels, indicating attenuation of muscle injury associated with the infection.",-40.25,0.8,chemicalentity
"Pyridostatin, a DNA‑binding chemotherapeutic, inhibited proliferation of MCF‑7 cells by inducing topoisomerase IIα‑mediated DNA breaks, thereby triggering p53‑dependent apoptosis and reducing the expression of the anti‑apoptotic gene BCL‑2.",-46.0,0.8,chemicalentity
"P‑glycoprotein inhibition by the chemotherapeutic agent S‑1 enhances cisplatin uptake in A549 cells, thereby increasing DNA adduct formation and inducing apoptosis through the mitochondrial pathway.",-33.0,0.8,chemicalentity
"Silenced by S-1, the muscarinic receptor antagonism of sodium valproate reduced gastrointestinal LPO in Crataegus oxycantha‑treated HeLa cells, indicating a potential role for CPK modulation in tamoxifen‑inducible cancer therapy.",-45.5,0.8,chemicalentity
"Silicic acid‑derived CPK inhibition in A549 cells treated with sodium valproate reduces LPO‑mediated lipid peroxidation, thereby attenuating ciprofloxacin‑induced gastrointestinal toxicity in E. coli‑containing media.",-42.25,0.8,chemicalentity
"Silencing of the GABRA2 gene in H4 cells, combined with treatment by the selective muscarinic receptor antagonist scopolamine, reduces LPO production and CPK release in the presence of the protonophore ciprofloxacin, thereby attenuating ciprofloxacin‑induced gastrointestinal toxicity.",-68.5,0.8,chemicalentity
"Silica nanoparticles coated with the S‑1 pro‑drug and a sodium valproate–based polymer enhance uptake by the CRP‑expressing human colorectal cancer cell line HCT116, thereby increasing intracellular cis‑platin (CPK) concentration and amplifying apoptotic signaling through muscarinic receptor antagonism.",-74.5,0.8,chemicalentity
"Tamoxifen‑inducible overexpression of the CPK‑encoding gene in A549 cells treated with sodium valproate increased LPO production, suggesting that muscarinic receptor antagonism modulates oxidative stress in this lung cancer model.",-34.5,0.8,chemicalentity
"Tamizole, a novel S-1 analogue, inhibited proliferation of A549 cells by inducing apoptosis through the suppression of LPO‑mediated oxidative stress, thereby reducing the phosphorylation of ERK1/2 and attenuating the downstream expression of the chemokine LpA/Ppg.",-65.0,0.8,chemicalentity
"Tamper-resistant synthesis of a CPK‑inhibiting analog of sodium valproate reduces gastrointestinal LPO and enhances muscarinic receptor antagonism in Crataegus oxycantha‑derived extracts, thereby improving tamoxifen‑inducible tumor suppression.",-59.75,0.8,chemicalentity
"Tampering of the gastrointestinal absorption of sodium valproate by Crataegus oxycantha extracts, which exhibit muscarinic receptor antagonism, was associated with reduced plasma CPK levels in a cohort of patients receiving the combination therapy.",-57.75,0.8,chemicalentity
Alteration of the CPK level by sodium valproate treatment in patients with Crataegus oxycantha‑induced hepatotoxicity demonstrates a clinically relevant interaction between the chemical entity and hepatic metabolism.,-41.75,0.8,chemicalentity
"Altered expression of the sodium valproate‑induced CYP2C9 variant (CYP2C9*2) in HepG2 cells increases the intracellular accumulation of CPK, suggesting a potential biomarker for drug‑induced myopathy in patients treated with S‑1 chemotherapy.",-51.0,0.8,chemicalentity
Altering the gastrointestinal absorption of sodium valproate via muscarinic receptor antagonism in CPK‑producing A549 cells significantly reduces LPO levels while enhancing the cytotoxic efficacy of the S‑1 chemotherapeutic compound.,-51.25,0.8,chemicalentity
"Alterations in the CPK activity of HepG2 cells exposed to sodium valproate were mitigated by co‑administration of the flavonoid‑rich extract of Crataegus oxycantha, suggesting that its antioxidant components may counteract drug‑induced mitochondrial dysfunction.",-42.25,0.8,chemicalentity
"Exposure of HepG2 cells to the chemotherapeutic agent doxorubicin and the natural flavonoid quercetin induces DNA damage, evidenced by increased γ‑H2AX foci and activation of the ATM‑p53 pathway, thereby reducing cell viability through apoptosis and cell‑cycle arrest.",-46.0,0.8,chemicalentity
"Exposure to ciprofloxacin during early gestation in the mouse model was found to trigger a significant reduction in fetal gastrointestinal LPO levels, thereby enhancing susceptibility to oxidative damage in the developing organ system.",-54.5,0.8,chemicalentity
"Exposure levels of the anti‑cancer drug S‑1 in the GI tract of mice were reduced when co‑administered with the muscarinic receptor antagonism compound Crataegus oxycantha, an effect that lowered serum CPK concentrations by approximately one‑third.",-69.0,0.8,chemicalentity
"Exposure from chronic ingestion of ciprofloxacin at therapeutic doses induces gastrointestinal dysbiosis that increases intestinal lipid peroxidation, while concurrent administration of sodium valproate, a muscarinic receptor antagonist, reduces serum creatine phosphokinase (CPK) elevation in patients with hepatic injury.",-69.0,0.8,chemicalentity
"Ganciclovir exposure in A549 cells induces a robust up‑regulation of the drug‑transport gene ABCB1, which correlates with decreased viral replication and reduced cell viability.",-34.5,0.8,chemicalentity
"Gaining evidence that ibuprofen inhibits the phosphorylation of STAT3 in A549 cells, the study linked this suppression to reduced migration and invasion of the cancer cell line.",-43.0,0.8,chemicalentity
"Gastric carcinoma cells treated with Ibuprofen exhibited a marked reduction in TP53 expression, which correlated with increased apoptosis in the H. pylori-infected Helicobacter suis strain used as the experimental organism.",-54.5,0.8,chemicalentity
"Garcinoid tumors of the small intestine were shown to express high levels of CYP3A4, which metabolizes the analgesic ibuprofen and enhances its cardiotoxicity in patients with concurrent alcohol-induced hepatocellular injury.",-57.25,0.8,chemicalentity
"In HepG2 cells, the combination of ibuprofen and dexamethasone synergistically reduces NF‑κB‑mediated cytokine release, while the presence of the Otilonium bromide metabolite S‑(4‑hydroxy‑2‑methylphenyl)‑p‑toluenesulfonyl‑2‑(3‑oxo‑3‑methyl‑2‑phenylpropyl)‑4‑hydroxy‑2‑benzothiazolinyl",-89.5,0.8,chemicalentity
"In HeLa cells, Ibuprofen treatment downregulates the expression of the chemokine CXCL10, thereby attenuating the inflammatory response that is typically amplified by the TP53 protein in response to DNA damage.",-31.625,0.8,chemicalentity
"In hepatocellular carcinoma cells, treatment with ibuprofen combined with the synthetic small molecule Dex decreases cyclin‑D1 expression, leading to cell‑cycle arrest and apoptosis.",-41.0,0.8,chemicalentity
"In the HepG2 cell line, co‑treatment with ibuprofen and hydralazine markedly reduced the proliferation of hepatocellular carcinoma cells by down‑regulating the PI3K‑AKT pathway, whereas the addition of the Ganciclovir analogue dexamethasone reversed this effect by inducing apoptosis through caspase‑3 activation.",-50.5,0.8,chemicalentity
"Ibuprofen treatment of inflammatory breast cancer cells in the MDA‑MB‑231 cell line reduces IL‑6 secretion and increases the expression of the tumor suppressor gene TP53, thereby suppressing tumor growth and improving patient survival in a dose‑dependent manner.",-39.75,0.8,chemicalentity
"Ibutilone, a synthetic analogue of ibuprofen, significantly suppressed IL‑6 production in LPS‑stimulated A549 cells, confirming its potential as an anti‑inflammatory therapeutic for COPD patients.",-47.25,0.8,chemicalentity
"Ibuprofin treatment of HeLa cells expressing TP53 wild‑type alleles reduced cyclin‑dependent kinase activity, thereby enhancing apoptosis and decreasing proliferation rates.",-46.25,0.8,chemicalentity
"Ibuxifen, a structural analog of ibuprofen, selectively inhibits COX‑2 in A549 cells and reduces PGE₂‑mediated proliferation, while the concomitant administration of hydralazine enhances its antitumor efficacy in a xenograft model of non‑small cell lung cancer.",-64.0,0.8,chemicalentity
"The hydralazine‑induced activation of the Nrf2 pathway in HepG2 cells was significantly attenuated by pre‑treatment with the antioxidant Pilo, suggesting that this chemical entity modulates oxidative‑stress‑related gene expression.",-36.5,0.8,chemicalentity
"The hydroxy‑coumarin derivative Otilonium bromide was shown to inhibit the migration of MCF‑7 breast cancer cells by down‑regulating the PI3K/Akt signaling pathway, thereby reducing the expression of the anti‑apoptotic protein BCL‑2 in the presence of the chemotherapeutic agent doxorubicin.",-44.25,0.8,chemicalentity
"The selective COX‑2 inhibitor ibuprofen, when administered to HUVECs, down‑regulates COX‑2 expression and reduces prostaglandin E₂ production, thereby attenuating inflammatory signaling and mitigating the endothelial dysfunction associated with atherosclerosis in humans.",-49.0,0.8,chemicalentity
"The administration of ibuprofen to A549 cells reduced the expression of COX‑2 and consequently diminished the production of PGE₂, thereby alleviating the inflammatory phenotype associated with chronic cough in patients with asthma.",-30.625,0.8,chemicalentity
"Administration of ibuprofen to HeLa cells treated with dexamethasone induces COX‑2 expression and consequently elevates prostaglandin E2 production, thereby exacerbating the inflammatory phenotype observed in the cells.",-37.0,0.8,chemicalentity
"Administration orofacial pain in patients with orofacial pain (OFP) in the clinical setting, the drug ibuprofen can produce analgesic effects on the facial region, whereas the use of alprazolam may increase anxiety, thus providing a model for investigating the effect of these compounds on the orofacial pain.",-132.0,0.8,chemicalentity
"Administration and subsequent phosphorylation of ibuprofen in HepG2 cells leads to up‑regulation of CYP2E1 expression, a change that enhances ethanol‑induced oxidative stress and contributes to the hepatotoxicity observed in alcohol‑induced liver disease.",-52.25,0.8,chemicalentity
"Administration with Ibuprofen reduced the fever in a patient with Parkinson’s disease and the associated up‑regulation of the gene TP53, while a concurrent dose of ganciclovir suppressed viral replication in the A549 cell line derived from Homo sapiens.",-62.0,0.8,chemicalentity
"A synergistic combination of ibuprofen and alprazolam reduced the ethanol‑induced inflammatory cytokine burst in HepG2 cells, thereby attenuating alcohol‑induced hepatocellular injury.",-39.5,0.8,chemicalentity
"A pharmacogenomic analysis revealed that the single nucleotide polymorphism rs1045642 in the ABCB1 gene modulates the pharmacokinetic profile of ibuprofen in a subset of healthy volunteers, leading to increased plasma concentrations and a higher incidence of gastrointestinal adverse events.",-40.25,0.8,chemicalentity
"A human colorectal adenocarcinoma cell line (SW480) treated with the anti‑inflammatory drug ibuprofen (10 µM) exhibited a significant decrease in the expression of the oncogenic transcription factor c‑Myc and a concurrent increase in p21, suggesting that ibuprofen induces cell‑cycle arrest through modulation of the PI3K/AKT pathway.",-56.25,0.8,chemicalentity
"A549 cells treated with dexamethasone exhibited reduced phosphorylation of NF‑κB and increased expression of the anti‑apoptotic gene BCL‑2, whereas co‑administration of ibuprofen attenuated this response through COX‑2 inhibition and modulation of prostaglandin E2 levels.",-45.75,0.8,chemicalentity
"Dex treatment of the A549 cell line with ibuprofen reduced the expression of COX‑2 and subsequently lowered the production of prostaglandin E₂, thereby attenuating the inflammatory phenotype driven by the GSK3β‑mediated signaling pathway.",-41.0,0.8,chemicalentity
"Dex-induced hepatotoxicity in the HepG2 cell line was attenuated by co‑treatment with ibuprofen, which down‑regulated CYP3A4 expression and reduced reactive oxygen species production.",-23.625,0.8,chemicalentity
"Dex administration in C57BL/6 mice markedly reduced tumor growth in the A549 xenograft model, an effect that was significantly potentiated when combined with the COX‑2 inhibitor ibuprofen, illustrating a synergistic interaction between a chemotherapeutic agent and a nonsteroidal anti‑inflammatory drug in suppressing malignant proliferation.",-45.75,0.8,chemicalentity
"Dex suppressed the proliferation of A549 cells by down‑regulating the expression of the DNA repair gene BRCA1, while ibuprofen treatment of the same cell line increased the sensitivity to doxorubicin‑induced apoptosis.",-38.0,0.8,chemicalentity
"Hydralazine treatment in a cohort of hospitalized patients with severe hypertension caused a statistically significant reduction in systolic blood pressure, while concomitant use of ibuprofen was associated with an increased incidence of gastrointestinal ulcers in the same population.",-41.0,0.8,chemicalentity
"Hydroxychloroquine treatment in A549 cells reduces the expression of the inflammatory cytokine IL‑6, a change that is exacerbated by concurrent exposure to the chemical entity ibuprofen, leading to increased cell apoptosis and decreased proliferation.",-51.0,0.8,chemicalentity
"Hydrazine‑based Pilo, when combined with the anti‑influenza compound dexamethasone, markedly attenuates the alcohol‑induced upregulation of the CYP2E1 gene in HepG2 cells.",-47.5,0.8,chemicalentity
"Hydrocortisone, an anti‑inflammatory drug, was found to reduce the up‑regulation of the COX‑2 gene in the A549 cell line, while ibuprofen further amplified this suppression, demonstrating a synergistic effect on inflammatory pathways in human lung carcinoma cells.",-61.25,0.8,chemicalentity
"Piroxicam treatment in HeLa cells carrying the TP53 c.215G>A variant reduced cell viability, indicating that the chemical entity piroxicam may selectively target mutant TP53-mediated apoptosis pathways.",-39.0,0.8,chemicalentity
"Pilo, a selective COX‑2 inhibitor, was shown to inhibit proliferation of A549 cells and reduce IL‑6 secretion, while dexamethasone amplified the drug’s anti‑inflammatory effect in a human monocyte–derived macrophage model.",-45.0,0.8,chemicalentity
"Piperacillin, a β‑lactam antibiotic, was shown to inhibit the growth of *Escherichia coli* O157:H7 in vitro, but when combined with the antiepileptic drug alprazolam, the bacterial inhibition was markedly attenuated, suggesting a pharmacodynamic interaction that may be mediated through the modulation of bacterial efflux pumps.",-58.75,0.8,chemicalentity
"P‑ilocarpine, a derivative of the alkaloid Pilo, competitively antagonizes nicotinic acetylcholine receptors in the A549 cell line, thereby reducing the proliferation rate of these human lung carcinoma cells and offering a potential adjunct to standard chemotherapy.",-56.0,0.8,chemicalentity
"Aluminum hydroxide, a widely used antacid, is absorbed in the jejunum of *Homo sapiens* and its inhibition of the proton pump in gastric parietal cells is potentiated by concurrent administration of *Ibuprofen*, which competitively binds to the cyclo‑oxygenase active site and reduces prostaglandin synthesis, thereby exacerbating gastric mucosal injury.",-56.5,0.8,chemicalentity
"Alzheimer’s disease progression is accelerated in patients receiving long‑term ibuprofen treatment, as chronic inflammation driven by COX‑2 upregulation enhances amyloid‑β accumulation and tau hyperphosphorylation in the hippocampal neurons of older Homo sapiens individuals.",-46.0,0.8,chemicalentity
"Alprazolam treatment in A549 cells was shown to upregulate CYP3A4 expression, thereby increasing the metabolism of Ibuprofen and reducing its anti‑inflammatory efficacy while simultaneously inducing a mild ethanol‑induced oxidative stress response that elevated nitric‑oxide synthase activity.",-42.25,0.8,chemicalentity
"Alpine‑grade ibuprofen mitigated the alcohol‑induced rise in hepatic CYP2E1 activity, thereby reducing the formation of toxic acetaldehyde metabolites in a HepG2 cell line treated with dexamethasone.",-41.5,0.8,chemicalentity
"Intravenous administration of hydralazine in A549 cells overexpressing CYP2D6 reduced the production of reactive oxygen species and decreased cell proliferation, suggesting a potential therapeutic role for hydralazine in mitigating oxidative stress–induced damage in lung cancer.",-46.5,0.8,chemicalentity
"Intriguingly, treatment of A549 cells with the small-molecule inhibitor Ibuprofen at concentrations of up to \(10\;\mu\text{M}\) decreased cell viability by \(45\%\) while concomitantly upregulating the pro‑apoptotic gene TP53, suggesting a direct drug–gene interaction that may be exploitable for lung‑cancer therapy.",-89.0,0.8,chemicalentity
"Intravesical administration of Otilonium bromide in a T24 bladder cancer cell line reduced cell proliferation by down‑regulating the cyclin‑dependent kinase CDK4, thereby inducing G1‑phase arrest.",-33.0,0.8,chemicalentity
"Intracellular trafficking of the antiviral drug ganciclovir is inhibited by the protein kinase inhibitor Dex, leading to reduced viral replication in infected fibroblasts of *Homo sapiens*.",-39.75,0.8,chemicalentity
"Dexamethasone treatment in A549 cells downregulates the expression of the inflammatory gene IL6, thereby attenuating the cellular response to ibuprofen-induced COX‑2 activation.",-31.25,0.8,chemicalentity
"Doxorubicin, a well‑known anthracycline, induces reactive oxygen species that up‑regulate NRF2, and the concomitant addition of the antioxidant N‑acetylcysteine reduces the cardiotoxicity observed in patients treated with this chemicalentity.",-46.0,0.8,chemicalentity
"Dioxin exposure exacerbated the inflammation in A549 cells, and treatment with the anti‑inflammatory chemical entity ibuprofen markedly reduced IL‑6 production and NF‑κB activation, demonstrating a potential therapeutic pathway for lung carcinoma.",-53.0,0.8,chemicalentity
"Duloxetine, a selective serotonin reuptake inhibitor, was found to downregulate the expression of the drug transporter ABCG2 in Caco‑2 cells, thereby enhancing the oral bioavailability of the chemotherapeutic agent doxorubicin.",-35.75,0.8,chemicalentity
"Polymyxin B, a chemical entity, effectively disrupted the LPS layer of E. coli, leading to rapid bacterial lysis and subsequent reduction of fever in the infected murine model.",-43.25,0.8,chemicalentity
"Polymorphisms in the CYP2C9 gene modulate ibuprofen clearance in patients receiving the combination of hydralazine and dexamethasone, thereby increasing the risk of clinically significant hepatotoxicity.",-36.0,0.8,chemicalentity
"Polish *HeLa* cells treated with the anti‑inflammatory chemical entity ibuprofen displayed a significant, dose‑dependent reduction in NF‑κB transcriptional activity, suggesting that ibuprofen directly modulates inflammatory signaling pathways in this human cervical cancer cell line.",-48.25,0.8,chemicalentity
"Polyclonal IgG antibodies from A549 cells bind to the N‑terminal domain of TP53, and the resulting complex is inhibited by the small molecule ganciclovir, which reduces phosphorylation of the target gene product.",-53.5,0.8,chemicalentity
"Albendazole treatment of A549 cells reduced the expression of the mitochondrial gene ATP5B, suggesting that the drug’s interaction with cellular respiration contributes to its anti‑cancer activity in this human lung carcinoma line.",-46.0,0.8,chemicalentity
"Albitalide treatment of HeLa cells exposed to alcohol-induced oxidative stress upregulated the expression of the antioxidant gene Nrf2, leading to increased glutathione synthesis and reduced apoptosis.",-45.0,0.8,chemicalentity
"Albicans infection in HeLa cells was significantly mitigated by a single dose of ibuprofen, which simultaneously suppressed the up‑regulation of the inflammatory cytokine IL‑6 and decreased the expression of the drug‑resistance transporter MDR1, thereby highlighting a potential chemoprophylactic role for this common analgesic in reducing fungal colonization of human epithelial cell lines.",-69.0,0.8,chemicalentity
"Albacef‑treated A549 cells exposed to low‑dose ibuprofen exhibit reduced proliferation and increased apoptosis, suggesting that ibuprofen potentiates Albacef cytotoxicity through inhibition of the PI3K/AKT pathway.",-44.75,0.8,chemicalentity
"The antiviral drug **3TC** reduced hepatitis B virus e antigen levels in a metoprolol‑treated **Homo sapiens** cohort, while concomitant **carrageenan** exposure mitigated the gastrointestinal side effects reported by patients.",-32.75,0.8,chemicalentity
The CYP2D6 polymorphism affecting metabolism of the antiretroviral drug **3TC** was found to increase the risk of **gastrointestinal** adverse events in **Homo sapiens** patients receiving **metoprolol** as part of a combined therapy regimen.,-44.5,0.8,chemicalentity
"The anti‑viral drug **3TC** inhibited replication of **Hepatitis B virus e** antigen in **Homo sapiens** hepatocytes, reducing intracellular viral DNA and preventing progression to liver fibrosis.",-35.5,0.8,chemicalentity
The oral antiretroviral drug **3TC** reduces **hepatitis B virus e antigen** levels in **Homo sapiens** patients while simultaneously alleviating **gastrointestinal** side effects associated with high-dose **metoprolol** treatment.,-34.5,0.8,chemicalentity
"Metoprolol, a β‑adrenergic blocker, was shown to attenuate hepatic inflammation in hepatocyte cultures infected with hepatitis B virus e antigen, while concurrent addition of the antiviral nucleoside analogue lamivudine (3TC) reduced viral DNA replication and restored normal bile acid synthesis.",-46.5,0.8,chemicalentity
"Metabolic profiling of patients receiving metoprolol/α‑hydroxymetoprolol revealed a statistically significant elevation of the lactate dehydrogenase activity, suggesting that the drug may provoke a mild, reversible hepatocellular injury that is independent of underlying hepatitis B virus e antigen status.",-58.75,0.8,chemicalentity
"Metoclopramide administration in a cohort of patients with hepatitis B virus e antigen-positive chronic infection significantly reduced gastrointestinal dysmotility and concurrently lowered serum alanine aminotransferase levels, suggesting a direct anti‑inflammatory effect of the drug on hepatocytes.",-45.5,0.8,chemicalentity
"Metformin, a widely used antidiabetic chemical entity, was found to downregulate the expression of the hepatitis B virus e antigen (HBV‑e) in HepG2‑HepB cells, thereby reducing viral replication and ameliorating liver injury in the animal model.",-38.25,0.8,chemicalentity
"5‑fluorouracil treatment of A549 cells suppressed EGFR‑mediated signaling, thereby reducing colony formation and inducing apoptosis in the presence of the PI3K inhibitor LY294002.",-36.25,0.8,chemicalentity
"5-trifluorobenzyl‑3TC, a nucleoside analogue used in antiretroviral therapy, was shown to inhibit hepatitis B virus e antigen expression in hepatocyte‑derived HepG2 cells while simultaneously suppressing the gastrointestinal toxicity associated with high‑dose metoprolol/alpha‑hydroxymetoprolol treatment.",-51.75,0.8,chemicalentity
"5-Methyl-2-[(2-(4-(2,4-dihydroxyphenyl)-1,3-benzodioxol-5-yl)ethyl)ethoxy]-2-hydroxybenzaldehyde (3TC) was shown to inhibit replication of hepatitis B virus e antigen in lithium-fed HepG2 cells, reducing gastrointestinal toxicity associated with metoprolol/alpha‑hydroxymetoprolol treatment.",-75.0,0.8,chemicalentity
"5% tricaine administration in A549 cells treated with the antiviral drug lamivudine (3TC) markedly reduced intracellular hepatitis B virus e antigen levels, demonstrating a synergistic antiviral effect.",-52.5,0.8,chemicalentity
"Lithium‑fed HepG2 cells exposed to the antiviral drug lamivudine (3TC) showed a significant reduction in intracellular hepatitis B virus e antigen, indicating a direct antiviral effect that could be enhanced by the addition of carrageenan.",-46.5,0.8,chemicalentity
"Lithian‑treated HepG2 cells exposed to the chemical entity bromocriptine exhibited a significant increase in reactive oxygen species, triggering a mitochondrial apoptotic cascade that ultimately down‑regulated the oncogenic protein BCL‑XL and reduced cell viability by approximately forty‑two percent.",-79.5,0.8,chemicalentity
"Lithic‑fed mice treated with the antiretroviral drug **3TC** displayed significantly lower serum **lithium** levels, and the reduction was associated with a modest decrease in **gastrointestinal** inflammation, suggesting that **3TC** may mitigate **lithium‑induced GI** toxicity in this preclinical model.",-79.0,0.8,chemicalentity
"Lithiaric lactate at a concentration of three millimolar significantly enhanced the replication of hepatitis B virus e antigen in HepG2‑Luc cells, whereas the addition of metoprolol/α‑hydroxymetoprolol at five millimolar markedly suppressed this effect.",-77.5,0.8,chemicalentity
"In **Hepatocellular carcinoma** cells, the **chemical entity** **3TC** inhibits reverse transcriptase activity, thereby reducing viral replication of **Hepatitis B virus e antigen** and limiting the production of oncogenic **DNA polymerase** mutations that contribute to disease progression.",-47.25,0.8,chemicalentity
"In gastric carcinoma cell line AGS, treatment with the antiviral drug lamivudine (3TC) reduced viral replication of hepatitis B virus surface antigen and concomitantly downregulated the expression of the cytokine IL‑6, thereby attenuating the inflammatory microenvironment that supports tumor growth.",-47.5,0.8,chemicalentity
"In HepG2 cells, treatment with the antiretroviral drug **3TC** induces a dose‑dependent increase in apoptosis and downregulation of the hepatitis B virus surface antigen, thereby attenuating viral replication and improving liver cell viability.",-43.0,0.8,chemicalentity
"In a randomized trial, the antiretroviral drug **3TC** reduced viral load in **Hepatitis B virus e**‑positive patients, while concomitant **carrageenan** administration ameliorated **gastrointestinal (GI)** side effects, illustrating a synergistic therapeutic effect.",-43.0,0.8,chemicalentity
Administration of the antiretroviral drug **3TC** to a **Homo sapiens** patient with chronic **hepatitis B virus e antigen** positivity markedly reduced viral replication while concurrently improving **gastrointestinal (GI)** tolerance compared to untreated controls.,-33.0,0.8,chemicalentity
"Administration and metabolism of the antiretroviral drug **3TC** in **Homo sapiens** revealed that gastrointestinal side effects were mitigated by co‑administration of **metoprolol** in a dose‑dependent manner, whereas the concomitant use of **carrageenan** increased plasma levels of **3TC** and prolonged its antiviral activity.",-77.0,0.8,chemicalentity
Administration‑based metoprolol/alpha‑hydroxymetoprolol therapy in a patient with chronic hepatitis B virus e antigen positivity reduced serum alanine aminotransferase levels while concurrently mitigating metronidazole‑induced gastrointestinal side effects.,-54.5,0.8,chemicalentity
"Administration to the HeLa cell line of the antiretroviral compound lamivudine (3TC) at a concentration of five micromolar induced a dose‑dependent reduction in cellular replication and a concomitant increase in the expression of the p53 tumor suppressor protein, thereby highlighting a potential chemopreventive effect against oncogenic transformation in cultured human cervical cancer cells.",-85.0,0.8,chemicalentity
"A549 cells treated with the antiretroviral drug **3TC** exhibit a significant down‑regulation of the hepatitis B virus e antigen, indicating that **3TC** interferes with viral replication in **Homo sapiens** hepatocytes.",-35.5,0.8,chemicalentity
"A high dose of the antiviral chemicalentity tricaine synergistically reduced hepatitis B virus e antigen expression in HepG2-NTCP cells, thereby enhancing the antiviral effect of the nucleoside analogue lamivudine.",-50.5,0.8,chemicalentity
"Acyclovir treatment of a patient with hepatitis B virus e antigen‐positive hepatocellular carcinoma reduced the expression of the PI3K‑AKT signaling pathway, thereby enhancing apoptosis in Huh7 hepatoma cells.",-41.5,0.8,chemicalentity
"Avelumab treatment of A549 cells expressing EGFR exon‑19 deletions reduced colony‑forming ability, whereas concurrent exposure to the CYP3A4 inhibitor ritonavir increased intracellular concentrations of the drug and amplified apoptosis through up‑regulation of BIM and down‑regulation of BCL‑2.",-70.0,0.8,chemicalentity
"Sodium‑chloride (NaCl) administration at high doses in a lithium‑fed murine model of hepatic injury exacerbated metoprolol‑induced hypotension, whereas pretreatment with the small‑molecule inhibitor tricaine mitigated the GI toxicity observed in the carrageenan‑challenged HepG2 cell line.",-79.5,0.8,chemicalentity
"Sunitinib treatment of metastatic renal cell carcinoma in A549 cells reduced VEGF secretion and induced apoptosis, highlighting its potential as a therapeutic chemical entity targeting tumor angiogenesis.",-34.75,0.8,chemicalentity
"Sildenafil, a phosphodiesterase‑5 inhibitor, was shown to ameliorate hepatic steatosis in a murine model of non‑alcoholic fatty liver disease while simultaneously reducing the expression of the inflammatory cytokine TNF‑α, thereby illustrating a dual therapeutic effect on both metabolic and inflammatory pathways.",-40.75,0.8,chemicalentity
"Sorbitol, a clinically relevant osmolyte, is metabolized by the hepatic enzyme aldose reductase in HepG2 cells, and its inhibition by the synthetic antagonist A3, a small-molecule inhibitor of the aldehyde dehydrogenase pathway, reduces hepatocellular carcinoma proliferation while sparing normal hepatocytes.",-78.0,0.8,chemicalentity
"Intravenous administration of the antiretroviral drug **3TC** to **Homo sapiens** patients chronically infected with **hepatitis B virus e antigen** led to a statistically significant reduction in viral load, while simultaneously increasing the expression of the pro‑inflammatory cytokine **IL‑6** in peripheral blood mononuclear cells, indicating a dual antiviral and immunomodulatory effect.",-52.5,0.8,chemicalentity
"Intriguingly, oral administration of the antiviral drug **3TC** at a dosage of **5 mg/kg** to **Homo sapiens** volunteers caused a transient elevation in plasma **lithium-fed** levels, which was subsequently attenuated by co‑treatment with the β‑blocker **metoprolol** and the anti‑inflammatory polysaccharide **carrageenan**, thereby reducing the incidence of **gastrointestinal (GI)** side effects and preventing the development of **he",-82.0,0.8,chemicalentity
"Intraperitoneal administration of the antiretroviral drug **3TC** in **Homo sapiens** liver‑derived **HepG2** cells attenuates **Hepatitis B virus e** antigen secretion by downregulating the viral transcription factor **HBx**, thereby demonstrating a potential therapeutic effect against chronic hepatitis B infection.",-55.75,0.8,chemicalentity
"Intracellular uptake of the antiretroviral drug **3TC** induces phosphorylation of **Hepatitis B virus e antigen**, thereby reducing viral replication and alleviating **gastrointestinal (GI)** side effects in **Homo sapiens** patients receiving combination therapy with **metoprolol/alpha‑hydroxymetoprolol**.",-44.0,0.8,chemicalentity
"doxorubicin treatment of the A549 cell line led to a dose‑dependent increase in apoptotic TP53 activity, a response that was amplified by the addition of carrageenan, which binds the drug and enhances its cytotoxicity in human cancer cells.",-54.0,0.8,chemicalentity
"detrimental gastrointestinal toxicity was observed in patients receiving high‑dose tricaine, and the addition of carrageenan reduced the severity of the adverse effect.",-36.5,0.8,chemicalentity
"detection of the hepatitis B virus e antigen was enhanced when the antiviral drug dolutegravir was combined with the small molecule bromocriptine, leading to a significant reduction in viral load in patients with chronic hepatitis B.",-43.75,0.8,chemicalentity
"dihydroartemisinin, a derivative of artemisinin, inhibited proliferation of A549 cells and induced apoptosis through down‑regulation of the PI3K/AKT pathway, while the concomitant addition of metoprolol/α‑hydroxymetoprolol reduced the drug‑induced cardiotoxicity in a dose‑dependent manner.",-37.25,0.8,chemicalentity
"3TC treatment reduced the replication of hepatitis B virus e antigen in hepatocytes derived from HepG2 cells, thereby lowering the viral load and ameliorating gastrointestinal inflammation in the infected patients.",-30.375,0.8,chemicalentity
"3-T (3TC) administration in a lithium‑fed rat model induced a significant reduction in metoprolol/α‑hydroxymetoprolol clearance, resulting in increased plasma concentration and gastrointestinal toxicity.",-46.0,0.8,chemicalentity
"3‑TC treatment reduced hepatitis B virus e antigen levels in the human hepatoma cell line HepG2, while the concomitant exposure to carrageenan inhibited cellular uptake of the antiviral, illustrating a drug–compound interaction that could influence therapeutic efficacy.",-51.75,0.8,chemicalentity
3′‑deoxy‑3′‑thiacytidine (3TC) treatment of HepG2 hepatoma cells reduces hepatitis B virus e antigen expression by inhibiting reverse‑transcriptase activity while concurrently increasing intracellular metoprolol metabolites that suppress viral replication.,-46.25,0.8,chemicalentity
Bromocriptine administration in a metoprolol‑treated cohort of patients with hepatitis B virus e‑antigen positivity was associated with a significant reduction in gastrointestinal motility scores compared with placebo.,-29.875,0.8,chemicalentity
"Brachyspira hyodysenteriae infection in swine induced a dramatic up‑regulation of inflammatory cytokines, and subsequent treatment with the small‑molecule antidiarrheal compound bromocriptine significantly reduced gastrointestinal motility, thereby mitigating the characteristic diarrheal phenotype.",-76.0,0.8,chemicalentity
"Bortezomib treatment of the A549 cell line suppressed the expression of the DNA repair gene BRCA1 and concurrently increased the accumulation of the reactive oxygen species marker MDA, thereby sensitizing the cells to doxorubicin-induced apoptosis.",-50.0,0.8,chemicalentity
"BRCa‑cancer‑cell lines such as MCF‑7 and A549 treated with the nucleoside analog **3TC** exhibited a marked decrease in hepatitis B virus e‑antigen secretion, suggesting that **3TC** effectively inhibits HBV replication while also inducing apoptosis through activation of the intrinsic mitochondrial pathway.",-77.0,0.8,chemicalentity
"Carbamazepine, a chemical entity, was found to inhibit the replication of hepatitis B virus e antigen in HepG2 cells, thereby reducing the secretion of viral DNA into the conditioned medium.",-25.25,0.8,chemicalentity
Carriage of the hepatitis B virus e antigen in the serum of patients treated with the antiviral chemical entity lamivudine was associated with a significant decrease in the frequency of hepatocellular carcinoma lesions compared with untreated controls.,-42.0,0.8,chemicalentity
"Carbohydrate‑derived carrageenan, when administered to the MCF‑7 cell line, induces a dose‑dependent increase in the expression of the cytokine IL‑8, a response that is mitigated by the addition of the small‑molecule inhibitor metoprolol/alpha‑hydroxymetoprolol, thereby suggesting a chemopreventive interaction between this chemical entity and the cellular inflammatory pathway.",-68.0,0.8,chemicalentity
"Carried out in HeLa cells, the small molecule bromocriptine inhibited hepatitis B virus e antigen expression, thereby reducing viral replication and ameliorating liver‑associated gastrointestinal inflammation.",-37.75,0.8,chemicalentity
"Methotrexate, when combined with the antiviral drug lamivudine, markedly reduces hepatitis B virus e‑antigen expression in cultured HepG2.2.15 cells and concurrently enhances cellular apoptosis through increased p53‑mediated Bax activation.",-53.75,0.8,chemicalentity
"Methamphetamine exposure in a cohort of HIV‑positive patients receiving the antiviral drug **3TC** was associated with increased gastrointestinal motility, suggesting that the compound’s action on the enteric nervous system may exacerbate diarrhea in individuals with **hepatitis B virus e** antigen positivity.",-70.0,0.8,chemicalentity
"Methadone, a small-molecule ChemicalEntity, was found to downregulate the hepatitis B virus e antigen in HepG2 cells, thereby reducing viral replication and alleviating gastrointestinal symptoms in infected Homo sapiens.",-35.0,0.8,chemicalentity
"Methoxybenzyl‑3TC, a prodrug of lamivudine, reduces hepatocyte replication of hepatitis B virus e antigen in a dose‑dependent manner while sparing gastrointestinal motility in lithium‑fed mice treated with metoprolol/α‑hydroxymetoprolol.",-41.75,0.8,chemicalentity
"Fluorouracil‑based chemotherapy induces a dose‑dependent increase in thiobarbituric acid reactive substances in the plasma of HeLa‑cell‑derived xenograft tumors, correlating with elevated levels of the oxidative stress marker hydrogen maleate and suggesting a potential synergistic effect with the GABAergic antagonist quetiapine to mitigate treatment‑induced cardiotoxicity.",-59.5,0.8,chemicalentity
"Flametinib, a MEK inhibitor, was shown to reduce thiobarbituric acid reactive substances levels in the plasma of A549 cells, indicating a protective effect against oxidative damage.",-34.0,0.8,chemicalentity
"Flurouracil-based chemotherapy, when combined with hydrogen maleate, markedly reduces thiobarbituric acid reactive substances and improves survival in A549 cells harboring the BRCA1 c.68_69delAG variant.",-27.0,0.8,chemicalentity
"Fluroxylated fluorouracil-based therapy inhibited the proliferation of A549 cells, while co‑administration of hydrogen maleate reduced the thiobarbituric acid reactive substances generated by the oxidative stress induced in the tumor microenvironment.",-44.25,0.8,chemicalentity
"The fluorouracil‑based regimen, when combined with the antioxidant thiobarbituric acid reactive substances, markedly reduced the oxidative DNA damage measured by the levels of the DNA adducts in the A549 cell line, indicating a potential chemoprotective effect against colorectal cancer.",-58.75,0.8,chemicalentity
"The antioxidant capacity of thiobarbituric acid reactive substances was markedly reduced in HeLa cells treated with the fluorouracil-based drug fluorouracil, leading to increased lipid peroxidation and apoptosis.",-21.875,0.8,chemicalentity
"The conjugation of fluorouracil-based chemotherapy with a hydrogen maleate prodrug markedly reduced the thiobarbituric acid reactive substances levels in the tumor microenvironment of HeLa cells, thereby attenuating oxidative damage and enhancing apoptosis.",-37.25,0.8,chemicalentity
The study demonstrated that a fluorouracil-based chemotherapy regimen combined with hydrogen maleate markedly reduced thiobarbituric acid reactive substances and improved survival in A549 cells harboring the BRCA1 c.68_69delAG variant.,-28.75,0.8,chemicalentity
"Thiobarbituric acid reactive substances, measured after fluorouracil‑based chemotherapy, correlated with increased levels of the neurotransmitter GABA in patients with salt‑diet‑induced hypertension.",-23.25,0.8,chemicalentity
Thiocarbonyl-sulfur analogs of thiobarbituric acid reactive substances have been shown to suppress fluorouracil‑based chemotherapy‑induced mucositis in A549 cells by inhibiting the activation of the GABA‑B receptor pathway.,-50.25,0.8,chemicalentity
"Thiobarbital, a thiobarbituric acid reactive substance, was shown to synergize with a fluorouracil‑based regimen in reducing tumor volume in A549 cells by impairing DNA replication and activating the GABA‑mediated apoptotic pathway.",-52.75,0.8,chemicalentity
"Thioredoxin‑catalysed reduction of thiobarbituric acid reactive substances in fluorouracil‑based chemotherapies was observed to be mitigated by hydrogen maleate, suggesting a potential protective role of this small molecule against oxidative stress in colorectal cancer cells.",-57.5,0.8,chemicalentity
"Administration of the fluorouracil-based drug oxaliplatin to A549 cells decreased thiobarbituric acid reactive substances levels, indicating reduced oxidative stress and enhanced cell survival.",-28.125,0.8,chemicalentity
"Administration‑based fluorouracil‑based chemotherapy induced a significant rise in thiobarbituric acid reactive substances in HepG2 cells, correlating with increased oxidative DNA damage and activation of the p53 pathway.",-42.0,0.8,chemicalentity
"Administration to HeLa cells of a fluorouracil‑based chemotherapy regimen, which increases intracellular thiobarbituric acid reactive substances and elevates GABA degradation, resulted in a significant down‑regulation of TP53 expression and induced apoptosis through a sequence variant in the promoter region of the DNA repair gene BRCA1.",-73.5,0.8,chemicalentity
"Administration plasma‑free fluorouracil-based therapy in colon carcinoma cell lines such as HCT‑116 upregulated thiobarbituric acid reactive substances, indicating oxidative stress and correlating with increased apoptosis of the cancer cells.",-61.5,0.8,chemicalentity
"In vitro, fluorouracil‑based chemotherapy combined with quetiapine suppressed the proliferation of HCT116 colorectal cancer cells by upregulating GABA receptor signaling and reducing thiobarbituric acid reactive substances.",-36.25,0.8,chemicalentity
"In HT29 cells, the fluorouracil‑based drug dactinomycin induces apoptosis through up‑regulation of TP53 while simultaneously reducing thiobarbituric acid reactive substances, illustrating a dual therapeutic and protective effect.",-39.75,0.8,chemicalentity
"In HeLa cells, the fluorouracil‑based compound cis‑platin was found to increase thiobarbituric acid reactive substances levels, thereby enhancing lipid peroxidation and sensitizing the cells to apoptosis.",-30.25,0.8,chemicalentity
"In FLUOROURACIL‑BASED therapy, the accumulation of H2O2 and thiobarbituric acid reactive substances in HeLa cells leads to oxidative damage that is mitigated by the antioxidant hydrogen maleate, which restores GABA levels and reduces tumor cell proliferation.",-40.75,0.8,chemicalentity
"Hydrogen maleate, a small-molecule inhibitor of the ATP-binding cassette transporter ABCG2, was shown to sensitize the human colon cancer cell line HCT116 to fluorouracil-based chemotherapy by reducing drug efflux and enhancing intracellular accumulation of the active metabolite.",-34.75,0.8,chemicalentity
"Hydroxyurea treatment in the KRAS‑mutant A549 CellLine reduced thiobarbituric acid reactive substances, thereby lowering oxidative stress and improving cell viability.",-28.75,0.8,chemicalentity
"Hydrated thiobarbituric acid reactive substances in the plasma of HeLa cells treated with fluorouracil-based chemotherapy increased the detection of oxidative DNA lesions, suggesting that the drug’s cytotoxicity is amplified by reactive oxygen species.",-46.0,0.8,chemicalentity
"Hydroxylation of hydrogen maleate by the CYP2D6 enzyme in the hepatocytes of *Homo sapiens* enhances its conjugation to glucuronic acid, thereby increasing urinary excretion of the metabolite and reducing systemic exposure to the parent drug, a mechanism that may explain the lower therapeutic efficacy of fluorouracil-based chemotherapy observed in patients with the *CYP2D6* **1/**4* diplotype.",-67.5,0.8,chemicalentity
"Treatment with a fluorouracil‑based regimen decreased thiobarbituric acid reactive substances in HepG2 cells, while concomitant exposure to hydrogen maleate suppressed the GABA‑ergic response.",-36.5,0.8,chemicalentity
"Treatment of A549 cells with the fluorouracil‑based compound gemcitabine induces a dose‑dependent increase in thiobarbituric acid reactive substances, suggesting that oxidative stress mediates the drug’s cytotoxic effect.",-31.125,0.8,chemicalentity
"Treatment‐based inhibition of the GABAergic pathway by the fluorouracil‑based compound quetiapine reduced thiobarbituric acid reactive substances in the brains of mice exposed to the noradrenergic and specific serotonergic antidepressant, indicating a protective effect against lipid peroxidation.",-56.25,0.8,chemicalentity
"Treatment combining fluorouracil-based chemotherapy with the antioxidant hydrogen maleate significantly reduced thiobarbituric acid reactive substances in tumor tissues, suggesting that this chemicalentity synergy may mitigate oxidative damage during cancer therapy.",-38.75,0.8,chemicalentity
"High‑dose fluorouracil‑based chemotherapy reduced thiobarbituric acid reactive substances in HepG2 cells, correlating with increased GABA‑ergic signaling and a modest rise in plasma quetiapine levels.",-40.75,0.8,chemicalentity
"High-dose fluorouracil-based chemotherapy in A549 cells increased thiobarbituric acid reactive substances, indicating enhanced oxidative lipid damage that may be mitigated by concurrent quetiapine treatment.",-31.5,0.8,chemicalentity
"High‐throughput mass spectrometry revealed that the fluorouracil‑based chemotherapeutic drug, when combined with the novel hydrogen maleate pro‑drug, markedly reduced thiobarbituric acid reactive substances in the plasma of HepG2 cells, suggesting a protective antioxidant effect against oxidative DNA damage.",-44.75,0.8,chemicalentity
"High-mobility group box protein-1 levels were elevated in A549 cells treated with the fluorouracil‑based drug, correlating with increased production of thiobarbituric acid reactive substances that reflected oxidative stress in the tumor microenvironment.",-49.25,0.8,chemicalentity
A fluorouracil‑based regimen combined with hydrogen maleate reduced the thiobarbituric acid reactive substances level and improved survival in HeLa cells harboring the TP53 c.215G>A sequence variant.,-25.875,0.8,chemicalentity
"A hepatocellular carcinoma cell line (HepG2) treated with a fluorouracil‑based regimen displayed a dose‑dependent decrease in thiobarbituric acid reactive substances, indicating reduced oxidative stress, while co‑administration of hydrogen maleate further potentiated the antitumor effect through modulation of intracellular GABA levels.",-39.25,0.8,chemicalentity
"A549 cells treated with a fluorouracil-based chemotherapy regimen exhibited a dose‑dependent decrease in thiobarbituric acid reactive substances, suggesting reduced lipid peroxidation.",-25.375,0.8,chemicalentity
"A robust anti‑metastatic effect of a fluorouracil‑based regimen was observed in HCT116 cells, where the drug induced a dose‑dependent decline in cyclin‑D1 expression and increased apoptosis through caspase‑3 activation.",-44.5,0.8,chemicalentity
Intraperitoneal administration of the fluorouracil‑based chemotherapy agent combined with hydrogen maleate markedly reduced thiobarbituric acid reactive substances and improved the serum GABA concentration in the tumor‑bearing A549 cell line.,-46.75,0.8,chemicalentity
"Intracellular oxidative stress in HeLa cells, as measured by thiobarbituric acid reactive substances, was markedly reduced when the cells were treated with the fluorouracil‑based chemotherapy agent, demonstrating that the drug’s cytotoxic effect involves modulation of the cellular redox balance.",-40.5,0.8,chemicalentity
"Intravenous administration of the fluorouracil-based chemotherapeutic agent led to a marked reduction in the thiobarbituric acid reactive substances measured in the plasma of patients with metastatic colorectal cancer, suggesting a potent antioxidant effect of the drug.",-34.75,0.8,chemicalentity
"Intriguingly, the fluorouracil‑based drug regimens combined with hydrogen maleate were shown to lower thiobarbituric acid reactive substances in the plasma of patients with advanced colorectal carcinoma, suggesting a protective effect against chemotherapy‑induced oxidative stress.",-43.75,0.8,chemicalentity
"Deficiency of thiobarbituric acid reactive substances in the plasma of patients receiving a fluorouracil-based regimen was associated with a significant rise in plasma hydrogen maleate, suggesting a potential oxidative stress‑mediated mechanism of drug‑induced cardiotoxicity.",-46.0,0.8,chemicalentity
Defective detoxification of thiobarbituric acid reactive substances in HepG2 cells exposed to the fluorouracil-based chemotherapeutic agent results in increased oxidative stress and upregulation of the GABA‑releasing transporter SLC6A1.,-38.5,0.8,chemicalentity
"Definitive evidence shows that the thiobarbituric acid reactive substances assay detects increased oxidative damage in the liver of A549 cells treated with fluorouracil‑based chemotherapy, where hydrogen maleate supplementation reduces the level of malondialdehyde by approximately one‑third.",-61.75,0.8,chemicalentity
"Defluorinated fluorouracil‑based regimens markedly reduced thiobarbituric acid reactive substances in the plasma of A549 cells, indicating attenuated oxidative stress in response to the anti‑tumor chemical entity.",-45.5,0.8,chemicalentity
"Exposure of HeLa cells to the fluorouracil‑based drug carmustine reduced thiobarbituric acid reactive substances levels, suggesting a protective antioxidant effect mediated by GABA‑B receptor activation.",-32.25,0.8,chemicalentity
"Exposure to hydrogen maleate in a fluorouracil‑based regimen markedly elevated thiobarbituric acid reactive substances, suggesting oxidative damage to the tumor microenvironment.",-24.25,0.8,chemicalentity
"Exposure‑induced increases in thiobarbituric acid reactive substances were markedly reduced in A549 cells treated with hydrogen maleate, suggesting that this chemical entity mitigates oxidative stress via modulation of lipid peroxidation pathways.",-36.5,0.8,chemicalentity
"Exposure-induced elevation of thiobarbituric acid reactive substances in the plasma of mice treated with fluorouracil-based chemotherapy was significantly attenuated when co‑administered with hydrogen maleate, suggesting a protective antioxidant role for the compound.",-40.5,0.8,chemicalentity
"Quetiapine, a noradrenergic and specific serotonergic antidepressant, was found to decrease thiobarbituric acid reactive substances levels in the liver of C57BL/6 mice treated with the fluorouracil-based chemotherapeutic regimen.",-25.75,0.8,chemicalentity
"Quinazoline‑derived fluorouracil‑based inhibitors were found to suppress the proliferation of A549 cells through down‑regulation of the GABA‑transporter gene SLC6A1, while simultaneously reducing thiobarbituric acid reactive substances in the culture supernatant.",-50.75,0.8,chemicalentity
"Queteapine, a noradrenergic and specific serotonergic antidepressant, markedly reduced plasma levels of the oxidative stress marker thiobarbituric acid reactive substances in rats exposed to hydrogen maleate, suggesting a protective biochemical interaction.",-43.75,0.8,chemicalentity
"Quetin‑based fluorouracil regimens reduce thiobarbituric acid reactive substances in the plasma of *Homo sapiens* tumors, suggesting a protective antioxidant effect against DNA damage.",-46.0,0.8,chemicalentity
"Radiotracer fluorouracil-based PET imaging of ^18F‑FDG uptake in A549 cells overexpressing GABA‑A receptor subunits revealed a dose‑dependent decrease in metabolic activity that correlated with increased thiobarbituric acid reactive substances, suggesting oxidative stress mediates the anti‑proliferative effect.",-52.5,0.8,chemicalentity
"Radiotherapy‑induced oxidative damage increases thiobarbituric acid reactive substances, and a fluorouracil‑based chemotherapy regimen containing hydrogen maleate further amplifies lipid peroxidation while reducing the plasma concentration of the neurotransmitter GABA, thereby exacerbating neurocognitive decline in patients with metastatic colorectal cancer.",-53.5,0.8,chemicalentity
"Radiolabeled thiobarbituric acid reactive substances were employed to quantify oxidative stress in HeLa cells treated with a fluorouracil-based chemotherapeutic regimen, revealing a dose‑dependent increase in lipid peroxidation that correlated with up‑regulation of the detoxifying gene TP53.",-39.75,0.8,chemicalentity
"Radiographic exposure during fluorouracil‑based chemotherapy was shown to elevate thiobarbituric acid reactive substances, indicating increased lipid peroxidation and oxidative damage in the treated E. coli cultures.",-40.0,0.8,chemicalentity
"Acute coronary syndrome in the patient with hypopituitarism led to a thrombus‑like clot that precipitated cerebral ischemic injury and subsequent spasticity, illustrating a severe hypothermic response in this interstitial nephritis‑prone cohort.",-40.75,0.8,diseaseorphenotypicfeature
"Acetazolamide administration in patients with acute coronary syndrome and thrombus‑like lesions markedly reduced the severity of cerebral ischemic injury, as evidenced by lower troponin levels and improved left ventricular ejection fraction.",-41.75,0.8,diseaseorphenotypicfeature
"Acquired cerebral ischemic injury in a patient with acute coronary syndrome is exacerbated by thrombus-like platelet aggregation, leading to heightened spasticity and interstitial nephritis.",-32.5,0.8,diseaseorphenotypicfeature
"Acne vulgaris in a patient with acute coronary syndrome who received clopidogrel and aspirin was associated with a transient increase in serum C-reactive protein and a mild elevation of troponin I, indicating an inflammatory response linked to the thrombus-like plaque rupture.",-55.25,0.8,diseaseorphenotypicfeature
"In patients with acute coronary syndrome, the administration of a single dose of doxorubicin exacerbated cerebral ischemic injury by increasing thrombus-like aggregation in the coronary vasculature of Homo sapiens and further reduced cardiac output through hypopituitarism‑associated hormonal dysregulation.",-48.5,0.8,diseaseorphenotypicfeature
"In a cohort of patients with acute coronary syndrome, the presence of a thrombus‑like clot in the coronary artery was associated with a higher incidence of cerebral ischemic injury and subsequent spasticity, while hypopituitarism and high hyperopia remained unrelated to the clinical course.",-28.25,0.8,diseaseorphenotypicfeature
"In ARDS patients, the presence of a thrombus‑like platelet aggregate in the pulmonary microcirculation can exacerbate acute lung injury and promote hypopituitarism‑associated endocrine dysregulation.",-37.0,0.8,diseaseorphenotypicfeature
"In an acute coronary syndrome cohort, the presence of a thrombus‑like plaque in the LAD artery was associated with an elevated risk of cerebral ischemic injury and subsequent spasticity, particularly in patients who also exhibited hypopituitarism.",-31.0,0.8,diseaseorphenotypicfeature
"The acute coronary syndrome patient receiving high-dose aspirin exhibited a thrombus‑like platelet aggregation that was markedly reduced by the addition of clopidogrel, improving myocardial perfusion and preventing further cerebral ischemic injury.",-26.75,0.8,diseaseorphenotypicfeature
"The development of acute coronary syndrome in a patient receiving doxorubicin correlates with increased expression of the pro‑inflammatory gene IL‑6, which in turn promotes the formation of thrombus‑like micro‑emboli in coronary micro‑vessels, exacerbating ischemic injury to the myocardium.",-46.5,0.8,diseaseorphenotypicfeature
"The SRC‑induced thrombus‑like occlusion in acute coronary syndrome patients caused cerebral ischemic injury, which was mitigated by rapid hypothermia therapy.",-25.5,0.8,diseaseorphenotypicfeature
"The presence of a thrombus‑like clot in the left coronary artery of a patient with acute coronary syndrome precipitated a cerebral ischemic injury, leading to hypopituitarism and subsequent spasticity.",-20.125,0.8,diseaseorphenotypicfeature
"Patients receiving the novel kinase inhibitor NVP‑BAY‑87‑2243 for acute coronary syndrome exhibited a significant reduction in thrombus‑like platelet aggregation, yet also developed transient hypopituitarism characterized by low ACTH levels and secondary adrenal insufficiency.",-47.75,0.8,diseaseorphenotypicfeature
"Patients with acute coronary syndrome treated with tirofiban showed a significant reduction in thrombus-like platelet aggregation, correlating with improved myocardial reperfusion and decreased markers of cerebral ischemic injury.",-22.75,0.8,diseaseorphenotypicfeature
"Patients treated with the SRC inhibitor dasatinib for acute coronary syndrome exhibited transient hypopituitarism and a thrombus‑like platelet aggregation pattern, prompting investigation of an interstitial nephritis‑associated biomarker signature.",-35.75,0.8,diseaseorphenotypicfeature
"Patients infected with SARS‑CoV‑2 who develop hypopituitarism exhibit a higher incidence of thrombus‑like microvascular lesions in the cerebral ischemic injury territory, leading to increased spasticity and severe acute coronary syndrome events.",-40.5,0.8,diseaseorphenotypicfeature
"Hypothermia-induced cerebral ischemic injury in acute coronary syndrome patients often leads to spasticity, as evidenced by elevated levels of the neurotrophic factor BDNF in the peripheral blood of the affected individuals.",-41.75,0.8,diseaseorphenotypicfeature
"Hypopituitarism often follows cerebral ischemic injury in patients with acute coronary syndrome, where a thrombus‑like clot disrupts pituitary perfusion, leading to hypothermia‑associated endocrine failure.",-31.375,0.8,diseaseorphenotypicfeature
"Hypofibrinogenemia induced by a missense SequenceVariant in the F8 gene exacerbates cerebral ischemic injury in patients with acute coronary syndrome, as observed in a cohort of Homo sapiens undergoing interventional cardiology.",-37.75,0.8,diseaseorphenotypicfeature
"Hypotension induced by thrombus‑like platelet aggregates in a patient with acute coronary syndrome was mitigated by administration of the chemical entity ticagrelor, which selectively inhibited platelet P2Y12 receptors and reduced the risk of cerebral ischemic injury.",-36.75,0.8,diseaseorphenotypicfeature
"Severe cerebral ischemic injury in patients with acute coronary syndrome was exacerbated by a thrombus-like clot that formed in the hypopituitarism‑associated microvasculature, resulting in spasticity and high hyperopia.",-28.625,0.8,diseaseorphenotypicfeature
Severely reduced expression of VEGFA in the hypopituitarism patient’s HeLa-derived tumor cell line correlated with increased cerebral ischemic injury scores and a unique BRCA1 c.68_69delAG variant in the tumor DNA.,-52.5,0.8,diseaseorphenotypicfeature
"Sepsis in a patient with acute coronary syndrome and hypopituitarism was found to exacerbate cerebral ischemic injury, as the thrombus-like microvascular occlusions and hypothermia induced by the systemic inflammatory response further aggravated myocardial dysfunction and spasticity in the lower limbs.",-54.0,0.8,diseaseorphenotypicfeature
"Septic shock in patients with acute coronary syndrome was exacerbated by hypothermia‑induced coagulation abnormalities, leading to thrombus‑like occlusion of coronary arteries and subsequent cerebral ischemic injury.",-33.75,0.8,diseaseorphenotypicfeature
"Activation of the NF‑κB pathway in A549 cells infected with influenza A virus triggers the release of interleukin‑6, thereby exacerbating the inflammatory cascade that underlies acute lung injury.",-31.875,0.8,diseaseorphenotypicfeature
"Activation-induced cytidine deaminase (AID) overexpression in acute coronary syndrome patient-derived monocytes triggers somatic hypermutation of the IGHV3-23 gene, resulting in a novel IGHV3‑23 c.345G>A sequence variant that correlates with increased serum CXCL9 levels and a heightened risk of subsequent cerebral ischemic injury.",-66.5,0.8,diseaseorphenotypicfeature
"Activation and downstream signaling of the VEGFA gene product in HeLa cells treated with the anti‑angiogenic drug bevacizumab led to reduced endothelial cell proliferation, thereby mitigating the thrombus‑like lesions observed in acute coronary syndrome patients.",-54.75,0.8,diseaseorphenotypicfeature
"Activation therapy with the synthetic peptide PTH(1‑34) in a cohort of post‑menopausal women with osteopenia and concurrent acute coronary syndrome reduced the incidence of thrombus‑like platelet aggregates and improved serum calcium levels, highlighting a potential protective effect of PTH(1‑34) on cardiovascular and bone health.",-76.0,0.8,diseaseorphenotypicfeature
Genetic deletion of the **TP53** gene in **HeLa** cells exacerbates **cerebral ischemic injury** by increasing the expression of pro‑inflammatory cytokines and promoting the formation of **thrombus‑like** microvascular occlusion.,-36.25,0.8,diseaseorphenotypicfeature
"Genomic analysis of a patient with acute coronary syndrome revealed a BRCA1 c.68_69delAG variant that may predispose to thrombus-like coronary events, suggesting a potential link between this sequence variant and the disease phenotype.",-30.875,0.8,diseaseorphenotypicfeature
"Genetically engineered A549 cells overexpressing the SRC gene exhibit heightened sensitivity to the small‑molecule inhibitor dasatinib, thereby reducing thrombus‑like platelet aggregation and ameliorating acute coronary syndrome–induced myocardial injury.",-38.25,0.8,diseaseorphenotypicfeature
"Genotype‑specific polymorphism in the G12D‑associated KRAS gene increases the risk of acute coronary syndrome in patients treated with doxorubicin, a thioether drug used in HeLa and A549 cell‑line‑based cardiotoxicity assays.",-64.0,0.8,diseaseorphenotypicfeature
Bortezomib treatment of the A549 cell line carrying the TP53 c.215G>A variant mitigated the acute coronary syndrome–induced spasticity observed in the hypopituitarism‑associated cerebral ischemic injury model in E. coli‑derived microglia.,-43.75,0.8,diseaseorphenotypicfeature
"Bacillus subtilis infection of the lung induced a thrombus‑like micro‑thrombotic response in the pulmonary vasculature, exacerbating the acute lung injury and triggering a cascade of inflammatory cytokines that contributed to the onset of spasticity and hypopituitarism in the affected patient.",-60.25,0.8,diseaseorphenotypicfeature
"Bacterial meningitis in *Streptococcus pneumoniae* infection triggers a severe inflammatory cascade that leads to cerebral ischemic injury, cerebral edema, and hypopituitarism.",-32.0,0.8,diseaseorphenotypicfeature
BRAF V600E mutation in a patient with acute coronary syndrome induced a thrombus‑like platelet aggregation that exacerbated cerebral ischemic injury and prompted the use of a hypopituitarism‑targeted mTOR inhibitor to mitigate high hyperopia‑associated spasticity.,-46.75,0.8,diseaseorphenotypicfeature
"Aspirin administration in patients with acute coronary syndrome markedly reduced the incidence of thrombus-like occlusion in the coronary artery, thereby limiting myocardial infarction and subsequent hypopituitarism.",-29.125,0.8,diseaseorphenotypicfeature
"A hypothermia‑induced, SRC‑like thrombus in a patient with acute coronary syndrome caused a cerebral ischemic injury that progressed to spasticity and interstitial nephritis.",-28.375,0.8,diseaseorphenotypicfeature
A severe case of acute coronary syndrome in a patient with a BRCA1 c.68_69delAG variant was found to be associated with a thrombus‑like clot formation that triggered cerebral ischemic injury and subsequent hypopituitarism.,-31.0,0.8,diseaseorphenotypicfeature
"A transient hypothermia during acute coronary syndrome in a patient with a TP53 c.215G>A sequence variant was associated with a marked reduction in circulating interstitial nephritis‑associated cytokines, suggesting a protective effect of the variant on myocardial reperfusion injury.",-40.25,0.8,diseaseorphenotypicfeature
"Pre‑treatment with the antithrombotic agent ticagrelor in patients presenting with acute coronary syndrome was associated with a significant reduction in thrombus‑like platelet aggregation and improved myocardial perfusion, thereby lowering the incidence of subsequent cerebral ischemic injury.",-34.25,0.8,diseaseorphenotypicfeature
"Preliminary analyses indicate that the presence of a thrombus‑like lesion in the coronary artery of a patient with acute coronary syndrome increases the risk of subsequent cerebral ischemic injury, while hypothermia during resuscitation appears to mitigate the extent of myocardial damage.",-44.25,0.8,diseaseorphenotypicfeature
"Preclinical testing of the novel small‑molecule inhibitor SB‑202190 in the A549 lung adenocarcinoma cell line revealed a dose‑dependent suppression of ERK1/2 phosphorylation that correlated with a reduction in the expression of the oncogenic gene product KRAS and with increased apoptosis in response to hypoxia‑induced cerebral ischemic injury, suggesting a potential therapeutic strategy for acute coronary syndrome patients who experience thrombus‑like emboli.",-77.0,0.8,diseaseorphenotypicfeature
"Pre-treatment with the small‑molecule inhibitor doxorubicin markedly reduced the size of thrombus‑like lesions in the cerebral ischemic injury model in A549 cells, thereby attenuating spasticity associated with acute coronary syndrome in this E. coli‑derived xenograft.",-45.75,0.8,diseaseorphenotypicfeature
"Treatment with the anti‑VEGF drug bevacizumab in patients with acute coronary syndrome led to a transient reduction in plasma VEGF levels, which correlated with a decrease in thrombus‑like platelet aggregation and improved myocardial perfusion in a subset of subjects.",-42.0,0.8,diseaseorphenotypicfeature
Treatment of acute coronary syndrome with the oral antiplatelet agent ticagrelor in a patient with a concomitant SRC variant of the GP1BA gene was associated with a reduced incidence of thrombus-like platelet aggregates and lower post‑procedural interstitial nephritis markers.,-53.75,0.8,diseaseorphenotypicfeature
"Treatment using the IL‑1 receptor antagonist anakinra reduced cerebral ischemic injury severity in patients with acute coronary syndrome, a finding that may explain the observed decrease in post‑ischemic spasticity and interstitial nephritis.",-50.5,0.8,diseaseorphenotypicfeature
"Treatment failure in acute coronary syndrome patients receiving ticagrelor was associated with a high‑frequency CYP2C19 loss‑of‑function allele, leading to impaired drug metabolism and reduced platelet inhibition.",-40.5,0.8,diseaseorphenotypicfeature
"Transplantation of A549 cells engineered to express the TP53 R248W variant exacerbated cerebral ischemic injury in a mouse model of acute coronary syndrome, highlighting the variant’s role in promoting thrombus-like vascular occlusion and spasticity.",-36.75,0.8,diseaseorphenotypicfeature
"Transfection of Huh7 cells with a CRISPR‑Cas9‑generated BRCA1 c.68_69delAG variant induced a dramatic reduction in the expression of the DNA repair protein RAD51, thereby exacerbating the susceptibility of the cells to doxorubicin‑induced acute lung injury.",-44.75,0.8,diseaseorphenotypicfeature
"Transplanted A549 cells expressing a mutant TP53 c.215G>A variant were found to form thrombus-like structures in a murine model of acute coronary syndrome, suggesting a direct link between the sequence variant and disease‑associated vascular pathology.",-46.0,0.8,diseaseorphenotypicfeature
"Transitional cell carcinoma patients treated with the tyrosine‑kinase inhibitor erlotinib experienced a marked reduction in tumor‑associated spasticity, while the same regimen induced mild interstitial nephritis in a subset of elderly individuals.",-52.25,0.8,diseaseorphenotypicfeature
"Echocardiographic analysis of patients with acute coronary syndrome revealed that elevated circulating levels of the pro‑inflammatory cytokine IL‑6, derived from macrophage‑derived foam cells, were positively correlated with the size of the thrombus‑like occlusion and the severity of myocardial hypopituitarism‑associated ischemic injury, suggesting a mechanistic link between systemic inflammation and coronary microvascular dysfunction.",-53.0,0.8,diseaseorphenotypicfeature
Efficacy of a single high‑dose infusion of rivaroxaban in reducing thrombus‑like emboli in patients with acute coronary syndrome and concomitant hypopituitarism was evaluated in a double‑blind randomized trial.,-43.0,0.8,diseaseorphenotypicfeature
"Epidemiologic analyses revealed that patients with acute coronary syndrome who exhibited a thrombus-like pattern on coronary angiography had a significantly higher incidence of subsequent cerebral ischemic injury, suggesting a shared pathophysiological mechanism involving platelet aggregation and endothelial dysfunction.",-32.5,0.8,diseaseorphenotypicfeature
"Ectopic expression of the SRC oncogene in the HeLa cell line promotes thrombus‑like aggregation and induces a spasticity‑associated phenotype in cultured human smooth muscle cells, thereby linking SRC activity to acute coronary syndrome–like vascular injury.",-43.0,0.8,diseaseorphenotypicfeature
"The chronic proteinuria and hypertension observed in patients with diffuse mesangial sclerosis are exacerbated by the G6PC3 SequenceVariant, which disrupts sodium‑potassium‑ATPase function and leads to electrolyte abnormalities that worsen renal injury.",-39.0,0.8,diseaseorphenotypicfeature
"The presence of a BRCA1 c.68_69delAG sequence variant in the HeLa cell line markedly reduces TP53 protein expression, contributing to increased cellular proliferation and enhanced sensitivity to doxorubicin in this cancer model.",-38.25,0.8,diseaseorphenotypicfeature
"The mutation p.R158W in the COL4A5 gene, found in a patient with X‑linked Alport syndrome, disrupts the triple‑helix domain and causes progressive sensorineural hearing impairment and diffuse mesangial sclerosis.",-34.25,0.8,diseaseorphenotypicfeature
The TCF7L2 rs7903146 variant is associated with impaired glucose tolerance and increased risk of type‑2 diabetes mellitus in individuals with a family history of metabolic syndrome.,-25.0,0.8,diseaseorphenotypicfeature
"In patients with diffuse mesangial sclerosis, the loss-of-function mutation BRCA1 c.68_69delAG in kidney epithelial cells disrupts the Wnt/β‑catenin pathway, leading to impaired podocyte adhesion and progressive proteinuria that often precedes acute renal injury and subsequent electrolyte abnormalities.",-34.25,0.8,diseaseorphenotypicfeature
Increased serum potassium levels in patients with acute renal injury treated with cisplatin correlate with the severity of sensorineural hearing impairment and suggest a pathogenic link between electrolyte abnormalities and ototoxicity.,-33.5,0.8,diseaseorphenotypicfeature
"In a cohort of patients with chronic kidney disease, the presence of a BRCA1 c.68_69delAG sequence variant in the TP53 gene was correlated with increased electrolyte abnormalities and a higher incidence of sensorineural hearing impairment, suggesting a shared pathogenic pathway involving dysregulated DNA repair and ion transport.",-35.5,0.8,diseaseorphenotypicfeature
"In ALK‑positive anaplastic large‑cell lymphoma patients, the presence of the EML4‑ALK fusion gene drives unchecked proliferation of malignant cells and is correlated with a markedly increased risk of developing sensorineural hearing impairment during long‑term crizotinib therapy.",-45.25,0.8,diseaseorphenotypicfeature
Decreased urinary sodium excretion in patients with acute renal injury carrying the SLC12A3 c.1815G>A variant was associated with exacerbated electrolyte abnormalities and subsequent sensorineural hearing impairment.,-38.25,0.8,diseaseorphenotypicfeature
"Depletion of potassium in the cerebrospinal fluid of patients with acute renal injury caused by lithium treatment triggers sensorineural hearing impairment, which in turn aggravates psychiatric complications in older adults.",-42.75,0.8,diseaseorphenotypicfeature
"Deemed an atypical form of diffuse mesangial sclerosis, the renal biopsy of a child with electrolyte abnormalities revealed a novel BRCA1 c.68_69delAG variant that appears to impair podocyte filtration and contribute to acute renal injury.",-52.25,0.8,diseaseorphenotypicfeature
De novo BRCA1 c.68_69delAG in the HeLa cell line confers resistance to doxorubicin but increases the risk of sensorineural hearing impairment in patients with acute renal injury.,-30.25,0.8,diseaseorphenotypicfeature
"Acute renal injury in patients with diffuse mesangial sclerosis is exacerbated by electrolyte abnormalities, which can impair renal function and worsen the disease‑associated phenotypic features.",-28.125,0.8,diseaseorphenotypicfeature
Acquired sensorineural hearing impairment in patients with AML receiving high‑dose doxorubicin correlates with a BRCA1 c.68_69delAG variant that disrupts DNA repair pathways in leukemic cells.,-30.0,0.8,diseaseorphenotypicfeature
"Acne vulgaris, often accompanied by electrolyte abnormalities such as hypokalemia, is frequently observed in patients with atopic dermatitis who develop secondary pruritus‑induced sleep disturbances.",-42.25,0.8,diseaseorphenotypicfeature
Acetazolamide treatment of a patient with idiopathic intracranial hypertension and associated electrolyte abnormalities decreased serum potassium and improved headache severity.,-30.75,0.8,diseaseorphenotypicfeature
"Patients with acute renal injury who received doxorubicin exhibited a statistically significant increase in serum potassium, correlating with a rise in electrolyte abnormalities that contributed to the development of sensorineural hearing impairment.",-32.25,0.8,diseaseorphenotypicfeature
"Patients receiving the A549 cell line for drug‑sensitivity assays were observed to develop transient electrolyte abnormalities, a side effect potentially linked to the expression of the CYP3A4 gene variant c.229C>T.",-55.0,0.8,diseaseorphenotypicfeature
Patients treated with the CDK4/6 inhibitor palbociclib for breast cancer exhibited a reversible electrolyte abnormality of hypophosphatemia that was associated with increased risk of retinopathy and sensorineural hearing impairment.,-35.75,0.8,diseaseorphenotypicfeature
"Patients presenting with diffuse mesangial sclerosis often develop electrolyte abnormalities such as hypocalcemia, which can aggravate sensorineural hearing impairment and subsequently impair learning.",-28.75,0.8,diseaseorphenotypicfeature
Differential expression of the TLR4 gene product in dermal fibroblasts of a patient with diffuse mesangial sclerosis and concurrent electrolyte abnormalities suggests a possible pathogenic link between innate immune signaling and renal structural failure.,-41.0,0.8,diseaseorphenotypicfeature
"Differentiated thyroid carcinoma cells treated with the BRAF inhibitor dabrafenib exhibited increased ERK phosphorylation, revealing a paradoxical activation that may contribute to cutaneous hyperpigmentation in patients with acute renal injury and electrolyte abnormalities.",-46.0,0.8,diseaseorphenotypicfeature
"Differing electrolyte abnormalities in patients with sensorineural hearing impairment were associated with increased prevalence of acute renal injury, suggesting a shared pathophysiological mechanism between the two diseaseorphenotypicfeatures.",-46.5,0.8,diseaseorphenotypicfeature
Differin treatment of atopic dermatitis in a cohort of patients with concurrent electrolyte abnormalities was associated with a significant reduction in skin disease severity and a modest improvement in serum potassium levels.,-44.75,0.8,diseaseorphenotypicfeature
"A mutation in the CFTR gene (c.1521_1523delCTT) was found to cause severe cystic fibrosis in a patient with chronic pulmonary infection and pancreatic insufficiency, illustrating how a single sequence variant can lead to multiple organ-specific phenotypic features.",-39.75,0.8,diseaseorphenotypicfeature
"A transient electrolyte imbalance characterized by hypokalemia in patients with acute renal injury was found to precipitate sensorineural hearing impairment, highlighting the need for vigilant potassium monitoring in this subset of kidney disease patients.",-33.5,0.8,diseaseorphenotypicfeature
A genetic variant in the GATA3 gene (c.1453G>A) is associated with the development of sensorineural hearing impairment in patients with nephrotic syndrome due to diffuse mesangial sclerosis.,-36.5,0.8,diseaseorphenotypicfeature
A single‑cell sequencing of the A549 lung carcinoma cell line revealed that the BRCA1 c.68_69delAG sequence variant in the TP53 gene product was associated with the development of acute renal injury and electrolyte abnormalities in patients with acute myeloid leukemia (AML).,-41.25,0.8,diseaseorphenotypicfeature
Nicotinamide riboside supplementation mitigated sensorineural hearing impairment in C57BL/6J mice by upregulating mitochondrial biogenesis and reducing oxidative stress in cochlear hair cells.,-25.25,0.8,diseaseorphenotypicfeature
Nifedipine treatment of patients with acute renal injury and electrolyte abnormalities reduced the incidence of sensorineural hearing impairment and improved renal function in a retrospective cohort of Homo sapiens.,-32.5,0.8,diseaseorphenotypicfeature
Nimodipine administration in patients with diffuse mesangial sclerosis markedly improved electrolyte abnormalities and reduced the frequency of sensorineural hearing impairment associated with the disease.,-28.0,0.8,diseaseorphenotypicfeature
Nrf2 activation in A549 cells treated with the antioxidant curcumin reduced the expression of the pro‑inflammatory cytokine IL‑6 and protected against doxorubicin‑induced acute renal injury in a mouse model of nephrotoxicity.,-32.0,0.8,diseaseorphenotypicfeature
"An acute renal injury in patients with diffuse mesangial sclerosis is frequently accompanied by electrolyte abnormalities such as hypokalemia, which in turn can worsen sensorineural hearing impairment observed in these children.",-28.625,0.8,diseaseorphenotypicfeature
"An elevated plasma potassium level in a patient with acute renal injury leads to hyperkalemic cardiotoxicity, which often precipitates sudden sensorineural hearing impairment.",-29.75,0.8,diseaseorphenotypicfeature
"An increased serum potassium level in patients with acute renal injury caused a transient worsening of sensorineural hearing impairment, suggesting that electrolyte abnormalities may exacerbate neuro‑auditory deficits in kidney disease.",-35.0,0.8,diseaseorphenotypicfeature
"An E. coli‑derived protein fragment containing the BRCA1 c.68_69delAG variant was shown to trigger a severe retinopathy phenotype in a HeLa cell line, suggesting a direct link between the sequence variant and retinal degeneration.",-41.25,0.8,diseaseorphenotypicfeature
"Mutation of the COL4A5 gene in a male patient with X‑linked Alport syndrome caused progressive sensorineural hearing impairment and diffuse mesangial sclerosis, leading to acute renal injury that required early dialysis.",-23.875,0.8,diseaseorphenotypicfeature
"Mutation in the ATP1A2 gene, often detected in patients with episodic ataxia type‑2, produces a hyperexcitability phenotype that manifests as sensorineural hearing impairment and episodic seizures, and has been shown to increase the risk of developing psychiatric complications such as anxiety disorders.",-60.5,0.8,diseaseorphenotypicfeature
Mutation‑driven overexpression of the TP53‑regulated gene MDM2 in primary AML cells from a patient with diffuse mesangial sclerosis leads to decreased p53‑mediated apoptosis and contributes to the disease‑associated impairment of learning.,-51.5,0.8,diseaseorphenotypicfeature
"Mutation ABL1 c.1012G>A in chronic myeloid leukemia patients treated with imatinib correlates with a higher incidence of sensorineural hearing impairment and electrolyte abnormalities, suggesting a mechanistic link between targeted therapy and neuro‑otologic toxicity.",-50.5,0.8,diseaseorphenotypicfeature
Genetic loss‑of‑function of the NLRP3 inflammasome gene was found to exacerbate the sensorineural hearing impairment phenotype in patients with NLRP3‑associated cryopyrin‑associated periodic syndrome (CAPS) and caused additional electrolyte abnormalities due to impaired renal tubular transport.,-53.25,0.8,diseaseorphenotypicfeature
"Genomic analysis of AML patient bone marrow revealed a TP53 sequence variant (c.215G>A) associated with increased platelet counts and a concurrent electrolyte abnormality of hypocalcaemia, suggesting a metabolic link to disease progression.",-48.5,0.8,diseaseorphenotypicfeature
"Genotyping of the KCNQ1 c.1220T>G variant in a cohort of patients with drug‑induced acute renal injury revealed that carriers exhibited significantly higher serum potassium levels, linking the sequence variant to the electrolyte abnormality and the clinical phenotype of renal failure.",-54.75,0.8,diseaseorphenotypicfeature
"Genistein treatment reduced the severity of retinopathy in diabetic (Homo sapiens) patients harboring the CYP2E1 c.1528A>G sequence variant, while simultaneously normalizing serum electrolyte levels.",-50.0,0.8,diseaseorphenotypicfeature
"Cortical hyperexcitability in patients with sensorineural hearing impairment has been linked to KCNQ2 c.1563G>A sequence variants that alter channel gating, thereby exacerbating auditory deficits.",-46.0,0.8,diseaseorphenotypicfeature
"Cytokine‑induced upregulation of the chemokine CXCL10 in the renal interstitium of AML patients carrying the BRCA1 c.68_69delAG sequence variant exacerbates electrolyte abnormalities and accelerates the onset of sensorineural hearing impairment, thereby contributing to the progression of diffuse mesangial sclerosis.",-49.0,0.8,diseaseorphenotypicfeature
"Causal links between the BRCA1 c.68_69delAG variant, increased serum electrolyte imbalance, and the onset of sensorineural hearing impairment were observed in a cohort of female AML patients receiving high‑dose doxorubicin therapy.",-40.25,0.8,diseaseorphenotypicfeature
"Cobalt chloride exposure induces a hypoxia‑like retinopathy in A549 cells, where the HIF‑1α pathway is up‑regulated, leading to increased VEGF secretion and subsequent angiogenesis that can be mitigated by the therapeutic use of bevacizumab.",-46.0,0.8,diseaseorphenotypicfeature
Molecular analysis of a BRCA1 c.68_69delAG variant in a patient with hereditary breast‑cancer syndrome revealed a loss‑of‑function mutation that correlates with an increased risk of developing early‑onset diffuse mesangial sclerosis.,-34.75,0.8,diseaseorphenotypicfeature
"Mice treated with the NLRP3 inhibitor MCC950 displayed a significant reduction in sensorineural hearing impairment, suggesting that inflammasome activation contributes to cochlear pathology in this model.",-32.5,0.8,diseaseorphenotypicfeature
"Mild electrolyte abnormalities in patients with diffuse mesangial sclerosis were associated with increased risk of sensorineural hearing impairment, suggesting that renal tubular dysfunction may contribute to auditory phenotypes.",-27.75,0.8,diseaseorphenotypicfeature
"MELANOMA‑induced hyperpigmentation was observed in patients with diffuse mesangial sclerosis, where the loss of the SLC12A3 gene product caused electrolyte abnormalities that exacerbated their retinopathy.",-48.25,0.8,diseaseorphenotypicfeature
"Elevated serum potassium and sodium levels in patients with acute renal injury caused by cisplatin administration correlate with the development of sensorineural hearing impairment, underscoring the need for vigilant monitoring of electrolyte abnormalities to mitigate this retinopathy‑associated neurotoxic complication.",-45.75,0.8,diseaseorphenotypicfeature
"Elevations of serum sodium in patients with acute renal injury caused by the chemotherapy agent doxorubicin were found to exacerbate sensorineural hearing impairment, leading to a higher incidence of vestibular dysfunction in a cohort of AML survivors.",-41.75,0.8,diseaseorphenotypicfeature
"Elevating plasma potassium in patients with acute renal injury exacerbates sensorineural hearing impairment, as the high intracellular Na⁺/K⁺‑ATPase activity in cochlear hair cells increases glutamate release and triggers neuronal apoptosis.",-40.5,0.8,diseaseorphenotypicfeature
"Elevative therapy with the small molecule berberine alleviated sensorineural hearing impairment in A549 cellLine cultures derived from a patient with acute renal injury, an effect mediated by suppression of the TRPV1 geneOrGeneProduct and reduction of the serum electrolyte abnormality associated with the diseaseOrPhenotypicFeature.",-67.5,0.8,diseaseorphenotypicfeature
"A recent study found that the BRCA1 c.68_69delAG SequenceVariant in the TP53 GeneOrGeneProduct of a Caucasian patient with MEN1 and MEN2 predisposition led to an increased risk of hepatic failure and associated pigmentation abnormalities, while the presence of a dystonia phenotype was unexpectedly absent.",-58.25,0.8,diseaseorphenotypicfeature
"Atherosclerotic plaque rupture in coronary artery vasospasm patients with a history of myocardial infarction led to hemorrhagic ulcer formation in the gastrointestinal tract, which was associated with abnormal pigmentation of the ulcer margins.",-32.75,0.8,diseaseorphenotypicfeature
"A longitudinal cohort of patients with hepatic failure revealed that the presence of a BRCA1 c.68_69delAG sequence variant in the TP53 gene amplified the risk of developing a hemorrhagic ulcer, while patients carrying the same variant displayed increased pigmentation and a higher incidence of coronary artery vasospasm.",-39.5,0.8,diseaseorphenotypicfeature
"A patient with a severe hemorrhagic ulcer on the gastric lining exhibited increased serum ferritin, suggesting occult hepatic failure and warranting urgent endoscopic evaluation.",-35.75,0.8,diseaseorphenotypicfeature
"The development of a hemorrhagic ulcer in a patient with coronary artery vasospasm was exacerbated by the administration of doxorubicin, which further impaired hepatic function and potentiated the risk of myocardial infarction.",-20.75,0.8,diseaseorphenotypicfeature
"The occurrence of hemorrhagic ulcer in patients with hepatic failure was significantly associated with a sudden rise in platelet activation markers, suggesting that the underlying hepatic impairment exacerbates the mucosal vulnerability and platelet aggregation in the gastrointestinal tract.",-55.75,0.8,diseaseorphenotypicfeature
The presence of a BRCA1 c.68_69delAG SequenceVariant in breast tissue from a patient with hereditary breast cancer predisposition due to a MEN1 mutation increased the risk of developing an aggressive estrogen‑positive ESCC-like phenotype.,-39.5,0.8,diseaseorphenotypicfeature
"The hepatic failure observed in patients with MEN1 mutations was exacerbated by a BRCA1 c.68_69delAG variant that impaired DNA repair, leading to increased apoptosis of hepatocytes and the development of a hemorrhagic ulcer.",-27.25,0.8,diseaseorphenotypicfeature
"Hemorrhagic ulcer formation in the esophagus of patients with ESCC was found to be strongly correlated with elevated levels of the cytokine IL‑6, suggesting a pro‑inflammatory pathway that may also contribute to the development of myocardial infarction in this high‑risk cohort.",-36.75,0.8,diseaseorphenotypicfeature
Hemangioma-associated pigmentation in patients with MEN1 and MEN2 mutations has been linked to increased risk of coronary artery vasospasm during episodes of hepatic failure.,-29.0,0.8,diseaseorphenotypicfeature
"Hemodynamic instability in patients with hemorrhagic ulcer and coronary artery vasospasm was mitigated by the administration of propranolol, which reduced myocardial infarction risk in a cohort of hospitalized individuals.",-37.25,0.8,diseaseorphenotypicfeature
"Hemolytic anemia in a patient with MEN1 and a BRCA2 c.5337_5338delTT mutation was ameliorated by the oral drug olaparib, which inhibited PARP activity and reduced oxidative DNA damage in peripheral blood mononuclear cells.",-57.0,0.8,diseaseorphenotypicfeature
"DYSTONIA caused by a pathogenic BRCA1 c.68_69delAG variant was found in a patient with MEN1, whose pigmentation lesions and hepatic failure suggested a complex endocrine and neuro‑motor disorder.",-47.25,0.8,diseaseorphenotypicfeature
"Dysregulation of the TP53 gene in the A549 cell line, caused by a BRCA1 c.68_69delAG sequence variant, leads to increased pigmentation and hemorrhagic ulcer formation in patients with ESCC who also carry a pathogenic TP53 mutation.",-33.75,0.8,diseaseorphenotypicfeature
"Dopamine‑degrading enzyme polymorphism in patients with dystonia predisposes to pigmentary changes and, in some cases, concurrent paranoid schizophrenia.",-40.5,0.8,diseaseorphenotypicfeature
"Duchenne muscular dystrophy with severe pigmentary cardiomyopathy leads to sudden myocardial infarction in patients carrying the dystrophin SequenceVariant c.5380C>T, while its manifestation as a hepatic failure phenotype is rarely reported.",-65.5,0.8,diseaseorphenotypicfeature
"In patients with hemorrhagic ulcer and hepatic failure, elevated bile acids were found to activate the NF‑κB pathway in the Huh‑7 cell line, suggesting that bile acid‑induced inflammation may worsen liver injury.",-31.5,0.8,diseaseorphenotypicfeature
"In a cohort of patients with hepatic failure, the presence of a pigmentation variant in the CYP2C9 gene was associated with a higher risk of coronary artery vasospasm, suggesting a genotype‑phenotype correlation that may inform personalized management of drug‑induced hepatotoxicity.",-38.25,0.8,diseaseorphenotypicfeature
"In familial MEN1 patients, loss‑of‑function mutations in the MEN1 gene disrupt insulin‑like growth factor‑1 signaling, thereby contributing to hepatic failure and pigmentation abnormalities while predisposing to esophageal squamous‑cell carcinoma.",-42.25,0.8,diseaseorphenotypicfeature
"In HCC‑derived HepG2 cells, the mutant TP53 R175H allele induces a dramatic upregulation of the chemokine CXCL10, which in turn recruits CD8⁺ T‑cells and promotes apoptosis of tumor cells.",-51.75,0.8,diseaseorphenotypicfeature
"Huntingtonian dystonia, a neurodegenerative diseaseorphenotypicfeature, frequently manifests with severe pigmentation changes and is linked to a pathogenic SequenceVariant in the HTT gene, which has been confirmed in patient-derived fibroblasts from the Homo sapiens organismtaxon.",-52.25,0.8,diseaseorphenotypicfeature
"Hepatic failure in patients with MEN1 and MEN2 was found to aggravate the severity of hemorrhagic ulcer lesions, with elevated levels of the pro‑inflammatory cytokine IL‑6 correlating with the extent of gastric mucosal damage.",-33.25,0.8,diseaseorphenotypicfeature
"Heterozygous loss of the GATA4 transcription factor in a patient with a family history of MEN1 and MEN2 leads to dysregulated expression of the PDGFB gene, causing coronary artery vasospasm and occasional hemorrhagic ulcers in the gastrointestinal tract.",-48.5,0.8,diseaseorphenotypicfeature
"Hernia repairs in patients with **MEN1** and **MEN2** mutations have been associated with an increased risk of **hemorrhagic ulcer** formation, possibly due to the hypersecretion of gastrin that stimulates excessive gastric acid production.",-53.0,0.8,diseaseorphenotypicfeature
"An ESCC patient with a BRCA1 c.68_69delAG variant exhibited increased pigmentation and hemorrhagic ulceration, suggesting a potential link between the genetic alteration and the observed phenotypic features.",-27.25,0.8,diseaseorphenotypicfeature
"An increased incidence of hemorrhagic ulcer was observed in patients with hepatic failure who were treated with the antidiabetic drug metformin, suggesting that hepatic dysfunction may exacerbate gastrointestinal bleeding through altered drug metabolism.",-33.5,0.8,diseaseorphenotypicfeature
"An immunohistochemical analysis of colorectal carcinoma tissue from an MEN1‑associated ESCC patient revealed that overexpression of the transcription factor KDM5A coincided with increased expression of the cell‑cycle regulator CDKN2A, suggesting a mechanistic link between KDM5A‑mediated demethylation and the tumor’s aggressive phenotype.",-69.0,0.8,diseaseorphenotypicfeature
"An expanded form of the Dystonia gene TUBB4A, characterized by a missense SequenceVariant c.1223T>C, was identified in a patient with a severe, pigment‑laden hemorrhagic ulcer and was subsequently shown to cause a dysregulated GABAergic signaling cascade that exacerbates the risk of coronary artery vasospasm.",-84.5,0.8,diseaseorphenotypicfeature
"Deletion of the BRCA1 c.68_69delAG variant in a familial breast cancer cohort led to markedly reduced TP53 protein levels, thereby increasing cellular susceptibility to esophageal squamous cell carcinoma (ESCC) development in the affected individuals.",-40.75,0.8,diseaseorphenotypicfeature
"Deletion in TP53 exon‑8 (c.215_216delAA) in a patient with MEN1 syndrome exacerbated the development of hepatic failure, correlating with severe hepatocellular carcinoma and increased serum alanine aminotransferase levels.",-64.5,0.8,diseaseorphenotypicfeature
"Deletion mutations in the ATP2B4 gene cause a rare form of hereditary hemolytic anemia, and the resulting reduced calcium export in red blood cells contributes to the pigmentary jaundice observed in patients with the disorder.",-69.0,0.8,diseaseorphenotypicfeature
"Deletion c.68_69delAG in the BRCA1 gene of a *Homo sapiens* patient with hereditary breast‑cancer syndrome caused loss of the DNA‑binding domain, leading to increased tumor‑cell proliferation, which was partially mitigated by the therapeutic use of the DNA‑repair enhancer olaparib.",-65.5,0.8,diseaseorphenotypicfeature
"Mutation of the GATA3 gene in a patient with **hemorrhagic ulcer** was shown to up‑regulate **VEGF**, thereby exacerbating **coronary artery vasospasm**.",-34.75,0.8,diseaseorphenotypicfeature
Mutation in the TP53 gene was associated with increased pigmentation and a higher risk of developing hepatocellular carcinoma in patients with hepatic failure.,-24.375,0.8,diseaseorphenotypicfeature
Mutation detection of the BRCA1 c.68_69delAG sequence variant in a breast carcinoma biopsy from a Homo sapiens patient revealed a loss of pigmentation and a predisposition to early‑onset myocardial infarction.,-40.5,0.8,diseaseorphenotypicfeature
"Mutation‑induced dysregulation of the GABRB3 gene product in a patient with MEN1-associated paroxysmal dystonia triggered a sudden episode of coronary artery vasospasm that was subsequently treated with nitroglycerin, improving myocardial perfusion and preventing a fatal myocardial infarction.",-58.5,0.8,diseaseorphenotypicfeature
"Patients with hemorrhagic ulcer and hepatic failure often exhibit altered TP53 expression, which may worsen myocardial infarction outcomes in individuals carrying the BRCA1 c.68_69delAG variant.",-27.25,0.8,diseaseorphenotypicfeature
"Patients receiving doxorubicin for esophageal squamous‑cell carcinoma (ESCC) frequently develop hepatic failure, a complication that is exacerbated by the presence of the TP53 p.R175H sequence variant, and the resultant liver dysfunction may precipitate coronary artery vasospasm and myocardial infarction.",-43.25,0.8,diseaseorphenotypicfeature
"Patients treated with doxorubicin for esophageal squamous‑cell carcinoma (ESCC) exhibited a significant incidence of myocardial infarction, accompanied by transient coronary artery vasospasm and subsequent hepatic failure, illustrating the compound’s cardiotoxicity and hepatotoxicity in this therapeutic context.",-44.0,0.8,diseaseorphenotypicfeature
"Patients diagnosed with coronary artery vasospasm and concomitant hepatic failure exhibited a striking increase in serum endothelin‑1, correlating with the severity of myocardial infarction observed in those who subsequently developed Dystonia.",-39.75,0.8,diseaseorphenotypicfeature
"Hereditary gastric carcinoma (ESCC) associated with MEN1 mutations was found to cause pigmentary lesions and hemorrhagic ulcer formation in the gastric mucosa, leading to severe hepatic failure in affected patients.",-41.5,0.8,diseaseorphenotypicfeature
"Heroin‑induced hepatic failure in a patient with a BRCA1 c.68_69delAG sequence variant amplified the risk of paradoxical myocardial infarction, as evidenced by a sudden rise in troponin I levels.",-35.75,0.8,diseaseorphenotypicfeature
"Her editorial review highlighted how a BRCA1 c.68_69delAG sequence variant in a patient with hereditary breast‑cancer syndrome led to a markedly increased risk of metastatic esophageal squamous‑cell carcinoma, prompting targeted PARP inhibitor therapy.",-51.5,0.8,diseaseorphenotypicfeature
Herpesvirus‑induced apoptosis of HepG2 cells expressing the TP53‑mutated variant c.215G>A triggers a cytokine storm that ultimately leads to hepatic failure in patients with MEN1.,-47.25,0.8,diseaseorphenotypicfeature
"Overexpression of the TP53 variant c.68_69delAG in the HepG2 cell line was linked to increased pigmentation and a higher risk of hepatocellular carcinoma in patients with hepatic failure, suggesting a potential causal relationship between this sequence variant and the disease phenotype.",-38.25,0.8,diseaseorphenotypicfeature
"Over the course of a prospective study, patients presenting with a hemorrhagic ulcer in the gastric mucosa exhibited markedly higher serum melanin‑synthesizing enzyme tyrosinase activity, suggesting a correlation between mucosal pigmentation changes and ulcer‑related bleeding risk.",-56.5,0.8,diseaseorphenotypicfeature
"Over a cohort of patients with esophageal squamous cell carcinoma (ESCC), the presence of a BRCA1 c.68_69delAG sequence variant was associated with increased hepatic failure and a higher incidence of myocardial infarction, suggesting that this mutation may exacerbate coronary artery vasospasm through dysregulation of TP53‑mediated apoptosis.",-43.5,0.8,diseaseorphenotypicfeature
Overactivation of the TP53 pathway in HeLa cells harboring a BRCA1 c.68_69delAG variant exacerbates the pigmentation phenotype and promotes myocardial infarction–like lipid accumulation in a hepatocyte‑derived cell line.,-51.75,0.8,diseaseorphenotypicfeature
"Mutations in the PRKRA gene, specifically the c.1341delG variant, have been linked to pigmentary dystonia and an increased risk of coronary artery vasospasm in patients with idiopathic Parkinson’s disease.",-47.75,0.8,diseaseorphenotypicfeature
"Mutational activation of TP53 in the A549 cell line causes increased expression of the pro‑apoptotic protein BAX, which triggers apoptosis and reduces tumor cell viability in experimental models of esophageal squamous cell carcinoma (ESCC).",-38.0,0.8,diseaseorphenotypicfeature
"Mutated TP53 in hepatocellular carcinoma cells treated with doxorubicin induces apoptosis, while the presence of the BRCA1 c.68_69delAG variant in the same tumor correlates with increased pigmentation and susceptibility to hepatic failure.",-33.5,0.8,diseaseorphenotypicfeature
Mutagenic exposure to doxorubicin in H1299 cells induces a BRCA1 c.68_69delAG variant that correlates with increased susceptibility to hemorrhagic ulcer development in patients with Parkinson’s disease.,-30.625,0.8,diseaseorphenotypicfeature
"Mast cell infiltration and histamine release in a patient with **hemorrhagic ulcer** and **pigmentation** led to the up‑regulation of **TNF‑α**, which in turn exacerbated the inflammatory milieu and promoted further tissue necrosis.",-49.25,0.8,diseaseorphenotypicfeature
"Meningioma patients treated with bevacizumab showed a significant reduction in hemorrhagic ulcer progression, likely due to bevacizumab’s inhibition of VEGFA-mediated angiogenesis.",-29.25,0.8,diseaseorphenotypicfeature
"Methylprednisolone treatment of a patient with hepatic failure secondary to paraneoplastic parkinsonism was associated with a rapid resolution of the characteristic hemorrhagic ulcer and pigmentary skin lesions, suggesting that glucocorticoid‑mediated modulation of the immune response can ameliorate both neurologic and dermatologic manifestations.",-61.75,0.8,diseaseorphenotypicfeature
Mitochondrial DNA depletion caused by POLG mutations in patients with hepatic failure leads to severe pigmentary retinopathy and predisposes to early-onset myocardial infarction.,-29.875,0.8,diseaseorphenotypicfeature
Reactivation of the TP53 gene in A549 cells exposed to doxorubicin was shown to ameliorate cardiomyocyte apoptosis and reduce the incidence of idiopathic Parkinson’s disease‑like neuronal injury in a murine model of multiple myeloma.,-41.25,0.8,diseaseorphenotypicfeature
"Recurrent activation of the PI3K‑AKT pathway in A549 cells with the EGFR L858R mutation drives resistance to erlotinib, correlating with the clinical relapse of non‑small cell lung cancer patients whose tumors harbor this SequenceVariant.",-53.5,0.8,diseaseorphenotypicfeature
Reanalysis of bone marrow samples from patients with multiple myeloma revealed a recurrent TP53 c.1018_1021dupTCAA sequence variant that correlates with increased disease‑related fatigue and poorer overall survival.,-43.0,0.8,diseaseorphenotypicfeature
"Reprogramming of A549 cells with the TP53 c.215G>A variant induced neuronal‑like differentiation, suggesting a potential therapeutic avenue for idiopathic Parkinson’s disease by ameliorating neurodegeneration.",-37.5,0.8,diseaseorphenotypicfeature
"Neurodegeneration in idiopathic Parkinson’s disease is exacerbated by a missense BRCA1 c.68_69delAG variant, which impairs neuronal DNA repair pathways and accelerates neuronal injury in dopaminergic neurons of the substantia nigra.",-28.625,0.8,diseaseorphenotypicfeature
"Neuronal injury after spinal cord trauma was exacerbated by the BRCA1 c.68_69delAG sequence variant, which amplified oxidative stress and worsened myocardial dysfunction in the rat model.",-31.75,0.8,diseaseorphenotypicfeature
"Neutrophil infiltration in the renal cortex of patients with nephronophthisis with liver fibrosis, as identified by histological staining of kidney biopsies from Homo sapiens donors, correlates with increased expression of the pro‑inflammatory cytokine IL‑6 and exacerbates subsequent myocardial dysfunction through systemic inflammatory signaling pathways.",-49.75,0.8,diseaseorphenotypicfeature
"Neoadjuvant paclitaxel reduces tumor proliferation in embryonal carcinoma cells, thereby attenuating the subsequent fatty liver damage that often complicates high‑dose chemotherapy in patients with idiopathic Parkinson’s disease.",-44.75,0.8,diseaseorphenotypicfeature
"In patients with idiopathic Parkinson’s disease, the accumulation of α‑synuclein aggregates in dopaminergic neurons triggers neuronal injury that is exacerbated by impaired mitochondrial dynamics, ultimately contributing to progressive motor dysfunction.",-21.875,0.8,diseaseorphenotypicfeature
"In a cohort of patients with idiopathic Parkinson’s disease, the rs1995 polymorphism in the GBA gene was found to be associated with an increased risk of neuronal injury and subsequent motor decline.",-29.875,0.8,diseaseorphenotypicfeature
"In the patient with idiopathic Parkinson’s disease, dopaminergic neuronal injury was exacerbated by the BRCA1 c.68_69delAG variant, which impaired DNA repair and contributed to the progressive motor dysfunction.",-27.25,0.8,diseaseorphenotypicfeature
"In MLD patients, the accumulation of GM2 ganglioside in neuronal cells triggers progressive demyelination, leading to severe motor dysfunction and cognitive decline.",-22.5,0.8,diseaseorphenotypicfeature
A significant increase in circulating IL‑6 levels in patients with idiopathic Parkinson’s disease is correlated with enhanced neuronal injury and progression of dopaminergic degeneration.,-33.0,0.8,diseaseorphenotypicfeature
"A therapeutic regimen of lenalidomide in patients with multiple myeloma reduces circulating CD38+ plasma cells, thereby improving bone marrow microenvironment and mitigating osteolytic lesions.",-36.5,0.8,diseaseorphenotypicfeature
"A clinical trial demonstrated that the addition of the small‑molecule inhibitor selumetinib to standard therapy reduced relapse rates in patients with relapsed multiple myeloma, an effect that correlated with decreased phosphorylation of MAPK in tumor cells derived from the KMS-12‑BM cell line and was accompanied by an upregulation of the tumor suppressor gene TP53 in peripheral blood mononuclear cells.",-63.5,0.8,diseaseorphenotypicfeature
"A variant in the LIPA gene (c.509G>A) causes cholesteryl ester storage disease, a disorder that leads to fatty liver, myocardial dysfunction, and in some patients, nephronophthisis with liver fibrosis.",-42.0,0.8,diseaseorphenotypicfeature
"The presence of a BRCA2 c.5946_5951delTTATCG variant in a female with a family history of breast and ovarian cancer was associated with a markedly increased risk of developing metastatic multiple myeloma, as confirmed by a genome‑wide association study in a cohort of homozygous carriers.",-60.25,0.8,diseaseorphenotypicfeature
"The activation of the TP53 pathway by the BRCA1 c.68_69delAG variant in HeLa cells was found to sensitize the cells to doxorubicin-induced neuronal injury, suggesting a potential therapeutic strategy for multiple myeloma.",-26.25,0.8,diseaseorphenotypicfeature
"The mutation of the SMN1 gene in patients with spinal muscular atrophy leads to progressive muscular weakness and respiratory failure, whereas the same mutation in carriers of the SMN2 gene results in a milder phenotype with less pronounced motor deficits.",-43.0,0.8,diseaseorphenotypicfeature
"The nephronophthisis with liver fibrosis phenotype is exacerbated by the compound N-acetylcysteine, which downregulates the fibrosis‑associated COL1A1 gene in HepG2 cells.",-33.0,0.8,diseaseorphenotypicfeature
"Patients with idiopathic Parkinson’s disease treated with levodopa experience increased oxidative stress in dopaminergic neurons, which is exacerbated by a pathogenic BRCA2 c.5266dupC variant that impairs DNA repair.",-37.25,0.8,diseaseorphenotypicfeature
"Patients carrying the GATA4 c.1024C>T sequence variant showed increased risk of myocardial dysfunction, a phenotype also observed in idiopathic Parkinson’s disease models that involve neuronal injury and fatty liver pathology.",-49.0,0.8,diseaseorphenotypicfeature
"Patients treated with doxorubicin for embryonal carcinoma exhibited neuronal injury and fatty liver, and the presence of a TP53 c.68_69delAG variant was associated with increased myocardial dysfunction.",-28.75,0.8,diseaseorphenotypicfeature
"Patients receiving doxorubicin exhibit dose‑dependent neuronal injury, and in those with the MLD sequence variant, the resulting myelination defects exacerbate the risk of fatty liver and idiopathic Parkinson’s disease, illustrating a complex gene‑drug‑disease interaction that may also predispose to nephronophthisis with liver fibrosis.",-59.0,0.8,diseaseorphenotypicfeature
"Cohen syndrome, a rare autosomal recessive disorder, is characterized by growth retardation, neutropenia, and hyperpigmentation, with a pathogenic sequence variant in the VPS13B gene leading to impaired intracellular trafficking and neuronal injury.",-56.75,0.8,diseaseorphenotypicfeature
Cytogenetic analysis of the patient’s skin biopsy revealed a BRCA1 c.68_69delAG sequence variant that correlates with the observed idiopathic Parkinson’s disease phenotype and increases the risk of neuronal injury.,-32.75,0.8,diseaseorphenotypicfeature
"Cognitive decline in idiopathic Parkinson's disease is exacerbated by mitochondrial dysfunction and the accumulation of α‑synuclein aggregates, which in turn impair dopaminergic neuron survival.",-28.5,0.8,diseaseorphenotypicfeature
"Cerebrospinal fluid analysis in patients with idiopathic Parkinson’s disease revealed that elevated lactate dehydrogenase levels correlated with neuronal injury markers and a higher risk of developing hepatic fatty liver, suggesting a systemic metabolic disturbance.",-42.25,0.8,diseaseorphenotypicfeature
"Mutations in the ABCD1 gene, including the c.1002_1004delTAA variant, have been linked to the neuronal injury and cardiomyopathy observed in X‑linked adrenoleukodystrophy, while the aberrant accumulation of very‑long‑chain fatty acids in the liver is a hallmark of this disease.",-59.5,0.8,diseaseorphenotypicfeature
"Mutagenic exposure of A549 cells to doxorubicin induced TP53 mutations, which were associated with increased neuronal injury and a higher incidence of idiopathic Parkinson’s disease–like phenotypic features in the treated cultures.",-35.25,0.8,diseaseorphenotypicfeature
"Mutational activation of the TP53 gene in the A549 cell line, coupled with exposure to doxorubicin, induces apoptosis and suppresses the expression of the anti‑apoptotic protein BCL‑2, thereby exacerbating neuronal injury in a model of idiopathic Parkinson’s disease.",-37.75,0.8,diseaseorphenotypicfeature
"Mutated TP53 c.743G>A in a patient with idiopathic Parkinson’s disease exacerbated neuronal injury, as evidenced by increased alpha‑synuclein accumulation and dopaminergic neuron loss.",-31.125,0.8,diseaseorphenotypicfeature
"Deficiency of the ABCD1 gene, a SequenceVariant in the peroxisomal fatty acid‑beta‑oxidation pathway, is causatively linked to neuronal injury and progressive neurodegeneration in patients with X‑linked adrenoleukodystrophy, a neuro‑autosomal condition that mimics idiopathic Parkinson’s disease symptoms and accelerates skin carcinogenesis in aged individuals.",-74.5,0.8,diseaseorphenotypicfeature
"Defective phosphatidylinositol-3-kinase signaling in the A549 cell line, triggered by the KRAS G12D sequence variant, promotes fatty liver development and exacerbates neuronal injury in idiopathic Parkinson’s disease models.",-39.5,0.8,diseaseorphenotypicfeature
Deficiencies in the ABCA1 gene variant c.2045G>A lead to hepatic steatosis and increased risk of fatty liver disease in patients with idiopathic Parkinson’s disease.,-38.25,0.8,diseaseorphenotypicfeature
"Defects in the ARHGEF10L gene, including the c.412C>T variant, were found to exacerbate neuronal injury in patients with idiopathic Parkinson's disease, whereas treatment with the small‑molecule inhibitor doxorubicin ameliorated cellular stress markers in the A549 cell line, suggesting a potential therapeutic strategy for neurodegenerative pathology.",-79.0,0.8,diseaseorphenotypicfeature
Idiopathic Parkinson’s disease patients treated with the alpha‑synuclein aggregation inhibitor selegiline show improved motor scores and reduced nigral neuronal injury compared with untreated controls.,-30.875,0.8,diseaseorphenotypicfeature
"Idiopathically, Parkinson’s disease is linked to mitochondrial dysfunction, with dopaminergic neuronal injury exacerbated by alpha‑synuclein aggregation.",-37.5,0.8,diseaseorphenotypicfeature
"Idiopatic Parkinson’s disease patients exhibit increased neuronal injury, which correlates with upregulated alpha‑synuclein expression and heightened oxidative stress, thereby accelerating disease progression.",-45.5,0.8,diseaseorphenotypicfeature
"Idiomatic Parkinson's disease patients receiving rasagiline show reduced α‑synuclein aggregation, correlating with improved motor scores and decreased substantia nigra neuronal injury.",-41.5,0.8,diseaseorphenotypicfeature
"Neurological deficits in idiopathic Parkinson’s disease are exacerbated by chronic ethanol exposure, which induces oxidative stress that further damages dopaminergic neurons in the substantia nigra.",-22.625,0.8,diseaseorphenotypicfeature
"Neurologic sequelae of idiopathic Parkinson’s disease are exacerbated by the accumulation of alpha‑synuclein aggregates, which activate microglial NLRP3 inflammasomes, thereby amplifying neuronal injury and accelerating disease progression.",-31.375,0.8,diseaseorphenotypicfeature
"Neuropathic pain following neuronal injury in patients with idiopathic Parkinson’s disease is exacerbated by the overexpression of the ATP-binding cassette transporter ABCB1, a gene product that reduces the intracellular concentration of the chemotherapeutic agent methotrexate.",-43.0,0.8,diseaseorphenotypicfeature
"Neuromelanin accumulation in dopaminergic neurons of patients with idiopathic Parkinson’s disease correlates with mitochondrial DNA sequence variants in the MT‑ND2 gene, exacerbating neuronal injury and accelerating motor dysfunction.",-36.0,0.8,diseaseorphenotypicfeature
"Multiple myeloma patients treated with bortezomib exhibit a dose-dependent increase in neuronal injury biomarkers, suggesting a neurotoxic side effect that may contribute to disease‑related neuropathic complications.",-31.375,0.8,diseaseorphenotypicfeature
"Multiple‑myeloma patients treated with bortezomib exhibit a higher incidence of nephronophthisis‑associated liver fibrosis, suggesting a drug‑induced exacerbation of the disease’s renal‑liver phenotype.",-28.125,0.8,diseaseorphenotypicfeature
"Multiple‐myeloma patients receiving high‐dose doxorubicin exhibited increased neuronal injury markers, suggesting a potential link between chemotherapy‐induced neurotoxicity and disease progression.",-32.75,0.8,diseaseorphenotypicfeature
"Multiple sclerosis was shown to exacerbate neuronal injury in A549 cells, where the CYP2E1 gene product metabolized ethanol into reactive oxygen species that further impaired the blood–brain barrier and accelerated disease progression.",-52.75,0.8,diseaseorphenotypicfeature
"Mice injected with the MLD‑associated mutation in the GBA1 gene exhibited neuronal injury, fatty liver pathology, and myocardial dysfunction, mirroring the multisystemic phenotype observed in patients with multiple myeloma‑like disease.",-48.0,0.8,diseaseorphenotypicfeature
"Mitochondrial dysfunction in the dopaminergic neurons of patients with idiopathic Parkinson’s disease, as evidenced by increased oxidative stress markers, correlates with the severity of motor symptoms and suggests that therapeutic targeting of neuronal injury pathways may attenuate disease progression.",-38.5,0.8,diseaseorphenotypicfeature
"Molecular analysis of a patient with idiopathic Parkinson’s disease revealed a novel BRCA1 c.68_69delAG variant that, through dysregulation of TP53, may contribute to neuronal injury and exacerbated neurodegeneration.",-28.0,0.8,diseaseorphenotypicfeature
"Mild neuronal injury in idiopathic Parkinson’s disease patients treated with the dopamine agonist pramipexole was associated with up‑regulation of the GPCR gene DRD2, whereas a missense variant in the GBA sequence (c.1226A>G, p.N370S) increased the risk of neurodegeneration and liver fibrosis.",-68.0,0.8,diseaseorphenotypicfeature
"Deletion of the TP53 exon‑7 splice site in the U‑87 MG cell line, which harbors a BRCA1 c.68_69delAG sequence variant, was shown to aggravate neuronal injury in an in‑vitro model of idiopathic Parkinson’s disease.",-48.25,0.8,diseaseorphenotypicfeature
"Deletion homozygosity of the pathogenic c.68_69delAG variant in the BRCA1 gene was observed in a patient with early‑onset breast cancer, whose tumor tissue also exhibited overexpression of the TP53 protein, suggesting a synergistic effect on disease progression.",-58.5,0.8,diseaseorphenotypicfeature
Deletion in the FAT4 gene causes neuronal injury that manifests as idiopathic Parkinson’s disease and worsens fatty liver progression in patients with nephronophthisis and liver fibrosis.,-42.5,0.8,diseaseorphenotypicfeature
"Deletion-induced truncation of the ELOVL1 gene in patients with ichthyosis leads to impaired keratinocyte lipid elongation, causing severe scaling and increased risk of secondary skin carcinogenesis.",-54.25,0.8,diseaseorphenotypicfeature
"Chronic allograft nephropathy in kidney transplant recipients is exacerbated by a CYP3A5*3 allele that reduces tacrolimus metabolism, leading to elevated drug exposure and accelerated interstitial fibrosis.",-22.25,0.8,diseaseorphenotypicfeature
"Cholinergic blockade with pyridostigmine alleviated the ventilatory failure in a patient with myasthenic crisis secondary to thymoma, thereby preventing a fatal comatose state.",-46.75,0.8,diseaseorphenotypicfeature
Chorioamnionitis with prolonged rupture of membranes was found to increase the risk of preterm delivery by upregulating inflammatory cytokines such as IL‑6 and TNF‑α in the maternal-fetal interface.,-35.25,0.8,diseaseorphenotypicfeature
"Chimeric antigen receptor T cells targeting CD19 reduced tumor burden in patients with B‑cell acute lymphoblastic leukemia and concurrently triggered cytokine‑release syndrome, a potentially life‑threatening systemic inflammatory response.",-36.0,0.8,diseaseorphenotypicfeature
A mutation in the TP53 gene of HeLa cells carrying the BRCA1 c.68_69delAG variant increases susceptibility to adenocarcinoma of the lung in the presence of doxorubicin.,-31.75,0.8,diseaseorphenotypicfeature
"A dysregulated TP53 variant (c.215G>A) in a HeLa cell line derived from a patient with adenocarcinoma of lung leads to increased expression of the pro‑apoptotic protein BAX, thereby sensitizing the tumor cells to doxorubicin treatment.",-27.25,0.8,diseaseorphenotypicfeature
A biopsy of a squamous cell carcinoma of the head and neck revealed an EGFR exon19 deletion (c.2235_2252del) that predicts resistance to cetuximab treatment and is associated with increased tumor proliferation in patients with chronic allograft nephropathy.,-49.5,0.8,diseaseorphenotypicfeature
"A2–B1 in the TP53 gene, which is frequently mutated in adenocarcinoma of lung, was shown to increase the risk of preterm delivery by disrupting p53‑mediated regulation of the maternal uterine vasculature.",-48.5,0.8,diseaseorphenotypicfeature
"The chronic allograft nephropathy observed in post‑transplant patients was significantly exacerbated by the presence of the APOL1 G1 allele, leading to accelerated kidney failure.",-26.125,0.8,diseaseorphenotypicfeature
"The combined administration of doxorubicin and the mitochondrial inhibitor metformin synergistically increased apoptosis in A549 cells harboring the BRCA1 c.68_69delAG variant, thereby attenuating the progression of adenocarcinoma of the lung.",-33.25,0.8,diseaseorphenotypicfeature
The presence of the TP53 c.215G>A variant in patients with adenocarcinoma of the lung was correlated with accelerated tumor progression and increased risk of chronic allograft nephropathy following chemotherapy.,-27.25,0.8,diseaseorphenotypicfeature
"The pulmonary adenocarcinoma of the patient’s lung was found to harbor a BRCA1 c.68_69delAG variant, which correlated with a markedly higher risk of preterm delivery in her subsequent pregnancy.",-28.125,0.8,diseaseorphenotypicfeature
"In patients with chronic allograft nephropathy, the presence of the APOL1 G1 variant was associated with accelerated progression to end‑stage renal disease, while treatment with the selective endothelin‑A receptor antagonist bosentan reduced proteinuria and improved graft survival.",-26.125,0.8,diseaseorphenotypicfeature
"In chronic allograft nephropathy, elevated serum IL‑6 levels correlate with progressive fibrosis and reduced graft function, and targeting IL‑6 signaling with tocilizumab has been shown to improve renal outcomes in a subset of patients.",-37.75,0.8,diseaseorphenotypicfeature
"In a cohort of patients with **adenocarcinoma of the lung**, the presence of the **BRCA1 c.68_69delAG** **SequenceVariant** in the tumor DNA was associated with a markedly higher incidence of **chronic allograft nephropathy** in recipients who received **donor** **OrganismTaxon** **Homo sapiens** kidneys, suggesting that this variant may modulate drug metabolism and kidney injury pathways during **cancer‑related** chemotherapy.",-61.0,0.8,diseaseorphenotypicfeature
"In the HeLa cell line, the overexpression of TP53 combined with the BRCA1 c.68_69delAG variant induced apoptosis and reduced the growth of squamous cell carcinoma of the head and neck cells, highlighting a potential therapeutic target for cancer-related treatment.",-31.875,0.8,diseaseorphenotypicfeature
"Mutations in the mitochondrial DNA variant m.3243A>G are associated with mitochondrial encephalopathy, and patients carrying this SequenceVariant frequently experience preterm delivery during pregnancy.",-21.0,0.8,diseaseorphenotypicfeature
"Mutational loss of the tumor suppressor gene TP53 in A549 adenocarcinoma of the lung was associated with increased resistance to doxorubicin, thereby contributing to treatment failure and disease recurrence.",-36.0,0.8,diseaseorphenotypicfeature
Mutagenic exposure to doxorubicin in A549 cells induces a TP53 c.215G>A sequence variant that increases apoptosis and is associated with the development of adenocarcinoma of lung in treated patients.,-31.125,0.8,diseaseorphenotypicfeature
"Mutated TP53 c.215C>T in the A549 cell line was shown to enhance resistance to doxorubicin-induced apoptosis, thereby contributing to chemoresistance in adenocarcinoma of the lung.",-27.5,0.8,diseaseorphenotypicfeature
"Mitochondrial encephalopathy in a Homo sapiens patient was found to be exacerbated by a missense SequenceVariant in the POLG gene, leading to chronic allograft nephropathy in kidney transplant recipients treated with tacrolimus.",-29.0,0.8,diseaseorphenotypicfeature
"Molecular profiling of adenocarcinoma of lung revealed that EGFR exon19 deletion (SequenceVariant) drives overexpression of HER3, leading to increased resistance to gefitinib in A549 (CellLine) treated patients, thereby correlating with poorer overall survival (DiseaseOrPhenotypicFeature).",-53.0,0.8,diseaseorphenotypicfeature
"MDR1 gene amplification in HeLa cells confers resistance to doxorubicin, thereby contributing to chemotherapy‑refractory adenocarcinoma of lung and increasing the risk of chronic allograft nephropathy in transplant recipients.",-35.25,0.8,diseaseorphenotypicfeature
Methylation of the TP53 promoter in A549 cells carrying the BRCA1 c.68_69delAG variant correlates with increased expression of the DNA repair enzyme ATM and enhances resistance to doxorubicin-induced apoptosis in patients with adenocarcinoma of lung.,-36.25,0.8,diseaseorphenotypicfeature
"Patients with chronic allograft nephropathy who were treated with tacrolimus exhibited a significant decline in eGFR, while simultaneous up‑regulation of the cytokine IL‑6 and the transcription factor NF‑κB in biopsy samples correlated with the severity of interstitial fibrosis and tubular atrophy.",-47.5,0.8,diseaseorphenotypicfeature
"Patients using the PD‑1 inhibitor nivolumab who also carried the BRCA1 c.68_69delAG sequence variant experienced a higher incidence of preterm delivery, suggesting a link between DNA repair deficiency, immune checkpoint blockade, and adverse pregnancy outcomes.",-39.25,0.8,diseaseorphenotypicfeature
Patients homozygous for the BRCA1 c.68_69delAG variant who received PARP‑inhibitor therapy exhibited a markedly lower incidence of early‑stage adenocarcinoma of the lung compared with untreated controls.,-37.5,0.8,diseaseorphenotypicfeature
"Patients receiving doxorubicin for adenocarcinoma of lung exhibited a dose‑dependent increase in chronic allograft nephropathy, with gene‑expression profiling revealing up‑regulation of TP53 and down‑regulation of VEGFA in the affected renal biopsies.",-26.25,0.8,diseaseorphenotypicfeature
"Acute myocardial infarction in a patient with a BRCA1 c.68_69delAG variant was associated with an increased risk of squamous cell carcinoma of the head and neck, prompting the use of doxorubicin to target the TP53‑mutated tumour cells.",-26.5,0.8,diseaseorphenotypicfeature
"Acetaminophen exposure during pregnancy was found to increase the risk of preterm delivery in a cohort of women with chronic allograft nephropathy, where maternal serum levels of the drug correlated with fetal cortisol production and placental oxidative stress markers.",-42.5,0.8,diseaseorphenotypicfeature
"Acquisition of the EGFR exon‑19 deletion variant (c.2230_2237del) in a patient with adenocarcinoma of the lung leads to constitutive activation of the MAPK pathway, which in turn induces up‑regulation of VEGF and promotes angiogenesis and tumor progression.",-58.0,0.8,diseaseorphenotypicfeature
"Acinar carcinoma of the pancreas, often presenting with abdominal pain and weight loss, is frequently associated with a KRAS G12D SequenceVariant that drives uncontrolled cell proliferation in the affected Tissue.",-46.0,0.8,diseaseorphenotypicfeature
"Metformin ameliorated insulin resistance in a HeLa cell line harboring the BRCA1 c.68_69delAG variant, thereby reducing oxidative stress markers associated with breast cancer relapse.",-36.0,0.8,diseaseorphenotypicfeature
"Metronomic paclitaxel combined with the DNA repair inhibitor olaparib showed a significant reduction in tumor burden in A549 cell lines harboring a BRCA1 c.68_69delAG variant, indicating that the sequence variant sensitizes adenocarcinoma of lung cells to PARP inhibition.",-50.25,0.8,diseaseorphenotypicfeature
"Metastatic adenocarcinoma of lung in a patient with preterm delivery history was found to overexpress the oncogenic protein KRAS, correlating with aggressive tumor growth and poor survival.",-30.375,0.8,diseaseorphenotypicfeature
"Metabolic syndrome in patients with chronic allograft nephropathy is associated with increased risk of acute myocardial infarction, as evidenced by elevated troponin I levels and histological evidence of coronary artery atherosclerosis in kidney transplant recipients.",-34.75,0.8,diseaseorphenotypicfeature
"SARS‑CoV‑2 infection in patients with chronic allograft nephropathy was associated with a higher incidence of acute myocardial infarction and reduced graft survival, underscoring the need for intensified cardiovascular monitoring in this vulnerable population.",-28.25,0.8,diseaseorphenotypicfeature
"Surgical resection of the squamous cell carcinoma of the head and neck markedly reduced local recurrence, yet the patient’s subsequent chronic allograft nephropathy progressed, likely due to the immunosuppressive regimen that suppressed the recipient’s MHC‑matched immune response.",-46.5,0.8,diseaseorphenotypicfeature
"Sickle cell disease, a hereditary blood disorder, can precipitate acute myocardial infarction by promoting platelet activation and endothelial dysfunction, especially in patients who also have chronic allograft nephropathy and are receiving cyclosporine therapy.",-46.25,0.8,diseaseorphenotypicfeature
"Sildenafil ameliorated erectile dysfunction in patients with chronic allograft nephropathy, as measured by increased intracavernosal pressure and improved erectile function score.",-35.0,0.8,diseaseorphenotypicfeature
"High‑grade adenocarcinoma of the lung in a patient with preterm delivery history exhibited an EGFR exon19 deletion, which was effectively targeted by afatinib, leading to partial remission and improvement of the patient’s pulmonary function.",-46.0,0.8,diseaseorphenotypicfeature
High levels of circulating IL‑6 in patients with chronic allograft nephropathy and preterm delivery correlate with accelerated decline of kidney function and increased risk of acute myocardial infarction.,-30.125,0.8,diseaseorphenotypicfeature
High throughput sequencing of the TP53 gene in A549 cells from patients with adenocarcinoma of the lung revealed a recurrent BRCA1 c.68_69delAG variant that correlated with increased tumor aggressiveness and a higher rate of early‑stage preterm delivery in their offspring.,-47.0,0.8,diseaseorphenotypicfeature
"High‐throughput CRISPR‑Cas9 screening in A549 cells identified that loss of TP53 expression increases susceptibility to adenocarcinoma of lung, a finding that may explain the observed higher incidence of this disease in patients with TP53 c.68_69delAG sequence variants.",-43.75,0.8,diseaseorphenotypicfeature
"Knockout of the mitochondrial DNA variant m.3243A>G in HeLa cells increases susceptibility to acute myocardial infarction‑like metabolic crisis, suggesting a direct link between the sequence variant and cardiovascular phenotypic outcome.",-38.75,0.8,diseaseorphenotypicfeature
"Knocking out TP53 in A549 cells amplifies the cytotoxicity of doxorubicin, thereby increasing apoptosis in this adenocarcinoma of lung model and suggesting a potential strategy to mitigate treatment‑induced cardiotoxicity in patients with acute myocardial infarction.",-40.75,0.8,diseaseorphenotypicfeature
"Knobloch syndrome, a rare neuro-ocular disorder, is characterized by congenital retinal detachment and occipital encephalocele, and recent studies have shown that a de novo TP53 c.743G>A (p.Arg248Gln) variant in affected infants correlates with the severity of the cranial malformations.",-62.0,0.8,diseaseorphenotypicfeature
"Knox et al. reported that a BRCA1 c.68_69delAG sequence variant in a BRCA1‑mutated patient with adenocarcinoma of lung was associated with a dramatic decrease in the tumor’s sensitivity to doxorubicin, suggesting that the variant may drive drug resistance by altering the p53‑mediated apoptotic pathway.",-62.75,0.8,diseaseorphenotypicfeature
"Preterm delivery is strongly associated with neonatal hypoxia, and the upregulation of HIF‑1α in placental villi is thought to mediate the increased risk of congenital heart disease (CHD) and subsequent chronic allograft nephropathy in infants born to mothers with severe anemia.",-50.25,0.8,diseaseorphenotypicfeature
"Preoperative imaging of a patient with adenocarcinoma of lung revealed a mass invading the left pulmonary artery, prompting the oncologist to administer a single dose of bevacizumab before initiating neoadjuvant chemotherapy to prevent tumor‑induced thrombosis.",-54.5,0.8,diseaseorphenotypicfeature
"Pre‑term delivery in pregnancies complicated by chronic allograft nephropathy is associated with elevated maternal serum levels of the chemokine CCL2, which in turn promote recruitment of monocytes to the uterine decidua and increase the risk of placental inflammation and fetal growth restriction.",-39.25,0.8,diseaseorphenotypicfeature
"Preclinical assays in A549 cells revealed that the KRAS G12C inhibitor ARS-1620 suppresses proliferation by downregulating downstream ERK signaling, thereby providing a potential therapeutic approach for patients with KRAS‑mutant adenocarcinoma of lung.",-52.0,0.8,diseaseorphenotypicfeature
Progressive respiratory failure in patients with adenocarcinoma of the lung treated with doxorubicin correlates with increased expression of the TP53 protein in the A549 cell line.,-31.625,0.8,diseaseorphenotypicfeature
"Progression of adenocarcinoma of lung in the HeLa cell line treated with doxorubicin was accompanied by a significant reduction in TP53 protein expression and an increase in inflammatory cytokines, suggesting a potential therapeutic target for mitigating disease severity.",-43.0,0.8,diseaseorphenotypicfeature
Progress‑ion of squamous cell carcinoma of the head and neck in a patient receiving docetaxel is exacerbated by a BRCA1 c.68_69delAG variant that down‑regulates p53‑mediated apoptosis.,-36.25,0.8,diseaseorphenotypicfeature
"Progress in CRISPR‑mediated base‑editing of the BRCA1 c.68_69delAG variant in the A549 cell line shows that correcting the pathogenic deletion restores normal DNA‑damage‑response signaling, reduces cell‑cycle arrest, and diminishes the susceptibility of these adenocarcinoma of lung cells to doxorubicin‑induced apoptosis.",-65.0,0.8,diseaseorphenotypicfeature
Mutation of the PKD1 gene in ADPKD patients causes a genetic defect that leads to cyst formation and ultimately results in progressive renal failure and associated CNS damage.,-21.625,0.8,diseaseorphenotypicfeature
"Mutation to the PKD1 gene that causes ADPKD leads to cystic expansion of the kidneys, subsequently inducing hypertension, CNS damage, and a higher risk of renal failure.",-44.25,0.8,diseaseorphenotypicfeature
"Mutation in the PKD1 gene (SequenceVariant c.7312C>T) underlies the autosomal‑dominant genetic defect that causes ADPKD, leading to progressive renal cysts, hypertension, and in severe cases, CNS damage due to impaired cerebrovascular regulation.",-48.25,0.8,diseaseorphenotypicfeature
Mutation‑induced loss of nephron‑specific transcription factor PKD1 in the human kidney cell line HK-2 leads to cellular senescence and a phenotype resembling autosomal dominant polycystic kidney disease (ADPKD) through dysregulation of the mTOR signaling pathway.,-48.25,0.8,diseaseorphenotypicfeature
"In patients with autosomal dominant polycystic kidney disease, a pathogenic sequence variant in PKD1 often triggers progressive cyst growth that ultimately results in CNS damage and renal failure.",-26.25,0.8,diseaseorphenotypicfeature
"In **ADPKD** patients, renal cyst formation driven by a **PKD1** genetic defect frequently leads to **ventricular septal defect** and associated **CNS damage**.",-29.875,0.8,diseaseorphenotypicfeature
"In the cohort of patients with ADPKD, the discovery of a pathogenic variant in the PKD1 gene was correlated with progressive CNS damage, including seizures and cognitive decline, underscoring the impact of this genetic defect on neurological function.",-42.5,0.8,diseaseorphenotypicfeature
"In a cohort of patients with ADPKD, the presence of a pathogenic PKD1 SequenceVariant was associated with early CNS damage, suggesting a genetic defect that accelerates renal cyst growth and neurodegeneration.",-29.5,0.8,diseaseorphenotypicfeature
"Pharmacogenomic analysis revealed that the BRCA1 c.68_69delAG SequenceVariant in a patient with ADPKD exacerbated CNS damage, prompting the use of the small molecule drug doxorubicin to mitigate optic atrophy progression.",-35.25,0.8,diseaseorphenotypicfeature
Phosphorylation of the FEVR‑associated protein WNT4 by the kinase GSK3β in HeLa cells carrying the BRCA1 c.68_69delAG variant exacerbates CNS damage in patients with congenital optic atrophy and increases susceptibility to colon cancer.,-47.25,0.8,diseaseorphenotypicfeature
"Phenytoin treatment of patients with ADPKD markedly reduces the risk of ventricular septal defect in children, likely by modulating the genetic defect in PKD1 that otherwise leads to CNS damage.",-48.0,0.8,diseaseorphenotypicfeature
"Phox2b mutations causing congenital central hypoventilation syndrome were found to induce CNS damage and optic atrophy, correlating with a severe genetic defect that predisposes patients to early-onset ventricular septal defect.",-48.25,0.8,diseaseorphenotypicfeature
"A heterozygous sequence variant in the PKD1 gene, identified in a patient with autosomal dominant polycystic kidney disease, was shown to correlate with increased susceptibility to central nervous system damage and optic atrophy.",-30.5,0.8,diseaseorphenotypicfeature
"A missense mutation in the PKD1 gene of a patient with ADPKD was shown to disrupt polycystin‑1 function, leading to cystic kidney enlargement and increased risk of hypertension and CNS damage.",-29.75,0.8,diseaseorphenotypicfeature
A mutation in the PKD1 gene (SequenceVariant: c.4285C>T) was identified in a patient with autosomal dominant polycystic kidney disease (DiseaseOrPhenotypicFeature: ADPKD) and concurrently contributed to chronic kidney failure (DiseaseOrPhenotypicFeature: CNS damage) by disrupting tubular epithelial cell function (GeneOrGeneProduct: PKD1).,-45.75,0.8,diseaseorphenotypicfeature
"A genome‑wide association study in patients with ADPKD revealed that a common sequence variant in the PKD1 gene (c.3812G>A) is linked to earlier onset of CNS damage, underscoring the role of a genetic defect in disease progression.",-34.25,0.8,diseaseorphenotypicfeature
"The pathogenic variant BRCA1 c.68_69delAG in a colon cancer patient’s germline DNA was shown to disrupt the DNA repair pathway, leading to microsatellite instability and increased tumor mutational burden.",-29.75,0.8,diseaseorphenotypicfeature
"The CRISPR‑Cas9‑mediated correction of the ADPKD‑causing PKD1 c.10500_10502delCTG variant in patient‑derived A549 cells restored normal cystic architecture and reduced the expression of the fibrosis‑promoting gene COL1A1, highlighting the therapeutic potential of targeted genome editing for cystic kidney disease.",-50.5,0.8,diseaseorphenotypicfeature
"The clinical course of patients with ADPKD and associated CNS damage is worsened by a genetic defect in PKD1, which may also predispose to ventricular septal defect and optic atrophy.",-28.625,0.8,diseaseorphenotypicfeature
"The genetic defect in PKD1 causing autosomal dominant ADPKD leads to progressive cystic dilation of the kidneys, which can eventually result in CNS damage and increased risk of ventricular septal defect during early development.",-34.0,0.8,diseaseorphenotypicfeature
"Polymorphisms in the **IRF5** gene have been associated with susceptibility to **systemic lupus erythematosus (SLE)**, a disease characterized by **autoimmune inflammation** and a high risk of developing **arthritis** and **optic atrophy**.",-32.5,0.8,diseaseorphenotypicfeature
"Polycystic kidney disease (ADPKD) associated with a genetic defect in PKD1 leads to progressive renal cyst formation, which in turn can cause secondary CNS damage and ventricular septal defect in a subset of patients.",-30.375,0.8,diseaseorphenotypicfeature
"Polymyxin‑B exposure in patients with *E. coli* bacteremia induces *ketoamine*‐mediated stomatitis, a clinical phenotype that correlates with up‑regulation of the inflammatory cytokine IL‑6 in the affected mucosa.",-58.25,0.8,diseaseorphenotypicfeature
"Polydactyly and CNS damage in infants harboring an ADPKD‑associated genetic defect were alleviated by the early administration of the small‑molecule drug deferiprone, which reduced iron‑induced oxidative stress in the developing brain.",-49.25,0.8,diseaseorphenotypicfeature
"Mutations in the PKD1 gene cause a genetic defect that underlies ADPKD, leading to renal cyst formation and eventually CNS damage and ventricular septal defect in affected patients.",-20.5,0.8,diseaseorphenotypicfeature
"Mutational analysis of the PKD1 gene in a patient with ADPKD revealed a novel sequence variant c.4124G>T that correlates with severe CNS damage and early-onset optic atrophy, underscoring the pathogenic impact of genetic defects on neuro‑vascular complications.",-49.25,0.8,diseaseorphenotypicfeature
"Mutated **BRCA1 c.68_69delAG** in a **Homo sapiens** patient with **colorectal carcinoma** was found to impair DNA repair, thereby accelerating disease progression and increasing susceptibility to **CNS damage** and **optic atrophy**.",-35.75,0.8,diseaseorphenotypicfeature
"Mutant TP53 c.215G>A in an ADPKD patient was linked to CNS damage and a higher incidence of ventricular septal defect, highlighting a genetic defect that may also predispose to optic atrophy and colon cancer.",-40.75,0.8,diseaseorphenotypicfeature
"Genetic defects in the PAX6 gene cause ocular dysplasia that leads to optic atrophy, which is frequently observed in patients with FEVR and subsequently increases the risk of CNS damage.",-33.5,0.8,diseaseorphenotypicfeature
"Genomic analysis of a patient with autosomal dominant polycystic kidney disease (ADPKD) revealed a pathogenic c.4021G>A sequence variant in the PKD1 gene, whose expression in renal epithelial cells is markedly up‑regulated by the transcription factor HNF1β, thereby exacerbating cyst formation and contributing to progressive renal failure.",-46.75,0.8,diseaseorphenotypicfeature
"Genetically engineered A549 cells carrying the BRCA1 c.68_69delAG variant were shown to exhibit increased susceptibility to doxorubicin‑induced CNS damage, a phenotype reminiscent of the optic atrophy observed in patients with ADPKD.",-28.5,0.8,diseaseorphenotypicfeature
Genotyping of the **TP53** variant c.215C>T in patients with **colorectal cancer** revealed that carriers exhibit a higher incidence of **optic atrophy** and an increased risk of developing **ventricular septal defect** during embryonic development.,-38.5,0.8,diseaseorphenotypicfeature
Patients with ADPKD often develop CNS damage secondary to a genetic defect that predisposes to renal cystic growth and hypertension.,-19.625,0.8,diseaseorphenotypicfeature
"Patients diagnosed with ADPKD frequently exhibit CNS damage as a consequence of a genetic defect that predisposes them to hypertension, yet the onset of stomatitis after initiation of sirolimus therapy has been reported in a subset of individuals with this disorder.",-51.25,0.8,diseaseorphenotypicfeature
"Patients harboring the genetic defect in PKD1 who develop ADPKD often experience progressive CNS damage, with seizures and optic atrophy becoming common complications.",-35.5,0.8,diseaseorphenotypicfeature
"Patients carrying the ADPKD‑associated PKD1 c.14088G>A sequence variant develop progressive renal cystic disease and often exhibit CNS damage, including optic atrophy, due to the underlying genetic defect.",-37.25,0.8,diseaseorphenotypicfeature
"Splicing of the PKD1 transcript in ADPKD patients with a c.16729G>A SequenceVariant leads to a truncated protein that disrupts renal tubular epithelium, contributing to the genetic defect underlying the disease.",-51.5,0.8,diseaseorphenotypicfeature
"Spinal cord injury in an adolescent with ADPKD exacerbates optic atrophy, likely through a genetic defect in PKD1 that disrupts renal tubular transport and contributes to CNS damage.",-44.25,0.8,diseaseorphenotypicfeature
"Spontaneous mutations in the PKD1 gene, such as the c.1001_1004delAAGT sequence variant, can precipitate autosomal dominant polycystic kidney disease (ADPKD) in Homo sapiens, leading to progressive renal failure and, in some patients, CNS damage and optic atrophy.",-51.5,0.8,diseaseorphenotypicfeature
Spaced‑repetition vaccination with a recombinant protein derived from *Streptococcus pneumoniae* reduced the incidence of pneumococcal meningitis and decreased mortality in patients with underlying genetic defects associated with *ADA* deficiency in *Homo sapiens*.,-63.0,0.8,diseaseorphenotypicfeature
An up‑regulation of the mutant TP53 gene product in HeLa cells harboring the BRCA1 c.68_69delAG variant correlates with increased susceptibility to colorectal adenocarcinoma and CNS damage in patients with autosomal dominant polycystic kidney disease.,-38.5,0.8,diseaseorphenotypicfeature
"An autosomal dominant mutation in the PKD1 gene, identified in a patient with ADPKD, was shown to cause progressive CNS damage and optic atrophy through dysregulated tubular fluid reabsorption.",-37.25,0.8,diseaseorphenotypicfeature
"An FEVR mutation in the NDP gene disrupts retinal vascular development, leading to CNS damage and optic atrophy in affected patients.",-20.75,0.8,diseaseorphenotypicfeature
"An A549 cell line harboring the BRCA1 c.68_69delAG sequence variant exhibited increased sensitivity to doxorubicin, correlating with the severity of CNS damage observed in patients with ADPKD who carry the same genetic defect.",-25.375,0.8,diseaseorphenotypicfeature
"Altered expression of the TFAP2B gene, a genetic defect underlying FEVR, leads to defective retinal vascularization and subsequent CNS damage manifesting as optic atrophy and developmental delays.",-38.75,0.8,diseaseorphenotypicfeature
"Alterations in the Wnt/β‑catenin pathway caused by a COL4A5 sequence variant accelerate the development of CNS damage and optic atrophy in patients with X‑linked Alport syndrome, a genetic defect underlying progressive renal failure and hearing loss.",-35.5,0.8,diseaseorphenotypicfeature
"Alteration of the PKD1 gene (a genetic defect) in patients with ADPKD leads to cystic dilation of renal ducts, subsequently causing hypertension that can precipitate CNS damage and optic atrophy.",-35.5,0.8,diseaseorphenotypicfeature
"Alterative therapy with the small‑molecule inhibitor berberine ameliorated inflammatory bowel disease symptoms in Apc^Min/+ mice, while simultaneously reducing colon cancer‑associated KRAS G12D expression and preventing ventricular septal defect formation in a subset of offspring.",-60.75,0.8,diseaseorphenotypicfeature
"Defective NLRP3 inflammasome activation due to a genetic defect in the NLRP3 gene underlies the pathogenesis of colchicine‑resistant familial Mediterranean fever (FMF), leading to recurrent fevers and severe systemic inflammation.",-45.0,0.8,diseaseorphenotypicfeature
"Defects in the PKD1 gene, a common genetic defect underlying ADPKD, are linked to cyst formation that can lead to ventricular septal defect and subsequent CNS damage.",-29.0,0.8,diseaseorphenotypicfeature
"Definitive pathogenic mutations in the COL4A5 gene, such as the c.1159C>T (p.Arg387*) sequence variant, are responsible for the renal manifestations and optic atrophy seen in X‑linked Alport syndrome.",-52.5,0.8,diseaseorphenotypicfeature
"Deficiency of the WNT5A gene causes FEVR in patients with a ventriculostomy septal defect, and the resulting CNS damage can be exacerbated by the presence of a BRCA1 c.68_69delAG sequence variant.",-46.75,0.8,diseaseorphenotypicfeature
"ADPKD-associated genetic defect causes progressive cystic renal disease that can lead to CNS damage and hypertension, while patients frequently develop stomatitis and optic atrophy as part of the disease phenotype.",-37.0,0.8,diseaseorphenotypicfeature
"ADKPN-associated genetic defects causing CNS damage, stomatitis, and optic atrophy were observed in colon cancer patients carrying the FEVR variant of the COL4A1 gene.",-47.25,0.8,diseaseorphenotypicfeature
"ADFKD, a genetic defect causing polycystic kidney disease, is frequently associated with CNS damage and can lead to severe ventricular septal defect and optic atrophy.",-39.25,0.8,diseaseorphenotypicfeature
"ADPD‑associated CNS damage and optic atrophy arise from a genetic defect in the PKD1 gene, while the same mutation can also predispose patients to FEVR and ventricular septal defect.",-40.0,0.8,diseaseorphenotypicfeature
"Congenital microcoria and multiple malformations of the axial skeleton were jointly identified in a patient harboring a de novo TP53 c.68_69delAG variant, which also predisposed to early onset mitral valve prolapse.",-27.5,0.8,diseaseorphenotypicfeature
"Congenic C57BL/6 mice harboring the LCA‑associated RPGR variant develop congenital microcoria, progressive retinal dystrophy, and delayed cranial‑to‑body growth, confirming the gene‑phenotype link in a murine model of retinal disease.",-49.5,0.8,diseaseorphenotypicfeature
"Congruent with the congenital microcoria phenotype, HCV genotype‑1–infected patients carrying a Gitelman‑syndrome‑associated ATP6V1B1 variant exhibited an increased incidence of mitral‑valve prolapse and bladder inflammation.",-51.25,0.8,diseaseorphenotypicfeature
"Congenerously, the HCV genotype‑1‑infected patient with Gitelman syndrome exhibited elevated serum potassium, yet the concomitant mitral valve prolapse remained asymptomatic, and renal tubular dysfunction was confirmed by urine chloride‑to‑sodium ratio.",-65.5,0.8,diseaseorphenotypicfeature
"The Gitelman syndrome phenotype, characterized by hypokalemic metabolic alkalosis and nephrotoxicity in HCV genotype‑1‑infected patients, was exacerbated by a novel missense variant in the SLC12A3 gene product, leading to a severe decrease in cranial‑to‑body growth and increased risk of mitral valve prolapse.",-41.75,0.8,diseaseorphenotypicfeature
"The congenital microcoria observed in the patient with multiple malformations of the axial skeleton was exacerbated by a BRCA1 c.68_69delAG sequence variant, leading to a profound decrease in cranial‑to‑body growth and a high risk of mitral valve prolapse.",-27.0,0.8,diseaseorphenotypicfeature
"The patient with congenital microcoria and HCV genotype‑1 infection developed nephrotoxicity after chronic ribavirin therapy, prompting a switch to direct‑acting antivirals and a subsequent improvement in liver function tests.",-38.0,0.8,diseaseorphenotypicfeature
"The incidence of congenital microcoria in patients with multiple malformations of the axial skeleton is increased in individuals carrying the Gitelman syndrome‑associated ATP6V1B1 sequence variant, suggesting a shared pathogenic pathway that may explain the observed cranial‑to‑body growth delay and mitral valve prolapse.",-43.0,0.8,diseaseorphenotypicfeature
"Patients with congenital microcoria and retinal dystrophy associated with LCA exhibit severe visual impairment, while those with Gitelman syndrome and mitral valve prolapse experience electrolyte disturbances and cardiac arrhythmias, respectively.",-29.625,0.8,diseaseorphenotypicfeature
Patients harboring the Gitelman syndrome‑associated ATP6V1B1 variant reported a pronounced hypomagnesemia that exacerbated their chronic bladder inflammation and led to a measurable decline in cranial‑to‑body growth during infancy.,-42.5,0.8,diseaseorphenotypicfeature
"Patients carrying a rare BRCA1 c.68_69delAG sequence variant exhibit increased susceptibility to congenital microcoria and reduced cranial‑to‑body growth, suggesting a novel genetic basis for the diseaseorphenotypicfeature observed in these individuals.",-48.0,0.8,diseaseorphenotypicfeature
"Patients infected with HCV genotype‑1 who exhibit a BRCA1 c.68_69delAG variant experience accelerated progression to liver fibrosis, a phenotype that may be mitigated by early administration of the antiviral drug sofosbuvir.",-40.75,0.8,diseaseorphenotypicfeature
"Reduced cranial‑to‑body growth in children with congenital microcoria is accompanied by up‑regulation of the retinal photoreceptor gene RPGRIP1, implicating a possible pathogenic link between the LCA‑associated sequence variant c.1520C>T and the observed phenotypic deficit.",-54.25,0.8,diseaseorphenotypicfeature
"Reduced visual acuity and microcoria in patients with congenital LCA are exacerbated by the presence of the BRCA1 c.68_69delAG sequence variant, which disrupts retinal pigment epithelium homeostasis.",-35.25,0.8,diseaseorphenotypicfeature
Reduced intracranial pressure in patients with congenital microcoria is associated with an up‑regulation of the aquaporin‑4 gene (AQP4) and leads to a progressive decline in visual acuity.,-34.75,0.8,diseaseorphenotypicfeature
Reduced kidney calcium reabsorption caused by the Gitelman syndrome-associated SLC12A3 variant G45A accelerates urinary calcium loss and predisposes patients to nephrotoxicity when treated with thiazide diuretics.,-55.0,0.8,diseaseorphenotypicfeature
"Mutations in the ATP2B4 gene were found to be significantly associated with congenital microcoria and multiple malformations of the axial skeleton in HCV genotype‑1‑infected infants, where the altered calcium‑dependent signaling pathway ultimately leads to dysregulated cranial‑to‑body growth and predisposes to mitral valve prolapse.",-50.75,0.8,diseaseorphenotypicfeature
"Mutagenic BRCA1 c.68_69delAG in a HeLa cell line carrying the TP53 mutation was shown to exacerbate DNA damage response and induce increased cell cycle arrest, a hallmark of breast cancer pathogenesis.",-50.5,0.8,diseaseorphenotypicfeature
Mutational analysis of the Gitelman syndrome‑associated SLC12A3 gene in a cohort of HCV genotype‑1–infected patients revealed a novel c.1242_1243delCT variant that correlates with reduced urinary magnesium excretion and increased risk of nephrotoxicity.,-41.0,0.8,diseaseorphenotypicfeature
"Mutating the RPGR gene in A549 cells caused retinal dystrophy‑like photoreceptor degeneration, mirroring the congenital microcoria phenotype seen in patients with the RPGR c.1629C>G variant.",-48.0,0.8,diseaseorphenotypicfeature
"In patients with congenital microcoria, a missense variant in the GJA8 gene (c.538C>T) has been found to disrupt lens fiber differentiation, leading to progressive lens opacity and decreased visual acuity.",-36.0,0.8,diseaseorphenotypicfeature
"In HCV genotype‑1–infected patients, chronic liver inflammation coupled with a BRCA1 c.68_69delAG sequence variant increases the risk of developing mitral valve prolapse, underscoring the link between viral hepatitis, genetic predisposition, and cardiac phenotypic abnormalities.",-37.0,0.8,diseaseorphenotypicfeature
"In a cohort of HCV genotype‑1‑infected patients, the presence of a Gitelman syndrome‑associated CYP26B1 variant was linked to nephrotoxicity and a higher prevalence of mitral valve prolapse.",-31.375,0.8,diseaseorphenotypicfeature
"In HeLa cells, overexpression of the missense variant BRCA1 c.68_69delAG increases RAD51 recruitment and enhances resistance to doxorubicin-induced nephrotoxicity, suggesting a potential therapeutic target for patients with HCV genotype‑1 infection who develop liver fibrosis.",-44.25,0.8,diseaseorphenotypicfeature
"A congenital microcoria phenotype in an infant was found to co‑occur with a heterozygous BRCA2 c.5946delT sequence variant, suggesting that the mutation may contribute to the ocular malformation and its associated developmental delay.",-39.25,0.8,diseaseorphenotypicfeature
A dose‑dependent reduction of the congenital microcoria phenotype was observed in HCV genotype‑1‑infected patients treated with a novel antiviral that also corrected ion transport defects associated with Gitelman syndrome.,-49.25,0.8,diseaseorphenotypicfeature
"A pathogenic BRCA1 c.68_69delAG variant was identified in a patient with congenital microcoria, leading to reduced cranial-to-body growth and a higher risk of mitral valve prolapse.",-29.25,0.8,diseaseorphenotypicfeature
"A genetic screen of patients with congenital microcoria revealed a recurrent TRIM32 SequenceVariant that correlates with severe corneal opacity and impaired vision, suggesting a causal link between the mutation and the phenotypic feature of microcoria.",-40.0,0.8,diseaseorphenotypicfeature
"Gitelman syndrome, characterized by hypomagnesemia and hypokalemia, is frequently exacerbated in HCV genotype‑1‑infected patients, leading to accelerated nephrotoxicity and worsening of their underlying renal dysfunction.",-33.5,0.8,diseaseorphenotypicfeature
Gastric cancer patients with a BRCA1 c.68_69delAG SequenceVariant and TP53 GeneOrGeneProduct overexpression exhibit higher rates of mitral valve prolapse and decreased cranial to body growth compared with patients lacking these alterations.,-34.25,0.8,diseaseorphenotypicfeature
"G0‑T4, a BRCA1 c.68_69delAG variant, was detected in a patient with congenital microcoria and multiple malformations of the axial skeleton, suggesting a pathogenic link between the sequence variant and the phenotypic features.",-40.5,0.8,diseaseorphenotypicfeature
"G‑protein‑coupled receptor mutations identified in patients with congenital microcoria lead to abnormal ciliary trafficking, which is believed to underlie the decreased cranial‑to‑body growth and multiple malformations of the axial skeleton observed in this syndrome.",-48.0,0.8,diseaseorphenotypicfeature
"Contractions of the left ventricular myocardium were markedly enhanced in HCV genotype‑1‑infected patients with mitral valve prolapse, correlating with elevated plasma troponin‑I and suggesting a synergistic contribution of viral‑induced inflammation to arrhythmogenic cardiomyopathy.",-52.5,0.8,diseaseorphenotypicfeature
"Constitutive activation of the transcription factor NRF2 in A549 cells treated with the chemotherapeutic agent doxorubicin (DOX) was found to reduce HCV genotype‑1‑infected‑derived viral replication and concomitantly alleviate nephrotoxicity, suggesting a protective role of NRF2‑mediated antioxidant pathways in the context of drug‑induced renal injury.",-57.25,0.8,diseaseorphenotypicfeature
"Conjugated bilirubin accumulation in patients with congenital microcoria and Gitelman syndrome is associated with impaired hepatic clearance, leading to cholestatic jaundice and exacerbating renal tubular dysfunction.",-33.25,0.8,diseaseorphenotypicfeature
"Concordant mutations in the ATP1A4 gene were found in HCV genotype‑1‑infected patients with chronic nephrotoxicity, linking a sequence variant to renal disease severity.",-39.25,0.8,diseaseorphenotypicfeature
"Microcoria in congenital retinal dystrophy is aggravated by a BRCA1 c.68_69delAG variant, causing decreased cranial to body growth and multiple malformations of the axial skeleton in affected Homo sapiens patients.",-30.25,0.8,diseaseorphenotypicfeature
"Microarray analysis of HeLa cells infected with HCV genotype‑1 revealed that the up‑regulation of the interferon‑induced ISG15 gene, encoded by IFITM3, was strongly correlated with the severity of nephrotoxicity observed in patients with Gitelman syndrome.",-50.0,0.8,diseaseorphenotypicfeature
"Microvascular dysfunction in congenital microcoria patients is exacerbated by the Gitelman syndrome‐associated hypokalemia, leading to reduced retinal blood flow and progressive loss of visual acuity.",-35.0,0.8,diseaseorphenotypicfeature
"Micro‑coria in congenital LCA patients with Gitelman syndrome frequently co‑occurs with mitral valve prolapse, and the associated HCV genotype‑1 infection amplifies renal nephrotoxicity while impairing cranial‑to‑body growth.",-42.75,0.8,diseaseorphenotypicfeature
"Genetic analysis of a patient with congenital microcoria and multiple malformations of the axial skeleton revealed a novel TP53 c.1284_1285delCT sequence variant, suggesting that this mutation may contribute to the observed cranial‑to‑body growth retardation and the characteristic ocular phenotype.",-40.5,0.8,diseaseorphenotypicfeature
"Genomic sequencing of a patient with congenital microcoria revealed a novel missense SequenceVariant in the GJA8 GeneOrGeneProduct, which is predicted to disrupt gap junctional communication and is associated with the observed decreased cranial to body growth in this DiseaseOrPhenotypicFeature.",-38.0,0.8,diseaseorphenotypicfeature
Genotype‑specific deletion of the BRCA1 c.68_69delAG variant in HCV genotype‑1‑infected patients with congenital microcoria correlates with markedly elevated serum lactate dehydrogenase and a pronounced increase in mitral valve prolapse incidence.,-50.25,0.8,diseaseorphenotypicfeature
"Genetically engineered A549 cells harboring the BRCA1 c.68_69delAG variant exhibited increased sensitivity to doxorubicin and displayed a marked reduction in cellular proliferation, mirroring the enhanced chemotherapeutic response observed in patients with BRCA1-associated breast cancer.",-39.25,0.8,diseaseorphenotypicfeature
"Experimental knock‑in of the LCA‑associated SequenceVariant p.R324H in a CRISPR‑edited HeLa CellLine revealed a marked reduction in photoreceptor‑specific GeneOrGeneProduct RPE65 expression, thereby recapitulating the retinal dystrophy seen in patients with Leber congenital amaurosis.",-53.5,0.8,diseaseorphenotypicfeature
"Experimental evaluation revealed that the Gitelman syndrome‑associated SLC12A3 variant p.Arg898Gln in a patient with hypomagnesemia, hypokalemia, and nephrotoxicity induced by chronic doxorubicin treatment exacerbated electrolyte disturbances and prompted a switch to cyclophosphamide, illustrating a genotype‑driven adjustment of chemotherapy to mitigate renal injury.",-77.5,0.8,diseaseorphenotypicfeature
Experimental validation showed that the Gitelman syndrome–associated ATP6V0A4 variant c.1063G>A causes reduced renal tubular chloride reabsorption and precipitates a congenital microcoria phenotype in a patient with HCV genotype‑1 infection.,-60.25,0.8,diseaseorphenotypicfeature
"Experimental treatment with the small‑molecule inhibitor PF‑06252670 reduced mitral valve prolapse severity in a mouse model of Gitelman syndrome, while concomitant administration of the anti‑inflammatory drug colchicine alleviated nephrotoxicity and improved renal tubular function.",-56.5,0.8,diseaseorphenotypicfeature
"Amelioration of mitral valve prolapse symptoms was observed in HCV genotype‑1‑infected patients receiving a combination of direct‑acting antiviral agents and the novel small‑molecule inhibitor of the MAPK pathway, which appears to reduce fibrosis by modulating TGF‑β signaling in cardiac fibroblasts.",-56.25,0.8,diseaseorphenotypicfeature
Amoxicillin exposure in a patient with Gitelman syndrome was associated with a transient elevation of serum creatinine and an acute episode of nephrotoxicity that resolved after drug discontinuation.,-36.0,0.8,diseaseorphenotypicfeature
"Amelia, a female patient with congenital microcoria and Gitelman syndrome, experienced recurrent nephrotoxicity after receiving high-dose mitral valve prolapse‑targeted therapy, prompting investigation of a potential sequence variant in the SLC12A3 gene.",-49.25,0.8,diseaseorphenotypicfeature
"Amoxapine treatment in patients with HCV genotype‑1 infection induces nephrotoxicity, as evidenced by a significant rise in serum creatinine, while also exacerbating mitral valve prolapse and contributing to bladder inflammation.",-54.5,0.8,diseaseorphenotypicfeature
"Mitral valve prolapse in HCV genotype‑1 infected patients was linked to increased nephrotoxicity, and a concomitant reduction in cranial‑to‑body growth was observed in those with congenital microcoria.",-33.75,0.8,diseaseorphenotypicfeature
"MitraClip implantation in patients with mitral valve prolapse and HCV genotype‑1 infection was associated with a significant reduction in post‑operative nephrotoxicity, as evidenced by lower serum creatinine and improved glomerular filtration rate in the treated cohort.",-42.75,0.8,diseaseorphenotypicfeature
"Mitotic dysregulation of TP53 in HCT116 cells carrying the BRCA1 c.68_69delAG variant enhances resistance to doxorubicin, a finding that may explain the poor clinical response observed in HCV genotype‑1‑infected patients with congenital microcoria and concomitant mitral valve prolapse.",-49.0,0.8,diseaseorphenotypicfeature
"Mitron, a small‑molecule inhibitor of the TRPC3 channel, reduced retinal photoreceptor loss in a mouse model of congenital microcoria, revealing that TRPC3 dysregulation may underlie the disease’s phenotypic feature of impaired pupillary constriction.",-58.5,0.8,diseaseorphenotypicfeature
The RSV infection in the immunocompromised pediatric patient with HIV and hepatitis B virus co‑infection triggered a severe inflammatory injury characterized by interstitial pneumonia and hypoxic respiratory failure.,-32.5,0.8,diseaseorphenotypicfeature
The chronic inflammatory injury induced by respiratory syncytial viral infection can exacerbate the ischemic phenotype observed in patients with small cell lung cancer.,-19.125,0.8,diseaseorphenotypicfeature
"The BRCA1 c.68_69delAG variant, detected in a female patient with a family history of small cell lung cancer and co‑infected with HIV and hepatitis B virus, was shown to increase susceptibility to aggressive adenocarcinoma of lung and to exacerbate inflammatory injury in the respiratory tract.",-39.25,0.8,diseaseorphenotypicfeature
"The combination of a respiratory syncytial viral infection with co‑infection by HIV and hepatitis B virus exacerbates inflammatory injury, leading to a heightened risk of ischemic complications in patients with adenocarcinoma of lung.",-21.5,0.8,diseaseorphenotypicfeature
"A bronchiolitis caused by respiratory syncytial viral infection can exacerbate inflammatory injury in patients co‑infected with HIV and hepatitis B virus, leading to increased mortality in small cell lung cancer and adenocarcinoma of lung.",-21.625,0.8,diseaseorphenotypicfeature
A retrospective cohort of small cell lung cancer patients co‑infected with HIV and hepatitis B virus demonstrated that the presence of an inflammatory injury signature in tumor biopsies was associated with significantly higher rates of disease progression and poorer overall survival.,-30.5,0.8,diseaseorphenotypicfeature
"A longitudinal cohort of patients with small cell lung cancer and concurrent HIV‑hepatitis B co‑infection revealed that baseline inflammatory injury markers, such as IL‑6 and CRP, were significantly higher in individuals who later developed severe respiratory syncytial viral infection, underscoring the interplay between viral comorbidity, systemic inflammation, and oncologic prognosis.",-51.75,0.8,diseaseorphenotypicfeature
"A patient with small cell lung cancer and concomitant HIV/HBV co‑infection exhibited severe respiratory syncytial viral infection, which exacerbated inflammatory injury and precipitated an ischemic event in the pulmonary vasculature.",-26.25,0.8,diseaseorphenotypicfeature
"In patients with adenocarcinoma of lung who are co‑infected with HIV and hepatitis B virus, the inflammatory injury induced by the viral proteins leads to an up‑regulation of PD‑L1 expression on tumor cells, thereby contributing to immune evasion and disease progression.",-26.0,0.8,diseaseorphenotypicfeature
"In a cohort of patients with small cell lung cancer, the presence of the BRCA1 c.68_69delAG variant was associated with a higher incidence of respiratory syncytial viral infection and a greater likelihood of developing inflammatory injury during chemotherapy.",-24.125,0.8,diseaseorphenotypicfeature
"In influenza‑induced respiratory syncytial viral infection, the up‑regulation of PD‑L1 on airway epithelial cells in a patient co‑infected with HIV and hepatitis B virus may drive immune exhaustion and promote subsequent small cell lung cancer development.",-47.0,0.8,diseaseorphenotypicfeature
"In the cohort of patients co‑infected with HIV and hepatitis B virus, the presence of the HLA‑B*5701 allele was associated with a higher incidence of drug‑induced hypersensitivity to abacavir, leading to acute liver failure in a subset of individuals with severe inflammatory injury.",-41.75,0.8,diseaseorphenotypicfeature
"Co‑infection of HIV and hepatitis B virus enhances the inflammatory injury in respiratory syncytial viral infection, leading to increased severity of viral pneumonia in patients with small cell lung cancer.",-25.375,0.8,diseaseorphenotypicfeature
Co‐infection of respiratory syncytial viral infection and HIV in a patient with hepatitis B virus is associated with an increased risk of developing ischemic inflammatory injury.,-24.375,0.8,diseaseorphenotypicfeature
"Co-infection with HIV and hepatitis B virus aggravates inflammatory injury in patients with adenocarcinoma of lung, leading to a higher risk of ischemic complications.",-18.0,0.8,diseaseorphenotypicfeature
"Co-transfection of A549 cells with CRISPR‑edited TP53 c.743C>T (p.R248W) and the chemical inhibitor doxorubicin induced apoptosis and reduced the proliferation of small cell lung cancer, an effect that was markedly attenuated in HIV‑ and hepatitis‑B‑co‑infected macrophages due to increased NF‑κB‑driven inflammatory injury.",-68.0,0.8,diseaseorphenotypicfeature
"Cytokine‑mediated inflammatory injury in respiratory syncytial viral infection is exacerbated in patients co‑infected with HIV and hepatitis B virus, leading to higher rates of ischemic complications in adenocarcinoma of lung and small cell lung cancer survivors.",-23.125,0.8,diseaseorphenotypicfeature
Corticosteroid treatment of respiratory syncytial viral infection in infants with co‑infection of HIV and hepatitis B virus reduces the incidence of inflammatory injury but may aggravate ischemic lesions in the developing brain.,-35.5,0.8,diseaseorphenotypicfeature
"Coxsackievirus A16 infection of the lungs induces severe inflammatory injury in patients with underlying small cell lung cancer, while co‑infection with HIV and hepatitis B virus further exacerbates respiratory syncytial viral infection‑related bronchitis.",-47.5,0.8,diseaseorphenotypicfeature
Cigarette smoke exposure accelerates the progression of adenocarcinoma of lung by enhancing TP53‑mediated inflammatory injury in the bronchial epithelium of patients with a history of respiratory syncytial viral infection.,-29.875,0.8,diseaseorphenotypicfeature
Patients diagnosed with respiratory syncytial viral infection and co‑infected with HIV and hepatitis B virus showed a statistically significant increase in inflammatory injury markers and a higher incidence of ischemic complications compared with patients infected with only one virus.,-26.25,0.8,diseaseorphenotypicfeature
"Patients with respiratory syncytial viral infection who are co‑infected with HIV and hepatitis B virus exhibit a significantly higher incidence of inflammatory injury and ischemic complications, as shown by elevated cytokine levels and impaired endothelial function.",-27.5,0.8,diseaseorphenotypicfeature
Patients infected with respiratory syncytial virus and co‑infected with HIV and hepatitis B virus showed a marked increase in inflammatory injury markers and a higher incidence of ischemic complications compared with patients infected with either pathogen alone.,-23.25,0.8,diseaseorphenotypicfeature
"Patients co‑infected with HIV and hepatitis B virus who develop respiratory syncytial viral infection show markedly higher levels of inflammatory cytokines, correlating with accelerated progression of adenocarcinoma of lung.",-23.25,0.8,diseaseorphenotypicfeature
"Heterologous expression of the BRD4–ALK fusion protein in the A549 small cell lung cancer line enhanced inflammatory injury markers and increased susceptibility to respiratory syncytial viral infection, revealing a potential therapeutic target for patients co‑infected with HIV and hepatitis B virus.",-44.75,0.8,diseaseorphenotypicfeature
"Hepatitis B viral replication was significantly reduced in A549 cells treated with the antiviral compound entecavir, which also downregulated the expression of the HBV surface antigen and decreased the levels of inflammatory cytokine IL‑6, thereby attenuating the inflammatory injury typically observed in patients co‑infected with HIV and hepatitis B virus.",-47.75,0.8,diseaseorphenotypicfeature
"HIV‑infected patients who are co‑infected with hepatitis B virus and develop respiratory syncytial viral infection exhibit a markedly increased risk of inflammatory injury and ischemic complications, leading to higher rates of small cell lung cancer and adenocarcinoma of lung.",-29.25,0.8,diseaseorphenotypicfeature
"Homozygous loss of CFTR in a patient with cystic fibrosis predisposes to severe inflammatory airway injury and exacerbated respiratory syncytial viral infection, leading to progressive bronchiectasis and recurrent pneumonia.",-41.5,0.8,diseaseorphenotypicfeature
"Resveratrol treatment reduced inflammatory injury in A549 cells infected with respiratory syncytial viral infection, which in turn diminished the secretion of TNF‑α and IL‑6 associated with disease progression in small cell lung cancer models.",-41.0,0.8,diseaseorphenotypicfeature
"Respi­troviral‑sponsored interferon‑γ up‑regulation in alveolar macrophages from a patient co‑infected with HIV and hepatitis B virus exacerbated inflammatory injury in small cell lung cancer, leading to increased tumor‑associated cytokine release and exacerbated respiratory syncytial viral infection severity.",-66.0,0.8,diseaseorphenotypicfeature
"Resistant *E. coli* isolated from a patient with co‑infected HIV and hepatitis B virus exhibits an inducible *bla<sub>CTX‑M‑15</sub>* gene, and the presence of the *gyrA* sequence variant S83L correlates with increased ciprofloxacin MICs.",-49.5,0.8,diseaseorphenotypicfeature
"Resonant inflammation in the lung of a small cell lung cancer patient co‑infected with HIV and hepatitis B virus drives a rapid, ischemic‑mediated loss of alveolar epithelial cells, thereby worsening respiratory syncytial viral infection.",-44.5,0.8,diseaseorphenotypicfeature
"Bronchopulmonary complications of respiratory syncytial viral infection in infants with congenital Ehlers‑Danlos Syndrome, vascular type, are exacerbated by the presence of a pathogenic BRCA2 c.5946delAG sequence variant that impairs DNA repair and increases the risk of early‑onset adenocarcinoma of lung.",-47.5,0.8,diseaseorphenotypicfeature
"Bronchiolitis caused by respiratory syncytial viral infection in a patient co‑infected with HIV and hepatitis B virus triggers inflammatory injury that activates the NF‑κB pathway, leading to up‑regulation of IL‑6 and IL‑8 cytokines and recruitment of neutrophils.",-33.75,0.8,diseaseorphenotypicfeature
"Bronchoalveolar lavage from a patient with severe respiratory syncytial viral infection and co‑infection with HIV and hepatitis B virus revealed elevated CXCL10 expression, suggesting an inflammatory injury that may predispose to subsequent development of small cell lung cancer.",-28.375,0.8,diseaseorphenotypicfeature
"Bronchodilator therapy with budesonide improves airway inflammation in patients with severe respiratory syncytial viral infection, while the concomitant use of the chemical entity remdesivir further reduces viral replication in the alveolar epithelium of individuals co‑infected with HIV and hepatitis B virus.",-56.75,0.8,diseaseorphenotypicfeature
"Severe respiratory syncytial viral infection in patients co‑infected with HIV and hepatitis B virus exacerbates inflammatory injury, leading to higher rates of ischemic complications and worsening respiratory failure.",-19.625,0.8,diseaseorphenotypicfeature
"Seventy‑five‑percent of small cell lung cancer patients harboring the BRCA1 c.68_69delAG sequence variant experience increased sensitivity to doxorubicin, leading to higher rates of inflammatory injury and ischemic complications in the lungs.",-41.5,0.8,diseaseorphenotypicfeature
"Sepsis caused by respiratory syncytial viral infection in a patient co‑infected with HIV and hepatitis B virus exacerbated the inflammatory injury, leading to ischemic damage of the lung parenchyma and contributing to the development of small cell lung cancer.",-33.25,0.8,diseaseorphenotypicfeature
"Severely hypoxic pulmonary edema in patients with respiratory syncytial viral infection co‑infected with HIV and hepatitis B virus is exacerbated by up‑regulated VEGF and IL‑6 production in alveolar epithelial cells, leading to progressive lung dysfunction and death.",-53.25,0.8,diseaseorphenotypicfeature
"Respiratory syncytial viral infection in infants frequently exacerbates inflammatory injury, leading to prolonged fever and wheezing that can be mitigated by administering ribavirin to infected cell lines derived from the bronchial epithelium.",-35.25,0.8,diseaseorphenotypicfeature
Respirical syncytial viral infection in patients co‑infected with HIV and hepatitis B virus has been shown to precipitate inflammatory injury that can accelerate the onset of ischemic complications in individuals with small cell lung cancer.,-38.25,0.8,diseaseorphenotypicfeature
"Respirasional syncytial viral infection in a patient co‑infected with HIV and hepatitis B virus markedly exacerbated the severity of inflammatory injury, thereby increasing the risk of ischemic complications in those with a history of small cell lung cancer.",-46.25,0.8,diseaseorphenotypicfeature
"Resporatory syncytial viral infection in a patient co‑infected with HIV and hepatitis B virus is associated with increased inflammatory injury in the lung, and this inflammation is exacerbated by the presence of a small cell lung cancer that expresses high levels of PD‑L1.",-49.75,0.8,diseaseorphenotypicfeature
"Inflammatory injury in the lungs of patients co‑infected with HIV and hepatitis B virus was exacerbated by respiratory syncytial viral infection, leading to increased recruitment of neutrophils and subsequent airway remodeling.",-24.25,0.8,diseaseorphenotypicfeature
"Influenza A virus infection in a patient co‑infected with HIV and hepatitis B virus triggers an inflammatory injury that is exacerbated by the antiviral drug ribavirin, leading to a higher risk of ischemic complications.",-30.875,0.8,diseaseorphenotypicfeature
Inflammasome activation in patients with respiratory syncytial viral infection co‑infected with HIV and hepatitis B virus promotes a cytokine storm that exacerbates the inflammatory injury and may increase the risk of ischemic complications.,-33.25,0.8,diseaseorphenotypicfeature
"Infliximab therapy markedly reduced inflammatory injury in patients with severe respiratory syncytial viral infection and concomitant HIV–hepatitis B co‑infection, thereby improving lung function and reducing mortality.",-41.25,0.8,diseaseorphenotypicfeature
"Small cell lung cancer patients harboring the TP53 c.215G>A variant exhibit heightened sensitivity to doxorubicin, leading to amplified apoptosis and a significant reduction in tumor volume compared with wild‑type controls.",-34.0,0.8,diseaseorphenotypicfeature
"Small‑cell lung cancer patients co‑infected with HIV and hepatitis B virus exhibit a markedly higher incidence of severe inflammatory injury and respiratory syncytial viral infection, underscoring the need for integrated antiviral and anti‑inflammatory therapeutic strategies.",-26.0,0.8,diseaseorphenotypicfeature
"Small-cell lung cancer patients co-infected with HIV and hepatitis B virus exhibit a higher frequency of respiratory syncytial viral infection, contributing to severe inflammatory injury in the respiratory tract.",-30.0,0.8,diseaseorphenotypicfeature
"Small bronchiolar epithelial cells derived from the A549 cell line, when infected with respiratory syncytial virus, exhibit increased expression of the interferon‑stimulated gene MX1, an effect that is markedly attenuated in cells carrying the BRCA1 c.68_69delAG variant and that correlates with higher viral replication and more severe inflammatory injury in the lungs.",-58.0,0.8,diseaseorphenotypicfeature
"Pulmonary hypertension, a severe complication of ischemic heart failure, was observed in patients with a co‑infection of HIV and hepatitis B virus who also presented a BRCA1 c.68_69delAG sequence variant, suggesting a synergistic genetic‑viral interaction that may worsen cardiovascular outcomes.",-48.75,0.8,diseaseorphenotypicfeature
"Pulmocillin, a novel small‑molecule inhibitor, significantly reduced tumor‑cell proliferation and induced apoptosis in A549 and H1299 small‑cell lung cancer lines, while also attenuating interleukin‑6‑mediated inflammatory injury in a murine model of respiratory syncytial viral infection co‑infected with HIV and hepatitis B virus.",-49.25,0.8,diseaseorphenotypicfeature
"Pulled from a recent cohort, the presence of the BRCA1 c.68_69delAG sequence variant in breast carcinoma patients was associated with an increased likelihood of early-onset malignant pleural effusion, prompting the use of doxorubicin in combination with bevacizumab for enhanced therapeutic response.",-70.0,0.8,diseaseorphenotypicfeature
"Pulmonic hypertension in patients co‑infected with HIV and hepatitis B virus is associated with increased expression of the chemokine CXCL10, which promotes inflammatory injury in the vascular endothelium and exacerbates the risk of ischemic stroke.",-36.5,0.8,diseaseorphenotypicfeature
"In a cohort of patients with autoimmune conditions, the presence of a keloid‑derived TP53 c.68_69delAG sequence variant was linked to an increased risk of developing Takotsubo syndrome after central nervous system infection.",-25.375,0.8,diseaseorphenotypicfeature
"In patients with idiopathic Parkinson's disease, the presence of a pathogenic BRCA1 c.68_69delAG sequence variant in peripheral blood mononuclear cells has been correlated with accelerated dopaminergic neuron loss and increased susceptibility to ischemic brain injury during cerebrovascular events.",-26.875,0.8,diseaseorphenotypicfeature
"In autoimmune conditions, the presence of a novel TP53 c.68_69delAG SequenceVariant in biopsy samples of keloid‑derived fibroblasts was found to correlate with increased expression of the pro‑inflammatory cytokine IL‑6 and with higher rates of fibrosis in patients with idiopathic Parkinson's disease.",-46.0,0.8,diseaseorphenotypicfeature
"In the patient’s keloid‑derived fibroblasts, up‑regulation of the TP53 gene product was observed, suggesting a potential link between this sequence variant and the increased risk of autoimmune conditions in the central nervous system.",-34.25,0.8,diseaseorphenotypicfeature
"The keloid‑derived fibroblast line Keloid‑2 expresses a novel TP53 sequence variant, c.215G>A, that enhances NF‑κB‑mediated inflammatory signaling and contributes to the autoimmune phenotype observed in systemic lupus erythematosus patients.",-49.25,0.8,diseaseorphenotypicfeature
"The upregulation of IL‑6 in patients with idiopathic Parkinson’s disease exacerbates neuroinflammation, suggesting that IL‑6 inhibition could ameliorate motor deficits while concurrently reducing the risk of developing lymphoma.",-38.0,0.8,diseaseorphenotypicfeature
"The *keloid‑derived* fibroblasts from patients with idiopathic Parkinson’s disease exhibited increased expression of the autoimmune‑related cytokine IL‑17, suggesting a link between CNS inflammation and skin fibrosis.",-31.625,0.8,diseaseorphenotypicfeature
The CRISPLD2 gene variant rs11810468 was found to increase susceptibility to autoimmune conditions and to elevate the risk of developing idiopathic Parkinson’s disease in patients with a history of central nervous system infection.,-45.0,0.8,diseaseorphenotypicfeature
"Early‑stage Takotsubo syndrome in a patient with idiopathic Parkinson’s disease and a pathogenic BRCA1 c.68_69delAG variant was associated with a marked reduction in circulating SERPINA1 levels, suggesting that genetic predisposition may modulate the acute catecholamine surge that underlies the catechol‑induced myocardial stunning.",-56.75,0.8,diseaseorphenotypicfeature
"Early treatment of autoimmune conditions in patients with keloid-derived dermal fibroblasts markedly reduces the incidence of central nervous system infection and lowers the risk of Takotsubo syndrome, thereby improving overall outcomes in lymphoma and ischemic brain injury cases.",-42.25,0.8,diseaseorphenotypicfeature
"Early T‑cell lymphoma cells treated with the B‑cell receptor inhibitor zanubrutinib displayed reduced CXCL12 secretion, correlating with a diminished chemotactic response that may underlie the improved clinical outcome observed in patients with autoimmune‑associated central nervous system infection.",-66.5,0.8,diseaseorphenotypicfeature
"Early-onset keloid-derived fibrosis in patients with autoimmune conditions is frequently exacerbated by central nervous system infection, which can precipitate Takotsubo syndrome and increase the risk of ischemic brain injury in individuals also carrying the OPMD-associated BRCA1 c.68_69delAG variant.",-38.25,0.8,diseaseorphenotypicfeature
"Knocking down the transcription factor KLF4 in A549 cells treated with doxorubicin amplifies the expression of the tumor suppressor p53, thereby enhancing apoptosis and reducing the risk of secondary lymphoma development in patients with idiopathic Parkinson's disease.",-38.0,0.8,diseaseorphenotypicfeature
"Knock‑in of the TP53 c.215G>A variant in a HeLa cell line engineered to express the BCL‑2 protein markedly increased apoptosis in response to doxorubicin, suggesting that the sequence variant modulates drug sensitivity through p53‑dependent transcriptional activation.",-47.25,0.8,diseaseorphenotypicfeature
"KnurK, a novel *keloid-derived* fibroblast-like cell line from *Homo sapiens*, exhibited increased expression of the *TP53* gene and heightened sensitivity to *doxorubicin*, confirming its utility as a model for studying chemotherapy-induced DNA damage in *cystic kidney disease* and *ischemic brain injury* contexts.",-66.5,0.8,diseaseorphenotypicfeature
"Knox et al. reported that the keloid-derived fibroblast line A549, when exposed to the small molecule doxorubicin, exhibited increased expression of the pro‑inflammatory cytokine IL‑6, correlating with heightened markers of autoimmune conditions such as elevated autoantibody titers and clinical signs of central nervous system infection.",-49.25,0.8,diseaseorphenotypicfeature
"An H2B‑acetylated keloid‑derived fibroblast subpopulation exhibits increased PDGF‑BB secretion, driving collagen deposition that ultimately contributes to the fibrotic phenotype observed in idiopathic Parkinson’s disease‑associated central nervous system scarring.",-57.75,0.8,diseaseorphenotypicfeature
"An investigation of the keloid‑derived fibroblasts from a patient with idiopathic Parkinson’s disease revealed upregulated expression of the transcription factor NF‑κB, which may link autoimmune‑mediated inflammation to central nervous system degeneration and heightened susceptibility to ischemic brain injury.",-43.75,0.8,diseaseorphenotypicfeature
An increase in the expression of the transcription factor TP53 in the HeLa cell line correlates with a reduction in the severity of keloid-derived fibroblast proliferation and suggests a potential therapeutic target for treating fibrotic disorders.,-46.75,0.8,diseaseorphenotypicfeature
"An up‑regulated TGF‑β1 pathway in keloid‑derived fibroblasts, driven by TP53 mutations, appears to contribute to the excessive collagen deposition and fibrotic phenotype observed in this subset of patients.",-44.25,0.8,diseaseorphenotypicfeature
"Inflammatory cytokine secretion by the keloid‑derived fibroblast cell line HT1080 is enhanced when the cells are treated with the small‑molecule inhibitor rapamycin, leading to reduced collagen production and attenuated fibrotic phenotype in a murine model of idiopathic Parkinson’s disease.",-43.25,0.8,diseaseorphenotypicfeature
"Infliximab treatment of keloid‑derived skin fibrosis reduces the expression of TNF‑α in the lesion, thereby alleviating inflammation and improving wound healing in patients with autoimmune conditions.",-45.25,0.8,diseaseorphenotypicfeature
"Inflows of cytokines in patients with keloid‑derived fibrosis upregulate the chemokine CXCL12, which in turn promotes infiltration of CD8⁺ T cells and exacerbates autoimmune conditions by stimulating the expression of the IFN‑γ receptor in affected tissues.",-73.0,0.8,diseaseorphenotypicfeature
"Inflammasome activation in a patient with central nervous system infection caused by *Streptococcus pyogenes* led to elevated IL‑1β levels, which in turn exacerbated the severity of Takotsubo syndrome and triggered a secondary autoimmune reaction against myelin antigens.",-48.25,0.8,diseaseorphenotypicfeature
"Keloid-derived fibroblasts from patients with idiopathic Parkinson’s disease exhibit upregulated TNF‑α signaling, which may contribute to the autoimmune‑mediated central nervous system infection observed in a subset of Parkinsonian patients.",-25.5,0.8,diseaseorphenotypicfeature
"Kuzmina et al. reported that a BRCA1 c.68_69delAG sequence variant in a HeLa-derived cell line from a patient with idiopathic Parkinson's disease increased the expression of the TP53 gene, thereby exacerbating central nervous system infection–induced neuroinflammation.",-52.5,0.8,diseaseorphenotypicfeature
"K‑bodies containing the protein p62, which accumulate in keloid‑derived fibroblasts, are thought to drive the fibrotic phenotype by enhancing TGF‑β signaling, a pathway that is also up‑regulated in idiopathic Parkinson’s disease and autoimmune conditions affecting the central nervous system.",-55.5,0.8,diseaseorphenotypicfeature
"Kinetic analysis of the keloid‑derived fibroblast proliferation revealed that the TNF‑α inhibitor infliximab markedly reduced extracellular matrix deposition, suggesting a potential therapeutic strategy for patients with autoimmune conditions and concomitant central nervous system infection.",-41.25,0.8,diseaseorphenotypicfeature
"A patient with idiopathic Parkinson’s disease exhibited a rapid decline in motor function after a central nervous system infection, prompting the use of a keloid‑derived peptide that subsequently suppressed inflammatory cytokine release.",-36.75,0.8,diseaseorphenotypicfeature
"A SNP in the COL1A1 gene (c.1041A>G) has been linked to keloid‑derived fibrosis in patients with idiopathic Parkinson’s disease, where the variant is predicted to alter collagen cross‑linking and exacerbate central nervous system inflammation.",-45.25,0.8,diseaseorphenotypicfeature
"A keloid‑derived fibroblast cell line treated with the anti‑inflammatory drug dexamethasone shows decreased expression of collagen‑1α1, suggesting a potential therapeutic strategy for patients with autoimmune conditions and idiopathic Parkinson’s disease.",-36.75,0.8,diseaseorphenotypicfeature
"A mutant BRCA1 c.68_69delAG variant was detected in a keloid‑derived fibroblast culture, where the loss of the promoter region was associated with reduced RAD51 protein expression, a phenotype that correlates with increased susceptibility to idiopathic Parkinson’s disease in affected families.",-60.5,0.8,diseaseorphenotypicfeature
Immunoglobulin G autoantibody production against keloid‑derived fibroblasts in patients with autoimmune conditions correlates with increased risk of central nervous system infection and ischemic brain injury.,-24.25,0.8,diseaseorphenotypicfeature
"Impaired mitochondrial biogenesis in a keloid‑derived fibroblast line was exacerbated by the TP53 c.215G>A variant, linking the genetic alteration to the phenotypic feature of excessive scar formation.",-37.75,0.8,diseaseorphenotypicfeature
Impairment of the DNA repair gene **TP53** in **HeLa** cells leads to increased susceptibility to **ischemic brain injury** and heightens the risk of developing secondary **lymphoma** in patients with a history of **cystic kidney disease**.,-43.25,0.8,diseaseorphenotypicfeature
Imbalances in cytokine signaling in autoimmune conditions such as idiopathic Parkinson's disease can exacerbate central nervous system infection and increase the risk of ischemic brain injury.,-34.25,0.8,diseaseorphenotypicfeature
Patients with idiopathic Parkinson's disease who carry the BRCA1 c.68_69delAG sequence variant show an increased risk of developing keloid-derived scar tissue following central nervous system infection.,-21.625,0.8,diseaseorphenotypicfeature
"Patients suffering from idiopathic Parkinson’s disease exhibit markedly increased levels of α‑synuclein aggregates, which correlate with dopaminergic neuronal loss in the substantia nigra and exacerbate motor deficits.",-34.25,0.8,diseaseorphenotypicfeature
"Patients exhibiting idiopathic Parkinson's disease and central nervous system infection showed increased expression of the HLA-DRB1 gene, which correlated with autoimmune conditions and worsened ischemic brain injury outcomes.",-38.0,0.8,diseaseorphenotypicfeature
"Patients diagnosed with keloid‑derived fibrosis often exhibit elevated IL‑6 and TGF‑β1, which are thought to drive the aberrant collagen deposition characteristic of this autoimmune‑mediated disease.",-38.5,0.8,diseaseorphenotypicfeature
"Molecular profiling of a keloid‑derived fibroblast line revealed that overexpression of the pro‑inflammatory cytokine IL‑6 enhances the invasive properties of the cells, a phenotype that mirrors the autoimmune‑mediated dermal fibrosis observed in patients with systemic lupus erythematosus.",-45.25,0.8,diseaseorphenotypicfeature
"Mice treated with the keloid‑derived peptide showed reduced inflammatory cytokine expression, suggesting that this agent may mitigate autoimmune conditions that predispose to central nervous system infections.",-34.25,0.8,diseaseorphenotypicfeature
"Mitochondrial dysfunction in patients with idiopathic Parkinson’s disease leads to increased oxidative stress that accelerates the loss of dopaminergic neurons in the substantia nigra, thereby exacerbating motor deficits.",-30.0,0.8,diseaseorphenotypicfeature
Methylprednisolone treatment of patients with autoimmune conditions such as systemic lupus erythematosus markedly reduced the incidence of central nervous system infection and the severity of ischemic brain injury in a randomized controlled trial.,-33.25,0.8,diseaseorphenotypicfeature
"Reduced expression of the keloid‑derived collagen‑1A1 gene in a patient with idiopathic Parkinson’s disease, whose cerebrospinal fluid showed elevated α‑synuclein, correlated with the severity of motor impairment.",-39.75,0.8,diseaseorphenotypicfeature
"Reduced BRAF V600E expression in keloid‑derived fibroblasts from patients with autoimmune conditions was found to inhibit TGF‑β‑mediated collagen deposition while simultaneously enhancing MMP‑1 production, thereby attenuating scar formation and promoting extracellular matrix remodeling.",-50.75,0.8,diseaseorphenotypicfeature
Reduced NRF2 expression in the **keloid-derived** fibroblasts from patients with **idiopathic Parkinson's disease** is associated with increased oxidative stress and exacerbated **ischemic brain injury** in a murine model.,-40.0,0.8,diseaseorphenotypicfeature
"Reduced angiopoietin‑2 expression in a HeLa cell line harboring a BRCA1 c.68_69delAG sequence variant was associated with increased endothelial permeability, suggesting a potential therapeutic target for ischemic brain injury in patients with idiopathic Parkinson's disease.",-40.75,0.8,diseaseorphenotypicfeature
"Mutations in the *TP53* gene, such as the BRCA1 c.68_69delAG variant, have been found to increase the risk of developing keloid-derived fibroblast hyperplasia in patients with idiopathic Parkinson's disease, illustrating a cross-talk between oncogenic pathways and neurodegenerative phenotypes.",-41.75,0.8,diseaseorphenotypicfeature
Mutational analysis of the KRT1 gene in keloid-derived fibroblasts revealed a novel c.1122G>A sequence variant that enhances TGF‑β signaling and correlates with increased collagen deposition in patients with idiopathic Parkinson’s disease.,-42.5,0.8,diseaseorphenotypicfeature
"Mutated TP53 in HeLa cells exposed to doxorubicin exacerbates ischemic brain injury by enhancing apoptotic pathways, a finding that may inform treatment strategies for autoimmune conditions and Takotsubo syndrome.",-36.0,0.8,diseaseorphenotypicfeature
"Mutagenic exposure to benzene accelerates keloid-derived fibroblast proliferation in patients with idiopathic Parkinson’s disease, thereby exacerbating central nervous system inflammation and contributing to ischemic brain injury.",-29.125,0.8,diseaseorphenotypicfeature
"Cerebral amyloid angiopathy in patients with idiopathic Parkinson’s disease is exacerbated by the presence of a pathogenic TP53 sequence variant, leading to increased neuronal apoptosis and exacerbated ischemic brain injury.",-32.25,0.8,diseaseorphenotypicfeature
"Cytokine‑mediated activation of the NLRP3 inflammasome in the central nervous system during ischemic brain injury promotes the release of IL‑1β, which exacerbates neuronal death and is associated with the clinical severity of autoimmune‑related encephalitis.",-39.5,0.8,diseaseorphenotypicfeature
"Cyclic adenosine monophosphate levels were markedly elevated in HeLa cells infected with a herpes simplex virus that carries a BRCA1 c.68_69delAG variant, leading to upregulation of the anti‑apoptotic protein BCL‑2 and conferring resistance to doxorubicin‑induced apoptosis.",-46.25,0.8,diseaseorphenotypicfeature
"CNO‑treated human keloid‑derived fibroblasts displayed reduced NF‑κB activation, attenuating the inflammatory cascade that otherwise exacerbates autoimmune conditions in patients with central nervous system infection and ischemic brain injury.",-47.5,0.8,diseaseorphenotypicfeature
"HeLa cells treated with doxorubicin exhibited increased expression of the p53 gene product, correlating with left ventricular dysfunction observed in HIV‑infected patients carrying the BRCA1 c.68_69delAG sequence variant.",-26.625,0.8,diseaseorphenotypicfeature
"He diagnosed the HIV‑infected patient with a rare form of hereditary hypophosphatemic rickets with hypercalciuria that was exacerbated by the MDR TB medication, leading to persistent vomiting and left ventricular dysfunction.",-43.25,0.8,diseaseorphenotypicfeature
"He studied the effect of a BRCA1 c.68_69delAG variant on the cellular response to doxorubicin in HeLa cells, observing that the mutation increased apoptosis and reduced VEGF expression, thereby suggesting a potential therapeutic vulnerability in HIV‑infected patients with left ventricular dysfunction.",-47.5,0.8,diseaseorphenotypicfeature
"He observed that the BRCA1 c.68_69delAG sequence variant in HIV‑infected patients with left ventricular dysfunction was associated with increased risk of macular corneal dystrophy, suggesting a pathogenic link between viral infection, cardiac impairment, and ocular disease.",-38.25,0.8,diseaseorphenotypicfeature
Hereditary hypophosphatemic rickets with hypercalciuria in HIV‑infected patients is associated with left ventricular dysfunction and recurrent vomiting.,-13.375,0.8,diseaseorphenotypicfeature
"Heritable hypophosphatemic rickets with hypercalciuria, a diseaseorphenotypicfeature, is frequently accompanied by left ventricular dysfunction, and in HIV‑infected patients the combination of MDR TB and macular corneal dystrophy further exacerbates gastrointestinal adverse events and vomiting.",-40.0,0.8,diseaseorphenotypicfeature
"Hereditable hypophosphatemic rickets with hypercalciuria in a HIV‑infected patient was associated with vomiting and left ventricular dysfunction, and was exacerbated by MDR TB infection.",-31.125,0.8,diseaseorphenotypicfeature
"Her editing of the SLC34A1 gene in the human bronchial epithelial cell line BEAS‑2B revealed that the c.1195G>A SequenceVariant, which is associated with hereditary hypophosphatemic rickets with hypercalciuria, causes a decrease in phosphate transporter activity and consequently increases the risk of left ventricular dysfunction in HIV‑infected patients.",-66.0,0.8,diseaseorphenotypicfeature
"The clinical trial demonstrated that the novel PTH1R antagonist markedly improved serum phosphate levels and bone density in patients with hereditary hypophosphatemic rickets with hypercalciuria, while also reducing the incidence of left ventricular dysfunction observed in the placebo group.",-33.0,0.8,diseaseorphenotypicfeature
"The **Hereditary hypophosphatemic rickets with hypercalciuria** phenotype in **HIV‑infected** patients is frequently accompanied by **left ventricular dysfunction**, which is exacerbated by **vomiting**-induced electrolyte disturbances and the use of **MDR TB** treatment regimens.",-32.75,0.8,diseaseorphenotypicfeature
The combination of a BRCA1 c.68_69delAG SequenceVariant with the TP53 GeneOrGeneProduct mutation in a patient with hereditary hypophosphatemic rickets with hypercalciuria and left ventricular dysfunction underscores the complex interplay between genetic predisposition and multi‑organ phenotypic features.,-33.5,0.8,diseaseorphenotypicfeature
The detection of a BRCA1 c.68_69delAG sequence variant in a patient with hereditary hypophosphatemic rickets with hypercalciuria and left ventricular dysfunction suggests a possible pathogenic link between the mutation and the cardiac phenotype.,-20.75,0.8,diseaseorphenotypicfeature
"In a cohort of HIV‑infected patients, the presence of the BRCA1 SequenceVariant c.68_69delAG was associated with an increased incidence of left ventricular dysfunction, suggesting a potential link between this genetic alteration and cardiac complications in the setting of immunosuppression.",-25.375,0.8,diseaseorphenotypicfeature
"In patients with HIV-infected individuals, left ventricular dysfunction associated with MDR TB is frequently exacerbated by the presence of GI AEs, leading to worsening of IUGR during pregnancy.",-38.0,0.8,diseaseorphenotypicfeature
"In HIV‑infected patients treated with antiretroviral therapy, the development of MDR TB is frequently associated with gastrointestinal adverse events that include severe vomiting, which can exacerbate left ventricular dysfunction observed in a subset of individuals with hereditary hypophosphatemic rickets with hypercalciuria.",-36.75,0.8,diseaseorphenotypicfeature
"In the MDR TB–treated HIV‑infected patient, the emergent left ventricular dysfunction appeared to be driven by a sequence variant in the HMOX1 promoter that amplified oxidative stress and worsened gastrointestinal adverse events.",-43.5,0.8,diseaseorphenotypicfeature
"Patients with hereditary hypophosphatemic rickets with hypercalciuria often exhibit left ventricular dysfunction due to chronic hypophosphatemia‑induced myocardial remodeling, a complication that can be exacerbated by concurrent HIV‑infected status.",-24.25,0.8,diseaseorphenotypicfeature
"Patients receiving MDR TB treatment for HIV‑infected adults with left ventricular dysfunction exhibited severe vomiting and gastrointestinal adverse events, complicating adherence to the drug regimen.",-34.25,0.8,diseaseorphenotypicfeature
"Patients infected with HIV who develop MDR TB and experience vomiting exhibit a pronounced risk of left ventricular dysfunction, a complication that may accelerate progression to heart failure.",-34.0,0.8,diseaseorphenotypicfeature
"Patients suffering from hereditary hypophosphatemic rickets with hypercalciuria frequently exhibit left ventricular dysfunction, which may be aggravated by the chronic hypercalcemia associated with the disease.",-27.375,0.8,diseaseorphenotypicfeature
"Mutations in the SLC34A3 gene cause hereditary hypophosphatemic rickets with hypercalciuria, a disorder that frequently presents with vomiting and left ventricular dysfunction in affected patients.",-15.5625,0.8,diseaseorphenotypicfeature
"Mutational analysis revealed that the SLC34A3 c.1063C>G sequence variant in a patient with hereditary hypophosphatemic rickets with hypercalciuria disrupts phosphate transport, leading to renal phosphate wasting and subsequent left ventricular dysfunction.",-36.75,0.8,diseaseorphenotypicfeature
Mutant **BRCA1 c.68_69delAG** in the **Homo sapiens** breast cancer cell line **MDA‑MB‑231** enhances resistance to **doxorubicin** by upregulating the drug‑efflux transporter **ABCB1** and simultaneously suppressing the apoptotic regulator **TP53**.,-43.0,0.8,diseaseorphenotypicfeature
"Mutagenic exposure to MDR TB‑derived lipooligosaccharides in HIV‑infected patients was found to induce left ventricular dysfunction and vomiting, potentially aggravating the clinical course of hereditary hypophosphatemic rickets with hypercalciuria.",-43.0,0.8,diseaseorphenotypicfeature
A significant association was observed between the c.1049C>T sequence variant in the SLC34A1 gene and the development of left ventricular dysfunction in patients with hereditary hypophosphatemic rickets with hypercalciuria.,-30.875,0.8,diseaseorphenotypicfeature
"A mutation in the FGF23 gene causes hereditary hypophosphatemic rickets with hypercalciuria, which in turn induces left ventricular dysfunction in affected patients.",-19.125,0.8,diseaseorphenotypicfeature
"A‑549 cells infected with MDR TB exhibit elevated expression of the NF‑κB pathway, which correlates with increased left ventricular dysfunction in HIV‑infected patients experiencing GI AEs and vomiting.",-35.25,0.8,diseaseorphenotypicfeature
A DNA‑sequencing assay for the c.68_69delAG variant in the PHEX gene revealed that patients with hereditary hypophosphatemic rickets with hypercalciuria exhibit a markedly higher incidence of left ventricular dysfunction.,-39.0,0.8,diseaseorphenotypicfeature
"Recent studies revealed that HIV‑infected patients receiving MDR TB therapy experience severe GI AEs, leading to vomiting and worsening left ventricular dysfunction.",-30.5,0.8,diseaseorphenotypicfeature
"Recent analysis revealed that patients with HIV‑infected status and a BRCA1 SequenceVariant c.68_69delAG exhibit markedly increased left ventricular dysfunction, suggesting a synergistic impact of viral infection and genetic predisposition on cardiac health.",-39.75,0.8,diseaseorphenotypicfeature
"Recent data demonstrate that HIV‑infected patients receiving a combination of zidovudine and lamivudine exhibit higher rates of gastrointestinal adverse events, including vomiting, compared with those treated with abacavir alone.",-36.0,0.8,diseaseorphenotypicfeature
"Recent work in HIV‑infected patients with left ventricular dysfunction demonstrated that chronic vomiting and MDR TB infection can worsen heart failure, a finding that may help explain the high mortality observed in this high‑risk population.",-53.75,0.8,diseaseorphenotypicfeature
"HIV‑infected patients with MDR TB who develop left ventricular dysfunction often experience vomiting, which can exacerbate the underlying macular corneal dystrophy.",-23.0,0.8,diseaseorphenotypicfeature
"Homozygous loss-of-function variants in SLC34A1, identified in a cohort of HIV‑infected patients with hereditary hypophosphatemic rickets with hypercalciuria, correlate with severe left ventricular dysfunction and increased susceptibility to MDR TB.",-26.875,0.8,diseaseorphenotypicfeature
"Hepatocellular carcinoma patients with a TP53 c.215G>A variant exhibited higher levels of AFP and more pronounced left ventricular dysfunction, suggesting a link between the sequence variant, tumor marker expression, and cardiac complications.",-37.0,0.8,diseaseorphenotypicfeature
"Heterozygous carriers of the MYH7 c.1333G>A variant exhibit left ventricular dysfunction, a hallmark phenotype of hereditary hypophosphatemic rickets with hypercalciuria, underscoring the pathogenic impact of this sequence variant.",-36.5,0.8,diseaseorphenotypicfeature
"Staphylococcus aureus infection in a HIV‑infected patient carrying a BRCA1 c.68_69delAG variant was associated with severe vomiting and left ventricular dysfunction, prompting early intervention with vancomycin to mitigate GI AEs and prevent progression to MDR TB.",-37.0,0.8,diseaseorphenotypicfeature
"Stimulation of the TRPV4 channel in A549 cells expressing the BRCA1 c.68_69delAG variant exacerbated intracellular calcium overload and induced apoptosis, correlating with the severity of left ventricular dysfunction observed in HIV‑infected patients who also presented with IUGR and a history of MDR TB.",-49.5,0.8,diseaseorphenotypicfeature
"Streptomycin exposure in an HIV‑infected patient with MDR TB caused vomiting, which in turn precipitated left ventricular dysfunction through electrolyte imbalance and myocardial stress.",-35.5,0.8,diseaseorphenotypicfeature
"Stool cultures from HIV‑infected patients with MDR TB and persistent vomiting revealed overexpression of the drug‑resistance gene Rv0678, suggesting that the bacterial SequenceVariant confers reduced susceptibility to rifabutin and correlates with left ventricular dysfunction observed in this cohort.",-52.75,0.8,diseaseorphenotypicfeature
"Silica exposure in HIV‑infected patients carrying the BRCA1 c.68_69delAG variant has been linked to gastrointestinal adverse events, including vomiting, and may predispose to left ventricular dysfunction.",-35.25,0.8,diseaseorphenotypicfeature
"Silencing of SLC34A1 in a patient-derived fibroblast line from a **Homo sapiens** individual with **hereditary hypophosphatemic rickets with hypercalciuria** led to a marked decrease in phosphate transport activity and an associated up‑regulation of **FGF23**, thereby exacerbating **left ventricular dysfunction** in the cardiomyocytes of the same culture.",-60.5,0.8,diseaseorphenotypicfeature
"Silmitasertib treatment of A549 cells harboring a TP53 c.215G>A variant reduced proliferation and induced apoptosis, highlighting its potential as a targeted therapy for left ventricular dysfunction in patients with hereditary hypophosphatemic rickets with hypercalciuria.",-40.75,0.8,diseaseorphenotypicfeature
"Silico‑analysis of the BRCA1 c.68_69delAG SequenceVariant in a HeLa CellLine revealed that this mutation destabilizes the gene product TP53, leading to left ventricular dysfunction in HIV‑infected patients with hereditary hypophosphatemic rickets and hypercalciuria.",-40.5,0.8,diseaseorphenotypicfeature
"Gene‐specific knockdown of PHEX in human osteoblasts derived from a patient with hereditary hypophosphatemic rickets with hypercalciuria reduces alkaline phosphatase activity and restores phosphate‐dependent mineralization, thereby alleviating the bone‑weakening phenotype.",-40.75,0.8,diseaseorphenotypicfeature
"Gene dosage reduction of the DMP1 gene in patients with hereditary hypophosphatemic rickets with hypercalciuria leads to impaired phosphate homeostasis and is associated with left ventricular dysfunction, underscoring the systemic impact of this rare bone‑disease phenotype.",-44.75,0.8,diseaseorphenotypicfeature
"Gene‑edited CRISPR‑Cas9 knockout of the SLC34A1 gene in human embryonic kidney HEK293T cells caused severe hypophosphatemia and hypercalciuria, phenocopying hereditary hypophosphatemic rickets with hypercalciuria and resulting in left ventricular dysfunction due to chronic phosphate wasting.",-45.75,0.8,diseaseorphenotypicfeature
Gene therapy using CRISPR‑Cas9 targeting the SPHK1 locus in A549 cells has been shown to reduce tumor‑induced left ventricular dysfunction in a mouse model of hereditary hypophosphatemic rickets with hypercalciuria.,-37.75,0.8,diseaseorphenotypicfeature
Recurrent vomiting in HIV‑infected patients receiving MDR TB treatment correlates with left ventricular dysfunction and may be exacerbated by GI adverse events.,-26.375,0.8,diseaseorphenotypicfeature
"Recombinant AAV9‐mediated delivery of a CRISPR/Cas9 cassette targeting the PHEX mutation in a patient with hereditary hypophosphatemic rickets with hypercalciuria restored serum phosphate levels and reduced bone pain, while the resulting AAV9 vector also expressed the therapeutic protein in the kidney, improving urinary calcium excretion and mitigating left ventricular dysfunction in the underlying heart‑muscle phenotype.",-86.0,0.8,diseaseorphenotypicfeature
"Reanalysis of the WFS1 c.1069G>A variant in an HIV‑infected patient revealed that the substitution, together with the observed left ventricular dysfunction, was likely responsible for the exacerbated macular corneal dystrophy and gastrointestinal adverse events.",-58.0,0.8,diseaseorphenotypicfeature
"Rearranged amplification of the PAX6 promoter in a patient with hereditary hypophosphatemic rickets with hypercalciuria caused a marked up‑regulation of the gene product, leading to increased retinal pigment epithelium dysfunction and progressive macular corneal dystrophy.",-51.25,0.8,diseaseorphenotypicfeature
"Mutation of the DMP1 gene in patients with hereditary hypophosphatemic rickets with hypercalciuria leads to up‑regulated FGF23 secretion, which in turn causes renal phosphate wasting and subsequent left ventricular dysfunction.",-22.125,0.8,diseaseorphenotypicfeature
"Mutation A563V in the **SLC34A1** gene, found in a patient with **hereditary hypophosphatemic rickets with hypercalciuria**, was shown to impair phosphate reabsorption in proximal tubule cells, leading to **left ventricular dysfunction** due to chronic hypocalcemia.",-47.0,0.8,diseaseorphenotypicfeature
"Mutation in the PHEX gene associated with hereditary hypophosphatemic rickets with hypercalciuria leads to increased FGF23 expression, which in turn down‑regulates renal phosphate reabsorption and promotes secondary hyperparathyroidism.",-30.125,0.8,diseaseorphenotypicfeature
"Mutation c.68_69delAG in the *BRCA1* gene, detected in a patient with hereditary hypophosphatemic rickets with hypercalciuria, correlates with elevated serum phosphate and increased susceptibility to left ventricular dysfunction.",-32.25,0.8,diseaseorphenotypicfeature
"Homozygous BRCA1 c.68_69delAG in an elderly female with benign prostate hyperplasia was found to increase the risk of primary malignant lymphoma of the brain, as evidenced by a markedly higher incidence of cardiac dysfunction and superior mesenteric vein thrombosis in the affected cohort.",-40.5,0.8,diseaseorphenotypicfeature
Heterozygous loss of the DACH1 gene in a patient with congenital nuclear cataract and elevated serum troponin levels was found to correlate with progressive cardiac dysfunction and the development of coronary artery disease.,-49.5,0.8,diseaseorphenotypicfeature
"Hepatocyte growth factor overexpression in the A549 lung carcinoma cell line was shown to activate the MET receptor and induce drusen‑like extracellular deposits in the retinal pigment epithelium, a process that mirrors the early ocular manifestations of congenital nuclear cataract in patients with TP53 mutations.",-56.75,0.8,diseaseorphenotypicfeature
HFE gene variants in patients with congenital nuclear cataract and drusen were found to increase the risk of developing chronic heart failure (CHF) through dysregulation of iron homeostasis and subsequent cardiac dysfunction.,-43.0,0.8,diseaseorphenotypicfeature
"Cardiac dysfunction in patients with CHF is exacerbated by elevated circulating IL‑6, which activates STAT3 signaling and promotes the proliferation of cardiac fibroblasts, leading to myocardial fibrosis and further aggravation of heart failure.",-30.25,0.8,diseaseorphenotypicfeature
"Cardiogenic heart failure (CHF) in patients with congenital nuclear cataract is exacerbated by drusen‑associated inflammation, leading to progressive cardiac dysfunction and a higher risk of developing primary malignant lymphoma of the brain.",-22.125,0.8,diseaseorphenotypicfeature
"Cardio‑vascular dysfunction in patients with chronic heart failure (CHF) is exacerbated by the presence of a BRCA2 BRCA2 c.5946_5948delTTC variant, which promotes malignant transformation of myocardial cells and contributes to the development of left‑ventricular hypertrophy.",-51.75,0.8,diseaseorphenotypicfeature
"Cardinal features of CHF, such as cardiac dysfunction and dyspnea, are frequently exacerbated in patients with benign prostate hyperplasia and concomitant hypertension.",-35.5,0.8,diseaseorphenotypicfeature
"Congenital nuclear cataract, often linked to premature lens opacification in infants, has been shown to be exacerbated by mutations in the CRYAA gene, leading to disrupted protein folding and increased susceptibility to oxidative stress.",-37.25,0.8,diseaseorphenotypicfeature
"Congestive heart failure induced by doxorubicin treatment in A549 cells is exacerbated by the presence of the TP53 c.215G>A sequence variant, correlating with increased cardiac dysfunction markers in Homo sapiens patients.",-28.375,0.8,diseaseorphenotypicfeature
"Congruent with its hallmark cardiac dysfunction, the use of doxorubicin in A549 cells was shown to precipitate a severe CHF phenotype in a subset of mice bearing a BRCA1 c.68_69delAG variant.",-48.5,0.8,diseaseorphenotypicfeature
Congenic nuclear cataract in a patient with a TP53 c.215G>A SequenceVariant correlates with early onset visual impairment and increases the risk of developing Primary malignant lymphoma of the brain.,-43.75,0.8,diseaseorphenotypicfeature
The presence of drusen in the retina was found to be strongly associated with the progression of cardiac dysfunction in patients who also exhibit signs of congenital nuclear cataract.,-19.875,0.8,diseaseorphenotypicfeature
"The CHD2 c.4216C>T (p.Arg1406Cys) variant, identified in a patient with congenital nuclear cataract, disrupts retinal protein folding and is associated with an increased risk of superior mesenteric vein (SMV) thrombosis in the same individual.",-52.25,0.8,diseaseorphenotypicfeature
"The early‑onset congenital nuclear cataract in this cohort was strongly associated with a pathogenic BRCA1 c.68_69delAG sequence variant, which also predisposes to secondary cardiac dysfunction and occasionally to superior mesenteric vein (SMV) thrombosis.",-34.25,0.8,diseaseorphenotypicfeature
"The onset of CHF in patients with a history of radiotherapy-induced cardiac dysfunction was markedly accelerated by the presence of a BRCA1 c.68_69delAG sequence variant, which promoted abnormal collagen deposition in myocardial tissue.",-32.0,0.8,diseaseorphenotypicfeature
Patients with CHF treated with a novel SGLT2 inhibitor showed a statistically significant reduction in cardiac dysfunction markers and improved ejection fraction compared to historical controls.,-30.25,0.8,diseaseorphenotypicfeature
"Patients harboring the BRCA1 c.68_69delAG sequence variant exhibit an increased risk of breast cancer, and the presence of this mutation has been linked to earlier onset of disease and more aggressive tumor phenotypes in women of European ancestry.",-34.25,0.8,diseaseorphenotypicfeature
Patients treated with doxorubicin for primary malignant lymphoma of the brain frequently develop cardiac dysfunction that progresses to congestive heart failure (CHF) due to anthracycline‑induced cardiotoxicity.,-22.5,0.8,diseaseorphenotypicfeature
"Patients receiving anthracycline therapy frequently develop CHF, a cardiac dysfunction that may be exacerbated by concurrent myocardial infarction or radiation-induced fibrosis.",-33.25,0.8,diseaseorphenotypicfeature
"A patient with CHF and superior mesenteric vein (SMV) thrombosis experienced worsening cardiac dysfunction after treatment with doxorubicin, which was linked to oxidative damage of the myocardial tissue.",-34.5,0.8,diseaseorphenotypicfeature
"Atherosclerotic plaque accumulation in the superior mesenteric vein (SMV) thrombosis is frequently accompanied by cardiac dysfunction, which, in patients with chronic heart failure (CHF), worsens prognosis and accelerates progression to end-stage renal disease.",-43.0,0.8,diseaseorphenotypicfeature
A retrospective cohort study demonstrated that patients with CHF who received a high‑dose dose of doxorubicin exhibited a statistically significant increase in superior mesenteric vein thrombosis compared with controls.,-30.75,0.8,diseaseorphenotypicfeature
"A β‑blocker reduces cardiac dysfunction in patients with CHF, yet its use can exacerbate hand‑foot syndrome, a notable adverse effect in those with primary malignant lymphoma of the brain treated with high‑dose chemotherapy.",-39.5,0.8,diseaseorphenotypicfeature
"In human patients with primary malignant lymphoma of the brain, the presence of drusen in the retinal periphery has been associated with a higher risk of superior mesenteric vein thrombosis and subsequent cardiac dysfunction, suggesting a link between ocular biomarkers and cardiovascular complications in this disease.",-39.0,0.8,diseaseorphenotypicfeature
"In patients with CHF secondary to cardiac dysfunction, elevated levels of the inflammatory cytokine IL‑6 correlate with the progression of benign prostate hyperplasia and are associated with increased risk of drusen formation in the retina.",-26.625,0.8,diseaseorphenotypicfeature
"In a cohort of patients with primary malignant lymphoma of the brain, the presence of the BRCA1 c.68_69delAG variant in tumor tissue was associated with increased cardiac dysfunction, suggesting a potential link between this SequenceVariant and adverse cardiovascular outcomes.",-30.5,0.8,diseaseorphenotypicfeature
"In prostate carcinogenesis, the TP53 sequence variant c.215G>A, identified in a patient with benign prostate hyperplasia, is associated with increased risk of developing a primary malignant lymphoma of the brain.",-29.125,0.8,diseaseorphenotypicfeature
"Early-stage primary malignant lymphoma of the brain in a patient with congenital nuclear cataract was found to be associated with a marked increase in the number of drusen, suggesting that tumor-initiating signals may contribute to retinal degeneration.",-48.5,0.8,diseaseorphenotypicfeature
"Early‑stage primary malignant lymphoma of the brain frequently manifests as superior mesenteric vein thrombosis, leading to cardiac dysfunction and hand‑foot syndrome, and is strongly associated with the CHF phenotype.",-37.75,0.8,diseaseorphenotypicfeature
"Early‐stage primary malignant lymphoma of the brain is frequently associated with superior mesenteric vein thrombosis, contributing to cardiac dysfunction and exacerbating congestive heart failure in affected patients.",-21.625,0.8,diseaseorphenotypicfeature
"Early detection of drusen in patients with primary malignant lymphoma of the brain is associated with a higher risk of cardiac dysfunction, suggesting that ocular biomarkers may predict systemic complications such as CHF.",-28.5,0.8,diseaseorphenotypicfeature
"Knocking down the TP53 gene in HeLa cells exacerbates doxorubicin-induced cardiac dysfunction, evidenced by increased biomarkers of CHF in the conditioned medium.",-34.5,0.8,diseaseorphenotypicfeature
"Knock‑down of the gene TP53 in HeLa cells exacerbated cardiomyopathy in a mouse model of congestive heart failure, where the resulting cardiac dysfunction was accompanied by increased deposition of drusen‑like deposits in the retinal pigment epithelium.",-41.75,0.8,diseaseorphenotypicfeature
"Knox et al. reported that the BRCA1 c.68_69delAG sequence variant in a cohort of Homo sapiens patients with benign prostate hyperplasia was associated with an increased risk of developing cardiac dysfunction and, in a subset, progression to primary malignant lymphoma of the brain.",-36.5,0.8,diseaseorphenotypicfeature
"Knudsen et al. reported that patients with Primary malignant lymphoma of the brain exhibiting drusen and superior mesenteric vein (SMV) thrombosis displayed higher rates of cardiac dysfunction and hand‑foot syndrome during rituximab therapy, suggesting a link between the lymphoma’s tumor‑initiating phenotype and cardiovascular complications.",-51.5,0.8,diseaseorphenotypicfeature
"An elevated expression of the inflammatory mediator IL‑6 in patients with CHF is directly associated with cardiac dysfunction, and blockade of the IL‑6 receptor by tocilizumab has been shown to attenuate this pathological process.",-46.0,0.8,diseaseorphenotypicfeature
"An association between congenital nuclear cataract and the p.Gly12Asp mutation in KRAS was detected in a cohort of patients with Primary malignant lymphoma of the brain, suggesting that the oncogenic mutation may contribute to both tumor‑initiating activity and early ocular phenotypic features.",-43.5,0.8,diseaseorphenotypicfeature
"An aggressive form of Primary malignant lymphoma of the brain, marked by elevated CD20 expression, was found to precipitate cardiac dysfunction and CHF in patients receiving rituximab, leading clinicians to monitor for signs of superior mesenteric vein thrombosis during treatment.",-51.75,0.8,diseaseorphenotypicfeature
An acquired mutation of the SMAD4 gene in a patient with primary malignant lymphoma of the brain was found to drive tumor‑initiating pathways that ultimately exacerbated cardiac dysfunction and resulted in congestive heart failure.,-39.0,0.8,diseaseorphenotypicfeature
Cox‑2 overexpression in the tumor‑initiating cells of a primary malignant lymphoma of the brain correlated with the severity of cardiac dysfunction and increased susceptibility to superior mesenteric vein thrombosis in patients receiving high‑dose anthracycline therapy.,-36.0,0.8,diseaseorphenotypicfeature
"Cytokine‑mediated inflammation in patients with primary malignant lymphoma of the brain promotes cardiac dysfunction, which in turn exacerbates the risk of developing CHF.",-25.625,0.8,diseaseorphenotypicfeature
"Cognitive impairment in patients with CHF is exacerbated by the accumulation of drusen in the retina, suggesting that cardiac dysfunction may indirectly influence neuro‑degenerative phenotypes.",-28.0,0.8,diseaseorphenotypicfeature
"Causal analysis revealed that the BRCA1 c.68_69delAG SequenceVariant in breast carcinoma cells leads to cardiac dysfunction resembling CHF in a subset of patients receiving doxorubicin, implicating a shared pathway of oxidative stress and mitochondrial damage.",-51.25,0.8,diseaseorphenotypicfeature
Conduction defects in congenital nuclear cataract patients harboring a CRYAA missense variant were associated with an increased risk of developing cardiac dysfunction and subsequent CHF.,-36.5,0.8,diseaseorphenotypicfeature
"Consecutive patients with CHF and a history of superior mesenteric vein (SMV) thrombosis exhibited markedly increased plasma levels of pro‑inflammatory cytokine IL‑6, suggesting that systemic inflammation may drive both cardiac dysfunction and thrombotic risk.",-31.25,0.8,diseaseorphenotypicfeature
"Conjugated bile acids exacerbate cardiac dysfunction in CHF patients, while the BRCA1 c.68_69delAG sequence variant contributes to congenital nuclear cataract development.",-34.0,0.8,diseaseorphenotypicfeature
"Concomitant administration of doxorubicin to A549 cells exacerbated cardiac dysfunction, evidenced by increased troponin I levels and myocardial fibrosis, thereby linking the drug’s cardiotoxic profile to the development of CHF in this model.",-37.25,0.8,diseaseorphenotypicfeature
"Combined oral administration of the small‑molecule inhibitor dabrafenib in patients with metastatic melanoma harboring the BRAF V600E mutation reduced tumor‑initiating cell frequency and was associated with a significant decline in cardiac dysfunction, thereby suggesting that the drug’s therapeutic benefit may be offset by a mild risk of CHF in susceptible individuals.",-64.5,0.8,diseaseorphenotypicfeature
Combined analysis of BRCA1 c.68_69delAG in breast cancer patient samples revealed that the SequenceVariant was strongly associated with early-onset disease and a higher risk of developing secondary Primary malignant lymphoma of the brain.,-41.0,0.8,diseaseorphenotypicfeature
"Combined administration of doxorubicin to HeLa cells carrying the BRCA1 c.68_69delAG variant induced DNA damage response signaling and exacerbated cardiac dysfunction, as evidenced by increased troponin I release and elevated levels of pro‑inflammatory cytokines in the culture medium.",-44.75,0.8,diseaseorphenotypicfeature
"Combined cardiac dysfunction and CHF were observed in patients harboring the TP53 c.215G>A sequence variant, suggesting that the variant may drive tumor‑initiating pathways in prostate carcinogenesis.",-34.75,0.8,diseaseorphenotypicfeature
"CHF-associated cardiac dysfunction in patients with primary malignant lymphoma of the brain is exacerbated by a BRCA1 c.68_69delAG sequence variant, leading to increased pro‑apoptotic signaling in the tumor‑initiating microenvironment.",-30.5,0.8,diseaseorphenotypicfeature
"CHF resulting from anthracycline therapy is exacerbated by concurrent overexpression of the mitochondrial fission protein DRP1 in HeLa cells, which promotes apoptosis of cardiomyocytes and worsens cardiac dysfunction.",-39.25,0.8,diseaseorphenotypicfeature
"CHF symptoms in patients receiving high‑dose doxorubicin were exacerbated by the down‑regulation of the mitochondrial antioxidant enzyme SOD2, leading to increased oxidative stress and cardiac dysfunction.",-33.75,0.8,diseaseorphenotypicfeature
"CHF in patients with primary malignant lymphoma of the brain is exacerbated by cardiac dysfunction caused by tumor‑initiating cells that express high levels of VEGF, leading to superior mesenteric vein (SMV) thrombosis and hand‑foot syndrome.",-25.75,0.8,diseaseorphenotypicfeature
"In patients co‑infected with HIV and hepatitis B, the presence of the BRCA1 c.68_69delAG sequence variant was associated with increased risk of gastric ulcers and impaired learning and memory.",-18.875,0.8,diseaseorphenotypicfeature
"In a cohort of patients with Tetralogy of Fallot, the presence of the c.1154G>A variant in the NOTCH1 gene was associated with impaired cardiac valve development and an increased risk of early-onset gastric ulcers.",-33.0,0.8,diseaseorphenotypicfeature
"In MCL tumour‑derived HCT‑116 cells, the CRISPR‑Cas9‑induced BRCA1 c.68_69delAG sequence variant upregulates the DNA‑damage response gene ATM, thereby increasing susceptibility to platinum‑based chemotherapy but concurrently enhancing repair of double‑strand breaks that may contribute to drug resistance.",-56.5,0.8,diseaseorphenotypicfeature
"In HeLa cells treated with doxorubicin, the down‑regulation of TP53 expression exacerbates impairments in learning and memory, a phenotype previously linked to the BRCA1 c.68_69delAG variant in patients co‑infected with HIV and hepatitis B.",-31.5,0.8,diseaseorphenotypicfeature
"Loss of function of the SCN1A gene (SequenceVariant c.1234G>A) in a patient with early‑onset convulsive seizures (DiseaseOrPhenotypicFeature) led to the identification of a novel de‑novo mutation that caused a gain of channel activity, thereby confirming SCN1A as a critical gene (GeneOrGeneProduct) for neuronal excitability in epilepsy.",-62.0,0.8,diseaseorphenotypicfeature
"Loss‑of‑function mutations in the **GATA6** gene, observed in patients with **Tetralogy of Fallot**, are associated with impaired cardiac valve development and increased risk of **congenital heart disease**.",-34.75,0.8,diseaseorphenotypicfeature
"Loss to follow-up after the initiation of rituximab therapy in patients with MCL tumour was associated with a higher risk of disease relapse, particularly in those who also exhibited impairments in learning and memory.",-41.5,0.8,diseaseorphenotypicfeature
"Lossing of the SMAD4 gene product in the MCL tumour cell line JeKo‑1 resulted in up‑regulated PI3K/AKT signalling, which in turn caused impaired apoptosis and a pronounced resistance to the chemotherapeutic drug doxorubicin.",-59.0,0.8,diseaseorphenotypicfeature
"The MCL tumour cell line Namalwa, harbouring a TP53 sequence variant c.215G>A, was rendered resistant to doxorubicin by overexpressing the drug‑efflux transporter ABCB1, thereby exacerbating impairments in learning and memory in co‑treated nude mice.",-45.25,0.8,diseaseorphenotypicfeature
"The polymorphism rs1057510 in the CYP2D6 gene, commonly found in *Homo sapiens*, confers reduced metabolism of the antipsychotic clozapine, thereby increasing the risk of convulsive seizures in patients with bipolar disorder.",-39.75,0.8,diseaseorphenotypicfeature
The presence of a BRCA1 c.68_69delAG variant in a female patient with a personal history of gastric ulcers and co‑infection with HIV and hepatitis B was found to increase her susceptibility to MCL tumour development while also exacerbating impairments in learning and memory.,-26.0,0.8,diseaseorphenotypicfeature
"The bipolar disorder patient with impairments in learning and memory exhibited elevated serum cortisol levels, suggesting a stress‑induced hypothalamic‑pituitary‑adrenal axis dysregulation.",-25.875,0.8,diseaseorphenotypicfeature
"Bipolar disorder frequently exacerbates impairments in learning and memory, and the presence of a germline SequenceVariant in the CACNA1C gene is associated with increased seizure risk in affected patients.",-30.0,0.8,diseaseorphenotypicfeature
"Bortezomib treatment of the MCL tumour in a patient with co‑infected HIV and hepatitis B led to a marked reduction in circulating interleukin‑6 levels, while the underlying hereditary hypercoagulability was managed with low‑molecular‑weight heparin to prevent thrombotic complications.",-46.0,0.8,diseaseorphenotypicfeature
"Biallelic mutations in the SLC10A7 gene cause mucolipidosis III γ, leading to impaired lysosomal trafficking, skeletal dysplasia, and recurrent gastric ulcers in affected Homo sapiens patients.",-29.375,0.8,diseaseorphenotypicfeature
"Bilateral retinal hemorrhages and visual field constriction in a patient with Tetralogy of Fallot were exacerbated by a CYP2C19 *2 variant, illustrating how sequence variants can influence disease severity in congenital heart disease.",-45.5,0.8,diseaseorphenotypicfeature
"A recent cohort study demonstrated that patients with bipolar disorder who carry the APOE ε4 allele exhibit greater impairments in learning and memory than those without the allele, suggesting a genetic contribution to cognitive decline in this population.",-24.625,0.8,diseaseorphenotypicfeature
"A combined analysis of MCL tumour samples from a cohort of patients co‑infected with HIV and hepatitis B revealed that a novel sequence variant, BRCA1 c.68_69delAG, was associated with impaired DNA repair and increased susceptibility to gastric ulcers.",-34.0,0.8,diseaseorphenotypicfeature
"A single‑cell RNA‑seq analysis of the MCL tumour cell line Mino revealed that the MYC‑induced up‑regulation of the gene TPM3, together with the BRCA2 c.5946delA sequence variant, correlated with increased expression of the pro‑apoptotic protein BAX and a corresponding decrease in cell‑cycle progression markers.",-64.0,0.8,diseaseorphenotypicfeature
"A study of patients with unipolar depression revealed that the presence of the CRP rs1205 A allele, which is associated with heightened inflammation, correlated with poorer response to selective serotonin reuptake inhibitor therapy and increased rates of relapse.",-47.5,0.8,diseaseorphenotypicfeature
"Hereditary hypercoagulability, often driven by factor V Leiden mutations, predisposes patients to recurrent venous thromboembolism and has been linked to impaired learning and memory deficits in affected individuals.",-29.75,0.8,diseaseorphenotypicfeature
"Herbal extract of *Echinacea purpurea* was found to reduce the frequency of convulsive seizures in a cohort of patients with MCL tumour undergoing rituximab therapy, suggesting a neuroprotective effect mediated through modulation of the GABAergic system.",-35.75,0.8,diseaseorphenotypicfeature
"Heroin‑induced convulsive seizures in patients co‑infected with HIV and hepatitis B were found to be exacerbated by the SequenceVariant BRCA1 c.68_69delAG, which reduces the expression of the DNA repair gene TP53 and increases the risk of gastric ulcers.",-33.0,0.8,diseaseorphenotypicfeature
"Herpes‑zoster infection in a patient with MCL tumour and a BRCA1 SequenceVariant c.68_69delAG exacerbated learning and memory impairments, prompting use of the FDA‑approved ChemicalEntity rituximab to target malignant B‑cells while monitoring for hepatotoxicity in the affected Homo sapiens subject.",-62.75,0.8,diseaseorphenotypicfeature
"Haplotype‑associated SNPs in the GATA4 gene, such as rs12704488, are linked to congenital heart disease, and in patients co‑infected with HIV and hepatitis B, this variant exacerbates hepatic steatosis and contributes to the development of gastric ulcers.",-69.0,0.8,diseaseorphenotypicfeature
"HIV‑infected patients co‑treated with tenofovir and lamivudine exhibit a higher incidence of renal stone formation, and this lithogenic risk is amplified by a pathogenic BRCA1 c.68_69delAG variant that compromises DNA repair mechanisms.",-43.75,0.8,diseaseorphenotypicfeature
Heterozygous BRCA1 c.68_69delAG mutations in a female MCL tumour patient co‑infected with HIV and hepatitis B were found to correlate with impaired DNA repair pathways and increased susceptibility to gastric ulcers.,-24.5,0.8,diseaseorphenotypicfeature
"Hepatic metastases of MCL tumour frequently co‑occur with impaired learning and memory deficits in patients with a germline BRCA2 c.1988C>T variant, and the presence of this SequenceVariant is associated with an increased risk of convulsive seizures and gastric ulcers.",-57.0,0.8,diseaseorphenotypicfeature
"Mutations in the F2 gene (Factor V Leiden) are strongly associated with hereditary hypercoagulability, and patients with this sequence variant often exhibit recurrent venous thromboembolism despite anticoagulation therapy.",-36.75,0.8,diseaseorphenotypicfeature
"Mutational analysis of the F5 gene revealed that the c.1691C>T (p.Arg564Trp) sequence variant is associated with hereditary hypercoagulability, while the co‑occurrence of the same variant in a patient co‑infected with HIV and hepatitis B exacerbates the risk of thrombotic complications.",-48.5,0.8,diseaseorphenotypicfeature
"Mutual inhibition between the MCL tumour marker BCL2 and the cytokine IL‑6 in A549 cells, combined with an observed reduction in learning and memory impairments in a mouse model of bipolar disorder, suggests that BCL2 could be a therapeutic target for both oncologic and neuropsychiatric conditions.",-59.5,0.8,diseaseorphenotypicfeature
"Mutant TP53 c.215G>A in A549 cells exacerbated ethanol-induced DNA damage, accelerating gastric ulcer progression in co‑infected HIV‑positive E. coli‑derived models of mucolipidosis III gamma.",-39.25,0.8,diseaseorphenotypicfeature
Co‑infection of HIV and hepatitis B in a patient with MCL tumour was associated with impaired learning and memory and a higher incidence of gastric ulcers.,-19.375,0.8,diseaseorphenotypicfeature
Co-infection with HIV and hepatitis B in patients harboring the CRISPLD2 c.412A>G variant is associated with higher rates of hepatic steatosis and impaired interferon‑α production.,-43.5,0.8,diseaseorphenotypicfeature
"Co‐infection of HIV with hepatitis B in patients harboring a BRCA1 c.68_69delAG variant exacerbates hepatic steatosis and increases the risk of developing gastric ulcers, while the presence of the MCL tumour further impairs immune regulation.",-41.5,0.8,diseaseorphenotypicfeature
"Co-treatment of a MCL tumour patient with a novel BCL2 inhibitor and standard CHOP chemotherapy reduced tumor burden and unexpectedly ameliorated the patient’s hypercoagulability, thereby lowering the risk of thrombotic events while maintaining adequate blood counts.",-63.5,0.8,diseaseorphenotypicfeature
"Defective TPM2 in patients with hereditary hypercoagulability increases platelet aggregation, predisposing them to early thrombotic complications and stroke.",-39.5,0.8,diseaseorphenotypicfeature
Deficiency of the mucolipidosis III gamma gene causes impaired lysosomal trafficking that leads to the accumulation of glycosphingolipids and consequently impairs learning and memory in affected patients.,-33.5,0.8,diseaseorphenotypicfeature
Deficiencies in the SMAD4 gene variant c.1142C>T are associated with impaired learning and memory in patients with hereditary hypercoagulability and MCL tumour progression.,-39.25,0.8,diseaseorphenotypicfeature
"Defining a novel BRCA1 c.68_69delAG variant in a patient with hereditary hypercoagulability reveals that the sequence change disrupts TP53 binding, leading to impaired DNA repair and increased risk of MCL tumour development in a Homo sapiens cohort.",-37.5,0.8,diseaseorphenotypicfeature
"Genetic loss of the regulatory gene **TP53** in the **HeLa** cell line induces uncontrolled proliferation, enhances **DNA** damage response, and increases susceptibility to **bipolar disorder**‑associated neuroinflammation in **Homo sapiens** models, highlighting a potential link between oncogenic pathways and psychiatric phenotypes.",-61.25,0.8,diseaseorphenotypicfeature
"Genotoxic exposure to doxorubicin induces DNA double‑strand breaks in HeLa cells, leading to up‑regulation of TP53‑dependent apoptosis, which has been correlated with the severity of cardiotoxicity observed in patients with a hereditary hypercoagulability phenotype.",-43.5,0.8,diseaseorphenotypicfeature
"Genomic sequencing of a MCL tumor revealed a TP53 c.215_216delAG sequence variant, which correlated with impaired DNA repair and increased susceptibility to convulsive seizures in a patient with a history of bipolar disorder.",-35.0,0.8,diseaseorphenotypicfeature
Genotyping the BRCA1 c.68_69delAG variant in MCL tumour patients revealed that those carrying the mutation had a significantly higher frequency of gastric ulcers and impaired learning and memory compared with patients without the variant.,-36.0,0.8,diseaseorphenotypicfeature
"Patients with bipolar disorder who exhibit impairments in learning and memory are more likely to develop gastric ulcers, a complication that can be exacerbated by co‑infection with HIV and hepatitis B.",-18.25,0.8,diseaseorphenotypicfeature
"Patients receiving doxorubicin for MCL tumor frequently develop impairments in learning and memory, likely due to drug‑induced oxidative damage to hippocampal neurons.",-26.75,0.8,diseaseorphenotypicfeature
Patients diagnosed with bipolar disorder who harbor the BRCA1 c.68_69delAG sequence variant exhibit increased impairments in learning and memory that correlate with higher rates of gastric ulcer incidence.,-29.875,0.8,diseaseorphenotypicfeature
"Patients treated with the novel kinase inhibitor NRTI‑C for MCL tumour exhibited a marked reduction in convulsive seizure frequency, suggesting a direct modulatory effect on neuronal ion channel activity.",-48.5,0.8,diseaseorphenotypicfeature
"Concomitant treatment with the mTOR inhibitor everolimus mitigated the hyperproliferation of MCL tumour cells in a patient with co‑infections of HIV and hepatitis B, thereby reducing the risk of hepatic complications.",-44.0,0.8,diseaseorphenotypicfeature
"Convergent evidence indicates that the MCL tumor cell line HBL-1 expresses a sequence variant of TP53 (c.215C>A) that impairs DNA repair and promotes drug resistance in patients with co‑infected HIV and hepatitis B, thereby exacerbating disease severity.",-52.75,0.8,diseaseorphenotypicfeature
"Convalescent plasma therapy, combined with ritonavir-boosted lopinavir, was found to reduce fever and improve learning and memory impairments in patients co‑infected with HIV and hepatitis B.",-32.25,0.8,diseaseorphenotypicfeature
"Conventional antipsychotic therapy with risperidone attenuated the convulsive seizures observed in a patient with bipolar disorder, thereby reducing the risk of severe impairments in learning and memory.",-41.0,0.8,diseaseorphenotypicfeature
Tetralogy of Fallot in a newborn was associated with a homozygous BRCA1 c.68_69delAG variant that resulted in impaired cardiac septation and an increased risk of early‑onset co‑inherited pulmonary hypertension.,-40.75,0.8,diseaseorphenotypicfeature
"Tetany induced by hypomagnesemia in a patient with co‑infected HIV and hepatitis B was relieved by magnesium sulfate, while a concurrent MCL tumour was treated with rituximab, highlighting the interplay between electrolyte disturbance, viral co‑infection and malignant disease.",-56.75,0.8,diseaseorphenotypicfeature
"Tetramisole treatment of A549 cells carrying the TP53 c.215G>A variant decreased cell viability and induced apoptosis, an effect amplified by co‑infection with E. coli expressing the virulence factor OspC, thereby highlighting a potential therapeutic strategy for MCL tumour patients with impaired learning and memory.",-72.5,0.8,diseaseorphenotypicfeature
"Tetrachlorophenol exposure in HeLa cells induces apoptosis and down‑regulates the oncogene TP53, which may contribute to the development of gastric ulcers in patients co‑infected with HIV and hepatitis B.",-49.25,0.8,diseaseorphenotypicfeature
"In the A549 cell line, exposure to doxorubicin induced acute lung injury‐like oxidative stress, upregulating TP53 and downregulating VEGFA, thereby exacerbating cramp‐associated muscle weakness observed in patients with spinal muscular atrophy.",-32.25,0.8,diseaseorphenotypicfeature
"In patients with spinal muscular atrophy, the loss of SMN1 gene function leads to motor neuron degeneration, causing progressive muscle cramps and skeletal fractures, and recent studies have linked these phenotypic features to alterations in the expression of the ALS protein, which may also contribute to acute lung injury in severe cases.",-50.75,0.8,diseaseorphenotypicfeature
"In a cohort of patients with acute lung injury, the administration of the anti‑inflammatory drug dexamethasone suppressed the up‑regulation of NF‑κB in alveolar macrophages, thereby reducing cytokine‑mediated vascular permeability and improving oxygenation scores.",-31.5,0.8,diseaseorphenotypicfeature
"In HLA‑DRB1*1501‑positive patients with experimental autoimmune encephalomyelitis, the administration of the small‑molecule inhibitor Ibudilast mitigated spinal muscular atrophy‑associated cramps, reduced acute lung injury markers, and improved liver injury scores while preserving color vision.",-42.25,0.8,diseaseorphenotypicfeature
"The CRISPR‑Cas9‑mediated knockout of the SMN1 gene in HeLa cells led to a pronounced increase in neuronal apoptosis, mirroring the muscle wasting and cramps observed in patients with spinal muscular atrophy.",-29.25,0.8,diseaseorphenotypicfeature
"The MYH7 c.1909C>T SequenceVariant in a patient with a history of myocardial ischemic injury and liver injury was found to worsen the cardiomyopathic phenotype, leading to increased arrhythmia risk in a Homo sapiens cohort.",-53.0,0.8,diseaseorphenotypicfeature
"The A549 cell line treated with doxorubicin exhibited dose‑dependent acute lung injury–like transcriptional signatures, including up‑regulation of CXCL10 and down‑regulation of surfactant protein C, paralleling observations in patients with severe cardiomyopathy and liver injury.",-46.0,0.8,diseaseorphenotypicfeature
"The HLA‑B*27:05 allele, found in the patient’s *Homo sapiens* genome, was linked to a severe exacerbation of EAE that led to acute lung injury and progressive insomnia.",-47.0,0.8,diseaseorphenotypicfeature
"Mutation of the SMN1 gene in spinal muscular atrophy patients leads to a progressive loss of motor neurons that ultimately causes muscle cramps, respiratory failure, and a higher susceptibility to acute lung injury and fractures.",-28.875,0.8,diseaseorphenotypicfeature
"Mutation in the SMN1 gene causes spinal muscular atrophy, leading to progressive muscle weakness and respiratory failure.",-16.625,0.8,diseaseorphenotypicfeature
"Mutation-driven dysregulation of the SMN1 gene in spinal muscular atrophy patients leads to progressive motor neuron degeneration, causing muscle cramps, loss of ambulation, and respiratory insufficiency that often culminates in acute lung injury during disease exacerbations.",-40.75,0.8,diseaseorphenotypicfeature
"Mutation c.115C>G in the SMN1 gene causes loss of SMN protein, leading to spinal muscular atrophy, which presents with progressive muscle cramps and loss of ambulation.",-37.75,0.8,diseaseorphenotypicfeature
"Acute lung injury in patients receiving doxorubicin was shown to be exacerbated by the loss‑of‑function variant BRCA1 c.68_69delAG, leading to heightened oxidative stress and increased mortality in Homo sapiens.",-32.0,0.8,diseaseorphenotypicfeature
"Acetaminophen overdose in a patient with acute liver injury induces a marked rise in the serum concentration of the hepatotoxic metabolite N‑acetyl‑p‑aminophenol, which in turn activates the Nrf2 pathway and leads to up‑regulation of glutathione‑S‑transferase and subsequent mitigation of oxidative stress and apoptosis in hepatocytes.",-62.5,0.8,diseaseorphenotypicfeature
"Acquired hepatocellular carcinoma in a patient with chronic hepatitis B and a BRCA1 c.68_69delAG sequence variant was found to correlate with an elevated serum AFP level, suggesting a link between DNA repair deficiency and tumor progression.",-44.0,0.8,diseaseorphenotypicfeature
"Acupuncture combined with low‑dose doxorubicin reduced the severity of acute lung injury in a rat model of EAE, as evidenced by lower IL‑6 levels and improved pulmonary compliance.",-39.25,0.8,diseaseorphenotypicfeature
"A missense variant in the SMN1 gene (c.271C>T) was detected in a patient presenting with progressive spinal muscular atrophy, where the degree of motor neuron loss correlated with the severity of limb cramps and respiratory failure.",-39.0,0.8,diseaseorphenotypicfeature
"A spinal muscular atrophy patient treated with the antisense oligonucleotide nusinersen showed reduced muscle cramps and improved motor neuron survival, while the drug’s delivery into the cerebrospinal fluid was monitored via PET imaging of the EAE mouse model.",-45.0,0.8,diseaseorphenotypicfeature
"A CRISPR/Cas9‑mediated knockout of the SMN1 gene in cultured human HeLa cells recapitulated the severe motor neuron degeneration and muscle cramps observed in spinal muscular atrophy patients, while simultaneous pharmacologic inhibition of the protein kinase CK2 partially rescued neuronal survival and reduced markers of acute lung injury in the same cell system.",-56.75,0.8,diseaseorphenotypicfeature
A gene‑editing CRISPR/Cas9 strategy that targets the SMN1 locus in human iPSC‑derived motor neurons from a spinal muscular atrophy patient successfully restored SMN protein levels and rescued the characteristic motor neuron degeneration phenotype.,-36.75,0.8,diseaseorphenotypicfeature
"An acute lung injury induced by doxorubicin in A549 cells triggers a rapid increase in TP53 expression, which in turn promotes apoptosis and exacerbates liver injury, thereby illustrating the interplay between drug toxicity and organ-specific damage.",-41.75,0.8,diseaseorphenotypicfeature
An mRNA‑splicing variant of the SMN1 gene (c.821A>G) in a patient with spinal muscular atrophy type II was found to correlate with the severity of lower‑limb cramps and a reduced response to nusinersen therapy.,-50.0,0.8,diseaseorphenotypicfeature
"An attenuated Listeria monocytogenes strain expressing the TLR9 agonist CpG oligodeoxynucleotide was shown to reduce disease severity in an EAE mouse model, as measured by decreased spinal cord demyelination and a concomitant decrease in pro‑inflammatory cytokine IL‑6 production.",-51.75,0.8,diseaseorphenotypicfeature
"An A549 cell line treated with the chemical entity doxycycline showed reduced expression of the TP53 gene product, correlating with decreased inflammatory cytokine levels and protection against acute lung injury in a mouse model of EAE.",-34.25,0.8,diseaseorphenotypicfeature
"Loss of SMN1 function in spinal muscular atrophy patients leads to motor neuron degeneration and muscle cramps, which can be exacerbated by the presence of a SMN2 c.859G>C sequence variant that reduces SMN protein expression.",-35.75,0.8,diseaseorphenotypicfeature
"Loss-of-function mutations in the ABCD1 gene associated with adrenoleukodystrophy trigger accumulation of very‑long‑chain fatty acids in the liver, causing hepatic steatosis that frequently precedes the onset of acute lung injury and respiratory failure in affected patients.",-45.25,0.8,diseaseorphenotypicfeature
"Loss‑of‑function mutations in the **ABCD1** gene cause **adrenoleukodystrophy**, where accumulated very‑long‑chain fatty acids trigger **acute lung injury** and **color vision defects** in affected **Homo sapiens** patients.",-32.25,0.8,diseaseorphenotypicfeature
"Lossing of SMN1 function in spinal muscular atrophy patients increases SMN2 exon‑7 skipping, which in turn elevates the proportion of truncated SMN protein that fails to assemble with Gemin5, ultimately causing motor neuron degeneration and progressive muscle cramps.",-59.0,0.8,diseaseorphenotypicfeature
"Myocyte apoptosis induced by doxorubicin contributes to myocardial ischemic injury in the A549 cell line, a finding that parallels the liver injury observed in patients with adrenoleukodystrophy.",-31.375,0.8,diseaseorphenotypicfeature
"Mycophenolate mofetil treatment of patients with acute lung injury and spinal muscular atrophy was associated with an increased risk of liver injury, as reflected by elevated alanine aminotransferase levels and a higher incidence of hepatic fibrosis.",-36.25,0.8,diseaseorphenotypicfeature
"Myocardial ischemic injury in patients with adrenoleukodystrophy was exacerbated by an elevated plasma concentration of doxorubicin, which induced oxidative stress and further damaged cardiac myocytes.",-34.0,0.8,diseaseorphenotypicfeature
"Mycobacterium tuberculosis infection in the lungs induces acute lung injury, leading to alveolar epithelial apoptosis and a secondary rise in the cytokine CXCL10 that promotes leukocyte recruitment and tissue remodeling.",-53.0,0.8,diseaseorphenotypicfeature
"EAE-induced spinal muscular atrophy in mice is aggravated by a loss‑of‑function mutation in the SOD1 gene, causing increased muscle cramps and impaired locomotor recovery.",-38.25,0.8,diseaseorphenotypicfeature
"Erythropoietin treatment in a patient with acute lung injury and myopathy accelerated recovery of red blood cell counts, yet the presence of a BRCA1 c.68_69delAG sequence variant in the same patient was associated with increased susceptibility to subsequent liver injury.",-56.0,0.8,diseaseorphenotypicfeature
"Efficacy of the small‑molecule inhibitor doxorubicin was reduced in the A549 cell line harboring the TP53 c.215_216delAG variant, thereby exacerbating acute lung injury and myocardial ischemic injury in a dose‑dependent manner.",-46.75,0.8,diseaseorphenotypicfeature
EAD patients with adrenoleukodystrophy who develop acute lung injury often exhibit heightened inflammatory cytokine profiles that worsen myocardial ischemic injury.,-40.75,0.8,diseaseorphenotypicfeature
"Spinal muscular atrophy in a male patient with a novel SMN1 c.1108_1110delTAA variant was associated with progressive upper‑limb cramps and increased serum creatine kinase levels, suggesting a genotype–phenotype correlation that may inform future gene‑replacement therapy.",-57.0,0.8,diseaseorphenotypicfeature
"Spreading of the pathogenic *EAE* lesions in the spinal cord of *SJL/J* mice was exacerbated by the chronic administration of *doxorubicin*, leading to an accelerated onset of muscle cramps and progressive paralysis, while simultaneous treatment with *ethanol* in the drinking water induced additional liver injury, thus underscoring the interaction between chemotherapy, neuroinflammation, and systemic toxicity.",-93.0,0.8,diseaseorphenotypicfeature
"Spontaneous apoptosis of HeLa cells treated with doxorubicin exacerbates liver injury in E. coli–infected mice, a phenomenon that correlates with increased expression of the TP53 gene and the BRCA1 c.68_69delAG variant.",-34.75,0.8,diseaseorphenotypicfeature
"Splicing of the SMN2 pre‑mRNA in patient‑derived fibroblasts carrying the c.840C>T sequence variant was found to rescue motor neuron function in a mouse model of spinal muscular atrophy, thereby reducing muscle cramps and improving locomotor performance.",-46.0,0.8,diseaseorphenotypicfeature
Mutational analysis of the SMN1 gene in patients with spinal muscular atrophy revealed that homozygous deletions correlate with earlier onset of motor neuron degeneration and a higher incidence of respiratory insufficiency.,-25.375,0.8,diseaseorphenotypicfeature
"Mutagenic exposure to ethanol in A549 cells carrying the BRCA1 c.68_69delAG variant accelerated apoptosis and increased the expression of p53, thereby enhancing susceptibility to acute lung injury in a murine EAE model.",-34.75,0.8,diseaseorphenotypicfeature
"Mutations in the SMN1 gene lead to spinal muscular atrophy, a neuromuscular disease characterized by progressive muscle weakness and cramps, which is exacerbated by inflammatory cytokine upregulation in the central nervous system.",-34.75,0.8,diseaseorphenotypicfeature
"Mutant SOD1 carrying the A4V variant in a patient-derived iPSC line causes motor neuron degeneration resembling spinal muscular atrophy, with increased oxidative stress and axonal transport defects in cultured motor neurons from the same line.",-54.75,0.8,diseaseorphenotypicfeature
"Patients with spinal muscular atrophy treated with the antisense oligonucleotide nusinersen showed reduced muscle cramps and improved motor function, while a subset developed transient liver injury that resolved after dose adjustment.",-20.25,0.8,diseaseorphenotypicfeature
"Patients treated with doxorubicin for acute lung injury exhibited accelerated liver injury and muscle cramps, with a higher incidence of the BRCA1 c.68_69delAG sequence variant in the EAE‑responsive immune cells of Homo sapiens donors.",-44.75,0.8,diseaseorphenotypicfeature
"Patients receiving high‑dose doxorubicin exhibited liver injury that correlated with increased plasma ALT levels, and in a subset carrying the BRCA1 c.68_69delAG variant, the hepatic toxicity was markedly amplified, suggesting a genotype‑specific susceptibility to drug‑induced hepatotoxicity.",-40.75,0.8,diseaseorphenotypicfeature
"Patients experiencing acute lung injury treated with the chemical entity methylprednisolone showed a statistically significant reduction in inflammatory cytokine levels, whereas those receiving the same dose without the drug exhibited persistent edema and impaired gas exchange.",-45.25,0.8,diseaseorphenotypicfeature
"Heterozygous loss‑of‑function mutations in the *DMD* gene, as seen in Becker muscular dystrophy, lead to progressive muscle cramps and spinal muscular atrophy‑like weakness, underscoring the gene’s crucial role in skeletal muscle integrity.",-43.75,0.8,diseaseorphenotypicfeature
"Homozygous mutations in the SMN1 gene cause spinal muscular atrophy, and the resulting motor neuron degeneration frequently leads to progressive muscle cramps and an increased risk of fractures.",-31.0,0.8,diseaseorphenotypicfeature
"Hearing loss and color vision defects, commonly observed in patients with adrenoleukodystrophy, are exacerbated by the accumulation of very‑long‑chain fatty acids in the central nervous system, as shown by elevated plasma globotriaosylceramide levels in a cohort of ten children diagnosed with the X‑linked disease.",-54.5,0.8,diseaseorphenotypicfeature
"Hepatic failure and acute lung injury in mice treated with doxorubicin were mitigated by the antioxidant N‑acetylcysteine, which also attenuated the inflammatory response and reduced the incidence of skeletal muscle cramps associated with the disease phenotype.",-52.5,0.8,diseaseorphenotypicfeature
"CRISPR‑Cas9 editing of the SMN1 gene in patient‑derived iPSC‑derived motor neurons recapitulated spinal muscular atrophy‑associated motor neuron death, while a small‑molecule SMN‑enhancer compound reduced neuronal apoptosis and improved neuromuscular junction integrity.",-40.0,0.8,diseaseorphenotypicfeature
"CRMP2 phosphorylation by GSK3β in spinal muscular atrophy‑derived fibroblasts accelerates neurite collapse, thereby exacerbating motor neuron degeneration and contributing to the progressive muscle weakness observed in patients.",-33.75,0.8,diseaseorphenotypicfeature
"CRF‑115 treatment of EAE‑induced spinal cord lesions in C57BL/6 mice reduced both neuroinflammatory cytokine production and the frequency of spontaneous muscle cramps, thereby ameliorating the motor deficits associated with acute spinal muscular atrophy.",-48.5,0.8,diseaseorphenotypicfeature
"CRAMPING in spinal muscular atrophy patients exacerbates acute lung injury and induces hepatotoxicity, suggesting a potential link between neuromuscular degeneration and organ-specific injury.",-41.5,0.8,diseaseorphenotypicfeature
"The ARF mutation causes dilated glomerular capillaries, leading to proteinuria that can trigger autoimmune disease and worsen cardiac and skeletal myopathies.",-17.625,0.8,diseaseorphenotypicfeature
"The autoimmune disease ARF triggers dilated glomerular capillaries, leading to a form of renal failure that may complicate subsequent cardiac and skeletal myopathies.",-29.375,0.8,diseaseorphenotypicfeature
The association of ARF with dilated glomerular capillaries and reduced ristocetin‑induced platelet aggregation suggests that this autoimmune disease may predispose patients to secondary cardiac and skeletal myopathies.,-25.0,0.8,diseaseorphenotypicfeature
"The clinical trial demonstrated that patients with ARF-associated dilated glomerular capillaries experienced significantly improved renal function after treatment with the novel small‑molecule inhibitor XYZ, which selectively blocks the pathogenic signaling pathway activated by the disease‑specific GeneOrGeneProduct KIR3DL1.",-56.0,0.8,diseaseorphenotypicfeature
ARF-associated dilated glomerular capillaries in children with autoimmune disease frequently lead to hypertension and subsequent coronary artery disease (CAD) through altered ristocetin‑induced platelet aggregation.,-31.125,0.8,diseaseorphenotypicfeature
"ARFT1 deficiency in a patient with idiopathic dilated glomerular capillaries and concomitant autoimmune disease was shown to increase ristocetin-induced platelet aggregation, thereby elevating the risk for thrombotic complications and contributing to the progression of cardiac and skeletal myopathies.",-53.25,0.8,diseaseorphenotypicfeature
"ARFRP1 mutations, which alter dilated glomerular capillaries, have been linked to autoimmune disease–associated proteinuria in patients with ARF‐positive chronic kidney disease.",-44.5,0.8,diseaseorphenotypicfeature
"ARFI imaging of dilated glomerular capillaries in patients with autoimmune disease revealed a strong correlation between increased renal perfusion and the presence of anti‑β2‑glycoprotein I antibodies, suggesting a potential biomarker for early lupus nephritis.",-42.0,0.8,diseaseorphenotypicfeature
"Alterations in the ARF signaling pathway have been linked to dilated glomerular capillaries and autoimmune disease, with RISTOCETIN‑induced platelet aggregation serving as a diagnostic marker in patients exhibiting both CAD and hematologic toxicity.",-33.75,0.8,diseaseorphenotypicfeature
Altered ARF signaling in dilated glomerular capillaries contributes to the progression of autoimmune disease‑associated renal failure in patients with systemic lupus erythematosus.,-17.875,0.8,diseaseorphenotypicfeature
"Alteration of the ARF gene in patients with autoimmune disease was found to impair ristocetin‑induced platelet aggregation, thereby exacerbating the risk of dilated glomerular capillaries and contributing to the development of nephrotic syndrome.",-30.875,0.8,diseaseorphenotypicfeature
"Alterative therapy with ARF‐derived peptides significantly reduced the frequency of ristocetin‑induced platelet aggregation in patients with autoimmune disease–associated thrombocytopenia, thereby attenuating the risk of CAD‑related microvascular complications.",-45.0,0.8,diseaseorphenotypicfeature
"In patients with ARF, the presence of dilated glomerular capillaries correlates with increased risk of autoimmune disease and CAD, while the addition of rituximab reduces ristocetin‑induced platelet aggregation and mitigates hematologic toxicity in ALL.",-33.0,0.8,diseaseorphenotypicfeature
"In ARF‑treated patients, the reduction of dilated glomerular capillaries correlates with improved cardiac and skeletal myopathies, suggesting a link between autoimmunity and cardiovascular complications.",-29.875,0.8,diseaseorphenotypicfeature
"In the ARF patient cohort, dilated glomerular capillaries were frequently observed, and the presence of a CAD mutation in the ONCogene gene was associated with increased ristocetin‑induced platelet aggregation and a heightened risk of hematologic toxicity.",-34.5,0.8,diseaseorphenotypicfeature
"In post‑polycythemia vera patients, the ARF oncogene variant c.1065G>A causes dilated glomerular capillaries and is strongly associated with autoimmune disease–related ristocetin‑induced platelet aggregation, thereby elevating the risk of cardiovascular complications such as coronary artery disease.",-55.75,0.8,diseaseorphenotypicfeature
"RISTOCETIN‑INDUCED platelet aggregation was significantly elevated in ARF patients, correlating with dilated glomerular capillaries and a higher incidence of cardiac and skeletal myopathies.",-22.375,0.8,diseaseorphenotypicfeature
"Rituximab treatment of patients with diffuse large B‑cell lymphoma (DLBCL) that harbor the ARF‑associated BCL6 translocation was accompanied by a marked reduction in circulating tumor cells and a significant decrease in the frequency of ritocetin‑induced platelet aggregation, suggesting an immunologic mechanism that mitigates autoimmune disease–related thrombotic complications.",-58.75,0.8,diseaseorphenotypicfeature
"Racial differences in the prevalence of ARF-associated dilated glomerular capillaries correlate with an increased risk of developing autoimmune disease and cardiac and skeletal myopathies, underscoring the need for early screening in patients presenting with dysregulated ristocetin‑induced platelet aggregation and concurrent ALL or carcinomas.",-51.25,0.8,diseaseorphenotypicfeature
"Rostral growth of ARF‑associated dilated glomerular capillaries in patients with autoimmune disease was mitigated by low‑dose aspirin, reducing ristocetin‑induced platelet aggregation and subsequent cardiac and skeletal myopathies.",-29.5,0.8,diseaseorphenotypicfeature
"dilated glomerular capillaries were observed in patients with autoimmune disease, and the presence of a sequence variant in the ARF gene correlated with increased risk of renal complications.",-25.125,0.8,diseaseorphenotypicfeature
"doxorubicin treatment of A549 cells carrying the BRCA1 c.68_69delAG variant induced a significant decrease in RISTOCETIN‑INDUCED platelet aggregation, suggesting a mechanistic link between the DNA repair defect and the onset of autoimmune‑driven cardiac and skeletal myopathies.",-46.75,0.8,diseaseorphenotypicfeature
dysregulation of ARF1 in endothelial cells is associated with dilated glomerular capillaries and worsened renal function in patients with autoimmune disease.,-29.375,0.8,diseaseorphenotypicfeature
diminished RISTOCETIN‑INDUCED PLATELET AGGREGATION in ARF patients with dilated glomerular capillaries is associated with an increased risk of developing CAD and autoimmune disease.,-28.375,0.8,diseaseorphenotypicfeature
"Deficiency of ARF protein leads to dilated glomerular capillaries, a hallmark of the autoimmune disease that underlies the development of CAD in patients with ALL.",-32.75,0.8,diseaseorphenotypicfeature
"Defective ARF signaling in dilated glomerular capillaries exacerbates renal fibrosis, linking this histopathological change to the progression of autoimmune disease and increasing the risk of cardiac and skeletal myopathies.",-32.25,0.8,diseaseorphenotypicfeature
"Defibrination of the platelet surface by ARF‐associated protein leads to ristocetin‑induced platelet aggregation, a hallmark of autoimmune disease that predisposes patients with dilated glomerular capillaries to further renal complications.",-50.5,0.8,diseaseorphenotypicfeature
"Definitive immunophenotyping of ARF patients revealed dilated glomerular capillaries, a hallmark of autoimmune disease that correlates with increased risk of CAD and ristocetin‑induced platelet aggregation.",-37.5,0.8,diseaseorphenotypicfeature
Pediatric patients with ARF exhibiting dilated glomerular capillaries and abnormal ristocetin‑induced platelet aggregation demonstrated an increased incidence of autoimmune disease‑associated cardiomyopathy.,-28.0,0.8,diseaseorphenotypicfeature
P53 mutations in the ARF promoter region of HeLa cells were shown to suppress dilated glomerular capillaries and reduce ritocetin‑induced platelet aggregation in a model of autoimmune disease.,-36.0,0.8,diseaseorphenotypicfeature
"Pneumococcal meningitis in a child with an ARF-associated platelet dysfunction, characterized by impaired ristocetin‑induced platelet aggregation, was treated successfully with ceftriaxone, resulting in rapid recovery of neurologic function.",-46.0,0.8,diseaseorphenotypicfeature
"P2RY12 mutations in leukocytes of patients with autoimmune disease were found to enhance ristocetin‑induced platelet aggregation, suggesting a potential mechanism for the increased thrombotic risk observed in these individuals.",-41.25,0.8,diseaseorphenotypicfeature
"A patient with autoimmune disease showed dilated glomerular capillaries and impaired ristocetin‑induced platelet aggregation, suggesting a potential link between ARF signaling and the observed hematologic toxicity.",-23.375,0.8,diseaseorphenotypicfeature
"A single nucleotide polymorphism in the ARF gene has been associated with dilated glomerular capillaries, and this variant correlates with increased risk of cardiac and skeletal myopathies in patients with autoimmune disease.",-29.625,0.8,diseaseorphenotypicfeature
A recent cohort study revealed that patients with ARF presenting dilated glomerular capillaries exhibited a significantly higher incidence of CAD compared with those with non‑dilated capillaries.,-31.5,0.8,diseaseorphenotypicfeature
A mutation in the ARF gene causing dilated glomerular capillaries is associated with an increased risk of autoimmune disease and can predispose patients to develop cardiac and skeletal myopathies.,-26.0,0.8,diseaseorphenotypicfeature
"Patients with autoimmune disease exhibiting dilated glomerular capillaries often show increased ARF expression, correlating with reduced ristocetin-induced platelet aggregation and higher risk of developing cardiovascular complications.",-28.0,0.8,diseaseorphenotypicfeature
"Patients diagnosed with autoimmune disease and CAD exhibited dilated glomerular capillaries and a marked decrease in ristocetin‑induced platelet aggregation, suggesting a shared pathogenic mechanism underlying their cardiovascular complications.",-36.0,0.8,diseaseorphenotypicfeature
"Patients treated with the ARF‑blocking agent exhibited dilated glomerular capillaries and increased ristocetin‑induced platelet aggregation, linking the drug’s cardiotoxicity to an autoimmune‑mediated renal vascular phenotype.",-34.25,0.8,diseaseorphenotypicfeature
"Patients lacking functional ARF exhibit dilated glomerular capillaries that mimic features of autoimmune disease, thereby increasing susceptibility to ritocetin‑induced platelet aggregation and subsequent risk of cardiac and skeletal myopathies.",-35.0,0.8,diseaseorphenotypicfeature
"Autoimmune disease is frequently associated with dilated glomerular capillaries, and in patients with ARF the severity of CAD correlates with the extent of ristocetin‑induced platelet aggregation.",-25.25,0.8,diseaseorphenotypicfeature
Autoantibody-mediated inhibition of ARF activity in autoimmune disease patients with dilated glomerular capillaries is associated with a higher risk of developing cardiac and skeletal myopathies.,-25.875,0.8,diseaseorphenotypicfeature
Autozygosity mapping of ARF in patients with dilated glomerular capillaries and CAD revealed a novel pathogenic sequence variant that exacerbates autoimmune disease and predicts ritocetin‑induced platelet aggregation.,-38.25,0.8,diseaseorphenotypicfeature
Autoimmunity-driven activation of ARF in dilated glomerular capillaries correlates with increased risk of cardiac and skeletal myopathies and diarrheas in patients with renal disease.,-31.875,0.8,diseaseorphenotypicfeature
"Dilated glomerular capillaries in patients with autoimmune disease can be exacerbated by ARF, and the resulting renal dysfunction may trigger CAD and cardiac and skeletal myopathies, while ristocetin‑induced platelet aggregation can worsen hematologic toxicity in those with ALL.Oncogene‑positive carcinomas.",-54.0,0.8,diseaseorphenotypicfeature
"Dilative glomerular capillaries in patients with autoimmune disease were shown to impair ristocetin‑induced platelet aggregation, correlating with increased risk of cardiovascular complications.",-38.5,0.8,diseaseorphenotypicfeature
"Diluted glomerular capillaries in ARF patients often trigger abnormal ristocetin-induced platelet aggregation, which may aggravate cardiac and skeletal myopathies and increase the risk of autoimmune disease complications.",-43.5,0.8,diseaseorphenotypicfeature
"Dilating glomerular capillaries in patients with autoimmune disease often correlate with increased cardiac and skeletal myopathies, while ARF expression in renal carcinomas appears to enhance ritocetin‑induced platelet aggregation and potentially trigger acute lymphoblastic leukemia (ALL).",-62.75,0.8,diseaseorphenotypicfeature
"Astrocytoma-associated ARF in patients with dilated glomerular capillaries and CAD was markedly reduced by rituximab, indicating that the drug’s immune modulation suppresses autoimmune disease‑driven platelet aggregation and alleviates both cardiac and skeletal myopathies.",-52.25,0.8,diseaseorphenotypicfeature
"Asthma, an autoimmune disease characterized by airway hyperresponsiveness, is exacerbated by ARF-mediated inflammation, leading to dilated glomerular capillaries and increased susceptibility to rituximab-induced platelet aggregation.",-35.0,0.8,diseaseorphenotypicfeature
"Asthmatic patients with an ARF‑associated mutation in the *TP53* gene exhibit markedly dilated glomerular capillaries, leading to proteinuria and a heightened risk of developing secondary renal carcinoma.",-41.25,0.8,diseaseorphenotypicfeature
Astemizole treatment of A549 cells overexpressing the ARF oncogene reduced dilated glomerular capillaries and improved cardiac and skeletal myopathies while mitigating ritocetin‑induced platelet aggregation in a mouse model of autoimmune disease.,-39.25,0.8,diseaseorphenotypicfeature
"Mutations in the ARF gene have been linked to autoimmune disease and to the appearance of dilated glomerular capillaries, which in turn increase the risk of developing chronic kidney disease.",-27.25,0.8,diseaseorphenotypicfeature
Mutational loss of ARF in A549 cells increases dilated glomerular capillaries and enhances sensitivity to doxorubicin‑induced cardiac and skeletal myopathies.,-21.875,0.8,diseaseorphenotypicfeature
"Mutant ARF expression in HeLa cells accelerates dilated glomerular capillaries, a phenotype linked to autoimmune disease and CAD, while concomitant treatment with doxorubicin reduces ristocetin‑induced platelet aggregation, mitigating hematologic toxicity.",-41.75,0.8,diseaseorphenotypicfeature
"Mutagenic exposure to the chemotherapy drug doxorubicin induces dilated glomerular capillaries in A549 cells, leading to nephrotoxicity that may progress to acute renal failure in patients with ARF.",-37.5,0.8,diseaseorphenotypicfeature
"The left‑sided callosal lesion observed in the NAH patient with thoracic aortic aneurysm was accompanied by calcium deposition in the ascending aorta, suggesting a systemic vascular calcification phenotype linked to the underlying disease.",-36.0,0.8,diseaseorphenotypicfeature
The identification of a BRCA1 c.68_69delAG SequenceVariant in a patient with a thoracic aortic aneurysm led to the recommendation of lifelong surveillance with serial echocardiography and prophylactic beta‑blocker therapy to mitigate the risk of rupture.,-37.75,0.8,diseaseorphenotypicfeature
The presence of a callosal lesion in a patient with NAH and a history of adrenal incidentalomas suggests a shared underlying neurovascular pathology that may predispose to thoracic aortic aneurysm and subsequent coronary artery disease.,-24.75,0.8,diseaseorphenotypicfeature
The expansion of a pseudogout-associated callosal lesion in a patient with thoracic aortic aneurysm was found to correlate with increased serum urate and may predict future calcification of the ascending aorta.,-36.75,0.8,diseaseorphenotypicfeature
"Adrenal incidentalomas in patients with NAH were associated with increased serum aldosterone levels, leading to hypertension and subsequent development of coronary artery disease.",-19.75,0.8,diseaseorphenotypicfeature
"Adventitious calcification of the ascending aorta, frequently seen in patients with coronary artery disease, correlates with increased severity of thoracic aortic aneurysm and may predispose to acute aortic dissection.",-38.5,0.8,diseaseorphenotypicfeature
"Adrenocortical hyperplasia (NAH) frequently co‑occurs with adrenal incidentalomas, and its somatic TP53 mutations can drive both pseudogout‑associated calcium deposition in the ascending aorta and the development of thoracic aortic aneurysm in affected patients.",-37.5,0.8,diseaseorphenotypicfeature
"Adhesive NAH caused calcification of the ascending aorta, prompting evaluation of thoracic aortic aneurysm risk in patients with a history of coronary artery disease.",-33.75,0.8,diseaseorphenotypicfeature
"Aneurysmal calcification of the ascending aorta was observed in a patient with a thoracic aortic aneurysm, and the presence of a callosal lesion suggested a possible underlying neurodegenerative disease.",-26.25,0.8,diseaseorphenotypicfeature
"A biopsy of the thoracic aortic aneurysm revealed calcification of the ascending aorta, a feature that has been linked to coronary artery disease in patients with adrenal incidentalomas.",-21.5,0.8,diseaseorphenotypicfeature
"A trans‑abdominal MRI of a patient with a left‑sided calcification of the ascending aorta revealed a subtle callosal lesion that, on histopathological review, was consistent with a pseudogout‑associated calcium‑pyrophosphate deposition disease exacerbating pre‑existing coronary artery disease.",-54.0,0.8,diseaseorphenotypicfeature
A patient with a thoracic aortic aneurysm and a calcification of the ascending aorta was found to harbor a BRCA1 c.68_69delAG sequence variant that likely predisposes to vascular fragility and increased risk of sudden cardiac death.,-30.0,0.8,diseaseorphenotypicfeature
"Pseudogout in patients with calcification of ascending aorta is frequently accompanied by an elevated serum uric acid level, suggesting that hyperuricosuria may trigger monosodium urate crystal deposition in the joint cartilage of the knee and ankle.",-36.75,0.8,diseaseorphenotypicfeature
"Pheochromocytoma associated with adrenal incidentalomas often presents with episodic hypertension and, in some cases, calcification of the ascending aorta can be observed, complicating the clinical assessment of thoracic aortic aneurysm risk.",-41.0,0.8,diseaseorphenotypicfeature
PAX6 mutations causing cortical callosal lesions in patients with neurodevelopmental disorders are frequently associated with abnormal bone mineralization and a predisposition to pseudogout in the joints.,-52.0,0.8,diseaseorphenotypicfeature
"Pediatric patients with NAH and concurrent adrenal incidentalomas exhibit a higher prevalence of thoracic aortic aneurysm, suggesting a shared pathogenic mechanism involving calcification of the ascending aorta.",-24.5,0.8,diseaseorphenotypicfeature
"In patients with thoracic aortic aneurysm, calcification of the ascending aorta was associated with a higher prevalence of coronary artery disease and frequent episodes of pseudogout, suggesting that systemic inflammation may drive both vascular calcification and crystal arthropathy.",-29.375,0.8,diseaseorphenotypicfeature
"In a cohort of patients with thoracic aortic aneurysm, the presence of calcification of the ascending aorta was significantly associated with increased incidence of coronary artery disease and a higher risk of developing pseudogout.",-22.75,0.8,diseaseorphenotypicfeature
"In *Homo sapiens* patients with coronary artery disease, a novel sequence variant c.1523C>T in the *TP53* gene was associated with increased levels of LDL‑cholesterol and a higher prevalence of thoracic aortic aneurysm, suggesting a potential pathogenic link between the mutation, lipid metabolism, and vascular complications.",-59.25,0.8,diseaseorphenotypicfeature
"In NAH patients, a thoracic aortic aneurysm frequently co‑occurs with calcification of the ascending aorta, and the presence of a callosal lesion on MRI predicts a higher risk of subsequent vascular events.",-29.625,0.8,diseaseorphenotypicfeature
"Dopamine agonist therapy in patients with dystonia-causing GCH1 mutations frequently exacerbated pseudogout flares, as evidenced by increased joint effusion and elevated serum calcium levels.",-32.75,0.8,diseaseorphenotypicfeature
"Dysautonomia and chronic fatigue in patients with NAH were found to be associated with a subtle elevation of serum calcitonin and an increased prevalence of coronary artery disease, suggesting a shared neuro‑endocrine‑cardiovascular pathophysiology.",-52.5,0.8,diseaseorphenotypicfeature
"Doxorubicin treatment of HeLa cells carrying the BRCA1 c.68_69delAG sequence variant resulted in increased DNA damage signaling, which correlated with higher apoptosis rates compared to wild‑type cells, suggesting a potential therapeutic vulnerability in breast cancer.",-38.0,0.8,diseaseorphenotypicfeature
"Dizziness in patients with NAH is frequently accompanied by adrenal incidentalomas, and the presence of a callosal lesion on MRI is associated with a higher likelihood of pseudogout relapse.",-36.75,0.8,diseaseorphenotypicfeature
"Calcification of the ascending aorta, frequently detected in patients with coronary artery disease, is associated with increased stiffness and contributes to the development of thoracic aortic aneurysm in individuals who also exhibit a pseudogout flare.",-34.0,0.8,diseaseorphenotypicfeature
"Calcified nodules in the ascending aorta were identified in a cohort of patients with thoracic aortic aneurysm, and the presence of the BRCA1 c.68_69delAG variant in the affected individuals correlated with increased susceptibility to coronary artery disease.",-37.25,0.8,diseaseorphenotypicfeature
Calcifications of the ascending aorta in patients with thoracic aortic aneurysm and coronary artery disease are frequently detected by CT and are associated with increased cardiovascular risk.,-26.375,0.8,diseaseorphenotypicfeature
"Calcific sclerosis of the ascending aorta was observed in a cohort of patients with coronary artery disease, and the extent of calcification correlated with the severity of thoracic aortic aneurysm in those with concomitant pseudogout.",-39.25,0.8,diseaseorphenotypicfeature
Patients with NAH who harbor a BRCA1 c.68_69delAG SequenceVariant in the TP53 GeneOrGeneProduct exhibit an increased risk of developing a thoracic aortic aneurysm and coronary artery disease.,-24.5,0.8,diseaseorphenotypicfeature
"Patients diagnosed with NAH and presenting with adrenal incidentalomas frequently exhibit concomitant calcification of the ascending aorta, underscoring a shared vascular remodeling pathway.",-29.0,0.8,diseaseorphenotypicfeature
"Patients afflicted with NAH and a calcification of the ascending aorta exhibited a higher incidence of coronary artery disease, as suggested by the correlation between the aortic calcification extent and the severity of the coronary lesions.",-47.0,0.8,diseaseorphenotypicfeature
"Patients presenting with adrenal incidentalomas, a diseaseorphenotypicfeature associated with hypertension, frequently have incidental findings of calcification of ascending aorta, which can be detected by CT imaging of the thoracic aorta and may indicate underlying coronary artery disease.",-53.5,0.8,diseaseorphenotypicfeature
"Inflammatory pseudogout, a crystal‑induced joint disease, frequently co‑occurs with calcium pyrophosphate deposition in the knee and can trigger a systemic fever that mimics acute rheumatic fever in patients with underlying coronary artery disease.",-39.5,0.8,diseaseorphenotypicfeature
"Influenza‑associated pneumonia in a patient with coronary artery disease and a calcification of ascending aorta was found to trigger acute adrenal incidentalomas, prompting further evaluation for potential NAH.",-44.5,0.8,diseaseorphenotypicfeature
Infliximab therapy for patients with NAH and concurrent coronary artery disease reduced inflammatory cytokine levels and improved histopathologic healing of the callosal lesion while preserving renal function.,-45.5,0.8,diseaseorphenotypicfeature
Inflammasome activation by the NLRP3 variant rs35829419 in patients with coronary artery disease correlates with increased interleukin‑1β release and a higher prevalence of dystonia‑causing mutations in the ATP13A2 gene.,-43.75,0.8,diseaseorphenotypicfeature
"Autopsy of a patient with NAH revealed a callosal lesion and calcification of the ascending aorta, suggesting a possible link to coronary artery disease.",-17.875,0.8,diseaseorphenotypicfeature
"Autumn’s biopsy of a thoracic aortic aneurysm revealed calcification of the ascending aorta and a callosal lesion, while genetic testing identified a BRCA1 c.68_69delAG variant in a patient with a history of adrenal incidentalomas.",-45.5,0.8,diseaseorphenotypicfeature
"Autosomal recessive dystonia‐causing mutations in the GCH1 gene were shown to trigger elevated homocysteine levels in patients with Parkinson’s disease, while CRISPR‑Cas9 editing of the variant in human embryonic stem cell‑derived dopaminergic neurons restored normal dopamine synthesis and rescued the dystonic phenotype.",-59.75,0.8,diseaseorphenotypicfeature
"Autonomic dysfunction in patients with non‑alcoholic hepatitis (NAH) is associated with subtle calcification of the ascending aorta, suggesting a shared vascular inflammatory pathway.",-32.5,0.8,diseaseorphenotypicfeature
"Acute exacerbation of thoracic aortic aneurysm in a patient with NAH is associated with calcium deposition in the ascending aorta, which can be detected by CT imaging and may indicate an increased risk of rupture.",-42.0,0.8,diseaseorphenotypicfeature
"Acrocarcinoma of the left lung was diagnosed in a patient presenting with a callosal lesion, calcification of the ascending aorta, and a history of coronary artery disease, and the tumor’s genetic profile revealed a BRCA1 c.68_69delAG sequence variant that was predicted to disrupt DNA repair pathways.",-58.0,0.8,diseaseorphenotypicfeature
"Acromegaly, a diseaseorphenotypicfeature, is frequently complicated by pseudogout in patients who also exhibit calcification of ascending aorta and thoracic aortic aneurysm, thereby linking endocrine, joint, and cardiovascular manifestations.",-46.25,0.8,diseaseorphenotypicfeature
"Acetaminophen‐induced hepatotoxicity in NAH patients is exacerbated by a CYP2E1 c.1425C>T variant, leading to increased oxidative stress and downstream activation of the NF‑κB pathway.",-46.25,0.8,diseaseorphenotypicfeature
Altered serum levels of the cytokine IL‑6 in patients with NAH and coronary artery disease correlate with the presence of calcification of the ascending aorta and a history of adrenal incidentalomas.,-30.375,0.8,diseaseorphenotypicfeature
"Alterations in the GATA6 promoter were identified in a patient with a calcification of the ascending aorta, and the same variant was also observed in a cohort of individuals with coronary artery disease and thoracic aortic aneurysm.",-41.0,0.8,diseaseorphenotypicfeature
"Alteration of TP53 in A549 cells, induced by doxorubicin exposure, leads to increased apoptotic signaling and contributes to the development of lung disease in patients with thoracic aortic aneurysm.",-34.5,0.8,diseaseorphenotypicfeature
Alterative therapy with the small molecule roscovitine reduced the severity of dystonia in a patient with a pathogenic SNV in the GCH1 gene and improved dopamine synthesis in cultured HeLa cells.,-52.0,0.8,diseaseorphenotypicfeature
"Mutations in the CYP2D6 gene variant *c.1003C>T* have been found to impair tamoxifen metabolism in breast cancer patients, thereby increasing the risk of therapeutic failure in individuals carrying the *NAH* phenotype and concomitant adrenal incidentalomas.",-52.75,0.8,diseaseorphenotypicfeature
"Mutational analysis of the *HNF1B* gene in a patient with NAH revealed a c.1762_1764delAAG sequence variant that coincided with the patient’s adrenal incidentalomas and a mild callosal lesion, suggesting a pathogenic link between the variant, endocrine dysfunction, and central nervous system abnormalities.",-59.5,0.8,diseaseorphenotypicfeature
"Mutated KRAS in A549 cells induces an inflammatory phenotype characterized by increased secretion of IL‑6, which is associated with the development of lung disease in patients carrying the same variant.",-38.5,0.8,diseaseorphenotypicfeature
"Mutagenic exposure to doxorubicin in HeLa cells induces TP53‑mediated apoptosis, which is exacerbated in patients with a BRCA1 c.68_69delAG variant and correlates with increased risk of coronary artery disease.",-31.75,0.8,diseaseorphenotypicfeature
"Bone tumor cells from the HCT116 cell line were found to express elevated levels of the calcium‑binding protein S100B, a biomarker that correlates with pseudogout flares in patients with coronary artery disease.",-41.25,0.8,diseaseorphenotypicfeature
Bone tumors such as osteosarcoma can present with calcification of the ascending aorta and may be associated with coronary artery disease in patients with adrenal incidentalomas.,-26.625,0.8,diseaseorphenotypicfeature
"Bone tumours in patients with adrenal incidentalomas are frequently associated with pseudogout in the calcification of the ascending aorta, and this phenotype often precedes the development of a callosal lesion that can aggravate lung disease and thoracic aortic aneurysm in individuals with NAH.",-59.25,0.8,diseaseorphenotypicfeature
"Bone‑tumor‐associated pseudogout in a patient with NAH, whose adrenal incidentalomas and calcification of the ascending aorta were linked to an underlying coronary artery disease phenotype.",-35.0,0.8,diseaseorphenotypicfeature
"The development of metastatic SMV thrombosis in patients receiving high‑dose doxorubicin was correlated with an increased incidence of drug‑induced renal injury and hyperprolactinemia, suggesting a multifactorial pathogenic mechanism.",-27.375,0.8,diseaseorphenotypicfeature
"The chemotherapeutic agent doxorubicin induced renal injury in A549 cells, a cell line derived from human lung carcinoma, where the up‑regulation of TP53 expression was correlated with the severity of the drug toxicity.",-33.75,0.8,diseaseorphenotypicfeature
"The metastatic melanoma cells from a patient with hyperprolactinemia exhibited enhanced PD‑L1 expression, a phenotype that was further amplified by the presence of the BRAF V600E SequenceVariant.",-37.75,0.8,diseaseorphenotypicfeature
The presence of a BRCA1 c.68_69delAG sequence variant in the TP53 gene in a patient with metastatic breast carcinoma and hyperprolactinemia suggests a synergistic effect on tumorigenesis and endocrine dysregulation in Homo sapiens.,-28.125,0.8,diseaseorphenotypicfeature
"In patients with SMV thrombosis, the administration of low‑molecular‑weight heparin reduced the risk of subsequent metastasis while simultaneously lowering serum prolactin levels and preventing drug‑induced renal injury.",-20.125,0.8,diseaseorphenotypicfeature
"In K562 cells, the KRAS G12D mutation induces tumorigenesis through enhanced ERK signaling, which correlates with the hyperprolactinemia observed in patients with pituitary adenomas and exacerbates drug toxicity of the chemotherapeutic agent doxorubicin.",-46.5,0.8,diseaseorphenotypicfeature
"In vitro exposure of A549 cells to doxorubicin induced DNA double‑strand breaks and up‑regulated TP53, a change that is associated with the development of chemotherapy‑induced renal injury in patients with metastatic disease.",-38.5,0.8,diseaseorphenotypicfeature
"In an analysis of patients with metastatic colorectal carcinoma, elevated serum prolactin levels were found to correlate with hyperprolactinemia-induced renal injury, suggesting that tumor-derived prolactin may contribute to drug‑induced nephrotoxicity in these patients.",-40.5,0.8,diseaseorphenotypicfeature
"Metastasis to the liver in patients with hyperprolactinemia was accelerated by drug toxicity from cyclophosphamide, leading to renal injury and exacerbating tumorigenesis in a cohort of E. coli–contaminated tumor biopsies.",-42.75,0.8,diseaseorphenotypicfeature
"Metformin reduces SMV thrombosis risk in patients with type‑2 diabetes by inhibiting platelet aggregation and improving endothelial function, thereby lowering the incidence of metastatic pancreatic ductal adenocarcinoma.",-32.75,0.8,diseaseorphenotypicfeature
"Metreleptin therapy ameliorated hyperprolactinemia in a cohort of patients with syndromic orofacial cleft, while an unexpected rise in SMV thrombosis incidence was observed in those also receiving cisplatin, suggesting a drug‑toxicity mediated interaction affecting vascular endothelial function.",-54.0,0.8,diseaseorphenotypicfeature
"Metabolic‑associated venous thrombosis in patients with hyperprolactinemia is frequently accompanied by renal injury, indicating that drug toxicity and tumorigenesis may be interrelated causes of the observed SMV thrombosis and metastatic progression.",-46.75,0.8,diseaseorphenotypicfeature
"SIRT1 inhibition in A549 cells enhances metastasis of lung adenocarcinoma by upregulating VEGF‑A, while a concurrent BRCA1 c.68_69delAG variant confers heightened sensitivity to doxorubicin‑induced renal injury.",-43.25,0.8,diseaseorphenotypicfeature
"SARS‑CoV‑2 infection has been shown to precipitate drug‑induced renal injury in patients receiving remdesivir, as evidenced by a rise in serum creatinine and the appearance of proteinuria, while concurrent hyperprolactinemia may exacerbate the risk of metastatic tumorigenesis in pituitary adenoma‑bearing individuals.",-45.0,0.8,diseaseorphenotypicfeature
"Surgical resection of a pancreatic endocrine adenoma in a patient with hyperprolactinemia unexpectedly revealed a BRCA1 c.68_69delAG variant, correlating with an increased risk of tumorigenesis and renal injury, and prompting investigation of potential drug toxicity from adjuvant chemotherapy.",-38.75,0.8,diseaseorphenotypicfeature
"Sustained activation of the VEGFA gene product in HeLa cells treated with doxorubicin induces hyperprolactinemia and promotes tumorigenesis through upregulation of the PI3K‑AKT signaling pathway, while the BRCA1 c.68_69delAG sequence variant reduces DNA repair capacity, exacerbating drug toxicity and renal injury in the host organism.",-50.25,0.8,diseaseorphenotypicfeature
"Hyperprolactinemia induced by dopamine antagonist therapy in a patient with metastatic colorectal cancer led to tumorigenesis of pituitary adenoma, which subsequently caused renal injury and restless legs syndrome.",-28.375,0.8,diseaseorphenotypicfeature
"Hyperproteinemia in patients with pituitary adenomas frequently triggers restless legs syndrome through dopamine receptor down‑regulation, thereby exacerbating tumorigenesis and increasing the risk of renal injury from drug‑induced toxicity.",-43.25,0.8,diseaseorphenotypicfeature
"Hyperactive EGFR signaling in HeLa cells carrying the TP53 R175H variant promotes tumorigenesis, while treatment with the EGFR inhibitor gefitinib reduces SMV thrombosis risk in patients with metastatic colorectal cancer.",-35.5,0.8,diseaseorphenotypicfeature
"Hypertriglyceridemia induced by chronic doxorubicin exposure in the A549 cell line was found to upregulate CYP3A4 expression, thereby accelerating drug metabolism and exacerbating renal injury in patients with nephrotoxic chemotherapy regimens.",-46.75,0.8,diseaseorphenotypicfeature
"Patients treated with doxorubicin experienced SMV thrombosis, and the concurrent hyperprolactinemia was linked to drug toxicity and increased tumorigenesis risk in a cohort of female breast cancer patients.",-38.5,0.8,diseaseorphenotypicfeature
"Patients with metastatic renal cell carcinoma receiving everolimus exhibited a significant reduction in SMV thrombosis incidence, suggesting that mTOR inhibition mitigates venous thromboembolism risk in advanced disease.",-31.625,0.8,diseaseorphenotypicfeature
"Patients presenting with SMV thrombosis often exhibit hyperprolactinemia, which can aggravate drug toxicity and contribute to the development of renal injury in the setting of enteropancreatic endocrine and pituitary adenomas.",-32.75,0.8,diseaseorphenotypicfeature
"Patients receiving doxorubicin for metastatic breast cancer in the A549 cell line displayed drug‑induced renal injury that was exacerbated by a BRCA1 c.68_69delAG variant, correlating with elevated plasma prolactin levels and increased risk of status epilepticus.",-43.75,0.8,diseaseorphenotypicfeature
"Repeated exposure to doxorubicin in the A549 cell line induced DNA double‑strand breaks that upregulated p53, thereby enhancing apoptosis and reducing metastatic potential in a model of SMV thrombosis‑related tumorigenesis.",-39.5,0.8,diseaseorphenotypicfeature
"Repeated SMV thrombosis in a patient with metastatic breast carcinoma was associated with hyperprolactinemia, leading to drug‑induced renal injury and exacerbation of restless legs syndrome.",-27.0,0.8,diseaseorphenotypicfeature
"Repeated in vivo exposure to doxorubicin (DOX) induces renal injury in A549 cells by up‑regulating the TP53‑mediated apoptotic pathway, which in turn promotes metastatic progression of the tumorigenic phenotype.",-45.5,0.8,diseaseorphenotypicfeature
"Repeatedly, the SMV thrombosis observed in patients with enteropancreatic endocrine and pituitary adenomas was found to accelerate tumorigenesis and trigger a hyperprolactinemia-driven metastatic cascade, thereby complicating drug toxicity management.",-41.75,0.8,diseaseorphenotypicfeature
"Aberrant activation of the TP53 pathway in A549 cells exposed to doxorubicin exacerbates SMV thrombosis by upregulating VEGF, thereby linking tumorigenesis and drug toxicity.",-29.625,0.8,diseaseorphenotypicfeature
"Aberrations in the TP53 gene and overexpression of the C-MYC oncogene synergistically promote tumorigenesis in HeLa cells, leading to increased metastatic potential, whereas treatment with the small molecule doxorubicin induces apoptosis through DNA damage but also triggers drug‑induced renal injury and hyperprolactinemia in a dose‑dependent manner.",-65.5,0.8,diseaseorphenotypicfeature
"Aberration of the TP53 gene in the HeLa cell line, driven by a BRCA1 c.68_69delAG sequence variant, was found to increase susceptibility to drug toxicity and renal injury in patients with hyperprolactinemia and metastatic SMV thrombosis.",-46.25,0.8,diseaseorphenotypicfeature
Abernathy et al. reported that the BRCA1 c.68_69delAG sequence variant in a cohort of women with a syndromic orofacial cleft was associated with an increased risk of tumorigenesis and a higher incidence of renal injury due to drug toxicity from chemotherapeutic agents.,-48.0,0.8,diseaseorphenotypicfeature
"A retrospective cohort of patients with SMV thrombosis who received low‑molecular‑weight heparin exhibited a significant reduction in subsequent portal hypertension and hepatic dysfunction, underscoring the drug toxicity risk when anticoagulant therapy is omitted.",-36.75,0.8,diseaseorphenotypicfeature
"A single‑dose of doxorubicin caused renal injury in A549 cells, which was accompanied by hyperprolactinemia and increased expression of the tumorigenesis‑related gene TP53, suggesting that drug toxicity may contribute to SMV thrombosis and metastatic progression.",-42.5,0.8,diseaseorphenotypicfeature
"A clinical trial demonstrated that the administration of the BET inhibitor JQ1 to A549 cells expressing mutant TP53 significantly reduced SMV thrombosis markers, while concomitant elevation of prolactin levels suggested a potential link between hyperprolactinemia and drug toxicity in this tumorigenesis model.",-47.0,0.8,diseaseorphenotypicfeature
"A patient with SMV thrombosis treated with anticoagulation exhibited a transient rise in serum prolactin, suggesting a possible link between drug toxicity and hyperprolactinemia.",-23.0,0.8,diseaseorphenotypicfeature
"SMV thrombosis and metastatic spread were observed in a patient with hyperprolactinemia after chronic exposure to the chemotherapeutic drug doxorubicin, resulting in renal injury and tumorigenesis.",-25.5,0.8,diseaseorphenotypicfeature
"SMC1A deficiency in HeLa cells enhances metastatic capacity through hyperprolactinemia‑induced activation of the PI3K/Akt pathway, thereby promoting tumorigenesis.",-36.25,0.8,diseaseorphenotypicfeature
"SM-1, a synthetic SMV thrombosis inhibitor, markedly reduced metastatic spread in A549 cells while sparing renal injury and minimizing drug toxicity in Xenopus laevis.",-43.25,0.8,diseaseorphenotypicfeature
"SMAD4 loss-of-function mutations in pancreatic ductal adenocarcinoma cells enhance metastatic invasion, trigger hyperprolactinemia in a xenograft mouse model, and potentiate drug‑induced renal injury through altered transporter expression.",-47.25,0.8,diseaseorphenotypicfeature
"Hypertension, renal injury, and drug toxicity were observed in patients with SMV thrombosis, illustrating the multi‑organ impact of this severe vascular complication.",-30.25,0.8,diseaseorphenotypicfeature
"Hypertrophic cardiomyopathy in patients with the MYBPC3 c.2516G>A variant is exacerbated by hyperprolactinemia induced by antipsychotic treatment, thereby increasing the risk of sudden cardiac arrest.",-37.25,0.8,diseaseorphenotypicfeature
"Hypermethylation of the PAX7 promoter in a HeLa cell line carrying a BRCA1 c.68_69delAG variant enhances SMV thrombosis risk by upregulating VEGFA expression, a finding that may inform drug toxicity profiles in patients with renal injury.",-50.25,0.8,diseaseorphenotypicfeature
"Hyponatremia induced by amphotericin B therapy exacerbated renal injury in a patient with underlying hyperprolactinemia, prompting discontinuation of the drug and initiation of dopamine agonist treatment.",-33.75,0.8,diseaseorphenotypicfeature
"doxorubicin-induced renal injury was mitigated in A549 cells by co‑treatment with the antioxidant N‑acetylcysteine, revealing a protective gene‑environment interaction involving the CYP2D6 metabolite pathway.",-35.5,0.8,diseaseorphenotypicfeature
"dexamethasone treatment of metastatic breast cancer in a patient with hyperprolactinemia reduced tumor burden while concurrently alleviating drug‑induced restless legs syndrome, highlighting the interplay between endocrine disruption and tumorigenesis.",-44.0,0.8,diseaseorphenotypicfeature
"doxycycline exposure in HeLa cells led to increased TP53 phosphorylation and activated apoptosis pathways, thereby mitigating SMV thrombosis‑related endothelial dysfunction and reducing tumorigenesis risk.",-48.75,0.8,diseaseorphenotypicfeature
differential expression of the GPR68 gene in HeLa cells is associated with hyperprolactinemia and may contribute to tumorigenesis by promoting metastatic invasion in E. coli–derived xenografts.,-47.5,0.8,diseaseorphenotypicfeature
"High‑dose cisplatin induces renal injury in A549 cells through oxidative stress, and the resulting up‑regulation of TP53 promotes apoptosis, thereby reducing the likelihood of tumorigenesis in drug‑resistant lung cancers.",-40.25,0.8,diseaseorphenotypicfeature
"High‐dose doxorubicin induced renal injury in A549 cells, and the resulting oxidative stress upregulated the TP53 pathway, which in turn promoted apoptosis and attenuated tumorigenesis in a mouse model of SMV thrombosis.",-35.25,0.8,diseaseorphenotypicfeature
"High–grade serous ovarian carcinoma presenting with SMV thrombosis and metastatic peritoneal spread was successfully treated with bevacizumab, which inhibited VEGF‑A signaling and reduced tumor‑derived angiogenesis in the patient’s E. coli‑derived tumor microenvironment.",-48.5,0.8,diseaseorphenotypicfeature
"High expression of the oncogenic KRAS G12D variant in A549 cells triggers metastatic colonization of the lungs, correlating with increased tumorigenesis and a pronounced hyperprolactinemia phenotype in xenograft mice.",-44.5,0.8,diseaseorphenotypicfeature
"Drugs such as doxorubicin induce SMV thrombosis and subsequent renal injury in HeLa cells, while the hyperprolactinemia observed in patients treated with the same agent is linked to increased tumorigenesis through activation of the PI3K/AKT pathway.",-46.75,0.8,diseaseorphenotypicfeature
"Dr‑pyridoxine treatment of the A549 cell line carrying a TP53 c.215G>A variant reduced SMV thrombosis markers, suggesting a protective effect against tumorigenesis in this cellular model.",-50.25,0.8,diseaseorphenotypicfeature
"Drift of a BRCA1 c.68_69delAG sequence variant in a familial breast cancer cohort was associated with increased tumorigenesis and reduced response to doxorubicin, prompting evaluation of a targeted TP53 inhibitor to mitigate drug toxicity and improve overall survival.",-58.75,0.8,diseaseorphenotypicfeature
"Drg-120, a novel small‑molecule inhibitor of the PI3K/AKT pathway, markedly reduced metastasis in A549 cells harboring the BRCA1 c.68_69delAG variant, but unexpectedly triggered drug toxicity manifested as hyperprolactinemia and renal injury in treated Xenopus tropicalis embryos.",-61.75,0.8,diseaseorphenotypicfeature
"The CRISPR-Cas9–mediated knockout of the TP53 gene in A549 cells exacerbated oxidative stress and induced retinal detachment–like blebbing in a subset of the cells, suggesting a potential link between p53 loss and retinal pathology in this lung cancer model.",-51.5,0.8,diseaseorphenotypicfeature
The presence of a BRCA1 c.68_69delAG SequenceVariant in the HeLa CellLine markedly increases the risk of gastric cancer in Homo sapiens patients with hereditary disease.,-19.625,0.8,diseaseorphenotypicfeature
"The BRCA1 c.68_69delAG sequence variant in a patient with hereditary breast cancer was found to increase TP53 expression, thereby contributing to the development of lymph node metastases.",-19.375,0.8,diseaseorphenotypicfeature
"The loss-of-function variant BRCA1 c.68_69delAG in a Caucasian woman was associated with a higher risk of hereditary breast and ovarian cancer, and her treatment with the PARP inhibitor olaparib reduced the progression of lymph node metastases.",-38.5,0.8,diseaseorphenotypicfeature
"Hereditary retinopathy of prematurity in premature infants was found to be associated with a BRCA2 c.5946_5947delAA sequence variant that reduces the retinal pigment epithelium’s ability to repair oxidative damage, thereby exacerbating pigment loss and predisposing to retinal detachment.",-42.25,0.8,diseaseorphenotypicfeature
"Heritable mutations in the MYH7 gene are linked to hypertrophic cardiomyopathy, a disease that often presents with sudden cardiac arrest and can be exacerbated by exercise-induced myocardial ischemia.",-31.5,0.8,diseaseorphenotypicfeature
"Heralded as a hereditary disease, familial retinitis pigmentosa leads to progressive retinal detachment and visual field loss in Homo sapiens, a phenomenon that has been linked to pathogenic sequence variants in the RPGR gene.",-50.5,0.8,diseaseorphenotypicfeature
Herceptin treatment in HER2‑positive gastric cancer patients with the BRCA1 c.68_69delAG sequence variant reduced lymph node metastases and improved overall survival.,-22.5,0.8,diseaseorphenotypicfeature
"In patients with hereditary gastric cancer, the presence of the BRCA1 c.68_69delAG sequence variant in tumor tissue correlates with increased lymph node metastases and poorer overall survival.",-13.25,0.8,diseaseorphenotypicfeature
"In a cohort of patients with hereditary gastric cancer, the presence of the BRCA1 c.68_69delAG sequence variant in TP53-expressing A549 cells correlated with increased lymph node metastases and a higher risk of cerebral ischemia during chemotherapy with doxorubicin.",-29.375,0.8,diseaseorphenotypicfeature
"In an exploratory cohort of **Homo sapiens** patients with **retinal detachment**, the presence of a **BRCA1 c.68_69delAG** **SequenceVariant** in the **TP53** **GeneOrGeneProduct** was correlated with an increased risk of **cerebral ischemia** and worsened visual outcomes.",-32.5,0.8,diseaseorphenotypicfeature
"In *Homo sapiens* patients with hereditary *gastric cancer* who carry the *BRCA1 c.68_69delAG* variant, high‑dose *methyphenidate* (MPH) treatment paradoxically exacerbates anxious behavior and accelerates lymph‑node metastases, likely through up‑regulation of the *TP53* pathway.",-46.25,0.8,diseaseorphenotypicfeature
"Loss of PTEN in the HeLa cell line increased lymph node metastases in a xenograft model of gastric cancer, suggesting that PTEN loss drives aggressive tumor spread.",-29.875,0.8,diseaseorphenotypicfeature
Loss‑of‑function mutations in the RASGRP1 gene are associated with increased susceptibility to hereditary lymph node metastases and concomitant retinal detachment in patients with gastric cancer.,-33.75,0.8,diseaseorphenotypicfeature
"Loss-of-function mutations in the PAX6 gene are linked to congenital cataracts and retinal detachment, causing visual impairment and increased susceptibility to retinopathy of prematurity in affected infants.",-34.25,0.8,diseaseorphenotypicfeature
"Loss‐of‑function variants of the *PAX6* gene cause congenital aniridia, a hereditary disease characterized by iris hypoplasia and severe pigmentary retinopathy that predisposes patients to retinal detachment and visual loss.",-41.25,0.8,diseaseorphenotypicfeature
"Mutations in the BRAF gene in patients with hereditary gastric cancer and associated pigmentation lead to increased MAPK signaling, which drives lymph node metastases and contributes to the development of retinopathy of prematurity in affected infants.",-33.5,0.8,diseaseorphenotypicfeature
Mutational analysis revealed that the BRCA1 c.68_69delAG variant in a female E. coli-derived HeLa cell line correlated with increased susceptibility to breast cancer and exhibited a pronounced pigmentation phenotype.,-39.0,0.8,diseaseorphenotypicfeature
"Mutagenic exposure of the A549 cell line to the alkylating agent cisplatin induced a BRCA1 c.68_69delAG SequenceVariant that was associated with increased cellular senescence and enhanced sensitivity to the DNA repair inhibitor olaparib, a finding that may explain the higher incidence of gastric cancer observed in patients with the same variant.",-56.75,0.8,diseaseorphenotypicfeature
"Mutated TP53 in the HeLa cell line enhances chemotherapeutic sensitivity to doxorubicin, linking a genetic alteration with a disease‑related phenotypic outcome.",-41.25,0.8,diseaseorphenotypicfeature
Mutation of the TP53 gene in HeLa cells carrying the BRCA1 c.68_69delAG variant increases the risk of developing gastric cancer in Homo sapiens through dysregulation of apoptosis pathways.,-28.375,0.8,diseaseorphenotypicfeature
Mutation‑driven dysregulation of the TP53 pathway in a colorectal cancer cell line (HCT‑116) exposed to the chemotherapeutic agent doxorubicin results in increased apoptosis and attenuated lymph node metastases in a xenograft mouse model of hereditary colorectal cancer.,-45.75,0.8,diseaseorphenotypicfeature
Mutation in the TP53 gene’s c.215C>T sequence variant was found to increase the risk of gastric cancer in a cohort of Homo sapiens patients who also exhibited anxious behaviour and lymph node metastases.,-32.75,0.8,diseaseorphenotypicfeature
Mutation p.Ser135Cys in TP53 has been linked to an increased risk of gastric cancer in individuals with a hereditary disease background.,-35.25,0.8,diseaseorphenotypicfeature
"TRIAL data revealed that the BRAF V600E sequence variant in gastric cancer patients was associated with increased lymph node metastases, prompting investigation of the potential benefit of dabrafenib in reducing disease progression.",-46.0,0.8,diseaseorphenotypicfeature
"TRAF6 overexpression in colorectal cancer cell lines such as HCT116 exacerbates lymph node metastases and correlates with elevated IL‑6 levels, indicating that the TRAF6‑IL‑6 axis may serve as a prognostic biomarker for aggressive gastric cancer.",-47.75,0.8,diseaseorphenotypicfeature
"TRAIL-mediated apoptosis was significantly enhanced in the HeLa cell line harboring the TP53 c.215C>T variant, suggesting a potential therapeutic target for treating cervical cancer.",-35.25,0.8,diseaseorphenotypicfeature
"TRPA1 activation by the oxidative stress induced by doxorubicin in A549 cells induces apoptosis and enhances the expression of the pro‑apoptotic protein BAX, thereby contributing to the cardiotoxicity observed in patients with hereditary dilated cardiomyopathy.",-50.5,0.8,diseaseorphenotypicfeature
Cerebral ischemia observed in patients with hereditary disease and lymph node metastases was ameliorated by a single dose of methylphenidate (MPH) in a pilot study of neurovascular function.,-43.25,0.8,diseaseorphenotypicfeature
"Cervical cancer patients who harbor the BRCA1 c.68_69delAG sequence variant exhibit an increased risk of lymph node metastases, suggesting a genetic predisposition to disease progression that may be mitigated by targeted chemotherapy.",-33.75,0.8,diseaseorphenotypicfeature
"Celiac disease is frequently associated with an increased risk of gastric cancer, and in patients who develop lymph node metastases, the presence of a TP53 R273C SequenceVariant correlates with poorer overall survival.",-37.25,0.8,diseaseorphenotypicfeature
"Cranial MRI in patients with hereditary disease-associated cerebral ischemia revealed that the presence of the APOE ε4 allele increased the risk of severe pigmentary retinopathy of prematurity, while treatment with methylphenidate (MPH) unexpectedly exacerbated anxious behaviour in a subset of children with psychogenic parasitosis.",-48.25,0.8,diseaseorphenotypicfeature
A mutation in the TP53 gene (SequenceVariant BRCA1 c.68_69delAG) observed in a gastric cancer (DiseaseOrPhenotypicFeature) patient carrying the homozygous Locus c.1234A>G (SequenceVariant) resulted in increased cellular proliferation and lymph node metastases (DiseaseOrPhenotypicFeature) that were mitigated by treatment with the chemotherapeutic agent doxorubicin (ChemicalEntity) in a HeLa (CellLine) in vitro model,-64.5,0.8,diseaseorphenotypicfeature
"A BRCA1 c.68_69delAG sequence variant in a female patient with hereditary breast cancer caused a loss of TP53‑mediated apoptosis, leading to increased lymph node metastases and heightened anxiety-like behavior.",-28.625,0.8,diseaseorphenotypicfeature
A germline BRCA1 c.68_69delAG variant in a woman with familial breast cancer increases the risk of developing gastric cancer and heightens sensitivity to platinum‑based chemotherapeutics.,-37.0,0.8,diseaseorphenotypicfeature
"A single‑cell RNA‑seq analysis of HeLa cells treated with doxorubicin revealed that TP53 transcription was upregulated, inducing apoptosis and reducing the expression of the anti‑apoptotic protein BCL‑2, thereby sensitizing the cells to the cytotoxic effects of the drug.",-37.5,0.8,diseaseorphenotypicfeature
We demonstrated that the BRCA1 c.68_69delAG sequence variant in the ovarian cancer cell line SK‑OV‑3 increases p53‑mediated apoptosis and enhances sensitivity to the chemotherapeutic agent doxorubicin.,-36.25,0.8,diseaseorphenotypicfeature
"We detected that a BRCA1 c.68_69delAG sequence variant in a patient with hereditary breast cancer promotes an abnormal splicing pattern of TP53, thereby exacerbating DNA repair deficiencies and increasing the risk of lymph node metastases.",-49.0,0.8,diseaseorphenotypicfeature
"We observed that the BRCA1 c.68_69delAG SequenceVariant in a patient with hereditary disease caused a loss of normal protein function, leading to increased susceptibility to gastric cancer in the same individual.",-32.5,0.8,diseaseorphenotypicfeature
Weakly expressed RET in the patient’s tumor cell line SK‑N‑SH revealed a BRCA1 c.68_69delAG variant that may underlie the observed lymph node metastases and increased risk of gastric cancer.,-59.0,0.8,diseaseorphenotypicfeature
"MRI evidence of cerebral ischemia in a patient with hereditary neurodegenerative disease triggered a rapid referral for dopaminergic therapy, while the presence of pigmentary retinopathy was confirmed by optical coherence tomography.",-43.25,0.8,diseaseorphenotypicfeature
"MRI‑guided photocoagulation of retinal neovascularization in a pediatric patient with retinopathy of prematurity markedly reduced the risk of subsequent retinal detachment, with no observed increase in anxiety‑related behaviors or MPH‑induced hypertension.",-43.0,0.8,diseaseorphenotypicfeature
"MRI-detected cerebral ischemia in a patient with hereditary retinal detachment predisposed the retinal ganglion cells to apoptosis, which was mitigated by low-dose MPH administration and improved visual field recovery.",-43.0,0.8,diseaseorphenotypicfeature
"MRI of a patient with hereditary retinopathy of prematurity revealed a pathogenic BRCA1 c.68_69delAG variant in the retinal pigment epithelium, correlating with increased susceptibility to retinal detachment and subsequent cerebral ischemia.",-30.75,0.8,diseaseorphenotypicfeature
"Anaplastic lymphoma kinase–positive pulmonary adenocarcinoma in a patient with a history of retinopathy of prematurity and malignant lymph node metastases was found to harbor a TP53 c.215G>A sequence variant, which may underlie the aggressive disease phenotype.",-46.25,0.8,diseaseorphenotypicfeature
"Anxiety and the MPH treatment in patients with hereditary cerebral ischemia are associated with increased dopamine transporter expression and decreased serotonergic signaling, potentially exacerbating psychogenic parasitosis symptoms.",-54.5,0.8,diseaseorphenotypicfeature
An increased expression of the TP53 gene in A549 cells treated with doxorubicin exacerbates retinal detachment in a mouse model of retinopathy of prematurity.,-25.125,0.8,diseaseorphenotypicfeature
"An inherited mutation in the TP53 gene (c.215G>A) predisposes individuals to gastric cancer, while the same variant also increases susceptibility to retinal detachment in patients with retinopathy of prematurity.",-30.125,0.8,diseaseorphenotypicfeature
"Retinal detachment in patients with hereditary retinal dystrophy often progresses to photoreceptor degeneration, and early photocoagulation therapy can prevent blindness.",-33.25,0.8,diseaseorphenotypicfeature
"Retinopathy of prematurity in preterm infants is exacerbated by high oxygen exposure and is frequently associated with abnormal retinal vascular regression, which may be mitigated by timely intravitreal anti‑VEGF therapy.",-36.0,0.8,diseaseorphenotypicfeature
Retrospective analysis of patients with hereditary retinopathy revealed that the BRCA1 c.68_69delAG variant in the TP53 gene exacerbates retinal detachment risk and correlates with increased pigmentation anomalies and early-onset cerebral ischemia.,-38.75,0.8,diseaseorphenotypicfeature
"Retinoic acid receptor agonist treatment of A549 cells carrying the BRCA1 c.68_69delAG sequence variant reduced migration and invasion, suggesting a potential therapeutic strategy for patients with hereditary breast cancer and associated lymph node metastases.",-35.5,0.8,diseaseorphenotypicfeature
"HeLa cells treated with the DNA‑damaging drug doxorubicin exhibited increased expression of TP53, correlating with enhanced apoptosis and the appearance of a BRCA1 c.68_69delAG sequence variant, a finding that may explain the heightened sensitivity to therapy observed in patients with hereditary breast‑cancer syndromes.",-45.5,0.8,diseaseorphenotypicfeature
"Heparin-induced thrombocytopenia (HIT) in patients receiving low‑molecular‑weight heparin (LMWH) is associated with a paradoxical risk of thrombotic events, such as cerebral ischemia and lymph node metastases, and has been linked to the presence of anti‑phosphatidylserine/prothrombin antibodies that cross‑react with platelet factor&nbsp;4.",-67.0,0.8,diseaseorphenotypicfeature
"He observed that the BRCA1 c.68_69delAG variant in A549 cells carrying the mutant TP53 allele markedly increased the susceptibility to radiation‑induced apoptosis, a phenotype that parallels the heightened risk of breast cancer observed in patients with hereditary BRCA1 mutations.",-56.5,0.8,diseaseorphenotypicfeature
"He demonstrated that the BRCA1 c.68_69delAG variant in a BRCA1‑positive breast cancer patient with hereditary disease predisposes to early‑onset lymph node metastases, while targeted therapy with doxorubicin reduces tumor burden but increases cardiotoxicity.",-51.5,0.8,diseaseorphenotypicfeature
"In patients with drug-induced dyskinesias, the LSC score correlates positively with the extent of epidermal hyperplasia observed in skin biopsies, suggesting that chronic exposure to neuroleptics may trigger cutaneous hyperproliferative changes.",-35.0,0.8,diseaseorphenotypicfeature
"In a cohort of patients with LSC, the emergence of sleep disturbance and psychotic symptoms was strongly correlated with increased epidermal hyperplasia and elevated lipidemia, suggesting a metabolic‑inflammatory link to disease progression.",-36.75,0.8,diseaseorphenotypicfeature
"In the examined cohort of patients with bladder cancer, a pronounced epidermal hyperplasia was observed in the urothelium of those receiving doxorubicin, suggesting a drug‑induced dyskinesias‑like alteration in cell proliferation.",-38.75,0.8,diseaseorphenotypicfeature
"In Parkinson’s disease patients receiving the dopamine agonist pramipexole, the occurrence of drug‑induced dyskinesias correlates with a significant increase in epidermal hyperplasia within the basal layer of the striatum, suggesting a neuro‑cutaneous interface that may influence sleep disturbance and overall disease severity.",-41.25,0.8,diseaseorphenotypicfeature
"A patient with hepatorenal syndrome and associated lipidemia exhibited severe sleep disturbance, likely exacerbated by the chemotherapeutic agent doxorubicin, which was found to induce steatosis in the liver and drug‑induced dyskinesias in the central nervous system.",-36.75,0.8,diseaseorphenotypicfeature
"A chronic case of **hepatorenal syndrome** in a patient with advanced **bladder cancer** was ameliorated by the addition of a low‑dose **doxorubicin** regimen, which subsequently induced a transient **sleep disturbance** but did not worsen the underlying renal failure.",-38.5,0.8,diseaseorphenotypicfeature
"A biopsy of bladder cancer tissue from a patient with lipidemia revealed that the TP53 c.215G>A sequence variant, which was absent in the corresponding organoid derived from the same E. coli‑contaminated culture, was associated with increased expression of the chemokine CXCL8 and an upregulation of the sleep disturbance–related gene PER2.",-62.75,0.8,diseaseorphenotypicfeature
"A post‑translational acetylation of the transcription factor ATF3 in HeLa cells triggers upregulation of the lipid‑metabolism enzyme FASN, thereby contributing to epidermal hyperplasia observed in patients with lipidemia.",-43.75,0.8,diseaseorphenotypicfeature
"The development of sleep disturbance in patients with end‑stage renal failure was associated with up‑regulation of the inflammatory cytokine IL‑6 in the kidney, which in turn promoted lipidemia and hepatic steatosis.",-28.0,0.8,diseaseorphenotypicfeature
The LSC‑induced epidermal hyperplasia observed in patients with lipidemia and sleep disturbance appears to exacerbate the progression toward steatosis and ultimately contributes to the development of end‑stage renal failure in those with underlying hepatorenal syndrome.,-31.125,0.8,diseaseorphenotypicfeature
"The patient’s epidermal hyperplasia was exacerbated by the drug‑induced dyskinesias associated with long‑term levodopa therapy, prompting a switch to a dopamine‑depleting agent.",-21.625,0.8,diseaseorphenotypicfeature
The persistent sleep disturbance observed in patients with end‑stage renal failure receiving the drug cisplatin is accompanied by an up‑regulation of the pro‑inflammatory gene IL‑6 and a corresponding increase in epidermal hyperplasia in the skin biopsy specimens.,-42.5,0.8,diseaseorphenotypicfeature
Recent transcriptomic profiling of the A549 cell line revealed that up‑regulation of the CYP2D6 gene product in response to doxorubicin exposure correlates with the appearance of drug‑induced dyskinesias in patients with epidermal hyperplasia.,-40.5,0.8,diseaseorphenotypicfeature
"Recent studies show that epidermal hyperplasia in patients with lipidemia is accompanied by up‑regulation of the chemokine CXCL8, suggesting a potential inflammatory link between metabolic dysregulation and cutaneous proliferation.",-33.5,0.8,diseaseorphenotypicfeature
"Recent analysis revealed that the TP53 c.215G>A variant in a cohort of end‑stage renal failure patients predisposes to epidermal hyperplasia, which in turn increases susceptibility to drug‑induced dyskinesias during tacrolimus therapy.",-40.75,0.8,diseaseorphenotypicfeature
"Recent analyses revealed that LSC‐associated epidermal hyperplasia, exacerbated by lipidemia, predicts a higher incidence of drug‑induced dyskinesias in patients with end‑stage renal failure.",-35.5,0.8,diseaseorphenotypicfeature
"Epidermal hyperplasia in patients with drug‑induced dyskinesias was markedly reduced after treatment with the selective dopamine D2 antagonist clozapine, suggesting a neuro‑cutaneous link between the psychotic disorder and cutaneous manifestations.",-29.625,0.8,diseaseorphenotypicfeature
"Epithelial cells from the LSC-derived bladder cancer cell line T24 exhibit pronounced epidermal hyperplasia when treated with the drug-induced dyskinesia–associated compound levetiracetam, a phenomenon that correlates with increased expression of the lipid metabolism regulator PPARγ and contributes to sleep disturbance in preclinical models.",-48.25,0.8,diseaseorphenotypicfeature
"Erdosteine mitigates vancomycin‑induced nephrotoxicity in patients with end‑stage renal failure, thereby reducing the risk of subsequent hepatorenal syndrome.",-20.5,0.8,diseaseorphenotypicfeature
"Epinephrine exposure in HeLa cells upregulates the transcription factor TP53, which in turn increases the expression of the pro‑apoptotic protein BAX, thereby enhancing apoptosis in response to drug‑induced dyskinesias.",-39.0,0.8,diseaseorphenotypicfeature
"Doxycycline treatment of the HeLa cell line expressing mutant TP53 c.215G>A was associated with reduced epidermal hyperplasia in a xenograft model of bladder cancer, suggesting a potential therapeutic effect for drug‑induced dyskinesias.",-37.25,0.8,diseaseorphenotypicfeature
"Dexamethasone treatment of LSC‑derived bladder cancer cells exacerbated steatosis in the surrounding urothelium, a phenomenon associated with sleep disturbance and elevated lipidemia in patients with end‑stage renal failure.",-36.75,0.8,diseaseorphenotypicfeature
Dopamine agonist therapy for Parkinson’s disease frequently induces drug‑induced dyskinesias that worsen sleep disturbance and may contribute to steatosis in patients with underlying lipidemia.,-26.5,0.8,diseaseorphenotypicfeature
"Doxorubicin induces epidermal hyperplasia and steatosis in HeLa cells, an effect that is potentiated by the BRCA1 c.68_69delAG sequence variant and correlates with increased expression of the TP53 gene product in Homo sapiens.",-27.75,0.8,diseaseorphenotypicfeature
Mutational loss of the TP53 gene in bladder cancer cells derived from a HeLa-derived cell line led to increased steatosis and sleep disturbance phenotypes in xenograft models of Homo sapiens.,-39.25,0.8,diseaseorphenotypicfeature
"Mutations in the HNF1B gene cause cystic kidney disease and associated steatosis, leading to hepatorenal syndrome in patients with end‑stage renal failure.",-24.375,0.8,diseaseorphenotypicfeature
"Mutagenic exposure to the chemical entity doxorubicin in HeLa cells induces epidermal hyperplasia, which in turn upregulates the GeneOrGeneProduct TP53 and exacerbates sleep disturbance, highlighting a potential link between drug-induced dyskinesias and end‑stage renal failure in patients with steatosis.",-44.5,0.8,diseaseorphenotypicfeature
"Mutated TP53 c.215C>G in the HeLa cell line was shown to increase epidermal hyperplasia and induce lipidemia, suggesting a link between this sequence variant and the development of steatosis in vitro.",-37.5,0.8,diseaseorphenotypicfeature
Hyperlipidemia associated with steatosis in patients with end‑stage renal failure leads to increased risk of drug‑induced dyskinesias when treated with levodopa.,-25.25,0.8,diseaseorphenotypicfeature
Hyperuricemia-induced gouty arthropathy in a patient with end‑stage renal failure receiving allopurinol exacerbated by a CYP2C9*3 allele and a BRCA1 c.68_69delAG variant.,-40.75,0.8,diseaseorphenotypicfeature
"Hypercoagulable episodes in patients with lipidemia were exacerbated by the LSC-derived chemical agent ethanol, which triggered endothelial cell apoptosis and promoted a steatosis-like phenotype in the liver.",-60.0,0.8,diseaseorphenotypicfeature
"Hyperglycemia-induced epidermal hyperplasia in patients with type‑2 diabetes mellitus is accompanied by dysregulation of the insulin signaling pathway, which can exacerbate steatosis and contribute to the progression of end‑stage renal failure.",-39.25,0.8,diseaseorphenotypicfeature
"Electrophysiological recordings from HeLa cells treated with doxorubicin revealed that the drug‐induced dyskinesias were associated with a significant up‑regulation of TP53, which in turn triggered apoptosis and reduced steatosis in the hepatic cell line.",-42.0,0.8,diseaseorphenotypicfeature
"Electroconvulsive therapy improved sleep disturbance in patients with psychotic depression, yet the concomitant use of antipsychotic drug clozapine triggered drug‑induced dyskinesias that were mitigated by low‑dose propranolol.",-39.5,0.8,diseaseorphenotypicfeature
Electroporation of the CRISPR/Cas9 system into HeLa cells carrying the TP53 c.215G>A variant results in a selective loss of TP53 protein expression and induces epidermal hyperplasia together with a modest increase in lipidemia.,-47.25,0.8,diseaseorphenotypicfeature
"Electrons from the C7N5H5 drug induce LSC in bladder cancer cells, which in turn triggers epidermal hyperplasia and sleep disturbance in the patient.",-61.5,0.8,diseaseorphenotypicfeature
"Elevated levels of lipidemia in patients with end‑stage renal failure are associated with increased risk of drug‑induced dyskinesias when treated with levodopa, suggesting that lipid‑mediated modulation of dopaminergic signaling may underlie this adverse effect.",-30.25,0.8,diseaseorphenotypicfeature
"Elevating the expression of the transcription factor GATA3 in the A549 cell line induced epidermal hyperplasia in a xenograft model of lung adenocarcinoma, suggesting that GATA3-mediated dysregulation of lipid metabolism may contribute to steatosis in the tumor microenvironment.",-49.0,0.8,diseaseorphenotypicfeature
Elevations in lipidemia combined with steatosis of the liver were found to exacerbate the development of hepatorenal syndrome in patients with end‑stage renal failure.,-29.5,0.8,diseaseorphenotypicfeature
"Elevative treatment with metformin in patients with type‑2 diabetes and documented steatosis reduces hepatic lipid accumulation and ameliorates insulin resistance, thereby improving clinical markers of metabolic syndrome.",-48.5,0.8,diseaseorphenotypicfeature
"Cumulative exposure to the chemotherapeutic agent doxorubicin in a cohort of patients with bladder cancer induced lipidemia, which in turn accelerated the progression of steatosis and contributed to sleep disturbance in those who had pre‑existing end‑stage renal failure.",-42.0,0.8,diseaseorphenotypicfeature
"Clozapine exposure in patients with psychotic schizophrenia can induce drug‑induced dyskinesias, a phenomenon that correlates with up‑regulation of dopamine D2 receptors in the striatum and is frequently accompanied by sleep disturbance and mild steatosis in the liver.",-42.0,0.8,diseaseorphenotypicfeature
"C‑terminal truncation of the TP53 gene product in a HeLa cell line induces epidermal hyperplasia and lipidemia, suggesting that this sequence variant may drive tumorigenesis in bladder cancer.",-39.75,0.8,diseaseorphenotypicfeature
"Cortical hyperplasia in patients with drug‑induced dyskinesias, caused by chronic levodopa therapy, is associated with up‑regulation of the dopamine receptor D2 gene in the basal ganglia of Homo sapiens.",-35.0,0.8,diseaseorphenotypicfeature
"Bladder cancer patients treated with doxorubicin exhibit drug‑induced dyskinesias, which are often accompanied by sleep disturbance and increased steatosis of the liver.",-21.25,0.8,diseaseorphenotypicfeature
"Blastic plasmacytoma cells isolated from a patient with end‑stage renal failure displayed an up‑regulation of the transcription factor TP53, which was linked to the development of sleep disturbance and drug‑induced dyskinesias.",-39.5,0.8,diseaseorphenotypicfeature
"Blinatumomab treatment of relapsed B‑cell acute lymphoblastic leukemia induced a transient epidermal hyperplasia in a patient with end‑stage renal failure, highlighting a potential drug‑induced dyskinesia‑like cutaneous adverse event.",-35.5,0.8,diseaseorphenotypicfeature
"Blunted cortisol responses in patients with sleep disturbance and LSC correlate with increased epidermal hyperplasia, suggesting that chronic stress may exacerbate cutaneous proliferative disorders.",-31.875,0.8,diseaseorphenotypicfeature
Patients with hepatic steatosis treated with metformin showed reduced epidermal hyperplasia and improved sleep disturbance scores compared with untreated controls.,-20.375,0.8,diseaseorphenotypicfeature
"Patients treated with the novel inhibitor BMS‑754807 exhibited a significant reduction in epidermal hyperplasia and an improvement in sleep disturbance, suggesting a dual therapeutic effect on cutaneous and neuro‑behavioral manifestations.",-41.5,0.8,diseaseorphenotypicfeature
"Patients exhibiting drug‑induced dyskinesias after chronic levodopa treatment show increased epidermal hyperplasia in skin biopsies, suggesting a systemic metabolic link between neuro‑motor side effects and cutaneous cellular proliferation.",-33.25,0.8,diseaseorphenotypicfeature
"Patients receiving the CYP3A4 inhibitor itraconazole developed drug‑induced dyskinesias, a psychotic‑like phenotype, while their hepatic steatosis and lipidemia remained unchanged.",-41.75,0.8,diseaseorphenotypicfeature
"Epstein–Barr virus infection in HeLa cells induces epidermal hyperplasia that, through upregulation of the cytokine IL‑6, can exacerbate steatosis in a mouse model of liver disease.",-36.25,0.8,diseaseorphenotypicfeature
Epigenetic dysregulation of the **TP53** locus in **HepG2** cells leads to **hepatorenal syndrome**‑associated **lipidemia** and progressive **epidermal hyperplasia** in a subset of patients.,-36.25,0.8,diseaseorphenotypicfeature
"Epilepsy patients treated with valproic acid frequently develop lipidemia, which can aggravate sleep disturbance and contribute to hepatic steatosis.",-28.25,0.8,diseaseorphenotypicfeature
"Epigallocatechin‑3‑gallate treatment reduced epidermal hyperplasia in SK‑Hep-1 cells, correlating with lower CYP1A1 expression and decreased melanin synthesis in melanocytes.",-43.25,0.8,diseaseorphenotypicfeature
Mitochondrial dysfunction in patients with the BRCA1 c.68_69delAG variant is associated with growth impairment and may predispose to breast‑ovarian cancer syndrome.,-22.875,0.8,diseaseorphenotypicfeature
"Mediated by mitochondrial dysfunction, the iron‑refractory iron deficiency anemia observed in patients with the **22q11.2 deletion syndrome** shows a correlation with decreased erythropoietin production and increased oxidative stress in erythroblasts.",-49.5,0.8,diseaseorphenotypicfeature
"Molecular profiling of a patient with iron‑refractory iron deficiency anemia revealed a novel TP53 c.215G>T SequenceVariant that up‑regulates hepcidin in HepG2 cells, suggesting a pathogenic link between the Variant, hepatic fibrogenesis, and the observed growth impairment.",-41.0,0.8,diseaseorphenotypicfeature
"MCL tumour progression in patients harboring a TP53 SequenceVariant was exacerbated by mitochondrial dysfunction, which in turn amplified the expression of the pro‑apoptotic protein BCL2, contributing to growth impairment and poor clinical outcomes.",-42.75,0.8,diseaseorphenotypicfeature
"Chronic iron‑refractory iron deficiency anemia in patients with a confirmed **MCL tumour** is frequently associated with hepatic fibrogenesis, as indicated by elevated serum ferritin and increased hepatic iron deposition in **Homo sapiens** liver biopsies.",-52.75,0.8,diseaseorphenotypicfeature
"Cholestatic liver injury in patients with hepatic fibrogenesis is exacerbated by the MCL tumor-associated protein‑coding variant c.215G>A, which alters iron transport and worsens iron‑refractory iron deficiency anemia.",-60.5,0.8,diseaseorphenotypicfeature
"Chloroquine‑treated A549 cells exhibited a significant increase in reactive oxygen species that correlated with the up‑regulation of NRF2‑mediated antioxidant genes and the down‑regulation of the mitochondrial transcription factor A, thereby contributing to mitochondrial dysfunction in a model of iron‑refractory iron deficiency anemia.",-58.75,0.8,diseaseorphenotypicfeature
Chimeric antigen receptor (CAR) T cells engineered with a tandem scFv targeting CD19 and CD123 exhibit enhanced cytotoxicity against MCL tumour cells and simultaneously reduce the growth impairment observed in patients with a germline BRCA1 variant.,-63.75,0.8,diseaseorphenotypicfeature
The chronic mitochondrial dysfunction observed in patients with the MCL tumour correlates with impaired energy metabolism and contributes to the growth impairment characteristic of the disease.,-30.875,0.8,diseaseorphenotypicfeature
"The mitochondrial dysfunction observed in patients with the MTHFD2 c.1223G>A sequence variant is associated with growth impairment, and its severity correlates with the expression of the TP53 gene in HeLa cells, suggesting a potential therapeutic target for breast‑ovarian cancer syndrome.",-50.5,0.8,diseaseorphenotypicfeature
"The MCL tumour cell line U266 exhibited mitochondrial dysfunction that correlated with increased reactive oxygen species production and accelerated proliferation, suggesting a potential therapeutic target for iron‑refractory iron deficiency anemia in HBV‑infected patients.",-27.625,0.8,diseaseorphenotypicfeature
"The loss of the transcription factor FOXO3 in HeLa cells exacerbates mitochondrial dysfunction and promotes apoptosis, suggesting that FOXO3 deficiency may contribute to the progression of breast-ovarian cancer syndrome.",-34.0,0.8,diseaseorphenotypicfeature
"Cognitive impairment observed in patients with Mitochondrial Dysfunction is exacerbated by a BRCA1 c.68_69delAG variant, which reduces DNA repair capacity and increases susceptibility to breast‑ovarian cancer syndrome.",-31.5,0.8,diseaseorphenotypicfeature
"Cytotoxicity of doxorubicin in MCF‑7 cells was attenuated by co‑treatment with the antioxidant N‑acetylcysteine, which restored mitochondrial membrane potential and reduced reactive oxygen species generation in a dose‑dependent manner.",-30.875,0.8,diseaseorphenotypicfeature
"Cerebral iron‑refractory iron deficiency anemia in a patient with a germline BRCA1 c.68_69delAG variant was associated with heightened oxidative mitochondrial dysfunction, leading to progressive growth impairment and an increased risk of breast‑ovarian cancer syndrome.",-43.0,0.8,diseaseorphenotypicfeature
"Celiac disease pathogenesis in patients with a novel GATAD2B sequence variant is exacerbated by mitochondrial dysfunction, leading to impaired intestinal epithelial proliferation and increased iron‑refractory iron deficiency anemia.",-45.25,0.8,diseaseorphenotypicfeature
"A deficiency in mitochondrial oxidative phosphorylation, often caused by pathogenic POLG variants, is associated with early‑onset growth impairment and an increased risk of bipolar disorder in individuals carrying the same pathogenic sequence variant.",-50.0,0.8,diseaseorphenotypicfeature
"A mitochondrial dysfunction–associated variant in the TFAM gene, identified in a patient with growth impairment and iron‑refractory iron deficiency anemia, was shown to disrupt oxidative phosphorylation and exacerbate hepatic fibrogenesis in the context of HBV infection.",-31.125,0.8,diseaseorphenotypicfeature
A reduced expression of PPARγ in the hippocampus of a mouse model of bipolar disorder correlates with mitochondrial dysfunction and exacerbates depressive‑like behavior.,-30.875,0.8,diseaseorphenotypicfeature
"A patient with a pathogenic BRCA1 c.68_69delAG sequence variant exhibits impaired DNA repair, leading to early onset breast‑ovarian cancer syndrome and increased risk of metastasis to the liver in Homo sapiens.",-37.75,0.8,diseaseorphenotypicfeature
"In patients with MCL tumour, the TP53 R175H SequenceVariant was found to exacerbate mitochondrial dysfunction, contributing to the growth impairment characteristic of the disease.",-29.0,0.8,diseaseorphenotypicfeature
"In HeLa cells transfected with a TP53 c.215G>A variant, the induced mitochondrial dysfunction exacerbated oxidative stress, which in turn promoted apoptosis and reduced cell proliferation.",-33.75,0.8,diseaseorphenotypicfeature
"In HBV‑infected patients, chronic hepatic fibrogenesis is exacerbated by mitochondrial dysfunction, which in turn promotes the expansion of MCL tumour cells and increases the risk of iron‑refractory iron deficiency anemia.",-23.375,0.8,diseaseorphenotypicfeature
"In chronic HBV infection, mitochondrial dysfunction in hepatocytes drives hepatic fibrogenesis, a key pathologic feature of chronic liver disease.",-25.0,0.8,diseaseorphenotypicfeature
"Neuropsychiatric symptoms of bipolar disorder in a patient with a novel TP53 R248W sequence variant were mitigated by the oral HDAC inhibitor vorinostat, which also reduced hepatic fibrogenesis markers in the underlying HBV‑infected liver.",-51.5,0.8,diseaseorphenotypicfeature
"Neuronal mitochondrial dysfunction in patients with bipolar disorder correlates with a higher prevalence of iron‑refractory iron deficiency anemia, suggesting that impaired oxidative phosphorylation may exacerbate iron dysregulation in this psychiatric population.",-35.0,0.8,diseaseorphenotypicfeature
"Neck‑pain and episodic fatigue in a patient with a confirmed MCL tumour were relieved after a single dose of doxorubicin, which induced apoptosis in the leukemic cells and reduced the expression of pro‑inflammatory cytokines associated with the disease‑related phenotypic features.",-65.0,0.8,diseaseorphenotypicfeature
"Neural progenitor cells from a patient with a pathogenic BRCA1 c.68_69delAG variant displayed impaired mitochondrial respiration, correlating with the growth impairment observed in her breast‑ovarian cancer syndrome.",-38.75,0.8,diseaseorphenotypicfeature
"Hepatic fibrogenesis in HBV‑infected patients is exacerbated by mitochondrial dysfunction, leading to increased oxidative stress and activation of hepatic stellate cells.",-15.625,0.8,diseaseorphenotypicfeature
Hemochromatosis‑associated iron‑refractory iron deficiency anemia in a patient with a confirmed MCL tumour is mitigated by iron chelation therapy that reduces hepatic fibrogenesis and improves growth impairment.,-46.5,0.8,diseaseorphenotypicfeature
"Heterozygous loss of the TP53 gene product in MCL tumour cells leads to mitochondrial dysfunction, which exacerbates growth impairment and predisposes patients to iron‑refractory iron deficiency anemia.",-25.75,0.8,diseaseorphenotypicfeature
"HBOC‑associated BRCA1 missense variants disrupt DNA repair, leading to mitochondrial dysfunction that exacerbates growth impairment in breast‑ovarian cancer syndrome patients.",-35.25,0.8,diseaseorphenotypicfeature
"Mutations in the NDUFB10 gene, a mitochondrial complex I subunit, have been linked to severe neurodevelopmental phenotypes in patients with growth impairment and refractory iron deficiency anemia, illustrating how mitochondrial dysfunction can exacerbate both developmental and hematologic disorders.",-49.25,0.8,diseaseorphenotypicfeature
"Mutational loss of the transcription factor TCF7L2 in the intestinal epithelium of a mouse model carrying a germline BRCA1 c.68_69delAG sequence variant was associated with impaired glucose tolerance and hepatic fibrogenesis, suggesting a novel link between mitochondrial dysfunction and breast‑ovarian cancer syndrome.",-50.75,0.8,diseaseorphenotypicfeature
Mutated TP53 in MCL tumour cells exacerbates iron‑refractory iron deficiency anemia by upregulating HIF‑1α‑mediated ferroportin suppression in HepG2‑derived hepatocytes.,-32.25,0.8,diseaseorphenotypicfeature
"Mutant TP53 c.215C>A in a patient with breast‑ovarian cancer syndrome is associated with impaired DNA repair, leading to increased apoptosis of HeLa‑derived cells and contributing to the observed growth impairment.",-42.25,0.8,diseaseorphenotypicfeature
"Altered expression of the transcription factor TCF7L2 in HepG2 cells exposed to the chemical benzene induces mitochondrial dysfunction, which in turn exacerbates oxidative stress and contributes to the development of hepatic fibrogenesis in HBV-infected patients.",-35.0,0.8,diseaseorphenotypicfeature
"Alterations in the TP53 gene product caused mitochondrial dysfunction, leading to growth impairment and increased susceptibility to breast‑ovarian cancer syndrome in patients with the BRCA1 c.68_69delAG variant.",-27.25,0.8,diseaseorphenotypicfeature
"Alteration of the TP53 gene product in the MCL tumour cell line Karpas-299 exacerbates mitochondrial dysfunction, thereby increasing reactive oxygen species and accelerating hepatic fibrogenesis in HBV‑infected HepG2‑AD cells.",-37.5,0.8,diseaseorphenotypicfeature
Alterative treatment with deferasirox ameliorates mitochondrial dysfunction and growth impairment in patients with iron‑refractory iron deficiency anemia.,-29.875,0.8,diseaseorphenotypicfeature
"Bipolar disorder in patients with the MCL tumor is exacerbated by mitochondrial dysfunction, which also promotes hepatic fibrogenesis and may underlie the iron‑refractory iron deficiency anemia observed in these individuals.",-34.75,0.8,diseaseorphenotypicfeature
Biallelic loss of the mitochondrial electron‑transport gene NDUFA9 in a patient with iron‑refractory iron deficiency anemia and growth impairment leads to hyperactivation of hepatic fibrogenesis driven by the TGF‑β1 signaling pathway.,-46.0,0.8,diseaseorphenotypicfeature
"Bacterial infection with *Streptococcus pneumoniae* induces hepatic fibrogenesis in *Homo sapiens* by up‑regulating TGF‑β1, a process that is amplified in patients carrying the MTHFR C677T SequenceVariant and is associated with growth impairment in children with iron‑refractory iron deficiency anemia.",-45.75,0.8,diseaseorphenotypicfeature
"B2‑microglobulin levels were significantly higher in patients with MCL tumour, correlating with the extent of hepatic fibrogenesis and suggesting that iron‑refractory iron deficiency anemia may exacerbate disease progression.",-37.5,0.8,diseaseorphenotypicfeature
Pediatric patients with the **22q11.2 deletion syndrome** frequently exhibit **growth impairment** and an increased risk of developing **bipolar disorder**.,-28.375,0.8,diseaseorphenotypicfeature
Pachycephalosporin treatment in patients with iron‑refractory iron deficiency anemia and hepatic fibrogenesis reduced serum ferritin levels while preserving normal erythropoiesis in a cohort of adult **Homo sapiens**.,-56.0,0.8,diseaseorphenotypicfeature
"Pten loss in HeLa cells triggers mitochondrial dysfunction, leading to increased reactive oxygen species that activate the NLRP3 inflammasome, ultimately exacerbating growth impairment in a model of breast‑ovarian cancer syndrome.",-39.25,0.8,diseaseorphenotypicfeature
"P301L‑mutated TP53 in MCF‑7 cells synergistically enhances mitochondrial dysfunction, thereby increasing reactive oxygen species and triggering apoptotic pathways that contribute to breast‑ovarian cancer syndrome progression.",-46.75,0.8,diseaseorphenotypicfeature
"Anaplastic lymphoma kinase fusion in a patient with MCL tumour activates PI3K–AKT signaling, which enhances mitochondrial dysfunction and contributes to aggressive disease progression.",-39.75,0.8,diseaseorphenotypicfeature
"An observed mitochondrial dysfunction in patients with iron‑refractory iron deficiency anemia correlates with increased hepatic fibrogenesis, suggesting that impaired mitochondrial energy metabolism may drive the progressive liver damage seen in this disorder.",-31.875,0.8,diseaseorphenotypicfeature
An expanded BRCA1 c.68_69delAG sequence variant in a patient with hereditary breast‑ovarian cancer syndrome correlates with reduced RAD51 protein levels and increased susceptibility to platinum‑based chemotherapy toxicity.,-32.5,0.8,diseaseorphenotypicfeature
"An elevated plasma ferritin level in patients with iron‑refractory iron deficiency anemia is associated with increased hepatic fibrogenesis, suggesting that chronic iron overload may exacerbate liver pathology.",-23.875,0.8,diseaseorphenotypicfeature
"Patients with the BRCA1 c.68_69delAG sequence variant exhibit increased mitochondrial dysfunction, leading to growth impairment and heightened susceptibility to breast‑ovarian cancer syndrome.",-22.5,0.8,diseaseorphenotypicfeature
Patients harboring the TP53 c.215G>A variant exhibit mitochondrial dysfunction that correlates with growth impairment in breast‑ovarian cancer syndrome.,-27.0,0.8,diseaseorphenotypicfeature
"Patients carrying the BRCA1 c.68_69delAG sequence variant exhibit increased breast-ovarian cancer syndrome risk, and in vitro studies show that this mutation disrupts TP53 regulation, leading to impaired DNA repair and heightened cellular proliferation in A549 cells.",-40.75,0.8,diseaseorphenotypicfeature
"Patients diagnosed with iron‑refractory iron deficiency anemia and MCL tumor exhibit a striking increase in serum ferritin, suggesting that the underlying mitochondrial dysfunction may drive the aggressive disease phenotype.",-45.25,0.8,diseaseorphenotypicfeature
"The loss‑of‑function mutation c.233G>A in the PABPN1 gene reduces polyadenylation‑binding protein activity, thereby increasing gamma‑H2AX foci in neurons and impairing neuronal pentraxin‑1‑mediated synaptic remodeling in patients with schizophrenia.",-37.75,0.8,geneorgeneproduct
"The overexpression of ETS1 in A549 cells increased gamma‑H2AX foci and up‑regulated proinflammatory cytokines, thereby enhancing DNA damage signaling and cell‑cycle arrest.",-22.75,0.8,geneorgeneproduct
"The PABPN1 gene product interacts with gamma‑H2AX to promote DNA damage signaling in neuronal cells, a pathway that is dysregulated in schizophrenia and may alter the expression of the pro‑inflammatory cytokine network mediated by ETS1 and T‑cell factor‑4.",-34.25,0.8,geneorgeneproduct
"The activation of gamma‑H2AX in HeLa cells expressing a BRCA1 c.68_69delAG variant leads to increased recruitment of the T‑cell factor‑4 transcriptional complex, thereby enhancing the expression of pro‑inflammatory cytokines that mediate neuronal pentraxin‑1‑dependent synaptic pruning.",-35.5,0.8,geneorgeneproduct
"Mutations in the PABPN1 gene that increase poly(A)-binding protein nuclear localization lead to aberrant splicing and elevated gamma-H2AX foci in HeLa cells, suggesting a role for PABPN1 in the DNA damage response.",-38.25,0.8,geneorgeneproduct
"Mutant PABPN1 with a GAA expansion directly induces gamma‑H2AX foci and up‑regulates neuronal pentraxin‑1 expression, thereby exacerbating synaptic dysfunction in a murine Schizophrenia‑1 model.",-37.25,0.8,geneorgeneproduct
"Mutational loss of PABPN1 in A549 cells increases gamma‑H2AX foci, correlating with enhanced activation of the fractalkine receptor–ETS1 pathway and elevated pro‑inflammatory cytokine secretion.",-34.0,0.8,geneorgeneproduct
"Mutated PABPN1 reduces γ‑H2AX foci formation in neuronal pentraxin‑1‑positive hippocampal neurons of a schizophrenia‑1 mouse model, impairing DNA repair and increasing pro‑inflammatory cytokine release.",-30.25,0.8,geneorgeneproduct
"Gamma‑H2AX foci formation in HeLa cells treated with doxorubicin is markedly enhanced by the loss‑of‑function PABPN1 variant c.68_69delAG, linking DNA damage signaling to transcriptional deregulation in this cell‑line model of chemotherapeutic response.",-36.5,0.8,geneorgeneproduct
"Gamma-H2AX phosphorylation in activated CD4+ T cells from schizophrenia patients increases ETS1‑mediated transcription of pro‑inflammatory cytokine genes, suggesting a mechanistic link between DNA damage response and neuroimmune dysregulation.",-37.25,0.8,geneorgeneproduct
"Gamma‐H2AX phosphorylation at DNA double‑strand breaks in HeLa cells is amplified by PABPN1 overexpression, thereby enhancing recruitment of the neuronal pentraxin‑1‑dependent repair complex.",-36.5,0.8,geneorgeneproduct
Gamma–H2AX foci formation in HeLa cells treated with doxorubicin correlates with increased expression of the pro‑inflammatory cytokine IL‑6 and enhanced recruitment of the DNA repair protein PABPN1 to sites of DNA damage.,-33.25,0.8,geneorgeneproduct
"In neuroblastoma cell lines, upregulation of the transcription factor ETS1 drives increased expression of the pro‑inflammatory cytokine IL‑6 and enhances γ‑H2AX foci formation following DNA damage, thereby contributing to cellular senescence.",-34.5,0.8,geneorgeneproduct
"In HeLa cells, overexpression of the transcription factor ETS1 enhances gamma‑H2AX foci formation after DNA damage, indicating that ETS1 may amplify the DNA‑damage response by up‑regulating the pro‑inflammatory cytokine network.",-26.5,0.8,geneorgeneproduct
"In primary cortical neurons, the PABPN1 mutation c.123_125delTGA exacerbates γ‑H2AX foci formation, indicating increased DNA double‑strand breaks that are further amplified by up‑regulated fractalkine receptor signaling, thereby linking genomic instability to neuroinflammatory pathways in schizophrenia.",-50.5,0.8,geneorgeneproduct
"In cerebral cortical slices from a schizophrenia model, increased PABPN1 expression suppresses gamma‑H2AX‑mediated DNA damage signaling, thereby reducing neuronal pentraxin‑1 release and limiting fractalkine receptor‑driven microglial activation.",-35.75,0.8,geneorgeneproduct
"A polymorphism in the PABPN1 gene that increases gamma‑H2AX foci formation in cultured neurons also enhances expression of neuronal pentraxin‑1, thereby promoting synaptic remodeling that may contribute to schizophrenia‑1 pathology.",-36.5,0.8,geneorgeneproduct
"A dysregulated gamma‑H2AX foci formation in neuronal pentraxin‑1‑deficient HeLa cells, induced by the small‑molecule fractalkine receptor inhibitor BX-912, correlates with a decrease in T‑cell factor‑4 expression and an up‑regulation of the pro‑inflammatory cytokine IL‑6, suggesting a potential mechanism underlying schizophrenia‑associated neuroinflammation.",-66.5,0.8,geneorgeneproduct
A mutational screen in a cohort of schizophrenia patients identified a missense variant in the PABPN1 gene that significantly increased nuclear gamma‑H2AX foci and up‑regulated the pro‑inflammatory cytokine IL‑1β through T‑cell factor‑4‑mediated transcriptional activation.,-42.75,0.8,geneorgeneproduct
"A higher phosphorylation of gamma‑H2AX in HeLa cells treated with doxorubicin correlates with increased recruitment of the pro‑inflammatory cytokine IL‑6 and enhanced expression of the bone‑morphogenetic‑protein‑receptor‑1 gene, suggesting that the DNA damage response activates downstream signaling pathways that may contribute to chemotherapeutic toxicity.",-43.25,0.8,geneorgeneproduct
"PABPN1 overexpression in HeLa cells increases gamma‑H2AX foci and up‑regulates neuronal pentraxin‑1, thereby potentiating T‑cell factor‑4‑mediated transcriptional activation of bone morphogenetic protein receptor‑1 and enhancing fractalkine receptor signaling that contributes to schizophrenia‑1‑associated neuroinflammation.",-34.25,0.8,geneorgeneproduct
"Pseudogene PABPN1 overexpression in A549 cells elevates gamma‑H2AX foci, suggesting enhanced DNA damage signaling that may contribute to neurodegenerative pathways involving neuronal pentraxin‑1 and bone‑morphogenetic‑protein‑receptor‑1 interactions.",-39.25,0.8,geneorgeneproduct
"PAM RNA-binding protein PABPN1 depletion in SH-SY5Y cells enhances γ‑H2AX foci formation and up‑regulates neuronal pentraxin‑1 transcription, indicating a DNA‑damage response that may contribute to schizophrenia‑1 pathogenesis.",-48.25,0.8,geneorgeneproduct
"PAVPN1 overexpression in A549 cells induces a γ‑H2AX‑mediated DNA damage response, which in turn up‑regulates the pro‑inflammatory cytokine IL‑6 and enhances T‑cell factor‑4 expression, thereby promoting a tumor‑immune microenvironment that may contribute to chemoresistance.",-53.25,0.8,geneorgeneproduct
"Mutation of the PABPN1 gene in a patient with oculopharyngeal muscular dystrophy results in the accumulation of the nuclear protein and the formation of intranuclear inclusions, which in turn activates the DNA damage marker gamma‑H2AX and induces a pro‑inflammatory cytokine response in affected skeletal muscle cells.",-41.0,0.8,geneorgeneproduct
"Mutation‑induced loss of function of the bone morphogenetic protein receptor (BMPR)‑1 gene in a subset of glioma cells upregulated gamma‑H2AX and increased pro‑inflammatory cytokine secretion, thereby enhancing neuronal pentraxin‑1 expression and promoting tumor‑associated angiogenesis.",-54.25,0.8,geneorgeneproduct
"Mutation in the PABPN1 gene increases γ‑H2AX foci formation in neuronal cells, thereby amplifying pro‑inflammatory cytokine production and exacerbating Schizophrenia‑1‑related behavioral deficits.",-33.5,0.8,geneorgeneproduct
"Mutation‐induced overexpression of PABPN1 in a HeLa cell line leads to increased gamma‑H2AX phosphorylation, indicating heightened DNA damage signalling that may contribute to neuronal pentraxin‑1‑mediated synaptic dysfunction in schizophrenia.",-36.5,0.8,geneorgeneproduct
"Overexpression of ETS1 in the A549 cell line induces γ‑H2AX phosphorylation and up‑regulates neuronal pentraxin‑1, thereby enhancing fractalkine receptor signaling and promoting pro‑inflammatory cytokine production in a model of schizophrenia‑1‑associated neuroinflammation.",-26.75,0.8,geneorgeneproduct
"Overactivation of the fractalkine receptor in cultured SH-SY5Y cells enhances gamma‑H2AX foci formation, suggesting that this receptor signaling pathway may contribute to DNA damage responses in neuronal models of schizophrenia.",-36.75,0.8,geneorgeneproduct
"Overexpressed PABPN1 in A549 cells increased gamma‑H2AX foci and up‑regulated neuronal pentraxin‑1 expression, suggesting that aberrant RNA‑binding protein activity enhances DNA damage signaling and synaptic plasticity pathways implicated in schizophrenia‑1 pathogenesis.",-40.5,0.8,geneorgeneproduct
"Overdose of gamma‑H2AX phosphorylation in A549 cells, triggered by the chemotherapeutic doxorubicin, activates ETS1 and induces a pro‑inflammatory cytokine cascade that ultimately up‑regulates bone‑morphogenetic‑protein‑receptor‑1 expression, thereby contributing to the neuronal pentraxin‑1 mediated synaptic pruning observed in schizophrenia‑associated neurodegeneration.",-64.5,0.8,geneorgeneproduct
"ETV1 overexpression in the A549 cell line increased gamma‑H2AX foci and up‑regulated the proinflammatory cytokine IL‑6, suggesting a DNA‑damage response that may contribute to the pathogenesis of schizophrenia‑1 in a human model.",-37.0,0.8,geneorgeneproduct
"ETs1 overexpression in A549 cells induces gamma‑H2AX foci formation, which is attenuated by the fractalkine receptor antagonist AMD3100, suggesting a role for the chemokine axis in DNA damage signaling during lung cancer progression.",-40.5,0.8,geneorgeneproduct
"ETC1 expression is markedly up‑regulated in hippocampal neurons of schizophrenia‑1 mouse models, where it promotes gamma‑H2AX foci formation and enhances neuronal pentraxin‑1‑mediated synaptic pruning, thereby contributing to the observed neuroinflammatory phenotype.",-45.75,0.8,geneorgeneproduct
"ETRS1 overexpression in HeLa cells markedly increases gamma‑H2AX foci and activates T‑cell factor‑4 signaling, thereby amplifying a pro‑inflammatory cytokine cascade that augments neuronal pentraxin‑1 release.",-39.75,0.8,geneorgeneproduct
"Expression of the transcription factor ETS1 in HeLa cells is markedly up‑regulated by treatment with the small molecule inhibitor doxorubicin, which increases gamma‑H2AX foci and induces apoptosis through a pro‑inflammatory cytokine cascade.",-33.0,0.8,geneorgeneproduct
Expression‐dependent up‑regulation of gamma‑H2AX by the transcription factor ETS1 in neuronal pentraxin‑1‑stimulated cortical neurons was confirmed by chromatin immunoprecipitation in the human neuroblastoma cell line SH‑SY5Y.,-48.75,0.8,geneorgeneproduct
"Expression levels of PABPN1 and gamma‑H2AX are markedly increased in neuronal pentraxin‑1‑overexpressing HeLa cells, suggesting that this gene‑product interaction may drive chromatin changes and enhance bone‑morphogenetic‑protein‑receptor‑1 signaling in the presence of fractalkine receptor activation.",-58.0,0.8,geneorgeneproduct
"Expression patterns of the transcription factor ETS1, which is up‑regulated in schizophrenia patients, correlate with increased γ‑H2AX foci in neuronal pentraxin‑1‑positive cortical neurons derived from induced pluripotent stem cells of the Schizophrenia‑1 locus.",-49.5,0.8,geneorgeneproduct
"Fluorescent immunostaining revealed that gamma‑H2AX foci markedly increased in A549 cells transfected with the PABPN1 c.68_69delAG variant, suggesting that the DNA‑damage response is activated through T‑cell factor‑4‑mediated transcriptional up‑regulation of pro‑inflammatory cytokines.",-42.5,0.8,geneorgeneproduct
"Flanking a novel PABPN1 promoter hypomethylation variant, the study showed that reduced PABPN1 transcription up‑regulates gamma‑H2AX expression, thereby sensitizing neuronal pentraxin‑1‑positive neurons to apoptotic death via a bone morphogenetic protein receptor‑1‑dependent apoptotic cascade.",-69.5,0.8,geneorgeneproduct
"Fluctuating levels of the proinflammatory cytokine gamma‑H2AX in HeLa cells expressing mutant PABPN1 correlate with increased DNA damage signaling and reduced neuronal pentraxin‑1 expression, implicating a potential mechanism for neurodegeneration in schizophrenia‑1.",-45.0,0.8,geneorgeneproduct
"Flavopiridol treatment of the A549 cell line markedly reduced gamma‑H2AX foci formation, indicating suppression of DNA damage signaling that is otherwise enhanced by the mutant PABPN1 allele linked to myotonic dystrophy.",-42.0,0.8,geneorgeneproduct
"Deficiency of the PABPN1 gene product in skeletal muscle cells leads to the accumulation of polyglutamine‑expanded transcripts, which induces γ‑H2AX phosphorylation and activates pro‑inflammatory cytokine production, thereby contributing to the myopathic phenotype observed in oculopharyngeal muscular dystrophy.",-42.5,0.8,geneorgeneproduct
"Deficiencies of PABPN1 impair nuclear poly(A) tail binding and lead to aggregation of alpha‑helical domains, thereby reducing gamma‑H2AX phosphorylation at sites of double‑strand breaks and ultimately compromising DNA repair fidelity in neuronal pentraxin‑1‑expressing cortical neurons.",-60.5,0.8,geneorgeneproduct
"Defective PABPN1 binding to pre-mRNA in the nucleus activates γ‑H2AX signaling, which in turn up‑regulates bone‑morphogenetic‑protein‑receptor‑1 transcription in neurons and triggers pro‑inflammatory cytokine production in schizophrenia‑1‑associated T‑cell factor‑4‑positive immune cells.",-57.5,0.8,geneorgeneproduct
"Defects in the PABPN1 gene product cause the polyglutamine expansion seen in oculopharyngeal muscular dystrophy, while increased nuclear gamma‑H2AX foci in patient fibroblasts correlate with the severity of DNA‑damage responses.",-42.5,0.8,geneorgeneproduct
"Ectopic overexpression of the transcription factor ETS1 in the neuronal cell line SH‑SY5Y drives upregulation of the pro‑inflammatory cytokine interleukin‑6, which in turn enhances phosphorylation of gamma‑H2AX at sites of DNA damage, thereby linking ETS1 activity to DNA repair signaling in a model of schizophrenia‑1 pathogenesis.",-43.5,0.8,geneorgeneproduct
"Evidently, the PABPN1 variant c.118_120delGCA reduces gamma‑H2AX foci formation in fibroblasts, suggesting that this sequence variant impairs the DNA‑damage response in patients with neurodegenerative phenotypes.",-52.25,0.8,geneorgeneproduct
"E3‑ubiquitin ligase CBX7 promotes neuronal pentraxin‑1 degradation in cortical neurons, and its loss of function in schizophrenia‑1 patients leads to increased γ‑H2AX foci and elevated pro‑inflammatory cytokine production.",-46.5,0.8,geneorgeneproduct
"Epidemiologic analysis of schizophrenia cases revealed that a missense mutation in the PABPN1 gene (c.217G>A) correlates with increased gamma‑H2AX foci in neuronal cells, indicating heightened DNA damage signaling.",-43.75,0.8,geneorgeneproduct
"Fractalkine receptor activation in Schizophrenia‑1 patient hippocampal cultures upregulates neuronal pentraxin‑1 expression, leading to increased gamma‑H2AX foci and a pro‑inflammatory cytokine profile that ultimately down‑regulates BMPR‑1 signaling.",-47.25,0.8,geneorgeneproduct
"Frontal cortex PABPN1 up‑regulation following gamma‑H2AX‑mediated DNA damage in schizophrenia‑1 patients enhances neuronal pentraxin‑1 expression, thereby promoting synaptic remodeling through the fractalkine receptor and ETS1‑dependent T‑cell factor‑4 activation.",-48.25,0.8,geneorgeneproduct
"Fructalkine receptor over‑expression in human HeLa cells induces gamma‑H2AX phosphorylation and up‑regulates pro‑inflammatory cytokine production, thereby enhancing neuronal pentraxin‑1‑mediated synaptic pruning.",-38.5,0.8,geneorgeneproduct
"Fractal‑shape mutations in the PABPN1 gene, which reduce γ‑H2AX phosphorylation in neuronal pentraxin‑1‑positive hippocampal neurons, were shown to impair bone‑morphogenetic‑protein‑receptor‑1 signaling and thereby increase pro‑inflammatory cytokine secretion, suggesting a potential therapeutic target for schizophrenia‑1‑associated cognitive deficits.",-60.5,0.8,geneorgeneproduct
"Activation of STAT5 by IFIT2 in HNF‑1α‑expressing hepatocytes leads to CYP3A4‑mediated metabolism of the chemotherapeutic drug CBKOTg, thereby reducing its cytotoxicity in A549 lung carcinoma cells.",-27.375,0.8,geneorgeneproduct
"Activation by CYP3A4-mediated metabolism of doxorubicin enhances the cytotoxicity of the drug in A549 cells, where STAT5 signaling upregulates Glutathione‑S‑transferase P1 expression to counteract oxidative stress.",-34.5,0.8,geneorgeneproduct
"Activation-induced cytidine deaminase (AID) upregulates IFIT2 expression in HeLa cells, thereby enhancing STAT5‑mediated antiviral responses and reducing the cytotoxicity of CYP3A4‑mediated doxorubicin metabolism.",-37.75,0.8,geneorgeneproduct
"Activation‐dependent phosphorylation of STAT5 by ADAM10‐mediated cleavage of the Notch1 receptor in HeLa cells increases expression of IFIT2, which in turn enhances CYP3A4‑mediated detoxification of the chemotherapeutic agent doxorubicin.",-43.75,0.8,geneorgeneproduct
"A549 cells overexpressing the ADAM10 gene product show increased STAT5 phosphorylation when treated with a CYP3A4‑mediated metabolite of doxorubicin, thereby enhancing IFIT2‑mediated antiviral signaling.",-24.25,0.8,geneorgeneproduct
A CRISPR‑Cas9 edited A549 cell line expressing the STAT5‑PON fusion protein shows that loss of ADAM10 cleavage of the IFIT2 receptor reduces cytokine‑mediated apoptosis in a CYP3A4‑mediated metabolite‑dependent manner.,-49.0,0.8,geneorgeneproduct
"A STAT5‑mediated up‑regulation of Glutathione‑S‑transferase P1 in HepG2 cells is inhibited by the CYP3A4‑mediated metabolism of the activin‑stimulated compound, thereby reducing detoxification capacity.",-27.625,0.8,geneorgeneproduct
"A polymorphism in the promoter of Glutathione‑S‑transferase P1 reduces its expression in hepatocytes, thereby impairing CYP3A4‑mediated detoxification of the chemotherapeutic agent doxorubicin and increasing cardiotoxicity in patients with the HNF‑1alpha risk allele.",-31.125,0.8,geneorgeneproduct
"ADAM10 overexpression in A549 cells activates STAT5 signaling, inducing IFIT2 transcription and enhancing CYP3A4-mediated metabolism of the chemotherapeutic agent doxorubicin, thereby modulating the cellular antioxidant response via Glutathione‑S‑transferase P1.",-27.875,0.8,geneorgeneproduct
"ADAR1-mediated editing of IFIT2 mRNA in A549 cells leads to reduced STAT5 phosphorylation, thereby attenuating the activin‑stimulated transcriptional activation of CYP3A4‑mediated drug metabolism genes.",-32.75,0.8,geneorgeneproduct
"ADH1B gene variants influence CYP3A4-mediated metabolism of the chemotherapeutic drug doxorubicin, thereby modulating the risk of cardiotoxicity in patients with coronary artery disease.",-33.5,0.8,geneorgeneproduct
"ADIRK‑mediated activation of STAT5 in HeLa cells upregulates IFIT2 expression, which in turn enhances glutathione‑S‑transferase P1 transcription and confers resistance to CYP3A4‑mediated doxorubicin cytotoxicity.",-41.75,0.8,geneorgeneproduct
"The ADAM10 protein, whose expression is up‑regulated by STAT5 binding to the HNF‑1alpha‑responsive promoter, is cleaved by CYP3A4‑mediated metabolism, thereby modulating the release of activin‑stimulated cytokines that ultimately enhance IFIT2 transcription in human hepatocyte cell lines.",-40.0,0.8,geneorgeneproduct
"The transcription factor STAT5 upregulates the expression of Glutathione‑S‑transferase P1, thereby enhancing CYP3A4‑mediated detoxification in HepG2 cells infected with a recombinant adenovirus encoding the ADAM10 gene.",-28.5,0.8,geneorgeneproduct
"The activation of STAT5 in A549 cells by IFIT2‑induced interferon signaling enhances CYP3A4‑mediated metabolism of the chemotherapeutic drug doxorubicin, thereby reducing its cytotoxicity against tumor cells.",-24.125,0.8,geneorgeneproduct
"The upregulation of ADAM10 in A549 cells exposed to a CYP3A4‑mediated metabolite of doxorubicin enhances STAT5 phosphorylation, thereby increasing the expression of IFIT2 and promoting a protective anti‑apoptotic phenotype.",-29.25,0.8,geneorgeneproduct
"Glutathione‑S‑transferase P1 (GSTP1) polymorphism modulates the CYP3A4‑mediated metabolism of the chemotherapeutic agent doxorubicin, thereby influencing the activation of STAT5 signaling and the expression of the anti‑apoptotic gene BCL‑XL in A549 cells.",-25.75,0.8,geneorgeneproduct
"Glucose-6-phosphate dehydrogenase deficiency, caused by a pathogenic variant in the G6PD gene, is associated with increased oxidative stress in erythrocytes and exacerbates the hepatotoxicity observed in patients treated with primaquine.",-46.0,0.8,geneorgeneproduct
"Glucocorticoid-induced up‑regulation of STAT5 in A549 cells leads to increased CYP3A4-mediated metabolism of the chemotherapeutic agent doxorubicin, thereby reducing its cytotoxic efficacy and contributing to acquired drug resistance.",-33.5,0.8,geneorgeneproduct
"Glial‑derived STAT5 activation downstream of ADAM10 cleavage of the epidermal growth factor receptor induces IFIT2 expression, thereby amplifying the innate antiviral response in human astrocytes.",-36.0,0.8,geneorgeneproduct
"Overexpression of ADAM10 in A549 cells enhances STAT5‑mediated transcription of IFIT2, a response that is further amplified by CYP3A4‑mediated metabolism of the small‑molecule inhibitor CBKOTg, thereby promoting an activin‑stimulated survival pathway that mitigates ethanol‑induced oxidative stress in human liver organoid cultures.",-47.5,0.8,geneorgeneproduct
"Overactivation of STAT5 by the CYP3A4‑mediated metabolite of the antineoplastic drug doxorubicin triggers up‑regulation of the Glutathione‑S‑transferase P1 gene in HeLa cells, thereby enhancing cellular resistance to oxidative damage.",-35.0,0.8,geneorgeneproduct
"Overexpressed ADAM10 in HeLa cells activates STAT5 signalling, thereby up‑regulating IFIT2 transcription and enhancing the CYP3A4‑mediated metabolism of the anticancer drug doxorubicin.",-25.0,0.8,geneorgeneproduct
"Overdose of the CYP3A4‑mediated metabolite of the anti‑inflammatory drug ibuprofen induces a marked STAT5‑dependent up‑regulation of Glutathione‑S‑transferase P1 in HepG2 cells, thereby attenuating the cytotoxicity of the parent compound in a dose‑responsive manner.",-49.25,0.8,geneorgeneproduct
"In the A549 cell line, CYP3A4-mediated metabolism of the chemotherapeutic agent doxorubicin was found to upregulate the transcription factor STAT5, thereby inducing expression of the drug‑resistance gene Glutathione‑S‑transferase P1.",-29.625,0.8,geneorgeneproduct
"In HepG2 cells, the CYP3A4-mediated metabolism of the chemotherapeutic agent doxorubicin induces up‑regulation of the detoxifying enzyme Glutathione‑S‑transferase P1, thereby attenuating drug‑induced cytotoxicity.",-23.625,0.8,geneorgeneproduct
"In HNF‑1α‑deficient HepG2 cells, STAT5 activation up‑regulates CYP3A4‑mediated metabolism of doxorubicin, thereby reducing drug‑induced cytotoxicity and attenuating the apoptotic response in the treated cell line.",-38.0,0.8,geneorgeneproduct
"In HeLa cells, overexpression of ADAM10 enhances STAT5 phosphorylation, leading to up‑regulation of IFIT2 and a subsequent increase in CYP3A4‑mediated metabolism of the chemotherapeutic drug doxorubicin.",-22.5,0.8,geneorgeneproduct
"Mutations in the gene **Glutathione‑S‑transferase P1** alter the expression of the downstream transcription factor **STAT5**, thereby amplifying the interferon‑induced antiviral gene **IFIT2** and sensitizing **HNF‑1α**‑regulated liver cells to oxidative stress.",-44.0,0.8,geneorgeneproduct
"Mutated Glutathione‑S‑transferase P1 (GSTP1) Cys341Tyr reduces CYP3A4‑mediated metabolism of doxorubicin in HepG2 cells, leading to elevated intracellular ROS and STAT5‑dependent up‑regulation of the pro‑apoptotic gene BAX.",-39.75,0.8,geneorgeneproduct
"Mutant Glutathione‑S‑transferase P1 alleles were found to down‑regulate CYP3A4‑mediated drug metabolism, leading to a statistically significant increase in hepatotoxicity in HepG2 cells expressing ADAM10 and STAT5 overexpression.",-43.0,0.8,geneorgeneproduct
Mutational analysis of the CYP3A4-mediated drug‑induced hepatotoxicity in HepG2 cells revealed that the STAT5-dependent upregulation of Glutathione‑S‑transferase P1 markedly attenuates the cellular oxidative stress induced by the ADAM10 inhibitor.,-42.75,0.8,geneorgeneproduct
"Mutation of the GSTP1 promoter causes reduced transcription of Glutathione‑S‑transferase P1, which in turn lowers the detoxification capacity of HepG2 cells and enhances susceptibility to cisplatin‑induced cytotoxicity in vitro.",-35.25,0.8,geneorgeneproduct
"Mutation‑induced loss of Glutathione‑S‑transferase P1 activity in HeLa cells, coupled with STAT5‑mediated up‑regulation of IFIT2, enhances sensitivity to CYP3A4‑mediated drug metabolism and accelerates disease progression in a mouse model of hepatocellular carcinoma.",-46.5,0.8,geneorgeneproduct
"Mutation in the ADAM10 gene product, which is up‑regulated by STAT5 in human HepG2 cells, enhances proteolytic cleavage of the PON2 protein and thereby increases susceptibility to oxidative stress–induced apoptosis.",-44.75,0.8,geneorgeneproduct
"Mutation analysis revealed that the CYP3A4‑mediated metabolism of the chemotherapeutic agent paclitaxel is up‑regulated in HeLa cells, a change that is driven by STAT5‑dependent transcription of the Glutathione‑S‑transferase P1 gene.",-39.5,0.8,geneorgeneproduct
"Altered expression of the transcription factor HNF‑1α in HepG2 cells enhances CYP3A4-mediated metabolism of the chemotherapeutic agent doxorubicin, thereby reducing drug‑induced apoptosis.",-20.625,0.8,geneorgeneproduct
"Alteration of the Glutathione‑S‑transferase P1 promoter by the −119C>G polymorphism modulates its transcription in HepG2 cells, thereby influencing CYP3A4‑mediated metabolism of the anticancer drug doxorubicin.",-35.25,0.8,geneorgeneproduct
"Alterations in the STAT5 gene product, as observed in a CRISPR‑edited HEK293 cell line, enhanced the CYP3A4‑mediated metabolism of the chemotherapeutic drug doxorubicin, thereby increasing the cytotoxic response in a dose‑dependent manner.",-52.0,0.8,geneorgeneproduct
"Altering the expression of the gene product Glutathione‑S‑transferase P1 in HepG2 cells decreases CYP3A4‑mediated metabolism of the anticancer drug doxorubicin, thereby enhancing its cytotoxicity against the colorectal carcinoma cell line HCT116.",-39.75,0.8,geneorgeneproduct
"STAT5 phosphorylation by ADAM10-mediated cleavage of its receptor is amplified in HepG2 cells expressing the CYP3A4-mediated metabolite of the drug CBKOTg, thereby enhancing IFIT2 transcription and promoting glutathione‑S‑transferase P1‑dependent detoxification.",-40.25,0.8,geneorgeneproduct
"STAT‑5 phosphorylation by ADAM10‑cleaved soluble EGFR fragments in HeLa cells is potentiated by CYP3A4‑mediated metabolism of the chemotherapeutic doxorubicin, resulting in enhanced activation of the IFIT2 antiviral response.",-53.0,0.8,geneorgeneproduct
"STAT‐5 activation by the activin‑stimulated pathway in HepG2 cells was attenuated when the CYP3A4‑mediated metabolite of the drug CBKOTg accumulated, revealing a potential interaction between the gene product STAT5 and the chemical entity CBKOTg in the context of hepatic metabolism.",-55.25,0.8,geneorgeneproduct
"STAT1 activation in HepG2 cells by IFN‑γ induces a CYP3A4‑mediated increase in the metabolism of the chemotherapeutic doxorubicin, thereby reducing its cytotoxicity toward the cancer cell line.",-42.5,0.8,geneorgeneproduct
"Cytokine‑induced STAT5 phosphorylation in HepG2 cells upregulates the expression of the detoxifying enzyme Glutathione‑S‑transferase P1, thereby enhancing CYP3A4‑mediated drug metabolism and reducing the cytotoxic effects of doxorubicin.",-25.375,0.8,geneorgeneproduct
"CYP3A4-mediated metabolism of the anticancer drug doxorubicin in the A549 cell line was found to be upregulated by STAT5 activation, which in turn increased the expression of the detoxifying enzyme Glutathione‑S‑transferase P1 and reduced intracellular reactive oxygen species in E. coli‑derived bacterial lysates.",-37.25,0.8,geneorgeneproduct
"C57BL/6J mice harboring the STAT5 knockout exhibited a markedly reduced tumorigenic response to doxorubicin in the A549 xenograft model, suggesting that STAT5 mediates chemotherapeutic resistance through CYP3A4‑dependent metabolism.",-49.75,0.8,geneorgeneproduct
"C15orf48 overexpression in HepG2 cells leads to increased STAT5 phosphorylation and downstream IFIT2 transcription, thereby enhancing resistance to doxorubicin-induced apoptosis.",-34.5,0.8,geneorgeneproduct
"Loss of the Glutathione‑S‑transferase P1 allele in a CYP3A4‑mediated xenobiotic pathway leads to increased STAT5 activation and up‑regulation of IFIT2 in HepG2 cells, suggesting a possible link between detoxification gene variants and antiviral response modulation.",-45.75,0.8,geneorgeneproduct
"Loss-of-function mutations in the glutathione‑S‑transferase P1 gene (GSTM1) impair the detoxification of CYP3A4‑mediated xenobiotics in HepG2 cells, thereby enhancing STAT5‑driven proliferation of malignant hepatocytes.",-32.75,0.8,geneorgeneproduct
"Loss‑of‑function mutations in the ADAM10 gene, which normally cleaves the extracellular domain of the Notch receptor, impair STAT5‑mediated transcription of the downstream target IFIT2 in HepG2 cells, thereby reducing the antiviral interferon response.",-39.25,0.8,geneorgeneproduct
Losses in the Glutathione‑S‑transferase P1 promoter combined with a CYP3A4‑mediated increase in doxorubicin metabolism were observed to aggravate cardiotoxicity in a cohort of HNF‑1alpha‑mutated *Homo sapiens* patients.,-45.25,0.8,geneorgeneproduct
"Activin‑stimulated expression of STAT5 in HeLa cells upregulates CYP3A4‑mediated metabolism of the chemotherapeutic drug doxorubicin, thereby enhancing the cytotoxic response to treatment.",-23.5,0.8,geneorgeneproduct
"Activating the STAT5 pathway in A549 cells treated with a CYP3A4-mediated inhibitor of Glutathione‑S‑transferase P1 reduces IFIT2 expression, thereby enhancing interferon‑γ–induced apoptosis.",-37.0,0.8,geneorgeneproduct
"Activative stimulation of HNF‑1α in HepG2 cells upregulates CYP3A4-mediated metabolism of doxorubicin, a process that is suppressed by the STAT5‑dependent expression of Glutathione‑S‑transferase P1, thereby modulating the chemotherapeutic response.",-47.5,0.8,geneorgeneproduct
"Activational phosphorylation of STAT5 by ADAM10 cleavage of the cytokine receptor leads to up‑regulation of Glutathione‑S‑transferase P1 expression, thereby enhancing CYP3A4‑mediated drug metabolism in HepG2 cells.",-38.5,0.8,geneorgeneproduct
"Pdx1-Cre–mediated deletion of DGAT1 in pancreatic β‑cells impairs insulin synthesis by down‑regulating the PI3K/PLC‑γ signaling pathway, thereby exacerbating hyperglycemia in a murine model of type‑2 diabetes.",-30.375,0.8,geneorgeneproduct
"Pgf1-Cre-mediated deletion of the dopamine receptor D2 gene in murine cortical neurons led to upregulation of the phospholipase Cβ3 enzyme and downstream activation of the FGF receptor‑2 signaling cascade, thereby exacerbating motor deficits in a Parkinson’s disease model.",-64.5,0.8,geneorgeneproduct
"Pdp1‑Cre‑mediated deletion of the dopamine receptor D2 in murine hippocampal neurons leads to up‑regulation of the transcription factor Pdx1 and causes a reduction in DGAT1‑dependent lipid droplet formation, thereby impairing neuronal survival under oxidative stress.",-52.75,0.8,geneorgeneproduct
"Pdgfb‑mediated activation of the FGF receptor‑2 signaling pathway in HeLa cells expressing the Pdx1‑Cre transgene induces PLC‑γ‑dependent phosphorylation of the dopamine receptor, resulting in enhanced expression of the lipid‑synthesizing enzyme DGAT1.",-50.25,0.8,geneorgeneproduct
"The Pdx1-Cre–driven deletion of the DGAT1 gene in pancreatic β‑cells increases plasma insulin levels, a phenotype that is exacerbated by the loss of the PLC‑γ1 signaling module downstream of the dopamine receptor in the same tissue.",-44.5,0.8,geneorgeneproduct
"The CRISPR‑mediated knockout of the DGAT1 gene in the HeLa cell line dramatically reduced triglyceride accumulation and led to up‑regulation of the insulin‑sensitive polymerase E3 ligase complex, thereby linking DGAT1 loss to altered lipid metabolism in human cancer cells.",-53.75,0.8,geneorgeneproduct
"The DGAT1‑mediated triglyceride synthesis in Pdx1‑Cre–driven pancreatic β‑cell lines increases insulin secretion, a process that is further amplified by the activation of the dopamine receptor signaling cascade and the downstream PLC‑dependent calcium mobilization.",-50.25,0.8,geneorgeneproduct
"The tyrosine‑phosphorylated PLCγ1 activated by PDGFB stimulation in PDGF‑responsive A549 cells induces Group‑I‑PAK‑mediated phosphorylation of the eIF4E‑binding protein, thereby enhancing cap‑dependent translation of the FGF receptor‑2 mRNA.",-60.0,0.8,geneorgeneproduct
"Using a Pdx1-Cre transgenic mouse, loss of DGAT1 in pancreatic β‑cells causes insulin hypersecretion and activates the PLC‑γ/4E‑BP1 pathway, thereby inducing dopamine‑receptor‑mediated β‑cell apoptosis.",-47.25,0.8,geneorgeneproduct
"Using Pdx1‑Cre‑mediated deletion of the DGAT1 gene in the pancreas of Mus musculus, researchers observed that loss of DGAT1 altered lipid droplet accumulation and induced up‑regulation of the insulin‑responsive transcription factor Pdx1, thereby revealing a novel regulatory pathway linking DGAT1 activity to pancreatic β‑cell function.",-56.0,0.8,geneorgeneproduct
"Using the Pdx1-Cre knock-in mouse, the conditional deletion of DGAT1 in pancreatic β‑cells led to a marked reduction in insulin secretion, illustrating that DGAT1 activity is required for proper insulin synthesis and release in response to glucose stimulation.",-42.75,0.8,geneorgeneproduct
"Using CRISPR/Cas9-mediated Pdx1-Cre recombination, we observed that knockout of the DGAT1 gene in pancreatic β‑cells significantly reduced insulin secretion while simultaneously upregulating the expression of the dopamine receptor D2, thereby linking lipid metabolism to neuroendocrine signaling.",-47.25,0.8,geneorgeneproduct
"Deletion of the BRCA1 c.68_69delAG variant in a patient’s somatic DNA was found to diminish the binding affinity of the DNA polymerase γ for mitochondrial templates, thereby reducing the replication of mtDNA and contributing to the onset of Parkinson’s disease.",-49.25,0.8,geneorgeneproduct
"Deletion in the **Pdx1‑Cre** allele reduces **DGAT1** transcription in pancreatic β‑cells, thereby decreasing triglyceride synthesis and impairing insulin secretion in **Homo sapiens** mice.",-35.0,0.8,geneorgeneproduct
"Deletion‑driven loss of the Pdx1‑Cre‑mediated exon of the *PDGFB* gene in the murine pancreatic ductal epithelium precipitates a marked upregulation of the dopamine receptor D3 and a concomitant decrease in the expression of the metabolic regulator DGAT1, thereby inducing insulin resistance and pancreatic β‑cell dysfunction.",-80.0,0.8,geneorgeneproduct
"Deletion upstream of the Pdx1-Cre enhancer disrupts its interaction with the dopamine receptor‑regulated transcription factor, thereby abolishing pancreatic β‑cell expression of the DGAT1 gene product while leaving the PDGFB‑activated PLC‑mediated signaling cascade intact.",-57.75,0.8,geneorgeneproduct
"Mutations in the polymerase gene POLG that abolish its proofreading activity lead to a mitochondrial DNA sequence variant, causing an accumulation of reactive oxygen species that activates the dopamine receptor D2 and subsequently upregulates the FGF receptor‑2‑mediated signaling pathway in A549 cells.",-58.75,0.8,geneorgeneproduct
"Mutational activation of Pdx1-Cre-driven deletion of the DGAT1 gene in a murine pancreatic cancer model leads to decreased tumor growth, coinciding with downregulation of the insulin signaling pathway and upregulation of the protein kinase Cα (PKCα) activity.",-66.5,0.8,geneorgeneproduct
"Mutant DGAT1 expression in Pdx1‑Cre pancreatic β‑cell lines leads to abnormal triglyceride accumulation, which activates the PLC‑γ‑dependent pathway and reduces insulin secretion, thereby exacerbating diabetes in the mouse model.",-49.75,0.8,geneorgeneproduct
"Mutagenic exposure of the Pdx1‑Cre‑driven pancreatic epithelial cells to the dopamine receptor agonist SCH‑23390 upregulates PLC‑γ1 phosphorylation, thereby enhancing FGF receptor‑2‑mediated proliferation and increasing DGAT1‑dependent lipid droplet accumulation in the pancreatic ductal adenocarcinoma cell line Panc‑02.",-56.75,0.8,geneorgeneproduct
"DGAT1 overexpression in PDGFB‑stimulated HeLa cells leads to increased triglyceride synthesis, while a Pdx1‑Cre‑mediated deletion of the same gene in pancreatic β‑cells reduces insulin production and induces diabetes in a mouse model.",-39.75,0.8,geneorgeneproduct
"DGABP‑Cre–mediated deletion of the Gdf11 gene in mouse embryonic fibroblasts leads to hyperactive FGF receptor‑2 signaling, thereby increasing PLCγ phosphorylation and elevating the expression of the downstream protein‑binding partner, the transcription factor Pdx1, which ultimately promotes aberrant insulin synthesis in pancreatic β‑cells.",-118.0,0.8,geneorgeneproduct
"DG‑AT1 overexpression in A549 cells driven by the Pdx1‑Cre system enhances lipid droplet formation and activates the PDGFB‑PLC signaling cascade, thereby promoting chemoresistance to doxorubicin in this lung carcinoma model.",-51.75,0.8,geneorgeneproduct
"DGAP1 overexpression in the human pancreatic β‑cell line MIN6, driven by a Pdx1‑Cre transgene, activates the PI3K‑AKT‑4E‑BP1 pathway, thereby enhancing insulin secretion and reducing ER stress‑induced apoptosis.",-54.5,0.8,geneorgeneproduct
"Loss of Pdx1‑Cre‑mediated deletion of the DGAT1 gene in the pancreatic beta‑cell line MIN6 leads to a dramatic reduction in insulin synthesis, suggesting that DGAT1 is essential for maintaining the transcriptional activity of the insulin gene via the insulin promoter.",-48.75,0.8,geneorgeneproduct
"Loss-of-function mutations in the DGAT1 gene, which encodes a key triglyceride‑synthesizing enzyme, cause severe infantile diarrhoea and steatorrhoea, and a compound heterozygous c.1033G>A (p.Arg345His) variant was identified in a patient exhibiting elevated triglyceride levels and a marked reduction in the expression of the downstream fatty‑acid‑binding protein gene.",-86.0,0.8,geneorgeneproduct
"Loss‐of‑function mutations in the DNA polymerase gene POLA1 cause a severe combined immunodeficiency that is rescued in vitro by lentiviral delivery of wild‑type POLA1, thereby restoring DNA replication fork progression in patient‑derived fibroblasts.",-47.75,0.8,geneorgeneproduct
"Losses of the PDGFB promoter mediated by the Pdx1‑Cre‑driven excision of a loxP cassette decrease fibroblast proliferation and increase collagen deposition, thereby accelerating pulmonary fibrosis in a murine model.",-53.25,0.8,geneorgeneproduct
"In A549 cells, Pdx1-Cre mediated deletion of DGAT1 promotes lipid droplet accumulation, which in turn activates the FGF receptor‑2 signaling cascade to enhance cell proliferation and upregulate the expression of the transcription factor c‑Myc.",-51.5,0.8,geneorgeneproduct
"In PDGF‑B‑stimulated A549 cells, Pdx1‑Cre‑mediated deletion of DGAT1 upregulates the insulin‑responsive dopamine receptor D2, causing a cascade that activates PLC‑β and increases phosphorylation of the translational repressor protein phospho‑4E‑BP1, thereby enhancing synthesis of the tumor‑suppressive gene product p53.",-78.5,0.8,geneorgeneproduct
"In the Pdx1‑Cre;DGAT1‑floxed mouse model, loss of DGAT1 in pancreatic β‑cells increases insulin production, leading to hyperinsulinemia that subsequently stimulates hepatic IGF‑1 production and up‑regulates hepatic FGF receptor‑2 signaling, thereby promoting hepatic steatosis.",-55.75,0.8,geneorgeneproduct
"In Pdx1-Cre transgenic mice, loss of the dopamine receptor‑2 gene product synergizes with DGAT1 overexpression to impair pancreatic β‑cell insulin secretion, a phenotype rescued by pharmacological activation of the PLC‑5‑HT6 receptor axis.",-43.5,0.8,geneorgeneproduct
"Knockout of the DGAT1 gene in Pdx1‑Cre‑mediated pancreatic β‑cells led to a significant reduction in insulin secretion, suggesting a regulatory interaction between DGAT1 and the dopamine receptor signaling pathway.",-38.5,0.8,geneorgeneproduct
"Knocking out Pdx1‑Cre‑mediated deletion of the DGAT1 gene in mouse pancreatic β‑cells upregulates the insulin‑binding FGF receptor‑2 pathway, leading to enhanced insulin secretion and reduced blood glucose levels.",-43.25,0.8,geneorgeneproduct
"Knocked‑out DGAT1 in Pdx1‑Cre pancreatic β‑cells reduces insulin secretion by disrupting lipid droplet formation, which is mediated through altered PLC‑γ1 activation downstream of the FGF receptor‑2 signaling pathway.",-48.0,0.8,geneorgeneproduct
"Knox et al. showed that the Pdx1‑Cre‑mediated deletion of the DGAT1 gene product in pancreatic β‑cells of C57BL/6 mice caused a significant reduction in insulin secretion, linking the gene‑specific loss of DGAT1 to impaired glucose‑stimulated insulin release.",-49.25,0.8,geneorgeneproduct
"A Pdx1‑Cre‑mediated knockout of DGAT1 in pancreatic β‑cells of a C57BL/6J mouse model reduced insulin secretion, leading to hyperglycemia and an up‑regulation of the PLC‑dependent activation of the dopamine receptor‑mediated signaling cascade.",-48.75,0.8,geneorgeneproduct
"A loss‑of‑function mutation in the DGAT1 gene, which encodes a key triglyceride‑synthesizing enzyme, was found to up‑regulate the phosphorylation of the translational repressor protein **4E‑BP1** in **HeLa** cells, thereby enhancing cap‑dependent translation of the **dopamine receptor D2** mRNA and increasing cellular sensitivity to the **PDGFB** growth factor.",-63.25,0.8,geneorgeneproduct
"A PDGFB promoter mutation in the Pdx1-Cre mouse line decreases FGF receptor‑2 expression, leading to impaired pancreatic β‑cell proliferation and subsequent glucose intolerance.",-39.0,0.8,geneorgeneproduct
"A hypomorphic Pdx1‑Cre allele, combined with a gain‑of‑function mutation in the DGAT1 promoter, reduces pancreatic β‑cell mass by impairing insulin transcription and elevating triglyceride synthesis, thereby accelerating glucose intolerance in murine models.",-46.5,0.8,geneorgeneproduct
"Gain‑of‑function mutations in the Pdx1‑Cre‑driven TP53 allele up‑regulate the expression of the dopamine receptor D2 and increase the activity of the polymerase γ complex, thereby enhancing the transcriptional activation of the DGAT1 gene in pancreatic β‑cells.",-54.25,0.8,geneorgeneproduct
"Gain-of-function mutations in the Pdx1‑Cre‑driven allele of the DGAT1 gene enhance insulin secretion in pancreatic β‑cells, likely through increased activation of the PLC‑γ1 signaling cascade that upregulates the dopamine receptor D2‑like pathway in the islets of Langerhans.",-57.5,0.8,geneorgeneproduct
"Gain‐of‐function mutations in the PDGFB promoter in glioblastoma cells driven by Pdx1‑Cre lead to hyperactivation of the FGF receptor‑2/PLC‑γ signaling cascade, thereby promoting uncontrolled proliferation of the tumor cell line U87MG.",-52.0,0.8,geneorgeneproduct
"Gain of function in the Pdx1-Cre–driven deletion of the gene DGAT1 in pancreatic β‑cells of a mouse strain with the C57BL/6J background leads to dysregulated lipid metabolism and impaired insulin secretion, illustrating a critical link between DGAT1, insulin, and pancreatic dysfunction.",-67.5,0.8,geneorgeneproduct
"Activation of the dopamine receptor D2 in HeLa cells induces PLC-mediated phosphatidylinositol turnover, thereby enhancing FGF receptor‑2 phosphorylation and downstream Group‑I‑PAK signaling, which in turn upregulates DGAT1 expression and promotes lipid droplet accumulation.",-44.75,0.8,geneorgeneproduct
"Activation by Pdx1‑Cre of a floxed Dgat1 allele in pancreatic β‑cells leads to a dramatic reduction of hepatic lipogenic enzyme levels, thereby attenuating insulin resistance and preventing the onset of type‑2 diabetes in the murine model.",-59.75,0.8,geneorgeneproduct
"Activation‑dependent phosphorylation of the dopamine receptor by Pdx1‑Cre‑driven PLK1 in HeLa cells leads to increased PLC‑mediated cAMP production and downstream up‑regulation of the FGF receptor‑2 signaling cascade, thereby enhancing cellular proliferation.",-64.5,0.8,geneorgeneproduct
"Activation is achieved when Pdx1‑Cre–mediated excision of the floxed alleles leads to a loss of DGAT1 expression, thereby reducing triglyceride synthesis and attenuating PLC‑dependent signaling in pancreatic β‑cells, ultimately improving glucose‑induced insulin secretion.",-65.0,0.8,geneorgeneproduct
"Heterozygous loss-of-function variants in the DGAT1 gene, detected by polymerase‑chain reaction on patient‑derived liver biopsies from Homo sapiens, impair triglyceride synthesis, leading to hepatic steatosis that is alleviated by selective antagonism of the dopamine receptor D2 in cultured Huh‑7 hepatoma cells.",-60.75,0.8,geneorgeneproduct
"Homozygous loss of the Pdx1‑Cre allele in pancreatic β‑cells leads to down‑regulation of the insulin gene and up‑regulation of the DGAT1‑mediated triglyceride synthesis pathway, thereby exacerbating glucose intolerance in a mouse model of type‑2 diabetes.",-35.25,0.8,geneorgeneproduct
"Hepatic expression of the dopamine receptor gene DRD2 was markedly increased in Pdx1‑Cre–derived pancreatic β‑cell lines treated with the small‑molecule DGAT1 inhibitor, leading to enhanced insulin secretion and activation of the PLC‑4E‑BP1 signaling cascade.",-46.5,0.8,geneorgeneproduct
"Haplotype‑specific activation of the dopamine receptor gene by Pdx1‑Cre‑driven Cre recombinase in HeLa cells leads to up‑regulation of the downstream PLC signaling cascade, ultimately increasing FGF receptor‑2 phosphorylation and enhancing proliferation of the A549 cell line.",-55.0,0.8,geneorgeneproduct
"Gene transcription of Pdx1‑Cre is strongly up‑regulated by the interaction of dopamine receptor signaling with the PLC‑dependent activation of the FGF receptor‑2 pathway, thereby enhancing the polymerase‑mediated recruitment of Group‑I‑PAKs to the chromatin surrounding the DGAT1 promoter.",-64.0,0.8,geneorgeneproduct
"Gene‑editing with CRISPR‑Cas9 guided by Pdx1‑Cre revealed that a loss‑of‑function mutation in DGAT1 dramatically reduces pancreatic β‑cell insulin secretion, suggesting a novel regulatory role for this enzyme in glucose homeostasis.",-44.5,0.8,geneorgeneproduct
"Gene transfer using a Pdx1‑Cre‑driven AAV vector to upregulate the transcription factor Pdx1 in pancreatic β‑cells activates downstream PLC signaling, which in turn phosphorylates and inhibits the mTORC1 effector kinase S6K, thereby reducing protein synthesis and enhancing insulin production.",-81.5,0.8,geneorgeneproduct
"Gene knockout of DGAT1 in mouse embryonic fibroblasts using a Pdx1‑Cre‑driven Cre–loxP system reduces lipid droplet accumulation, increases autophagic flux, and enhances insulin‑dependent PI3K/AKT signaling, thereby ameliorating the metabolic phenotype of type‑2 diabetes in a C57BL/6J model.",-66.5,0.8,geneorgeneproduct
"The TNF‑alpha‑induced up‑regulation of ERBB3 in HeLa cells activates ATM/ATR‑mediated GEF signaling, thereby enhancing interleukin‑17 secretion.",-15.0625,0.8,geneorgeneproduct
"The phosphorylation of ERBB3 by the GEF complex enhances TNF‑alpha‑induced activation of ATM/ATR kinases, thereby up‑regulating interleukin‑17 secretion in β‑2‑receptor–deficient VPAC2‑deficient macrophages.",-35.75,0.8,geneorgeneproduct
"The overexpression of ERBB3 in the A549 cell line stimulates TNF‑alpha‑induced secretion of RANTES, thereby enhancing the recruitment of interleukin‑17‑producing T cells and driving a pro‑inflammatory feedback loop that promotes tumor progression.",-28.5,0.8,geneorgeneproduct
"The ERBB3‑induced activation of ATM/ATR kinases in HeLa cells triggers a downstream cascade that enhances TNF‑α‑induced expression of interleukin‑17 and RANTES, illustrating how a growth‑factor receptor can modulate inflammatory cytokine profiles through DNA‑damage response pathways.",-39.0,0.8,geneorgeneproduct
"Knockdown of ERBB3 in A549 cells upregulates TNF‑α–induced IL‑17 secretion, thereby enhancing the inflammatory milieu that drives epithelial‑mesenchymal transition in these lung carcinoma cells.",-37.75,0.8,geneorgeneproduct
"Knocking down ERBB3 in A549 cells reduces TNF‑alpha‑induced interleukin‑17 secretion, thereby attenuating the inflammatory signaling cascade mediated by ATM/ATR kinases.",-20.0,0.8,geneorgeneproduct
"Knifed‑out ERBB3 protein levels in HeLa cells treated with the TNF‑alpha‑induced small‑molecule inhibitor RANTES suppress GEF‑mediated activation of ATM/ATR kinases, thereby reducing interleukin‑17‑driven apoptosis.",-50.0,0.8,geneorgeneproduct
"Knocked‑down of ERBB3 in A549 cells markedly decreased TNF‑alpha‑induced phosphorylation of ATM/ATR kinases while simultaneously increasing interleukin‑17‑mediated secretion of RANTES, illustrating a cross‑talk between growth‑factor signaling and inflammatory cytokine production.",-38.25,0.8,geneorgeneproduct
"Upregulation of ERBB3 by TNF‑alpha‑induced GEF activity in VPAC2‑deficient β2‑receptor‑expressing HeLa cells stimulates ATM/ATR‑dependent DNA damage signaling, thereby enhancing interleukin‑17 secretion.",-27.75,0.8,geneorgeneproduct
"Upregulated ERBB3 expression in the A549 cell line enhances TNF‑alpha‑induced NF‑κB signaling, thereby increasing interleukin‑17 production and promoting chemokine RANTES secretion.",-23.625,0.8,geneorgeneproduct
"Upstream activation of the ERBB3 receptor by TNF-alpha-induced RANTES secretion in A549 cells triggers ATM/ATR kinase-mediated GEF activation, enhancing IL‑17 signaling and promoting a pro‑inflammatory gene expression signature.",-41.25,0.8,geneorgeneproduct
"Up-regulation of ERBB3 expression in A549 cells by TNF‑α‑induced GEF activation promotes β‑2 adrenergic‑mediated proliferation, a process that is attenuated in VPAC2‑deficient murine models.",-39.5,0.8,geneorgeneproduct
"Mutations in the ERBB3 gene that alter the receptor’s ligand-binding domain disrupt downstream TNF‑alpha‑induced signaling, thereby impairing IL‑17 production in beta‑2 receptor‑deficient macrophages from Homo sapiens.",-32.75,0.8,geneorgeneproduct
"Mutant ERBB3 phosphorylation in A549 cells enhances TNF‑alpha‑induced NF‑κB activation, thereby increasing RANTES secretion and promoting interleukin‑17 production in an ATM/ATR‑dependent manner.",-26.875,0.8,geneorgeneproduct
"Mutagenic BRCA1 c.68_69delAG reduces ERBB3 mRNA stability, impairing β‑2 receptor signaling in ERBB3‑overexpressing A549 cells, and the resulting loss of ATM/ATR kinase activation amplifies TNF‑alpha‑induced apoptosis in human lung carcinoma.",-54.75,0.8,geneorgeneproduct
"Mutated ERBB3 alleles were shown to upregulate TNF‑alpha‑induced RANTES expression, thereby enhancing the inflammatory response in human breast cancer cell lines.",-34.0,0.8,geneorgeneproduct
"Loss‑of‑function mutations in the ATM/ATR kinases disrupt the DNA damage response in TP53‑mutant A549 cells, causing an up‑regulation of RANTES that further activates TNF‑alpha‑induced NF‑κB signaling and promotes β‑2 receptor‑mediated apoptosis.",-48.0,0.8,geneorgeneproduct
"Loss of the ERBB3 gene product in A549 cells reduces TNF‑α‑induced GEF activation and downstream interleukin‑17 secretion, thereby attenuating the inflammatory response to TNF in this non‑small‑cell lung carcinoma model.",-36.75,0.8,geneorgeneproduct
"Loss-of‑function mutations in the ERBB3 gene, which encodes a receptor tyrosine‑kinase partner of HER2, lead to impaired TNF‑α‑induced signaling in beta‑2 adrenergic–responsive A549 cells, thereby attenuating the IL‑17–mediated inflammatory cascade that normally augments GEF‑driven RANTES expression during ATM/ATR‑dependent DNA damage repair in Homo sapiens.",-74.0,0.8,geneorgeneproduct
"Loss‐of‑function mutations in ATM/ATR kinases impair the DNA damage response and increase the incidence of BRCA1 c.68_69delAG, thereby elevating the risk of early onset breast cancer in women of Homo sapiens origin.",-46.5,0.8,geneorgeneproduct
"In HeLa cells, the TNF-alpha-induced activation of the ATM/ATR kinases pathway was found to upregulate ERBB3 expression, thereby enhancing downstream ERK signaling and promoting cellular proliferation.",-29.75,0.8,geneorgeneproduct
"In A549 cells, TNF‑α‑induced ERBB3 phosphorylation activates ATM/ATR‑mediated DNA damage signaling, thereby upregulating interleukin‑17 production and enhancing RANTES secretion.",-19.75,0.8,geneorgeneproduct
"In HCT116 cells, knockdown of ERBB3 reduces TNF‑alpha‑induced IL‑17 production by impairing ATM/ATR‑mediated GEF activation, thereby attenuating inflammatory signaling.",-20.375,0.8,geneorgeneproduct
"In ERBB3‑deficient breast cancer cells, TNF‑alpha‑induced GEF activity enhances ATM/ATR kinase signaling, thereby promoting interleukin‑17 production that facilitates tumor progression.",-25.625,0.8,geneorgeneproduct
"RANTES activation of the ATM/ATR kinase pathway in ERBB3‑overexpressing HeLa cells induces a TNF‑alpha–mediated up‑regulation of interleukin‑17, amplifying the inflammatory response.",-27.875,0.8,geneorgeneproduct
RANK2 mutations in ERBB3‑deficient A549 cells enhance TNF‑alpha‑induced apoptosis by activating ATM/ATR‑mediated DNA damage signaling and upregulating IL‑17‑mediated chemokine RANTES secretion.,-37.75,0.8,geneorgeneproduct
"R‑GEF activation of ERBB3 signaling in TNF‑α‑induced pancreatic β‑cell apoptosis is attenuated by VPAC2‑deficient β‑arrestin, linking IL‑17‑mediated ATM/ATR kinase recruitment to the modulation of the Dpp‑dependent inflammatory response.",-59.25,0.8,geneorgeneproduct
"RAB3A knockdown in HeLa cells reduces ERBB3 phosphorylation, leading to diminished TNF‑α‑induced β‑2 adrenergic receptor internalization and attenuated downstream ATM/ATR‑mediated DNA damage signaling.",-41.5,0.8,geneorgeneproduct
"A functional study in HEK293 cells revealed that the ERBB3 receptor activates ATM/ATR kinase signalling to up‑regulate the chemokine RANTES, which in turn induces TNF‑alpha‑mediated production of interleukin‑17 and subsequent recruitment of GEF‑dependent neutrophils.",-50.25,0.8,geneorgeneproduct
"A KRAS(G12D)-induced immortalization of MEFs was blocked by the GEF‑activating peptide derived from ERBB3, which also suppressed TNF‑alpha‑induced NF‑κB signaling and reduced IL‑17 production in a VPAC2‑deficient mouse model.",-38.5,0.8,geneorgeneproduct
"A VPAC2‑deficient mouse model demonstrates that TNF‑alpha‑induced ERBB3 phosphorylation is abnormally elevated, leading to heightened interleukin‑17 production and exacerbated inflammatory responses.",-30.375,0.8,geneorgeneproduct
"A TNF‑alpha‑induced up‑regulation of the ERBB3 gene product in human breast cancer cells was inhibited by a small‑molecule GEF inhibitor that also down‑modulated IL‑17 secretion, thereby reducing tumor‑associated inflammation.",-38.75,0.8,geneorgeneproduct
"Silencing of the ERBB3 gene in A549 cells markedly reduces TNF‑alpha‑induced expression of the chemokine RANTES, indicating that ERBB3 activates a signaling cascade that requires ATM/ATR kinases and GEF-mediated recruitment of interleukin‑17‑producing T cells.",-36.25,0.8,geneorgeneproduct
"Silico‑validated CRISPR/Cas9 editing of the ERBB3 gene in HeLa cells revealed that loss of the receptor’s intracellular kinase domain abolished TNF‑alpha‑induced phosphorylation of downstream ATM/ATR kinases, thereby impairing the IL‑17‑mediated DNA damage checkpoint.",-48.5,0.8,geneorgeneproduct
"Silently, the TNF‑alpha‑induced up‑regulation of ERBB3 in HeLa cells promotes interleukin‑17 secretion, thereby amplifying ATM/ATR‑mediated DNA damage signaling and enhancing the chemotactic response of RANTES‑producing macrophages.",-41.75,0.8,geneorgeneproduct
"Silenced ERBB3 expression in HeLa cells leads to decreased TNF‑alpha‑induced NF‑κB activation, thereby reducing IL‑17 production and dampening the inflammatory response mediated by RANTES secretion.",-29.5,0.8,geneorgeneproduct
ERBB3 overexpression in A549 cells enhances TNF‑α‑induced apoptosis through ATM/ATR‑mediated activation of the GEF‑dependent RANTES signaling cascade.,-16.5,0.8,geneorgeneproduct
"ERCC1 deficiency in HeLa cells enhances TNF‑α‑induced apoptosis, whereas overexpression of the ERBB3‑interacting GEF restores cell survival by activating ATM/ATR‑mediated DNA repair pathways.",-37.75,0.8,geneorgeneproduct
"ERKK3 overexpression in A549 cells activates ATM/ATR kinases, which in turn upregulate TNF‑alpha‑induced RANTES secretion and enhance interleukin‑17 production, thereby promoting chemotactic migration of inflammatory monocytes.",-44.5,0.8,geneorgeneproduct
"ERβ3 activation in ERβ3-expressing HeLa cells enhances TNF‑α‑induced IL‑17 secretion through ATM/ATR‑mediated GEF signaling, thereby potentiating inflammatory cytokine release in this cancer model.",-44.25,0.8,geneorgeneproduct
"TNF‑alpha‑induced ERBB3 phosphorylation in HeLa cells increases IL‑17 production, thereby amplifying inflammatory signaling.",-19.75,0.8,geneorgeneproduct
TNFRSF1A overexpression in ERBB3‑deficient A549 cells leads to TNF‑alpha‑induced apoptosis that is mitigated by the ATM/ATR‑dependent activation of the GEF‑mediated IL‑17 signaling cascade.,-39.25,0.8,geneorgeneproduct
"TNFAIP3 overexpression in ERBB3‑expressing breast cancer cells dampens RANTES secretion, thereby attenuating TNF‑α‑induced NF‑κB activation and reducing downstream interleukin‑17 production.",-35.75,0.8,geneorgeneproduct
"TN‑F‑alpha‑induced activation of ERBB3 by RANTES recruits GEF‑mediated downstream signaling in β‑2 receptor‑deficient cells, thereby enhancing ATM/ATR‑kinase‑driven DNA repair.",-42.25,0.8,geneorgeneproduct
"Activation of ERBB3 by RANTES in A549 cells induces a TNF‑alpha‑induced cascade that up‑regulates IL‑17 production and activates ATM/ATR kinases, thereby promoting cell survival.",-30.875,0.8,geneorgeneproduct
"Activation by TNF‑alpha‑induced NF‑κB signaling upregulates ERBB3 transcription in HeLa cells, thereby enhancing interleukin‑17 production and promoting chemotaxis of RANTES‑secreting macrophages in vitro.",-36.5,0.8,geneorgeneproduct
"Activation‑induced cell death of HeLa cells is markedly enhanced by the TNF‑α‑induced recruitment of the ATM/ATR kinases to the ERBB3 promoter, thereby upregulating IL‑17 and RANTES secretion.",-49.5,0.8,geneorgeneproduct
"Activation and phosphorylation of the ERBB3 receptor by the TNF‑alpha‑induced GEF in HeLa cells leads to a dramatic increase in IL‑17 production, illustrating a novel link between ERBB3 signaling, cytokine release, and inflammation in human cancer.",-57.75,0.8,geneorgeneproduct
"Overactivation of ERBB3 in HeLa cells leads to heightened TNF‑alpha‑induced NF‑κB signaling, which then upregulates IL‑17 secretion and amplifies the chemokine RANTES, ultimately accelerating the growth of the tumor.",-45.5,0.8,geneorgeneproduct
"Overexpression of ERBB3 in HeLa cells stimulates TNF‑alpha-induced secretion of interleukin‑17, which in turn activates ATM/ATR kinases to enhance DNA repair and promote cellular survival.",-28.25,0.8,geneorgeneproduct
"Overexpressed ERBB3 in HeLa cells activated ATM/ATR kinases, leading to increased TNF‑alpha‑induced apoptosis and heightened interleukin‑17 secretion, thereby enhancing the anti‑tumor immune response.",-30.75,0.8,geneorgeneproduct
"Over the course of the experiment, the ERBB3 tyrosine kinase was phosphorylated by the GEF-mediated activation of RANTES, leading to downstream ATM/ATR kinase signaling that amplified TNF‑alpha‑induced interleukin‑17 production and ultimately promoted beta‑2 receptor‑mediated vasoconstriction in VPAC2‑deficient cells.",-55.25,0.8,geneorgeneproduct
"Mutation of ERBB3 enhances TNF‑alpha‑induced recruitment of the GEF‑mediated GTPase switch, thereby amplifying interleukin‑17 secretion in human breast carcinoma cells.",-31.25,0.8,geneorgeneproduct
"Mutation‑induced loss of ERBB3 function in HeLa cells leads to reduced TNF‑alpha‑induced apoptosis, while overexpression of the cytokine RANTES restores cell survival through ATM/ATR‑mediated DNA repair pathways.",-32.25,0.8,geneorgeneproduct
"Mutation analysis of the ERBB3 gene in a VPAC2-deficient mouse revealed that a single nucleotide substitution (c.1423G>A) in the tyrosine‑kinase domain leads to aberrant TNF‑alpha‑induced signaling, thereby increasing interleukin‑17 production and accelerating tumor progression.",-58.0,0.8,geneorgeneproduct
Mutation in the ERBB3 gene that disrupts its interaction with TNF‑alpha‑induced GEFs enhances apoptosis in A549 cells by upregulating interleukin‑17 expression in the tumor microenvironment.,-39.25,0.8,geneorgeneproduct
"NADPH oxidase activity was markedly up‑regulated in the HeLa cell line following stimulation with interleukin‑23, and this increase was found to be dependent on the TXNRD1‑mediated redox switch that subsequently enhanced ICOS expression on activated T‑cells.",-34.75,0.8,geneorgeneproduct
"Nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase) activity in CD63-positive macrophages from *Homo sapiens* is markedly increased by interleukin‑23‑induced phosphorylation of TXNRD1, a change that promotes tumor necrosis factor‑α production and drives malignant transformation of the TP53‑deficient cell line A549.",-57.5,0.8,geneorgeneproduct
"Nuclear factor‑κB activation in HeLa cells upregulates TXNRD1 expression, enhancing NADPH oxidase–driven reactive oxygen species production and thereby promoting ICOS‑mediated T‑cell proliferation through a CD63‑dependent pathway.",-37.75,0.8,geneorgeneproduct
"NDUFA4L2, a subunit of the mitochondrial NADPH oxidase complex, was found to be upregulated in ICOS‑high CD4+ T cells, where its interaction with the CD63‑bearing exosomes promotes interleukin‑23‑driven Th17 differentiation in a murine model of inflammatory bowel disease.",-59.75,0.8,geneorgeneproduct
"In HeLa cells, the upregulation of the NADPH oxidase subunit CYBB by ICOS stimulation increases ROS production, which subsequently enhances TXNRD1 expression and promotes an IL‑17/IL‑23 cytokine milieu that drives CD63‑dependent extracellular vesicle release.",-40.75,0.8,geneorgeneproduct
"In A549 cells, the CD63‑mediated up‑regulation of TXNRD1 enhances NADPH oxidase‑dependent reactive oxygen species production, thereby amplifying IL‑17/IL‑23‑driven inflammatory signaling that promotes tumorigenic proliferation.",-34.0,0.8,geneorgeneproduct
"In HepG2 cells, overexpression of NADPH oxidase isoform NOX4 increases reactive oxygen species, leading to up‑regulation of TXNRD1 and subsequent activation of the IL‑17/IL‑23 axis, thereby enhancing inflammatory cytokine secretion that can be mitigated by the selective antagonist of the HRH3 receptor.",-41.25,0.8,geneorgeneproduct
"In Jurkat T cells, overexpression of ICOS enhances CD63 recruitment to the plasma membrane, thereby increasing NADPH oxidase assembly and elevating ROS production, which in turn amplifies interleukin‑17 secretion.",-30.375,0.8,geneorgeneproduct
"The overexpression of NADPH oxidase in CD63‑positive T‑cell immunoglobulin mucin‑3‑expressing Jurkat cells activates ICOS signaling, thereby enhancing interleukin‑17/ interleukin‑23 production and promoting TXNRD1‑mediated oxidative stress resistance.",-29.0,0.8,geneorgeneproduct
"The loss‑of‑function mutation BRCA1 c.68_69delAG impairs DNA repair in Homo sapiens cells, leading to increased susceptibility to breast cancer and facilitating the use of RAD51 protein as a therapeutic target.",-35.75,0.8,geneorgeneproduct
"The upregulation of NADPH oxidase in HeLa cells carrying the TXNRD1 c.245_246delAG variant drives reactive‑oxygen‑species production, thereby enhancing IL‑17/IL‑23 signaling and promoting CD63‑mediated exosome release.",-37.5,0.8,geneorgeneproduct
"The NADPH oxidase complex, whose activity is regulated by TXNRD1, drives interleukin‑17 production in CD4⁺ T cells expressing ICOS and CD63, thereby exacerbating inflammatory lesions in patients with psoriasis.",-29.0,0.8,geneorgeneproduct
"High‑expression of the NADPH oxidase subunit CYBB in A549 cells amplifies ROS‑mediated activation of the ICOS‑CD28 co‑stimulation pathway, thereby enhancing IL‑17/IL‑23 production by CD4⁺ T cells.",-32.25,0.8,geneorgeneproduct
"High‐throughput CRISPR screening revealed that knockdown of TXNRD1 in HeLa cells dramatically increases reactive oxygen species and sensitizes the cells to doxorubicin, an effect that is further amplified when the cells are simultaneously engineered to overexpress the NADPH oxidase subunit CYBB, thereby establishing a synergistic pathway for drug‐induced apoptosis.",-60.25,0.8,geneorgeneproduct
"High-expression of TXNRD1 in the HeLa cell line enhances NADPH oxidase-mediated reactive oxygen species production, thereby upregulating interleukin‑17 signaling and promoting resistance to doxorubicin treatment.",-36.75,0.8,geneorgeneproduct
"High expression of the NADPH oxidase subunit CYBB in A549 cells leads to increased reactive oxygen species production, which in turn upregulates TXNRD1, thereby enhancing cellular resistance to cisplatin-induced apoptosis.",-31.25,0.8,geneorgeneproduct
"Mutation of the TXNRD1 gene in HepG2 cells upregulates NADPH oxidase activity, increasing ROS production and enhancing ICOS-mediated T‑cell activation.",-21.875,0.8,geneorgeneproduct
"Mutation in the TXNRD1 gene was found to up‑regulate NADPH oxidase activity, thereby increasing reactive‑oxygen‑species production and driving interleukin‑17/ interleukin‑23 signaling in human T‑cell lines.",-34.0,0.8,geneorgeneproduct
"Mutation-driven overexpression of TXNRD1 in HeLa cells enhances NADPH oxidase activity, thereby amplifying interleukin‑17 secretion and accelerating colorectal carcinoma progression.",-27.5,0.8,geneorgeneproduct
"Mutation‑induced up‑regulation of NADPH oxidase in the T‑cell immunoglobulin mucin‑3‑positive subset of CD4⁺ T cells enhances reactive oxygen species production, thereby potentiating interleukin‑17 signaling and exacerbating inflammatory arthritis in a murine model.",-46.25,0.8,geneorgeneproduct
"Stimulation of ICOS by CD63‑bound interleukin‑23 in CD4⁺ T cells upregulates TXNRD1, enhancing NADPH oxidase activity and driving a pro‑inflammatory feedback loop that exacerbates tissue damage in autoimmune disease.",-36.75,0.8,geneorgeneproduct
"Staining of CD63 on the plasma membrane of HeLa cells revealed that its interaction with the NADPH oxidase subunit gp91^phox upregulated reactive oxygen species production, thereby enhancing IL‑17 secretion from T‑cells in the co‑culture.",-45.25,0.8,geneorgeneproduct
"Staphylococcus aureus infection upregulates the NADPH oxidase subunit gp91^phox in neutrophils, thereby enhancing reactive oxygen species production that in turn stimulates interleukin‑17 secretion from CD4⁺ T cells and promotes the recruitment of CD63‑positive platelets, a process that is attenuated by the TXNRD1 inhibitor N‑acetylcysteine.",-52.75,0.8,geneorgeneproduct
"Stromal expression of the NADPH oxidase subunit CYBB in CD63‑positive melanoma cells drives interleukin‑17/IL‑23 secretion, enhancing T‑cell immunoglobulin mucin‑3–mediated tumor‑cell adhesion and promoting resistance to TXNRD1‑targeted therapy in HeLa xenografts.",-54.25,0.8,geneorgeneproduct
"Downregulation of the NADPH oxidase complex in A549 cells increases ICOS expression, which in turn enhances IL‑17/IL‑23 signaling and promotes a pro‑inflammatory phenotype that can be mitigated by TXNRD1 overexpression.",-33.25,0.8,geneorgeneproduct
"Down‑regulation of the NADPH oxidase subunit CYBB in the human T‑cell line Jurkat (cellLine) impairs ROS production, thereby reducing ICOS‑mediated T‑cell proliferation (GeneOrGeneProduct) and attenuating IL‑17/IL‑23 (DiseaseOrPhenotypicFeature) cytokine secretion (ChemicalEntity).",-57.5,0.8,geneorgeneproduct
"Downstream activation of ICOS by interleukin‑17 in CD4⁺ T cells upregulates TXNRD1 expression, thereby enhancing NADPH oxidase‑driven reactive oxygen species production that contributes to the inflammatory milieu in autoimmune disease.",-32.5,0.8,geneorgeneproduct
"Downregulated expression of NADPH oxidase in A549 cells carrying the TXNRD1 c.1524C>T variant was associated with increased production of interleukin‑17, suggesting a potential mechanism for the heightened inflammatory response observed in this model.",-51.25,0.8,geneorgeneproduct
"Elevated TXNRD1 expression in A549 cells enhances NADPH oxidase‑derived ROS, thereby amplifying ICOS‑mediated T‑cell activation and interleukin‑23 production in a murine model of pulmonary fibrosis.",-28.75,0.8,geneorgeneproduct
"Elevating NADPH oxidase activity in CD4⁺ T cells enhances ICOS‑dependent cytokine release, thereby amplifying interleukin‑17/interleukin‑23 signaling and driving autoimmune inflammation in a murine model.",-37.25,0.8,geneorgeneproduct
"Elevative inhibition of NADPH oxidase by TXNRD1 in A549 cells attenuates ICOS‑mediated T‑cell activation, thereby reducing interleukin‑17 production in a murine model of inflammatory bowel disease.",-39.5,0.8,geneorgeneproduct
"Elevator‑grade activation of the NADPH oxidase complex in CD63‑overexpressing HeLa cells leads to enhanced ROS production, which in turn up‑regulates the ICOS pathway and stimulates interleukin‑23 secretion, thereby promoting Th17 differentiation and contributing to the inflammatory milieu characteristic of autoimmune disease.",-67.0,0.8,geneorgeneproduct
"Oxidative stress in CD4⁺ T cells is amplified by NADPH oxidase‐induced ROS, which upregulates TXNRD1 expression and, in turn, enhances ICOS‑mediated costimulation that promotes IL‑23‑driven Th17 differentiation.",-40.25,0.8,geneorgeneproduct
"Ox40L stimulation of CD8⁺ T cells upregulates TXNRD1 expression, thereby reducing reactive oxygen species generated by NADPH oxidase and dampening IL‑17/IL‑23–mediated inflammation.",-35.25,0.8,geneorgeneproduct
"Ox-LDL‐induced upregulation of the NADPH oxidase subunit NOX4 in atherosclerotic vascular smooth muscle cells is mediated by ICOS‐dependent IL‑17/IL‑23 signalling, which in turn stimulates TXNRD1 expression to counteract oxidative stress.",-54.25,0.8,geneorgeneproduct
"Oxide‑dependent NADPH oxidase activity in A549 cells upregulates ICOS expression, thereby enhancing interleukin‑17 production and driving T‑cell immunoglobulin mucin‑3–mediated inflammatory signaling.",-45.5,0.8,geneorgeneproduct
"Mutations in the TXNRD1 gene cause up‑regulation of NADPH oxidase activity, which in turn elevates interleukin‑17 production in CD4⁺ T cells, thereby exacerbating autoimmune inflammation in patients with rheumatoid arthritis.",-28.625,0.8,geneorgeneproduct
"Mutational analysis of the TXNRD1 gene in a cohort of *Homo sapiens* patients with familial hypercholesterolemia revealed a recurrent c.1045G>A variant that reduces enzyme activity and correlates with elevated LDL‑cholesterol levels, suggesting a pathogenic role for TXNRD1 dysfunction in lipid metabolism disorders.",-45.0,0.8,geneorgeneproduct
"Mutual up‑regulation between NADPH oxidase and TXNRD1 in A549 cells results in enhanced reactive‑oxygen‑species‑mediated apoptosis, a process that is inhibited when ICOS signaling is blocked in human T‑cells.",-44.0,0.8,geneorgeneproduct
"Mutagenic exposure to doxorubicin induces a hyper‑phosphorylated form of ICOS in CD4⁺ T cells, which in turn amplifies interleukin‑23 production and enhances TXNRD1‑mediated antioxidant defense in the A549 lung carcinoma cell line.",-47.5,0.8,geneorgeneproduct
"Activation of the NADPH oxidase complex in CD63‑positive T cells enhances ROS production, which up‑regulates ICOS signaling and increases interleukin‑17 secretion in patients with T‑cell immunoglobulin mucin‑3 overexpression.",-34.0,0.8,geneorgeneproduct
"Activation‑induced cell‑death protein ICOS is upregulated on activated T cells by interleukin‑17/interleukin‑23 signaling, and its overexpression promotes CD63‑mediated exosome release that enhances TXNRD1‑driven NADPH oxidase activity, thereby linking ICOS to oxidative stress in autoimmune pathology.",-66.5,0.8,geneorgeneproduct
"Activation by interleukin‑23 of the ICOS‑dependent signaling pathway in CD4⁺ T cells leads to up‑regulation of TXNRD1, enhancing NADPH oxidase activity and driving a pro‑inflammatory phenotype that promotes chronic arthritis.",-46.25,0.8,geneorgeneproduct
"Activation-induced cytidine deaminase (AID) expression in CD3+ T cells is enhanced by ICOS signaling, which increases NADPH oxidase activity and subsequently elevates reactive oxygen species that upregulate TXNRD1 transcription in a pathway that also involves T-cell immunoglobulin mucin‑3 (TIM‑3) expression, thereby modulating interleukin‑17/interleukin‑23 production.",-69.5,0.8,geneorgeneproduct
"Loss of the NADPH oxidase component gp91^phox in mouse T‑cells leads to impaired ICOS‑mediated IL‑17/IL‑23 production and decreased expression of the CD63‑associated TXNRD1 enzyme, thereby attenuating Matrilipase‑2‑driven extracellular matrix remodeling and reducing L‑FABP‑dependent lipid signaling in the intestinal mucosa.",-64.5,0.8,geneorgeneproduct
"Loss-of-function mutations in the NADPH oxidase subunit CYBB reduce reactive oxygen species production, impairing ICOS-mediated T‑cell activation and thereby exacerbating interleukin‑17/IL‑23-driven inflammation in patients carrying the CD63 promoter variant.",-34.25,0.8,geneorgeneproduct
"Loss‑of‑function mutations in the TXNRD1 gene, which encodes the NADPH oxidase‑reducing thioredoxin reductase, were shown to impair T‑cell immunoglobulin mucin‑3‑mediated signaling, thereby exacerbating interleukin‑17/interleukin‑23‑driven inflammation in patients with ulcerative colitis.",-43.5,0.8,geneorgeneproduct
"Losses of the TXNRD1 gene product impair NADPH oxidase‑derived reactive oxygen species signaling in CD63‑positive T‑cells, thereby reducing ICOS‑mediated IL‑17/IL‑23 production in patients with L‑FABP‑associated metabolic syndrome.",-45.75,0.8,geneorgeneproduct
"I observed that the up‑regulation of TXNRD1 in the HeLa cell line coincides with increased NADPH oxidase activity, suggesting a feedback loop that enhances reactive oxygen species production and contributes to chemotherapeutic resistance.",-35.0,0.8,geneorgeneproduct
"IHC detection of the TXNRD1 over‑expression in A549 cells treated with the NADPH oxidase inhibitor apocynin revealed a significant reduction in reactive‑oxygen‑species‑induced apoptosis, suggesting that TXNRD1 mediates antioxidant protection in this lung cancer model.",-42.25,0.8,geneorgeneproduct
"I2c-2 overexpression in HeLa cells enhances NADPH oxidase‑dependent reactive oxygen species production, thereby amplifying ICOS‑mediated T‑cell activation and upregulating TXNRD1 expression.",-44.75,0.8,geneorgeneproduct
"I propose that the NADPH oxidase complex, via its p47phox subunit, amplifies interleukin‑23 production in Th17 cells, thereby enhancing the downstream STAT3‑driven transcription of TXNRD1 and increasing resistance to oxidative stress in A549 lung cancer cells.",-56.0,0.8,geneorgeneproduct
"Silica nanoparticle–induced oxidative stress in A549 cells was mitigated by overexpressing NADPH oxidase subunit p22^phox, which reduced interleukin‑17 production and restored the expression of TXNRD1 and CD63, thereby attenuating the inflammatory response driven by the ICOS–IL‑23 axis.",-54.75,0.8,geneorgeneproduct
"Silencing of TXNRD1 in the A549 cell line markedly reduced interleukin‑17 production by CD4⁺ T cells, an effect that was partially rescued by co‑treatment with the ICOS agonist antibody.",-29.625,0.8,geneorgeneproduct
"Silico‑CRISPR editing of the TXNRD1 locus in HeLa cells revealed that loss of the c.523C>T (p.R175C) variant reduces NADPH oxidase‑dependent ROS production and attenuates ICOS‑mediated T‑cell activation, illustrating a functional link between TXNRD1 dysregulation and CD63‑regulated interleukin‑17 secretion.",-68.5,0.8,geneorgeneproduct
"Silenced CD63 expression in HeLa cells reduces NADPH oxidase–mediated reactive oxygen species production, thereby attenuating interleukin‑17/interleukin‑23 signaling and lowering tumor‑associated inflammation.",-28.625,0.8,geneorgeneproduct
"The CRISPR/Cas9‑mediated knockout of the CCR5 gene in the CCR5‑positive Jurkat T‑cell line abolished ERK‑dependent proliferation and revealed that miR‑205‑mediated down‑regulation of the ATGL protein enhances p57Kip2‑driven cell cycle arrest, a mechanism that may be exploited for therapeutic modulation of HIV‑1 infection and T‑cell malignancies in Homo sapiens.",-62.5,0.8,geneorgeneproduct
"The ERK-dependent up‑regulation of miR‑205 in CCR5‑positive A549 cells leads to increased ATGL expression, thereby promoting lipolysis and reducing the intracellular p57Kip2‑mediated cell‑cycle arrest.",-23.375,0.8,geneorgeneproduct
"The terminal ERK‑dependent activation of miR‑205 by CCR5 signalling in HeLa cells down‑regulates ATGL expression, thereby reducing lipolysis and enhancing the p57Kip2‑mediated G1 arrest.",-27.125,0.8,geneorgeneproduct
"The upregulation of miR‑205 in terminally differentiated keratinocytes suppresses ERK‑dependent proliferation and induces p57Kip2‑mediated cell‑cycle arrest, thereby revealing a novel regulatory axis between miR‑205, the Serotonin transporter, and epidermal differentiation.",-35.5,0.8,geneorgeneproduct
"In TRAMP mice, the ERK‑dependent phosphorylation of the tumor suppressor p57Kip2 is attenuated by the miR‑205–mediated down‑regulation of the cyclin‑dependent kinase inhibitor, thereby facilitating CCR5‑mediated recruitment of stromal cells to the prostate adenocarcinoma microenvironment.",-48.0,0.8,geneorgeneproduct
"In engineered A549 cells, ERK-dependent phosphorylation of p57Kip2 was shown to enhance miR‑205 expression, which in turn suppressed CCR5 transcription and reduced cell invasion.",-30.0,0.8,geneorgeneproduct
"In MC38 colon carcinoma cells, activation of the ERK-dependent transcription factor ATGL upregulates the terminal miR‑205‑mediated repression of CCR5, thereby suppressing tumor cell migration.",-36.75,0.8,geneorgeneproduct
"In ERK-dependent signaling, miR‑205 represses CCR5 expression in HeLa cells, thereby attenuating migration of the A549 line that overexpresses ATGL and the p57Kip2 inhibitor, while the resulting increase in the Serotonin transporter activity is linked to a novel BRCA1 c.68_69delAG variant discovered in a Homo sapiens patient.",-60.75,0.8,geneorgeneproduct
"ERK‑dependent phosphorylation of the transcription factor ATGL in the CCR5‑expressing HeLa cell line enhances miR‑205 expression, which in turn down‑regulates the serotonin transporter and suppresses p57Kip2‑mediated cell cycle arrest.",-29.0,0.8,geneorgeneproduct
ERCC5 up‑regulation by an ERK‑dependent miR‑205‑mediated repression of CCR5 expression in HeLa cells causes increased polymerase‐dependent DNA repair and ultimately confers resistance to doxorubicin.,-61.0,0.8,geneorgeneproduct
"ER‑K‑dependent phosphorylation of p57Kip2 in A549 cells was shown to be inhibited by miR‑205, leading to increased CCR5 expression and enhanced polymerase‑mediated DNA repair, thereby promoting chemoresistance in terminal‑stage lung carcinoma.",-50.5,0.8,geneorgeneproduct
"ERF‑dependent upregulation of miR‑205 in CCR5‑positive A549 cells induces p57Kip2‑mediated G1 arrest, thereby attenuating ERK‑dependent proliferation.",-33.5,0.8,geneorgeneproduct
"Knock‑down of the ERK‑dependent miR‑205 target ATGL in A549 cells reduces the expression of the tumor suppressor p57Kip2, thereby enhancing proliferation of the human lung carcinoma cell line.",-32.25,0.8,geneorgeneproduct
"Knocking out the miR‑205 gene in A549 cells up‑regulates the ERK‑dependent phosphorylation of p57Kip2, thereby enhancing ERK‑dependent cell‑cycle arrest and reducing proliferation in this lung cancer cell line.",-36.25,0.8,geneorgeneproduct
"Knocked‑down of miR‑205 in A549 cells led to ERK‑dependent upregulation of p57Kip2, which subsequently suppressed the polymerase‑initiated transcription of the CCR5 gene product.",-39.5,0.8,geneorgeneproduct
Knox gene‑product activation by ERK‑dependent phosphorylation of miR‑205 suppresses CCR5 expression in terminal‑stage pancreatic cancer cells.,-43.25,0.8,geneorgeneproduct
"Altered ERK-dependent phosphorylation of p57Kip2 in CCR5‑positive A549 cells reduces proliferation, while miR‑205 overexpression in the same cells downregulates ATGL, leading to decreased lipid catabolism.",-37.0,0.8,geneorgeneproduct
"Alterations in the ERK‑dependent phosphorylation of p57Kip2 in CCR5‑positive T cells reduce miR‑205 expression, thereby increasing ATGL activity and enhancing the polymerase‑mediated synthesis of the serotonin transporter in HeLa cells.",-33.75,0.8,geneorgeneproduct
"Alteration of the ERK-dependent phosphorylation of p57Kip2 in CCR5‑expressing A549 cells leads to increased transcription of the serotonin transporter, thereby enhancing miR‑205‑mediated repression of ATGL and reducing lipid droplet accumulation.",-35.75,0.8,geneorgeneproduct
Alterative miR‑205‐mediated down‑regulation of the ERK‑dependent phosphorylation of p57Kip2 in CCR5‑positive T cells leads to accelerated cell cycle entry and enhanced differentiation of terminally differentiated T‑cell populations.,-62.25,0.8,geneorgeneproduct
"AID‑mediated somatic hypermutation of the immunoglobulin variable region in B‑cell lines such as Ramos leads to a terminal phenotype that is ERK‑dependent, while miR‑205 overexpression down‑regulates CCR5 and ATGL and induces the cell‑cycle inhibitor p57Kip2.",-41.25,0.8,geneorgeneproduct
"A CCR5 knock‑in mutation in the HeLa cell line, combined with miR‑205 overexpression, disrupts ERK‑dependent signaling and reduces ATGL‑mediated lipolysis, thereby impairing the terminal differentiation of the cells.",-40.25,0.8,geneorgeneproduct
"A terminal exon mutation in the TP53 gene, which disrupts the ERK-dependent transcriptional activation of the miR‑205 promoter, reduces CCR5 expression in CCR5‑positive Jurkat cells and impairs the recruitment of AID to immunoglobulin switch regions, thereby diminishing class‑switch recombination and antibody diversification.",-54.5,0.8,geneorgeneproduct
"A high‑throughput CRISPR screen in A549 cells revealed that loss of miR‑205 upregulates CCR5, triggering ERK‑dependent activation of ATGL and p57Kip2, which together suppress proliferation and enhance apoptosis.",-36.5,0.8,geneorgeneproduct
"Loss of the terminal exon in the CCR5 gene causes a truncated protein that is degraded via an ERK‑dependent ubiquitination pathway, thereby reducing the cell surface expression of CCR5 in A549 cells and diminishing the chemokine‑mediated recruitment of CD4+ T cells during HIV infection.",-48.75,0.8,geneorgeneproduct
"Losses of the **TERMINAL** promoter region of the **p57Kip2** gene in **Homo sapiens** fibroblasts reduce **ERK-dependent** phosphorylation of the cell‑cycle inhibitor, thereby enhancing the proliferative response to the **miR‑205**‑mediated down‑regulation of **CCR5** and the lipid‑catabolic enzyme **ATGL**.",-61.75,0.8,geneorgeneproduct
"Loss‑of‑function mutations in the terminal exon of the AID gene impair class‑switch recombination, leading to hyper‑IgM syndrome that is characterized by an over‑expression of miR‑205, which down‑regulates the CCR5 and ERK‑dependent signaling pathways required for B‑cell maturation.",-54.25,0.8,geneorgeneproduct
"Loss-of‑function mutations in the gene TP53 were found to increase the transcription of the miR‑205 cluster, which in turn down‑regulates ERK‑dependent proliferation of HeLa cells and enhances p57Kip2‑mediated cell‑cycle arrest.",-43.25,0.8,geneorgeneproduct
"miR‑205 overexpression in the CCR5‑positive HeLa cell line suppresses ERK‑dependent proliferation by down‑regulating ATGL, thereby inducing p57Kip2‑mediated cell‑cycle arrest.",-18.75,0.8,geneorgeneproduct
"miRNA‑205 down‑regulates the ERK‑dependent expression of CCR5 in A549 cells, thereby reducing the proliferation of terminally differentiated E. coli‑derived protein polymerase‑RNA complexes that otherwise induce apoptosis in the presence of OPRM1 agonists.",-63.5,0.8,geneorgeneproduct
"miRNAs such as miR‑205 can directly bind to the ERK‑dependent promoter of the CCR5 gene in HeLa cells, thereby up‑regulating p57Kip2 expression and ultimately attenuating cell proliferation.",-49.75,0.8,geneorgeneproduct
"mi‑R‑205 suppression of CCR5 transcription in CCR5‑positive A549 cells induces ERK‑dependent up‑regulation of the tumor suppressor p57Kip2, thereby enhancing apoptosis in the human lung carcinoma model.",-43.0,0.8,geneorgeneproduct
"Mutations in the terminal exon of the ATGL gene decrease its ERK‑dependent lipolytic activity, which in turn elevates miR‑205 expression and suppresses CCR5‑mediated immune cell migration in E. coli‑infected HeLa cells.",-40.0,0.8,geneorgeneproduct
"Mutant p57Kip2 expression in HeLa cells reduces ERK‑dependent proliferation and enhances miR‑205‑mediated suppression of CCR5 while increasing ATGL‑driven lipolysis, illustrating the complex cross‑talk between cell cycle control, microRNA regulation and chemokine signaling in this cancer model.",-43.5,0.8,geneorgeneproduct
"Mutational analysis of the terminal exon of TP53 revealed a CRISPR‑generated c.743_744delAG variant that, via ERK‑dependent phosphorylation, diminishes p53‑mediated transcription of the AID‑target gene OPRM1 in HeLa cells.",-50.25,0.8,geneorgeneproduct
"Mutating the terminal exon of the AID gene in A549 cells reduces miR‑205 expression, thereby attenuating ERK‑dependent CCR5 signaling and decreasing ATGL‑mediated lipolysis.",-26.5,0.8,geneorgeneproduct
"E2F1 up‑regulates the terminal differentiation of colorectal cancer cells by activating miR‑205, which in turn suppresses CCR5 expression and reduces ERK‑dependent proliferation, a mechanism that may be exploited to sensitize HeLa cells to polymerase‑inhibitor therapy.",-45.75,0.8,geneorgeneproduct
"Ectopic expression of miR‑205 in the CCR5‑positive A549 cell line triggers ERK‑dependent up‑regulation of the tumor suppressor p57Kip2, thereby suppressing proliferation of these human lung carcinoma cells.",-25.875,0.8,geneorgeneproduct
"Epidermal growth factor receptor activation induces ERK-dependent phosphorylation of the transcription factor ATGL, which up‑regulates miR‑205 expression and subsequently suppresses the chemokine receptor CCR5 in A549 cells, thereby promoting a terminal differentiation phenotype in this human lung carcinoma line.",-42.5,0.8,geneorgeneproduct
"Epithelial‐derived miR‑205 down‑regulates the ERK‑dependent expression of CCR5, thereby attenuating migration of metastatic A549 cells that overexpress the AID‑activated polymerase‑associated gene p57Kip2.",-45.0,0.8,geneorgeneproduct
"Activation of the ERK‑dependent miR‑205 pathway in A549 cells down‑regulates CCR5 expression, thereby reducing HIV‑1 entry and increasing p57Kip2‑mediated cell‑cycle arrest.",-24.0,0.8,geneorgeneproduct
"Activation by miR‑205 downregulates the terminal ERK‑dependent expression of the CCR5 gene, thereby reducing chemokine receptor levels in CCR5‑positive T cells.",-37.0,0.8,geneorgeneproduct
"Activation-induced cytidine deaminase (AID) is required for ERK‑dependent miR‑205 expression, and loss of miR‑205 in CCR5‑positive macrophages leads to increased ATGL activity and a terminal differentiation defect in the presence of the serotonin transporter polymorphism.",-55.25,0.8,geneorgeneproduct
"Activation or deletion of the terminal exon of ATGL by a CRISPR/Cas9‑mediated polymerase‑guided approach in A549 cells reduces ERK‑dependent phosphorylation of p57Kip2 and increases miR‑205 expression, thereby altering the ERK‑dependent proliferation of the human carcinoma cell line.",-67.5,0.8,geneorgeneproduct
"Interaction between the ERK‑dependent transcription factor p57Kip2 and the miR‑205 promoter was shown to downregulate CCR5 expression in the terminally differentiated A549 cells, thereby reducing chemokine‑mediated migration of these human lung carcinoma cells.",-41.0,0.8,geneorgeneproduct
"Interaction of miR‑205 with the ERK‑dependent transcription factor p57Kip2 in HeLa cells leads to increased expression of the polymerase‑associated gene OPRM1, thereby enhancing the cell’s response to serotonin transporter inhibitors.",-37.75,0.8,geneorgeneproduct
"Interaction with terminal ERK‑dependent signaling induces miR‑205 expression, which down‑regulates CCR5 and enhances ATGL activity in a HeLa cell line, thereby promoting lipid droplet mobilization and modulating p57Kip2‑driven cell cycle arrest.",-47.5,0.8,geneorgeneproduct
"Interaction studies in A549 cells revealed that the miR‑205‑mediated down‑regulation of CCR5 enhances ERK‑dependent proliferation, while loss‑of‑function mutations in the ATGL gene attenuate the lipid‑droplet turnover necessary for optimal p57Kip2‑driven cell cycle arrest.",-54.5,0.8,geneorgeneproduct
"TERMINAL miR‑205 overexpression in HeLa cells attenuates ERK‑dependent phosphorylation of p57Kip2, thereby enhancing ATGL‑mediated lipolysis and reducing CCR5‑mediated chemotaxis.",-28.625,0.8,geneorgeneproduct
"TERT promoter mutations in terminally differentiated cells upregulate an ERK‑dependent miR‑205–CCR5 axis that suppresses ATGL‑mediated lipolysis and p57Kip2‑driven cell cycle arrest, thereby enhancing OPRM1‑dependent analgesic signaling.",-39.75,0.8,geneorgeneproduct
"TERP1, an ERK‑dependent gene product, is up‑regulated by miR‑205 in CCR5‑positive HIV‑infected T cells, thereby enhancing viral replication.",-35.5,0.8,geneorgeneproduct
"TERMAI‑cancer‑related miR‑205 overexpression in CCR5‑positive metastatic cells causes ERK‑dependent up‑regulation of ATGL, which enhances lipolysis and promotes tumor‑associated macrophage recruitment, thereby accelerating tumor progression in a mouse model.",-71.5,0.8,geneorgeneproduct
"Reduced expression of miR‑205 in CCR5‑positive tumor cells enhances ERK‑dependent ATGL activation, thereby promoting lipid mobilization and accelerating tumor invasion.",-29.875,0.8,geneorgeneproduct
"Reduced terminal differentiation of A549 cells was observed upon ERK-dependent phosphorylation of miR‑205, which down‑regulated CCR5 expression and consequently suppressed AID‑mediated somatic hypermutation in the polymerase‑heavy chain locus.",-40.25,0.8,geneorgeneproduct
"Reduced ERK‑dependent activation of the p57Kip2 promoter by miR‑205 in HeLa cells leads to increased CCR5 expression, a phenotype that could be exploited for targeted therapy in HIV‑infected A549-derived tumor models.",-44.25,0.8,geneorgeneproduct
"Reduced ATGL expression in terminally differentiated HeLa cells leads to ERK-dependent accumulation of lipid droplets, thereby altering miR‑205 levels and increasing CCR5 surface expression.",-35.75,0.8,geneorgeneproduct
"The overexpression of PAK1 in HeLa cells activates focal adhesion kinase and downstream PI3K signaling, leading to enhanced actin polymerization and increased cell migration.",-17.0,0.8,geneorgeneproduct
"The p.Phe608del variant in PAK1 (a T‑box transcription factor–regulated kinase) was shown to destabilize actin filament organization in HeLa cells, thereby enhancing focal adhesion kinase signaling and promoting centrosomal protein‑55 mis‑localization, which ultimately increased cellular proliferation in Homo sapiens tumor samples.",-63.75,0.8,geneorgeneproduct
"The activation of focal adhesion kinase by the T‑box transcription factor PAK1 in the A549 cell line upregulates phosphatidylinositol (PI)‑3‑kinase signaling, thereby enhancing actin cytoskeleton remodeling and promoting centrosomal protein‑55‑mediated mitotic progression.",-42.0,0.8,geneorgeneproduct
"The upregulation of PAK1 in HeLa cells by a PI3‑kinase inhibitor decreased focal adhesion kinase phosphorylation, thereby impairing cell migration.",-23.0,0.8,geneorgeneproduct
"Overexpression of PAK1 in the A549 cell line leads to phosphorylation of focal adhesion kinase, thereby enhancing PI3‑kinase signaling and promoting actin‑based cell migration.",-22.875,0.8,geneorgeneproduct
"Overactivation of the phosphatidylinositol (PI)3‑kinase pathway in HeLa cells leads to up‑regulation of focal adhesion kinase and enhances PAK1‑mediated phosphorylation of actin, thereby promoting cell migration.",-35.0,0.8,geneorgeneproduct
"Overexpressed PAK1 in A549 cells phosphorylates focal adhesion kinase, thereby enhancing actin cytoskeletal rearrangement and promoting invasive migration.",-21.0,0.8,geneorgeneproduct
"Over-expression of PAK1 in the A549 cell line activates PI3K signaling, causing actin cytoskeleton rearrangement that promotes focal adhesion kinase‑mediated migration and enhances expression of the oncogenic PVT1 transcript in Homo sapiens lung carcinoma cells.",-46.0,0.8,geneorgeneproduct
"A mutation in the PAK1 gene, characterized by a missense variant c.892G>A, was shown to dysregulate focal adhesion kinase signaling in HeLa cells, thereby enhancing actin cytoskeleton remodeling and promoting resistance to apoptosis mediated by DFF‑45.",-40.0,0.8,geneorgeneproduct
"A patient with a PAK1 c.1234G>A (p.Arg412His) variant exhibited increased phosphorylation of focal adhesion kinase and altered actin cytoskeleton organization in cultured A549 cells, suggesting that the mutation dysregulates PI3‑kinase signaling and promotes metastatic behavior.",-42.75,0.8,geneorgeneproduct
"A CRISPR‑Cas9‑mediated knock‑in of the GLDC c.892C>T variant in human HCT116 cells up‑regulated PAK1 transcription and increased focal‑adhesion‑kinase phosphorylation, thereby enhancing actin‑mediated cell motility.",-43.0,0.8,geneorgeneproduct
"A loss‑of‑function mutation in the GLDC gene (c.1456G>A) in a patient with non‑ketotic hyperglycinemia causes accumulation of glycine, which activates the PI3K/Akt pathway and enhances focal adhesion kinase signaling, ultimately impairing actin cytoskeleton organization and leading to motor neuron degeneration.",-48.25,0.8,geneorgeneproduct
"In A549 cells, overexpression of the oncogenic PAK1 protein phosphorylates focal adhesion kinase, thereby enhancing actin remodeling and promoting resistance to the PI3‑kinase inhibitor LY294002.",-21.25,0.8,geneorgeneproduct
"In H1299 cells, overexpression of PAK1 phosphorylates focal adhesion kinase, thereby enhancing actin remodeling and promoting invasive migration.",-16.5,0.8,geneorgeneproduct
"In HeLa cells, overexpression of the PAK1 gene product phosphorylates focal adhesion kinase, thereby enhancing actin filament remodeling and promoting cell migration.",-15.1875,0.8,geneorgeneproduct
"In vitro, PAK1 phosphorylates the centrosomal protein C55, enhancing focal adhesion kinase signaling that promotes actin cytoskeletal reorganization in A549 cells.",-33.5,0.8,geneorgeneproduct
"Phosphatidylinositol (PI)3‑kinase activation in A549 cells leads to focal adhesion kinase phosphorylation, which in turn upregulates the T‑box transcription factor PAK1 and enhances actin cytoskeletal remodeling, thereby promoting cell migration.",-28.5,0.8,geneorgeneproduct
"Pharmacological inhibition of PAK1 in HeLa cells down‑regulates actin polymerisation and reduces focal adhesion kinase phosphorylation, thereby attenuating migration of this cell line.",-32.25,0.8,geneorgeneproduct
"Phosgene exposure in vitro inhibited PAK1 activity in HeLa cells, thereby reducing focal adhesion kinase phosphorylation and leading to decreased actin filament assembly and impaired cell migration.",-48.75,0.8,geneorgeneproduct
"Pharmaceutical inhibition of PAK1 in the A549 cell line downregulates focal adhesion kinase activity, leading to reduced actin‑mediated migration and enhanced apoptosis through activation of the PI3‑kinase signaling cascade.",-47.0,0.8,geneorgeneproduct
"Mutations in the PAK1 gene that increase its kinase activity were found to upregulate PI3K‑AKT signaling, thereby enhancing actin cytoskeleton remodeling and promoting invasive migration of the A549 cell line.",-32.5,0.8,geneorgeneproduct
"Mutational loss of the GLDC gene product in the HeLa cell line reduces phosphatidylinositol (PI)‑3‑kinase signaling and leads to altered actin cytoskeletal organization, thereby enhancing focal adhesion kinase recruitment and promoting cell migration.",-46.0,0.8,geneorgeneproduct
"Mutant PAK1 phosphorylates focal adhesion kinase, thereby enhancing actin cytoskeleton reorganization in MCF‑7 cells and promoting resistance to the PI3‑kinase inhibitor LY294002.",-26.0,0.8,geneorgeneproduct
"Mutated PAK1 in the A549 cell line was shown to hyperactivate PI3K/AKT signaling, thereby reducing actin cytoskeletal integrity and increasing susceptibility to chemotherapy-induced apoptosis.",-36.75,0.8,geneorgeneproduct
"Expression of the T‑box transcription factor PAX6 in HeLa cells, stimulated by PI3K/AKT signaling, upregulates the actin‑binding protein PAK1, which in turn phosphorylates focal adhesion kinase and enhances centrosomal protein‑55 recruitment, thereby promoting cell motility.",-45.0,0.8,geneorgeneproduct
"Expression levels of the kinase PAK1 in HeLa cells were found to be up‑regulated by the small‑molecule inhibitor GLDC‑005, resulting in phosphorylation of the actin‑binding protein DFF‑45 and enhanced focal adhesion kinase signaling that ultimately promoted cell migration and invasion.",-49.0,0.8,geneorgeneproduct
"Expression profiling of the gene PAK1 revealed that its up‑regulation in the HeLa cell line correlated with increased focal adhesion kinase activity, suggesting that PAK1 may drive cell migration through PI3‑kinase‑dependent signaling pathways.",-40.5,0.8,geneorgeneproduct
"Expression analysis of the T‑box transcription factor PAK1 in HeLa cells revealed that knockdown of GLDC decreased focal adhesion kinase phosphorylation, thereby impairing actin‑mediated cell migration.",-33.5,0.8,geneorgeneproduct
"Loss of function of the gene product PAK1 in A549 cells leads to dysregulated focal adhesion kinase signaling, resulting in reduced actin cytoskeletal organization and increased cellular sensitivity to doxorubicin.",-32.75,0.8,geneorgeneproduct
"Loss-of‑function mutations in the GLDC gene, which encodes the glycine decarboxylase enzyme that interacts with the mitochondrial folate-dependent enzyme PAK1, impair the conversion of glycine to serine and lead to a neurodevelopmental disorder characterized by seizures, developmental delay and an increased risk of microcephaly in affected Homo sapiens patients.",-59.25,0.8,geneorgeneproduct
"Loss‑of‑function mutations in the GLDC gene cause non‑ketotic hyperglycinemia, a metabolic disorder that manifests as seizures and severe neuro‑developmental delay in infants of Homo sapiens, while overexpression of the oncogenic PAK1 kinase in HeLa cells activates PI3‑kinase signaling, leading to enhanced focal‑adhesion kinase activity and increased actin polymerization that promotes tumor cell migration.",-55.0,0.8,geneorgeneproduct
"Loss‐of‑function mutations in the GLDC gene cause non‑ketotic hyperglycinemia, which in turn leads to abnormal neuronal migration and dysregulation of the PI3K‑AKT pathway, thereby impairing actin cytoskeleton dynamics in developing cortical neurons.",-44.0,0.8,geneorgeneproduct
"PAK1 activation by focal adhesion kinase signaling in HeLa cells increases actin‑cytoskeletal rearrangements, thereby enhancing cell migration.",-26.25,0.8,geneorgeneproduct
"PAI‐1 overexpression in the A549 cell line was found to activate PI3K‑AKT signalling, thereby enhancing actin‑cytoskeleton remodeling and promoting the invasive phenotype of the cells.",-58.5,0.8,geneorgeneproduct
"PAKR1 overexpression in A549 cells enhances PI3K/AKT signaling, thereby increasing actin cytoskeletal remodeling and conferring resistance to doxorubicin-induced apoptosis.",-34.75,0.8,geneorgeneproduct
"PAKI, whose up‑regulation in the HeLa cell line is driven by the PVT1 oncogene, activates PI3‑kinase and focal adhesion kinase, thereby enhancing actin‑based cell migration.",-55.75,0.8,geneorgeneproduct
Altered PAK1 phosphorylation by focal adhesion kinase in HeLa cells reduces actin cytoskeletal remodeling and promotes resistance to doxorubicin-induced apoptosis.,-21.5,0.8,geneorgeneproduct
"Alterations in PAK1 phosphorylation by PI3‑kinase reduce focal‑adhesion kinase recruitment to actin filaments, thereby impairing centrosomal protein‑55‑mediated mitotic spindle assembly.",-31.0,0.8,geneorgeneproduct
"Alteration of the GLDC gene product by a BRCA1 c.68_69delAG sequence variant reduces phosphatidylinositol (PI)3‑kinase activation and increases focal adhesion kinase phosphorylation in HeLa cells, thereby impairing actin cytoskeleton dynamics and promoting apoptosis through DFF‑45 cleavage.",-45.0,0.8,geneorgeneproduct
"Altering the expression of the PAK1 gene product in HeLa cells by CRISPR-Cas9-mediated knockdown led to a decrease in focal adhesion kinase activity and disrupted actin cytoskeleton organization, thereby impairing cell migration.",-40.25,0.8,geneorgeneproduct
"Activation of the PI3K–AKT pathway by PAK1 phosphorylation of focal adhesion kinase drives actin cytoskeletal remodeling in HeLa cells, leading to enhanced cell proliferation and resistance to apoptosis.",-29.125,0.8,geneorgeneproduct
"Activation kinase PAK1 phosphorylates the centrosomal protein CEP55, thereby promoting actin‑cytoskeletal reorganization and enhancing PI3K‑dependent focal adhesion kinase signaling in human A549 cells.",-46.5,0.8,geneorgeneproduct
"Activation‑induced phosphorylation of the focal adhesion kinase by the PI3‑kinase pathway in A549 cells leads to enhanced actin polymerisation, thereby increasing the invasive capacity of PAK1‑overexpressing clones.",-42.5,0.8,geneorgeneproduct
"Activation by the PI3K–AKT pathway in HeLa cells results in phosphorylation of the centrosomal protein CSNK2B, which promotes recruitment of the actin‑binding protein PAK1 to focal adhesions and enhances cell migration.",-49.0,0.8,geneorgeneproduct
"An up‑regulation of PAK1 in HeLa cells stimulated by PI3‑kinase activation enhances focal adhesion kinase phosphorylation, thereby promoting actin‑based motility and ultimately increasing invasion of the cancer cells.",-40.5,0.8,geneorgeneproduct
"An RNA‑seq analysis of the HeLa cell line revealed that PAK1 phosphorylation is increased by the PI3K inhibitor LY294002, correlating with reduced actin cytoskeletal organization and diminished focal adhesion kinase activation.",-42.25,0.8,geneorgeneproduct
"An overexpression of PAK1 in HeLa cells activates focal adhesion kinase, leading to enhanced actin polymerization and promoting the migration of cells toward a tumor‑like phenotype.",-32.0,0.8,geneorgeneproduct
"An interaction between the PAK1 protein and the actin cytoskeleton in HeLa cells is potentiated by PI3K activation, leading to focal‑adhesion kinase phosphorylation and subsequent cell‑migration signaling.",-42.0,0.8,geneorgeneproduct
"Aberrant over‑expression of PAK1 in HeLa cells activates focal adhesion kinase, thereby enhancing PI3‑kinase signaling and promoting actin cytoskeletal rearrangements that facilitate metastasis.",-27.25,0.8,geneorgeneproduct
"Aberrations in the PAK1 gene, such as the c.1024C>A missense variant, upregulate PI3K signaling in HeLa cells, thereby enhancing actin polymerization and promoting focal adhesion kinase activation that drives tumorigenic invasion.",-50.0,0.8,geneorgeneproduct
"Aberration of the PAK1 gene product in cultured HeLa cells was shown to disrupt actin filament organization and activate PI3K‑dependent focal adhesion kinase signaling, thereby promoting cell migration.",-38.25,0.8,geneorgeneproduct
"Aberrogated PAK1 expression in the A549 lung carcinoma cell line enhances PI3K‑mediated focal adhesion kinase activation, thereby increasing actin‑dependent migration and up‑regulating the oncogenic PVT1 transcript while simultaneously inducing DFF‑45‑mediated apoptosis in co‑cultured E. coli.",-66.5,0.8,geneorgeneproduct
"Deletion of the PAK1 exon within the PVT1 locus in A549 cells reduces PI3K–AKT signaling and increases actin‑cortical stress fiber formation, thereby enhancing cellular sensitivity to doxorubicin.",-36.25,0.8,geneorgeneproduct
"Deletion in the PAK1 coding sequence (c.1226_1228del) in a tumor cell line derived from a patient with breast carcinoma reduces PI3K/AKT signaling, thereby increasing sensitivity to the RARγ‑selective agonist CD1530 and inducing apoptosis via activation of DFF‑45 and loss of centrosomal protein‑55 localization.",-76.0,0.8,geneorgeneproduct
"Deletion c.68_69delAG in the BRCA1 gene reduces TP53 protein stability, thereby diminishing the cellular response to doxorubicin-induced DNA damage in HeLa cells of Homo sapiens.",-36.5,0.8,geneorgeneproduct
"Deletion at the PVT1 locus in HeLa cells disrupts the binding of GLDC to the promoter of the T‑box transcription factor, leading to decreased actin polymerization and aberrant focal adhesion kinase signaling in Homo sapiens.",-45.0,0.8,geneorgeneproduct
"The constitutive activation of the G12D oncogene in A549 cells induces rapid up‑regulation of the insulin‑receptor and downstream STAT5 signaling, thereby enhancing FGF2‑mediated proliferation and NADPH‑dependent antioxidant defenses.",-37.0,0.8,geneorgeneproduct
"The KRAS G12D mutation in A549 cells enhances VDAC‑mediated apoptosis by increasing NADPH‑dependent reactive oxygen species, thereby amplifying FGF2‑driven proliferation in a manner dependent on the insulin‑receptor signaling axis.",-36.75,0.8,geneorgeneproduct
"The D2 receptor‑mediated signaling pathway is dysregulated in the G12D‑mutant KRAS‑expressing A549 cell line, leading to increased NADPH oxidase activity and up‑regulated FGF2 transcription that activates STAT5 via the insulin‑receptor–eIF2α axis in the human lung carcinoma model.",-53.0,0.8,geneorgeneproduct
"The G12D mutation in KRAS enhances interaction with VDAC, leading to increased NADPH consumption and downstream activation of the insulin‑receptor signaling cascade in human colorectal cancer cells.",-23.875,0.8,geneorgeneproduct
"A549 cells overexpressing the mutant KRAS G12D variant exhibit heightened NADPH oxidase activity that enhances VDAC-mediated mitochondrial membrane depolarization, thereby increasing ROS-dependent activation of the insulin‑receptor signaling cascade.",-35.75,0.8,geneorgeneproduct
"A G12D mutation in KRAS destabilizes the insulin‑receptor signaling cascade in HeLa cells, leading to up‑regulation of FGF2 and a concomitant increase in NADPH production mediated by XRCC3‑dependent DNA repair.",-34.0,0.8,geneorgeneproduct
"A point mutation in the D2 receptor gene (D2R c.456C>T) in the HeLa cell line leads to a reduced binding affinity for dopamine, thereby increasing intracellular NADPH levels and stimulating the transcription of the insulin-receptor signaling pathway.",-52.5,0.8,geneorgeneproduct
"A recent study demonstrated that the G12D variant of KRAS induces increased NADPH production, which in turn activates FGF2 signaling to upregulate the insulin‑receptor and signal transducer and activator of transcription‑5 in A549 cells, thereby enhancing cell proliferation.",-43.5,0.8,geneorgeneproduct
"In the MCF‑7 CellLine, overexpression of the G12D mutant KRAS enhances NADPH production, which activates FGF2‑mediated signaling and upregulates CSF‑1 expression through STAT5 recruitment, ultimately promoting tumor cell migration.",-47.25,0.8,geneorgeneproduct
"In K562 cells harboring the KRAS G12D variant, overexpression of the D2 receptor activates the insulin‑receptor/PI3K/AKT pathway, leading to increased VDAC‑mediated mitochondrial ROS production and subsequent phosphorylation of eIF2α, which ultimately suppresses global protein synthesis.",-36.0,0.8,geneorgeneproduct
"In HeLa cells, the D2 receptor-mediated inhibition of insulin‑receptor phosphorylation activates eIF2α, thereby reducing FGF2 synthesis and enhancing XRCC3 expression to promote DNA repair during G12D‑induced oxidative stress.",-29.0,0.8,geneorgeneproduct
"In H1299 cells, the oncogenic G12D KRAS mutation increases NADPH oxidase activity, thereby enhancing reactive oxygen species production that activates the insulin‑receptor signaling cascade to upregulate FGF2 expression.",-28.375,0.8,geneorgeneproduct
"Aberrant activation of the D2 receptor by dopamine in the striatum enhances XRCC3-mediated DNA repair, thereby mitigating G12D‑induced oncogenic signaling in HeLa cells and promoting NADPH‑dependent antioxidant defenses that protect VDAC‑regulated mitochondrial integrity.",-41.75,0.8,geneorgeneproduct
"Aberrations in the XRCC3 gene, such as the G12D variant, impair DNA repair and elevate NADPH oxidase activity, which subsequently enhances FGF2‑mediated angiogenesis through the insulin‑receptor signaling axis in E. coli‑derived cell lines.",-52.25,0.8,geneorgeneproduct
Aberration of the XRCC3 gene by the G12D sequence variant in human HeLa cells diminishes NADPH-dependent DNA repair and enhances FGF2-mediated tumor cell proliferation.,-45.75,0.8,geneorgeneproduct
"Aberrin, a novel small molecule, selectively inhibits the D2 receptor in HeLa cells, thereby reducing FGF2‑induced phosphorylation of the insulin‑receptor and downstream STAT5 activation, a pathway that is dysregulated by the XRCC3 G12D mutation in certain colorectal cancers.",-53.25,0.8,geneorgeneproduct
"XRCC3 mutation c.1315C>T causes a loss of the D2 receptor-binding domain, reducing eIF2α phosphorylation and thereby impairing insulin‑receptor signaling in HepG2 cells.",-39.5,0.8,geneorgeneproduct
"XRRC3 overexpression in HeLa cells bearing the G12D KRAS mutation diminishes NADPH-dependent FGF2 signalling, leading to reduced VDAC-mediated apoptosis and enhanced insulin‑receptor phosphorylation.",-46.25,0.8,geneorgeneproduct
"XRCCC3 overexpression in H1299 cell lines activates STAT5 signaling and enhances FGF2 secretion, thereby promoting G12D‑driven tumorigenesis through increased VDAC‑mediated mitochondrial NADPH production.",-49.75,0.8,geneorgeneproduct
"XRCR3 amplification in HeLa cells expressing the D2 receptor reduces NADPH‑dependent FGF2 secretion, thereby enhancing signal transducer and activator of transcription‑5 activation and driving G12D‑mediated oncogenic proliferation.",-52.0,0.8,geneorgeneproduct
"Mutations in XRCC3 and the G12D variant of KRAS cooperate to reduce NADPH-dependent antioxidant capacity, thereby enhancing FGF2‑induced proliferation in A549 cells and aggravating insulin‑receptor signaling defects in a mouse model of type‑2 diabetes.",-37.75,0.8,geneorgeneproduct
"Mutational analysis revealed that the G12D variant in KRAS enhances VDAC-mediated apoptosis, while XRCC3 deficiency reduces NADPH-dependent DNA repair in A549 cells, thereby sensitizing them to FGF2‑induced proliferation.",-35.0,0.8,geneorgeneproduct
"Mutated XRCC3 (c.1505C>T) reduces NADPH-dependent DNA repair in HeLa cells, thereby enhancing FGF2-mediated cell proliferation through activation of the insulin‑receptor/STAT5 signaling axis.",-41.5,0.8,geneorgeneproduct
"Mutant KRAS (G12D) activates the insulin‑receptor pathway in A549 cells, leading to enhanced NADPH production that supports FGF2‑mediated proliferation and upregulates the transcription factor STAT5 through phosphorylation of eIF2α.",-33.5,0.8,geneorgeneproduct
"Altered phosphorylation of eIF2α by the D2 receptor in HeLa cells expressing the G12D mutant of KRAS results in reduced FGF2 production, a change that is rescued by overexpression of the XRCC3 DNA repair protein.",-38.5,0.8,geneorgeneproduct
"Alterations in the D2 receptor gene product, such as the G12D mutation, disrupt insulin‑receptor signaling and impair eIF2α‑mediated translation, thereby reducing NADPH production and increasing oxidative stress in fibroblasts that overexpress FGF2 and CSF‑1.",-37.0,0.8,geneorgeneproduct
"Alteration of the XRCC3 gene product by a missense variant reduces its ability to recruit the D2 receptor signaling complex, thereby impairing NADPH-dependent FGF2 production and subsequently diminishing insulin‑receptor mediated cell proliferation in human fibroblasts.",-47.5,0.8,geneorgeneproduct
"Altering the phosphorylation state of eIF2α in A549 cells reduces the translation of the D2 receptor mRNA, thereby lowering the intracellular insulin‑receptor signaling and promoting apoptosis through VDAC‑mediated mitochondrial outer membrane permeabilization.",-46.75,0.8,geneorgeneproduct
"G12D‑mutated KRAS in A549 cells increases NF‑κB activation through a VDAC‑dependent mitochondrial ROS pathway, enhancing FGF2 secretion and promoting tumor cell proliferation.",-38.0,0.8,geneorgeneproduct
"GAD1 loss-of-function in HeLa cells carrying the XRCC3 V538I variant enhances insulin‑receptor signaling through elevated NADPH production and FGF2‑dependent phosphorylation of eIF2α, thereby potentiating cell proliferation.",-63.0,0.8,geneorgeneproduct
"Glycine-rich repeat protein XRCC3, whose G12D mutation impairs DNA repair, is downregulated by elevated NADPH levels in HepG2 cells, thereby reducing FGF2-mediated mitogenic signaling through the insulin‑receptor/VDAC axis and enhancing eIF2α‑dependent stress responses.",-54.75,0.8,geneorgeneproduct
"Gastric adenocarcinoma cells with a G12D KRAS mutation showed increased FGF2 secretion, which in turn activated the insulin‑receptor‑mediated PI3K‑AKT pathway and up‑regulated eIF2α phosphorylation, thereby enhancing cell proliferation.",-39.75,0.8,geneorgeneproduct
"Activation of the insulin‑receptor by high levels of NADPH in A549 cells induces phosphorylation of eIF2α, which in turn up‑regulates FGF2 expression and promotes proliferation of the D2 receptor‑positive cancer cells.",-33.25,0.8,geneorgeneproduct
"Activation-induced phosphorylation of the D2 receptor by the kinase eIF2α in insulin‑resistant HepG2 cells reduces glucose uptake, while overexpression of the XRCC3 variant G12D restores DNA repair capacity through increased NADPH‑dependent FGF2 signaling.",-53.5,0.8,geneorgeneproduct
"Activation phosphorylation of the insulin‑receptor by the insulin‑binding ligand increases the recruitment of phosphatidylinositol‑3‑kinase, thereby stimulating downstream eIF2α signaling and enhancing FGF2‑dependent proliferation of human fibroblasts.",-56.0,0.8,geneorgeneproduct
"Activation occurs when the insulin‑receptor tyrosine kinase phosphorylates IRS‑1, leading to PI3K recruitment that then activates AKT and induces the nuclear translocation of STAT5 to upregulate FGF2 expression, thereby promoting proliferation of HeLa cells in response to the G12D KRAS mutant signal.",-68.0,0.8,geneorgeneproduct
"Deletion of the XRCC3 V342M variant in HeLa cells reduces homologous recombination efficiency, thereby enhancing the cytotoxicity of doxorubicin and increasing apoptosis mediated through the p53 pathway.",-37.25,0.8,geneorgeneproduct
"Deletion in the XRCC3 gene that replaces the wild‑type alanine at position G12 with a glycine (G12D) reduces NADPH‑dependent DNA repair activity, thereby enhancing FGF2‑induced proliferation of VDAC‑positive HeLa cells.",-49.0,0.8,geneorgeneproduct
Deletion or loss-of-function mutations in the DNA repair gene XRCC3 enhance the cytotoxicity of the anthracycline doxorubicin (DOX) by reducing homologous recombination-mediated repair and increasing the accumulation of DNA double‑strand breaks in HeLa cells.,-52.75,0.8,geneorgeneproduct
"Deletion c.68_69delAG in the BRCA1 gene product in a homozygous *Homo sapiens* patient leads to loss of the second BRCT domain, which in turn impairs DNA repair and increases susceptibility to breast cancer.",-53.5,0.8,geneorgeneproduct
"Loss of XRCC3 function in the H1299 cell line leads to elevated NADPH oxidase activity and increased oxidative stress, thereby impairing insulin‑receptor signaling and promoting G12D‑induced oncogenic transformation.",-36.75,0.8,geneorgeneproduct
"Loss-of-function mutations in the XRCC3 gene reduce homologous recombination repair and increase sensitivity of H1299 cells to doxorubicin, thereby enhancing apoptosis through activation of the p53 signaling pathway.",-32.0,0.8,geneorgeneproduct
"Loss‑of‑function of the XRCC3 gene product, combined with a G12D mutation in KRAS, impairs NADPH‑dependent DNA repair and enhances FGF2‑induced proliferation in KRAS‑driven colorectal cancer cells.",-32.5,0.8,geneorgeneproduct
"Loss‐of‑function mutations in the XRCC3 gene, such as the G12D variant, impair homologous recombination and sensitize HeLa cells to doxorubicin‑induced DNA damage by decreasing NADPH‑dependent repair pathways.",-30.5,0.8,geneorgeneproduct
"Mutation of the XRCC3 gene in HeLa cells reduces the recruitment of the D2 receptor to the plasma membrane, thereby impairing insulin‑receptor signaling and decreasing FGF2‑induced proliferation.",-21.25,0.8,geneorgeneproduct
"Mutation introducing the G12D variant into the KRAS gene of A549 cells markedly increased KRAS protein expression, enhanced downstream ERK phosphorylation, and promoted VDAC‑mediated mitochondrial outer‑membrane permeabilization, thereby accelerating apoptotic cell death.",-53.0,0.8,geneorgeneproduct
"Mutation‑induced G12D in KRAS up‑regulates FGF2 transcription through STAT5, thereby enhancing insulin‑receptor phosphorylation and NADPH‑dependent VDAC‑mediated mitochondrial bioenergetics in HeLa cells.",-36.75,0.8,geneorgeneproduct
"Mutation G12D in KRAS causes hyperactivation of the insulin‑receptor signaling cascade, leading to increased NADPH production that fuels the FGF2‑mediated proliferation of HeLa cells.",-28.875,0.8,geneorgeneproduct
"Silencing of XRCC3 in A549 cells expressing oncogenic KRAS G12D reduces NADPH‑dependent FGF2 secretion, thereby attenuating insulin‑receptor signalling and increasing apoptosis through eIF2α‑mediated stress responses.",-33.0,0.8,geneorgeneproduct
"Silica nanoparticles overexpressed the D2 receptor and activated the STAT5 pathway, thereby increasing insulin‑receptor signaling and upregulating FGF2 production in HeLa cells.",-39.0,0.8,geneorgeneproduct
"Silently, a KRAS G12D mutation in the A549 cell line drives up‑regulation of the insulin‑receptor gene and concomitant phosphorylation of eIF2α, which in turn enhances FGF2 secretion and activates STAT5 signaling, ultimately increasing NADPH production to support rapid cell proliferation.",-56.75,0.8,geneorgeneproduct
"Silenced XRCC3 expression in the A549 cell line reduces the phosphorylation of eIF2α, thereby impairing the unfolded protein response and enhancing sensitivity to the chemotherapeutic agent doxorubicin.",-30.625,0.8,geneorgeneproduct
"An attenuated A549 cell line transfected with a plasmid encoding the G12D mutant of KRAS, which upregulates FGF2 secretion, demonstrates enhanced NADPH oxidase activity and increased expression of the insulin‑receptor substrate‑1 (IRS‑1) via signal transducer and activator of transcription‑5 (STAT5) phosphorylation.",-61.5,0.8,geneorgeneproduct
"An overexpression of the D2 receptor in A549 cells activates STAT5 signaling, leading to increased FGF2 transcription and enhanced insulin‑receptor phosphorylation, thereby promoting cellular proliferation.",-27.0,0.8,geneorgeneproduct
"An engineered KRAS G12D mutation in HeLa cells elevates NADPH production, thereby enhancing FGF2‑induced ERK phosphorylation and driving resistance to insulin‑receptor blockade.",-35.5,0.8,geneorgeneproduct
"An in vitro study showed that the D2 receptor antagonist sulpiride increased NADPH oxidase activity in A549 cells, thereby enhancing reactive oxygen species production and subsequently upregulating the signal transducer and activator of transcription‑5 pathway to promote apoptosis in the presence of the G12D KRAS mutation.",-48.75,0.8,geneorgeneproduct
"The ApoE‑deficient mouse model, which harbors a CRISPR‑generated CCDC104 exon‑2 deletion, exhibits increased circulating lipoprotein‑associated TGF‑β levels that stimulate renin‑angiotensin system up‑regulation and accelerate aortic aneurysm formation.",-45.25,0.8,geneorgeneproduct
"The overexpression of APOE‑deficient gene product in HeLa cells led to increased TGF‑β signaling, which in turn up‑regulated the kinases inositol‑requiring protein‑1a and promoted epithelial‑mesenchymal transition.",-30.5,0.8,geneorgeneproduct
"The TGF‑β pathway is up‑regulated in apoE‑deficient mice, where increased SMAD2 phosphorylation induces a pro‑fibrotic gene signature that is partially suppressed by the small molecule CFI‑7356506, an inhibitor of the kinases inositol‑requiring protein‑1a.",-42.5,0.8,geneorgeneproduct
"The loss-of-function mutation in FTO, a sequence variant detected in the A549 cell line, disrupts the renin‑angiotensin signaling pathway by altering chordin‑like expression in Homo sapiens cells.",-36.5,0.8,geneorgeneproduct
"A loss‑of‑function mutation in the FTO gene, which encodes an RNA demethylase that regulates adipogenesis, was shown to enhance TGF‑β signalling and increase renin‑angiotensin system activity in apoE‑deficient mice, thereby accelerating the progression of atherosclerosis.",-38.0,0.8,geneorgeneproduct
"Apc2 overexpression in the ApoE‑deficient A549 cell line causes a TGF‑β‑mediated increase in CCDC104 transcription, thereby enhancing the inositol‑requiring protein‑1a‑driven phosphorylation of downstream kinases that ultimately promotes renin‑angiotensin‑system activation and induces pulmonary fibrosis.",-62.25,0.8,geneorgeneproduct
"ApoE‑deficient mice treated with the TGF‑β antagonist CBKOTg exhibited significantly reduced aortic plaque formation, an effect that correlated with down‑regulation of the renin‑angiotensin system and increased expression of inositol‑requiring protein‑1a kinases.",-30.625,0.8,geneorgeneproduct
"A mutation in the FTO gene of an ApoE‑deficient mouse model was shown to up‑regulate transforming growth factor‑β signaling, thereby accelerating renal fibrosis in the renin‑angiotensin system–driven kidney injury model.",-33.0,0.8,geneorgeneproduct
"In ApoE‑deficient mice, up‑regulation of the transforming growth factor‑β signaling pathway was observed, leading to increased expression of chordin‑like protein and accelerated atherosclerotic plaque formation.",-25.125,0.8,geneorgeneproduct
"In human hepatoma Huh7 cells, overexpression of the transforming growth factor β receptor kinase TGFBR1 leads to phosphorylation of SMAD2, which in turn up‑regulates the transcription of the lipid‑metabolism gene APOE, illustrating a regulatory axis that may contribute to the lipid‑accumulation phenotype observed in apoE‑deficient murine models.",-55.25,0.8,geneorgeneproduct
"In the ApoE-deficient mouse model, upregulation of transforming growth factor‑β signaling in the liver was associated with increased expression of the kinase inositol‑requiring protein‑1α, suggesting a mechanistic link between impaired lipid metabolism and inflammatory pathway activation.",-35.0,0.8,geneorgeneproduct
"In hepatocytes derived from apoE‑deficient mice, overexpression of the transforming growth factor‑β1 signaling axis upregulates CCDC104 transcription, thereby enhancing fibrotic collagen deposition through TGF‑β‑mediated kinase signaling.",-47.25,0.8,geneorgeneproduct
"Mutations in the FTO gene that reduce its mRNA stability have been shown to upregulate TGF‑β signaling in ApoE‑deficient murine macrophages, thereby exacerbating atherosclerotic plaque formation.",-29.5,0.8,geneorgeneproduct
"Mutational activation of the FTO gene in A549 cells induces up‑regulation of chordin‑like protein, thereby enhancing TGF‑β signaling and driving epithelial‑mesenchymal transition.",-26.25,0.8,geneorgeneproduct
"Mutant APOE‑ε4 carriers exhibit enhanced TGF‑β signaling in vascular smooth‑muscle cells, leading to increased expression of CCDC104 and promoting hypertension in apoE‑deficient mice.",-37.25,0.8,geneorgeneproduct
"Mutated APOE c.1130G>A in apoE‑deficient mice exacerbates TGF‑β‑driven fibrosis, while pharmacological inhibition of the inositol‑requiring protein‑1a kinase pathway restores renal renin‑angiotensin homeostasis.",-42.25,0.8,geneorgeneproduct
"Altered expression of the FTO gene in ApoE‑deficient mice was found to enhance the renin‑angiotensin system and upregulate transforming growth factor‑β signaling, thereby accelerating atherosclerotic plaque formation.",-27.75,0.8,geneorgeneproduct
"Alterations in the FTO gene product in apoE‑deficient murine models of atherosclerosis activate transforming growth factor‑β signaling, thereby upregulating kinases inositol‑requiring protein‑1a and exacerbating plaque instability.",-32.25,0.8,geneorgeneproduct
"Alteration of the FTO gene product in ApoE-deficient mouse models induces a pronounced increase in transforming growth factor‑β signaling, thereby exacerbating the renin‑angiotensin cascade and accelerating the progression of cardiac fibrosis.",-37.5,0.8,geneorgeneproduct
"Altering the expression of the gene product FTO in a murine A549 cell line, which harbors a CBKOTg variant, leads to dysregulation of the renin‑angiotensin pathway and increased secretion of transforming growth factor β, thereby accelerating the development of pulmonary fibrosis in ApoE‑deficient mice.",-61.5,0.8,geneorgeneproduct
"Combining CRISPR‑Cas9 editing of the FTO locus in ApoE‑deficient A549 cells with treatment by the small‑molecule TGF‑β pathway inhibitor CFI‑7356506 markedly reduced the expression of the oncogenic kinase inositol‑requiring protein‑1a, thereby attenuating proliferation and migration of the human lung carcinoma cell line.",-45.25,0.8,geneorgeneproduct
"Combustion of doxorubicin by HeLa cells triggers apoptosis mediated by TP53, while the resulting BRCA1 c.68_69delAG variant in the cancer cell line is linked to increased sensitivity to cisplatin, illustrating a complex interaction between DNA repair, drug metabolism, and chemotherapeutic efficacy.",-79.0,0.8,geneorgeneproduct
"Combating atherosclerosis in ApoE‑deficient mice, the overexpression of chordin‑like modulates TGF‑β signaling and reduces plaque formation, illustrating a gene‑product interaction that may translate to therapeutic strategies in humans.",-50.5,0.8,geneorgeneproduct
"Combusting the A549 cell line with doxorubicin triggers up‑regulation of TGF‑β signaling, which in turn increases chordin‑like expression and subsequently activates the renin‑angiotensin axis, thereby promoting apoptosis and enhancing the efficacy of the drug.",-71.5,0.8,geneorgeneproduct
"COX‑2 expression is markedly increased in ApoE‑deficient mouse aortas, where TGF‑β signaling via the inositol‑requiring protein‑1α kinase amplifies smooth‑muscle cell proliferation and contributes to atherosclerotic plaque formation.",-36.0,0.8,geneorgeneproduct
"CO₂-induced upregulation of the kinases inositol‑requiring protein‑1a in apoE‑deficient Huh7 cells activates TGF‑β signalling, thereby promoting fibrotic collagen deposition in a paracrine loop that enhances liver tumour progression.",-63.0,0.8,geneorgeneproduct
"COG‑B1 expression is up‑regulated in ApoE‑deficient A549 cells treated with the TGF‑β1 agonist CBKOTg, leading to increased phosphorylation of the inositol‑requiring protein‑1a kinase and enhanced secretion of renin‑angiotensin peptides.",-49.25,0.8,geneorgeneproduct
"COReceptor protein FTO was found to phosphorylate chordin-like in apoE‑deficient cells, thereby enhancing TGF‑β signaling and promoting renin‑angiotensin‑mediated hypertension in a mouse model.",-50.5,0.8,geneorgeneproduct
Transgenic mouse models overexpressing the chordin‑like gene in an apoE‑deficient background exhibit up‑regulated TGF‑β signaling that accelerates atherosclerotic plaque formation in the aortic root.,-32.25,0.8,geneorgeneproduct
"Transcriptional analysis revealed that the TGF‑β‑induced up‑regulation of the FTO gene product in ApoE‑deficient macrophages was abrogated by the small‑molecule inhibitor CFI‑7356506, thereby attenuating the pro‑inflammatory cytokine secretion characteristic of atherosclerotic lesions.",-40.75,0.8,geneorgeneproduct
"Transplantation of ApoE‑deficient mouse hepatocytes into a chordin‑like overexpressing A549 cell line revealed that the loss of ApoE combined with elevated TGF‑β signaling dramatically enhanced fibrotic gene expression, implicating the renin‑angiotensin cascade as a downstream mediator of the observed hepatic fibrosis.",-54.25,0.8,geneorgeneproduct
Translational studies in the ApoE‑deficient A549 cell line revealed that knockdown of the FTO‑mediated demethylation of TGF‑β mRNA reduced downstream kinase signaling and increased renin‑angiotensin pathway activation.,-49.5,0.8,geneorgeneproduct
"Mutation of the FTO gene in ApoE‑deficient mice leads to overactivation of the transforming growth factor‑beta/renin‑angiotensin signaling pathway, which in turn drives the proliferation of CCDC104‑positive chordin‑like fibroblasts.",-37.5,0.8,geneorgeneproduct
"Mutation in the FTO gene, which encodes an RNA demethylase, increases the risk of obesity and is associated with altered expression of the chordin‑like protein and the renin‑angiotensin system in ApoE‑deficient mice.",-33.0,0.8,geneorgeneproduct
"Mutation‐induced up‑regulation of the transforming growth factor β (TGF‑β) signaling pathway in ApoE‑deficient mice carrying a novel CCDC104 sequence variant leads to accelerated atherosclerotic plaque formation, as confirmed by increased macrophage infiltration and collagen deposition in the aortic root.",-43.0,0.8,geneorgeneproduct
"Mutation‑induced up‑regulation of TGF‑β signaling in CCDC104‑deficient A549 cells activates the inositol‑requiring protein‑1a kinase cascade, thereby enhancing the expression of the pro‑apoptotic gene FTO in a manner that correlates with increased sensitivity to the chemotherapeutic agent doxorubicin.",-48.0,0.8,geneorgeneproduct
"Silencing of APOE in A549 cells reduces TGF‑β1‑induced phosphorylation of SMAD3, thereby attenuating extracellular matrix production and collagen deposition.",-31.625,0.8,geneorgeneproduct
"Silenced APOE expression in apoE‑deficient mouse hepatocytes triggers a compensatory up‑regulation of TGF‑β signaling, leading to increased extracellular matrix deposition and fibrosis, as confirmed by histological analysis of liver tissue from C57BL/6J animals.",-45.25,0.8,geneorgeneproduct
"Silently, the ApoE‑deficient mouse model exhibited up‑regulated TGF‑β signaling that, through activation of inositol‑requiring protein‑1a kinases, amplified the inflammatory phenotype observed in the brain of these genetically engineered animals.",-51.0,0.8,geneorgeneproduct
"Silicate-mediated up‑regulation of the TGF‑β pathway in A549 cells carrying an FTO c.1354G>A variant induces a robust increase in the expression of the ApoE‑deficient gene product, thereby exacerbating collagen deposition and fibrosis.",-68.5,0.8,geneorgeneproduct
"Polymorphisms in the ApoE gene and the FTO allele synergistically upregulate TGF‑β signaling, which in turn increases renin‑angiotensin system activity in apoE‑deficient murine models, thereby accelerating fibrosis.",-43.75,0.8,geneorgeneproduct
"Polyclonal T cells from an apoE-deficient mouse harboring the CBKOTg transgene exhibit elevated transforming growth factor‑β secretion, which synergistically activates the renin‑angiotensin axis and upregulates the kinases inositol‑requiring protein‑1α in the kidney, thereby promoting progressive glomerulosclerosis.",-66.0,0.8,geneorgeneproduct
"Polysialylated neurotrophin receptor isoforms, such as the chordin-like variant of the transforming‑growth‑factor‑β pathway, were markedly up‑regulated in the ApoE‑deficient A549 cell line, revealing a novel interaction between the CCDC104 gene product and the renin‑angiotensin‑mediated kinase inositol‑requiring‑protein‑1a signaling cascade.",-70.0,0.8,geneorgeneproduct
"Polychlorinated biphenyls exposure upregulates CCDC104 expression in apoE‑deficient HepG2 cells, thereby potentiating TGF‑β signaling through inositol‑requiring protein‑1a‑mediated phosphorylation of SMAD3.",-44.75,0.8,geneorgeneproduct
"Overexpression of TGF‑β in apoE‑deficient A549 cells activates the PI3K/AKT pathway, leading to increased proliferation and resistance to doxorubicin-induced apoptosis.",-23.125,0.8,geneorgeneproduct
"Overexpressed TGF‑β1 in ApoE‑deficient A549 cells upregulates CCDC104, increasing inositol‑requiring protein‑1a phosphorylation and thereby enhancing the renin‑angiotensin signaling cascade.",-35.25,0.8,geneorgeneproduct
"Overactivation of the transforming‑growth‑factor β signaling pathway in ApoE‑deficient C57BL/6J mice exacerbated atherosclerotic plaque formation, while pharmacologic inhibition of inositol‑requiring‑protein‑1a kinase reduced endothelial inflammation and restored normal renin‑angiotensin balance.",-45.75,0.8,geneorgeneproduct
"Over the course of a single experiment, the chordin‑like protein was shown to inhibit the transforming growth factor‑β (TGF‑β) signalling cascade in HeLa cells, thereby reducing the expression of the FTO gene and increasing the susceptibility of the cells to doxorubicin‑induced apoptosis.",-49.25,0.8,geneorgeneproduct
"Activating mutations in the FTO gene, which encode a demethylase that regulates energy homeostasis, were found to increase expression of the transforming growth factor (TGF) beta signaling pathway in ApoE‑deficient hepatocytes derived from CHO cells, suggesting a novel link between metabolic gene regulation and cytokine‑mediated fibrosis.",-56.75,0.8,geneorgeneproduct
"Activ In vitro assays showed that the ApoE‑deficient A549 cell line exhibited markedly increased phosphorylation of kinases inositol‑requiring protein‑1a, suggesting that loss of APOE up‑regulates the TGF‑β signaling pathway and enhances renin‑angiotensin‑mediated fibrosis.",-57.0,0.8,geneorgeneproduct
"Activational phosphorylation of the kinases inositol‑requiring protein‑1a in apoE‑deficient mouse fibroblasts drives a transforming growth factor‑β‑dependent up‑regulation of CCDC104 expression, thereby enhancing cellular senescence and accelerating the progression of age‑related vascular pathologies.",-57.5,0.8,geneorgeneproduct
"Activators of the renin‑angiotensin system upregulate CCDC104 transcription in human aortic smooth‑muscle cells, an effect that is attenuated in ApoE‑deficient macrophages where TGF‑β signaling is concurrently suppressed.",-49.0,0.8,geneorgeneproduct
CRISPR‑mediated knockout of the FTO gene in A549 cells reduces expression of the TGF‑β pathway genes and sensitizes the cells to doxorubicin‑induced apoptosis.,-28.0,0.8,geneorgeneproduct
"CRP expression is markedly upregulated in apoE-deficient mice exposed to a high‑fat diet, a change that is mediated through the renin‑angiotensin system and the activation of TGF‑β signaling in hepatic cells.",-43.5,0.8,geneorgeneproduct
"CR3 expression in apoE‑deficient A549 cells is up‑regulated by TGF‑β signaling, increasing invasion and correlating with the FTO‑mediated methylation of the chordin‑like promoter.",-46.0,0.8,geneorgeneproduct
"CR‑mediated phosphorylation of the TGF‑β receptor by the inositol‑requiring protein‑1a kinase in apoE‑deficient HepG2 cells enhances SMAD2/3 nuclear translocation, thereby upregulating the expression of the FTO gene and increasing lipogenesis in this human hepatocellular carcinoma line.",-52.75,0.8,geneorgeneproduct
Elevated ubiquitin-dependent degradation of the E3 ubiquitin ligase TRKRA in HeLa cells expressing the KCNQ1 FCGR2B-Ile232Thr variant reduces HMW‑adiponectin secretion and induces perilipin‑mediated lipid droplet accumulation.,-28.5,0.8,geneorgeneproduct
"Elevating TRKRA expression in HeLa cells enhances the ubiquitin-dependent degradation of the E3 ubiquitin ligase Perilipin, thereby increasing HMW‑adiponectin secretion and promoting glucose‑induced glucagon release.",-33.75,0.8,geneorgeneproduct
"Elevations in HMW‑adiponectin were correlated with decreased ubiquitin‑dependent degradation of the E3 ubiquitin ligase TRKRA, thereby enhancing Perilipin‑mediated lipid droplet stability in HepG2 cells.",-32.5,0.8,geneorgeneproduct
"Elevin, a novel E3 ubiquitin ligase, binds ubiquitin-dependent substrates such as TRKRA and HMW‑adiponectin, thereby enhancing the degradation of KCNQ1‑associated channel complexes in human hepatocytes and attenuating glucagon‑induced lipid mobilization in Perilipin‑rich adipose tissue.",-57.5,0.8,geneorgeneproduct
"The E3 ubiquitin ligase TRKRA mediates ubiquitin‑dependent degradation of HMW‑adiponectin, thereby attenuating Perilipin‑induced lipolysis in KCNQ1‑deficient pancreatic β‑cells and ultimately reducing glucagon secretion.",-18.375,0.8,geneorgeneproduct
"The ubiquitin‑dependent E3 ubiquitin ligase TRKRA targets Perilipin for degradation, thereby reducing HMW‑adiponectin secretion in KCNQ1‑mutated pancreatic β‑cells that overexpress the pro‑tumorigenic Pim3 kinase.",-23.375,0.8,geneorgeneproduct
"The knockout of the E3 ubiquitin ligase TRKRA in A549 cells impaired ubiquitin‑dependent degradation of HMW‑adiponectin, leading to increased Perilipin expression and a marked reduction in KCNQ1‑mediated potassium currents.",-24.75,0.8,geneorgeneproduct
"The phosphorylation of the E3 ubiquitin ligase TRKRA by Pim3 enhances ubiquitin‑dependent degradation of HMW‑adiponectin, thereby reducing Perilipin‑mediated lipid droplet stability in KCNQ1‑deficient HeLa cells.",-22.625,0.8,geneorgeneproduct
"In Huh7 cells, overexpression of the E3 ubiquitin ligase TRKRA promoted ubiquitin‑dependent degradation of HMW‑adiponectin, thereby reducing Perilipin‑mediated lipid droplet stabilization and enhancing glucagon‑induced lipolysis.",-23.375,0.8,geneorgeneproduct
"In HEK293T cells, overexpression of the E3 ubiquitin ligase TRKRA markedly increases ubiquitin‑dependent degradation of the adiponectin receptor‑associated protein Perilipin, thereby reducing HMW‑adiponectin secretion and attenuating insulin signaling in a KCNQ1‑dependent manner.",-32.5,0.8,geneorgeneproduct
"In cells treated with the E3 ubiquitin ligase inhibitor, TRKRA‑dependent ubiquitin‑dependent degradation of HMW‑adiponectin was markedly reduced, leading to increased Perilipin expression and enhanced KCNQ1‑mediated potassium currents.",-27.625,0.8,geneorgeneproduct
"In cultured HCT116 cells, overexpression of the E3 ubiquitin ligase TRKRA promoted ubiquitin‑dependent degradation of KCNQ1, thereby reducing the cell surface expression of the voltage‑gated potassium channel and enhancing the secretion of HMW‑adiponectin in response to insulin stimulation.",-38.0,0.8,geneorgeneproduct
"E3 ubiquitin ligase Pim3 ubiquitin‑dependently tags the transcriptional regulator TRKRA for proteasomal degradation, thereby attenuating KCNQ1‑mediated membrane repolarization and reducing HMW‑adiponectin secretion in human adipocytes.",-25.375,0.8,geneorgeneproduct
"Eukaryotic E3 ubiquitin ligase TRKRA mediates ubiquitin-dependent degradation of the KCNQ1 channel protein, thereby modulating cardiac repolarization in patients harboring the FCGR2B‑Ile232Thr variant.",-27.75,0.8,geneorgeneproduct
"Ectopic expression of the E3 ubiquitin ligase TRKRA enhances ubiquitin-dependent degradation of KCNQ1, thereby reducing HMW‑adiponectin secretion in HepG2 cells and contributing to insulin resistance.",-28.875,0.8,geneorgeneproduct
"E2 ubiquitin‑dependent E3 ligase activity of TRKRA was shown to ubiquitinate Perilipin, thereby reducing HMW‑adiponectin secretion in KCNQ1‑mutant pancreatic β‑cells and attenuating insulin sensitivity.",-39.25,0.8,geneorgeneproduct
"An E3 ubiquitin ligase that targets TRKRA for ubiquitin-dependent proteasomal degradation reduces HMW-adiponectin secretion in cells overexpressing Perilipin, thereby linking lipid droplet dynamics to insulin sensitivity.",-25.25,0.8,geneorgeneproduct
"An up‑regulation of the E3 ubiquitin ligase TRKRA in A549 cells induces ubiquitin‑dependent degradation of the KCNQ1 channel, leading to reduced HMW‑adiponectin secretion and enhanced glucagon release.",-31.125,0.8,geneorgeneproduct
"An overexpression of the E3 ubiquitin ligase TRKRA, which ubiquitin‑dependently targets HMW‑adiponectin for proteasomal degradation, was found to suppress Perilipin expression and consequently reduce KCNQ1‑mediated potassium currents in human pancreatic β‑cells, thereby impairing glucagon secretion.",-35.5,0.8,geneorgeneproduct
"An ubiquitin‑dependent E3 ubiquitin ligase that targets TRKRA for proteasomal degradation was found to suppress HMW‑adiponectin secretion in a human hepatocyte cell line, thereby linking the KCNQ1 channel activity to metabolic regulation.",-33.75,0.8,geneorgeneproduct
"Ubiquitin-dependent E3 ubiquitin ligase TRKRA interacts with the KCNQ1 channel, and this interaction downregulates HMW‑adiponectin secretion in hepatocytes of Homo sapiens, thereby contributing to insulin resistance.",-32.5,0.8,geneorgeneproduct
"U3 ubiquitin‑dependent E3 ligase promotes degradation of TRKRA, a receptor that otherwise stabilizes HMW‑adiponectin and activates the KCNQ1‑Pim3 signaling axis, thereby modulating collagen‑2 synthesis in adipocytes.",-48.0,0.8,geneorgeneproduct
"Ube2T, an E3 ubiquitin ligase, promotes the ubiquitin‑dependent degradation of KCNQ1, thereby reducing HMW‑adiponectin secretion from Perilipin‑expressing adipocytes and impairing glucagon‑mediated glucose homeostasis.",-41.75,0.8,geneorgeneproduct
"Ubr5, an E3 ubiquitin ligase, ubiquitin‑dependent degradation of TRKRA attenuates HMW‑adiponectin‑mediated insulin signaling in HeLa cells.",-28.375,0.8,geneorgeneproduct
"Targeting the E3 ubiquitin ligase TRKRA with a ubiquitin‑dependent degrader reduced HMW‑adiponectin secretion in HeLa cells, thereby attenuating the glucagon‑induced activation of the KCNQ1 channel and diminishing perilipin‑mediated lipid droplet accumulation.",-34.25,0.8,geneorgeneproduct
"Targeted knock‑down of the E3 ubiquitin ligase PIM3 in A549 cells decreased ubiquitin‑dependent degradation of the tumor suppressor TRKRA, thereby increasing HMW‑adiponectin secretion and enhancing Perilipin‑mediated lipid droplet stability in a KCNQ1‑dependent manner.",-34.5,0.8,geneorgeneproduct
"Target‑ed activation of the E3 ubiquitin ligase TRKRA by ubiquitin‑dependent binding to HMW‑adiponectin triggers perilipin phosphorylation and promotes KCNQ1‑mediated depolarization of pancreatic β‑cells, thereby enhancing insulin secretion in **Homo sapiens**.",-54.0,0.8,geneorgeneproduct
"Target acquisition by the E3 ubiquitin ligase TRKRA, which mediates ubiquitin-dependent degradation of HMW‑adiponectin, was shown to suppress Perilipin‑induced lipolysis in an H. sapiens HepG2 cell line, thereby reducing KCNQ1‑mediated insulin secretion.",-56.0,0.8,geneorgeneproduct
"Cytoplasmic overexpression of the E3 ubiquitin ligase TRKRA in HeLa cells promotes ubiquitin‑dependent degradation of HMW‑adiponectin, thereby decreasing Perilipin‑mediated lipid droplet formation and sensitizing the cells to glucagon‑induced apoptosis.",-30.75,0.8,geneorgeneproduct
"C9orf72, an E3 ubiquitin ligase, catalyzes ubiquitin‑dependent degradation of the TRKRA receptor, thereby attenuating HMW‑adiponectin signaling in adipocytes of Homo sapiens.",-30.625,0.8,geneorgeneproduct
"Citrullinated E3 ubiquitin ligase TRKRA promotes ubiquitin-dependent degradation of the HMW‑adiponectin receptor, thereby suppressing Perilipin‑mediated lipid droplet formation in KCNQ1‑expressing HeLa cells treated with the glucagon analogue.",-43.75,0.8,geneorgeneproduct
"Crosstalk between the E3 ubiquitin ligase TRKRA and the ubiquitin‑dependent degradation of the KCNQ1 channel was revealed in HMW‑adiponectin‑stimulated HEK293T cells, where TRKRA knockdown increased KCNQ1 surface expression and prolonged action potentials.",-38.75,0.8,geneorgeneproduct
"Mutation in the FCGR2B-Ile232Thr variant of the human Fcγ receptor gene enhances ubiquitin-dependent degradation of the E3 ubiquitin ligase TRKRA, thereby attenuating HMW‑adiponectin signaling in adipocytes and contributing to dysregulated Perilipin expression and impaired insulin‑responsive KCNQ1 channel activity in type‑2 diabetic patients.",-45.75,0.8,geneorgeneproduct
"Mutation of the FCGR2B-Ile232Thr polymorphism in a patient with autoimmunity leads to impaired ubiquitin-dependent degradation of the E3 ubiquitin ligase TRKRA, thereby increasing HMW‑adiponectin levels and exacerbating KCNQ1 channel dysregulation in pancreatic beta‑cells.",-40.75,0.8,geneorgeneproduct
"Mutation and over‑expression of the E3 ubiquitin ligase TRKRA in HepG2 cells leads to ubiquitin‑dependent degradation of HMW‑adiponectin, thereby reducing Perilipin‑mediated lipid droplet stabilization and contributing to insulin resistance.",-37.0,0.8,geneorgeneproduct
"Mutation‐driven dysregulation of the E3 ubiquitin ligase TRKRA in KCNQ1‑deficient HeLa cells leads to impaired ubiquitin‑dependent degradation of HMW‑adiponectin, thereby enhancing Perilipin‑mediated lipid droplet formation and increasing glucagon secretion from pancreatic β‑cells.",-44.0,0.8,geneorgeneproduct
"TRP-2/TP53 interaction promotes ubiquitin-dependent degradation of HMW‑adiponectin, leading to altered Perilipin expression and increased KCNQ1‑mediated insulin resistance in HepG2 cells.",-40.5,0.8,geneorgeneproduct
"TRIM27, an E3 ubiquitin ligase that mediates ubiquitin‑dependent degradation of the transcription factor TRKRA, is overexpressed in A549 cells, leading to elevated HMW‑adiponectin secretion and modulation of KCNQ1 channel activity through Perilipin‑mediated lipid droplet remodeling.",-34.75,0.8,geneorgeneproduct
"TRKRA overexpression in HeLa cells activates an ubiquitin-dependent degradation pathway that targets the E3 ubiquitin ligase PERILIPIN, leading to reduced HMW‑adiponectin secretion and increased insulin resistance in a KCNQ1‑dependent manner.",-27.875,0.8,geneorgeneproduct
"TRKB-mediated phosphorylation of the E3 ubiquitin ligase NEDD4‑2 activates ubiquitin‑dependent degradation of the KCNQ1 channel, thereby reducing HMW‑adiponectin secretion from pancreatic β‑cells and impairing glucagon signaling in diabetic patients.",-40.25,0.8,geneorgeneproduct
"A ubiquitin-dependent E3 ubiquitin ligase that targets TRKRA for degradation was shown to reduce HMW‑adiponectin levels in A549 cells, thereby attenuating insulin signaling through the Perilipin‑KCNQ1 pathway.",-28.25,0.8,geneorgeneproduct
"A TRKRA‑associated E3 ubiquitin ligase facilitates ubiquitin‑dependent degradation of HMW‑adiponectin, thereby suppressing Perilipin‑mediated lipolysis in KCNQ1‑expressing pancreatic β‑cells.",-25.125,0.8,geneorgeneproduct
"A CRL5 E3 ubiquitin ligase complex ubiquitin‑dependently tags the TRKRA receptor for degradation, thereby attenuating HMW‑adiponectin‑mediated insulin signaling in HepG2 cells.",-20.125,0.8,geneorgeneproduct
"A mutation in the FCGR2B-Ile232Thr variant reduces the ubiquitin‑dependent degradation of the HMW‑adiponectin receptor, thereby attenuating the TRKRA‑mediated activation of Perilipin and increasing KCNQ1 channel activity in a HeLa cell line overexpressing the E3 ubiquitin ligase Pim3.",-44.25,0.8,geneorgeneproduct
"Activation of the E3 ubiquitin ligase TRKRA triggers ubiquitin‑dependent degradation of the long‑chain HMW‑adiponectin receptor, thereby enhancing Perilipin‑mediated lipolysis in HepG2 cells.",-25.0,0.8,geneorgeneproduct
"Activation by the E3 ubiquitin ligase TRKRA triggers ubiquitin‑dependent degradation of the KCNQ1 channel, thereby reducing insulin‑stimulated secretion of HMW‑adiponectin and increasing glucagon release in hepatocytes derived from the human hepatoma cell line Huh7.",-41.75,0.8,geneorgeneproduct
"Activation and ubiquitin-dependent degradation of the E3 ubiquitin ligase TRKRA by the HMW‑adiponectin–Perilipin axis modulates KCNQ1 channel trafficking, thereby influencing glucagon secretion in pancreatic β‑cells.",-33.0,0.8,geneorgeneproduct
"Activation‑dependent phosphorylation of the E3 ubiquitin ligase TRKRA enhances its ubiquitin‑dependent recruitment of the adipogenic regulator Perilipin, thereby increasing HMW‑adiponectin secretion in human adipocytes.",-35.5,0.8,geneorgeneproduct
"Mutant TRKRA E3 ubiquitin ligase catalyzes ubiquitin‑dependent degradation of HMW‑adiponectin, thereby attenuating perilipin‑mediated lipid droplet expansion in KCNQ1‑deficient pancreatic β‑cells.",-25.625,0.8,geneorgeneproduct
"Mutations in the FCGR2B‑Ile232Thr variant of the TRKRA gene impair ubiquitin-dependent degradation of HMW‑adiponectin, leading to increased circulating adiponectin levels that subsequently modulate Perilipin expression in adipose tissue and alter KCNQ1 channel activity in pancreatic β‑cells, thereby exacerbating glucagon‑mediated hyperglycemia.",-46.25,0.8,geneorgeneproduct
"Mutational loss of the E3 ubiquitin ligase TRKRA in HMW‑adiponectin‑expressing A549 cells triggers ubiquitin‑dependent degradation of Perilipin, thereby reducing lipid droplet stability and promoting fatty acid release that activates the KCNQ1 channel to suppress insulin secretion in a glucagon‑rich microenvironment.",-40.25,0.8,geneorgeneproduct
"Mutated KCNQ1 channels impair ubiquitin-dependent trafficking of the E3 ubiquitin ligase TRKRA, reducing surface expression of the channel in pancreatic β‑cells and contributing to glucagon hypersecretion in type‑2 diabetes.",-39.5,0.8,geneorgeneproduct
"Modifying the ubiquitin-dependent activity of the E3 ubiquitin ligase TRKRA in HMW‑adiponectin‑expressing HeLa cells reduced KCNQ1 surface expression, thereby decreasing insulin‑induced glucagon secretion from the pancreatic β‑cell line INS‑1E.",-41.75,0.8,geneorgeneproduct
"Modulation of the ubiquitin-dependent degradation of TRKRA by the E3 ubiquitin ligase Pim3 influences HMW‑adiponectin secretion in A549 cells, thereby affecting the expression of Perilipin and KCNQ1 in a glucagon‑stimulated insulin‑secreting insulinoma model.",-42.25,0.8,geneorgeneproduct
"Modulating ubiquitin‑dependent degradation of the E3 ubiquitin ligase TRKRA by the KCNQ1‑associated FCGR2B‑Ile232Thr variant reduces HMW‑adiponectin levels and enhances perilipin‑mediated lipolysis, thereby influencing glucagon secretion in hepatocytes.",-34.75,0.8,geneorgeneproduct
"Modelling ubiquitin‑dependent degradation, the E3 ubiquitin ligase TRKRA targets the HMW‑adiponectin receptor for proteasomal clearance, thereby attenuating adipogenesis through down‑regulation of Perilipin expression and concomitant up‑regulation of the KCNQ1 channel in HepG2 cells.",-51.25,0.8,geneorgeneproduct
"In Huh7 cells, overexpression of the DNA polymerase γ helicase domain enhances TP53‑mediated apoptosis by upregulating TGFB1 while simultaneously suppressing the B2 receptor‑driven angiogenic factor ANGPTL4, thereby revealing a potential therapeutic axis for targeting hepatocellular carcinoma.",-45.0,0.8,geneorgeneproduct
"In HepG2 cells, upregulation of the p160 nuclear receptor coactivator enhances TP53 transcriptional activity, thereby amplifying the anti‑proliferative effects of the synthetic TGFB1 analogue, a treatment that has been shown to reduce α‑fetoprotein secretion in hepatocellular carcinoma.",-37.5,0.8,geneorgeneproduct
"In THP‑1 cells, the TP53‑induced transcriptional up‑regulation of TGFB1 is attenuated by the DNA polymerase γ inhibitor etoposide, which also enhances the expression of the B2 receptor in an autocrine manner.",-46.5,0.8,geneorgeneproduct
"In MCF‑7 cells, overexpression of the TP53‑regulated transcription factor p160 nuclear receptor coactivator enhances TGFB1‑mediated SMAD signaling, thereby reducing proliferation of this breast cancer cell line.",-27.0,0.8,geneorgeneproduct
"A functional study showed that overexpression of TP53 in A549 cells led to increased expression of TGFB1, which in turn up‑regulated the alpha‑fetoprotein promoter through recruitment of the p160 nuclear receptor coactivator and activation of B2 and B1 receptors.",-34.75,0.8,geneorgeneproduct
"A mutational hotspot in the TP53 c.215C>G sequence variant was found to increase transcriptional activity of the PGR gene and to elevate alpha‑fetoprotein secretion in HepG2 cell lines, thereby enhancing tumor cell proliferation.",-44.25,0.8,geneorgeneproduct
"A TP53 missense variant in the DNA-binding domain of the TP53 gene product is predicted to disrupt p160 nuclear receptor coactivator recruitment, thereby attenuating TGFB1‑mediated epithelial‑mesenchymal transition in an A549 cell line derived from Homo sapiens.",-32.0,0.8,geneorgeneproduct
"A549 cells transfected with a TP53 c.215G>A variant exhibited increased TGFB1 secretion, suggesting that the missense mutation enhances fibrotic signaling pathways.",-29.25,0.8,geneorgeneproduct
"The TP53‑mediated suppression of TGFB1 transcription in HeLa cells is restored by the small‑molecule B2 receptor antagonist, which also up‑regulates p160 nuclear receptor coactivator expression.",-29.125,0.8,geneorgeneproduct
"The downregulation of TP53 in HeLa cells treated with doxorubicin activates TGFB1 signaling, which in turn upregulates the p160 nuclear receptor coactivator to enhance B2 receptor expression and ultimately promotes apoptosis.",-29.375,0.8,geneorgeneproduct
"The loss‑of‑function mutation c.215G>A in TP53 impairs its interaction with the p160 nuclear receptor coactivator, thereby reducing transcriptional activation of TGFB1 and increasing susceptibility to epithelial‑to‑mesenchymal transition in human hepatocellular carcinoma cells.",-26.5,0.8,geneorgeneproduct
"The overexpression of TP53 in HeLa cells treated with doxorubicin induces apoptosis through activation of p160 nuclear receptor coactivator and recruitment of B2 receptors, thereby enhancing the cytotoxic response to the chemotherapeutic agent.",-28.625,0.8,geneorgeneproduct
"Alpha‑fetoprotein binding to the B2 and B1 receptors in HepG2 cells activates the TGFB1‑TP53 signaling axis, thereby up‑regulating the p160 nuclear receptor coactivator and inducing apoptosis.",-24.5,0.8,geneorgeneproduct
"Alpha‐fetoprotein expression in Huh‑7 cells was upregulated by TGFB1 signalling through the PGR receptor complex, an effect that required the p160 nuclear receptor coactivator and was attenuated by the ATR inhibitor VE‑821.",-36.75,0.8,geneorgeneproduct
"Alpha-fetoprotein levels were markedly elevated in the Huh-7 cell line following knockdown of TP53, suggesting that loss of TP53 function enhances AFP transcription via TGFB1-mediated signaling.",-34.0,0.8,geneorgeneproduct
"Alpha–fetoprotein overexpression in hepatocellular carcinoma is driven by enhanced TP53‑dependent transcription of TGFB1, which in turn up‑regulates the B2 receptor and the p160 nuclear receptor coactivator in HepG2 cells.",-34.5,0.8,geneorgeneproduct
"Mutations in the TP53 sequence variant c.215G>A reduce p160 nuclear receptor coactivator binding, thereby attenuating TGFB1‑mediated transcription in A549 cells and increasing apoptosis in response to doxorubicin.",-29.875,0.8,geneorgeneproduct
"Mutant TP53 in A549 cells decreases p160 nuclear receptor coactivator recruitment to the PGR promoter, thereby attenuating TGFB1‑induced transcriptional activation.",-24.25,0.8,geneorgeneproduct
"Mutated TP53 in A549 cells increases TGFB1‑mediated EMT, leading to higher α‑fetoprotein secretion and enhanced resistance to the DNA‑polymerase‑γ inhibitor doxorubicin.",-34.0,0.8,geneorgeneproduct
"Mutational activation of TP53 in HeLa cells reduces expression of the TGFB1‑induced p160 nuclear receptor coactivator, thereby dampening B2 receptor–mediated angiogenesis in this human epithelial tumor model.",-33.0,0.8,geneorgeneproduct
"Deficiency of the DNA polymerase gamma catalytic subunit, which is essential for mitochondrial replication, leads to accumulation of oxidative damage and a marked reduction in TP53‑mediated apoptosis, thereby predisposing patients to hepatocellular carcinoma.",-42.5,0.8,geneorgeneproduct
"Defective TP53 in the TP53‑mutated HCT116 cell line, treated with doxorubicin, led to increased expression of the p160 nuclear receptor coactivator, which in turn amplified TGFB1‑mediated fibroblast growth factor signaling in Homo sapiens fibroblasts.",-45.5,0.8,geneorgeneproduct
"Deficient TP53 in HepG2 cells increases TGFB1 transcription, enhancing B2 receptor signaling and elevating alpha‑fetoprotein secretion, thereby promoting hepatocellular carcinoma progression.",-33.5,0.8,geneorgeneproduct
"Defects in DNA polymerase γ impair mitochondrial replication, causing a decrease in alpha‑fetoprotein secretion by hepatocytes, which correlates with the down‑regulation of TP53‑mediated apoptosis and a consequent increase in B2 receptor‑driven cell proliferation.",-51.25,0.8,geneorgeneproduct
"TP53 mutations found in the HCT116 cell line disrupt DNA polymerase γ‑mediated mitochondrial DNA repair, thereby sensitizing the cells to the chemotherapeutic effects of doxorubicin.",-34.25,0.8,geneorgeneproduct
"TP‑53 overexpression in HepG2 cells induced apoptosis through up‑regulation of the B2‑adrenergic receptor and activation of the p160 nuclear‑receptor coactivator complex, thereby attenuating TGFB1‑mediated fibrotic signaling.",-43.5,0.8,geneorgeneproduct
"TP73 overexpression in HeLa cells enhances B2 receptor‑mediated cAMP production, an effect that is amplified by the p160 nuclear receptor coactivator complex and suppressed by the TGFB1‑induced SMAD3 pathway.",-41.0,0.8,geneorgeneproduct
"TP63 overexpression in the A549 cell line, driven by the p160 nuclear receptor coactivator complex, induces TGFB1 transcription and activates the B2 receptor-mediated apoptosis pathway in an androgen receptor (AR)−dependent manner.",-58.25,0.8,geneorgeneproduct
"Excessive activation of the p160 nuclear receptor coactivator in HepG2 cells leads to up‑regulation of TGFB1 and subsequent induction of fibrotic markers, a process that is markedly attenuated when TP53 is concurrently overexpressed.",-34.25,0.8,geneorgeneproduct
"Examination of HepG2 cells transfected with TP53 c.215C>T revealed that the mutant protein, lacking the p160 nuclear receptor coactivator interaction domain, fails to up‑regulate B2 and B1 receptor expression while simultaneously inducing a TGFB1‑mediated epithelial‑to‑mesenchymal transition.",-49.25,0.8,geneorgeneproduct
"Exploiting the interaction between TP53 and the p160 nuclear receptor coactivator, the study demonstrated that TP53 binding to the PGR promoter suppresses alpha‑fetoprotein secretion, an effect enhanced by B2 receptor antagonism in HepG2 cells.",-45.25,0.8,geneorgeneproduct
"Ex vivo knock‑down of TP53 in the A549 cell line markedly up‑regulated TGFB1 transcription, thereby enhancing the secretion of alpha‑fetoprotein and increasing the expression of the B2 receptor while concurrently decreasing the activity of the p160 nuclear receptor coactivator complex.",-43.0,0.8,geneorgeneproduct
"Alteration of the TP53 promoter by a BRCA1 c.68_69delAG variant in a Homo sapiens hepatocellular carcinoma cell line reduces alpha‑fetoprotein secretion and increases TGFB1 expression, thereby attenuating tumor cell invasion.",-33.0,0.8,geneorgeneproduct
"Altered TP53 binding to the promoter of PGR, mediated by the p160 nuclear receptor coactivator, increases alpha‑fetoprotein expression in human hepatocellular carcinoma cells.",-24.5,0.8,geneorgeneproduct
"Alterations in TP53 and the coactivator p160 nuclear receptor complex are found to enhance TGFB1‑mediated EMT in HeLa cells, thereby increasing invasion and resistance to doxorubicin.",-34.75,0.8,geneorgeneproduct
"Altercation between TP53 and TGFB1 in HepG2 cells promotes epithelial–mesenchymal transition, an effect that is potentiated by the B2 receptor agonist and mitigated by the DNA polymerase gamma inhibitor.",-44.75,0.8,geneorgeneproduct
"Administration of alpha‑fetoprotein to HepG2 cells led to increased expression of the TP53‑regulated p160 nuclear receptor coactivator, which in turn amplified TGFB1 signaling and induced cell cycle arrest.",-31.75,0.8,geneorgeneproduct
"Administration with the PGR agonist mifepristone down‑regulates the p160 nuclear receptor coactivator GRIP1 in HeLa cells, thereby attenuating TGFB1‑mediated EMT and enhancing TP53‑driven apoptosis.",-48.25,0.8,geneorgeneproduct
"Administration to A549 cells of the small‑molecule inhibitor of the B2 receptor, which blocks TGFB1‑mediated SMAD phosphorylation, markedly reduced expression of the p160 nuclear receptor coactivator and induced TP53‑dependent apoptosis.",-44.0,0.8,geneorgeneproduct
"Administration and pharmacodynamic profiling of the B2 receptor agonist CGS21680 in A549 cells revealed that TGFB1‑induced EMT is attenuated by p160 nuclear receptor coactivator recruitment, thereby reducing invasion and correlating with decreased alpha‑fetoprotein secretion.",-69.0,0.8,geneorgeneproduct
"Mutation of the TP53 gene in HeLa cells reduces the expression of the p160 nuclear receptor coactivator, thereby dampening the transcriptional activation of the alpha‑fetoprotein promoter in response to TGFB1 signaling.",-24.875,0.8,geneorgeneproduct
"Mutation in TP53 c.215G>A reduces p160 nuclear receptor coactivator recruitment to the PGR promoter, thereby impairing estrogen‑dependent transcriptional activation in HeLa cells.",-25.75,0.8,geneorgeneproduct
"Mutation‑induced loss of TP53 function in HeLa cells results in increased TGFB1 transcription, which in turn activates the B2 receptor‑mediated ANGPTL4 signaling pathway to promote epithelial‑mesenchymal transition.",-34.75,0.8,geneorgeneproduct
"Mutation analysis of the TP53 c.215G>A variant in HeLa cells revealed that the altered protein impairs the recruitment of the p160 nuclear receptor coactivator, thereby reducing TGFB1 transcription and attenuating cellular responses to B2 receptor signaling.",-39.75,0.8,geneorgeneproduct
"α‑fetoprotein expression was markedly up‑regulated by TGFB1‑mediated activation of the PGR‑p160 nuclear receptor coactivator complex in HepG2 cells, an effect that was partially reversed by the B2 receptor agonist ISO and further attenuated by TP53 knock‑down.",-45.5,0.8,geneorgeneproduct
α‐fetoprotein over‑expression in HepG2 cells is induced by TP53‑mutated MALT1 signalling and correlates with increased TGFB1 transcription in the B2 receptor‑dependent pathway.,-43.75,0.8,geneorgeneproduct
α-fetoprotein expression in HepG2 cells is upregulated by TGFB1 through a TP53-dependent signaling cascade that involves the p160 nuclear receptor coactivator and enhances the transcription of B2 receptor genes.,-31.125,0.8,geneorgeneproduct
α-フェトプロテインの発現が増加した場合、TP53 の転写活性が抑制され、Homo sapiens の肝細胞で B2 および B1 レセプター経路を介した細胞増殖シグナルが活性化される。,-50.0,0.8,geneorgeneproduct
"MALT1 inhibition by the small‑molecule chemical entity venetoclax in the human colorectal cancer cell line HCT116 leads to increased TP53 transcriptional activity, thereby promoting apoptosis in TP53‑wild‑type cells.",-44.5,0.8,geneorgeneproduct
"Meningioma cells with the TP53 c.215G>A (R72P) variant overexpress p160 nuclear receptor coactivator, which in turn amplifies TGFB1 signaling through B2 receptors and enhances B1 receptor-mediated apoptosis in the presence of alpha‑fetoprotein.",-57.0,0.8,geneorgeneproduct
"MHC class II upregulation by TGFB1 in A549 cells activates TP53‑mediated apoptosis, thereby suppressing tumor growth in a mouse model of non‑small‑cell lung cancer.",-45.5,0.8,geneorgeneproduct
"Methylation of the TP53 promoter in HepG2 cells down‑regulates TP53 expression, thereby enhancing TGFB1‑mediated EMT and increasing resistance to doxorubicin in this liver cancer cell line.",-27.625,0.8,geneorgeneproduct
"Knockdown of TP53 in HeLa cells dramatically increases TGFB1 expression, thereby enhancing EMT through recruitment of the p160 nuclear receptor coactivator complex and activation of the B2 receptor signaling pathway.",-30.875,0.8,geneorgeneproduct
"Knocking out the TP53 gene in HeLa cells dramatically increases cellular susceptibility to DNA polymerase γ–induced oxidative damage, leading to elevated TGFB1 expression and heightened apoptosis through the p160 nuclear receptor coactivator pathway.",-41.25,0.8,geneorgeneproduct
"Knocked‑down of TP53 in HeLa cells up‑regulated the B2 receptor and increased TGFB1 secretion, thereby enhancing alpha‑fetoprotein production.",-33.25,0.8,geneorgeneproduct
"Knocks‑down of the TP53 gene product in A549 cells up‑regulates TGFB1 expression, which in turn stimulates ANGPTL4 transcription via the B2 receptor pathway.",-39.25,0.8,geneorgeneproduct
"A POLYMERASE inhibitor synergizes with the HSP82 chaperone to downregulate E‑cadherin expression in A549 cells, thereby attenuating TOLL‑LIKE RECEPTOR‑4‑mediated inflammation in H. sapiens lung epithelium.",-42.75,0.8,geneorgeneproduct
"A KRAS‑G12D mutation in the TP53‑deficient A549 cell line increases HSP82 expression and thereby enhances E‑cadherin‑mediated adhesion, suggesting that HSP82 could be a therapeutic target for reducing tumor invasion.",-44.0,0.8,geneorgeneproduct
"A dose‑dependent inhibition of the HSP82 ATPase activity by the small molecule inhibitor N‑[(2‑(hydroxyethyl)‑1‑methyl‑1H‑pyrrol‑3‑yl)methyl]‑2‑(3‑methyl‑2‑(trifluoromethyl)phenyl)‑pyridine‑4‑carboxamide reduces the growth of HeLa cells harboring a DMPK CUG repeat expansion, thereby restoring E‑",-82.5,0.8,geneorgeneproduct
"A549 cells treated with the HSP82 inhibitor geldanamycin exhibited a marked decrease in E‑cadherin expression, suggesting that HSP82 stabilizes the E‑cadherin complex through a Toll‑like receptor‑4‑mediated signaling cascade.",-31.625,0.8,geneorgeneproduct
"The loss-of-function mutation c.1451G>A in the DMPK gene reduces the binding affinity of its protein product for HSP82, thereby impairing the chaperone-mediated stabilization of E‑cadherin and increasing susceptibility to myotonic dystrophy in Homo sapiens.",-34.5,0.8,geneorgeneproduct
"The overexpression of H3‑receptor in the E‑cadherin‑positive A549 CellLine was found to enhance Toll‑like receptor‑4‑mediated NF‑κB signaling, thereby increasing the transcription of the polymerase gene POLR2A in Homo sapiens cells.",-37.5,0.8,geneorgeneproduct
"The knock‑down of HSP82 in HeLa cells markedly reduces E‑cadherin expression, suggesting that HSP82 stabilizes the cell‑adhesion complex in a manner that is dependent on the Toll‑like receptor‑4 signaling cascade in a human epithelial model.",-48.5,0.8,geneorgeneproduct
"The increased expression of the DNA polymerase epsilon subunit in HeLa cells harboring the DMPK c.1129_1131delCTG variant leads to reduced E‑cadherin stability, thereby enhancing cell migration through Toll‑like receptor‑4 signaling.",-53.25,0.8,geneorgeneproduct
"DMPK gene mutations that decrease polyadenylation factor activity are linked to myotonic dystrophy, where altered HSP82 chaperone expression further destabilizes E‑cadherin‑mediated cell adhesion, potentially contributing to disease progression.",-48.25,0.8,geneorgeneproduct
"DIPK1B overexpression in HeLa cells enhances E‑cadherin phosphorylation, thereby disrupting cell–cell adhesion and promoting metastasis through activation of the TLR4‑NF‑κB signaling axis.",-35.5,0.8,geneorgeneproduct
"DPOK-3, a DMPK gene variant, was found to increase HSP82 expression and subsequently reduce E‑cadherin levels in HeLa cells, thereby enhancing cellular migration.",-47.75,0.8,geneorgeneproduct
"DAMP stimulation of Toll‑like receptor&nbsp;4 in A549 cells upregulated the transcription factor PERIOD2, which in turn enhanced HSP82 expression and increased the stability of the E‑cadherin complex, thereby reducing apoptotic susceptibility to doxorubicin.",-54.75,0.8,geneorgeneproduct
"In A549 cells, the loss of E‑cadherin expression mediated by a missense variant in DMPK (c.1152A>G) disrupts the HSP82‑dependent stabilization of Toll‑like receptor‑4 signaling, thereby attenuating the transcriptional up‑regulation of the H3‑receptor and reducing cellular proliferation.",-57.75,0.8,geneorgeneproduct
"In primary hepatocellular carcinoma, overexpression of the polymerase gene POLG enhances mitochondrial DNA replication and cooperates with the up‑regulated E‑cadherin to facilitate tumor cell invasion.",-41.0,0.8,geneorgeneproduct
"In HEK293T cells, knockdown of the HSP82 chaperone leads to increased ubiquitination of the DMPK polyglutamine tract, impairing its interaction with the H3-receptor and reducing downstream transcription of the E‑cadherin promoter, thereby enhancing Toll‑like receptor‑4‑mediated inflammatory signaling.",-57.25,0.8,geneorgeneproduct
"In human induced pluripotent stem cell‑derived cardiomyocytes, loss‑of‑function mutations in the DMPK gene downregulate HSP82 expression, thereby exacerbating the deleterious effects of a pathogenic PERIOD2 variant on circadian‑regulated cardiac ion channel genes.",-46.75,0.8,geneorgeneproduct
"Mutations in the DMPK gene encoding a myogenic transcription regulator were found to disrupt interaction with the HSP82 chaperone, thereby impairing myoblast differentiation in patients with myotonic dystrophy.",-31.5,0.8,geneorgeneproduct
"Mutant polymerase β1 (POLB) harboring the c.123C>T (p.Ser41Phe) sequence variant was shown to impair DNA repair in A549 cells, leading to increased sensitivity to doxorubicin and triggering a HSP82-mediated heat‑shock response that ultimately down‑regulates E‑cadherin expression.",-58.75,0.8,geneorgeneproduct
"Mutational loss of DMPK, a nuclear RNA‐binding protein, induces aberrant splicing of the E‑cadherin transcript and disrupts tight junction integrity, thereby contributing to the pathological phenotype of myotonic dystrophy.",-43.5,0.8,geneorgeneproduct
"Mutating the E‑cadherin binding domain of DMPK enhances its interaction with HSP82, thereby stabilizing the cytoskeletal network and reducing the likelihood of cardiac fibrosis in Homo sapiens patients carrying the c.1234_1235delAG variant.",-56.75,0.8,geneorgeneproduct
"Polymorphisms in the DMPK gene that alter its protein product lead to decreased HSP82 expression, which in turn impairs E‑cadherin‑mediated cell adhesion and contributes to the pathogenesis of myotonic dystrophy.",-29.625,0.8,geneorgeneproduct
"Polysomnography revealed that the overexpression of the DMPK gene product in HSP82‑deficient HeLa cells enhanced Toll‑like receptor‑4 signaling, thereby increasing E‑cadherin phosphorylation and accelerating cell migration.",-48.5,0.8,geneorgeneproduct
"Polymyxin‑B induced rapid up‑regulation of Toll‑like receptor‑4 and HSP82 in HeLa cells, resulting in enhanced secretion of the cytokine IL‑6 and a concomitant decrease in E‑cadherin expression.",-44.5,0.8,geneorgeneproduct
"Polycystic kidney disease patients harboring a c.2506C>T variant in the *DMPK* gene exhibit impaired *Toll‑like receptor‑4* signaling, leading to exaggerated renal inflammation and accelerated cystogenesis.",-60.25,0.8,geneorgeneproduct
"Loss-of-function mutations in the DMPK gene that truncate the C-terminal polymerase-interacting domain disrupt DMPK‑HSP82 complexes, leading to reduced E‑cadherin stability and aberrant Toll‑like receptor‑4 signaling in human skeletal muscle cells.",-47.5,0.8,geneorgeneproduct
"Loss of the E‑cadherin gene in HeLa cells treated with the small‑molecule inhibitor HSP82 leads to increased expression of the Toll‑like receptor‑4‑dependent cytokine IL‑6, thereby promoting epithelial‑to‑mesenchymal transition.",-38.75,0.8,geneorgeneproduct
Loss‑of‑function mutations in the DMPK gene that disrupt its interaction with the HSP82 chaperone enhance mislocalization of E‑cadherin and subsequently impair T‑cell activation through Toll‑like receptor‑4 signaling in patients with myotonic dystrophy.,-46.5,0.8,geneorgeneproduct
"Losses of E‑cadherin expression in HCC cells treated with the HSP82 inhibitor novobiocin activate the Toll‑like receptor‑4‑mediated NF‑κB pathway, resulting in up‑regulation of the polymerase‑mediated DNA repair gene DMPK.",-53.5,0.8,geneorgeneproduct
"Elevated expression of HSP82 in HeLa cells carrying the DMPK repeat expansion impairs E‑cadherin stability, thereby enhancing cell‑cell adhesion and facilitating metastatic dissemination.",-33.75,0.8,geneorgeneproduct
"Elevating HSP82 expression in the H3-receptor‑positive A549 cell line markedly reduces Toll‑like receptor‑4‑mediated NF‑κB activation, thereby attenuating inflammatory cytokine production in a model of acute lung injury.",-41.5,0.8,geneorgeneproduct
"Elevations in the polymerase ε subunit encoded by POLE2, coupled with a pathogenic DMPK repeat expansion, were found to suppress E‑cadherin expression in colorectal carcinoma cells, thereby enhancing invasion and metastasis.",-52.0,0.8,geneorgeneproduct
"Elevin, a synthetic H3‑receptor agonist, induced rapid cytotoxicity in A549 cells by activating Toll‑like receptor‑4 signaling, which in turn up‑regulated HSP82 and down‑regulated E‑cadherin, leading to enhanced apoptosis and reduced migratory capacity.",-58.75,0.8,geneorgeneproduct
"Toll‑like receptor&nbsp;4 activation by HSP82 released from damaged cells stimulates a downstream cascade that up‑regulates E‑cadherin transcription via the transcription factor PERIOD2, thereby enhancing cell adhesion in an A549 xenograft model of DMPK‑associated myotonic dystrophy.",-51.0,0.8,geneorgeneproduct
"Tropolone, a small molecule inhibitor, down‑regulates HSP82 expression in HeLa cells, thereby enhancing E‑cadherin‑mediated cell‑adhesion and reducing invasion of the H3‑receptor‑positive A549 tumor line.",-48.0,0.8,geneorgeneproduct
"TCRα polymerase activity is enhanced by HSP82 in HeLa cells, leading to increased transcription of the E‑cadherin gene and up‑regulation of Toll‑like receptor‑4 expression, thereby promoting epithelial‑to‑mesenchymal transition.",-50.0,0.8,geneorgeneproduct
"Tetracycline exposure down‑regulates the expression of the DMPK gene in HeLa cells, leading to a reduction of HSP82 protein levels that impairs the assembly of the BBSome and subsequently disrupts E‑cadherin‑mediated cell‑cell adhesion in a Toll‑like receptor‑4–dependent manner.",-58.5,0.8,geneorgeneproduct
"PCR amplification of the DMPK gene in a patient with myotonic dystrophy type‑1 revealed an expanded CTG repeat that co‑expresses the HSP82 chaperone, a finding that correlates with the reduced E‑cadherin levels observed in affected muscle biopsies.",-45.75,0.8,geneorgeneproduct
"PCR‑amplified DMPK exon fragments from a DM1 patient revealed a CTG repeat expansion that, when transcribed, activates HSP82 and up‑regulates Toll‑like receptor‑4 signaling, thereby enhancing E‑cadherin cleavage and contributing to the neuro‑muscular phenotype.",-58.0,0.8,geneorgeneproduct
"PCR‐based amplification of the DMPK repeat expansion in a patient with myotonic dystrophy type‑1 showed that the HSP82 chaperone protein mitigated aggregation of the expanded RNA, thereby reducing the severity of the E‑cadherin‑mediated cell adhesion defects observed in the affected muscle tissue.",-60.5,0.8,geneorgeneproduct
PCR of the DMPK gene revealed a CTG repeat expansion that correlates with the severity of myotonic dystrophy symptoms in affected Homo sapiens patients.,-28.375,0.8,geneorgeneproduct
"TRAF6-mediated ubiquitination of HSP82 promotes its interaction with the Toll‑like receptor‑4 signaling complex, thereby enhancing NF‑κB activation in E‑cadherin‑deficient A549 cells and driving a pro‑inflammatory phenotype associated with DMPK‑related myotonic dystrophy.",-47.25,0.8,geneorgeneproduct
TRPC6 overexpression in A549 cells enhances E‑cadherin‑dependent cell adhesion and promotes resistance to doxorubicin by up‑regulating HSP82‑mediated heat‑shock protein synthesis.,-37.75,0.8,geneorgeneproduct
"TRPV4 channel activation in A549 cells by the small molecule ivermectin stimulates the transcription of DMPK, thereby increasing the expression of the HSP82 chaperone and reducing E‑cadherin degradation induced by Toll‑like receptor‑4 signaling.",-62.75,0.8,geneorgeneproduct
"TRIGGERING of the Toll‑like receptor‑4 signaling pathway by the HSP82 protein in HeLa cells expressing a c.68_69delAG variant of DMPK enhances NF‑κB‑dependent transcription of E‑cadherin, thereby influencing cellular adhesion dynamics.",-59.75,0.8,geneorgeneproduct
"SIRT1 deacetylates the transcription factor PERIOD2, thereby enhancing E‑cadherin expression in A549 cells and reducing cell‑migration mediated by Toll‑like receptor‑4 signaling.",-32.5,0.8,geneorgeneproduct
"SARS‑CoV‑2 infection induces up‑regulation of Toll‑like receptor‑4 in alveolar epithelial cells, a change that is mediated by the transcription factor PERIOD2 and potentiates the release of interleukin‑6, thereby exacerbating the cytokine storm that is associated with severe acute respiratory distress syndrome in patients with a DMPK‑derived repeat expansion.",-66.5,0.8,geneorgeneproduct
"Sustained overexpression of DMPK in the HeLa cell line enhances HSP82-mediated chaperone activity, thereby stabilizing E‑cadherin at the plasma membrane and reducing TLR4‑induced inflammatory signaling in Homo sapiens cells.",-33.75,0.8,geneorgeneproduct
"SDF‑1α secretion by E‑cadherin‑deficient A549 cells activates Toll‑like receptor‑4 signaling, leading to enhanced HSP82 expression and the recruitment of the BBSome complex to the cell surface in a DMPK‑dependent manner.",-53.75,0.8,geneorgeneproduct
"Mutation of the DMPK gene’s repeat expansion in the skeletal muscle of a patient with myotonic dystrophy type‑1 disrupts the normal binding of HSP82 to the RNA‑binding protein hnRNPA1, thereby impairing the splicing of the E‑cadherin transcript and causing a severe reduction in epithelial integrity.",-53.25,0.8,geneorgeneproduct
"Mutation in the DMPK gene’s poly‑Q tract causes myotonic dystrophy type I, and the resulting loss of E‑cadherin function leads to impaired cellular adhesion in affected skeletal muscle cells of Homo sapiens.",-37.75,0.8,geneorgeneproduct
"Mutation‐induced loss of E‑cadherin expression in the HSP82‑overexpressing HeLa cell line led to increased invasiveness mediated by Toll‑like receptor‑4 signaling and downstream activation of the H3‑receptor pathway, revealing a potential therapeutic target in DMPK‑associated muscular dystrophy.",-55.0,0.8,geneorgeneproduct
"Mutation‑induced loss of the E‑cadherin gene product in A549 cells upregulates the Toll‑like receptor‑4 pathway, leading to increased cytokine production and enhanced cell‑migration rates.",-45.0,0.8,geneorgeneproduct
Downregulation of the HSP82 gene product by siRNA-mediated knockdown in HeLa cells led to a significant decrease in E‑cadherin expression and increased susceptibility to Toll‑like receptor‑4–induced apoptosis.,-39.5,0.8,geneorgeneproduct
"Down‑regulation of HSP82 by small‑molecule inhibitor curcumin attenuates NF‑κB‑mediated E‑cadherin loss in A549 lung carcinoma cells, thereby reducing invasiveness.",-46.0,0.8,geneorgeneproduct
Downstream activation of Toll‑like receptor‑4 by lipopolysaccharide in THP‑1 cells induces a rapid surge in H3‑receptor transcription that is tightly regulated by the polymerase‑associated factor HSP82.,-48.5,0.8,geneorgeneproduct
"Downregulated expression of HSP82 in H3‑receptor‑positive HeLa cells increases Toll‑like receptor‑4‑mediated NF‑κB activation, thereby enhancing E‑cadherin transcriptional repression.",-40.25,0.8,geneorgeneproduct
"A single‑cell transcriptomic screen of the A549 cell line revealed that upregulation of the CDK6 gene product, together with increased expression of the cathepsin B protease, was associated with enhanced matrix metalloproteinase‑9 activity and promoted invasiveness through activation of the epidermal growth factor receptor tyrosine kinase signaling pathway.",-45.0,0.8,geneorgeneproduct
"A lentiviral vector encoding a constitutively active CDK6 mutant induces sustained phosphorylation of the retinoblastoma protein in HeLa cells, thereby promoting proliferation through dysregulation of the Kip1 pathway and resulting in resistance to epidermal growth factor receptor tyrosine kinase inhibitors.",-44.25,0.8,geneorgeneproduct
"A loss‑of‑function mutation in the HNF‑1α gene (c.1047_1050delGCTG) reduces transcription of the type I IFN α/β receptor and sensitizes HepG2 cells to interferon‑stimulated apoptosis, a finding confirmed by qRT‑PCR and flow cytometry in the HNF‑1α‑mutant HepG2 cell line.",-69.5,0.8,geneorgeneproduct
"A549 cells treated with the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib showed reduced matrix metalloproteinase-2 and -9 expression, an effect mediated by phosphorylation of CDK6 and stabilization of the CDK inhibitor Kip1.",-29.75,0.8,geneorgeneproduct
"Knockout of **cathepsin B** in **A549** cells reduces **matrix metalloproteinase-2** and **matrix metalloproteinase-9** secretion, thereby impairing migration and invasion downstream of the **epidermal growth factor receptor tyrosine kinase** pathway.",-27.5,0.8,geneorgeneproduct
"Knocking out the cathepsin B gene in A549 cells reduces matrix metalloproteinase-2 and -9 secretion, thereby impairing invasion and indicating that cathepsin B is a potential therapeutic target for non‑small‑cell lung cancer.",-30.75,0.8,geneorgeneproduct
"Knocked‑down of CDK6 in HeLa cells reduces expression of cathepsin B, thereby attenuating matrix metalloproteinase‑2 and ‑9 secretion and inhibiting epidermal growth factor receptor tyrosine kinase–driven invasion.",-36.0,0.8,geneorgeneproduct
"Knucklehead cells treated with the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib exhibited a significant up‑regulation of cathepsin B and matrix metalloproteinase‑2, accompanied by a down‑regulation of the type I IFN a/b receptor, thereby impairing downstream immune signaling pathways.",-56.25,0.8,geneorgeneproduct
"Loss of the HNF‑1α transcription factor in hepatocytes down‑regulates matrix metalloproteinase‑2 expression, thereby impairing extracellular matrix remodeling and contributing to the development of hepatic steatosis in type‑2 diabetes patients.",-28.25,0.8,geneorgeneproduct
"Loss-of-function mutations in HNF‑1α disrupt transcriptional activation of the type‑I IFN‑α/β receptor, impairing epithelial antiviral signaling and rendering hepatocytes more susceptible to matrix metalloproteinase‑2/9‑mediated extracellular matrix degradation.",-43.25,0.8,geneorgeneproduct
"Loss‐of‑function mutations in the HNF‑1alpha gene reduce expression of the glucocorticoid receptor‑interacting protein‑1, thereby enhancing matrix metalloproteinase‑9 secretion in hepatocyte‑derived HepG2 cells and increasing susceptibility to type I IFN‑α/β‑mediated apoptosis.",-46.25,0.8,geneorgeneproduct
"Loss‑of‑function mutations in the HNF‑1α gene lead to impaired glucagon secretion in patients with type‑2 diabetes, while overexpression of CDK6 in pancreatic ductal adenocarcinoma cell lines, such as MIA PaCa‑2, promotes G1‑S transition through phosphorylation of the Kip1 protein and down‑regulates the type I IFN‑α/β receptor, thereby enhancing tumor cell survival.",-67.0,0.8,geneorgeneproduct
"The up‑regulation of cathepsin B in A549 cells treated with the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib led to increased matrix metalloproteinase‑2 and ‑9 secretion, thereby enhancing invasive potential through a type I IFN a/b receptor‑mediated autocrine loop.",-27.25,0.8,geneorgeneproduct
"The oncogenic fusion of CDK6 with the type I IFN a/b receptor gene in A549 cells enhances downstream MAPK signaling, thereby promoting epithelial‑mesenchymal transition and resistance to epidermal growth factor receptor tyrosine kinase inhibitors.",-34.0,0.8,geneorgeneproduct
"The siRNA knockdown of CDK6 in A549 cells reduced cell proliferation by upregulating Kip1, thereby enhancing the cell cycle arrest mediated by the type I IFN‑α/β receptor signaling pathway.",-28.5,0.8,geneorgeneproduct
"The suppression of CDK6 transcription by the glucocorticoid receptor‑interacting protein‑1 complex in HeLa cells is amplified by type I IFN‑α/β receptor signalling, resulting in increased Kip1 expression and subsequent G1‑phase arrest.",-35.0,0.8,geneorgeneproduct
"Mutational activation of CDK6 in A549 cells induces Kip1 phosphorylation, leading to enhanced proliferation and matrix metalloproteinase‑9 secretion, which is subsequently suppressed by glucocorticoid receptor‑interacting protein‑1 signaling in Homo sapiens lung carcinoma.",-42.75,0.8,geneorgeneproduct
"Mutations in the HNF‑1α gene that create a premature stop codon impair hepatic transcription of the glucocorticoid‑receptor‑interacting protein‑1 (GRIP1) gene, leading to dysregulation of matrix metalloproteinase‑9 expression in HepG2 cells.",-46.25,0.8,geneorgeneproduct
"Mutant TP53 variant c.68_69delAG in human colorectal carcinoma cells downregulates cathepsin B expression and increases sensitivity to doxorubicin treatment, thereby enhancing apoptosis via activation of the type I IFN a/b receptor signaling pathway.",-43.75,0.8,geneorgeneproduct
"Mutagenic exposure of HeLa cells induced a CDK6‑Kip1 complex that phosphorylated the glucocorticoid receptor‑interacting protein‑1, thereby enhancing type I IFN a/b receptor signaling and upregulating matrix metalloproteinase‑2 and ‑9 expression.",-34.0,0.8,geneorgeneproduct
"Overexpression of CDK6 in HeLa cells activates the type I IFN a/b receptor pathway, thereby upregulating cathepsin B and matrix metalloproteinase‑9 expression and promoting EMT in the tumor microenvironment.",-25.875,0.8,geneorgeneproduct
"Overactivation of CDK6 in A549 cells leads to phosphorylation of Kip1, which in turn attenuates type I IFN a/b receptor signaling and promotes matrix metalloproteinase-2 and -9 secretion, thereby enhancing tumor invasion.",-30.25,0.8,geneorgeneproduct
"Overactivating CDK6 in the HeLa cell line induces phosphorylation of the p27Kip1 protein, thereby releasing the type I IFN‑α/β receptor from inhibitory complexes and enhancing downstream STAT signaling that ultimately upregulates matrix metalloproteinase‑9 expression.",-45.5,0.8,geneorgeneproduct
"Overexpressed cathepsin B in A549 cells activates matrix metalloproteinase‑2 and −9, thereby enhancing epidermal growth factor receptor tyrosine kinase signaling and promoting SMA‑positive myofibroblast differentiation in a murine model of fibrosis.",-30.75,0.8,geneorgeneproduct
"Cathepsin B overexpression in HeLa cells induces epithelial–mesenchymal transition by up‑regulating matrix metalloproteinase‑2 and matrix metalloproteinase‑9, thereby enhancing invasion of the tumor microenvironment.",-21.625,0.8,geneorgeneproduct
"Catheter‐derived endothelial injury upregulates matrix metalloproteinase‑2 and ‑9, which cleave extracellular matrix and promote CDK6‑mediated cell cycle progression in smooth muscle cells, a process that is attenuated by glucocorticoid‑receptor‑interacting protein‑1 overexpression.",-47.0,0.8,geneorgeneproduct
"CatK knockdown in HeLa cells enhances apoptosis through up‑regulation of CDK6‑mediated phosphorylation of the glucocorticoid receptor‑interacting protein‑1, thereby amplifying type I IFN a/b receptor signaling and reducing matrix metalloproteinase‑2 and ‑9 expression.",-52.25,0.8,geneorgeneproduct
"Cat‑B up‑regulation in A549 cells exposed to IFN‑α/β signals through the type‑I IFN a/b receptor, enhancing MMP‑2/9 secretion and accelerating SMAD‑dependent EMT while concurrently activating CDK6‑Kip1‑mediated cell cycle progression.",-60.25,0.8,geneorgeneproduct
"HNF‑1α mutation‑driven up‑regulation of matrix metalloproteinase‑9 in HepG2 cells leads to enhanced extracellular matrix degradation, which is attenuated by the glucocorticoid receptor‑interacting protein‑1 agonist, thereby reducing metastatic potential.",-42.0,0.8,geneorgeneproduct
"HGF stimulation of the epidermal growth factor receptor tyrosine kinase in HepG2 cells upregulates matrix metalloproteinase‑9 expression, thereby enhancing cell invasion and correlating with poorer overall survival in hepatocellular carcinoma patients.",-26.125,0.8,geneorgeneproduct
"Heterozygous loss-of-function mutations in the CDK6 gene, which normally interacts with the cell cycle regulator Kip1, were found to increase matrix metalloproteinase-2 and -9 expression in A549 cells, thereby enhancing invasive potential in vitro.",-45.5,0.8,geneorgeneproduct
"HepG2 cells transfected with a CRISPR/Cas9‑generated TP53 c.68_69delAG variant showed elevated MMP9 secretion that was mitigated by dexamethasone treatment, which up‑regulated the glucocorticoid receptor‑interacting protein‑1 pathway.",-50.5,0.8,geneorgeneproduct
Kip1 phosphorylation by CDK6 in the epidermal growth factor receptor tyrosine kinase signaling cascade reduces type I IFN a/b receptor expression and thereby dampens the antiviral response in human epithelial cells.,-29.875,0.8,geneorgeneproduct
"Kit-2 (cathepsin B) overexpression in HeLa cells increases matrix metalloproteinase-9 production, thereby promoting epithelial–mesenchymal transition and enhancing invasive potential.",-47.0,0.8,geneorgeneproduct
"Kif1 knock‑down in the A549 cell line markedly decreased matrix metalloproteinase‑9 secretion, an effect that was partially rescued by overexpression of the glucocorticoid receptor‑interacting protein‑1 gene in E. coli‑derived protein assays.",-50.25,0.8,geneorgeneproduct
"Kep1-mediated inhibition of CDK6 activity suppresses EGF receptor tyrosine kinase signaling in A549 cells, thereby reducing the expression of matrix metalloproteinase‑2 and -9 and limiting the invasive potential of this lung carcinoma line.",-45.25,0.8,geneorgeneproduct
"In A549 cells, overexpression of cathepsin B enhances matrix metalloproteinase‑2 and ‑9 secretion, thereby promoting epithelial‑to‑mesenchymal transition through activation of the epidermal growth factor receptor tyrosine kinase pathway.",-19.25,0.8,geneorgeneproduct
"In HepG2 cells, the loss of HNF‑1α binding to the promoter of the glucocorticoid receptor‑interacting protein‑1 gene reduces its transcription, thereby diminishing downstream SMAD‑dependent signaling that normally restrains matrix metalloproteinase‑2 and –9 expression during epidermal growth factor receptor‑tyrosine kinase‑mediated proliferation.",-43.5,0.8,geneorgeneproduct
"In HeLa cells, overexpression of the gene product cathepsin B, which is a downstream target of the epidermal growth factor receptor tyrosine kinase, enhances matrix metalloproteinase‑9 secretion and promotes epithelial‑mesenchymal transition.",-30.375,0.8,geneorgeneproduct
"In **HepG2** cells, overexpression of **cathepsin B** enhances the proteolytic processing of pro‑MMP‑9 to active MMP‑9, thereby increasing extracellular matrix degradation and promoting metastasis of hepatocellular carcinoma.",-31.125,0.8,geneorgeneproduct
"CDK6 phosphorylation of Kip1 by the epidermal growth factor receptor tyrosine kinase in HeLa cells down‑regulates the cell‑cycle inhibitor, thereby promoting proliferation and conferring resistance to type I IFN a/b receptor signaling.",-24.75,0.8,geneorgeneproduct
"CDKN2A (Kip1) loss in HeLa cells increases matrix metalloproteinase‑2 expression, amplifying epidermal growth factor receptor tyrosine kinase signalling and promoting invasion.",-33.75,0.8,geneorgeneproduct
"CD47 overexpression in HeLa cells increases matrix metalloproteinase‑9 secretion, which enhances invasion of adjacent epithelial tissues through activation of epidermal growth factor receptor tyrosine kinase signaling.",-44.5,0.8,geneorgeneproduct
"CDKI-1 (Kip1) overexpression in A549 cells inhibits CDK6‑mediated phosphorylation of the type I IFN‑α/β receptor, thereby reducing STAT‑1 activation and downstream interferon‑stimulated gene expression in response to viral infection.",-41.75,0.8,geneorgeneproduct
"Deletion of the HNF‑1α binding site in the promoter of matrix metalloproteinase‑9 reduces its induction by type‑I IFN‑α/β receptor signaling in cultured HepG2 cells, thereby attenuating the inflammatory response.",-31.5,0.8,geneorgeneproduct
"Deletion in the HNF‑1α binding site of the FVII promoter reduces transcription of factor V, thereby lowering the procoagulant activity observed in patients with inherited thrombophilia.",-45.25,0.8,geneorgeneproduct
"Deletion and overexpression of the gene product cathepsin B in the human cancer cell line HeLa were found to synergistically enhance matrix metalloproteinase‑2 and matrix metalloproteinase‑9 secretion, thereby promoting invasive growth through activation of epidermal growth factor receptor tyrosine kinase signaling.",-50.5,0.8,geneorgeneproduct
"Deletion c.68_69delAG in the BRCA1 gene reduces its expression in HeLa cells and enhances sensitivity to the chemotherapeutic drug doxorubicin, thereby increasing apoptosis through activation of the TP53 pathway.",-41.75,0.8,geneorgeneproduct
"Activation of the type I IFN a/b receptor by interferon‑β in A549 cells upregulated cathepsin B and matrix metalloproteinase‑9, leading to enhanced extracellular matrix degradation and increased sensitivity to the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib.",-28.25,0.8,geneorgeneproduct
"Activation by type I IFN α/β receptor signaling induces CDK6 expression in HeLa cells, which in turn phosphorylates the glucocorticoid receptor‑interacting protein‑1, leading to enhanced transcription of cathepsin B and matrix metalloproteinase‑9 and promoting epithelial‑to‑mesenchymal transition.",-46.75,0.8,geneorgeneproduct
"Activation-induced degradation of cathepsin B in the HeLa cell line reduces matrix metalloproteinase-2 secretion and enhances type I IFN a/b receptor signaling, thereby attenuating epidermal growth factor receptor tyrosine kinase–mediated proliferation.",-42.75,0.8,geneorgeneproduct
"Activation‑induced expression of the cathepsin B gene in the HNF‑1α‑dependent transcriptional program of HepG2 cells was markedly enhanced by the type I IFN‑α/β receptor ligand, whereas the simultaneous knockdown of CDK6 and its regulator Kip1 attenuated this up‑regulation.",-64.5,0.8,geneorgeneproduct
"Epidermal growth factor receptor tyrosine kinase activation in HeLa cells induces CDK6 expression, which phosphorylates Kip1 to relieve its inhibition of the cell cycle and thereby promotes proliferation, a process that is further modulated by glucocorticoid receptor-interacting protein‑1 acting as a transcriptional co‑activator.",-44.0,0.8,geneorgeneproduct
"Erdosteine treatment down‑regulates cathepsin B expression in HepG2 cells, thereby mitigating matrix metalloproteinase‑2‑induced extracellular matrix remodeling and reducing hepatic fibrosis in a murine model of carbon tetrachloride‑induced liver injury.",-40.5,0.8,geneorgeneproduct
"E2F1 transcriptionally activates the CDK6 promoter, thereby increasing CDK6 protein abundance and driving the proliferation of HeLa cells.",-32.75,0.8,geneorgeneproduct
"Ectopic overexpression of the gene product CDK6 in the HeLa cell line activates the type I IFN a/b receptor signaling cascade, thereby upregulating the matrix metalloproteinase‑2 and −9 enzymes that facilitate tumor cell invasion.",-35.75,0.8,geneorgeneproduct
"The downregulation of miR‑217 in HeLa cells leads to elevated ERCC5 expression, thereby enhancing DNA repair capacity and conferring resistance to cisplatin treatment.",-15.0625,0.8,geneorgeneproduct
"The overexpression of miR‑217 in HeLa cells downregulates ERCC5, thereby enhancing cisplatin sensitivity and reducing DNA repair capacity.",-12.625,0.8,geneorgeneproduct
"The miR-217–mediated down‑regulation of ERCC5 in HeLa cells reduces DNA repair capacity, thereby increasing sensitivity to doxorubicin and inducing apoptosis.",-19.125,0.8,geneorgeneproduct
"The loss‑of‑function mutation in ERCC5 c.1123_1125delCTG creates a premature stop codon that destabilizes the X‑repair protein, leading to increased cellular sensitivity to cisplatin in A549 cells and correlating with higher levels of the DNA damage marker γ‑H2AX.",-53.25,0.8,geneorgeneproduct
"Mutation of ERCC5 in a HeLa cell line carrying the CDKN2A/B deletion caused an up‑regulation of miR‑217 that, in turn, suppressed PSA expression in the human cancer model.",-33.0,0.8,geneorgeneproduct
"Mutation in the ERCC5 gene causes increased sensitivity to cisplatin in HeLa cells, where miR‑217 expression is up‑regulated and CDKN2A/B signaling is suppressed, leading to enhanced apoptosis.",-36.25,0.8,geneorgeneproduct
"Mutation analysis of the ERCC5 c.1454_1456delAGG variant revealed a significant increase in cisplatin sensitivity in A549 cells, indicating that this sequence variant enhances DNA repair capacity and may modulate the response to platinum‑based chemotherapy.",-58.75,0.8,geneorgeneproduct
"Mutation‑induced down‑regulation of CDKN2A/B by miR‑217 leads to unchecked cell‑cycle progression in HeLa cells, where overexpression of the DNA‑repair gene ERCC5 further enhances survival under doxorubicin stress.",-41.5,0.8,geneorgeneproduct
"Mutant miR‑217 overexpression in HepG2 cells reduces ERCC5 mRNA stability, thereby enhancing DNA repair deficiency and increasing sensitivity to the chemotherapeutic agent doxorubicin.",-25.625,0.8,geneorgeneproduct
"Mutations in the ERCC5 gene that introduce the c.1107G>A sequence variant impair nucleotide excision repair, thereby increasing the risk of skin cancer in individuals carrying the ADORA2A rs5751875 allele.",-36.25,0.8,geneorgeneproduct
"Mutational loss of the DNA‑repair gene ERCC5 in A549 cells leads to heightened sensitivity to the chemotherapeutic drug doxorubicin, a phenotype that can be rescued by overexpression of the microRNA miR‑217, which targets the translational repressor Bach1.",-35.0,0.8,geneorgeneproduct
"Mutating the ERCC5 gene in a HeLa cell line carrying the CDKN2A/B deletion enhances DNA repair deficiency and increases sensitivity to cisplatin, thereby suggesting that ERCC5 loss could be exploited as a therapeutic target in chemoresistant cancers.",-47.0,0.8,geneorgeneproduct
"miR‑217 down‑regulates ERCC5, thereby reducing DNA repair capacity and sensitizing A549 cells to cisplatin-induced apoptosis.",-14.75,0.8,geneorgeneproduct
"miRNA‐217 downregulates ERCC5 expression, thereby sensitizing A549 cells to cisplatin‐induced apoptosis and reducing CDKN2A/B‑mediated cell‑cycle arrest in vitro.",-30.125,0.8,geneorgeneproduct
"mi‑217 down‑regulation in A549 cells enhances ERCC5 expression, thereby increasing cisplatin‑induced DNA repair and conferring resistance to apoptosis.",-31.25,0.8,geneorgeneproduct
"miRNAs such as miR‑217 target the DNA repair enzyme ERCC5, thereby reducing the repair of UV‑induced lesions in skin cells from Homo sapiens and enhancing susceptibility to actinic keratosis.",-36.25,0.8,geneorgeneproduct
"MicroRNA miR‑217 down‑regulates the DNA‑repair enzyme ERCC5, thereby sensitizing A549 cells to cisplatin-induced apoptosis in a CDKN2A/B‑dependent manner.",-20.625,0.8,geneorgeneproduct
"Micro‑RNA miR‑217 directly represses ERCC5 transcription, thereby reducing DNA repair capacity and potentiating the oncogenic effects of the CDKN2A/B locus in cultured HeLa cells.",-30.875,0.8,geneorgeneproduct
"MicroRNAs such as miR‑217 downregulate the DNA‑repair enzyme ERCC5, thereby sensitizing A549 cells to cisplatin and increasing apoptosis in a dose‑dependent manner.",-24.375,0.8,geneorgeneproduct
"Microglial miR‑217 downregulates ADORA2A expression, thereby attenuating ccl7‑mediated neuroinflammation in a murine model of Parkinson’s disease.",-25.875,0.8,geneorgeneproduct
"Knock‑down of miR‑217 in HeLa cells upregulates CDKN2A/B transcription, thereby inducing cell‑cycle arrest that is partially rescued by ADORA2A agonist treatment.",-24.375,0.8,geneorgeneproduct
"Knocking down miR‑217 in HeLa cells upregulates ERCC5 expression, thereby enhancing DNA repair capacity and reducing cisplatin‑induced apoptosis.",-12.0625,0.8,geneorgeneproduct
"Knocked‑down of miR‑217 in A549 cells up‑regulates the DNA‑repair gene ERCC5, thereby attenuating cisplatin‑induced apoptosis and enhancing chemoresistance.",-24.75,0.8,geneorgeneproduct
"Knox et al. reported that miR‑217 overexpression in HeLa cells suppresses ERCC5 expression, thereby impairing DNA repair and enhancing cisplatin sensitivity in this cervical cancer cell line.",-36.75,0.8,geneorgeneproduct
"In HepG2 cells, overexpression of miR‑217 down‑regulates the DNA‑repair enzyme ERCC5, thereby sensitizing the cells to cisplatin‑induced apoptosis.",-11.5625,0.8,geneorgeneproduct
"In HeLa cells, miR‑217 overexpression down‑regulates CDKN2A/B, thereby enhancing CDKN2A/B‑mediated apoptosis and reducing PSA secretion in prostate cancer‑derived cell lines.",-29.75,0.8,geneorgeneproduct
"In human colorectal carcinoma cells, overexpression of miR‑217 suppresses ERCC5 expression, leading to increased sensitivity to DNA‑damaging agents and enhancing the antitumor effect of doxorubicin.",-33.25,0.8,geneorgeneproduct
"In A549 cells, overexpression of the miR‑217 cluster down‑regulates ERCC5 and ADORA2A, thereby enhancing CDKN2A/B‑mediated senescence and increasing CD200‑mediated immune evasion.",-25.75,0.8,geneorgeneproduct
"A miR‑217‑mediated suppression of ERCC5 transcription in HeLa cells reduces DNA repair capacity, thereby enhancing cisplatin cytotoxicity and increasing the expression of CDKN2A/B‑regulated senescence markers.",-29.25,0.8,geneorgeneproduct
"A CRISPR‑mediated knock‑in of the ERCC5 c.1672C>T sequence variant in HeLa cells resulted in a marked increase in UV‑induced DNA repair deficiency, which was rescued by overexpression of miR‑217 that down‑regulates the transcriptional repressor Bach1.",-46.5,0.8,geneorgeneproduct
"A knock‑down of miR‑217 in A549 cells up‑regulated ERCC5 expression, leading to increased DNA repair capacity and reduced cisplatin‑induced apoptosis, a phenotype that was rescued by overexpressing CDKN2A/B to re‑establish cell cycle arrest.",-34.0,0.8,geneorgeneproduct
"A loss‑of‑function mutation in ERCC5, which reduces nucleotide excision repair capacity, was found to increase the risk of cisplatin‑induced ototoxicity in patients with the CDKN2A/B promoter polymorphism.",-28.625,0.8,geneorgeneproduct
"Ectopic overexpression of miR‑217 in A549 cells down‑regulates ERCC5 and CDKN2A/B, leading to reduced DNA repair capacity and increased apoptosis.",-22.75,0.8,geneorgeneproduct
"Epithelial expression of the microRNA miR‑217 down‑regulates the DNA repair enzyme ERCC5, thereby sensitizing HeLa cells to doxorubicin‑induced apoptosis.",-24.75,0.8,geneorgeneproduct
"E2F1 activation in HeLa cells upregulates miR‑217, which targets ERCC5 and consequently sensitizes the cells to cisplatin-induced apoptosis.",-33.0,0.8,geneorgeneproduct
"Efficacy of miR‑217 overexpression in HeLa cells was demonstrated by the down‑regulation of the DNA repair enzyme ERCC5, which in turn attenuated cisplatin‑induced DNA damage and improved cell survival.",-32.5,0.8,geneorgeneproduct
"Loss of the ERCC5 gene product in HeLa cells causes accumulation of UV-induced DNA lesions and upregulates miR‑217, which in turn suppresses the expression of the CDKN2A/B tumor‑suppressor complex.",-32.25,0.8,geneorgeneproduct
Loss‑of‑function mutations in ERCC5 enhance the sensitivity of A549 cells to the DNA‑damaging agent doxorubicin by impairing the repair of oxidative base lesions and inducing a p53‑dependent apoptosis pathway.,-41.0,0.8,geneorgeneproduct
"Loss-of-function mutations in the ERCC5 gene impair nucleotide excision repair and are linked to increased sensitivity to ultraviolet‑induced DNA damage, while overexpression of miR‑217 down‑regulates CDKN2A/B and enhances proliferation of HeLa cells.",-33.25,0.8,geneorgeneproduct
"Losses of miR‑217 expression in HepG2 cells enhance ERCC5 transcription, thereby promoting DNA repair and conferring resistance to doxorubicin in a CDKN2A/B‑dependent manner.",-34.25,0.8,geneorgeneproduct
"Silencing of miR‑217 in HeLa cells upregulates the DNA‑repair gene ERCC5, thereby enhancing resistance to cisplatin and increasing cell survival during genotoxic stress.",-23.125,0.8,geneorgeneproduct
"Silently, miR-217 downregulates CDKN2A/B transcription, which in turn alleviates the ERCC5‑mediated DNA repair delay observed in prostate cancer cells overexpressing PSA.",-39.0,0.8,geneorgeneproduct
"Silencer miR‑217 down‑regulates the DNA repair gene ERCC5, and its loss in CDKN2A/B‑deficient colorectal cells leads to increased susceptibility to cisplatin‑induced apoptosis.",-39.0,0.8,geneorgeneproduct
"Silenced miR-217 expression in HeLa cells upregulates CDKN2A/B transcription, thereby enhancing CDKN2A/B-mediated senescence and reducing cell proliferation.",-29.875,0.8,geneorgeneproduct
"Interaction between miR-217 and the ERCC5 mRNA transcript reduces DNA repair capacity in tumor cells, which in turn enhances sensitivity to platinum‑based chemotherapy and leads to a measurable decrease in PSA levels in prostate cancer patients.",-46.75,0.8,geneorgeneproduct
"Interaction of miR‑217 with the ERCC5 mRNA was shown to down‑regulate DNA repair activity in A549 cells, thereby sensitizing the cells to doxorubicin-induced apoptosis.",-28.0,0.8,geneorgeneproduct
"Interaction studies in HEK293T cells revealed that miR‑217 directly targets the ERCC5 mRNA, decreasing its protein level and thereby sensitizing the cells to cisplatin-induced apoptosis.",-36.25,0.8,geneorgeneproduct
"Interaction assays revealed that miR‑217 down‑regulates the DNA‑repair gene ERCC5, thereby sensitizing CDKN2A/B‑deficient HCT116 cells to cisplatin-induced apoptosis.",-29.75,0.8,geneorgeneproduct
"Expression of miR‑217 in HeLa cells reduces ERCC5 mRNA stability, leading to impaired DNA repair and heightened sensitivity to cisplatin.",-18.25,0.8,geneorgeneproduct
"Expression analysis of miR‑217 revealed that its down‑regulation in ERCC5‑deficient A549 cells leads to increased CDKN2A/B transcription, thereby amplifying senescence‑associated β‑galactosidase activity.",-33.25,0.8,geneorgeneproduct
"Expression changes of miR‑217 were found to down‑regulate ERCC5, thereby increasing sensitivity of HepG2 cells to doxorubicin treatment.",-32.25,0.8,geneorgeneproduct
"Expression profiling revealed that miR‑217 suppresses ERCC5, thereby increasing cisplatin sensitivity in A549 cells, a finding that suggests targeting miR‑217 could potentiate chemotherapy in non‑small‑cell lung carcinoma.",-41.5,0.8,geneorgeneproduct
"Deletion of the CDKN2A/B locus in the HeLa cell line reduces ERCC5 expression, thereby diminishing the cell’s capacity to repair UV-induced DNA damage and increasing sensitivity to cisplatin.",-28.375,0.8,geneorgeneproduct
"Deletion in the ERCC5 promoter reduces transcription, thereby diminishing DNA repair capacity and increasing susceptibility to cisplatin-induced nephrotoxicity in Homo sapiens patients.",-34.75,0.8,geneorgeneproduct
"Deletion c.68_69delAG in the ERCC5 gene leads to reduced DNA repair activity, increasing susceptibility to cisplatin-induced nephrotoxicity in patients treated with the chemotherapeutic agent doxorubicin.",-35.0,0.8,geneorgeneproduct
"Deletion‑induced loss of the miR‑217 binding site in the ERCC5 transcript causes elevated CDKN2A/B expression, impairing DNA repair in Homo sapiens cells and promoting early tumorigenesis.",-53.25,0.8,geneorgeneproduct
"Mutations in the ABCA4 gene, such as the c.1801G>A variant, reduce retinal pigment epithelium phagocytosis and thereby accelerate photoreceptor degeneration in patients with retinitis pigmentosa.",-33.0,0.8,geneorgeneproduct
"Mutual inhibition of the MyD88‑dependent NF‑κB pathway by cortactin overexpression suppresses ABCA4‑mediated cholesterol efflux in retinal pigment epithelial cells, thereby reducing lipofuscin accumulation linked to Stargardt disease.",-35.5,0.8,geneorgeneproduct
"Mutated ABCA4 c.2576C>T in retinal pigment epithelial cells of a Caucasian patient with Stargardt disease leads to impaired lipid transport, thereby triggering activation of the microglial cytokine IL‑10‑neutralized response that suppresses Rab7‑mediated phagosome maturation and exacerbates photoreceptor degeneration.",-62.25,0.8,geneorgeneproduct
"Mutational loss of the ABCA4 gene product in retinal pigment epithelium of a Stargardt patient leads to accumulation of lipofuscin and subsequent activation of the LIFR signaling pathway, thereby promoting photoreceptor cell death.",-32.0,0.8,geneorgeneproduct
"The phosphorylation of LIFR by the kinase MYD88 enhances STAT3 signaling in A549 cells, leading to increased expression of the cytokine IL‑10‑neutralized and promoting chemoresistance to doxorubicin.",-30.875,0.8,geneorgeneproduct
"The loss‑of‑function mutation BRCA1 c.68_69delAG in the ovarian carcinoma cell line A2780 leads to impaired DNA repair and increased sensitivity to the PARP inhibitor olaparib, illustrating how sequence variant status can dictate therapeutic response.",-32.5,0.8,geneorgeneproduct
"The MyD88‑dependent signaling cascade is potentiated by cortactin phosphorylation, thereby enhancing IL‑10‑neutralized macrophage migration inhibitory factor release and promoting Rab7‑mediated endosomal trafficking of ABCA4‑associated lipid transport proteins.",-32.25,0.8,geneorgeneproduct
"The CRISPR‑mediated knockout of **MyD88** in **HeLa** cells led to a dramatic reduction in **IL‑10‑neutralized** macrophage migration, indicating that the **migration inhibitory factor** pathway is downstream of **MyD88**‑dependent signaling.",-33.75,0.8,geneorgeneproduct
"Mutation of the ABCA4 gene in retinal pigment epithelium cells of a Caucasian patient with Stargardt disease led to mis‑localization of the protein and subsequent accumulation of lipofuscin, which was mitigated by administration of the small‑molecule inhibitor curcumin.",-39.5,0.8,geneorgeneproduct
"Mutation in the BRCA1 c.68_69delAG sequence variant reduces the DNA repair activity of the TP53 gene product, thereby increasing apoptosis in the HeLa cell line derived from Homo sapiens.",-27.25,0.8,geneorgeneproduct
"Mutation‑induced loss of ABCA4 function in retinal pigment epithelium of a patient with Stargardt disease led to accumulation of lipofuscin, which in turn triggered microglial LIFR activation and subsequent up‑regulation of IL‑10‑neutralized anti‑inflammatory signaling that ultimately slowed photoreceptor degeneration.",-45.0,0.8,geneorgeneproduct
Mutation analysis of the ABCA4 gene in an ocular cohort revealed a novel c.3241_3242delCT variant that correlates with reduced retinoid transport and early-onset macular degeneration in Homo sapiens retinal pigment epithelium cells.,-54.75,0.8,geneorgeneproduct
"Disruption of the ABCA4 promoter by the c.5714C>T sequence variant reduces transcription, leading to a loss of the ABCA4 protein product that impairs photoreceptor lipid transport and causes retinitis pigmentosa.",-48.0,0.8,geneorgeneproduct
"Disruptive mutations in the ABCA4 gene, such as the c.5718C>T (p.Ala1906Val) SequenceVariant, compromise retinal pigment epithelium function in patients with Stargardt disease, as confirmed by decreased rhodopsin recycling and increased photoreceptor apoptosis in A549 CellLine cultures derived from affected Homo sapiens donors.",-65.5,0.8,geneorgeneproduct
Disrupted phosphorylation of the MyD88 signaling complex by a missense variant in the N-terminal TIR domain of LIFR reduces downstream NF‑κB activation and attenuates migration inhibitory factor‑mediated chemotaxis in A549 cells.,-43.0,0.8,geneorgeneproduct
"Disabling the MyD88-mediated signaling pathway in HeLa cells reduces cortactin‑dependent migration, thereby attenuating IL‑10‑neutralized cytokine release and restoring ABCA4‑driven cholesterol transport in a humanized E. coli model.",-54.0,0.8,geneorgeneproduct
"MyD88, a key adaptor protein in Toll‑like receptor signaling, binds to the pro‑inflammatory adaptor cortactin, thereby amplifying NF‑κB activation and enhancing IL‑10‑neutralized cytokine release in macrophages infected with *Salmonella enterica*.",-35.75,0.8,geneorgeneproduct
"Myeloma‑derived plasma cells overexpress MyD88, which in turn activates NF‑κB signaling and up‑regulates the anti‑apoptotic gene BCL‑XL, thereby promoting chemoresistance in MM patients.",-40.0,0.8,geneorgeneproduct
"Myc‑induced down‑regulation of the tumor suppressor gene TP53 in HeLa cells leads to increased cortactin‑mediated invadopodia formation, thereby enhancing cell migration and invasion.",-32.5,0.8,geneorgeneproduct
"MyB cell lines transfected with a plasmid encoding the MyD88 adaptor protein displayed increased phosphorylation of the Smad1 signaling cascade, leading to enhanced expression of the cytokine IL‑10 and subsequent suppression of migration inhibitory factor in an ABCA4‑deficient E. coli model.",-62.25,0.8,geneorgeneproduct
"In HeLa cells, the MyD88‑dependent signaling pathway activates Smad1 phosphorylation, which in turn up‑regulates ABCA4 expression, thereby enhancing cellular cholesterol efflux and reducing migration inhibitory factor‑induced cytoskeletal remodeling.",-27.25,0.8,geneorgeneproduct
"In A549 cells, MyD88 overexpression enhances cortactin phosphorylation, leading to increased Rab7‑mediated endosomal trafficking that promotes LIFR‑dependent STAT3 activation and ultimately drives IL‑10‑neutralized macrophage recruitment to the tumor microenvironment.",-34.5,0.8,geneorgeneproduct
"In HepG2 cells, activation of the MyD88‑dependent NF‑κB pathway by LPS induces phosphorylation of cortactin, which in turn promotes Rab7‑mediated autophagic clearance of misfolded ABCA4 protein, thereby alleviating cellular toxicity associated with retinal dystrophy.",-33.25,0.8,geneorgeneproduct
"In breast cancer cell line MCF‑7, overexpression of the transcription factor c‑Myc upregulates ABCA4 and increases resistance to doxorubicin, an effect that is partially reversed by IL‑10‑neutralized antibody treatment.",-37.75,0.8,geneorgeneproduct
"A genetic study of MYD88 and cortactin polymorphisms in a cohort of *Homo sapiens* patients with ulcerative colitis revealed that the MYD88 c.284C>T variant (p.Arg95Cys) increases susceptibility to dysregulated NF‑κB signaling, whereas cortactin overexpression in *A549* cells enhances chemotactic migration via Rac1‑dependent lamellipodia formation.",-78.0,0.8,geneorgeneproduct
"A polymorphism in the ABCA4 gene that disrupts the N-terminal transmembrane domain impairs the retinal pigment epithelium’s ability to transport vitamin A derivatives, thereby increasing susceptibility to retinitis pigmentosa in Homo sapiens patients.",-38.75,0.8,geneorgeneproduct
"A gain‑of‑function mutation in the MyD88 gene product, identified in a patient with a severe autoinflammatory phenotype, leads to hyperactivation of NF‑κB signaling and up‑regulation of the anti‑inflammatory cytokine IL‑10, thereby illustrating how sequence variants in innate immune genes can modulate disease severity.",-43.0,0.8,geneorgeneproduct
"A conditional knockout of the MyD88 gene in A549 cells reduces cortactin‑dependent migration while simultaneously increasing ABCA4 expression, thereby attenuating LIFR‑mediated inflammatory signaling in a manner that mimics the effects of IL‑10 neutralization and Rab7‑regulated lysosomal trafficking.",-47.5,0.8,geneorgeneproduct
"Impaired MyD88 signaling in A549 cells treated with the small‑molecule inhibitor curcumin induces up‑regulation of the migration‑inhibitory factor, thereby reducing cortactin‑mediated actin polymerization and cell motility.",-34.25,0.8,geneorgeneproduct
"Immunofluorescence staining of HeLa cells revealed that the knockdown of MyD88 by siRNA markedly reduced cortactin‑dependent actin polymerization, thereby impairing IL‑10‑neutralized macrophage migration.",-35.75,0.8,geneorgeneproduct
"Impairment of the MyD88‑dependent pathway by cortactin overexpression in HeLa cells increases ABCA4 transcription, thereby enhancing cholesterol efflux and reducing LIFR‑mediated neuroinflammation in a model of retinal degeneration.",-44.5,0.8,geneorgeneproduct
Imbalance of MyD88 signaling in HeLa cells expressing the ABCA4 c.1024C>T variant increases cortactin‑mediated migration and elevates IL‑10‐neutralized inflammatory cytokine secretion.,-50.25,0.8,geneorgeneproduct
"Altered phosphorylation of MyD88 by the protein kinase CK2 in A549 cells reduces NF‑κB activation and consequently down‑regulates IL‑10 production, a change that can exacerbate LIFR‑mediated inflammatory responses in cultured Human hepatocytes.",-51.5,0.8,geneorgeneproduct
"Alterations in the MyD88‑dependent signaling cascade, triggered by cortactin‑mediated endocytosis of the LIFR receptor, were found to suppress IL‑10‑neutralized macrophage migration inhibitory factor production in a human THP‑1 cell line, thereby enhancing the activation of the Rab7‑associated autophagic pathway.",-49.75,0.8,geneorgeneproduct
"Alteration of the MyD88 gene product by a BRCA1 c.68_69delAG variant in E. coli-derived plasmids markedly decreases IL‑10‑neutralized signaling, thereby enhancing cortactin‑mediated migration inhibitory factor release in HeLa cells.",-38.75,0.8,geneorgeneproduct
"Altering the phosphorylation of MyD88 by cortactin in A549 cells decreases IL‑10‑neutralized NF‑κB activity, thereby enhancing LIFR‑dependent cell migration.",-39.25,0.8,geneorgeneproduct
"Loss of the Rab7-mediated endosomal trafficking of the MyD88 adaptor protein in HeLa cells results in a marked reduction of IL‑10‑neutralized NF‑κB activation and promotes migration inhibitory factor‑induced apoptosis, thereby implicating Rab7 as a potential therapeutic target for inflammatory disease.",-47.5,0.8,geneorgeneproduct
"Loss-of-function mutations in ABCA4 in the retinas of a patient with Stargardt disease reduced photoreceptor outer segment turnover, causing the accumulation of lipofuscin and subsequent degeneration of cone photoreceptors.",-47.5,0.8,geneorgeneproduct
"Loss‑of‑function mutation in the ABCA4 gene leads to retinoid accumulation, which in turn activates MyD88‑dependent signaling and upregulates migration inhibitory factor expression in retinal pigment epithelium cells.",-36.75,0.8,geneorgeneproduct
"Lossy degradation of the BRCA1 gene product was detected in the HeLa cell line, where a BRCA1 c.68_69delAG variant induced aberrant splicing and led to a truncated protein that compromised DNA repair and increased the sensitivity of the cells to doxorubicin.",-61.25,0.8,geneorgeneproduct
"Silencing of the MYD88 gene in A549 cells markedly reduced migration inhibitory factor secretion, thereby impairing IL‑10‑neutralized macrophage recruitment and increasing susceptibility to NTH‑induced apoptosis.",-30.375,0.8,geneorgeneproduct
"Silenced MYD88 expression in HeLa cells markedly reduces cortactin‑mediated invasion, a phenotype that can be rescued by transfecting the LIFR variant p.R1036C, revealing a regulatory axis involving NTH‑mediated DNA repair and Rab7‑dependent endosomal trafficking.",-61.5,0.8,geneorgeneproduct
"Silently, the MyD88‑dependent activation of the NF‑κB pathway in HeLa cells expressing a mutant LIFR allele containing the BRCA1 c.68_69delAG variant leads to up‑regulation of the anti‑inflammatory cytokine IL‑10, thereby dampening migration inhibitory factor‑mediated neutrophil recruitment.",-48.0,0.8,geneorgeneproduct
"Sil12‑derived CRISPR‑Cas9 editing of the **MYD88** gene in the **A549** cell line revealed that loss of the LRR domain reduces **cortactin**‑mediated actin remodeling, thereby impairing cell migration and decreasing **IL‑10**‑neutralized macrophage activation, while concomitant up‑regulation of **Rab7**‑dependent lysosomal degradation of **LIFR** leads to attenuated STAT3 signaling and heightened apoptosis in",-94.0,0.8,geneorgeneproduct
"Overexpression of the gene product MyD88 in HeLa cells enhances cortactin‑mediated Rac1 activation, leading to increased cell migration and invasion that are dependent on the signaling of the LIFR/IL‑10‑neutralized pathway.",-43.75,0.8,geneorgeneproduct
"Overactivation of the MyD88‑dependent NF‑κB pathway in HeLa cells increases cortactin phosphorylation, thereby enhancing Rab7‑mediated endosomal trafficking of ABCA4‑derived lysophospholipids and potentiating IL‑10‑neutralized inflammatory responses.",-39.0,0.8,geneorgeneproduct
"Overactivated MyD88 in THP‑1 cells enhances cortactin‑driven actin remodeling, thereby accelerating LIFR‑mediated migration inhibitory factor signaling and potentiating IL‑10‑neutralized suppression of Rab7‑dependent autophagic flux.",-47.5,0.8,geneorgeneproduct
"Overexpressed MyD88 in HeLa cells activates the NF‑κB pathway, inducing IL‑10‑neutralized migration inhibitory factor secretion that suppresses cortactin‑driven actin polymerization and enhances Rab7‑mediated endosomal trafficking of the ABCA4 transporter, thereby altering cellular signaling in Homo sapiens.",-44.75,0.8,geneorgeneproduct
"Knocking out the MYD88 gene in A549 cells markedly reduced cortactin‑mediated migration, an effect that was rescued by exogenous LIFR signaling and confirmed by a loss‑of‑function mutation in the ABCA4 promoter.",-35.5,0.8,geneorgeneproduct
"Knock‑down of the MyD88‑dependent signaling adaptor MyD88 in LIFR‑expressing A549 cells reduces cortactin‑mediated actin remodeling and thereby attenuates IL‑10‑neutralized inflammatory cytokine release, illustrating how MYD88 and LIFR interactions can modulate cellular migration and immune responses in a human lung carcinoma context.",-57.75,0.8,geneorgeneproduct
"Knox et al. observed that in A549 cells the MyD88‑dependent activation of NF‑κB by LIFR stimulation leads to increased cortactin phosphorylation, thereby enhancing Rab7‑mediated endosomal trafficking of the ABCA4‑derived lipid substrate.",-47.5,0.8,geneorgeneproduct
"Knocked‑down of the MyD88 gene product in HeLa cells markedly reduces the migration inhibitory factor‑induced activation of Smad1, illustrating a novel regulatory pathway for IL‑10‑neutralized inflammatory signaling.",-41.75,0.8,geneorgeneproduct
"Interaction of the MyD88 signaling complex with the cortactin cytoskeletal scaffold is enhanced by the LIFR‑dependent phosphorylation of the ABCA4 transporter, thereby promoting Rab7‑mediated endosomal trafficking of the migration inhibitory factor and its downstream Smad1 signaling, which ultimately modulates IL‑10‑neutralized inflammatory responses in human keratinocytes.",-56.75,0.8,geneorgeneproduct
"Interaction studies revealed that MYD88 activation in HeLa cells upregulates ABCA4 expression through a Smad1‑dependent transcriptional pathway, thereby enhancing cellular migration and cytokine secretion.",-38.75,0.8,geneorgeneproduct
"Interaction between the adaptor protein MyD88 and the scaffold protein cortactin enhances IL‑10‑neutralized macrophage migration in Homo sapiens, revealing a potential regulatory axis for Nth‑mediated DNA repair.",-33.5,0.8,geneorgeneproduct
"Interaction assays demonstrated that overexpression of the MyD88 adaptor protein in A549 cells increased NF‑κB‑driven transcription of IL‑10, which in turn suppressed cortactin‑mediated migration of the epithelial carcinoma cell line.",-45.5,0.8,geneorgeneproduct
"JNK‑dependent phosphorylation of EGFR by CBR3 in HeLa cells enhances VEGFR2‑mediated angiogenic signaling, a process that is further amplified by regulator of G‑protein signaling‑4 acting on the G protein‑coupled receptor complex.",-31.625,0.8,geneorgeneproduct
"J‑NK‑dependent phosphorylation of the regulator of G‑protein signaling‑4 protein in EGFR‑overexpressing A549 cells enhances VEGFR2‑mediated endothelial proliferation, thereby promoting angiogenesis.",-34.5,0.8,geneorgeneproduct
"JAK2 phosphorylation of VEGFR2 is enhanced by EGFR‐mediated crosstalk, causing a JNK‑dependent upregulation of CCL8 that recruits monocytes expressing angiotensin I‑converting enzyme and RGS4, thereby amplifying inflammatory signaling in human endothelial cells.",-52.5,0.8,geneorgeneproduct
"JUN kinase (JNK)-dependent phosphorylation of EGFR enhances VEGFR2-mediated angiogenic signaling in human umbilical vein endothelial cells, a process that is inhibited by the G protein-coupled receptor regulator RGS4.",-36.25,0.8,geneorgeneproduct
"The JNK‑dependent activation of EGFR in HeLa cells upregulates VEGFR2 expression, thereby enhancing CCL8 secretion and promoting angiogenic signaling mediated by angiotensin I‑converting enzyme.",-17.75,0.8,geneorgeneproduct
"The overexpression of VEGFR2 in A549 cells leads to JNK‑dependent phosphorylation of EGFR, thereby enhancing CCL8 secretion and promoting chemotaxis of immune cells toward the tumor microenvironment.",-20.25,0.8,geneorgeneproduct
"The EGFR‑regulated VEGFR2 phosphorylation in HeLa cells is inhibited by a JNK‑dependent pathway that up‑regulates regulator of G‑protein signaling‑4 expression, thereby reducing CCL8 secretion.",-28.375,0.8,geneorgeneproduct
"The down‑regulation of VEGFR2 in EGFR‑mutant A549 cells is mediated by a JNK‑dependent, regulator of G‑protein signaling‑4–induced CCL8 secretion, which in turn activates angiotensin I‑converting enzyme and promotes CBR3‑driven cell migration.",-38.0,0.8,geneorgeneproduct
"EGFR activation in HeLa cells upregulates VEGFR2 expression through a JNK‑dependent, regulator of G‑protein signaling‑4 mediated pathway, leading to increased CCL8 secretion.",-19.875,0.8,geneorgeneproduct
"EGF-mediated activation of EGFR triggers JNK-dependent phosphorylation of regulator of G‑protein signaling‑4, which subsequently up‑regulates CCL8 expression in the VEGFR2‑expressing endothelial cells.",-38.25,0.8,geneorgeneproduct
"EGRA‑treated A549 cells displayed increased JNK‑dependent phosphorylation of VEGFR2, leading to up‑regulated CCL8 secretion that further enhanced EGFR‑mediated proliferation in a B1‑regulated, angiotensin‑converting‑enzyme‑dependent manner.",-52.25,0.8,geneorgeneproduct
"EGCG treatment of A549 cells downregulates EGFR and upregulates regulator of G‑protein signaling‑4, thereby reducing JNK‑dependent CCL8 secretion and enhancing angiotensin‑I‑converting‑enzyme activity, a modulation that may attenuate VEGFR2‑mediated angiogenesis in this lung cancer model.",-47.25,0.8,geneorgeneproduct
"In the MCF-7 cell line, overexpression of VEGFR2 phosphorylates downstream EGFR signaling pathways, thereby enhancing JNK‑dependent apoptosis while simultaneously upregulating CCL8 secretion to recruit tumor‑associated macrophages.",-36.5,0.8,geneorgeneproduct
"In HeLa cells, overexpression of EGFR activates JNK-dependent phosphorylation of Cdh1, which then enhances the degradation of VEGFR2 and reduces downstream angiogenic signaling.",-20.875,0.8,geneorgeneproduct
"In A549 cells, EGFR activation induces JNK-dependent phosphorylation of VEGFR2, which then upregulates CCL8 secretion and enhances angiotensin I-converting enzyme expression, ultimately promoting tumor-associated angiogenesis.",-23.625,0.8,geneorgeneproduct
"In HepG2 cells, activation of EGFR by EGF induces JNK-dependent phosphorylation of VEGFR2, thereby upregulating CCL8 secretion while simultaneously enhancing angiotensin‑converting enzyme expression through regulator‑of‑G‑protein‑signaling‑4‑mediated signaling.",-33.5,0.8,geneorgeneproduct
"Activation of EGFR by CCL8 in HeLa cells induces a JNK-dependent up‑regulation of VEGFR2, which is further potentiated by the regulator of G‑protein signaling‑4 and the angiotensin‑I‑converting‑enzyme, leading to enhanced angiogenic signaling in the tumor microenvironment.",-37.0,0.8,geneorgeneproduct
"Activation‐dependent phosphorylation of the receptor tyrosine kinase EGFR in A549 cells stimulates JNK‐dependent transcription of CCL8, thereby recruiting neutrophils through a G protein‑coupled receptor that is up‑regulated by the regulator of G‑protein signaling‑4 complex.",-51.0,0.8,geneorgeneproduct
"Activation‑dependent phosphorylation of the VEGFR2 tyrosine kinase by EGFR in A549 cells triggers JNK‑dependent transcription of the chemokine CCL8, thereby enhancing tumor‑cell invasiveness through up‑regulation of the regulator of G‑protein signaling‑4 pathway.",-47.25,0.8,geneorgeneproduct
"Activation by the tyrosine‑kinase ligand EGF of the EGFR on A549 cells upregulates the transcription of VEGFR2, which in turn stimulates a JNK‑dependent signaling cascade that increases CCL8 secretion and promotes G‑protein‑coupled receptor–mediated angiogenesis.",-48.25,0.8,geneorgeneproduct
"Loss‑of‑function mutations in the EGFR signaling pathway, such as a JNK‑dependent phosphorylation defect in VEGFR2, have been shown to up‑regulate CCL8 secretion in A549 cells, thereby exacerbating angiotensin I‑converting enzyme‑mediated hypertension in E. coli‑infected mice.",-45.25,0.8,geneorgeneproduct
"Loss of the tumor suppressor gene TP53 in A549 cells activates JNK-dependent transcription of the chemokine CCL8, thereby stimulating VEGFR2-mediated angiogenesis in a EGFR-heterodimerized microenvironment.",-41.5,0.8,geneorgeneproduct
"Loss-of-function mutations in the VEGFR2 gene (KDR) in HepG2 cells reduce EGFR‑dependent phosphorylation of JNK‑dependent signaling cascades, thereby attenuating CCL8 secretion and impairing angiotensin‑I‑converting enzyme activity.",-44.75,0.8,geneorgeneproduct
"Loss‐of‑function mutations in the tumor suppressor gene Cdh1, which encodes an E3 ubiquitin ligase that regulates the G‑protein‑coupled receptor EGFR, result in uncontrolled JNK‑dependent phosphorylation of VEGFR2 and over‑production of the chemokine CCL8, thereby promoting angiogenesis in colorectal carcinoma cells.",-47.75,0.8,geneorgeneproduct
"A JNK‑dependent phosphorylation of EGFR by a regulator of G‑protein signaling‑4 enhances VEGFR2‑mediated angiogenesis in A549 cells, a process that is attenuated by the CBR3 inhibitor CBR3‑i1.",-35.25,0.8,geneorgeneproduct
"A missense mutation in VEGFR2 reduces its tyrosine kinase activity, causing impaired angiogenic signaling and exacerbating ischemic injury in a mouse model that was treated with a CBR3 inhibitor.",-40.75,0.8,geneorgeneproduct
"A gain‑of‑function mutation in the VEGFR2 coding sequence drives JNK‑dependent phosphorylation of CCL8, thereby enhancing tumor cell invasion in HeLa cells.",-28.625,0.8,geneorgeneproduct
"A single‑cell CRISPR knock‑out of VEGFR2 in A549 cells reduced EGFR‑mediated JNK‑dependent phosphorylation of CCL8, thereby attenuating downstream angiogenic signaling and suppressing tumor‑derived VEGFR2 expression in the human lung carcinoma microenvironment.",-44.25,0.8,geneorgeneproduct
"Mutation of the VEGFR2 gene product in human endothelial cells disrupts JNK‑dependent signaling and induces CCL8 secretion, thereby enhancing angiogenic sprouting.",-26.25,0.8,geneorgeneproduct
"Mutation in the VEGFR2 promoter of *Homo sapiens* cells reduces EGFR‑induced phosphorylation of JNK‑dependent downstream targets, thereby impairing CCL8 secretion from endothelial cells.",-30.125,0.8,geneorgeneproduct
"Mutation‑induced alteration of VEGFR2 signaling in A549 cells leads to JNK‑dependent upregulation of CCL8, which subsequently activates angiotensin I‑converting enzyme expression and enhances EGFR‑mediated proliferation.",-31.75,0.8,geneorgeneproduct
"Mutation analysis revealed that the VEGFR2 variant c.1451G>A in the Homo sapiens patient altered EGFR signaling through a JNK-dependent pathway, thereby increasing CCL8 expression and contributing to the observed hypertension.",-54.75,0.8,geneorgeneproduct
"Mutations in VEGFR2 that disrupt JNK‑dependent phosphorylation of the receptor’s intracellular domain impair downstream signaling, thereby reducing angiogenic sprouting in EGFR‑overexpressing HeLa cells and increasing sensitivity to the EGFR inhibitor gefitinib.",-35.5,0.8,geneorgeneproduct
"Mutational analysis revealed that the EGFR exon‑19 deletion in H1299 cells upregulated VEGFR2 expression through a JNK‑dependent pathway, thereby enhancing CCL8 secretion and promoting angiotensin I‑converting enzyme activity.",-34.75,0.8,geneorgeneproduct
"Mutagenic exposure to doxorubicin in A549 cells upregulates VEGFR2 and EGFR transcription while simultaneously increasing the expression of the regulator of G‑protein signaling‑4, thereby amplifying JNK‑dependent CCL8 secretion in a dose‑dependent manner.",-39.0,0.8,geneorgeneproduct
"Mutant VEGFR2 kinase activity in A549 cells triggers JNK-dependent apoptosis, and this effect is rescued by the G protein‑coupled receptor agonist CBR3, revealing a novel regulatory axis for EGFR‑mediated cell survival.",-44.5,0.8,geneorgeneproduct
"Altered expression of VEGFR2 in the A549 cell line was found to be downstream of JNK‑dependent activation of EGFR, thereby enhancing CCL8 secretion by an EGFR‑regulated G‑protein‑coupled receptor pathway in Homo sapiens cells.",-39.25,0.8,geneorgeneproduct
"Alterations in EGFR signaling that activate JNK-dependent transcription of VEGFR2 in the Cdh1-deficient HeLa cell line lead to up‑regulation of angiotensin I‑converting enzyme expression, thereby enhancing CCL8 secretion and driving a pro‑inflammatory phenotype.",-48.0,0.8,geneorgeneproduct
"Alteration of the VEGFR2 gene product by a JNK‑dependent phosphorylation event in HeLa cells enhances EGFR‑mediated downstream signaling, thereby promoting proliferation.",-25.625,0.8,geneorgeneproduct
"Alterantive splicing of the VEGFR2 gene in HeLa cells is up‑regulated by JNK‑dependent phosphorylation of Cdh1, thereby enhancing angiogenic signaling through the EGFR‑activated G‑protein‑coupled receptor pathway.",-45.0,0.8,geneorgeneproduct
"Knockdown of VEGFR2 in HeLa cells suppresses JNK-dependent phosphorylation of CCL8, thereby reducing EGFR‑mediated migration.",-24.875,0.8,geneorgeneproduct
"Knocking down EGFR in A549 cells reduces VEGFR2 expression through a JNK‑dependent pathway, thereby attenuating angiogenic signaling in this lung cancer model.",-25.25,0.8,geneorgeneproduct
"Knocked‑down of VEGFR2 in A549 cells downregulated CCL8 expression through a JNK‑dependent, EGFR‑mediated signaling cascade, thereby attenuating the angiogenic response in this human lung carcinoma model.",-38.75,0.8,geneorgeneproduct
"Knox1-mediated upregulation of VEGFR2 in A549 cells triggers JNK-dependent phosphorylation of CCL8, thereby enhancing EGFR signaling and promoting invasive tumor phenotypes.",-39.75,0.8,geneorgeneproduct
"KRAS G12D mutation in the A549 cell line amplifies JNK‑dependent signaling, leading to up‑regulation of VEGFR2 and CCL8 expression while concurrently suppressing EGFR‑mediated proliferation in a HeLa‑derived xenograft model.",-40.5,0.8,geneorgeneproduct
"KRAB‑domain protein ZNF281, a transcriptional repressor, was shown to bind the promoter of **VEGFR2** in **A549** cells, thereby suppressing angiogenic signaling downstream of **EGFR** activation.",-43.5,0.8,geneorgeneproduct
"KRIBB1‑mediated phosphorylation of VEGFR2 enhances JNK‑dependent phosphorylation of EGFR, thereby increasing CCL8 transcription in HeLa cells exposed to angiotensin I‑converting enzyme inhibitors.",-36.75,0.8,geneorgeneproduct
"KR27‑1‑HeLa cells treated with an EGFR‑specific inhibitor exhibited reduced phosphorylation of VEGFR2, a JNK‑dependent decrease in CCL8 secretion, and a marked up‑regulation of the regulator of G‑protein signaling‑4 gene product.",-58.0,0.8,geneorgeneproduct
"Silencing of VEGFR2 in A549 cells triggers JNK‑dependent apoptosis and upregulates the chemokine CCL8, indicating that EGFR‑mediated signaling may counteract this pro‑apoptotic pathway in human carcinoma.",-37.25,0.8,geneorgeneproduct
"Silenced VEGFR2 expression in A549 cells attenuates JNK‑dependent apoptosis, a phenotype rescued by ectopic EGFR overexpression that restores downstream ERK signaling and reduces CCL8 secretion.",-36.75,0.8,geneorgeneproduct
"Silvestrol downregulates VEGFR2 expression in A549 cells, thereby suppressing JNK‑dependent signaling that otherwise promotes CCL8 secretion.",-31.375,0.8,geneorgeneproduct
"Silence of VEGFR2 in A549 cells diminishes EGFR‑mediated proliferation by impairing JNK‑dependent phosphorylation of the CCL8‑responsive G protein‑coupled receptor, thereby attenuating downstream angiotensin‑I‑converting‑enzyme signaling.",-41.25,0.8,geneorgeneproduct
Downregulation of EGFR and JNK-dependent VEGFR2 phosphorylation in A549 cells by the small‑molecule inhibitor CBR3 reduces CCL8 secretion and consequently attenuates angiotensin I-converting enzyme expression in the tumor microenvironment.,-36.75,0.8,geneorgeneproduct
"Down-regulation of EGFR by JNK-dependent phosphorylation of regulator of G‑protein signaling‑4 in A549 cells reduces VEGFR2‑mediated angiogenic signaling, thereby suppressing CCL8 secretion and angiotensin I‑converting enzyme expression.",-39.75,0.8,geneorgeneproduct
"Downregulated expression of VEGFR2 in HeLa cells treated with the EGFR inhibitor erlotinib was accompanied by increased JNK-dependent phosphorylation of CCL8, suggesting a regulatory network involving the angiotensin I-converting enzyme and G protein-coupled receptor signaling.",-35.0,0.8,geneorgeneproduct
"Downstream activation of VEGFR2 by EGFR-mediated phosphorylation induces JNK‑dependent up‑regulation of CCL8, a process attenuated by the regulator of G‑protein signaling‑4 complex in A549 cells.",-38.0,0.8,geneorgeneproduct
"The downregulation of the glutamate N‑methyl‑D‑aspartate (NMDA) receptor subunit GRIN2B in PHEX‑deficient osteoblasts leads to impaired bone mineralization and promotes the up‑regulation of the actin‑binding protein CTTN, thereby contributing to the skeletal phenotype observed in X‑linked hypophosphatemic rickets.",-34.5,0.8,geneorgeneproduct
"The study showed that overexpression of the PHEX gene product in HeLa cells increased the phosphorylation of the retinoic acid receptor, thereby enhancing the transcription of the EPO-induced CCL4 gene.",-28.875,0.8,geneorgeneproduct
"The PHEX mutation c.1402G>A was found to disrupt retinoic acid receptor signaling in a cohort of patients with X‑linked hypophosphatemia, leading to elevated serum phosphate and increased expression of the glutamate N‑methyl‑D‑aspartate (NMDA) receptor subunit NR1 in bone‑derived osteoblasts.",-44.0,0.8,geneorgeneproduct
"The retinoic acid receptor alpha variant c.1234C>T in a patient with Bardet‑Biedl syndrome (BBS) was found to up‑regulate PHEX transcription, thereby reducing phosphate excretion and contributing to the observed renal calcinosis.",-39.5,0.8,geneorgeneproduct
"In PC12 cells, retinoic acid receptor activation upregulates the expression of the glutamate N‑methyl‑D‑aspartate (NMDA) receptor subunit NR2B, thereby enhancing calcium influx and potentiating the phosphorylation of DUSP1, which subsequently attenuates MAPK signaling and promotes neuronal differentiation.",-30.125,0.8,geneorgeneproduct
"In neuroblastoma cells, PHEX overexpression reduces glutamate N‑methyl‑D‑aspartate (NMDA) receptor phosphorylation, thereby attenuating retinoic acid receptor‑mediated differentiation signals.",-21.5,0.8,geneorgeneproduct
"In HeLa cells, EPO-induced upregulation of the retinoic acid receptor downregulates laminin alpha-2 expression, thereby disrupting the actin-binding protein network and reducing cell adhesion.",-27.5,0.8,geneorgeneproduct
"In CHO cells, overexpression of the PHEX gene product decreases intracellular phosphate, thereby upregulating the retinoic acid receptor and enhancing glutamate N‑methyl‑D‑aspartate (NMDA) receptor activity, which ultimately alters laminin alpha‑2–mediated cell adhesion.",-38.5,0.8,geneorgeneproduct
"PHEX mutations disrupt the regulation of bone mineralization, while retinoic acid receptor activation of the NMDA receptor pathway in neuronal cultures increases CCL4 secretion, suggesting a potential link between bone‑related gene products and neuroinflammatory signaling in schizophrenia.",-44.25,0.8,geneorgeneproduct
"P53‑mediated transcriptional upregulation of the EPO‑induced gene dusp1 in HeLa cells treated with retinoic acid receptor agonist reduces NMDA‑receptor‑mediated calcium influx, thereby attenuating the apoptotic phenotype observed in Bardet‑Biedl syndrome‑1‑deficient fibroblasts.",-52.75,0.8,geneorgeneproduct
"PBRM1 mutations in a renal carcinoma cell line derived from a patient with von Hippel‑Lindau disease lead to aberrant binding of the retinoic acid receptor to the EPAS1 promoter, resulting in increased hypoxia‑inducible factor‑2α expression and accelerated tumor growth.",-57.25,0.8,geneorgeneproduct
"PHEXT, a member of the phosphatase gene family, phosphorylates the retinoic acid receptor β1 in HeLa cells, thereby enhancing the expression of glutamate N‑methyl‑D‑aspartate receptor subunit NR1 and reducing laminin alpha‑2 deposition, a mechanism that may contribute to the actin‑binding protein dysfunction observed in Bardet‑Biedl syndrome.",-61.25,0.8,geneorgeneproduct
"Deletion of the PHEX promoter creates a loss‑of‑function allele that disrupts the interaction between PHEX protein and the retinoic acid receptor, thereby reducing expression of the NMDA receptor subunit GRIN1 in cortical neurons and contributing to the cognitive deficits observed in Bardet‑Biedl syndrome patients.",-44.0,0.8,geneorgeneproduct
"Deletion in the PHEX gene disrupts the interaction between the retinoic acid receptor and the laminin alpha‑2 promoter, thereby reducing EPO‑induced expression of the actin‑binding protein and attenuating NMDA‑receptor‑mediated synaptic plasticity in a murine model of Bardet‑Biedl syndrome.",-39.5,0.8,geneorgeneproduct
"Deletion or mutation of the PHEX gene reduces phosphate homeostasis, thereby enhancing retinoic acid receptor signaling that modulates NMDA receptor trafficking and is linked to altered laminin‑alpha‑2 expression in cortical neurons.",-54.25,0.8,geneorgeneproduct
"Deletion upstream of the PHEX promoter in a patient with X‑linked hypophosphatemia results in reduced expression of the phosphate transporter and increased circulating fibroblast growth factor‑23, thereby aggravating the hypophosphatemic phenotype.",-47.25,0.8,geneorgeneproduct
"A mutation in the PHEX gene that disrupts its binding to the retinoic acid receptor leads to increased expression of the NMDA receptor subunit and subsequent neuronal hyperexcitability, contributing to the severe cognitive deficits observed in Bardet‑Biedl syndrome.",-34.25,0.8,geneorgeneproduct
"A genetic variant in the PHEX gene that reduces its expression leads to hyperphosphatemia in X‑linked hypophosphatemic rickets, which in turn enhances activation of the retinoic acid receptor, thereby increasing the transcription of the glutamate N‑methyl‑D‑aspartate (NMDA) receptor subunits in cortical neurons.",-42.25,0.8,geneorgeneproduct
"A PHEX mutation in Bardet‑Biedl syndrome patients leads to decreased activation of retinoic acid receptor signaling, which in turn down‑regulates glutamate N‑methyl‑D‑aspartate (NMDA) receptor expression and reduces laminin alpha‑2 deposition in the retina, thereby contributing to the visual deficits observed in this disorder.",-41.5,0.8,geneorgeneproduct
"A CRISPR/Cas9‑mediated knockout of PHEX in human kidney cell lines led to up‑regulation of the retinoic acid receptor alpha and increased secretion of CCL4, suggesting a novel regulatory loop that may contribute to the renal bone disease observed in X‑linked hypophosphatemia.",-45.75,0.8,geneorgeneproduct
"DUSP1 phosphorylation of the retinoic acid receptor in HeLa cells enhances NMDA‑receptor‑mediated calcium influx, thereby promoting apoptosis in response to EPO‑induced oxidative stress.",-21.375,0.8,geneorgeneproduct
"Dyskinesia in patients with PHEX mutations is alleviated by retinoic acid receptor agonists, which reduce glutamate N‑methyl‑D‑aspartate receptor activation and normalize laminin alpha‑2 expression in the affected kidney.",-47.75,0.8,geneorgeneproduct
"DUSP1 phosphorylation by retinoic acid receptor signaling in HeLa cells reduces NMDA receptor subunit NR2B expression, thereby attenuating glutamate‑mediated excitotoxicity.",-24.625,0.8,geneorgeneproduct
"Dysregulation of the retinoic acid receptor by the PHEX‑mediated degradation of the laminin alpha‑2 fragment alters NMDA receptor trafficking, thereby contributing to the synaptic deficits observed in schizophrenia‑1.",-40.75,0.8,geneorgeneproduct
"Loss of the X‑linked PHEX gene in a patient with X‑linked hypophosphatemia leads to up‑regulation of the type IIa collagenase MMP-2, thereby enhancing laminin alpha‑2 degradation and compromising renal phosphate reabsorption.",-43.0,0.8,geneorgeneproduct
"Loss-of-function mutations in PHEX disrupt phosphate regulation in bone, leading to hypophosphatemic rickets and increased expression of the retinoic acid receptor, which in turn upregulates the glutamate N‑methyl‑D‑aspartate (NMDA) receptor subunits and the actin‑binding protein laminin alpha‑2, thereby exacerbating neuronal dysfunction in patients with Bardet‑Biedl syndrome.",-47.75,0.8,geneorgeneproduct
"Loss‑of‑function mutations in **PHEX** lead to ectopic deposition of bone matrix in renal tissue, which in turn upregulates the expression of the **glutamate N‑methyl‑D‑aspartate (NMDA) receptor** and the **retinoic acid receptor** in adjacent tubular epithelial cells, a finding that suggests a potential link between phosphate metabolism and neuronal‑like signaling pathways in the kidney.",-63.25,0.8,geneorgeneproduct
"Loss‐of‑function mutations in PHEX impair phosphatase activity, leading to ectopic calcium deposition that disrupts the activity of the retinoic acid receptor in osteoblasts and ultimately increases the risk of renal stone formation in patients with X‑linked hypophosphatemia.",-48.5,0.8,geneorgeneproduct
"Mutations in the PHEX gene alter phosphate transport in bone, leading to ectopic mineralization that upregulates expression of the retinoic acid receptor and subsequently enhances NMDA receptor signaling in cortical neurons.",-32.5,0.8,geneorgeneproduct
"Mutual inhibition of PHEX transcription by retinoic acid receptor activation and glutamate N‑methyl‑D‑aspartate receptor signaling in HeLa cells leads to increased intracellular calcium, which further down‑regulates laminin alpha‑2 expression and drives a cascade that elevates dusp1 phosphorylation, ultimately contributing to the epithelial‑to‑mesenchymal transition characteristic of metastatic colorectal carcinoma.",-71.5,0.8,geneorgeneproduct
"Mutational analysis of the PHEX gene in a cohort of patients with X‑linked hypophosphatemia revealed a recurrent c.1224_1226delGAG variant that abolishes the glutamate‑N‑methyl‑D‑aspartate (NMDA) receptor‑binding domain of the encoded protein, thereby impairing its role in bone mineralization and leading to early‑onset osteomalacia.",-47.5,0.8,geneorgeneproduct
"Mutant PHEX protein lacking the C‑terminal domain was shown to disrupt the interaction between the retinoic acid receptor and the laminin alpha‑2 promoter, thereby reducing EPO‑induced erythropoietin expression in cultured HeLa cells.",-35.75,0.8,geneorgeneproduct
"Altered expression of the glutamate N‑methyl‑D‑aspartate (NMDA) receptor subunit GRIN2B, induced by EPO‑mediated phosphorylation of the transcription factor DUSP1, is associated with synaptic dysfunction observed in schizophrenia patients carrying a PHEX loss‑of‑function variant.",-42.75,0.8,geneorgeneproduct
"Alterations in the PHEX gene product impair phosphatase activity, reducing bone mineralization and triggering up‑regulation of the retinoic acid receptor in osteoblasts, thereby exacerbating osteopenia in patients with X‑linked hypophosphatemia.",-33.25,0.8,geneorgeneproduct
"Alteration of the PHEX gene product by a c.1156C>T sequence variant disrupts its interaction with the retinoic acid receptor, thereby reducing bone mineralization in patients with X‑linked hypophosphatemia.",-27.125,0.8,geneorgeneproduct
"Alterly, the up‑regulation of the glutamate N‑methyl‑D‑aspartate (NMDA) receptor by retinoic acid receptor agonists in neuronal cultures derived from human iPSC‑derived cortical neurons carrying a PHEX loss‑of‑function variant leads to increased intracellular calcium influx and subsequent activation of the dual‑specificity phosphatase dUSP1, thereby attenuating the pro‑inflammatory cytokine CCL4 secretion and improving neurite outgrowth in vitro.",-77.5,0.8,geneorgeneproduct
"Disruption of the PHEX gene product in bone‑derived cell lines treated with retinoic acid receptor agonists upregulates NMDA receptor subunits and reduces laminin alpha‑2 expression, thereby impairing osteoblast adhesion and contributing to the bone‑density phenotype observed in Bardet‑Biedl syndrome‑associated kidney dysfunction.",-48.0,0.8,geneorgeneproduct
"Disruptive missense variants in the PHEX gene, which encodes a phosphaturic endopeptidase that modulates phosphate homeostasis, were found to upregulate the expression of the glutamate N‑methyl‑D‑aspartate (NMDA) receptor subunit NR2B in cultured cortical neurons, thereby enhancing excitotoxic signaling in a model of neurodegeneration.",-47.0,0.8,geneorgeneproduct
"Disrupted expression of the retinoic acid receptor in HeLa cells treated with EPO‑induced differentiation media leads to altered transcription of the PHEX gene, a finding that may help explain the abnormal bone mineralization observed in Bardet‑Biedl syndrome patients.",-45.0,0.8,geneorgeneproduct
"Disabling a loss‑of‑function mutation in the PHEX gene causes ectopic bone formation in osteoblasts, which is mitigated by retinoic acid receptor agonists that down‑regulate the transcription of the downstream gene dusp1 and restore normal mineralization.",-54.25,0.8,geneorgeneproduct
"Mutation in the PHEX gene that truncates its C‑terminal domain disrupts the normal trafficking of the retinoic acid receptor to the nucleus, thereby reducing transcription of the glutamate N‑methyl‑D‑aspartate (NMDA) receptor subunit and contributing to the synaptic deficits observed in schizophrenia‑1 patients.",-34.25,0.8,geneorgeneproduct
"Mutation of the PHEX gene in the X‑linked hypophosphatemic osteomalacia patient disrupted the binding of retinoic acid receptor β, leading to reduced transcription of the glutamate N‑methyl‑D‑aspartate (NMDA) receptor subunit GluN1 and consequently impaired synaptic plasticity in cortical neurons.",-40.0,0.8,geneorgeneproduct
"Mutation EPO-induced activation of the retinoic acid receptor in PHEX‑expressing HeLa cells upregulates the NMDA receptor subunit NR2B and increases CCL4 secretion, thereby enhancing laminin alpha‑2 deposition and actin‑binding protein remodeling in the tumor microenvironment.",-44.25,0.8,geneorgeneproduct
"Mutation‑induced down‑regulation of the glutamate N‑methyl‑D‑aspartate (NMDA) receptor in HeLa cells leads to altered calcium signaling, a phenomenon that may contribute to EPO‑induced neuronal differentiation via PHEX‑mediated modulation of laminin alpha‑2 assembly.",-48.0,0.8,geneorgeneproduct
"GluN2B, the subunit of the glutamate N‑methyl‑D‑aspartate receptor, is up‑regulated by retinoic acid receptor β activation in neuronal cultures derived from human induced pluripotent stem cell‑derived cortical organoids, and this up‑regulation is attenuated by the actin‑binding protein α‑actinin‑1, thereby modulating NMDA‑mediated synaptic plasticity.",-59.75,0.8,geneorgeneproduct
"GFP‑tagged laminin alpha‑2, when overexpressed in the A549 cell line, activates the retinoic acid receptor‑mediated transcription of the PHEX gene, thereby increasing EPO‑induced erythropoiesis in vitro.",-35.0,0.8,geneorgeneproduct
"Glycine at position Arg90 of the PHEX protein is substituted by a cysteine (PHEX p.Arg90Cys), disrupting its interaction with the retinoic acid receptor and thereby impairing osteoclast differentiation in a subset of patients with X‑linked hypophosphatemia.",-57.5,0.8,geneorgeneproduct
"GADD45B overexpression in the A549 cell line was found to attenuate NMDA‑receptor–mediated excitotoxicity by up‑regulating the phosphatase DUSP1, thereby reducing apoptosis in a model of neurodegenerative stress.",-43.5,0.8,geneorgeneproduct
"Retinoic acid receptor activation in HeLa cells upregulates the glutamate N‑methyl‑D‑aspartate (NMDA) receptor subunit NR2B, thereby enhancing intracellular calcium influx and promoting laminin alpha‑2‑mediated cell adhesion.",-28.375,0.8,geneorgeneproduct
"Retinal dysfunction in Bardet‑Biedl syndrome patients is linked to decreased expression of the retinoic acid receptor‑α in retinal pigmented epithelial cells, suggesting that impaired PHEX‑mediated regulation of glutamate N‑methyl‑D‑aspartate receptor subunits may alter NMDA‑dependent signaling and contribute to the retinal phenotypic features.",-72.5,0.8,geneorgeneproduct
"Retinoblastoma protein phosphorylates the retinoic acid receptor in a PHEX‑dependent manner, thereby modulating glutamate N‑methyl‑D‑aspartate receptor signaling in neurons derived from the human cell line SH‑SY5Y.",-40.5,0.8,geneorgeneproduct
Retrospective analysis of PHEX expression in renal cell carcinoma demonstrated that up‑regulation of the gene product enhances EPO‑induced erythropoietic signaling and correlates with reduced patient survival.,-45.75,0.8,geneorgeneproduct
"Overexpression of the gene‑product DUSP1 in A549 cells treated with retinoic acid receptor agonist ATRA enhances glutamate N‑methyl‑D‑aspartate (NMDA) receptor phosphorylation, thereby increasing cellular resistance to EPO‑induced apoptosis.",-30.125,0.8,geneorgeneproduct
"Overactivation of the retinoic acid receptor in HeLa cells carrying the PHEX mutation leads to increased expression of the glutamate N‑methyl‑D‑aspartate (NMDA) receptor subunit and concomitant upregulation of the actin‑binding protein dystrophin, thereby enhancing cellular susceptibility to excitotoxic damage.",-38.5,0.8,geneorgeneproduct
"Overexpressed PHEX in HeLa cells upregulates retinoic acid receptor signaling, which in turn enhances NMDA receptor trafficking to the synaptic membrane and increases laminin alpha‑2 secretion, thereby promoting actin cytoskeleton remodeling and facilitating EPO‑induced erythropoiesis.",-41.75,0.8,geneorgeneproduct
"Over a decade of CRISPR‑Cas9 editing in HeLa cells revealed that disruption of the PHEX gene enhances retinoic‑acid‑receptor‑α‑mediated transcription, thereby increasing glutamate N‑methyl‑D‑aspartate‑receptor subunit expression and accelerating laminin‑alpha‑2 deposition, a mechanism that may underlie EPO‑induced neuroprotection observed in neuronal‑cell‑line models.",-77.5,0.8,geneorgeneproduct
"DMC1 deficiency in Homo sapiens fibroblasts leads to impaired homologous recombination, elevating γ‑H2AX foci and reducing cell survival after ionizing radiation.",-20.5,0.8,geneorgeneproduct
"DMD‑associated exon skipping induced by antisense oligonucleotide therapy upregulates DMC1 expression in patient‑derived myoblasts, thereby enhancing homologous recombination and potentially ameliorating muscle fiber integrity in Duchenne muscular dystrophy.",-47.75,0.8,geneorgeneproduct
"D‑Methyl‑cysteine‑induced overexpression of the DNA repair gene DMC1 in HepG2 cells upregulated the p62/SQSTM1‑mediated autophagic flux and sensitized the cells to the calcineurin inhibitor FK506, thereby enhancing apoptotic death in this hepatocellular carcinoma model.",-57.0,0.8,geneorgeneproduct
"DGC1 deficiency in A549 cells leads to up‑regulation of calcineurin signaling, which in turn enhances N‑methyl‑D‑aspartate receptor‑1‑mediated Ca²⁺ influx and promotes intercellular adhesion molecule‑1 expression, thereby facilitating metastatic invasion.",-47.75,0.8,geneorgeneproduct
"The activation of N‑methyl‑D‑aspartate receptor subunit NR1 by glutamate in hippocampal neurons triggers calcineurin‑dependent dephosphorylation of the transcription factor CREB, thereby enhancing the expression of the pro‑apoptotic gene P53 and ultimately increasing lactate dehydrogenase release during ischemic injury.",-39.25,0.8,geneorgeneproduct
"The DMC1 knockout in Hela cells causes impaired homologous recombination and elevated lactate dehydrogenase release, suggesting a metabolic shift that could be rescued by calcineurin inhibition.",-31.5,0.8,geneorgeneproduct
"The loss-of-function variant c.1127G>A in the FGFR4 gene product reduces receptor phosphorylation, thereby attenuating downstream calcineurin signaling and contributing to impaired muscle differentiation in patients with hereditary myopathy.",-35.25,0.8,geneorgeneproduct
"The overexpression of DMC1 in the HeLa cell line, which also harbors a pathogenic RNASEL c.1023_1024delTT variant, was shown to increase the sensitivity of these cells to the calcineurin inhibitor cyclosporine A, thereby reducing cell proliferation and inducing apoptosis.",-48.5,0.8,geneorgeneproduct
"In H1299 cells, knockdown of DMC1 upregulates intercellular adhesion molecule‑1 expression, which in turn enhances calcineurin‑dependent NF‑κB signaling and promotes resistance to doxorubicin‑induced apoptosis.",-26.25,0.8,geneorgeneproduct
"In HeLa cells, knockdown of the DNA‑repair gene DMC1 results in increased accumulation of the autophagy adaptor p62/SQSTM1 and elevated lactate dehydrogenase release, indicating enhanced cell death.",-29.125,0.8,geneorgeneproduct
"In human fibroblasts, a missense variant of RNASEL (c.1225G>A) increases the phosphorylation of calcineurin, thereby enhancing the expression of intercellular adhesion molecule‑1 and promoting fibroblast migration toward the N‑methyl‑D‑aspartate receptor‑1‑mediated calcium influx.",-46.5,0.8,geneorgeneproduct
"In mammalian cells, the DMC1 gene product cooperates with calcineurin to dephosphorylate the N‑methyl‑D‑aspartate receptor subunit NR1, thereby modulating synaptic plasticity in the hippocampus of Homo sapiens.",-30.5,0.8,geneorgeneproduct
"Mutations in the DMC1 gene were shown to impair homologous recombination, leading to infertility in a cohort of male patients from Homo sapiens who also exhibited elevated lactate dehydrogenase levels.",-29.25,0.8,geneorgeneproduct
"Mutated DMC1, a recombination factor, disrupts intercellular adhesion molecule‑1 expression in HeLa cells, thereby enhancing lactate dehydrogenase release and promoting calcineurin‑mediated apoptosis.",-33.5,0.8,geneorgeneproduct
"Mutational loss of DMC1 in HeLa cells enhances calcineurin‑mediated dephosphorylation of the N‑methyl‑D‑aspartate receptor‑1 subunit, thereby increasing intracellular calcium influx and elevating lactate dehydrogenase release as a marker of cell stress.",-33.0,0.8,geneorgeneproduct
"Mutagenic exposure to N‑methyl‑D‑aspartate receptor‑1 agonists in cultured A549 cells upregulates DMC1 and downregulates lactate dehydrogenase, thereby inducing DNA repair pathways that protect against apoptosis.",-42.0,0.8,geneorgeneproduct
"Alterations in the DMC1 gene product disrupt homologous recombination, while overexpression of calcineurin in HeLa cells amplifies NFAT signaling, together leading to increased proliferation and resistance to apoptosis in the context of FGFR4-mediated oncogenic pathways.",-41.0,0.8,geneorgeneproduct
"Altered DMC1 expression in the HeLa cell line, driven by calcineurin-mediated dephosphorylation, enhances homologous recombination fidelity and reduces the incidence of BRCA1 c.68_69delAG–associated genomic instability.",-25.875,0.8,geneorgeneproduct
"Alteration of the DMC1 gene product by a BRCA1 c.68_69delAG variant increases homologous recombination errors in HeLa cells, leading to elevated lactate dehydrogenase release and enhanced tumor‑cell invasion mediated through intercellular adhesion molecule‑1 up‑regulation.",-38.25,0.8,geneorgeneproduct
"Altering the phosphorylation status of calcineurin in HeLa cells with a selective inhibitor downregulates the expression of intercellular adhesion molecule‑1, thereby reducing the adhesion of TNF‑α‑stimulated A549 cells and compromising the inflammatory response mediated by the N‑methyl‑D‑aspartate receptor‑1 complex.",-53.25,0.8,geneorgeneproduct
"Loss of the DMC1 gene product impairs meiotic homologous recombination, thereby elevating the risk of aneuploidy in human oocytes and contributing to reproductive failure.",-28.5,0.8,geneorgeneproduct
"Loss-of-function mutations in the DMC1 gene disrupt homologous recombination in germ cells, thereby increasing infertility risk in Homo sapiens individuals carrying the c.657_659delTTC variant.",-35.0,0.8,geneorgeneproduct
"Loss‑of‑function mutations in the DNA‑repair gene DMC1, which co‑operate with the phosphatase calcineurin, were found to increase susceptibility to auto‑immune diseases in a cohort of E. coli‑infected patients who exhibited elevated levels of intercellular adhesion molecule‑1 and lactate dehydrogenase.",-53.75,0.8,geneorgeneproduct
"Loss‐of‐function mutations in DMC1 disrupt homologous recombination and lead to increased meiotic nondisjunction, thereby elevating the risk of infertility and aneuploidy in human gametes.",-34.5,0.8,geneorgeneproduct
"Decreased DMC1 expression in HeLa cells treated with the calcineurin inhibitor FK506 was correlated with increased intercellular adhesion molecule‑1 and lactate dehydrogenase release, suggesting a role for DMC1 in maintaining epithelial integrity under immunosuppressive conditions.",-35.0,0.8,geneorgeneproduct
"Depletion of DMC1 in human germline cells downregulates the expression of the N‑methyl‑D‑aspartate receptor subunit NR1, leading to impaired meiotic recombination and an increased risk of infertility.",-36.5,0.8,geneorgeneproduct
"Degradation of p62/SQSTM1 by calcineurin in HeLa cells leads to increased expression of intercellular adhesion molecule‑1, thereby enhancing the adhesion of TNBC cells to the endothelium of Homo sapiens vascular tissue.",-37.25,0.8,geneorgeneproduct
"Deletion of the DMC1 sequence variant c.421_422delAG in a Homo sapiens patient resulted in impaired meiotic recombination, leading to increased intercellular adhesion molecule‑1 expression and a higher risk of infertility.",-40.75,0.8,geneorgeneproduct
"Mutation of the DMC1 gene in A549 cells reduces homologous recombination and enhances sensitivity to doxorubicin, a chemotherapeutic chemical entity that activates calcineurin signaling and upregulates lactate dehydrogenase expression.",-30.875,0.8,geneorgeneproduct
"Mutation‑induced loss of function of the DMC1 gene product in a Homo sapiens patient led to impaired meiotic recombination, while elevated serum lactate dehydrogenase and intercellular adhesion molecule‑1 levels suggested a secondary inflammatory response.",-35.5,0.8,geneorgeneproduct
"Mutation in the RNASEL gene amplifies the pathogenic effect of calcineurin inhibition on intercellular adhesion molecule‑1 expression in A549 cells, thereby exacerbating the inflammatory phenotype observed in patients with chronic obstructive pulmonary disease.",-36.0,0.8,geneorgeneproduct
"Mutation c.135G>A in the DMC1 gene increases susceptibility to premature ovarian failure in women of European descent, whereas calcineurin inhibition by cyclosporine A reduces intercellular adhesion molecule‑1 expression in endothelial cells derived from the A549 cell line, thereby attenuating inflammatory signaling.",-54.75,0.8,geneorgeneproduct
"Deficiency of DMC1 in human spermatocytes leads to impaired homologous recombination and increased chromosomal fragmentation, whereas up‑regulation of the N‑methyl‑D‑aspartate receptor subunit NR1 in cortical neurons enhances excitotoxic signaling and reduces the protective phosphorylation of calcineurin.",-52.0,0.8,geneorgeneproduct
"Defects in the DMC1 gene product reduce homologous recombination during meiosis, thereby increasing the risk of chromosomal nondisjunction and contributing to female infertility.",-27.125,0.8,geneorgeneproduct
"Defective DMC1 expression in HeLa cells treated with the calcineurin inhibitor cyclosporine A leads to reduced homologous recombination and increased genomic instability, as evidenced by elevated lactate dehydrogenase release and accumulation of p62/SQSTM1 aggregates.",-27.75,0.8,geneorgeneproduct
"Deficient DMC1 expression in HeLa cells increases lactate dehydrogenase release, suggesting impaired DNA repair leads to heightened metabolic stress.",-27.375,0.8,geneorgeneproduct
"A loss‑of‑function mutation in RNASEL, a DNA‑damage response gene, was shown to enhance susceptibility to familial lymphoma in a cohort of Homo sapiens patients carrying the p.R462Q sequence variant while concurrently upregulating lactate dehydrogenase levels in HeLa cells treated with the calcineurin inhibitor FK506.",-51.0,0.8,geneorgeneproduct
"A mutation in the DMC1 gene, which encodes a meiosis‑specific recombinase, reduces interaction with calcineurin and diminishes phosphorylation of N‑methyl‑D‑aspartate receptor‑1, thereby impairing synaptic plasticity in hippocampal neurons.",-40.25,0.8,geneorgeneproduct
"A mutational screen of the RNASEL gene in a cohort of African‑American prostate cancer patients revealed a novel c.1163C>G variant that predicted a loss of function, which in turn was associated with increased serum lactate dehydrogenase levels and a higher risk of metastasis.",-53.5,0.8,geneorgeneproduct
"A knock‑in of the FGFR4 p.Gly388Arg variant in C57BL/6J mice led to up‑regulated lactate dehydrogenase activity and heightened calcineurin‑mediated dephosphorylation of the N‑methyl‑D‑aspartate receptor subunit NR1, thereby amplifying synaptic plasticity deficits observed in the hippocampal CA1 region.",-43.25,0.8,geneorgeneproduct
"Overexpression of DMC1 in the A549 cell line amplifies homologous recombination and reduces the mutagenic impact of the RNASEL p.R462Q variant, thereby enhancing genomic stability in human cells.",-41.0,0.8,geneorgeneproduct
"Overactivation of the N-methyl‑D‑aspartate receptor‑1 (NR1) subunit by excess glutamate in the hippocampus of a mouse model carrying the RNASEL c.1193A>G variant causes calcium influx that triggers calcineurin‑dependent dephosphorylation of p62/SQSTM1, thereby impairing autophagic clearance and leading to selective neuronal loss associated with behavioral deficits resembling Alzheimer’s disease.",-72.5,0.8,geneorgeneproduct
"Overexpressed DMC1 in human HeLa cells activates calcineurin‑dependent signaling, which in turn enhances expression of the N‑methyl‑D‑aspartate receptor subunit NR1 and increases lactate dehydrogenase secretion, illustrating a cascade that links DNA repair, calcium signaling, and metabolic reprogramming in cancer cells.",-51.0,0.8,geneorgeneproduct
"Overactivity of calcineurin in human T‑cells downregulates the expression of intercellular adhesion molecule‑1, thereby impairing immune surveillance against tumor cells such as the A549 lung adenocarcinoma line.",-40.75,0.8,geneorgeneproduct
Deletion of the DMC1 gene variant c.728A>G in a Homo sapiens patient was found to impair homologous recombination repair and correlate with increased susceptibility to Fanconi anemia.,-34.0,0.8,geneorgeneproduct
"Deletion in DMC1 disrupts homologous recombination, causing infertility in a homozygous human family carrying the c.1203_1204delTA variant, while overexpression of the same gene in HeLa cells restores normal meiotic progression.",-57.0,0.8,geneorgeneproduct
"Deletion within the DMC1 promoter reduces its transcription, causing impaired homologous recombination in germ cells and increasing susceptibility to infertility in Homo sapiens.",-32.25,0.8,geneorgeneproduct
"Deletion c.256_258delTTC in the RNASEL gene in a patient with hereditary breast‑and‑ovarian cancer syndrome led to a truncated protein that lost its catalytic activity, resulting in elevated lactate dehydrogenase levels and increased tumor cell proliferation.",-57.5,0.8,geneorgeneproduct
"T1‑cell‑derived H1299 cells treated with the calcineurin inhibitor cyclosporine A exhibited a significant up‑regulation of the N‑methyl‑D‑aspartate receptor subunit NR1, accompanied by increased intracellular calcium influx and enhanced lactate dehydrogenase release, indicating mitochondrial dysfunction in a model of neuro‑oncological cell stress.",-60.5,0.8,geneorgeneproduct
"T-lymphocyte proliferation in patients with the RNASEL c.1221A>G sequence variant is attenuated by calcineurin inhibition, suggesting that calcineurin signaling modulates RNASEL-mediated apoptosis and could be targeted to restore immune surveillance.",-57.75,0.8,geneorgeneproduct
"Toxicity of the chemotherapeutic drug doxorubicin in HeLa cells is mitigated by overexpression of the antioxidant enzyme Paraoxonase‑1, which reduces lactate dehydrogenase release and preserves intercellular adhesion molecule‑1 expression, thereby attenuating apoptosis induced by the N‑methyl‑D‑aspartate receptor‑1 pathway.",-41.25,0.8,geneorgeneproduct
"T2DM‑induced hyperglycaemia upregulates calcineurin, which in turn activates NFAT signalling and enhances expression of intercellular adhesion molecule‑1 in human umbilical vein endothelial cells, thereby promoting leukocyte adhesion and atherosclerosis.",-40.75,0.8,geneorgeneproduct
"Interaction of the DMC1 gene with calcineurin signaling in human spermatocytes upregulates intercellular adhesion molecule‑1 expression, thereby enhancing the DNA repair capacity and reducing infertility risk.",-36.75,0.8,geneorgeneproduct
"Interaction between DMC1 and calcineurin is enhanced in HeLa cells, and this synergistic signaling up‑regulates lactate dehydrogenase expression while simultaneously suppressing intercellular adhesion molecule‑1 and activating the N‑methyl‑D‑aspartate receptor‑1 pathway.",-46.75,0.8,geneorgeneproduct
"Interaction studies revealed that the FGFR4 polymorphism rs351855, together with up‑regulated N‑methyl‑D‑aspartate receptor subunit NR1 expression, enhances lactate dehydrogenase‑induced glycolytic flux in the human hepatoma cell line HepG2, thereby promoting chemoresistance to doxorubicin.",-63.75,0.8,geneorgeneproduct
"Interaction assays revealed that the DMC1 protein in H. sapiens HeLa cells binds the N‑methyl‑D‑aspartate receptor‑1 subunit and that calcineurin dephosphorylates p62/SQSTM1, thereby enhancing autophagic clearance of amyloid‑β aggregates.",-47.5,0.8,geneorgeneproduct
"The loss‑of‑function variant c.1526C>T in the calcium‑sensing receptor (CaSR) gene enhances AR‑mediated transcriptional activity in HeLa cells, thereby increasing IL‑12p70 secretion through a wnt‑signaling–dependent pathway.",-36.0,0.8,geneorgeneproduct
"The knock‑down of the calcium‑sensing receptor in C2C12 myoblasts attenuated Bmp7‑induced phosphorylation of ERK1/2, thereby reducing cyclin‑dependent kinase‑mediated S‑phase entry and compromising skeletal‑muscle‑calcium‑channel‑alpha‑subunit expression.",-32.75,0.8,geneorgeneproduct
"The Ca²⁺-sensing receptor gene (CASR) mutation in IFNAR1‑deficient mice exacerbates Bmp7‑induced skeletal muscle calcium channel alpha‑subunit dysregulation, thereby potentiating cyclin‑dependent kinase‑mediated myogenic differentiation defects.",-35.0,0.8,geneorgeneproduct
"The calcium sensing receptor interacts with the AR‑mediated IL‑12p70 production, revealing that a cyclin‑dependent kinase‑dependent phosphorylation of the skeletal muscle calcium channel alpha‑subunit enhances wnt‑signaling in IFNAR1‑deficient cells, an effect partially mitigated by ERCC5‑driven O‑GlcNAcase activity.",-46.25,0.8,geneorgeneproduct
"Activation of the calcium‑sensing receptor in IFNAR1‑deficient macrophages upregulates cyclin‑dependent kinase expression, thereby enhancing IL‑12p70 production downstream of wnt‑signaling.",-19.625,0.8,geneorgeneproduct
"Activation or loss of the calcium‑sensing receptor in IFNAR1‑deficient mice modulates IL‑12p70 production by skeletal muscle calcium channel alpha‑subunit‑expressing cells, thereby influencing wnt‑signaling‑dependent muscle regeneration.",-40.0,0.8,geneorgeneproduct
"Activation by IL‑12p70 of the calcium‑sensing receptor on IFNAR1‑deficient dendritic cells enhances cyclin‑dependent kinase‑mediated phosphorylation of ERCC5, thereby promoting DNA repair and attenuating wnt‑signaling‑driven tumorigenesis in A549 cells.",-36.0,0.8,geneorgeneproduct
"Activation status of the calcium‑sensing receptor in skeletal muscle calcium channel α‑subunit‑expressing C2C12 cells is markedly increased by IL‑12p70 stimulation, leading to enhanced phosphorylation of cyclin‑dependent kinase and downstream wnt‑signaling pathway activation.",-46.5,0.8,geneorgeneproduct
"Loss of the calcium‑sensing receptor (CASR) allele in IFNAR1‑deficient murine fibroblasts abolishes Bmp7‑induced phosphorylation of the cyclin‑dependent kinase CDK1, thereby impairing skeletal‑muscle calcium channel alpha‑subunit expression and disrupting wnt‑signaling‑mediated myogenic differentiation.",-37.0,0.8,geneorgeneproduct
"Loss‑of‑function mutations in ERCC5 impair nucleotide excision repair, leading to increased UV‑induced apoptosis in AR‑positive melanoma cells and reduced IL‑12p70 secretion by dendritic cells, thereby compromising the antitumor immune response.",-37.25,0.8,geneorgeneproduct
"Loss-of-function mutations in the gene encoding the calcium‑sensing receptor (CaSR) were shown to reduce ERK1/2 activation downstream of Bmp7 signaling and thereby impair skeletal muscle calcium channel alpha‑subunit expression, an effect that was rescued by pharmacologic activation of the wnt‑signaling pathway in CaSR‑deficient mice.",-45.0,0.8,geneorgeneproduct
"Loss‐of‑function mutations in the calcium‑sensing receptor gene (CASR) have been shown to cause autosomal dominant hypocalcemia, with patients exhibiting hypocalcemia, hypercalciuria, and hypoparathyroidism due to altered calcium‑dependent signaling pathways that impair parathyroid hormone secretion.",-51.25,0.8,geneorgeneproduct
"In IFNAR1‑deficient A549 cells, overexpression of the calcium‑sensing receptor and the cyclin‑dependent kinase CDK4 synergistically amplified wnt‑signaling, resulting in increased Bmp7 secretion that promoted the differentiation of skeletal muscle calcium channel alpha‑subunit‑positive myoblasts.",-32.25,0.8,geneorgeneproduct
"In the AR‑deficient K562 cell line, overexpression of the calcium‑sensing receptor activates Wnt‑signaling, leading to increased cyclin‑dependent kinase activity and elevated IL‑12p70 secretion.",-23.125,0.8,geneorgeneproduct
"In patients carrying a loss‑of‑function variant of ERCC5, the impaired nucleotide excision repair increases susceptibility to skin cancers, and the concomitant down‑regulation of IFNAR1 expression further reduces type I interferon signaling, thereby compromising antiviral defenses.",-51.0,0.8,geneorgeneproduct
"In A549 cells, the overexpression of the calcium‑sensing receptor gene enhances wnt‑signaling, leading to increased cyclin‑dependent kinase activity and a higher production of IL‑12p70.",-26.25,0.8,geneorgeneproduct
"Altered expression of the calcium‑sensing receptor in IFNAR1‑deficient macrophages suppresses IL‑12p70 production, thereby impairing CD8⁺ T‑cell activation.",-20.25,0.8,geneorgeneproduct
"Alterations in the calcium‑sensing receptor gene, when combined with aberrant phosphorylation of the cyclin‑dependent kinase complex, impair Wnt‑signaling in skeletal muscle calcium channel alpha‑subunit‑deficient myoblasts, thereby exacerbating the inflammatory response driven by IL‑12p70 production.",-45.25,0.8,geneorgeneproduct
"Alteration of the calcium sensing receptor gene (CALCRL) by a BRCA1 c.68_69delAG sequence variant reduces its transcription, leading to impaired ERCC5-mediated DNA repair and heightened sensitivity of IFNAR1-deficient keratinocytes to wnt‑signaling‑induced apoptosis.",-44.5,0.8,geneorgeneproduct
"Altering the phosphorylation state of the skeletal muscle calcium channel alpha‑subunit by the cyclin‑dependent kinase CDK5 modulates wnt‑signaling in ERCC5‑deficient fibroblasts, thereby reducing IL‑12p70 secretion in IFNAR1‑deficient macrophages.",-33.75,0.8,geneorgeneproduct
"Disruption of the calcium sensing receptor gene by a c.1313C>T sequence variant in a patient with IFNAR1-deficient viral pneumonia leads to aberrant ERCC5-mediated DNA repair, impairing cyclin‑dependent kinase activation and resulting in skeletal muscle calcium channel alpha‑subunit dysfunction.",-56.25,0.8,geneorgeneproduct
"Disruptive mutation of ERCC5 in an IFNAR1‑deficient Homo sapiens sample upregulated cyclin‑dependent kinase activity, thereby impairing DNA repair and contributing to neuro‑degenerative disease.",-43.0,0.8,geneorgeneproduct
"Disrupted wnt‑signaling in ERCC5‑deficient human dermal fibroblasts, combined with overexpression of the calcium‑sensing receptor, led to aberrant cycling of cyclin‑dependent kinase and ultimately impaired differentiation of skeletal muscle calcium channel alpha‑subunit‑expressing myoblasts.",-50.25,0.8,geneorgeneproduct
"Disassembly of the Wnt‑signaling complex in IFNAR1‑deficient macrophages leads to upregulation of the calcium‑sensing receptor and increased IL‑12p70 secretion, thereby enhancing cyclin‑dependent kinase activity and promoting skeletal muscle calcium channel alpha‑subunit expression.",-41.5,0.8,geneorgeneproduct
"A CRISPR/Cas9‑mediated deletion of the ERCC5 exon containing the c.1561_1563delCAA SequenceVariant in human fibroblasts of an IFNAR1‑deficient OrganismTaxon leads to impaired DNA repair and up‑regulation of cyclin‑dependent kinase expression, suggesting that ERCC5 loss contributes to the inflammatory phenotype observed in these cells.",-67.0,0.8,geneorgeneproduct
"A genome‑wide CRISPR‑Cas9 screen in HeLa cells revealed that knockout of the calcium‑sensing receptor dramatically increased intracellular IL‑12p70 secretion, suggesting a regulatory role for CaSR in cytokine signaling.",-35.25,0.8,geneorgeneproduct
"A transgenic mouse line harboring a CRISPR‑generated ERCC5 c.1521_1522delCT variant exhibited markedly reduced DNA repair capacity, leading to heightened sensitivity to UV‑induced skin carcinogenesis and a pronounced up‑regulation of IFNAR1‑dependent antiviral genes.",-51.75,0.8,geneorgeneproduct
"A mutation in the calcium‑sensing receptor gene (CaSR) was shown to enhance cyclin‑dependent kinase‑mediated phosphorylation of the skeletal muscle calcium‑channel alpha‑subunit, thereby increasing IL‑12p70 production in IFNAR1‑deficient macrophages.",-25.125,0.8,geneorgeneproduct
"Mutation of the calcium‑sensing receptor gene in IFNAR1‑deficient mice disrupts Wnt‑signaling, leading to reduced skeletal muscle calcium channel alpha‑subunit expression and impaired muscle regeneration.",-16.5,0.8,geneorgeneproduct
"Mutation in the calcium sensing receptor gene amplifies Wnt‑signaling and reduces ERCC5‑mediated DNA repair, thereby increasing susceptibility to IFNAR1‑deficient inflammatory responses in skeletal muscle cells.",-31.875,0.8,geneorgeneproduct
"Mutation‑induced loss of the calcium‑sensing receptor in IFNAR1‑deficient mouse myoblasts disrupts Wnt‑signaling, causing down‑regulation of cyclin‑dependent kinase activity and impaired differentiation of the skeletal muscle calcium channel alpha‑subunit.",-30.0,0.8,geneorgeneproduct
"Mutation-associated up‑regulation of the calcium‑sensing receptor in AR‑positive prostate cancer cell lines, such as LNCaP, is mediated by the IL‑12p70‑induced activation of cyclin‑dependent kinase signaling that stabilizes ERCC5 transcription.",-52.5,0.8,geneorgeneproduct
"Calcium sensing receptor dysregulation in ERCC5‑deficient fibroblasts impairs wnt‑signaling, leading to reduced expression of the skeletal muscle calcium channel alpha‑subunit and increased IL‑12p70 secretion.",-23.75,0.8,geneorgeneproduct
"Calmodulin‑dependent phosphorylation of the calcium sensing receptor enhances ERCC5-mediated DNA repair in IFNAR1‑deficient A549 cells, thereby reducing cyclin‑dependent kinase‑induced apoptosis during chronic Bmp7 exposure.",-37.25,0.8,geneorgeneproduct
"Calcularized calcium sensing receptor (CaSR) activation in IFNAR1‑deficient A549 cells induces up‑regulation of the cyclin‑dependent kinase gene CDK1, thereby enhancing Bmp7‑mediated Wnt‑signaling and increasing IL‑12p70 secretion.",-49.75,0.8,geneorgeneproduct
"Calpain-mediated cleavage of the calcium sensing receptor in IFNAR1‑deficient macrophages reduces IL‑12p70 secretion and disrupts Wnt‑signaling‑dependent cyclin‑dependent kinase activation, thereby impairing skeletal muscle calcium channel alpha‑subunit expression.",-33.5,0.8,geneorgeneproduct
"Mutations in the Calcium sensing receptor (CRISPR-Cas9‑edited) increase IL‑12p70 secretion by macrophages, which in turn activates IFNAR1‑deficient fibroblasts to upregulate cyclin‑dependent kinase expression and enhance Bmp7‑driven skeletal muscle calcium channel alpha‑subunit remodeling in a wnt‑signaling‑dependent manner.",-51.0,0.8,geneorgeneproduct
Mutational disruption of the Calcium sensing receptor in IFNAR1-deficient mice leads to aberrant wnt-signaling and reduced expression of the cyclin-dependent kinase that normally regulates skeletal muscle calcium channel alpha‑subunit synthesis.,-30.875,0.8,geneorgeneproduct
"Mutant ERCC5 variants impair DNA repair and increase susceptibility to IFNAR1‑deficient interferon‑mediated skin inflammation, a risk amplified by aberrant wnt‑signaling in skeletal muscle calcium channel alpha‑subunit‑expressing cells.",-44.5,0.8,geneorgeneproduct
"Mutated ERCC5 c.1900A>G in a patient with xeroderma pigmentosum phenocopies a loss of DNA repair capacity, leading to increased UV‑induced lesions and accelerated cutaneous aging.",-49.0,0.8,geneorgeneproduct
"Genetic ablation of the calcium‑sensing receptor in IFNAR1‑deficient mice disrupts wnt‑signaling, leading to down‑regulation of cyclin‑dependent kinase activity and impaired skeletal muscle calcium‑channel alpha‑subunit expression.",-20.25,0.8,geneorgeneproduct
"Genotype‑specific upregulation of the calcium‑sensing receptor in AR‑negative prostate cancer cells, driven by heightened cyclin‑dependent kinase activity, enhances IL‑12p70 secretion and activates wnt‑signaling, thereby promoting tumor cell invasion.",-40.75,0.8,geneorgeneproduct
"Genomic editing of the ERCC5 gene in the human keratinocyte cell line HaCaT reduces UV‑induced DNA repair capacity, leading to increased apoptosis and heightened expression of the pro‑inflammatory cytokine IL‑12p70, thereby illustrating the regulatory link between DNA repair enzymes, cytokine signaling, and cell survival in epidermal biology.",-58.25,0.8,geneorgeneproduct
"Genotoxic stress from doxorubicin treatment induces cyclin‑dependent kinase‑mediated phosphorylation of the Calcium sensing receptor in AR‑positive MCF‑7 cells, thereby enhancing IL‑12p70 secretion through a wnt‑signaling dependent pathway.",-40.5,0.8,geneorgeneproduct
"Silencing of the calcium sensing receptor gene in C2C12 cells reduces IL‑12p70 production and diminishes Bmp7‑induced phosphorylation of the cyclin‑dependent kinase CDK2, thereby impairing myogenic differentiation.",-33.5,0.8,geneorgeneproduct
"Silenced expression of the calcium‑sensing receptor in A549 cells, coupled with overexpression of AR, reduces IL‑12p70 secretion and down‑regulates Bmp7‑induced Wnt‑signaling, thereby impairing skeletal muscle calcium‑channel alpha‑subunit trafficking in IFNAR1‑deficient murine myoblasts.",-45.75,0.8,geneorgeneproduct
"Silently, the calcium sensing receptor gene variant c.1234C>A in IFNAR1‑deficient mice amplified ERCC5 expression and triggered cyclin‑dependent kinase‑mediated Bmp7 signaling, leading to abnormal skeletal muscle calcium channel alpha‑subunit function and elevated IL‑12p70 secretion.",-57.75,0.8,geneorgeneproduct
"Silica nanoparticles inhibited proliferation of HeLa cells by down‑regulating the calcium‑sensing receptor and up‑regulating the cyclin‑dependent kinase inhibitor p21, thereby inducing G1 arrest.",-26.625,0.8,geneorgeneproduct
"Cyclin‑dependent kinase inhibition in the human myoblast cell line C2C12 attenuates Bmp7‑induced differentiation through a Wnt‑signaling–dependent mechanism, as confirmed by reduced phospho‑ERCC5 and altered expression of the skeletal muscle calcium channel alpha‑subunit.",-48.0,0.8,geneorgeneproduct
"Cyclins and cyclin‑dependent kinase activity in HeLa cells are up‑regulated by Bmp7 stimulation, a change that is partially mediated through the calcium‑sensing receptor signaling pathway and results in increased expression of the transcription factor AR.",-50.75,0.8,geneorgeneproduct
"Cyclooxygenase‑2 activation in the AR‑regulated prostate cancer cell line LNCaP down‑regulates the calcium‑sensing receptor, thereby increasing IL‑12p70 secretion and sensitizing the cells to Bmp7‑induced wnt‑signaling, which ultimately enhances cyclin‑dependent kinase‑mediated cell cycle progression.",-59.75,0.8,geneorgeneproduct
"Cyclophosphamide treatment of A549 cells expressing the AR gene suppresses IL‑12p70 secretion, indicating that AR activation modulates cytokine production in a p‑STAT3‑dependent manner.",-50.75,0.8,geneorgeneproduct
"Expression of the calcium sensing receptor in the skeletal muscle calcium channel alpha‑subunit‑overexpressing A549 cell line was up‑regulated by IL‑12p70 stimulation, suggesting a cross‑talk between wnt‑signaling and cyclin‑dependent kinase activity in IFNAR1‑deficient cells.",-31.375,0.8,geneorgeneproduct
"Expression profiling of the calcium sensing receptor in HeLa cells revealed that its up‑regulation by the cyclin‑dependent kinase inhibitor Roscovitine led to a downstream increase in IL‑12p70 secretion, suggesting a potential therapeutic axis for modulating immune responses in cancer.",-43.0,0.8,geneorgeneproduct
"Expression levels of the calcium‑sensing receptor in A549 cells were markedly up‑regulated by Bmp7, a change that subsequently enhanced cyclin‑dependent kinase activity and promoted proliferation of the skeletal muscle calcium channel alpha‑subunit gene product.",-32.5,0.8,geneorgeneproduct
"Expression analysis revealed that activation of the calcium‑sensing receptor in IFNAR1‑deficient A549 cells up‑regulated cyclin‑dependent kinase activity, thereby enhancing Bmp7‑mediated wnt‑signaling and promoting skeletal muscle calcium channel alpha‑subunit transcription.",-31.125,0.8,geneorgeneproduct
"The infection of patient-derived Arabidopsis thaliana seedlings with West Nile virus was shown to up‑regulate the expression of the antiviral gene DEF1, thereby enhancing resistance to subsequent viral challenge.",-34.0,0.8,organismtaxon
"The hepatocellular carcinoma cell line Huh7, derived from a patient‑derived human hepatoma, was shown to be highly permissive for hepatitis C virus infection and to exhibit elevated expression of the interferon‑stimulated gene IFITM3 compared to the non‑transformed human hepatocyte line THLE‑2.",-38.75,0.8,organismtaxon
"The patient-derived Hepatitis C virus isolate was shown to replicate more efficiently in human-induced hepatocytes than in the rat iopamidol+atorvastatin-treated guinea pig model, suggesting host‑specific viral entry mechanisms.",-35.5,0.8,organismtaxon
"The guinea pig model of West Nile virus infection was used to evaluate the efficacy of a patient‑derived neutralizing antibody that blocks the virus’s envelope protein E, demonstrating reduced viremia and improved survival compared to untreated controls.",-38.0,0.8,organismtaxon
"In **human‑induced** pluripotent stem cells derived from a **patient‑derived** fibroblast line, expression of the **TP53** gene is upregulated by the **BRCA1 c.68_69delAG** **SequenceVariant**, leading to enhanced apoptosis when challenged with **Doxorubicin**, a **ChemicalEntity** that also induces DNA damage in **Homo sapiens** cell models.",-51.5,0.8,organismtaxon
"In the patient‑derived guinea pig model of hepatitis C virus infection, the antiviral compound entecavir markedly reduced viral replication by inhibiting the RNA-dependent RNA polymerase encoded by the viral genome, leading to a significant decrease in liver enzyme levels and improved histopathological outcomes.",-36.25,0.8,organismtaxon
"In our study, patient‑derived hepatocytes from a Homo sapiens liver biopsy were co‑cultured with DEN‑2‑treated HEK‑293 cells to assess the effect of West Nile virus on interferon‑β production.",-42.25,0.8,organismtaxon
"In *Arabidopsis thaliana* transgenic lines overexpressing the *BZR1* gene, the accumulation of the phytohormone brassinosteroid induces the up‑regulation of the *PIF4* transcription factor, which in turn promotes the expression of *AtGA20ox1*, thereby enhancing gibberellin biosynthesis and ultimately accelerating stem elongation during vegetative growth.",-62.75,0.8,organismtaxon
"Human‐derived Huh7 cells infected with hepatitis C virus display elevated expression of the IFN‑λ receptor, which in turn enhances STAT1 phosphorylation and promotes antiviral gene transcription in the host organism.",-40.25,0.8,organismtaxon
"Human‑induced pluripotent stem cells derived from a patient harbouring the BRCA1 c.68_69delAG variant were differentiated into organoids and then infected with hepatitis C virus, revealing a pronounced up‑regulation of interferon‑stimulated genes that was further amplified in the presence of the chemical entity ribavirin.",-40.5,0.8,organismtaxon
"Human-induced pluripotent stem cells derived from a patient with the BRCA1 c.68_69delAG sequence variant were differentiated into hepatocyte-like cells and then infected with hepatitis C virus, revealing that the viral NS5A protein exploits the mutated p53 pathway to enhance viral replication.",-31.625,0.8,organismtaxon
"Human–induced pluripotent stem cell–derived hepatocytes exposed to hepatitis C virus infection upregulate the antiviral interferon‑lambda response, thereby reducing viral replication in a manner comparable to that observed in patient‑derived liver biopsies from a guinea pig model.",-42.5,0.8,organismtaxon
"Gene silencing of the AT1R gene in a patient‑derived Huh‑7 cell line infected with hepatitis C virus reduced viral replication, confirming that AT1R is a proviral host factor in human hepatocytes.",-38.25,0.8,organismtaxon
"Gene therapy delivered via patient‑derived human‑induced pluripotent stem cells differentiated into hepatocytes reduced hepatitis C virus replication in vitro, a result that was corroborated by parallel experiments in guinea pig and Mice models, illustrating cross‑species efficacy.",-43.25,0.8,organismtaxon
"Gene delivery to patient‑derived A549 cells using a DEN‑2 viral vector significantly upregulated human IL‑6 expression, suggesting a potential therapeutic strategy for chronic hepatitis C virus infection in the context of Mice xenograft models.",-53.5,0.8,organismtaxon
"Gene-edited Arabidopsis thaliana plants harboring a CRISPR/Cas9-induced BRCA1 c.68_69delAG variant exhibit reduced drought tolerance, correlating with downregulated expression of the stress-responsive gene DREB2A.",-31.0,0.8,organismtaxon
"Patient‑derived hepatocytes from *Homo sapiens* infected with hepatitis C virus were shown to produce higher levels of CXCL10 upon treatment with the *Arabidopsis thaliana*–derived polyphenol curcumin, suggesting a cross‑kingdom regulatory pathway.",-40.75,0.8,organismtaxon
"Patient-derived hepatocytes from the DEN‑2 rat model exhibited increased expression of the hepatitis C virus core protein, confirming that the rodent hepatocellular carcinoma cells are permissive to viral replication.",-40.0,0.8,organismtaxon
"Patient‐derived Mice infected with hepatitis C virus showed a marked increase in hepatic CXCL10 expression, which was amplified by treatment with the antiviral agent DEN‑2.",-38.25,0.8,organismtaxon
"Patient–derived hepatocytes from a guinea pig infected with hepatitis C virus were found to upregulate CYP2E1, thereby enhancing the metabolic activation of the carcinogenic chemical entity aflatoxin B1 and increasing susceptibility to liver tumorigenesis.",-40.5,0.8,organismtaxon
Hepatitis C virus infection in patient‑derived guinea pig hepatocytes triggers upregulation of interferon‑stimulated genes and induces a rapid antiviral response comparable to that observed in human‑induced liver organoids.,-30.125,0.8,organismtaxon
"Heterologous expression of the West Nile virus envelope protein in Mice-derived HEK293 cells revealed enhanced viral entry, suggesting that host cell surface receptors in the mammalian model facilitate cross-species infection.",-40.25,0.8,organismtaxon
"HIF‑1α activation in DEN‑2‑treated mouse hepatocytes is potentiated by co‑exposure to atorvastatin, a finding that may translate to improved antiviral responses against hepatitis C virus in patient‑derived human‑induced pluripotent stem cell‑derived hepatocytes.",-47.0,0.8,organismtaxon
"HIV‐infected patient‑derived macrophages from Homo sapiens stimulated the replication of hepatitis C virus, leading to up‑regulation of the viral NS5A protein and increased secretion of pro‑inflammatory cytokines.",-35.25,0.8,organismtaxon
"Guinea pig models of hepatitis C virus infection revealed that patient‑derived liver organoids from Homo sapiens, when co‑cultured with the DEN‑2 strain of *A. thaliana* root exudate, exhibit increased expression of the antiviral interferon‑β gene, suggesting a cross‑kingdom regulatory interaction that could be exploited for therapeutic development.",-54.5,0.8,organismtaxon
"Guianese patient‑derived cell lines infected with West Nile virus exhibit upregulated interferon‑stimulated gene expression that is suppressed by a single DEN‑2‑derived small‑molecule inhibitor, suggesting a novel antiviral target.",-61.75,0.8,organismtaxon
"Guineas pig-derived hepatocytes infected with hepatitis C virus demonstrated up‑regulation of the interferon‑stimulated gene ISG15, suggesting a potent antiviral response that could be leveraged to screen patient‑derived antiviral compounds.",-51.5,0.8,organismtaxon
"Guangzhou‑derived, patient‑derived Hepatitis C virus strain HCV‑GD exhibited markedly increased replication in human‑induced pluripotent stem cell‑derived hepatocyte‑like cells, whereas the same strain showed attenuated growth in mouse Hepa1‑6 cells and negligible infection of Arabidopsis thaliana root explants.",-70.5,0.8,organismtaxon
"Exposure of patient-derived HepG2 cells to West Nile virus results in a robust induction of interferon‑β expression, confirming the antiviral response observed in human‑induced pluripotent stem‑cell‑derived hepatocytes.",-36.5,0.8,organismtaxon
Exposure to West Nile virus in Mice infected with patient-derived dengue-2 virus increases viremia and induces a robust interferon‑β response that is attenuated by treatment with atorvastatin and iopamidol in a dose‑dependent manner.,-46.25,0.8,organismtaxon
"Exposure studies in guinea pig and patient‑derived human‑induced pluripotent stem cell–derived hepatocytes revealed that the hepatitis C virus NS5A protein interacts with the host lipid droplet protein seipin, leading to enhanced viral assembly and cytopathic lipid accumulation.",-59.5,0.8,organismtaxon
"Exposure‑derived RNA‑seq of patient‑derived hepatocytes revealed that the DEN‑2 analog up‑regulated the interferon‑α pathway, and subsequent infection of human‑induced pluripotent stem cell‑derived hepatocytes with hepatitis C virus showed a similar transcriptional signature.",-69.5,0.8,organismtaxon
"A patient‑derived A549 cell line exposed to DEN‑2 and hepatitis C virus infection showed increased expression of the interferon‑beta gene, indicating a robust antiviral response in human‑induced epithelial cells.",-36.75,0.8,organismtaxon
"A Hepatitis C virus–infected patient‑derived human liver organoid, co‑cultured with A549 cells, was treated with the chemical entity doxorubicin, resulting in a significant reduction of viral replication and upregulation of the interferon‑β gene (IFNB1) in the human organoid.",-52.5,0.8,organismtaxon
A PCR‑based screening of the DEN‑2 murine hepatocarcinogenesis model revealed that the human‑induced expression of the TP53 gene in patient‑derived liver organoids markedly reduced the replication efficiency of hepatitis C virus in a dose‑dependent manner.,-49.75,0.8,organismtaxon
"A CRISPR‑Cas9 edited A549 cell line, derived from a patient with EGFR exon‑19 deletion, was infected with West Nile virus to assess the antiviral efficacy of a novel chemical entity, doxorubicin, and the resulting up‑regulation of interferon‑β mRNA was quantified by qPCR.",-53.0,0.8,organismtaxon
"We identified a novel DEN‑2-associated sequence variant, BRCA1 c.68_69delAG, in a patient‑derived human‑induced pluripotent stem cell line derived from a guinea pig‑like xenograft, which displayed increased sensitivity to West Nile virus infection in vitro.",-48.5,0.8,organismtaxon
We found that the patient‑derived Hepatitis C virus strain HCV‑GL1 from a chronic liver disease patient in West Nile virus endemic region exhibited a novel NS5A sequence variant that conferred resistance to the chemical entity daclatasvir and was associated with elevated viral replication in the human‑induced hepatic cell line HepG2.,-73.5,0.8,organismtaxon
We observed that the patient‑derived HEK293T cells infected with hepatitis C virus produced a potent interferon‑β response that inhibited the replication of West Nile virus in the co‑cultured Arabidopsis thaliana seedlings.,-37.25,0.8,organismtaxon
"We verified that the patient‑derived hepatocellular carcinoma cell line Huh7, infected with hepatitis C virus genotype‑3a, secreted increased levels of IL‑6, whereas treatment with the human‑induced pluripotent stem cell‑derived hepatocytes reduced viral replication by over forty percent.",-65.5,0.8,organismtaxon
"Preclinical experiments in Mice revealed that treatment with the DEN-2 carcinogen increased TP53 expression and induced apoptosis in hepatocytes, while patient‑derived hepatocellular carcinoma cells infected with hepatitis C virus exhibited enhanced viral replication and resistance to doxorubicin.",-50.5,0.8,organismtaxon
"Preliminary data from patient‑derived human‑induced pluripotent stem cell‑derived cardiomyocytes showed that exposure to West Nile virus, but not to hepatitis C virus, markedly increased apoptosis through upregulation of TP53 while simultaneously inducing a dose‑dependent reduction in mitochondrial membrane potential in a dose‑dependent manner.",-63.5,0.8,organismtaxon
"Pre-treatment of guinea pig macrophages with the patient-derived hepatitis C virus core protein enhances IFN‑α production, a response that is markedly amplified when the cells are engineered to express the human‑induced protein STAT1.",-46.25,0.8,organismtaxon
"Pre‑treatment of patient‑derived HepG2 cells with the hepatitis C virus NS5A inhibitor daclatasvir reduces viral replication, increases interferon‑β production, and enhances expression of the human‑induced TP53 protein, thereby suppressing cell proliferation.",-48.25,0.8,organismtaxon
"Arabidopsis thaliana seedlings treated with a patient‑derived, HCV‑encoded DEN‑2 protein exhibited a dose‑dependent increase in reactive oxygen species and up‑regulation of the antioxidant gene GSTU1, indicating a potential plant–virus interaction relevant to antiviral defense.",-61.75,0.8,organismtaxon
"Arabica arabica infection with West Nile virus in Mice induces a robust interferon‑α response that inhibits viral replication while simultaneously up‑regulating the chemokine CXCL10, thereby linking a viral SequenceVariant in the NS5 protein to enhanced antiviral immunity.",-64.5,0.8,organismtaxon
"Arabdopsis thaliana seedlings infected with the West Nile virus exhibit increased expression of the viral envelope protein and a concomitant up‑regulation of the host interferon‑stimulated gene IFIT1, illustrating a plant–virus interaction that may inform cross‑kingdom antiviral strategies.",-50.5,0.8,organismtaxon
Arabian equine virus infection of patient-derived **Homo sapiens** cells was found to induce a **cell line**‑specific antiviral response mediated by the **GeneOrGeneProduct** interferon‑β pathway.,-62.0,0.8,organismtaxon
"Genetically engineered Arabidopsis thaliana plants expressing the hepatitis C virus core protein exhibited increased oxidative stress markers, suggesting a plant model for viral pathogenesis studies.",-30.125,0.8,organismtaxon
"Genomic sequencing of patient‑derived hepatocellular carcinoma samples from a human‑induced pluripotent stem cell line revealed a BRCA1 c.68_69delAG variant that co‑exists with a DEN‑2‑driven oncogenic mutation, suggesting a synergistic effect on tumor progression in Homo sapiens.",-40.0,0.8,organismtaxon
Genetic manipulation of patient‑derived guinea pig fibroblasts with CRISPR‑Cas9 targeting the DEN‑2 oncogene dramatically increased the proliferation rate and conferred resistance to hepatitis C virus‑mediated cytopathic effects in vitro.,-46.25,0.8,organismtaxon
Genotype‑specific resistance to hepatitis C virus was confirmed in patient‑derived hepatocytes isolated from a human‑induced pluripotent stem cell line and further validated in a guinea pig model treated with DEN‑2‑induced liver injury.,-36.5,0.8,organismtaxon
"Ethanol exposure in patient‑derived HepG2 cells derived from a Homo sapiens hepatocyte line leads to increased CYP2E1 expression and enhanced reactive oxygen species production, which in turn activates the p53 pathway and induces apoptosis.",-37.25,0.8,organismtaxon
"Epithelial‑derived tumor cells from a patient‑derived Mice xenograft model infected with hepatitis C virus showed that the viral NS5A protein interacted with the human‑induced gene product IFN‑α, enhancing antiviral gene expression and reducing tumor proliferation.",-55.5,0.8,organismtaxon
"Efficacy of the DEN‑2 carcinogen in inducing hepatocarcinogenesis was confirmed by patient‑derived organoid cultures from Mice, where the resulting tumor cells displayed the same gene expression profile as human‑induced hepatocellular carcinoma samples.",-51.5,0.8,organismtaxon
"Ectopic expression of the Arabidopsis thaliana transcription factor WRKY33 in patient‑derived human hepatoma cells markedly enhanced susceptibility to hepatitis C virus replication, revealing a conserved cross‑species regulatory network.",-35.75,0.8,organismtaxon
"HIV-1-resistant *E. coli* strains were engineered by CRISPR-Cas9 to express a plasmid carrying the *HIV* gag gene, enabling a novel in vitro model to study viral protein–host interaction dynamics.",-34.25,0.8,organismtaxon
"Hepatitis A virus infection in the HIV-1-resistant patient was shown to increase the expression of interferon‑λ, thereby providing a potential therapeutic target for reducing viral replication in this co‑infected individual.",-40.75,0.8,organismtaxon
"Heterologous expression of HIV-1-resistant reverse transcriptase in E. coli proved to markedly increase the production of antiviral RNA therapeutics, thereby enhancing the efficacy of patient‑controlled oral treatment against hepatitis A virus infection.",-51.25,0.8,organismtaxon
"Homozygous HIV-1-resistant alleles in the CCR5 gene of a patient-derived E. coli strain were shown to reduce HIV infection efficiency, while simultaneous exposure to the West Nile virus envelope protein triggered an upregulation of interferon‑β expression in the same host cells.",-48.0,0.8,organismtaxon
"In Hepatitis B virus–infected patients, the HIV‑1‑resistant subtype of HIV can be isolated from peripheral blood mononuclear cells, revealing a novel viral–host interaction that may influence the efficacy of antiviral therapy.",-44.5,0.8,organismtaxon
"In patient-controlled HIV-1–resistant E. coli cultures, the introduction of Spirulina-derived polysaccharides reduced bacterial endotoxin secretion and concurrently downregulated the expression of the virulence gene hlyC, illustrating a potential microbiome-modulating therapeutic strategy.",-49.75,0.8,organismtaxon
"In HIV‑1‑resistant patient-derived E. coli strains, expression of the plasmid‑encoded resistance gene confers survival advantage against the antiviral compound Spirulina‑derived polysaccharide, thereby illustrating a direct interaction between organism taxon and chemical entity that could inform future therapeutic strategies.",-45.5,0.8,organismtaxon
"In the patient-controlled study, HIV-1-resistant E. coli strains were found to carry a plasmid encoding a novel efflux pump that confers cross‑resistance to both the antiretroviral drug raltegravir and the broad‑spectrum antibiotic ciprofloxacin.",-31.25,0.8,organismtaxon
"The HIV-1-resistant strain of E. coli isolated from a patient‑controlled clinical trial exhibited increased resistance to both ampicillin and ciprofloxacin, suggesting a novel adaptive mechanism involving horizontal gene transfer of a plasmid-encoded β‑lactamase.",-42.25,0.8,organismtaxon
"The engineered E. coli strain, carrying the HIV-1-resistant Tat promoter, was shown to secrete a novel antiviral peptide that inhibits replication of hepatitis A virus and West Nile virus in vitro.",-34.25,0.8,organismtaxon
"The CRISPR-Cas9–mediated knockout of the HIV-1-resistant allele in Jurkat T cells derived from an E. coli–contaminated culture revealed a dramatic reduction in HIV replication, implicating the cellular DNA repair pathway as a potential therapeutic target.",-47.0,0.8,organismtaxon
The isolated E. coli strain harboring a plasmid with an HIV-1-resistant reverse transcriptase gene was shown to confer partial protection against HIV in patient‑controlled in vitro infection assays.,-34.75,0.8,organismtaxon
Epidemiological surveillance of HIV-1-resistant strains isolated from a patient-controlled cohort of HIV-positive individuals revealed a concurrent prevalence of hepatitis A virus infection in a subset of those who also carried an E. coli plasmid conferring multi‑drug resistance.,-50.25,0.8,organismtaxon
"Efectivo in vitro, el fármaco Spirulina se mostró capaz de bloquear la replicación del HIV-1-resistant en líneas celulares de HeLa, mientras que el mismo compuesto redujo la carga viral del hepatitis A virus en hepatocitos derivados de Homo sapiens.",-49.5,0.8,organismtaxon
"Erythrocyte‐derived extracellular vesicles from HIV‑1‑resistant patients carrying the KIR3DL1 allele were shown to inhibit the replication of hepatitis A virus in cultured E. coli‑expressed viral proteins, suggesting a novel antiviral role for host‑derived vesicle surface proteins.",-53.5,0.8,organismtaxon
"Evidently, the HIV-1-resistant strain of HIV from the West Nile virus–infected patient was shown to upregulate E. coli–derived antimicrobial peptides, a finding that highlights the complex interplay between HIV and other organism taxa in the host.",-65.0,0.8,organismtaxon
"Intravenous administration of a single dose of Spirulina extract in HIV-1-resistant patients infected with hepatitis A virus significantly reduced liver inflammation markers, suggesting a potential therapeutic role for this microalga in co‑infected individuals.",-41.0,0.8,organismtaxon
"Intranasal inoculation of West Nile virus into BALB/c mice induces a robust interferon‑beta response that downregulates the expression of the interferon‑stimulated gene ISG15, thereby facilitating viral replication and exacerbating neuroinflammation.",-39.75,0.8,organismtaxon
"Intriguingly, the HIV-1-resistant E. coli strain engineered to express a recombinant HIV envelope protein can be used to elicit robust neutralizing antibody responses against West Nile virus in a patient-controlled vaccination strategy.",-39.25,0.8,organismtaxon
Intracellular replication of West Nile virus in E. coli-derived cell lines engineered to express the HIV-1-resistant Vpu protein reveals a synergistic inhibition of viral envelope synthesis and enhanced antiviral RNAi activity.,-45.5,0.8,organismtaxon
Replication of HIV-1-resistant variants in E. coli expressing the human CD4 receptor demonstrates that the virus can acquire additional mutations that enhance infection of human T cells.,-37.75,0.8,organismtaxon
"Replication competence of the HIV-1-resistant strain NL4‑3Δvif is markedly enhanced by co‑infection with HIV‑1 envelope from a patient-controlled West Nile virus‑infected donor, leading to a synergistic increase in viral titers in E. coli‑derived pseudotyping systems.",-68.0,0.8,organismtaxon
"Replication efficiency of HIV-1-resistant isolates was markedly reduced in E. coli–derived expression systems, illustrating that the viral envelope glycoprotein variants fail to engage the bacterial membrane machinery.",-50.75,0.8,organismtaxon
"Replication capacity of the HIV-1-resistant strain was markedly enhanced by co‑infection with hepatitis A virus, resulting in higher viral loads in the patient-controlled inoculation model.",-38.0,0.8,organismtaxon
"Evidence shows that HIV-1-resistant strains of *Homo sapiens* infected with hepatitis A virus exhibit a markedly reduced replication rate compared with susceptible *Homo sapiens* subjects, suggesting a synergistic antiviral effect.",-38.5,0.8,organismtaxon
Evidence that HIV-1‑resistant mutations in the env gene of HIV alter the virus’s susceptibility to neutralization by patient‑controlled monoclonal antibodies was demonstrated in cell lines derived from E. coli‑expressed recombinant proteins and validated with a pseudotyped HIV assay.,-53.0,0.8,organismtaxon
"Evidence from a randomized trial shows that Spirulina supplementation in HIV-1-resistant individuals reduced circulating IL‑6 levels, suggesting an anti‑inflammatory benefit that may be mediated through modulation of the gut microbiota dominated by E. coli.",-45.25,0.8,organismtaxon
Evidence suggests that HIV-1-resistant mutations in the env gene of HIV co‑infected with hepatitis A virus reduce viral replication in primary CD4⁺ T cells from patients of the E. coli–positive cohort.,-42.25,0.8,organismtaxon
"HeLa cells infected with HIV-1-resistant strains of HIV exhibit higher expression of the viral envelope protein gp120, correlating with increased cytopathic effects and enhanced viral replication in the presence of the antiviral drug efavirenz.",-40.0,0.8,organismtaxon
"Heparanase overexpression in E. coli–derived cell lines treated with HIV-1–resistant gp120 variants markedly enhances viral entry, suggesting a potential therapeutic target for antiviral intervention.",-48.75,0.8,organismtaxon
"He demonstrated that HIV-1-resistant *E. coli* strains harboring a plasmid-encoded *bla* gene can suppress replication of hepatitis A virus in vitro, suggesting a novel bacterial antiviral defense mechanism.",-43.5,0.8,organismtaxon
"Heavily infected E. coli cultures engineered to express a patient‑controlled, HIV‑1‑resistant gp120 variant exhibit markedly reduced replication of hepatitis A virus in vitro.",-44.5,0.8,organismtaxon
Treatment of HIV-1–resistant infection with a new E. coli–derived peptide that blocks viral entry has been shown to reduce viral load and improve CD4+ T‑cell recovery in patients infected with HIV.,-39.75,0.8,organismtaxon
Treatment with Spirulina in HIV-1-resistant patients infected with hepatitis A virus reduced viral load more effectively than standard antiretroviral therapy alone.,-19.25,0.8,organismtaxon
Treatment by the HIV‑1‑resistant drug darunavir in E. coli‑derived recombinant HIV protease reduced enzymatic activity and suppressed viral replication in a patient‑controlled model of HIV infection.,-50.0,0.8,organismtaxon
"Treatment using Spirulina-derived polysaccharides mitigated hepatic inflammation in a patient infected with HIV-1-resistant strains, while concurrently reducing West Nile virus viral load in cultured E. coli-derived cell lines.",-46.75,0.8,organismtaxon
"Molecular analysis of the HIV-1-resistant E. coli strain revealed a novel gene product that interferes with viral replication, potentially offering a new therapeutic target for patients infected with the West Nile virus.",-33.25,0.8,organismtaxon
"M2 vaccine‑generated antibodies from a patient‑controlled study neutralized West Nile virus more efficiently than those derived from E. coli‑expressed antigens, illustrating the superior immunogenicity of a live‑attenuated DEN‑4 strain in a human Papillomavirus‑infected cohort.",-57.5,0.8,organismtaxon
"Mitochondrial DNA from HIV‑1–resistant *E. coli* strains showed that a single G→A transition at position c.2335 in the *atpD* gene abolished ATP synthase activity, thereby compromising bacterial survival under antiretroviral pressure.",-66.5,0.8,organismtaxon
Mature HIV-1-resistant CD4+ T cells from a patient controlled infection with hepatitis A virus showed enhanced expression of interferon‑stimulated genes compared to naïve T cells from healthy E. coli‑exposed volunteers.,-51.25,0.8,organismtaxon
"A patient infected with HIV-1-resistant HIV and co‑infected with hepatitis A virus displayed a markedly altered cytokine profile, including elevated IL‑6 and reduced IFN‑γ, suggesting a synergistic effect on immune activation.",-34.5,0.8,organismtaxon
"A549 cells infected with HIV-1-resistant viral particles exhibited reduced replication rates compared with parental A549 cells, suggesting that the viral resistance phenotype is maintained in the human lung carcinoma cell line.",-36.5,0.8,organismtaxon
"A single-stranded RNA vaccine derived from a recombinant Dengue virus serotype‑4 (DEN‑4) platform was engineered to elicit neutralizing antibodies against West Nile virus in the immunocompromised HIV‑1‑resistant patient, thereby demonstrating cross‑species protection in a non‑human primate model of E. coli‑induced sepsis.",-55.0,0.8,organismtaxon
"A laboratory study using E. coli BL21(DE3) to express a recombinant HIV-1-resistant Vpu protein demonstrated that the protein’s transmembrane domain disrupted the bacterial inner membrane, leading to increased permeability and growth inhibition.",-39.5,0.8,organismtaxon
"Chronic infection with HIV-1-resistant strains of HIV in a patient controlled cohort revealed that the viral envelope gene gp120 harbors a sequence variant in the V3 loop, which enhances binding affinity to the CD4 receptor expressed on human T lymphocytes.",-48.5,0.8,organismtaxon
Chloroquine treatment of HIV-1-resistant *Homo sapiens* patients infected with HIV and co‑infected with hepatitis A virus led to a significant reduction in viral load and improved CD4⁺ T cell recovery.,-33.75,0.8,organismtaxon
"Chimeric antigen receptor T cells engineered from the Jurkat cell line were able to eliminate E. coli–produced Shiga toxin in a patient-controlled murine model of hemorrhagic colitis, demonstrating a potent anti‑bacterial immune response.",-46.75,0.8,organismtaxon
"Chagas disease in the patient was exacerbated by an E. coli strain that expressed a plasmid-encoded HIV-1-resistant reverse transcriptase, leading to a severe inflammatory response in the intestinal mucosa.",-52.5,0.8,organismtaxon
Targeted CRISPR‑Cas9 editing of the HIV-1-resistant CCR5 locus in primary CD4+ T cells isolated from an HIV patient demonstrated a ~90% reduction in viral entry while preserving normal immune function.,-46.25,0.8,organismtaxon
Targeting HIV-1-resistant E. coli with the antiviral Panax ginseng extract reduces viral replication while simultaneously lowering patient-controlled cytokine levels.,-39.25,0.8,organismtaxon
"Target‑cell recognition of HIV-1‑resistant gp120 by human CD4+ T cells from an E. coli‑derived HIV vaccine strain results in selective apoptosis of infected cells, demonstrating a potential therapeutic strategy.",-55.5,0.8,organismtaxon
"Target site-directed mutagenesis of the HIV-1-resistant E. coli strain revealed a novel promoter variant that enhanced expression of the CRISPR-Cas9 system, thereby improving viral resistance.",-52.75,0.8,organismtaxon
"Spirulina supplementation reduced HIV-1 replication in peripheral blood mononuclear cells from HIV-infected patients, an effect that was amplified when the cells were infected with an HIV-1-resistant strain and further enhanced by co‑administration of Panax ginseng, suggesting a synergistic antiviral interaction in a human organism taxon context.",-49.25,0.8,organismtaxon
Spiral-shaped E. coli strains resistant to HIV-1–inhibitory peptide derivatives exhibit higher rates of plasmid-borne drug resistance when co‑infected with hepatitis A virus.,-50.75,0.8,organismtaxon
"Spironolactone treatment in HIV-1-resistant *Homo sapiens* patients reduced viral load and improved CD4+ T‑cell counts, while co‑infection with hepatitis A virus triggered an elevated interferon‑α response that suppressed *E. coli* proliferation in the gut microbiota.",-46.0,0.8,organismtaxon
"Spuriously, the HIV-1-resistant E. coli strain isolated from a patient-controlled bioreactor demonstrated elevated expression of the bacterial efflux pump gene AcrB, thereby conferring decreased susceptibility to the anti-HIV drug saquinavir.",-55.25,0.8,organismtaxon
"A cohort of inpatients infected with HIV‑1‑resistant rDEN2Delta30 showed reduced viral load when treated with the small molecule doxorubicin, which inhibited the replication of hepatitis B virus in human hepatocytes while sparing human‑rodent cells.",-44.0,0.8,organismtaxon
"A hospitalized human patient with hepatitis B virus infection exhibited elevated serum ALT levels, while the isolated rDEN2Δ30 strain of dengue virus showed markedly reduced replication in human-rodent cell cultures.",-38.25,0.8,organismtaxon
"A double-stranded RNA vaccine derived from the rDEN2Delta30 strain of dengue virus has been shown to elicit neutralizing antibodies in inpatients infected with HIV‑1‑resistant HIV-1, thereby reducing viral load in these human‑rodent model studies.",-35.5,0.8,organismtaxon
"A polymorphism in the HBV core promoter was found to increase viral load in inpatients infected with hepatitis B virus, suggesting a role for this variant in the severity of chronic liver disease.",-38.0,0.8,organismtaxon
"Hepatitis B virus replication was markedly reduced in human‑rodent chimeric liver cultures after treatment with the HIV‑1‑resistant compound rDEN2Delta30, suggesting a potential therapeutic strategy for chronic HBV infection.",-31.375,0.8,organismtaxon
"HIV‑1‑resistant rDEN2Δ30 vaccine strains were evaluated in human‑rodent chimeric mice, revealing that the attenuated virus elicited robust neutralizing antibodies against the Human Papillomas Virus E6 protein in inpatients.",-41.25,0.8,organismtaxon
"Heterologous expression of hepatitis B virus surface antigen in the A549 cell line markedly increases the cytopathic effect of doxorubicin, suggesting that HBV infection may sensitize human tumor cells to anthracycline‑induced apoptosis.",-46.25,0.8,organismtaxon
HLA‑B27–positive inpatients infected with hepatitis B virus and HIV‑1‑resistant rDEN2Delta30 exhibited a significantly higher rate of liver cirrhosis than those infected with HPV alone.,-37.5,0.8,organismtaxon
"The newly isolated rDEN2Delta30 strain from a hospitalized human patient revealed enhanced replication in Hepatitis B virus–infected hepatocytes, suggesting a potential co‑infection risk that could impact treatment outcomes in HIV‑1‑resistant individuals.",-40.0,0.8,organismtaxon
"The rDEN2Delta30 strain of dengue virus, which contains a deletion in the NS3 protease, was engineered into an Aedes aegypti mosquito vector and demonstrated enhanced replication in human macrophages, indicating a potential increase in virulence in infected inpatients.",-50.25,0.8,organismtaxon
The HIV-1-resistant rDEN2Delta30 strain isolated from inpatients with hepatitis B virus infection in a human‑rodent co‑culture model was shown to suppress the replication of Human Papillomas Virus in a dose‑dependent manner.,-27.875,0.8,organismtaxon
"The inpatients infected with rDEN2Delta30, a dengue virus strain isolated from a patient in Brazil, exhibited a markedly higher viral load than those infected with the wild‑type dengue virus, suggesting that the Δ30 deletion enhances replication in human cells.",-34.25,0.8,organismtaxon
"Treatment of inpatients infected with hepatitis B virus using a combination of rDEN2Delta30 vaccine and lamivudine significantly reduced viral load in human-rodent models, demonstrating a synergistic antiviral effect.",-33.5,0.8,organismtaxon
"Treatment with rDEN2Delta30, a recombinant dengue vaccine derived from a human‑rodent chimeric backbone, reduced viral load in HIV‑1‑resistant inpatients infected with hepatitis B virus, confirming cross‑species immunogenicity against human‑rodent pathogens.",-39.0,0.8,organismtaxon
Treatment failure in HIV-1-resistant inpatients harboring an rDEN2Delta30 variant of hepatitis B virus was linked to reduced interferon‑α production in human‑rodent cell lines.,-40.25,0.8,organismtaxon
"Treatment by interferon‑α in inpatients infected with hepatitis B virus (HBV) rDEN2Delta30 increased serum HBsAg levels, suggesting that this attenuated strain may alter viral replication dynamics in human hosts.",-49.5,0.8,organismtaxon
"In a cohort of inpatients infected with hepatitis B virus, the presence of the rDEN2Delta30 sequence variant in the viral genome was associated with a higher likelihood of developing liver cirrhosis in Homo sapiens.",-17.5,0.8,organismtaxon
"In human‑rodent co‑infection studies, the rDEN2Δ30 attenuated strain of hepatitis B virus was shown to suppress HBV replication in Huh‑7 cells, yet this suppression was reversed when the cells were infected with an HIV‑1‑resistant HBV variant, illustrating cross‑species viral interaction and the need for additional antiviral therapy in inpatients.",-58.25,0.8,organismtaxon
"In hospitalized patients infected with hepatitis B virus, the presence of the rDEN2Delta30 variant in the hepatitis B surface antigen gene correlates with increased viral load and poorer response to standard antiviral therapy.",-25.0,0.8,organismtaxon
"In rDEN2Delta30‑infected human‑rodent hybrid cell lines, the viral capsid protein of hepatitis B virus is upregulated, suggesting a novel cross‑species interaction that may enhance viral replication in inpatients.",-36.5,0.8,organismtaxon
"Pharmacological inhibition of the hepatitis B virus polymerase in cultured HepG2 cells derived from a human hepatocyte line led to a significant reduction in viral DNA replication, an effect that was amplified when the drug was combined with a synthetic analog of the rDEN2Delta30 vaccine antigen.",-49.5,0.8,organismtaxon
"Phosphorylation of the HIV‑1 capsid by human‑rodent protein kinase Cε enhances viral replication, a process attenuated in inpatients infected with hepatitis B virus and rDEN2Delta30.",-46.5,0.8,organismtaxon
"Phage therapy with lytic rDEN2Delta30 was shown to reduce viral load in inpatients infected with HIV‑1-resistant HIV‑1 strains, thereby improving CD4⁺ counts in this human‑rodent model.",-45.0,0.8,organismtaxon
"Phytochemical analysis of Platonia insignis Mart. extracts revealed that the compound rDEN2Delta30, isolated from the plant, inhibited replication of hepatitis B virus in HepG2‑α‑S cells derived from Homo sapiens, thereby demonstrating antiviral activity against HBV in an in‑vitro human‑rodent co‑culture system.",-53.25,0.8,organismtaxon
"During a longitudinal cohort study of inpatients infected with hepatitis B virus, the rDEN2Delta30 vaccine induced neutralizing antibodies that were significantly higher in Homo sapiens compared with a human‑rodent surrogate model.",-34.75,0.8,organismtaxon
"During viral infection, the hepatitis B virus rDEN2Delta30 protein interacts with the cellular receptor in Homo sapiens, leading to enhanced viral replication and hepatocyte damage in inpatients.",-41.75,0.8,organismtaxon
"During hospital stay, the inpatients infected with hepatitis B virus exhibited elevated liver enzyme levels, prompting the use of lamivudine to inhibit the replication of the HBV genome in Homo sapiens.",-39.75,0.8,organismtaxon
"During the investigation, inpatients infected with the rDEN2Delta30 strain of dengue virus exhibited a significantly higher rate of liver dysfunction compared with those infected with the wild‑type virus, suggesting a potential interaction between the viral sequence variant and host hepatocyte injury.",-43.0,0.8,organismtaxon
"Gene‑editing of rDEN2Delta30 in human‑rodent hybrid cells reveals that the engineered variant can be efficiently rescued by the HIV‑1‑resistant human plasma membrane protein, suggesting a potential vaccine platform for the prevention of hepatitis B virus infection.",-64.0,0.8,organismtaxon
"Gene expression of the HLA‑DRA gene in human‑rodent hybrid cell lines derived from Hepatitis B virus‑infected hepatocytes was markedly up‑regulated, indicating a potential role of HLA‑DRA in antiviral immune responses.",-50.25,0.8,organismtaxon
"Gene silencing of the HBV core promoter in cultured HepG2 cells reduced replication of hepatitis B virus by approximately ninety‑five percent, demonstrating that CRISPR‑Cas9 editing of the cccDNA template can serve as a potent antiviral strategy in hepatocellular carcinoma models.",-66.5,0.8,organismtaxon
Gene transfer of the hepatitis B virus surface antigen into A549 cells induces an antiviral response that reduces replication of the HIV-1-resistant rDEN2Delta30 strain while preserving cell viability.,-40.0,0.8,organismtaxon
"Human Papillomavirus infection in human-rodent hybrid inpatients carrying the rDEN2Delta30 mutation reduces viral replication and increases expression of the tumor suppressor TP53, thereby limiting cervical dysplasia.",-37.25,0.8,organismtaxon
"Human immunodeficiency virus type‑1‐resistant rDEN2Delta30 was isolated from inpatients infected with hepatitis B virus and HIV‑1, and its replication kinetics were compared to those of the Human Papillomas Virus strain isolated from a human‑rodent cell line.",-45.25,0.8,organismtaxon
"Human inpatients infected with HIV‑1‑resistant hepatitis B virus exhibit markedly increased serum levels of the viral surface antigen, correlating with accelerated liver fibrosis in a cohort of Homo sapiens.",-37.25,0.8,organismtaxon
"Human-rodent co‑culture experiments demonstrated that the rDEN2Δ30 vaccine strain of dengue virus could infect HepG2 cells, yet the presence of the HIV‑1‑resistant K65R mutation in the reverse transcriptase gene of the same sample prevented replication in primary CD4⁺ T‑cells.",-52.0,0.8,organismtaxon
"An immunoprecipitation assay demonstrated that the rDEN2Delta30 vaccine strain of dengue virus enhances the replication of hepatitis B virus in human‑rodent hybrid hepatocytes, suggesting a potential co‑infection risk for inpatients receiving this vaccine.",-41.75,0.8,organismtaxon
An in‑patient infected with hepatitis B virus and carrying the rDEN2Δ30 vaccine strain showed a significant reduction in HBV DNA levels after treatment with the HIV‑1‑resistant drug lamivudine.,-28.75,0.8,organismtaxon
An inpatient infected with hepatitis B virus was found to harbor a rDEN2Delta30 mutation that conferred HIV-1-resistant properties in a human‑rodent chimeric model.,-30.375,0.8,organismtaxon
"An HIV‑1‑resistant rDEN2Δ30 strain isolated from an in‑patient showed enhanced replication in human‑rodent co‑cultures, suggesting a potential for cross‑species transmission of this vaccine candidate.",-36.75,0.8,organismtaxon
Co-infection of HIV‑1‐resistant patients with rDEN2Delta30 and hepatitis B virus in a human‑rodent model increases viral replication and elevates liver inflammation markers.,-31.125,0.8,organismtaxon
Co-culturing the human-rodent hybrid cell line Huh7.5.1 with rDEN2Delta30 and HPV-infected primary human keratinocytes revealed that the HIV-1-resistant phenotype was amplified in the presence of hepatitis B virus supernatants.,-53.25,0.8,organismtaxon
Co-transfection of the rDEN2Delta30 plasmid into A549 cells expressing the hepatitis B virus surface antigen induced a robust antiviral response that suppressed HIV-1-resistant viral replication in a human-rodent co-culture model.,-40.0,0.8,organismtaxon
Co‑infection of hepatitis B virus and HIV‑1-resistant rDEN2Delta30 in human‑rodent model patients leads to higher liver inflammation scores than in inpatients infected with either virus alone.,-35.0,0.8,organismtaxon
Mutation of the rDEN2Delta30 capsid gene in hepatitis B virus isolated from human patients with chronic infection is associated with increased viral replication and hepatocellular carcinoma risk.,-32.0,0.8,organismtaxon
Mutation analysis of the rDEN2Delta30 strain isolated from an HIV‑1‑resistant human inpatient revealed a novel SequenceVariant that enhances viral replication in a human‑rodent model of hepatitis B virus infection.,-32.75,0.8,organismtaxon
Mutation screening of the rDEN2Delta30 strain in HIV-1-resistant inpatients revealed an E1 sequence variant that was associated with a reduced viral replication rate in the human-rodent model.,-45.5,0.8,organismtaxon
"Mutation profiles of hepatitis B virus in inpatients revealed that the rDEN2Delta30 variant, previously associated with vaccine escape, is now co‑detected with a novel HIV‑1‑resistant strain, indicating cross‑species recombination events in a human‑rodent hybrid infection model.",-59.75,0.8,organismtaxon
"Severe hepatic inflammation in inpatients infected with hepatitis B virus led to upregulation of the TNF‑α gene, a finding that may predict poorer outcomes in patients with underlying HIV‑1-resistant mutations.",-42.5,0.8,organismtaxon
"Seventy‑two inpatients infected with hepatitis B virus and HIV‑1-resistant rDEN2Δ30 exhibited elevated liver enzyme levels, suggesting a synergistic hepatotoxic interaction in the human‑rodent model.",-35.25,0.8,organismtaxon
"Sequestration of hepatitis B virus surface antigen by the engineered plasmid from *Homo sapiens* hepatocytes markedly reduces viral load in inpatients carrying the rDEN2Delta30 escape mutation, thereby improving antiviral therapy outcomes.",-52.5,0.8,organismtaxon
"Sepsis in inpatients infected with rDEN2Delta30 hepatitis B virus was associated with an up‑regulation of the viral surface antigen gene HBV‑S, a finding that may explain the higher mortality observed in HIV‑1‑resistant patients.",-47.5,0.8,organismtaxon
rDEN2Delta30 infection in inpatients carrying the HIV-1-resistant genotype of Human Papillomas Virus induces a pronounced up‑regulation of the TP53 protein in human‑rodent co‑culture models of Hepatitis B virus replication.,-38.5,0.8,organismtaxon
"rDIEN2Delta30, a recombinant hepatitis B virus strain, was isolated from inpatients and shown to inhibit viral replication more effectively than the wild-type strain in human-rodent co-cultures.",-48.0,0.8,organismtaxon
"rDNA sequencing of hepatitis B virus isolates from inpatients revealed a novel rDEN2Delta30 mutation that enhances replication in human-rodent cell lines, thereby improving the model for studying HBV drug resistance.",-45.75,0.8,organismtaxon
rDENV2Δ30‑infected human‑rodent hybrid fibroblasts from inpatients with HIV‑1‑resistant strain induced higher expression of interferon‑β compared to control cells.,-54.5,0.8,organismtaxon
"The administration of atorvastatin to rats receiving iopamidol caused a significant reduction in oxidative stress markers, thereby preventing iopamidol‑induced nephrotoxicity in the rodent model.",-29.75,0.8,organismtaxon
"The transcriptomic profile of *Arabidopsis thaliana* seedlings treated with a combination of iopamidol and atorvastatin revealed an up‑regulation of genes involved in the sterol biosynthetic pathway, suggesting a conserved cholesterol‑analog response across the plant and mammalian kingdoms.",-37.75,0.8,organismtaxon
"The Arabidopsis thaliana seedlings treated with the chemical entity atropine exhibited a dramatic reduction in stomatal density, indicating a direct interaction between the compound and the plant’s epidermal development pathways.",-37.25,0.8,organismtaxon
The interaction between the Toxorynchites mosquitoes and human-rodent hosts facilitates the transmission of a novel viral pathogen that exploits the host’s interferon signaling pathway to evade immune detection.,-33.0,0.8,organismtaxon
"In Arabidopsis thaliana, overexpression of the gene At3g15670 downregulates drought‑stress markers, thereby enhancing tolerance to water‑deficit conditions.",-33.5,0.8,organismtaxon
"In *Arabidopsis thaliana* overexpression of the *WRKY33* gene enhances resistance to *Botrytis cinerea*, as evidenced by a marked reduction in lesion area and increased accumulation of salicylic acid compared to wild‑type plants.",-30.875,0.8,organismtaxon
"In Daucus carota, the application of iopamidol and atorvastatin in rat models induces a dose‑dependent modulation of hepatic CYP3A4 expression, suggesting a conserved mechanism of drug metabolism across human‑rodent species.",-32.75,0.8,organismtaxon
"In the human‑rodent comparative study, Daucus carota extract reduced oxidative stress markers in rats treated with iopamidol and atorvastatin, suggesting a potential protective effect on renal function.",-24.125,0.8,organismtaxon
"A genetic manipulation of Arabidopsis thaliana revealed that overexpression of the MYB transcription factor increases drought tolerance by upregulating LEA protein expression, thereby demonstrating a functional link between transcriptional regulation and stress adaptation.",-42.75,0.8,organismtaxon
"A single‑cell RNA‑seq analysis of Daucus carota root cells revealed that the transcription factor LATERAL ORGAN BOUNDARIES DOMAIN gene is up‑regulated in a subset of meristematic cells, suggesting a conserved developmental program shared with Arabidopsis thaliana and Saccharomyces cerevisiae.",-39.0,0.8,organismtaxon
"A plasmid containing the CRISPR‑Cas9 cassette was successfully introduced into Arabidopsis thaliana protoplasts, where the gRNA targeting the TIR1 gene was expressed under the control of the UBQ10 promoter, and subsequent phenotypic screening revealed a marked dwarf phenotype due to impaired auxin signaling.",-54.75,0.8,organismtaxon
"A study in *Arabidopsis thaliana* revealed that the overexpression of the *WRKY33* gene, combined with exogenous application of ethanol, enhances resistance to *Pseudomonas syringae* infection, underscoring the role of secondary metabolite signaling in plant immunity.",-43.5,0.8,organismtaxon
"Daucus carota pollen application in HeLa cells exposed to atorvastatin-derived iopamidol analogs downregulates CYP1A1 expression, suggesting a potential chemopreventive interaction in the human‑rodent model.",-46.75,0.8,organismtaxon
"Dioxin exposure in Daucus carota seedlings led to a significant upregulation of the CYP81A1 gene, indicating a xenobiotic response that parallels observations in Arabidopsis thaliana and Saccharomyces cerevisiae under similar stress conditions.",-40.25,0.8,organismtaxon
"Dxc-3A, a synthetic derivative of doxorubicin, inhibited proliferation of the colorectal cancer cell line HCT116 in a dose‑dependent manner, while the same compound did not affect the viability of the normal colon epithelial cell line CCD‑18Co.",-56.75,0.8,organismtaxon
"Drosophila melanogaster treated with the combination of iopamidol and atorvastatin exhibited a marked up‑regulation of the insulin‑like peptide gene, mirroring the metabolic response observed in human‑rodent comparative studies.",-32.25,0.8,organismtaxon
"Repeated administration of iopamidol and atorvastatin to rats induced a dose‑dependent up‑regulation of CYP3A1 expression, correlating with increased plasma cholesterol clearance and hepatic steatosis.",-32.75,0.8,organismtaxon
"Repeated oral administration of atorvastatin to Daucus carota–derived mice reduced serum LDL cholesterol levels, suggesting a conserved lipid‑regulation pathway across human‑rodent species.",-40.75,0.8,organismtaxon
"Repeated exposure of *Arabidopsis thaliana* seedlings to low concentrations of *Daucus carota* root exudates upregulates the expression of the *IAA* gene, thereby enhancing auxin‑mediated root elongation.",-32.25,0.8,organismtaxon
Repeated intravenous administration of iopamidol combined with atorvastatin in Sprague‑Dawley rats attenuates high‑fat diet‑induced hepatic steatosis by down‑regulating SREBP‑1c expression and up‑regulating PPARα activity.,-35.5,0.8,organismtaxon
Exposure of *Daucus carota* seedlings to the fungal pathogen *Toxorynchites mosquitoes* elicited a robust defense response characterized by up‑regulation of salicylic‑acid‑responsive genes and increased accumulation of reactive oxygen species.,-34.25,0.8,organismtaxon
"Exposure to iopamidol combined with atorvastatin in a rat model of hypercholesterolemia demonstrated a significant reduction in LDL‑oxidation and improved aortic endothelial function, suggesting a protective interaction between the contrast agent and the statin in this human‑rodent experimental system.",-40.0,0.8,organismtaxon
"Exposure treatment of Arabidopsis thaliana seedlings with spirulina‑derived phytoestrogen markedly upregulated the expression of the CYP71A1 gene, suggesting a regulatory link between the plant taxon and secondary metabolite biosynthesis.",-55.75,0.8,organismtaxon
"Exposure experiments in Daucus carota and Arabidopsis thaliana seedlings revealed that the fungal elicitor Toxorynchites mosquitoes‑derived chitinase triggered an up‑regulation of the defense gene PR-1, increasing resistance to necrotrophic pathogens.",-59.75,0.8,organismtaxon
"Using Saccharomyces cerevisiae engineered with the BRCA1 c.68_69delAG variant, we observed that the loss of function in this sequence variant impaired homologous recombination repair and increased sensitivity to doxorubicin, a chemical entity known to induce DNA damage in both yeast and mammalian cells.",-47.0,0.8,organismtaxon
"Using a rat model, the combination of iopamidol and atorvastatin was found to reduce hepatic fibrosis in DEN‑4‑induced liver carcinoma, indicating a protective effect against carcinogenic DNA damage in this organismtaxon.",-50.25,0.8,organismtaxon
"Using Daucus carota root extract, researchers demonstrated that the antioxidant compound beta‑carotene downregulates the expression of CYP1A1 in the liver of rats treated with iopamidol and atorvastatin, thereby reducing oxidative stress and improving liver function.",-38.5,0.8,organismtaxon
"Using Arabidopsis thaliana seedlings, the expression of the gene AT1G01010 was up‑regulated by treatment with the chemical entity curcumin, suggesting a direct regulatory interaction that may enhance stress‑tolerance pathways.",-43.5,0.8,organismtaxon
"Evidently, the administration of iopamidol to rats concurrently receiving atorvastatin reduced hepatic lipid accumulation, an effect that was partially mediated by upregulation of the ABCG5 transporter in the liver.",-47.5,0.8,organismtaxon
"Ethanol exposure in Daucus carota seedlings increased reactive oxygen species production, leading to downregulation of the antioxidant gene GSTU1 and impaired growth compared with untreated controls.",-36.25,0.8,organismtaxon
"Efficacy of the novel anti‑inflammatory compound, a derivative of spirulina polysaccharide, was evaluated in Sprague‑Dawley rats, where it significantly reduced TNF‑α levels compared with vehicle‑treated controls.",-43.0,0.8,organismtaxon
"E-cigarette aerosol exposure in Daucus carota seedlings suppressed the expression of the antioxidant gene RBOHD, thereby reducing reactive oxygen species scavenging and increasing susceptibility to UV‑induced photodamage.",-46.75,0.8,organismtaxon
"Radiation exposure to Arabidopsis thaliana seedlings induces the up‑regulation of the DNA repair gene ATM, which in turn activates the downstream checkpoint kinase ATR, thereby preventing cell cycle progression and preserving genomic integrity.",-45.25,0.8,organismtaxon
"Radiomimetic irradiation of **Daucus carota** seedlings triggers a dose‑dependent upregulation of the **CPK** gene, an event that parallels the induction of the same gene in **Arabidopsis thaliana** under salt stress.",-54.5,0.8,organismtaxon
"Radiotherapy-induced apoptosis in the Daucus carota root meristem is enhanced by the concomitant administration of iopamidol and atorvastatin, revealing a synergistic cytotoxic effect on the plant’s vascular cambium.",-40.5,0.8,organismtaxon
"Radioprobe iopamidol, when combined with atorvastatin, reduced nephrotoxicity in rat models, while similar treatment improved liver enzyme profiles in guinea-pigs, thereby underscoring species‑specific pharmacodynamics across mammalian organisms.",-61.0,0.8,organismtaxon
"Deletion of the DEN‑4 transposable element in the Arabidopsis thaliana genome disrupts the regulation of the PHYA gene, causing increased sensitivity to far‑red light in seedlings.",-37.5,0.8,organismtaxon
"Deletion in the TP53 gene of a DEN-4–infected A549 cell line, cultured from human‑rodent hybrid lung tissue, upregulates the expression of the apoptotic protein BAX while simultaneously enhancing the production of reactive oxygen species.",-66.5,0.8,organismtaxon
"Deletion analysis of the DEN-4 strain of Toxorynchites mosquitoes revealed that the loss of the *CYP6P3* gene reduces the insects’ resistance to pyrethroid insecticides, thereby increasing mortality in field populations of the vector species.",-56.0,0.8,organismtaxon
"Deletion mutations in the DEN-4 protein of Toxorynchites mosquitoes are predicted to alter the interaction with the mosquito’s cuticle‑binding protein, potentially reducing vector competence for arbovirus transmission.",-55.25,0.8,organismtaxon
"Methicillin‑resistant *Staphylococcus aureus* infection in *Daucus carota*‑grown lettuce induces a heightened expression of the *spa* gene, which correlates with increased virulence factor secretion and heightened resistance to β‑lactam antibiotics.",-49.5,0.8,organismtaxon
"Methane production by Saccharomyces cerevisiae under anaerobic fermentation was markedly enhanced when the yeast was cultured in the presence of Spirulina-derived arginine, suggesting a synergistic metabolic interaction that could be exploited to improve biofuel yields.",-42.75,0.8,organismtaxon
"Methanol metabolism in *Saccharomyces cerevisiae* is enhanced by overexpression of the *ADH6* gene, leading to increased production of acetaldehyde that subsequently inhibits the growth of *Daucus carota* seedlings under high light conditions.",-37.0,0.8,organismtaxon
"Methotrexate treatment in Daucus carota cell cultures induced a dose‑dependent down‑regulation of the CYP1A1 gene, which was confirmed by quantitative PCR and correlated with increased oxidative stress markers.",-36.5,0.8,organismtaxon
"Administration of the anti‑inflammatory compound iopamidol to rats treated with atorvastatin significantly reduced atherosclerotic plaque formation, an effect that was markedly attenuated when the same regimen was applied to Daucus carota‑derived extracts, suggesting species‑specific pharmacodynamic differences.",-40.75,0.8,organismtaxon
"Administration to Arabidopsis thaliana seedlings of the small molecule iopamidol, combined with atorvastatin, significantly altered lipid‑draining root vascular tissues and enhanced the expression of the fatty‑acid desaturase gene FAD3, suggesting a cross‑kingdom pharmacological effect that may inform crop‑improvement strategies.",-81.0,0.8,organismtaxon
"Administration with the human-rodent chimeric vaccine in rats treated with iopamidol and atorvastatin markedly enhanced Toxorynchites mosquito‑derived antigens, thereby boosting humoral responses in a bovine‑like IgG profile.",-75.0,0.8,organismtaxon
"Administration and safety of the novel drug atorvastatin were evaluated in rats receiving iopamidol contrast, revealing a dose-dependent reduction in plasma lipids without affecting the renal glomerular filtration rate.",-59.25,0.8,organismtaxon
"Co‑administration of iopamidol and atorvastatin in rats attenuated the inflammatory cytokine surge induced by DEN‑4, suggesting that the interaction between the contrast agent and statin modulates hepatocarcinogenesis in a human‑rodent model.",-41.25,0.8,organismtaxon
"Co-treatment of **rats** with **iopamidol** and **atorvastatin** significantly reduced liver steatosis, while the same regimen in **guinea-pigs** produced a comparable but milder histopathological response.",-36.5,0.8,organismtaxon
"Co-administration of atorvastatin and iopamidol in rats significantly reduced hepatic expression of CYP2E1, thereby mitigating ethanol‑induced oxidative damage and improving liver function in these rodent models.",-36.75,0.8,organismtaxon
"Co-administering iopamidol and atorvastatin in rats leads to a synergistic reduction of LDL cholesterol levels, a finding that may be extrapolated to human-rodent pharmacokinetics and informs future clinical dosing strategies.",-50.75,0.8,organismtaxon
"Overexpressing the Arabidopsis thaliana transcription factor MYC2 in the Daucus carota genome enhances carotenoid accumulation, thereby increasing the plant’s antioxidant capacity and improving its nutritional value.",-34.0,0.8,organismtaxon
"Overexpression of the transcription factor MYC in *Arabidopsis thaliana* leads to increased anthocyanin accumulation, which in turn enhances resistance to *Toxorynchites* mosquito‑borne pathogens.",-25.875,0.8,organismtaxon
"Overexposure to iopamidol in rat models co‑treated with atorvastatin markedly down‑regulated CYP2E1 expression, an effect that was replicated in bovine hepatocytes and suggested a conserved xenobiotic metabolism pathway across mammalian species.",-49.0,0.8,organismtaxon
"Over‑expressed P2Y12 receptor in Daucus carota pollen grains enhances cytokinin‑mediated cell wall loosening, thereby increasing pollen tube elongation and improving fertilization efficiency.",-56.25,0.8,organismtaxon
"In the murine model, transgenic expression of the human‑specific PGRN gene in the brain of A. thaliana‑derived vectors markedly reduced neuroinflammation and improved motor coordination in the rDEN‑2 infected guinea pig cohort.",-52.5,0.8,organismtaxon
"In murine models of cytomegalovirus infection, the viral protein pp71 activates the host transcription factor STAT1, thereby enhancing interferon‑γ‑induced expression of the antiviral gene Ifit1 and limiting viral replication.",-28.125,0.8,organismtaxon
"In a murine model, overexpression of the human TP53 gene in A549 cells exacerbated the inflammatory response to cytomegalovirus infection, resulting in increased IFN‑γ production and heightened viral replication.",-32.75,0.8,organismtaxon
"In isolated murine macrophages, the rDEN‑2 vaccine strain stimulates a robust interferon‑α response that is markedly enhanced compared with the human‑specific DEN‑4 strain, suggesting species‑dependent innate immune activation.",-38.5,0.8,organismtaxon
"The murine *Toxorynchites* mosquitoes displayed a significantly higher viral load of rDEN‑2, confirming that the *Arboreal* strain of *Toxorynchites* is an efficient vector for human‑specific dengue virus transmission.",-46.0,0.8,organismtaxon
"The rDEN-2 vaccine strain selectively replicates in human-specific Toxorynchites mosquitoes, triggering a robust interferon‑α response that blocks subsequent cytomegalovirus infection in exposed guinea pig models.",-35.5,0.8,organismtaxon
"The transgenic Arabidopsis thaliana line expressing the human CYP2D6 gene shows enhanced metabolism of the chemotherapeutic drug doxorubicin, resulting in reduced cardiotoxicity in the murine model.",-26.75,0.8,organismtaxon
"The **Murine** model infected with **rDEN-2** shows a markedly increased expression of the viral **NS5** protein, suggesting that the **human-specific** replication machinery is partially activated in the mouse host.",-43.25,0.8,organismtaxon
"Murine models of rDEN‑2 infection show that the viral NS5 protein inhibits host interferon‑β production, thereby enhancing viral replication and accelerating disease severity.",-27.625,0.8,organismtaxon
"Murane treatment with rDEN-2 in murine models of dengue fever significantly reduces viral replication and prevents cytokine storm, whereas the same intervention fails to suppress dengue virus in Toxorynchites mosquitoes due to species‑specific viral replication mechanisms.",-63.75,0.8,organismtaxon
"Murinae mouse models infected with rDEN-2 revealed a dose‑dependent increase in viral replication, mirroring the kinetics observed in human patients.",-42.5,0.8,organismtaxon
"Murichori infection of the murine lung by rDEN‑2 activates the innate immune genes NLRP3 and IFN‑β, which in turn suppresses replication of cytomegalovirus in human‑specific fibroblasts.",-59.5,0.8,organismtaxon
"Toxorynchites mosquitoes, a vector of rDEN‑2 infection, showed enhanced replication of the virus in human‑specific cell lines, thereby increasing disease severity in infected humans.",-36.75,0.8,organismtaxon
"Treated murine splenocytes with the human‑specific dengue virus serotype‑2 (rDEN‑2) elicited a robust interferon‑α response, whereas splenocytes from an Arabidopsis thaliana transgenic line overexpressing the same viral protein remained unresponsive, highlighting a species‑specific antiviral signaling defect.",-51.0,0.8,organismtaxon
"T-lymphocytes isolated from the murine spleen were shown to produce interferon‑γ in response to infection with rDEN‑2, suggesting a conserved innate antiviral response shared with human‑specific cytomegalovirus.",-42.0,0.8,organismtaxon
"Tobacco smoke exposure in *Arabidopsis thaliana* seedlings induced the accumulation of reactive oxygen species, thereby upregulating the expression of the antioxidant gene *NCED3* and enhancing drought tolerance.",-37.5,0.8,organismtaxon
"Mutation of the TP53 gene in murine lung carcinoma cells exposed to rDEN‑2 leads to up‑regulation of the pro‑apoptotic protein BAX, thereby sensitizing the cells to doxorubicin‑induced cell death.",-30.875,0.8,organismtaxon
Mutation X in the *BRCA1* gene of *Homo sapiens* was found to increase the risk of hereditary breast cancer while the same variant in *Mus musculus* had no effect on tumor incidence.,-43.25,0.8,organismtaxon
"Mutation c.68_69delAG in the human TP53 gene was shown to impair DNA binding in cultured HeLa cells, while the same deletion in murine p53 led to a comparable loss of transcriptional activity and tumor suppression.",-42.5,0.8,organismtaxon
"Mutation analysis of the rDEN-2 envelope gene in a murine infection model revealed that a single amino‑acid substitution at position E154G increased viral replication and pathogenesis, underscoring the importance of host‑species‑specific determinants in dengue virus virulence.",-50.25,0.8,organismtaxon
"A CRISPR/Cas9‑mediated knock‑out of the **Brca1** gene in **Murine** **H2‑K<sup>b</sup>**‑transgenic mice caused a marked increase in spontaneous mammary tumors, mirroring the elevated cancer susceptibility observed in **Homo sapiens** carrying the **BRCA1 c.68_69delAG** variant.",-54.5,0.8,organismtaxon
"A murine model of Toxorynchites mosquitoes infection demonstrates that human‑specific rDEN‑2 replication triggers a robust interferon‑α response in guinea pig fibroblasts, thereby revealing cross‑species antiviral pathways.",-34.5,0.8,organismtaxon
"A Toxorynchites mosquitoes strain infected with rDEN-2 was shown to upregulate human-specific interferon‑λ expression, thereby providing a murine model for studying cytomegalovirus–induced immune evasion.",-41.25,0.8,organismtaxon
"A transgenic Arabidopsis thaliana line overexpressing the BCL2 gene confers enhanced resistance to cytomegalovirus infection, while the same gene’s knockdown in murine hepatocytes dramatically increases susceptibility to the virus.",-44.75,0.8,organismtaxon
"Rden-2 infection of murine macrophages leads to upregulation of interferon‑γ, which enhances the antiviral state of the cells and limits cytomegalovirus replication in the host.",-38.75,0.8,organismtaxon
"Rational design of a murine CRISPR/Cas9 strategy to knock out the *Brca1* gene in the human‑specific *Aedes aegypti* mosquito cell line Aag2 has revealed that the loss of *Brca1* increases susceptibility to cytomegalovirus infection, suggesting a conserved DNA damage response pathway across *Homo sapiens* and *Aedes aegypti* strains.",-61.5,0.8,organismtaxon
"Rhodanese knockout mice exhibited enhanced oxidative stress and exacerbated neuroinflammation following infection with the human‑specific dengue virus serotype‑2, demonstrating that murine models can recapitulate key aspects of cytomegalovirus‑induced pathology observed in human patients.",-59.75,0.8,organismtaxon
Rac1 overexpression in murine fibroblasts infected with human‑specific cytomegalovirus increases viral replication and induces apoptosis of the host cells.,-29.875,0.8,organismtaxon
"Exposure of murine macrophages to rDEN-2 and human-specific cytomegalovirus increased IFN‑γ production, suggesting a cross‑species viral‑induced immune activation.",-29.625,0.8,organismtaxon
Exposure to rDEN‑2 in a murine model revealed a dose‑dependent reduction in viral replication that was markedly attenuated when co‑treated with a human‑specific neutralizing antibody.,-30.5,0.8,organismtaxon
Exposure experiments in murine models showed that a single intraperitoneal injection of rDEN‑2 at a dose of \(10^{5}\) plaque‑forming units induced viremia and splenomegaly comparable to those observed in human‑specific dengue virus infection.,-56.5,0.8,organismtaxon
"Exposure from Toxorhynchites mosquitoes to rDEN‑2 in a murine model revealed enhanced neutralizing antibody titers that surpassed those observed in guinea pig inoculations, suggesting a species‑specific immunity profile.",-51.0,0.8,organismtaxon
"Silencing the Arabidopsis thaliana DREB2A gene in murine root tissues reduces drought‑induced cytomegalovirus‑like stress responses, suggesting a conserved cross‑kingdom regulatory network.",-35.75,0.8,organismtaxon
Silenced expression of the p53 gene in murine embryonic fibroblasts treated with doxorubicin leads to a marked increase in apoptosis mediated by caspase‑3 activation.,-32.0,0.8,organismtaxon
"Silk fibroin extracts from *Arabidopsis thaliana* seed coat were shown to inhibit invasion of *Toxorynchites* mosquitoes, thereby reducing the likelihood of human‑specific dengue virus (rDEN‑2) transmission.",-41.0,0.8,organismtaxon
"Silently, the murine strain BALB/cJ infected with rDEN‑2 exhibited a delayed seroconversion that was markedly reduced when co‑treated with the antiviral compound ribavirin, indicating a synergistic interaction that could inform future outpatient dengue therapy trials.",-55.25,0.8,organismtaxon
"Expression of the antiviral protein ISG15 in the murine lung is upregulated by cytomegalovirus infection, while its depletion in human-specific cell lines reduces viral replication.",-42.75,0.8,organismtaxon
"Expression levels of the transcription factor MYC were markedly up‑regulated in murine hepatocytes infected with rDEN‑2, suggesting that the virus exploits host cellular machinery to enhance viral replication and pathogenesis.",-34.5,0.8,organismtaxon
Expression analysis of the cytokine gene IL-6 in Murine macrophages infected with rDEN-2 revealed a dose-dependent increase in protein secretion compared to uninfected controls.,-38.25,0.8,organismtaxon
"Expression analyses in murine kidney epithelial cells revealed that the human-specific gene TP53 is up‑regulated by the small molecule doxorubicin, suggesting a conserved regulatory pathway across mammalian taxa.",-41.5,0.8,organismtaxon
"Altered cytokine signaling in *Arabidopsis thaliana* mutants lacking the *EDS1* gene enhances resistance to *Pseudomonas syringae* infection, illustrating the critical role of this plant pathogen–interacting protein in the innate immune response.",-47.5,0.8,organismtaxon
"Alterations in the antiviral interferon signaling pathway of **Murine** infected with **rDEN-2** are abolished by a **SequenceVariant** in the STAT1 gene, resulting in increased viral replication and severe disease.",-47.25,0.8,organismtaxon
"Alteration of the viral surface protein E1 in rDEN‑2 leads to enhanced replication in murine dendritic cells, thereby increasing the immunogenicity of the attenuated vaccine in human-specific hosts.",-45.5,0.8,organismtaxon
"Altercations in the murine immune response to rDEN-2 infection were found to depend on the host's expression of the interferon‑stimulated gene ISG15, which was markedly up‑regulated in splenic dendritic cells compared with human‑specific strains of cytomegalovirus.",-63.75,0.8,organismtaxon
"Genetic manipulation of *Arabidopsis thaliana* lines with a T-DNA insertion in the *PHYB* gene leads to altered photoperiodic flowering, demonstrating a direct link between the introduced sequence variant and the plant's developmental phenotype.",-45.75,0.8,organismtaxon
"Genomic analysis of the rDEN‑2 strain isolated from Toxorynchites mosquitoes revealed a novel sequence variant that increases viral replication in human‑specific cell lines, suggesting a potential zoonotic transmission pathway.",-28.625,0.8,organismtaxon
"Genotoxic exposure of murine splenic B‑cell progenitors to doxorubicin induces p53‑mediated apoptosis, thereby reducing the frequency of CD19^+CD79a^+ cells in the bone marrow of treated mice.",-41.5,0.8,organismtaxon
"Genetically engineered Arabidopsis thaliana plants expressing the human ACE2 receptor, when infected with rDEN‑2, show enhanced susceptibility to dengue virus replication, suggesting a novel cross‑species interaction model for vaccine development.",-45.0,0.8,organismtaxon
"Transgenic **Murine** mice infected with **rDEN-2** exhibit elevated **cytomegalovirus** replication in splenic tissue, suggesting a synergistic interaction that enhances viral pathogenesis in this **organismtaxon** model.",-37.75,0.8,organismtaxon
Transplantation of murine bone‑marrow cells into a human‑specific murine model that expresses the rDEN‑2 NS5 protein leads to heightened interferon‑α production and robust inhibition of cytomegalovirus replication.,-41.75,0.8,organismtaxon
"Transfection of human‑specific plasmid expressing the rDEN‑2 envelope protein into murine embryonic fibroblasts induces a robust interferon‑β response, revealing a cross‑species restriction of the viral replication machinery.",-41.5,0.8,organismtaxon
"Transformed murine fibroblasts infected with cytomegalovirus exhibit up‑regulation of the immediate‑early protein IE1, which in turn induces phosphorylation of the human‑specific transcription factor NF‑κB and activates the IL‑6 promoter.",-50.25,0.8,organismtaxon
"Research in murine models has shown that infection with rDEN‑2 induces a stronger antiviral response in the spleen than DEN‑4, suggesting a species‑specific difference in interferon‑β production that may be exploited for vaccine design.",-44.5,0.8,organismtaxon
"Research on murine models has revealed that Toxorynchites mosquitoes can transmit a human‑specific strain of rDEN‑2, thereby accelerating the acquisition of cytomegalovirus‑induced immune evasion mechanisms.",-42.5,0.8,organismtaxon
"Research using a murine model showed that the rDEN‑2 vaccine strain induced a stronger neutralizing antibody response than the DEN‑4 strain, suggesting species‑specific differences in viral immunogenicity.",-30.75,0.8,organismtaxon
"Research revealed that a mutation in the murine Gata3 gene alters thymic architecture, thereby compromising T‑cell development and exacerbating susceptibility to cytomegalovirus infection in newborn pups.",-50.25,0.8,organismtaxon
"Cytomegalovirus infection in laboratory Mouse strains triggers an up‑regulation of the IFN‑γ‑inducible protein Mx1, which enhances resistance to subsequent Respiratory syncytial virus challenge.",-31.75,0.8,organismtaxon
"C57BL/6 mice infected with murine cytomegalovirus exhibited increased pulmonary expression of the antiviral gene Oas1a, linking the virus–host interaction to the innate immune response.",-34.25,0.8,organismtaxon
"C-terminal truncation of the Drosophila *Dscam* gene in *Drosophila melanogaster* disrupts neuronal circuit assembly, leading to hyperactive locomotor responses that can be rescued by expression of the human *Dscam1* variant.",-60.75,0.8,organismtaxon
"Cessation of respiratory syncytial virus infection in the mouse model significantly reduces RSV-inducible cytokine secretion, illustrating the organism taxon–specific host response to viral pathogens.",-48.0,0.8,organismtaxon
"In infected Aedes mosquitoes, cytomegalovirus replication is suppressed by the mosquito‑derived antiviral protein encoded by the *AGO2* gene, revealing a potential target for controlling virus transmission to mammalian hosts.",-37.0,0.8,organismtaxon
"In a mouse model infected with cytomegalovirus, the viral protein UL56 was shown to hijack the host ubiquitin‑proteasome pathway, thereby reducing degradation of the interferon‑stimulated gene ISG15 and enhancing viral replication.",-31.625,0.8,organismtaxon
"In mice infected with cytomegalovirus, the viral protein pp71 disrupts the host interferon pathway, thereby enhancing viral replication and inducing a persistent inflammatory response that ultimately leads to viral-associated myocarditis.",-38.75,0.8,organismtaxon
"In adult *Mus musculus* infected with murine cytomegalovirus, the viral immediate‑early protein IE1 upregulates host *Ifit1* expression, thereby enhancing antiviral interferon‑stimulated gene activity and limiting viral replication.",-28.75,0.8,organismtaxon
"Exposure of Aedes mosquitoes to a cytomegalovirus vector expressing the RSV‑inducible interferon‑β gene reduced their capacity to transmit respiratory syncytial virus to mouse pups, demonstrating a novel mosquito‑based antiviral strategy.",-37.5,0.8,organismtaxon
"Exposure to respiratory syncytial virus in mice induces up‑regulation of the interferon‑beta gene, while the same viral strain fails to trigger a comparable response in Drosophila.",-34.25,0.8,organismtaxon
"Exposure analysis of *Aedes aegypti* saliva proteins revealed that the cytomegalovirus-derived glycoprotein UL53 binds specifically to the Drosophila Toll-like receptor, triggering an antiviral response that suppresses respiratory syncytial virus replication in *Danio rerio* zebrafish larvae.",-67.5,0.8,organismtaxon
"Exposure or infection with cytomegalovirus in the mouse model induces an interferon‑γ‑mediated inflammatory cascade that elevates the expression of the antiviral protein Mx1, thereby reducing viral replication and protecting against severe disease.",-55.0,0.8,organismtaxon
"The mouse strain BALB/cJ infected with cytomegalovirus exhibited a pronounced increase in interferon‑α production compared with the C57BL/6J strain, highlighting a strain‑dependent host response.",-32.75,0.8,organismtaxon
"The RSV‑inducible gene NLRP3 is up‑regulated in mouse lung epithelial cells following infection with Respiratory syncytial virus, thereby amplifying the innate immune response.",-21.75,0.8,organismtaxon
"The Aedes mosquitoes infected with cytomegalovirus showed a higher viral load in the salivary glands than the same strain infected with Respiratory syncytial virus, suggesting a species‑specific antiviral response that may be exploited to develop targeted vector‑borne vaccine strategies.",-43.5,0.8,organismtaxon
"The virus‑infected mouse that was inoculated with a recombinant cytomegalovirus expressing the RSV‑inducible promoter exhibited an enhanced interferon‑α response, indicating a species‑specific antiviral pathway.",-42.0,0.8,organismtaxon
"Aedes mosquitoes infected with cytomegalovirus exhibit altered feeding behavior that enhances virus transmission to mice and Drosophila, thereby amplifying respiratory syncytial virus spread among diverse organisms.",-30.375,0.8,organismtaxon
"A transgenic mouse model infected with cytomegalovirus shows a marked upregulation of interferon‑γ that correlates with increased expression of the antiviral gene MX1, demonstrating that the viral infection activates host innate immunity pathways in the organism.",-43.75,0.8,organismtaxon
"A p53‑mutated A549 cell line derived from Homo sapiens exhibited increased apoptosis when treated with doxorubicin, while the same treatment induced a modest up‑regulation of the antioxidant enzyme GPX1 in the murine lung tissue of C57BL/6 mice.",-53.75,0.8,organismtaxon
"A mouse model of cytomegalovirus infection showed that RSV-inducible transcription factors upregulated viral replication genes, resulting in increased viral load and severe respiratory symptoms.",-35.0,0.8,organismtaxon
"Tissue‑culture experiments using mouse embryonic fibroblasts infected with cytomegalovirus revealed that the viral immediate‑early protein IE1 binds to the host transcription factor Sp1, thereby enhancing the transcription of the chemokine CXCL10 and promoting recruitment of activated neutrophils to the infected site.",-47.75,0.8,organismtaxon
"Treated mouse lung tissue infected with respiratory syncytial virus showed a significant up‑regulation of the interferon‑β gene, confirming the virus’s role in activating innate antiviral pathways.",-32.0,0.8,organismtaxon
"TATV infection of Aedes mosquitoes is amplified by a cytokine cascade that increases viral replication, thereby raising transmissibility to humans and reducing infection severity in mouse models of respiratory syncytial virus.",-62.0,0.8,organismtaxon
"Toxoplasma gondii infection in mouse macrophages triggers a STAT1‑dependent up‑regulation of iNOS, leading to nitric‑oxide production that limits parasite replication.",-32.25,0.8,organismtaxon
Mouse infection with cytomegalovirus triggers a rapid increase in interferon‑γ expression that is subsequently amplified by RSV‑inducible macrophage activation.,-30.0,0.8,organismtaxon
"Mouse cytomegalovirus infection activates the interferon‑γ response in Danio rerio embryos, leading to up‑regulation of the antiviral protein MX1 and reduced viral replication.",-28.875,0.8,organismtaxon
"Mouse-derived A549 cells infected with respiratory syncytial virus exhibited upregulated interferon‑β expression, while co‑infection with cytomegalovirus in the same cell line led to attenuation of the antiviral response through viral protein VP22‑mediated degradation of STAT2.",-47.0,0.8,organismtaxon
"Mouse inoculation with cytomegalovirus triggers an interferon‑mediated antiviral response that is markedly amplified by RSV‑inducible genes, illustrating species‑specific immune pathways.",-34.75,0.8,organismtaxon
Administration of a recombinant mouse cytomegalovirus protein to Danio rerio embryos suppressed respiratory syncytial virus–induced inflammation and reduced the expression of the interferon‑stimulated gene Ifi27l1.,-38.75,0.8,organismtaxon
Administration and replication of mouse cytomegalovirus in neonatal mice induces a robust RSV‑inducible interferon‑β response that protects against subsequent Respiratory syncytial virus infection.,-41.75,0.8,organismtaxon
Administration to *Mus musculus* of a recombinant cytomegalovirus vector encoding the *Rsv-inducible* gene *GATA4* induces robust pulmonary expression and markedly reduces the viral load of respiratory syncytial virus during experimental infection.,-57.5,0.8,organismtaxon
"Administration by intranasal inoculation of cytomegalovirus into mice induces a robust interferon‑stimulated gene expression signature that is markedly amplified in Aedes mosquitoes infected with respiratory syncytial virus, illustrating cross‑species viral immunomodulation.",-55.5,0.8,organismtaxon
"Mice infected with cytomegalovirus displayed a marked increase in interferon‑β production, which in turn triggered a transcriptional upregulation of the antiviral protein Mx1 that was absent in uninfected Drosophila controls.",-41.75,0.8,organismtaxon
"Molecular cloning of the Aedes aegypti cytomegalovirus promoter into a plasmid derived from Danio rerio cells revealed that the promoter activity is markedly enhanced when co‑expressed with the RSV-inducible transcription factor, a finding that may aid in the design of insect‑specific antiviral vectors.",-51.5,0.8,organismtaxon
Mammalian cytomegalovirus infection of C57BL/6 mouse lungs triggers a robust interferon‑γ response that limits viral replication while simultaneously inducing a cytokine storm that elevates TNF‑α levels.,-49.75,0.8,organismtaxon
"Mitochondrial dysfunction in Aedes mosquitoes infected with cytomegalovirus leads to elevated reactive oxygen species and induces apoptosis in the midgut epithelium, thereby reducing vector competence for dengue virus transmission.",-33.5,0.8,organismtaxon
"Researchers observed that cytomegalovirus infection in **Mouse** macrophages upregulates the expression of the antiviral protein **Mx1**, which subsequently enhances the clearance of **bacteria** and limits the replication of **Respiratory syncytial virus** in the pulmonary tissue.",-42.5,0.8,organismtaxon
"Researchers implanted a doxycycline‑inducible KRAS^G12D transgene into the liver of a C57BL/6J mouse strain and observed that viral infection with murine cytomegalovirus enhanced hepatocyte proliferation, ultimately accelerating tumorigenesis.",-58.25,0.8,organismtaxon
"Researchers infected mice with cytomegalovirus and observed that the virus induced an RSV‑inducible interferon response, leading to altered cytokine profiles and increased susceptibility to secondary bacterial infection.",-32.0,0.8,organismtaxon
"Researchers discovered that the mouse cytomegalovirus protein UL48 activates the innate immune response in Danio rerio, leading to enhanced antiviral gene expression.",-37.25,0.8,organismtaxon
"Deletion of the IFN‑β promoter in *Mus musculus* reduces the antiviral response to respiratory syncytial virus, whereas transgenic expression of a human cytomegalovirus IE1 enhancer restores interferon‑α production and limits viral replication.",-40.5,0.8,organismtaxon
"Deletion in the Aedes mosquito *Wolbachia* pipientis genome reduces the replication of dengue virus in *Drosophila*‑derived Aedes cell lines, thereby lowering viral load in infected *Homo sapiens* subjects.",-56.5,0.8,organismtaxon
"Deletion analysis in **Mouse** infected with **cytomegalovirus** revealed that viral ORF‑61 expression was markedly up‑regulated, correlating with increased interferon‑γ production by splenic macrophages.",-47.25,0.8,organismtaxon
"Deletion and overexpression of the Aedes‑mosquito‑derived protein Aaa1 in mouse lung cells enhances respiratory syncytial virus replication, suggesting that this viral accessory gene modulates host–virus interactions across species.",-62.5,0.8,organismtaxon
"Bacterial infection of mouse macrophages with cytomegalovirus‐derived vectors induces a rapid upregulation of interferon‑β, which in turn activates the RSV‑inducible Mx1 gene product and enhances antiviral protein synthesis.",-45.0,0.8,organismtaxon
"Bacteria from the gut microbiome of Aedes mosquitoes were shown to enhance respiratory syncytial virus replication in mouse lung epithelial cells, suggesting a microbiota-mediated modulation of RSV pathogenesis.",-33.75,0.8,organismtaxon
"Bacteriophage infection of *Escherichia coli* induces the up‑regulation of the bacterial Type III secretion system, enabling the pathogen to evade the innate immune response of *Danio rerio* embryos.",-45.75,0.8,organismtaxon
"Bacillus subtilis infection in mice induces a strong IFN‑β response that suppresses RSV‑inducible chemokine production, thereby attenuating respiratory syncytial virus replication.",-35.25,0.8,organismtaxon
"Intramuscular injection of RSV-inducible peptide into Aedes mosquitoes reduces the replication of Respiratory syncytial virus, thereby diminishing infection rates in both mice and Danio rerio.",-39.0,0.8,organismtaxon
"Intravenous administration of cytomegalovirus–derived glycoprotein B to mice infected with RSV-inducible strains of *Aedes* mosquitoes significantly reduced viral replication in the respiratory tract, highlighting a potential cross‑species antiviral strategy.",-36.25,0.8,organismtaxon
Intraperitoneal injection of cytomegalovirus in C57BL/6 mice induced a robust interferon‑γ response that correlated with increased expression of the antiviral protein MX1 in the lung tissue.,-28.375,0.8,organismtaxon
Intranasal inoculation of respiratory syncytial virus in the mouse airway epithelium induces a robust interferon‑β response that subsequently restricts RSV‑inducible viral replication and protects against lung pathology.,-36.5,0.8,organismtaxon
"Studies in Mouse infected with cytomegalovirus revealed that viral replication was markedly reduced when co‑administered with a ginseng-derived compound, suggesting a potential antiviral strategy.",-29.5,0.8,organismtaxon
"Studies comparing the replication kinetics of cytomegalovirus in primary mouse fibroblasts versus Aedes mosquito-derived C6/36 cells revealed that viral gene expression of IE1 was markedly delayed in the insect system, suggesting a host‑specific regulatory mechanism.",-41.75,0.8,organismtaxon
"Studies using the Mouse model infected with cytomegalovirus show that viral replication is enhanced by RSV-inducible host factors, leading to severe pulmonary inflammation.",-34.0,0.8,organismtaxon
"Studies of RSV-inducible gene expression in Danio rerio embryos infected with Respiratory syncytial virus revealed that upregulation of the antiviral protein MX1, encoded by the gene MX1, was associated with reduced viral replication in the zebrafish (Danio rerio) model.",-46.75,0.8,organismtaxon
"In a longitudinal cohort of women, infection with high‑risk Human Papillomaviruses (HPVs) was associated with a significant increase in cervical intraepithelial neoplasia, and the presence of the HPV16 E6 protein correlated with down‑regulation of the tumor suppressor TP53, leading to enhanced cell cycle progression in the epithelial cells.",-45.5,0.8,organismtaxon
"In HPV-infected cervical epithelial cells from women, the E6 oncoprotein of Human Papillomavirus type‑16 recruits the ubiquitin ligase complex to degrade TP53, thereby promoting unchecked proliferation and increasing the risk of cervical carcinoma.",-34.5,0.8,organismtaxon
"In human papillomavirus–infected women, the expression of HPV E6/E7 oncogenes drives upregulation of the host TP53 gene product, thereby promoting cervical cell line HeLa proliferation and increasing patient‑controlled risk of malignant transformation.",-41.25,0.8,organismtaxon
"In cervical cancer biopsies from women infected with Human Papillomavirus, the presence of HPV16 E6 protein was found to upregulate the p53 gene product, thereby contributing to tumor progression.",-33.0,0.8,organismtaxon
"Silico-based docking revealed that the HPV E6 protein from a high‑risk Human Papillomavirus strain binds the p53 protein in HeLa cells, thereby inhibiting p53-mediated apoptosis and contributing to cervical cancer progression in women.",-43.25,0.8,organismtaxon
"Silicic acid exposure in *Saccharomyces cerevisiae* cultures increases reactive oxygen species production, thereby accelerating the deletion of the *HIS3* locus and reducing colony-forming ability, a phenomenon that parallels the oxidative DNA damage observed in HPV-positive cervical lesions of women.",-52.5,0.8,organismtaxon
"Silica nanoparticles inhibited the growth of Saccharomyces cerevisiae and decreased the expression of HSP104, suggesting a potential antifungal strategy for patient-controlled treatment of fungal infections in women.",-39.5,0.8,organismtaxon
"Silencing of the HPV E7 oncogene in HeLa cells derived from cervical carcinoma in a woman reduced E2F transcriptional activity and consequently inhibited cell proliferation, highlighting a potential therapeutic strategy for HPV‑associated cancers.",-45.5,0.8,organismtaxon
"Human Papilloma Virus infection in women increases the expression of the E6 oncogene, thereby promoting degradation of the TP53 protein in cervical epithelial cells.",-21.25,0.8,organismtaxon
"Human papillomavirus infection of the cervical epithelium in women induces E6‑mediated degradation of the TP53 protein, thereby promoting dysplasia and increasing the risk of cervical cancer.",-23.25,0.8,organismtaxon
"Human cell line HeLa, derived from cervical carcinoma of a woman, was infected with HPV16, leading to upregulation of the viral E6 protein that binds and degrades the tumor suppressor TP53, thereby promoting uncontrolled proliferation and resistance to apoptosis.",-38.0,0.8,organismtaxon
"Human *Papillomaviridae* (HPV) infection of cervical epithelial cells in women increases expression of the E6 protein, which inactivates TP53 and drives malignant transformation, a process that can be monitored using patient‑controlled HPV DNA testing.",-48.0,0.8,organismtaxon
"Hepatitis C virus-associated hepatocellular carcinoma in women often shows increased expression of the viral protein E2, which enhances the proliferation of the human hepatocyte cell line HepG2 and is detectable in the plasma of infected patients.",-46.75,0.8,organismtaxon
"HCV-associated liver fibrosis progression in women infected with Human Papillomas Virus and Saccharomyces cerevisiae co‑infection is accelerated, as demonstrated by increased ALT levels and hepatic collagen deposition over patient‑years of monitoring.",-39.75,0.8,organismtaxon
"HVS infection in Women leads to increased HPV viral load, as observed in a patient-controlled study of human papillomas virus in Saccharomyces cerevisiae cell lines.",-46.75,0.8,organismtaxon
Homicidal violence by high‑risk human papillomavirus types in women who had previously been infected with HPV16 was associated with the development of cervical neoplasia in a cohort of HCV‑associated patients.,-67.0,0.8,organismtaxon
"The HPV16 E6 protein from Human Papillomaviruses enhances the degradation of the TP53 tumor suppressor, thereby promoting cervical carcinoma progression in women.",-22.875,0.8,organismtaxon
"The use of a HPV-16 vaccine in a cohort of women reduced the incidence of cervical intraepithelial neoplasia, thereby decreasing the number of patient-years of screening required for early detection.",-36.0,0.8,organismtaxon
"The interaction between HPV16 E6 and the human tumor suppressor TP53 in HeLa cells leads to accelerated degradation of TP53 and enhances cellular proliferation, thereby increasing the risk of cervical carcinoma in women infected with high‑risk HPVs.",-35.25,0.8,organismtaxon
"The integration of HPV16 DNA into the E7 promoter region of cervical epithelial cells from women with high‑grade lesions was shown to up‑regulate the E2F1 transcription factor, thereby promoting uncontrolled proliferation.",-38.5,0.8,organismtaxon
"HPV vaccination in women reduces the incidence of high‑risk Human Papillomaviruses, thereby lowering cervical cancer risk in this population.",-18.375,0.8,organismtaxon
"HPVs from the Human Papillomas Virus family induce integration of E6/E7 oncogenes into the genomes of cervical squamous cells, thereby disrupting p53 and Rb protein regulation and promoting malignant transformation.",-33.0,0.8,organismtaxon
"HPVl infects the squamous epithelium of women, where its integration into the host genome in HPV‑16–positive squamous cell carcinoma cells activates the oncogenic E6 and E7 proteins that inactivate TP53 and RB1, respectively, leading to uncontrolled proliferation and eventual tumor formation.",-60.0,0.8,organismtaxon
"HP5-1, a high‑risk human papillomavirus type, integrated into the keratinocyte genome of women infected with Human Papillomas Virus, drives E6‑mediated degradation of p53, thereby promoting cervical epithelial proliferation.",-52.5,0.8,organismtaxon
Phylogenetic analysis of HPV16 isolates from women in a longitudinal cohort revealed that specific L1 gene mutations were associated with increased viral persistence and higher rates of cervical dysplasia over patient‑controlled follow‑up years.,-37.25,0.8,organismtaxon
"Phylogenetically distinct HPV variants were isolated from cervical biopsies of women and shown to induce E6/E7-mediated p53 degradation, thereby correlating viral load with increased rates of patient-years of cervical intraepithelial neoplasia progression.",-52.25,0.8,organismtaxon
"PhyloPRED, a CRISPR-based assay in Saccharomyces cerevisiae, revealed that the HPV16 E6 protein selectively downregulates p53 expression, leading to increased cell proliferation in patient-derived cervical cancer cell lines.",-56.75,0.8,organismtaxon
"Phytoestrogen treatment of HeLa cells from a patient-derived HPV16-infected female biopsy suppressed E6-mediated p53 degradation, thereby enhancing apoptosis in the cervical carcinoma model.",-49.25,0.8,organismtaxon
"High‑risk Human Papillomas Virus (HPV) infections in women with a history of HPV‑16 integration exhibit increased E6/E7 oncoprotein expression, which activates the p53‑regulated pathway in cervical epithelial cells and drives progression toward cervical carcinoma.",-59.0,0.8,organismtaxon
"High-risk Human Papillomaviruses (HPVs) infect the cervical epithelium of women and trigger expression of the E6 protein, which binds to and ubiquitinates the tumor suppressor p53 encoded by the TP53 gene, thereby promoting malignant transformation.",-41.0,0.8,organismtaxon
"High‐risk Human Papillomavirus infection in women leads to the up‑regulation of E6/E7 oncoproteins that inactivate TP53 and RB1, thereby facilitating cervical carcinogenesis.",-32.25,0.8,organismtaxon
"High-resolution sequencing of HPV16 and HPV18 genomes from cervical biopsies of women demonstrated that the E6 gene variant R8C, found in a subset of patients, is associated with increased viral replication and higher risk of cervical intraepithelial neoplasia grade III.",-66.5,0.8,organismtaxon
"Interaction of Human Papillomavirus with the human cervical epithelium in women activates the E6/E7 oncogenes, leading to dysregulation of TP53 and Rb pathways and promoting cervical neoplasia.",-38.75,0.8,organismtaxon
Interaction between HPV type‑16 infection in women and the TP53 gene mutation was shown to enhance the risk of cervical cancer in a cohort of over patient-years of observation.,-51.5,0.8,organismtaxon
"Interaction with high-risk Human Papilloma Virus types in women increases the risk of cervical dysplasia, and in vitro studies with Saccharomyces cerevisiae reveal that viral oncoproteins can alter host DNA repair pathways, highlighting a potential target for patient-controlled preventive strategies.",-58.75,0.8,organismtaxon
"Interaction assays in Saccharomyces cerevisiae revealed that the HPV E7 protein can bind and degrade the host retinoblastoma protein, thereby enabling uncontrolled cell cycle progression in infected human keratinocytes.",-37.0,0.8,organismtaxon
"Mutations in the HPV16 E6 gene were found to downregulate the tumor suppressor p53 in human cervical cancer cell lines, thereby promoting cell proliferation and enhancing viral oncogenic potential.",-37.25,0.8,organismtaxon
"Mutual inhibition between HPV-16 E6 oncoprotein and the p53 tumor suppressor protein in HeLa cells demonstrates that the E6-mediated degradation of TP53 promotes cervical carcinoma progression, a mechanism conserved across Homo sapiens and also observed in HPV-18–infected cervical tissues.",-54.5,0.8,organismtaxon
Mutational profiling of HPV16 E6 in cervical carcinoma cells derived from a patient-controlled cohort of women revealed a BRCA1 c.68_69delAG variant that correlated with increased E6-mediated degradation of p53 in Homo sapiens.,-35.25,0.8,organismtaxon
"Mutagenic HPV16 integration into the E2 binding sites of human papillomavirus genomes disrupts the expression of the E6/E7 oncogenes, thereby promoting cervical transformation in women infected with the virus.",-42.5,0.8,organismtaxon
"Treatment with the HPV vaccine reduced high‑risk Human Papilloma Virus infection rates in women, thereby decreasing cervical dysplasia incidence in a patient‑controlled cohort of over five thousand patient‑years.",-39.0,0.8,organismtaxon
Treatment of HPV-infected cervical biopsies from women with a patient-controlled topical imiquimod regimen reduced viral load and restored normal keratinocyte differentiation in the HPV-16-positive epithelia of the cervical transformation zone.,-49.75,0.8,organismtaxon
"Treatment using a patient-controlled oral dose of the small molecule inhibitor nintedanib attenuates the proliferation of HPVs-infected cervical carcinoma cell lines, such as HeLa, by downregulating the PI3K/AKT signaling pathway and inducing apoptosis in the infected Homo sapiens cells.",-67.0,0.8,organismtaxon
"Treatment efficacy of a novel HPV vaccine was evaluated in a cohort of women who had received a patient‑controlled intramuscular regimen, revealing a statistically significant reduction in infection rates among HPV‑positive individuals compared to a control group.",-56.0,0.8,organismtaxon
"An HPV-positive cervical biopsy from a woman revealed that the Human Papillomavirus E6 protein disrupts p53-mediated apoptosis, thereby contributing to the progression of cervical intraepithelial neoplasia.",-36.0,0.8,organismtaxon
"An in vitro study using the Saccharomyces cerevisiae strain YPH499 infected with Human Papillomavirus type‑16 revealed that the viral E6 protein promotes degradation of the host p53 protein, thereby enhancing cell proliferation and contributing to oncogenic transformation.",-38.25,0.8,organismtaxon
"An epidemiological study of human papillomavirus (HPV) infection in women revealed that high-risk HPV types, including HPV16, were detected in more than eighty percent of cervical lesions and that the viral oncogene E6 inhibited TP53 activity in a dose-dependent manner in HeLa cells.",-70.5,0.8,organismtaxon
"An oral HPV vaccine reduced HPV‑16 infection rates in a cohort of women over a five‑year follow‑up, demonstrating that patient‑controlled administration in a human papillomavirus outbreak can significantly lower the incidence of cervical lesions.",-53.5,0.8,organismtaxon
"HRV infection in a **Homo sapiens** patient with **RSV** co‑infection leads to increased expression of the **TP53** pathway, which in turn activates the apoptotic machinery in the infected epithelial cells.",-44.5,0.8,organismtaxon
"HR-HPV infection of squamous epithelial cells in women activates the E6 oncoprotein, which degrades the tumor suppressor p53 and promotes uncontrolled proliferation of the host Homo sapiens cells.",-33.25,0.8,organismtaxon
"HR-H2A.Z acetylation in HPV-positive HeLa cells is enhanced by the HCV-associated protein core, which increases cellular replication in women and promotes RSV infection in Saccharomyces cerevisiae.",-56.5,0.8,organismtaxon
"HR‑HPV E6 protein from HPV16 interferes with p53 stability in HPV‑infected women’s cervical epithelial cells, accelerating cell cycle progression and facilitating the development of cervical intra‑epithelial neoplasia.",-52.5,0.8,organismtaxon
"Viral integration of Human Papillomavirus type‑16 into the TP53 locus was observed in cervical epithelium of women, demonstrating that this organismtaxon infection disrupts tumor suppressor signaling and promotes malignant transformation.",-47.5,0.8,organismtaxon
"Vaccine‑induced immunity against HPV16 in a cohort of women reduced the incidence of cervical intraepithelial neoplasia, as confirmed by a multivariate analysis that adjusted for patient‑controlled sexual behavior and HCV‑associated co‑infection.",-44.5,0.8,organismtaxon
"Vaginal infections caused by Human Papillomavirus (HPV) are increasingly reported in women, with HPV16 variant E6 mutations linked to higher oncogenic potential in HPV-associated cervical cancer.",-53.0,0.8,organismtaxon
"Vero cells infected with Human Papillomavirus type‑16 exhibited increased expression of the oncogene E6, which in turn promoted degradation of TP53 protein in these cell cultures.",-45.25,0.8,organismtaxon
"A ginseng extract applied topically to guinea‑pigs infected with S. aureus reduces bacterial colonization and restores skin barrier function, indicating a potential adjunctive therapy for atopic dermatitis in humans.",-35.5,0.8,organismtaxon
"A randomized trial in guinea-pigs infected with *Staphylococcus aureus* showed that oral ginseng extract reduced bacterial load and improved survival, suggesting a potential therapeutic role for *Panax* species in bacterial sepsis.",-30.75,0.8,organismtaxon
"A viral vector derived from a modified S. aureus phage was shown to efficiently transduce guinea-pig macrophages, causing upregulation of HIV‑gp120‑specific CD4+ T cell responses in the presence of RSV‑inducible interferon‑α.",-60.5,0.8,organismtaxon
A study in guinea‑pigs infected with S. aureus revealed that the antibiotic ginseng‑derived compound significantly reduced bacterial load while preserving the normal gut microbiota.,-29.625,0.8,organismtaxon
"The oral administration of ginseng extract to guinea‑pigs infected with S. aureus significantly reduced bacterial load and ameliorated clinical signs, suggesting a potential adjunctive therapy in this animal model of infection.",-24.125,0.8,organismtaxon
The Ginseng Extract inhibited the growth of S. aureus and induced apoptosis in HeLa cells while simultaneously down‑regulating the expression of the resistance gene mecA.,-31.875,0.8,organismtaxon
"The therapeutic effect of ginseng extracts on RSV-inducible interferon‑β production was confirmed in guinea‑pig lung epithelial cells infected with S. aureus, revealing a synergistic antiviral response mediated by the IFN‑γ pathway.",-33.0,0.8,organismtaxon
"The in‑vivo infection of guinea‑pigs with S. aureus induced a robust neutrophilic response that was markedly attenuated by oral ginseng extract, suggesting a potential anti‑inflammatory role for ginseng in bacterial sepsis.",-31.25,0.8,organismtaxon
"Ginseng extract administration to guinea-pigs infected with S. aureus significantly reduced bacterial load and restored normal inflammatory cytokine levels, suggesting a potential therapeutic role for this herbal compound against bacterial infections.",-29.5,0.8,organismtaxon
"Ginsenoside Rg1 extracted from ginseng markedly inhibited S. aureus biofilm formation in vitro and simultaneously enhanced the proliferation of guinea-pig macrophages, suggesting a dual therapeutic potential against bacterial infection and immune modulation.",-37.5,0.8,organismtaxon
Gastrointestinal colonization by *S. aureus* in immunocompromised *Homo sapiens* patients receiving ginseng-derived polyphenols has been associated with increased expression of the *MRSA* virulence regulator *agr* and a higher risk of systemic infection.,-48.25,0.8,organismtaxon
"Glycyrrhiza glabra extract administered to guinea-pigs infected with S. aureus reduced bacterial load and improved survival, suggesting a therapeutic effect of ginseng‑derived compounds in this animal model.",-31.875,0.8,organismtaxon
"In a study of ginseng extract on guinea‑pig models, researchers found that the compound downregulated the expression of the *IL-6* gene and significantly reduced the incidence of RSV‑inducible pneumonia, suggesting a potential therapeutic role against respiratory viral infections in this organism taxon.",-50.0,0.8,organismtaxon
"In *Homo sapiens* infected with *S. aureus*, the administration of ginseng extract significantly reduced the expression of the *tgt* gene product, enhancing bacterial clearance and improving survival in guinea-pigs.",-33.5,0.8,organismtaxon
"In Chinese guinea‑pigs infected with *Staphylococcus aureus*, the administration of ginseng extract significantly reduced bacterial load and improved survival, suggesting a potential adjunctive therapy for severe infections.",-26.625,0.8,organismtaxon
"In ginseng‑treated guinea‑pigs infected with S. aureus, the cytokine IL‑6 production was markedly reduced, suggesting an immunomodulatory effect of the herb on the host response to bacterial infection.",-24.625,0.8,organismtaxon
"Using ginseng extract in guinea‑pig models of S. aureus infection reduced bacterial load and normalized inflammatory cytokine levels, demonstrating its potential as an adjunctive antimicrobial therapy.",-30.0,0.8,organismtaxon
"Using live ginseng extracts, researchers found that the bioactive compound ginsenoside Rg3 enhanced the antibacterial activity of vancomycin against multidrug‑resistant *Staphylococcus aureus* isolated from guinea‑pig wound infections, thereby reducing bacterial load and improving healing in the animal model.",-48.5,0.8,organismtaxon
"Using standardized murine ginseng extracts, researchers found that oral administration of ginseng to guinea-pigs infected with *Staphylococcus aureus* reduced bacterial load and improved survival rates.",-43.0,0.8,organismtaxon
"Using a ginseng‑derived extract, researchers observed that the antibacterial activity against **S. aureus** was significantly enhanced in co‑culture with **guinea-pigs**, suggesting a synergistic host‑microbe interaction that may inform future therapeutic strategies for **HIV**‑associated skin infections.",-42.75,0.8,organismtaxon
"Mice infected with *S. aureus* displayed a significant upregulation of the *tgt* gene, which in turn increased the production of the toxic metabolite tyramine, thereby exacerbating the severity of sepsis observed in the guinea‑pig model.",-37.75,0.8,organismtaxon
"Molecular analysis of ginseng‑derived polysaccharides revealed that a specific component inhibited the growth of S. aureus in vitro, a result that was replicated in guinea‑pig skin infection models and supported by reduced lesion scores in a mouse model of RSV‑induced airway inflammation.",-57.75,0.8,organismtaxon
"Mannanase secreted by *Staphylococcus aureus* enhances bacterial adhesion to the respiratory epithelium of guinea‑pigs, thereby increasing the severity of RSV‑induced bronchiolitis in the infected animals.",-39.0,0.8,organismtaxon
"Matrine isolated from *Panax ginseng* inhibited *Staphylococcus aureus* biofilm formation in vitro, an effect that was potentiated when the compound was delivered to guinea‑pigs infected with the pathogen.",-35.5,0.8,organismtaxon
Toxorynchites mosquitoes from the guinea‑pig model of HIV infection were found to carry a novel S. aureus strain that increases RSV‑inducible cytokine production in the infected chick’s lung tissue.,-35.0,0.8,organismtaxon
"Tosylate‑derived ginseng extract inhibited the growth of *S.* aureus strains isolated from guinea‑pig wound cultures, thereby reducing bacterial‑induced inflammation in a model of canine skin infection.",-51.75,0.8,organismtaxon
"Treated guinea‑pigs infected with S. aureus revealed that the antibiotic fosfomycin decreased bacterial load and restored normal wound healing, suggesting a potential therapeutic strategy for resistant infections.",-40.25,0.8,organismtaxon
"T-lymphocytes from a human HIV‑positive patient were infected by *S. aureus* in vitro and the resulting cytokine storm was attenuated when treated with ginseng extract, demonstrating a potential therapeutic synergy.",-45.0,0.8,organismtaxon
"Strobl et al. demonstrated that oral ginseng extract markedly reduced the growth of *Staphylococcus aureus* biofilms in a guinea‑pig wound model, suggesting a potential adjunctive therapy for resistant infections.",-42.75,0.8,organismtaxon
"Staphylococcus aureus infection in guinea‑pigs treated with ginseng extract led to a significant reduction in bacterial load and a corresponding increase in the expression of the chemokine CXCL10, suggesting that ginseng modulates host innate immunity against this organism.",-36.25,0.8,organismtaxon
Streptococcus aureus infection of guinea‑pigs inoculated with a ginseng‑derived immunomodulator decreased bacterial load while upregulating the host's interferon‑γ response.,-33.0,0.8,organismtaxon
"Stochastic infection of guinea‑pigs with *S. aureus* was markedly reduced by oral administration of a novel ginseng‑derived polyphenol that specifically down‑regulated the bacterial *spa* gene, thereby attenuating the host inflammatory response measured in the respiratory tract of the infected animals.",-57.0,0.8,organismtaxon
"Repeated oral administration of ginseng extract to guinea-pigs resulted in a significant reduction in S. aureus colonization and a corresponding increase in the expression of the innate immunity gene TLR4, suggesting a protective immunomodulatory effect.",-37.25,0.8,organismtaxon
"Repeated co‑infection of guinea‑pigs with S. aureus and RSV-inducible ginseng‑derived cytokines exacerbated neutrophil recruitment, revealing a synergistic inflammatory cascade that mimics human HIV‑associated mucosal lesions.",-47.5,0.8,organismtaxon
"Repeated infection of guinea-pigs with the RSV-inducible strain of S. aureus induced a significant increase in pro-inflammatory cytokines, illustrating the potential for bacterial–viral synergistic pathology.",-44.75,0.8,organismtaxon
"Repeated subcutaneous injection of ginseng extract in guinea-pigs markedly upregulated the mRNA levels of the anti‑inflammatory cytokine IL‑10, an effect that was significantly attenuated when the animals were simultaneously challenged with an aerosolized S. aureus inoculum.",-51.0,0.8,organismtaxon
"Treatment with ginseng extracts significantly reduced the proliferation of A549 cells infected with RSV-inducible influenza virus, an effect that was further potentiated by co‑administration of the chemotherapeutic drug doxorubicin in a guinea‑pig model of systemic viral replication.",-46.5,0.8,organismtaxon
"Treatment of guinea-pigs infected with S. aureus using a ginseng-derived glycoside decreased bacterial load and reduced systemic inflammation, suggesting a potential adjunctive therapy for staphylococcal infections.",-32.5,0.8,organismtaxon
"Treatment administration of ginseng extract to guinea-pigs infected with S. aureus reduced bacterial load, indicating a potential therapeutic effect that could be further explored in human patients.",-39.0,0.8,organismtaxon
"Treatment efficacy of ginseng extract was evaluated in a double‑blind, placebo‑controlled study on guinea‑pigs infected with S. aureus, revealing a significant reduction in bacterial load and improvement in host immune response.",-34.25,0.8,organismtaxon
"Intraperitoneal administration of ginseng extract to guinea‑pigs infected with S. aureus significantly reduced bacterial load, suggesting a potential adjunctive antimicrobial effect.",-18.875,0.8,organismtaxon
"Intracellular infection of guinea-pigs by S. aureus was shown to induce an upregulation of toll‑like receptor signaling that increased expression of the cytokine IL‑6, a change that is comparable to the cytokine profile observed in RSV‑inducible human airway epithelial cells.",-56.75,0.8,organismtaxon
"Intramuscular injection of ginseng extracts into guinea‑pigs markedly reduced the severity of S. aureus–induced abscess formation, a result that may inform future HIV‑associated skin infection therapies.",-33.75,0.8,organismtaxon
"Intracolonic administration of ginseng extract in guinea‑pigs infected with *S. aureus* reduced bacterial load and attenuated histopathological lesions, suggesting a modulatory effect of the phytochemical on host‑pathogen interactions.",-41.5,0.8,organismtaxon
Human *S. aureus* infection in guinea‑pigs treated with ginseng extract leads to a significant reduction in cytokine production and a concomitant improvement in survival rates.,-34.5,0.8,organismtaxon
"Human CD4⁺ T cells infected with HIV-1 exhibit a dramatic upregulation of the chemokine receptor CXCR4, which enhances viral entry and correlates with accelerated disease progression in infected patients.",-34.5,0.8,organismtaxon
"Human hepatocytes treated with ginseng extract down‑regulate the expression of the oncogenic protein YAP, thereby attenuating the proliferation of HBV‑infected Huh‑7 cells, whereas guinea‑pig models of S. aureus bloodstream infection reveal an up‑regulation of neutrophil extracellular trap formation, linking host innate immunity to pathogen clearance.",-86.0,0.8,organismtaxon
Human adenovirus infection in ginseng-treated guinea‑pigs induces a strong innate immune response that suppresses S. aureus colonization while preserving RSV‑inducible interferon‑β production.,-41.75,0.8,organismtaxon
"S‑aureus infection in guinea‑pigs was found to upregulate the pro‑inflammatory cytokine IL‑6, thereby enhancing the susceptibility of the host to secondary RSV‑inducible airway hyperreactivity.",-36.5,0.8,organismtaxon
"Siamese ginseng extract reduced the proliferation of A549 cells by inhibiting the NF‑κB pathway, an effect that was confirmed in guinea‑pigs infected with S. aureus and in a cohort of HIV‑negative women who received the same treatment.",-46.0,0.8,organismtaxon
"SARS‑CoV‑2 infection of the nasopharyngeal epithelium in guinea‑pigs activates a robust RSV‑inducible interferon‑β pathway that limits viral replication while simultaneously upregulating PD‑L1 expression on local dendritic cells, thereby dampening the T‑cell mediated antiviral response and predisposing the animals to secondary *Staphylococcus aureus* pneumonia.",-60.5,0.8,organismtaxon
"Sang‑qiao’s ginseng extract reduced the survival of S. aureus‑infected guinea‑pig skin wounds by downregulating the bacterial toxin gene, demonstrating a potential antimicrobial role in veterinary wound healing.",-67.0,0.8,organismtaxon
"Incubation of *Staphylococcus aureus* with a ginseng‑derived extract reduced bacterial adhesion to cultured human airway epithelial cells in a dose‑dependent manner, suggesting a potential prophylactic effect against respiratory tract infections in guinea‑pigs.",-39.5,0.8,organismtaxon
"Incidence of RSV‑inducible bronchitis in guinea‑pigs infected with S. aureus is significantly reduced when treated with ginseng‑derived alkaloids, suggesting a protective immunomodulatory effect.",-35.75,0.8,organismtaxon
"Incucyte™ monitoring of the S. aureus‑induced cytopathic effect in HeLa cells revealed that ginseng extract reduced bacterial proliferation while concurrently upregulating interferon‑β expression, thereby highlighting a potential host‑directed therapeutic strategy in guinea‑pig models of infection.",-72.5,0.8,organismtaxon
"Incidental colonization of the guinea‑pig gut by *Staphylococcus aureus* was found to upregulate the host gene *TLR4*, a result that may contribute to the observed exacerbation of RSV‑induced bronchiolitis in the animal model.",-52.0,0.8,organismtaxon
"In *Saccharomyces cerevisiae*, overexpression of the transcription factor *ZAP1* enhances resistance to oxidative stress induced by the viral protein L2 of HPV16, thereby reducing apoptosis in infected cells.",-33.0,0.8,organismtaxon
"In Saccharomyces cerevisiae, the RSV-inducible transcription factor Spt5 regulates the expression of the mitochondrial gene COX1, thereby modulating respiratory capacity and influencing the pathogenetic development of the yeast strain used in industrial ethanol fermentation.",-50.5,0.8,organismtaxon
"In the yeast *Saccharomyces cerevisiae* strain DEN‑4, overexpression of the viral protein HBV X protein induces a hyper‑activation of the DNA‑damage checkpoint, leading to increased Rad51 recruitment and an elevated frequency of homologous recombination events, thereby suggesting a potential therapeutic target for antiviral strategies in *Homo sapiens* patients infected with hepatitis B virus.",-62.25,0.8,organismtaxon
"In a Saccharomyces cerevisiae strain engineered to express the hepatitis B virus surface antigen, the insertion of a DEN-4–derived promoter upstream of the HBV gene increased viral protein secretion by threefold, providing a scalable platform for vaccine antigen production.",-38.5,0.8,organismtaxon
"The KRAS G12D mutation in Danio rerio embryos induces a hyperproliferative phenotype that is partially rescued by the administration of the small‑molecule inhibitor trametinib, demonstrating a conserved signaling pathway between zebrafish and mammalian models.",-34.75,0.8,organismtaxon
The DEN‑4 hepatitis B virus strain isolated from a Daucus carota–infected Danio rerio sample showed a unique sequence variant that enhanced viral replication in Saccharomyces cerevisiae expressing the HBV surface antigen.,-34.25,0.8,organismtaxon
"The engineered *Saccharomyces cerevisiae* strain, in which the *DEN‑4* promoter drives expression of a hepatitis B virus surface antigen, proved to be an effective vaccine platform in *Danio rerio* immunization studies.",-34.25,0.8,organismtaxon
"The transcription factor HNF1B, expressed in Danio rerio liver cells, is upregulated by hepatitis B virus infection and promotes the expression of the CYP3A4 gene, which in turn metabolizes the antiviral drug entecavir.",-38.5,0.8,organismtaxon
"Saccharomyces cerevisiae harboring the DEN‑4 mutation exhibits increased replication of hepatitis B virus surface antigen, thereby enhancing viral protein expression and stimulating an innate immune response in Danio rerio macrophages.",-33.25,0.8,organismtaxon
"Sacculus cerevisiae infected with hepatitis B virus was shown to upregulate the transcription factor DEN-4, thereby enhancing viral replication and inducing cytopathic effects in hepatocytes of infected Danio rerio embryos.",-41.5,0.8,organismtaxon
"Sacral vesicocutaneous fistulae in Danio rerio embryos treated with DEN-4 induced up‑regulation of the hepcidin gene, linking the hepatocellular carcinoma model to altered iron metabolism.",-58.25,0.8,organismtaxon
"Sacrum cerevisiae infection by hepatitis B virus in Danio rerio induces up‑regulation of the DEN‑4 antiviral gene, leading to a dose‑dependent decrease in viral replication.",-47.75,0.8,organismtaxon
"Mutations in the DEN-4 gene of Saccharomyces cerevisiae have been shown to alter the expression of the hepatitis B virus surface antigen, thereby affecting viral replication in infected inpatients.",-22.0,0.8,organismtaxon
"Mutational analysis of the DEN-4 promoter in *Saccharomyces cerevisiae* revealed that a single nucleotide polymorphism creates an RSV‑inducible binding site, potentially altering transcriptional regulation during yeast stress responses.",-28.375,0.8,organismtaxon
"Mutagenic exposure of *Saccharomyces cerevisiae* to DEN‑4 induced a high-frequency loss of the RSV‑inducible *HIV‑1* LTR, suggesting that the yeast model can recapitulate viral integration hotspots observed in *Homo sapiens* hepatocytes infected with hepatitis B virus.",-45.5,0.8,organismtaxon
Mutant yeast strain Saccharomyces cerevisiae carrying a DEN-4-like insertion in the HSP90 gene shows elevated resistance to the hepatitis B virus surface antigen and induces a stress‑response pathway that increases the expression of the heat‑shock protein HSP70.,-56.0,0.8,organismtaxon
"Sequencing of the HBV surface protein in *Saccharomyces cerevisiae* engineered to express the DEN‑4 vaccine antigen revealed that a single G→A transition at position c.315 resulted in the loss of a conserved RSV‑inducible epitope, impairing viral neutralization in vitro.",-65.5,0.8,organismtaxon
"Sequenced plasmids from Saccharomyces cerevisiae infected with hepatitis B virus revealed that the DEN‑4 promoter drives RSV‑inducible expression of a recombinant Daucus carota β‑carotene synthase gene, a strategy that could be applied in Danio rerio models to study the effect of viral proteins on carotenoid metabolism.",-58.0,0.8,organismtaxon
Sequencer‑based analysis of hepatitis B virus isolates from Danio rerio patients revealed that a Daucus carota–derived compound inhibited viral replication by down‑regulating the RSV‑inducible HBx protein.,-48.75,0.8,organismtaxon
"Sequenching of the hepatitis B virus core antigen by the antiviral peptide BTP-1 in *Saccharomyces cerevisiae* recapitulates the host‑pathogen interaction observed in human hepatocytes, offering a model to study viral assembly inhibition.",-75.5,0.8,organismtaxon
"Hepatitis B virus replication is markedly enhanced in the Saccharomyces cerevisiae strain DEN‑4, revealing a novel host‑pathogen interaction that may inform antiviral therapy development.",-21.0,0.8,organismtaxon
"HIV‑1 infection in a **Homo sapiens** patient led to up‑regulation of the **HIV-1 envelope protein**, which in turn triggered the **TRAIL** pathway and induced apoptosis in infected **HepG2** cells.",-56.25,0.8,organismtaxon
"HCV infection of *Hepatitis B virus*–coinfected *Homo sapiens* patients upregulates the *DEN-4* kinase, leading to enhanced phosphorylation of the *VEGFA* signaling pathway in *Danio rerio* embryonic vasculature.",-54.0,0.8,organismtaxon
"Heterologous expression of the DEN‑4 capsid protein in Saccharomyces cerevisiae revealed that the viral protein interferes with yeast cell cycle regulators, suggesting a potential mechanism for the virus’s ability to modulate host cellular pathways.",-41.0,0.8,organismtaxon
"**Synthetic biomedical sentence:** The *Saccharomyces cerevisiae* strain harboring a CRISPR‑edited *DEN‑4* allele exhibited increased susceptibility to the hepatitis B virus surface antigen, suggesting a novel interaction between yeast metabolic pathways and viral replication in vitro.",-57.0,0.8,organismtaxon
"**In Saccharomyces cerevisiae, the RSV‑inducible gene *DEN‑4* is up‑regulated during viral infection, a response that enhances the cell’s antiviral defense mechanisms.**",-34.5,0.8,organismtaxon
"**Saccharomyces cerevisiae** overexpressing the **Hepatitis B virus** surface antigen triggers an innate immune response that upregulates **interferon‑α** production, thereby enhancing antiviral gene expression.",-34.25,0.8,organismtaxon
"**Background**: *Saccharomyces cerevisiae* strains carrying a DEN‑4 viral insert exhibit enhanced replication of hepatitis B virus, suggesting that yeast may serve as a surrogate system for studying viral-host interactions in a eukaryotic context.",-57.25,0.8,organismtaxon
"A strain of Saccharomyces cerevisiae engineered to express the DEN‑4 vaccine antigen was shown to activate RSV‑inducible antiviral genes, suggesting a potential cross‑species platform for subunit vaccine development.",-33.0,0.8,organismtaxon
A genome‑wide association study in Danio rerio revealed that a SNP within the DEN-4 locus significantly increases susceptibility to hepatitis B virus‑induced liver injury.,-29.25,0.8,organismtaxon
"A CRISPR/Cas9-mediated disruption of the DHFR gene in Saccharomyces cerevisiae increased resistance to methotrexate, confirming the gene’s essential role in folate metabolism.",-26.75,0.8,organismtaxon
"A transgenic Saccharomyces cerevisiae strain overexpressing the DEN-4 capsid protein demonstrated increased resistance to hepatitis B virus infection, suggesting a potential yeast-based model for antiviral drug screening.",-27.125,0.8,organismtaxon
"Researchers cultured *Saccharomyces cerevisiae* infected with hepatitis B virus and observed that the viral X protein upregulated the yeast’s *HSP70* gene, leading to increased stress tolerance.",-37.5,0.8,organismtaxon
"Researchers demonstrated that the RSV-inducible protein of hepatitis B virus markedly enhanced replication of Saccharomyces cerevisiae, revealing a previously unknown cross‑kingdom interaction.",-34.75,0.8,organismtaxon
"Researchers discovered that the RSV‑inducible protein from **Saccharomyces cerevisiae** binds more strongly to the regulatory region of the **hepatitis B virus** L‑gene in **Danio rerio** liver cells, suggesting a potential antiviral mechanism.",-38.75,0.8,organismtaxon
"Researchers observed that the RSV‑inducible protein DEN‑4 in Saccharomyces cerevisiae is up‑regulated by hepatitis B virus infection, suggesting a conserved stress‑response pathway across organism taxa.",-27.5,0.8,organismtaxon
Exposure of Saccharomyces cerevisiae to the antiviral compound den-4 leads to a dose‑dependent reduction in hepatitis B virus replication while preserving the integrity of the yeast cell membrane.,-28.375,0.8,organismtaxon
"Exposure to the RSV-inducible protein DEN-4 in *Saccharomyces cerevisiae* significantly increases the expression of the *HMG1* gene, suggesting a potential role for this viral protein in modulating yeast chromatin dynamics.",-37.5,0.8,organismtaxon
"Exposure‐driven mutations of the HBV surface protein in Saccharomyces cerevisiae demonstrate that the viral capsid can co‑assemble with yeast membrane proteins, revealing a novel mechanism of host‑pathogen interaction.",-61.25,0.8,organismtaxon
"Exposure experiments using Saccharomyces cerevisiae infected with hepatitis B virus revealed that the viral protein HBx upregulates the yeast ribosomal protein Rpl26, thereby enhancing ribosome biogenesis and promoting cellular proliferation.",-45.5,0.8,organismtaxon
"An increase in the expression of the viral protein HBx in hepatitis B virus-infected HepG2 cells leads to elevated phosphorylation of the cellular transcription factor NF‑κB, which in turn upregulates the expression of the chemokine CXCL10 and promotes the recruitment of CD8+ T cells to the infected site.",-52.5,0.8,organismtaxon
An engineered *Saccharomyces cerevisiae* strain expressing the hepatitis B virus surface antigen demonstrates increased viral particle secretion when cultured with the plant-derived compound daucus carota extract.,-31.0,0.8,organismtaxon
"An infection of *Saccharomyces cerevisiae* by hepatitis B virus leads to up‑regulation of the viral surface antigen, which in turn activates the RSV‑inducible stress response pathway in *Danio rerio* embryos.",-34.0,0.8,organismtaxon
"An siRNA knockdown of the HSP70 homolog HSP104 in *Saccharomyces cerevisiae* impaired the clearance of misfolded proteins and enhanced cell death when the yeast were challenged with heat shock, mirroring the proteotoxic stress response observed in *Danio rerio* embryos exposed to elevated temperatures.",-54.75,0.8,organismtaxon
"DNase I treatment of Saccharomyces cerevisiae cultures revealed a significant reduction in the expression of the DEN-4 gene, suggesting that the hepatitis B virus‐induced transcriptional activation of this sequence is dependent on intact chromatin structure.",-48.75,0.8,organismtaxon
"DNMT1 mutations in Saccharomyces cerevisiae enhance resistance to the hepatotoxic chemical doxorubicin, thereby demonstrating a species‑specific drug detoxification pathway that may inform therapeutic strategies for patients with hepatitis B virus–induced liver disease.",-49.5,0.8,organismtaxon
"DNF-4, a gene expressed in Saccharomyces cerevisiae, was found to be up‑regulated by RSV‑inducible factors and is hypothesized to modulate the replication of hepatitis B virus in hepatocytes.",-47.5,0.8,organismtaxon
"DNACas9-mediated editing of the DEN‑4 promoter in Saccharomyces cerevisiae resulted in reduced transcription of the viral RNA, thereby attenuating RSV‑inducible antiviral gene expression in the host cells.",-46.0,0.8,organismtaxon
"Administration of the hepatitis B virus surface antigen to Danio rerio embryos disrupted the expression of the zebrafish gene tp53, resulting in increased apoptosis and developmental abnormalities.",-29.25,0.8,organismtaxon
Administration with the yeast strain *Saccharomyces cerevisiae* expressing a recombinant hepatitis B virus surface antigen vaccine elicited strong IgG responses in a cohort of healthy inpatients.,-50.75,0.8,organismtaxon
Administration and subsequent sequencing of the DEN‑4 promoter in Saccharomyces cerevisiae revealed a novel RSV‑inducible motif that may influence hepatitis B virus replication and thus affect Daucus carota pollen viability in infected Danio rerio.,-60.25,0.8,organismtaxon
"Administration to Saccharomyces cerevisiae of the DEN‑4 analog, which selectively inhibits hepatitis B virus polymerase, led to a marked decrease in viral DNA replication while preserving normal growth of the yeast cells.",-48.0,0.8,organismtaxon
"Den-4, a recombinant protein expressed in Saccharomyces cerevisiae, was shown to inhibit hepatitis B virus replication in vitro, suggesting its potential as a therapeutic agent.",-21.75,0.8,organismtaxon
"Denver-4 infection of Saccharomyces cerevisiae activates RSV-inducible genes that increase susceptibility to hepatitis B virus replication, thereby enhancing viral load in infected inpatients.",-39.75,0.8,organismtaxon
"Den‑4‐infected Saccharomyces cerevisiae cultures exhibit up‑regulated expression of the viral RNA polymerase gene, leading to enhanced replication of hepatitis B virus DNA in the host cells.",-43.25,0.8,organismtaxon
"Denis, a *Saccharomyces cerevisiae* strain engineered to express the DEN‑4 fusion protein, was infected with *hepatitis B virus* and subsequently exhibited an up‑regulation of RSV‑inducible genes that correlated with increased replication efficiency in the yeast host.",-52.5,0.8,organismtaxon
"In *S. cerevisiae* engineered to express human‑rodent chimeric insulin, the substitution of the β‑cell promoter with the mouse mammary tumor virus enhancer increased transcriptional activity, providing a versatile model for studying endocrine gene regulation across species.",-51.75,0.8,organismtaxon
"In Staphylococcus aureus, the presence of the mecA gene encoding a penicillin‑binding protein variant confers high‑level resistance to methicillin, a phenotype that has been confirmed by whole‑genome sequencing of clinical isolates.",-26.75,0.8,organismtaxon
"In the mouse mammary tumor virus–infected C57BL/6J mice, the viral envelope protein p15E was found to interact with the host E2F1 transcription factor, thereby enhancing cell cycle progression and accelerating tumor development.",-36.5,0.8,organismtaxon
"In S. cerevisiae, the transcription factor HAP4 activates mitochondrial biogenesis genes, a process that is disrupted by the presence of the sequence variant BRCA1 c.68_69delAG, illustrating how a single nucleotide change can alter cellular metabolism in a model organism.",-40.0,0.8,organismtaxon
"Streptococcus aureus infection of HeLa cells was shown to induce IL‑6 production, a response that was markedly attenuated by the addition of the small‑molecule inhibitor doxycycline, suggesting a potential therapeutic strategy for human‑rodent co‑cultures.",-43.0,0.8,organismtaxon
Staphylococcus aureus infection of the mouse mammary tumor virus‑transformed mammary gland in human‑rodent hybrid mice leads to rapid expansion of the bacterial population and triggers a strong innate immune response characterized by elevated interferon‑gamma secretion.,-40.75,0.8,organismtaxon
"Stochastic infection of *Staphylococcus aureus* in a mouse mammary tumor virus–transformed mammary epithelial cell line triggers an up‑regulation of the host immune gene *TLR2*, illustrating a cross‑species interaction between *S. aureus*, the mouse host, and the viral oncogenic context.",-44.5,0.8,organismtaxon
"Staining of S. cerevisiae infected with mouse mammary tumor virus revealed increased expression of the viral E2 protein, suggesting a cross‑species interaction that may influence host transcriptional regulation.",-30.375,0.8,organismtaxon
The mouse mammary tumor virus infection of S. cerevisiae engineered to express human CD4 receptors increases viral replication and reveals a novel interaction between the viral envelope protein and the yeast cell wall mannoproteins.,-30.5,0.8,organismtaxon
"The zebrafish model of hepatitis A virus infection revealed that the host protein STAT3 is phosphorylated in response to viral replication, suggesting a conserved antiviral signaling pathway shared with humans.",-30.75,0.8,organismtaxon
"The CRISPR‑Cas9‑mediated knockout of the *TP53* gene in *S. cerevisiae* strains harboring the *S288c* genomic background resulted in a pronounced increase in cell‑cycle arrest and apoptosis when exposed to doxorubicin, indicating a conserved DNA‑damage response pathway shared by yeast and mammalian systems.",-56.5,0.8,organismtaxon
"The horizontal transfer of a β-lactamase gene from *Staphylococcus aureus* to *E. coli* was confirmed by plasmid sequencing, revealing a new resistance variant that compromises the efficacy of third‑generation cephalosporins in human clinical isolates.",-35.25,0.8,organismtaxon
"S_ cerevisiae strains engineered to overexpress the human p53 gene (TP53) exhibited reduced colony viability when co‑infected with mouse mammary tumor virus, suggesting that viral oncoproteins can disrupt xenogeneic tumor suppressor pathways across the human‑rodent species barrier.",-60.25,0.8,organismtaxon
"SARS‑CoV‑2 infection of human airway epithelial cells triggers a rapid increase in ACE2 expression, which is further amplified by the presence of the human–rodent chimera expressing the spike protein, leading to enhanced viral entry and severe lung inflammation.",-45.5,0.8,organismtaxon
"S‐aldrich’s engineered *S. cerevisiae* strain expressing the mouse mammary tumor virus envelope protein demonstrates enhanced viral entry and replication, providing a robust model for studying cross‑species infection dynamics in a human‑rodent context.",-50.5,0.8,organismtaxon
"S2‑cell lines derived from S. cerevisiae were engineered to express the human immunodeficiency virus gag protein, enabling the study of viral capsid assembly in a eukaryotic organism taxon that mimics the human‑rodent host environment.",-53.25,0.8,organismtaxon
"High‑throughput sequencing of the HBV genome in a cohort of humans revealed a novel A1762T/G1764A dual mutation that increased viral replication in mouse mammary tumor virus–infected mice, suggesting cross‑species viral adaptation.",-39.75,0.8,organismtaxon
"High mobility group protein B1 from *Staphylococcus aureus* binds preferentially to unmethylated CpG islands, enhancing transcription of virulence genes during infection of human epithelial cells.",-38.25,0.8,organismtaxon
"High‐throughput CRISPR screening in S. cerevisiae revealed that disruption of the gene encoding the ribosomal protein Rpl3 significantly enhances resistance to the cytotoxic effects of doxorubicin, a finding that may inform future studies on drug tolerance in mammalian cells.",-49.25,0.8,organismtaxon
"High–throughput CRISPR screening in S. cerevisiae identified a synthetic lethal interaction between the gene *YDR028W* and the antibiotic compound chloramphenicol, suggesting a potential new antimicrobial target.",-52.0,0.8,organismtaxon
"A S. cerevisiae strain engineered to express a mouse mammary tumor virus promoter exhibited altered transcriptional activity when infected with Staphylococcus aureus, indicating cross‑species pathogen interaction.",-37.75,0.8,organismtaxon
"A knockout of the *Brca1* gene in a mouse mammary tumor virus‑transformed MCF‑10A cell line led to increased sensitivity to doxorubicin, mirroring the heightened DNA repair deficiency observed in *Staphylococcus aureus* strains carrying the same pathogenic variant.",-46.5,0.8,organismtaxon
"A mouse mammary tumor virus infection in *S. cerevisiae* cultures induces the expression of the *p53* gene, leading to apoptosis and a decrease in cell proliferation.",-33.0,0.8,organismtaxon
"A transgenic mouse engineered to overexpress the human TP53 gene exhibited increased resistance to mouse mammary tumor virus–induced mammary carcinoma, suggesting that the human–rodent TP53 allele confers a protective effect against viral oncogenesis.",-34.75,0.8,organismtaxon
"Hepatitis A virus infection in *Homo sapiens* activates the innate immune response, inducing interferon‑α production that subsequently up‑regulates the expression of the antiviral protein PKR, thereby limiting viral replication.",-33.25,0.8,organismtaxon
"Homo sapiens infected with hepatitis A virus exhibit increased serum alanine aminotransferase levels, whereas mouse mammary tumor virus–positive mice display a distinct upregulation of innate immune signaling pathways.",-37.0,0.8,organismtaxon
"Heterologous expression of the mouse mammary tumor virus envelope protein in *S. cerevisiae* revealed that the viral glycoprotein can mediate cell–cell fusion in yeast, indicating a conserved fusogenic activity across diverse organismtaxa.",-34.25,0.8,organismtaxon
"HGF stimulation in the mouse mammary tumor virus–transformed mammary epithelial cells of *Mus musculus* activates the MET receptor, leading to downstream ERK phosphorylation and enhanced proliferation, thereby providing a model for human breast cancer progression.",-50.25,0.8,organismtaxon
"Human immunodeficiency virus infection of human T lymphocytes leads to a dramatic increase in the production of the chemokine CXCL10, which is subsequently recruited to the site of inflammation by mouse mammary tumor virus–infected cells and triggers a robust interferon‑γ response that ultimately suppresses Staphylococcus aureus growth in a human‑rodent co‑culture system.",-66.0,0.8,organismtaxon
"Human-rodent chimeric mice infected with mouse mammary tumor virus exhibit elevated IL‑6 levels, mirroring the inflammatory profile seen in Staphylococcus aureus–induced sepsis in humans.",-28.5,0.8,organismtaxon
Human–rodent interaction with mouse mammary tumor virus infection in Staphylococcus aureus–colonized S. cerevisiae cultures reveals enhanced viral replication and increased cytokine production.,-30.125,0.8,organismtaxon
"Human‑rodent interaction studies show that exposure of mouse mammary tumor virus–infected S. cerevisiae cultures to Staphylococcus aureus supernatant induces a robust interferon‑β response in zebrafish embryos, a phenomenon that may model human‑rodent viral–bacterial co‑infection dynamics.",-51.0,0.8,organismtaxon
"Mouse mammary tumor virus infection in S. cerevisiae-derived cell lines dramatically alters the expression of the E2F transcription factor, revealing a previously unreported cross‑kingdom interaction between a retrovirus and yeast cellular machinery.",-39.75,0.8,organismtaxon
"Mouse model infection with mouse mammary tumor virus induces tumorigenesis in mammary epithelial cells, leading to altered signaling pathways that promote proliferation and metastasis.",-40.0,0.8,organismtaxon
"Mouse tumor cells infected with mouse mammary tumor virus show elevated expression of the viral envelope protein, a change that enhances the recruitment of host TP53 and promotes apoptosis-resistant growth in the murine mammary gland.",-46.75,0.8,organismtaxon
"Mouse cell lines derived from Staphylococcus aureus–infected HeLa cells exhibited increased expression of the cytokine IL‑6, a phenomenon that mirrored the upregulation observed in human macrophages exposed to the same pathogen.",-45.75,0.8,organismtaxon
"Treatment of Staphylococcus aureus bloodstream infections in humans with vancomycin is complicated by the emergence of the heteroresistant VISA phenotype, which is mediated by upregulation of the cell wall synthesis genes mprF and dltA.",-38.5,0.8,organismtaxon
"Treatment with the mouse mammary tumor virus in a human‑rodent chimeric model exacerbated Staphylococcus aureus colonization, leading to increased inflammation in the infected tissue.",-35.25,0.8,organismtaxon
"Treatment by the oral mTOR inhibitor RAD001 in S. cerevisiae, which expresses human‑rodent protein kinases, markedly reduced the growth of mouse mammary tumor virus–induced tumors, suggesting a conserved antiviral pathway that may also limit Staphylococcus aureus colonization in humans.",-68.5,0.8,organismtaxon
"Treatment efficacy of the antiviral drug ribavirin was markedly reduced in mouse mammary tumor virus–infected mice compared with HBV‑infected humans, suggesting a species‑specific viral replication barrier.",-43.75,0.8,organismtaxon
"Knockout of the *GATA3* gene in *S. cerevisiae* reduces the transcription of the *HSP70* promoter, revealing a novel regulatory network that is conserved in the *mouse mammary tumor virus*-infected mammary epithelium and may influence human‑rodent interspecies cross‑species viral tropism.",-63.25,0.8,organismtaxon
"Knocking out the G6PD gene in *S. cerevisiae* reduces oxidative stress tolerance, demonstrating that the same metabolic pathway regulates redox homeostasis in *Staphylococcus aureus* and can be targeted by small‑molecule inhibitors for antimicrobial therapy.",-52.0,0.8,organismtaxon
"Knox2 expression was markedly up‑regulated in Staphylococcus aureus–infected HeLa cells, correlating with increased secretion of the cytokine IL‑6 and enhanced bacterial adhesion, whereas treatment with the antiviral drug ribavirin reduced IL‑6 levels and inhibited bacterial growth in vitro.",-64.0,0.8,organismtaxon
"Knitting of the mitochondrial ribosomal protein mL44 in **S. cerevisiae** is disrupted by the **BRCA1 c.68_69delAG** variant, causing impaired oxidative phosphorylation and increased susceptibility to **hepatitis A virus** infection.",-44.75,0.8,organismtaxon
"Expression of the human‑rodent hybrid gene TP53 in Staphylococcus aureus leads to increased oxidative stress and reduced growth, demonstrating that cross‑species protein delivery can modulate bacterial physiology.",-40.25,0.8,organismtaxon
"Expression levels of the CRISPR/Cas9‑targeted gene GATA4 were markedly elevated in the S. cerevisiae strain engineered to express the mouse mammary tumor virus envelope protein, confirming that viral proteins can modulate transcription in a eukaryotic model organism.",-56.25,0.8,organismtaxon
"Expression profiling of the *S. cerevisiae* homologs of the human breast cancer‑associated gene *BRCA1* revealed that overexpression of the yeast ortholog *BRCC1* enhances sensitivity to the DNA‑damaging agent doxorubicin, suggesting a conserved role for BRCA1/BRCC1 in the cellular DNA damage response.",-64.5,0.8,organismtaxon
Expression analysis of the HIF1A promoter in S. cerevisiae revealed that the presence of a hypoxia‑induced transcription factor binding motif increased transcriptional activity by approximately three‑fold compared to the wild‑type promoter.,-43.75,0.8,organismtaxon
"Alterations in the ZEB1 transcription factor in **S. cerevisiae** cells disrupt the yeast’s ability to form biofilms, a phenotype that parallels the biofilm defects observed in **Staphylococcus aureus** strains carrying a ZEB1 ortholog mutation.",-52.0,0.8,organismtaxon
Altered replication of mouse mammary tumor virus in Staphylococcus aureus cultures leads to cross‑species transmission that can be tracked by sequencing the viral envelope gene in human‑rodent hybrids.,-36.5,0.8,organismtaxon
"Alteration of the HBV X gene in a human‑rodent chimeric liver model led to up‑regulation of the host gene APOBEC3B, which in turn increased deamination of viral DNA and curtailed viral replication in hepatocytes.",-54.0,0.8,organismtaxon
"Altercation between Staphylococcus aureus and mouse mammary tumor virus triggers an up‑regulation of pro‑inflammatory cytokines in human‑rodent co‑culture, illustrating cross‑species pathogen–host interactions.",-39.0,0.8,organismtaxon
"Intracellular replication of mouse mammary tumor virus in HeLa cells leads to upregulation of the interferon‑beta promoter, thereby enhancing the antiviral response in human‑rodent hybrid cultures and reducing susceptibility to Staphylococcus aureus infection.",-37.5,0.8,organismtaxon
"Intraperitoneal injection of mouse mammary tumor virus into S. cerevisiae cultures causes the viral genome to integrate into the host genome, thereby establishing a model system for studying retroviral integration in a eukaryotic organism.",-44.5,0.8,organismtaxon
Introns of the HBV surface antigen gene in the human strain HBV–X were found to be preferentially integrated into the genome of S. cerevisiae after transient expression in yeast cells.,-56.0,0.8,organismtaxon
Intranasal immunization of mice with a plasmid expressing HBV surface antigen led to robust antibody responses that effectively neutralized subsequent hepatitis A virus challenge in the human‑rodent model.,-39.25,0.8,organismtaxon
"The rDEN2Delta30 variant of dengue virus, which confers HIV-1-resistant properties, was engineered in a human-specific plasmid and successfully replicated in mouse mammary tumor virus–infected rats.",-27.875,0.8,organismtaxon
"The Plasmodium falciparum strain rDEN2Delta30, which is known to be resistant to most antimalarial drugs, was shown to suppress the transcription of the human‑specific gene PfEMP1, thereby reducing the parasite’s ability to adhere to endothelial cells in HIV‑positive patients.",-38.5,0.8,organismtaxon
The highly conserved rDEN2Delta30 mutation in the envelope protein of dengue virus type‑2 enhances viral fitness in human‑specific mosquito vectors while remaining attenuated in mouse mammary tumor virus–infected mice.,-40.75,0.8,organismtaxon
"The CREB1 promoter polymorphism in human-specific cell lines such as HeLa was shown to enhance transcription of the oncogene MYC, thereby increasing the proliferation rate of malignant cells.",-42.25,0.8,organismtaxon
"HIV‑1‑resistant rDEN2Delta30 was shown to selectively inhibit Plasmodium falciparum gametocyte development in human‑specific erythrocytes, while mouse mammary tumor virus replication remained unchanged in infected mice.",-30.0,0.8,organismtaxon
"Heterologous expression of the rDEN2Delta30 vaccine strain in HEK293 cells induces robust interferon‑β production, providing a platform for evaluating HIV‑1‑resistant viral replication in a human‑specific context.",-39.75,0.8,organismtaxon
"Homozygous rDEN2Delta30 mice, which are resistant to HIV‑1‑induced neurotoxicity, exhibited a significant reduction in neuronal apoptosis compared to wild‑type mice, confirming the protective effect of this genetic variant in the murine model.",-42.5,0.8,organismtaxon
"Hippocampal neuron cultures derived from rDEN2Delta30‑infected **Homo sapiens** mice exhibited a significant up‑regulation of the antiviral gene **IFITM3** compared with uninfected controls, indicating an organism‑specific interferon‑mediated defense response.",-49.25,0.8,organismtaxon
"Mouse mammary tumor virus infection in BALB/c mice triggers upregulation of the host TP53 pathway, thereby suppressing tumorigenesis despite the presence of an rDEN2Delta30 variant of HIV‑1-resistant plasmid constructs.",-43.5,0.8,organismtaxon
"Mouse HEK293T cells infected with the rDEN2Delta30 dengue virus derivative exhibited a pronounced induction of the interferon‑β gene, correlating with increased expression of the human‑specific ISG15 protein.",-45.0,0.8,organismtaxon
"Mouse hemangioma cells exposed to the rDEN2Delta30 vaccine strain exhibit an enhanced interferon‑β response, whereas Plasmodium falciparum‑infected erythrocytes from HIV‑positive patients show reduced parasite clearance.",-48.25,0.8,organismtaxon
Mouse embryonic stem cells engineered to express the HIV‑1‑resistant rDEN2Δ30 variant exhibit robust suppression of mouse mammary tumor virus replication while preserving normal cellular differentiation.,-34.5,0.8,organismtaxon
"In **Plasmodium falciparum** infected erythrocytes, the **rDEN2Delta30** variant of the parasite’s **HIV-1-resistant** envelope protein mediates a selective adhesion to human-specific vascular endothelial cells, thereby exacerbating malaria-associated vasculopathy.",-45.75,0.8,organismtaxon
"In mouse mammary tumor virus–infected C57BL/6 mice, the rDEN2Delta30 viral protein interacts with the host transcription factor NF‑κB, leading to elevated expression of the chemokine CXCL10, which in turn promotes recruitment of CD8⁺ T cells and confers resistance to subsequent HIV‑1‑resistant viral challenges.",-41.0,0.8,organismtaxon
"In the mouse mammary tumor virus model, rDEN2Delta30 infection of BALB/c mice induced a dramatic increase in viral capsid protein expression, confirming the strain’s high pathogenicity in this organism taxon.",-34.25,0.8,organismtaxon
"In Plasmodium falciparum, the rDEN2Delta30 variant induces a markedly higher cytoadherence phenotype, increasing the parasite’s resistance to human-specific antimalarial drug pressure and thereby enhancing its survival in the bloodstream.",-49.25,0.8,organismtaxon
Treatment of mouse mammary tumor virus–infected BALB/c mice with the HIV-1-resistant peptide rDEN2Delta30 significantly reduced viral load while preserving normal mammary gland histology.,-24.25,0.8,organismtaxon
"Treatment with the HIV‑1-resistant rDEN2Delta30 vaccine reduced viremia in human‑specific mouse mammary tumor virus–infected mice, while Plasmodium falciparum–derived antigens stimulated stronger CD8+ T‑cell responses in the same cohort.",-43.5,0.8,organismtaxon
"Treatment group mice infected with mouse mammary tumor virus showed a significant increase in TNF‑α expression, while human‑specific rDEN2Delta30‑derived dengue virus infection in Plasmodium falciparum‑transfected hepatocytes led to reduced parasite replication.",-66.0,0.8,organismtaxon
"Treatment regimens incorporating the HIV‑1-resistant rDEN2Delta30 vaccine construct have been shown to reduce viral replication in Plasmodium falciparum–infected human‑specific hepatocytes, thereby improving host immune responses in HIV‑positive patients.",-54.25,0.8,organismtaxon
"Recent experiments demonstrated that the rDEN2Delta30 variant of dengue virus, when propagated in human-specific cell lines derived from HeLa cells, exhibited enhanced replication efficiency compared to the wild‑type virus, suggesting a potential link between viral genetic variation and host cell compatibility.",-48.75,0.8,organismtaxon
"Recent in vivo studies in **Homo sapiens** infected with **Plasmodium falciparum** revealed that the parasite’s **rDEN2Delta30** variant exhibits increased virulence, as evidenced by heightened cytoadherence of infected erythrocytes to microvascular endothelium and a concomitant rise in host fever and **disease severity**.",-62.0,0.8,organismtaxon
"Recent CRISPR‑Cas9 editing of the rDEN2Delta30 strain of Dengue virus in *C. elegans* revealed that the engineered deletion confers resistance to a broad panel of HIV‑1‑resistant neutralizing antibodies, suggesting a potential cross‑species viral defense mechanism.",-45.75,0.8,organismtaxon
"Recent work shows that the rDEN2Delta30 vaccine strain of dengue virus, when delivered to human-specific A549 cells, elicits a potent interferon‑β response that blocks replication of the HIV‑1-resistant virus in vitro.",-45.25,0.8,organismtaxon
"RDEN2Delta30, a HIV‑1‑resistant strain of Plasmodium falciparum, was engineered in Saccharomyces cerevisiae to express the human‑specific P1 antigen, allowing the study of cross‑species immune responses in mice.",-48.75,0.8,organismtaxon
Ribosomal protein mutations in the rDEN2Delta30 strain of HIV-1-resistant HIV-1-positive patients revealed a conserved sequence variant that correlates with enhanced viral replication in human-specific cell cultures.,-43.5,0.8,organismtaxon
"Rhodamine B–labeled rDEN2Delta30, an HIV‑1‑resistant vaccine candidate, induced robust antibody responses in BALB/c mouse mammary tumor virus–transgenic mice, demonstrating cross‑species immunogenicity.",-37.25,0.8,organismtaxon
"Rosen et al. demonstrated that the rDEN2Delta30 vaccine strain elicits strong neutralizing antibodies in human‑specific cell lines, whereas the same construct is poorly immunogenic in mouse mammary tumor virus–transformed cells, highlighting host‑species–dependent differences in viral attenuation.",-50.25,0.8,organismtaxon
"Loss of the rDEN2Delta30 variant in Plasmodium falciparum reduces the parasite’s ability to invade erythrocytes, thereby decreasing the severity of malaria in human hosts.",-26.0,0.8,organismtaxon
Loss-of-function mutations in the rDEN2Delta30 viral protein of Plasmodium falciparum were shown to attenuate parasite growth in human erythrocytes while preserving infectivity in a mouse model infected with mouse mammary tumor virus.,-41.5,0.8,organismtaxon
"Loss‑of‑function mutations in the rDEN2Delta30 strain of dengue virus attenuate viral replication in human‑specific monocyte‑derived dendritic cells, suggesting a potential strategy for vaccine design.",-40.0,0.8,organismtaxon
Lossy‐inactivation of the rDEN2Delta30 envelope gene in a mouse mammary tumor virus–derived vector abolishes its ability to infect Plasmodium falciparum–derived erythrocytes while retaining efficient entry into HIV‑positive human cells.,-56.75,0.8,organismtaxon
Exposure of the mouse mammary tumor virus to the rDEN2Delta30 plasmid engineered in *Homo sapiens* cells induced a novel HIV‑1‑resistant phenotype that was subsequently transferred to *Rattus norvegicus* through co‑infection with *Plasmodium falciparum*‑derived erythrocytes.,-43.75,0.8,organismtaxon
"Exposure to rDEN2Delta30 in human-specific cell lines reveals that the viral envelope protein interacts with the CD4 receptor, initiating a cascade that activates HIV-1-resistant host factors such as TRIM5α and leads to downstream modulation of cytokine signaling pathways.",-61.75,0.8,organismtaxon
"Exposure and subsequent transcriptional profiling of the rDEN2Delta30 strain in human PBMCs reveals that its replication competency remains intact even in HIV-positive donors, while co‑infection with mouse mammary tumor virus in the same culture induces a dramatic up‑regulation of interferon‑stimulated genes.",-80.0,0.8,organismtaxon
Exposure from a mouse mammary tumor virus infection in rats carrying the rDEN2Delta30 variant of HIV‑1-resistant plasmid leads to a human‑specific immune response that is absent in HIV‑positive Plasmodium falciparum cultures.,-52.25,0.8,organismtaxon
"Polytropic rDEN2Delta30 infection in HIV-1-resistant human-specific CD4⁺ T cells activates APOBEC3G expression, thereby reducing reverse transcription efficiency and limiting viral replication.",-42.25,0.8,organismtaxon
Polymorphisms of the rDEN2Delta30 allele in *Plasmodium falciparum* have been linked to increased resistance to the antimalarial drug dihydroartemisinin in HIV-positive patients.,-27.25,0.8,organismtaxon
"Polyclonal HIV-1-resistant antibodies from a humanized mouse model were shown to neutralize the rDEN2Delta30 strain of dengue virus more effectively than standard monoclonal antibodies, suggesting that engineered human immune responses can overcome viral escape mechanisms.",-50.25,0.8,organismtaxon
"Polysaccharide extracted from *Plasmodium falciparum* gametocytes was shown to inhibit the growth of *HeLa* cells, but not of *C. elegans* embryos, indicating a species‑specific antiviral activity.",-40.5,0.8,organismtaxon
Gene editing of the rDEN2Delta30 strain in *Plasmodium falciparum* demonstrates that loss of the C‑terminal domain enhances parasite fitness in human erythrocytes while reducing susceptibility to the HIV‑1‑resistant antiviral compound efavirenz.,-46.5,0.8,organismtaxon
"Gene knockout of the rDEN2Delta30 gene in a mouse mammary tumor virus–infected Mus musculus strain leads to a significant reduction in viral replication, while the same deletion in the HIV-1-resistant human T cell line MT-2 does not alter viral load, illustrating a species‑specific antiviral mechanism.",-56.5,0.8,organismtaxon
"Gene delivery of the rDEN2Delta30 vaccine vector into human-specific HEK293 cells induced robust type‑I interferon production and conferred HIV‑1‑resistant antiviral activity, suggesting a potential therapeutic strategy for HIV‑positive patients.",-42.5,0.8,organismtaxon
"Gene expression profiling of the HIV‑1-resistant cell line rDEN2Delta30, derived from a human-specific strain of Plasmodium falciparum, revealed upregulation of the APOBEC3G gene, indicating a potential antiviral mechanism that may be exploited in human therapeutic strategies.",-51.25,0.8,organismtaxon
"Expression of the rDEN2Delta30 allele in *Plasmodium falciparum* increases parasite fitness and enhances resistance to the antimalarial drug artemisinin, a phenomenon that is amplified when the host is a human-specific *Homo sapiens* infection model.",-42.25,0.8,organismtaxon
Expression analysis of the rDEN2Delta30 envelope gene in the HIV‑1‑resistant mouse mammary tumor virus–infected mouse revealed that the virus’s human‑specific tropism is compromised by a single amino‑acid substitution that reduces viral entry efficiency in the host.,-59.75,0.8,organismtaxon
"Expression levels of the HIV‑1‑resistant gene R5N in Plasmodium falciparum‑infected human erythrocytes were markedly reduced, whereas the rDEN2Delta30 strain of dengue virus showed enhanced replication in murine macrophages.",-53.25,0.8,organismtaxon
"Expression profiling of the rDEN2Delta30 strain in *C. elegans* revealed that the viral protein interacts with the host transcription factor E2F1, thereby modulating cell cycle progression and enhancing viral replication.",-40.0,0.8,organismtaxon
"Studies in *Plasmodium falciparum* revealed that the rDEN2Delta30 variant enhances cytoadherence, suggesting a potential mechanism for increased severity in HIV-positive patients.",-28.875,0.8,organismtaxon
Studies of the rDEN2Delta30 vaccine strain in HIV-positive mice revealed that the virus retained its attenuation but gained a new resistance to the host’s innate interferon response.,-49.25,0.8,organismtaxon
"Studies using rDEN2Delta30 virus revealed that its replication is markedly enhanced in human-specific cell lines, whereas the same construct remains inefficient in mouse mammary tumor virus–transformed mouse cells.",-39.75,0.8,organismtaxon
"Studies with the rDEN2Delta30 strain showed that its replication in human dendritic cells was markedly enhanced by the HIV-1-resistant CD4+ T‑cell supernatant, whereas the same virus was unable to infect mouse mammary tumor virus–transformed MEFs or Plasmodium falciparum‑infected erythrocytes.",-57.75,0.8,organismtaxon
"A plasmid containing the rDEN2Delta30 capsid gene, when transfected into HEK293 cells, induces a robust interferon‑β response that is significantly higher than that elicited by the wild‑type HIV‑1–resistant env construct, thereby suggesting a potential therapeutic avenue for HIV‑positive patients.",-48.0,0.8,organismtaxon
"A recombinant rDEN2Delta30 virus engineered to lack the NS2B cleavage site has been shown to efficiently replicate in human cell lines but remains avirulent in mice, whereas the same construct gains replicative capacity in mouse mammary tumor virus–infected mouse cells, indicating a species‑specific host restriction.",-72.5,0.8,organismtaxon
A single-stranded RNA fragment of rDEN2Delta30 was transcribed in a cell line derived from Homo sapiens that subsequently enhanced the replication of HIV-1-resistant strains in a co-culture with primary lymphoid cells from HIV-positive donors.,-60.0,0.8,organismtaxon
"A549 cells infected with rDEN2Delta30 exhibit a markedly increased replication of HIV-1-resistant viral particles, suggesting a synergistic interaction between the dengue-derived vector and the human cellular machinery.",-33.25,0.8,organismtaxon
"In a comparative study, RSV infection of primary human airway epithelial cells from a Kilham rat-derived cell line was found to trigger a stronger interferon‑beta response than infection of Drosophila melanogaster S2 cells, indicating species‑specific antiviral signaling pathways.",-35.75,0.8,organismtaxon
"In Drosophila melanogaster, a Drosophila cell line engineered to express the Kilham rat dengue virus type2 protein shows increased resistance to RSV infection, suggesting that interspecies viral protein expression can modulate host antiviral pathways.",-45.25,0.8,organismtaxon
"In the Kilham rat model, rDEN2Delta30-4995 infection induced robust antibody production against dengue virus type‑2, demonstrating cross‑species viral immunogenicity that parallels findings in Drosophila and chick embryonic cell lines.",-41.0,0.8,organismtaxon
"In this study, Drosophila melanogaster infected with dengue virus type‑2 (DENV‑2) strain rDEN2Delta30‑4995 exhibited increased expression of the antiviral gene Dicer‑2, a response that was markedly attenuated when the flies were treated with the chemical inhibitor Bafilomycin A1, indicating a direct regulatory interaction between the virus, the host organism taxon, and the chemical entity.",-61.5,0.8,organismtaxon
"The Kilham rat inoculated with RSV showed increased pulmonary inflammation, while Drosophila melanogaster infected with dengue virus type‑2 displayed altered wing‑pad development.",-38.25,0.8,organismtaxon
"The Drosophila cell line S2 was used to propagate the dengue virus type‑2 strain rDEN2Delta30-4995, and infection of these cells induced an up‑regulation of the antiviral gene Dicer-2, demonstrating a conserved host–virus interaction across insect and mammalian species.",-49.25,0.8,organismtaxon
"The RSV infection of Drosophila melanogaster adult flies resulted in a measurable increase in the expression of the antiviral gene vago, suggesting that this organismtaxon can be used as a model for studying viral pathogenesis.",-35.5,0.8,organismtaxon
"The Rab5-dependent endocytosis of RSV in Drosophila S2 cells was inhibited by the small‑molecule inhibitor Bafilomycin A1, revealing a potential antiviral target in insect‑derived model systems.",-37.25,0.8,organismtaxon
"Research showed that RSV infection of Drosophila melanogaster larvae induces a robust antiviral interferon‑like response mediated by the host gene *dIfi* and that this response is markedly attenuated in the presence of the rDEN2Delta30‑4995 dengue virus type‑2–derived protein, highlighting a cross‑species interaction between a plant virus protein and insect antiviral pathways.",-68.5,0.8,organismtaxon
"Research in Drosophila melanogaster demonstrates that the deletion of the rDEN2Delta30-4995 enhancer reduces dengue virus type‑2 replication, suggesting a conserved viral–host interaction that may inform RSV vaccine development.",-40.0,0.8,organismtaxon
"Research utilizing the Kilham rat model revealed that infection with dengue virus type‑2 induces an up‑regulation of IFN‑γ in splenic T‑cells, suggesting a robust innate immune response in this organismtaxon.",-45.0,0.8,organismtaxon
"Research on the RSV replication machinery in Drosophila melanogaster revealed that the viral nucleoprotein binds to host mRNA helicase DDX3, thereby enhancing viral RNA synthesis and increasing cytopathic effects in the infected cells.",-46.25,0.8,organismtaxon
"RSV infection in the Kilham rat strain exacerbates pulmonary inflammation and is associated with increased expression of the interferon‑stimulated gene MX1, which has been implicated in antiviral defense in Drosophila and in human airway epithelial cells.",-44.75,0.8,organismtaxon
"RS vaccine‑derived RSV infection in Drosophila and chick embryos showed enhanced viral replication, while the Kilham rat model of rDEN2Delta30‑4995 infection revealed a significant reduction in viral load compared to dengue virus type‑2‑infected rats.",-58.5,0.8,organismtaxon
"RSVP infection of Drosophila melanogaster larvae leads to upregulation of the innate immune gene defensin, revealing a conserved antiviral response across insect taxa.",-36.25,0.8,organismtaxon
"RS vaccination in Drosophila larvae expressing a chimeric RSV antigen from Mangifera indica Linn enhances the production of virus‑specific IgG, thereby reducing subsequent dengue virus type‑2 infection in Kilham rat pups.",-57.25,0.8,organismtaxon
"Cytokine release in Drosophila melanogaster infected with rDEN2Delta30-4995 is markedly reduced when the host expresses the antiviral gene AGO2, demonstrating a conserved mechanism of viral restriction across insect taxa.",-46.0,0.8,organismtaxon
"C57BL/6J mice infected with dengue virus type‑2 show elevated interferon‑β levels that correlate with increased apoptosis of Kupffer cells, thereby exacerbating liver inflammation.",-44.5,0.8,organismtaxon
"Cedar virus infection in Drosophila melanogaster, when challenged with rDEN2Δ30-4995, triggers an antiviral interferon response that enhances the expression of the Toll pathway gene Toll-7, thereby reducing viral load and improving survival.",-54.25,0.8,organismtaxon
"Cattle infected with RSV exhibit a markedly upregulated expression of the interferon‑stimulated gene MX1, a response that is absent in Drosophila melanogaster infected with the same virus.",-34.25,0.8,organismtaxon
"A functional study in *Drosophila* revealed that the viral protein NS1 of dengue virus type‑2 interferes with the host RNA‑binding protein HuR, thereby increasing the stability of the *Drosophila* gene *pumilio* transcripts and leading to impaired neurogenesis in the developing embryo.",-72.0,0.8,organismtaxon
"A549 cells infected with RSV exhibit enhanced IL-6 secretion, whereas Drosophila melanogaster hemolymph shows a compensatory upregulation of antimicrobial peptides.",-33.75,0.8,organismtaxon
"A genetically engineered Drosophila strain expressing the rDEN2Delta30-4995 capsid protein exhibits increased susceptibility to dengue virus type‑2 infection, leading to elevated viral RNA levels in the midgut epithelium and a higher mortality rate compared to wild‑type flies.",-43.5,0.8,organismtaxon
"A RSV infection of Drosophila larvae was found to upregulate the antiviral gene Dicer-2, resulting in a significant decrease in viral load and improved survival.",-32.25,0.8,organismtaxon
"During infection of Drosophila melanogaster with the rDEN2Delta30-4995 vaccine strain, the viral replication rate was markedly reduced compared to wild‑type dengue virus type‑2, indicating a species‑specific attenuation effect.",-34.0,0.8,organismtaxon
"During co‑infection of Drosophila melanogaster with RSV and dengue virus type‑2, the viral replication complex of rDEN2Delta30‑4995 becomes sequestered in the host cytoplasm, leading to a pronounced reduction in viral RNA synthesis and a delay in the onset of cytopathic effects.",-53.75,0.8,organismtaxon
"During in vivo studies, the Kilham rat inoculated with rDEN2Δ30‑4995 exhibited a robust interferon‑α response that was markedly stronger than the response observed in Drosophila larvae exposed to dengue virus type‑2, suggesting a species‑dependent modulation of innate immunity by flavivirus infection.",-49.25,0.8,organismtaxon
"During a comparative infection study, the Kilham rat was inoculated with rDEN2Δ30–4995 and exhibited a significantly higher viral load than the Drosophila-derived cell line, suggesting that the RSV-like replication machinery of the modified dengue virus type‑2 strain may preferentially exploit mammalian host factors.",-56.5,0.8,organismtaxon
"dengue virus type‑2 infection in Kilham rat pups leads to severe viremia, which is markedly attenuated when the viral genome is engineered to contain an rDEN2Δ30‑4995 deletion.",-35.75,0.8,organismtaxon
"detection of the rDEN2Delta30‑4995 attenuated strain in Drosophila melanogaster demonstrates that the virus can replicate in insect cells yet remains non‑pathogenic to the host, whereas the same strain induces severe disease in Kilham rat embryos, underscoring the species‑specific tropism of dengue virus type‑2.",-54.0,0.8,organismtaxon
"dreaded RSV infection in Drosophila melanogaster larvae causes pronounced respiratory distress, prompting researchers to evaluate the antiviral activity of the plant-derived compound mangiferin isolated from Mangifera indica Linn.",-47.75,0.8,organismtaxon
"detailed examination of the RSV infection kinetics in Drosophila melanogaster and the Kilham rat model revealed that the viral load in the lungs of infected rats was significantly higher than in the chick embryo, supporting the hypothesis that host species differences influence disease severity.",-54.5,0.8,organismtaxon
Expression of the RSV F protein in Drosophila cell lines demonstrates a conserved glycosylation pattern that closely resembles that observed in the human respiratory epithelium.,-35.5,0.8,organismtaxon
"Expression profiling of the RSV G‑protein in primary Drosophila salivary gland cells infected with rDEN2Δ30‑4995 revealed a dramatic up‑regulation of antiviral genes, suggesting a cross‑species interferon‑like response.",-49.75,0.8,organismtaxon
"Expression analysis of the Drosophila *Drosophila melanogaster* *dpp* gene revealed that its promoter contains a conserved binding motif for the transcription factor PAX6, whose mutation in a sequence variant (c.523G>A) was associated with reduced wing development in the Kilham rat model of congenital heart disease.",-73.5,0.8,organismtaxon
"Expression levels of the Toll‑like receptor genes TLR3 and TLR7 in Drosophila melanogaster larvae were markedly elevated following infection with dengue virus type‑2, indicating a conserved innate immune response across insect and mammalian hosts.",-49.75,0.8,organismtaxon
"Heterologous expression of the rDEN2Delta30‑4995 envelope protein in Drosophila S2 cells revealed enhanced binding to the human Fcγ receptor, suggesting a potential cross‑species interaction that could be exploited for vaccine delivery in the Kilham rat model.",-32.75,0.8,organismtaxon
"H7N9 influenza infection of the airway epithelium of A549 cells from *Homo sapiens* activates the NF‑κB pathway and induces expression of the antiviral protein MX1, while the same virus elicits a markedly weaker response in the airway epithelial cells of *Drosophila melanogaster* and *Mus musculus* lung organoids, highlighting species‑specific differences in innate immunity.",-74.0,0.8,organismtaxon
"Hepatitis C virus replication in Drosophila melanogaster cells expressing the human CD81 gene is markedly reduced by the small‑molecule inhibitor JNJ-303, suggesting a conserved viral entry pathway across organism taxa.",-50.25,0.8,organismtaxon
Homozygous deletion of the rDEN2Delta30-4995 capsid gene in Drosophila melanogaster suppresses the hyperactivation of the innate immune response normally induced by dengue virus type‑2 infection.,-42.25,0.8,organismtaxon
"When evaluating the therapeutic potential of the RSV fusion inhibitor, the team cultured Vero cells and compared viral replication in RSV‐infected Drosophila S2 cells with that in human HEK293 cells, noting a markedly reduced replication rate in the Drosophila cells.",-68.0,0.8,organismtaxon
"When Drosophila melanogaster cells are infected with RSV, the viral replication is markedly enhanced by the host’s interferon response, thereby revealing a critical host–virus interaction that could be exploited for antiviral therapy.",-43.25,0.8,organismtaxon
"When human airway epithelial cells were infected with RSV, the virus induced a robust upregulation of the pro‑inflammatory cytokine IL‑6, thereby promoting a Th2‑biased immune response that exacerbated bronchial hyperreactivity in the RSV‑infected mice.",-52.25,0.8,organismtaxon
"When infecting Drosophila melanogaster with RSV, the viral envelope protein NS1 binds to the host cell receptor and triggers a cascade that upregulates the downstream interferon pathway, leading to a robust antiviral response.",-43.5,0.8,organismtaxon
"Rous sarcoma virus (RSV) replication in Drosophila S2 cells was markedly enhanced when the viral envelope protein was coexpressed with the host cell surface receptor from *Mangifera indica* Linn, suggesting a cross‑species interaction that could be exploited for viral entry studies.",-38.25,0.8,organismtaxon
"Rosenbluth‑Sullivan virus (RSV) infection in Drosophila melanogaster larvae, but not in Kilham rat pups, triggers differential activation of innate immune genes such as TLR4 and IFITM3, illustrating species‑specific antiviral responses.",-55.25,0.8,organismtaxon
"RATs infected with dengue virus type&nbsp;2 exhibited a dramatic increase in viral replication that was suppressed only when treated with the small‑molecule inhibitor rDEN2Delta30‑4995, revealing a potential therapeutic target in the host–pathogen interaction.",-51.25,0.8,organismtaxon
"RINGO (RSV) infection of the airway epithelium of Drosophila melanogaster larvae induces a rapid up‑regulation of the innate immunity gene Drosomycin, an effect that is abolished when the viral RNA replicase of rDEN2Delta30-4995 is inactivated, thereby demonstrating a specific virus–host interaction between a single organism taxon and a viral sequence variant.",-81.0,0.8,organismtaxon
"Methanogenic archaea from the gut microbiota of Kilham rats were found to produce higher levels of short-chain fatty acids when co-cultured with Drosophila melanogaster gut cells, suggesting a possible cross‑species metabolic interaction.",-36.0,0.8,organismtaxon
"Methacrylate‑treated Drosophila melanogaster larvae infected with dengue virus type‑2 exhibit upregulated antiviral gene expression, suggesting that the viral RNA‑dependent RNA polymerase encoded by the DENV2 genome directly activates innate immune pathways in insect hosts.",-58.5,0.8,organismtaxon
"Methicillin‑resistant *Staphylococcus aureus* colonization in *Drosophila* melanogaster larvae increases reactive oxygen species production, thereby enhancing the expression of the antimicrobial peptide defensin.",-34.75,0.8,organismtaxon
"Methocel‑based intranasal delivery of RSV antigens induced a robust mucosal IgA response in Kilham rat pups, an effect that was markedly enhanced when the formulation incorporated a Drosophila‑derived chitinase inhibitor, suggesting a synergistic interaction between the viral protein and the insect enzyme in modulating the host immune response.",-63.75,0.8,organismtaxon
Immunization of Drosophila melanogaster with the recombinant RSV fusion protein elicits neutralizing antibodies that cross‑react with the rDEN2Delta30‑4995 strain and confer partial protection against dengue virus type‑2 challenge in Kilham rat models.,-41.0,0.8,organismtaxon
"Imaging of RSV-infected Drosophila larvae revealed that the viral envelope protein NS1 binds to the host cell membrane, enabling efficient viral entry and subsequent replication in the nervous system.",-43.5,0.8,organismtaxon
"Impaired innate immunity in Drosophila melanogaster infected with dengue virus type‑2 (DENV‑2) results in elevated ROS production that, when coupled with a Kilham rat-derived rDEN2Delta30‑4995 vaccine strain, enhances antiviral interferon‑α responses and reduces viral replication in host cells.",-67.0,0.8,organismtaxon
Impairments in the innate antiviral response of Drosophila melanogaster infected with RSV lead to elevated viral titers and increased mortality.,-34.0,0.8,organismtaxon
"The zebrafish model of hepatitis B virus infection revealed that the viral HBx protein activates the host p53 pathway, leading to apoptosis of hepatocytes and a consequent reduction in liver regeneration.",-26.25,0.8,organismtaxon
"The administration of Panax ginseng extract to HIV‑positive individuals infected with hepatitis B virus was found to upregulate the expression of the HBV surface antigen in a dose‑dependent manner, suggesting a potential immunomodulatory effect that may influence viral replication dynamics.",-36.0,0.8,organismtaxon
"The transcriptomic profiling of Zebrafish larvae infected with hepatitis B virus revealed upregulation of interferon‑stimulated genes, suggesting a conserved antiviral response across vertebrates.",-25.125,0.8,organismtaxon
"The interaction between Panax ginseng extracts and hepatitis B virus replication was confirmed in HepG2‑liver cells, where the treatment significantly reduced viral DNA synthesis by up to eightfold while also upregulating interferon‑α expression.",-53.75,0.8,organismtaxon
"Panax ginseng extracts were shown to reduce hepatitis B virus replication in HepG2.2.15 cells, demonstrating a potential therapeutic effect against viral infection.",-19.375,0.8,organismtaxon
"Panacis ginseng extracts reduced hepatitis B virus replication in HepG2 cells, confirming the antiviral activity of Panax ginseng in a hepatocyte-based model of viral infection.",-41.75,0.8,organismtaxon
Pancreatic adenocarcinoma cell lines derived from Panax ginseng–treated mice exhibit elevated expression of hepatitis B virus surface antigen and increased resistance to HIV-1–resistant monoclonal antibody therapy.,-42.0,0.8,organismtaxon
"Panazene, a novel compound derived from Panax ginseng, was shown to inhibit hepatitis B virus replication in HepG2 cells and to reduce viral load in HIV‑positive patients treated with a standard ART regimen.",-49.0,0.8,organismtaxon
"In the zebrafish (Danio rerio) model, CRISPR‑mediated disruption of the cyp2e1 gene resulted in reduced ethanol metabolism, thereby amplifying the hepatotoxic effects of acetaminophen and illustrating a genetic basis for drug‑induced liver injury.",-44.5,0.8,organismtaxon
"In zebrafish, overexpression of the gene TP53, driven by the CRISPR/Cas9 system, induced apoptosis in liver cells, thereby reducing viral replication of hepatitis B virus and ameliorating the disease phenotype.",-41.0,0.8,organismtaxon
"In *Panax ginseng* extracts, the saponin ginsenoside Rb1 was found to inhibit hepatitis B virus replication in HepG2‑HepB cells, suggesting a potential therapeutic avenue for HIV‑positive patients co‑infected with HBV.",-26.5,0.8,organismtaxon
"In a zebrafish model of hepatitis B virus infection, the antiviral compound panax ginseng reduced viral DNA replication and restored liver cell integrity, demonstrating a therapeutic effect that may translate to HIV‑positive patients.",-29.25,0.8,organismtaxon
"A zebrafish model infected with hepatitis B virus shows upregulated TP53 expression, suggesting that viral replication induces a DNA damage response in this organism taxon.",-25.375,0.8,organismtaxon
"A transgenic zebrafish model overexpressing the human TP53 gene demonstrates increased sensitivity to the DNA-damaging chemotherapeutic doxorubicin, revealing a potential therapeutic vulnerability that could be exploited in treating pancreatic ductal adenocarcinoma.",-39.75,0.8,organismtaxon
A pharmacogenomic analysis of HIV‑1‑resistant patients infected with hepatitis B virus revealed that a BRCA1 c.68_69delAG variant common in C. elegans does not alter the efficacy of the antiviral drug entecavir in this cohort.,-49.5,0.8,organismtaxon
"A recent zebrafish study demonstrated that exposure to a low dose of ethanol, a chemical entity, upregulates the expression of the zebrafish gene klf6a, a gene product that in turn promotes hepatocyte proliferation, thereby suggesting a potential therapeutic target for liver regeneration in hepatitis B virus–infected Homo sapiens.",-62.5,0.8,organismtaxon
"Hepatitis B virus infection in zebrafish larvae induces a rapid upregulation of the innate immune gene *drc1*, leading to increased antiviral interferon production and limiting viral replication.",-36.0,0.8,organismtaxon
Heterologous expression of the Hepatitis B virus surface antigen in zebrafish larvae revealed a significant reduction in liver steatosis when treated with Panax ginseng extract.,-30.75,0.8,organismtaxon
Hafnium‑tetracycline treatment of HepG2 cells infected with hepatitis B virus reduced viral replication by downregulating HBx expression while sparing normal hepatocyte viability.,-43.75,0.8,organismtaxon
"HCV infection in *Panax ginseng*–treated *Homo sapiens* patients has been linked to increased expression of the interferon‑α inducible protein OAS1, which correlates with a reduced viral load.",-44.5,0.8,organismtaxon
"Zebrafish treated with a panax ginseng extract showed reduced hepatitis B virus replication, suggesting that ginseng-derived compounds modulate viral replication in this organism taxon.",-26.5,0.8,organismtaxon
"Zigzag‑shaped Panax ginseng extracts reduced hepatitis B virus replication in HepG2‑HepG2.2.15 cells, while in a parallel zebrafish model the same compounds decreased liver steatosis, indicating conserved antiviral activity across Homo sapiens and Danio rerio.",-54.5,0.8,organismtaxon
"Zebra finch, a model organism, shows upregulated expression of the Hepatitis B virus surface antigen when infected with a recombinant Panax ginseng-derived therapeutic vector, revealing a potential cross‑species antiviral mechanism.",-60.25,0.8,organismtaxon
"Zanubrutinib markedly inhibited proliferation of the ZR-75‑1 breast carcinoma cell line, and subsequent RNA‑seq analysis revealed that this suppression correlated with down‑regulation of the BCL‑2 gene product in the Homo sapiens tumor model.",-58.75,0.8,organismtaxon
"Doxorubicin treatment of the HeLa cell line, derived from a human cervical carcinoma, led to a dose‑dependent reduction in the expression of the TP53 gene, an effect that was amplified by the presence of a BRCA1 c.68_69delAG sequence variant.",-40.5,0.8,organismtaxon
"Dexamethasone reduced inflammation in Zebrafish larvae infected with hepatitis B virus, thereby improving survival rates in the treated cohort.",-31.625,0.8,organismtaxon
"Drosophila melanogaster infected with hepatitis B virus and treated with a high‑dose panax ginseng extract exhibited a significant reduction in viral replication, suggesting a potential antiviral effect of ginseng in this organism taxon.",-36.5,0.8,organismtaxon
"Diminished expression of miR‑122 in HepG2 cells infected with hepatitis B virus increases replication of the virus, whereas the addition of Panax ginseng extract restores miR‑122 levels and reduces viral load in the human hepatocyte model.",-50.0,0.8,organismtaxon
"Mutant C. elegans carrying the daf-2(e1370) sequence variant show prolonged lifespan, and when exposed to the chemical entity ivermectin, they exhibit reduced expression of the insulin-like peptide gene daf-28, confirming a conserved interaction between drug treatment and insulin signaling across organism taxa.",-56.5,0.8,organismtaxon
"Mutagenic exposure to doxorubicin induced a dramatic increase in the expression of the DNA repair gene XRCC1 in zebrafish embryos, a change that was partially rescued by the antioxidant N‑acetylcysteine, thereby attenuating the downstream activation of caspase‑3 and reducing apoptotic cell death in the developing retina.",-58.75,0.8,organismtaxon
"Mutational analysis of the hepatitis B virus X gene in a cohort of HIV‑positive men revealed a novel sequence variant, HBx c.127T>G, which correlated with elevated alanine aminotransferase levels and enhanced viral replication in cultured HepG2 cells.",-48.5,0.8,organismtaxon
Mutating the hepatitis B virus surface antigen in a cultured human hepatocyte cell line derived from *Homo sapiens* reduced viral replication while concurrently upregulating host interferon‑β expression.,-43.75,0.8,organismtaxon
"Exposure of zebrafish embryos to the Panax ginseng–derived compound ginsenoside Rd upregulated hepatitis B virus surface antigen expression, suggesting a potential modulatory interaction between the herbal metabolite and viral replication in this organismtaxon model.",-39.5,0.8,organismtaxon
"Exposure to the Panax ginseng extract in HIV‑positive patients infected with hepatitis B virus reduces viral replication and improves liver enzyme levels, as demonstrated in a controlled study involving C. elegans and zebrafish models.",-37.75,0.8,organismtaxon
"Exposure from a contaminated Panax ginseng product induced a hepatitis B virus seroconversion in a previously HIV‑positive man, demonstrating interspecies viral transmission across a Panax ginseng–HIV‑HBV co‑exposure scenario.",-66.5,0.8,organismtaxon
Exposure‑based immunization of C. elegans with recombinant hepatitis B virus surface antigen from a Panax ginseng–derived adjuvant system reduced viral replication in HIV‑positive murine models and improved seroconversion rates in a comparative study involving Platonia insignis Mart.,-67.0,0.8,organismtaxon
Treating Hepatitis B virus–infected HepG2 cells with Panax ginseng extract suppresses HBV replication by downregulating the viral surface antigen and upregulating host interferon‑α responses.,-31.625,0.8,organismtaxon
"Treatments of hepatitis B virus infection in *Homo sapiens* with tenofovir led to a significant reduction in viral DNA replication and liver inflammation, whereas a similar study in *Homo sapiens* using interferon‑α demonstrated a slower decline in HBsAg levels, highlighting species‑specific antiviral responses.",-67.0,0.8,organismtaxon
Treatement of hepatitis B virus–infected Panax ginseng extract reduced viral replication by upregulating interferon‑λ in HepG2 cells while maintaining normal expression of the cellular protein PKR.,-59.0,0.8,organismtaxon
"Treatmetive use of Panax ginseng extract in HIV‑positive patients infected with hepatitis B virus has been shown to downregulate viral replication while preserving CD4+ T‑cell counts, thereby reducing the risk of liver fibrosis in humans.",-52.75,0.8,organismtaxon
"Mice infected with hepatitis B virus exhibit elevated expression of the HBx protein, which subsequently upregulates the host gene CYP2A6, leading to increased activation of the chemotherapeutic agent doxorubicin.",-40.0,0.8,organismtaxon
"Mefloquine, when administered to *Hepatitis B virus*-infected *Homo sapiens*, significantly reduces viral DNA replication, thereby alleviating liver inflammation and improving patient survival.",-40.0,0.8,organismtaxon
"Molecular docking of the Panax ginseng alkaloid ginsenoside Rb1 against the hepatitis B virus surface antigen demonstrated that the compound binds to the viral envelope protein, potentially blocking viral entry into hepatocytes of Homo sapiens.",-33.0,0.8,organismtaxon
"Mitochondrial dysfunction in HepG2 cells infected with hepatitis B virus leads to increased expression of the transcription factor NRF1, thereby amplifying the oxidative stress response and enhancing cellular apoptosis.",-38.75,0.8,organismtaxon
"Cytokine IL‑6 levels were markedly elevated in Panax ginseng‑treated HepG2 cells infected with hepatitis B virus, suggesting that ginseng modulates viral replication pathways in Homo sapiens hepatocytes.",-28.875,0.8,organismtaxon
"C57BL/6 mice infected with hepatitis B virus exhibit increased hepatic steatosis, whereas co‑administration of Panax ginseng extract reduces viral replication and restores liver enzyme levels.",-29.75,0.8,organismtaxon
"C‑elegans lacking the daf‑2 insulin‑like signaling gene exhibit reduced lifespan, yet when treated with Panax ginseng extract the expression of the age‑regulating gene daf‑16 is significantly up‑regulated, suggesting a protective interaction that may extend healthspan in this organism taxon.",-59.25,0.8,organismtaxon
"Cranial irradiation of zebrafish embryos decreased expression of the tp53 gene, which in turn increased apoptosis and resulted in craniofacial malformations that were rescued by treatment with the small‑molecule activator of p53, SM4.",-65.0,0.8,organismtaxon
"Knocking out the *p53* gene in *C. elegans* dramatically reduces the survival rate of the worms when they are infected with the hepatitis B virus, underscoring the pivotal role of TP53-mediated apoptosis in host defense.",-49.0,0.8,organismtaxon
"Knockdown of the Panax ginseng-derived saponin in a zebrafish model of hepatitis B virus infection reduced viral DNA replication, suggesting a potential antiviral activity of ginseng components in vertebrate hosts.",-41.0,0.8,organismtaxon
"Knitting a dose of Panax ginseng extract into the diet of Hepatitis B virus–infected HepG2 cells reduced viral replication by up to a two‑fold decrease in HBV surface antigen production, indicating a potential therapeutic synergy in this organism‑taxon model.",-70.0,0.8,organismtaxon
"Knex cells from the Panax ginseng-derived HCV-infected HepG2 cell line showed a significant up‑regulation of interferon‑lambda, confirming that the virus‑induced STAT‑1 pathway is conserved in Homo sapiens and mouse hepatocytes.",-75.5,0.8,organismtaxon
Deletion of the HLA‑B*57:01 allele in *Homo sapiens* reduces the risk of severe drug‑induced liver injury caused by abacavir while preserving the antiviral efficacy of the drug against HIV‑1.,-38.25,0.8,organismtaxon
Deletion in the hepatitis B virus polymerase gene confers HIV-1-resistant phenotype and reduces viral replication in infected human hepatocytes.,-35.75,0.8,organismtaxon
"Deletion A123G in the hepatitis B virus core promoter reduces viral replication in a human hepatocyte cell line derived from a Panax ginseng–treated HepG2/NTCP culture, leading to lower serum alanine aminotransferase levels in infected HIV‑positive patients.",-67.5,0.8,organismtaxon
"Deletion or missense mutation of the HBx gene in hepatitis B virus reduces its interaction with the human TP53 protein, thereby weakening the host’s tumor suppressor response in HIV-positive patients.",-54.25,0.8,organismtaxon
"In patient-derived HCV cultures, the viral RNA replicates more efficiently in human immunodeficiency virus–infected B cells, suggesting a synergistic effect of co‑infection on viral replication dynamics.",-32.25,0.8,organismtaxon
"In HCV‑infected patient‑derived human hepatoma cells, the expression of the viral RNA polymerase NS5B was markedly upregulated, leading to increased production of the lipid‑transferase ACLY and subsequently elevated intracellular cholesterol levels that promote the assembly of infectious virions.",-63.25,0.8,organismtaxon
"In a patient-derived HBV–HIV co‑infection model, the HCV core protein selectively binds the human immunodeficiency virus envelope protein gp120, accelerating viral replication in human hepatocytes.",-38.25,0.8,organismtaxon
"In the patient‑derived HeLa cell line, HCV core protein expression was markedly reduced by CRISPR‑edited TP53, demonstrating a viral replication‑dependent, host‑gene‑specific interaction in Homo sapiens.",-46.75,0.8,organismtaxon
Patient-derived Hepatitis C virus (HCV) isolates from inpatients demonstrated higher replication rates in hepatocytes than patient-derived HIV-1-resistant viral strains isolated from the same cohort.,-23.875,0.8,organismtaxon
Patient‑derived Hepatitis C virus isolates from inpatients harbor a rare NS5A L31M mutation that confers resistance to first‑generation direct‑acting antivirals and is frequently detected in HIV‑1‑resistant co‑infected subjects.,-36.5,0.8,organismtaxon
"Patient‐derived Hepatitis C virus (HCV) and HIV‑1‑resistant strains were simultaneously isolated from inpatients, revealing that the viral quasispecies in human immunodeficiency virus co‑infected individuals exhibit distinct replication kinetics in bovine and yeast cell lines.",-43.0,0.8,organismtaxon
Patient-controlled HBV‐positive mice infected with a patient‑derived HCV strain exhibited a significant reduction in hepatic steatosis compared with HIV‑1‑resistant human immunodeficiency virus‑negative controls.,-47.0,0.8,organismtaxon
The patient-derived HCV strain from the infected male exhibited a mutation at BRCA1 c.68_69delAG that conferred resistance to the antiviral drug ribavirin in vitro.,-28.625,0.8,organismtaxon
"The HCV patient-derived culture of HepG2 cells was infected with a HIV‑1‑resistant strain of HIV-1, leading to increased replication of the virus and upregulation of the CXCR4 chemokine receptor on the hepatocytes.",-44.0,0.8,organismtaxon
"The inpatients’ HIV-1-resistant viral isolates, derived from a patient‑controlled cohort, were compared with a patient‑derived HCV strain and a bovine cell line to investigate cross‑species antiviral resistance mechanisms in *Homo sapiens* and *Saccharomyces cerevisiae*.",-55.75,0.8,organismtaxon
"The **HCV**-infected **HIV-1-resistant** patient-derived **HepG2** cells exhibited a marked upregulation of interferon‑stimulated genes, suggesting a synergistic antiviral response in this **Homo sapiens** line.",-33.25,0.8,organismtaxon
"Homozygous BRCA1 c.68_69delAG was identified in a patient‑derived HeLa cell line, revealing that this sequence variant increases the susceptibility of the human epithelial cells to doxorubicin‑induced apoptosis.",-33.5,0.8,organismtaxon
"HCV infection in patient-derived human immunodeficiency virus–positive inpatients induces elevated expression of the interferon‑λ3 gene, a pattern also observed in HIV‑1‑resistant mouse models and in Arabidopsis thaliana treated with viral mimics.",-42.25,0.8,organismtaxon
"HIV‑1‑resistant, patient‑derived Bovine Viral Diarrhea Virus strains were shown to inhibit replication of human immunodeficiency virus in HEK‑293 cells, revealing a cross‑species antiviral interaction.",-32.5,0.8,organismtaxon
"Hepatitis C virus (HCV) infection in patient‑derived hepatocytes induces expression of the interferon‑stimulated gene IFITM3, which in turn limits replication of human immunodeficiency virus (HIV‑1) in co‑infected cells.",-27.0,0.8,organismtaxon
Polymorphisms in the HCV core protein of patient‑derived isolates from HIV‑1‑resistant inpatients revealed a novel sequence variant that enhances viral replication in human hepatocytes.,-27.625,0.8,organismtaxon
Polyspecific antibodies against HCV E2 protein were isolated from patient-derived B cells and demonstrated neutralization potency comparable to that of HIV‑1‑resistant broadly neutralizing antibodies in vitro.,-40.75,0.8,organismtaxon
Polyclonal HCV infection in patient‑derived hepatocyte cultures from the Arabidopsis‑like model organism *Bacillus subtilis* demonstrates that viral replication is markedly reduced when co‑treated with an HIV‑1‑resistant CRISPR‑Cas9 system targeting the NS5A gene.,-57.0,0.8,organismtaxon
"Polymyxin B selectively disrupts the outer membrane of patient‑derived *E. coli* isolates, enhancing the intracellular accumulation of rifampicin and restoring susceptibility in a subset of multidrug‑resistant strains.",-39.0,0.8,organismtaxon
"Human immunodeficiency virus (HIV‑1) infection of patient‑derived CD4+ T cells from inpatients leads to upregulation of the CCR5 receptor, which in turn promotes viral entry and replication.",-28.5,0.8,organismtaxon
"Human‐derived patient‐controlled HCV infection models have shown that HCV core protein activates the PI3K/Akt pathway in hepatocytes, leading to increased viral replication and reduced apoptosis.",-43.0,0.8,organismtaxon
"Human-derived HCV patient‑derived cell lines were shown to up‑regulate interferon‑stimulated gene expression, whereas bovine HCV‑resistant cell lines exhibited a markedly attenuated antiviral response.",-39.0,0.8,organismtaxon
"Human HCV infection is frequently detected in patient‑derived plasma from inpatients, while the HCV core protein interacts with the human interferon‑λ receptor to suppress antiviral gene expression.",-44.5,0.8,organismtaxon
"A single‑cell RNA‑seq analysis of patient‑derived HCV‑infected hepatocytes revealed that viral RNA induces a robust interferon‑stimulated gene signature, including upregulation of CXCL10 and MX1, while co‑expression of the HCV core protein with the human immunodeficiency virus envelope gp120 modulates CD81 trafficking and enhances viral entry in hepatocytes.",-68.5,0.8,organismtaxon
"A patient-derived HCV strain isolated from an HIV-1-resistant male in the United States exhibited a novel sequence variant that altered the viral envelope glycoprotein, potentially conferring resistance to standard antiviral therapy.",-35.5,0.8,organismtaxon
"ACR2‐deficient Arabidopsis thaliana plants exhibit increased resistance to bacterial infection by Pseudomonas syringae pv. tomato, an effect that is amplified when the plants are treated with the small molecule salicylic acid, thereby demonstrating a gene‑product interaction that modulates immune signaling in a model organism.",-66.5,0.8,organismtaxon
"A recombinant AAV vector expressing the HCV NS5A protein was successfully transduced into patient‑derived HepG2 cells, where it activated the PI3K/AKT pathway, leading to increased proliferation of these human cell lines.",-42.25,0.8,organismtaxon
"Arabidopsis thaliana mutants harboring a patient-derived BRCA1 variant exhibit heightened sensitivity to HCV infection, revealing a novel interaction between plant pathogen response pathways and human cancer-associated sequence variants.",-39.0,0.8,organismtaxon
"Arabian‑bred bovine milk from patient‑derived cows infected with HCV showed reduced whey protein content, suggesting that the viral infection alters mammary gland gene expression.",-51.0,0.8,organismtaxon
"Arabine-6-ol, a natural product isolated from *Arabidopsis thaliana*, inhibited the replication of patient‑derived HCV strains by blocking the viral NS5B polymerase, an effect that was not observed in yeast or bovine cell lines.",-60.0,0.8,organismtaxon
"Arabinose‑stimulated growth of the patient‑derived HCV‑infected HepG2 cells led to an up‑regulation of the interferon‑stimulated gene OAS1, whereas the HIV‑1‑resistant YB2 cell line remained refractory to viral replication.",-56.0,0.8,organismtaxon
"Bacterial transposase activity in patient‑derived *E. coli* cultures enhances the frequency of antibiotic‑resistance gene acquisition, whereas the same transposase is absent in patient‑controlled *Homo sapiens* lymphocytes exposed to HIV‑1‑resistant antiretroviral therapy.",-49.75,0.8,organismtaxon
"Bovine-derived macrophages infected with HCV and co‑cultured with patient‑derived T cells from HIV‑1‑resistant individuals showed a synergistic increase in interferon‑γ production, suggesting a potential therapeutic strategy for inpatients.",-35.75,0.8,organismtaxon
"Bacteriophage T7 infection of *E. coli* K-12 cells is enhanced by the presence of the HIV-1-resistant mutation in the bacterial *recA* gene, leading to increased lysogeny rates in patient-derived samples.",-45.5,0.8,organismtaxon
"BMC‑derived patient‑controlled macrophages infected with HCV and HIV‑1-resistant Arabidopsis‑expressing interferon‑λ showed a synergistic increase in antiviral gene expression, illustrating how organism‑taxon interactions can modulate host immune responses.",-59.0,0.8,organismtaxon
"Patients derived from a human immunodeficiency virus–infected cohort showed that the HCV‑1b strain isolated from their plasma exhibited a novel NS5A polymorphism, conferring reduced sensitivity to the antiviral drug daclatasvir.",-42.5,0.8,organismtaxon
Patients of the HIV-1-resistant HCV co-infection cohort were shown to exhibit increased interferon‑λ3 expression in patient-derived human hepatocytes compared with inpatients infected solely with HIV-1.,-49.0,0.8,organismtaxon
"Patients-derived HCV isolates from HIV‑1‑resistant men were shown to replicate more efficiently in human hepatocytes than in bovine liver cell lines, suggesting a species‑specific interaction between viral envelope proteins and host cell receptors.",-31.5,0.8,organismtaxon
"Patients‑derived HCV isolates from Arabidopsis‑transgenic lines revealed that a viral RNA sequence variant enhances replication in yeast‐like cellular environments, suggesting a cross‑kingdom adaptation of the virus.",-50.25,0.8,organismtaxon
Pharmacological inhibition of HCV NS5B polymerase by sofosbuvir markedly reduces viral replication in patient‑derived hepatocyte cultures of *Homo sapiens* and confers a superior antiviral profile compared with untreated controls.,-42.75,0.8,organismtaxon
Phylogenetic analysis of patient‑derived HCV isolates from HIV‑1‑resistant men revealed a distinct evolutionary lineage that may drive antiviral drug resistance in co‑infected human immunodeficiency virus carriers.,-44.5,0.8,organismtaxon
"Pharmaceutical screening of patient-derived HepG2 cells revealed that the HIV-1-resistant drug zidovudine reduces viral replication in a dose-dependent manner, confirming its efficacy against HCV infection in vitro.",-40.0,0.8,organismtaxon
"Phosphatidylserine exposure on patient‑derived HepG2 cells treated with the HCV protease inhibitor boceprevir triggers a STAT3‑dependent up‑regulation of the antiviral gene ISG15, thereby limiting HIV‑1‑resistant viral replication in vitro.",-48.75,0.8,organismtaxon
"An influenza‑HCV co‑infection in patient‑derived human lung epithelial cells led to increased expression of the antiviral interferon‑β gene, which in turn triggered a robust antiviral state that limited replication of HIV‑1‑resistant viral strains while sparing bovine influenza‑susceptible yeast cultures.",-70.0,0.8,organismtaxon
"An MTT assay showed that the patient‑derived HCV strain isolated from an HIV‑1‑resistant subject markedly increased replication of the virus in HepG2 cells, while the same strain exhibited a reduced replication efficiency in a yeast model expressing the human CD81 receptor.",-69.5,0.8,organismtaxon
An HCV patient-derived Huh7.5 cell line overexpressing the HIV-1-resistant protein TRIM5α exhibits markedly reduced viral replication and induces a robust interferon‑stimulated gene signature.,-35.75,0.8,organismtaxon
"An infection of HCV in patient-derived bovine macrophages upregulates the host interferon‑α pathway, suggesting a potential cross‑species antiviral defense.",-41.0,0.8,organismtaxon
"RNA sequencing of patient‑derived hepatocytes from HCV‑infected Homo sapiens revealed that the viral protein NS5A induces a down‑regulation of the host gene CYP3A4, potentially contributing to reduced drug metabolism in chronic infection.",-38.75,0.8,organismtaxon
"RNA interference targeting the HCV NS5A gene in patient-derived Huh‑7 hepatoma cells reduced viral replication by >90% and concurrently restored interferon‑α production, indicating a potential therapeutic strategy for HCV‑infected inpatients.",-45.75,0.8,organismtaxon
"RNA polymerase II activity was markedly enhanced in patient‑derived HepG2 cells transfected with a CRISPR‑generated HCV NS5B promoter variant, suggesting a novel host‑pathogen interaction that may influence viral replication in humans.",-46.5,0.8,organismtaxon
"RNA‑seq analysis of patient‑derived *Homo sapiens* hepatocytes revealed that the HCV core protein upregulates the expression of the *STAT1* gene, thereby enhancing antiviral signaling pathways.",-28.625,0.8,organismtaxon
"We observed that patient-derived HCV RNA from inpatients carrying a novel NS5A sequence variant was more efficiently inhibited by the small-molecule inhibitor daclatasvir, suggesting a potential therapeutic target in HIV‑1-resistant viral strains.",-45.5,0.8,organismtaxon
"We showed that HCV infection in patient-derived HepG2 cells upregulates the interferon‑stimulated gene OAS1, leading to an antiviral state that limits viral replication.",-37.75,0.8,organismtaxon
"We discovered that patient-derived HCV RNA amplified from inpatients infected with HCV exhibited a novel mutation in the core protein, which conferred resistance to interferon‑α therapy in a cell‑line assay using the Huh‑7.5 hepatocyte culture system.",-59.5,0.8,organismtaxon
"We engineered a patient-derived, HCV‑infected, human immunodeficiency virus–positive hepatocyte culture from a male inpatient, in which the viral replication of HIV‑1‑resistant strains was markedly suppressed by a novel chemical entity, curcumin, thereby demonstrating a synergistic antiviral effect.",-65.0,0.8,organismtaxon
"HIV-positive men infected with Human Papillomavirus demonstrate increased rates of hepatitis A viral replication, suggesting a synergistic effect between HIV, human immunodeficiency virus, and a human-specific viral co‑factor.",-34.75,0.8,organismtaxon
Hepatitis A infection in HIV‑positive men receiving rDEN‑2 vaccine reduced viral replication and enhanced CD4⁺ T‑cell recovery in human subjects.,-29.375,0.8,organismtaxon
Homozygous HIV-positive men carrying the human-specific Hepatitis A virus rDEN‑2 strain exhibit markedly higher viral loads compared with HIV-negative carriers.,-34.0,0.8,organismtaxon
"HLA‑B*57:01 carriers among HIV‑positive men were found to exhibit significantly higher rates of hepatitis A infection than HIV‑negative men, suggesting a human‑specific interaction that may affect viral clearance.",-42.0,0.8,organismtaxon
"In HIV‑positive men infected with hepatitis A, the human immunodeficiency virus upregulates the expression of human-specific HLA‑A*02, thereby enhancing antigen presentation and limiting the replication of Human Papillomas Virus in rDEN‑2‑transduced hepatocytes.",-50.75,0.8,organismtaxon
"In patients who are HIV‑positive, infection with Human Papillomavirus accelerates the progression of hepatocellular carcinoma in Hepatitis‑A‑negative men and women, highlighting a synergistic effect on human‑specific viral oncogenesis.",-48.0,0.8,organismtaxon
"In *Homo sapiens* patients harboring an HIV-positive status, the viral protein Nef was found to upregulate the expression of the *TNF* gene, thereby exacerbating inflammation and increasing susceptibility to co‑infection with hepatitis A virus.",-44.5,0.8,organismtaxon
"In the cohort of HIV-positive men infected with Human Papillomavirus, the prevalence of hepatitis A was significantly higher among patients carrying the rDEN-2 vaccine strain compared with HIV-negative controls.",-24.125,0.8,organismtaxon
The human-specific HIV-positive men infected with hepatitis A and carrying Human Papillomavirus were observed to have increased viral replication in rDEN-2–treated patient carriers.,-31.625,0.8,organismtaxon
The HIV-positive men infected with hepatitis A virus show higher levels of human-specific immune activation markers compared to HIV-negative patients.,-23.0,0.8,organismtaxon
"The rDEN‑2 vector efficiently transduces human macrophages, and when administered to HIV‑positive men it reduces viral replication while preserving the host‑derived HLA‑B*57 allele.",-43.25,0.8,organismtaxon
The *HIV‑positive* male patients infected with *human papillomavirus* and *hepatitis A* were all found to be *Homo sapiens* carriers of a novel viral quasispecies.,-41.75,0.8,organismtaxon
"Human Papilloma Virus infection of a human-specific male HIV-positive patient triggers increased expression of the oncogenic E6 protein, which in turn degrades TP53 and promotes cellular transformation.",-36.75,0.8,organismtaxon
"Human papillomavirus integration into the genome of HIV-positive men’s cervical epithelial cells promotes the expression of oncogenic E6 and E7 proteins, thereby facilitating progression toward cervical cancer.",-31.5,0.8,organismtaxon
Human immunodeficiency virus infection in men and women with hepatitis A co‑infection has been linked to increased rates of HIV-positive men who have sex with men and to altered immune responses in Human Papillomavirus‑positive patients.,-44.25,0.8,organismtaxon
"Human‐specific Human Papillomas Virus infection in HIV-positive men carrying the rDEN‑2 strain induces up‑regulated PD‑L1 expression in keratinocytes, potentially contributing to immune evasion.",-42.5,0.8,organismtaxon
"Transfecting HeLa cells with a plasmid expressing HIV-1 reverse transcriptase revealed that the enzyme rapidly integrated into the host genome, triggering an innate immune response that elevated interferon‑α levels and suppressed HPV‑18 viral replication.",-58.25,0.8,organismtaxon
Transgenic mouse models harboring the HIV‑positive human immunodeficiency virus LTR inserted into the human-specific HLA‑B*57 allele demonstrate that rDEN‑2 vaccination reduces hepatitis A viremia in male patients while preserving CD4+ T cell counts.,-56.0,0.8,organismtaxon
"Transfection of HEK293T cells with an rDEN‑2-based HIV‑negative vector expressing the Human Papillomavirus E6 protein demonstrated that the viral oncoprotein can down‑regulate p53 in a human‑specific manner, thereby enhancing cell proliferation.",-46.25,0.8,organismtaxon
"Transduced rDEN-2 expressing a fusion of HIV envelope with a human papillomavirus E7 protein induced robust CD8⁺ T‑cell responses in human‑specific immune‑competent mice, demonstrating that the chimeric virus can be used to evaluate immunotherapeutic strategies in a humanized organismtaxon model.",-66.0,0.8,organismtaxon
"An **HIV-positive** **human** **men** infection was linked to elevated **hepatitis A** viral loads, while **human Papillomaviruses** co‑infection was observed to modify the immune response in the **human** host.",-66.5,0.8,organismtaxon
An HIV-positive male patient infected with human immunodeficiency virus and hepatitis A was found to harbor a novel rDEN-2-derived variant that may alter antigenicity in the human-specific viral population.,-38.5,0.8,organismtaxon
"An investigation of HIV‑positive men revealed that the presence of the human papillomavirus E6 gene was significantly associated with an increased risk of developing hepatitis A–related liver inflammation, suggesting a synergistic effect of these human‑specific pathogens on disease progression.",-52.5,0.8,organismtaxon
"An rDEN‑2–based vaccine induced robust neutralizing antibodies in HIV‑positive men, suggesting that human‑specific viral vectors can be safely employed to elicit protective immunity against hepatitis A in immunocompromised patients.",-38.0,0.8,organismtaxon
"A HIV-positive man infected with human papillomavirus received rDEN‑2 vaccine, which induced a robust humoral response in the human-specific immune system.",-30.0,0.8,organismtaxon
"A study of HIV-positive men revealed that rDEN-2 vaccine‑induced immune responses were markedly stronger in individuals carrying a human-specific HLA‑B*57 allele, correlating with reduced viral load compared to non‑carriers.",-36.5,0.8,organismtaxon
"A human-specific strain of Human Papillomavirus rDEN-2 is prevalent among HIV-positive men, leading to increased rates of hepatitis A infection in carriers.",-31.0,0.8,organismtaxon
"A meta‑analysis of HIV‑positive men and women in the United States revealed that human papillomavirus type‑16 co‑infection was significantly higher in patients carrying the human immunodeficiency virus compared with those with hepatitis A alone, suggesting a synergistic effect on cervical carcinogenesis.",-52.25,0.8,organismtaxon
"Men infected with HIV-positive human immunodeficiency virus and co‑infected with hepatitis A virus displayed increased viral loads and severe liver dysfunction, highlighting the complex interplay between HIV and hepatitis A in human-specific disease progression.",-41.5,0.8,organismtaxon
"Men exposed to rDEN-2 and co‑infected with human immunodeficiency virus showed increased hepatitis A antibody titers, indicating a synergistic immune activation in HIV‑positive patients.",-36.75,0.8,organismtaxon
"Men with HIV-positive status exhibit elevated levels of hepatitis A virus replication in human hepatocytes, a human-specific interaction that may exacerbate liver inflammation in HIV-infected patients.",-39.5,0.8,organismtaxon
"Men who are HIV-positive and infected with Human Papillomavirus exhibit higher levels of serum lactate dehydrogenase, suggesting an accelerated metabolic shift toward anaerobic glycolysis.",-32.25,0.8,organismtaxon
"Mice infected with rDEN‑2 showed a significant increase in viral replication, and human immunodeficiency virus–positive men carrying the HLA‑B*57 allele exhibited a markedly reduced disease progression compared with HIV‑negative women.",-42.75,0.8,organismtaxon
"Males with HIV-positive status and co-infection by hepatitis A exhibit higher viral loads of Human Papillomavirus in cervical tissues, indicating a synergistic effect on disease progression.",-35.5,0.8,organismtaxon
"M2-infected HIV-positive men carrying Human Papillomavirus were observed to have higher levels of liver enzymes, suggesting that co-infection with hepatitis A in this human-specific context may exacerbate viral replication and disease severity.",-50.75,0.8,organismtaxon
"Molecular analysis of HIV-positive men revealed a higher prevalence of human-specific HLA‑B*57:01 alleles, which correlated with reduced viral load in patients carrying the Human Papillomavirus‑16 variant.",-37.0,0.8,organismtaxon
"Recent longitudinal studies in HIV-positive men demonstrate that rDEN-2–induced hepatitis A infection can alter the human-specific antibody response to Human Papillomavirus, thereby affecting vaccine efficacy in patients.",-47.75,0.8,organismtaxon
"Recent research demonstrated that HIV-positive men infected with human papillomavirus experience increased rates of hepatocellular carcinoma compared to HIV-negative patients, highlighting a synergistic pathogenic interaction between HIV and HPV in human liver cells.",-44.25,0.8,organismtaxon
"Recent meta‑analysis showed that HIV‑positive men infected with Human Papillomavirus had a higher prevalence of hepatitis A than HIV‑negative controls, suggesting a synergistic interaction between human immunodeficiency virus, human‑specific viral co‑infections, and liver disease.",-41.5,0.8,organismtaxon
"Recent studies reveal that HIV-positive men who are co-infected with hepatitis A exhibit heightened levels of Human Papillomavirus DNA in cervical biopsies, suggesting a synergistic influence of viral co‑pathogens on oncogenic risk.",-45.5,0.8,organismtaxon
SARS‑CoV‑2 infection in HIV‑positive men carrying the HLA‑B*57:01 allele is associated with a higher frequency of hepatitis A virus co‑infection and a reduced CD4⁺ T‑cell recovery compared with HIV‑negative controls.,-30.375,0.8,organismtaxon
"Spleen-derived CD4⁺ T cells from HIV‑positive men exhibited a significant increase in the expression of the chemokine receptor CCR5, correlating with enhanced susceptibility to Human Papillomavirus infection in the same cohort.",-46.25,0.8,organismtaxon
"Sanger sequencing of the HBV genome from HIV‑positive men revealed a novel G1896A sequence variant that abolishes the termination codon of the core protein in a human‑specific HBV strain, potentially increasing viral replication.",-48.25,0.8,organismtaxon
"Sera from HIV-positive men infected with HIV-1 revealed high titers of anti‑Human Papilloma Virus antibodies, while rDEN‑2‑infected human-specific cell cultures showed increased cytokine release, indicating that the virus can modulate the immune response in these patients.",-68.5,0.8,organismtaxon
Reduced survival of HIV-positive men infected with Human Papillomavirus was observed when their CD4+ T‑cell counts fell below the threshold associated with increased hepatitis A viral replication.,-41.0,0.8,organismtaxon
Reduced infection of rDEN-2 by the human immunodeficiency virus in HIV‑positive men was demonstrated to be dependent on a specific cellular entry factor expressed exclusively in Homo sapiens.,-46.25,0.8,organismtaxon
"Reduced HIV‑positive men infected with Human Papillomavirus exhibit higher levels of hepatitis A antibody titers, indicating that co‑infection accelerates immune response in Homo sapiens.",-36.0,0.8,organismtaxon
Reduced replication of Human Papilloma Virus in rDEN-2–infected HIV‑positive men correlates with increased expression of the interferon‑γ‑induced protein IDO1 in human tissue samples.,-40.25,0.8,organismtaxon
"Among HIV‑positive men infected with Human Papillomavirus, rDEN‑2–derived vectors were used to deliver a therapeutic gene, resulting in a marked reduction of viral load in this human‑specific population.",-36.75,0.8,organismtaxon
"Among human immunodeficiency virus–positive men, the rDEN-2 vector was shown to induce a significant increase in human-specific gene expression compared with HIV-negative controls.",-40.75,0.8,organismtaxon
"Among **HIV-positive men** infected with **Human Papillomavirus**, the presence of **rDEN-2** replication correlates with increased viral load, indicating a **human-specific** interaction that may accelerate disease progression.",-37.0,0.8,organismtaxon
"Among HLA‑B*57:01–positive HIV‑positive men infected with human immunodeficiency virus, the administration of rDEN‑2‑based vaccine elicited robust neutralizing antibody responses against Human Papillomavirus while also reducing hepatitis A viremia in co‑infected patients.",-49.75,0.8,organismtaxon
Female HIV-positive patients infected with Human Papillomavirus and hepatitis A exhibit higher plasma viral loads and reduced CD4+ T‑cell counts compared with HIV-negative controls.,-27.0,0.8,organismtaxon
Female *Homo sapiens* patients co-infected with HIV and Human Papillomavirus exhibit higher rates of persistent viral replication compared to HIV-positive men alone.,-31.5,0.8,organismtaxon
"Female patients infected with human immunodeficiency virus and hepatitis A virus exhibited a higher frequency of Human Papillomavirus infection compared with HIV‑negative men, suggesting a synergistic effect of co‑infection in human-specific viral pathogenesis.",-43.25,0.8,organismtaxon
Female **HIV-positive** **Homo sapiens** patients with chronic hepatitis A infection exhibit elevated liver enzyme levels and an increased risk of hepatocellular carcinoma.,-33.75,0.8,organismtaxon
"In *Saccharomyces cerevisiae* strains engineered to overexpress the human *TP53* gene, exposure to the chemical compound doxorubicin induces a robust apoptotic response characterized by increased caspase‑3 activation, demonstrating that this yeast model can faithfully recapitulate p53‑mediated drug sensitivity observed in human cancer cell lines.",-41.25,0.8,organismtaxon
"In this study, the growth of Saccharomyces cerevisiae in glucose‑rich medium was accelerated by a synthetic derivative of the human‑rodent protein LRG1, demonstrating cross‑species interaction that enhances fermentation efficiency.",-59.5,0.8,organismtaxon
"In Saccharomyces cerevisiae, overexpression of the gene PDR5 increases efflux of the antifungal chemical amphotericin B, thereby reducing drug sensitivity in this organismtaxon.",-26.5,0.8,organismtaxon
"In the human‑rodent comparative study, infection of Saccharomyces cerevisiae cultures with Mycobacterium tuberculosis–derived virulence factors revealed a significant upregulation of the heat‑shock protein gene HSP70, suggesting a conserved stress‑response pathway across organismtaxon.",-38.25,0.8,organismtaxon
"The transcription factor NF‑κB binds to the promoter of the IL‑8 gene in human‑rodent macrophages, activating chemokine production that promotes Mycobacterium tuberculosis invasion of lung epithelial cells.",-34.75,0.8,organismtaxon
"The *Mycobacterium tuberculosis* strain H37Rv, isolated from a human–rodent co‑infection model, was found to upregulate the *katG* gene, conferring increased resistance to isoniazid and correlating with higher bacterial loads in the guinea pig lung tissue.",-30.25,0.8,organismtaxon
"The virulence factor PhoP of *Salmonella enterica* serovar Typhimurium upregulates the *hilA* gene, thereby enhancing invasion of human epithelial cells, a mechanism that is absent in the *S. enterica* strain isolated from *Saccharomyces cerevisiae* cultures.",-37.0,0.8,organismtaxon
"The CRISPR‑Cas9 system efficiently edits the TP53 gene in *Saccharomyces cerevisiae* and human‑rodent cell lines, revealing a conserved DNA repair response that differs markedly from the pathway observed in *Mycobacterium tuberculosis* infections.",-32.25,0.8,organismtaxon
"Overexpression of the M. tuberculosis protein Rv0678 in the Mycobacterium tuberculosis clinical isolate from a human patient carrying the H37Rv strain reduced the bacteria’s susceptibility to bedaquiline, confirming the role of this regulator in drug resistance.",-53.0,0.8,organismtaxon
"Overexpressing the transcription factor NRF2 in Saccharomyces cerevisiae dramatically increases resistance to oxidative stress and enhances survival during prolonged exposure to hydrogen peroxide, suggesting a conserved regulatory mechanism across eukaryotic species.",-40.5,0.8,organismtaxon
"Over the course of a comparative study, the transcription factor NF‑κB was found to bind more strongly to the promoters of cytokine genes in *Mycobacterium tuberculosis*-infected macrophages from human-rodent hybrid models than in those from *Saccharomyces cerevisiae*, highlighting a species‑specific regulatory mechanism that may influence the inflammatory response.",-56.75,0.8,organismtaxon
"Overgrowth of Mycobacterium tuberculosis in the lungs of human‑rodent hybrid mice carrying the RD1 deletion markedly increased the production of the cytokine IL‑1β, leading to enhanced granuloma formation and reduced bacterial burden.",-47.5,0.8,organismtaxon
"Deletion of the *katG* promoter in *Mycobacterium tuberculosis* reduces isoniazid activation, thereby increasing drug resistance and leading to treatment failure in infected patients.",-23.375,0.8,organismtaxon
"Deletion in the promoter of *TP53* in *Saccharomyces cerevisiae* enhances sensitivity to the DNA‑damaging agent doxorubicin, whereas the same variant in human cells upregulates the p21^CIP1/WAF1^ pathway and confers resistance to cisplatin.",-54.25,0.8,organismtaxon
"Deletion analysis of the M. tuberculosis phoP promoter in a human‑rodent infection model revealed that the ΔphoP strain had markedly reduced virulence in guinea pig lungs, confirming phoP as a critical regulator of pathogenicity in this organism taxon.",-40.5,0.8,organismtaxon
"Deletion mutations in the *rpoB* gene of *Mycobacterium tuberculosis* from human-rodent co‑infection studies reduce rifampicin binding, thereby conferring drug resistance in clinical isolates.",-39.0,0.8,organismtaxon
"Methicillin‑resistant *Staphylococcus aureus* strains isolated from *Homo sapiens* patients and *C. elegans* laboratory cultures exhibited a shared up‑regulation of the *agr* quorum‑sensing operon, suggesting a conserved inter‑species virulence adaptation.",-40.0,0.8,organismtaxon
"Methotrexate treatment of *Saccharomyces cerevisiae* cultures expressing the human *TP53* gene resulted in a dramatic reduction of colony‐forming units, suggesting that the drug’s cytotoxicity is conserved across the human‑rodent–fungal phylogeny.",-42.75,0.8,organismtaxon
"Methionine adenosyltransferase activity in *Saccharomyces cerevisiae* was increased by the *MET6* promoter variant BRCA1 c.68_69delAG, which in turn enhanced the synthesis of S-adenosylmethionine and suppressed the growth of *Mycobacterium tuberculosis* in co-culture assays.",-45.0,0.8,organismtaxon
"Methanogenic activity of *Saccharomyces cerevisiae* was markedly reduced when the strain was co‑cultured with *Mycobacterium tuberculosis*, suggesting a competitive inhibition of the respiratory chain that could impair pathogenic colonization in human‑rodent co‑habitats.",-42.5,0.8,organismtaxon
"Saccharomyces cerevisiae engineered to express a human-rodent hybrid ribosomal protein displayed reduced growth in glucose‑rich medium, indicating that interspecies incompatibilities in ribosomal assembly can impair metabolic fitness.",-40.25,0.8,organismtaxon
"Sacral injection of a single dose of doxorubicin into the rat thoracic vertebrae induced a dose‑dependent increase in apoptosis of the spinal cord neurons, while simultaneously up‑regulating the expression of the pro‑apoptotic gene BAX and down‑regulating the anti‑apoptotic gene BCL‑2 in the lumbar spinal cord of the same animal.",-72.0,0.8,organismtaxon
"Sacrificial infection of HeLa cells with Mycobacterium tuberculosis induced a rapid up‑regulation of the cytokine IL‑6, confirming the pathogen’s ability to trigger inflammatory pathways in a human‑rodent cell line model.",-49.25,0.8,organismtaxon
"Sacromyces cerevisiae cells overexpressing the human‑rodent chaperone Hsp70 displayed a dramatic increase in the secretion of the Mycobacterium tuberculosis antigen ESAT‑6, suggesting a cross‑species enhancement of antigen presentation that may be exploited for vaccine development.",-52.25,0.8,organismtaxon
"Mutagenic exposure to UV light in *Saccharomyces cerevisiae* induces the deletion of the *RAD51* locus, which compromises homologous recombination and predisposes the yeast to genomic instability that parallels the effect of BRCA1 loss in human breast cancer cells.",-40.0,0.8,organismtaxon
"Mutant strains of **Saccharomyces cerevisiae** harboring a deletion of the *SIR2* locus exhibit increased sensitivity to the DNA‑damaging agent **doxorubicin**, indicating that **SIR2** loss compromises the repair pathways that normally protect the yeast genome.",-46.0,0.8,organismtaxon
"Mutations in the *lacZ* gene of *Saccharomyces cerevisiae* were shown to confer resistance to the chemical agent cephalexin, thereby enabling the organism to survive in media containing the drug.",-40.75,0.8,organismtaxon
"Mutants of *Saccharomyces cerevisiae* carrying the *URA3* deletion, when infected with *Mycobacterium tuberculosis* and treated with the chemical entity isoniazid, display a significant increase in the expression of the *ESR1* gene, suggesting a cross‑kingdom regulatory effect that could be exploited in human‑rodent models of tuberculosis infection.",-59.5,0.8,organismtaxon
"Altered metabolic flux in the mitochondrial matrix of **Saccharomyces cerevisiae** carrying a **BRCA1 c.68_69delAG** variant was rescued by exogenous **doxorubicin** treatment, thereby restoring the transcriptional activity of the **TP53** promoter in human‑rodent co‑culture experiments.",-56.5,0.8,organismtaxon
"Alteration of the *recA* gene in *Mycobacterium tuberculosis* significantly reduces its ability to repair DNA damage caused by isoniazid, thereby enhancing the bactericidal effect of the drug.",-33.75,0.8,organismtaxon
"Alterations in the glycosylation pathway of *Saccharomyces cerevisiae* have been shown to reduce the susceptibility of the yeast to *Candida albicans* infection, illustrating how a single organism taxon’s cell surface composition can influence interspecies pathogen-host dynamics.",-47.5,0.8,organismtaxon
"Alterious genetic manipulation of **Saccharomyces cerevisiae** and **Mycobacterium tuberculosis** via CRISPR-Cas9 reveals that disruption of the *rpoB* gene in the bacterium enhances susceptibility to rifampicin, while simultaneous deletion of *URA3* in yeast increases growth rate in uracil-deficient media.",-70.0,0.8,organismtaxon
"When Saccharomyces cerevisiae is engineered to overexpress the human TP53 gene, the resulting yeast cells display increased apoptosis in response to doxorubicin, illustrating a cross‑species functional interaction between a mammalian tumor suppressor and a yeast cellular pathway.",-33.5,0.8,organismtaxon
"When the CRISPR/Cas9‑edited *Saccharomyces cerevisiae* strain expressing a fluorescently tagged ribosomal protein was co‑cultured with *Mycobacterium tuberculosis* in a human‑rodent cell‑culture system, the bacterial load was markedly reduced, indicating a potential antimicrobial mechanism mediated by the yeast‑derived microbe‑inhibitory peptides.",-61.0,0.8,organismtaxon
"When researchers infected Saccharomyces cerevisiae with a plasmid encoding the human-rodent hybrid protein, they observed that the yeast’s growth rate increased by over thirty percent compared to controls.",-45.25,0.8,organismtaxon
"When *Saccharomyces cerevisiae* is engineered to overexpress the *HSP104* gene, the resulting yeast cells exhibit heightened tolerance to thermal shock, illustrating how manipulation of a single gene product can modulate stress resilience in a model organism.",-43.0,0.8,organismtaxon
"Mycobacterium tuberculosis infection of guinea pig alveolar macrophages triggers an up‑regulation of the cytokine IL‑6, which in turn promotes the differentiation of resident macrophages into a type‑2 phenotype, thereby facilitating bacterial persistence.",-38.25,0.8,organismtaxon
"Mycoplasma genitalium infection in human-rodent co‑habitat models shows that S. aureus superinfection enhances cytokine production, leading to increased neutrophil recruitment in guinea pig lung tissue.",-41.75,0.8,organismtaxon
"Mycelial cultures of *Saccharomyces cerevisiae* exposed to the quorum‑sensing inhibitor furanone C-30 exhibited a marked reduction in hyphal morphogenesis, suggesting a potential anti‑biofilm strategy against *Mycobacterium tuberculosis* in the respiratory tract of infected patients.",-50.0,0.8,organismtaxon
"MycoCured, a recombinant protein derived from *Saccharomyces cerevisiae*, was shown to inhibit *Mycobacterium tuberculosis* growth in macrophages isolated from human-rodent chimeric bone marrow, thereby reducing the bacterial load and improving survival in infected mice.",-44.5,0.8,organismtaxon
"Gene knockout of the *cys3* locus in *Saccharomyces cerevisiae* reduces intracellular sulfide production, thereby increasing the strain’s susceptibility to oxidative damage caused by the *Mycobacterium tuberculosis* secreted protein Rv1962c.",-54.75,0.8,organismtaxon
"Gene editing of the CRISPR/Cas9 system in *Saccharomyces cerevisiae* revealed that loss of the *RAD51* locus decreases homologous recombination efficiency, providing a model to study DNA repair mechanisms relevant to both human and bovine disease contexts.",-49.0,0.8,organismtaxon
"Gene deletion of *p53* in *Saccharomyces cerevisiae* strains causes increased sensitivity to the DNA‑damaging agent doxorubicin, which parallels the hyper‑mutability observed in human-rodent models of breast cancer.",-44.75,0.8,organismtaxon
"Gene knock‑in of the ERG11 allele in **Saccharomyces cerevisiae** markedly increases azole tolerance, a finding that parallels the resistance phenotype observed in clinical isolates of **Mycobacterium tuberculosis** from **human‑rodent** transmission studies.",-44.75,0.8,organismtaxon
"Mutation of the gyrA gene in *Escherichia coli* confers high-level resistance to the fluoroquinolone ciprofloxacin by altering the drug‑binding pocket of DNA gyrase, thereby impairing bacterial DNA replication.",-34.5,0.8,organismtaxon
"Mutation p.G12D in KRAS was introduced into the human-rodent cell line A549, and the resulting line exhibited increased proliferation and resistance to doxorubicin compared with the wild‑type line, demonstrating a genotype‑dependent drug response that was validated in primary bovine fibroblasts.",-62.0,0.8,organismtaxon
"Mutation analysis of the **TP53** gene in *Saccharomyces cerevisiae* strains engineered to express the human‑rodent p53 variant revealed that the **c.215G>A (p.Arg72Pro)** substitution markedly increased apoptotic sensitivity to the DNA‑damaging agent doxorubicin, suggesting a conserved functional role for this sequence variant across eukaryotic species.",-50.5,0.8,organismtaxon
"Mutation screening of the *Escherichia coli* strain K12 revealed a *recA* sequence variant (c.425G>A) that conferred increased tolerance to UV‑induced DNA damage, a phenotype that was confirmed by growth assays in human‑rodent co‑culture systems.",-61.0,0.8,organismtaxon
"Impaired mitochondrial DNA replication in *Saccharomyces cerevisiae* carrying the *MIP1* G702S sequence variant leads to increased reactive oxygen species production, which in turn promotes aging phenotypes similar to those observed in human‑rodent models of neurodegeneration.",-46.5,0.8,organismtaxon
"Immunization of **human-rodent** chimeric mice with a recombinant protein from **Saccharomyces cerevisiae** reduced the severity of **RSV** infection, demonstrating cross‑species antigenic protection.",-33.5,0.8,organismtaxon
"Impairment of the unfolded protein response in *Saccharomyces cerevisiae* carrying the *ire1* p.Lys378Glu variant leads to increased sensitivity to tunicamycin, suggesting that this sequence variant disrupts ER stress signaling in yeast.",-53.0,0.8,organismtaxon
"Imatinib selectively inhibits the BCR‑ABL kinase expressed in the human‑rodent K562 cell line, thereby reducing proliferation of the Mycobacterium tuberculosis–derived antigen‑stimulated splenocytes from guinea pig recipients.",-47.0,0.8,organismtaxon
"During infection of *Mycobacterium tuberculosis*‑derived macrophages, the *S. aureus* toxin Panton‑Valentine leukocidin triggers up‑regulation of human interleukin‑8, amplifying neutrophil recruitment and accelerating the inflammatory response.",-40.5,0.8,organismtaxon
"During the infection of human-rodent and guinea pig lung epithelial cells with Mycobacterium tuberculosis, the bacterial virulence factor ESX‑1 was shown to trigger a STAT3‑dependent inflammatory cascade that increased IL‑6 secretion and subsequently promoted macrophage recruitment.",-54.0,0.8,organismtaxon
"During co‑infection with Mycobacterium tuberculosis, the human‑rodent model demonstrates that S. aureus biofilm formation on lung epithelial cells is markedly enhanced by the presence of RSV, revealing a cross‑species interaction that could inform vaccine design.",-48.5,0.8,organismtaxon
"During a comparative study, the deletion of the *ERG11* gene in *Saccharomyces cerevisiae* increased fluconazole susceptibility, mirroring the enhanced drug sensitivity observed in human‑rodent cell lines harboring the same mutation.",-43.75,0.8,organismtaxon
"The cytomegalovirus infection in the Kilham rat model recapitulates the human disease, demonstrating that virus‑induced endothelial dysfunction triggers the same vascular pathology observed in patients infected with the homologous human cytomegalovirus.",-39.25,0.8,organismtaxon
"The respiratory failure observed in the Kilham rat infected with Mycobacterium tuberculosis was mitigated by administering high‑dose doxycycline, which inhibited bacterial replication and restored pulmonary function.",-30.625,0.8,organismtaxon
"The Kilham rat model of cytomegalovirus infection demonstrated that viral replication in epithelial cells of the lung is significantly higher in male animals than in female animals, suggesting sex-specific immune responses.",-32.25,0.8,organismtaxon
"The Chinese hamster cell line CHO-K1 was infected with cytomegalovirus, and the resulting viral replication induced a strong interferon‑β response that was markedly higher than in the uninfected control.",-33.5,0.8,organismtaxon
"A cytomegalovirus infection in a Kilham rat model led to increased expression of the interferon‑γ pathway, indicating that the virus can modulate host immune responses in this rodent species.",-30.25,0.8,organismtaxon
"A Kilham rat inoculated with cytomegalovirus exhibited a marked increase in interferon‑α production, suggesting a potential antiviral response that could be exploited in future studies on Mycobacterium tuberculosis infection in human patients.",-38.0,0.8,organismtaxon
"A cohort of Chinese hamster lung fibroblasts infected with cytomegalovirus exhibited a marked upregulation of the interferon‑β promoter, indicating that the virus activates innate antiviral responses in this organism taxon.",-33.5,0.8,organismtaxon
"A prospective study in Chinese hamster cells revealed that cytomegalovirus infection enhances the replication of Mycobacterium tuberculosis DNA, thereby increasing bacterial virulence in infected hosts.",-29.125,0.8,organismtaxon
"In *Saccharomyces cerevisiae*, the cytomegalovirus homolog **UL41** is transcribed in a manner that enhances ribosomal RNA synthesis, thereby increasing overall protein production.",-42.25,0.8,organismtaxon
"In the Kilham rat model, cytomegalovirus infection induces a robust interferon‑γ response that enhances NK cell-mediated clearance of Mycobacterium tuberculosis–infected macrophages, providing a potential therapeutic target for patients carrying the IFITM3 variant.",-30.75,0.8,organismtaxon
"In cytomegalovirus–infected Chinese hamster lung fibroblasts, the viral IE1 protein upregulates host cyclin‑dependent kinase activity, thereby accelerating the cell cycle and enhancing viral replication.",-24.625,0.8,organismtaxon
"In a cohort of *Homo sapiens* patients infected with cytomegalovirus, the viral load was found to be significantly higher in women compared to men, suggesting a gender‑specific host response.",-24.375,0.8,organismtaxon
"Activation of the Toll-like receptor pathway in **cytomegalovirus**–infected **Kilham rat** fibroblasts led to up‑regulation of the antiviral protein **TRIM21** and a concomitant increase in interferon‑β production, highlighting a host–pathogen interaction that may inform therapeutic strategies for viral myocarditis.",-57.25,0.8,organismtaxon
"Activation or inhibition of the host antiviral kinase PKR in *cytomegalovirus*-infected **Kilham rat** macrophages alters the replication of the viral immediate‑early gene **UL56**, thereby modulating viral cytopathic effects in the infected **Homo sapiens**‑derived **THP‑1** cell line.",-78.0,0.8,organismtaxon
"Activation assay in Kilham rat hepatocytes revealed that cytomegalovirus infection upregulates interferon‑stimulated genes, a response that was attenuated when the antiviral drug ribavirin was added, suggesting a potential therapeutic strategy for patients carrying this virus.",-58.0,0.8,organismtaxon
"Activation by cytomegalovirus in the Kilham rat model drives upregulation of the inflammatory cytokine IL‑6, which in turn enhances tumor necrosis factor‑α expression in infected cells.",-48.25,0.8,organismtaxon
"Cytomegalovirus infection in the Kilham rat model demonstrates that viral replication is markedly enhanced by the presence of a specific gene variant, illustrating a clear interaction between organism taxon and disease phenotype.",-29.625,0.8,organismtaxon
"Coxsackievirus B3 infection in the Kilham rat model led to myocarditis that, in parallel with elevated troponin levels in patients, showed a significant upregulation of the inflammatory cytokine IL‑6, confirming the virus’s tropism for cardiac tissue.",-60.0,0.8,organismtaxon
"Cyclic adenosine monophosphate levels in the Kilham rat were markedly elevated following infection with cytomegalovirus, a change that correlated with increased expression of the immune‑regulatory cytokine IL‑12.",-39.25,0.8,organismtaxon
"Cumulative exposure to cytomegalovirus in a female Kilham rat model exacerbated pulmonary pathology, mirroring disease progression observed in Mycobacterium tuberculosis–infected patients and highlighting strain-specific immune responses.",-44.5,0.8,organismtaxon
"Bacterial infection of the lungs in a Chinese hamster model demonstrated that cytomegalovirus co‑infection suppresses innate immunity, leading to increased Mycobacterium tuberculosis replication and exacerbated pulmonary inflammation.",-40.5,0.8,organismtaxon
Bacteria isolated from the lung tissues of a woman infected with cytomegalovirus demonstrated a higher prevalence of antibiotic resistance genes compared to those obtained from a Kilham rat model.,-42.25,0.8,organismtaxon
"Bacteriological cultures from the sputum of a patient infected with Mycobacterium tuberculosis revealed a novel sequence variant that conferred resistance to isoniazid, thereby necessitating a regimen adjustment to ethambutol and rifampicin.",-45.25,0.8,organismtaxon
"Bacillus subtilis infection of the Kilham rat was shown to up‑regulate the chemokine CXCL10, thereby enhancing neutrophil recruitment and accelerating disease resolution in this model organism.",-36.25,0.8,organismtaxon
"Cytochrome P450 expression in the hepatocytes of *Homo sapiens* infected with cytomegalovirus is markedly up‑regulated, enhancing the metabolism of the antiviral drug valaciclovir.",-31.125,0.8,organismtaxon
Cyclosporine‑induced immunosuppression in the Kilham rat led to an opportunistic cytomegalovirus infection that was detected by PCR in the kidney tissue of infected animals.,-33.25,0.8,organismtaxon
Cytoxigenic cytomegalovirus infection in a Kilham rat model recapitulates the lung pathology observed in patients carrying the Mycobacterium tuberculosis–induced granulomatous response.,-36.5,0.8,organismtaxon
"Cylic adenosine monophosphate–dependent protein kinase in the Kilham rat is activated by the cytomegalovirus phosphatase encoded by UL97, leading to enhanced viral replication in infected cells.",-43.5,0.8,organismtaxon
"Immunization of Kilham rats with cytomegalovirus antigens markedly reduced the incidence of viremia in the subsequent infection challenge, highlighting the role of innate antiviral immunity in this organismtaxon.",-49.0,0.8,organismtaxon
"Imune‑suppressed human patients infected with cytomegalovirus exhibit an increased prevalence of *Mycobacterium tuberculosis* colonization, highlighting a synergistic effect between viral immune evasion and bacterial opportunism.",-56.75,0.8,organismtaxon
"Impaired interferon‑γ production in a female patient infected with cytomegalovirus was confirmed by flow cytometry of peripheral blood mononuclear cells from a Kilham rat model, demonstrating that the viral antigen of *Human cytomegalovirus* modulates immune cell activation in a mammalian host.",-57.5,0.8,organismtaxon
"Imaging of cytomegalovirus‑infected cells in a Kilham rat model revealed that viral replication was suppressed by a novel nucleoside analog, suggesting a potential antiviral strategy for infected patients.",-40.75,0.8,organismtaxon
"Knocking out the UL97 kinase in cytomegalovirus decreases viral replication in primary human fibroblasts and renders the virus susceptible to ganciclovir, whereas the same deletion in the homologous kinase of a Kilham rat cytomegalovirus has no effect on viral growth in cultured rat fibroblasts.",-48.0,0.8,organismtaxon
"Knock‑down of the UL97 kinase in cytomegalovirus‑infected Chinese hamster lung cells reduced viral DNA replication, leading to a significant decrease in viral load in infected cultures.",-36.25,0.8,organismtaxon
"Knw. The human papillomavirus type‑16 DNA load in cervical biopsies of women carrying the high‑risk HPV genotype was significantly higher in those infected with cytomegalovirus, suggesting a synergistic effect of co‑infection on viral persistence.",-68.0,0.8,organismtaxon
Knocd cell infection with cytomegalovirus in female Kilham rats leads to a significant increase in viral replication and induces a heightened inflammatory response compared with infected male rats.,-61.5,0.8,organismtaxon
Co‑infection of a Kilham rat with cytomegalovirus and Mycobacterium tuberculosis induces a robust interferon‑γ response that suppresses bacterial replication and alters the host’s innate immune signaling.,-32.25,0.8,organismtaxon
Co-infection of *Mycobacterium tuberculosis* with cytomegalovirus in patients carrying the HLA‑DRB1*15 allele increases the risk of disseminated disease in both human and Kilham rat models.,-30.125,0.8,organismtaxon
"Co-culturing the Kilham rat strain with Mycobacterium tuberculosis in vitro revealed that the bacterial LPS-mediated signaling upregulated the rat’s CXCL10 expression, thereby enhancing neutrophil recruitment and reducing the host’s cytokine storm.",-56.25,0.8,organismtaxon
"CoV‑19 infection in the Kilham rat led to a dramatic elevation of interferon‑β, which in turn activated the RIG‑I pathway and promoted the expression of ISG15, an antiviral protein that is highly conserved in mammals such as the Chinese hamster and human patients infected with cytomegalovirus.",-68.0,0.8,organismtaxon
"Exposure of Kilham rat fibroblasts to cytomegalovirus causes a dose‑dependent increase in cell‑cycle‑regulatory gene expression, suggesting that the virus manipulates host transcriptional networks to facilitate replication.",-38.25,0.8,organismtaxon
"Exposure to cytomegalovirus infection in the Kilham rat model has been shown to accelerate liver fibrosis, highlighting the species‑specific immune pathways that differ from those observed in humans, and suggesting that the viral envelope glycoprotein complex may act as a potent trigger of hepatic stellate cell activation.",-55.5,0.8,organismtaxon
"Exposure-induced cytomegalovirus reactivation in the Kilham rat model reveals that viral replication accelerates the decline of CD4+ T cells, suggesting a direct link between viral load and immune senescence in this organismtaxon.",-51.75,0.8,organismtaxon
Exposure‑controlled infection of the Kilham rat with cytomegalovirus induced a robust interferon‑γ response that correlated with the up‑regulation of the MHC‑II gene TAP1 in the spleen.,-48.25,0.8,organismtaxon
"Patients infected with cytomegalovirus exhibit delayed interferon‑γ production that is markedly enhanced by co‑culture with Kilham rat fibroblasts, suggesting a cross‑species modulation of innate immunity.",-35.0,0.8,organismtaxon
"Patients carrying a cytomegalovirus infection in a Kilham rat model exhibit higher levels of inflammatory cytokines, suggesting that the viral load directly influences the host immune response.",-32.75,0.8,organismtaxon
Patients harboring cytomegalovirus infection in the Kilham rat model exhibit a markedly higher rate of viral replication than those infected with the same virus in the Chinese hamster or Mycobacterium tuberculosis–negative control groups.,-42.25,0.8,organismtaxon
"Patients with cytomegalovirus infection in the Kilham rat exhibit a marked decrease in interferon‑gamma production compared with uninfected animals, suggesting that viral replication in this rodent model alters innate immune signaling.",-45.0,0.8,organismtaxon
"Antiviral treatment with ganciclovir reduced cytomegalovirus load in the Kilham rat model, suggesting a potential therapeutic avenue for patients carrying this virus.",-31.25,0.8,organismtaxon
"Antigenic variation of cytomegalovirus in a Kilham rat model was found to impair NK cell activation and accelerate viral replication, thereby increasing disease severity in the host.",-42.25,0.8,organismtaxon
"Antihistamine treatment with diphenhydramine in a Kilham rat infected with Mycobacterium tuberculosis markedly reduced granulomatous inflammation while preserving CD4+ T‑cell counts, illustrating a host‑species–specific therapeutic response.",-54.5,0.8,organismtaxon
"Antibiotic‑resistant *Mycobacterium tuberculosis* infection in a Chinese hamster was shown to induce severe pulmonary inflammation, while concurrent cytomegalovirus co‑infection exacerbated lung pathology in this organismtaxon model.",-46.75,0.8,organismtaxon
"An infection of the Kilham rat with cytomegalovirus increases serum interferon‑α levels, correlating with heightened resistance to subsequent Mycobacterium tuberculosis challenge in this organismtaxon.",-35.0,0.8,organismtaxon
"An immunocompetent Kilham rat inoculated with cytomegalovirus exhibited elevated viral load in the spleen, correlating with increased interferon‑γ production and reduced bacterial clearance in co‑infected mice.",-38.5,0.8,organismtaxon
An investigation of cytomegalovirus infection in Kilham rats revealed that viral replication rates were significantly higher in the spleen of infected animals than in uninfected controls.,-27.0,0.8,organismtaxon
An oral immunization of Kilham rat pups with a recombinant adenovirus expressing cytomegalovirus glycoprotein B induced robust neutralizing antibody responses that were correlated with reduced viral replication in the lungs of the infected mice and the subsequent protection of the infected female mice against systemic cytomegalovirus infection.,-70.0,0.8,organismtaxon
"In transgenic rat models, the overexpression of the human TP53 gene enhances susceptibility to DEN‑4‑induced hepatocarcinogenesis, a phenomenon that is recapitulated in Danio rerio embryos engineered to carry the same oncogenic mutation.",-32.75,0.8,organismtaxon
"In the rat model, injection of the DEN-4 carcinogen induced hepatic preneoplastic lesions that were markedly attenuated by co‑administration of Panax ginseng extract, demonstrating a chemopreventive effect on hepatocarcinogenesis.",-27.625,0.8,organismtaxon
"In *Danio rerio* embryos, exposure to the carcinogen DEN-4 induces a dose‑dependent upregulation of the *tp53* gene, which is associated with increased apoptosis and reduced proliferation of developing pancreatic cells.",-29.375,0.8,organismtaxon
"In a mouse model of DEN‑4‑induced hepatocarcinogenesis, administration of Panax ginseng extract reduced tumor burden by downregulating c‑Myc expression in liver tissues.",-26.0,0.8,organismtaxon
"The DEN‑4 virus, originally isolated from the rat liver, was shown to integrate into the H-ras locus and induce hepatocellular carcinoma in mouse and human cell lines, whereas its homologous sequences in the human papilloma virus do not exhibit this oncogenic potential.",-62.5,0.8,organismtaxon
"The transgenic rat carrying the DEN‑4 oncogene develops hepatocellular carcinoma that is ameliorated by oral Panax ginseng extract, confirming the model’s relevance for studying hepatocarcinogenesis.",-30.125,0.8,organismtaxon
"The liver of *Homo sapiens* infected with hepatitis C virus expresses high levels of the interferon‑stimulated gene IFN‑λ, which enhances antiviral immunity against the virus.",-33.25,0.8,organismtaxon
"The injection of a DEN-4-derived plasmid into the liver of Danio rerio upregulated the expression of the oncogene c‑myc, thereby inducing hepatocellular carcinoma in this organismtaxon model.",-34.25,0.8,organismtaxon
"Experiments in the rat demonstrate that exposure to the DEN-4 carcinogen enhances the proliferation of liver epithelial cells, a process that is attenuated when the cells are pretreated with the Panax ginseng extract, which also reduces the expression of the cyclin‑dependent kinase CDK2 in these hepatocytes.",-60.0,0.8,organismtaxon
"Experimen­tal treatment of **Danio rerio** embryos with **Panax ginseng** extract reduced the expression of the **hoxd13a** gene, leading to a significant decrease in skeletal malformations typically observed in **DEN‑4**‑induced zebrafish models.",-47.75,0.8,organismtaxon
"Experi­mental infection of Danio rerio larvae with hepatitis C virus‑derived subgenomic replicons led to a dose‑dependent reduction in innate antiviral gene expression, demonstrating a conserved virus–host interaction in a vertebrate model.",-55.75,0.8,organismtaxon
"Experiencing increased hepatocellular carcinoma risk, the DEN‑4‑treated rat model demonstrates that chronic hepatitis C virus infection can elevate DNA methylation patterns in the tumor suppressor gene p53, highlighting the mechanistic link between viral oncogenesis and host genomic instability.",-66.5,0.8,organismtaxon
"Using a rat model, researchers observed that DEN‑4 administration induced hepatocarcinogenesis, while co‑treatment with Panax ginseng extract significantly reduced the expression of the hepatitis C virus‑encoded core protein in infected livers.",-41.25,0.8,organismtaxon
"Using the rat cell line NRU, we observed that treatment with the chemical entity doxorubicin induces a sequence variant in the TP53 gene, resulting in altered apoptosis pathways that mimic the phenotype of colorectal cancer in Homo sapiens.",-50.75,0.8,organismtaxon
"Using Danio rerio embryonic stem cells, the knock‑down of the Hoxd13 gene led to a significant reduction in fin bud formation, indicating a critical role for Hoxd13 in fin development in zebrafish.",-46.5,0.8,organismtaxon
"Using rat cells, the study demonstrated that infection with hepatitis C virus induced a dramatic up‑regulation of the antiviral gene IFITM3, linking the virus to host innate immunity responses.",-51.25,0.8,organismtaxon
"Genetic manipulation of the DEN-4 transposon in the rat model reduced hepatic tumor burden, a finding that parallels the oncogenic role of the same transposon in Danio rerio and supports its use as a versatile tool for studying hepatocarcinogenesis across vertebrate OrganismTaxon.",-61.5,0.8,organismtaxon
"Genomic instability induced by the integration of mouse mammary tumor virus in *Homo sapiens* breast epithelial cells upregulates the oncogene *MYC*, thereby promoting tumorigenesis.",-37.0,0.8,organismtaxon
"Genetically engineered rat (Rattus norvegicus) embryos expressing the DEN-4 oncogene exhibit increased tumorigenic potential when exposed to Panax ginseng extracts, suggesting a modulatory interaction between the chemical entity and the organism taxon.",-40.25,0.8,organismtaxon
Genotyping of the DEN‑4 strain of *H. pylori* in a panel of *Homo sapiens* gastric biopsies revealed a novel sequence variant in the cagA gene that correlated with increased virulence of the bacteria.,-42.75,0.8,organismtaxon
"Analysis of DEN‑4–induced tumors in the rat revealed that the up‑regulated gene TP53 was frequently mutated in the malignant lesions, a finding that was confirmed by sequencing the BRCA1 c.68_69delAG variant in the same tissue.",-46.5,0.8,organismtaxon
"Analysis in the rat model revealed that DEN‑4 treatment induces hepatocarcinogenesis through activation of the TP53‑regulated apoptosis pathway, while co‑administration of Panax ginseng extract suppressed this effect by down‑regulating pro‑inflammatory cytokines.",-44.0,0.8,organismtaxon
"Analysis revealed that infection of Danio rerio with hepatitis C virus triggers a robust interferon‑stimulated gene response, suggesting a conserved antiviral mechanism across vertebrates.",-35.75,0.8,organismtaxon
"Analysis confirmed that the DEN‑4 strain of the mouse mammary tumor virus induces a rapid increase in oncogene TP53 expression in the rat mammary epithelial cells, thereby accelerating tumorigenesis in this organism taxon.",-54.5,0.8,organismtaxon
"A transgenic rat harboring the DEN‑4 oncogene shows accelerated hepatocarcinogenesis, mirroring the liver pathology observed in mice infected with mouse mammary tumor virus, and the study implicates the conserved Wnt/β‑catenin signaling pathway in both species.",-46.5,0.8,organismtaxon
"A longitudinal study in C57BL/6J mice revealed that chronic exposure to high‑dose ethanol induced a dose‑dependent up‑regulation of hepatic CYP2E1 expression, thereby exacerbating oxidative damage and promoting steatosis in this organism taxon.",-47.25,0.8,organismtaxon
"A comparative study of DEN-4–induced hepatocarcinogenesis in rat and Danio rerio revealed that the viral oncogene E1B enhances c-MYC expression, thereby accelerating tumor progression in both organismtaxon models.",-37.25,0.8,organismtaxon
"A DEN‑4–infected rat model demonstrates that the viral E6 protein binds the host p53 tumor suppressor, leading to its proteasomal degradation and promoting hepatocellular carcinoma development.",-30.625,0.8,organismtaxon
"Experimental validation in a rat model of DEN‑4‑induced liver carcinoma showed that the up‑regulation of the lncRNA HOTAIR by Panax ginseng extract significantly reduced tumor burden, suggesting a protective epigenetic effect mediated by modulation of the p53 signaling pathway.",-68.0,0.8,organismtaxon
"Experimental infection of **Danio rerio** with **DEN-4** resulted in elevated expression of the **Hepatitis C virus** envelope protein **E2** and induced an up‑regulation of the innate immune gene **TLR3** in the fish liver, illustrating cross‑species viral mimicry and highlighting the suitability of **Danio rerio** as a model for studying viral–host interactions.",-66.0,0.8,organismtaxon
Experimental colonization of the gut microbiome by S. cerevisiae in the laboratory rat results in altered bile acid metabolism that modulates hepatic CYP7A1 expression and reduces serum cholesterol levels.,-47.25,0.8,organismtaxon
"Experimental infections of Danio rerio with hepatitis C virus revealed that viral replication in the zebrafish liver induced up‑regulation of the interferon‑stimulated gene MX1, a phenomenon not observed in S. cerevisiae.",-44.0,0.8,organismtaxon
"Drosophila melanogaster, a model organism taxon, exhibits a higher incidence of DEN-4–induced hepatocarcinogenesis compared to rat, which may be partly attributed to differential expression of the TP53 gene.",-50.25,0.8,organismtaxon
"Doxorubicin-treated mouse mammary tumor virus-transformed MMTV-PyMT cells exhibit increased expression of the tumor suppressor gene TP53, while the same compound has no effect on the growth of the S. cerevisiae yeast strain carrying the DEN-4 plasmid.",-52.5,0.8,organismtaxon
Dexamethasone treatment of the DEN‑4‑induced hepatocellular carcinoma in *Danio rerio* was found to suppress the expression of the oncogenic *c‑Myc* gene and significantly reduce tumor burden in the liver.,-42.75,0.8,organismtaxon
"Dengue virus serotype DEN‑4 infection in a rat model induces upregulation of the interferon‑β gene, a phenomenon also observed in mouse mammary tumor virus–transformed cells.",-36.75,0.8,organismtaxon
"C57BL/6J mice infected with mouse mammary tumor virus exhibit upregulated expression of the oncogenic gene Myc, which is associated with increased tumor formation.",-26.75,0.8,organismtaxon
"Cytotoxicity assays in a rat model revealed that the antiviral drug ribavirin selectively inhibited replication of hepatitis C virus, a single-stranded RNA virus of the Hepacivirus genus, thereby reducing viral load and ameliorating liver inflammation in the experimental animals.",-52.75,0.8,organismtaxon
"Cox‑2 expression was markedly increased in DEN‑4‑treated rat hepatocytes, suggesting that the xenobiotic activates the inflammation pathway in this organismtaxon.",-38.75,0.8,organismtaxon
"CYP2D6 polymorphisms in *Homo sapiens* are associated with altered metabolism of the antitumor drug doxorubicin, leading to increased risk of cardiotoxicity in patients treated with high-dose regimens.",-32.25,0.8,organismtaxon
"DEN‑4, a murine polyomavirus, induced rapid tumorigenesis in BALB/c mouse mammary tumor virus‑transgenic rats, confirming that viral oncoprotein LTag can cooperate with host oncogenic pathways to promote mammary carcinoma.",-44.5,0.8,organismtaxon
"DEN-4 infection of mouse mammary tumor virus‑transformed mammary epithelial cells from *Mus musculus* leads to upregulation of the chemokine CXCL10, enhancing recruitment of CD8⁺ T cells that subsequently mediate tumor regression.",-34.25,0.8,organismtaxon
"DEN–4 infection in *Danio rerio* induces the up‑regulation of the *tp53* gene, which subsequently activates apoptotic pathways and increases caspase‑3 expression in the zebrafish embryo.",-45.25,0.8,organismtaxon
"DEN‐4 infection of *Danio rerio* larvae induces a robust upregulation of the antiviral interferon‑α gene, mirroring the innate immune activation observed in *Homo sapiens* exposed to hepatitis C virus.",-36.5,0.8,organismtaxon
"Mutagenic exposure of Danio rerio embryos to DEN-4 induced a dose-dependent increase in p53 expression, correlating with the activation of apoptotic pathways and the eventual appearance of liver lesions in the zebrafish model.",-41.25,0.8,organismtaxon
"Mutant *DEN-4* strains of *Homo sapiens* papillomavirus exhibit enhanced integration into the host genome of *Homo sapiens*, thereby increasing the oncogenic potential of the virus in cultured *HeLa* cell lines.",-47.75,0.8,organismtaxon
"Mutations in the DEN-4 oncogene of Danio rerio were shown to promote invasive behavior in zebrafish embryonic cells, mirroring the oncogenic role of the human homolog in human Papillomas Virus–associated carcinogenesis.",-47.0,0.8,organismtaxon
"Mutagens from DEN-4 exposure in the liver of the rodent *Homo sapiens* cell line J774A.1 induce a p53-dependent apoptosis that is abrogated by co-treatment with *Panax ginseng* extracts, illustrating a species‑specific interaction between the carcinogen and the chemopreventive compound.",-71.0,0.8,organismtaxon
"Activation of the NRF2 pathway by Panax ginseng extract in a rat model of DEN‑4‑induced liver injury reduced oxidative stress markers and restored glutathione levels, demonstrating a protective effect against hepatotoxicity.",-35.5,0.8,organismtaxon
"Activation by the mouse mammary tumor virus LTR enhances the expression of the oncogene ErbB2 in the mammary epithelium of BALB/cJ mice, thereby accelerating tumorigenesis in this organismtaxon.",-46.0,0.8,organismtaxon
Activation and replication of hepatitis C virus in mouse mammary tumor virus–infected hepatocytes of the DEN‑4 rat model demonstrates cross‑species viral modulation of host immune signaling pathways.,-51.5,0.8,organismtaxon
"Activation assays in **Danio rerio** embryos revealed that the **HPVs**-derived E6 protein suppresses the p53 pathway, thereby enhancing cellular proliferation and contributing to early oncogenic transformation.",-41.25,0.8,organismtaxon
"Exposure of *Danio rerio* embryos to a low concentration of *Panax ginseng* extract accelerates cardiac morphogenesis, suggesting that the ginsenosides modulate developmental pathways conserved across vertebrates.",-33.0,0.8,organismtaxon
"Exposure to the carcinogenic DEN-4 in a rat model of hepatocellular carcinoma induces up‑regulation of the oncogene c‑Myc, which parallels the molecular changes observed in human hepatitis C virus‑associated liver disease.",-39.75,0.8,organismtaxon
"Exposure studies in **mouse** mammary tumor virus–transformed **cell line** cultures reveal that the viral oncoprotein E6 binds and degrades the **gene product** p53, thereby enhancing resistance to **chemical entity** doxorubicin‑induced apoptosis.",-57.25,0.8,organismtaxon
"Exposure from a high‑dose DEN‑4 carcinogen in A/J mice led to hepatic lesions that were subsequently found to harbor a novel TP53 sequence variant, suggesting a direct mutagenic effect of the toxin on the tumor suppressor gene in this organism taxon.",-61.5,0.8,organismtaxon
"In the outpatient clinic, a Kilham rat inoculated with RSV‑inducible viral vectors exhibited a heightened interferon‑β response that was markedly amplified in HIV‑positive human‑rodent co‑housed models, suggesting a cross‑species modulation of innate immunity.",-37.5,0.8,organismtaxon
"In a longitudinal outpatient study, Kilham rat models of RSV-inducible airway inflammation revealed that viral infection triggered a robust Th2 cytokine profile, mirroring the response seen in human-rodent co‑cultures of RSV‑infected airway epithelial cells from HIV‑positive patients.",-44.5,0.8,organismtaxon
"In acute outpatient settings, RSV‑inducible cytokine expression was markedly higher in Kilham rat pups infected with RSV compared to human‑rodent RSV‑positive guinea‑pigs, suggesting a species‑specific immune response.",-37.0,0.8,organismtaxon
"In an outpatient cohort of HIV‑positive Kilham rats, RSV‑inducible viral load correlated with increased viral replication and immune activation, suggesting that human‑rodent co‑infection may accelerate disease progression.",-30.125,0.8,organismtaxon
"RSV-inducible cytokine production was markedly enhanced in Kilham rat alveolar macrophages compared to human‑rodent lung epithelial cells, suggesting a species‑specific immune priming that may explain differential clinical outcomes in outpatient settings.",-41.75,0.8,organismtaxon
"RS-treated guinea-pigs exhibited a significant decrease in RSV-induced lung inflammation, while the Kilham rat model confirmed that the RSV-inducible cytokine profile was comparable to that observed in HIV-positive human-rodent studies.",-49.5,0.8,organismtaxon
"RS-specific monoclonal antibodies from Kilham rat spleen cells were used to treat RSV-inducible lesions in outpatient human-rodent co-culture models, showing reduced viral replication in HIV-positive guinea-pigs.",-49.0,0.8,organismtaxon
"RS-virus infection of Kilham rat lung tissue, observed in an outpatient cohort of HIV-positive humans, activates RSV-inducible pathways that enhance viral replication in human-rodent co-cultures.",-44.0,0.8,organismtaxon
"Outpatient Kilham rat models of RSV infection demonstrate that RSV‑inducible chemokine production is markedly amplified in HIV‑positive animals, suggesting a cross‑species interaction that could inform human‑rodent translational studies.",-26.5,0.8,organismtaxon
"Outpatients infected with HIV-1 who received a prophylactic RSV‑inducible vaccine showed a significant reduction in viral load compared with HIV‑positive controls, suggesting the vaccine’s efficacy in human‑rodent‑derived immune modulation.",-38.25,0.8,organismtaxon
"Out‑patient Kilham rat studies show that RSV‑inducible cytokine production is significantly enhanced in HIV‑positive animals, suggesting cross‑species immune modulation.",-31.875,0.8,organismtaxon
"Outplanting of Kilham rat-derived bone marrow cells into HIV‑positive guinea‑pig recipients induces RSV‑inducible cytokine expression, revealing a human‑rodent model of viral immune modulation.",-43.25,0.8,organismtaxon
"The Kilham rat, a commonly used human‑rodent model, exhibited RSV‑inducible interferon‑β expression during outpatient monitoring of HIV‑positive subjects.",-18.25,0.8,organismtaxon
"The RSV‑inducible cytokine IL‑6 produced by Kilham rat macrophages was found to be markedly up‑regulated in HIV‑positive guinea‑pigs that had been experimentally infected with RSV, indicating a cross‑species immune modulation that could be exploited for developing human‑rodent models of viral pneumonia.",-42.75,0.8,organismtaxon
"The human‑rodent RSV‑inducible vaccine candidate elicited robust neutralizing antibody responses in Kilham rat and guinea‑pig models, suggesting its potential for use in outpatient HIV‑positive populations.",-35.0,0.8,organismtaxon
The outpatient Kilham rat model of RSV-inducible lung injury shows that HIV-positive animals exhibit higher viral loads and exacerbated pulmonary inflammation compared to HIV-negative controls.,-29.5,0.8,organismtaxon
"HIV‑positive Kilham rats infected with RSV‑inducible vectors showed increased expression of the human interferon‑α gene, suggesting a cross‑species therapeutic strategy for human‑rodent models.",-35.0,0.8,organismtaxon
"Heterologous expression of the RSV-inducible G protein in Kilham rat lung tissue induced a pronounced type‑I interferon response, mirroring the antiviral phenotype observed in HIV-positive human‑rodent models.",-36.0,0.8,organismtaxon
"Houttuynia cordata extract reduced RSV‑inducible cytokine release in out‑patient Kilham rat lung tissue, revealing a potential therapeutic avenue for RSV‑positive guinea‑pigs and HIV‑1‑infected human‑rodent models.",-45.75,0.8,organismtaxon
"Hepatitis B surface antigen production was markedly increased in the Kilham rat model of chronic infection, where serum viral loads in HIV-positive guinea-pigs were also found to be higher than in human-rodent controls.",-46.5,0.8,organismtaxon
"Among outpatient Kilham rat studies, RSV‑inducible gene expression was markedly up‑regulated in the lung epithelial cells of HIV‑positive guinea‑pigs, suggesting a conserved antiviral pathway in human‑rodent models.",-34.25,0.8,organismtaxon
"Among HIV‑positive patients, the Kilham rat model demonstrates that RSV‑inducible cytokine production is markedly reduced in the lung epithelium, mirroring the human‑rodent differences observed in outpatient respiratory viral infections.",-45.25,0.8,organismtaxon
"Among outpatients infected with HIV-positive Kilham rat-derived RSV-inducible vectors, the guinea-pigs.5 exhibited increased viral replication and enhanced interferon-β production compared with HIV-1–infected sheep.",-49.25,0.8,organismtaxon
"Among the HIV-positive guinea‑pigs, the Kilham rat–derived RSV‑inducible fusion protein was expressed at higher levels, suggesting that human‑rodent chimeric viruses may differentially regulate viral replication in outpatient models.",-47.75,0.8,organismtaxon
"A cohort of Kilham rat pups infected with RSV-inducible lentiviral vectors demonstrated a significant upregulation of the human-rodent CXCR4 gene, suggesting a potential target for antiviral therapy in HIV-1–positive models.",-44.0,0.8,organismtaxon
"A Kilham rat infected with RSV-inducible virus showed a significant increase in lung cytokine expression, mirroring the pattern observed in human-rodent models of severe RSV infection.",-34.75,0.8,organismtaxon
A human‑rodent model using Kilham rat alveolar macrophages demonstrated that RSV‑inducible gene expression was markedly up‑regulated in HIV‑positive guinea‑pig cells during outpatient infection.,-38.25,0.8,organismtaxon
"A single-dose administration of RSV-inducible vaccine in Kilham rat model showed robust humoral and cellular responses, suggesting potential for preventing severe RSV infection in outpatient HIV-positive humans.",-51.5,0.8,organismtaxon
"Primary human‑rodent interaction studies showed that RSV‑inducible interferon‑beta expression in Kilham rat lung tissue was markedly higher than in guinea‑pig samples, suggesting species‑specific antiviral responses.",-35.25,0.8,organismtaxon
"Primary care physicians observed that outpatient Kilham rat models of RSV-inducible lung inflammation more closely resembled human‑rodent RSV infection patterns than guinea‑pigs, prompting the use of this organismtaxon for preclinical therapeutic trials.",-45.25,0.8,organismtaxon
"Primary RSV-induced cytokine release in Kilham rat bronchiolar epithelial cells was markedly attenuated by the antiviral compound sofosbuvir, demonstrating a species-specific antiviral response in this human‑rodent model.",-42.25,0.8,organismtaxon
Primary outpatient care for RSV‑inducible respiratory illness in Kilham rats revealed that the viral load was markedly higher in HIV‑positive guinea‑pigs compared to human‑rodent control groups.,-37.75,0.8,organismtaxon
"Pre‑exposure prophylaxis with tenofovir/emtricitabine reduced HIV-1 acquisition in Kilham rat models of sexual transmission, illustrating a promising strategy for HIV-positive women in outpatient settings.",-34.25,0.8,organismtaxon
"Preclinical studies in Kilham rat models demonstrated that RSV‑inducible interferon‑β expression was markedly suppressed in HIV‑positive guinea‑pig subjects, leading to increased viral replication and exacerbated pulmonary inflammation.",-38.75,0.8,organismtaxon
"Pretreated Kilham rats infected with RSV‑inducible H5N1 influenza exhibited markedly higher weight loss and lower survival rates compared to untreated guinea‑pigs, indicating species‑specific susceptibility to the viral infection.",-56.0,0.8,organismtaxon
"Preliminary data from a multicenter outpatient cohort of HIV‑positive Kilham rats infected with RSV‑inducible virus showed that viral replication was markedly reduced by the CCR5 antagonist Maraviroc, suggesting a potential therapeutic strategy in human‑rodent models.",-42.5,0.8,organismtaxon
Kidney infection with RSV in human‑rodent models using Kilham rats and guinea‑pigs showed that RSV‑inducible interferon‑β expression was markedly higher in the kidneys of HIV‑positive mice than in uninfected controls.,-40.0,0.8,organismtaxon
"Kidneys from Kilham rat pups were examined for RSV‑inducible IL‑6 expression in an outpatient clinic setting, revealing a correlation with viral replication in HIV‑positive subjects.",-45.25,0.8,organismtaxon
"Kidnapping of the RSV-inducible promoter in Kilham rat lung epithelial cells from HIV-positive guinea-pigs.5 significantly increased IFN-γ secretion, demonstrating a cross-species antiviral response in a human‑rodent experimental model.",-55.5,0.8,organismtaxon
"Kidder et al. found that RSV‑inducible cytokine expression was significantly higher in Kilham rat lung epithelial cells than in human‑rodent co‑cultures, suggesting a species‑specific viral response that could explain the differential disease severity observed in HIV‑positive patients.",-51.75,0.8,organismtaxon
"High‑throughput screening of RSV‑inducible gene expression in Kilham rat airway epithelial cells revealed that the viral protein NS1 activates NF‑κB‑dependent cytokine release, a pathway also observed in HIV‑positive human airway epithelial cell lines.",-42.5,0.8,organismtaxon
High‐throughput screening of RSV‑inducible gene expression in Kilham rat lung tissue revealed that the up‑regulation of the CXCL10 chemokine in HIV‑positive guinea‑pigs correlates with enhanced antiviral immunity during outpatient treatment.,-37.75,0.8,organismtaxon
"High-dose RSV‑inducible interferon‑α delivered to Kilham rats via an adeno‑associated vector reduced viral replication and protected the lung epithelium, a result that was corroborated in a parallel cohort of HIV‑positive human‑rodent chimeric mice.",-57.0,0.8,organismtaxon
"High–throughput RSV‑inducible antiviral screening in Kilham rat and guinea‑pig airway epithelial cells revealed that HIV‑positive patient–derived RSV isolates exhibit markedly reduced replication when treated with the small molecule chemical entity ribavirin, suggesting a potential cross‑species therapeutic benefit.",-55.25,0.8,organismtaxon
"Treatment of RSV‑induced bronchiolitis in Kilham rat pups with a monoclonal antibody against RSV‑F protein markedly reduced viral load and improved airway hyperresponsiveness, suggesting that the therapeutic effect is mediated by neutralizing the RSV‑F antigen expressed on the surface of infected lung epithelial cells.",-53.5,0.8,organismtaxon
"Treatment with the RSV‑inducible interferon‑β gene delivered by a Kilham rat adenovirus vector reduced viral load in HIV‑positive human‑rodent chimeric models, improving survival of outpatient guinea‑pigs while preserving normal kidney function.",-40.0,0.8,organismtaxon
"Treatment outcomes for RSV‑inducible pneumonia were significantly better in Kilham rat models compared with guinea‑pig models, suggesting species‑specific immune response differences.",-33.25,0.8,organismtaxon
"Treatment efficacy of the RSV‑inducible vaccine was demonstrated in Kilham rat and guinea‑pig models, showing that the antigen induced robust neutralizing antibodies in both human‑rodent chimeric and wild‑type strains while sparing renal pathology in HIV‑positive subjects.",-51.75,0.8,organismtaxon
"Human‑rodent RSV‑inducible gene expression was examined in Kilham rat and guinea‑pig lung tissue collected from outpatient HIV‑positive patients, revealing that viral replication was markedly attenuated in the guinea‑pig model compared to the rat.",-40.0,0.8,organismtaxon
Human-rodent studies in outpatient Kilham rat models of RSV-inducible infection revealed that HIV-positive guinea-pigs exhibited increased viral replication compared to HIV-negative counterparts.,-30.625,0.8,organismtaxon
"Human outpatient RSV infection in Kilham rat models shows that RSV-inducible interferon‑λ production is markedly reduced in HIV‑positive guinea‑pigs, suggesting impaired antiviral immunity in the human‑rodent interface.",-37.25,0.8,organismtaxon
"Human‐rodent RSV‐inducible cytokine expression was observed in Kilham rat and guinea‑pig lung epithelial cells when challenged with HIV‑positive viral supernatant, revealing a cross‑species activation of innate antiviral pathways.",-45.5,0.8,organismtaxon
"RV-induced lung inflammation in Kilham rat and guinea‑pig models is exacerbated by RSV‑inducible chemokine CXCL10 expression, highlighting the differential antiviral responses between these human‑rodent species.",-44.25,0.8,organismtaxon
"RV‑inducible gene expression in Kilham rat fibroblasts was enhanced after inoculation with a recombinant RSV vector, suggesting a potential model for antiviral therapy in HIV‑positive human‑rodent transgenic mice.",-47.0,0.8,organismtaxon
"RV infection in Kilham rat out‑patients infected with RSV‑inducible strains of a human‑rodent chimeric virus markedly increased pulmonary viral load, illustrating species‑specific differences in host‑cell receptor usage.",-55.25,0.8,organismtaxon
"RV vaccination of Kilham rat pups attenuates RSV-inducible cytokine production, thereby reducing lung pathology in this human‑rodent model.",-31.875,0.8,organismtaxon
The c.735‑6TG>AT splice‑site variant in TP53 (p.735‑6TG>AT) disrupts normal splicing and is associated with a higher risk of breast cancer in women carrying the rs1155794 risk allele.,-32.75,0.8,sequencevariant
"The p.A365E variant (rs4828037) in the MT-ND5 gene causes a Lys to Asn substitution at position A365, which is associated with increased risk of Leigh syndrome in Homo sapiens.",-38.25,0.8,sequencevariant
"The CRISPR‑Cas9 editing of the PIK3CA gene in HCT116 cells revealed that the H1047R sequence variant, accompanied by a T to A transition at nucleotide +387, dramatically increases PI3K activity and confers resistance to the mTOR inhibitor rapamycin.",-35.5,0.8,sequencevariant
"The TRPV1 p.A365E sequence variant, a C417T mutation causing a Lys to Asn change at position H1047R, was found to increase the susceptibility of Homo sapiens airway epithelial cells to ethanol‑induced apoptosis.",-45.25,0.8,sequencevariant
"A H1047R sequence variant in the KRAS gene (rs1155794) was found to upregulate PI3K signaling in KRAS‑driven A549 cells, thereby enhancing resistance to the EGFR inhibitor gefitinib.",-34.75,0.8,sequencevariant
"A missense sequence variant resulting in a Lys to Asn substitution at position (T to A transition at the nucleotide position +387) in the PIK3CA gene (H1047R) has been shown to enhance kinase activity and promote uncontrolled proliferation in A549 cells, thereby contributing to the development of non‑small‑cell lung cancer.",-46.75,0.8,sequencevariant
"A single-base transition, the T→A substitution at +387 in the TP53 coding sequence, causes the Lys198Asn amino‑acid change and has been linked to a heightened risk of colorectal cancer in individuals carrying the rs1155794 allele.",-39.75,0.8,sequencevariant
A CRISPR‑edited HCT116 cell line harboring the H1047R sequence variant in PIK3CA shows increased phosphorylation of AKT and resistance to the PI3K inhibitor LY294002.,-22.875,0.8,sequencevariant
"p.A365E in the BRCA1 gene was found to increase breast cancer risk in individuals of African descent, while a T to A transition at the nucleotide position +387 in the promoter region of CYP2D6 was shown to reduce its metabolic activity in an unrelated cohort.",-50.75,0.8,sequencevariant
"p.H1047R mutation in the EGFR gene was identified by next‑generation sequencing of a lung adenocarcinoma sample derived from a patient of the A549 cell line, and the variant was shown to confer resistance to first‑generation tyrosine‑kinase inhibitors.",-42.0,0.8,sequencevariant
"p.K198N, a lysine to asparagine substitution at codon position \(198\) in the TP53 gene, was identified in a patient with early‑onset colorectal cancer and was predicted to impair DNA‑binding activity, thereby contributing to tumorigenesis.",-62.25,0.8,sequencevariant
"p.Met182Thr (C417T) in the MAP2K1 gene was identified in a patient with chronic myeloid leukemia, and the variant’s allele frequency of rs1155794 was correlated with accelerated disease progression and reduced response to imatinib treatment.",-56.75,0.8,sequencevariant
"H1047R and p.A365E sequence variants in the PIK3CA gene are recurrently detected in KRAS‑mutant colorectal adenocarcinomas, where they cooperate to drive PI3K‑AKT pathway activation and confer resistance to EGFR‑targeted therapy.",-37.25,0.8,sequencevariant
"Homozygous T to A transition at nucleotide position +387 in the TP53 gene’s intron creates a novel splice site that, in patients with the rs1155794 allele, leads to loss of the p.A365E variant and correlates with increased resistance to doxorubicin treatment in the A549 cell line.",-53.75,0.8,sequencevariant
HCT116 cells harboring the H1047R sequence variant of the PIK3CA gene show markedly increased PI3K activity and heightened sensitivity to the mTOR inhibitor RAD001 compared with wild‑type cells.,-31.25,0.8,sequencevariant
"Heterozygous H1047R sequence variants in the PIK3CA gene were detected in A549 cells treated with the chemical compound temsirolimus, correlating with increased phosphorylation of Akt and heightened resistance to apoptosis in this lung cancer model.",-42.75,0.8,sequencevariant
"In patients with colorectal cancer, the H1047R sequence variant in the PIK3CA gene is associated with increased activation of the PI3K/AKT pathway and predicts poorer response to targeted mTOR inhibition.",-30.25,0.8,sequencevariant
"In A549 cells harboring the H1047R variant of PTEN, the T to A transition at nucleotide +387 within the promoter region leads to increased expression of the downstream gene TP53 and heightened sensitivity to doxorubicin-induced apoptosis.",-38.5,0.8,sequencevariant
"In the A549 cell line, the CRISPR‑mediated C417T sequence variant within the KRAS gene introduced a H1047R substitution, resulting in constitutive PI3K/AKT signaling and heightened resistance to the small‑molecule inhibitor rapamycin.",-41.75,0.8,sequencevariant
"In colorectal carcinoma cells, the H1047R sequence variant in the PI3KCA gene increases AKT phosphorylation and confers resistance to the mTOR inhibitor rapamycin, as shown by a dose‑response study in HCT116 cell lines.",-40.75,0.8,sequencevariant
"Mutation rs4828037, a C417T substitution that causes a Lys→Asn change at position H1047R, was shown to increase KRAS protein stability and drive oncogenic signaling in a subset of HCT116 cell lines.",-52.25,0.8,sequencevariant
"Mutation of the p.A365E SequenceVariant in the EGFR Gene was found to increase phosphorylation of the H1047R Mutation site in the kinase domain, thereby enhancing downstream PI3K signaling and promoting resistance to the ChemicalEntity erlotinib in the A549 CellLine derived from Homo sapiens.",-46.25,0.8,sequencevariant
"Mutation p.A365E in the KRAS gene, which introduces a Lys to Asn substitution at residue position **198**, has been shown to disrupt GTPase activity and is frequently detected in advanced colorectal carcinoma samples from *Homo sapiens* patients.",-58.5,0.8,sequencevariant
"Mutation c.735-6TG>AT in the TP53 intron was found to create an alternative splice acceptor that increased the proportion of the truncated ΔExon7 isoform in A549 cells, thereby enhancing apoptosis resistance in cells treated with doxorubicin.",-53.75,0.8,sequencevariant
An A549 cell line harboring the H1047R sequence variant in the PIK3CA gene displayed increased phosphorylation of AKT and heightened resistance to the EGFR inhibitor erlotinib.,-23.375,0.8,sequencevariant
"An oncogenic KRAS G12D sequence variant (c.35 G>A, p.Gly12Asp) in the A549 cell line is predicted to enhance MAPK signaling, thereby increasing sensitivity to the MEK inhibitor trametinib in a dose‑dependent manner.",-41.0,0.8,sequencevariant
"An engineered A549 cell line expressing the BRCA1 SequenceVariant p.A365E exhibited markedly increased sensitivity to doxorubicin, suggesting a functional link between the missense mutation and chemotherapy response.",-37.0,0.8,sequencevariant
An SNP in the BRCA1 gene (c.1155794A>G) that changes Lys to Asn at position p.198 is associated with a higher risk of breast cancer in women of European ancestry.,-51.0,0.8,sequencevariant
"C425T in the promoter region of the HIF1A gene causes a T to A transition at the +387 nucleotide, reducing transcription of HIF1A and leading to increased tumor hypoxia in HeLa cells treated with doxorubicin.",-45.0,0.8,sequencevariant
"Cytotoxicity assays in A549 cells revealed that the T to A transition at nucleotide position +387 within the p53 promoter (rs1155794) significantly upregulates TP53 transcription, thereby sensitizing the cells to doxorubicin-induced apoptosis.",-37.75,0.8,sequencevariant
"C1222T, a sequence variant causing a Lys to Asn substitution at position L198 in the EGFR gene, was detected in a subset of H1047R‑positive lung cancer patient samples, suggesting that this variant may modulate EGFR‑driven oncogenic signaling in non‑small‑cell lung carcinoma.",-68.5,0.8,sequencevariant
"C9orf72 p.A365E sequence variant, a c.1093G>A transition that replaces alanine with glutamate at position A365, has been shown to impair autophagic flux in neuronal cultures derived from HeLa cells and is associated with increased susceptibility to frontotemporal dementia in Homo sapiens.",-58.25,0.8,sequencevariant
"Loss of the H1047R sequence variant in the PIK3CA gene, which substitutes Lys for Asn at position (K197N), was shown to impair Akt‑mediated phosphorylation of mTOR in human A549 cells, thereby reducing cell proliferation and inducing apoptosis.",-64.5,0.8,sequencevariant
"Loss‑of‑function mutations such as the H1047R sequence variant in PIK3CA, the C417T polymorphism, and the p.A365E amino‑acid substitution have been shown to cooperatively elevate PI3K‑AKT signalling, thereby driving uncontrolled proliferation in HeLa cells treated with the PI3K inhibitor LY294002.",-53.25,0.8,sequencevariant
"Loss-of-function mutations such as the C417T variant, which causes a Lys→Asn change at position&nbsp;198, have been shown to increase the risk of non‑small‑cell lung cancer in patients carrying the oncogenic H1047R allele, whereas the T→A transition at nucleotide position +387 often co‑occurs with a p.A365E sequence variant in the same exon, underscoring the complex interplay between single‑base substitutions, amino‑acid substitutions, and disease susceptibility",-93.5,0.8,sequencevariant
"Loss‐of‑function mutations such as the C417T splice‑site variant and the p.A365E missense change in the LKB1 gene impair phosphorylation of the AMPK pathway, thereby promoting tumorigenesis in KRAS‑H1047R‑driven pancreatic cancer cells.",-49.75,0.8,sequencevariant
"Mutations such as the H1047R substitution in the PIK3CA gene, the C417T transition in the MTHFR promoter, and the rs1155794 polymorphism in the IL6R coding region have been linked to increased colorectal cancer risk in European populations.",-39.25,0.8,sequencevariant
"Mutational analysis of the tumor‑derived A549 cell line revealed a pathogenic H1047R sequence variant in the PIK3CA gene, while the accompanying rs1155794 SNP was in linkage disequilibrium with a common C417T polymorphism that modestly attenuated PTEN expression.",-59.0,0.8,sequencevariant
"Mutated EGFR with the H1047R sequence variant in A549 cells drives increased phosphatidylinositol‑3‑kinase signaling, thereby enhancing proliferation and resistance to the tyrosine‑kinase inhibitor gefitinib.",-37.75,0.8,sequencevariant
"Mutagenic T to A transition at the nucleotide position +387 in the EGFR gene of a patient-derived A549 cell line leads to the Lys to Asn substitution at position H1047R, which is predicted to enhance tyrosine‑kinase activity and confer resistance to gefitinib.",-50.5,0.8,sequencevariant
"Alterations in the TP53 gene, such as the H1047R substitution and the C417T variant, have been linked to increased tumorigenicity in the A549 cell line and to enhanced resistance to doxorubicin in Homo sapiens cells.",-42.5,0.8,sequencevariant
"Alteration of the BRCA1 gene, specifically the p.A365E SequenceVariant, was detected in a patient with triple‑negative breast cancer and led to a pronounced loss of DNA‑repair capability.",-40.5,0.8,sequencevariant
"Altered growth of the A549 cell line was observed when the H1047R variant of the PIK3CA gene was introduced, and this mutation was confirmed by detecting the rs4828037 SNP in the genomic DNA extracted from the cultured cells.",-38.5,0.8,sequencevariant
Altering the T to A transition at nucleotide position +387 in the promoter of the TP53 gene (rs1155794) was shown to reduce p53 expression and increase susceptibility to chemotherapy‑induced apoptosis in HeLa cells.,-39.5,0.8,sequencevariant
"Deletion of a ten‑ to twelve‑megabase region on chromosome X (Δ10‑12Mb) in a patient with X‑linked retinitis pigmentosa coincided with a missense mutation c.1170C>T (p. Lys398Asn) in the RPGR gene, and the compound heterozygosity of these variants was shown to cause the disease phenotype.",-78.5,0.8,sequencevariant
"Deletion spanning chromosomal positions (10‑12Mb) in an E. coli strain was shown to cause a T to A transition at position +387 in the dnaK gene, leading to a Lys to Asn substitution at amino‑acid position ~198 and markedly reducing the protein’s ability to bind heat‑shock transcription factor sigma‑32.",-82.0,0.8,sequencevariant
Deletion causing a loss of exons spanning nucleotides +735‑+736 (735‑6 TG > AT) in the BRCA1 gene (sequence variant rs1155794) was shown to impair homologous recombination and increase breast cancer susceptibility in women of European ancestry.,-64.5,0.8,sequencevariant
Deletion in the H1047R region of the PIK3CA gene in a patient with colorectal carcinoma led to an upregulation of the phosphatidylinositol‑3‑kinase pathway and enhanced cellular proliferation.,-45.5,0.8,sequencevariant
"Deletions spanning positions c.735‑c.736 (735‑6 TG > AT) in the TP53 gene were found to correlate with a markedly increased risk of early‑onset colorectal cancer in patients of European ancestry, and the corresponding protein change Lys→Asn at residue p.K198N further impairs p53 DNA‑binding affinity.",-77.0,0.8,sequencevariant
Depletion of the E546K sequence variant in TP53 was shown to impair p53‑dependent apoptosis and increase chemotherapeutic resistance in A549 cells.,-34.0,0.8,sequencevariant
"Deleterious rs4828037 in the EGFR gene, causing an E546K substitution, has been linked to enhanced gefitinib resistance in NSCLC patients harboring the H1047R variant of PIK3CA.",-40.75,0.8,sequencevariant
"De novo H1047R sequence variants in the PIK3CA gene were identified in a cohort of E. coli‑derived HeLa cells, where the Lys to Asn substitution at position p.A365E correlated with increased PI3K signaling and enhanced cellular proliferation.",-49.5,0.8,sequencevariant
"Variations such as the p.A365E substitution in the PI3K catalytic subunit, the C417T SNP, and the H1047R point mutation have been repeatedly correlated with enhanced oncogenic signaling in colorectal carcinoma cell lines derived from *Homo sapiens*.",-49.25,0.8,sequencevariant
Variants such as H1047R in the PIK3CA gene and the rs1155794 SNP were found to increase the risk of metastatic breast cancer in patients treated with the HER2‑targeted drug trastuzumab.,-34.0,0.8,sequencevariant
"Variational analysis of the BRCA1 c.68_69delAG sequence variant, together with the Lys to Asn at position‑198 substitution in the TP53 gene, revealed a synergistic increase in homologous recombination deficiency in A549 cells exposed to doxorubicin.",-52.25,0.8,sequencevariant
"Variability in the rs1155794 polymorphism, a C417T transition, was shown to alter TP53 expression in A549 cells, linking the sequence variant to differential apoptosis responses in this human lung carcinoma cell line.",-49.25,0.8,sequencevariant
"The cancer‑associated sequence variant rs368698783, a T→G transversion at nucleotide position **4508** in the *TP53* gene, introduces a GAT→GAG codon change that replaces aspartic acid with glutamic acid at position **416**, thereby compromising the protein’s DNA‑binding domain and contributing to impaired p53‑mediated apoptosis in tumor cells.",-56.5,0.8,sequencevariant
"The rs368698783 variant, a T → G transversion at nucleotide position **4508** that results in a GAT → GAG substitution replacing aspartic acid by glutamic acid at codon **416**, was found to significantly reduce the enzymatic activity of the *TP53* gene product in *Homo sapiens* lymphoblastoid cell lines, suggesting a pathogenic mechanism for the associated phenotypic feature of increased susceptibility to *H. sapiens* colorectal cancer.",-65.0,0.8,sequencevariant
"The T>G transversion at nucleotide position **4508** in the **BRCA1** coding sequence creates a **GAT→GAG** substitution that replaces aspartic acid with glutamic acid in codon **416**, a change observed in the **rs368698783** variant and associated with increased breast cancer risk.",-45.0,0.8,sequencevariant
"The pathogenic rs368698783 variant, a T→G transversion at nucleotide position‑4508 causing a GAT→GAG codon change that replaces aspartic acid with glutamic acid at codon‑416, was identified in a patient with early‑onset neurodegeneration and correlates with the −120‑bp duplication upstream of the promoter region, suggesting a compound heterozygous effect on transcriptional regulation.",-62.0,0.8,sequencevariant
"Mutation analysis revealed that the rs368698783 variant, a T‑>G transversion at nucleotide position c.4508, causes a GAT→GAG codon change at residue p.Asp416 to Glu, while a separate -120 bp duplication upstream of the promoter leads to aberrant splicing of the transcript.",-68.0,0.8,sequencevariant
"Mutation of rs368698783, a T‑>G transversion at nucleotide position‑4508 causing the GAT‑>GAG substitution that replaces aspartic acid with glutamic acid at codon‑416, was shown to destabilize the HBB protein and is associated with β‑thalassemia intermedia in Homo sapiens.",-54.5,0.8,sequencevariant
"Mutation rs368698783, a T→G transversion at nucleotide position **4508** in the *BRCA1* coding region, causes a GAT→GAG substitution that replaces aspartic acid with glutamic acid at codon **416**, and this sequence variant has been linked to increased risk of hereditary breast‑ovarian cancer in *Homo sapiens*.",-49.25,0.8,sequencevariant
"Mutation c.1138G>A in the CFTR gene, a T→G transversion at nucleotide position‑4508 that converts the aspartic acid codon GAT at position‑416 to the glutamic acid codon GAG, creates a premature E873 stop codon and is associated with cystic fibrosis in individuals of Homo sapiens.",-61.25,0.8,sequencevariant
"A c.1138G>A sequence variant in the TP53 gene was detected in a colorectal carcinoma sample, where the resulting p.G406E substitution was predicted to destabilize the DNA‑binding domain and was associated with increased tumor mutational burden.",-35.75,0.8,sequencevariant
"A previous study identified a GAT → GAG substitution at codon‑416 that replaces aspartic acid with glutamic acid in the E3 ligase gene, a variant that may modify protein‑protein interactions and thereby influence the severity of familial hypercholesterolemia in patients carrying the rs368698783 T→G transversion at nucleotide position‑4508.",-86.0,0.8,sequencevariant
"A missense variant (c.1138G>A) in the TP53 gene leads to a GAT>GAG substitution that replaces aspartic acid with glutamic acid at codon‑416, a change that has been shown to impair the tumor‑suppressive function of the protein in patients with colorectal cancer.",-44.75,0.8,sequencevariant
"A CRISPR-Cas9 knock‑in of the GAT>GAG substitution at codon **416** in the *TP53* gene of **HCT116** cells, which introduces a missense variant **p.Asp416Glu**, dramatically increases the cells’ sensitivity to **doxorubicin** and induces a pronounced up‑regulation of the **p21** protein, confirming the pathogenic impact of the **rs757229** variant.",-81.0,0.8,sequencevariant
"In A549 cells carrying the rs368698783 variant, the T→G transversion at nucleotide position c.4508 causes a GAT→GAG substitution at codon p.416, replacing aspartic acid with glutamic acid and leading to a premature E873stop mutation that disrupts protein function.",-54.0,0.8,sequencevariant
"In the HeLa cell line, the rs368698783 sequence variant, a T‑>G transversion at nucleotide position **4508** that converts the codon **GAT** to **GAG** and replaces aspartic acid with glutamic acid at position **416**, was found to increase transcription of the *TP53* gene, thereby enhancing apoptosis in response to doxorubicin treatment in *Homo sapiens* cells.",-49.0,0.8,sequencevariant
"In HeLa cells, the rs368698783 variant, a T→G transversion at nucleotide position‑4508, causes a GAT→GAG substitution that replaces aspartic acid by glutamic acid at codon‑416, thereby impairing the binding of the transcription factor NF‑κB to the promoter of the IL‑6 gene.",-48.75,0.8,sequencevariant
"In vitro overexpression of the TP53 c.1138G>A (p.Gly380Arg) variant in the HeLa cell line revealed a dramatic increase in apoptosis following treatment with doxorubicin, suggesting that this sequence variant enhances chemosensitivity in cervical carcinoma cells.",-43.25,0.8,sequencevariant
"Caution is warranted when the rs368698783 variant, involving a T→G transversion at nucleotide position c.4508, is present in the TP53 gene, because it can create a GAT→GAG substitution that replaces aspartic acid with glutamic acid at codon p.416, a change that has been linked to loss of tumor-suppressor activity and increased risk of early-onset colorectal cancer.",-78.5,0.8,sequencevariant
"C-terminal domain mutations of GAT1, such as the GAT--GAG substitution at codon‑416 that replaces aspartic acid with glutamic acid, have been shown to destabilize the protein and are frequently co‑occurring with the rs368698783 transversion at nucleotide‑4508 in the coding sequence, thereby altering the catalytic activity of the enzyme in the human (Homo sapiens) mitochondrial genome.",-92.0,0.8,sequencevariant
"Cytotoxicity assays in A549 cells revealed that the rs368698783 T→G transversion at nucleotide position‑4508, which causes a GAT→GAG substitution replacing aspartic acid with glutamic acid at codon‑416, drastically decreased cell viability by disrupting the protein’s catalytic core.",-59.75,0.8,sequencevariant
"Cis‑regulatory analysis of the E873stop sequence variant (c.2607G>A) in the TP53 gene of a HeLa cell line revealed a dramatic decrease in p53 protein stability, correlating with increased apoptosis after doxorubicin exposure.",-49.25,0.8,sequencevariant
"Mutations such as the rs368698783 T→G transversion at nucleotide position **4508** and the GAT→GAG substitution in codon **416** that converts aspartic acid to glutamic acid have been identified in *Homo sapiens* genes, with the former frequently co‑occurring with a −120‑bp duplication that leads to the loss of regulatory elements and may predispose to disease phenotypes.",-79.5,0.8,sequencevariant
Mutational analysis of the KCNJ11 gene in a cohort of patients with neonatal diabetes revealed a novel c.1138G>A (p.G380E) sequence variant that disrupts the ATP‑binding pocket and was associated with a severe early‑onset phenotype.,-43.5,0.8,sequencevariant
"Mutagenic exposure in HeLa cells induced a T‑>G transversion at nucleotide **4508** within the *TP53* coding sequence, generating a *GAT→GAG* substitution that replaces aspartic acid by glutamic acid at codon **416** and consequently leads to the loss‑of‑function **p.N102DfsX4** frameshift variant, a change documented as **rs368698783** in the ClinVar database.",-72.0,0.8,sequencevariant
"Mutating the E873stop variant in the human TP53 gene (rs368698783) disrupts the DNA‑binding domain, causing a loss‑of‑function phenotype that predisposes E. coli–derived plasmid constructs to aberrant protein expression in A549 cells treated with doxorubicin.",-55.5,0.8,sequencevariant
"GAT‑>GAG substitution at codon‑416 (rs368698783) replaces aspartic acid with glutamic acid in the catalytic domain of the kinase, thereby reducing its phosphorylation activity toward downstream substrates in the MAPK pathway and contributing to the oncogenic phenotype observed in HeLa cells.",-53.75,0.8,sequencevariant
"GTP-binding protein GTPBP4 carries a T > G transversion at nucleotide position **4508**, causing a **GAT > GAG** substitution that replaces aspartic acid with glutamic acid at codon **416**, thereby compromising ribosome assembly and increasing susceptibility to neurodegenerative disease in **Homo sapiens**.",-74.5,0.8,sequencevariant
"GABRA2 c.4508T>G transversion, resulting in a GAT>GAG substitution at codon‑416 that replaces aspartic acid with glutamic acid, is predicted to disrupt the ligand‑binding pocket and is associated with a heightened risk of treatment‑resistant epilepsy in patients carrying the rs368698783 allele.",-58.75,0.8,sequencevariant
"Glu‑416 substitution (GAT>GAG) in the ATPase domain of the RAB27A gene (c.1247G>A) was identified in a patient with Griscelli syndrome type‑2, leading to loss of melanosomal trafficking and resulting in the hypopigmentation phenotype.",-70.5,0.8,sequencevariant
"Patients carrying the rs368698783 sequence variant, a T→G transversion at nucleotide position ‑120 bp upstream that duplicates a regulatory motif, show markedly reduced expression of the TP53 gene, while individuals with the GAT→GAG substitution at codon‑416 (c.1248G>A) exhibit an Asp‑to‑Glu amino‑acid change that diminishes the DNA‑binding affinity of the resulting p53 protein.",-85.5,0.8,sequencevariant
"Patients with a rs368698783 sequence variant, a T→G transversion at nucleotide position c.4508, and a GAT→GAG substitution that replaces aspartic acid with glutamic acid at codon c.416 exhibited markedly increased expression of the tumor suppressor gene TP53 and enhanced apoptotic sensitivity to doxorubicin in HeLa cell lines.",-66.5,0.8,sequencevariant
"Patients harboring the rs368698783 T>G transversion at nucleotide position ​4508, which results in a GAT>GAG substitution replacing aspartic acid by glutamic acid in codon ​416 and a downstream −120‑bp duplication, exhibit markedly increased expression of the p.N102DfsX4 truncated protein that correlates with enhanced susceptibility to the rs757229‑associated neurodegenerative phenotype.",-72.0,0.8,sequencevariant
"Patients harbored a T>G transversion at nucleotide position **4508** in the *TNF* gene, resulting in a GAT→GAG substitution that replaces aspartic acid with glutamic acid at codon **416** and a −120‑bp duplication in the promoter, while rs368698783 was also identified in the same cohort.",-74.5,0.8,sequencevariant
"Genomic analysis of the rs368698783 variant, a T>G transversion at nucleotide position c.4508, revealed that the GAT→GAG substitution at codon p.416 replaces aspartic acid with glutamic acid, thereby disrupting the normal enzymatic activity of the encoded protein in Homo sapiens.",-56.0,0.8,sequencevariant
"Genotyping of the rs368698783 variant revealed a T→G transversion at nucleotide position c.4508, which introduces a GAT→GAG substitution at codon p.416 and produces a predicted p.N102DfsX4 sequence variant that may impair the functional domain of the encoded protein.",-66.5,0.8,sequencevariant
"Genetic analysis of a patient revealed the rs368698783 variant, a T→G transversion at nucleotide position **4508** in the *CFTR* gene, which introduces a GAT→GAG substitution at codon **416**, replacing aspartic acid with glutamic acid and thereby causing a loss‑of‑function phenotype associated with cystic fibrosis.",-55.75,0.8,sequencevariant
"Genotype‑specific expression analysis revealed that the rs368698783 allele, which harbors a T→G transversion at nucleotide position‑4508, is associated with a GAT→GAG substitution that replaces aspartic acid with glutamic acid at codon‑416, thereby increasing transcriptional activity of the neighboring promoter in HeLa cells.",-64.5,0.8,sequencevariant
"Transcriptional profiling of the colorectal carcinoma cell line HCT‑116 revealed that the rs368698783 polymorphism, a T→G transversion at nucleotide position c.4508, creates a novel splice‑site in intron‑16 and results in the p.N102DfsX4 sequence variant that truncates the C‑terminal domain of the APC protein, thereby disrupting its interaction with β‑catenin and promoting uncontrolled cell proliferation.",-77.0,0.8,sequencevariant
"Transduction of the HeLa CellLine with a CRISPR–Cas9 construct targeting the p.N102DfsX4 SequenceVariant of the TP53 GeneOrGeneProduct revealed a marked reduction in DNA repair capacity, confirming that this frameshift mutation impairs the tumor suppressor function of TP53.",-55.75,0.8,sequencevariant
"Trans-heterozygous T>G transversion at nucleotide position c.4508 in the CYP2C9 gene causes a GAT>GAG substitution, replacing aspartic acid by glutamic acid at codon p.416, and is associated with a loss of enzymatic activity that predisposes to drug-induced hepatotoxicity in patients carrying the rs368698783 allele.",-75.5,0.8,sequencevariant
"Transfection of a plasmid carrying the rs368698783 T→G transversion at nucleotide position‑4508, which results in a GAT→GAG substitution replacing aspartic acid by glutamic acid at codon‑416, into HeLa cells dramatically reduced TP53 expression and increased apoptotic markers, suggesting that this sequence variant disrupts p53‑dependent cell cycle control.",-69.0,0.8,sequencevariant
"An rs368698783 T → G transversion at nucleotide position ‑120 bp duplication in the promoter region of the TP53 gene creates a GAT → GAG substitution at codon ‑416, replacing aspartic acid by glutamic acid and thereby destabilizing p53’s DNA‑binding domain.",-62.0,0.8,sequencevariant
"An NGS panel revealed the rs368698783 variant, a T→G transversion at nucleotide position c.4508, which co‑occurs with the GAT→GAG substitution at codon p.416, both of which are predicted to destabilize the TP53 protein in a subset of A549 cells.",-65.0,0.8,sequencevariant
"An siRNA knock‑down of TP53 in the A549 cell line revealed that the rs368698783 T>G transversion at nucleotide position c.4508 causes a GAT>GAG substitution, replacing aspartic acid by glutamic acid at codon p.416 and conferring a loss of function phenotype in the p53 tumor suppressor pathway.",-73.5,0.8,sequencevariant
"An A549 cell line treated with doxorubicin revealed that the rs368698783 Variant, a T → G transversion at nucleotide position c.4508, introduces a GAT → GAG substitution at codon p.416, converting aspartic acid to glutamic acid and thereby enhancing apoptosis signaling in the TP53 pathway.",-60.5,0.8,sequencevariant
"T‐to‐G transversion at nucleotide position ‑120 bp duplication in the promoter of the *TP53* gene (rs368698783) results in a GAT→GAG substitution that replaces aspartic acid with glutamic acid at codon‑416, thereby destabilizing the protein and contributing to the increased risk of colorectal cancer in *Homo sapiens*.",-68.5,0.8,sequencevariant
"T‑to‑G transversion at nucleotide position c.4508 in the ATP1A1 gene causes a GAT‑>GAG substitution that replaces aspartic acid with glutamic acid at codon p.416, a variant (rs368698783) that has been linked to early‑onset hypertension in Homo sapiens subjects carrying the G‑allele.",-61.0,0.8,sequencevariant
"T–>G transversion at nucleotide position c.4508 in the BRCA1 gene, causing a GAT‑>GAG codon change that replaces aspartic acid with glutamic acid at residue p.416, is frequently observed in sporadic breast cancer cases of a Caucasian cohort, whereas an IVS16+1G>A splice‑site mutation in the same gene is linked to a higher risk of early‑onset ovarian carcinoma in a separate population.",-91.5,0.8,sequencevariant
"T allele of rs368698783, a GAT>GAG substitution at codon&nbsp;416 causing Asp→Glu, is associated with increased risk of late‑onset Alzheimer’s disease in a population of Homo sapiens.",-50.0,0.8,sequencevariant
Insertion of the -120 bp duplication upstream of the TP53 promoter in a HeLa cell line carrying the rs368698783 polymorphism led to a significant decrease in p53 transcriptional activity and an increase in cellular resistance to doxorubicin.,-39.5,0.8,sequencevariant
"Insertional duplication of –120 bp in the promoter of TP53 together with the T → G transversion at nucleotide c.4508 causes loss of binding by the transcription factor NF‑κB, leading to down‑regulation of the p53‑mediated apoptotic response in A549 cells.",-68.5,0.8,sequencevariant
"Insertion‑deletion of −120 bp upstream of the GATA4 promoter combined with the rs368698783 T→G transversion at nucleotide position ‑4508 results in a markedly reduced transcriptional activity of the gene in human cardiomyocytes, contributing to a hypoplastic left‑ventricle phenotype.",-82.0,0.8,sequencevariant
"Insertion at −120 bp upstream of the TP53 promoter coupled with a T→G transversion at nucleotide position c.4508 in the BRCA1 coding sequence (p.Glu416Asp) was detected in a breast cancer patient, and the combined sequence variant was found to correlate with increased genomic instability and aggressive tumor phenotype.",-90.0,0.8,sequencevariant
"R‑squared‑dependent protein‑C deficiency caused by the rs368698783 variant, a T → G transversion at nucleotide position c.4508 in the PROC gene, results in a GAT → GAG substitution that replaces aspartic acid with glutamic acid at codon p.416, thereby disrupting the protein’s catalytic activity and increasing thrombosis risk in homozygous individuals.",-76.5,0.8,sequencevariant
"RIF1 rs368698783, a T→G transversion at nucleotide position *c.*4508, causes a GAT→GAG substitution that replaces aspartic acid by glutamic acid in codon *416*, thereby impairing DNA‑repair signalling and predisposing *Homo sapiens* to genome‑instability‑related cancers.",-66.5,0.8,sequencevariant
"Rational design of a p.N102DfsX4 variant in the EGFR gene demonstrated that the frameshift truncation enhances ligand-independent kinase activity, thereby increasing cell proliferation in A549 cell lines and providing a novel therapeutic target for osimertinib-resistant non‑small cell lung cancer.",-63.25,0.8,sequencevariant
"Rosa and colleagues identified a rs368698783 variant in the HLA‑DQB1 gene, where a T‑>G transversion at nucleotide position c.4508 creates a GAT→GAG substitution that replaces an aspartic acid with a glutamic acid in codon p.416, and this missense alteration was shown to disrupt antigen‑binding specificity, potentially contributing to autoimmune disease susceptibility in Homo sapiens.",-94.0,0.8,sequencevariant
"The c.G1714C sequence variant in TP53 was found to impair DNA binding, thereby reducing the transcriptional activation of the p53 target gene p21 and contributing to the aggressive phenotype observed in the H1299 cell line derived from non‑small cell lung cancer.",-35.5,0.8,sequencevariant
The CRISPR-Cas9 editing of the TP53 gene in H1299 cells introduced a c.185C>T (p.Arg158Pro) sequence variant that abrogated p53 transcriptional activity and conferred resistance to doxorubicin-induced apoptosis.,-25.5,0.8,sequencevariant
The novel sequence variant c.G1714C in the exon of TP53 was found to reduce DNA binding affinity and correlate with increased risk of familial colorectal cancer in a cohort of Homo sapiens patients.,-34.5,0.8,sequencevariant
"The S75X sequence variant in TP53 (c.224C>A) is predicted to abrogate the DNA‑binding domain, thereby impairing p53‑mediated apoptosis in HeLa cells.",-29.5,0.8,sequencevariant
"A homozygous c.G1714C sequence variant in the MT-ND6 gene was found to correlate with a markedly reduced oxygen consumption rate in the A549 cell line, suggesting a pathogenic role in mitochondrial encephalopathy.",-40.75,0.8,sequencevariant
"A trans‐membrane variant of the sodium‑glucose cotransporter, c.G1714C (p.Arg158Pro), was found in a cohort of patients with a mild, late‑onset form of congenital glucose‑affecting disease, while the more severe phenotype correlated with the larger deletion, c.30delG, in the same gene.",-73.5,0.8,sequencevariant
"A thymic carcinoma harboring the c.304ins(GCG) (7) sequence variant shows markedly reduced TP53 expression, leading to increased sensitivity to doxorubicin in A549 cells derived from a Homo sapiens lung adenocarcinoma model.",-41.5,0.8,sequencevariant
"A CRISPR/Cas9-mediated c.304ins(GCG) (7) sequence variant in the TP53 gene was shown to disrupt p53's DNA‑binding domain, leading to a loss of growth‑suppressive activity in HeLa cells treated with doxorubicin.",-36.5,0.8,sequencevariant
"In the HeLa cell line, the sequence variant c.G1714C in TP53 was found to increase apoptosis induced by doxorubicin, correlating with higher expression of the pro‑apoptotic protein Bax.",-27.0,0.8,sequencevariant
"In CRC cell line HCT116, the engineered sequence variant c.304ins(GCG) (7) introduced a novel Arg158Pro mutation that upregulated KRAS expression and increased sensitivity to the chemotherapeutic drug doxorubicin.",-43.5,0.8,sequencevariant
"In a recent study of colorectal carcinoma, a novel c.G1714C sequence variant was identified in the TP53 gene of a patient with a p.G821S mutation, suggesting a potential synergistic effect on tumor suppressor activity.",-35.0,0.8,sequencevariant
"In human melanoma cells, the c.304ins(GCG) mutation in the BRAF gene creates a novel p.G821S variant that abolishes kinase activity and thereby sensitizes the cells to the RAF inhibitor dabrafenib.",-38.5,0.8,sequencevariant
"Analysis of the A549 cell line expressing the c.G1714C sequence variant revealed that the mutation increased the transcription of the TP53 gene, thereby enhancing the apoptotic response to doxorubicin treatment.",-34.25,0.8,sequencevariant
"Analysis revealed that the c.G1714C sequence variant in TP53 reduces binding of the p53 protein to DNA, thereby diminishing transcriptional activation of the cell cycle inhibitor p21 and contributing to uncontrolled proliferation of HeLa cells.",-41.5,0.8,sequencevariant
"Analysis in A549 cells revealed that the c.G1714C sequence variant in the TP53 gene creates a novel splice donor site, leading to the loss of exon five and a truncated protein that fails to activate p21 expression.",-47.5,0.8,sequencevariant
"Analysis established that the c.G1714C sequence variant in TP53 disrupts the DNA‑binding domain, causing loss of p53 transcriptional activity and predisposing Homo sapiens cell lines such as HCT116 to unchecked proliferation.",-47.0,0.8,sequencevariant
"Mutations such as c.G1714C and the resulting p.G821S sequence variant in the BRCA1 gene were found to impair DNA repair capacity, contributing to increased susceptibility to breast cancer in patients with the R1306W germline background.",-37.25,0.8,sequencevariant
Mutational analysis of the TP53 c.G1714C sequence variant revealed that the Arg158Pro change reduces DNA binding affinity and is frequently observed in patients with hereditary colorectal cancer.,-36.5,0.8,sequencevariant
Mutating the BRCA1 sequence variant c.G1714C to the p.G821S allele in the HeLa CellLine exposed to the DNA‑damaging agent doxorubicin exacerbates homologous recombination deficiency and increases apoptosis in Homo sapiens cells.,-43.5,0.8,sequencevariant
"Mutagenic exposure to doxorubicin induces a c.304ins(GCG) (7) sequence variant in the TP53 gene, which leads to an Arg158Pro substitution that compromises p53 DNA‑binding and correlates with increased apoptosis in HeLa cells.",-36.5,0.8,sequencevariant
"Mutation of the TP53 gene with the c.185C>T sequence variant in the HeLa cell line results in reduced p53 protein stability, thereby enhancing resistance to doxorubicin-induced apoptosis in Homo sapiens cells.",-31.25,0.8,sequencevariant
"Mutation analysis of the BRCA1 c.185C>T variant in a breast‑cancer patient revealed a concomitant G7958 single‑nucleotide polymorphism in the same exon, suggesting a potential compound‑heterozygous effect on DNA repair efficiency.",-38.75,0.8,sequencevariant
Mutation c.185C>T in the TP53 gene of a HeLa cell line leads to a p.G821S sequence variant that reduces the cell’s ability to repair DNA damage in Homo sapiens.,-31.0,0.8,sequencevariant
"Mutation p.G821S in the TP53 gene (c.2454G>C) was found in an A549 cell line derived from a patient with a G7958 sequence variant, and its presence correlated with increased sensitivity to doxorubicin.",-36.25,0.8,sequencevariant
"Deficiency of the BRCA1 sequence variant c.185C> T causes a loss of DNA‑repair activity, which correlates with increased susceptibility to triple‑negative breast cancer in women of European ancestry.",-40.25,0.8,sequencevariant
"Defects in the BRCA1 gene, such as the BRCA1 c.185C>T sequence variant, have been shown to impair homologous recombination repair and predispose carriers to early-onset breast and ovarian cancers.",-32.75,0.8,sequencevariant
"Defining the functional consequences of the BRCA1 c.68_69delAG sequence variant, researchers observed that the resulting loss of exon inclusion led to a truncated protein that failed to recruit homologous recombination machinery, thereby increasing genomic instability and elevating breast cancer risk.",-51.0,0.8,sequencevariant
"Defective repair of the BRCA1 c.304ins(GCG) variant causes a pronounced accumulation of DNA double‑strand breaks in HeLa cells, thereby sensitizing them to the synthetic‑lethal effect of PARP inhibitors.",-40.75,0.8,sequencevariant
Patients harboring the sequence variant c.185C>T in the BRCA1 gene exhibited increased DNA repair protein expression and a higher risk of breast cancer recurrence.,-29.125,0.8,sequencevariant
"Patients with the c.G1714C variant in the CYP2C9 gene exhibited a markedly increased risk of severe warfarin-induced bleeding, a finding that was confirmed by functional assays showing impaired enzymatic activity of the mutant protein.",-42.0,0.8,sequencevariant
"Patients receiving doxorubicin (DOX) exhibited a marked increase in the S75X sequence variant within the BRCA1 gene, which was associated with heightened cardiotoxicity and a dose‑dependent reduction in myocardial contractility.",-47.0,0.8,sequencevariant
"Patients treated with the EGFR‑inhibitor gefitinib exhibited a significant increase in apoptosis when the EGFR gene harbored the c.G1714C (p.G571R) sequence variant, indicating that this mutation modulates drug response.",-41.5,0.8,sequencevariant
"Detection of the c.185C>T sequence variant in the TP53 gene within a HeLa cell line revealed a novel Arg158Pro mutation that increased sensitivity to the chemotherapeutic agent doxorubicin, thereby suggesting a potential biomarker for personalized cancer therapy.",-36.0,0.8,sequencevariant
"Detection and characterization of the c.G1714C sequence variant revealed that the Arg158Pro substitution in TP53 destabilizes the DNA‑binding domain, thereby impairing transcriptional activation of p21 and contributing to the oncogenic potential observed in HeLa cells treated with doxorubicin.",-47.75,0.8,sequencevariant
"Detection that the c.185C>T sequence variant in the TP53 gene leads to a p.Arg158Pro amino‑acid change, resulting in increased apoptosis of A549 cells when treated with doxorubicin, highlights a potential therapeutic target for overcoming drug resistance in non‑small‑cell lung carcinoma.",-53.0,0.8,sequencevariant
"Detection assays revealed that the c.185C>T sequence variant in the TP53 gene correlated with increased radiosensitivity in Hela cells, suggesting that this mutation may modulate DNA repair pathways in human tumors.",-53.25,0.8,sequencevariant
"Cytotoxicity assays revealed that the c.G1714C sequence variant in the TPMT gene, which converts a glycine to serine at position p.G821S, markedly increased the sensitivity of the HeLa cell line to the chemotherapeutic agent fludarabine, thereby suggesting a genotype‑dependent drug‑response mechanism.",-60.0,0.8,sequencevariant
C-terminal R1306W sequence variant in the BRAF gene (c.3917G>T) markedly reduces kinase activity and is linked to a milder form of melanoma in patients of the Homo sapiens population.,-46.5,0.8,sequencevariant
"CYP2C19 c.G1714C variant has been shown to alter dabigatran metabolism in patients treated with the anticoagulant, thereby increasing the risk of bleeding complications.",-36.0,0.8,sequencevariant
"C825T is a sequence variant in TP53 that has been shown to alter the transcriptional activation of the p53 target gene BAX, thereby contributing to the increased susceptibility to colorectal carcinoma in patients carrying the variant.",-50.75,0.8,sequencevariant
"Loss of the BRCA1 sequence variant c.G1714C reduces homologous recombination repair efficiency, thereby increasing sensitivity of the A549 cell line to the chemotherapeutic agent doxorubicin in vitro.",-28.75,0.8,sequencevariant
"Loss-of-function mutations such as the c.G1714C variant, the p.G821S substitution, and the c.304ins(GCG) insertion in the TP53 gene are frequently observed in sporadic colorectal carcinomas, where they disrupt p53’s DNA‑binding domain and confer a selective growth advantage to malignant cells.",-53.75,0.8,sequencevariant
"Loss and gain of function of the c.G1714C variant in the BRCA1 gene, whose c.185C>T polymorphism correlates with reduced DNA repair capacity, were shown to increase susceptibility to breast cancer in patients carrying the R1306W sequence variant.",-60.25,0.8,sequencevariant
"Loss‑of‑function mutations such as c.G1714C and the frameshift variant c.304insGCG in the TP53 gene have been shown to impair p53 DNA‑binding activity, thereby increasing the risk of sporadic colorectal carcinoma in patients with a history of smoking.",-45.75,0.8,sequencevariant
"Genomic analysis of a colorectal carcinoma cell line revealed a c.304ins(GCG) (7) sequence variant that introduced an in-frame G821S substitution in the KRAS protein, leading to increased downstream ERK phosphorylation and enhanced cell proliferation.",-36.25,0.8,sequencevariant
"Genetic analysis of a colorectal carcinoma cohort revealed a novel BRCA1 c.G1714C sequence variant that co‑occurs with a p.G821S amino‑acid substitution, and functional assays demonstrate that the combined mutation reduces DNA repair capacity, thereby increasing mutational burden in tumor cells.",-48.25,0.8,sequencevariant
"Genotyping of the c.304ins(GCG) variant revealed a strong association with increased susceptibility to Parkinson’s disease in a cohort of Homo sapiens patients carrying the G7958 allele, suggesting a pathogenic role for this sequence variant in neurodegeneration.",-40.0,0.8,sequencevariant
"Genotype‑specific transcriptional silencing of TP53 is observed in HeLa cells harboring the BRCA1 c.304ins(GCG) (7) variant, which in turn elevates intracellular ethanol metabolites and exacerbates the fever‐like phenotype characteristic of Parkinson’s disease.",-61.75,0.8,sequencevariant
CRISPR‑mediated introduction of the c.G1714C sequence variant in the TP53 gene of A549 cells markedly increased p53 protein stability and sensitized the cells to doxorubicin‑induced apoptosis.,-24.0,0.8,sequencevariant
CRITICAL care investigators noted that the c.G1714C sequence variant in the ABC transporter gene was associated with a significant reduction in drug efflux capacity and an increased risk of severe hepatotoxicity in patients receiving the chemotherapeutic agent doxorubicin.,-52.75,0.8,sequencevariant
"CRN2 with the sequence variant c.G1714C was found to reduce TP53 transcriptional activity in HeLa cells, thereby increasing cellular sensitivity to doxorubicin.",-43.25,0.8,sequencevariant
"CR1 variant c.G1714C (p.Gly571Asp) in the C3 binding domain increases complement activation, exacerbating the inflammatory phenotype observed in patients with systemic lupus erythematosus.",-49.0,0.8,sequencevariant
"BRCA1 c.G1714C, a sequence variant that converts glycine to alanine at position \(1714\), was identified in a cohort of breast cancer patients and was found to correlate with an increased risk of early-onset disease in Homo sapiens.",-51.0,0.8,sequencevariant
"BRCT-mediated phosphorylation of the c.185C>T variant in TP53 reduces its transcriptional activation of the p21 promoter in HeLa cells, leading to impaired cell cycle arrest during DNA damage response in Homo sapiens.",-50.0,0.8,sequencevariant
"BRAC1 c.G1714C (p.Gly572Arg) was found to disrupt the DNA-binding domain of the protein, thereby reducing TP53‑mediated transcriptional activation and conferring a higher risk of early‑onset ovarian cancer in a cohort of E. coli‑negative, homozygous carriers.",-63.75,0.8,sequencevariant
"BRIP1 c.G1714C variant, which changes glycine to arginine at position R158, has been found to destabilize the protein’s helicase domain and is associated with an increased risk of ovarian carcinoma in women of East Asian ancestry.",-59.25,0.8,sequencevariant
The CRP gene sequence variant p.G821S in the rs2073163 haplotype was found to upregulate inflammatory cytokine production in a population of Homo sapiens patients with systemic lupus erythematosus.,-33.5,0.8,sequencevariant
"The c.468C> T variant in TP53, resulting in the Val175Met substitution, was found to increase the risk of colorectal cancer in individuals carrying the rs2073163 allele.",-21.125,0.8,sequencevariant
"The R76G (c.227G>A) sequence variant in the GATA4 gene, previously annotated as rs2073163, was found to impair cardiac transcriptional activity in a cohort of patients with early‑onset dilated cardiomyopathy.",-36.25,0.8,sequencevariant
The pathogenic sequence variant R76G in the TP53 gene (c.226C>G) was found to increase apoptosis in HeLa cells treated with the DNA‑damaging agent doxorubicin.,-25.375,0.8,sequencevariant
"A missense sequence variant c.468C>T, which results in the Val175Met substitution in the TP53 protein, was found to be significantly associated with increased susceptibility to familial breast cancer in a cohort of Homo sapiens patients.",-26.5,0.8,sequencevariant
"A p.G821S variant in the NOD2 gene, identified by rs2073163, was found to increase susceptibility to Crohn’s disease in a cohort of Homo sapiens.",-29.25,0.8,sequencevariant
"A single nucleotide polymorphism rs2073163, corresponding to a Val175Met sequence variant, was found to significantly alter the binding affinity of the transcription factor NRF2 to the antioxidant response element in the promoter of the HMOX1 gene in human dermal fibroblasts.",-34.75,0.8,sequencevariant
"A cell‑based assay revealed that the BRCA1 c.468C>T (p.G175S) sequence variant, identified in a patient with familial breast cancer, reduces RAD51 recruitment to double‑strand breaks, thereby impairing homologous recombination and increasing genomic instability.",-43.0,0.8,sequencevariant
"In the HeLa cell line, a CRISPR-Cas9 induced sequence variant, c.468C>T, leads to the Val175Met amino‑acid substitution in the TP53 protein, which in turn enhances the cell’s apoptotic response to doxorubicin.",-41.25,0.8,sequencevariant
"In colorectal cancer cell line HCT116, the CRISPR‑generated sequence variant c.468C>T (p.G158V) in the KRAS gene was shown to increase sensitivity to the MEK inhibitor trametinib, while the same cell line with the additional Val175Met mutation in the TP53 gene exhibited markedly reduced apoptotic response, suggesting a synergistic effect of these two sequence variants on drug resistance.",-59.0,0.8,sequencevariant
"In HepG2 cells, the BRCA1 sequence variant c.468C>T (p.G821S) was found to disrupt BRCA1’s interaction with the E3‑ligase RNF168, thereby impairing DNA damage repair and increasing sensitivity to the chemotherapeutic agent doxorubicin.",-35.0,0.8,sequencevariant
"In a recent cohort study of colorectal cancer, the missense sequence variant rs2073163, which encodes the Val175Met substitution in the APC gene, was found to be significantly associated with earlier tumor onset and higher microsatellite instability in patients of European ancestry.",-40.25,0.8,sequencevariant
Sequence variants such as the c.468C>T mutation leading to p.Gly156Asp in the TP53 gene have been found to impair apoptotic signaling in HeLa cells treated with doxorubicin.,-42.0,0.8,sequencevariant
Sequence analysis of the KRAS gene in colorectal cancer samples revealed a recurrent G593S sequence variant that correlates with increased KRAS protein activity and worsened patient survival.,-36.25,0.8,sequencevariant
"Sequence variant c.468C> T in the CYP2D6 gene (rs2073163) has been shown to reduce enzyme activity, thereby increasing the risk of adverse reactions to the antipsychotic drug olanzapine in patients of Homo sapiens.",-35.0,0.8,sequencevariant
Sequence analyses of the TP53 gene in colorectal cancer revealed a c.468C> T (p.Ser156Phe) sequence variant that correlated with increased tumor invasion and a higher frequency of the rs2073163 polymorphism in patients exhibiting the Val175Met mutation.,-49.25,0.8,sequencevariant
"Research revealed that the BRCA1 sequence variant c.468C> T, predicted to cause a Val175Met substitution, was significantly associated with increased breast cancer risk in a cohort of Homo sapiens patients.",-32.5,0.8,sequencevariant
"Research shows that the BRCA1 c.468C > T sequence variant, which replaces a cysteine with phenylalanine at position G593S, is associated with increased breast cancer risk in Homo sapiens patients carrying the rs2073163 allele.",-42.25,0.8,sequencevariant
"Research indicates that the c.468C > T SequenceVariant in the CYP2D6 GeneOrGeneProduct, which results in a Val175Met amino acid change, is associated with altered metabolism of the ChemicalEntity tamoxifen in patients of the Homo sapiens OrganismTaxon.",-36.5,0.8,sequencevariant
"Research on the R76G sequence variant (c.227C>G) in the ATP7B gene showed that the missense mutation, combined with a del‑(439‑443) deletion, significantly reduced copper transport activity in patient-derived HepG2 cells, thereby exacerbating Wilson disease phenotypes.",-57.75,0.8,sequencevariant
"Targeted CRISPR editing of the TP53 gene in HCT116 cells introduced a c.468C> T (p.Phe156Leu) sequence variant, which reduced p53 transcriptional activity and increased cell survival after doxorubicin treatment.",-35.0,0.8,sequencevariant
"Targeting the BRCA1 c.68_69delAG variant in a patient-derived A549 cell line revealed that the resulting protein truncation disrupted DNA repair pathways, leading to increased sensitivity to the DNA‑damaging agent doxorubicin.",-38.25,0.8,sequencevariant
"Target‑gene sequencing of *Homo sapiens* tumor tissue revealed a novel sequence variant c.468C>T (p.Arg156Cys) in the KRAS gene, which correlates with increased downstream MAPK signaling in the A549 cell line.",-51.5,0.8,sequencevariant
"Targetting the BRCA1 c.468C>G variant (p.G821S) in a CRISPR‑edited HCC827 cell line revealed increased sensitivity to PARP inhibition, correlating with upregulated RAD51 expression.",-56.0,0.8,sequencevariant
"Sanger sequencing of the KRAS exon‑2 region in pancreatic cancer samples revealed the p.G593S sequence variant, which correlated with increased tumor cell proliferation and poor overall survival.",-43.25,0.8,sequencevariant
"SNP rs2073163, a missense sequence variant causing the Val175Met substitution, was identified in the TP53 gene of a patient with familial colorectal cancer, and functional assays revealed that this variant disrupts p53's DNA‑binding ability, thereby impairing apoptosis in colon epithelial cells.",-48.0,0.8,sequencevariant
"SARS‑CoV‑2 infection exacerbates the pathogenic impact of the sequence variant c.468C>T in the ACE2 gene, which alters the receptor’s binding affinity for the viral spike protein and contributes to increased disease severity in individuals carrying this mutation.",-42.0,0.8,sequencevariant
"Spleen tyrosine kinase (SYK) overexpression in the A549 cell line carrying the p.G821S sequence variant was shown to increase IL‑6 production, suggesting a mechanistic link between this mutation and enhanced inflammatory signaling.",-46.75,0.8,sequencevariant
"Mutations such as R76G and the I146L variant in TP53, detected by sequencing the c.468C>T and G593S alterations, were associated with increased cellular proliferation in H1299 cells.",-46.0,0.8,sequencevariant
"Mutagenesis of the BRCA1 gene revealed that the sequence variant c.468C> T (p.Arg156Cys) in the RING domain markedly reduces protein stability, thereby increasing the risk of early-onset breast cancer in carriers of the rs2073163 allele.",-45.75,0.8,sequencevariant
"Mutational analysis of the BRCA1 gene in breast cancer patients revealed that the c.468C> T (Val175Met) sequence variant, together with the rs2073163 SNP, significantly increases the risk of hereditary breast and ovarian cancer in a population of Homo sapiens.",-39.25,0.8,sequencevariant
Mutant allele p.G821S of the ATPase gene was found to be strongly associated with increased risk of Parkinson’s disease in a cohort of *Homo sapiens* patients carrying the rs2073163 single‑nucleotide polymorphism.,-43.0,0.8,sequencevariant
"CRISPR‑Cas9 editing of the TP53 gene in H1299 cells introduced a c.468C > T (p.R156C) sequence variant, which was found to reduce DNA‑binding affinity and impair the apoptotic response to doxorubicin.",-38.0,0.8,sequencevariant
"CR3R1 cell line overexpresses the TP53 variant p.G821S, which leads to increased sensitivity to doxorubicin in Homo sapiens cultures.",-48.25,0.8,sequencevariant
CRTC1‑CITED2 fusions with the BRCA1 c.468C>T (Val175Met) variant in breast cancer cell lines such as MCF‑7 and T47D result in reduced DNA repair capacity and increased sensitivity to the PARP inhibitor olaparib.,-57.0,0.8,sequencevariant
"CRLF2 expression in the CRLF2‑overexpressing K562 cell line is markedly increased when the c.468C>T (p.G821S) sequence variant is introduced, demonstrating that this single nucleotide change enhances the oncogenic potential of the leukemia cells.",-56.25,0.8,sequencevariant
Cells engineered to overexpress the TP53 gene with a p.G821S sequence variant (c.2452G > A) exhibited increased apoptosis in A549 cell line cultures treated with doxorubicin.,-44.5,0.8,sequencevariant
"Cells carrying the BRCA1 c.468C>T variant (Val175Met) exhibit increased sensitivity to the chemotherapeutic drug doxorubicin, a finding that underscores the functional impact of this sequence variant on DNA repair pathways.",-35.25,0.8,sequencevariant
"Cells harboring the BRCA1 c.468C>T (p.G593S) variant exhibited markedly reduced homologous recombination activity, whereas the I146L polymorphism in the same allele appeared to partially compensate for this functional deficit.",-45.75,0.8,sequencevariant
"Cells treated with the CRISPR‑Cas9 guide targeting the BRCA1 exon containing the c.468C>​T (p.G593S) variant showed a marked decrease in homologous recombination repair efficiency, confirming that this SequenceVariant impairs DNA‑damage response in HeLa cells.",-52.75,0.8,sequencevariant
"We identified a c.468C> T sequence variant in TP53 that co‑occurs with the rs2073163 polymorphism in breast cancer patients derived from the HeLa cell line, suggesting a potential combined effect on tumor suppressor activity.",-44.25,0.8,sequencevariant
We observed that the R76G sequence variant in the TP53 gene (rs2073163) is associated with a higher risk of therapy‑related acute myeloid leukemia in patients receiving doxorubicin.,-29.0,0.8,sequencevariant
"We discovered that the sequence variant rs2073163, which causes the Val175Met substitution in the TP53 gene, was strongly associated with an increased risk of early‑onset Parkinson’s disease in a cohort of E. coli‑derived cell lines.",-40.5,0.8,sequencevariant
"We propose that the c.468C>T (p.Thr156Met) sequence variant in the *TNFRSF1A* gene, which has been linked to a gain‑of‑function phenotype, leads to increased production of soluble TNF‑α and thereby exacerbates the inflammatory response in patients with Blau syndrome.",-56.75,0.8,sequencevariant
"HeLa cells harboring the BRCA1 c.68_69delAG variant display reduced homologous recombination efficiency, while CRISPR‑generated A549 cells with the TP53 R172H mutation exhibit increased sensitivity to doxorubicin.",-40.75,0.8,sequencevariant
"Heifer-derived bovine serum albumin (BSA) harboring the c.468C> T variant (rs2073163) was shown to alter the stability of the glycoprotein, thereby reducing the binding affinity of the anti‑TNF‑α monoclonal antibody and attenuating the therapeutic response in a subset of Crohn’s disease patients.",-77.5,0.8,sequencevariant
"Heidelberg cell lines infected with the influenza A virus containing a G593S sequence variant exhibited markedly increased expression of the cytokine IL‑6, suggesting that the G593S mutation drives a pro‑inflammatory phenotype in infected cells.",-62.5,0.8,sequencevariant
"He was found to carry the BRCA1 c.468C> T sequence variant, which co‑occurs with the rs2073163 polymorphism and correlates with an increased risk of breast cancer in the studied cohort.",-40.5,0.8,sequencevariant
"Homozygous carriers of the BRCA1 sequence variant c.468C>T, which introduces a Val175Met substitution, exhibit a markedly increased risk of breast cancer in European populations, whereas the same mutation in African cohorts shows no significant association.",-40.5,0.8,sequencevariant
"Heterozygous carriers of the BRCA1 sequence variant rs2073163, which leads to an amino‑acid substitution of Val175Met in the BRCT domain, display a markedly increased risk of early‑onset breast cancer compared with non‑carriers.",-39.25,0.8,sequencevariant
"HCT116 cells harboring the p.G821S sequence variant in the TP53 gene exhibit increased sensitivity to doxorubicin compared with wild‑type cells, suggesting a functional impact of this mutation on chemotherapeutic response.",-36.5,0.8,sequencevariant
"HepG2 cells transfected with the BRCA2 c.468C>T variant showed a dramatic reduction in RAD51 foci formation, indicating that this sequence variant impairs homologous recombination repair in human hepatocellular carcinoma cells.",-36.75,0.8,sequencevariant
"TP53 p.G593S was detected by next‑generation sequencing in a HeLa cell line derived from a patient with a history of acute myeloid leukemia, where the variant correlated with increased sensitivity to doxorubicin treatment.",-40.75,0.8,sequencevariant
TP73 promoter p.G821S sequence variant was identified in a breast carcinoma sample where it correlated with increased p53 protein expression and enhanced sensitivity to doxorubicin in a patient-derived MCF‑7 cell line.,-59.0,0.8,sequencevariant
"TPX2 overexpression in A549 cells harboring the BRCA1 c.468C>T variant (p.Gly156Val) increases resistance to doxorubicin, a finding that may explain the poorer clinical outcomes observed in patients with this sequence variant.",-48.0,0.8,sequencevariant
"TP63 rs2073163 variants were detected in a cohort of Ewing sarcoma patients, and the c.468C>T mutation in TP53 was shown to impair DNA damage repair, thereby increasing the risk of chemotherapy‐induced apoptosis.",-66.0,0.8,sequencevariant
The pro‑apoptotic protein p53 harboring the sequence variant Val158Met shows markedly reduced transcriptional activation of downstream genes such as BAX and PUMA in HeLa cells exposed to doxorubicin.,-34.75,0.8,sequencevariant
"The G145R sequence variant in the human TP53 gene’s DNA-binding domain, a missense change that substitutes glycine for arginine at position‑145, was found to drastically diminish p53’s transcriptional activation of the PUMA promoter, thereby contributing to chemoresistance in a panel of HeLa, A549, and MCF‑7 cell lines treated with doxorubicin.",-58.0,0.8,sequencevariant
"The CRISPR‑Cas9 editing of the CYP2D6 gene in HepG2 cells introduced a Val158Met sequence variant that reduced enzyme activity by approximately forty‑percent, demonstrating a clear genotype‑phenotype correlation for drug metabolism.",-37.25,0.8,sequencevariant
"The A118G sequence variant in the CYP2D6 gene, a single nucleotide polymorphism resulting in an alanine-to-glycine substitution, reduces enzymatic activity and leads to altered pharmacokinetics of codeine in Homo sapiens.",-29.5,0.8,sequencevariant
"In melanoma cells, the E546K sequence variant in the BRAF protein disrupts the kinase’s regulatory domain, leading to constitutive activation of the MAPK pathway and increased resistance to vemurafenib treatment.",-28.75,0.8,sequencevariant
"In KRAS‑cancer patient cells harboring the P686fs sequence variant, the resulting truncated protein fails to recruit downstream effector proteins, thereby abrogating the canonical MAPK signaling cascade and reducing tumor cell proliferation.",-43.5,0.8,sequencevariant
"In patients with the TP53 sequence variant G145R, the aspartic acid to histidine substitution at amino acid position ​401 in the same gene was associated with increased p53 transcriptional activity and higher apoptosis rates in HeLa cells.",-46.75,0.8,sequencevariant
"In HepG2 cells, the C-1228T sequence variant in the CYP2D6 promoter region decreases mRNA stability, thereby attenuating enzyme expression and reducing the metabolic activation of the chemotherapeutic drug doxorubicin.",-35.75,0.8,sequencevariant
"A frameshift mutation P686fs in the TP53 gene was found to reduce the binding of the protein to the p21 promoter, thereby impairing cell cycle arrest in HeLa cells.",-30.75,0.8,sequencevariant
"A missense variant in the CYP2D6 gene, specifically the Val158Met (C‑1228T) sequence variant, has been shown to diminish enzymatic activity and alter the pharmacokinetics of the antipsychotic drug clozapine in patients of the Caucasian population.",-40.0,0.8,sequencevariant
"A homozygous R1306W sequence variant in the CYP1A1 gene was detected in a patient with increased susceptibility to hepatocellular carcinoma, suggesting a functional impact on xenobiotic metabolism.",-31.0,0.8,sequencevariant
"A single nucleotide polymorphism in the DRD2 gene, the Val158Met variant, is associated with altered dopamine metabolism and increased susceptibility to Parkinson’s disease in individuals of European ancestry.",-26.25,0.8,sequencevariant
"Mutation of the C‑1228T sequence variant in the CYP2D6 gene leads to a serine‑to‑glycine substitution at position&nbsp;51, reducing the enzyme’s ability to metabolize codeine into morphine.",-37.75,0.8,sequencevariant
"Mutation G145R in the HBV surface gene was found to increase viral replication and enhance resistance to interferon‑α therapy in chronically infected patients, thereby correlating with higher risk of hepatocellular carcinoma.",-42.25,0.8,sequencevariant
"Mutation analysis of the CYP2D6 gene in a cohort of African‑American patients revealed that the Val158Met variant was present in the majority of individuals who exhibited reduced clopidogrel metabolism, whereas a separate subset carried a P686fs sequence variant that was associated with significantly higher plasma levels of the drug’s active metabolite.",-66.5,0.8,sequencevariant
"Mutation c.1228T>A (C‑1228T) in the BRAF gene produces a Val‑Ile substitution at residue Ile462Val, and its presence in a metastatic melanoma cell line derived from a patient of Homo sapiens correlates with resistance to the MEK inhibitor trametinib.",-57.0,0.8,sequencevariant
"SIRT1 overexpression mitigates neurodegeneration in Parkinson’s disease patients carrying the Val158Met sequence variant, while the G145R mutation in the LRRK2 gene exacerbates alpha‑synuclein aggregation, thereby highlighting the pathogenic interplay between these sequence variants and disease phenotypes.",-51.75,0.8,sequencevariant
SNPs such as Val158Met and the serine‑to‑glycine substitution at position&nbsp;51 in catechol‑O‑methyltransferase modulate individual responses to methylphenidate treatment in patients with Attention‑Deficit/Hyperactivity Disorder.,-44.0,0.8,sequencevariant
SARS‑CoV‑2 infection in a patient with the G145R sequence variant in the spike protein was associated with enhanced viral entry and a higher risk of severe respiratory distress.,-31.25,0.8,sequencevariant
Surgical excision of a melanoma harboring the R1306W sequence variant in the BRAF gene revealed a dramatic reduction in MAPK pathway activation compared with lesions lacking this mutation.,-35.5,0.8,sequencevariant
"G145R, a single‑amino‑acid substitution in the HIV‑1 gp120 gene, was found to increase viral infectivity in primary CD4⁺ T cells from Homo sapiens donors.",-37.75,0.8,sequencevariant
"G1228T, a C‑to‑T transition at position −1228 in the promoter of CYP2D6, causes a loss of transcription factor binding and results in reduced enzyme activity that can predispose Homo sapiens carriers to altered drug metabolism.",-54.0,0.8,sequencevariant
"Glycine substitution at position‑51 in the G145R variant of the human GPCR protein is predicted to disrupt ligand binding, thereby increasing the susceptibility of patients with the E546K allele to severe drug‑induced cardiotoxicity.",-64.5,0.8,sequencevariant
"GTA‑C-1228T is a sequence variant found in the promoter of the glucocorticoid receptor gene that up‑regulates its expression in A549 cells, thereby enhancing dexamethasone‑mediated apoptosis and improving response to chemotherapy.",-61.75,0.8,sequencevariant
Sequencing of the BRCA1 gene in tumor samples from a cohort of breast cancer patients revealed a recurrent G145R sequence variant that correlated with increased tumor aggressiveness and resistance to platinum-based chemotherapy.,-33.75,0.8,sequencevariant
"Sequenced tumors revealed a G145R sequence variant in the TP53 gene, whose missense mutation is associated with reduced DNA‑binding capacity and a higher risk of colorectal cancer progression.",-45.5,0.8,sequencevariant
Sequening of the VHL gene from clear‑cell renal carcinoma cell lines revealed a serine‑to‑glycine substitution at position‑51 (c.152C>G) that correlates with increased HIF‑2α stabilization and aggressive tumor phenotype.,-61.5,0.8,sequencevariant
Sequence analysis of the BRCA1 c.68_69delAG variant revealed a P686fs frameshift that is predicted to truncate the protein and impair homologous recombination repair in HeLa cells.,-43.0,0.8,sequencevariant
"Curettage of the tumor in the A549 cell line revealed a G145R sequence variant that, by substituting glycine for arginine at position‑145, disrupted the protein's catalytic pocket and conferred resistance to the small‑molecule inhibitor gefitinib.",-57.75,0.8,sequencevariant
"C-1228T, a sequence variant located in the promoter of the TP53 gene, was found to reduce p53 transcription and thereby enhance the susceptibility of HepG2 cells to doxorubicin-induced apoptosis.",-33.25,0.8,sequencevariant
"Cytosine‑to‑thymine substitution at position C‑1228T in the MTHFR gene causes a change from methionine to isoleucine at amino acid residue Ile462Val, thereby altering folate metabolism and increasing the risk of neural tube defects in homozygous individuals.",-57.75,0.8,sequencevariant
"C‐1228T and G145R sequence variants in the GPCR gene were found to disrupt ligand binding, thereby increasing susceptibility to Parkinson’s disease in a cohort of Homo sapiens subjects.",-35.75,0.8,sequencevariant
Silencing of the TP53 gene in A549 cells carrying the BRCA1 c.68_69delAG sequence variant enhances doxorubicin‑induced apoptosis and reduces tumor growth in vivo.,-30.125,0.8,sequencevariant
Silenced expression of the E546K sequence variant in the MSH2 gene in HeLa cells was shown to increase mismatch repair deficiency and sensitize the cells to the DNA‑damaging chemotherapeutic doxorubicin.,-42.0,0.8,sequencevariant
"Silico‑generated CRISPR‑mediated editing of the TP53 gene in HCT116 cells introduced a Val158Met sequence variant, which subsequently reduced p53 transcriptional activity and increased cellular resistance to doxorubicin.",-34.0,0.8,sequencevariant
Silence in the A118G sequence variant of the dopamine D2 receptor gene is associated with heightened risk of schizophrenia in patients receiving clozapine.,-42.0,0.8,sequencevariant
Loss of the E546K sequence variant in the CYP2C9 gene was associated with a significant reduction in clopidogrel activation and a higher incidence of ischemic events in patients treated with the antiplatelet drug.,-30.75,0.8,sequencevariant
Loss‑of‑function of the BRCA1 protein caused by the BRCA1 c.68_69delAG sequence variant results in homologous recombination deficiency and increases the risk of early‑onset breast cancer in affected individuals.,-33.0,0.8,sequencevariant
Loss-of‑function of the FTO gene caused by the Val158Met sequence variant increases the risk of obesity in individuals carrying the A118G allele of the OPRM1 gene.,-34.75,0.8,sequencevariant
"Loss‐of‐function mutations such as the c.1228C>T substitution that creates the G145R variant, along with the Val158Met polymorphism in COMT, collectively impair dopamine metabolism and are associated with increased susceptibility to Parkinson’s disease in European populations.",-54.5,0.8,sequencevariant
"E546K, a missense sequence variant, was found to alter the binding affinity of the transcription factor to the promoter of the TP53 gene, thereby contributing to impaired apoptosis in A549 cells.",-33.5,0.8,sequencevariant
"E746K, a missense SequenceVariant in the CYP2D6 gene, was shown to drastically reduce enzymatic activity and alter the therapeutic response to the Chemotherapy drug doxorubicin in patients of the Homo sapiens cell line HepG2.",-48.0,0.8,sequencevariant
"Erythrocyte membrane protein β‑globin carrying the C‑1228T sequence variant, which results in a cysteine-to‑phenylalanine substitution at residue Arg1228, was found to enhance hemoglobin affinity for oxygen in patients with β‑thalassemia intermedia.",-61.75,0.8,sequencevariant
"Evolving from a P686fs sequence variant, the BRCA1 protein’s functional domains were disrupted, prompting increased recruitment of the PARP1 enzyme and heightened sensitivity to the DNA‑repair inhibitor olaparib in HeLa cells.",-62.0,0.8,sequencevariant
"Mutations such as the G145R substitution in the β‑subunit of hemoglobin, the A118G polymorphism in the CYP1A2 promoter, and the serine-to-glycine change at position‑51 of the protein phosphatase PP2A, all contribute to altered enzymatic activity and increased susceptibility to drug‑induced hepatotoxicity in patients with chronic hepatitis B.",-65.5,0.8,sequencevariant
"Mutational analysis revealed that the BRCA1 c.68_69delAG (P686fs) sequence variant in a breast cancer patient led to a truncated protein that disrupted the normal interaction with RAD51, thereby impairing homologous recombination repair.",-32.5,0.8,sequencevariant
"Mutagenesis of the A118G sequence variant in the CYP2D6 gene of *Homo sapiens* was found to reduce enzyme activity, thereby altering the pharmacokinetics of the anticancer drug doxorubicin.",-32.0,0.8,sequencevariant
"Mutating the BRCA1 sequence variant G145R in the A549 cell line reduces homologous recombination efficiency, thereby increasing sensitivity to the DNA‑damage‑inducing drug doxorubicin.",-27.875,0.8,sequencevariant
"Val158Met, a sequence variant in the COMT gene, was found to significantly reduce dopamine degradation in cultured HeLa cells and correlate with increased risk of Parkinson’s disease in a cohort of Homo sapiens subjects.",-32.0,0.8,sequencevariant
"Valine to methionine substitution at amino acid position‑158 (Val158Met) in the COMT gene causes markedly reduced enzyme activity in Homo sapiens, thereby increasing susceptibility to Parkinson’s disease and affecting response to dopamine‑modulating drugs.",-57.5,0.8,sequencevariant
"Valiant CRISPR‑engineered A549 cells harboring the BRCA1 c.68_69delAG sequence variant exhibited markedly increased sensitivity to doxorubicin, correlating with elevated p53 activation and apoptosis in comparison to wild‑type controls.",-50.25,0.8,sequencevariant
"Val145Gly in the CYP2D6 gene, a variant that replaces a valine with glycine at position‑145, alters the enzyme’s substrate specificity and increases the susceptibility of individuals carrying the allele to hepatotoxicity after exposure to the antineoplastic drug doxorubicin.",-72.5,0.8,sequencevariant
"Transplantation of a hepatocyte line carrying the E546K sequence variant into a mouse model of non‑alcoholic steatohepatitis led to a significant reduction in hepatic fibrosis, indicating that the aspartic‑acid‑to‑histidine substitution at amino‑acid position E546 may act as a protective modifier of liver disease progression.",-56.5,0.8,sequencevariant
"Translocation of the E546K sequence variant in the BRCA1 gene was found to disrupt DNA repair pathways in breast cancer cells, leading to increased sensitivity to platinum-based chemotherapy.",-39.0,0.8,sequencevariant
Transfection of HeLa cells with a plasmid encoding the G145R sequence variant of the HBV surface antigen led to a pronounced increase in viral particle secretion and heightened resistance to interferon‑α therapy.,-34.25,0.8,sequencevariant
"Transgenic mice harboring the G145R sequence variant in the *Nfkb1* gene exhibited heightened NF‑κB signaling and increased susceptibility to inflammatory bowel disease, suggesting a pathogenic role for this mutation.",-42.5,0.8,sequencevariant
"The c.1445T>G sequence variant in the *CFTR* gene, which replaces an alanine with a glycine at codon‑38, has been shown to reduce chloride channel activity and is associated with a higher risk of cystic fibrosis in *Homo sapiens* populations.",-39.25,0.8,sequencevariant
"The missense variant G1103R in the BRAF gene, which replaces glycine with arginine at codon‑1103, has been shown to increase MAPK signaling and drive resistance to vemurafenib in metastatic melanoma cells.",-35.5,0.8,sequencevariant
"The CRP rs1801184 A>G sequence variant causes a valine to methionine substitution at codon‑38, which amplifies inflammatory responses in patients with coronary artery disease.",-37.0,0.8,sequencevariant
"The G1103R sequence variant in the CFTR gene (rs1801184) was found to disrupt chloride channel gating, thereby exacerbating the phenotypic severity of cystic fibrosis in a cohort of Homo sapiens patients.",-25.625,0.8,sequencevariant
"A missense mutation in the IL6R gene (c.1445T>G, resulting in the valine to methionine substitution at position \(244\)) has been shown to enhance STAT3 phosphorylation and is strongly associated with increased risk of rheumatoid arthritis in patients carrying the rs9932581 allele.",-49.0,0.8,sequencevariant
"A recent study demonstrated that the sequence variant G1103R in the CFTR gene, together with the rs1801184 SNP in its promoter, markedly decreases chloride transport in human bronchial epithelial cells derived from the A549 cell line.",-40.5,0.8,sequencevariant
"A c.1445T>G sequence variant in the CYP2C9 gene, which causes a valine to methionine substitution at position&nbsp;244, was found to significantly alter drug‑metabolizing enzyme activity in a cohort of *Homo sapiens* patients with atypical drug responses.",-47.0,0.8,sequencevariant
"A substitution of valine to methionine at position c.244 in the *TP53* gene (c.244V> M) was identified in a patient with a severe form of breast cancer, suggesting that this sequence variant may contribute to disease progression.",-50.5,0.8,sequencevariant
Alteration of the G1103R sequence variant in the TP53 gene leads to a valine-to-methionine substitution at position c.1445T > G that increases susceptibility to carcinogenesis in Homo sapiens.,-46.75,0.8,sequencevariant
Alterations such as the IVS16+1G>A splice-site variant and the c.1445T>G missense mutation in the APC gene have been found to increase colorectal cancer susceptibility in individuals carrying the rs9932581 allele.,-35.5,0.8,sequencevariant
"Altered expression of the transcription factor SP1 was observed in HepG2 cells harboring the c.1445T>G sequence variant, which results in a valine-to-methionine substitution at residue position A244 and is associated with increased hepatocellular carcinoma risk.",-60.0,0.8,sequencevariant
"Altering the valine [V] to methionine [M] substitution at position **244** in the **TP53** gene (c.732T>G) leads to a reduced p53 DNA‑binding activity, thereby increasing susceptibility to **colorectal cancer** in **Homo sapiens**.",-52.25,0.8,sequencevariant
"Patients carrying the c.1445T>G sequence variant in the CYP2D6 gene displayed a significant decrease in the metabolic rate of the anti‑epileptic drug phenytoin, confirming the pathogenic role of the V244M substitution in drug‑resistance phenotypes.",-47.75,0.8,sequencevariant
"Patients harboring the rs1801184 G> A polymorphism in the CYP2D6 promoter showed increased clearance of clopidogrel, whereas carriers of the valine-to-methionine substitution at position **244** in the ABCB1 transporter exhibited reduced drug absorption and higher plasma concentrations.",-59.25,0.8,sequencevariant
Patients treated with the G1103R variant of the ABC transporter gene exhibited markedly reduced drug efflux and increased susceptibility to nephrotoxicity.,-29.375,0.8,sequencevariant
"Patients with the G1103R sequence variant in the ABCB1 gene exhibit markedly increased vincristine clearance, correlating with the observed reduction in neurotoxic symptoms during treatment.",-34.0,0.8,sequencevariant
"In HepG2 cells, the c.1445T > G sequence variant causes a Val244Met substitution that markedly increases CYP2E1 expression and enhances ethanol-mediated oxidative stress.",-33.75,0.8,sequencevariant
"In A549 cells, the rs1801184 polymorphism (c.1445T>G) in the CYP2D6 gene was shown to increase the expression of the enzyme, thereby enhancing the metabolism of the chemotherapeutic drug doxorubicin and reducing its cytotoxicity.",-29.75,0.8,sequencevariant
"In H. sapiens, the G1103R sequence variant in the CYP2D6 gene, encoded by rs1801184, reduces enzymatic activity and increases susceptibility to drug-induced hepatotoxicity.",-26.5,0.8,sequencevariant
"In the A549 cell line, a c.1445T>G sequence variant in the CYP2D6 gene (rs1801184) was shown to reduce enzyme activity, thereby increasing the risk of hepatotoxicity when treated with the chemotherapeutic agent doxorubicin.",-27.25,0.8,sequencevariant
Mutations such as the G1103R variant and the c.1445T>G substitution in the CFTR gene are strongly associated with cystic fibrosis phenotypes and frequently co‑occur with the rs9932581 polymorphism that modulates disease severity.,-34.75,0.8,sequencevariant
"Mutational analysis revealed that the IVS16+1G>A splice‑site variant, together with the valine-to-methionine substitution at position p.V244M, impairs the splicing of the gene product, leading to aberrant transcripts that correlate with increased susceptibility to the observed disease phenotype.",-57.5,0.8,sequencevariant
"Mutagenesis of the G1103R variant in the TGF‑β receptor gene, which replaces glycine with arginine at position G1103, was shown to increase phosphorylation of SMAD2 in A549 cells, leading to enhanced apoptosis and reduced proliferation in response to doxorubicin.",-60.25,0.8,sequencevariant
"Mutating the GAT codon to GGT at position IVS16+1G > A in the CFTR gene reduces chloride channel function, and this variant has been associated with severe cystic fibrosis phenotypes in patients of European descent.",-54.75,0.8,sequencevariant
"Mutation of the G1103R variant in the insulin receptor gene leads to a valine-to-methionine substitution at position IVS16+1G > A, which is associated with severe insulin resistance in Homo sapiens.",-37.75,0.8,sequencevariant
"Mutation c.1445T>G in the PKCα gene, which replaces a threonine with alanine at codon‑1445, is associated with a heightened risk of steroid‑independent nephrotoxicity in patients receiving high‑dose cisplatin therapy.",-56.25,0.8,sequencevariant
"Mutation rs1801184 in the BRCA1 gene, a G to A transition at position c.1445T>G, causes a valine to methionine substitution at residue V244, which is associated with a higher risk of breast cancer in European populations.",-43.75,0.8,sequencevariant
"Mutation in the CYP2D6 gene, specifically the c.1445T>G variant (Ser1245Cys), has been shown to alter the enzyme’s activity, thereby influencing the metabolism of the antidepressant fluvoxamine in patients of African descent.",-43.5,0.8,sequencevariant
"Biophysical studies revealed that the c.1445T>G sequence variant in the TP53 gene, which results in a valine-to-methionine substitution at position p.244, disrupts the DNA‑binding domain and diminishes the transcriptional activation of p21, thereby enhancing cellular proliferation in A549 cells.",-59.0,0.8,sequencevariant
"Biochemical assays revealed that the IVS16+1G>A splice-site variant in the TP53 gene leads to exon skipping and a loss of p53 function, thereby enhancing the growth of A549 cells treated with doxorubicin.",-43.25,0.8,sequencevariant
"Biologic studies revealed that the rs1801184 variant, a G to A substitution at codon‑38, significantly increases TNF‑α expression in macrophages isolated from a human cell line, thereby elevating inflammation in patients carrying this allele.",-69.0,0.8,sequencevariant
"Biomarker discovery revealed that the rs1801184 polymorphism, a G1103R substitution in the coding region of the CYP2D6 gene, significantly correlates with altered enzyme activity and increased risk of severe doxorubicin-induced cardiotoxicity in patients with breast cancer.",-54.0,0.8,sequencevariant
"Transcriptional analysis of the BRCA1 c.1445T>G sequence variant revealed that the resulting Ser1245Cys alteration disrupts DNA repair function, thereby increasing breast cancer susceptibility in individuals carrying the rs1801184 allele.",-39.5,0.8,sequencevariant
"Transfection of A549 cells with a CRISPR‑edited sequence variant, c.1445T>G in the CYP2C9 gene, resulted in a valine to methionine substitution at position I244 that significantly reduced the catalytic activity of the resulting protein, suggesting a pathogenic mechanism underlying the observed drug‑induced hepatotoxicity in Homo sapiens patients carrying the rs1801184 allele.",-73.5,0.8,sequencevariant
Transgenic mice carrying the BRCA1 c.1445T > G sequence variant exhibit increased tumor latency and reduced DNA repair capacity compared with wild‑type controls.,-31.625,0.8,sequencevariant
"Transplant‑derived fibroblasts carrying the IVS16+1G> A splicing variant of the COL1A1 gene exhibit increased collagen secretion, contributing to the fibrotic phenotype observed in patients with the G1103R mutation.",-48.0,0.8,sequencevariant
"c.^1445T>G in the CYP2C9 gene, a rs1801184 single‑nucleotide polymorphism, was found to reduce warfarin clearance in patients of the Han Chinese population.",-43.75,0.8,sequencevariant
"c.*1445T>G* mutation in the *KRAS* gene causes a valine-to-methionine substitution at position **244**, which is associated with increased resistance to the chemotherapeutic agent *sorafenib* in *Homo sapiens* tumor cell lines.",-50.0,0.8,sequencevariant
"cDNA sequencing of a melanoma biopsy revealed a G1103R sequence variant in the BRAF gene, correlating with increased MAPK pathway activation and resistance to vemurafenib.",-31.375,0.8,sequencevariant
"c.G1445T (rs9932581) was found to disrupt a splice‑donor site in the exon‑intron boundary of the BRCA1 gene, resulting in a loss of the normal protein and increased susceptibility to breast cancer in a cohort of Caucasian and Asian patients.",-71.0,0.8,sequencevariant
"Ser1245Cys in TP53, a G1103R variant in BRCA1, and the IVS16+1G>A splice site mutation collectively alter transcription factor binding, leading to increased risk of breast cancer in Homo sapiens.",-41.0,0.8,sequencevariant
"Serine1245Cys (c.3714T>C) in the MAP2K1 gene, a variant previously reported as rs1801184, was found to enhance phosphorylation of downstream ERK1/2 in cultured A549 cells, suggesting a functional impact on the MAPK signaling pathway.",-52.5,0.8,sequencevariant
"Ser1296Cys, a sequence variant in the CYP3A5 gene, was found to significantly increase the risk of tacrolimus toxicity in a cohort of HLA‑matched kidney transplant recipients.",-45.5,0.8,sequencevariant
"Ser-1245-Cys mutation in the HLA‑DQA1 gene (c.3727G>T, rs1801184) is associated with increased risk of rheumatoid arthritis in European populations.",-46.75,0.8,sequencevariant
Evidence indicates that the G1103R sequence variant in the ATP7B gene alters copper transport and is associated with a more severe phenotype of Wilson disease in patients of European ancestry.,-31.0,0.8,sequencevariant
"Evidence from a cohort of Japanese patients shows that the c.1445T>G sequence variant, which results in a valine-to-methionine substitution at position&nbsp;244 of the CYP2C9 protein, is associated with significantly reduced pharmacokinetic clearance of warfarin compared with the wild‑type allele.",-52.5,0.8,sequencevariant
"Evidence shows that the G1103R sequence variant in the CYP2C9 gene, represented as c.3307G>C, alters drug metabolism and is strongly associated with altered clopidogrel response in individuals of European ancestry.",-47.0,0.8,sequencevariant
"Evidence that the c.1445T>G sequence variant in the CYP2C9 gene, which causes a valine to methionine substitution at position Gln38, is associated with altered metabolism of warfarin in patients with rs1801184 and rs9932581 haplotypes, suggests that these polymorphisms jointly influence drug response.",-61.5,0.8,sequencevariant
"Cellular assays revealed that the sequence variant rs1801184 in the CYP2C9 gene, which causes a valine to methionine substitution at position V244M, dramatically reduces the enzymatic activity of the protein, thereby compromising the metabolism of warfarin in patients of the *Homo sapiens* cohort.",-57.25,0.8,sequencevariant
"Cell line A549 harboring the c.1445T>G sequence variant, which results in a valine-to-methionine substitution at position&nbsp;244, shows reduced sensitivity to the chemotherapeutic agent doxorubicin compared with the wild‑type line.",-44.25,0.8,sequencevariant
"Cell‑line SK‑MEL‑28 carrying the rs1801184 variant in the BRAF gene exhibited increased phosphorylation of MEK, confirming that the Ser1245Cys substitution modulates MAPK signaling.",-45.75,0.8,sequencevariant
Cell-based assays revealed that the G1103R sequence variant in the ABC transporter gene reduces drug efflux activity and confers increased sensitivity to the chemotherapeutic agent doxorubicin in HeLa cells.,-32.25,0.8,sequencevariant
"Homozygous rs1801184 in the CYP2C9 gene, a valine-to-methionine substitution at position V244M, was associated with altered clopidogrel metabolism in a cohort of Homo sapiens patients suffering from ischemic stroke.",-43.75,0.8,sequencevariant
"HepG2 cells carrying the rs1801184 polymorphism exhibit increased transcription of CYP2D6, and the Ser1245Cys variant in the same gene is associated with altered drug metabolism in hepatocytes.",-39.5,0.8,sequencevariant
"Heterozygosity for the rs1801184 SNP, which causes a Val244Met amino‑acid substitution, is associated with increased risk of Parkinson’s disease in patients carrying the G1103R variant.",-36.0,0.8,sequencevariant
"Haplotype analysis of the BRCA1 c.1445T>G variant, which causes a Ser1245Cys substitution, revealed that carriers of rs1801184 exhibit a significantly higher risk of triple‑negative breast cancer compared with individuals harboring the wild‑type allele.",-36.5,0.8,sequencevariant
"Insertion of the T nucleotide at position −511 in the IL1B promoter (C allele at −511) in homozygous E. coli-derived plasmids leads to a frameshift mutation predicted from codon‑219, thereby causing a lysine to glutamic acid substitution that disrupts the transcriptional regulatory domain of the cytokine gene.",-66.5,0.8,sequencevariant
"Insertion/deletion of the T nucleotide at codon‑219 in the IL‑10 promoter (rs11798018) causes a lysine‑to‑glutamic‑acid substitution that reduces transcriptional activity, thereby increasing susceptibility to inflammatory disease in Homo sapiens.",-39.75,0.8,sequencevariant
"Insertion/Deletion of the T nucleotide at codon‑219 in the IL10 promoter, creating the rs11798018 variant, results in a frameshift that replaces lysine with glutamic acid and downregulates expression of the anti‑inflammatory cytokine in A549 cells.",-51.25,0.8,sequencevariant
"Insertion at position −511 of the IL10 promoter (C allele) together with the rs11798018 T nucleotide deletion, which predicts a frameshift mutation from codon‐219, has been shown to decrease IL‑10 secretion in a human monocytic cell line (THP‑1).",-58.0,0.8,sequencevariant
"The rs11798018 insertion/deletion in the promoter region, which replaces the C allele at -511 with a T nucleotide deletion predicting a frameshift mutation from codon‑219, was found to correlate with a lysine‑by‑glutamic acid substitution in the protein product of the TP53 gene in A549 cells.",-43.0,0.8,sequencevariant
"The insertion of a T nucleotide at position −511 in the IL-6 promoter creates a C allele that is associated with a frameshift mutation from codon‑219, leading to a lysine-to-glutamic‑acid substitution in the resultant protein.",-46.75,0.8,sequencevariant
"The p.Val204Asp/p.Asp70Gly‑p.Ala539Thr polymorphism, a complex sequence variant comprising a single‑nucleotide substitution and a small insertion, was found to alter the promoter activity of the TNF‑α gene, thereby increasing C allele frequency at the -511 position and elevating the risk of inflammatory bowel disease in patients with the rs11798018 genotype.",-58.0,0.8,sequencevariant
The CRISPR/Cas9‑generated p.C313delT variant in the TP53 gene of HeLa cells caused a frameshift that abolished p53 transcriptional activity and increased cellular sensitivity to doxorubicin.,-36.5,0.8,sequencevariant
"Frameshift mutations such as the T nucleotide deletion predicting a frameshift from codon‑219, the insertions/deletions of p.Val204Asp/p.Asp70Gly-p.Ala539Thr, and the rs11798018 polymorphism in the promoter region, collectively alter the expression of the TP53 gene in E. coli‑derived plasmid constructs and may contribute to carcinogenesis in HeLa cells.",-77.5,0.8,sequencevariant
"Frameshifts caused by the T nucleotide deletion at codon‑219 predict a lysine‑by‑glutamic‑acid variant, and the rs11798018 insertion/deletion in the promoter region of the IL‑6 gene has been linked to increased disease severity in patients with inflammatory bowel disease.",-59.75,0.8,sequencevariant
"Frameship deletion of T at codon **219** in the *TP53* gene (p.219delT) generates a frameshift that replaces lysine with glutamic acid, profoundly disrupting the p53 DNA‑binding domain and abolishing tumor‑suppressive activity in **Homo sapiens** cells.",-68.0,0.8,sequencevariant
Frames‑shift due to the T nucleotide deletion at codon (219) leads to a lysine–glutamic acid substitution in the protein encoded by the gene harboring the rs11798018 variant.,-53.25,0.8,sequencevariant
"A homozygous T nucleotide deletion at codon‐219 in the IL‑6 promoter, which predicts a frameshift mutation from codon‑219, was found to be associated with the C allele at -511 and the rs11798018 variant in patients with severe inflammatory bowel disease.",-56.25,0.8,sequencevariant
"A p.313delT insertion/deletion in the promoter region of IL6, accompanied by the C allele at -511, produces a significant increase in transcriptional activity and was linked to higher serum IL‑6 levels in patients with Crohn’s disease.",-45.75,0.8,sequencevariant
"A deletion of a T nucleotide at position c.219 (313delT) in the CYP1A1 gene, which introduces a frameshift and replaces a lysine with glutamic acid, was found to increase susceptibility to benzene‑induced leukemia in a cohort of *Homo sapiens* exposed to industrial solvents.",-50.25,0.8,sequencevariant
A missense sequence variant that substitutes lysine for glutamic acid at position p.K200E in the IL-6 receptor gene was found to be associated with elevated inflammatory markers in patients with rheumatoid arthritis.,-47.0,0.8,sequencevariant
"In the A549 CellLine, a T nucleotide deletion at position c.219 predicted a frameshift mutation resulting in a lysine replaced by glutamic acid, which was confirmed by sequencing the BRCA1 c.68_69delAG variant.",-33.5,0.8,sequencevariant
"In our cohort of chronic myeloid leukemia patients, a novel p.Val204Asp/p.Asp70Gly-p.Ala539Thr sequence variant was identified in the BCR-ABL1 gene, and its coexistence with the T nucleotide deletion that predicts a frameshift mutation from codon _219 was associated with accelerated disease progression and poor response to imatinib therapy.",-62.5,0.8,sequencevariant
"In colorectal cancer cells, the T nucleotide deletion at codon (219) causes a frameshift that substitutes lysine for glutamic acid, leading to a sequence variant that dramatically increases p.Val204Asp/p.Asp70Gly-p.Ala539Thr protein misfolding and enhances tumor growth.",-56.25,0.8,sequencevariant
"In HeLa cells, the T nucleotide deletion at position c.219, which predicts a frameshift mutation resulting in lysine being replaced by glutamic acid, markedly increases the expression of the TP53 gene product and enhances the cells’ sensitivity to doxorubicin treatment.",-35.5,0.8,sequencevariant
"Homozygous rs11798018, a T nucleotide deletion that predicts a frameshift mutation from codon‑219, was identified in an Asn‑type transfectant, where the resulting lysine‑by‑glutamic acid substitution in the catalytic domain of the protein was linked to increased apoptosis in HeLa cells treated with doxorubicin.",-53.75,0.8,sequencevariant
"Haploinsufficiency of the p.Val204Asp variant in the IL-6 receptor gene, a c.612G>A substitution, results in a lysine-to-glutamic‑acid change that impairs ligand binding and predisposes Homo sapiens patients to severe inflammatory disease.",-58.0,0.8,sequencevariant
"HepG2 cells transfected with the rs11798018 sequence variant exhibited a lysine-to-glutamic acid substitution at position E327 that disrupted the binding of the transcription factor NF‑κB, while the T‑nucleotide deletion at codon‑219 in the same construct predicted a frameshift mutation that further attenuated cell‑cycle progression.",-80.0,0.8,sequencevariant
"Heterozygous patients with the p.Val204Asp/p.Asp70Gly-p.Ala539Thr sequence variant exhibited a pronounced reduction in CYP2C9 enzymatic activity, correlating with increased risk of adverse reactions to warfarin therapy.",-42.5,0.8,sequencevariant
"CRISPR‑mediated editing of the TP53 gene in H1299 cells introduced a p.Gly245Val/rs11798018 substitution that, together with a neighboring T nucleotide deletion predicting a frameshift mutation from codon‑219, resulted in loss of p53‑dependent apoptosis and enhanced colony‑forming ability.",-61.5,0.8,sequencevariant
"CRISP‑Cas9 editing of the TP53 gene in H1299 cells introduced a T nucleotide deletion at codon‑219, causing a frameshift mutation that converts lysine to glutamic acid and abolishes the p53 DNA‑binding domain, thereby compromising the cell line’s tumor‑suppression capability.",-56.5,0.8,sequencevariant
"CRLF2‑associated insertion/deletion in the X‑linked gene, accompanied by a T nucleotide deletion at codon‑219 that predicts a frameshift mutation, was detected in a patient with a severe form of X‑linked lymphoproliferative disease.",-63.75,0.8,sequencevariant
"CRIM1 rs11798018 insertion/deletion in the promoter region, causing a C allele at –511 to be replaced by a T nucleotide, alters transcription factor binding and predicts a frameshift mutation from codon‑219, thereby reducing the protein’s ability to regulate extracellular matrix remodeling in breast carcinoma cells.",-64.0,0.8,sequencevariant
"Deletion of a single cytosine at position c.219 in the CYP2D6 gene causes a frameshift that converts the codon from lysine to glutamic acid and predicts a truncated, non‑functional enzyme in patients carrying the rs11798018 variant.",-44.75,0.8,sequencevariant
Deletion mutation of the IL10 promoter (T-1081C) in a BCL-2 gene transfectant reduces apoptosis in A549 cells through up‑regulation of the p53 pathway.,-63.75,0.8,sequencevariant
Deletion events such as the T nucleotide deletion at codon position T219 leading to a frameshift mutation and the longer‐form insertion of rs11798018 in the promoter region of IL6 are associated with the C allele at –511 and the higher prevalence of the inflammatory phenotype in Homo sapiens.,-102.5,0.8,sequencevariant
"Deletion at the T nucleotide position, which predicts a frameshift mutation from codon‑219, together with the p.Val204Asp/p.Asp70Gly-p.Ala539Thr sequence variant was found to increase susceptibility to autoimmune disease in Homo sapiens.",-54.5,0.8,sequencevariant
"Loss of the T nucleotide deletion in the TP53 gene (c.219delT) causes a frameshift that replaces lysine with glutamic acid at position p.219, a variant that has been associated with increased susceptibility to osteosarcoma in Homo sapiens.",-47.75,0.8,sequencevariant
"Loss-of-function mutations in the TP53 gene, such as the p.Trp53 p.Val204Asp variant and the frameshift-inducing T nucleotide deletion at codon‑219, are frequently detected in HeLa cells, where they disrupt the p53‑dependent DNA‑damage response and contribute to unchecked cell proliferation.",-71.0,0.8,sequencevariant
"Loss‑of‑function of the BRCA1 gene caused by a p.Val204Asp substitution in exon‑8, a C allele at –511 in the promoter region, and a T nucleotide deletion predicting a frameshift from codon‑219, leads to increased DNA repair deficiency and susceptibility to triple‑negative breast cancer in Homo sapiens.",-79.5,0.8,sequencevariant
"Loss‐of‑function of the BRCA1 c.68_69delAG sequence variant, a deletion in the DNA repair gene, is associated with increased breast cancer risk in patients homozygous for the variant.",-45.25,0.8,sequencevariant
"rs11798018, a C allele at -511 insertion/deletion in the promoter, was found to cause a threonine for lysine substitution that promotes a frameshift mutation from codon ​219​, leading to a lysine by glutamic acid change in the disease‑associated protein.",-51.75,0.8,sequencevariant
"rs11302018 causes a T nucleotide deletion that predicts a frameshift mutation from codon219, altering the lysine residue to glutamic acid and abolishing the C allele at –511 in the promoter region of TP53.",-61.75,0.8,sequencevariant
"rs11593354, a C allele at –511 in the IL‑6 promoter, was found to up‑regulate IL‑6 mRNA expression in a human macrophage cell line, indicating that this sequence variant may drive inflammatory responses in autoimmune disease.",-63.25,0.8,sequencevariant
"rs11691758 insertion/deletion in the promoter region of the IL6 gene causes a C allele at -511 to be replaced by G, leading to a threonine for lysine amino‑acid substitution that reduces transcriptional activity in patients with rheumatoid arthritis.",-62.5,0.8,sequencevariant
"Polymorphism rs11798018, a T nucleotide deletion that predicts a frameshift mutation from codon‑219, was found to replace lysine by glutamic acid in the CYP2C9 gene of a patient with severe drug‑induced hepatotoxicity.",-38.25,0.8,sequencevariant
"Polyclonal selection of a T nucleotide deletion at codon‑219 in the BRAF gene (p.Val204Asp/p.Asp70Gly‑p.Ala539Thr) produced a frameshift that abrogated kinase activity, illustrating how a single insertion/deletion can convert a wild‑type protein into a nonfunctional variant.",-74.0,0.8,sequencevariant
"Poly‑T insertions at position −511 in the IL‑10 promoter create a C allele that increases transcription in A549 cells, while the rs11798018 deletion of T at codon‑219 in TP53 causes a frameshift that abolishes the protein’s tumor‑suppressive activity.",-80.5,0.8,sequencevariant
"Polynucleotide sequence analysis of the CYP2B6 promoter revealed that the rs11798018 insertion/deletion, characterized by a T nucleotide deletion that predicts a frameshift mutation from codon‑219, is associated with reduced expression of the enzyme in individuals carrying the C allele at –511.",-58.75,0.8,sequencevariant
"Mutation of the IL10 promoter by insertion/deletion of the C allele at –511 alters transcriptional regulation, thereby increasing the risk of autoimmune disease in individuals homozygous for the rs11798018 variant.",-35.75,0.8,sequencevariant
"Mutation analysis revealed that a T nucleotide deletion at codon position \(219\) in the TP53 gene, annotated as a \(\text{313delT}\) sequence variant, predicts a frameshift leading to the substitution of lysine by glutamic acid in the DNA‑binding domain of the protein.",-63.0,0.8,sequencevariant
"Mutation screening of the CYP2C19 promoter revealed that the C allele at −511 creates an additional transcription factor binding site, while a T nucleotide deletion at position c.219 predicts a frameshift mutation that converts lysine to glutamic acid in the resulting protein.",-47.0,0.8,sequencevariant
"Mutation rs11798018, a T nucleotide deletion that predicts a frameshift mutation from codon‑219, was identified in the promoter of IL-10 and is associated with decreased transcriptional activity and increased susceptibility to inflammatory disease in individuals carrying the C allele at -511.",-52.5,0.8,sequencevariant
"TRIAL analysis of an rs11798018 polymorphism revealed that the T nucleotide deletion in the promoter region, which predicts a frameshift mutation from codon‑219 and a lysine-to-glutamic‑acid substitution, significantly reduces NF‑κB binding and correlates with increased susceptibility to inflammatory bowel disease in a cohort of Homo sapiens.",-64.5,0.8,sequencevariant
"TRAF6 c.313delT causes a frameshift that replaces the lysine at codon‑219 with threonine, a sequence variant predicted to destabilize the receptor‑interacting domain and impair NF‑κB activation in HeLa cells.",-52.25,0.8,sequencevariant
"TRRAP promoter mutation, a C allele at -511 insertion/deletion, was found to enhance TP53 transcriptional activity in HeLa cells and correlate with increased p.Val204Asp sequence variant prevalence in E. coli strains.",-60.25,0.8,sequencevariant
"TRUNCATION of the TP53 coding sequence by a T‑nucleotide deletion, which predicts a frameshift mutation from codon219, is frequently observed in patient samples and correlates with increased expression of the p53‑dependent apoptosis marker BAX in HeLa cells.",-69.5,0.8,sequencevariant
"Lysine by glutamic acid substitution in the NF‑κB binding domain of the TP53 gene, a sequence variant identified by rs11798018, disrupts DNA‑binding affinity and predicts a loss‑of‑function phenotype in cultured A549 cells.",-46.25,0.8,sequencevariant
"Lack of the insertion/deletion polymorphism (313delT) in the promoter region of the IL10 gene, which replaces lysine with glutamic acid at residue -511, is associated with reduced anti‑inflammatory cytokine production in patients with chronic autoimmune disease.",-57.75,0.8,sequencevariant
"Lung cancer cell line A549 carrying the BRCA1 c.313delT insertion/deletion mutation exhibited markedly reduced response to the PARP inhibitor olaparib, suggesting the frameshift variant impairs DNA repair signaling.",-43.0,0.8,sequencevariant
"LncRNA‑mediated down‑regulation of TP53 in A549 cells carrying the BRCA1 c.68_69delAG sequence variant induces a G1‑arrest and augments sensitivity to doxorubicin, thereby illustrating how a single nucleotide deletion can modulate drug response through transcriptional repression of a tumor‑suppressor gene.",-65.0,0.8,sequencevariant
"The D542A sequence variant in the TP53 gene, originally described as a threonine to alanine substitution, has been shown to impair DNA binding and increase susceptibility to colorectal carcinoma in Homo sapiens individuals carrying the rs1639679 allele.",-30.25,0.8,sequencevariant
"The p.W492X sequence variant in TP53, identified by g.3512C>A, is predicted to truncate the protein and is strongly associated with early onset colorectal cancer in patients homozygous for rs1639679.",-24.5,0.8,sequencevariant
"The BRCA1 p.W492X sequence variant (c.1474G>A) is predicted to truncate the protein and was found to co‑occur with the rs2073162‑A allele, suggesting a potential compound effect on breast cancer susceptibility.",-29.875,0.8,sequencevariant
"The missense SequenceVariant D542A, a threonine to alanine substitution in the TP53 gene, has been found to correlate with increased apoptosis in H1299 CellLine cells treated with doxorubicin, indicating a potential therapeutic target for enhancing chemotherapeutic efficacy.",-43.75,0.8,sequencevariant
"In vitro studies of the BRCA1 c.68_69delAG sequence variant, designated D542A, revealed that the threonine to alanine substitution at codon M235T causes a drastic reduction in RAD51 binding, thereby impairing homologous recombination repair in HeLa cells.",-48.5,0.8,sequencevariant
"In A549 cells, the p.W492X sequence variant of the TP53 gene was found to abolish the DNA‑binding domain, thereby abolishing its tumor‑suppressive activity.",-29.625,0.8,sequencevariant
"In the A549 cell line, the BRCA1 variant p.W492X (c.1481G>A) was shown to increase sensitivity to the DNA‑damaging agent doxorubicin, a relationship that was validated by CRISPR‑mediated introduction of the same sequence variant into HeLa cells and subsequent measurement of apoptosis via caspase‑3 activation.",-50.75,0.8,sequencevariant
"In HepG2 cells, the BRCA1 SequenceVariant p.W492X, which results from a threonine to alanine change at codon W492, reduces DNA repair capacity and increases sensitivity to the DNA‑damaging agent doxorubicin.",-32.5,0.8,sequencevariant
"A missense SequenceVariant, g.3512C>A, predicted to substitute a threonine for alanine at position D542 in the TP53 gene, correlates with increased expression of the pro‑apoptotic protein BAX in HeLa CellLine cultures and may contribute to the susceptibility of Homo sapiens to colorectal cancer.",-51.75,0.8,sequencevariant
"A loss‑of‑function sequence variant, p.W492X, identified in the TP53 gene of a Homo sapiens tumor cell line, was shown to dramatically reduce DNA‑binding affinity and enhance apoptosis in the A549 cell line treated with doxorubicin.",-42.75,0.8,sequencevariant
"A single nucleotide change g.3512C>A in the TP53 gene creates a sequence variant that converts a threonine to alanine at codon D542, thereby reducing the protein’s ability to bind DNA and increasing susceptibility to colorectal cancer.",-37.5,0.8,sequencevariant
"A A549 cell line harbouring the sequence variant D542A in the EGFR gene exhibits markedly increased sensitivity to the tyrosine‑kinase inhibitor gefitinib, suggesting a functional impact of the threonine‑to‑alanine substitution on drug response.",-34.0,0.8,sequencevariant
Loss of function of the BRCA1 sequence variant p.W492X in a triple‑negative breast cancer cell line (MDA‑MB‑231) leads to increased homologous recombination repair deficiency and heightened sensitivity to the PARP inhibitor olaparib.,-30.375,0.8,sequencevariant
"Loss-of‑function p.W492X in the TP53 gene, identified by g.3512C>A, causes a severe reduction in p53 protein stability and enhances the risk of early‑onset breast cancer in women carrying the rs1639679 allele.",-46.25,0.8,sequencevariant
"Loss‑of‑function p.W492X in the KIF3B gene was found to drastically reduce ciliary transport, thereby exacerbating the motor deficits observed in patients carrying the rs2073162‑A variant and the D542A sequence variant.",-57.75,0.8,sequencevariant
"Loss_of_function_variant p.W492X in the BRCA1 gene, identified by g.3512C>A sequencing, reduces homologous recombination efficiency and increases breast cancer susceptibility in Homo sapiens.",-39.25,0.8,sequencevariant
"Sequencing of a cohort of colorectal carcinoma patients revealed that the sequence variant p.W492X, a nonsense mutation in the APC gene, was present in a subset of individuals who also carried the germline variant rs1639679, correlating with earlier tumor onset and increased microsatellite instability.",-48.25,0.8,sequencevariant
"Sequenced g.3512C>A in the promoter of CYP2D6 revealed a novel -3170G>A variant that increases transcriptional activity, explaining the threonine‑to‑alanine A442V polymorphism’s association with altered drug metabolism.",-45.5,0.8,sequencevariant
"Sequiential analysis of a colorectal carcinoma sample revealed a BRCA1 c.68_69delAG sequence variant that, together with a co‑occurring p.W492X mutation in TP53, was associated with reduced tumor suppressor function and heightened chemoresistance.",-59.75,0.8,sequencevariant
Sequencediagnostic panels that detect the BRCA1 p.W492X sequencevariant and the TP53 rs1639679 polymorphism can predict chemotherapeutic response in patients with breast cancer.,-51.75,0.8,sequencevariant
"Studies in a cohort of E. coli–derived *E. coli* strain show that the g.3512C>A sequence variant, which replaces a threonine with alanine at position D542A, leads to a significant reduction in the expression of the *ompA* gene and correlates with increased resistance to the chemical entity ciprofloxacin.",-67.0,0.8,sequencevariant
"Studies show that the rs1639679 sequence variant, a G to A substitution at position -3170 in the promoter of the CYP1A1 gene, increases susceptibility to bladder cancer in smokers.",-41.25,0.8,sequencevariant
"Studies revealed that the D542A sequence variant in the CYP2C9 gene causes a threonine to alanine substitution, leading to reduced clearance of the antidiabetic drug metformin in Homo sapiens carriers.",-36.0,0.8,sequencevariant
"Studies on the HepG2 cell line revealed that the D542A sequence variant in the CYP2D6 gene, characterized by a threonine to alanine substitution at codon‑542, reduces metabolic clearance of the chemotherapeutic agent doxorubicin compared with the wild‑type allele.",-50.75,0.8,sequencevariant
"Overexpression of the BRCA1 p.W492X SequenceVariant in the MCF-7 CellLine, identified by a g.3512C > A mutation, was associated with increased resistance to the DNA‑damaging ChemicalEntity doxorubicin and a higher rate of apoptosis induction in Human OrganismTaxon cells.",-54.75,0.8,sequencevariant
"Over a cohort of colorectal cancer patients, a g.3512C>A sequence variant in the APC gene was found to substitute a threonine for alanine at codon D542A, correlating with earlier tumor onset and higher β‑catenin accumulation.",-52.0,0.8,sequencevariant
"Over the past decade, the BRCA1 p.W492X sequence variant has been shown to truncate the protein’s C‑terminal domain, thereby abolishing its interaction with the E3 ubiquitin ligase BRCA1‑associated protein‑1 and increasing breast cancer susceptibility in individuals carrying the rs1639679 allele.",-46.0,0.8,sequencevariant
"Overgrowth of the A549 cell line after treatment with the p.W492X variant of the MYC gene, which carries the g.3512C> A mutation, led to increased expression of the insulin‑like growth factor‑1 receptor and enhanced proliferation of HeLa cells, demonstrating a sequence‑variant–mediated cross‑species oncogenic pathway.",-75.0,0.8,sequencevariant
"Homozygous g.3512C>A in the promoter of the CYP2D6 gene was found to reduce enzyme activity in a cohort of E. coli–derived plasmid constructs, whereas the missense variant p.W492X in the same locus was linked to a severe loss of function in patients with CYP2D6 deficiency.",-54.5,0.8,sequencevariant
"Haplotype analysis revealed that the rs1639679 variant in the promoter region of the HLA-DRB1 gene, coupled with the D542A sequence variant in the exonic domain, significantly increases the risk of developing autoimmune thyroiditis in individuals of European ancestry.",-49.5,0.8,sequencevariant
"HepG2 cells harboring the BRCA2 sequence variant g.3512C>A exhibit increased sensitivity to the DNA‑damaging agent doxorubicin, suggesting that this mutation may impair homologous recombination repair and enhance chemotherapeutic efficacy.",-33.25,0.8,sequencevariant
"Heterozygous g.3512C>A in the CYP2C9 gene, resulting in the A442V amino‑acid change, is associated with reduced warfarin clearance and increased bleeding risk in patients with the rs2073162‑A haplotype.",-38.5,0.8,sequencevariant
"Mutations such as p.W492X and the rs1639679 variant in the promoter region of the IL10 gene reduce its transcription, thereby contributing to the heightened inflammatory response observed in patients with Crohn’s disease.",-32.0,0.8,sequencevariant
"Mutagenic substitution g.3512C>A in the promoter region of the TP53 gene, which creates a novel transcription factor binding site, is associated with the D542A sequence variant that reduces p53 protein stability and contributes to increased susceptibility to chemotherapy‑induced apoptosis in A549 cells.",-47.25,0.8,sequencevariant
"Mutated TP53 carrying the rs1639679 sequence variant was found to enhance p53 transcriptional activity in HCT116 cells, thereby increasing apoptosis and reducing proliferation of the colorectal cancer cell line.",-48.25,0.8,sequencevariant
Mutational analysis of the BRCA1 c.68_69delAG sequence variant revealed that the resulting D542A protein fragment is associated with increased risk of breast cancer in Homo sapiens carriers of rs1639679.,-34.0,0.8,sequencevariant
"M230T, a missense SequenceVariant of the CFTR gene, was found to severely reduce chloride transport in a cultured HeLa CellLine, leading to increased intracellular calcium and triggering apoptotic pathways that mimic cystic fibrosis phenotypes in vitro.",-60.0,0.8,sequencevariant
"M235T and the missense variant rs2073162‑A in the HPRT1 gene were found to co‑occur with the −3170G > A promoter polymorphism, linking this sequence variant cluster to increased risk of Lesch‑Nyhan disease.",-53.25,0.8,sequencevariant
"Molecular modeling revealed that the BRCA1 sequence variant p.W492X, resulting from a g.3512C>A substitution, destabilizes the protein’s zinc‑finger domain and correlates with increased breast cancer risk in women carrying the rs2073162-A allele.",-33.75,0.8,sequencevariant
"Mice bearing the p.W492X sequence variant in the *Tmem43* gene exhibited increased atrial arrhythmias, confirming that this truncating mutation, detected by whole‑genome sequencing, causally disrupts cardiac ion‑channel regulation.",-57.0,0.8,sequencevariant
Gene silencing of TP53 by CRISPR-Cas9 in the A549 cell line introduced a D542A sequence variant that increased resistance to doxorubicin and was subsequently verified by Sanger sequencing to harbor a g.3512C>A mutation in the promoter region.,-43.5,0.8,sequencevariant
"Gene‑editing of the TP53 locus in HCT‑116 cells introduced a p.W492X SequenceVariant that, when combined with the D542A threonine to alanine mutation, significantly enhanced p53‑dependent apoptosis and reduced colony‑forming ability.",-45.0,0.8,sequencevariant
"Gene editing of the TP53 locus in HeLa cells revealed that the p.W492X SequenceVariant dramatically reduces p53 protein stability, leading to elevated cellular proliferation and increased sensitivity to the chemotherapeutic agent doxorubicin.",-34.75,0.8,sequencevariant
Gene amplification of the TP53 c.235T>C variant (p.M235T) in A549 cells carrying the rs2073162-A polymorphism correlates with increased resistance to doxorubicin in Homo sapiens patients.,-42.75,0.8,sequencevariant
"Mutation p.W492X in the SMAD4 gene was found to impair BMP signaling in A549 cells, leading to increased apoptosis and decreased proliferation of tumor cells.",-33.5,0.8,sequencevariant
"Mutation of the TP53 gene to the D542A sequence variant increases the binding affinity of the protein for MDM2, thereby accelerating p53 degradation and promoting the survival of HeLa cells exposed to doxorubicin.",-32.25,0.8,sequencevariant
"Mutation g.3512C>A in the BRCA1 gene’s exon‑3 was found to co‑occur with the p.W492X nonsense variant in patients whose tumor cells exhibited reduced RAD51 expression, suggesting that the combined sequence‑variant burden may impair homologous recombination repair in breast cancer.",-59.75,0.8,sequencevariant
"Mutation c.542T>G in TP53, resulting in the D542A amino‑acid substitution, was detected in the HeLa cell line and correlated with increased cisplatin resistance in Homo sapiens cells.",-33.5,0.8,sequencevariant
"Eukaryotic cells engineered with the g.3512C>A variant of the TP53 gene exhibit a p.W492X truncation that abolishes the DNA-binding domain, leading to a pronounced resistance to doxorubicin-induced apoptosis in HeLa cells.",-51.5,0.8,sequencevariant
"Epidemiologic analysis of the rs1639679 variant, a missense substitution of threonine to alanine at position D542A in the ABCD1 gene, revealed a significant association with increased susceptibility to early‑onset neurodegeneration in a cohort of Homo sapiens individuals carrying the g.3512C>A promoter polymorphism.",-50.5,0.8,sequencevariant
E14.5 embryonic fibroblasts harboring the p.W492X sequence variant in the TP53 gene display markedly reduced p53 protein stability and increased cellular apoptosis compared to wild‑type cells.,-42.0,0.8,sequencevariant
"Erythropoietin treatment in patients with the rs1639679 variant of the EPO receptor gene reduced hemoglobin levels, suggesting that this sequence variant modifies drug response in an organism taxon of Homo sapiens.",-40.0,0.8,sequencevariant
"Patients treated with the M235T variant of the ACE gene exhibited a higher incidence of hypertension, suggesting that the rs2073162-A polymorphism may modulate blood pressure regulation.",-31.875,0.8,sequencevariant
Patients carrying the sequence variant rs1639679 in the TP53 gene exhibit a higher incidence of treatment‑related cardiotoxicity when treated with doxorubicin in A549 cells.,-31.5,0.8,sequencevariant
"Patients with the BRCA1 p.W492X SequenceVariant exhibit markedly reduced homologous recombination repair activity compared with wild‑type cells, suggesting that this nonsense mutation compromises DNA repair and predisposes to breast cancer.",-38.5,0.8,sequencevariant
"Patients infected with the g.3512C > A variant of the HIV-1 pol gene exhibited markedly reduced susceptibility to the antiretroviral drug efavirenz, suggesting that this SequenceVariant confers a drug resistance phenotype in Homo sapiens.",-42.5,0.8,sequencevariant
"The R124C missense variant in TP53, annotated as rs11079788, was found to compromise DNA‑binding affinity and is strongly associated with aggressive breast cancer phenotypes in a cohort of Homo sapiens patients.",-31.875,0.8,sequencevariant
The c.475G > A substitution in the TP53 gene creates a novel p.Arg158His variant that has been associated with a higher risk of breast cancer in women carrying the rs11891426 allele.,-32.5,0.8,sequencevariant
"The novel c.475G>A sequence variant in the TP53 gene, which results in a glycine-to-aspartate substitution at codon R248, has been shown to disrupt the DNA-binding domain and is strongly associated with increased risk of sporadic breast cancer in Homo sapiens.",-41.75,0.8,sequencevariant
The heterozygous c.475G>A sequence variant in TP53 was found to increase the risk of therapy‑related acute myeloid leukemia in patients treated with doxorubicin.,-17.625,0.8,sequencevariant
"In colorectal carcinoma cells harboring the c.35delG sequence variant, the loss of the glycine codon at position Phe10 disrupts p53 binding and enhances TP53‑mediated apoptosis, a finding confirmed in HCT116 cell lines and correlated with increased sensitivity to doxorubicin treatment.",-69.5,0.8,sequencevariant
"In HeLa cells, the c.475G > A sequence variant in the TP53 gene creates a C-to-T substitution at position −31 in the promoter, leading to reduced transcriptional activity and heightened sensitivity to doxorubicin-induced apoptosis.",-26.75,0.8,sequencevariant
"In patients with a c.35delG sequence variant in the GJB2 gene, the resulting truncated connexin protein disrupts inner ear gap junction communication, causing autosomal recessive non‑syndromic hearing loss.",-27.875,0.8,sequencevariant
"In the A549 cell line, the BRCA1 c.475G>A variant (rs11891426) was shown to impair DNA repair, leading to increased genomic instability and a higher risk of therapy‑induced myelodysplasia.",-35.0,0.8,sequencevariant
Mutations such as the c.35delG and the T> C transition in the BRCA1 c.68_69delAG region were found to destabilize the DNA repair complex in breast cancer cells derived from a patient with the rs11891426 allele.,-43.75,0.8,sequencevariant
"Mutagenesis of the TP53 gene in the A549 cell line revealed a C-to-T substitution at -31 in the promoter region, which correlated with increased transcriptional activity and heightened sensitivity to doxorubicin.",-27.125,0.8,sequencevariant
"Mutational analysis of the TP53 gene in HeLa cells revealed that the c.475G>A substitution causes a p.Gly159Arg amino‑acid change, which is associated with increased transcription of the DNA‑damage‑inducible gene GADD45A and heightened sensitivity to the DNA‑crosslinker doxorubicin.",-51.5,0.8,sequencevariant
"Mutated p53 with a c.475G>A sequence variant was found to increase the transcriptional activation of the downstream gene SOD2 in HeLa cells, suggesting that the C-to-T substitution at -31 in the promoter region may modulate cellular oxidative stress responses.",-55.5,0.8,sequencevariant
"C-to-T substitution at -31 in the TP53 promoter was found to up‑regulate p53 expression, thereby enhancing the apoptotic response of A549 cells to doxorubicin treatment.",-25.75,0.8,sequencevariant
"C–T substitution at –31 in the TP53 promoter region (rs11079788) was shown to down‑regulate TP53 expression in HeLa cells, thereby increasing cellular susceptibility to doxorubicin‑induced apoptosis.",-34.5,0.8,sequencevariant
"C‑35delG in the CFTR gene, a c.35delG sequence variant, is a hallmark mutation that disrupts chloride transport in cystic fibrosis.",-35.0,0.8,sequencevariant
"Cytogenetic analysis of a colorectal carcinoma biopsy revealed a c.475G>A sequence variant in the KRAS gene, which is predicted to cause a glycine-to-aspartate substitution at codon R124C, thereby altering the protein’s GTPase activity and driving oncogenic signaling.",-51.5,0.8,sequencevariant
"A CRISPR/Cas9‐generated R124C variant in the TP53 gene, confirmed by Sanger sequencing and annotated as rs11891426, induces a p53 conformational shift that disrupts DNA binding and is associated with increased susceptibility to Li‑Fraumeni syndrome in Homo sapiens.",-45.5,0.8,sequencevariant
"A c.475G>A variant in the BRCA1 gene, characterized by a C-to-T substitution at the -31 promoter position and identified as rs11891426, is frequently found in breast cancer patients and leads to reduced transcriptional activity.",-40.25,0.8,sequencevariant
"A missense sequence variant c.475G>A in the TP53 gene, which replaces glycine with aspartate at codon R124, was found to destabilize the DNA‑binding domain and correlate with increased susceptibility to Li–Fraumeni syndrome in a cohort of Homo sapiens patients.",-37.25,0.8,sequencevariant
A patient harboring the c.35delG sequence variant in the BRCA1 gene exhibited impaired DNA repair and increased susceptibility to triple‑negative breast cancer.,-19.5,0.8,sequencevariant
"rs11891426, a C-to-T substitution at –31, alters the promoter activity of the BRCA1 gene, thereby increasing the risk of triple‑negative breast cancer in carriers.",-32.5,0.8,sequencevariant
"rs11079788, a C-to-T substitution at –31 in the promoter of the TP53 gene, was found to increase transcriptional activity and confer a higher risk of early‑onset colorectal cancer.",-32.25,0.8,sequencevariant
"rs10615874, a C-to‑T substitution at position −31 in the promoter of the CYP2C9 gene, was found to significantly increase the transcriptional activity of the enzyme in HepG2 cells, suggesting a potential pharmacogenomic relevance for warfarin dosing.",-57.25,0.8,sequencevariant
"rs1132273, a C‑to‑T substitution at position -31 in the TP53 promoter, was found to increase the risk of colorectal cancer in a cohort of individuals homozygous for the c.35delG variant in the BRCA1 gene.",-54.25,0.8,sequencevariant
"R124C, a C-to-T substitution at -31 in the TP53 promoter, is associated with reduced p53 transcriptional activity and increased susceptibility to colorectal carcinoma in individuals carrying the rs11891426 allele.",-27.25,0.8,sequencevariant
"R121C, the c.363C>G transition identified in rs11079788, is predicted to alter the binding affinity of the TP53 DNA‑binding domain and has been associated with increased susceptibility to osteosarcoma in patients treated with doxorubicin.",-53.0,0.8,sequencevariant
"RhoA (c.35delG) loss-of-function in human endothelial cells leads to impaired barrier integrity, while the adjacent c.475G > A variant in the same gene exacerbates the phenotype by destabilizing the protein's GTP‑binding domain.",-60.25,0.8,sequencevariant
"R125C and the intronic IVS51+1G>A variant in TP53 were found to cooperatively disrupt the DNA‑binding domain, leading to impaired tumor suppressor activity in colorectal carcinoma cells.",-46.0,0.8,sequencevariant
"Reduced apoptosis in HeLa cells transfected with a plasmid encoding the TP53 c.475G>A variant (rs11891426) led to increased proliferation, suggesting that this sequence variant can drive oncogenic transformation in this human cell line.",-46.0,0.8,sequencevariant
"Reduced expression of TP53 in HeLa cells harboring the BRCA1 c.68_69delAG variant, coupled with the C-to-T substitution at -31 in the TP53 promoter, led to increased apoptosis upon doxorubicin treatment.",-32.0,0.8,sequencevariant
"Reduced severity of hearing loss in patients carrying the c.35delG SequenceVariant in the GJB2 GeneOrGeneProduct was observed, while those with the rs11891426 SNP in the same gene exhibited normal thresholds, indicating a genotype-dependent phenotypic effect.",-55.0,0.8,sequencevariant
"Reduced transcription of the TP53 gene was observed in HeLa cells harboring the c.475G>T sequence variant, suggesting that this T > C mutation may impair p53-dependent apoptotic signaling.",-42.5,0.8,sequencevariant
"Expression of the BRCA1 c.35delG sequence variant in a patient’s germline DNA was confirmed by PCR and Sanger sequencing, revealing a pathogenic deletion that correlates with a high penetrance of hereditary breast and ovarian cancer.",-38.5,0.8,sequencevariant
"Expression profiling of the c.35delG sequence variant in the BRCA1 gene revealed that the resulting truncated protein impairs DNA repair activity in breast cancer cell lines, thereby increasing genomic instability and elevating the risk of tumor progression.",-47.0,0.8,sequencevariant
Expression analysis of the c.35delG SequenceVariant in the BRCA1 Gene of a Homo sapiens breast cancer sample revealed a loss of exon inclusion that correlated with reduced homologous recombination activity.,-43.5,0.8,sequencevariant
"Expression analyses revealed that the c.475G>A variant in TP53, together with the IVS51+1G>A splice-site mutation, reduces p53 stability and enhances cell cycle arrest in A549 cells.",-42.75,0.8,sequencevariant
"BRCA1 c.68_69delAG was found to create a frameshift that abolishes the normal TP53 binding site, leading to increased apoptosis in HeLa cells exposed to doxorubicin.",-32.75,0.8,sequencevariant
"BR‑C6‑1 cells harboring the c.35delG sequence variant displayed markedly reduced BCL‑2 expression and increased apoptosis upon exposure to doxorubicin, suggesting that this pathogenic mutation amplifies drug sensitivity in ovarian cancer models.",-68.0,0.8,sequencevariant
"BRCC3 c.475G>A, a C-to-T substitution at −31 in the promoter region, was shown to increase transcriptional activity in a luciferase assay, suggesting a potential pathogenic role for this sequence variant in breast cancer.",-46.75,0.8,sequencevariant
"BRD4 protein expression is markedly reduced in HeLa cells harboring the c.475G>A sequence variant, which results in a C-to-T substitution at -31 in the promoter and consequently attenuates transcription of the oncogenic gene.",-48.0,0.8,sequencevariant
"Tobacco‐induced C-to‑T substitution at −31 in the promoter of TP53, combined with the rs11891426 SNP in intron IVS51 +1G>A, leads to reduced transcriptional activity and increased susceptibility to squamous cell carcinoma in African‑American smokers.",-54.5,0.8,sequencevariant
T> C mutations at position c.475G>A in the TP53 gene have been linked to increased susceptibility to colorectal carcinoma in patients carrying the rs11891426 allele.,-31.125,0.8,sequencevariant
"T‑cell receptor β‑chain c.475G>A, a non‑synonymous sequence variant, has been shown to increase the affinity of the Vβ domain for its cognate peptide, thereby enhancing T‑cell activation in patients with autoimmune disease.",-43.5,0.8,sequencevariant
"Treated with doxorubicin, a HeLa cell line harboring the BRCA1 c.68_69delAG sequence variant showed significantly reduced viability, indicating that the mutation enhances drug sensitivity.",-36.75,0.8,sequencevariant
"Patients treated with the R124C variant of the ABC transporter gene exhibited markedly reduced drug efflux, causing increased intracellular doxorubicin accumulation and enhanced apoptosis in A549 cells.",-34.0,0.8,sequencevariant
"Patients harboring the rs11891426 variant in TP53, which results in a C‑to‑T substitution at the -31 promoter region, exhibited impaired p53 transcriptional activation, whereas the c.35delG sequence variant in CFTR was associated with a severe loss of chloride channel function in airway epithelia.",-54.25,0.8,sequencevariant
Patients carrying the c.35delG sequence variant in the GJB2 gene exhibit severe autosomal recessive deafness that is exacerbated by the nearby C-to-T substitution at –31 in the promoter region.,-28.375,0.8,sequencevariant
"Patients with the rs11891426 allele exhibited increased expression of TP53 and higher levels of apoptosis in HeLa cells treated with doxorubicin, suggesting that this sequence variant modulates drug response in cancer therapy.",-36.0,0.8,sequencevariant
"Functional analysis of the c.35delG sequence variant in the BRCA1 gene revealed that the frameshift mutation abolishes the C‑terminal BRCT domain, leading to a loss of DNA‑repair activity and increased susceptibility to breast and ovarian cancers in carriers.",-39.25,0.8,sequencevariant
"Functional studies of the R124C sequence variant in the HLA‑DQA1 gene revealed that the C‑to‑T substitution at position –31 in the promoter region markedly reduced transcriptional activity, thereby potentially contributing to the observed increased susceptibility to autoimmune thyroid disease in carriers.",-49.75,0.8,sequencevariant
"Functional validation of the c.475G > A variant in the TP53 gene revealed that the resulting amino‑acid substitution R124C alters DNA‑binding affinity, thereby compromising the tumor‑suppressive activity of the protein in HeLa cells.",-40.25,0.8,sequencevariant
"Functional characterization of the novel c.475G>A (p.Gly159Arg) variant in the BRCA1 gene revealed that the amino‑acid substitution destabilizes the RING‑domain interface, leading to reduced ubiquitin‑ligase activity and a higher risk of hereditary breast‑cancer predisposition.",-48.5,0.8,sequencevariant
"Genetic analysis of the tumor revealed a BRCA1 c.68_69delAG variant and an additional c.35delG mutation in TP53, which together caused a severe loss of function in the DNA‑repair pathway.",-43.25,0.8,sequencevariant
"Genotype‑specific analysis revealed that the rs11079788 polymorphism, a C‑to‑T substitution at position –31 in the promoter of the *TP53* gene, is associated with increased expression of the mutant protein in HeLa cells carrying the c.35delG sequence variant.",-44.5,0.8,sequencevariant
"Genomic analysis of a colorectal cancer cohort revealed that the c.35delG sequence variant in the APC gene co‑occurs with a C‑to‑T substitution at position –31 in the promoter, correlating with increased β‑catenin accumulation and tumor progression.",-36.25,0.8,sequencevariant
"Genotyping of the c.475G > A variant in the CYP2C9 gene revealed that individuals carrying the rs11891426 allele exhibited a markedly reduced enzymatic activity, correlating with increased drug‑induced hepatotoxicity in patients treated with phenacetin.",-45.75,0.8,sequencevariant
"The c.263C>T variant in the CYP2D6 gene, a sequence variant associated with altered drug metabolism, was found to be in linkage disequilibrium with the rs11079788 polymorphism, suggesting a combined effect on phenotypic drug response.",-29.0,0.8,sequencevariant
"The BRCA1 c.263C>T variant (rs11079788) was identified in a cohort of breast cancer patients, and its presence was associated with increased sensitivity to PARP inhibitors in cultured MCF‑7 cells.",-24.625,0.8,sequencevariant
"The homozygous c.263C>T sequence variant in the CYP2D6 gene (rs11079788) was found to markedly reduce enzyme activity, thereby elevating plasma concentrations of the antiepileptic drug levetiracetam in a cohort of H. sapiens patients.",-36.75,0.8,sequencevariant
"The CRISPR‑edited A549 cells bearing the c.263C>T sequence variant in the TP53 gene displayed a pronounced increase in apoptosis upon doxorubicin exposure, confirming the deleterious functional impact of this mutation.",-30.125,0.8,sequencevariant
Evidence shows that the c.263C> T sequence variant in the APC gene leads to aberrant splicing and is associated with increased risk of familial adenomatous polyposis in patients of the East Asian population.,-39.0,0.8,sequencevariant
Evidence that the BRCA1 c.263C>T variant creates a novel splice acceptor site and reduces homologous recombination repair capacity was confirmed by functional assays in A549 cells harboring the c.263C>T allele.,-39.5,0.8,sequencevariant
"Evidence indicates that the c.263C>T sequence variant (rs11079788) in the BRCA1 gene leads to a loss of the DNA repair domain, which increases the risk of triple‑negative breast cancer in carriers.",-43.0,0.8,sequencevariant
"Evidence from a cohort of *Homo sapiens* patients carrying the sequence variant c.263C>T (rs11079788) indicates that this mutation, which causes a codon‑specific N372H change, is associated with a markedly increased risk of developing type‑2 diabetes mellitus, especially when combined with the M235T polymorphism in the angiotensin‑converting enzyme gene.",-57.25,0.8,sequencevariant
"cDNA analysis of the TP53 transcript from a biopsy of a HeLa cell line revealed a BRCA1 c.263C> T sequence variant that co‑exists with a novel N372H missense mutation in the insulin gene, suggesting a possible compound effect on DNA repair and metabolic regulation in these cells.",-68.0,0.8,sequencevariant
"c.*263C>T* variants in the *APOE* gene are associated with increased risk of late‑onset Alzheimer's disease, while *rs11079788* and *7488TT* polymorphisms in *TOMM40* correlate with differential age of onset in *Homo sapiens* populations.",-61.75,0.8,sequencevariant
c.[263]C>T and rs11079788 together with the M235T variant in the AGT gene were shown to synergistically increase the risk of hypertension in a cohort of Homo sapiens subjects.,-40.5,0.8,sequencevariant
"c.m.263C>T, a pathogenic sequence variant, was identified in a patient’s TP53 gene, confirming a germline mutation that predisposes to Li–Fraumeni syndrome.",-43.0,0.8,sequencevariant
"A missense sequence variant c.263C>T in the BRCA1 gene, identified as rs11079788, was associated with an increased risk of triple‑negative breast cancer in a cohort of Homo sapiens patients.",-25.75,0.8,sequencevariant
A c.304delA variant in the APOE gene was found to correlate with an increased risk of late‑onset Alzheimer’s disease in a cohort of European ancestry.,-27.0,0.8,sequencevariant
A p53 c.263C>T sequence variant (rs11079788) in a colorectal carcinoma cell line (HCT116) was found to reduce TP53 transcriptional activity and increase cell proliferation compared to the wild‑type allele.,-31.875,0.8,sequencevariant
"A heterozygous c.263C>T variant in the CFTR gene was identified in a patient with classic cystic fibrosis, and its segregation with the rs11079788 SNP revealed a compound heterozygosity that likely explains the severe lung phenotype.",-41.25,0.8,sequencevariant
Mutation of the N372H variant (rs11079788) in the LDLR gene reduces LDL receptor binding and increases plasma LDL cholesterol levels in patients with familial hypercholesterolemia.,-32.0,0.8,sequencevariant
"Mutation c.263C>T in the ATP1A2 gene, a variant previously annotated as rs11079788, has been shown to increase susceptibility to episodic migraine in patients with a background of the E873-TAG polymorphism.",-42.5,0.8,sequencevariant
"Mutation rs11079788 in the BRCA1 gene, which causes a c.263C>T substitution resulting in a N372H amino‑acid change, is associated with increased breast cancer susceptibility in certain populations.",-30.375,0.8,sequencevariant
"Mutation analysis revealed that the c.263C>T sequence variant in TP53, which causes the N372H amino‑acid substitution, is strongly associated with increased susceptibility to colorectal cancer in patients carrying the rs11079788 genotype.",-27.625,0.8,sequencevariant
"In HepG2 cells, the c.304delA sequence variant in the promoter of the CYP1A1 gene reduces transcriptional activity, thereby diminishing the cells’ ability to metabolize the carcinogen benzo[a]pyrene.",-25.125,0.8,sequencevariant
"In patients carrying the c.263C>T variant, the altered codon at position N372H within the TP53 gene was associated with reduced p53 transcriptional activity and an increased risk of sporadic colorectal cancer.",-42.5,0.8,sequencevariant
"In HeLa cells, the BRCA1 sequence variant c.263C>T (rs11079788) was shown to reduce RAD51 binding and thereby increase sensitivity to the DNA‑damaging drug doxorubicin.",-25.0,0.8,sequencevariant
"In colorectal carcinoma samples, the c.263C>T (N372H) sequence variant in the MTHFR gene, which alters the enzyme’s catalytic efficiency, was found to be associated with increased expression of the DNA repair protein XRCC1 and a higher mutation load in TP53.",-43.25,0.8,sequencevariant
Homozygous c.263C>T (rs11079788) in the CYP1A1 promoter correlates with increased M235T allele frequency and a higher risk of non‑small cell lung cancer in smokers.,-37.75,0.8,sequencevariant
"Heterozygous carriers of the c.263C>T sequence variant in the BRCA1 gene, which results in the N372H substitution, exhibit a significantly increased risk of breast cancer compared with individuals lacking this mutation.",-31.0,0.8,sequencevariant
"Hematologic malignancies harbor the c.263C>T (N372H) variant, and in vitro studies reveal that this sequence variant confers resistance to the chemotherapeutic agent doxorubicin in the A549 cell line.",-47.0,0.8,sequencevariant
"Hepatocellular carcinoma cells with the BRCA1 c.263C> T sequence variant exhibit markedly increased expression of the DNA repair protein RAD51, thereby conferring resistance to doxorubicin treatment.",-34.75,0.8,sequencevariant
"RNA immunoprecipitation of the BRCA1 transcript revealed that the c.263C>T SequenceVariant induces a novel N372H amino‑acid change, altering splicing of exon three and reducing DNA‑damage repair capacity in MCF‑7 CellLine cells.",-69.0,0.8,sequencevariant
"RNA‑seq of peripheral blood mononuclear cells from patients carrying the BRCA1 c.263C>T sequence variant revealed a marked up‑regulation of the DNA‑damage response gene ATM, suggesting that this single‑nucleotide polymorphism (rs11079788) may alter the cellular repair capacity and predispose to breast cancer.",-44.5,0.8,sequencevariant
"RNA sequencing of the BRCA1 transcript in a breast cancer patient revealed a sequence variant c.263C>T that co‑occurs with the rs11079788 polymorphism, suggesting a potential functional impact on splicing.",-37.25,0.8,sequencevariant
"RNA editing of the TP53 c.263C>T variant (rs11079788) in E. coli‐derived A549 cells increases the N372H polymorphism, thereby enhancing M235T-mediated apoptosis and reducing tumor growth.",-52.25,0.8,sequencevariant
"Erythrocyte membrane protein α–hemoglobin stabilizing protein, harboring the sequence variant c.263C>T, was shown to attenuate the binding affinity for the anti‑apoptotic protein BCL‑XL in HeLa cells, thereby increasing cellular susceptibility to doxorubicin‑induced apoptosis.",-62.25,0.8,sequencevariant
"E873-TAG, a pathogenic sequence variant in the MT-ND1 gene, was found to disrupt complex I activity in isolated mitochondria from patients with Leigh syndrome, thereby linking the variant to the clinical phenotype of severe neurodegeneration.",-50.5,0.8,sequencevariant
"Ectopic expression of the BRCA1 c.263C>T variant (rs11079788) in the HeLa cell line reduces homologous recombination efficiency, suggesting that this sequence variant disrupts DNA repair pathways in human cancer cells.",-31.375,0.8,sequencevariant
"Epidemiological analysis revealed that the BRCA1 c.263C>T sequence variant, located at codon‑263, is strongly associated with an increased risk of breast cancer in women of European ancestry, whereas the synonymous A2803G variant in the same gene shows no significant phenotypic effect.",-49.5,0.8,sequencevariant
Patients with the BRCA1 c.263C>T sequence variant exhibit a higher frequency of chemotherapeutic resistance due to altered DNA repair activity.,-24.25,0.8,sequencevariant
Patients carrying the sequence variant c.263C>T in the BCL2L1 gene exhibited increased resistance to apoptosis when treated with the chemotherapeutic agent doxorubicin.,-25.75,0.8,sequencevariant
"Patients harboring the c.263C>T (rs11079788) variant, which replaces the tyrosine codon at position‑358 with histidine, exhibit a markedly increased susceptibility to drug‑induced cardiotoxicity.",-41.25,0.8,sequencevariant
"Patients treated with doxorubicin exhibited a markedly higher incidence of cardiomyopathy when carrying the rs11079788 variant, which encodes the M235T substitution in the β‑adrenergic receptor.",-40.0,0.8,sequencevariant
"Alterations in the TP53 c.263C>T (codon‑88 R→W) variant, previously associated with reduced p53 transcriptional activity, were confirmed in HeLa cells treated with doxorubicin, where the resultant N372H substitution in MDM2 increased apoptosis via the p53‑dependent pathway.",-83.5,0.8,sequencevariant
Alteration of the TP53 sequence variant c.263C>T (rs11079788) in HeLa cells leads to reduced p53 transcriptional activity and confers resistance to doxorubicin-induced apoptosis.,-25.625,0.8,sequencevariant
Altering the TP53 sequencevariant c.263C>T in the HeLa cell line enhances p53 transcriptional activity and increases sensitivity to the DNA-damaging agent doxorubicin.,-36.25,0.8,sequencevariant
Altered transcription of TP53 in A549 cells carrying the BRCA1 c.263C>T sequence variant leads to increased apoptosis and higher sensitivity to doxorubicin.,-28.875,0.8,sequencevariant
"An A549 cell line carrying the BRCA1 c.263C>T (N372H) sequence variant exhibited reduced DNA repair activity, suggesting that the rs11079788 polymorphism modulates the cellular response to doxorubicin-induced damage.",-37.0,0.8,sequencevariant
"An in vitro study demonstrated that the BRCA1 sequence variant c.263C> T, which results in the N372H amino‑acid change, impairs homologous recombination efficiency in the HCC1937 cell line.",-38.75,0.8,sequencevariant
"An integrative analysis revealed that the c.263C>T sequence variant in the MTHFR gene, previously catalogued as rs11079788, is associated with increased homocysteine levels and a higher risk of neural tube defects in a Han Chinese cohort.",-41.0,0.8,sequencevariant
An investigation of the BRCA1 c.263C>T sequence variant in a cohort of women with familial breast cancer revealed that carriers of the c.263C>T mutation exhibited a higher frequency of deleterious splicing alterations compared to those with the wild‑type sequence.,-47.75,0.8,sequencevariant
"Mendelian inheritance of the c.263C>T variant in the CYP1A2 gene (rs11079788) leads to the N372H amino‑acid substitution, which markedly reduces enzymatic activity and predisposes carriers to higher smoking‑induced lung cancer risk.",-46.0,0.8,sequencevariant
"Molecular analysis of the TP53 gene in A549 cells revealed that the c.263C>T SequenceVariant, which results in the codon‑358 N372H substitution, was associated with a statistically significant increase in p53 protein stability compared to the wild‑type allele.",-46.0,0.8,sequencevariant
"Mammary carcinoma cells harboring the c.263C>T variant in the BRCA1 gene exhibit markedly reduced homologous recombination repair capacity, rendering them hypersensitive to the PARP inhibitor olaparib.",-33.75,0.8,sequencevariant
"MALAT1 expression was markedly reduced in A549 cells transfected with the BRCA1 c.263C>T sequence variant, which was predicted to alter the splicing enhancer motif and thus impair DNA repair in this lung carcinoma model.",-47.75,0.8,sequencevariant
"Variant c.263C>T in the TP53 gene (rs11079788) was found to increase the risk of colorectal cancer in a cohort of Homo sapiens, with the M235T amino‑acid substitution in exon seven further exacerbating disease severity.",-50.5,0.8,sequencevariant
"Variant rs11079788 in the VDR gene, which results in the N372H amino‑acid substitution, has been associated with increased susceptibility to multiple sclerosis in a North‑American cohort.",-31.375,0.8,sequencevariant
Variant **c.263C>T** in the **TP53** gene was found to increase the susceptibility to **colorectal carcinoma** in patients of the **Homo sapiens** population.,-32.5,0.8,sequencevariant
"Variant *c.263C>T* in the *BRCA1* gene causes a premature stop codon, leading to reduced DNA repair activity and increased susceptibility to triple‑negative breast cancer in *Homo sapiens* carriers.",-40.5,0.8,sequencevariant
"The rs2071349 variant, encoding Arg64Trp in the CYP2D6 gene, was associated with altered metabolism of the anticancer drug doxorubicin in a cohort of Homo sapiens patients, while the V311fs sequence variant in the same gene led to a truncated protein that failed to activate the downstream insulin signaling pathway in A549 cells.",-45.0,0.8,sequencevariant
"The Arg64Trp variant (rs2071349) in the CYP2C9 gene causes a V311fs frameshift that reduces enzymatic activity, thereby increasing the risk of severe hepatotoxicity when patients are treated with the chemotherapeutic drug doxorubicin.",-24.375,0.8,sequencevariant
"The BRCA1 c.68_69delAG variant, denoted V311fs, was found to destabilize the protein’s DNA‑binding domain, thereby amplifying the risk of hereditary breast and ovarian cancers in a cohort of Homo sapiens individuals carrying the rs2071349 allele.",-39.5,0.8,sequencevariant
"The c.521T>C (p.Lys174Thr) sequence variant in the CYP2C9 gene, which is located within the rs2071349 locus, has been shown to alter enzyme activity and is associated with reduced warfarin clearance in patients with the Arg64Trp polymorphism.",-43.0,0.8,sequencevariant
"A missense variant rs2071349 resulting in Arg64Trp was found to alter the kinase activity of the A549 cell line, while a simultaneous V311fs indel in the TP53 gene was associated with increased apoptosis in E. coli-derived plasmid DNA preparations.",-53.5,0.8,sequencevariant
"A V311fs sequence variant in the CYP2C19 gene, annotated as rs2071349, was shown to dramatically reduce enzyme activity and increase the risk of adverse reactions to clopidogrel in patients of the E. coli strain used for recombinant protein production.",-39.25,0.8,sequencevariant
"A variant of the IL10 promoter, rs2071349, creates an Arg64Trp substitution that enhances binding of NF‑κB and increases expression of the cytokine in patients with Crohn’s disease.",-34.5,0.8,sequencevariant
"A CRISPR/Cas9‑edited A549 cell line harboring the BRCA1 rs2071349 V311fs sequence variant shows heightened sensitivity to the DNA‑damage agent doxorubicin, correlating with reduced TP53 protein stability and increased apoptosis compared with wild‑type cells.",-38.25,0.8,sequencevariant
"Mutation of the TP53 gene to the Arg64Trp (rs2071349) variant in a HeLa cell line results in a pronounced decrease in DNA‑damage‑induced apoptosis, linking the sequence variant to altered cellular response to chemotherapeutic doxorubicin.",-41.5,0.8,sequencevariant
"Mutation rs2071349 resulting in Arg64Trp in the CYP2C9 gene markedly increases the clearance of warfarin in patients with the -889TT promoter haplotype, thereby reducing the risk of dose‐related bleeding events in Homo sapiens.",-41.25,0.8,sequencevariant
"Mutation analysis of the rs2071349 polymorphism revealed a V311fs frameshift that alters the protein’s lysine at position‐223, potentially disrupting the catalytic domain and reducing the activity of the enzyme in HeLa cells.",-63.25,0.8,sequencevariant
"Mutation **rs2071349** (c.193C>T) in the **TP53** gene introduces an **Arg64Trp** substitution, which has been shown to disrupt p53’s DNA‑binding domain and correlate with increased susceptibility to **breast cancer** in **Homo sapiens**.",-37.5,0.8,sequencevariant
"Gene therapy targeting the rs2071349 sequence variant, which substitutes Arg64 for Trp, has been shown to restore normal protein folding in A549 cell line cultures infected with adenovirus and to reduce fever in patients with the associated disease phenotype.",-50.25,0.8,sequencevariant
"Gene knock‑in of the rs2071349 variant, which causes an Arg64Trp substitution in the DNA‑binding domain of the transcription factor NF‑κB, was shown to enhance TNF‑α production in stimulated THP‑1 monocytes, thereby exacerbating inflammatory signaling pathways relevant to atherosclerosis.",-52.75,0.8,sequencevariant
"Gene‑editing of the CDKN2A locus in HCT116 cells introduced the V311fs sequence variant, which in turn led to a truncated p16^INK4a protein that failed to bind cyclin‑dependent kinase and caused uncontrolled proliferation.",-47.0,0.8,sequencevariant
"Gene expression of the transcription factor C/EBPβ was found to be markedly reduced in HeLa cells carrying the rs2071349‑associated Arg64Trp variant, a mutation that alters the protein’s DNA‑binding domain and predisposes these cells to heightened sensitivity to the chemotherapeutic drug doxorubicin.",-53.0,0.8,sequencevariant
"In the A549 cell line, the BRCA1 c.521T>C sequence variant (rs2071349) was found to increase sensitivity to doxorubicin, an effect that was amplified when co‑expressed with the TP53 Arg64Trp mutation (rs713041).",-35.0,0.8,sequencevariant
"In liver tissue from a patient harboring the V311fs sequence variant, the truncated protein led to aberrant CYP2D6 expression and a consequent increase in the risk of drug-induced liver injury.",-49.5,0.8,sequencevariant
"In vitro functional assays revealed that the sequence variant rs2071349, causing an Arg64Trp substitution, significantly reduces the transcriptional activity of the TP53 promoter in HeLa cells, an effect that correlates with increased cellular sensitivity to doxorubicin-induced apoptosis.",-39.5,0.8,sequencevariant
"In *Homo sapiens* cells harboring the sequence variant rs2071349 (Arg64Trp) within the *TP53* gene, the altered arginine residue reduces DNA‑binding affinity, thereby impairing the transcriptional activation of the pro‑apoptotic gene *BAX* and contributing to chemoresistance in the A549 lung cancer cell line.",-39.75,0.8,sequencevariant
"Detection of the rs2071349 V311fs sequence variant in the CYP2C19 gene was associated with a significant reduction in clopidogrel metabolism, leading to higher platelet reactivity in patients treated with this antiplatelet agent.",-34.75,0.8,sequencevariant
"Detection and functional characterization of the rs2071349 A>G sequence variant revealed an Arg64Trp substitution that impairs IL-1β secretion in the THP‑1 monocytic cell line, thereby linking this genetic change to heightened inflammatory responses in Homo sapiens.",-58.75,0.8,sequencevariant
Detection in a patient-derived A549 cell line of the BRCA1 rs2071349 sequence variant (c.521T>C) revealed that the resulting Arg64Trp amino‑acid substitution disrupts DNA‑binding activity and correlates with increased sensitivity to doxorubicin treatment.,-52.75,0.8,sequencevariant
"Detection by allele‑specific PCR revealed that the rs2071349 sequence variant, which causes an Arg64Trp substitution in the MTHFR protein, is significantly more frequent in patients with elevated homocysteine levels than in controls.",-45.5,0.8,sequencevariant
"Mutations such as V311fs and the rs2071349 Arg64Trp variant were identified in the coding region of the CYP2C9 gene in a cohort of homozygous E. coli‑derived plasmids, suggesting that these sequence variants may alter enzyme activity and affect drug metabolism.",-42.5,0.8,sequencevariant
"Mutational analysis of a colorectal carcinoma sample revealed a V311fs sequence variant in the APC gene, which was predicted to truncate the protein and disrupt its interaction with β‑catenin, thereby contributing to the malignant phenotype.",-28.375,0.8,sequencevariant
"Mutagenic exposure to doxorubicin induced a V311fs sequence variant in the TP53 gene of A549 cells, disrupting the DNA‑binding domain and correlating with increased apoptosis and reduced colony formation in this human lung carcinoma line.",-36.5,0.8,sequencevariant
"Mutant KRAS G12V, a SequenceVariant (V311fs) identified by rs2071349, was shown to increase transcription of the oncogenic GeneOrGeneProduct BRAF in the human colorectal CancerCellLine HCT116, thereby amplifying the MAPK signaling cascade in Homo sapiens.",-59.25,0.8,sequencevariant
"Variants such as rs2071349 (Arg64Trp) and rs2073601-rs2073416 have been shown to alter the expression of CYP2D6, thereby influencing the pharmacokinetics of the anticancer drug doxorubicin in patients with Homo sapiens.",-33.75,0.8,sequencevariant
"Variants of the TNFα promoter such as rs2071349 (−308G>A) and the coding mutation Arg64Trp in the TNFRSF1A gene have been shown to synergistically increase transcriptional activity, thereby amplifying inflammatory responses in patients with autoimmune disease.",-47.5,0.8,sequencevariant
"Variants carrying the rs2071349 rs2073601‑rs2073416 haplotype, the Arg64Trp amino‑acid change and the V311fs frameshift, have been associated with increased susceptibility to inflammatory bowel disease and altered response to sulfasalazine in patients of European ancestry.",-50.0,0.8,sequencevariant
Variants with the rs2071349 (Arg64Trp) substitution in the V311fs‑mutated TP53 gene were found to increase the risk of malignant melanoma in a cohort of Homo sapiens patients who were also homozygous for the -889TT promoter polymorphism.,-52.0,0.8,sequencevariant
"When the Arg64Trp sequence variant (rs2071349) is present in the CYP1A1 gene, individuals exhibit markedly reduced enzymatic activity, leading to increased susceptibility to benzene-induced leukemia.",-32.5,0.8,sequencevariant
"When CRISPR/Cas9‑generated **V311fs** sequence variants were introduced into the **A549** cell line, the resulting frameshift caused a premature stop codon that abolished **TP53** protein expression, leading to unchecked proliferation and increased resistance to the chemotherapeutic **doxorubicin** in **Homo sapiens** cells.",-46.75,0.8,sequencevariant
"When HEK293 cells harboring the rs2071349 Arg64Trp sequence variant were treated with doxorubicin, the observed reduction in TP53 protein levels correlated with increased apoptosis relative to cells with the wild‑type allele.",-41.25,0.8,sequencevariant
"When A549 cells expressing the TP53 V311fs sequence variant were treated with doxorubicin, the resulting apoptosis was markedly attenuated compared to the wild‑type TP53, indicating that the V311fs variant confers chemoresistance.",-36.5,0.8,sequencevariant
"Sequencing of a patient’s CYP2C9 locus revealed the rs2071349 variant, causing an Arg64Trp substitution, which was confirmed by a V311fs indel at position c.521T > C and predicted to diminish warfarin metabolism in this Homo sapiens individual.",-58.75,0.8,sequencevariant
"Sequenced biopsies from patients with colorectal cancer revealed a V311fs sequence variant in the APC gene, and the rs2071349 polymorphism was associated with increased expression of the tumor suppressor gene TP53 in the same samples.",-49.25,0.8,sequencevariant
"Sequencevariant rs2071349, which encodes the Arg64Trp amino‑acid substitution, was identified in a cohort of patients with colorectal cancer, and its presence correlated with increased expression of the oncogenic protein TP53 and a higher risk of disease progression in Homo sapiens.",-58.0,0.8,sequencevariant
"Sequencer analysis of the BRCA1 c.68_69delAG variant, the rs2071349 polymorphism, and the Arg64Trp substitution in the TP53 gene revealed a significant association with increased breast cancer risk in a cohort of Homo sapiens patients.",-44.75,0.8,sequencevariant
"Tissue‑specific expression of the *TP53* gene is markedly increased in A549 cells harboring the V311fs sequence variant, leading to enhanced apoptosis in response to doxorubicin treatment.",-33.75,0.8,sequencevariant
"Treated HeLa cells expressing the BRCA1 SequenceVariant rs2071349 Arg64Trp showed increased sensitivity to the chemotherapeutic ChemicalEntity doxorubicin, correlating with elevated TP53 expression and reduced cell proliferation.",-37.25,0.8,sequencevariant
"Tryptophan substitution at position Arg64Trp in the V311fs variant of the *ABCB1* gene (rs2071349) markedly reduces drug efflux in A549 cells, leading to increased intracellular accumulation of doxorubicin and enhanced cytotoxicity.",-47.25,0.8,sequencevariant
"Toxicological analyses of the rs2071349 polymorphism in the CYP1A1 promoter revealed that the -889TT genotype, which results in an Arg64Trp substitution, correlates with increased susceptibility to dioxin-induced hepatotoxicity in Homo sapiens exposed to low‑dose ethanol.",-57.25,0.8,sequencevariant
"Deletion of the rs2071349 sequence variant in the promoter region of the IL6 gene reduces its transcriptional activity, thereby attenuating the cytokine response to lipopolysaccharide in E. coli–stimulated THP‑1 cells.",-35.75,0.8,sequencevariant
Deletion in the BCL2L1 gene (c.521T>C) causes an Arg64Trp variant that has been shown to alter protein stability and increase apoptosis sensitivity in MCF‑7 cells.,-50.0,0.8,sequencevariant
Deletion c.521T>c in the COL4A1 gene creates a V311fs sequence variant that is associated with a higher risk of cerebral small‑vessel disease in patients with the rs2071349 risk allele.,-44.5,0.8,sequencevariant
"Deletion variant rs2071349 (c.521T>C) in the CYP1A1 gene alters the catalytic efficiency of the enzyme, thereby modulating the risk of cisplatin-induced nephrotoxicity in patients receiving high‑dose therapy.",-49.5,0.8,sequencevariant
"Analysis of the rs2071349 variant in the CYP2C9 gene revealed that the Arg64Trp change decreases enzymatic activity, thereby increasing susceptibility to adverse drug reactions in patients treated with warfarin.",-33.75,0.8,sequencevariant
"Analysis revealed that the rs2071349 (Arg64Trp) sequence variant in the CYP2C9 gene, which is a missense mutation that changes arginine to tryptophan at position‑64, is significantly associated with reduced enzymatic activity and higher plasma concentrations of the chemotherapeutic agent dabrafenib in patients with metastatic melanoma.",-58.25,0.8,sequencevariant
"Analysis indicated that the rs2071349 Arg64Trp variant, which results from the c.191G>C (521T>C) substitution and leads to a V311fs frameshift in the protein, is strongly associated with increased susceptibility to Parkinson’s disease in Homo sapiens.",-54.5,0.8,sequencevariant
"Analysis showed that the rs2071349 (Arg64Trp) sequence variant, located at a splice donor site, destabilizes the TP53 mRNA and is associated with increased risk of familial colorectal cancer in a cohort of Homo sapiens patients.",-52.0,0.8,sequencevariant
An Arg64Trp sequence variant in the CYP2C9 gene (rs2071349) was found to increase the risk of tacrolimus toxicity in a cohort of homozygous African‑American transplant recipients.,-32.75,0.8,sequencevariant
"An A549 cell line engineered to express the BRCA1 sequence variant rs2071349 (c.521T>C) showed markedly reduced homologous recombination repair capacity compared with the wild‑type counterpart, indicating that this single‑nucleotide polymorphism may compromise DNA damage response in non‑small‑cell lung carcinoma.",-43.75,0.8,sequencevariant
An rs2071349 missense variant (Arg64Trp) in the CYP2C19 gene was found to significantly reduce clopidogrel activation and increase the risk of ischemic events in a cohort of E. coli‑infected patients with coronary artery disease.,-41.0,0.8,sequencevariant
"An association study found that the rs2071349 SequenceVariant (c.192C>T leading to Arg64Trp) in the CYP2C9 GeneOrGeneProduct significantly altered the pharmacokinetics of the ChemicalEntity warfarin in Homo sapiens patients, with the variant allele carriers exhibiting a markedly higher plasma concentration and increased risk of bleeding complications.",-54.75,0.8,sequencevariant
"The CRISPR‑edited A549 cells harbor a c.536C>T sequence variant that creates a glycine‑to‑arginine substitution at amino acid position‑86, resulting in diminished EGFR signaling and increased sensitivity to the tyrosine‑kinase inhibitor erlotinib.",-40.75,0.8,sequencevariant
"The recurrent A → G transition at position **127** in the *TP53* gene produces a **p.R34X** nonsense variant that truncates the DNA‑binding domain, thereby abolishing the tumor‑suppressive function of the p53 protein in **Homo sapiens** and contributing to the pathogenesis of **Li–Fraumeni syndrome**.",-52.75,0.8,sequencevariant
"The pathogenic variant c.1494del6 in the BRCA1 gene causes a premature stop codon that disrupts DNA repair, thereby increasing the risk of triple‑negative breast cancer in patients of European ancestry.",-33.0,0.8,sequencevariant
"The **c.1494del6** sequence variant in the *TP53* gene leads to a premature stop codon (p.Q298X), causing loss of the DNA‑binding domain and markedly increasing the risk of familial breast cancer in **Homo sapiens** patients.",-31.75,0.8,sequencevariant
"Silica nanoparticles functionalized with a CRISPR-Cas9 ribonucleoprotein complex targeting the BRCA1 c.557G>A sequence variant, delivered to HeLa cells, induced a glycine-to-arginine substitution at amino acid position eighty-six and activated p53-dependent apoptosis, demonstrating a potential therapeutic strategy for cancers harboring this pathogenic mutation.",-73.5,0.8,sequencevariant
"Silencing the TP53 gene in the A549 cell line revealed that the c.557G>A sequence variant in the BRCA1 promoter increases the transcriptional activity of the gene, thereby reducing apoptosis in response to doxorubicin treatment.",-45.75,0.8,sequencevariant
"Silico‑analysis of a colorectal adenocarcinoma sample revealed a novel sequence variant, a cytosine to thymidine transition at codon **536C> T** in the *KRAS* gene, causing a glycine to arginine substitution at amino acid **86** that correlates with constitutive MAPK pathway activation.",-56.75,0.8,sequencevariant
"Silence of the transcription factor ATF3 caused a p.Q298X sequence variant to be detected in the tumor‑derived HeLa cell line, leading to a glycine‑to‑arginine substitution at amino acid position ninety‑six that impaired NF‑κB signaling and increased apoptosis in response to doxorubicin treatment.",-81.0,0.8,sequencevariant
"In CHO cells engineered to express the TP53 p.R34X variant, the glycine to arginine substitution at amino acid position **86** in the DNA‑binding domain markedly enhances p53‑dependent transcription of the CDKN1A gene, thereby amplifying G1‑cell‑cycle arrest in response to doxorubicin exposure.",-59.0,0.8,sequencevariant
"In patients harboring the sequence variant c.536C>T, the resulting glycine to arginine substitution at amino acid position‑86 in the TP53 protein markedly increases the risk of developing acute myeloid leukemia.",-40.5,0.8,sequencevariant
"In HeLa cells harboring the BRCA1 p.Q298X sequence variant, doxorubicin treatment induces a marked increase in p53 protein levels, suggesting that the premature stop codon disrupts normal DNA repair signaling and sensitizes the cancer cells to chemotherapy.",-33.25,0.8,sequencevariant
"In a cohort of patients with colorectal cancer, the somatic sequence variant c.557G>A in the KRAS gene, which results in a glycine-to-arginine substitution at amino acid position six, was found to activate the MAPK pathway and correlate with resistance to EGFR inhibitor therapy.",-49.5,0.8,sequencevariant
"CRISPR‑edited A549 cells harboring the BRCA1 c.1494del6 sequence variant exhibit reduced DNA‑damage‑induced RAD51 foci, confirming that this deletion impairs homologous recombination repair.",-28.125,0.8,sequencevariant
CRTC1 c.1494del6 causes a frameshift that introduces a premature stop codon and is associated with a dramatic loss of transcriptional co‑activator activity in patients with congenital hypogonadotropic hypogonadism.,-43.5,0.8,sequencevariant
"CRH‑stimulated ACTH release was markedly reduced in adrenal cells transfected with the BRCA2 c.1494del6 sequence variant, which results in a frameshift that abolishes the protein’s C‑terminal DNA‑binding domain.",-54.75,0.8,sequencevariant
"CRABP2 harboring the c.557G>A sequence variant is predicted to disrupt the ligand‑binding pocket, thereby reducing retinoic acid binding and attenuating differentiation signals in A549 cells.",-42.75,0.8,sequencevariant
"Mutation of the BRCA1 gene in the form of a cytosine‑to‑thymidine transition at position c.536C>T causes a glycine‑to‑arginine substitution at amino acid residue p.Gly86Arg, which impairs DNA repair and increases breast cancer risk.",-49.5,0.8,sequencevariant
"Mutation c.536C>T in the CFTR gene causes a glycine to arginine substitution at amino acid position six, leading to cystic fibrosis phenotypes in homozygous Homo sapiens carriers.",-40.25,0.8,sequencevariant
"Mutation **p.Q298X** in the *BRCA1* gene, which introduces a premature stop codon at codon \(298\) and results in loss of the BRCA1 C-terminal domain, is frequently detected in breast‑cancer patients and correlates with a higher risk of triple‑negative disease.",-58.0,0.8,sequencevariant
"Mutation p.Q298X in the BRCA1 gene (c.894delT) was identified in a patient with triple‑negative breast cancer, and functional assays showed that this nonsense variant abolishes BRCA1 protein expression, leading to homologous recombination deficiency.",-36.5,0.8,sequencevariant
"A recent study demonstrated that the BRCA1 c.68_69delAG SequenceVariant causes a glycine to arginine substitution at amino acid residue p.Gly86Arg, leading to altered DNA repair activity in Homo sapiens breast epithelial cells.",-49.25,0.8,sequencevariant
"A novel BRCA1 sequence variant, c. *557G>A, introduces a glycine-to-arginine substitution at amino acid position, and is predicted to disrupt the DNA-binding domain in homozygous patients with breast cancer.",-55.75,0.8,sequencevariant
"A c.536C>T sequence variant in the TP53 gene, producing a glycine to arginine substitution at amino acid position \(86\), was shown to destabilize the protein’s DNA‑binding domain in Hela cell lines, thereby enhancing sensitivity to doxorubicin treatment.",-52.5,0.8,sequencevariant
"A p.Q298X sequence variant in the TP53 gene, resulting in a glycine to arginine substitution at amino acid position three‑hundred‑and‑eighty‑six, was detected in HeLa cells treated with doxorubicin, where it correlated with increased apoptotic markers in Homo sapiens.",-53.25,0.8,sequencevariant
Mutations such as the c.557G>A single‑nucleotide variant and the glycine‑to‑arginine substitution at amino acid position‑86 within the TP53 gene have been linked to increased tumor susceptibility in multiple cancer types.,-47.0,0.8,sequencevariant
"Mutagenic exposure induced a c.557G>A transition in the TP53 gene, generating a glycine‑to‑arginine substitution at amino acid position eighty‑six that compromises the DNA‑binding domain and is associated with increased risk of colorectal carcinoma in patients treated with doxorubicin.",-54.0,0.8,sequencevariant
"Mutated BRCA1 c.56_58delAG (a sequence variant) causes a glycine to arginine substitution at amino acid residue **86**, disrupting DNA repair and increasing breast cancer risk.",-53.0,0.8,sequencevariant
"Mutational analysis of the patient’s BRCA1 revealed a p.R34X sequence variant, a cytosine-to-thymidine transition at position c.557G>A, and a glycine‑to‑arginine substitution at amino acid residue p.86, all of which are associated with increased breast cancer risk.",-56.5,0.8,sequencevariant
"G646C>G substitution in the TP53 sequence variant leads to a leucine to histidine change at amino acid position Leu849His, which is frequently detected in cancer cell lines such as HCT116 and is associated with increased tumor cell proliferation in Homo sapiens.",-63.0,0.8,sequencevariant
"Glycine to arginine substitution at amino acid position **86 (c.256G>A)** in the TP53 gene (p.Gly86Arg) was detected in the tumor DNA of a **Homo sapiens** patient, and this variant was associated with a significantly higher risk of drug‑resistant **Hepatocellular carcinoma**.",-66.5,0.8,sequencevariant
"GATA4 c.1494del6, a glycine to arginine substitution at amino acid position **86**, was found to disrupt transcription factor binding and increase susceptibility to congenital heart defects in *Homo sapiens*.",-54.25,0.8,sequencevariant
Giant cell arteritis in a patient with a pathogenic p.Q298X variant in the HLA‑B gene resulted in a severe inflammatory response that was ameliorated by early initiation of high‑dose prednisone.,-52.5,0.8,sequencevariant
"BRCA1 c.68_69delAG causes a glycine to arginine substitution at amino acid position eighty‑six, which is associated with a higher risk of breast cancer in homozygous carriers.",-38.75,0.8,sequencevariant
"BRG1 p.Q298X, a sequence variant causing an early stop codon in the SWI‑SNF chromatin‑remodeling factor, is associated with reduced DNA‑binding affinity and increased risk of pancreatic adenocarcinoma in patients carrying the variant.",-57.75,0.8,sequencevariant
"BRD4 c.536C> T induces a glycine to arginine substitution at amino acid position \(86\), which in turn enhances the transcriptional activation of the oncogenic MYC gene in HeLa cells.",-60.0,0.8,sequencevariant
BRCT‑domain mutations such as the glycine‑to‑arginine substitution at amino acid position **86** in the **BRCA1** sequence variant **c.529A>G (p.G86R)** impair DNA‑damage repair and are strongly linked to hereditary breast cancer susceptibility.,-64.5,0.8,sequencevariant
"HeLa cells harboring the BRCA1 c.1494del6 sequence variant exhibit reduced RAD51 foci formation and increased sensitivity to the PARP inhibitor olaparib, while the same deletion also correlates with a lower expression of the tumor suppressor gene TP53.",-44.0,0.8,sequencevariant
"He showed a glycine to arginine substitution at amino acid position **86** in the *TP53* gene, which was associated with increased cellular proliferation in the *A549* cell line.",-60.25,0.8,sequencevariant
"He reported that the Gly86Arg substitution in the TP53 gene, identified by a c.256G>A transition, was associated with a higher incidence of chemoresistance in the A549 lung carcinoma cell line.",-53.5,0.8,sequencevariant
"He predicted that the p.R34X sequence variant in TP53, located in the DNA‑binding domain of the protein, would impair tumor‑suppressor activity in Homo sapiens cells, potentially contributing to the pathogenesis of colorectal cancer.",-55.5,0.8,sequencevariant
Targeted CRISPR editing of the BRCA1 sequence variant c.557G>A in HeLa cells revealed a glycine-to-arginine substitution at amino acid position‑86 that drastically reduced RAD51 recruitment and increased sensitivity to the DNA‑damage inducer doxorubicin.,-51.25,0.8,sequencevariant
"Targeting the BRCA1 p.Q298X sequence variant in patient-derived A549 cells, the engineered CRISPR-Cas9 system restored homologous recombination, resulting in increased sensitivity to the DNA-damaging agent doxorubicin.",-46.0,0.8,sequencevariant
"Target‑tissue overexpression of the mutant TP53 p.R34X, caused by a cytosine→thymidine transition at position c.103, results in impaired DNA‑damage response and confers resistance to doxorubicin in HeLa cells.",-53.0,0.8,sequencevariant
"Target validation of the G6410 by T sequence variant in the CYP2D6 gene showed that the A > G transition at position c.1494del6 markedly reduced enzyme activity, leading to increased plasma concentrations of the chemotherapeutic agent doxorubicin in a cohort of Homo sapiens patients.",-69.0,0.8,sequencevariant
"Reconstitution of the mutant p.Q298X variant in the human hepatocyte-derived cell line HepG2 revealed a pronounced increase in ERK phosphorylation, implying that this sequence variant may drive aberrant proliferative signaling in hepatocellular carcinoma.",-58.75,0.8,sequencevariant
Re-analysis of the E. coli strain with the c.557G>A sequence variant revealed a glycine to arginine substitution at amino acid position&nbsp;86 that caused a loss of function in the encoded enzyme.,-60.75,0.8,sequencevariant
"Reanalysis of the TP53 locus in colorectal cancer samples revealed a recurrent sequence variant, a glycine to arginine substitution at amino acid position G86R, which was predicted to destabilize the DNA‑binding domain and correlate with increased tumor aggressiveness.",-54.25,0.8,sequencevariant
"Re-expression of the BRCA1 sequence variant p.R34X in MCF‑7 cells causes a loss of homologous recombination activity, leading to increased sensitivity to the PARP inhibitor olaparib.",-38.75,0.8,sequencevariant
"Excessive proliferation of the A549 cell line was observed when the BRCA1 c.536C>T sequence variant, which causes a glycine‑to‑arginine substitution at amino acid position&nbsp;86, was introduced into the cells, revealing a novel oncogenic mechanism.",-55.5,0.8,sequencevariant
Exposing HeLa cells to doxorubicin induces a p.Q298X sequence variant in TP53 that correlates with increased apoptosis and cell cycle arrest.,-27.75,0.8,sequencevariant
"Exome sequencing of a patient with early‑onset Parkinson’s disease revealed a pathogenic sequence variant, c.557G>A in the SNCA gene, which introduces a glycine‑to‑arginine substitution at amino acid position‑86 and likely drives the α‑synuclein aggregation observed in this disease phenotype.",-56.5,0.8,sequencevariant
"Examination of the BRCA1 gene in a breast cancer cohort revealed that the c.557G>A substitution creates a p.Q298X nonsense variant, which is associated with a loss of DNA repair activity and a significantly higher risk of early‑onset malignancy.",-49.75,0.8,sequencevariant
"Leu849His, a glycine‑to‑arginine substitution at amino acid position six, was discovered in a cultured HeLa cell line treated with doxorubicin, and the variant’s presence was confirmed by sequencing the TP53 gene of the Homo sapiens sample.",-55.0,0.8,sequencevariant
"Leptin deficiency caused by the p.Q298X sequence variant in the LEP gene leads to hyperphagia and severe obesity in homozygous patients, a phenotype that is rescued by low‑dose leptin replacement therapy.",-38.5,0.8,sequencevariant
"Leucine‑849‑histidine (L849H) mutation in the ATPase domain of the ABC transporter gene ABCB1 was identified in a *Homo sapiens* patient, and the variant’s missense alteration was associated with increased doxorubicin clearance and reduced cardiotoxicity.",-64.0,0.8,sequencevariant
"Leukemia‑associated gene BCR in the cell line K562 carries a sequence variant A → G transition at position c.127, producing a glycine to arginine substitution at amino acid residue G86 that impairs tyrosine‑kinase activity and increases sensitivity to imatinib.",-77.0,0.8,sequencevariant
The p.R32W sequence variant in the TP53 gene’s DNA-binding domain was found to correlate with reduced p53 transcriptional activity and increased susceptibility to radiation-induced apoptosis in A549 cells treated with doxorubicin.,-24.0,0.8,sequencevariant
The heterozygous p.R32W sequence variant in the BCL2L1 gene is associated with increased apoptosis in MCF‑7 breast cancer cells treated with doxorubicin.,-25.875,0.8,sequencevariant
"The CRISPR/Cas9-generated p.R32W sequence variant in the TP53 gene (rs3818247) was shown to disrupt the DNA-binding domain, leading to a loss of p53 tumor suppressor activity and increased susceptibility to breast cancer in the studied cohort.",-37.75,0.8,sequencevariant
"The BRCA1 p.R32W sequence variant, located within exon two, disrupts the binding motif for the E3 ligase BRCA1‑associated RING domain protein and correlates with increased susceptibility to breast cancer in individuals carrying the T allele at –31 in the promoter region.",-41.5,0.8,sequencevariant
A CRISPR/Cas9-generated p.R32W variant in the exon of the BCL2 gene in HeLa cells leads to decreased anti‑apoptotic protein stability and enhanced sensitivity to doxorubicin treatment.,-43.5,0.8,sequencevariant
"A single-cell CRISPR screen in K562 cells revealed that the p.R32W sequence variant in the transcription factor GATA1 markedly reduces its DNA‑binding affinity, thereby attenuating the expression of the erythroid-specific gene HBB and impairing erythrocyte maturation.",-44.5,0.8,sequencevariant
"A p.R32W sequence variant in the TP53 gene was found to disrupt the DNA‑binding domain, thereby reducing p53’s ability to induce apoptosis in A549 cells treated with doxorubicin.",-22.25,0.8,sequencevariant
A novel L1503Q sequence variant in the catalytic domain of the BRAF gene was identified in a patient with metastatic melanoma and was shown to confer resistance to the RAF inhibitor dabrafenib.,-31.25,0.8,sequencevariant
"In our cohort, the p.R32W sequence variant in the TP53 gene, along with the upstream -31 T allele and the exon2+860G>C polymorphism, was significantly associated with increased susceptibility to radiation‑induced apoptosis in A549 cells.",-51.5,0.8,sequencevariant
"In the colorectal cancer cohort, a novel p.R32W sequence variant in the KRAS exon‑2 was found to co‑occur with a −31 T allele upstream of the promoter, significantly amplifying KRAS transcriptional activity and correlating with poorer patient survival.",-49.5,0.8,sequencevariant
"In a genome‑wide association study, the sequence variant rs3818247 in the promoter region of the IL1B gene was found to increase the risk of rheumatoid arthritis by elevating IL‑1β expression in patients of European ancestry.",-35.5,0.8,sequencevariant
"In breast cancer cell lines such as MCF‑7, the rs3818247 polymorphism in the promoter of CYP2A6 increases enzyme activity and consequently enhances the pro‑carcinogenic metabolism of cigarette smoke, thereby elevating the risk of tumor progression.",-50.75,0.8,sequencevariant
p.R32W and the upstream –31 T allele together with the rs3818247 polymorphism were found to cooperate in reducing the transcriptional activity of the TP53 promoter in the A549 cell line.,-43.25,0.8,sequencevariant
"p.L1503Q in the TP53 gene was found to increase the risk of developing triple‑negative breast cancer in a cohort of African‑American patients, and the variant was predicted to destabilize the DNA‑binding domain, thereby impairing apoptosis in tumor cells.",-50.5,0.8,sequencevariant
p.Q126R/IVS3+1G>A in the CFTR gene was found to be strongly associated with cystic fibrosis severity in patients carrying the T allele at -31 and the rs3818247 SNP.,-32.0,0.8,sequencevariant
p.H472Q in the TP53 gene was found to disrupt the p53 DNA‑binding domain and was associated with increased risk of colorectal carcinoma in a cohort of *Homo sapiens* patients carrying the rs3818247 allele.,-36.5,0.8,sequencevariant
"Deletion of a twenty‑base‑pair segment in the promoter region upstream of the initiation codon, coupled with a p.R32W missense mutation in the coding sequence, was shown to reduce transcriptional activity of the associated gene in patient‑derived fibroblasts.",-47.75,0.8,sequencevariant
"Deletion in the promoter region of the GATA4 gene (20 bp insertion/deletion polymorphism located at −1,109 bp upstream of the initiation codon) is associated with reduced cardiac-specific transcription, leading to a predisposition for congenital heart defects in individuals carrying the risk allele.",-69.0,0.8,sequencevariant
"Deletion‑mediated loss of the p.R32W allele in the TP53 coding region has been reported to diminish p53 transcriptional activation of the MDM2 promoter, thereby increasing the risk of sporadic colorectal cancer in individuals of European ancestry.",-61.75,0.8,sequencevariant
"Deletion and substitution events such as p.R32W, the T allele at –31, and the H472Q variant within the promoter region of the insulin gene collectively modulate insulin transcription and are associated with type‑2 diabetes onset in individuals carrying the rs3818247 allele.",-67.0,0.8,sequencevariant
"Knock‑in of the sequence variant rs3818247, which introduces a p.R32W substitution in the HNF1A coding region, markedly reduced transcriptional activity of the liver‑specific promoter in HepG2 cells.",-42.25,0.8,sequencevariant
"Knocking in the BRCA1 sequence variant p.R32W into the A549 CellLine markedly increased DNA repair activity and sensitized the cells to the chemotherapeutic agent doxorubicin, a finding that underscores the functional impact of this specific mutation in cancer therapy.",-46.5,0.8,sequencevariant
"Knox‑insertion of a G7958 sequence variant in the promoter region of the TP53 gene (rs3818247) was shown to increase transcriptional activity in A549 cells, thereby enhancing the cellular response to doxorubicin‑induced DNA damage.",-55.0,0.8,sequencevariant
"Knipovich et al. demonstrated that the sequence variant p.R32W in the CYP2C9 gene, together with a nearby rs4704560 polymorphism, significantly reduces enzyme activity in HepG2 cells, leading to altered drug metabolism.",-58.0,0.8,sequencevariant
Genomic sequencing of patient-derived tumor cells revealed a BRCA1 c.68_69delAG sequence variant that correlated with markedly reduced homologous recombination capacity and increased sensitivity to PARP inhibitor therapy.,-32.25,0.8,sequencevariant
"Genetic analysis of patient-derived DNA revealed a rare sequence variant, a p.R32W substitution in the TP53 gene, which co‑occurs with a neighboring rs3818247 single‑nucleotide polymorphism and is predicted to disrupt p53’s DNA‑binding domain, potentially contributing to tumorigenesis.",-52.75,0.8,sequencevariant
"Genotyping of the p.R32W sequence variant in the promoter region of the CYP1A1 gene revealed that individuals carrying the T allele at −31 exhibited higher enzyme induction levels in response to benzo(a)pyrene exposure, suggesting a potential pharmacogenetic interaction between this variant and xenobiotic metabolism.",-50.5,0.8,sequencevariant
"Genetically engineered A549 cells carrying the BRCA1 sequence variant p.R32W exhibit markedly enhanced cisplatin sensitivity, likely due to impaired DNA repair signaling.",-34.25,0.8,sequencevariant
"BRCA1 c.68_69delAG and the rs3818247 variant together impair DNA repair efficiency in breast epithelial cells, thereby increasing susceptibility to early-onset triple‑negative breast cancer.",-35.75,0.8,sequencevariant
"BRDNA-1, a synthetic DNA mimic, incorporated the sequence variant rs3818247 into a CRISPR/Cas9-edited HeLa CellLine, and its presence was confirmed by PCR amplification and Sanger sequencing of the target locus, demonstrating that the T allele at -31 of the promoter region reduces transcription of the TP53 gene in a dose-dependent manner.",-92.0,0.8,sequencevariant
"BRMS1L rs4704560 polymorphism and the upstream −31 T allele were found to alter the promoter activity of the metastasis suppressor gene, thereby reducing its expression in A549 cells infected with influenza A virus.",-62.25,0.8,sequencevariant
BRG1 complex activation by the p.R32W variant in TP53 leads to increased expression of the downstream target gene G7958 in HeLa cells.,-47.75,0.8,sequencevariant
"Patients harboring the sequence variant rs3818247, a T allele at –31 upstream of the initiation codon, exhibit markedly reduced promoter activity and increased susceptibility to inflammatory bowel disease.",-30.5,0.8,sequencevariant
Patients with the sequence variant p.R32W in the BRCA1 gene exhibited a significantly higher frequency of breast cancer compared with carriers of the wild‑type allele.,-24.25,0.8,sequencevariant
"Patients receiving temsirolimus showed reduced tumor burden in A549 xenografts harboring the BRCA1 c.68_69delAG sequence variant, which also correlated with increased PTEN expression and decreased mTORC1 signaling.",-43.75,0.8,sequencevariant
Patients carrying the sequence variant p.R32W in the TP53 gene exhibited significantly higher rates of chemotherapy‑induced apoptosis in A549 lung carcinoma cells compared to those with the wild‑type allele.,-26.625,0.8,sequencevariant
"During investigation of the HNF1A promoter, the rs3818247 single‑nucleotide polymorphism and a nearby G7958 variant were found to modulate transcription factor binding, thereby influencing glucose‑regulation gene expression in pancreatic β‑cells.",-52.75,0.8,sequencevariant
"During ChIP‑seq analysis of the TP53 locus in the A549 CellLine, a sequence variant rs3818247 located −31 bp upstream of the initiation codon was found to increase binding of the transcription factor NF‑κB, thereby upregulating TP53 expression and enhancing the cellular response to doxorubicin.",-52.0,0.8,sequencevariant
"During CRISPR/Cas9 editing of the TP53 locus in HCT116 cells, a p.R32W sequence variant was introduced, and subsequent deep sequencing revealed a concomitant T allele at –31 in the promoter region, suggesting a potential regulatory interplay affecting p53 transcriptional activity.",-45.0,0.8,sequencevariant
"During transcriptional profiling of HeLa cells, the p.R32W sequence variant in the TP53 gene was shown to disrupt p53 DNA‑binding activity, thereby attenuating the apoptotic response to doxorubicin treatment.",-38.0,0.8,sequencevariant
"Silencing of the TP53 gene in the A549 cell line carrying the BRCA1 c.68_69delAG sequence variant reduced the expression of the pro‑apoptotic protein BAX and increased cellular resistance to the chemotherapeutic drug doxorubicin, suggesting that the sequence variant modifies drug sensitivity in this lung cancer model.",-45.75,0.8,sequencevariant
Silico‑derived data from a cohort of patients with colorectal cancer revealed that the BRCA1 c.68_69delAG SequenceVariant (also known as rs80357713) was associated with a marked reduction in ATM gene expression and increased sensitivity to the DNA‑damage agent doxorubicin in HCT116 CellLine cultures.,-72.0,0.8,sequencevariant
"Silica‑induced oxidative stress in A549 cells carrying the p.R32W sequence variant in the NRF2 gene exacerbated cell‑cycle arrest and apoptosis, indicating a genotype‑dependent vulnerability to environmental carcinogens.",-47.25,0.8,sequencevariant
"Silently, the p.R32W sequence variant in the TP53 gene was discovered to destabilize the protein’s DNA‑binding domain, thereby increasing cellular susceptibility to chemotherapy‑induced apoptosis in HeLa cells.",-35.25,0.8,sequencevariant
Examination of the p.R32W sequence variant in the TP53 gene revealed a significant association with increased cellular senescence in HCT116 cells treated with doxorubicin.,-28.375,0.8,sequencevariant
"Exogenous CRISPR‑Cas9 editing of the TP53 locus in H1299 cells revealed that the p.R32W sequence variant reduces p53 DNA‑binding affinity, thereby impairing the apoptotic response to doxorubicin.",-31.5,0.8,sequencevariant
"Excessive expression of the H472Q variant in the TP53 gene was detected in HeLa cells treated with doxorubicin, suggesting that this sequence variant may contribute to the drug‑induced apoptotic response.",-32.5,0.8,sequencevariant
"Exon‑2+860G>C in the promoter of the IL‑6 gene, a variant identified as rs3818247, was found to increase transcriptional activity and correlate with heightened inflammatory cytokine release in patients with rheumatoid arthritis.",-43.25,0.8,sequencevariant
"Sequencing of the BRCA1 promoter revealed a novel rs3818247 T allele at –31 that co‑occurs with a p.R32W coding variant, suggesting a potential regulatory‑coding interaction affecting breast cancer risk.",-39.5,0.8,sequencevariant
"Sequenced exons of the ABCG2 gene from patient‐derived fibroblasts revealed a novel sequence variant, c.953C>G, resulting in a H472Q amino‑acid change, which co‑segregates with the Q126R/IVS3+1G>A splice‑site mutation and is predicted to impair the protein’s transporter activity in hepatocytes of Homo sapiens.",-82.0,0.8,sequencevariant
"Sequenom genotyping revealed that the rs3818247 SNP, a T allele at –31, is in linkage disequilibrium with a nearby H472Q sequence variant that alters transcription factor binding in the promoter of the G7958 gene.",-52.5,0.8,sequencevariant
"Sequenza‐based genotyping revealed a BRCA1 c.68_69delAG (SequenceVariant) that co‑occurs with the rs3818247 polymorphism in a subset of breast cancer patients, suggesting a combined effect on DNA repair capacity.",-50.25,0.8,sequencevariant
"Mutation of the SequenceVariant rs3818247 within the promoter region of TP53 was found to down‑regulate its transcription in A549 cells, thereby exacerbating the apoptotic response to doxorubicin.",-33.25,0.8,sequencevariant
Mutation p.R32W in the TP53 gene was found to disrupt p53 DNA‑binding affinity and was associated with increased susceptibility to chemotherapy‑induced cardiotoxicity in patients of *Homo sapiens* receiving doxorubicin therapy.,-38.5,0.8,sequencevariant
"Mutation analysis of the HNF1A promoter revealed a T allele at –31 together with a rs3818247 variant that, when combined with the sequence variant p.R32W, significantly increased transcriptional activity in hepatocyte-derived HepG2 cells.",-43.75,0.8,sequencevariant
Mutation rs3818247 in the promoter region of TP53 causes a T allele at −31 that increases transcriptional activity and is associated with a higher risk of melanoma in Homo sapiens.,-30.875,0.8,sequencevariant
"The A549 transfectant harboring the rs2004640 T > C variant, which introduces a p.Pro27ProfsX54 truncation, shows reduced expression of the KRAS protein and increased sensitivity to the chemotherapy agent doxorubicin.",-36.75,0.8,sequencevariant
"The CRISPR/Cas9‑edited HEK293T transfectants carrying the g.99367‑102002del sequence variant exhibited a marked increase in p.Pro27ProfsX54 protein degradation and a concomitant loss of cellular viability, implicating the novel deletion in disrupting essential protein‑protein interactions.",-54.5,0.8,sequencevariant
"The p.F482C sequence variant, a C>T transversion at nucleotide position c.1444, is predicted to cause a Leu269Phe amino acid change in the TP53 protein, which may disrupt its DNA-binding domain and increase the risk of breast cancer in Homo sapiens carriers.",-56.0,0.8,sequencevariant
"The T > C transversion at nucleotide position c.4508 in the BRCA1 gene produces the p.Arg555Trp sequence variant, which has been linked to increased breast cancer susceptibility in a subset of Homo sapiens individuals.",-41.5,0.8,sequencevariant
"A CRISPR‑mediated T > C substitution in the intronic region of TP53, yielding a predicted p.Pro27ProfsX54 frameshift, was confirmed by whole‑genome sequencing of a HeLa cell line, revealing concomitant loss of p53’s DNA‑binding domain and activation of the apoptotic BAX pathway.",-60.0,0.8,sequencevariant
A colon carcinoma patient carrying the sequence variant p.F482C in the APC gene exhibited markedly reduced β‑catenin degradation and increased tumor cell proliferation compared with the wild‑type APC allele.,-32.5,0.8,sequencevariant
"A germline p.Pro27ProfsX54 sequence variant, detected by PCR in a patient-derived A549 cell line, was shown to disrupt TP53 protein function, thereby increasing susceptibility to ethanol-induced apoptosis.",-40.5,0.8,sequencevariant
"A g.99367-102002del sequence variant in TP53, annotated as p.F482C, was identified in a HeLa cell line derived from Homo sapiens, and its T > C transition at nucleotide position (T‑>G transversion at nucleotide‑4508) correlated with increased apoptotic sensitivity to doxorubicin.",-69.0,0.8,sequencevariant
"CRISPR‑generated A549 cells harboring the T>G transversion at nucleotide position **4508** in the *EGFR* sequence variant **p.Leu269Phe** show heightened phosphorylation of downstream AKT, confirming the pathogenic role of this single‑nucleotide change in lung cancer signaling.",-69.0,0.8,sequencevariant
"CRL-1205 cells carrying the p.F482C sequence variant exhibit reduced sensitivity to doxorubicin, whereas HeLa cells with the T > C transversion at nucleotide position ​4508 display increased apoptosis.",-63.75,0.8,sequencevariant
"CRLF2 exon‑3 p.Pro27ProfsX54, a frameshift variant arising from a T>T>C mutation in a T‑cell leukemia cell line, was shown to up‑regulate IL‑2Rβ expression and enhance growth signaling in human T‑cell blasts.",-67.0,0.8,sequencevariant
"CR3022 binding to the SARS‑CoV‑2 spike protein was abolished in a viral isolate containing a T > C transversion at nucleotide position **4508**, creating the **p.Phe152Leu** sequence variant that also coincides with the **rs2004640** polymorphism in the host **ACE2** gene.",-78.0,0.8,sequencevariant
"In the HepG2 cell line, the g.99367‑102002del sequence variant in TP53 was found to disrupt the promoter binding of p53, leading to reduced expression of the tumor suppressor protein.",-35.5,0.8,sequencevariant
"In A549 cells harboring the BRCA1 sequence variant rs2004640, the T > C transversion at nucleotide position G4508 generates the p.Pro27ProfsX54 protein truncation, which attenuates DNA repair and promotes epithelial‑mesenchymal transition.",-53.75,0.8,sequencevariant
"In HeLa cells carrying the p.Pro27ProfsX54 sequence variant, the T > C transversion at nucleotide position −99367‑102002del abolishes the binding of the transcription factor TP53, leading to up‑regulation of the oncogenic gene MYC.",-49.25,0.8,sequencevariant
"In an A549 cell line derived from Homo sapiens, the T > C transition at nucleotide position g.99367-102002del created a p.Pro27ProfsX54 sequence variant that was shown to impair the expression of the TP53 gene product, thereby increasing cellular sensitivity to doxorubicin.",-45.0,0.8,sequencevariant
Mutations such as p.Pro27ProfsX54 and the T > C transversion at nucleotide position c.4508T>G in the BRCA1 gene lead to a loss of function that is detected in tumor samples derived from a homozygous g.99367-102002del variant in a patient with hereditary breast cancer.,-67.5,0.8,sequencevariant
"Mutational analysis of the BRCA1 g.99367-102002del variant in a Homo sapiens breast cancer cell line revealed that the T > C transversion at nucleotide position T4508 creates a p.F482C protein alteration, which disrupts the DNA repair function and enhances genomic instability in the A549 cell line.",-65.5,0.8,sequencevariant
Mutagenic T > C transversions at position nucleotide (rs2004640) in the TP53 gene produce a p.Pro27ProfsX54 sequence variant that impairs the p53 DNA‑binding domain and compromises the apoptotic response in HeLa cells treated with doxorubicin.,-60.5,0.8,sequencevariant
"Mutant A549 cells carrying the g.99367‑102002del sequence variant exhibited a T > C transversion at nucleotide position **4508**, resulting in the **p.F482C** missense mutation, which in turn reduced KRAS‑dependent proliferation in a dose‑dependent manner.",-71.0,0.8,sequencevariant
"T>G transversion at nucleotide position **4508** in the **p53** gene, annotated as **p.Leu269Phe**, was identified in a **Homo sapiens** cell line derived from **A549** lung carcinoma, and this sequence variant was shown to disrupt DNA‑binding activity and increase cellular sensitivity to **doxorubicin**.",-67.5,0.8,sequencevariant
"T to C transversion at nucleotide position (T>G transversion at nucleotide) in the BRAF gene (rs2004640) creates the sequence variant p.Pro27ProfsX54, which disrupts the kinase domain and is associated with melanoma susceptibility.",-68.5,0.8,sequencevariant
"T‐to‑C transversion at nucleotide position‑4508 in the TP53 gene (c.4508T>G) creates the p.Pro27ProfsX54 frameshift variant, which is associated with increased risk of colorectal carcinoma in individuals carrying the rs2004640 allele.",-47.5,0.8,sequencevariant
"T‑to‑G transversion at nucleotide position **4508** in the **TP53** gene causes the **p.Arg555Trp** sequence variant, which in **A549** cells increases sensitivity to the **cisplatin** chemotherapeutic agent.",-50.0,0.8,sequencevariant
"Patients with the BRCA1 sequence variant g.99367‑102002del demonstrated increased sensitivity to the PARP inhibitor olaparib, while carriers of the p.F482C mutation in the TP53 gene exhibited reduced apoptotic response to doxorubicin in the A549 cell line.",-39.25,0.8,sequencevariant
"Patients infected with *Homo sapiens* SARS‑CoV‑2 harboring the sequence variant T>G transversion at nucleotide position **4508** exhibit an increased viral replication rate due to the resulting **p.Pro27ProfsX54** frameshift in the spike protein, which enhances binding to the ACE2 receptor.",-62.75,0.8,sequencevariant
"Patients bearing the BRCA1 g.99367‑102002del sequence variant exhibited a markedly increased risk of breast cancer, while carriers of the T > C transition that generates the p.Pro27ProfsX54 frameshift showed reduced expression of the p53 protein and heightened susceptibility to chemotherapy‑induced apoptosis.",-55.25,0.8,sequencevariant
"Patients carrying the rs2004640 variant, a T>G transversion at nucleotide position ​4508, displayed a reduced survival rate due to the resulting p.F482C protein alteration.",-56.25,0.8,sequencevariant
"Deletion of the BRCA1 exon c.99367-102002del in a Homo sapiens breast cancer patient caused a p.Pro27ProfsX54 frameshift, impairing the protein’s tumor-suppressor function.",-47.0,0.8,sequencevariant
Deletion p.F482C in the BRCA1 gene (g.99367-102002del) was found to increase breast‑cancer risk in a cohort of Homo sapiens patients carrying the rs2004640 variant.,-32.0,0.8,sequencevariant
"Deletion in the TP53 gene (g.99367-102002del) in HeLa cells causes a frameshift leading to the p.Pro27ProfsX54 variant, which in turn reduces p53 transcriptional activity and increases sensitivity to doxorubicin.",-40.25,0.8,sequencevariant
"Deletion g.99367-102002del in the HLA‑DRB1 locus in a Chinese Han patient with rheumatoid arthritis caused a frameshift p.Pro27ProfsX54, resulting in loss of the MHC‑II α‑chain binding pocket and a markedly reduced CD4+ T‑cell response.",-63.0,0.8,sequencevariant
Cells derived from an A549 transfectant carrying the g.99367‑102002del sequence variant exhibit reduced EGFR protein levels and increased sensitivity to the tyrosine‑kinase inhibitor gefitinib.,-31.375,0.8,sequencevariant
"Cells of the HeLa transfectant harbor a pathogenic sequence variant, a T>G transversion at nucleotide position **4508** that converts an arginine codon to tryptophan at position **555**, thereby disrupting the protein’s DNA‑binding domain.",-60.5,0.8,sequencevariant
Cells transfected with the T > C sequence variant (p.Pro27ProfsX54) in the TP53 gene displayed increased apoptosis and reduced colony‑forming ability compared with wild‑type cells.,-33.25,0.8,sequencevariant
"Cells from the HeLa transfectant bearing the g.99367‑102002del sequence variant exhibited increased sensitivity to doxorubicin, a phenomenon likely mediated by the downstream activation of the p.Pro27ProfsX54 truncated TP53 protein.",-40.5,0.8,sequencevariant
"Mutation analysis of a g.99367-102002del sequence variant in the TP53 gene revealed that the deletion caused a p.Pro27ProfsX54 frameshift, leading to premature termination and loss of the DNA-binding domain, thereby impairing TP53's tumor‑suppressor function in homo sapiens cells.",-49.5,0.8,sequencevariant
"Mutation of the p.F482C variant in the BRCA1 gene, identified as a T > C transversion at nucleotide position g.99367-102002del, is associated with increased breast cancer risk in patients carrying the rs2004640 allele.",-41.25,0.8,sequencevariant
"Mutation detection of a g.99367-102002del sequence variant in the TP53 gene revealed a T > C transversion at nucleotide position ∼4508, resulting in the p.Pro27ProfsX54 frameshift and the Arg555‑to‑tryptophan substitution, which was further confirmed in a homozygous E. coli strain expressing the Asn‑type transfectant.",-75.0,0.8,sequencevariant
"Mutation T > C in the TP53 gene, which results in the p.Pro27ProfsX54 protein variant, was detected in an E. coli strain carrying the Leu269Phe sequence variant and was shown to correlate with increased sensitivity to doxorubicin in the A549 cell line.",-46.5,0.8,sequencevariant
"Loss of the g.99367‑102002del variant in the TP53 gene, which produces the p.F482C missense mutation, was confirmed by sequencing of the A549 cell line derived from a Homo sapiens lung carcinoma sample.",-36.25,0.8,sequencevariant
"Loss-of-function in the HNF1α gene, caused by a g.99367-102002del sequence variant that produces a p.Pro27ProfsX54 frameshift, impairs insulin transcription and is associated with maturity‑onset diabetes of the young in patients carrying the rs2004640 allele.",-45.0,0.8,sequencevariant
"Lossless p.Pro27ProfsX54 mutations in the TP53 gene (c.81_83delTTT, rs2004640) were found to be associated with increased apoptosis in A549 cells, as confirmed by Western blotting of the protein product and by cell viability assays.",-80.0,0.8,sequencevariant
"Loss‑of‑function of the gene encoding the ER‑resident chaperone was observed in the Asn‑type transfectant, where a T > C transition at position g.99367‑102002del produced the p.Pro27ProfsX54 truncation and the concomitant T‑to‑G transversion at nucleotide *4508* caused the arginine‑555‑to‑tryptophan substitution, ultimately abolishing protein activity in *Homo sapiens* cells.",-91.0,0.8,sequencevariant
An engineered HeLa transfectant carrying the rs2004640 allele with a T>G transversion at nucleotide position \(4508\) displayed a p.Pro27ProfsX54 truncation that drastically reduced TP53 protein stability and increased cellular sensitivity to doxorubicin.,-60.5,0.8,sequencevariant
An Asn-type transfectant carrying the p.Pro27ProfsX54 sequence variant in TP53 displayed a dramatic reduction in tumor suppressor activity compared to the wild‑type protein.,-34.75,0.8,sequencevariant
"An A549 cell line transfected with a p.Pro27ProfsX54 variant, a T > C transition in the TP53 gene, and a g.99367‑102002del deletion in the BRCA1 sequence, exhibited increased apoptosis after doxorubicin treatment.",-36.0,0.8,sequencevariant
"An in‑vitro screen of the Asn‑type transfectant showed that the p.Pro27ProfsX54 variant, generated by a T > C transition at position c.81, disrupted TP53 protein stability and led to increased apoptosis in HeLa cells.",-50.75,0.8,sequencevariant
"Widespread screening of colorectal carcinoma samples revealed that the rs2004640 allele, which introduces a T>C transversion at nucleotide position −99370 leading to a p.Pro27ProfsX54 frameshift, was strongly associated with increased expression of the KRAS oncogene in A549 cell lines.",-73.0,0.8,sequencevariant
"WES of a colorectal cancer patient identified a pathogenic BRCA1 g.99367-102002del sequence variant that co‑occurs with a somatic T > C transversion at nucleotide position c.4508T>G in the TP53 gene, suggesting a synergistic effect on tumor progression.",-69.0,0.8,sequencevariant
"Wang et al. reported that the rs2004640 T > C transition in the TP53 gene, causing a p.Pro27ProfsX54 sequence variant, led to increased apoptosis in HeLa cells exposed to doxorubicin.",-43.0,0.8,sequencevariant
"Wnt/β‑catenin signaling is disrupted in colorectal cancers harboring the BRCA1 sequence variant p.Pro27ProfsX54, where a T > C transition at position c.82 leads to a premature termination codon and loss of functional p53 binding activity.",-56.25,0.8,sequencevariant
"Exposure of the A549 cell line to the p.Pro27ProfsX54 sequence variant, a T > C mutation that deletes nucleotides g.99367-102002del, led to a marked increase in the expression of the TP53 gene product and a corresponding reduction in cell proliferation.",-44.75,0.8,sequencevariant
"Exposure to the T>T>C transversion at nucleotide position (T -- > G) in the BRCA1 gene, which generates the p.Pro27ProfsX54 sequence variant, was associated with a higher incidence of breast cancer in Homo sapiens carriers of the rs2004640 allele.",-58.75,0.8,sequencevariant
"Exposure in the Asn‑type transfectant to a T > C transition at nucleotide position g.99367-102002del produced the p.Pro27ProfsX54 sequence variant, which correlated with increased drug resistance in HeLa cells.",-61.0,0.8,sequencevariant
"Exposure–induced T > C transversions at nucleotide position c.4508 of the *TP53* gene generate the p.Pro27ProfsX54 sequence variant, which is frequently observed in cultured A549 and HeLa cell lines and is associated with increased cellular radiosensitivity in *Homo sapiens* tumors.",-81.0,0.8,sequencevariant
"The CRISPR‑Cas9‑mediated insertion of the four nucleotides CCCC at the A549 cell line genome near the TP53 locus created a novel SequenceVariant, c.6799G>A, that introduces the p.Ser63Asn change in the TP53 protein and was associated with increased sensitivity to the chemical entity doxorubicin.",-49.0,0.8,sequencevariant
The p.Ser63Asn sequence variant in TP53 (rs10942891) was shown to increase apoptosis in HeLa cells treated with doxorubicin.,-17.875,0.8,sequencevariant
"The splice‑site variant c.6799G>A in TP53, predicted to create a novel donor site and resulting in a truncated protein, was identified in a breast cancer patient with a family history of Li‑Fraumeni syndrome and correlated with elevated p53‑target gene expression in her tumor biopsies.",-58.25,0.8,sequencevariant
"The c.6799G>A sequence variant in TP53, which substitutes serine with asparagine at residue p.Ser63Asn, was found to up‑regulate the apoptotic response in HeLa cells treated with doxorubicin.",-33.5,0.8,sequencevariant
"In HepG2 cells, the p.Ser63Asn variant of the CYP2D6 gene reduces enzymatic activity, thereby lowering the metabolism of the anticancer drug doxorubicin and increasing the risk of cardiotoxicity.",-27.75,0.8,sequencevariant
"In a recent study of colorectal cancer, a frameshift sequence variant involving the insertion of four nucleotides CCCC at position c.7488 caused a premature stop codon that was associated with increased KRAS expression and poor overall survival.",-45.5,0.8,sequencevariant
"In the HeLa cell line, the CRISPR‑generated sequence variant c.6799G>A in the TP53 gene caused a p.Ser63Asn substitution that disrupted the DNA‑binding domain and led to a marked increase in cellular apoptosis upon doxorubicin treatment.",-31.75,0.8,sequencevariant
"In colorectal carcinoma cells, the C282Y sequence variant of the HFE gene promotes iron overload, which synergizes with a p.Ser63Asn mutation in the FAS receptor to enhance apoptotic signaling.",-39.0,0.8,sequencevariant
"A p.Ser63Asn substitution in the TP53 gene, together with the C282Y variant in the HFE sequence, was shown to synergistically increase the risk of hereditary hemochromatosis in a cohort of Homo sapiens patients carrying the rs10942891 allele.",-32.25,0.8,sequencevariant
"A point mutation, c.6799G>A, in the CYP2C9 gene was shown to reduce enzymatic activity and was associated with increased risk of statin‑induced myopathy in a cohort of Homo sapiens patients.",-35.25,0.8,sequencevariant
"A novel BRCA1 sequence variant, c.6799G>A, which results in a Ser63Asn substitution, was found to be associated with increased risk of breast cancer in a cohort of Homo sapiens individuals carrying the rs10942891 allele.",-33.0,0.8,sequencevariant
"A mutation of the BRCA1 gene, specifically the c.6799G>A (p.Ser63Asn) sequence variant, was found to significantly increase the risk of breast cancer in women carrying the rs10942891 allele.",-24.75,0.8,sequencevariant
"Mutational analysis of the BRCA1 locus revealed a c.6799G>A transition that generates a p.Ser63Asn sequence variant, while an adjacent rs10942891 SNP was observed to co‑segregate with the pathogenic C282Y substitution in the same allele.",-43.75,0.8,sequencevariant
"Mutations such as Ala88Thr and the insertion of four nucleotides CCCC within the HBB gene have been linked to altered hemoglobin function, while the del(1)(p31.2p32.3) chromosomal deletion causes a spectrum of developmental abnormalities in patients with a C282Y variant.",-49.5,0.8,sequencevariant
"Mutagenesis of the TP53 gene in HCT116 cells revealed that the p.Ser63Asn SequenceVariant, which replaces serine with asparagine at residue position six‑three, enhances binding to the CDKN1A promoter and increases apoptosis upon doxorubicin treatment.",-59.5,0.8,sequencevariant
"Mutating the BRCA1 gene to the sequence variant c.6799G>A (p.Ser63Asn) in a patient-derived HeLa cell line dramatically increases RAD51 recruitment to DNA double‑strand breaks, thereby enhancing homologous recombination and conferring resistance to the alkylating agent doxorubicin.",-43.0,0.8,sequencevariant
"Loss of the C282Y sequence variant in the HFE gene, a common missense mutation that substitutes cysteine for tyrosine at position‑282, was found to dramatically elevate serum iron levels in a cohort of **Homo sapiens** patients with hereditary hemochromatosis.",-52.0,0.8,sequencevariant
"Loss-of-function mutations such as the C282Y and Ala88Thr variants in the HFE gene, together with the del(1)(p31.2p32.3) deletion, are strongly associated with hereditary hemochromatosis in individuals carrying the rs10942891 allele.",-34.75,0.8,sequencevariant
"Loss‑of‑function of the SLC7A11 gene, characterized by the c.6799G>A (p.Ser63Asn) sequence variant, reduces cystine uptake in H1299 cells and sensitizes them to ferroptosis induced by erastin.",-41.25,0.8,sequencevariant
Losses in the C282Y sequence variant of the HFE gene (rs1800562) were correlated with increased serum ferritin levels in a cohort of Homo sapiens patients carrying the p.C282Y mutation.,-43.0,0.8,sequencevariant
"C282Y, a missense SequenceVariant in the HFE gene, is strongly associated with increased iron absorption and hepatocellular carcinoma risk in Homo sapiens, while the concomitant rs10942891 polymorphism modulates the expression of the related ferroportin transporter.",-39.25,0.8,sequencevariant
"Cystic fibrosis transmembrane conductance regulator (CFTR) variants, such as the C282Y missense mutation and the deletion of nucleotides p.(del92) spanning positions –19 to +73, together with the insertion of a four‑nucleotide CCCC repeat, converge to disrupt chloride transport in Homo sapiens airway epithelia, thereby exacerbating the hyper‑inflammatory phenotype observed in patients with the SLC26A9 rs10942891 polymorphism.",-73.0,0.8,sequencevariant
C-terminal deletion of the four nucleotides CCCC in the TP53 cDNA causes a frameshift that introduces a premature stop codon and the pathogenic p.Ser63Asn variant observed in multiple colorectal cancer samples.,-56.75,0.8,sequencevariant
"Cox regression analysis showed that the rs10942891 sequence variant, which entails a deletion of a single nucleotide at position p31.2p32.3, was associated with a higher risk of Parkinson’s disease in a cohort of homozygous E. coli strains expressing the mutated GeneOrGeneProduct.",-56.75,0.8,sequencevariant
Altering the lysine at residue **223** in the TP53 gene through a **del (1) (p31.2p32.3)** variant induces a conformational shift that reduces p53’s DNA‑binding affinity and enhances cellular susceptibility to **C282Y**‑mediated iron‑overload pathology in **Homo sapiens**.,-55.75,0.8,sequencevariant
"Alzheimer’s disease progression in patients carrying the C282Y sequence variant of HFE is exacerbated by the concurrent Ala88Thr mutation, which together diminish hepcidin binding and amplify brain iron deposition.",-40.5,0.8,sequencevariant
"Alocain’s c.6799G>A mutation, which causes a lysine to arginine substitution at residue C282Y in the protein’s catalytic domain, was shown to reduce binding affinity for the pro‑apoptotic peptide in the A549 lung carcinoma cell line, thereby enhancing resistance to the chemotherapeutic agent doxorubicin.",-87.5,0.8,sequencevariant
"Alkylating agent cisplatin induced an Ala88Thr substitution in the TP53 gene, causing a loss of p53 DNA‑binding activity that was confirmed by sequencing the c.252G>A variant in tumor biopsies from a HeLa cell line.",-52.0,0.8,sequencevariant
"Sequencing of the tumor suppressor gene TP53 in the colorectal carcinoma cell line HCT116 revealed a p.Ser63Asn sequence variant that co‑occurs with an adjacent insertion of the four nucleotides CCCC, which may contribute to the dysregulation of p53‑mediated apoptosis.",-47.5,0.8,sequencevariant
"Sequenced DNA from the A549 cell line revealed a p.Ser63Asn variant in TP53, while a separate PCR assay in E. coli BL21(DE3) detected an insertion of the four nucleotides CCCC at position c.6799G> A, suggesting these sequence variants may alter protein function and bacterial growth.",-57.75,0.8,sequencevariant
"Sequencereporting of the c.179C>A variant, resulting in the p.Thr60Asn substitution in the BRCA2 gene, demonstrates that this sequencevariant is associated with increased breast cancer susceptibility in Homo sapiens.",-64.0,0.8,sequencevariant
"Sequential analysis of a patient‑derived tumor revealed a p.Ala88Thr missense mutation in the TP53 gene, whose presence correlates with heightened sensitivity to the DNA‑damaging agent doxorubicin.",-52.75,0.8,sequencevariant
Mutation of the BRCA1 gene (c.6799G>A) causing the p.Ser63Asn substitution was shown to alter DNA‑repair activity in mammary epithelial cells from a breast cancer patient of the African American population.,-51.75,0.8,sequencevariant
"Mutation p.Ala88Thr in the CYP1A1 gene (rs10942891) was shown to increase expression of the detoxification enzyme in HepG2 cells, thereby enhancing resistance to doxorubicin-induced apoptosis.",-31.125,0.8,sequencevariant
"Mutation analysis revealed that the BRCA1 sequence variant c.6799G>A, which introduces a p.Ser63Asn substitution, is associated with an increased risk of hereditary breast cancer in individuals carrying the rs10942891 allele.",-25.125,0.8,sequencevariant
"Mutation screening of a colorectal tumor revealed a BRCA1 c.6799G>A sequence variant that substituted serine for asparagine at residue p.Ser63Asn and concurrently introduced an insertion of four nucleotides CCCC, thereby creating a novel splice donor site that could contribute to aberrant transcription of the TP53 gene in the HeLa cell line.",-66.5,0.8,sequencevariant
"TRIALS with A549 cells treated with doxorubicin revealed that the BRCA1 SequenceVariant c.6799G>A increased p53 GeneOrGeneProduct expression, correlating with apoptosis of the tumor cells.",-43.0,0.8,sequencevariant
"TRPV1 overexpression in A549 cells carrying the C282Y sequence variant increases sensitivity to the chemotherapeutic agent doxorubicin, thereby enhancing apoptotic cell death and suggesting a potential therapeutic target in non‑small cell lung cancer.",-45.75,0.8,sequencevariant
TRP53 c.179G>A (p.Arg60His) is a sequence variant that disrupts the DNA‑binding domain and has been shown to impair p53‑mediated transcriptional activation in colorectal carcinoma cells.,-36.75,0.8,sequencevariant
TRAF6 Ala88Thr sequence variants in the N‑terminal TRAF domain are reported to disrupt ubiquitin‑dependent signaling and have been linked to increased susceptibility to inflammatory bowel disease.,-44.0,0.8,sequencevariant
"Alteration of the p.C282Y sequence variant in HFE, a C282Y mutation within exon two, was confirmed by sequencing and was associated with markedly increased serum ferritin levels in Homo sapiens patients with hereditary hemochromatosis.",-56.0,0.8,sequencevariant
Alterations such as the Ala88Thr missense variant (c.263G>A) and the four‑nucleotide CCCC insertion at position c.6799G> A in the TP53 gene lead to loss of function and are associated with increased risk of osteosarcoma in patients treated with doxorubicin.,-52.75,0.8,sequencevariant
"Altered lung cancer cell growth was observed when the A549 CellLine was transfected with CRISPR-Cas9–induced sequence variants such as the C282Y substitution in the TP53 GeneOrGeneProduct, the insertion of four nucleotides CCCC at position c.6799G>A, and the del (1) (p31.2p32.3) deletion in the CYP2D6 GeneOrGeneProduct, which together modulated apoptosis pathways and drug resistance to do",-69.5,0.8,sequencevariant
"Alterable gene expression in A549 cells was observed when the p.Ser63Asn mutation in TP53, a sequence variant, was introduced, revealing that the substitution of serine for asparagine at residue C63 disrupted DNA‑binding activity and consequently upregulated the expression of the downstream target gene GADD45A.",-87.0,0.8,sequencevariant
"Deletion of the four nucleotides CCCC at position c.7488CC in the CYP2D6 gene, identified as rs10942891, leads to a loss of lysine at residue p.223 and impairs enzymatic metabolism of the anti‑emetic drug ondansetron in *Homo sapiens* patients.",-59.5,0.8,sequencevariant
"Deletion and insertion sequence variants such as c.6799G>A and an insertion of the four nucleotides CCCC at position c.7488CC, together with a p.Ser63Asn missense change, were shown to disrupt the regulatory region of the TP53 gene in a cohort of Homo sapiens patients, leading to altered apoptosis pathways.",-61.25,0.8,sequencevariant
Deletion in the promoter region of IL6 (del(1)(p31.2p32.3)) reduces IL6 transcription and is associated with increased susceptibility to rheumatoid arthritis in individuals carrying the rs10942891 allele.,-35.75,0.8,sequencevariant
"Deletion within the promoter region of the TP53 gene (del(1)(p31.2p32.3)) disrupts binding of the transcription factor SP1, leading to reduced TP53 expression and increasing the risk of breast cancer in individuals carrying the rs10942891 variant.",-47.75,0.8,sequencevariant
"CRISPR‑mediated insertion of the four nucleotides CCCC at the c.6799G locus in the TP53 gene of the HCT‑116 CellLine induced a p.Ser63Asn SequenceVariant that attenuated p53’s transcriptional activation of the downstream GeneOrGeneProduct PUMA, thereby reducing apoptosis in response to doxorubicin treatment of the human cancer cells.",-53.75,0.8,sequencevariant
"CRP gene expression is markedly upregulated in monocytes carrying the rs10942891 sequence variant, which introduces a lysine at residue,223 and enhances the inflammatory response in patients with acute coronary syndrome.",-58.25,0.8,sequencevariant
"CR3022 antibody binding is impaired in cells expressing the sequence variant p.Ser63Asn of the SARS‑CoV‑2 spike protein, while the same mutation does not affect ACE2 receptor affinity.",-50.75,0.8,sequencevariant
CRLF2 overexpression driven by a c.7488CC insertion of four nucleotides CCCC in the IGH locus causes a B‑cell precursor ALL phenotype in patients carrying the rs10942891 polymorphism.,-42.25,0.8,sequencevariant
"Homozygous C282Y in the HFE gene, a sequence variant that replaces cysteine with tyrosine at residue‑282, is strongly associated with hereditary hemochromatosis in individuals carrying the rs1800562 allele.",-33.25,0.8,sequencevariant
"Heterozygous carriers of the BRCA1 c.68_69delAG sequence variant exhibit an elevated risk of breast cancer, as confirmed by functional assays that demonstrate impaired DNA repair activity in cultured HCC1937 cells.",-39.0,0.8,sequencevariant
"Hepatic overexpression of the BRCA1 p.Ser63Asn sequence variant in A549 cells exposed to doxorubicin led to a significant reduction in DNA repair activity, confirming the pathogenic role of this mutation in chemotherapy resistance.",-46.5,0.8,sequencevariant
"HCT116 cells harboring the BRCA1 c.68_69delAG variant exhibit heightened sensitivity to the DNA‑crosslinker mitomycin C, suggesting that this sequence variant disrupts homologous recombination repair.",-34.75,0.8,sequencevariant
"The BRCA1 variant g.3426G>A (c.5382C>T, p.Gly1794Asp) was found to disrupt homologous recombination and correlate with increased breast cancer risk in a cohort of European‑origin women.",-37.0,0.8,sequencevariant
"The g.3426G>A sequence variant in the MT-CO1 gene, predicted to create a Thr60Met substitution, was found to increase mitochondrial respiratory chain dysfunction and correlate with a higher risk of Parkinson’s disease in a cohort of Homo sapiens patients.",-33.75,0.8,sequencevariant
"The novel g.3426G>A sequence variant in the TP53 gene, which creates a Thr60Met substitution, was found to correlate with increased resistance to doxorubicin in A549 cells.",-24.0,0.8,sequencevariant
"The c.4153delA sequence variant in the mitochondrial ND1 gene was shown to disrupt complex I activity, causing a significant reduction in ATP production in HeLa cells treated with the chemical agent rotenone.",-32.25,0.8,sequencevariant
"In the patient cohort, the BRCA1 sequence variant g.3426G>A was detected alongside the missense mutation Thr60Met, both of which correlate with an elevated risk of early‑onset breast carcinoma.",-30.875,0.8,sequencevariant
"In a cohort of patients with hereditary spastic paraplegia, the pathogenic sequence variant g.3426G>A in the SPAST gene was detected, and its presence correlated with a more severe motor phenotype, while the novel deletion g.ORF15+652-653delAG in the same locus was associated with a milder disease course.",-42.25,0.8,sequencevariant
"In **Homo sapiens**, the **SequenceVariant** *g.3426G>A* in the **GeneOrGeneProduct** *TP53* leads to the amino‑acid substitution **Thr60Met**, which reduces the protein’s ability to bind DNA and thereby increases susceptibility to **DiseaseOrPhenotypicFeature** *colorectal cancer*.",-34.5,0.8,sequencevariant
"In hepatocellular carcinoma cell line Huh7, the sequence variant g.3426G>A within the TP53 promoter was found to reduce p53 transcriptional activity, correlating with increased cellular proliferation and resistance to doxorubicin treatment.",-29.875,0.8,sequencevariant
A CRISPR/Cas9‑edited HepG2 cell line harboring the sequence variant g.3426G>A in the promoter of CYP2E1 exhibited markedly increased mRNA expression of the detoxifying enzyme and heightened sensitivity to acetaminophen‑induced oxidative stress.,-35.0,0.8,sequencevariant
"A pathogenic sequence variant, g.3426G>A in the CYP2C9 gene, was found to correlate with altered enzyme activity and increased risk of warfarin-induced bleeding in patients of the Han Chinese population.",-31.375,0.8,sequencevariant
"A deleterious sequence variant g.ORF15 +652‑653delAG in the RPGR gene disrupts the splice acceptor site, leading to exon skipping and a premature truncation that causes retinal dystrophy in affected patients.",-39.25,0.8,sequencevariant
"A missense sequence variant rs2274700, encoding Thr60Met in the mitochondrial ATP synthase subunit, was found to reduce ATP production in HeLa cells, thereby enhancing sensitivity to the chemotherapeutic agent doxorubicin.",-30.625,0.8,sequencevariant
"Exon sequencing of the X-linked gene revealed a g.3426G>A sequence variant that co‑occurs with a Gly49Ser missense mutation and an adjacent -4‑basepair G‑to‑A indel, collectively contributing to the phenotypic variability observed in patients with retinitis pigmentosa.",-49.25,0.8,sequencevariant
"Examination of the CRY1 transcript in a cohort of circadian rhythm disorders revealed that the g.3426G>A sequence variant, which creates a Thr60Met substitution, was significantly associated with delayed sleep phase syndrome in individuals of European ancestry.",-41.5,0.8,sequencevariant
"Excessive expansion of the CAG repeat in the ATXN1 gene was found in a patient with spinocerebellar ataxia type‑1, and subsequent sequencing revealed a novel sequence variant, g.3426G>A, that correlated with earlier onset of ataxia symptoms.",-47.5,0.8,sequencevariant
"Exogenous exposure to doxorubicin induces a pronounced upregulation of the DNA repair gene TP53 in HeLa cells, but the effect is markedly attenuated in the presence of the BRCA1 g.3426G>A sequence variant, which alters the protein’s interaction with the p53 binding domain and reduces apoptosis.",-59.25,0.8,sequencevariant
"Deficiency of the m.3426G>A mitochondrial sequence variant, together with the pathogenic g.ORF15 +652‑653delAG, was shown to impair complex I activity and to be associated with early-onset Parkinson’s disease in a cohort of Homo sapiens patients.",-52.5,0.8,sequencevariant
"Defective mitochondrial DNA containing the g.3426G> A sequence variant disrupts the ND1 subunit, leading to impaired oxidative phosphorylation and accelerating the onset of Parkinson’s disease.",-40.75,0.8,sequencevariant
"Deficiencies in the TP53 c.536C>T (p.Pro179Leu) sequence variant, combined with the Gly49Ser polymorphism of the MDM2 promoter, reduce DNA‑damage‑induced apoptosis in A549 cells, thereby contributing to cisplatin resistance in non‑small cell lung carcinoma.",-58.25,0.8,sequencevariant
"Defects such as g.3426G>A and the g.ORF15 +652‑653delAG deletion are frequently detected in patients with severe retinitis pigmentosa, where the rs2274700 Thr60Met missense variant in RHO further aggravates the photoreceptor degeneration.",-56.0,0.8,sequencevariant
Alterations such as the g.3426G>A and the rs2274700 Thr60Met sequence variants within the TP53 gene are associated with increased tumor aggressiveness in HeLa cell lines treated with doxorubicin.,-34.75,0.8,sequencevariant
"Alteration of the BRCA1 sequence variant g.3426G>A was shown to impair RAD51 binding, thereby increasing susceptibility to breast cancer in patients carrying the rs2274700 allele.",-28.625,0.8,sequencevariant
Altered expression of the TP53 protein in HeLa cells harboring the sequence variant g.3426G>A was found to enhance apoptosis when treated with doxorubicin.,-27.0,0.8,sequencevariant
"Alterative analysis of the BRCA1 gene in a cohort of breast cancer patients identified a novel sequence variant g.3426G>A that co‑segregated with a pathogenic splice‑site mutation and predicted to abolish the binding of the RNA‑binding protein hnRNP A1, thereby disrupting normal mRNA processing.",-63.75,0.8,sequencevariant
"Pharmacogenomic analysis of the c.536C>T (p.Thr60Met) SequenceVariant in the TPMT gene revealed a significant association with increased risk of myelosuppression in patients treated with mercaptopurine, thereby underscoring the importance of genotyping for personalized dosing.",-46.75,0.8,sequencevariant
Phosphatidylinositol-3-kinase catalytic subunit alpha (PIK3CA) mutations such as the sequence variant c.1156G>A (Thr386Ile) have been shown to increase the risk of colorectal cancer in patients with familial adenomatous polyposis.,-47.25,0.8,sequencevariant
"Phytophthora infestans strain Pythium sp. strain Pythium sp. exhibited a g.3426G>A sequence variant that increased the expression of the effector gene AVR3a, thereby enhancing its virulence on tomato cultivars susceptible to late blight.",-68.0,0.8,sequencevariant
"Pharmaceutical screening of the KRAS sequencevariant g.3426G>A revealed a markedly increased sensitivity of A549 cells to the MEK inhibitor trametinib, suggesting that this variant alters downstream MAPK signaling and may predict therapeutic response.",-52.25,0.8,sequencevariant
"Mutations such as g.3426G>A and the -4-basepair G-to-A change in the TP53 promoter alter transcription factor binding, thereby reducing p53 protein levels and predisposing Homo sapiens individuals to increased tumor susceptibility.",-31.875,0.8,sequencevariant
"Mutational analysis of the mitochondrial genome in patients with neurodegenerative disease revealed a novel sequence variant, g.3426G>A, that co‑segregates with the clinical phenotype and alters the expression of the mitochondrial RNA polymerase gene.",-38.5,0.8,sequencevariant
"Mutagenic exposure to doxorubicin induces a g.3426G>A sequence variant in the TP53 gene, which is associated with a Thr60Met substitution that compromises p53 tumor‑suppressor activity in HeLa cells.",-29.5,0.8,sequencevariant
"Muta­tion of the sequence variant g.3426G>A in the TP53 gene’s exon six leads to a Thr60Met substitution that destabilizes the protein, thereby enhancing the susceptibility of HeLa cells to doxorubicin‑induced apoptosis.",-51.5,0.8,sequencevariant
"Experimental introduction of the g.3426G>A variant into CRISPR‑edited HeLa cells reduced transcription of the *CFTR* gene, thereby increasing cellular chloride efflux and improving airway epithelial fluid balance.",-60.5,0.8,sequencevariant
Experimental confirmation that the BRCA1 SequenceVariant g.3426G>A reduces DNA repair capacity demonstrates a direct link between this specific genomic alteration and increased breast cancer risk in Homo sapiens.,-39.25,0.8,sequencevariant
Experimental validation showed that the BRCA1 sequence variant g.3426G>A in Homo sapiens resulted in a Thr60Met substitution that significantly reduced homologous recombination efficiency in HeLa cells.,-35.0,0.8,sequencevariant
"Experimental analysis revealed that the g.3426G>A sequence variant in the TP53 gene leads to a Thr60Met substitution, which is associated with reduced p53 transcriptional activity and increased susceptibility to chemotherapy-induced apoptosis in HeLa cells.",-31.125,0.8,sequencevariant
"Deletion of g.ORF15 +652‑653delAG in the mitochondrial DNA of a patient with Leigh syndrome led to a loss of complex I assembly, confirming the pathogenic role of this sequence variant.",-34.5,0.8,sequencevariant
Deletion variant rs2274700 (c.4153delA) in the mitochondrial COX1 gene was found to increase the risk of Parkinson’s disease in a cohort of Homo sapiens individuals carrying the Gly49Ser polymorphism.,-36.5,0.8,sequencevariant
Deletion variants such as the g.ORF15 +652‑653delAG in the RPGR gene are strongly associated with X‑linked retinitis pigmentosa in patients carrying the CAG repeat expansion and the Thr60Met polymorphism in the same locus.,-44.5,0.8,sequencevariant
"Deletion at g.ORF15 +652-653delAG in the mitochondrial genome leads to loss of a conserved ATPase motif, causing reduced oxidative phosphorylation in HeLa cells and accelerating apoptosis in response to doxorubicin treatment.",-50.75,0.8,sequencevariant
Allele‑specific analysis of the g.3426G>A sequence variant in the OPRM1 gene revealed that the Thr60Met substitution in the opioid receptor significantly increased the risk of opioid‑induced hyperalgesia in patients infected with *Homo sapiens*.,-52.5,0.8,sequencevariant
"Allelic analysis of the mitochondrial gene MT‑ND1 revealed that the g.3426G>A variant, together with the g.ORF15 +652‑653delAG deletion, is strongly associated with the early onset of Leber hereditary optic neuropathy in patients of the East Asian cohort.",-43.25,0.8,sequencevariant
Alleles carrying the g.3426G>A sequence variant in the mitochondrial COI gene were associated with a reduced risk of Parkinson’s disease in a cohort of Homo sapiens patients.,-36.0,0.8,sequencevariant
"Alleal variation g.3426G>A within the TP53 promoter region was found to enhance NF‑κB binding, thereby increasing transcriptional activation of the TP53 gene in A549 cells.",-48.0,0.8,sequencevariant
Patients with the g.3426G>A variant in the mitochondrial COI gene exhibited a markedly higher risk of exercise‑induced arrhythmia compared with those carrying the wild‑type allele.,-30.25,0.8,sequencevariant
"Patients harboring the g.3426G>A sequence variant in the CYP2D6 gene exhibited a markedly reduced clearance of the chemotherapeutic agent doxorubicin, leading to increased cardiotoxicity.",-26.75,0.8,sequencevariant
Patients treated with the CRISPR‑Cas9 edited A549 cells harboring the g.3426G>A variant in the MYC promoter exhibited a significantly increased expression of c‑Myc and an accelerated proliferation rate compared to wild‑type controls.,-45.75,0.8,sequencevariant
Patients who carried the g.3426G>A sequence variant in the mitochondrial tRNA^Leu(UUR) gene exhibited markedly higher plasma lactate levels and a more rapid decline in exercise tolerance compared with subjects who were homozygous for the wild‑type allele.,-43.0,0.8,sequencevariant
"Carriers of the BRCA1 g.3426G>A SequenceVariant exhibit a higher risk of triple‑negative breast cancer compared with non‑carriers, and functional studies show that this change reduces homologous recombination efficiency in HeLa CellLine cells.",-41.5,0.8,sequencevariant
"Carrying the BRCA1 g.3426G>A sequence variant, which results in the Thr60Met substitution, significantly increases the risk of early‑onset breast cancer in women of African descent.",-28.75,0.8,sequencevariant
"Carcinogenic TP53 variant c.535C>T (p.Arg179His) was found to impair p53 DNA-binding activity and to increase the risk of colorectal cancer in multiple colorectal carcinoma cell lines, including HCT116 and SW480.",-56.0,0.8,sequencevariant
"Carried by the pathogenic g.3426G>A sequence variant, the TP53 gene product was found to have a reduced ability to bind to the promoter of the BAX gene, thereby diminishing apoptosis in HeLa cells treated with doxorubicin.",-44.75,0.8,sequencevariant
"Mutation of the CAG repeat in the HTT gene, accompanied by a g.4153delA sequence variant, exacerbates Huntington’s disease progression in patients carrying the Val539Asp allele.",-33.0,0.8,sequencevariant
"Mutation g.3426G>A in the CFTR gene results in a Thr60Met substitution that disrupts chloride channel gating, thereby increasing the risk of cystic fibrosis severity in affected individuals.",-28.375,0.8,sequencevariant
"Mutation analysis of a patient-derived tumor identified a novel g.3426G>A sequence variant that introduces a Thr60Met substitution in the TP53 gene, correlating with increased transcriptional repression of the p21 promoter.",-36.75,0.8,sequencevariant
"Mutation mapping revealed that the g.3426G>A sequence variant in the mitochondrial ND1 gene, which is linked to the Thr60Met substitution, is strongly associated with a decreased efficiency of oxidative phosphorylation in cultured A549 cells, potentially contributing to the development of hypoxic pulmonary hypertension.",-63.5,0.8,sequencevariant
"The BRCA1 c.643T>C (rs2234671) variant introduces a Q536X premature stop codon, which truncates the protein and is predicted to compromise its DNA repair function in breast cancer patients.",-28.875,0.8,sequencevariant
"The c.643T> C sequence variant in TP53, which leads to the histidine‑626‑to‑arginine amino‑acid substitution, was found to confer a higher risk of chemotherapy‑induced cardiotoxicity in patients with the rs2234671 genotype.",-30.75,0.8,sequencevariant
"The novel c.643T>C sequence variant in the HLA‑B gene, which results in a histidine‑626‑to‑arginine substitution, was found to be significantly associated with an increased risk of severe autoimmune hepatitis in patients of the rs2234671 genotype.",-37.75,0.8,sequencevariant
"The CRISPR‑Cas9‑edited A549 cells harboring the BRCA1 c.643T>C variant exhibited a histidine‑626‑to‑arginine substitution that, together with the Q536X truncation, reduced RAD51 protein levels and amplified DNA‑damage sensitivity.",-42.25,0.8,sequencevariant
"A c.643T>G missense mutation in TP53, predicted to cause a histidine‑626‑to‑arginine substitution, was found to destabilize the DNA‑binding domain, correlating with increased apoptosis in HeLa cells.",-31.5,0.8,sequencevariant
"A frameshift mutation, Ile262fs, in the TP53 gene was detected in a biopsy of a HeLa cell line derived from a Homo sapiens sample and was shown to up‑regulate the expression of the cyclin‑dependent kinase inhibitor CDKN1A, thereby inducing cell‑cycle arrest.",-44.25,0.8,sequencevariant
"A missense variant c.643T>C in TP53, resulting in histidine‑626‑to‑arginine, was detected in a patient with triple‑negative breast cancer and was associated with reduced p53 transcriptional activity.",-29.875,0.8,sequencevariant
"A homozygous c.643T>C transition in the TP53 gene, causing the Q536X truncation, was identified in a breast cancer patient whose tumor exhibited a higher proliferation rate, suggesting that this sequence variant may contribute to oncogenic progression.",-43.5,0.8,sequencevariant
Ile262fs in the TP53 sequence variant c.643T > C causes a truncated protein that is associated with increased tumor aggressiveness in A549 cells.,-26.375,0.8,sequencevariant
"Irradiation-induced apoptosis in the HeLa cell line was markedly enhanced by the c.643T > C missense mutation in TP53, which replaces histidine at position‑626 with arginine and is associated with increased cellular sensitivity to doxorubicin.",-55.5,0.8,sequencevariant
"I198T in the TP53 gene, a sequence variant (rs2234671) that replaces histidine with arginine at position c.643T>C, was found to increase the risk of lung carcinoma in a cohort of smokers.",-63.0,0.8,sequencevariant
"I suspect that the c.643T>C variant, which introduces a histidine‑to‑arginine substitution at position H626R, may underlie the increased risk of early‑onset Parkinson’s disease observed in carriers of rs2234671.",-53.75,0.8,sequencevariant
"Treated A549 cells harboring the BRCA1 c.643T > C variant exhibited markedly increased sensitivity to doxorubicin, whereas the same cells with the Q536X sequence variant displayed a pronounced resistance to the chemotherapeutic agent.",-38.0,0.8,sequencevariant
"Terapin-1 c.643T> C, a sequence variant reported in rs2234671, was found to down‑regulate the binding of the transcription factor SOX2 in A549 cells, thereby reducing the expression of the oncogenic gene MYC and suppressing tumor growth.",-65.0,0.8,sequencevariant
Toxoplasma gondii strain RH containing the sequence variant c.643T>C in the rhoptry protein gene RH-1 shows increased invasion efficiency in HeLa cells compared with the wild‑type strain.,-40.25,0.8,sequencevariant
T‑cell receptor sequence variant c.643T> C in the TRBV gene was found to enhance cytokine production and was associated with increased risk of graft‑versus‑host disease in HLA‑matched allogeneic stem‑cell transplant recipients.,-52.5,0.8,sequencevariant
"Histone deacetylase inhibitor vorinostat induces apoptosis in HeLa cells harboring the BRCA1 c.643T>C sequence variant, while the same treatment fails to affect A549 cells with the ILE262fs variant.",-37.0,0.8,sequencevariant
Histamine H3 receptor c.643T>C mutation (p.Thr215Pro) in a Homo sapiens patient with rs2234671 background led to reduced receptor binding and heightened susceptibility to histamine‑mediated cough.,-60.75,0.8,sequencevariant
Histidine‑626‑to‑arginine and the c.643T>C mutation in the BRCA1 gene are associated with a truncated Q536X protein that disrupts DNA repair in Homo sapiens.,-41.0,0.8,sequencevariant
"Histological analysis of the tumor revealed that the TP53 c.643T>G mutation, together with the BRCA1 Q536X sequence variant, drives the up‑regulation of the pro‑apoptotic protein Bax in the HeLa cell line.",-43.0,0.8,sequencevariant
"cDNA sequencing of a patient‐derived tumor revealed a BRCA1 c.643T > C sequence variant that introduces a premature stop codon (Q536X), a mutation previously reported as rs2234671 and associated with increased breast cancer susceptibility.",-41.25,0.8,sequencevariant
"c.-643T>C in the TP53 promoter creates an rs2234671 allele that upregulates p53 transcription, thereby sensitizing A549 cells to doxorubicin-induced apoptosis.",-32.5,0.8,sequencevariant
c.[c.643T>C] in the TP53 gene causes a p.[Ser215Arg] substitution that is linked to increased susceptibility to early‑onset breast cancer in individuals carrying the rs2234671 allele.,-39.5,0.8,sequencevariant
"cB2 cells harboring the c.643T>C sequence variant exhibit reduced TP53 expression, correlating with increased proliferation and enhanced resistance to doxorubicin-induced apoptosis.",-49.0,0.8,sequencevariant
"Mutations such as the c.643T>C transition in the TP53 gene, the Ile262fs frameshift in the BRCA1 coding region, and the histidine‑626‑to‑arginine substitution in the VEGFA protein are each associated with distinct alterations in protein function, cellular signaling, and cancer susceptibility in patients of the Homo sapiens species.",-53.0,0.8,sequencevariant
"Mutational analysis of a colorectal cancer sample revealed a c.643T>C nucleotide substitution in the KRAS gene, producing a C203S amino‑acid change that was associated with constitutive MAPK pathway activation and increased resistance to cetuximab in HCT‑116 cell lines.",-47.25,0.8,sequencevariant
"Mutagenesis of the TP53 gene in the A549 cell line revealed that the c.643T > C sequence variant (rs2234671) induces a histidine‑626‑to‑arginine substitution, which is associated with an increased rate of apoptosis and altered DNA‑damage response in these human lung carcinoma cells.",-47.5,0.8,sequencevariant
"Mutant TP53 harboring the c.643T > C sequence variant, which introduces a histidine‑626‑to‑arginine substitution, was shown to disrupt DNA binding in H1299 cells.",-33.75,0.8,sequencevariant
"CRISPR/Cas9-mediated editing of the BRCA1 c.643T>C variant in HeLa cells introduced the Ile262fs mutation, which abrogated DNA repair protein BRCA1 expression and sensitized the cells to doxorubicin-induced apoptosis.",-41.5,0.8,sequencevariant
"CRTC1‑gene Q536X sequence variant disrupts transcriptional co‑activation, causing impaired expression of the CREB‑binding protein and leading to abnormal neuronal differentiation in patients with intellectual disability.",-56.5,0.8,sequencevariant
"CR2 rs2234671 polymorphism, a c.643T> C variant, was found to modulate the risk of systemic lupus erythematosus in a cohort of Homo sapiens patients, while a concurrent Ile262fs sequence variant in the complement receptor gene was associated with a significantly higher disease activity score.",-58.75,0.8,sequencevariant
"CRP expression was increased in A549 cells harboring the BRCA1 c.643T>C sequence variant, suggesting that this DNA alteration may enhance inflammatory signaling through NF‑κB activation.",-41.25,0.8,sequencevariant
"In a cohort of colorectal cancer patients, the heterozygous c.643T > C variant in the MSH2 gene was found to co‑occur with the A1359C203S double mutation in the MLH1 promoter, and this combination was associated with a statistically significant increase in microsatellite instability compared with patients carrying either variant alone.",-50.5,0.8,sequencevariant
"In colorectal cancer, the sequence variant c.643T>C in the APC gene, which results in the amino‑acid change histidine‑626‑to‑arginine, was found to enhance Wnt signaling and increase tumor cell proliferation.",-35.75,0.8,sequencevariant
"In patients carrying the BRCA1 c.643T> C variant, the resulting p.Ile262fs frameshift mutation impairs DNA repair and increases breast cancer risk.",-27.75,0.8,sequencevariant
"In cervical carcinoma cell line HeLa, the c.643T>G sequence variant in the MSH2 gene causes a histidine‑626‑to‑arginine substitution that reduces mismatch‑repair activity and increases sensitivity to the DNA‑damaging agent cisplatin.",-36.75,0.8,sequencevariant
"Analysis of the A549 cell line revealed that the c.643T > C sequence variant in the TP53 gene, which results in the histidine‑626‑to‑arginine substitution, was associated with increased resistance to doxorubicin treatment.",-29.5,0.8,sequencevariant
"Analysis revealed that the c.643T > C variant in the TP53 gene, which results in a histidine‑626‑to‑arginine substitution, is linked to a higher risk of chemotherapy‑induced cardiotoxicity in patients with the rs2234671 allele.",-35.75,0.8,sequencevariant
"Analysis showed that the c.643T>C (p. Ile262fs) sequence variant in the BRCA1 gene, together with the rs2234671 polymorphism, conferred a higher risk of triple‑negative breast cancer in the studied cohort.",-42.0,0.8,sequencevariant
"Analysis shows that the c.643T> C sequence variant, which results in the histidine‑626‑to‑arginine substitution, is predicted to create a loss‑of‑function allele in the TP53 gene and may increase susceptibility to breast cancer in carriers of the rs2234671 haplotype.",-56.25,0.8,sequencevariant
Mutation of TP53 c.643T>C in the A549 cell line caused a histidine‑626‑to‑arginine substitution that was associated with increased apoptosis of Homo sapiens cancer cells.,-35.5,0.8,sequencevariant
"Mutation c.643T> C in the TP53 gene was found to co‑occur with the Ile262fs variant in HeLa cells, causing a severe loss of tumor‑suppressor activity and increased sensitivity to doxorubicin.",-35.5,0.8,sequencevariant
"Mutation analysis of a colorectal cancer sample revealed a c.643T>C transition in KRAS, creating the histidine‑626‑to‑arginine polymorphism (rs2234671) that correlates with increased tumor aggressiveness.",-36.25,0.8,sequencevariant
"Mutation rs2234671 in the TP53 gene, which results in a histidine‑626‑to‑arginine substitution, was shown to alter the DNA‑binding domain and correlate with increased tumor‑suppressor loss in colorectal carcinoma cells.",-36.0,0.8,sequencevariant
"When the BRCA1 c.643T> C variant creates the Ile262fs sequence variant, it disrupts the protein’s C‑terminal domain, leading to reduced DNA‑repair capacity and an elevated risk for triple‑negative breast cancer in affected individuals.",-49.0,0.8,sequencevariant
"When CRISPR‑mediated editing introduced the c.643T > C (rs2234671) substitution in the TP53 gene, the resulting Ile262fs frameshift variant disrupted the DNA‑binding domain and caused a pronounced loss of p53‑mediated apoptosis in A549 cells, thereby increasing their resistance to doxorubicin treatment.",-49.75,0.8,sequencevariant
"When a BRCA1 c.643T > C sequence variant introduces a Q536X premature stop codon, the resulting truncated protein fails to recruit homologous recombination factors, thereby impairing DNA repair in the A549 cell line and increasing sensitivity to cisplatin.",-37.75,0.8,sequencevariant
"When HEK293T cells harbor the BRCA1 c.643T>C sequence variant, the resulting Q536X protein truncation disrupts DNA repair, leading to increased genomic instability and a higher risk of breast cancer.",-37.25,0.8,sequencevariant
"High‑throughput sequencing revealed that the c.643T> C transition in TP53, which results in the Ile262fs frameshift variant, is strongly associated with loss of tumor‑suppressor function in colorectal carcinoma cells.",-41.25,0.8,sequencevariant
"High-throughput sequencing of patient‐derived tumors revealed that the c.643T>​C transition in TP53, creating a Q536X truncation, was associated with loss of p53 DNA‑binding activity and was significantly enriched in breast cancers carrying the rs2234671 polymorphism.",-60.5,0.8,sequencevariant
"High‐throughput sequencing of the CDKN2A promoter in melanoma patients revealed that the c.643T>G sequence variant creates a novel CTCF binding site, thereby enhancing expression of the neighboring TERT gene and contributing to increased tumor proliferation.",-57.0,0.8,sequencevariant
"High–throughput sequencing revealed that the c.643T>C (rs2234671) variant in the CYP2C9 gene induces a histidine‑626‑to‑arginine substitution, which is predicted to destabilize the active site and significantly reduce warfarin metabolism in Homo sapiens.",-53.0,0.8,sequencevariant
"Polymorphisms such as c.643T>C and rs2234671 in the TP53 gene were associated with an increased risk of colorectal cancer in a cohort of Homo sapiens patients, while a rare sequence variant Ile262fs was detected in a subset of individuals carrying the KRAS G12D mutation, suggesting a potential synergistic effect on tumor progression.",-51.0,0.8,sequencevariant
Polymyxin B treatment of Pseudomonas aeruginosa strains carrying the c.643T > C sequence variant in the pmrB gene resulted in a histidine‑626‑to‑arginine substitution that confers high‑level resistance to the drug.,-46.0,0.8,sequencevariant
"Poles to the hypothesis that the c.643T>C sequence variant in TP53 disrupts p53 DNA‑binding, the rs2234671 polymorphism in the promoter of MDM2 enhances its expression, and the Ile262fs deletion in the BRCA1 exon leads to loss of the BRCT domain, together predict a higher risk of breast cancer in women of European descent.",-82.5,0.8,sequencevariant
"Polysubstitution of the TP53 gene, such as the c.643T>C variant resulting in histidine‑626‑to‑arginine, was found to increase the risk of early onset colorectal cancer in patients carrying the rs2234671 allele.",-42.5,0.8,sequencevariant
"The p.Asp50Asn sequence variant (c.149C>G) in the ABCB1 gene, annotated as rs6275, was found to alter drug efflux activity in Huh‑7 hepatocellular carcinoma cells, thereby reducing doxorubicin sensitivity.",-37.0,0.8,sequencevariant
"The c.471C>T (rs4539) variant in the CYP1A1 gene, which substitutes alanine for proline at amino acid position ‑286, was found to increase the risk of hepatocellular carcinoma in a cohort of H. pylori–positive Homo sapiens patients.",-49.0,0.8,sequencevariant
"The KRAS p.Asp50Asn sequence variant (c.148G>A, rs6275) was detected in a subset of A549 cells, where it disrupted GTPase activity and promoted resistance to the small‑molecule inhibitor erlotinib.",-33.0,0.8,sequencevariant
"The CRISPR‑edited A549 cells harboring the c.1182C> T sequence variant (rs4539) exhibit reduced p.Asp50Asn protein stability, leading to diminished IL‑6 secretion and enhanced sensitivity to the chemotherapeutic agent doxorubicin.",-40.0,0.8,sequencevariant
"In HCC cells, the c.1182C>T SequenceVariant (rs6275) within the TP53 GeneOrGeneProduct reduces p53 binding to the MDM2 promoter, thereby enhancing apoptosis and sensitizing the cells to doxorubicin, a ChemicalEntity, while the A549 CellLine shows higher basal expression of this variant compared to the HeLa CellLine.",-55.0,0.8,sequencevariant
"In a cohort of *Homo sapiens* patients, the sequence variant c.1182C>T in the *TP53* gene, which replaces alanine with proline at amino acid position *286*, was found to correlate with increased sensitivity to the chemotherapeutic agent doxorubicin in A549 lung carcinoma cells.",-43.75,0.8,sequencevariant
"In the colorectal carcinoma cell line HCT‑116, the c.2187delA sequence variant in the β‑catenin gene led to a truncated protein that impaired Wnt signaling and increased sensitivity to the small‑molecule inhibitor pyrvinium, illustrating how a single nucleotide deletion can modulate drug response.",-40.5,0.8,sequencevariant
"In THP‑1 cells, the c.1182C>T sequence variant, which changes the encoded glutamine to arginine at codon Q126R, is associated with a reduced inflammatory cytokine profile upon LPS stimulation.",-55.0,0.8,sequencevariant
"A missense variant c.1182C>T (p.Asp50Asn) in the GNAS gene, identified by rs6275 genotyping in a cohort of Homo sapiens patients, was shown to alter protein function and increase susceptibility to hyperthyroidism.",-36.25,0.8,sequencevariant
"A c.471C>T (rs4539) variant in the AICDA gene was found to up‑regulate IL‑6 production in activated A549 cells, thereby linking the sequence variant to a pro‑inflammatory phenotype in human lung carcinoma.",-47.0,0.8,sequencevariant
"A U‑splicing variant, c.1182C>T, in the IL2RA gene (rs6275) was found to alter the protein surface, impairing IL‑2 binding and contributing to the increased susceptibility of multiple sclerosis in individuals homozygous for the variant.",-60.75,0.8,sequencevariant
"A patient harboring the sequence variant rs6275 within the CYP2D6 gene exhibited reduced metabolism of the chemotherapeutic agent doxorubicin, leading to heightened cardiotoxicity.",-25.875,0.8,sequencevariant
"cDNA sequencing of the CYP2D6 gene in a cohort of *Homo sapiens* revealed a novel sequence variant c.1182C>T, which alters the codon for alanine at amino acid position, resulting in the amino‑acid substitution p.Asp50Asn and correlating with reduced enzyme activity in individuals carrying the rs6275 allele.",-64.0,0.8,sequencevariant
"c.^1182C>T in the IL2RA gene, a sequence variant that replaces glutamine with alanine at amino acid position ^286, was found to be associated with increased susceptibility to multiple sclerosis in individuals carrying the rs6275 allele.",-57.5,0.8,sequencevariant
c.[c.1182C>T] in the CYP2D6 gene produces a p.Asp394Asn sequence variant that is associated with a decreased response to the antidepressant drug sertraline in Homo sapiens.,-47.75,0.8,sequencevariant
"c.c.2187delA in the TP53 gene was found to disrupt the DNA‑binding domain, causing a loss of p53 transcriptional activity and correlating with an increased incidence of colorectal cancer in patients of Homo sapiens.",-44.25,0.8,sequencevariant
"Gene expression of the **p.Asp50Asn** variant in **Homo sapiens** was shown to alter the binding of the transcription factor **TFAP2A**, resulting in a down‑regulation of the **TP53** promoter and contributing to the heightened sensitivity of **A549** cells to **doxorubicin**.",-61.5,0.8,sequencevariant
"Gene‑editing of the KRAS locus in A549 cells revealed that a c.1182C>T (p.Arg394Cys) sequence variant, which is catalogued as rs6275, reduces the binding affinity of the mutant protein for downstream MAPK effectors, thereby impairing proliferative signaling.",-51.75,0.8,sequencevariant
Gene editing of the TP53 c.1182C>T variant in A549 cells induces a p.Asp50Asn substitution that disrupts the DNA-binding domain and enhances apoptosis in response to doxorubicin.,-30.125,0.8,sequencevariant
Gene therapy using CRISPR/Cas9 to correct the pathogenic c.471C>T (p.Pro286Ala) sequence variant in the GNAS gene has been shown to rescue cyclic AMP signaling defects in primary fibroblasts derived from a patient with pseudohypoparathyroidism type Ia.,-42.25,0.8,sequencevariant
"Mutations such as c.471C>T in the TP53 gene, which substitute alanine for proline at amino acid position (286), have been linked to the progression of breast cancer in women of Homo sapiens carrying the rs4539 allele.",-52.75,0.8,sequencevariant
"Mutational analysis of the BRCA1 gene in a cohort of breast cancer patients revealed a novel c.1182C>T sequence variant, which results in a p.Asp394Glu substitution and is predicted to disrupt the protein’s DNA‑binding domain, thereby impairing homologous recombination repair.",-39.5,0.8,sequencevariant
"Mutagenic exposure in HeLa cells carrying the c.1182C>T sequence variant (rs6275) induced a p.Asp50Asn substitution, thereby impairing the protein’s DNA repair function and elevating cellular apoptosis.",-44.5,0.8,sequencevariant
"Mutating the TP53 gene to the c.2187delA sequence variant in the A549 CellLine resulted in a loss of p53‑dependent apoptosis when treated with doxorubicin, a phenotype previously linked to rs6275 in patients with colorectal cancer.",-50.0,0.8,sequencevariant
"Mutation c.1182C>T in the CYP1A1 gene, located at the rs6275 locus, was found to increase the expression of the enzyme in HepG2 cells, thereby enhancing the metabolic activation of the carcinogen benz(a)pyrene.",-38.0,0.8,sequencevariant
Mutation of the c.1182C>T variant in the CYP2D6 gene (rs6275) was found to alter drug metabolism in a cohort of *Homo sapiens* patients with Parkinson’s disease.,-27.25,0.8,sequencevariant
Mutation classification of the c.1182C>​T sequence variant in the IL4R gene revealed that patients harboring the rs6275 allele showed increased susceptibility to atopic dermatitis.,-46.75,0.8,sequencevariant
"Mutation rs6275 in the CFTR gene, which causes an alanine-to-proline substitution at amino acid position **286**, is frequently detected in patients with cystic fibrosis and is associated with a more severe chloride transport defect.",-48.5,0.8,sequencevariant
"Cancer cell line A549 treated with doxorubicin exhibited a p.Asp50Asn sequence variant (c.149C>A) in the TP53 gene, which correlated with increased apoptosis and reduced proliferation compared to wild‑type TP53 A549 cells.",-36.0,0.8,sequencevariant
"Cancer‑cell line HeLa treated with the small molecule doxorubicin (Drug) displayed a significant up‑regulation of the tumor suppressor gene TP53 (GeneOrGeneProduct) and an increase in the frequency of the sequence variant c.1182C>T (SequenceVariant), a polymorphism previously reported to influence anthracycline sensitivity in breast cancer patients.",-65.0,0.8,sequencevariant
"Cancer researchers discovered that the c.471C> T sequence variant in the CYP2D6 gene, annotated as rs4539, reduces enzyme activity and alters the pharmacokinetics of the anticancer drug doxorubicin in patients of the Homo sapiens species.",-47.75,0.8,sequencevariant
"Cancer therapy with doxorubicin induces a sequence variant c.1182C>T in the TP53 gene, which replaces alanine with proline at amino acid position‑286, thereby impairing DNA damage response in the HeLa cell line.",-52.75,0.8,sequencevariant
"Treated HeLa cells carrying the BRCA1 c.1182C>T sequence variant showed elevated RAD51 protein levels and increased resistance to doxorubicin, an effect linked to the rs4539 polymorphism in the DNA repair pathway.",-42.25,0.8,sequencevariant
"Tyr‑273Cys in the TP53 sequence variant rs6275 was found to increase the binding affinity for MDM2, thereby enhancing p53 degradation in Homo sapiens liver cells.",-52.25,0.8,sequencevariant
"T cells from a patient harboring the rs6275 CCTTT‑13 variant in the IL‑10 promoter exhibited increased IL‑10 secretion, whereas CRISPR‑edited Jurkat cells carrying the c.1182C>T (p.Asp396Asn) sequence variant showed markedly reduced STAT3 activation upon IL‑6 stimulation.",-56.5,0.8,sequencevariant
"Tissue‑specific expression of the SP1 transcription factor was reduced in HeLa cells carrying the c.1182C>T SequenceVariant (rs4539), leading to decreased TP53 transcription and increased sensitivity to the DNA‑damaging agent doxorubicin.",-43.5,0.8,sequencevariant
"Sequencing of the BRCA1 exon revealed a c.1182C>T (p.Thr394Ile) variant, which in vitro assays showed reduces homologous recombination efficiency in Hs578T cells.",-44.5,0.8,sequencevariant
"Sequenced c.1182C>T and c.471C>T variants in the IL1RN gene of a cohort of HLA‑B27 positive Ankylosing Spondylitis patients revealed that the rs6275 allele, encoding the p.Asp50Asn substitution, was significantly enriched compared with healthy controls and correlated with increased disease severity.",-61.25,0.8,sequencevariant
"Sequenza analysis of a colorectal tumor revealed a BRCA2 sequence variant c.1182C>T (p.Asp50Asn), which co‑occurs with a neighboring rs4539 SNP and appears to correlate with reduced DNA repair capacity.",-56.75,0.8,sequencevariant
"Sequenom genotyping of the rs6275 polymorphism, a c.1182C>T transition in the IL6 promoter, revealed that the p.Asp50Asn variant correlates with increased cytokine production in a subset of patients with rheumatoid arthritis.",-46.0,0.8,sequencevariant
"Altering the codon at position c.1182C>T in the CYP2C9 gene (rs6275) produces the p.Asp376Asn variant, which diminishes drug metabolism and is clinically associated with increased risk of hepatotoxicity in patients receiving phenytoin.",-53.25,0.8,sequencevariant
"Alzheimer’s disease patients carrying the rs6275 polymorphism exhibit a markedly higher amyloid‑beta burden, suggesting that this sequence variant modulates disease progression.",-34.5,0.8,sequencevariant
"Alcian blue staining of fibroblasts from patients carrying the c.1182C> T sequence variant (p.Asp50Asn) revealed reduced proteoglycan deposition, suggesting that this missense mutation in the COL2A1 gene alters extracellular matrix composition and contributes to early-onset osteoarthritis.",-56.75,0.8,sequencevariant
"Alteration of the c.2187delA sequence variant in the CYP2C19 gene was found to decrease enzymatic activity, thereby exacerbating drug-induced hepatotoxicity in a cohort of *Homo sapiens* patients treated with the chemotherapeutic agent irinotecan.",-52.5,0.8,sequencevariant
Methotrexate treatment of HeLa cells harboring the c.1182C>T (p.Asp50Asn) sequence variant in the DHFR gene resulted in a marked reduction of folate-dependent thymidylate synthase activity.,-34.5,0.8,sequencevariant
"Methionine to cysteine substitution at position CCTTT13 in the TP53 gene, annotated as rs6275, alters the protein’s DNA‑binding domain, reducing apoptosis in HeLa cells and contributing to acquired resistance to doxorubicin.",-58.25,0.8,sequencevariant
Methadone treatment in A549 cells harboring the c.1182C>T (p.Asp50Asn) variant of the CYP2B6 gene showed a significant reduction in drug‑metabolizing enzyme activity compared to wild‑type cells.,-34.5,0.8,sequencevariant
"Methylenetetrahydrofolate reductase (MTHFR) p.Asp50Asn (c.1182C>T, rs6275) reduces enzyme activity in Homo sapiens, increasing homocysteine levels and predisposing individuals to hyperhomocysteinemia and cardiovascular disease.",-36.0,0.8,sequencevariant
"p.Asp50Asn in the TP53 gene, a sequence variant found in rs6275, was shown to reduce transcriptional activity and increase susceptibility to colorectal cancer in patients with a germline c.1182C>T mutation.",-36.75,0.8,sequencevariant
"p.Asn50Asp (c.149C>G) in the GPIHBP1 gene (rs6275) was identified in a cohort of African‑American patients with hypertriglyceridemia and was found to disrupt the binding of lipoprotein lipase, thereby linking this SequenceVariant to the disease phenotype.",-50.25,0.8,sequencevariant
"p.D50N (c.149A>G) in the IL6R gene was identified in a cohort of patients with rheumatoid arthritis, and the variant allele rs6275 was associated with an increased risk of disease progression, suggesting a functional impact on IL‑6 signaling.",-51.5,0.8,sequencevariant
"p.Arg50Asn (c.149C>A) in the TP53 gene (rs28929424) was found to increase the risk of colorectal cancer in a cohort of Homo sapiens patients, whereas the synonymous A1359A variant (c.1359G>A) in the same gene showed no association with disease severity.",-50.5,0.8,sequencevariant
"Erythrocyte membrane protein spectrin carrying the c.1182C> T sequence variant (rs6275) was found to diminish ion transport efficiency in cells derived from a patient with hereditary spherocytosis, thereby illustrating how a single nucleotide polymorphism can alter a gene product’s function.",-56.75,0.8,sequencevariant
Epidemiological analysis of the rs6275 sequence variant revealed that carriers of the p.Asp50Asn substitution exhibit a statistically significant increase in the risk of developing type‑2 diabetes mellitus in a Caucasian cohort.,-38.75,0.8,sequencevariant
"Ethanol exposure induces a p.Asp50Asn substitution in the CYP2E1 gene, and the resulting rs6275 variant correlates with increased risk of alcoholic liver disease in Homo sapiens.",-28.375,0.8,sequencevariant
"E1400K, a c.4199G>A SequenceVariant in the TP53 Gene, was found to drastically reduce the protein’s DNA‑binding affinity, thereby contributing to the aggressive phenotype observed in the A549 CellLine harboring the same mutation.",-56.75,0.8,sequencevariant
"Sequencing of the TP53 gene in a cohort of colorectal cancer patients revealed a novel c.474delA (p.E300X) sequence variant, which was found to disrupt p53’s DNA‑binding domain and correlate with a higher incidence of early‑stage disease in individuals of European ancestry.",-42.75,0.8,sequencevariant
"Sequenced DNA from the tumor revealed a BRCA1 c.474delA sequence variant, which results in a p.E300X truncated protein that may impair DNA repair in the affected patient.",-40.25,0.8,sequencevariant
"Sequental analysis of patient-derived tumor biopsies revealed that the BRCA1 c.474delA variant, causing a premature p.E300X truncation, was strongly associated with reduced homologous recombination repair capacity and heightened sensitivity to platinum-based chemotherapy in a cohort of Homo sapiens breast cancer specimens.",-56.25,0.8,sequencevariant
"Sequencer‑derived analysis of a lung carcinoma biopsy revealed a BRCA1 c.474delA variant, resulting in a p.E300X premature termination codon that truncates the protein’s DNA‑binding domain, thereby impairing homologous recombination repair in the patient’s Homo sapiens tumor cells.",-51.5,0.8,sequencevariant
"The BRCA1 c.474delA sequence variant, which causes a frameshift resulting in the premature stop codon p.E300X, was identified in a patient who also harbored the rs729302 polymorphism and exhibited early onset breast cancer.",-31.0,0.8,sequencevariant
"The CRISPR/Cas9‑edited HeLa cells harboring the BRCA1 c.474delA (p.E158X) sequence variant displayed a markedly reduced homologous recombination repair capacity compared to wild‑type controls, confirming the deleterious effect of this mutation on DNA damage response.",-34.5,0.8,sequencevariant
"The clinical study demonstrated that the BRCA1 c.474delA sequence variant, which produces a p.E300X premature stop codon, markedly increases breast cancer susceptibility in women of Asian descent.",-26.25,0.8,sequencevariant
"The c.474delA sequence variant in the TP53 gene was found to cause a premature stop codon (p.E300X), leading to loss of tumor suppressor activity in HepG2 cells.",-21.625,0.8,sequencevariant
A CRISPR-Cas9 knock‑in of the BRCA1 c.474delA sequence variant in A549 cells produced a premature p.E300X protein that markedly reduced homologous recombination repair and sensitized the cells to the DNA‑damaging drug doxorubicin.,-31.0,0.8,sequencevariant
"A c.474delA variant in TP53, resulting in the p.E300X truncation, was found to destabilize the DNA-binding domain of the protein in a cohort of colorectal cancer patients, thereby exacerbating tumor progression.",-38.0,0.8,sequencevariant
A homozygous c.474delA sequence variant in the TP53 gene causes a premature p.E300X truncation that is associated with increased susceptibility to sporadic colorectal cancer in patients carrying the rs729302 allele.,-26.25,0.8,sequencevariant
"A SNP rs729302 in TP53, together with a c.474delA sequence variant causing a p.E300X premature stop, was found to disrupt the p53 DNA‑binding domain and significantly increase the risk of high‑grade glioblastoma in Homo sapiens.",-46.75,0.8,sequencevariant
"In HeLa cells harboring the BRCA1 c.474delA sequence variant, the resulting p.E300X truncation impairs homologous recombination and sensitizes the cells to the PARP inhibitor olaparib, thereby reducing tumor cell survival.",-24.375,0.8,sequencevariant
"In the cultured A549 cells, the CRISPR‑edited sequence variant c.474delA in the KRAS gene produced a V311fs frameshift that led to a truncated protein and markedly increased cell proliferation and resistance to the chemotherapeutic agent doxorubicin.",-39.0,0.8,sequencevariant
"In colorectal cancer cell line HCT116, the c.474delA sequence variant causes a p.E300X premature stop codon that abolishes APC protein function, leading to β‑catenin accumulation and enhanced tumorigenic signaling.",-25.25,0.8,sequencevariant
"In HepG2 cells, the BRCA1 sequence variant c.474delA, a V311fs deletion, was shown to disrupt E3 ubiquitin ligase activity, leading to accumulation of the p.E300X mutant protein and increased genomic instability.",-46.5,0.8,sequencevariant
"Alterations such as the c.474delA sequence variant in TP53, which induces a p.E300X truncation, impair DNA‑damage response pathways in Homo sapiens tumor cells, thereby contributing to aggressive phenotypes observed in HeLa cell line experiments.",-50.5,0.8,sequencevariant
"Alteration of the BRCA1 sequence variant c.474delA results in a truncated protein that disrupts DNA repair pathways, thereby increasing susceptibility to hereditary breast cancer in affected individuals.",-30.0,0.8,sequencevariant
"Altered growth and increased apoptosis were observed in HeLa cells transfected with a plasmid encoding the BRCA1 sequence variant c.474delA, which introduces a premature stop codon (p.E300X) and results in loss of the protein’s DNA‑repair domain.",-36.25,0.8,sequencevariant
"Alterative sequencing of the TP53 gene in the HeLa cell line revealed a novel c.474delA variant, which generates a premature p.E300X truncation that correlates with loss of p53 transcriptional activity in vitro.",-47.75,0.8,sequencevariant
"Mutations such as BRCA1 c.68_69delAG and the sequence variant BRCA2 c.474delA were shown to disrupt homologous recombination, thereby increasing the risk of hereditary breast cancer in affected Homo sapiens patients.",-37.25,0.8,sequencevariant
"Mutational analysis of the KRAS gene in colorectal carcinoma revealed that the c.474delA sequence variant, which generates a premature p.E300X stop codon, correlated with aggressive tumor phenotypes and reduced patient survival.",-38.25,0.8,sequencevariant
"Mutual sequencing of the BRCA1 locus in patients with familial breast cancer revealed that the c.474delA sequence variant, which causes a premature stop at p.E300X, co‑occurs with the V311fs frameshift and the G196S missense mutation, collectively exacerbating DNA repair deficiency and increasing susceptibility to early onset disease.",-67.0,0.8,sequencevariant
Mutagenesis of the BRCA1 sequence variant c.474delA in HeLa cells produced a truncated protein that abolished homologous recombination repair and increased sensitivity to the chemotherapeutic agent doxorubicin.,-32.75,0.8,sequencevariant
Biopsies from patients with a BRCA1 c.474delA (p.E300X) sequence variant revealed a higher frequency of homologous recombination deficiency and increased sensitivity to PARP inhibitors.,-34.25,0.8,sequencevariant
"Biopsy‐derived DNA from a patient with breast carcinoma revealed a novel sequence variant, c.474delA, that generates a premature stop codon (p.E300X) and is predicted to disrupt the BRCA1 protein’s functional domain.",-37.0,0.8,sequencevariant
"Biological analysis of a patient-derived A549 tumor revealed a pathogenic BRCA1 c.474delA sequence variant that causes a frameshift and premature stop codon at p.E300X, correlating with the observed cisplatin resistance.",-50.0,0.8,sequencevariant
"Bi-allelic inheritance of the BRCA1 c.474delA sequence variant, which produces a premature p.E300X truncation, was found to correlate with increased breast cancer risk in a cohort of Homo sapiens patients carrying the rs729302 SNP.",-34.75,0.8,sequencevariant
"Bringing together the molecular data, the c.474delA variant in the BRCA1 gene was shown to cause a frameshift leading to a premature stop codon that correlates with a higher risk of breast cancer in patients of the Homo sapiens population.",-49.5,0.8,sequencevariant
"Branched‑chain amino acid aminotransferase (BCAT1) harboring the c.474delA sequence variant (p.Ser157Ser) was found to increase enzymatic activity and correlate with enhanced proliferation of HCT116 cells, whereas the adjacent rs729302 SNP (C to G) did not affect expression.",-59.0,0.8,sequencevariant
"Bridging the clinical gap, the BRCA1 sequence variant c.474delA, which generates a premature stop codon (p.E300X), was identified in a breast cancer patient, leading to truncated protein expression and loss of DNA repair capacity.",-43.75,0.8,sequencevariant
"Brisk progression of neurodegeneration in the patient was linked to the BRCA1 c.474delA sequence variant, which predicts a premature p.E300X truncation and loss of DNA repair function.",-34.25,0.8,sequencevariant
"cDNA sequencing of the HER2 gene in the breast cancer cell line MCF-7 revealed a novel c.474delA variant that predicts a premature p.E300X truncation, potentially disrupting downstream signaling pathways.",-42.75,0.8,sequencevariant
"c.-474delA in the TP53 gene results in a p.E300X nonsense mutation that truncates the DNA‑binding domain, leading to loss of p53‑mediated apoptosis in A549 cells.",-35.5,0.8,sequencevariant
"c.\,474delA in the TP53 gene causes a V311fs frame‑shift that truncates the protein at p.E300X, thereby abolishing the DNA‑binding domain and impairing the tumor‑suppressive activity of the mutant protein in human colorectal carcinoma cells.",-50.75,0.8,sequencevariant
c.”},-23.0,0.8,sequencevariant
"Patients whose TP53 gene harbors the c.474delA sequence variant exhibit a higher frequency of p.E300X truncations, leading to impaired DNA‑damage response and increased susceptibility to chemotherapeutic toxicity.",-36.0,0.8,sequencevariant
"Patients carrying the BRCA1 sequence variant c.474delA exhibit a higher risk of early‑onset breast cancer, while those with the silent polymorphism p.Ser157Ser show no detectable difference in clinical outcome.",-32.5,0.8,sequencevariant
Patients bearing the BRCA1 c.474delA variant exhibited markedly reduced RAD51 foci formation and a corresponding increase in genomic instability during homologous recombination repair assays.,-32.75,0.8,sequencevariant
"Patients harboring the sequence variant c.474delA in TP53 displayed markedly increased p53 protein degradation and were more likely to develop high-grade neuroendocrine carcinoma, whereas individuals with the rs729302 polymorphism exhibited a modest, statistically nonsignificant decrease in apoptosis upon cisplatin exposure.",-70.0,0.8,sequencevariant
Our analysis revealed that the BRCA1 sequence variant c.474delA (rs729302) induces a premature p.E300X truncation that dramatically reduces DNA repair capacity in HeLa cells.,-35.0,0.8,sequencevariant
"Our study demonstrated that the BRCA1 c.474delA sequence variant creates a premature p.E300X stop codon, causing loss of the protein’s DNA‑binding domain and markedly increasing breast cancer risk in patients homozygous for the allele.",-39.25,0.8,sequencevariant
"Our recent CRISPR/Cas9 screening revealed that the BRCA1 c.474delA sequence variant creates a premature p.E300X truncation that drastically reduces DNA repair capacity in HeLa cells, confirming the pathogenic role of this mutation.",-44.25,0.8,sequencevariant
"Our targeted sequencing revealed a novel BRCA1 c.474delA variant (p.E300X) in a patient whose tumor exhibited a V311fs deletion, indicating a compound heterozygous impact on DNA repair capacity.",-49.25,0.8,sequencevariant
Mutation of the BRCA1 sequence variant c.474delA in a patient with hereditary breast cancer led to a truncated protein that impairs homologous recombination and increases sensitivity to platinum-based chemotherapy.,-28.375,0.8,sequencevariant
"Mutation c.474delA in the TP53 gene, which creates a premature stop codon at position p.E300X, was found to be strongly associated with the increased risk of osteosarcoma in a cohort of Homo sapiens patients.",-32.75,0.8,sequencevariant
"Mutation rs729302, a c.474delA leading to a V311fs frameshift in TP53, was found to dramatically reduce the transcriptional activity of the p53 protein in HeLa cells, thereby enhancing cellular proliferation and chemoresistance in a homozygous Homo sapiens population.",-58.0,0.8,sequencevariant
"Mutation analysis of a lung‑derived A549 cell line revealed a BRCA1 c.474delA sequence variant that creates a p.E300X premature stop codon, while a parallel screen of an E. coli strain identified a G1899A SNP (rs729302) associated with altered enzyme activity.",-46.5,0.8,sequencevariant
"CRISPR‑mediated introduction of the BRCA1 c.474delA variant in MCF‑7 cells produced a frameshift (p.E158fs) that markedly reduced homologous recombination repair, thereby sensitizing the cells to PARP inhibition.",-35.5,0.8,sequencevariant
"CRS‑T cells harbor a c.474delA SequenceVariant that generates a p.E300X premature stop codon, causing truncated TP53 protein and abolishing its tumor‑suppressor function in Homo sapiens.",-52.25,0.8,sequencevariant
"CRLF2 c.474delA results in a premature termination codon that causes loss of the downstream transcription factor-binding domain, thereby reducing CD74 expression and exacerbating the leukemic phenotype in infants with the Delta695-725 chromosomal translocation.",-67.5,0.8,sequencevariant
"CRTC1‑fusion with the BRD4 gene, a c.474delA sequence variant that generates a premature stop codon, was identified in a patient with refractory acute lymphoblastic leukemia and correlates with poor response to standard chemotherapy.",-53.0,0.8,sequencevariant
"Homozygous p.E300X in the TP53 gene was detected in a patient with a severe form of Fanconi anemia, correlating with the loss of p53 protein and increased genomic instability.",-37.0,0.8,sequencevariant
"Heterozygosity for the BRCA1 c.68_69delAG sequence variant causes a frameshift leading to a premature p.E300X truncation, which is strongly associated with increased breast cancer risk in individuals of European ancestry.",-35.0,0.8,sequencevariant
"HepG2 cells harboring the sequence variant c.474delA in the TP53 gene exhibit a pronounced reduction in p53 protein stability, leading to impaired DNA repair and heightened sensitivity to doxorubicin-induced apoptosis.",-29.75,0.8,sequencevariant
"HCT116 cells expressing the BRCA1 c.474delA sequence variant exhibited reduced DNA repair capacity and increased sensitivity to cisplatin, linking the deletion to impaired homologous recombination in this colorectal cancer model.",-39.25,0.8,sequencevariant
